PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Temmerman, M; Khosla, R; Laski, L; Mathews, Z; Say, L				Temmerman, Marleen; Khosla, Rajat; Laski, Laura; Mathews, Zoe; Say, Lale		Women Hlth Working Grp Global	Women's health priorities and interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPING-COUNTRIES; SYSTEMS; CARE		[Temmerman, Marleen; Khosla, Rajat; Say, Lale] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Laski, Laura] United Nations Populat Fund, Tech Div, Sexual & Reprod Hlth Branch, New York, NY USA; [Mathews, Zoe] Univ Southampton, Global Hlth & Social Stat, Southampton, Hants, England	World Health Organization; United Nations Population Fund; University of Southampton	Khosla, R (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	khoslar@who.int	Matthews, Zoe/HGD-0506-2022; , lalesay/AAG-1912-2021; Bhutta, Zulfiqar/L-7822-2015	Matthews, Zoe/0000-0003-1533-6618; Bhutta, Zulfiqar/0000-0003-0637-599X				AbouZahr C., 2013, ICPD 2014 EXP M WOM; Branca F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4173; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Centers for Disease Control and Prevention, 2012, SEX VIOL FACTS GLANC; Commission on Information and Accountability for Women's and Children's Health, 2011, COMM INF ACC WOM CHI; De los Angeles CP, 2014, J PUBLIC MENTAL HLTH, V13, P4; Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564; Germain A., 2013, INT C HUM RIGHTS; Haberland N, 2015, J ADOLESCENT HEALTH, V56, pS15, DOI 10.1016/j.jadohealth.2014.08.013; Independent Expert Review Group (iERG), 2013, EV WOM EV CHILD STRE; International Diabetes Federation, 2011, POL BRIEF DIAB PREGN; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; NCD Alliance, 2011, NONC DIS PRIOR WOM H; Nelson DE, 2013, AM J PUBLIC HEALTH, V103, P641, DOI 10.2105/AJPH.2012.301199; Save the Children, 2013, SURV 1 DAY STAT WORL; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Singh S, 2014, ADDING IT COSTS BENE; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; United Nations Inter-agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; United Nations Secretary-General, 2014, SUMM REP ASS STAT IM; Van Lerberghe W, 2014, LANCET, V384, P1215, DOI 10.1016/S0140-6736(14)60919-3; WHO Aga Khan University PMNCH, 2011, ESS INT COMM GUID RE; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization, 2012, SAF AB TECHN POL GUI, P90; World Health Organization, 2011, BREAST CANC PREV CON; World Health Organization, 2014, UPD WHO COMM END CHI; World Health Organization, 2010, WORK IND FAM COMM IM; World Health Organization, 2014, GLOB HLTH EST 2000 2; World Health Organization, 2005, DES HLTH FIN SYST RE; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization, 2012, WHO GLOB REP MORT AT; World Health Organization Department of Mental Health and Substance Dependence, 2009, GEND DISP MENT HLTH	40	33	33	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4147					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9LW	26371228				2022-12-28	WOS:000361678200003
J	Motzer, RJ; Escudier, B; McDermott, DF; George, S; Hammers, HJ; Srinivas, S; Tykodi, SS; Sosman, JA; Procopio, G; Plimack, ER; Castellano, D; Choueiri, TK; Gurney, H; Donskov, F; Bono, P; Wagstaff, J; Gauler, TC; Ueda, T; Tomita, Y; Schutz, FA; Kollmannsberger, C; Larkin, J; Ravaud, A; Simon, JS; Xu, LA; Waxman, IM; Sharma, P				Motzer, R. J.; Escudier, B.; McDermott, D. F.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Procopio, G.; Plimack, E. R.; Castellano, D.; Choueiri, T. K.; Gurney, H.; Donskov, F.; Bono, P.; Wagstaff, J.; Gauler, T. C.; Ueda, T.; Tomita, Y.; Schutz, F. A.; Kollmannsberger, C.; Larkin, J.; Ravaud, A.; Simon, J. S.; Xu, L-A; Waxman, I. M.; Sharma, P.		CheckMate 025 Investigators	Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-PROGRAMMED DEATH-1; PROGNOSTIC-FACTORS; SURVIVAL; CONFIDENCE; SAFETY; B7-H1	BACKGROUND Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated with encouraging overall survival in uncontrolled studies involving previously treated patients with advanced renal-cell carcinoma. This randomized, open-label, phase 3 study compared nivolumab with everolimus in patients with renal-cell carcinoma who had received previous treatment. METHODS A total of 821 patients with advanced clear-cell renal-cell carcinoma for which they had received previous treatment with one or two regimens of antiangiogenic therapy were randomly assigned (in a 1: 1 ratio) to receive 3 mg of nivolumab per kilogram of body weight intravenously every 2 weeks or a 10-mg everolimus tablet orally once daily. The primary end point was overall survival. The secondary end points included the objective response rate and safety. RESULTS The median overall survival was 25.0 months (95% confidence interval [CI], 21.8 to not estimable) with nivolumab and 19.6 months (95% CI, 17.6 to 23.1) with everolimus. The hazard ratio for death with nivolumab versus everolimus was 0.73 (98.5% CI, 0.57 to 0.93; P=0.002), which met the prespecified criterion for superiority (P <= 0.0148). The objective response rate was greater with nivolumab than with everolimus (25% vs. 5%; odds ratio, 5.98 [95% CI, 3.68 to 9.72]; P<0.001). The median progression-free survival was 4.6 months (95% CI, 3.7 to 5.4) with nivolumab and 4.4 months (95% CI, 3.7 to 5.5) with everolimus (hazard ratio, 0.88; 95% CI, 0.75 to 1.03; P=0.11). Grade 3 or 4 treatment-related adverse events occurred in 19% of the patients receiving nivolumab and in 37% of the patients receiving everolimus; the most common event with nivolumab was fatigue (in 2% of the patients), and the most common event with everolimus was anemia (in 8%). CONCLUSIONS Among patients with previously treated advanced renal-cell carcinoma, overall survival was longer and fewer grade 3 or 4 adverse events occurred with nivolumab than with everolimus.	[Motzer, R. J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [George, S.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Escudier, B.] Inst Gustave Roussy, Villejuif, France; [Ravaud, A.] Hop St Andre, Bordeaux Univ Hosp, Bordeaux, France; [McDermott, D. F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Choueiri, T. K.] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; [Choueiri, T. K.] Harvard Univ, Sch Med, Boston, MA USA; [Hammers, H. J.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Srinivas, S.] Stanford Canc Inst, Stanford, CA USA; [Tykodi, S. S.] Univ Washington, Seattle, WA 98195 USA; [Tykodi, S. S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Sosman, J. A.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Procopio, G.] Fdn Ist Nazl Tumori, Milan, Italy; [Plimack, E. R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Castellano, D.] Hosp Univ 12 Octubre, Madrid, Spain; [Gurney, H.] Westmead Hosp, Sydney, NSW, Australia; [Gurney, H.] Macquarie Univ, Sydney, NSW 2109, Australia; [Donskov, F.] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Bono, P.] Helsinki Univ Cent Hosp, Helsinki, Finland; [Bono, P.] Univ Helsinki, Helsinki, Finland; [Wagstaff, J.] South West Wales Canc Inst, Swansea, W Glam, Wales; [Wagstaff, J.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Larkin, J.] Royal Marsden Hosp, London SW3 6JJ, England; [Gauler, T. C.] Univ Duisburg Essen, Univ Hosp Essen, Duisburg, Germany; [Ueda, T.] Chiba Canc Ctr, Chiba 2608717, Japan; [Tomita, Y.] Niigata Univ, Niigata, Japan; [Schutz, F. A.] Hosp Sao Jose, Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil; [Kollmannsberger, C.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Simon, J. S.; Waxman, I. M.] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Xu, L-A] Bristol Myers Squibb Co, Hopewell, NJ USA; [Sharma, P.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; UNICANCER; Gustave Roussy; CHU Bordeaux; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Stanford Cancer Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Vanderbilt University; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fox Chase Cancer Center; Hospital Universitario 12 de Octubre; University of Sydney; Macquarie University; Aarhus University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Swansea University; Royal Marsden NHS Foundation Trust; University of Duisburg Essen; Chiba Cancer Center; Niigata University; British Columbia Cancer Agency; Bristol-Myers Squibb; Bristol-Myers Squibb; University of Texas System; UTMD Anderson Cancer Center	Motzer, RJ (corresponding author), Mem Hosp, Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	motzerr@mskcc.org	Recondo, Gonzalo/GNP-1009-2022; Gurney, Howard/ABF-6924-2020; Kimura, Go/Y-7843-2018; Gravis, Gwenaelle/CAG-3019-2022; Choueiri, Toni/K-5238-2019; Procopio, Giuseppe/K-2072-2016; Volovat, Constantin/N-6580-2013; Straume, Oddbjorn/C-2186-2017	Recondo, Gonzalo/0000-0002-4755-9325; Gurney, Howard/0000-0003-0217-5261; Kimura, Go/0000-0003-0088-9324; Gravis, Gwenaelle/0000-0002-3127-1554; Choueiri, Toni/0000-0002-9201-3217; Procopio, Giuseppe/0000-0002-2498-402X; Meiler, Jens/0000-0001-8945-193X; Donskov, Frede/0000-0002-8449-863X; Volovat, Constantin/0000-0003-1582-0135; OUDARD, Stephane/0000-0003-0893-285X; Wagstaff, John/0000-0002-1140-5981; Straume, Oddbjorn/0000-0001-8867-3645; Larkin, James/0000-0001-5569-9523; Ravaud, Alain/0000-0001-9455-6744; Motzer, Robert/0000-0001-6925-2327; George, Saby/0000-0002-0444-5870; McDermott, Ray/0000-0002-8952-4315	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by Bristol-Myers Squibb	[Anonymous], 2015, AF EV PRESCR INF; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Cella D, 2007, VALUE HEALTH, V10, P285, DOI 10.1111/j.1524-4733.2007.00183.x; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cogswell JP, CANC IMMUNOTHERAPY D; Dabney R, 2014, TARGET ONCOL, V9, P183, DOI 10.1007/s11523-013-0303-8; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2014, ANN ONCOL, V25, P49, DOI 10.1093/annonc/mdu259; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisher R, 2013, SEMIN CANCER BIOL, V23, P38, DOI 10.1016/j.semcancer.2012.06.004; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamid O, 2013, EXPERT OPIN BIOL TH, V13, P847, DOI 10.1517/14712598.2013.770836; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Koch G.G., 1990, STAT METHODOLOGY PHA, P391; Lee Sylvia, 2011, Cancers (Basel), V3, P3856, DOI 10.3390/cancers3043856; Li HR, 2015, J CLIN ONCOL, V33; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; National Cancer Institute, 2010, COMM TERM CRIT ADV E; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Paz-Ares L, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.18_suppl.lba109; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	32	3883	4013	7	187	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1803	1813		10.1056/NEJMoa1510665	http://dx.doi.org/10.1056/NEJMoa1510665			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26406148	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000364144000004
J	Broz, P				Broz, Petr			IMMUNOLOGY Caspase target drives pyroptosis	NATURE			English	Editorial Material							INFLAMMATORY CASPASES; ROCK-I; ACTIVATION; CLEAVAGE		Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Broz, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	petr.broz@unicas.ch	Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790				Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Ruge F, 2011, J INVEST DERMATOL, V131, P572, DOI 10.1038/jid.2010.379; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683	12	91	120	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					642	643		10.1038/nature15632	http://dx.doi.org/10.1038/nature15632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26375000				2022-12-28	WOS:000363832100031
J	Adamson, J; Hewitt, CE; Torgerson, DJ				Adamson, Joy; Hewitt, Catherine E.; Torgerson, David J.			Producing better evidence on how to improve randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESPONSE RATES; RECRUITMENT; PARTICIPANTS; CONDUCT; DESIGN		[Adamson, Joy; Hewitt, Catherine E.; Torgerson, David J.] Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England	University of York - UK	Torgerson, DJ (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England.	david.torgerson@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Hewitt, Catherine Elizabeth/0000-0002-0415-3536; Adamson, Joy/0000-0002-9860-0850				[Anonymous], 2011, SYNOPSIS VITAMIN D L; Brealey SD, 2007, J CLIN EPIDEMIOL, V60, P1046, DOI 10.1016/j.jclinepi.2007.04.003; Brueton Valerie C, 2013, Cochrane Database Syst Rev, pMR000032, DOI 10.1002/14651858.MR000032.pub2; Clark L, 2015, J CLIN EPIDEMIO 0127; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Donovan JL, 2003, J CLIN EPIDEMIOL, V56, P605, DOI 10.1016/S0895-4356(03)00083-0; Garner R, 2005, J CONSUM PSYCHOL, V15, P230, DOI 10.1207/s15327663jcp1503_8; Haynes LC, 2013, J POLICY ANAL MANAG, V32, P718, DOI 10.1002/pam.21717; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jennings CG, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0582-8; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Mitchell N, 2012, J CLIN EPIDEMIOL, V65, P1348, DOI 10.1016/j.jclinepi.2012.05.008; Pighills A, 2009, J CLIN EPIDEMIOL, V62, P1332, DOI 10.1016/j.jclinepi.2009.01.017; Rick J, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-407; Smith Valerie, 2013, J Evid Based Med, V6, P136, DOI 10.1111/jebm.12049; Tilbrook HE, 2015, J EVAL CLIN PRACT, V21, P202, DOI 10.1111/jep.12284; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; Treweek S, 2013, TRIALS S1, V14, P0121; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]	19	16	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2015	351								h4923	10.1136/bmj.h4923	http://dx.doi.org/10.1136/bmj.h4923			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GR	26408289				2022-12-28	WOS:000361960500002
J	Bellen, HJ; Yamamoto, S				Bellen, Hugo J.; Yamamoto, Shinya			Morgan's Legacy: Fruit Flies and the Functional Annotation of Conserved Genes	CELL			English	Editorial Material							DROSOPHILA-MELANOGASTER; MECHANISMS; RESOURCE; DISEASES	In 1915, "The Mechanism of Mendelian Heredity" was published by four prominent Drosophila geneticists. They discovered that genes form linkage groups on chromosomes inherited in a Mendelian fashion and laid the genetic foundation that promoted Drosophila as a model organism. Flies continue to offer great opportunities, including studies in the field of functional genomics.	[Bellen, Hugo J.; Yamamoto, Shinya] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Bellen, Hugo J.; Yamamoto, Shinya] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Bellen, Hugo J.; Yamamoto, Shinya] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Bellen, Hugo J.] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.edu	Yamamoto, Shinya/ABB-2837-2021	Yamamoto, Shinya/0000-0003-2172-8036; Bellen, Hugo/0000-0001-5992-5989	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM067858] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1915, SCIENCE; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; Jan YN, 2008, SCIENCE, V319, P45, DOI 10.1126/science.1154050; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Lupski JR, 1996, AM J HUM GENET, V58, P21; Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Perrimon N., 2014, METHODS DROSOPHILA, V68; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wangler MF, 2015, GENETICS, V199, P639, DOI 10.1534/genetics.114.171785; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002	14	58	58	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					12	14		10.1016/j.cell.2015.09.009	http://dx.doi.org/10.1016/j.cell.2015.09.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406362	Green Accepted, Bronze			2022-12-28	WOS:000361846500003
J	Linhoff, MW; Garg, SK; Mandel, G				Linhoff, Michael W.; Garg, Saurabh K.; Mandel, Gail			A High-Resolution Imaging Approach to Investigate Chromatin Architecture in Complex Tissues	CELL			English	Article							CPG-BINDING PROTEIN-2; INACTIVE X-CHROMOSOME; IN-SITU HYBRIDIZATION; RETT-SYNDROME; NUCLEAR COMPARTMENT; DNA METHYLATION; HUMAN GENOME; MECP2 BINDS; REVEALS; ORGANIZATION	We present ChromATin, a quantitative high-resolution imaging approach for investigating chromatin organization in complex tissues. This method combines analysis of epigenetic modifications by immunostaining, localization of specific DNA sequences by FISH, and high-resolution segregation of nuclear compartments using array tomography (AT) imaging. We then apply this approach to examine how the genome is organized in the mammalian brain using female Rett syndrome mice, which are a mosaic of normal and Mecp2-null cells. Side-by-side comparisons within the same field reveal distinct heterochromatin territories in wild-type neurons that are altered in Mecp2-null nuclei. Mutant neurons exhibit increased chromatin compaction and a striking redistribution of the H4K20me3 histone modification into pericentromeric heterochromatin, a territory occupied normally by MeCP2. These events are not observed in every neuronal cell type, highlighting ChromATin as a powerful in situ method for examining cell-type-specific differences in chromatin architecture in complex tissues.	[Linhoff, Michael W.; Garg, Saurabh K.; Mandel, Gail] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Garg, Saurabh K.; Mandel, Gail] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Mandel, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	mandelg@ohsu.edu		Phanwar-Wood, ibanri/0000-0003-0488-1370	Rett Syndrome Research Trust; NIH [HD056503, NS022518];  [MDA255543]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022518, P30NS061800] Funding Source: NIH RePORTER	Rett Syndrome Research Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ibanri Phanwar-Wood at the Stanford Cell Sciences Imaging Facility for exceptional sectioning, Peter Lansdorp at ERIBA for the major satellite PNA, Hiroshi Kimura at the Tokyo Institute of Technology for providing antibodies, Andrea Ansari for technical assistance, Lori Vaskalis for scientific illustration, and Aurelie Snyder in The Jungers Center Advanced Light Microscopy Core for Imaris instruction (P30 NS061800). M.W.L. thanks Kristina Micheva, Gordon Wang, Forrest Collman, and Brad Busse for advice on the array tomography procedure. Funding was provided generously by grants from Rett Syndrome Research Trust and NIH (HD056503 and NS022518) to G.M. M.W.L. received financial support from Fund for Science and MDA255543. G.M. is an Investigator of the Howard Hughes Medical Institute.	ADLER DA, 1995, MAMM GENOME, V6, P491, DOI 10.1007/BF00356163; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Falconer E, 2010, NATURE, V463, P93, DOI 10.1038/nature08644; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Matthiesen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040675; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Politz JCR, 2013, ANNU REV CELL DEV BI, V29, P241, DOI 10.1146/annurev-cellbio-101512-122317; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rego A, 2008, J CELL SCI, V121, P1119, DOI 10.1242/jcs.026104; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Song CD, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-17; Stuss DP, 2013, NUCLEIC ACIDS RES, V41, P4888, DOI 10.1093/nar/gkt213; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; WILSON WD, 1990, BIOCHEMISTRY-US, V29, P8452, DOI 10.1021/bi00488a036; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180	49	43	43	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					246	255		10.1016/j.cell.2015.09.002	http://dx.doi.org/10.1016/j.cell.2015.09.002			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406379	Bronze, Green Accepted			2022-12-28	WOS:000361846500035
J	Werner, A; Iwasaki, S; McGourty, CA; Medina-Ruiz, S; Teerikorpi, N; Fedrigo, I; Ingolia, NT; Rape, M				Werner, Achim; Iwasaki, Shintaro; McGourty, Colleen A.; Medina-Ruiz, Sofia; Teerikorpi, Nia; Fedrigo, Indro; Ingolia, Nicholas T.; Rape, Michael			Cell-fate determination by ubiquitin-dependent regulation of translation	NATURE			English	Article							TREACHER-COLLINS-SYNDROME; MAMMALIAN-CELLS; CYCLIN-E; GENE; MUTATIONS; INHIBITION; EXPRESSION; LIGASES	Metazoan development depends on the accurate execution of differentiation programs that allow pluripotent stem cells to adopt specific fates1. Differentiation requires changes to chromatin architecture and transcriptional networks, yet whether other regulatory events support cell-fate determination is less well understood. Here we identify the ubiquitin ligase CUL3 in complex with its vertebrate- specific substrate adaptor KBTBD8 (CUL3(KBTBD8)) as an essential regulator of human and Xenopus tropicalis neural crest specification. CUL3(KBTBD8) monoubiquitylates NOLC1 and its paralogue TCOF1, the mutation of which underlies the neurocristopathy Treacher Collins syndrome(2,3). Ubiquitylation drives formation of aTCOF1-NOLC1 platform that connects RNA polymerase I with ribosome modification enzymes and remodels the translational program of differentiating cells in favour of neural crest specification. We conclude that ubiquitin-dependent regulation of translation is an important feature of cell-fate determination.	[Werner, Achim; Teerikorpi, Nia; Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Werner, Achim; Iwasaki, Shintaro; McGourty, Colleen A.; Medina-Ruiz, Sofia; Teerikorpi, Nia; Fedrigo, Indro; Ingolia, Nicholas T.; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	mrape@berkeley.edu	Iwasaki, Shintaro/AAO-7743-2021	Iwasaki, Shintaro/0000-0001-7724-3754; Rape, Michael/0000-0003-4849-6343	California Institute of Regenerative Medicine; Human Frontier Science Fellowship; NSF graduate student fellowship; UC Mexus-Conacyt fellowship; NIH [GM42341, S10RR029668, S10RR027303, S10RR025622]; Basic Biology Award from the California Institute of Regenerative Medicine [RB-02222]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR025622, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE025314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341, R01GM083064] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Human Frontier Science Fellowship(Human Frontier Science Program); NSF graduate student fellowship(National Science Foundation (NSF)); UC Mexus-Conacyt fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Biology Award from the California Institute of Regenerative Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Harland, J. Schaletzky, R. Zoncu, J. Corn, A. Manford and E. Oh for advice and critical reading of the manuscript, and all members of the Rape and Ingolia laboratories for helpful discussions. A.W. was funded in part by a postdoctoral fellowship the California Institute of Regenerative Medicine; S.I. is supported by a Human Frontier Science Fellowship; C.A.M. was supported by an NSF graduate student fellowship; and S.M.-R. was supported by a UC Mexus-Conacyt fellowship and NIH GM42341. This work used the Vincent J. Coates Genomics Sequencing Laboratory and Proteomics/Mass Spectrometry Laboratory at UC Berkeley (NIH grants S10RR029668, S10RR027303 and S10RR025622). This work was funded by a Basic Biology Award from the California Institute of Regenerative Medicine to M.R. (RB-02222). M.R. is an investigator of the Howard Hughes Medical Institute.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; Dixon J, 1996, NAT GENET, V12, P130; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Freed EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002892; Gurdon JB, 2013, DEVELOPMENT, V140, P2449, DOI 10.1242/dev.097170; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Jiang BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037070; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sondalle SB, 2014, BBA-MOL BASIS DIS, V1842, P758, DOI 10.1016/j.bbadis.2013.11.004; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Voigt J, 2006, DEVELOPMENT, V133, P559, DOI 10.1242/dev.02201; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	36	108	112	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					523	+		10.1038/nature14978	http://dx.doi.org/10.1038/nature14978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399832	Green Accepted, Green Submitted			2022-12-28	WOS:000361599900051
J	Yang, BX; El Farran, CA; Guo, HC; Yu, T; Fang, HT; Wang, HF; Schlesinger, S; Seah, YFS; Goh, GYL; Neo, SP; Li, YH; Lorincz, MC; Tergaonkar, V; Lim, TM; Chen, LY; Gunaratne, J; Collins, JJ; Goff, SP; Daley, GQ; Li, H; Bard, FA; Loh, YH				Yang, Bin Xia; El Farran, Chadi A.; Guo, Hong Chao; Yu, Tao; Fang, Hai Tong; Wang, Hao Fei; Schlesinger, Sharon; Seah, Yu Fen Samantha; Goh, Germaine Yen Lin; Neo, Suat Peng; Li, Yinghui; Lorincz, Matthew C.; Tergaonkar, Vinay; Lim, Tit-Meng; Chen, Lingyi; Gunaratne, Jayantha; Collins, James J.; Goff, Stephen P.; Daley, George Q.; Li, Hu; Bard, Frederic A.; Loh, Yuin-Han			Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells	CELL			English	Article							PRIMER-BINDING SITE; MURINE LEUKEMIA-VIRUS; LONG TERMINAL REPEAT; ENDOGENOUS RETROVIRUSES; DEPENDENT RESTRICTION; DNA-REPLICATION; HISTONE H3.3; HP1; METHYLATION; EXPRESSION	Embryonic stem cells (ESCs) repress the expression of exogenous proviruses and endogenous retroviruses (ERVs). Here, we systematically dissected the cellular factors involved in provirus repression in embryonic carcinomas (ECs) and ESCs by a genome-wide siRNA screen. Histone chaperones (Chaf1a/b), sumoylation factors (Sumo2/Ube2i/Sae1/Uba2/Senp6), and chromatin modifiers (Trim28/Eset/At-f7ip) are key determinants that establish provirus silencing. RNA-seq analysis uncovered the roles of Chaf1a/b and sumoylation modifiers in the repression of ERVs. ChIP-seq analysis demonstrates direct recruitment of Chaf1a and Sumo2 to ERVs. Chaf1a reinforces transcriptional repression via its interaction with members of the NuRD complex (Kdm1a, Hdac1/2) and Eset, while Sumo2 orchestrates the provirus repressive function of the canonical Zfp809/Trim28/Eset machinery by sumoylation of Trim28. Our study reports a genome-wide atlas of functional nodes that mediate proviral silencing in ESCs and illuminates the comprehensive, interconnected, and multi-layered genetic and epigenetic mechanisms by which ESCs repress retroviruses within the genome.	[Yang, Bin Xia; El Farran, Chadi A.; Yu, Tao; Fang, Hai Tong; Wang, Hao Fei; Seah, Yu Fen Samantha; Loh, Yuin-Han] A STAR Inst Mol & Cell Biol, Epigenet & Cell Fates Lab, Singapore 138673, Singapore; [El Farran, Chadi A.; Yu, Tao; Wang, Hao Fei; Lim, Tit-Meng; Loh, Yuin-Han] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Guo, Hong Chao; Chen, Lingyi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Schlesinger, Sharon; Goff, Stephen P.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Schlesinger, Sharon; Goff, Stephen P.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Goh, Germaine Yen Lin; Bard, Frederic A.] A STAR Inst Mol & Cell Biol, Membrane Traff Lab, Singapore 138673, Singapore; [Neo, Suat Peng; Gunaratne, Jayantha] A STAR Inst Mol & Cell Biol, Quantitat Prote Grp, Singapore 138673, Singapore; [Gunaratne, Jayantha] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Li, Yinghui; Tergaonkar, Vinay] A STAR Inst Mol & Cell Biol, Lab NF KB Signaling, Div Canc Genet & Therapeut, Singapore 138673, Singapore; [Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Collins, James J.] MIT, Inst Med Engn & Sci, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Collins, James J.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Goff, Stephen P.] Howard Hughes Med Inst, New York, NY 10032 USA; [Daley, George Q.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Li, Hu] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Ctr Individualized Med, Rochester, MN 55905 USA; [Tergaonkar, Vinay; Bard, Frederic A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Nankai University; Columbia University; Columbia University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of British Columbia; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; National University of Singapore	Loh, YH (corresponding author), A STAR Inst Mol & Cell Biol, Epigenet & Cell Fates Lab, 61 Biopolis Dr Proteos, Singapore 138673, Singapore.	yhloh@imcb.a-star.edu.sg	Farran, Chadi A. El/AAG-1439-2020; Guo, Hongchao/AAM-4717-2020; Guo, Hongchao/AAG-8981-2020; Li, Yinghui/K-8253-2018; Schlesinger, Sharon/A-5283-2016; Goff, Stephen P/K-6337-2014; Loh, Yuin-Han/E-1096-2014; Bard, Frederic Andre Jean/G-9914-2011	Farran, Chadi A. El/0000-0002-9374-103X; Guo, Hongchao/0000-0002-8884-7358; Schlesinger, Sharon/0000-0001-9549-2383; Goff, Stephen P/0000-0003-0693-5547; Seah, Samantha/0000-0002-8589-8459; Loh, Yuin-Han/0000-0002-4715-6454; WANG, HAOFEI/0000-0001-8914-442X; Lorincz, Matthew/0000-0003-0885-0467; Li, Yinghui/0000-0002-9023-9466; Bard, Frederic Andre Jean/0000-0002-3783-4805; Yu, Tao/0000-0002-7753-7741	Mayo Clinic Center for Individualized Medicine; NIH [R01 CA30488]; A*Star Investigatorship research award; Biomedical Research Council, Agency for Science, Technology and Research, Singapore; NATIONAL CANCER INSTITUTE [R01CA030488, R37CA030488] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*Star Investigatorship research award(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council, Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Yang Lin for helpful discussion. We thank Wong Chee Wai for technical assistance. H.L. is supported by Mayo Clinic Center for Individualized Medicine. S.P.G. is supported by NIH grant R01 CA30488. Y.-H.L. is supported by the A*Star Investigatorship research award. We are grateful to the Biomedical Research Council, Agency for Science, Technology and Research, Singapore for research funding.	Agarwal S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7002; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; Friedli M, 2014, GENOME RES, V24, P1251, DOI 10.1101/gr.172809.114; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kumar P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-290; Leung DC, 2011, P NATL ACAD SCI USA, V108, P5718, DOI 10.1073/pnas.1014660108; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maksakova IA, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-15; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Maxwell PH, 2007, EUKARYOT CELL, V6, P1069, DOI 10.1128/EC.00092-07; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; PETERSEN R, 1991, MOL CELL BIOL, V11, P1214, DOI 10.1128/MCB.11.3.1214; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; Reichmann J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002486; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Schlesinger S, 2013, EMBO REP, V14, P73, DOI 10.1038/embor.2012.182; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shoemaker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-460; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang GZ, 2014, J VIROL, V88, P1825, DOI 10.1128/JVI.02578-13; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	57	118	122	5	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					230	245		10.1016/j.cell.2015.08.037	http://dx.doi.org/10.1016/j.cell.2015.08.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26365490	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000361846500034
J	Zeng, WW; Pirzgalska, RM; Pereira, MMA; Kubasova, N; Barateiro, A; Seixas, E; Lu, YH; Kozlova, A; Voss, H; Martins, GG; Friedman, JM; Domingos, AI				Zeng, Wenwen; Pirzgalska, Roksana M.; Pereira, Mafalda M. A.; Kubasova, Nadiya; Barateiro, Andreia; Seixas, Elsa; Lu, Yi-Hsueh; Kozlova, Albina; Voss, Henning; Martins, Gabriel G.; Friedman, Jeffrey M.; Domingos, Ana I.			Sympathetic Neuro-adipose Connections Mediate Leptin-Driven Lipolysis	CELL			English	Article							PHYSIOLOGICAL-RESPONSE; INSULIN-RESISTANCE; WHITE FAT; TISSUE; INNERVATION; MICE; THERMOGENESIS; STARVATION; GENE; STIMULATION	Leptin is a hormone produced by the adipose tissue that acts in the brain, stimulating white fat breakdown. We find that the lipolytic effect of leptin is mediated through the action of sympathetic nerve fibers that innervate the adipose tissue. Using intravital two-photon microscopy, we observe that sympathetic nerve fibers establish neuro-adipose junctions, directly "enveloping'' adipocytes. Local optogenetic stimulation of sympathetic inputs induces a local lipolytic response and depletion of white adipose mass. Conversely, genetic ablation of sympathetic inputs onto fat pads blocks leptin-stimulated phosphorylation of hormone-sensitive lipase and consequent lipolysis, as do knockouts of dopamine beta-hydroxylase, an enzyme required for catecholamine synthesis. Thus, neuro-adipose junctions are necessary and sufficient for the induction of lipolysis in white adipose tissue and are an efferent effector of leptin action. Direct activation of sympathetic inputs to adipose tissues may represent an alternative approach to induce fat loss, circumventing central leptin resistance.	[Pirzgalska, Roksana M.; Pereira, Mafalda M. A.; Kubasova, Nadiya; Barateiro, Andreia; Seixas, Elsa; Domingos, Ana I.] Inst Gulbenkian Ciencias, Obes Lab, P-2780156 Oeiras, Portugal; [Zeng, Wenwen; Lu, Yi-Hsueh; Kozlova, Albina; Friedman, Jeffrey M.] Rockefeller Univ, Lab Mol Genet, New York, NY 10021 USA; [Zeng, Wenwen; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Martins, Gabriel G.] Inst Gulbenkian Ciencias, Adv Microscopy Unit, P-2780156 Oeiras, Portugal; [Voss, Henning] Weill Cornell Med Coll, Dept Radiol, New York, NY 10021 USA; [Barateiro, Andreia] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, P-1649003 Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Instituto Gulbenkian de Ciencia; Cornell University; Universidade de Lisboa	Domingos, AI (corresponding author), Inst Gulbenkian Ciencias, Obes Lab, P-2780156 Oeiras, Portugal.	dominan@igc.gulbenkian.pt	iMed.ULisboa, NeuronGliaBiol/B-5403-2014; Martins, Gabriel G/AAG-4074-2020; Voss, Henning/C-2194-2009; Barateiro, Andreia/AAE-1711-2021; Zeng, Wenwen/D-7276-2017; Pirzgalska, Roksana/AAM-3922-2020; Barateiro, Andreia/I-5746-2014; Martins, Gabriel G/A-1538-2012	Martins, Gabriel G/0000-0002-6506-9776; Voss, Henning/0000-0003-2811-2074; Zeng, Wenwen/0000-0001-8544-3318; Pirzgalska, Roksana/0000-0003-2314-0439; Barateiro, Andreia/0000-0002-0378-4854; Martins, Gabriel G/0000-0002-6506-9776; Kubasova, Nadiya/0000-0003-0063-1825; Domingos, Ana/0000-0002-7938-4814; Seixas, Elsa/0000-0003-2819-2051	Fundacao para a Ciencia e Tecnologia (FCT); European Molecular Biology Organization (EMBO); JPB Foundation; FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); JPB Foundation; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT), the European Molecular Biology Organization (EMBO), and the JPB Foundation. The FCT supported A.I.D., R.M.P., M.M.A.P., N.K., G.G.M., A.B., and E.S. The JPB Foundation supported the work of W.Z., Y.H.L., and A.K. J.M.F. is a Howard Hughes Medical Institute (HHMI) investigator.	Arvaniti K, 1998, AM J PHYSIOL-REG I, V275, pR105, DOI 10.1152/ajpregu.1998.275.1.R105; Awad S, 2009, CLIN NUTR, V28, P497, DOI 10.1016/j.clnu.2009.04.014; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CORRELL JW, 1963, SCIENCE, V140, P387, DOI 10.1126/science.140.3565.387; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Domingos AI, 2013, ELIFE, V2, DOI 10.7554/eLife.01462; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Elia M, 1999, OBES RES, V7, P597, DOI 10.1002/j.1550-8528.1999.tb00720.x; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Gualda EJ, 2013, NAT METHODS, V10, P599, DOI 10.1038/nmeth.2508; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HOLZER P, 1991, PHARMACOL REV, V43, P143; Koffler M, 1996, J DIABETES COMPLICAT, V10, P109, DOI 10.1016/1056-8727(94)00077-8; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; Montez JM, 2005, P NATL ACAD SCI USA, V102, P2537, DOI 10.1073/pnas.0409530102; NEWMAN WP, 1983, METABOLISM, V32, P590, DOI 10.1016/0026-0495(83)90029-X; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P586, DOI 10.1101/pdb.top116; Rafael J, 2000, AM J PHYSIOL-REG I, V278, pR790, DOI 10.1152/ajpregu.2000.278.3.R790; Rezai-Zadeh K, 2013, PHYSIOL BEHAV, V121, P49, DOI 10.1016/j.physbeh.2013.02.014; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tavernier G, 2005, MOL PHARMACOL, V68, P793, DOI 10.1124/mol.105.014670; THOMPSON GE, 1986, Q J EXP PHYSIOL CMS, V71, P559, DOI 10.1113/expphysiol.1986.sp003016; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; YOUNGSTROM TG, 1995, AM J PHYSIOL-REG I, V268, pR744, DOI 10.1152/ajpregu.1995.268.3.R744	40	261	277	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					84	94		10.1016/j.cell.2015.08.055	http://dx.doi.org/10.1016/j.cell.2015.08.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406372	Green Submitted, Bronze			2022-12-28	WOS:000361846500023
J	Hayashi-Takagi, A; Yagishita, S; Nakamura, M; Shirai, F; Wu, YI; Loshbaugh, AL; Kuhlman, B; Hahn, KM; Kasai, H				Hayashi-Takagi, Akiko; Yagishita, Sho; Nakamura, Mayumi; Shirai, Fukutoshi; Wu, Yi I.; Loshbaugh, Amanda L.; Kuhlman, Brian; Hahn, Klaus M.; Kasai, Haruo			Labelling and optical erasure of synaptic memory traces in the motor cortex	NATURE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; IN-VIVO; MESSENGER-RNA; OPTOGENETIC STIMULATION; PROTEIN-SYNTHESIS; NEURAL CIRCUITS; LEARNING RULES; PLASTICITY; NEURONS	Dendritic spines are the major loci of synaptic plasticity and are considered as possible structural correlates of memory. Nonetheless, systematic manipulation of specific subsets of spines in the cortex has been unattainable, and thus, the link between spines and memory has been correlational. We developed a novel synaptic optoprobe, AS-PaRac1 (activated synapse targeting photoactivatable Rac1), that can label recently potentiated spines specifically, and induce the selective shrinkage of AS-PaRac1-containing spines. In vivo imaging of AS-PaRac1 revealed that a motor learning task induced substantial synaptic remodelling in a small subset of neurons. The acquired motor learning was disrupted by the optical shrinkage of the potentiated spines, whereas it was not affected by the identical manipulation of spines evoked by a distinct motor task in the same cortical region. Taken together, our results demonstrate that a newly acquired motor skill depends on the formation of a task-specific dense synaptic ensemble.	[Hayashi-Takagi, Akiko; Yagishita, Sho; Nakamura, Mayumi; Shirai, Fukutoshi; Kasai, Haruo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 1130033, Japan; [Hayashi-Takagi, Akiko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yagishita, Sho; Kasai, Haruo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Wu, Yi I.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06032 USA; [Loshbaugh, Amanda L.; Kuhlman, Brian; Hahn, Klaus M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Loshbaugh, Amanda L.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hayashi-Takagi, A (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 1130033, Japan.	hayashi888@m.u-tokyo.ac.jp; hkasai@m.u-tokyo.ac.jp	Yagishita, Sho/HII-4239-2022; Yagishita, Sho/Y-6908-2019	Yagishita, Sho/0000-0003-2854-773X; Yagishita, Sho/0000-0003-2854-773X; Kasai, Haruo/0000-0003-2327-9027; Hahn, Klaus/0000-0002-1970-7562	Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Japan) [2000009, 26221011, 23689055, 24116003]; PRESTO program (JST); brain/MIND from Japan Agency for Medical Research and Development (AMED); SICP from Japan Agency for Medical Research and Development (AMED); National Institutes of Health [GM102924, NS071216]; Human Frontier Science Program; Grants-in-Aid for Scientific Research [24116003] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036877] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO program (JST)(Japan Science & Technology Agency (JST)); brain/MIND from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); SICP from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Bito and H. Okuno for the generous gift of the Arc promoter; F. Murakami for the information about Arc 39 UTR; M. Yuzaki, K. Inokuchi, and K. Fox for discussions. This research was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Japan; No. 2000009 to H. K. and No. 26221011 to H. K. and A.H.-T., No. 23689055 and No. 24116003 to A.H.-T.), the PRESTO program (JST) to A. H-T., the brain/MIND and SICP projects from Japan Agency for Medical Research and Development (AMED) to H.K., the National Institutes of Health grant GM102924 to K. M. H., NS071216 to Y.I.W. and the Research Grant from the Human Frontier Science Program to H. K., K. M. H. and B.K.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kasai H, 2010, EUR J NEUROSCI, V32, P241, DOI 10.1111/j.1460-9568.2010.07344.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kobayashi H, 2005, EUR J NEUROSCI, V22, P2977, DOI 10.1111/j.1460-9568.2005.04508.x; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Ren M, 2014, J NEUROSCI, V34, P6583, DOI 10.1523/JNEUROSCI.0167-14.2014; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zhang Y, 2015, NAT NEUROSCI, V18, P402, DOI 10.1038/nn.3936	50	364	370	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					333	+		10.1038/nature15257	http://dx.doi.org/10.1038/nature15257			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26352471	Green Accepted, Green Submitted			2022-12-28	WOS:000361297900034
J	Le Noury, J; Nardo, JM; Healy, D; Jureidini, J; Raven, M; Tufanaru, C; Abi-Jaoude, E				Le Noury, Joanna; Nardo, John M.; Healy, David; Jureidini, Jon; Raven, Melissa; Tufanaru, Catalin; Abi-Jaoude, Elia			Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS	OBJECTIVES To reanalyse SmithKline Beecham's Study 329 (published by Keller and colleagues in 2001), the primary objective of which was to compare the efficacy and safety of paroxetine and imipramine with placebo in the treatment of adolescents with unipolar major depression. The reanalysis under the restoring invisible and abandoned trials (RIAT) initiative was done to see whether access to and reanalysis of a full dataset from a randomised controlled trial would have clinically relevant implications for evidence based medicine. DESIGN Double blind randomised placebo controlled trial. SETTING 12 North American academic psychiatry centres, from 20 April 1994 to 15 February 1998. PARTICIPANTS 275 adolescents with major depression of at least eight weeks in duration. Exclusion criteria included a range of comorbid psychiatric and medical disorders and suicidality. INTERVENTIONS Participants were randomised to eight weeks double blind treatment with paroxetine (20-40 mg), imipramine (200-300 mg), or placebo. MAIN OUTCOME MEASURES The prespecified primary efficacy variables were change from baseline to the end of the eight week acute treatment phase in total Hamilton depression scale (HAM-D) score and the proportion of responders (HAM-D score <= 8 or >= 50% reduction in baseline HAM-D) at acute endpoint. Prespecified secondary outcomes were changes from baseline to endpoint in depression items in K-SADS-L, clinical global impression, autonomous functioning checklist, self-perception profile, and sickness impact scale; predictors of response; and number of patients who relapse during the maintenance phase. Adverse experiences were to be compared primarily by using descriptive statistics. No coding dictionary was prespecified. RESULTS The efficacy of paroxetine and imipramine was not statistically or clinically significantly different from placebo for any prespecified primary or secondary efficacy outcome. HAM-D scores decreased by 10.7 (least squares mean) (95% confidence interval 9.1 to 12.3), 9.0 (7.4 to 10.5), and 9.1 (7.5 to 10.7) points, respectively, for the paroxetine, imipramine and placebo groups (P=0.20). There were clinically significant increases in harms, including suicidal ideation and behaviour and other serious adverse events in the paroxetine group and cardiovascular problems in the imipramine group. CONCLUSIONS Neither paroxetine nor high dose imipramine showed efficacy for major depression in adolescents, and there was an increase in harms with both drugs. Access to primary data from trials has important implications for both clinical practice and research, including that published conclusions about efficacy and safety should not be read as authoritative. The reanalysis of Study 329 illustrates the necessity of making primary trial data and protocols available to increase the rigour of the evidence base.	[Le Noury, Joanna; Healy, David] Bangor Univ, Sch Med Sci, Bangor, Gwynedd, Wales; [Nardo, John M.] Emory Univ, Atlanta, GA USA; [Jureidini, Jon; Raven, Melissa] Univ Adelaide, Robinson Res Inst, Crit & Eth Mental Hlth Res Grp, Adelaide, SA, Australia; [Tufanaru, Catalin] Univ Adelaide, Fac Hlth Sci, Joanna Briggs Inst, Adelaide, SA, Australia; [Abi-Jaoude, Elia] Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada	Bangor University; Emory University; Robinson Research Institute; University of Adelaide; University of Adelaide; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Jureidini, J (corresponding author), Univ Adelaide, Robinson Res Inst, Crit & Eth Mental Hlth Res Grp, Adelaide, SA, Australia.	Jon.Jureidini@adelaide.edu.au	Jureidini, Jon/AFS-5457-2022; Tufanaru, Catalin/M-3104-2017; Raven, Melissa/R-6620-2017	Tufanaru, Catalin/0000-0002-3457-8770; Raven, Melissa/0000-0002-8781-6031	Baum, Hedlund, Aristei and Goldman, Los Angeles, CA	Baum, Hedlund, Aristei and Goldman, Los Angeles, CA	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: DH has been and is an expert witness for plaintiffs in legal cases involving GlaxoSmithKline's drug paroxetine. He is also a witness for plaintiffs in actions involving other antidepressants with the same mechanism of action as paroxetine, and is on the advisory board of the Foundation for Excellence in Mental Health Care. DH and JLN are founder members of RxISK. JJ has been paid by Baum, Hedlund, Aristei and Goldman, Los Angeles, CA, to provide expert analysis and opinion about documents obtained from GlaxoSmithKline in a class action over Study 329, and from Forest in relation to paediatric citalopram randomised controlled trials. Some of the authors are in discussions with an academic publisher regarding adapting the case of Study 329 as a book for educational purposes.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; [Anonymous], 2010, HLTH SKEPTICISM INT; Brecher M., 1991, REV EVALUATION CLIN; Correspondence between Jureidini and GSK, 2013, BMJ-BRIT MED J, V347, pf6754; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Ebrahim S, 2014, JAMA-J AM MED ASSOC, V312, P1024, DOI 10.1001/jama.2014.9646; Fava M, 2006, J CLIN PSYCHIAT, V67, P14; FAWCETT J, 1987, PSYCHOPHARMACOL BULL, V23, P309; FITZGERALD K, 1995, HUM PSYCHOPHARM CLIN, V10, P215, DOI 10.1002/hup.470100308; GlaxoSmithKline, PAR PAED AD PAT; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hughes S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005535; Jureidini JN, 2014, BMJ-BRIT MED J, V349, pg4353; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Jureidini JN, 2011, ACCOUNT RES, V18, P45, DOI 10.1080/08989621.2011.542683; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kline R.B., 2013, SIGNIFICANCE TESTING; Kraus JE, 2013, COMMUNICATION; LEWINSOHN PM, 1994, J AM ACAD CHILD PSY, V33, P809, DOI 10.1097/00004583-199407000-00006; Maund E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3510; McHenry LB, 2008, ACCOUNT RES, V15, P152, DOI 10.1080/08989620802194384; R Core Team, R LANG ENV STAT COMP; Sigafoos A D, 1988, Adolesc Psychiatry, V15, P432; SmithKline Beecham, MULT DOUBL BLIND PLA; Treasure T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004385; Winter C, 2011, MEDDRA CLIN TRIALS I	26	145	147	0	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4320	10.1136/bmj.h4320	http://dx.doi.org/10.1136/bmj.h4320			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26376805	Green Published, hybrid			2022-12-28	WOS:000361678800002
J	Relman, DA				Relman, David A.			The Human Microbiome and the Future Practice of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), VA Palo Alto Hlth Care Syst 154T, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354				Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005	8	48	50	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1127	1128		10.1001/jama.2015.10700	http://dx.doi.org/10.1001/jama.2015.10700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372576				2022-12-28	WOS:000361284500018
J	Branca, F; Piwoz, E; Schultink, W; Sullivan, LM				Branca, Francesco; Piwoz, Ellen; Schultink, Werner; Sullivan, Lucy Martinez			Nutrition and health in women, children, and adolescent girls	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Branca, Francesco] WHO, Dept Nutr Hlth & Dev, CH-1211 Geneva 27, Switzerland; [Piwoz, Ellen] Bill & Melinda Gates Fdn, Seattle, WA USA; [Schultink, Werner] Unicef, Nutr, New York, NY USA; [Sullivan, Lucy Martinez] 1000 Days, Washington, DC USA	World Health Organization; Bill & Melinda Gates Foundation; UNICEF	Branca, F (corresponding author), WHO, Dept Nutr Hlth & Dev, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	brancaf@who.int						Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Hoddinott J., 2015, SCN News, P59; Hoddinott J, 2013, GCC WORKING PAPER SE, P13; International Bank for Reconstruction and Development World Bank, 2006, REP NUTR CENTR DEV S; International Food Policy Research Institute, 2014, GLOB NUTR REP 2014 A; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Second International Conference on Nutrition, 2014, 2 INT C NUTR C OUTC; Second International Conference on Nutrition, 2014, 2 INT C NUTR INF NOT; United Nations, 2014, MILL DEV GOALS REP 2; United Nations, 2015, ADD AB ACT AG 3 INT; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; World Health Organization, 2010, Global recommendations on physical activity for health; World Health . Organization, 2013, GUID CALC SUPPL PREG; World Health Organization, 2015, NUTR COUNS AD AD HIV; World Health Organization, 2014, WHA GLOB NUTR TARG 2; World Health Organization, 2014, COMPR IMPL PLAN MAT; World Health Organization, 2013, ESS NUTR ACT IMPR MA	18	53	57	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4173					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371218	hybrid			2022-12-28	WOS:000361678200006
J	Were, WM; Daelmans, B; Bhutta, ZA; Duke, T; Bahl, R; Boschi-Pinto, C; Young, M; Starbuck, E; Bhan, MK				Were, Wilson M.; Daelmans, Bernadette; Bhutta, Zulfiqar A.; Duke, Trevor; Bahl, Rajiv; Boschi-Pinto, Cynthia; Young, Mark; Starbuck, Eric; Bhan, Maharaj K.			Children's health priorities and interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MIDDLE-INCOME COUNTRIES; INTEGRATION; IMPLEMENTATION; EXPERIENCE; SETTINGS; QUALITY; PROGRAM; SYSTEMS; WORKERS; INFANT		[Were, Wilson M.] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Child Hlth Serv, CH-1211 Geneva, Switzerland; [Daelmans, Bernadette] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Policy Planning & Programme, CH-1211 Geneva, Switzerland; [Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Res & Dev, CH-1211 Geneva, Switzerland; [Boschi-Pinto, Cynthia] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Child Epidemiol, CH-1211 Geneva, Switzerland; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Duke, Trevor] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Paediat, Melbourne, Vic, Australia; [Duke, Trevor] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Young, Mark] United Nations Children Fund UNICEF, Hlth Sect, Child Hlth Unit, New York, NY USA; [Starbuck, Eric] Save Children, Dept Global Hlth, Child Hlth & Pandem Preparedness, Fairfield, CT USA; [Bhan, Maharaj K.] Indian Inst Technol, New Delhi, India	World Health Organization; World Health Organization; World Health Organization; World Health Organization; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; University of Melbourne; University of Melbourne; UNICEF; Save the Children; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Were, WM (corresponding author), WHO, Dept Maternal Newborn Child & Adolescent Hlth, Child Hlth Serv, CH-1211 Geneva, Switzerland.	werew@who.int	Pinto, Cynthia Boschi/AAA-6990-2020	Pinto, Cynthia Boschi/0000-0002-0069-7974				Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; [Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], UN HLTH COV; Atun R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-780; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Gill CJ, 2013, LANCET, V381, P1487, DOI 10.1016/S0140-6736(13)60314-1; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Gounder CR, 2012, TROP MED INT HEALTH, V17, P1426, DOI 10.1111/j.1365-3156.2012.03100.x; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Kendrick D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006020.pub3; Lalonde AB, 2010, J OBSTET GYNAECOL CA, V32, P1130, DOI 10.1016/S1701-2163(16)34734-X; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S5; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S4; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S2; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Marmot Michael, 2009, Glob Health Promot, VSuppl 1, P23, DOI 10.1177/1757975909103742; McGuire S, 2015, ADV NUTR, V6, P134, DOI 10.3945/an.114.007781; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Partapuri T, 2012, J INFECT DIS, V205, pS20, DOI 10.1093/infdis/jir771; Partnership for Maternal Newborn and Child Health, 2015, REP FEEDB CONS DRAFT; Peden M., 2008, World report on child injury prevention; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Thury Chad, 2015, S D Med, VSpec No, P18; UNICEF, 2020, LEV TRENDS CHILD MOR; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; WHO, 2013, COMP WHO REC MAT NEW; WHO Aga Khan University PMNCH, 2011, ESS INT COMM GUID RE; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Health Organization, 2015, GOLB TECHN STRAT MAL; World Health Organization, GLOB HLTH OBS GHO DA; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2015, INT REP COMM END CHI; World Health Organization, 2013, END PREV DEATHS PNEU; World Health Organization, 2014, EV NEWB ACT PLAN END; Yuan BB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-634	42	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4300					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371225	hybrid			2022-12-28	WOS:000361678200013
J	Cabot, RC				Cabot, Richard C.			Women in Medicine (Reprinted from JAMA vol 65, pg 947-948, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		CABOT RC, 1915, JAMA-J AM MED ASSOC, V65, P947	1	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1076	1076		10.1001/jama.2014.11972	http://dx.doi.org/10.1001/jama.2014.11972			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348764				2022-12-28	WOS:000360840700026
J	Livingston, G; Frankish, H				Livingston, Gill; Frankish, Helen			A global perspective on dementia care: a Lancet Commission	LANCET			English	Editorial Material							ALZHEIMER-DISEASE; LASER-AD; CAREGIVERS; PEOPLE		[Livingston, Gill] UCL, Div Psychiat, London W1T 7NF, England; [Frankish, Helen] The Lancet, London, England	University of London; University College London	Livingston, G (corresponding author), UCL, Div Psychiat, London W1T 7NF, England.	g.livingston@ucl.ac.uk		Livingston, Gill/0000-0001-6741-5516				Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Gallagher D, 2011, AM J ALZHEIMERS DIS, V26, P205, DOI 10.1177/1533317511400307; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Lincoln P, 2014, LANCET, V383, P1805, DOI 10.1016/S0140-6736(14)60758-3; Livingston G, 2014, BRIT J PSYCHIAT, V205, P436, DOI 10.1192/bjp.bp.113.141119; Livingston G, 2014, LANCET PSYCHIAT, V1, P539, DOI 10.1016/S2215-0366(14)00073-X; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Prince M, 2015, WORLD ALZHEIMERS REP; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976	12	15	15	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					933	934		10.1016/S0140-6736(15)00078-1	http://dx.doi.org/10.1016/S0140-6736(15)00078-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR2TE	26369450				2022-12-28	WOS:000361182700004
J	Mimoz, O; Lucet, JC; Kerforne, T; Pascal, J; Souweine, B; Goudet, V; Mercat, A; Bouadma, L; Lasocki, S; Alfandari, S; Friggeri, A; Wallet, F; Allou, N; Ruckly, S; Balayn, D; Lepape, A; Timsit, JF				Mimoz, Olivier; Lucet, Jean-Christophe; Kerforne, Thomas; Pascal, Julien; Souweine, Bertrand; Goudet, Veronique; Mercat, Alain; Bouadma, Lila; Lasocki, Sigismond; Alfandari, Serge; Friggeri, Arnaud; Wallet, Florent; Allou, Nicolas; Ruckly, Stephane; Balayn, Dorothee; Lepape, Alain; Timsit, Jean-Francois		CLEAN Trial Investigators	Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial	LANCET			English	Article							CRITICALLY-ILL ADULTS; INTENSIVE-CARE-UNIT; IMPREGNATED SPONGES; BLOOD; COLONIZATION; GUIDELINES; DIAGNOSIS; CULTURES	Background Intravascular-catheter-related infections are frequent life-threatening events in health care, but incidence can be decreased by improvements in the quality of care. Optimisation of skin antisepsis is essential to prevent short-term catheter-related infections. We hypothesised that chlorhexidine-alcohol would be more effective than povidone iodine-alcohol as a skin antiseptic to prevent intravascular-catheter-related infections. Methods In this open-label, randomised controlled trial with a two-by-two factorial design, we enrolled consecutive adults (age >= 18 years) admitted to one of 11 French intensive-care units and requiring at least one of central-venous, haemodialysis, or arterial catheters. Before catheter insertion, we randomly assigned (1:1:1:1) patients via a secure web-based random-number generator (permuted blocks of eight, stratified by centre) to have all intravascular catheters prepared with 2% chlorhexidine-70% isopropyl alcohol (chlorhexidine-alcohol) or 5% povidone iodine-69% ethanol (povidone iodine-alcohol), with or without scrubbing of the skin with detergent before antiseptic application. Physicians and nurses were not masked to group assignment but microbiologists and outcome assessors were. The primary outcome was the incidence of catheter-related infections with chlorhexidine-alcohol versus povidone iodine-alcohol in the intention-totreat population. This study is registered with ClinicalTrials.gov, number NCT01629550 and is closed to new participants. Findings Between Oct 26, 2012, and Feb 12, 2014, 2546 patients were eligible to participate in the study. We randomly assigned 1181 patients (2547 catheters) to chlorhexidine-alcohol (594 patients with scrubbing, 587 without) and 1168 (2612 catheters) to povidone iodine-alcohol (580 patients with scrubbing, 588 without). Chlorhexidine-alcohol was associated with lower incidence of catheter-related infections (0.28 vs 1.77 per 1000 catheter-days with povidone iodine-alcohol; hazard ratio 0.15, 95% CI 0.05-0.41; p=0.0002). Scrubbing was not associated with a significant difference in catheter colonisation (p=0.3877). No systemic adverse events were reported, but severe skin reactions occurred more frequently in those assigned to chlorhexidine-alcohol (27 [3%] patients vs seven [1%] with povidone iodine-alcohol; p=0.0017) and led to chlorhexidine discontinuation in two patients. Interpretation For skin antisepsis, chlorhexidine-alcohol provides greater protection against short-term catheter-related infections than does povidone iodine-alcohol and should be included in all bundles for prevention of intravascular catheter-related infections.	[Mimoz, Olivier; Kerforne, Thomas; Balayn, Dorothee] CHU Poitiers, Serv Anesthesie & Reanimat, F-86021 Poitiers, France; [Mimoz, Olivier] Univ Poitiers, UFR Med Pharm, Poitiers, France; [Mimoz, Olivier] INSERM, U1070, Pharmacol Agents AntiInfect, Poitiers, France; [Lucet, Jean-Christophe] Hop Xavier Bichat, AP HP, Infect Control Unit, Paris, France; [Lucet, Jean-Christophe; Bouadma, Lila; Timsit, Jean-Francois] INSERM, IAME Team 5, UMR 1137, DeSCID Decis Sci Infect Dis Control & Care, Paris, France; [Lucet, Jean-Christophe; Bouadma, Lila; Timsit, Jean-Francois] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Pascal, Julien] CHU Clermont Ferrand, Serv Reanimat Adultes, Clermont Ferrand, France; [Pascal, Julien] CHU Clermont Ferrand, Unite Surveillance Continue, Clermont Ferrand, France; [Souweine, Bertrand] CHU Clermont Ferrand, Serv Reanimat Med, Clermont Ferrand, France; [Goudet, Veronique] CHU Poitiers, Serv Reanimat Med, Poitiers, France; [Mercat, Alain] CHU Angers, Dept Reanimat Med & Med Hyperbare, Angers, France; [Lasocki, Sigismond] CHU Angers, Serv Reanimat Chirurg, Angers, France; [Alfandari, Serge] CH Tourcoing, Serv Reanimat & Malad Infect, Tourcoing, France; [Friggeri, Arnaud; Wallet, Florent; Lepape, Alain] CHU Lyon Sud, Serv Anesthesie & Reanimat Med & Chirurg, Lyon, France; [Allou, Nicolas] Hop Bichat Claude Bernard, Serv Reanimat Chirurg, F-75877 Paris 18, France; [Ruckly, Stephane] OutcomeRea, Paris, France	CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Poitiers; Universite de Poitiers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Mimoz, O (corresponding author), CHU Poitiers, Serv Anesthesie & Reanimat, F-86021 Poitiers, France.	olivier.mimoz@chu-poitiers.fr	Friggeri, Arnaud/AAE-7644-2020; souweine, bertrand/HHR-8972-2022; Mercat, Alain/AFU-4426-2022; lasocki, sigismond/G-9443-2016; Alfandari, Serge/AAF-2022-2020	Friggeri, Arnaud/0000-0003-4687-2173; Alfandari, Serge/0000-0002-9672-725X; LEPAPE, Alain/0000-0001-5950-7533; wallet, florent/0000-0003-3174-6246; mimoz, olivier/0000-0003-1737-7915	University Hospital of Poitiers, CareFusion	University Hospital of Poitiers, CareFusion	University Hospital of Poitiers, CareFusion.	[Anonymous], 2009, ANN FR ANESTH, V28, P912; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Eardley WGP, 2012, INT J LOW EXTR WOUND, V11, P213, DOI 10.1177/1534734612450589; Fowler J Jr, 2001, Am J Contact Dermat, V12, P3, DOI 10.1053/ajcd.2001.21472; Frasca D, 2010, CRIT CARE, V14, DOI 10.1186/cc8853; Girard Raphaele, 2012, J Infect Public Health, V5, P35, DOI 10.1016/j.jiph.2011.10.007; Goudet V, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-114; Haute Autorite de Sante, 2012, METH GUID CHOIC METH; Lee E, 1992, NATO ASI SER, P237; Lefebvre A, 2015, J HOSP INFECT, V89, P28, DOI 10.1016/j.jhin.2014.10.004; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Mermel LA, 2011, CLIN INFECT DIS, V52, P211, DOI 10.1093/cid/ciq108; Mimoz O, 1996, CRIT CARE MED, V24, P1818, DOI 10.1097/00003246-199611000-00010; Mimoz O, 1999, ANN INTERN MED, V131, P834, DOI 10.7326/0003-4819-131-11-199912070-00006; Mimoz O, 2007, ARCH INTERN MED, V167, P2066, DOI 10.1001/archinte.167.19.2066; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; Parienti JJ, 2004, CRIT CARE MED, V32, P708, DOI 10.1097/01.CCM.0000115265.05604.7B; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rotter M., 2012, HOSP EPIDEMIOLOGY IN, V3rd ed., P1365; Schwebel C, 2012, CRIT CARE MED, V40, P11, DOI 10.1097/CCM.0b013e31822f0604; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Timsit JF, 2002, CRIT CARE MED, V30, P2003, DOI 10.1097/00003246-200209000-00009; ZAMORA JL, 1985, SURGERY, V98, P25	26	166	177	3	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2069	2077		10.1016/S0140-6736(15)00244-5	http://dx.doi.org/10.1016/S0140-6736(15)00244-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26388532				2022-12-28	WOS:000365987600028
J	Sternlicht, H; Bakris, GL				Sternlicht, Hillel; Bakris, George L.			Spironolactone for resistant hypertension-hard to resist?	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; BLOOD-PRESSURE; DENERVATION; POTASSIUM		[Sternlicht, Hillel; Bakris, George L.] Univ Chicago, Dept Med, ASH Comprehens Hypertens Ctr, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA	University of Chicago	Sternlicht, H (corresponding author), Univ Chicago, Dept Med, ASH Comprehens Hypertens Ctr, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA.	gbakris@gmail.com		Sternlicht, Hillel/0000-0002-8855-0220				Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P884, DOI 10.1001/jama.2015.10081; Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P151, DOI 10.1001/jama.2015.7446; Bakris GL, 2000, KIDNEY INT, V58, P2084, DOI 10.1111/j.1523-1755.2000.00381.x; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Dahal K, 2015, AM J HYPERTENS, V28, P1376, DOI 10.1093/ajh/hpv031; Egan BM, 2009, AM J HYPERTENS, V22, P792, DOI 10.1038/ajh.2009.63; Elmula FEMF, 2013, HYPERTENSION, V62, P526, DOI 10.1161/HYPERTENSIONAHA.113.01452; Iliescu R, 2015, AM J PHYSIOL-RENAL, V309, pF583, DOI 10.1152/ajprenal.00246.2015; Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Williams B., 2015, LANCET	12	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2032	2034		10.1016/S0140-6736(15)00264-0	http://dx.doi.org/10.1016/S0140-6736(15)00264-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26414969	hybrid			2022-12-28	WOS:000365987600005
J	Shi, JJ; Zhao, Y; Wang, K; Shi, XY; Wang, Y; Huang, HW; Zhuang, YH; Cai, T; Wang, FC; Shao, F				Shi, Jianjin; Zhao, Yue; Wang, Kun; Shi, Xuyan; Wang, Yue; Huang, Huanwei; Zhuang, Yinghua; Cai, Tao; Wang, Fengchao; Shao, Feng			Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death	NATURE			English	Article							III SECRETION APPARATUS; BACTERIAL FLAGELLIN; NLRC4 INFLAMMASOME; INTRACELLULAR LPS; ACTIVATION; MECHANISMS; RECEPTORS; IMMUNITY	Inflammatory caspases (caspase-1, -4, -5 and -11) are critical for innate defences. Caspase-1 is activated by ligands of various canonical inflammasomes, and caspase-4, -5 and -11 directly recognize bacterial lipopolysaccharide, both of which trigger pyroptosis. Despite the crucial role in immunity and endotoxic shock, the mechanism for pyroptosis induction by inflammatory caspases is unknown. Here we identify gasdermin D (Gsdmd) by genome-wide clustered regularly interspaced palindromic repeat (CRISPR)-Cas9 nuclease screens of caspase-11- and caspase-1-mediated pyroptosis in mouse bone marrow macrophages. GSDMD-deficient cells resisted the induction of pyroptosis by cytosolic lipopolysaccharide and known canonical inflammasome ligands. Interleukin-1 beta release was also diminished in Gsdmd(-/-) cells, despite intact processing by caspase-1. Caspase-1 and caspase-4/5/11 specifically cleaved the linker between the amino-terminal gasdermin-N and carboxy-terminal gasdermin-C domains in GSDMD, which was required and sufficient for pyroptosis. The cleavage released the intramolecular inhibition on the gasdermin-N domain that showed intrinsic pyroptosis-inducing activity. Other gasdermin family members were not cleaved by inflammatory caspases but shared the autoinhibition; gain-of-function mutations in Gsdma3 that cause alopecia and skin defects disrupted the autoinhibition, allowing its gasdermin-N domain to trigger pyroptosis. These findings offer insight into inflammasome-mediated immunity/diseases and also change our understanding of pyroptosis and programmed necrosis.	[Shi, Jianjin] Tsinghua Univ, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Sch Life Sci, Beijing 100084, Peoples R China; [Shi, Jianjin; Zhao, Yue; Wang, Kun; Shi, Xuyan; Wang, Yue; Huang, Huanwei; Zhuang, Yinghua; Cai, Tao; Wang, Fengchao; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Shao, Feng] Collaborat Innovat Ctr Canc Med, Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tsinghua University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhao, Yue/A-5285-2018	Zhao, Yue/0000-0003-1509-9261; Shi, Jianjin/0000-0001-8048-5180	Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]; Program for International Collaborations [31461143006]; National Basic Research Program of China 973 Program [2012CB518700, 2014CB849602]; Howard Hughes Medical Institute; Beijing Scholar Program	Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)); Program for International Collaborations; National Basic Research Program of China 973 Program(National Basic Research Program of China); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beijing Scholar Program	We thank J. Ding for recombinant protein purification and X. Wang for reagents. We thank members of the Shao laboratory for helpful discussions and technical assistance. This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202), the China National Science Foundation Program for Distinguished Young Scholars (31225002) and Program for International Collaborations (31461143006), and the National Basic Research Program of China 973 Program (2012CB518700 and 2014CB849602) to F.S. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and the Beijing Scholar Program to F.S.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Fujii T, 2008, GENESIS, V46, P418, DOI 10.1002/dvg.20412; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065; Kumar S, 2012, J DERMATOL SCI, V67, P190, DOI 10.1016/j.jdermsci.2012.05.001; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Ruge F, 2011, J INVEST DERMATOL, V131, P572, DOI 10.1038/jid.2010.379; Saeki N., 2011, ENDOTHELIUM EPITHELI; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shi PL, 2015, BIOCHEM J, V468, P325, DOI 10.1042/BJ20150204; Sun LM, 2014, TRENDS BIOCHEM SCI, V39, P587, DOI 10.1016/j.tibs.2014.10.003; Tanaka S, 2013, G3-GENES GENOM GENET, V3, P1843, DOI 10.1534/g3.113.007393; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou Y, 2012, AM J PATHOL, V180, P763, DOI 10.1016/j.ajpath.2011.10.034	32	2583	2766	86	857	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					660	665		10.1038/nature15514	http://dx.doi.org/10.1038/nature15514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26375003				2022-12-28	WOS:000363832100040
J	Kesselheim, AS; Maggs, LR; Sarpatwari, A				Kesselheim, Aaron S.; Maggs, Lara R.; Sarpatwari, Ameet			Experience With the Priority Review Voucher Program for Drug Development	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kesselheim, Aaron S.; Maggs, Lara R.; Sarpatwari, Ameet] Harvard Univ, Program Regulat Therapeut & Law PORTAL, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Maggs, Lara/0000-0002-8642-2540				Anderson T, 2009, LANCET, V373, P1414, DOI 10.1016/S0140-6736(09)60804-7; Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Doshi P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4665; Pecoul B, PLOS BLOGS; Philippidis A., 2014, GENETIC ENG BIO 0304	5	30	30	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1687	1688		10.1001/jama.2015.11845	http://dx.doi.org/10.1001/jama.2015.11845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26414802				2022-12-28	WOS:000363706300012
J	Carey, EJ; Ali, AH; Lindor, KD				Carey, Elizabeth J.; Ali, Ahmad H.; Lindor, Keith D.			Primary biliary cirrhosis	LANCET			English	Article							URSODEOXYCHOLIC ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; LIVER FIBROSIS PROGRESSION; QUALITY-OF-LIFE; RISK-FACTORS; AUTOIMMUNE HEPATITIS; BIOCHEMICAL RESPONSE; NATURAL-HISTORY; ANTIMITOCHONDRIAL ANTIBODY; HISTOLOGICAL PROGRESSION	Primary biliary cirrhosis is a chronic cholestatic liver disease characterised by destruction of small intrahepatic bile ducts, leading to fibrosis and potential cirrhosis through resulting complications. The serological hallmark of primary biliary cirrhosis is the antimitochondrial antibody, a highly disease-specific antibody identified in about 95% of patients with primary biliary cirrhosis. These patients usually have fatigue and pruritus, both of which occur independently of disease severity. The typical course of primary biliary cirrhosis has changed substantially with the introduction of ursodeoxycholic acid (UDCA). Several randomised placebo-controlled studies have shown that UDCA improves transplant-free survival in primary biliary cirrhosis. However, about 40% of patients do not have a biochemical response to UDCA and would benefit from new therapies. Liver transplantation is a life-saving surgery with excellent outcomes for those with decompensated cirrhosis. Meanwhile, research on nuclear receptor hormones has led to the development of exciting new potential treatments. This Seminar will review the current understanding of the epidemiology, pathogenesis, and natural history of primary biliary cirrhosis, discuss management of the disease and its sequelae, and introduce research on new therapeutic options.	[Carey, Elizabeth J.; Ali, Ahmad H.; Lindor, Keith D.] Mayo Clin, Div Gastroenterol & Hepatol, Phoenix, AZ USA; [Lindor, Keith D.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ 85004 USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Downtown Phoenix	Lindor, KD (corresponding author), Arizona State Univ, Coll Hlth Solut, Phoenix, AZ 85004 USA.	Keith.lindor@asu.edu			Intercept Pharmaceuticals; NGM Biopharmaceuticals	Intercept Pharmaceuticals; NGM Biopharmaceuticals	EJC receives research funding from Intercept Pharmaceuticals and NGM Biopharmaceuticals. KDL serves as a consultant in clinical trials of experimental drugs for cholestatic liver disease and is an unpaid advisor for Lumena Pharmaceuticals and Intercept Pharmaceuticals. AHA declares no competing interests.	Abbas G, 2010, NAT REV GASTRO HEPAT, V7, P313, DOI 10.1038/nrgastro.2010.62; Addison T.G.W., 1851, GUYS HOSP REP, V7, P265; Agmon-Levin N, 2015, IMMUNOL RES, V61, P141, DOI 10.1007/s12026-014-8594-0; AHRENS EH, 1950, MEDICINE, V29, P299, DOI 10.1097/00005792-195012000-00002; Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Ala A, 2006, HEPATOLOGY, V43, P525, DOI 10.1002/hep.21076; Ali AH, 2011, J CLIN GASTROENTEROL, V45, pE66, DOI 10.1097/MCG.0b013e3181f18c4e; Angulo P, 1999, HEPATOLOGY, V29, P644, DOI 10.1002/hep.510290301; Angulo P, 1999, LIVER, V19, P115, DOI 10.1111/j.1478-3231.1999.tb00020.x; BALAN V, 1994, MAYO CLIN PROC, V69, P923, DOI 10.1016/S0025-6196(12)61815-1; Baldursdottir TR, 2012, EUR J GASTROEN HEPAT, V24, P824, DOI 10.1097/MEG.0b013e328353753d; Batts KP, 1996, AM J GASTROENTEROL, V91, P2314; BAUM H, 1985, MOL ASPECTS MED, V8, P201, DOI 10.1016/0098-2997(85)90007-X; Beuers U, 2015, J HEPATOL, V62, pS25, DOI 10.1016/j.jhep.2015.02.023; Beuers U, 2014, HEPATOLOGY, V60, P399, DOI 10.1002/hep.26909; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bjornsson E, 2010, LIVER INT, V30, P251, DOI 10.1111/j.1478-3231.2009.02160.x; Boonstra K, 2014, LIVER INT, V34, pE31, DOI 10.1111/liv.12434; Boonstra K, 2012, J HEPATOL, V56, P1181, DOI 10.1016/j.jhep.2011.10.025; Bosch A, 2015, J HEPATOL, V62, pS783, DOI 10.1016/S0168-8278(15)31345-3; Carbone M, 2014, EUR J IMMUNOL, V44, P945, DOI 10.1002/eji.201344270; Carbone M, 2013, J HEPATOL, V59, P490, DOI 10.1016/j.jhep.2013.04.017; Carbone M, 2013, GASTROENTEROLOGY, V144, P560, DOI 10.1053/j.gastro.2012.12.005; Carey EJ, 2013, EVID BASED MED, V18, pe55; Cash WJ, 2013, LIVER INT, V33, P1166, DOI 10.1111/liv.12191; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; CHRISTENSEN E, 1980, GASTROENTEROLOGY, V78, P236; COLINA F, 1992, GASTROENTEROLOGY, V102, P1319; COMBES B, 1995, HEPATOLOGY, V22, P759, DOI 10.1016/0270-9139(95)90294-5; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Corpechot C, 2012, J HEPATOL, V56, P218, DOI 10.1016/j.jhep.2011.03.031; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Corpechot C, 2010, J HEPATOL, V53, P162, DOI 10.1016/j.jhep.2010.02.019; Cuperus FJC, 2014, CURR OPIN GASTROEN, V30, P279, DOI 10.1097/MOG.0000000000000056; Dahlqvist G, 2014, J HEPATOL, V60, pS188, DOI 10.1016/S0168-8278(14)60526-2; Deutsch M, 2008, EUR J GASTROEN HEPAT, V20, P5, DOI 10.1097/MEG.0b013e3282f163ed; Dubel L, 1995, J HEPATOL, V23, P674, DOI 10.1016/0168-8278(95)80033-6; Efe C, 2014, AUTOIMMUN REV, V13, P931, DOI 10.1016/j.autrev.2014.05.008; Floreani A, 2015, CLIN REV ALLERG IMMU, V48, P192, DOI 10.1007/s12016-014-8427-x; Floreani A, 2015, J CLIN GASTROENTEROL, V49, P57, DOI 10.1097/MCG.0000000000000029; FRAZER IH, 1985, J IMMUNOL, V135, P1739; Friedrich-Rust M, 2010, J CLIN GASTROENTEROL, V44, P58, DOI 10.1097/MCG.0b013e3181a84b8d; Gan SI, 2009, DIGEST DIS SCI, V54, P2242, DOI 10.1007/s10620-008-0613-3; Gershwin ME, 2005, HEPATOLOGY, V42, P1194, DOI 10.1002/hep.20907; Gossard AA, 2007, LIVER INT, V27, P1086, DOI 10.1111/j.1478-3231.2007.01538.x; Guanabens N, 2005, J HEPATOL, V42, P573, DOI 10.1016/j.jhep.2004.11.035; Guanabens N, 2003, AM J GASTROENTEROL, V98, P2268, DOI 10.1016/S0002-9270(03)00550-1; Guanabens N, 2013, HEPATOLOGY, V58, P2070, DOI 10.1002/hep.26466; HAMLYN AN, 1983, GUT, V24, P940, DOI 10.1136/gut.24.10.940; HEATHCOTE EJ, 1994, HEPATOLOGY, V19, P1149, DOI 10.1002/hep.1840190512; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Hosonuma K, 2015, AM J GASTROENTEROL, V110, P423, DOI 10.1038/ajg.2015.20; Ikeda F, 2012, J GASTROEN HEPATOL, V27, P1320, DOI 10.1111/j.1440-1746.2012.07114.x; Imam MH, 2014, SEMIN LIVER DIS, V34, P329, DOI 10.1055/s-0034-1383731; Imam MH, 2012, CLIN GASTROENTEROL H, V10, P182, DOI 10.1016/j.cgh.2011.09.013; Invernizzi P, 2003, J HEPATOL, V38, P401, DOI 10.1016/S0168-8278(02)00440-3; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; Jones DEJ, 2007, ALIMENT PHARM THER, V25, P471, DOI 10.1111/j.1365-2036.2006.03223.x; Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026; Jones DEJ, 2006, GUT, V55, P536, DOI 10.1136/gut.2005.080317; Jones DEJ, 2006, HEPATOLOGY, V43, P633, DOI 10.1002/hep.21104; Jones EA, 2007, HEPATO-GASTROENTEROL, V54, P1196; JONES EA, 1990, HEPATOLOGY, V11, P884, DOI 10.1002/hep.1840110526; Kaplan MM, 2005, ANN INTERN MED, V143, P546, DOI 10.7326/0003-4819-143-7-200510040-00024; Khurana S, 2006, LIVER INT, V26, P943, DOI 10.1111/j.1478-3231.2006.01326.x; Kim W R, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13197; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Kumagi T, 2010, AM J GASTROENTEROL, V105, P2186, DOI 10.1038/ajg.2010.216; LACERDA MA, 1995, AM J GASTROENTEROL, V90, P247; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Lammert C, 2013, DIGEST LIVER DIS, V45, P589, DOI 10.1016/j.dld.2013.01.028; Lens S, 2014, LIVER INT, V34, P197, DOI 10.1111/liv.12290; Levy C, 2014, CLIN GASTROENTEROL H, V12, P1398, DOI 10.1016/j.cgh.2013.12.010; Lindor KD, 1997, MAYO CLIN PROC, V72, P1137, DOI 10.4065/72.12.1137; Lindor KD, 1996, GASTROENTEROLOGY, V110, P1515, DOI 10.1053/gast.1996.v110.pm8613058; LINDOR KD, 1994, GASTROENTEROLOGY, V106, P1284, DOI 10.1016/0016-5085(94)90021-3; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Locke GR, 1996, HEPATOLOGY, V23, P52, DOI 10.1002/hep.510230108; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; MAHL TC, 1994, J HEPATOL, V20, P707, DOI 10.1016/S0168-8278(05)80139-4; Mattalia A, 1998, HEPATOLOGY, V27, P656, DOI 10.1002/hep.510270303; Mayo MJ, 2007, HEPATOLOGY, V45, P666, DOI 10.1002/hep.21553; McDonald C, 2010, J HEPATOL, V53, P1095, DOI 10.1016/j.jhep.2010.05.036; McNally RJQ, 2014, AM J EPIDEMIOL, V179, P492, DOI 10.1093/aje/kwt308; Mells GF, 2013, HEPATOLOGY, V58, P273, DOI 10.1002/hep.26365; Mendes F, 2008, GASTROENTEROL CLIN N, V37, P479, DOI 10.1016/j.gtc.2008.02.006; Metcalf JV, 1997, INT J EPIDEMIOL, V26, P830, DOI 10.1093/ije/26.4.830; Momah N, 2012, LIVER INT, V32, P790, DOI 10.1111/j.1478-3231.2011.02678.x; Mullarkey ME, 2005, TISSUE ANTIGENS, V65, P199, DOI 10.1111/j.1399-0039.2005.00351.x; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Nakamura M, 2014, SEMIN LIVER DIS, V34, P334, DOI 10.1055/s-0034-1383732; Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371; Newton JL, 2006, HEPATOLOGY, V44, P91, DOI 10.1002/hep.21230; Newton JL, 2011, EUR J GASTROEN HEPAT, V23, P566, DOI 10.1097/MEG.0b013e3283470256; O'Donohue JW, 2005, ALIMENT PHARM THER, V21, P1041, DOI 10.1111/j.1365-2036.2005.02430.x; ONISHI S, 1994, J HEPATOL, V21, P1053, DOI 10.1016/S0168-8278(05)80617-8; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Parikh-Patel A, 2001, HEPATOLOGY, V33, P16, DOI 10.1053/jhep.2001.21165; Phillips JR, 2001, AM J GASTROENTEROL, V96, P2745, DOI 10.1111/j.1572-0241.2001.04134.x; PODESTA A, 1991, DIGEST DIS SCI, V36, P216, DOI 10.1007/BF01300759; Poupon R, 2006, HEPATOLOGY, V44, P85, DOI 10.1002/hep.21229; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Poupon RE, 2003, J HEPATOL, V39, P12, DOI 10.1016/S0168-8278(03)00192-2; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; POUPON RE, 1994, NEW ENGL J MED, V330, P1342, DOI 10.1056/NEJM199405123301903; Pusl T, 2006, J HEPATOL, V45, P887, DOI 10.1016/j.jhep.2006.08.008; Quarneti C, 2015, LIVER INT, V35, P636, DOI 10.1111/liv.12560; Raszeja-Wyszomirska J, 2014, PRZ GASTROENTEROL, V9, P82, DOI 10.5114/pg.2014.42502; Rautiainen H, 2007, SCAND J GASTROENTERO, V42, P1347, DOI 10.1080/00365520701396034; Rudic JS, 2011, COCHRANE DB SYST REV, V12; Selmi C, 2009, CURR MOL MED, V9, P45, DOI 10.2174/156652409787314525; SHERLOCK S, 1959, GASTROENTEROLOGY, V37, P574; Shibata M, 2004, J GASTROENTEROL, V39, P255, DOI 10.1007/s00535-003-1285-6; Silveira MG, 2008, HEPATOLOGY, V48, P1149, DOI 10.1002/hep.22458; Silveira MG, 2007, AM J GASTROENTEROL, V102, P1244, DOI 10.1111/j.1572-0241.2007.01136.x; Solaymani-Dodaran M, 2008, AM J GASTROENTEROL, V103, P2784, DOI 10.1111/j.1572-0241.2008.02092.x; Sorokin A, 2007, ATHEROSCLEROSIS, V194, P293, DOI 10.1016/j.atherosclerosis.2006.11.036; Springer J, 1999, AM J GASTROENTEROL, V94, P47; Stanca CM, 2005, AM J GASTROENTEROL, V100, P1104, DOI 10.1111/j.1572-0241.2005.41315.x; Talwalkar JA, 2003, LANCET, V362, P53, DOI 10.1016/S0140-6736(03)13808-1; Talwalkar JA, 2006, DIGEST DIS SCI, V51, P1985, DOI 10.1007/s10620-006-9397-5; Talwalkar JA, 2003, CLIN GASTROENTEROL H, V1, P297, DOI 10.1016/S1542-3565(03)00134-4; Tanaka A, 2001, AM J GASTROENTEROL, V96, P8; Tandon P, 2007, AM J GASTROENTEROL, V102, P1528, DOI 10.1111/j.1572-0241.2007.01200.x; Theal JJ, 2005, HEPATOLOGY, V41, P1305, DOI 10.1002/hep.20698; Tomiyama Y, 2013, INTERNAL MED, V52, P1553, DOI 10.2169/internalmedicine.52.0010; Trivedi M, 2010, ANN HEPATOL, V9, P177, DOI 10.1016/S1665-2681(19)31658-8; Trivedi PJ, 2016, GUT, V65, P321, DOI 10.1136/gutjnl-2014-308351; Trivedi PJ, 2014, CLIN GASTROENTEROL H, V12, P1179, DOI 10.1016/j.cgh.2013.11.030; Zein CO, 2007, GUT, V56, P1165; Zein CO, 2006, HEPATOLOGY, V44, P1564, DOI 10.1002/hep.21423; Zein CO, 2005, HEPATOLOGY, V42, P762, DOI 10.1002/hep.20866; Zhu GQ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000609	140	320	353	4	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1565	1575		10.1016/S0140-6736(15)00154-3	http://dx.doi.org/10.1016/S0140-6736(15)00154-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26364546				2022-12-28	WOS:000362878200031
J	Lin, KX; Chen, Q; Gerhardt, MR; Tong, LC; Kim, SB; Eisenach, L; Valle, AW; Hardee, D; Gordon, RG; Aziz, MJ; Marshak, MP				Lin, Kaixiang; Chen, Qing; Gerhardt, Michael R.; Tong, Liuchuan; Kim, Sang Bok; Eisenach, Louise; Valle, Alvaro W.; Hardee, David; Gordon, Roy G.; Aziz, Michael J.; Marshak, Michael P.			Alkaline quinone flow battery	SCIENCE			English	Article							ENERGY-STORAGE	Storage of photovoltaic and wind electricity in batteries could solve the mismatch problem between the intermittent supply of these renewable resources and variable demand. Flow batteries permit more economical long-duration discharge than solid-electrode batteries by using liquid electrolytes stored outside of the battery. We report an alkaline flow battery based on redox-active organic molecules that are composed entirely of Earth-abundant elements and are nontoxic, nonflammable, and safe for use in residential and commercial environments. The battery operates efficiently with high power density near room temperature. These results demonstrate the stability and performance of redox-active organic molecules in alkaline flow batteries, potentially enabling cost-effective stationary storage of renewable energy.	[Lin, Kaixiang; Tong, Liuchuan; Kim, Sang Bok; Hardee, David; Gordon, Roy G.; Marshak, Michael P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chen, Qing; Gerhardt, Michael R.; Gordon, Roy G.; Aziz, Michael J.; Marshak, Michael P.] Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Eisenach, Louise; Valle, Alvaro W.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Harvard University	Gordon, RG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	gordon@chemistry.harvard.edu; aziz@seas.harvard.edu; michael.marshak@colorado.edu	Tong, Liuchuan/I-4476-2014; Aziz, Michael/AAK-4866-2020; Marshak, Michael P/N-3213-2013; Gerhardt, Michael R./AAG-2371-2019	Tong, Liuchuan/0000-0001-6211-6322; Aziz, Michael/0000-0001-9657-9456; Marshak, Michael P/0000-0002-8027-2705; Gerhardt, Michael R./0000-0002-1272-3607; Chen, Qing/0000-0003-3106-9281	U.S. Department of Energy Advanced Research Projects Agency-Energy [DE-AR0000348]; Harvard John A. Paulson School of Engineering and Applied Sciences	U.S. Department of Energy Advanced Research Projects Agency-Energy(United States Department of Energy (DOE)); Harvard John A. Paulson School of Engineering and Applied Sciences	This work was funded by the U.S. Department of Energy Advanced Research Projects Agency-Energy award no. DE-AR0000348 and the Harvard John A. Paulson School of Engineering and Applied Sciences. Methods, along with any additional extended data display items and source data, are available in the supplementary materials; references unique to these sections appear only in the online version of the paper. M.P.M., K.L., R.G.G., and M.J.A. formulated the project. K.L., S.B.K., and D.H. synthesized, analyzed, and purified the compounds. K.L., L.T., and S.B.K. collected and analyzed the NMR and mass spectroscopy data. K.L., A.W.V., and L.E. measured solubility. K.L., Q.C., L.E., and M.R.G. collected and analyzed the electrochemical data. K.L., Q.C., M.R.G., M.P.M., R.G.G., and M.J.A. wrote the paper, and all authors contributed to revising the paper.	[Anonymous], 1974, WHO TECHN REP SER; Balaban TS, 2006, HELV CHIM ACTA, V89, P333, DOI 10.1002/hlca.200690037; Biello D, 2014, SCI AM, V311, P66, DOI 10.1038/scientificamerican1114-66; Chen Q, 2016, J ELECTROCHEM SOC, V163, pA5010, DOI 10.1149/2.0021601jes; Darling RM, 2014, ENERG ENVIRON SCI, V7, P3459, DOI 10.1039/c4ee02158d; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Er S, 2015, CHEM SCI, V6, P885, DOI 10.1039/c4sc03030c; Goldstein J. R., 2015, NOVEL FLOW BATTERY U; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; Joseph G. G. I., 2011, HIGH PERFORMANCE FLO; Linden D., 2002, HDB BATTERIES; Nguyen T, 2010, ELECTROCHEM SOC INTE, V19, P54, DOI 10.1149/2.F06103if; PAL H, 1994, J CHEM SOC FARADAY T, V90, P711, DOI 10.1039/ft9949000711; Quan M, 2007, J AM CHEM SOC, V129, P12847, DOI 10.1021/ja0743083; Skyllas-Kazacos M, 2011, J ELECTROCHEM SOC, V158, pR55, DOI 10.1149/1.3599565; Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v	16	643	668	51	745	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1529	1532		10.1126/science.aab3033	http://dx.doi.org/10.1126/science.aab3033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404834				2022-12-28	WOS:000361707000045
J	Day, CP; Merlino, G; Van Dyke, T				Day, Chi-Ping; Merlino, Glenn; Van Dyke, Terry			Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges	CELL			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; IN-VIVO; TUMOR XENOGRAFTS; CLINICAL-RESPONSE; SURVIVAL BENEFIT; DRUG-RESISTANCE; RETINOIC ACID; MICE; PATHWAY	Significant advances have been made in developing novel therapeutics for cancer treatment, and targeted therapies have revolutionized the treatment of some cancers. Despite the promise, only about five percent of new cancer drugs are approved, and most fail due to lack of efficacy. The indication is that current preclinical methods are limited in predicting successful outcomes. Such failure exacts enormous cost, both financial and in the quality of human life. This Primer explores the current status, promise, and challenges of preclinical evaluation in advanced mouse cancer models and briefly addresses emerging models for early-stage preclinical development.	[Day, Chi-Ping; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Van Dyke, Terry] NCI, Ctr Adv Preclin Res, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	gmerlino@helix.nih.gov; vandyket@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC011167, ZIABC008756] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC008756-21] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abate-Shen C., 2014, MOUSE MODELS CANC LA; Ablain J, 2014, INT J CANCER, V135, P2262, DOI 10.1002/ijc.29081; Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Bailey M, 2013, VET IMMUNOL IMMUNOP, V152, P13, DOI 10.1016/j.vetimm.2012.09.022; Barriuso J, 2015, CLIN CANCER RES, V21, P969, DOI 10.1158/1078-0432.CCR-14-2921; Beatty GL, 2013, CLIN CANCER RES, V19, P6286, DOI 10.1158/1078-0432.CCR-13-1320; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]; Cao JX, 2013, MOL CELL, V51, P409, DOI 10.1016/j.molcel.2013.08.010; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen Z, 2014, CLIN CANCER RES, V20, P1204, DOI 10.1158/1078-0432.CCR-13-1733; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Chiu CW, 2010, J CLIN ONCOL, V28, P4425, DOI 10.1200/JCO.2010.28.0198; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Couzin-Frankel J, 2014, SCIENCE, V344, P24, DOI [10.1126/science.344.6179.24, 10.1126/science.346.6205.24]; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Day CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109956; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Fiebig H H, 1984, Behring Inst Mitt, P343; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Gao Guangxun, 2014, Curr Mol Pharmacol, V7, P44; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; Goldstein D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju413; Gonzalez Frank J., 2004, Human Genomics, V1, P300; Hagedorn EJ, 2014, EXP CELL RES, V329, P220, DOI 10.1016/j.yexcr.2014.07.030; Hanash S, 2011, CANCER J, V17, P423, DOI 10.1097/PPO.0b013e3182383cab; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Ilie M, 2015, CANCER MED-US, V4, P201, DOI 10.1002/cam4.357; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kannan K, 2003, P NATL ACAD SCI USA, V100, P1221, DOI 10.1073/pnas.0336397100; Kortmann U, 2011, CLIN CANCER RES, V17, P783, DOI 10.1158/1078-0432.CCR-10-1382; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Leaf C, 2004, FORTUNE, V149, P76; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lunardi A, 2015, TRENDS MOL MED, V21, P1, DOI 10.1016/j.molmed.2014.10.008; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; MATTERN J, 1988, CANCER METAST REV, V7, P263, DOI 10.1007/BF00047755; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Mou HW, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0178-7; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Pandolfi PP, 2001, HUM MOL GENET, V10, P769, DOI 10.1093/hmg/10.7.769; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Quignon F, 1997, BBA-REV CANCER, V1333, pM53, DOI 10.1016/S0304-419X(97)00025-5; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Reinhold WC, 2015, HUM GENET, V134, P3, DOI 10.1007/s00439-014-1482-9; Riley RR, 2003, CANCER RES, V63, P4862; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Scheer N, 2014, XENOBIOTICA, V44, P96, DOI 10.3109/00498254.2013.815831; Scheer N, 2013, DRUG DISCOV TODAY, V18, P1200, DOI 10.1016/j.drudis.2013.07.007; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shultz Leonard D, 2014, Cold Spring Harb Protoc, V2014, P694, DOI 10.1101/pdb.top073585; Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sparreboom A, 1996, CANCER RES, V56, P2112; Stebbing J, 2014, CANCER-AM CANCER SOC, V120, P2006, DOI 10.1002/cncr.28696; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Stiedl Patricia, 2015, Methods Mol Biol, V1267, P3, DOI 10.1007/978-1-4939-2297-0_1; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Szabova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095649; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Texido Gemma, 2013, Methods Mol Biol, V986, P281, DOI 10.1007/978-1-62703-311-4_18; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Walrath JC, 2010, ADV CANCER RES, V106, P113, DOI 10.1016/S0065-230X(10)06004-5; Weaver Z, 2012, CANCER RES, V72, P5921, DOI 10.1158/0008-5472.CAN-12-0736; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zhang BB, 2015, FAM CANCER, V14, P487, DOI 10.1007/s10689-015-9802-3; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	107	347	360	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					39	53		10.1016/j.cell.2015.08.068	http://dx.doi.org/10.1016/j.cell.2015.08.068			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406370	Bronze, Green Accepted			2022-12-28	WOS:000361846500020
J	Franco, HL; Kraus, WL				Franco, Hector L.; Kraus, W. Lee			No Driver behind the Wheel? Targeting Transcription in Cancer	CELL			English	Editorial Material							COVALENT CDK7 INHIBITOR; LUNG-CANCER; C-MYC	Exploiting the dependence of cancer cells on transcription can be used as an effective strategy for targeting aggressive and therapeutically recalcitrant tumors. Wang et al. show that inhibiting transcription using THZ1, a small-molecule inhibitor of cyclin-dependent kinase CDK7, induces apoptotic cell death in triple-negative breast cancers.	[Franco, Hector L.; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Lab Signaling & Gene Regulat, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Franco, Hector L.; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Basic Reprod Biol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kraus, WL (corresponding author), Univ Texas SW Med Ctr Dallas, Lab Signaling & Gene Regulat, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.	lee.kraus@utsouthwestern.edu		Franco, Hector/0000-0001-9354-0679				Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063	10	21	22	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					28	30		10.1016/j.cell.2015.09.013	http://dx.doi.org/10.1016/j.cell.2015.09.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406367	Bronze			2022-12-28	WOS:000361846500017
J	Narayanan, D; Turk, M; Feldmann, R; Robitaille, T; Hopkins, P; Thompson, R; Hayward, C; Ball, D; Faucher-Giguere, CA; Keres, D				Narayanan, Desika; Turk, Matthew; Feldmann, Robert; Robitaille, Thomas; Hopkins, Philip; Thompson, Robert; Hayward, Christopher; Ball, David; Faucher-Giguere, Claude-Andre; Keres, Dusan			The formation of submillimetre-bright galaxies from gas infall over a billion years	NATURE			English	Article							INITIAL MASS FUNCTION; STAR-FORMATION; MOLECULAR GAS; HIGH-REDSHIFT; RADIATIVE-TRANSFER; STELLAR FEEDBACK; MILKY-WAY; ELEMENTAL ABUNDANCES; INFRARED-EMISSION; NUMBER COUNTS	Submillimetre-bright galaxies at high redshift are the most luminous, heavily star-forming galaxies in the Universe1 and are characterized by prodigious emission in the far-infrared, with a flux of at least five millijanskys at a wavelength of 850micrometres. Theyreside inhaloes with masses about 10(13) times that of the Sun2, have low gas fractions compared to main-sequence disks at a comparable redshift3, trace complex environments(4,5) and are not easily observable at optical wavelengths(6). Their physical origin remains unclear. Simulations have been able to form galaxies with the requisite luminosities, but have otherwise been unable to simultaneously match the stellar masses, star formation rates, gas fractions and environments(7-10). Here we report a cosmological hydrodynamic galaxy formation simulation that is able to forma submillimetre galaxy that simultaneously satisfies the broad range of observed physical constraints. We find that groups of galaxies residing in massive dark matter haloes have increasing rates of star formation that peak at collective rates of about 500-1,000 solarmasses per year at redshifts of two to three, by which time the interstellar medium is sufficiently enriched with metals that the region may be observed as a submillimetre-selected system. The intense star formation rates are fuelled in part by the infall of a reservoir gas supply enabled by stellar feedback at earlier times, not through major mergers. With a lifetime of nearly a billion years, our simulations show that the submillimetre-bright phase of high-redshift galaxies is prolonged and associated with significant mass buildup in early-Universe proto-clusters, and that many submillimetre- bright galaxies are composed of numerous unresolved components (for which there is some observational evidence(11)).	[Narayanan, Desika] Haverford Coll, Haverford, PA 19041 USA; [Turk, Matthew] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61820 USA; [Feldmann, Robert] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Feldmann, Robert] Univ Calif Berkeley, Theoret Astrophys Ctr, Berkeley, CA 94720 USA; [Robitaille, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Hopkins, Philip; Hayward, Christopher] CALTECH, TAPIR, Pasadena, CA 91125 USA; [Thompson, Robert] Univ Western Cape, ZA-7535 Cape Town, South Africa; [Thompson, Robert; Ball, David] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Hayward, Christopher] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Ball, David] Whitman Coll, Walla Walla, WA 99362 USA; [Faucher-Giguere, Claude-Andre] Northwestern Univ, CIERA, Evanston, IL 60208 USA; [Keres, Dusan] Univ Calif San Diego, CASS, La Jolla, CA 92093 USA	Haverford College; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Max Planck Society; California Institute of Technology; University of the Western Cape; University of Arizona; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Whitman College; Northwestern University; University of California System; University of California San Diego	Narayanan, D (corresponding author), Haverford Coll, 370 West Lancaster Ave, Haverford, PA 19041 USA.	dnarayan@haverford.edu	Faucher-Giguere, Claude-Andre/AAC-5298-2019	Turk, Matthew/0000-0002-5294-0198; Robitaille, Thomas/0000-0002-8642-1329; Feldmann, Robert/0000-0002-1109-1919; Hayward, Christopher/0000-0003-4073-3236; Narayanan, Desika/0000-0002-7064-4309; Hopkins, Philip/0000-0003-3729-1684	NSF [AST-1009452, AST-1442650, AST-1412836, AST-1412153]; NASA HST [AR-13906.001]; Cottrell College Science Award; Gordon and Betty Moore Foundation [GBMF4561, 776]; Alfred P. Sloan Foundation; NASA [PF3-140106, NNX15AB22G, HF-51304.01-A]; Direct For Mathematical & Physical Scien [1412153, 1005024] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1411920, 1455342, 1445357] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [1535651] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA HST(National Aeronautics & Space Administration (NASA)); Cottrell College Science Award; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank M. J. Michalowski for providing observational data. Partial support for D.N. was provided by NSF AST-1009452, AST-1442650, NASA HST AR-13906.001 and a Cottrell College Science Award. P.H., C.H., M.T. and R.T. were funded by the Gordon and Betty Moore Foundation (GBMF4561 and grant no. 776). P.H. acknowledges the Alfred P. Sloan Foundation for support. C.-A. F.-G. was supported by NASA awards PF3-140106, NNX15AB22G and NSF AST-1412836. D.K. was supported by NSF AST-1412153. R.F. was supported by NASA HF-51304.01-A, and is a Hubble fellow. The simulations here were run on Stampede at TACC through NSF XSEDE allocations TG-AST120025, TG-AST130039 and TG-AST140023, NASA Pleiades, and the Haverford College cluster.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Agertz O, 2007, MON NOT R ASTRON SOC, V380, P963, DOI 10.1111/j.1365-2966.2007.12183.x; Angles-Alcazar D, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/127; Baugh CM, 2005, MON NOT R ASTRON SOC, V356, P1191, DOI 10.1111/j.1365-2966.2004.08553.x; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Bothwell MS, 2013, MON NOT R ASTRON SOC, V429, P3047, DOI 10.1093/mnras/sts562; Casey CM, 2014, PHYS REP, V541, P45, DOI 10.1016/j.physrep.2014.02.009; Chakrabarti S, 2008, ASTROPHYS J, V688, P972, DOI 10.1086/591721; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Conroy C, 2010, ASTROPHYS J, V712, P833, DOI 10.1088/0004-637X/712/2/833; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Cox T. J., 2010, MNRAS, V186; Daddi E, 2009, ASTROPHYS J, V694, P1517, DOI 10.1088/0004-637X/694/2/1517; Dave R, 2012, MON NOT R ASTRON SOC, V421, P98, DOI 10.1111/j.1365-2966.2011.20148.x; Dave R, 2010, MON NOT R ASTRON SOC, V404, P1355, DOI 10.1111/j.1365-2966.2010.16395.x; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Dwek E, 1998, ASTROPHYS J, V501, P643, DOI 10.1086/305829; Faucher-Giguere CA, 2015, MON NOT R ASTRON SOC, V449, P987, DOI 10.1093/mnras/stv336; Feldmann R, 2015, MON NOT R ASTRON SOC, V446, P1939, DOI 10.1093/mnras/stu2207; Ferland GJ, 2013, REV MEX ASTRON ASTR, V49, P137; Finkelstein SL, 2013, NATURE, V502, P524, DOI 10.1038/nature12657; Fu H, 2013, NATURE, V498, P338, DOI 10.1038/nature12184; Geach JE, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L19; Gonzalez JE, 2011, MON NOT R ASTRON SOC, V413, P749, DOI 10.1111/j.1365-2966.2010.18169.x; Governato F, 1997, NEW ASTRON, V2, P91, DOI 10.1016/S1384-1076(97)00011-0; Hahn O, 2011, MON NOT R ASTRON SOC, V415, P2101, DOI 10.1111/j.1365-2966.2011.18820.x; Hainline LJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/96; Hayward CC, 2014, MON NOT R ASTRON SOC, V442, P1992, DOI 10.1093/mnras/stu957; Hayward CC, 2013, MON NOT R ASTRON SOC, V428, P2529, DOI 10.1093/mnras/sts222; Hayward CC, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/159; Hezaveh YD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/132; Hickox RC, 2012, MON NOT R ASTRON SOC, V421, P284, DOI 10.1111/j.1365-2966.2011.20303.x; Hodge JA, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/91; Hopkins PF, 2014, MON NOT R ASTRON SOC, V445, P823, DOI 10.1093/mnras/stu1736; Hopkins PF, 2014, MON NOT R ASTRON SOC, V445, P581, DOI 10.1093/mnras/stu1738; Hopkins PF, 2013, MON NOT R ASTRON SOC, V433, P78, DOI 10.1093/mnras/stt690; Hopkins PF, 2013, MON NOT R ASTRON SOC, V433, P69, DOI 10.1093/mnras/stt688; Hopkins PF, 2013, MON NOT R ASTRON SOC, V432, P2647, DOI 10.1093/mnras/stt723; Hopkins PF, 2013, MON NOT R ASTRON SOC, V430, P1901, DOI 10.1093/mnras/stt017; Hopkins PF, 2013, MON NOT R ASTRON SOC, V428, P2840, DOI 10.1093/mnras/sts210; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3488, DOI 10.1111/j.1365-2966.2012.20578.x; Hopkins PF, 2011, MON NOT R ASTRON SOC, V417, P950, DOI 10.1111/j.1365-2966.2011.19306.x; Ivison RJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/137; Jonsson P, 2006, MON NOT R ASTRON SOC, V372, P2, DOI 10.1111/j.1365-2966.2006.10884.x; Katz N, 1996, ASTROPHYS J SUPPL S, V105, P19, DOI 10.1086/192305; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Kocevski DD, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/148; Kroupa P, 2002, SCIENCE, V295, P82, DOI 10.1126/science.1067524; Krumholz MR, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/36; Krumholz MR, 2008, ASTROPHYS J, V689, P865, DOI 10.1086/592490; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Lucy LB, 1999, ASTRON ASTROPHYS, V344, P282; Mannucci F, 2006, MON NOT R ASTRON SOC, V370, P773, DOI 10.1111/j.1365-2966.2006.10501.x; Michalowski MJ, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201016308; Michalowski MJ, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201424174; Murray SG, 2013, ASTRON COMPUT, V3-4, P23, DOI 10.1016/j.ascom.2013.11.001; Narayanan D, 2013, MON NOT R ASTRON SOC, V433, P1223, DOI 10.1093/mnras/stt784; Narayanan D, 2012, MON NOT R ASTRON SOC, V426, P1178, DOI 10.1111/j.1365-2966.2012.21893.x; Narayanan D, 2012, MON NOT R ASTRON SOC, V421, P3127, DOI 10.1111/j.1365-2966.2012.20536.x; Narayanan D, 2010, MON NOT R ASTRON SOC, V401, P1613, DOI 10.1111/j.1365-2966.2009.15790.x; Narayanan D, 2009, MON NOT R ASTRON SOC, V400, P1919, DOI 10.1111/j.1365-2966.2009.15581.x; Pascucci I, 2004, ASTRON ASTROPHYS, V417, P793, DOI 10.1051/0004-6361:20040017; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Robitaille TP, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219073; Robitaille TP, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117150; Shimizu I, 2012, MON NOT R ASTRON SOC, V427, P2866, DOI 10.1111/j.1365-2966.2012.22107.x; Sijacki D, 2012, MON NOT R ASTRON SOC, V424, P2999, DOI 10.1111/j.1365-2966.2012.21466.x; Simpson JM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/81; Springel V, 2005, MON NOT R ASTRON SOC, V361, P776, DOI 10.1111/j.1365-2966.2005.09238.x; Stadel J.G., 2001, THESIS U WASHINGTON; Swinbank AM, 2004, ASTROPHYS J, V617, P64, DOI 10.1086/425171; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Tacconi LJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/74; Thompson R, 2014, PYGADGETREADER GADGE; Thompson R., 2015, SPHGR SMOOTHED PARTI; Torrey P, 2015, MON NOT R ASTRON SOC, V447, P2753, DOI 10.1093/mnras/stu2592; Treister E, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/2/L39; Turk MJ, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/9; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Vladilo G, 1998, ASTROPHYS J, V493, P583, DOI 10.1086/305148; Watson D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117120; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Weiss A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/88	87	131	132	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					496	+		10.1038/nature15383	http://dx.doi.org/10.1038/nature15383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399829	Green Accepted, Green Submitted			2022-12-28	WOS:000361599900045
J	Cummings, JL; Lyketsos, CG; Peskind, ER; Porsteinsson, AP; Mintzer, JE; Scharre, D; De La Gandara, JE; Agronin, M; Davis, CS; Nguyen, U; Shin, P; Tariot, PN; Siffert, J				Cummings, Jeffrey L.; Lyketsos, Constantine G.; Peskind, Elaine R.; Porsteinsson, Anton P.; Mintzer, Jacobo E.; Scharre, DouglasW.; De La Gandara, Jose E.; Agronin, Marc; Davis, Charles S.; Uyen Nguyen; Shin, Paul; Tariot, Pierre N.; Siffert, Joao			Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSEUDOBULBAR AFFECT; NEUROPSYCHIATRIC SYMPTOMS; BEHAVIORAL SYMPTOMS; PLACEBO-RESPONSE; IN-VITRO; AGGRESSION; DESIGN; RECOMMENDATIONS; PROGRESSION; MANAGEMENT	IMPORTANCE Agitation is common among patients with Alzheimer disease; safe, effective treatments are lacking. OBJECTIVE To assess the efficacy, safety, and tolerability of dextromethorphan hydrobromide-quinidine sulfate for Alzheimer disease-related agitation. DESIGN, SETTING, AND PARTICIPANTS Phase 2 randomized, multicenter, double-blind, placebo-controlled trial using a sequential parallel comparison design with 2 consecutive 5-week treatment stages conducted August 2012-August 2014. Patients with probable Alzheimer disease, clinically significant agitation (Clinical Global Impressions-Severity agitation score >= 4), and a Mini-Mental State Examination score of 8 to 28 participated at 42 US study sites. Stable dosages of antidepressants, antipsychotics, hypnotics, and antidementia medications were allowed. INTERVENTIONS In stage 1, 220 patients were randomized in a 3: 4 ratio to receive dextromethorphan-quinidine (n = 93) or placebo (n = 127). In stage 2, patients receiving dextromethorphan-quinidine continued; those receiving placebo were stratified by response and rerandomized in a 1: 1 ratio to dextromethorphan-quinidine (n = 59) or placebo (n = 60). MAIN OUTCOMES AND MEASURES The primary end point was change from baseline on the Neuropsychiatric Inventory (NPI) Agitation/Aggression domain (scale range, 0 [absence of symptoms] to 12 [symptoms occur daily and with marked severity]). RESULTS A total of 194 patients (88.2%) completed the study. With the sequential parallel comparison design, 152 patients received dextromethorphan-quinidine and 127 received placebo during the study. Analysis combining stages 1 (all patients) and 2 (rerandomized placebo nonresponders) showed significantly reduced NPI Agitation/Aggression scores for dextromethorphan-quinidine vs placebo( ordinaryleastsquareszstatistic,-3.95; P < .001). In stage 1, mean NPI Agitation/Aggression scores were reduced from 7.1 to 3.8 with dextromethorphan-quinidine and from 7.0 to 5.3 with placebo. Between-groupt reatment differences were significantin stage 1(leasts quaresmean, -1.5; 95% CI, -2.3 to -0.7; P <. 001). In stage 2, NPI Agitation/Aggression scores were reduced from 5.8 to 3.8 with dextromethorphan-quinidine and from 6.7 to 5.8 with placebo. Between-group treatment differences were also significant in stage 2(least squares mean,-1.6; 95% CI,-2.9 to -0.3; P=.02). Adverseevents included falls (8.6% for dextromethorphan-quinidine vs3.9% for placebo), diarrhea (5.9% vs 3.1% respectively), and urinary tract infection (5.3% vs 3.9% respectively). Serious adverse events occurred in 7.9% with dextromethorphan-quinidine vs 4.7% with placebo. Dextromethorphan-quinidinewas not associated with cognitive impairment, sedation, or clinically significant QTc prolongation. CONCLUSIONS AND RELEVANCE In this preliminary 10-week phase 2 randomized clinical trial of patients with probable Alzheimer disease, combination dextromethorphan-quinidine demonstrated clinically relevant efficacy for agitation and was generally well tolerated.	[Cummings, Jeffrey L.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV 89106 USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview, Johns Hopkins Memory & Alzheimers Treatment Ctr, Baltimore, MD USA; [Peskind, Elaine R.] Univ Washington, Sch Med, VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Porsteinsson, Anton P.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Mintzer, Jacobo E.] Roper St Francis Hosp, Clin Biotechnol Res Inst, Charleston, SC USA; [Mintzer, Jacobo E.] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Scharre, DouglasW.] Ohio State Univ, Columbus, OH 43210 USA; [De La Gandara, Jose E.] Quantum Labs Inc, W Palm Beach, FL USA; [Agronin, Marc] Miami Jewish Hlth Syst, Miami, FL USA; [Davis, Charles S.] CSD Biostat Inc, Tucson, AZ USA; [Uyen Nguyen; Shin, Paul; Siffert, Joao] Avanir Pharmaceut Inc, Aliso Viejo, CA USA; [Tariot, Pierre N.] Banner Alzheimers Inst, Phoenix, AZ USA	Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Rochester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University System of Ohio; Ohio State University; Banner Research; Banner Health; Banner Alzheimer's Institute	Cummings, JL (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA.	cumminj@ccf.org	Cummings, Jeffrey/AAC-5947-2019	Cummings, Jeffrey/0000-0001-8944-4158; Porsteinsson, Anton/0000-0002-0166-1738	Avanir Pharmaceuticals Inc.	Avanir Pharmaceuticals Inc.	This study was funded by Avanir Pharmaceuticals Inc.	Brooks BR, 2004, NEUROLOGY, V63, P1364; Chen YF, 2011, CONTEMP CLIN TRIALS, V32, P592, DOI 10.1016/j.cct.2011.04.006; CODD EE, 1995, J PHARMACOL EXP THER, V274, P1263; Cummings J, 2015, INT PSYCHOGERIATR, V27, P7, DOI 10.1017/S1041610214001963; Daly JP, 2012, PSYCHOSOMATICS, V53, P470, DOI 10.1016/j.psym.2011.11.001; Damaj MI, 2005, J PHARMACOL EXP THER, V312, P780, DOI 10.1124/jpet.104.075093; Doros G, 2013, STAT MED, V32, P2767, DOI 10.1002/sim.5728; Fava M, 2003, PSYCHOTHER PSYCHOSOM, V72, P115, DOI 10.1159/000069738; Fox C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035185; Fridericia LS, 2003, ANN NONINVAS ELECTRO, V8, P343, DOI 10.1046/j.1542-474X.2003.08413.x; Gilley DW, 2004, PSYCHOL MED, V34, P1129, DOI 10.1017/S0033291703001831; Gitlin LN, 2012, JAMA-J AM MED ASSOC, V308, P2020, DOI 10.1001/jama.2012.36918; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Herrmann N, 2011, CNS DRUGS, V25, P425, DOI 10.2165/11588160-000000000-00000; Herrmann N, 2007, DEMENT GERIATR COGN, V23, P116, DOI 10.1159/000097757; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Lopez OL, 2003, J NEUROPSYCH CLIN N, V15, P346, DOI 10.1176/appi.neuropsych.15.3.346; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mintzer JE, 2007, AM J GERIAT PSYCHIAT, V15, P918, DOI 10.1097/JGP.0b013e3181557b47; Nguyen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089985; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; PARSONS CG, 1995, NEUROPHARMACOLOGY, V34, P1239, DOI 10.1016/0028-3908(95)00092-K; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Rabins PV, 2013, ALZHEIMERS DEMENT, V9, P204, DOI 10.1016/j.jalz.2012.01.003; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; Salzman C, 2008, J CLIN PSYCHIAT, V69, P889, DOI 10.4088/JCP.v69n0602; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Soto M, 2015, INT PSYCHOGERIATR, V27, P181, DOI 10.1017/S1041610214001720; Tamura RN, 2007, CLIN TRIALS, V4, P309, DOI 10.1177/1740774507081217; Tariot PN, 2011, ARCH GEN PSYCHIAT, V68, P853, DOI 10.1001/archgenpsychiatry.2011.72; Tractenberg RE, 2003, J GERIATR PSYCH NEUR, V16, P94, DOI 10.1177/0891988703016002006; Trzepacz PT, 2013, INT PSYCHOGERIATR, V25, P707, DOI 10.1017/S1041610212002141; ZELLNER A, 1962, J AM STAT ASSOC, V57, P348, DOI 10.2307/2281644	34	112	119	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1242	1254		10.1001/jama.2015.10214	http://dx.doi.org/10.1001/jama.2015.10214			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393847	Bronze			2022-12-28	WOS:000362110700013
J	Schmidt-Hansen, M; Bennett, MI; Hilgart, J				Schmidt-Hansen, Mia; Bennett, Michael I.; Hilgart, Jennifer			Oxycodone for Cancer Pain in Adult Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schmidt-Hansen, Mia] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Bennett, Michael I.] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Hilgart, Jennifer] Univ South Wales, Welsh Inst Hlth & Social Care, Swansea, W Glam, Wales	University of Leeds; University of South Wales	Schmidt-Hansen, M (corresponding author), Natl Collaborating Ctr Canc, Pk House,Greyfriars Rd, Cardiff CF10 3AF, S Glam, Wales.	mia.schmidt-hansen@wales.nhs.uk	Bennett, Michael I/A-1620-2009; Hilgart, Jennifer/AAD-8659-2020	Bennett, Michael I/0000-0002-8369-8349; Hilgart, Jennifer/0000-0001-9688-5429				ARKINSTALL WW, 1989, CAN MED ASSOC J, V140, P653; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; National Institute for Health and Care Excellence, OP PALL CAR CG140; Portenoy RK, 2014, J CLIN ONCOL, V32, P1662, DOI 10.1200/JCO.2013.52.5188; Ripamonti CI, 2012, ANN ONCOL, V23, P139, DOI 10.1093/annonc/mds233; Schmidt-Hansen M, 2015, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003870	7	8	9	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1282	1283		10.1001/jama.2015.8556	http://dx.doi.org/10.1001/jama.2015.8556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393852	Green Published			2022-12-28	WOS:000362110700018
J	Richards, T				Richards, Tessa			Patient commentary: Consider the person alongside the pathology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Eigenmann F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4630; Mulley A. G., 2012, PATIENTS PREFERENCES; Richards T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6913	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4878	10.1136/bmj.h4878	http://dx.doi.org/10.1136/bmj.h4878			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26378063				2022-12-28	WOS:000361678800010
J	Chopra, V; Flanders, SA; Saint, S; Woller, SC; O'Grady, NP; Safdar, N; Trerotola, SO; Saran, R; Moureau, N; Wiseman, S; Pittiruti, M; Akl, EA; Lee, AY; Courey, A; Swaminathan, L; LeDonne, J; Becker, C; Krein, SL; Bernstein, SJ				Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay; Woller, Scott C.; O'Grady, Naomi P.; Safdar, Nasia; Trerotola, Scott O.; Saran, Rajiv; Moureau, Nancy; Wiseman, Stephen; Pittiruti, Mauro; Akl, Elie A.; Lee, Agnes Y.; Courey, Anthony; Swaminathan, Lakshmi; LeDonne, Jack; Becker, Carol; Krein, Sarah L.; Bernstein, Steven J.			The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method	ANNALS OF INTERNAL MEDICINE			English	Article							INSERTED CENTRAL CATHETERS; CENTRAL VENOUS CATHETERS; BLOOD-STREAM INFECTION; DEEP-VEIN THROMBOSIS; INTENSIVE-CARE-UNIT; HOME PARENTERAL-NUTRITION; RISK-FACTORS; UPPER-EXTREMITY; CANCER-PATIENTS; RETROSPECTIVE ANALYSIS	Use of peripherally inserted central catheters (PICCs) has grown substantially in recent years. Increasing use has led to the realization that PICCs are associated with important complications, including thrombosis and infection. Moreover, some PICCs may not be placed for clinically valid reasons. Defining appropriate indications for insertion, maintenance, and care of PICCs is thus important for patient safety. An international panel was convened that applied the RAND/UCLA Appropriateness Method to develop criteria for use of PICCs. After systematic reviews of the literature, scenarios related to PICC use, care, and maintenance were developed according to patient population (for example, general hospitalized, critically ill, cancer, kidney disease), indication for insertion (infusion of peripherally compatible infusates vs. vesicants), and duration of use (<= 5 days, 6 to 14 days, 15 to 30 days, or >= 31 days). Within each scenario, appropriateness of PICC use was compared with that of other venous access devices. After review of 665 scenarios, 253 (38%) were rated as appropriate, 124 (19%) as neutral/uncertain, and 288 (43%) as inappropriate. For peripherally compatible infusions, PICC use was rated as inappropriate when the proposed duration of use was 5 or fewer days. Midline catheters and ultrasonography-guided peripheral intravenous catheters were preferred to PICCs for use between 6 and 14 days. In critically ill patients, nontunneled central venous catheters were preferred over PICCs when 14 or fewer days of use were likely. In patients with cancer, PICCs were rated as appropriate for irritant or vesicant infusion, regardless of duration. The panel of experts used a validated method to develop appropriate indications for PICC use across patient populations. These criteria can be used to improve care, inform quality improvement efforts, and advance the safety of medical patients.	Univ Michigan, Sch Med, Patient Safety Enhancement Program, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA; [Chopra, Vineet] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; Oakwood Hosp, Dearborn, MI USA; Intermt Med Ctr, Murray, KY USA; Univ Utah, Sch Med, Salt Lake City, UT USA; NIH, Ctr Clin, Bethesda, MD 20892 USA; Greater Baltimore Med Ctr, Baltimore, MD USA; William S Middleton Mem Vet Affairs Hosp, Madison, WI USA; Univ Wisconsin, Sch Med, Div Infect Dis, Madison, WI USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; PICC Excellence, Hartwell, GA USA; Univ Cattolica Sacro Cuore, Rome, Italy; Amer Univ Beirut, Beirut, Lebanon; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Beaumont Health; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Greater Baltimore Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Pennsylvania Medicine; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; American University of Beirut; University of British Columbia	Chopra, V (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA.	vineetc@umich.edu	Krein, Sarah L/E-2742-2014; Pittiruti, Mauro/M-2259-2019; Saint, Sanjay/AAF-5126-2019; Woller, Scott C./AAV-6187-2021; Moureau, Nancy L/P-1084-2019; Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Krein, Sarah L/0000-0003-2111-8131; Woller, Scott C./0000-0002-2522-2705; Akl, Elie A/0000-0002-3444-8618; Bernstein, Steven/0000-0003-3359-7168; Chopra, Vineet/0000-0001-8670-9376; Moureau, Nancy/0000-0002-6338-0990; Meddings, Jennifer/0000-0001-9503-0293	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS022835] Funding Source: NIH RePORTER; AHRQ HHS [1-K08-HS022835-01, K08 HS022835] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Abdullah JJ, 2005, BRIT J RADIOL, V78, P596, DOI 10.1259/bjr/32639616; Ahn DH, 2013, J ONCOL PRACT, V9, pE8, DOI 10.1200/JOP.2012.000595; Akers Adam S, 2009, J Hosp Med, V4, pE1, DOI 10.1002/jhm.446; AKL EA, 2011, COCHRANE DATABASE; Al Raiy B, 2010, AM J INFECT CONTROL, V38, P149, DOI 10.1016/j.ajic.2009.06.008; Al-Tawfiq JA, 2012, ANN SAUDI MED, V32, P169, DOI 10.5144/0256-4947.2012.169; Alexandrou E, 2014, CRIT CARE MED, V42, P536, DOI 10.1097/CCM.0b013e3182a667f0; Alhimyary A, 1996, Nutr Clin Pract, V11, P199, DOI 10.1177/0115426596011005199; Alkindi Salam, 2012, J Infect Public Health, V5, P57, DOI 10.1016/j.jiph.2011.10.004; Allan ND, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/921617; Allen AW, 2000, J VASC INTERV RADIOL, V11, P1309, DOI 10.1016/S1051-0443(07)61307-4; *AM SOC NEPHROL, 2012, CHOOSING WISELY; Amerasekera SSH, 2009, CLIN RADIOL, V64, P832, DOI 10.1016/j.crad.2009.02.021; Anderson N Richard, 2004, J Infus Nurs, V27, P313, DOI 10.1097/00129804-200409000-00005; Anderson N Richard, 2005, Nursing, V35, P28; [Anonymous], 2011, J INFUS NURS; Armstrong SD, 2013, BURNS, V39, P632, DOI 10.1016/j.burns.2012.08.017; *ASSOC VASC ACCESS, 2011, POSITION STATEMENT; Aw A, 2012, THROMB RES, V130, P323, DOI 10.1016/j.thromres.2012.02.048; Bai XH, 2013, J CANCER RES THER, V9, P664, DOI 10.4103/0973-1482.126475; BAI YG, 2010, CHIN J CLIN NUTR, V18, P16; Barr DA, 2012, EUR J CLIN MICROBIOL, V31, P2611, DOI 10.1007/s10096-012-1604-z; BATES SM, 2012, CHEST E351S, V141; Baumgarten K, 2013, OCHSNER J, V13, P352; Baxi SM, 2013, INFECT CONT HOSP EP, V34, P785, DOI 10.1086/671266; Bellesi S, 2013, SUPPORT CARE CANCER, V21, P531, DOI 10.1007/s00520-012-1554-0; Bernstein SJ, 1999, HEART, V81, P470, DOI 10.1136/hrt.81.5.470; Bonciarelli G, 2011, J VASC ACCESS, V12, P292, DOI 10.5301/JVA.2011.7736; Bonizzoli M, 2011, INTENS CARE MED, V37, P284, DOI 10.1007/s00134-010-2043-x; BOTTINO J, 1979, CANCER, V43, P1937, DOI 10.1002/1097-0142(197905)43:5<1937::AID-CNCR2820430554>3.0.CO;2-T; Burg T, 2005, AM J OBSTET GYNECOL, V193, pS81, DOI 10.1016/j.ajog.2005.10.551; Burns Tim, 2010, Radiol Manage, V32, P28; Butler PJ, 2011, CARDIOVASC INTER RAD, V34, P120, DOI 10.1007/s00270-010-9974-z; Caparas JV, 2014, J VASC ACCESS, V15, P251, DOI 10.5301/jva.5000220; Cape AV, 2014, JPEN-PARENTER ENTER, V38, P595, DOI 10.1177/0148607113489994; Catalano O, 2011, ACTA RADIOL, V52, P148, DOI 10.1258/ar.2010.100294; Cavill I, 1997, BRIT J HAEMATOL, V98, P1041; Chakravarthy SB, 2005, CHEST, V128, p193S, DOI 10.1378/chest.128.4_MeetingAbstracts.193S-b; Chemaly RF, 2002, CLIN INFECT DIS, V34, P1179, DOI 10.1086/339808; Cheong K, 2004, INTERN MED J, V34, P234, DOI 10.1111/j.1444-0903.2004.00447.x; Chittick P, 2013, INFECT CONT HOSP EP, V34, P980, DOI 10.1086/671726; Chopra V, 2014, ANN INTERN MED, V161, P562, DOI 10.7326/M14-0703; Chopra V, 2014, AM J MED, V127, P319, DOI 10.1016/j.amjmed.2014.01.001; Chopra V, 2013, J HOSP MED, V8, P635, DOI 10.1002/jhm.2095; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Chopra V, 2013, J HOSP MED, V8, P309, DOI 10.1002/jhm.2031; Chopra V, 2012, JAMA-J AM MED ASSOC, V308, P1527, DOI 10.1001/jama.2012.12704; Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Connolly SM, 2012, DERMATOL SURG, V38, P1582, DOI 10.1111/j.1524-4725.2012.02574.x; CORESH J, 2014, JAMA-J AM MED ASSOC, V11, P2518; Cortelezza A, 2003, LEUKEMIA LYMPHOMA, V44, P1495, DOI 10.1080/1042819031000103980; Cotogni P, 2013, JPEN-PARENTER ENTER, V37, P375, DOI 10.1177/0148607112460552; Couban S, 2005, J CLIN ONCOL, V23, P4063, DOI 10.1200/JCO.2005.10.192; Crnich CJ, 2002, CLIN INFECT DIS, V34, P1362, DOI 10.1086/340105; Curigliano G, 2007, SUPPORT CARE CANCER, V15, P1213, DOI 10.1007/s00520-007-0277-0; Dal Molin A, 2014, J VASC ACCESS, V15, P241, DOI 10.5301/jva.5000225; Daneman N, 2012, J VASC INTERV RADIOL, V23, P123, DOI 10.1016/j.jvir.2011.09.024; Dariushnia SR, 2010, J VASC INTERV RADIOL, V21, P976, DOI 10.1016/j.jvir.2010.03.006; DAWSON RB, 2013, INFECT CONTROL TO, V42, P6; Debourdeau P, 2013, J THROMB HAEMOST, V11, P71, DOI 10.1111/jth.12071; Debourdeau P, 2009, ANN ONCOL, V20, P1459, DOI 10.1093/annonc/mdp052; Del Principe MI, 2013, THROMB RES, V132, P511, DOI 10.1016/j.thromres.2013.08.007; DeLemos C, 2011, CRIT CARE NURSE, V31, P70, DOI 10.4037/ccn2011911; Deutsch GB, 2014, J SURG RES, V191, P1, DOI 10.1016/j.jss.2013.03.047; Di Nisio M, 2010, J THROMB HAEMOST, V8, P684, DOI 10.1111/j.1538-7836.2010.03771.x; Diaz K, 2012, AM J INFECT CONTROL, V40, P65, DOI 10.1016/j.ajic.2011.03.018; Duerksen DR, 1999, JPEN-PARENTER ENTER, V23, P85, DOI 10.1177/014860719902300285; Durrani Q, 2009, CRIT CARE MED, V37, pA365; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Ters M, 2012, AM J KIDNEY DIS, V60, P601, DOI 10.1053/j.ajkd.2012.05.007; Elen Hughes Meinir, 2014, Br J Nurs, V23, pS14; Elia F, 2012, AM J EMERG MED, V30, P712, DOI 10.1016/j.ajem.2011.04.019; Elsharkawy H, 2009, MINERVA ANESTESIOL, V75, P471; Evans RS, 2013, CHEST, V143, P627, DOI 10.1378/chest.12-0923; Evans RS, 2010, CHEST, V138, P803, DOI 10.1378/chest.10-0154; Fagnani D, 2007, ANN ONCOL, V18, P551, DOI 10.1093/annonc/mdl431; Fearonce G, 2010, J BURN CARE RES, V31, P31, DOI 10.1097/BCR.0b013e3181cb8eaa; FITCH K, 2001, RAND UCLA APPROPRI; Fletcher JJ, 2011, NEUROCRIT CARE, V15, P454, DOI 10.1007/s12028-011-9554-3; Fletcher SJ, 2000, BRIT J ANAESTH, V85, P188; *FOOD DRUG ADM TAS, 1989, FDA DRUG BULL; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Frizzelli R, 2008, INTERN EMERG MED, V3, P325, DOI 10.1007/s11739-008-0142-2; Furuya EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015452; Gibson C, 2013, J VASC INTERV RADIOL, V24, P1323, DOI 10.1016/j.jvir.2013.04.010; Gong P, 2012, ASIAN PAC J CANCER P, V13, P1873, DOI 10.7314/APJCP.2012.13.5.1873; Goransson KE, 2012, J VASC ACCESS, V13, P16, DOI 10.5301/JVA.2011.8418; Grant JD, 2008, J INVEST MED, V56, P131; Grant JD, 2012, THROMB HAEMOSTASIS, V108, P1097, DOI 10.1160/TH12-05-0352; Gregg SC, 2010, J CRIT CARE, V25, P514, DOI 10.1016/j.jcrc.2009.09.003; Griffiths Vivien, 2007, Nurs Stand, V22, P48; Grove JR, 2000, J VASC INTERV RADIOL, V11, P837, DOI 10.1016/S1051-0443(07)61797-7; Gunst M, 2011, SURG INFECT, V12, P279, DOI 10.1089/sur.2008.058; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hadaway L, 2011, J ASS VASC ACCESS, V16, P20, DOI [10.2309/java.16-1-4, DOI 10.2309/JAVA.16-1-4]; HADAWAY L, 2001, J VASC ACCESS DEV, P33; Hadaway L, 2012, AM J NURS, V112, P32, DOI 10.1097/01.NAJ.0000422253.72836.c1; Hadaway L, 2012, J INFUS MURS, V35, P230, DOI 10.1097/NAN.0b013e31825af099; Harnage Sophie, 2012, Br J Nurs, V21, pS10; Hornsby S, 2005, J INFUS MURS, V28, P45, DOI 10.1097/00129804-200501000-00006; HOSHAL VL, 1975, ARCH SURG-CHICAGO, V110, P644; Hughes ME, 2011, J ASS VASC ACCESS, V16, P8, DOI [10.2309/java.16-1-3, DOI 10.2309/JAVA.16-1-3]; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Itkin M, 2014, J VASC INTERV RADIOL, V25, P85, DOI 10.1016/j.jvir.2013.10.009; Jin JF, 2013, J CLIN NURS, V22, P1791, DOI 10.1111/jocn.12004; Joffe HV, 2002, CIRCULATION, V106, P1874, DOI 10.1161/01.CIR.0000031705.57473.1C; Johansson E, 2013, ACTA ONCOL, V52, P1241, DOI 10.3109/0284186X.2013.806820; Johansson E, 2013, ACTA ONCOL, V52, P886, DOI 10.3109/0284186X.2013.773072; Johnston AJ, 2012, J VASC ACCESS, V13, P421, DOI 10.5301/jva.5000071; Jones MA, 2010, J VASC SURG, V51, P108, DOI 10.1016/j.jvs.2009.07.124; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kelly Linda J, 2013, Br J Nurs, V22, pS18; King MM, 2006, SOUTH MED J, V99, P1073, DOI 10.1097/01.smj.0000240707.22171.12; Konstantinou EA, 2012, J VASC NURS, V30, P88, DOI 10.1016/j.jvn.2012.03.001; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; Latham HE, 2012, J CLIN MONIT COMPUT, V26, P85, DOI 10.1007/s10877-012-9337-1; Lawson EH, 2012, J CLIN EPIDEMIOL, V65, P1133, DOI 10.1016/j.jclinepi.2012.07.002; Lee A, 2008, THROMB RES, V123, pS50, DOI 10.1016/j.thromres.2008.08.017; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; Lelkes V, 2013, CLIN IMAG, V37, P917, DOI 10.1016/j.clinimag.2013.04.009; Leroyer C, 2013, MED MALADIES INFECT, V43, P350, DOI 10.1016/j.medmal.2013.06.013; Leung TK, 2011, CANCER NURS, V34, pE25, DOI 10.1097/NCC.0b013e3181f1ad6f; Leung TK, 2006, BIO-MED MATER ENG, V16, P183; Li J, 2014, EUR J ONCOL NURS, V18, P94, DOI 10.1016/j.ejon.2013.08.003; Liu YT, 2014, EUR J EMERG MED, V21, P18, DOI 10.1097/MEJ.0b013e328363bebc; Llorente C, 2011, J EVAL CLIN PRACT, V17, P188, DOI 10.1111/j.1365-2753.2010.01421.x; Lobo BL, 2009, J HOSP MED, V4, P417, DOI 10.1002/jhm.442; Lopez-Briz E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008462.pub2; LOUPUS D, 2008, J ASS VASC ACCESS, V13, P82; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Malinoski D, 2013, J TRAUMA ACUTE CARE, V74, P454, DOI 10.1097/TA.0b013e31827a0b2f; Marnejon T, 2012, J VASC ACCESS, V13, P231, DOI 10.5301/jva.5000039; Marschall J, 2014, INFECT CONT HOSP EP, V35, P753, DOI [10.1086/676533, 10.1017/S0899823X00193870]; Meddings J, 2015, ANN INTERN MED, V162, pS1, DOI 10.7326/M14-1304; Meddings J, 2014, BMJ QUAL SAF, V23, P277, DOI 10.1136/bmjqs-2012-001774; MERMEL LA, 1995, ANN INTERN MED, V123, P841, DOI 10.7326/0003-4819-123-11-199512010-00005; Mermis Joel D, 2014, Ann Am Thorac Soc, V11, P1404, DOI 10.1513/AnnalsATS.201404-175OC; MERRELL SW, 1994, WESTERN J MED, V160, P25; Meyer BM, 2011, J ASS VASC ACCESS, V16, P144, DOI [10.2309/java.16-3-3, DOI 10.2309/JAVA.16-3-3]; Meyer BM, 2012, J INFUS MURS, V35, P34, DOI 10.1097/NAN.0b013e31823bc8fd; Meyer P, 2014, J CRIT CARE, V29, P823, DOI 10.1016/j.jcrc.2014.04.022; *MICHIGAN HOSP MED, 2013, VENOUS THROMBOEM; Milstone AM, 2010, INFECT CONT HOSP EP, V31, P1184, DOI 10.1086/656589; Minkovich L, 2011, CAN J ANESTH, V58, P709, DOI 10.1007/s12630-011-9512-8; Miyagaki H, 2012, CLIN NUTR, V31, P48, DOI 10.1016/j.clnu.2011.09.002; Mollee P, 2011, J HOSP INFECT, V78, P26, DOI 10.1016/j.jhin.2011.01.018; Morden P, 2014, AM J ROENTGENOL, V202, pW13, DOI 10.2214/AJR.13.10625; Moureau N, 2013, BRIT J ANAESTH, V110, P347, DOI 10.1093/bja/aes499; Moureau N, 2002, J VASC INTERV RADIOL, V13, P1009, DOI 10.1016/S1051-0443(07)61865-X; Mukherjee S, 2001, BRIT J CANCER, V85, P66; Nash EF, 2009, J VASC INTERV RADIOL, V20, P347, DOI 10.1016/j.jvir.2008.11.018; *NATL KID FDN, 2013, KIDNEY INT, P1; Nifong TP, 2011, CHEST, V140, P48, DOI 10.1378/chest.10-2637; NUNOO RHO, 2011, J AM COLL SURGEONS, V213, pS23; O'Brien J, 2013, J AM COLL RADIOL, V10, P864, DOI 10.1016/j.jacr.2013.06.003; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2011, CLEV CLIN J MED, V78, P10, DOI 10.3949/ccjm.77a.10015; Oliver Gemma, 2014, Br J Nurs, V23 Suppl 19, pS10, DOI 10.12968/bjon.2014.23.Sup19.S10; Ong B, 2006, Australas Radiol, V50, P451, DOI 10.1111/j.1440-1673.2006.01623.x; Paauw JD, 2008, JPEN-PARENTER ENTER, V32, P443, DOI 10.1177/0148607108319801; PARI C, 2011, J VASC ACCESS, V12, P81; Patel BM., 2007, J PATIENT SAF, V3, P142, DOI DOI 10.1097/PTS.0B013E31813E33E5; Patel GS, 2014, SUPPORT CARE CANCER, V22, P121, DOI 10.1007/s00520-013-1941-1; Paz-Fumagalli R, 1997, J Spinal Cord Med, V20, P341; Penney-Timmons Elayne, 2004, J Infus Nurs, V27, P431, DOI 10.1097/00129804-200411000-00009; Periard D, 2008, J THROMB HAEMOST, V6, P1281, DOI 10.1111/j.1538-7836.2008.03053.x; Periard D, 2010, LEUKEMIA LYMPHOMA, V51, P1391, DOI 10.3109/10428194.2010.508824; Petree Cindy, 2012, Radiol Technol, V83, P532; Pikwer A, 2012, ANAESTHESIA, V67, P65, DOI 10.1111/j.1365-2044.2011.06911.x; Pingleton SK, 2013, ACAD MED, V88, P1454, DOI 10.1097/ACM.0b013e3182a4aa51; Pittiruti M, 2015, J CARDIOTHOR VASC AN, V29, P491, DOI 10.1053/j.jvca.2014.05.020; Pittiruti M, 2012, CRIT CARE, V16, DOI 10.1186/cc11181; Pittiruti M, 2009, CLIN NUTR, V28, P365, DOI 10.1016/j.clnu.2009.03.015; Pongruangporn M, 2013, INFECT CONT HOSP EP, V34, P184, DOI 10.1086/669083; Potet J, 2013, EUR RADIOL, V23, P2042, DOI 10.1007/s00330-013-2778-1; Qiu XX, 2014, INT J NURS STUD, V51, P955, DOI 10.1016/j.ijnurstu.2013.10.021; RAAD II, 1994, JAMA-J AM MED ASSOC, V271, P1014, DOI 10.1001/jama.271.13.1014; Richters A, 2014, BONE MARROW TRANSPL, V49, P264, DOI 10.1038/bmt.2013.172; Rickard CM, 2012, LANCET, V380, P1066, DOI 10.1016/S0140-6736(12)61082-4; Robinson MK, 2005, JPEN-PARENTER ENTER, V29, P374, DOI 10.1177/0148607105029005374; Romagnoli E, 2010, THROMB RES, V125, pS170, DOI 10.1016/S0049-3848(10)70066-9; Ros M, 2005, EJC SUPPL, V3, P442; ROSENTHAL K, 2008, NURSING, V38; RUPP SM, 2012, ANESTHESIOLOGY, V116, P539, DOI DOI 10.1097/ALN.0B013E31823C9569; Rutkoff GS, 2014, J ASS VASC ACCESS, V19, P172, DOI [10.1016/j.java.2014.06.002, DOI 10.1016/J.JAVA.2014.06.002]; Saber W, 2011, J THROMB HAEMOST, V9, P312, DOI 10.1111/j.1538-7836.2010.04126.x; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; SANSIVERO G, 2011, J VASC ACCESS, V12, P81, DOI DOI 10.5301/JVA.2011.6368; Santolim Thais Queiroz, 2012, Br J Nurs, V21, pS30; Santori G, 2008, TRANSPL P, V40, P2021, DOI 10.1016/j.transproceed.2008.05.018; Sasadeusz KJ, 1999, RADIOLOGY, V213, P303, DOI 10.1148/radiology.213.1.r99se12303; Schimp VL, 2003, GYNECOL ONCOL, V89, P301, DOI 10.1016/S0090-8258(03)00074-X; Seeley MA, 2007, J INFUS MURS, V30, P280; Sharp R, 2014, INT J NURS STUD, V51, P694, DOI 10.1016/j.ijnurstu.2013.09.002; Shea CD, 2006, AM J GASTROENTEROL, V101, pS460, DOI 10.14309/00000434-200609001-01180; Simcock L., 2008, J ASS VASC ACCESS, V13, P191, DOI [10.2309/java.13-4-6, DOI 10.2309/JAVA.13-4-6]; Simonova G, 2012, ANAESTH INTENS CARE, V40, P460, DOI 10.1177/0310057X1204000311; Skaff ER, 2012, LEUKEMIA LYMPHOMA, V53, P1090, DOI 10.3109/10428194.2011.639879; Skiest DJ, 2000, CLIN INFECT DIS, V30, P949, DOI 10.1086/313822; Smith JR, 1998, AM J SURG, V176, P208, DOI 10.1016/S0002-9610(98)00121-4; Smith RN, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6570; Snelling R, 2001, J Intraven Nurs, V24, P38; *SOC GEN INT MED, 2015, CHOOSING WISELY; Song LP, 2013, EXP THER MED, V6, P891, DOI 10.3892/etm.2013.1267; Sperry BW, 2012, J VASC ACCESS, V13, P91, DOI 10.5301/jva.5000014; Stokowski G, 2009, J INFUS MURS, V32, P145, DOI 10.1097/NAN.0b013e3181a1a98f; Strahilevitz J, 2001, LEUKEMIA LYMPHOMA, V40, P365, DOI 10.3109/10428190109057936; Tejedor SC, 2012, INFECT CONT HOSP EP, V33, P50, DOI 10.1086/663645; Thakarar K, 2014, AM J INFECT CONTROL, V42, P417, DOI 10.1016/j.ajic.2013.11.016; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Tiwari MM, 2011, J HOSP INFECT, V78, P128, DOI 10.1016/j.jhin.2011.03.004; Toure A, 2015, CLIN NUTR, V34, P49, DOI 10.1016/j.clnu.2013.12.017; Tran H, 2010, LEUKEMIA LYMPHOMA, V51, P1473, DOI 10.3109/10428194.2010.481065; Trerotola SO, 2007, J VASC INTERV RADIOL, V18, P513, DOI 10.1016/j.jvir.2007.01.020; Trerotola SO, 2010, RADIOLOGY, V256, P312, DOI 10.1148/radiol.10091860; Trick WE, 2004, INFECT CONT HOSP EP, V25, P266, DOI 10.1086/502390; Tuffaha HW, 2014, APPL HEALTH ECON HEA, V12, P51, DOI 10.1007/s40258-013-0077-2; Turcotte S, 2006, WORLD J SURG, V30, P1605, DOI 10.1007/s00268-005-0174-y; Ugas Mohamed Ali, 2012, Ann Surg Innov Res, V6, P8, DOI 10.1186/1750-1164-6-8; Van Rooden CJ, 2005, J THROMB HAEMOST, V3, P2409, DOI 10.1111/j.1538-7836.2005.01398.x; Vesely TM, 2003, J VASC INTERV RADIOL, V14, P527, DOI 10.1097/01.RVI.0000071097.76348.72; Vidal V, 2008, J RADIOL, V89, P495, DOI 10.1016/S0221-0363(08)71453-7; Vizcarra C, 2014, J INFUS MURS, V37, P121, DOI 10.1097/NAN.0000000000000028; Walker G., 2013, BR J NURS, V22, pS9, DOI DOI 10.12968/BJ0N.2013.22.SUP19.S9; Wallis MC, 2014, INFECT CONT HOSP EP, V35, P63, DOI 10.1086/674398; Walshe LJ, 2002, J CLIN ONCOL, V20, P3276, DOI 10.1200/JCO.2002.11.135; Webster J, 2013, COCHRANE DB SYST REV, V4; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Wilson TJ, 2012, INTENS CARE MED, V38, P272, DOI 10.1007/s00134-011-2418-7; Wojnar DG, 2013, J INFUS MURS, V36, P291, DOI 10.1097/NAN.0b013e318297c1a8; Worley TA, 2007, CHEST, V132, p492S; Worth LJ, 2009, SUPPORT CARE CANCER, V17, P811, DOI 10.1007/s00520-008-0561-7; Xing L, 2012, ASIA-PAC J CLIN ONCO, V8, pE12, DOI 10.1111/j.1743-7563.2011.01508.x; Yamada R, 2010, J PAIN SYMPTOM MANAG, V40, P60, DOI 10.1016/j.jpainsymman.2009.11.327; Yap YS, 2006, EUR J CANCER CARE, V15, P342, DOI 10.1111/j.1365-2354.2006.00664.x; Yi XL, 2014, J CLIN NURS, V23, P837, DOI 10.1111/jocn.12227; Yue Zhi-Ying, 2010, Hu Li Za Zhi, V57, P79; Zhu MW, 2008, CHIN J CLIN NUTR, V16, P160; Zingg W, 2011, J HOSP INFECT, V77, P304, DOI 10.1016/j.jhin.2010.11.011; Zochios V, 2014, J VASC ACCESS, V15, P329, DOI 10.5301/jva.5000239; Zwicker JI, 2014, J THROMB HAEMOST, V12, P796, DOI 10.1111/jth.12527; [No title captured], DOI DOI 10.2309/JAVA.12-4-8	244	271	282	10	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6		S			S1	+		10.7326/M15-0744	http://dx.doi.org/10.7326/M15-0744			48	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FV	26369828				2022-12-28	WOS:000361367000001
J	Laski, L				Laski, Laura		Expert Consultative Grp Every	Realising the health and wellbeing of adolescents	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Laski, Laura; Expert Consultative Grp Every] United Nations Populat Fund, Tech Div, Sexual & Reprod Hlth Branch, New York, NY 10158 USA	United Nations Population Fund	Laski, L (corresponding author), United Nations Populat Fund, Tech Div, Sexual & Reprod Hlth Branch, New York, NY 10158 USA.	laski@unfpa.org	Patton, George C/B-5246-2013	Patton, George C/0000-0001-5039-8326; Matthews, Zoe/0000-0003-1533-6618; Neal, Sarah/0000-0003-1812-7221				Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; High Level Task Force for ICPD, 2015, SMART INV FIN POST 2; International Planned Parenthood Foundation CORAM, 2014, OV PROT SERV MULT ST; Mahy M, 2014, EPIDEMIOLOGICAL SUMM; McCoy D, 2009, HEALTH POLICY PLANN, V24, P321, DOI 10.1093/heapol/czp033; Moscicki AB, 2007, DIS MARKERS, V23, P229, DOI 10.1155/2007/136906; UNFPA, 2011, MARR TOO YOUNG; UNFPA, 2014, STAT WORLD POP POW 1; UNFPA State of the World Population, 2013, MOTH CHILDH; Unicef, 2014, HIDD PLAIN SIGHT STA; United Nations Population Fund (UNFPA), 2011, POP DYN LEAST DEV CO; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Vogel JP, 2015, ARCH DIS CHILD, V100, pS43, DOI 10.1136/archdischild-2013-305514; Waddington C, 2014, B WORLD HEALTH ORGAN, V93, P57; Warstrom, 2014, MENTIMETER; WHO, 2014, HLTH WORLDS AD 2 CHA; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2007, HELP PAR DEV COUNTR	19	24	25	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4119	10.1136/bmj.h4119	http://dx.doi.org/10.1136/bmj.h4119			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371214	Green Accepted, hybrid			2022-12-28	WOS:000361678200002
J	Lau, W; Sattely, ES				Lau, Warren; Sattely, Elizabeth S.			Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone	SCIENCE			English	Article							PODOPHYLLUM-HEXANDRUM; ARYLTETRALIN LIGNANS; CLONING; PURIFICATION; EXPRESSION; REDUCTASE; PROTEIN; YEAST	Podophyllotoxin is the natural product precursor of the chemotherapeutic etoposide, yet only part of its biosynthetic pathway is known. We used transcriptome mining in Podophyllum hexandrum (mayapple) to identify biosynthetic genes in the podophyllotoxin pathway. We selected 29 candidate genes to combinatorially express in Nicotiana benthamiana (tobacco) and identified six pathway enzymes, including an oxoglutarate-dependent dioxygenase that closes the core cyclohexane ring of the aryltetralin scaffold. By coexpressing 10 genes in tobacco-these 6 plus 4 previously discovered-we reconstitute the pathway to (-)-4'-desmethylepipodophyllotoxin (the etoposide aglycone), a naturally occurring lignan that is the immediate precursor of etoposide and, unlike podophyllotoxin, a potent topoisomerase inhibitor. Our results enable production of the etoposide aglycone in tobacco and circumvent the need for cultivation of mayapple and semisynthetic epimerization and demethylation of podophyllotoxin.	[Lau, Warren; Sattely, Elizabeth S.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Sattely, ES (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	sattely@stanford.edu			NIH [R00 GM089985, DP2 AT008321]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [DP2AT008321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM089985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants R00 GM089985 and DP2 AT008321 (E.S.S.). We thank J. Rajniak, A. P. Klein, and M. Voges (Stanford) for critical reading of the manuscript, and members of the Sattely lab for helpful discussions. We thank J.-G. Kim (Stanford) for assistance with N. benthamiana transient expression, quantitative reverse transcription polymerase chain reactions (qRT-PCR) and RNA-Seq library preparation, G. Lomonossoff (John Innes Centre) for plasmid pEAQ, and D. Nelson for CYP nomenclature assignment. We thank the Stanford Center for Genomics and Personalized Medicine for RNA sequencing services and the Stanford Genetics Bioinformatics Service Center for computational resources. Gene sequences have been deposited into GenBank (accession numbers: KT390155 to KT390182). RNA Sequencing data have been deposited into the National Center for Biotechnology Information, NIH, Sequence Read Archive (accession number: SRP061783). E.S.S., W.L., and Stanford University have filed a provisional patent application. Supplementary materials contain additional data.	BROOMHEAD AJ, 1991, PHYTOCHEMISTRY, V30, P1489, DOI 10.1016/0031-9422(91)84194-W; Brown S, 2015, P NATL ACAD SCI USA, V112, P3205, DOI 10.1073/pnas.1423555112; Canel C, 2000, PHYTOCHEMISTRY, V54, P115, DOI 10.1016/S0031-9422(00)00094-7; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; DinkovaKostova AT, 1996, J BIOL CHEM, V271, P29473, DOI 10.1074/jbc.271.46.29473; Gordaliza M, 2004, TOXICON, V44, P441, DOI 10.1016/j.toxicon.2004.05.008; JACKSON DE, 1984, PHYTOCHEMISTRY, V23, P1037, DOI 10.1016/S0031-9422(00)82604-7; JACKSON DE, 1984, PHYTOCHEMISTRY, V23, P1147, DOI 10.1016/S0031-9422(00)82628-X; Kamal A, 2015, EXPERT OPIN THER PAT, V25, P1025, DOI 10.1517/13543776.2015.1051727; KAMIL WM, 1986, PHYTOCHEMISTRY, V25, P2093, DOI 10.1016/0031-9422(86)80072-3; KAMIL WM, 1986, PHYTOCHEMISTRY, V25, P2089, DOI 10.1016/0031-9422(86)80071-1; Lata H, 2009, METHODS MOL BIOL, V547, P387, DOI 10.1007/978-1-60327-287-2_31; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Nag A., 2011, J CELL PLANT SCI, V2, P19; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Qua Y, 2015, P NATL ACAD SCI USA, V112, P6224, DOI 10.1073/pnas.1501821112; Rajesh M, 2013, PLANT CELL TISS ORG, V114, P71, DOI 10.1007/s11240-013-0307-1; STAHELIN HF, 1991, CANCER RES, V51, P5; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Wankhede DP, 2013, PROTOPLASMA, V250, P1239, DOI 10.1007/s00709-013-0505-z; Xia ZQ, 2001, J BIOL CHEM, V276, P12614, DOI 10.1074/jbc.M008622200	24	223	253	15	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1224	1228		10.1126/science.aac7202	http://dx.doi.org/10.1126/science.aac7202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359402	Green Accepted			2022-12-28	WOS:000360968400043
J	O'Connor, SE				O'Connor, Sarah E.			Fighting cancer while saving the mayapple	SCIENCE			English	Editorial Material							ETOPOSIDE		John Innes Ctr, Dept Biol Chem, Norwich NR4 7UK, Norfolk, England		O'Connor, SE (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UK, Norfolk, England.	markus.arndt@univie.ac.at						Chazin ED, 2014, MINI-REV MED CHEM, V14, P953, DOI 10.2174/1389557514666141029233037; Farkya S, 2004, APPL MICROBIOL BIOT, V65, P504, DOI 10.1007/s00253-004-1680-9; Fu Y, 2009, CURR MED CHEM, V16, P3966, DOI 10.2174/092986709789352277; Keglevich P, 2012, MOLECULES, V17, P5893, DOI 10.3390/molecules17055893; Lau W, 2015, SCIENCE, V349, P1224, DOI 10.1126/science.aac7202; McChesney JD, 2007, PHYTOCHEMISTRY, V68, P2015, DOI 10.1016/j.phytochem.2007.04.032; Nag A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu076; Sainsbury F, 2014, CURR OPIN PLANT BIOL, V19, P1, DOI 10.1016/j.pbi.2014.02.003; STAHELIN HF, 1991, CANCER RES, V51, P5	9	5	5	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1167	1168		10.1126/science.aad1801	http://dx.doi.org/10.1126/science.aad1801			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359390				2022-12-28	WOS:000360968400023
J	Littman, DR				Littman, Dan R.			Releasing the Brakes on Cancer Immunotherapy	CELL			English	Editorial Material							T-CELLS; ANTI-PD-1 ANTIBODY; IN-VITRO; CTLA-4; CD28; VIVO	This year's Lasker similar to DeBakey Clinical Research Award goes to James Allison for discovering that antibody blockade of the T cell molecule CTLA-4 unleashes the body's immune response against malignant tumors. This has led to development of multiple "immune checkpoint therapies'' that are prolonging and saving the lives of thousands of cancer patients.	[Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Littman, Dan R.] Howard Hughes Med Inst, Chevy Chase, MD USA	New York University; Howard Hughes Medical Institute	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.	dan.littman@med.nyu.edu						HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoos A, 2007, J IMMUNOTHER, V30, P1, DOI 10.1097/01.cji.0000211341.88835.ae; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	14	79	83	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1186	1190		10.1016/j.cell.2015.08.038	http://dx.doi.org/10.1016/j.cell.2015.08.038			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359975	Bronze			2022-12-28	WOS:000361247900004
J	Pham, HH; Pilotte, J; Rajkumar, R; Richter, E; Cavanaugh, S; Conway, PH				Pham, Hoangmai H.; Pilotte, John; Rajkumar, Rahul; Richter, Elizabeth; Cavanaugh, Sean; Conway, Patrick H.			Medicare's Vision for Delivery-System Reform - The Role of ACOs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pham, Hoangmai H.; Pilotte, John; Rajkumar, Rahul; Richter, Elizabeth; Cavanaugh, Sean; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Pham, HH (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA.							Department of Health and Human Services, 2015, BETT SMART HEALTH HI; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Pham HH, 2014, JAMA-J AM MED ASSOC, V312, P1635, DOI 10.1001/jama.2014.13109	3	12	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					987	990		10.1056/NEJMp1507319	http://dx.doi.org/10.1056/NEJMp1507319			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ9TV	26352812				2022-12-28	WOS:000360959000002
J	Zhang, W; Cheng, LE; Kittelmann, M; Li, JF; Petkovic, M; Cheng, T; Jin, P; Guo, ZH; Gopfert, MC; Jan, LY; Jan, YN				Zhang, Wei; Cheng, Li E.; Kittelmann, Maike; Li, Jiefu; Petkovic, Maja; Cheng, Tong; Jin, Peng; Guo, Zhenhao; Goepfert, Martin C.; Jan, Lily Yeh; Jan, Yuh Nung			Ankyrin Repeats Convey Force to Gate the NOMPC Mechanotransduction Channel	CELL			English	Article							TRP CHANNEL; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ION-CHANNEL; DROSOPHILA; TRANSDUCTION; FAMILY; TRAAK; MECHANISMS; MEMBRANE	Howmetazoanmechanotransduction channels sense mechanical stimuli is not well understood. The NOMPC channel in the transient receptor potential (TRP) family, a mechanotransduction channel for Drosophila touch sensation and hearing, contains 29 Ankyrin repeats (ARs) that associate with microtubules. These ARs have been postulated to act as a tether that conveys force to the channel. Here, we report that these N-terminal ARs form a cytoplasmicdomain essential forNOMPC mechanogating in vitro, mechanosensitivity of touch receptor neurons in vivo, and touch-induced behaviors of Drosophila larvae. Duplicating the ARs elongates the filaments that tether NOMPC to microtubules in mechanosensory neurons. Moreover, microtubule association is required for NOMPC mechanogating. Importantly, transferring the NOMPC ARs to mechanoinsensitive voltage-gated potassium channels confers mechanosensitivity to the chimeric channels. These experiments strongly support a tethermechanismofmechanogating for the NOMPC channel, providing insights into the basis ofmechanosensitivity ofmechanotransduction channels.	[Zhang, Wei; Cheng, Li E.; Li, Jiefu; Petkovic, Maja; Cheng, Tong; Jin, Peng; Guo, Zhenhao; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; [Zhang, Wei; Cheng, Li E.; Li, Jiefu; Petkovic, Maja; Cheng, Tong; Jin, Peng; Guo, Zhenhao; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA; [Zhang, Wei; Cheng, Li E.; Li, Jiefu; Petkovic, Maja; Cheng, Tong; Jin, Peng; Guo, Zhenhao; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94158 USA; [Kittelmann, Maike; Goepfert, Martin C.] Univ Gottingen, Dept Cellular Neurobiol, D-37077 Gottingen, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Gottingen	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu	889, CRC/L-1607-2018; zhang, wei/H-7371-2014; /M-8065-2017	889, CRC/0000-0002-6678-3138; zhang, wei/0000-0002-1648-3364; Gopfert, Martin/0000-0001-8201-5334; /0000-0002-0062-4652; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; Kittelmann, Maike/0000-0002-9710-1136	DFG [SPP 1608 GO 1092/2-1, GO 1092/1-2, SFB 889 A1]; BRAINseed award; NIH [R37NS040929, 5R01MH084234]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929, R01NS040929] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); BRAINseed award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Zuker (Columbia University) for fly lines and J. Howard (Yale University) for a NOMPC antibody. We thank S.Q. Zhang and H.H. Yang for help on chimeric protein design, S. Yadav for assistance on antibody staining, D. Kamiyama and M. He for assistance on TIRF microscopy, and J. Trimmer for Kv2.1 clones. We thank S. Younger, S. Barbel, and M. Winkler for technical support and members of the Y.N.J. and M.C.G. labs for their discussion. This work was supported by DFG grants (SPP 1608 GO 1092/2-1, GO 1092/1-2, and SFB 889 A1) (to M.C.G.), a BRAINseed award (to Y.N.J., P.A., and Y.W.J.), and NIH grants (R37NS040929 and 5R01MH084234) (to Y.N.J.). L.Y.J. and Y.N.J. are investigators of the Howard Hughes Medical Institute.	Anishkin A, 2013, P NATL ACAD SCI USA, V110, P4886, DOI 10.1073/pnas.1302018110; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bechstedt S, 2008, CURR BIOL, V18, pR869, DOI 10.1016/j.cub.2008.07.069; Boekhoff-Falk G, 2005, DEV DYNAM, V232, P550, DOI 10.1002/dvdy.20207; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chadha A, 2015, NEUROSCI LETT, V597, P111, DOI 10.1016/j.neulet.2015.04.033; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gong JX, 2013, EUR J NEUROSCI, V38, P2057, DOI 10.1111/ejn.12214; Grillet N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.285pt5; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kalia J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01523; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Liang X, 2013, CURR BIOL, V23, P755, DOI 10.1016/j.cub.2013.03.065; Liang X, 2011, CYTOSKELETON, V68, P1, DOI 10.1002/cm.20493; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Montell C, 2004, NOVART FDN SYMP, V258, P263; Montell C, 2004, NOVART FDN SYMP, V258, P12; Montell C, 2004, NOVART FDN SYMP, V258, P98; Montell Craig, 2004, Novartis Found Symp, V258, P3; Morgan CP, 2013, CURR BIOL, V23, pR887, DOI 10.1016/j.cub.2013.08.031; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Phillips KR, 2008, CURR OPIN OTOLARYNGO, V16, P445, DOI 10.1097/MOO.0b013e32830f4ac8; Prager-Khoutorsky M, 2014, NEURON, V83, P866, DOI 10.1016/j.neuron.2014.07.023; Ramdya P, 2015, NATURE, V519, P233, DOI 10.1038/nature14024; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Sotomayor M, 2005, BIOPHYS J, V88, p288A; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Tsubouchi A, 2012, CURR BIOL, V22, P2124, DOI 10.1016/j.cub.2012.09.019; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Yang YW, 1998, STRUCTURE, V6, P619, DOI 10.1016/S0969-2126(98)00063-X; Zanini D, 2013, CURR BIOL, V23, pR349, DOI 10.1016/j.cub.2013.03.045; Zhang W, 2014, ELIFE, V3, DOI 10.7554/eLife.03293; Zhang W, 2013, P NATL ACAD SCI USA, V110, P13612, DOI 10.1073/pnas.1312477110	56	126	130	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1391	1403		10.1016/j.cell.2015.08.024	http://dx.doi.org/10.1016/j.cell.2015.08.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359990	Green Accepted, Bronze			2022-12-28	WOS:000361247900026
J	Stoll, BJ; Hansen, NI; Bell, EF; Walsh, MC; Carlo, WA; Shankaran, S; Laptook, AR; Sanchez, PJ; Van Meurs, KP; Wyckoff, M; Das, A; Hale, EC; Ball, MB; Newman, NS; Schibler, K; Poindexter, BB; Kennedy, KA; Cotten, CM; Watterberg, KL; D'Angio, CT; DeMauro, SB; Truog, WE; Devaskar, U; Higgins, RD				Stoll, Barbara J.; Hansen, Nellie I.; Bell, Edward F.; Walsh, Michele C.; Carlo, Waldemar A.; Shankaran, Seetha; Laptook, Abbot R.; Sanchez, Pablo J.; Van Meurs, Krisa P.; Wyckoff, Myra; Das, Abhik; Hale, Ellen C.; Ball, M. Bethany; Newman, Nancy S.; Schibler, Kurt; Poindexter, Brenda B.; Kennedy, Kathleen A.; Cotten, C. Michael; Watterberg, Kristi L.; D'Angio, Carl T.; DeMauro, Sara B.; Truog, William E.; Devaskar, Uday; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst	Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT OUTCOMES; LATE-ONSET SEPSIS; NATIONAL-INSTITUTE; CHILD-HEALTH; RESEARCH NETWORK; NECROTIZING ENTEROCOLITIS; ANTENATAL CORTICOSTEROIDS; PREMATURE-INFANTS; WEEKS GESTATION; SURVIVAL	IMPORTANCE Extremely preterm infants contribute disproportionately to neonatal morbidity and mortality. OBJECTIVE To review 20-year trends in maternal/neonatal care, complications, and mortality among extremely preterm infants born at Neonatal Research Network centers. DESIGN, SETTING, PARTICIPANTS Prospective registry of 34 636 infants, 22 to 28 weeks' gestation, birth weight of 401 to 1500 g, and born at 26 network centers between 1993 and 2012. EXPOSURES Extremely preterm birth. MAIN OUTCOMES AND MEASURES Maternal/neonatal care, morbidities, and survival. Major morbidities, reported for infants who survived more than 12 hours, were severe necrotizing enterocolitis, infection, bronchopulmonary dysplasia, severe intracranial hemorrhage, cystic periventricular leukomalacia, and/or severe retinopathy of prematurity. Regression models assessed yearly changes and were adjusted for study center, race/ethnicity, gestational age, birth weight for gestational age, and sex. RESULTS Use of antenatal corticosteroids increased from 1993 to 2012 (24%[348 of 1431 infants]) to 87%(1674 of 1919 infants]; P < .001), as did cesarean delivery (44%[625 of 1431 births] to 64%[1227 of 1921]; P < .001). Delivery room intubation decreased from 80%(1144 of 1433 infants) in 1993 to 65%(1253 of 1922) in 2012 (P < .001). After increasing in the 1990s, postnatal steroid use declined to 8%(141 of 1757 infants) in 2004 (P < .001), with no significant change thereafter. Although most infants were ventilated, continuous positive airway pressure without ventilation increased from 7%(120 of 1666 infants) in 2002 to 11% (190 of 1756 infants) in 2012 (P < .001). Despite no improvement from 1993 to 2004, rates of late-onset sepsis declined between 2005 and 2012 for infants of each gestational age (median, 26 weeks [37% {109 of 296} to 27%{85 of 320}]; adjusted relative risk [RR], 0.93 [95% CI, 0.92-0.94]). Rates of other morbidities declined, but bronchopulmonary dysplasia increased between 2009 and 2012 for infants at 26 to 27 weeks' gestation (26 weeks, 50%[130 of 258] to 55%[164 of 297]; P < .001). Survival increased between 2009 and 2012 for infants at 23 weeks' gestation (27%[41 of 152] to 33%[50 of 150]; adjusted RR, 1.09 [95% CI, 1.05-1.14]) and 24 weeks (63%[156 of 248] to 65%[174 of 269]; adjusted RR, 1.05 [95% CI, 1.03-1.07]), with smaller relative increases for infants at 25 and 27 weeks' gestation, and no change for infants at 22, 26, and 28 weeks' gestation. Survival without major morbidity increased approximately 2% per year for infants at 25 to 28 weeks' gestation, with no change for infants at 22 to 24 weeks' gestation. CONCLUSIONS AND RELEVANCE Among extremely preterm infants born at US academic centers over the last 20 years, changes in maternal and infant care practices and modest reductions in several morbidities were observed, although bronchopulmonary dysplasia increased. Survival increased most markedly for infants born at 23 and 24 weeks' gestation and survival without major morbidity increased for infants aged 25 to 28 weeks. These findings may be valuable in counseling families and developing novel interventions.	[Stoll, Barbara J.; Hale, Ellen C.] Emory Univ, Sch Med, Dept Pediat, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Hansen, Nellie I.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Walsh, Michele C.; Newman, Nancy S.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Carlo, Waldemar A.] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Shankaran, Seetha] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Sanchez, Pablo J.] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Ctr Perinatal Res, Columbus, OH 43210 USA; [Van Meurs, Krisa P.; Ball, M. Bethany] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Van Meurs, Krisa P.; Ball, M. Bethany] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Wyckoff, Myra] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Schibler, Kurt] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Poindexter, Brenda B.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Kennedy, Kathleen A.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX USA; [Cotten, C. Michael] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [D'Angio, Carl T.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [DeMauro, Sara B.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Truog, William E.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Devaskar, Uday] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	Children's Healthcare of Atlanta (CHOA); Emory University; Research Triangle Institute; University of Iowa; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Alabama System; University of Alabama Birmingham; Wayne State University; Brown University; Women & Infants Hospital Rhode Island; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Stanford University; Lucile Packard Children's Hospital (LPCH); University of Texas System; University of Texas Southwestern Medical Center Dallas; Research Triangle Institute; Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Health Science Center Houston; Duke University; University of New Mexico; University of New Mexico's Health Sciences Center; University of Rochester; University of Pennsylvania; Children's Mercy Hospital; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stoll, BJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, 1760 Haygood Dr,Ste W400, Atlanta, GA 30322 USA.	bstoll@emory.edu	Patel, Ravi/B-7218-2011; Truog, William/R-5576-2019; Das, Abhik/AAF-1883-2020; DeMauro, Sara/ABD-6568-2021; pan, tao/O-7308-2014	Patel, Ravi/0000-0002-7444-5550; Das, Abhik/0000-0003-2722-0479; DeMauro, Sara/0000-0003-1647-4000; Bell, Edward/0000-0002-5568-0889; Hansen, Nellie/0000-0003-4794-9646; Stark, Ann/0000-0002-6051-1190	National Institutes of Health (NIH); Eunice Kennedy Shriver NICHD; National Center for Research Resources; National Center for Advancing Translational Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD036790, U10HD034216, U10HD040461, U10HD027853, UG1HD027880, U10HD053109, U10HD021385, U10HD068270, U10HD027851, UG1HD087229, UG1HD053109, U10HD040689, U10HD053124, UG1HD034216, U10HD068278, U10HD068263, U10HD027904, U10HD040492, UG1HD021385, U10HD068244, U10HD021364, U10HD021373, U10HD027880, UG1HD021364, U10HD027871, UG1HD068284, U10HD068284, U10HD027856, U10HD053119, U10HD053089, UG1HD053089] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD040521, U10HD021397, U10HD040498, U10HD021415, U10HD034167, U10HD027881] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041, UL1TR001425, UL1TR001117, UL1TR001111, UL1TR001449] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122, M01RR008084, M01RR006022, M01RR016587] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The National Institutes of Health (NIH), the Eunice Kennedy Shriver NICHD, the National Center for Research Resources, and the National Center for Advancing Translational Sciences provided grant support for the NRN Generic Database Study to maintain a high-risk preterm infant registry through cooperative agreements.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Behrman RE, 2007, PRETERM BIRTH CAUSES; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berger TM, 2012, ARCH DIS CHILD-FETAL, V97, pF323, DOI 10.1136/fetalneonatal-2011-301008; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; FANAROFF AA, 1995, AM J OBSTET GYNECOL, V173, P1423, DOI 10.1016/0002-9378(95)90628-2; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Grisaru-Granovsky S, 2014, EARLY HUM DEV, V90, P821, DOI 10.1016/j.earlhumdev.2014.08.009; Guinsburg R, 2012, J PERINATOL, V32, P913, DOI 10.1038/jp.2012.28; HACK M, 1995, AM J OBSTET GYNECOL, V172, P457, DOI 10.1016/0002-9378(95)90557-X; HACK M, 1991, PEDIATRICS, V87, P587; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Kaplan HC, 2011, PEDIATRICS, V127, P427, DOI 10.1542/peds.2010-2141; Kulkarni AD, 2013, NEW ENGL J MED, V369, P2218, DOI 10.1056/NEJMoa1301467; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Malloy MH, 2012, J PERINATOL, V32, P722, DOI 10.1038/jp.2012.22; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McCabe ERB, 2014, PEDIATRICS, V134, P1193, DOI 10.1542/peds.2014-2541; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Raju TNK, 2014, AM J OBSTET GYNECOL, V210, P406, DOI 10.1016/j.ajog.2014.02.027; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, pf5980; Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873; Shah PS, 2012, J PERINATOL, V32, P132, DOI 10.1038/jp.2011.68; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; Soll RF, 2013, PEDIATRICS, V132, P222, DOI 10.1542/peds.2013-0501; Stevenson DK, 1998, AM J OBSTET GYNECOL, V179, P1632, DOI 10.1016/S0002-9378(98)70037-7; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Tyson JE, 2003, CLIN PERINATOL, V30, P363, DOI 10.1016/S0095-5108(03)00028-9; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wirtschafter DD, 2011, PEDIATRICS, V127, P419, DOI 10.1542/peds.2010-1449; Wong D, 2014, ARCH DIS CHILD-FETAL, V99, pF12, DOI 10.1136/archdischild-2013-304705; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	44	1401	1461	3	86	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1039	1051		10.1001/jama.2015.10244	http://dx.doi.org/10.1001/jama.2015.10244			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348753	Green Accepted, Bronze			2022-12-28	WOS:000360840700016
J	Dheda, K; Barry, CE; Maartens, G				Dheda, Keertan; Barry, Clifton E., III; Maartens, Gary			Tuberculosis	LANCET			English	Review							EXTENSIVELY DRUG-RESISTANT; GAMMA RELEASE ASSAYS; RECONSTITUTION INFLAMMATORY SYNDROME; XPERT MTB/RIF ASSAY; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; DIAGNOSTIC-ACCURACY; ANTITUBERCULOSIS TREATMENT	Although the worldwide incidence of tuberculosis has been slowly decreasing, the global disease burden remains substantial (similar to 9 million cases and similar to 1.5 million deaths in 2013), and tuberculosis incidence and drug resistance are rising in some parts of the world such as Africa. The modest gains achieved thus far are threatened by high prevalence of HIV, persisting global poverty, and emergence of highly drug-resistant forms of tuberculosis. Tuberculosis is also a major problem in health-care workers in both low-burden and high-burden settings. Although the ideal preventive agent, an effective vaccine, is still some time away, several new diagnostic technologies have emerged, and two new tuberculosis drugs have been licensed after almost 50 years of no tuberculosis drugs being registered. Efforts towards an effective vaccine have been thwarted by poor understanding of what constitutes protective immunity. Although new interventions and investment in control programmes will enable control, eradication will only be possible through substantial reductions in poverty and overcrowding, political will and stability, and containing co-drivers of tuberculosis, such as HIV, smoking, and diabetes.	[Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Maartens, Gary] Univ Cape Town, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Barry, Clifton E., III] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Barry, Clifton E., III] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Barry, Clifton E., III; Maartens, Gary] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.; Dheda, K (corresponding author), Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Barry, III, Clifton/H-3839-2012; Maartens, Gary/F-3836-2014	Barry, III, Clifton/0000-0002-2927-270X; Maartens, Gary/0000-0003-3080-6606	Foundation of Innovative New Diagnostics (FIND); eNose Company; Statens Serum Institut; bioMeriux; ALERE; Oxford Immunotec; Qiagen; Cepheid; Antrum Biotec; Hain Lifescience; Hain Life science; YD Daignostics; FIND; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693, ZIAAI001214] Funding Source: NIH RePORTER	Foundation of Innovative New Diagnostics (FIND); eNose Company; Statens Serum Institut; bioMeriux; ALERE; Oxford Immunotec; Qiagen; Cepheid; Antrum Biotec; Hain Lifescience; Hain Life science; YD Daignostics; FIND; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KD reports grants from Foundation of Innovative New Diagnostics (FIND), eNose Company, Statens Serum Institut, and bioMeriux, and grants and personal fees from ALERE, Oxford Immunotec, Cellestis (now Qiagen), Cepheid, Antrum Biotec, and Hain Lifescience. Additionally, KD has a patent "Characterisation of novel tuberculosis-specific urinary biomarkers" pending, a patent "A smart mask for monitoring cough-related infectious diseases" pending, and a patent "Device for diagnosing EPTB" issued. CEB reports grants from Cepheid, Hain Life science, YD Daignostics, and FIND. GM served on the data safety and monitoring board for Janssen for the TMC207 C208 and C207 phase 2 trials in patients with multidrug-resistant MDR tuberculosis, 2007-12.	Adams S, 2015, EUR RESPIR J, V45, P1364, DOI 10.1183/09031936.00138414; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Allwood BW, 2013, RESPIRATION, V86, P76, DOI 10.1159/000350917; American Thoracic Society CDC and Infectious Diseases Society of America, 2003, TREATM TUB; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Andrade BB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004433; [Anonymous], 1987, Am Rev Respir Dis, V136, P1339; [Anonymous], 2011, NONCOMMERCIAL CULTUR; [Anonymous], UPTO DATE; [Anonymous], 2014, US DEL TREATM MULT R; [Anonymous], 2011, TUB CLIN DIAGN MAN T; [Anonymous], 2011, GUID INT TUB CAS FIN; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Berti E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S3; Boeree MJ, 2015, AM J RESP CRIT CARE, V191, P1058, DOI 10.1164/rccm.201407-1264OC; Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chambers ST, 2012, CURR OPIN PULM MED, V18, P228, DOI 10.1097/MCP.0b013e328351f98b; Chang KC, 2013, ANTIMICROB AGENTS CH, V57, P4097, DOI 10.1128/AAC.00120-13; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Chigutsa E, 2015, ANTIMICROB AGENTS CH, V59, P38, DOI 10.1128/AAC.03931-14; Chigutsa E, 2011, ANTIMICROB AGENTS CH, V55, P4122, DOI 10.1128/AAC.01833-10; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Cohen T, 2014, CLIN TUBERCULOSIS, P19; Coleman MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009500; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Critchley JA, 2013, LANCET INFECT DIS, V13, P223, DOI 10.1016/S1473-3099(12)70321-3; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; Cruciani M, 2001, CLIN INFECT DIS, V33, P1922, DOI 10.1086/324352; Cucchetto G, 2015, INFECTION, V43, P277, DOI 10.1007/s15010-014-0711-4; Dawson R, 2015, LANCET, V385, P1738, DOI 10.1016/S0140-6736(14)62002-X; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Dheda K, 2008, A TREATISE OF TUBERC; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diacon AH, 2007, ANTIMICROB AGENTS CH, V51, P2994, DOI 10.1128/AAC.01474-06; Diacon AH, 2015, AM J RESP CRIT CARE, V191, P943, DOI 10.1164/rccm.201410-1801OC; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002; Dorman SE, 2015, AM J RESP CRIT CARE, V191, P333, DOI 10.1164/rccm.201410-1843OC; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Evans TG, 2013, VACCINE, V31, pB223, DOI 10.1016/j.vaccine.2012.11.081; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; Field N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0679-9; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Ghesani N, 2014, AM J RESP CRIT CARE, V189, P748, DOI 10.1164/rccm.201311-1976LE; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Heinrich N, 2015, J ANTIMICROB CHEMOTH, V70, P1558, DOI 10.1093/jac/dku553; Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Kerkhoff AD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-307; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; Lange C, 2014, MANAGEMENT OF PATIEN; Langley I, 2014, LANCET GLOB HEALTH, V2, pE581, DOI 10.1016/S2214-109X(14)70291-8; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Mac Kenzie WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018358; Matsumiya M, 2015, J INFECT DIS, V211, P1499, DOI 10.1093/infdis/jiu615; Mayosi BM, 2014, NEW ENGL J MED, V371, P1121, DOI 10.1056/NEJMoa1407380; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Moodley L, 2014, J THORAC DIS, V6, P202, DOI 10.3978/j.issn.2072-1439.2013.12.40; Muller B, 2011, INT J TUBERC LUNG D, V15, P344; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Ong CWM, 2014, AM J RESP CRIT CARE, V190, P9, DOI 10.1164/rccm.201311-2106PP; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pandie S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-101; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Peter JG, 2013, LANCET RESP MED, V1, P471, DOI 10.1016/S2213-2600(13)70120-6; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Robertson BD, 2012, TUBERCULOSIS, V92, P447, DOI 10.1016/j.tube.2012.06.004; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Ryan F, 1994, FORGOTTEN PLAGUE BAT; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sharma SK, 2010, CLIN INFECT DIS, V50, P833, DOI 10.1086/650576; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; Steffen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014014; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Sun AY, 2013, AM J EPIDEMIOL, V178, P1740, DOI 10.1093/aje/kwt210; Tadokera R, 2011, EUR RESPIR J, V37, P1248, DOI 10.1183/09031936.00091010; Theron G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub2; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Uthman OA, 2015, ANN INTERN MED, V163, P32, DOI 10.7326/M14-2979; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; van Zyl-Smit RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028815; Vorster M, 2014, CURR OPIN PULM MED, V20, P287, DOI 10.1097/MCP.0000000000000043; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Weiner M, 2010, ANTIMICROB AGENTS CH, V54, P4192, DOI 10.1128/AAC.00353-10; Whitelaw A, 2011, EUR RESPIR J, V38, P1393, DOI 10.1183/09031936.00023211; WHO, 2014, GLOBAL TUBERCULOSIS; WHO, 2011, INT ROADM TUB RES; WHO, 2013, USE BED TREATM MULT; WHO, 2006, STOP TOB STRATEGY BU; WHO, 2014, THE ROLE OF SURGERY; WHO, 2011, WHO UPDATED REFERENC; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; Wood R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106622; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2013, GLOB STRAT TARG TUB; World Health Organization, 2011, SAM DAY DIAGN TUB MI; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2011, RAPID IMPLEMENTATION; World Health Organization (WHO), 2013, US MOL LIN PROB ASS; Young BL, 2014, EUR RESPIR J, V43, P1719, DOI 10.1183/09031936.00175113; YUZBASIYANGURKAN V, 1991, J LAB CLIN MED, V118, P458	157	348	369	17	179	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1211	1226		10.1016/S0140-6736(15)00151-8	http://dx.doi.org/10.1016/S0140-6736(15)00151-8			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	26377143				2022-12-28	WOS:000372412000033
J	Thapar, A; Cooper, M				Thapar, Anita; Cooper, Miriam			Attention deficit hyperactivity disorder	LANCET			English	Review							CHILD ADHD SYMPTOMS; 33-YEAR FOLLOW-UP; DEFICIT/HYPERACTIVITY DISORDER; MENTAL-HEALTH; WORLDWIDE PREVALENCE; ADOLESCENT OUTCOMES; MATERNAL DEPRESSION; GREAT-BRITAIN; YOUNG-PEOPLE; ADULTS	Attention deficit hyperactivity disorder (ADHD) is a childhood-onset neurodevelopmental disorder with a prevalence of 1.4-3.0%. It is more common in boys than girls. Comorbidity with childhood-onset neurodevelopmental disorders and psychiatric disorders is substantial. ADHD is highly heritable and multifactorial; multiple genes and non-inherited factors contribute to the disorder. Prenatal and perinatal factors have been implicated as risks, but definite causes remain unknown. Most guidelines recommend a stepwise approach to treatment, beginning with non-drug interventions and then moving to pharmacological treatment in those most severely affected. Randomised controlled trials show short-term benefits of stimulant medication and atomoxetine. Meta-analyses of blinded trials of non-drug treatments have not yet proven the efficacy of such interventions. Longitudinal studies of ADHD show heightened risk of multiple mental health and social difficulties as well as premature mortality in adult life.	[Thapar, Anita; Cooper, Miriam] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Child & Adolescent Psychiat Sect, Cardiff CF24 4HQ, S Glam, Wales; [Thapar, Anita; Cooper, Miriam] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales	Cardiff University; Cardiff University	Thapar, A (corresponding author), Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.	thapar@cardiff.ac.uk	Thapar, Anita/AAH-5555-2020	Thapar, Anita/0000-0002-3689-737X; Cooper, Miriam/0000-0002-4695-5481	MRC; ESRC; Wellcome Trust; Medical Research Council [MR/L010305/1, G1000632] Funding Source: researchfish; MRC [G1000632] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We have been funded by the MRC, ESRC, and the Wellcome Trust.	Ahuja A, 2013, J PEDIATR-US, V163, P890, DOI 10.1016/j.jpeds.2013.02.043; Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; Asherson P, 2014, J PSYCHOPHARMACOL, V28, P837, DOI 10.1177/0269881114542453; Bastain TM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00012; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Biederman J, 2005, AM J PSYCHIAT, V162, P1083, DOI 10.1176/appi.ajp.162.6.1083; Bushe CJ, 2014, J PSYCHOPHARMACOL, V28, P204, DOI 10.1177/0269881113478475; Bussing R, 2010, J AM ACAD CHILD PSY, V49, P595, DOI 10.1016/j.jaac.2010.03.006; Coghill DR, 2014, PSYCHOL MED, V44, P1989, DOI 10.1017/S0033291713002547; Coghill DR, 2014, PSYCHOL MED, V44, P1087, DOI 10.1017/S0033291713001761; Coghill DR, 2014, BIOL PSYCHIAT, V76, P603, DOI 10.1016/j.biopsych.2013.10.005; Collishaw S, 2015, J CHILD PSYCHOL PSYC, V56, P370, DOI 10.1111/jcpp.12372; CONNERS CK, 1969, AM J PSYCHIAT, V126, P884, DOI 10.1176/ajp.126.6.884; Cortese S, 2013, BIOL PSYCHIAT, V74, P591, DOI 10.1016/j.biopsych.2013.02.025; Cortese S, 2013, J CHILD PSYCHOL PSYC, V54, P227, DOI 10.1111/jcpp.12036; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Cortese S, 2012, CURR PSYCHIAT REP, V14, P568, DOI 10.1007/s11920-012-0310-y; Daley D, 2014, J AM ACAD CHILD ADOL, V53, p[e1, 835]; Dalsgaard S, 2014, EUR PSYCHIAT, V29, P259, DOI 10.1016/j.eurpsy.2013.06.004; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Dalsgaard S, 2013, J CHILD ADOL PSYCHOP, V23, P432, DOI 10.1089/cap.2012.0111; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; Dykens EM, 2000, J CHILD PSYCHOL PSYC, V41, P407, DOI 10.1017/S0021963000005667; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Faraone SV, 2000, GENET EPIDEMIOL, V18, P1; Fliers E, 2009, J AM ACAD CHILD PSY, V48, P25, DOI 10.1097/CHI.0b013e31818b1ca2; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Galanter CA, 2008, CHILD ADOLESC PSYCHI, V17, pviii; Galanter CA, 2008, CHILD ADOL PSYCH CL, V17, P325, DOI 10.1016/j.chc.2007.11.001; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greven CU, 2015, JAMA PSYCHIAT, V72, P490, DOI 10.1001/jamapsychiatry.2014.3162; Hall CL, 2015, J PSYCHOPHARMACOL, V29, P39, DOI 10.1177/0269881114550353; Hamshere ML, 2013, AM J PSYCHIAT, V170, P909, DOI 10.1176/appi.ajp.2013.12081129; Harold GT, 2013, J CHILD PSYCHOL PSYC, V54, P1038, DOI 10.1111/jcpp.12100; Hawkey E, 2014, CLIN PSYCHOL REV, V34, P496, DOI 10.1016/j.cpr.2014.05.005; Jensen CM, 2015, ADHD-ATTEND DEFICIT, V7, P27, DOI 10.1007/s12402-014-0142-1; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kendler KS, 2013, MOL PSYCHIATR, V18, P1058, DOI 10.1038/mp.2013.50; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Kreppner JM, 2001, J ABNORM CHILD PSYCH, V29, P513; Kurlan R, 2002, NEUROLOGY, V59, P414, DOI 10.1212/WNL.59.3.414; Langley K, 2010, BRIT J PSYCHIAT, V196, P235, DOI 10.1192/bjp.bp.109.066274; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Lifford KJ, 2009, J CHILD PSYCHOL PSYC, V50, P1468, DOI 10.1111/j.1469-7610.2009.02107.x; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; MOFFITT TE, 1990, CHILD DEV, V61, P893, DOI 10.1111/j.1467-8624.1990.tb02830.x; Moffitt TE, 2015, AM J PSYCHIAT, V172, P967, DOI 10.1176/appi.ajp.2015.14101266; Mongia M, 2012, CURR PSYCHIAT REP, V14, P561, DOI 10.1007/s11920-012-0303-x; Moriyama TS, 2013, CNS SPECTRUMS, V18, P296, DOI 10.1017/S109285291300031X; National Institute for Health and Care Excellence, CLIN GUID 72 ATT DEF; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Obel C, 2011, INT J EPIDEMIOL, V40, P338, DOI 10.1093/ije/dyq185; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Reichow B, 2013, J AUTISM DEV DISORD, V43, P2435, DOI 10.1007/s10803-013-1793-z; Rhodes SM, 2012, J CHILD PSYCHOL PSYC, V53, P128, DOI 10.1111/j.1469-7610.2011.02436.x; Rice F, 2010, PSYCHOL MED, V40, P335, DOI 10.1017/S0033291709005911; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Russell VA, 2011, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0935S54; Rutter M, 2007, J CHILD PSYCHOL PSYC, V48, P1200, DOI 10.1111/j.1469-7610.2007.01792.x; Rutter M, 2012, P NATL ACAD SCI USA, V109, P17149, DOI 10.1073/pnas.1121258109; Sayal K, 2002, BRIT J PSYCHIAT, V181, P43, DOI 10.1192/bjp.181.1.43; Sayal K, 2010, PSYCHIAT SERV, V61, P803, DOI 10.1176/ps.2010.61.8.803; SCHACHAR R, 1987, J AM ACAD CHILD PSY, V26, P728, DOI 10.1097/00004583-198709000-00019; Schweren LJS, 2013, EUR NEUROPSYCHOPHARM, V23, P1151, DOI 10.1016/j.euroneuro.2012.10.014; Scottish Intercollegiate Guidelines Network, 2009, MAN ATT DEF HYP DIS; Sellers R, 2015, J CHILD PSYCHOL PSYC, V56, P49, DOI 10.1111/jcpp.12273; Sexton CC, 2012, J LEARN DISABIL-US, V45, P538, DOI 10.1177/0022219411407772; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Shaw P, 2010, HUM BRAIN MAPP, V31, P917, DOI 10.1002/hbm.21028; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Simonoff E, 2013, J CHILD PSYCHOL PSYC, V54, P527, DOI 10.1111/j.1469-7610.2012.02569.x; Skoglund C, 2014, J CHILD PSYCHOL PSYC, V55, P61, DOI 10.1111/jcpp.12124; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sontag TA, 2010, ADHD-ATTEND DEFICIT, V2, P1, DOI 10.1007/s12402-010-0019-x; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; State M, 2015, RUTTERS CHILD ADOLES; Stevenson J, 2014, J CHILD PSYCHOL PSYC, V55, P416, DOI 10.1111/jcpp.12215; Still GF, 1902, LANCET, V1, P1008; Stuhec M, 2015, J CHILD ADOL PSYCHOP, V25, P254, DOI 10.1089/cap.2014.0071; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Taylor E, 1996, J AM ACAD CHILD PSY, V35, P1213, DOI 10.1097/00004583-199609000-00019; Thapar A, 2015, RUTTERS CHILD ADOLES; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Thapar A, 2009, BIOL PSYCHIAT, V66, P722, DOI 10.1016/j.biopsych.2009.05.032; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Thompson JMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108210; Tremmery S, 2007, EUR CHILD ADOLES PSY, V16, P327, DOI 10.1007/s00787-007-0604-5; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; van Lieshout M, 2013, CLIN PSYCHOL REV, V33, P539, DOI 10.1016/j.cpr.2013.02.003; Weissman MM, 2006, JAMA-J AM MED ASSOC, V295, P1389, DOI 10.1001/jama.295.12.1389; Weissman MM, 2015, AM J PSYCHIAT, V172, P450, DOI 10.1176/appi.ajp.2014.13121679; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Wise J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h522; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Woodward L, 1997, J CHILD PSYCHOL PSYC, V38, P479, DOI 10.1111/j.1469-7610.1997.tb01533.x; World Health Organization, 2018, INT CLASSIFICATION D; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Young S, 2015, PSYCHOL MED, V45, P247, DOI 10.1017/S0033291714000762; Young S, 2015, PSYCHOL MED, V2015, P1, DOI DOI 10.1017/S0033291715000756	122	477	490	28	346	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1240	1250		10.1016/S0140-6736(15)00238-X	http://dx.doi.org/10.1016/S0140-6736(15)00238-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG9OB	26386541	Green Accepted			2022-12-28	WOS:000372412000035
J	Sovio, U; White, IR; Dacey, A; Pasupathy, D; Smith, GCS				Sovio, Ulla; White, Ian R.; Dacey, Alison; Pasupathy, Dharmintra; Smith, Gordon C. S.			Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study	LANCET			English	Article							PERINATAL DEATH; WEIGHT STANDARD; RISK; TERM	Background Fetal growth restriction is a major determinant of adverse perinatal outcome. Screening procedures for fetal growth restriction need to identify small babies and then differentiate between those that are healthy and those that are pathologically small. We sought to determine the diagnostic effectiveness of universal ultrasonic fetal biometry in the third trimester as a screening test for small-for-gestational-age (SGA) infants, and whether the risk of morbidity associated with being small differed in the presence or absence of ultrasonic markers of fetal growth restriction. Methods The Pregnancy Outcome Prediction (POP) study was a prospective cohort study of nulliparous women with a viable singleton pregnancy at the time of the dating ultrasound scan. Women participating had clinically indicated ultrasonography in the third trimester as per routine clinical care and these results were reported as usual (selective ultrasonography). Additionally, all participants had research ultrasonography, including fetal biometry at 28 and 36 weeks' gestational age. These results were not made available to participants or treating clinicians (universal ultrasonography). We regarded SGA as a birthweight of less than the 10th percentile for gestational age and screen positive for SGA an ultrasonographic estimated fetal weight of less than the 10th percentile for gestational age. Markers of fetal growth restriction included biometric ratios, utero-placental Doppler, and fetal growth velocity. We assessed outcomes for consenting participants who attended research scans and had a livebirth at the Rosie Hospital (Cambridge, UK) after the 28 weeks' research scan. Findings Between Jan 14, 2008, and July 31, 2012, 4512 women provided written informed consent of whom 3977 (88%) were eligible for analysis. Sensitivity for detection of SGA infants was 20% (95% CI 15-24; 69 of 352 fetuses) for selective ultrasonography and 57% (51-62; 199 of 352 fetuses) for universal ultrasonography (relative sensitivity 2.9, 95% CI 2.4-3.5, p<0.0001). Of the 3977 fetuses, 562 (14.1%) were identified by universal ultrasonography with an estimated fetal weight of less than the 10th percentile and were at an increased risk of neonatal morbidity (relative risk [RR] 1.60, 95% CI 1.22-2.09, p=0.0012). However, estimated fetal weight of less than the 10th percentile was only associated with the risk of neonatal morbidity (p(interaction)=0.005) if the fetal abdominal circumference growth velocity was in the lowest decile (RR 3.9, 95% CI 1.9-8.1, p=0.0001). 172 (4%) of 3977 pregnancies had both an estimated fetal weight of less than the 10th percentile and abdominal circumference growth velocity in the lowest decile, and had a relative risk of delivering an SGA infant with neonatal morbidity of 17.6 (9.2-34.0, p<0.0001). Interpretation Screening of nulliparous women with universal third trimester fetal biometry roughly tripled detection of SGA infants. Combined analysis of fetal biometry and fetal growth velocity identified a subset of SGA fetuses that were at increased risk of neonatal morbidity. Copyright (C) Sovio et al. Open Access article distributed under the terms of CC BY.	[Sovio, Ulla; Dacey, Alison; Smith, Gordon C. S.] Univ Cambridge, Natl Inst Hlth Res Cambridge, Dept Obstet & Gynaecol, Comprehens Biomed Res Ctr, Cambridge CB2 2SW, England; [White, Ian R.] Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England; [Pasupathy, Dharmintra] Kings Coll London, Guys & St Thomas NHS Fdn Trust, Kings Hlth Partners, Div Womens Hlth,Womens Hlth Acad Ctr, London WC2R 2LS, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; White, Ian/0000-0002-6718-7661; Pasupathy, Dharmintra/0000-0002-6722-1006	National Institute for Health Research; Medical Research Council; Sands; GE Healthcare; Medical Research Council [MC_U105260558] Funding Source: researchfish; MRC [MC_U105260558] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sands; GE Healthcare(General ElectricGE Healthcare); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Institute for Health Research, Medical Research Council, Sands, and GE Healthcare.	ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P1319; American College of Obstetricians and Gynecologists, 2009, Obstet Gynecol, V113, P451, DOI 10.1097/AOG.0b013e31819930b0; Bais JMJ, 2004, EUR J OBSTET GYN R B, V116, P164, DOI 10.1016/j.ejogrb.2004.01.037; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bhide A, 2013, ULTRASOUND OBST GYN, V41, P234, DOI 10.1002/uog.12371; Bricker L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001451.pub3; Bukowski R, 2003, AM J OBSTET GYNECOL, V188, P1011, DOI 10.1067/mob.2003.233; Chauhan SP, 2013, AM J PERINAT, V30, P33, DOI 10.1055/s-0032-1321497; De Reu PAOM, 2010, J PERINAT MED, V38, P311, DOI [10.1515/JPM.2010.027, 10.1515/jpm.2010.027]; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Gu W, 2009, BIOSTATISTICS, V10, P172, DOI 10.1093/biostatistics/kxn025; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Kosinski AS, 2013, STAT MED, V32, P964, DOI 10.1002/sim.5587; Loughna P, 2009, ULTRASOUND, V17, P160, DOI 10.1179/174313409X448543; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; McIntyre S, 2013, OBSTET GYNECOL, V122, P869, DOI 10.1097/AOG.0b013e3182a265ab; Moraitis AA, 2014, OBSTET GYNECOL, V124, P274, DOI 10.1097/AOG.0000000000000388; *NICE, 2004, GUID DEV METH INF NA; NICE, 2008, NICE GUID ANT US; NICE National Collaborating Centre for Women's and Children's Health, 2010, NICE GUID HYP PREGN; NICE National Collaborating Centre for Women's and Children's Health, 2008, NICE GUID DIAB PREGN; Noble M, 2008, ENGLISH INDICES DEPR; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Pasupathy Dharmintra, 2008, BMC Pregnancy Childbirth, V8, P51, DOI 10.1186/1471-2393-8-51; Pasupathy D, 2009, JAMA-J AM MED ASSOC, V302, P660, DOI 10.1001/jama.2009.1111; Pilliod RA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.039; Smith GCS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001274; Sparks TN, 2011, J MATERN-FETAL NEO M, V24, P708, DOI 10.3109/14767058.2010.516285; Stacey T, 2012, AUST NZ J OBSTET GYN, V52, P242, DOI 10.1111/j.1479-828X.2011.01406.x	31	342	353	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2089	2097		10.1016/S0140-6736(15)00131-2	http://dx.doi.org/10.1016/S0140-6736(15)00131-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26360240	Green Published, hybrid			2022-12-28	WOS:000365987600030
J	Trimble, CL; Morrow, MP; Kraynyak, KA; Shen, XF; Dallas, M; Yan, J; Edwards, L; Parker, RL; Denny, L; Giffear, M; Brown, AS; Marcozzi-Pierce, K; Shah, D; Slager, AM; Sylvester, AJ; Khan, A; Broderick, KE; Juba, RJ; Herring, TA; Boyer, J; Lee, J; Sardesai, NY; Weiner, DB; Bagarazzi, ML				Trimble, Cornelia L.; Morrow, Matthew P.; Kraynyak, Kimberly A.; Shen, Xuefei; Dallas, Michael; Yan, Jian; Edwards, Lance; Parker, R. Lamar; Denny, Lynette; Giffear, Mary; Brown, Ami Shah; Marcozzi-Pierce, Kathleen; Shah, Divya; Slager, Anna M.; Sylvester, Albert J.; Khan, Amir; Broderick, Kate E.; Juba, Robert J.; Herring, Timothy A.; Boyer, Jean; Lee, Jessica; Sardesai, Niranjan Y.; Weiner, David B.; Bagarazzi, Mark L.			Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial	LANCET			English	Article							E2 BINDING-SITES; NATURAL-HISTORY; CANCER; BURDEN; ELECTROPORATION; IMMUNOTHERAPY; METHYLATION; INTEGRATION; EXPRESSION; REGRESSION	Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs), cervical intraepithelial neoplasia (CIN) is common, and current treatments are ablative and can lead to long-term reproductive morbidity. We assessed whether VGX-3100, synthetic plasmids targeting HPV-16 and HPV-18 E6 and E7 proteins, delivered by electroporation, would cause histopathological regression in women with CIN2/3. Methods Efficacy, safety, and immunogenicity of VGX-3100 were assessed in CIN2/3 associated with HPV-16 and HPV-18, in a randomised, double-blind, placebo-controlled phase 2b study. Patients from 36 academic and private gynaecology practices in seven countries were randomised (3: 1) to receive 6 mg VGX-3100 or placebo (1 mL), given intramuscularly at 0, 4, and 12 weeks. Randomisation was stratified by age (<25 vs >= 25 years) and CIN2 versus CIN3 by computer-generated allocation sequence (block size 4). Funder and site personnel, participants, and pathologists were masked to treatment. The primary efficacy endpoint was regression to CIN1 or normal pathology 36 weeks after the first dose. Per-protocol and modified intention-to-treat analyses were based on patients receiving three doses without protocol violations, and on patients receiving at least one dose, respectively. The safety population included all patients who received at least one dose. The trial is registered at ClinicalTrials.gov (number NCT01304524) and EudraCT (number 2012-001334-33). Findings Between Oct 19, 2011, and July 30, 2013, 167 patients received either VGX-3100 (n=125) or placebo (n=42). In the per-protocol analysis 53 (49.5%) of 107 VGX-3100 recipients and 11 (30.6%) of 36 placebo recipients had histopathological regression (percentage point difference 19.0 [95% CI 1.4-36.6]; p=0.034). In the modified intention-to-treat analysis 55 (48.2%) of 114 VGX-3100 recipients and 12 (30.0%) of 40 placebo recipients had histopathological regression (percentage point difference 18.2 [95% CI 1.3-34.4]; p=0.034). Injection-site reactions occurred in most patients, but only erythema was significantly more common in the VGX-3100 group (98/125, 78.4%) than in the placebo group (24/42, 57.1%; percentage point difference 21.3 [95% CI 5.3-37.8]; p=0.007). Interpretation VGX-3100 is the first therapeutic vaccine to show efficacy against CIN2/3 associated with HPV-16 and HPV-18. VGX-3100 could present a non-surgical therapeutic option for CIN2/3, changing the treatment outlook for this common disease.	[Trimble, Cornelia L.] Johns Hopkins Univ, Sch Med, Dept Gynecol Obstet, Baltimore, MD 21287 USA; [Trimble, Cornelia L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Trimble, Cornelia L.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Morrow, Matthew P.; Kraynyak, Kimberly A.; Dallas, Michael; Yan, Jian; Giffear, Mary; Brown, Ami Shah; Marcozzi-Pierce, Kathleen; Shah, Divya; Slager, Anna M.; Sylvester, Albert J.; Khan, Amir; Juba, Robert J.; Herring, Timothy A.; Lee, Jessica; Sardesai, Niranjan Y.; Bagarazzi, Mark L.] Inovio Pharmaceut Inc, Plymouth Meeting, PA USA; [Shen, Xuefei; Broderick, Kate E.; Boyer, Jean] Inovio Pharmaceut Inc, San Diego, CA USA; [Edwards, Lance] Suffolk Obstet & Gynecol LLP, Port Jefferson, NY USA; [Parker, R. Lamar] Lyndhurst Gynecol Associates, Winston Salem, NC USA; [Denny, Lynette] Univ Cape Town, Dept Obstet & Gynaecol, Groote Schuur Hosp, Cape Town, South Africa; [Weiner, David B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Cape Town; University of Pennsylvania; Pennsylvania Medicine	Trimble, CL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol Obstet, Phipps 255,600 North Wolfe St, Baltimore, MD 21287 USA.	ctrimbl@jhmi.edu	Bagarazzi, Mark L/AAU-1383-2021; Wang, Jing/M-5607-2016	Sardesai, Niranjan/0000-0001-6920-1167; Herring, Timothy/0000-0002-3475-8616	Inovio Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA006973, P30CA016520] Funding Source: NIH RePORTER	Inovio Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Inovio Pharmaceuticals.	Bach PB, 2010, LANCET, V375, P963, DOI 10.1016/S0140-6736(09)62029-8; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Broderick KE, 2015, EXPERT REV VACCINES, V14, P195, DOI 10.1586/14760584.2015.990890; Brun JL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.020; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Daayana S, 2010, BRIT J CANCER, V102, P1129, DOI 10.1038/sj.bjc.6605611; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Ferenczy A, 1996, OBSTET GYNECOL, V87, P332, DOI 10.1016/0029-7844(95)00453-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grimm C, 2012, OBSTET GYNECOL, V120, P152, DOI 10.1097/AOG.0b013e31825bc6e8; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hoy T, 2009, CURR MED RES OPIN, V25, P2343, DOI 10.1185/03007990903136378; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; Insinga RP, 2008, GYNECOL ONCOL, V111, P188, DOI 10.1016/j.ygyno.2008.07.032; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Leung TW, 2015, J MED VIROL, V87, P1022, DOI 10.1002/jmv.24129; Massad LS, 2013, OBSTET GYNECOL, V121, P829, DOI 10.1097/AOG.0b013e3182883a34; Mehrotra DV, 2000, STAT MED, V19, P811, DOI 10.1002/(SICI)1097-0258(20000330)19:6<811::AID-SIM390>3.0.CO;2-Z; Mehrotra DV, 2001, DRUG INF J, V35, P1343, DOI 10.1177/009286150103500430; Mehrotra DV, 2010, ANAL CLIN TRIALS THE; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; Reuschenbach M, 2015, CANCER-AM CANCER SOC, V121, P1966, DOI 10.1002/cncr.29315; Smith C, 2012, BLOOD, V120, P3237, DOI 10.1182/blood-2012-03-420182; Soderlund-Strand A, 2014, J MED VIROL, V86, P634, DOI 10.1002/jmv.23806; Stokley S, 2014, MMWR-MORBID MORTAL W, V63, P620; Trimble CL, 2005, CLIN CANCER RES, V11, P4717, DOI 10.1158/1078-0432.CCR-04-2599; Trimble CL, 2010, CANCER IMMUNOL IMMUN, V59, P799, DOI 10.1007/s00262-009-0806-4; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Whiteside MA, 2008, CANCER-AM CANCER SOC, V113, P2981, DOI 10.1002/cncr.23750; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; WRIGHT TC, 1992, OBSTET GYNECOL, V79, P173; Yan J, 2009, VACCINE, V27, P431, DOI 10.1016/j.vaccine.2008.10.078; Yan J, 2008, VACCINE, V26, P5210, DOI 10.1016/j.vaccine.2008.03.069	44	376	400	8	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2078	2088		10.1016/S0140-6736(15)00239-1	http://dx.doi.org/10.1016/S0140-6736(15)00239-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26386540	Green Accepted			2022-12-28	WOS:000365987600029
J	Bondy-Denomy, J; Garcia, B; Strum, S; Du, MJ; Rollins, MF; Hidalgo-Reyes, Y; Wiedenheft, B; Maxwell, KL; Davidson, AR				Bondy-Denomy, Joseph; Garcia, Bianca; Strum, Scott; Du, Mingjian; Rollins, MaryClare F.; Hidalgo-Reyes, Yurima; Wiedenheft, Blake; Maxwell, Karen L.; Davidson, Alan R.			Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins	NATURE			English	Article							GUIDED SURVEILLANCE COMPLEX; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; RNA; DNA; RECOGNITION; RESISTANCE; SEQUENCE; CASCADE	The battle for survival between bacteria and the viruses that infect them (phages) has led to the evolution of many bacterial defence systems and phage-encoded antagonists of these systems. Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR-associated (cas) genes comprise an adaptive immune system that is one of the most widespread means by which bacteria defend themselves against phages(1-3). We identified the first examples of proteins produced by phages that inhibit a CRISPR-Cas system(4). Here we performed biochemical and in vivo investigations of three of these anti-CRISPR proteins, and show that each inhibits CRISPR-Cas activity through a distinct mechanism. Two block the DNA-binding activity of the CRISPR-Cas complex, yet do this by interacting with different protein subunits, and using steric or non-steric modes of inhibition. The third anti-CRISPR protein operates by binding to the Cas3 helicase-nuclease and preventing its recruitment to the DNA-bound CRISPR-Cas complex. In vivo, this anti-CRISPR can convert the CRISPR-Cas system into a transcriptional repressor, providing the first example-to our knowledge-of modulation of CRISPR-Cas activity by a protein interactor. The diverse sequences and mechanisms of action of these anti-CRISPR proteins imply an independent evolution, and foreshadow the existence of other means by which proteins may alter CRISPR-Cas function.	[Bondy-Denomy, Joseph; Garcia, Bianca; Du, Mingjian; Hidalgo-Reyes, Yurima; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Strum, Scott; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rollins, MaryClare F.; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto; Montana State University System; Montana State University Bozeman; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	karen.maxwell@utoronto.ca; alan.davidson@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480; Du, Mingjian/0000-0002-9464-4098; Strum, Scott/0000-0003-3618-9936	Canadian Institutes of Health Research (CIHR) [MOP-130482, MOP-136845]; CIHR Canada Graduate Scholarship Doctoral Award; Ontario Graduate Scholarship award; National Institutes of Health [R01GM108888, P20GM103500]; National Science Foundation EPSCoR [EPS-110134]; M.J. Murdock Charitable Trust; Montana State University Agricultural Experimental Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108888, R01GM110270, P20GM103500] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship award(Ontario Graduate Scholarship); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCoR(National Science Foundation (NSF)); M.J. Murdock Charitable Trust; Montana State University Agricultural Experimental Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Navarre and E. Westra for reading the manuscript. This work was supported by an Operating Grant to A.R.D. (MOP-130482) and to K.L.M. (MOP-136845), both of which were from the Canadian Institutes of Health Research (CIHR). J.B.-D. was supported by a CIHR Canada Graduate Scholarship Doctoral Award and an Ontario Graduate Scholarship award. Research in the Wiedenheft laboratory is supported by the National Institutes of Health (P20GM103500 and R01GM108888), the National Science Foundation EPSCoR (EPS-110134), the M.J. Murdock Charitable Trust, and the Montana State University Agricultural Experimental Station.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jore MM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003657; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945	21	214	228	31	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					136	+		10.1038/nature15254	http://dx.doi.org/10.1038/nature15254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416740	Green Accepted			2022-12-28	WOS:000362095100049
J	Efferson, C; Vogt, S; Elhadi, A; Ahmed, HE; Fehr, E				Efferson, Charles; Vogt, Sonja; Elhadi, Amy; Ahmed, Hilal El Fadil; Fehr, Ernst			Female genital cutting is not a social coordination norm	SCIENCE			English	Editorial Material									[Efferson, Charles; Vogt, Sonja; Fehr, Ernst] Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland	University of Zurich	Efferson, C (corresponding author), Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland.	charles.eferson@econ.uzh.ch; sonja.vogt@econ.uzh.ch; ernst.fehr@econ.uzh.ch		Efferson, Charles/0000-0001-8244-4497; Vogt, Sonja/0000-0002-5462-309X	Swiss National Committee of UNICEF; European Research Council grant on the "Foundations of Economic Preferences"	Swiss National Committee of UNICEF; European Research Council grant on the "Foundations of Economic Preferences"	We thank the Gezira State government, the Sudan National Council for Child Welfare, the Gezira State Council for Child Welfare, and the national field office of UNICEF in Sudan. Funded primarily by the Swiss National Committee of UNICEF and is also part of an European Research Council grant on the "Foundations of Economic Preferences."	Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; [Anonymous], 2013, END FEM GEN MUT CUTT; Diop N., 2004, TOSTAN PROGRAM EVALU, DOI 10.31899/rh2.1002; Featherstone L., 2014, UK ANNOUNCES MEASURE; Gruenbaum E., 2001, FEMALE CIRCUMCISION, DOI DOI 10.9783/9780812292510; Hoff K., 2015, 7198 WORLD BANK; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Mackie G., 2009, SOCIAL DYNAMICS ABAN; Shell-Duncan B, 2011, SOC SCI MED, V73, P1275, DOI 10.1016/j.socscimed.2011.07.022; TOSTAN, 2013, COMM EMP PROGR; TOSTAN, 2013, TOSTAN ANN REP FIN; UNFPA UNICEF, 2013, JOINT EV UNFPA UNICE; WHO, 2018, FEM GEN MUT	13	46	48	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1446	1447		10.1126/science.aaa7978	http://dx.doi.org/10.1126/science.aaa7978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR9WA	26404811				2022-12-28	WOS:000361707000021
J	Boyd, RW				Boyd, Robert W.			NUCLEAR PHYSICS Neutrons with a twist	NATURE			English	Editorial Material							ORBITAL ANGULAR-MOMENTUM; BEAMS		[Boyd, Robert W.] Univ Ottawa, Sch Elect Engn & Comp Sci, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Boyd, Robert W.] Univ Ottawa, Max Planck Ctr Extreme & Quantum Photon, Ottawa, ON K1N 6N5, Canada; [Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA	University of Ottawa; University of Ottawa; University of Rochester	Boyd, RW (corresponding author), Univ Ottawa, Sch Elect Engn & Comp Sci, Dept Phys, Ottawa, ON K1N 6N5, Canada.	boydrw@mac.com						ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; BAZHENOV VY, 1990, JETP LETT+, V52, P429; BEIJERSBERGEN MW, 1993, OPT COMMUN, V96, P123, DOI 10.1016/0030-4018(93)90535-D; Bolduc E, 2013, OPT LETT, V38, P3546, DOI 10.1364/OL.38.003546; Clark CW, 2015, NATURE, V525, P504, DOI 10.1038/nature15265; Harris J, 2015, NAT PHYS, V11, P629, DOI [10.1038/nphys3404, 10.1038/NPHYS3404]; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; Leach J, 2010, SCIENCE, V329, P662, DOI 10.1126/science.1190523; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]	12	4	4	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					462	464		10.1038/525462a	http://dx.doi.org/10.1038/525462a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399824				2022-12-28	WOS:000361599900037
J	Scott, N; Prigge, M; Yizhar, O; Kimchi, T				Scott, Niv; Prigge, Matthias; Yizhar, Ofer; Kimchi, Tali			A sexually dimorphic hypothalamic circuit controls maternal care and oxytocin secretion	NATURE			English	Article							DOPAMINERGIC-NEURONS; PARENTAL BEHAVIOR; SEX-DIFFERENCES; EXPRESSION; ORGANIZATION; KISSPEPTIN; BETA; MICE	It is commonly assumed, but has rarely been demonstrated(1,2), that sex differences in behaviour arise from sexual dimorphism in the underlying neural circuits(3,4). Parental care is a complex stereotypic behaviour towards offspring that is shared by numerous species(5). Mice display profound sex differences in offspring-directed behaviours. At their first encounter, virgin females behave maternally towards alien pups while males will usually ignore the pups or attack them(6-9). Here we show that tyrosine hydroxylase (TH)-expressing neurons in the anteroventral periventricular nucleus (AVPV) of the mouse hypothalamus are more numerous in mothers than in virgin females and males, and govern parental behaviours in a sex-specific manner. In females, ablating the AVPV TH+ neurons impairs maternal behaviour whereas optogenetic stimulation or increased TH expression in these cells enhancematernal care. In males, however, this same neuronal cluster has no effect on parental care but rather suppresses intermale aggression. Furthermore, optogenetic activation or increased TH expression in the AVPV TH+ neurons of female mice increases circulating oxytocin, whereas their ablation reduces oxytocin levels. Finally, we show that AVPV TH+ neurons relay a monosynaptic input to oxytocin-expressing neurons in the paraventricular nucleus. Our findings uncover a previously unknown role for this neuronal population in the control of maternal care and oxytocin secretion, and provide evidence for a causal relationship between sexual dimorphism in the adult brain and sex differences in parental behaviour.	[Scott, Niv; Prigge, Matthias; Yizhar, Ofer; Kimchi, Tali] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yizhar, O; Kimchi, T (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ofer.yizhar@weizmann.ac.il; tali.kimchi@weizmann.ac.il	YIZHAR, OFER/AAV-8497-2021	Yizhar, Ofer/0000-0003-4228-1448	Clore Center for Biological Physics; Minerva postdoctoral fellowship; Minerva Foundation [711131]; Women's Health Research Center; Gruber Foundation [720667]; ISF [1324/15, 1351/12]; Jenna and Julia Birnbach Career Development Chair; Marie Curie CIG [321919]; ERC StG [337637]; Nollman Career Development Chair	Clore Center for Biological Physics; Minerva postdoctoral fellowship; Minerva Foundation; Women's Health Research Center; Gruber Foundation; ISF(Israel Science Foundation); Jenna and Julia Birnbach Career Development Chair; Marie Curie CIG; ERC StG; Nollman Career Development Chair	We thank M. Dayan, E. Elharrar, I. Sofer, Y. Pen, Y. Beny, N. Zhilka and E. Massasa for their assistance with the experiments; R. Levy for help with virus production; A. Chen and A. Ramot for sharing equipment and reagents. A. Mizrahi, S. Wagner, and the Yizhar and Kimchi groups, for comments on the manuscript; D. Anderson for providing the Cre-dependent anterograde virus and V. Grinevich for providing the OT: Venus virus. M.P. was supported by the Clore Center for Biological Physics and a Minerva postdoctoral fellowship. This work was supported by grants from Minerva Foundation 711131, Women's Health Research Center, Gruber Foundation 720667, ISF 1324/15, the Jenna and Julia Birnbach Career Development Chair to T.K.; and Marie Curie CIG 321919, ERC StG 337637, ISF 1351/12, the Nollman Career Development Chair to O.Y.	Aumann TD, 2013, BRAIN BEHAV, V3, P617, DOI 10.1002/brb3.163; Cao JY, 2011, J COMP NEUROL, V519, P2954, DOI 10.1002/cne.22648; Chalfin L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5569; DeVries GJ, 1997, ANN NY ACAD SCI, V807, P273; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Liu XH, 2013, ENDOCRINOLOGY, V154, P340, DOI 10.1210/en.2012-1602; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lonstein JS, 2007, HDB NEUROCHEMISTRY M, P197; Love TM, 2014, PHARMACOL BIOCHEM BE, V119, P49, DOI 10.1016/j.pbb.2013.06.011; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Numan M., 2003, HORM BR BEHAV; Numan M, 2010, BEHAV NEUROSCI, V124, P715, DOI 10.1037/a0021548; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Semaan SJ, 2010, CURR OPIN NEUROBIOL, V20, P424, DOI 10.1016/j.conb.2010.04.004; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Simerly RB, 1998, BEHAV BRAIN RES, V92, P195, DOI 10.1016/S0166-4328(97)00191-5; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Zuloaga DG, 2014, J COMP NEUROL, V522, P358, DOI 10.1002/cne.23400	36	139	141	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					519	+		10.1038/nature15378	http://dx.doi.org/10.1038/nature15378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SK	26375004				2022-12-28	WOS:000427190300001
J	Moore, DL; Pilz, GA; Arauzo-Bravo, MJ; Barral, Y; Jessberger, S				Moore, D. L.; Pilz, G. A.; Arauzo-Bravo, M. J.; Barral, Y.; Jessberger, S.			A mechanism for the segregation of age in mammalian neural stem cells	SCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; ASYMMETRIC SEGREGATION; DAMAGED PROTEINS; CHROMATIN; PROLIFERATION; NUCLEUS; MITOSIS	Throughout life, neural stem cells (NSCs) generate neurons in the mammalian brain. Using photobleaching experiments, we found that during cell division in vitro and within the developing mouse forebrain, NSCs generate a lateral diffusion barrier in the membrane of the endoplasmic reticulum, thereby promoting asymmetric segregation of cellular components. The diffusion barrier weakens with age and in response to impairment of lamin-associated nuclear envelope constituents. Weakening of the diffusion barrier disrupts asymmetric segregation of damaged proteins, a product of aging. Damaged proteins are asymmetrically inherited by the nonstem daughter cell in embryonic and young adult NSC divisions, whereas in the older adult brain, damaged proteins are more symmetrically distributed between progeny. Thus, these data identify a mechanism of how damage that accumulates with age is asymmetrically distributed during somatic stem cell division.	[Moore, D. L.; Pilz, G. A.; Jessberger, S.] Univ Zurich, Fac Med & Sci, Brain Res Inst, CH-8057 Zurich, Switzerland; [Arauzo-Bravo, M. J.] Biodonostia Hlth Res Inst, San Sebastian 20014, Spain; [Arauzo-Bravo, M. J.] Basque Fdn Sci, IKERBASQUE, Bilbao 48013, Spain; [Barral, Y.] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland	University of Zurich; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jessberger, S (corresponding author), Univ Zurich, Fac Med & Sci, Brain Res Inst, CH-8057 Zurich, Switzerland.	jessberger@hifo.uzh.ch	Jessberger, Sebastian/AAJ-4032-2020; Marcos, Arauzo-Bravo/A-1706-2011	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Moore, Darcie/0000-0002-0854-7655; Jessberger, Sebastian/0000-0002-0056-8275; Barral, Yves/0000-0002-0989-3373	Swiss National Science Foundation; EMBO Young Investigator program; Zurich Neuroscience Center; European Research Council; EMBO long-term fellowship; ETH	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); Zurich Neuroscience Center; European Research Council(European Research Council (ERC)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); ETH(ETH Zurich)	Data have been deposited in NCBI's Gene Expression Omnibus with accession number GSE61367. Supplement contains additional data. We thank M. Gotz for providing support for pilot slice culture experiments and conceptual input; L. Clay, B. Boettcher, A. Denoth Lippuner, X. Wang, M. Knobloch, D. Wuthrich, and R. A. Machado for experimental help; C. Balazs and M. Kirschmann for programming analyses tools; S. Rinehart for artwork; F. H. Gage, S. Aigner, and D. C. Lie for comments on the manuscript; and the light microscopy facilities of the University of Zurich Center for Microscopy and Image Analysis and ETH Zurich (ScopeM) for technical support. Supported by the Swiss National Science Foundation, the EMBO Young Investigator program, the Zurich Neuroscience Center (S.J.), the European Research Council (Y.B.), an EMBO long-term fellowship (G.A.P.), and the ETH fellow program and a Human Frontier Science Program long-term fellowship (D.L.M.).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Henderson KA, 2008, CURR OPIN CELL BIOL, V20, P723, DOI 10.1016/j.ceb.2008.09.004; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ogrodnik M, 2014, P NATL ACAD SCI USA, V111, P8049, DOI 10.1073/pnas.1324035111; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046	18	98	100	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1334	1338		10.1126/science.aac9868	http://dx.doi.org/10.1126/science.aac9868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383951				2022-12-28	WOS:000361357700048
J	Oliver, D				Oliver, David			David Oliver: Welcoming carers on to the wards	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Age UK Local Government Association NHS Confederation, 2012, DEL DIGN SEC DIGN CA; Alzheimer's Society, 2009, COUNT COST CAR PEOPL; [Anonymous], 2015, GUARDIAN; Campaign John's, 2015, 3 EX GOOD PRACT BRIS; Cornwell J., 2012, CALL ACTION; Cornwell J., 2012, CARE FRAIL OLDER PEO; Edwards S., 2015, GUARDIAN; House of Lords Select Committee on Public Service and Demographic Change, 2013, READ AG; NHS England, 2019, NHS INT PEOPL PLAN; Nottingham University Hospitals NHS Trust, 2015, VIS TIM AR A CHANG; Oliver D, 2014, MAKING HLTH CARE SYS	11	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2015	351								h4959	10.1136/bmj.h4959	http://dx.doi.org/10.1136/bmj.h4959			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9ME	26385852	Bronze			2022-12-28	WOS:000361679100002
J	Arndt, M; Brand, C				Arndt, Markus; Brand, Christian			Interference of atomic clocks	SCIENCE			English	Editorial Material							GRAVITATIONAL REDSHIFT; QUANTUM; WAVES		[Arndt, Markus] Univ Vienna, Fac Phys, VCQ, A-1090 Vienna, Austria; QuNaBioS, A-1090 Vienna, Austria	University of Vienna	Arndt, M (corresponding author), Univ Vienna, Fac Phys, VCQ, Boltzmanngasse 5, A-1090 Vienna, Austria.	markus.arndt@univie.ac.at	Brand, Christian/C-9842-2011; Arndt, Markus/P-3852-2019; Arndt, Markus/A-4571-2012	Brand, Christian/0000-0003-3872-7769; Arndt, Markus/0000-0002-9487-4985; Arndt, Markus/0000-0002-9487-4985				Arndt M, 2014, NAT PHYS, V10, P271, DOI [10.1038/nphys2863, 10.1038/NPHYS2863]; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; De Broglie L, 1923, NATURE, V112, P540, DOI 10.1038/112540a0; Dickerson SM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.083001; Durr S, 1998, NATURE, V395, P33, DOI 10.1038/25653; Margalit Y, 2015, SCIENCE, V349, P1205, DOI 10.1126/science.aac6498; Muller H, 2010, NATURE, V463, P926, DOI 10.1038/nature08776; RAUCH H, 1975, PHYS LETT A, V54, P425, DOI 10.1016/0375-9601(75)90798-7; Wolf P, 2010, NATURE, V467, pE1, DOI 10.1038/nature09340; Zych M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1498	11	6	6	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1168	1169		10.1126/science.aad0683	http://dx.doi.org/10.1126/science.aad0683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9XH	26359391				2022-12-28	WOS:000360968400024
J	Hugo, W; Shi, HB; Sun, L; Piva, M; Song, CY; Kong, XJ; Moriceau, G; Hong, AY; Dahlman, KB; Johnson, DB; Sosman, JA; Ribas, A; Lo, RS				Hugo, Willy; Shi, Hubing; Sun, Lu; Piva, Marco; Song, Chunying; Kong, Xiangju; Moriceau, Gatien; Hong, Aayoung; Dahlman, Kimberly B.; Johnson, Douglas B.; Sosman, Jeffrey A.; Ribas, Antoni; Lo, Roger S.			Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance	CELL			English	Article							BRAF INHIBITOR RESISTANCE; RAF INHIBITION; MUTANT; MECHANISMS; CELLS; MEK; VEMURAFENIB; EFFICACY; RECEPTOR; DRIVES	Clinically acquired resistance to MAPK inhibitor (MAPKi) therapies for melanoma cannot be fully explained by genomic mechanisms and may be accompanied by co-evolution of intra-tumoral immunity. We sought to discover non-genomic mechanisms of acquired resistance and dynamic immune compositions by a comparative, transcriptomic-methylomic analysis of patient-matched melanoma tumors biopsied before therapy and during disease progression. Transcriptomic alterations across resistant tumors were highly recurrent, in contrast to mutations, and were frequently correlated with differential methylation of tumor cell-intrinsic CpG sites. We identified in the tumor cell compartment supraphysiologic c-MET up-expression, infra-physiologic LEF1 down-expression and YAP1 signature enrichment as drivers of acquired resistance. Importantly, high intra-tumoral cytolytic T cell inflammation prior to MAPKi therapy preceded CD8 T cell deficiency/exhaustion and loss of antigen presentation in half of disease-progressive melanomas, suggesting cross-resistance to salvage anti-PD-1/PD-L1 immunotherapy. Thus, melanoma acquires MAPKi resistance with highly dynamic and recurrent non-genomic alterations and co-evolving intra-tumoral immunity.	[Hugo, Willy; Shi, Hubing; Sun, Lu; Piva, Marco; Song, Chunying; Kong, Xiangju; Moriceau, Gatien; Hong, Aayoung; Lo, Roger S.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Hugo, Willy; Shi, Hubing; Sun, Lu; Piva, Marco; Song, Chunying; Kong, Xiangju; Moriceau, Gatien; Hong, Aayoung; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Dahlman, Kimberly B.] Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Johnson, Douglas B.; Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; [Dahlman, Kimberly B.; Johnson, Douglas B.; Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lo, RS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA.	rlo@mednet.ucla.edu	Piva, Marco/F-2748-2019	Hugo, Willy/0000-0002-1426-7190; Piva, Marco/0000-0001-6906-6065; Shi, Hubing/0000-0002-2926-3440	Burroughs Wellcome Fund; Stand Up To Cancer; Melanoma Research Alliance; NIH [1R01CA176111, 1P01CA168585, K12CA0906525]; Wade F.B. Thompson/Cancer Research Institute CLIP Grant; SWOG/ Hope Foundation; Ressler Family Foundation; Ian Copeland Melanoma Fund; T.J. Martell Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE [P01CA168585, P30CA016042, R01CA176111] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Stand Up To Cancer; Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wade F.B. Thompson/Cancer Research Institute CLIP Grant; SWOG/ Hope Foundation; Ressler Family Foundation; Ian Copeland Melanoma Fund; T.J. Martell Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to G. Bollag (Plexxikon Inc.) for providing PLX4032 and Donald Hucks for tissue processing. This work was funded by Burroughs Wellcome Fund (to R.S.L.), Stand Up To Cancer (to R.S.L.), Melanoma Research Alliance (to R.S.L.), the NIH (1R01CA176111 to R.S.L.; 1P01CA168585 to A.R. and R.S.L.; K12CA0906525 to D.B.J.), Wade F.B. Thompson/Cancer Research Institute CLIP Grant (to R.S.L.), the SWOG/ Hope Foundation (to R.S.L. and A.R.), the Ressler Family Foundation (to R.S.L. and A.R.), the Ian Copeland Melanoma Fund (to R.S.L.), and the T.J. Martell Foundation and the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (to K.B.D.).	Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; de Andrade LF, 2014, CANCER RES, V74, P7298, DOI 10.1158/0008-5472.CAN-14-1339; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Laurent S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-108; Lidsky M, 2014, J BIOL CHEM, V289, P27714, DOI 10.1074/jbc.M113.532432; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Mok S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1377-8; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2015, CANCER DISCOV, V5, P264, DOI 10.1158/2159-8290.CD-14-0293; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sanchez-Laorden B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004815; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2014, CANCER DISCOV, V4, P69, DOI 10.1158/2159-8290.CD-13-0279; Shi HB, 2012, CANCER DISCOV, V2, P414, DOI 10.1158/2159-8290.CD-12-0022; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312	30	387	393	5	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1271	1285		10.1016/j.cell.2015.07.061	http://dx.doi.org/10.1016/j.cell.2015.07.061			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359985	Bronze, Green Accepted			2022-12-28	WOS:000361247900017
J	Panigrahi, B; Martin, KA; Li, Y; Graves, AR; Vollmer, A; Olson, L; Mensh, BD; Karpova, AY; Dudman, JT				Panigrahi, Babita; Martin, Kathleen A.; Li, Yi; Graves, Austin R.; Vollmer, Alison; Olson, Lars; Mensh, Brett D.; Karpova, Alla Y.; Dudman, Joshua T.			Dopamine Is Required for the Neural Representation and Control of Movement Vigor	CELL			English	Article							BASAL GANGLIA; PARKINSONS-DISEASE; DORSOMEDIAL STRIATUM; ACTION SELECTION; DORSAL STRIATUM; ARM MOVEMENTS; NEURONS; REWARD; INFORMATION; DISORDERS	Progressive depletion of midbrain dopamine neurons (PDD) is associated with deficits in the initiation, speed, and fluidity of voluntary movement. Models of basal ganglia function focus on initiation deficits; however, it is unclear how they account for deficits in the speed or amplitude of movement (vigor). Using an effort-based operant conditioning task for headfixed mice, we discovered distinct functional classes of neurons in the dorsal striatum that represent movement vigor. Mice with PDD exhibited a progressive reduction in vigor, along with a selective impairment of its neural representation in striatum. Restoration of dopaminergic tone with a synthetic precursor ameliorated deficits in movement vigor and its neural representation, while suppression of striatal activity during movement was sufficient to reduce vigor. Thus, dopaminergic input to the dorsal striatum is indispensable for the emergence of striatal activity that mediates adaptive changes in movement vigor. These results suggest refined intervention strategies for Parkinson's disease.	[Panigrahi, Babita; Martin, Kathleen A.; Li, Yi; Graves, Austin R.; Vollmer, Alison; Mensh, Brett D.; Karpova, Alla Y.; Dudman, Joshua T.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Olson, Lars] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Howard Hughes Medical Institute; Karolinska Institutet	Dudman, JT (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	dudmanj@janelia.hhmi.org		Graves, Austin/0000-0003-1087-3684; Dudman, Joshua/0000-0002-4436-1057; Martin, Kathleen/0000-0002-5544-2127	Howard Hughes Medical Institute (HHMI); Swedish Research Council (ERC) [322744]; Swedish Brain Power	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Swedish Research Council (ERC); Swedish Brain Power	We thank members of the A.Y.K. and J.T.D. labs for critical reading and feedback on the manuscript. J.T.D. and A.Y.K. are Group Leaders at Janelia Research Campus and this work was supported by the Howard Hughes Medical Institute (HHMI). B.P. was an HHMI Medical Fellow. L.O. is supported by the Swedish Research Council (ERC grant 322744) and Swedish Brain Power. L.O. is a co-owner of a company that owns commercial rights to the MitoPark mouse.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Baraduc P, 2013, J NEUROSCI, V33, P665, DOI 10.1523/JNEUROSCI.1482-12.2013; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Bryden DW, 2011, EUR J NEUROSCI, V33, P2308, DOI 10.1111/j.1460-9568.2011.07705.x; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Desmurget M, 2010, J NEUROSCI, V30, P7685, DOI 10.1523/JNEUROSCI.0163-10.2010; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Gallivan JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00215; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hernandez LF, 2013, J NEUROSCI, V33, P4782, DOI 10.1523/JNEUROSCI.3746-12.2013; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HORAK FB, 1984, J NEUROPHYSIOL, V52, P290, DOI 10.1152/jn.1984.52.2.290; Isomura Y, 2013, J NEUROSCI, V33, P10209, DOI 10.1523/JNEUROSCI.0381-13.2013; Leonardo A, 2005, J COMP PHYSIOL A, V191, P995, DOI 10.1007/s00359-005-0026-0; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Martinu K, 2012, EUR J NEUROSCI, V35, P572, DOI 10.1111/j.1460-9568.2011.07979.x; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Muranishi M, 2011, EXP BRAIN RES, V209, P235, DOI 10.1007/s00221-011-2545-y; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niva Y, 2007, ANN NY ACAD SCI, V1104, P357, DOI 10.1196/annals.1390.018; Osborne JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089007; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pan WX, 2013, NAT NEUROSCI, V16, P71, DOI 10.1038/nn.3283; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Rueda-Orozcol PE, 2015, NAT NEUROSCI, V18, P453, DOI 10.1038/nn.3924; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Stalnaker TA, 2012, J NEUROSCI, V32, P10296, DOI 10.1523/JNEUROSCI.0832-12.2012; Stein JF, 1999, CURR OPIN NEUROL, V12, P667, DOI 10.1097/00019052-199912000-00001; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Wang AY, 2013, NAT NEUROSCI, V16, P639, DOI 10.1038/nn.3377; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	46	139	141	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1418	1430		10.1016/j.cell.2015.08.014	http://dx.doi.org/10.1016/j.cell.2015.08.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359992	Bronze			2022-12-28	WOS:000361247900028
J	Grange, S; Bekri, S; Artaud-Macari, E; Francois, A; Girault, C; Poitou, AL; Benhamou, Y; Vianey-Saban, C; Benoist, JF; Chatelet, V; Tamion, F; Guerrot, D				Grange, Steven; Bekri, Soumeya; Artaud-Macari, Elise; Francois, Arnaud; Girault, Christophe; Poitou, Anne-Laure; Benhamou, Ygal; Vianey-Saban, Christine; Benoist, Jean-Francois; Chatelet, Valerie; Tamion, Fabienne; Guerrot, Dominique			Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency	LANCET			English	Editorial Material									[Grange, Steven; Girault, Christophe; Poitou, Anne-Laure; Tamion, Fabienne] Rouen Univ Hosp, Med Intens Care Unit, F-76031 Rouen, France; [Bekri, Soumeya] Rouen Univ Hosp, Metab Biochem Dept, F-76031 Rouen, France; [Artaud-Macari, Elise] Rouen Univ Hosp, Dept Pneumol, F-76031 Rouen, France; [Francois, Arnaud] Rouen Univ Hosp, Dept Pathol, F-76031 Rouen, France; [Poitou, Anne-Laure; Guerrot, Dominique] Rouen Univ Hosp, Dept Nephrol, F-76031 Rouen, France; [Benhamou, Ygal] Rouen Univ Hosp, Dept Internal Med, F-76031 Rouen, France; [Girault, Christophe] Univ Rouen, Sch Med, UPRES EA 3830, Rouen, France; [Benhamou, Ygal; Tamion, Fabienne; Guerrot, Dominique] Univ Rouen, Sch Med, INSERM, U1096, Rouen, France; [Girault, Christophe; Tamion, Fabienne; Guerrot, Dominique] IRIB, Rouen, France; [Vianey-Saban, Christine] Hosp Civils Lyon, Ctr Biol & Pathol Est, Bron, France; [Benoist, Jean-Francois] Hop Robert Debre, Dept Biochem, F-75019 Paris, France; [Chatelet, Valerie] Caen Univ Hosp, Dept Nephrol, Caen, France	CHU de Rouen; CHU de Rouen; CHU de Rouen; CHU de Rouen; CHU de Rouen; CHU de Rouen; Universite de Franche-Comte; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Rouen Normandie; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie	Grange, S (corresponding author), Rouen Univ Hosp, Med Intens Care Unit, 1 Rue Germont, F-76031 Rouen, France.	steven.grange@chu-rouen.fr	Guerrot, Dominique/N-7769-2019; Chatelet, Valerie/ABD-8719-2020	Guerrot, Dominique/0000-0002-5953-5785; Chatelet, Valerie/0000-0002-3107-9087; Bekri, Soumeya/0000-0001-6184-7270				Brunelli SM, 2002, PEDIATR NEPHROL, V17, P800, DOI 10.1007/s00467-002-0895-1; Fischer S, 2014, J INHERIT METAB DIS, V37, P831, DOI 10.1007/s10545-014-9687-6; Gall ECL, 2014, AM J KIDNEY DIS, V63, P119, DOI 10.1053/j.ajkd.2013.08.031; Huemer M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0161-1; Komhoff M, 2013, PEDIATRICS, V132, pE540, DOI 10.1542/peds.2012-2581	5	43	47	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					1011	1012		10.1016/S0140-6736(15)00076-8	http://dx.doi.org/10.1016/S0140-6736(15)00076-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369474				2022-12-28	WOS:000361182700034
J	Russell, P; Floridis, J				Russell, Patrick; Floridis, John			Hypertrichosis lanuginosa acquisita: a rare dermatological disorder	LANCET			English	Editorial Material									[Russell, Patrick] Flinders Med Ctr, Bedford Pk, SA, Australia; [Floridis, John] Royal Darwin Hosp, Darwin, NT 0810, Australia	Flinders Medical Centre	Floridis, J (corresponding author), Royal Darwin Hosp, Darwin, NT 0810, Australia.	John.Floridis@nt.gov.au							0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2035	2035		10.1016/S0140-6736(15)00121-X	http://dx.doi.org/10.1016/S0140-6736(15)00121-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26364545				2022-12-28	WOS:000375881500032
J	McCormack, S; Dunn, DT; Desai, M; Dolling, DI; Gafos, M; Gilson, R; Sullivan, AK; Clarke, A; Reeves, I; Schembri, G; Mackie, N; Bowman, C; Lacey, CJ; Apea, V; Brady, M; Fox, J; Taylor, S; Antonucci, S; Khoo, SH; Rooney, J; Nardone, A; Fisher, M; McOwan, A; Phillips, AN; Johnson, AM; Gazzard, B; Gill, ON				McCormack, Sheena; Dunn, David T.; Desai, Monica; Dolling, David I.; Gafos, Mitzy; Gilson, Richard; Sullivan, Ann K.; Clarke, Amanda; Reeves, Iain; Schembri, Gabriel; Mackie, Nicola; Bowman, Christine; Lacey, Charles J.; Apea, Vanessa; Brady, Michael; Fox, Julie; Taylor, Stephen; Antonucci, Simone; Khoo, Saye H.; Rooney, James; Nardone, Anthony; Fisher, Martin; McOwan, Alan; Phillips, Andrew N.; Johnson, Anne M.; Gazzard, Brian; Gill, Owen N.			Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial	LANCET			English	Article							ANTIRETROVIRAL PROPHYLAXIS; AFRICAN WOMEN; TRANSMISSION; TENOFOVIR; MEN; UK	Background Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection. However, this benefit could be counteracted by risk compensation in users of PrEP. We did the PROUD study to assess this effect. Methods PROUD is an open-label randomised trial done at 13 sexual health clinics in England. We enrolled HIV-negative gay and other men who have sex with men who had had anal intercourse without a condom in the previous 90 days. Participants were randomly assigned (1: 1) to receive daily combined tenofovir disoproxil fumarate (245 mg) and emtricitabine (200 mg) either immediately or after a deferral period of 1 year. Randomisation was done via web-based access to a central computer-generated list with variable block sizes (stratified by clinical site). Follow-up was quarterly. The primary outcomes for the pilot phase were time to accrue 500 participants and retention; secondary outcomes included incident HIV infection during the deferral period, safety, adherence, and risk compensation. The trial is registered with ISRCTN (number ISRCTN94465371) and ClinicalTrials.gov (NCT02065986). Findings We enrolled 544 participants (275 in the immediate group, 269 in the deferred group) between Nov 29, 2012, and April 30, 2014. Based on early evidence of effectiveness, the trial steering committee recommended on Oct 13, 2014, that all deferred participants be offered PrEP. Follow-up for HIV incidence was complete for 243 (94%) of 259 patient-years in the immediate group versus 222 (90%) of 245 patient-years in the deferred group. Three HIV infections occurred in the immediate group (1.2/100 person-years) versus 20 in the deferred group (9.0/100 person-years) despite 174 prescriptions of post-exposure prophylaxis in the deferred group (relative reduction 86%, 90% CI 64-96, p=0.0001; absolute difference 7.8/100 person-years, 90% CI 4.3-11.3). 13 men (90% CI 9-23) in a similar population would need access to 1 year of PrEP to avert one HIV infection. We recorded no serious adverse drug reactions; 28 adverse events, most commonly nausea, headache, and arthralgia, resulted in interruption of PrEp. We detected no difference in the occurrence of sexually transmitted infections, including rectal gonorrhoea and chlamydia, between groups, despite a suggestion of risk compensation among some PrEP recipients. Interpretation In this high incidence population, daily tenofovir-emtricitabine conferred even higher protection against HIV than in placebo-controlled trials, refuting concerns that effectiveness would be less in a real-world setting. There was no evidence of an increase in other sexually transmitted infections. Our findings strongly support the addition of PrEP to the standard of prevention for men who have sex with men at risk of HIV infection. Copyright (C) McCormack et al. Open Access article distributed under the terms of CC BY.	[McCormack, Sheena; Dunn, David T.; Desai, Monica; Dolling, David I.; Gafos, Mitzy] UCL, MRC Clin Trials Unit, London WC2B 6NH, England; [Desai, Monica; Nardone, Anthony; Gill, Owen N.] Publ Hlth England Ctr Infect Dis Surveillance & C, HIV & STI Dept, London, England; [Gilson, Richard] Cent & NorthWest London NHS Fdn Trust, Mortimer Market Ctr, London, England; [Sullivan, Ann K.; Gazzard, Brian] Chelsea & Westminster Healthcare NHS Fdn Trust, St Stephens Ctr, London, England; [Clarke, Amanda; Fisher, Martin] Brighton & Sussex Univ Hosp NHS Trust, Royal Sussex Cty Hosp, Claude Nicol Ctr, Brighton, E Sussex, England; [Reeves, Iain] Homerton Univ Hosp NHS Fdn Trust, London, England; [Schembri, Gabriel] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Sexual Hlth, Manchester, Lancs, England; [Mackie, Nicola] Imperial Coll Healthcare NHS Fdn Trust, St Marys Hosp, London, England; [Bowman, Christine] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Lacey, Charles J.] Univ York, York Teaching Hosp, York YO10 5DD, N Yorkshire, England; [Lacey, Charles J.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Apea, Vanessa] Barts Hlth NHS Trust, Ambrose King Ctr, London, England; [Apea, Vanessa] Barts Hlth NHS Trust, Sexual Hlth Ctr, London, England; [Brady, Michael] Kings Coll Hosp NHS Fdn Trust, London, England; [Fox, Julie] Guys & St Thomas NHS Fdn Trust, London, England; [Taylor, Stephen] Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [McCormack, Sheena; Antonucci, Simone; McOwan, Alan] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Rooney, James] Gilead Sci Foster City, Foster City, CA USA; [Khoo, Saye H.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Gilson, Richard; Phillips, Andrew N.; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England	Medical Research Council Clinical Trials Unit; University of London; University College London; Public Health England; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Manchester; Imperial College London; University of Sheffield; University of York - UK; University of Hull; University of York - UK; Barts Health NHS Trust; Barts Health NHS Trust; King's College Hospital NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Heart of England NHS Foundation Trust; University of Birmingham; Imperial College London; Gilead Sciences; University of Liverpool; University of London; University College London	McCormack, S (corresponding author), UCL, MRC Clin Trials Unit, Aviat House, London WC2B 6NH, England.	s.mccormack@ucl.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Gafos, Mitzy/0000-0002-7894-1498; Taylor, stephen/0000-0001-5496-6482; fox, Julie/0000-0002-0583-8019; Johnson, Anne/0000-0003-1330-7100; Nardone, Anthony/0000-0003-1138-0937; Dunn, David/0000-0003-1836-4446	MRC Clinical Trials Unit at University College London; Public Health England; UK National Institute of Health Research Clinical Research Network; Gilead Sciences; MRC [MC_UU_12023/1, MC_U122861322] Funding Source: UKRI; Medical Research Council [MC_UU_12023/1, MC_U122861322, MC_UU_12023/23] Funding Source: researchfish; National Institute for Health Research [ACF-2008-20-002] Funding Source: researchfish	MRC Clinical Trials Unit at University College London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; UK National Institute of Health Research Clinical Research Network; Gilead Sciences(Gilead Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We dedicate this paper to the late Professor Martin Fisher, who championed treatment and prevention in the UK for two decades, and whose leadership and companionship we miss. The study was supported by ad hoc funding from the MRC Clinical Trials Unit at University College London and an innovations grant from Public Health England, and most clinics received support through the UK National Institute of Health Research Clinical Research Network. Gilead Sciences provided Truvada, distributed drug to clinics, and awarded a grant for the additional diagnostic tests including drug concentrations in plasma. We thank the PROUD participants who recognised the need for the study design, the dedication of the clinic teams, and the oversight that the governance committees provided as the study evolved, including the community engagement group who helped to boost recruitment and advised us on dissemination. A full list of contributors is given in the appendix.	Aghaizu A, 2015, BASHH SPRING C 2015; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2014, PREEXP PROPH PREV HI; Antonucci S, 2014, 20 INT AIDS C JUL 20; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Brown AE, 2014, AIDS, V28, P281, DOI 10.1097/QAD.0000000000000137; Browne OT, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2339; Buchbinder SP, 2014, LANCET INFECT DIS, V14, P468, DOI 10.1016/S1473-3099(14)70025-8; Cambiano V, 2015, BASHH SPRING C 2015; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; European Centre for Disease Prevention and Control, 2012, EV HIV TREATM PREV E; European Medicines Agency, 2012, EMA1712642012; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2012, INT J STD AIDS, V23, P1, DOI 10.1258/ijsa.2011.051211; Molina JM, 2015, C RETR OPP INF FEB 2; Nakagawa F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125018; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Public Health England, 2014, HIV UK 2014 REP; Sellier PO, 2011, NEW ENGL J MED, V364, P1373, DOI 10.1056/NEJMc1101504; Standards Unit Microbiology Services Public Health England, 2013, UK STAND MICR INV SE; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van de Vijver DAMC, 2013, AIDS, V27, P2943, DOI 10.1097/01.aids.0000433237.63560.20; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231	29	1126	1137	5	128	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					53	60		10.1016/S0140-6736(15)00056-2	http://dx.doi.org/10.1016/S0140-6736(15)00056-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26364263	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000367457300027
J	Khullar, D; Jha, AK; Jena, AB				Khullar, Dhruv; Jha, Ashish K.; Jena, Anupam B.			Reducing Diagnostic Errors - Why Now?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Khullar, Dhruv; Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; National Bureau of Economic Research	Khullar, D (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				NIH HHS [DP5 OD017897] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Croskerry Pat, 2012, Healthc Q, V15 Spec No, P50; Hota B, 2007, ARCH INTERN MED, V167, P1026, DOI 10.1001/archinte.167.10.1026; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Singh H, 2012, BMJ QUAL SAF, V21, P93, DOI 10.1136/bmjqs-2011-000304; Wachter RM, 2010, HEALTH AFFAIR, V29, P1605, DOI 10.1377/hlthaff.2009.0513	5	39	41	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2491	2493		10.1056/NEJMp1508044	http://dx.doi.org/10.1056/NEJMp1508044			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ7SG	26397948	Green Accepted			2022-12-28	WOS:000367299700003
J	Chopra, V; Saint, S				Chopra, Vineet; Saint, Sanjay			Vascular catheter infections: time to get technical	LANCET			English	Editorial Material							NATIONAL-SURVEY; METAANALYSIS; CARE		[Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Healthcare Syst, Patient Safety Enhancement Program, Ann Arbor, MI 48105 USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [Chopra, Vineet; Saint, Sanjay] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Chopra, V (corresponding author), Ann Arbor VA Healthcare Syst, Patient Safety Enhancement Program, Ann Arbor, MI 48105 USA.	vineetc@umich.edu	Saint, Sanjay/AAF-5126-2019	Chopra, Vineet/0000-0001-8670-9376	AHRQ HHS [K08 HS022835] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS022835] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Apisarnthanarak A, 2012, INFECT CONT HOSP EP, V33, P711, DOI 10.1086/666330; Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007; Chopra V, 2013, BMJ QUAL SAF, V22, P93, DOI 10.1136/bmjqs-2012-001480; Chopra V, 2012, JAMA-J AM MED ASSOC, V308, P1527, DOI 10.1001/jama.2012.12704; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Krein SL, 2012, J GEN INTERN MED, V27, P773, DOI 10.1007/s11606-011-1935-y; Labeau SO, 2011, LANCET INFECT DIS, V11, P845, DOI 10.1016/S1473-3099(11)70127-X; Maki DG, 2014, LANCET, V384, P1345, DOI 10.1016/S0140-6736(14)61813-4; Mimoz O, 2015, LANCET; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Saint S, 2015, PREVENTING HOSP INFE; Saint S, 2015, INFECT CONTROL HO S1, V31, pS14	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2034	2036		10.1016/S0140-6736(15)00245-7	http://dx.doi.org/10.1016/S0140-6736(15)00245-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26388530				2022-12-28	WOS:000365987600006
J	Amant, F; Vandenbroucke, T; Verheecke, M; Fumagalli, M; Halaska, MJ; Boere, I; Han, S; Gziri, MM; Peccatori, F; Rob, L; Lok, C; Witteveen, P; Voigt, JU; Naulaers, G; Vallaeys, L; Van den Heuvel, F; Lagae, L; Mertens, L; Claes, L; Van Calsteren, K				Amant, F.; Vandenbroucke, T.; Verheecke, M.; Fumagalli, M.; Halaska, M. J.; Boere, I.; Han, S.; Gziri, M. M.; Peccatori, F.; Rob, L.; Lok, C.; Witteveen, P.; Voigt, J-U; Naulaers, G.; Vallaeys, L.; Van den Heuvel, F.; Lagae, L.; Mertens, L.; Claes, L.; Van Calsteren, K.		INCIP	Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSPLACENTAL TRANSFER; AMERICAN-SOCIETY; BREAST-CANCER; CHEMOTHERAPY; CHILDREN; ANTHRACYCLINES; ECHOCARDIOGRAM; PERFORMANCE; BIRTH; FETAL	BACKGROUND Data on the long-term outcome of children who are exposed to maternal cancer with or without treatment during pregnancy are lacking. METHODS In this multicenter case-control study, we compared children whose mothers received a diagnosis of cancer during the pregnancy with matched children of women without a cancer diagnosis. We used a health questionnaire and medical files to collect data regarding neonatal and general health. All children were prospectively assessed (by means of a neurologic examination and the Bayley Scales of Infant Development) at 18 months, 36 months, or both. A cardiac assessment was performed at 36 months. RESULTS A total of 129 children (median age, 22 months; range, 12 to 42) were included in the group whose mother had cancer (prenatal-exposure group) with a matching number in the control group. During pregnancy, 96 children (74.4%) were exposed to chemotherapy (alone or in combination with other treatments), 11 (8.5%) to radiotherapy (alone or in combination), 13 (10.1%) to surgery alone, 2 (1.6%) to other drug treatments, and 14 (10.9%) to no treatment. Birth weight was below the 10th percentile in 28 of 127 children (22.0%) in the prenatal-exposure group and in 19 of 125 children (15.2%) in the control group (P = 0.16). There was no significant between-group difference in cognitive development on the basis of the Bayley score (P = 0.08) or in subgroup analyses. The gestational age at birth was correlated with the cognitive outcome in the two study groups. Cardiologic evaluation among 47 children at 36 months of age showed normal cardiac findings. CONCLUSIONS Prenatal exposure to maternal cancer with or without treatment did not impair the cognitive, cardiac, or general development of children in early childhood. Prematurity was correlated with a worse cognitive outcome, but this effect was independent of cancer treatment.	[Amant, F.; Vandenbroucke, T.; Verheecke, M.; Han, S.] Univ Hosp Leuven, Dept Gynecol Oncol, B-3000 Louvain, Belgium; [Amant, F.; Vandenbroucke, T.; Verheecke, M.; Han, S.] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium; [Voigt, J-U] Univ Hosp Leuven, Dept Cardiol, B-3000 Louvain, Belgium; [Naulaers, G.; Vallaeys, L.; Lagae, L.] Univ Hosp Leuven, Dept Pediat, B-3000 Louvain, Belgium; [Van Calsteren, K.] Univ Hosp Leuven, Dept Obstet, B-3000 Louvain, Belgium; [Naulaers, G.; Lagae, L.; Van Calsteren, K.] Katholieke Univ Leuven, Dept Growth & Regenerat, Leuven, Belgium; [Claes, L.] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Gziri, M. M.] Clin Univ St Luc, Dept Obstet, B-1200 Brussels, Belgium; [Fumagalli, M.] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neonatal Intens Care Unit, Milan, Italy; [Peccatori, F.] European Inst Oncol, Fertil & Reprod Unit, Milan, Italy; [Halaska, M. J.; Rob, L.] Charles Univ Prague, Dept Obstet & Gynecol, Prague, Czech Republic; [Boere, I.] Erasmus MC, Inst Canc, Dept Med Oncol, Rotterdam, Netherlands; [Amant, F.; Lok, C.] Antoni van Leeuwenhoek Netherlands Canc Inst, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands; [Witteveen, P.] Univ Med Ctr Utrecht, Ctr Canc, Dept Med Oncol, Utrecht, Netherlands; [Van den Heuvel, F.] Univ Oxford, Dept Phys, Oxford, England; [Van den Heuvel, F.] Univ Oxford, Dept Nucl Phys, Oxford OX1 3RH, England; [Van den Heuvel, F.] Univ Oxford, Dept Med Phys, Oxford, England; [Mertens, L.] Univ Toronto, Hosp Sick Children, Dept Cardiol, Toronto, ON M5G 1X8, Canada	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS European Institute of Oncology (IEO); Charles University Prague; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Oxford; University of Oxford; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Amant, F (corresponding author), Univ Hosp Leuven, Dept Gynecol Oncol, Herestr 49, B-3000 Louvain, Belgium.	frederic.amant@uzleuven.be	Van den Heuvel, Frank/GOK-2337-2022; Peccatori, Fedro Alessandro/AAP-7058-2020; Halaska, Michael/AFR-7383-2022; Van den Heuvel, Frank/CAE-9338-2022; Naulaers, Gunnar/AAC-5022-2019; Rob, Lukas/AFQ-9215-2022; Peccatori, Fedro/AAL-3450-2021; Amant, Frédéric/W-7436-2019; Fumagalli, Monica/K-6717-2016; Lok, Christianne/ABB-4416-2020	Van den Heuvel, Frank/0000-0001-9904-502X; Peccatori, Fedro Alessandro/0000-0001-8227-8740; Van den Heuvel, Frank/0000-0001-9904-502X; Rob, Lukas/0000-0003-3770-651X; Amant, Frédéric/0000-0002-5452-4905; Fumagalli, Monica/0000-0002-0186-0710; Naulaers, Gunnar/0000-0003-0735-4808; Voigt, Jens-Uwe/0000-0002-0575-1888; Claes, Laurence/0000-0002-2287-3158; Mertens, Luc/0000-0001-7308-1268; Han, Sileny/0000-0002-7476-3372	Research Foundation-Flanters	Research Foundation-Flanters	Funded by Research Foundation-Flanters and others	Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Aviles A, 2006, ANN ONCOL, V17, P286, DOI 10.1093/annonc/mdj053; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; Bayley N, 1993, BAYLEY SCALES INFANT; Bayley N., 2005, BAYLEY SCALES INFANT; Berveiller P, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.007; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Cardonick EH, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.032; Cotechini T, 2015, PLACENTA, V36, P960, DOI 10.1016/j.placenta.2015.05.016; Cunningham F.G., 2010, WILLIAMS OBSTET STUD, P842; Gziri MM, 2012, ACTA OBSTET GYN SCAN, V91, P1465, DOI 10.1111/j.1600-0412.2012.01524.x; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Loibl S, 2012, LANCET ONCOL, V13, P887, DOI 10.1016/S1470-2045(12)70261-9; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Lowe JR, 2012, ACTA PAEDIATR, V101, pE55, DOI 10.1111/j.1651-2227.2011.02517.x; Luis SA, 2009, J MED IMAG RADIAT ON, V53, P559, DOI 10.1111/j.1754-9485.2009.02124.x; Mir O, 2008, CANCER, V113, P3069, DOI 10.1002/cncr.23935; Murthy RK, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0500-0; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Rakers F, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.020; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Van Calsteren K, 2010, GYNECOL ONCOL, V119, P594, DOI 10.1016/j.ygyno.2010.08.019; Van Calsteren K, 2010, INT J GYNECOL CANCER, V20, P1456, DOI 10.1111/IGC.0b013e3181fb18c8; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; van der Giessen PH, 2001, RADIOTHER ONCOL, V58, P209, DOI 10.1016/S0167-8140(00)00326-1	27	196	209	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1824	1834		10.1056/NEJMoa1508913	http://dx.doi.org/10.1056/NEJMoa1508913			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26415085	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000364144000006
J	Smith, JM				Smith, Jeanette M.			Garden Gyorgy Kepes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		HOY AH, 1984, GYORGY KEPES LIGHT G, P1; KEPES G, 1978, GYORGY KEPES MIT YEA, P1	2	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1210	1211		10.1001/jama.2014.11993	http://dx.doi.org/10.1001/jama.2014.11993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393832				2022-12-28	WOS:000362110700028
J	Lee, D; Lu, H; Gu, Y; Choi, SY; Li, SD; Ryu, S; Paudel, TR; Song, K; Mikheev, E; Lee, S; Stemmer, S; Tenne, DA; Oh, SH; Tsymbal, EY; Wu, X; Chen, LQ; Gruverman, A; Eom, CB				Lee, D.; Lu, H.; Gu, Y.; Choi, S-Y.; Li, S-D.; Ryu, S.; Paudel, T. R.; Song, K.; Mikheev, E.; Lee, S.; Stemmer, S.; Tenne, D. A.; Oh, S. H.; Tsymbal, E. Y.; Wu, X.; Chen, L-Q.; Gruverman, A.; Eom, C. B.			Emergence of room-temperature ferroelectricity at reduced dimensions	SCIENCE			English	Article							THIN-FILMS; ELECTRON-MICROSCOPY; SPIN POLARIZATION; OXIDE INTERFACES; TUNNEL-JUNCTIONS; ENHANCEMENT; SRTIO3; ELECTRORESISTANCE; NANOSCALE; MEMORIES	The enhancement of the functional properties of materials at reduced dimensions is crucial for continuous advancements in nanoelectronic applications. Here, we report that the scale reduction leads to the emergence of an important functional property, ferroelectricity, challenging the long-standing notion that ferroelectricity is inevitably suppressed at the scale of a few nanometers. A combination of theoretical calculations, electrical measurements, and structural analyses provides evidence of room-temperature ferroelectricity in strain-free epitaxial nanometer-thick films of otherwise nonferroelectric strontium titanate (SrTiO3). We show that electrically induced alignment of naturally existing polar nanoregions is responsible for the appearance of a stable net ferroelectric polarization in these films. This finding can be useful for the development of low-dimensional material systems with enhanced functional properties relevant to emerging nanoelectronic devices.	[Lee, D.; Ryu, S.; Lee, S.; Eom, C. B.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; [Lu, H.; Paudel, T. R.; Tsymbal, E. Y.; Gruverman, A.] Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA; [Lu, H.; Paudel, T. R.; Tsymbal, E. Y.; Gruverman, A.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA; [Gu, Y.; Chen, L-Q.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Choi, S-Y.] Korea Inst Mat Sci, Dept Mat Modeling & Characterizat, Chang Won 642831, South Korea; [Li, S-D.; Wu, X.] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Song, K.; Oh, S. H.] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang 790784, South Korea; [Mikheev, E.; Stemmer, S.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Tenne, D. A.] Boise State Univ, Dept Phys, Boise, ID 83725 USA	University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea Institute of Materials Science (KIMS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pohang University of Science & Technology (POSTECH); University of California System; University of California Santa Barbara; Idaho; Boise State University	Gruverman, A (corresponding author), Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA.	agruverman2@unl.edu; eom@engr.wisc.edu	Lee, Sanghan/AAH-1105-2019; Gruverman, Alexei/P-3537-2014; Eom, Chang-Beom/I-5567-2014; Lee, Daesu/G-6407-2011; Gu, Yijia/A-6418-2013; Choi, Si-Young/X-8167-2019; Chen, LongQing/I-7536-2012; Lee, Daesu/K-3536-2019; Stemmer, Susanne/H-6555-2011; Tenne, Dmitri/C-3294-2009; Oh, Sang Ho/AAG-1891-2020; Tsymbal, Evgeny/G-3493-2013	Lee, Sanghan/0000-0002-5807-864X; Gruverman, Alexei/0000-0003-0492-2750; Gu, Yijia/0000-0001-8036-6309; Choi, Si-Young/0000-0003-1648-142X; Chen, LongQing/0000-0003-3359-3781; Lee, Daesu/0000-0002-0646-5226; Stemmer, Susanne/0000-0002-3142-4696; Tenne, Dmitri/0000-0003-2697-8958; Oh, Sang Ho/0000-0001-5808-7821; Tsymbal, Evgeny/0000-0002-6728-5480; Song, Kyung/0000-0003-3734-1039	National Science Foundation (NSF) under Designing Materials to Revolutionize and Engineer our Future (DMREF) [DMR-1234096]; NSF through the Materials Research Science and Engineering Center (MRSEC) [DMR-1420645]; Global Frontier Hybrid Interface Materials of the National Research Foundation of Korea - Korea Government [2013M3A6B1078872]; Penn State NSF-MRSEC Center for Nanoscale Science [DMR-1420620]; NSF [DMR-1410714, DMR-1006136]; Computational Design of Functional Layered Materials, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences [DE-SC0012575]; Asian Office of Aerospace Research and Development (AOARD) [FA2386-15-1-4046]; Brain Korea 21 PLUS project for Center for Creative Industrial Materials [F14SN02D1707]; National Research Foundation (NRF) of Korea - Korean Government [2015R1A2A2A01007904]; MRSEC Program of the National Science Foundation [DMR-1121053]; Direct For Mathematical & Physical Scien [1234096] Funding Source: National Science Foundation	National Science Foundation (NSF) under Designing Materials to Revolutionize and Engineer our Future (DMREF); NSF through the Materials Research Science and Engineering Center (MRSEC); Global Frontier Hybrid Interface Materials of the National Research Foundation of Korea - Korea Government; Penn State NSF-MRSEC Center for Nanoscale Science; NSF(National Science Foundation (NSF)); Computational Design of Functional Layered Materials, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Asian Office of Aerospace Research and Development (AOARD); Brain Korea 21 PLUS project for Center for Creative Industrial Materials; National Research Foundation (NRF) of Korea - Korean Government; MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation (NSF) under Designing Materials to Revolutionize and Engineer our Future (DMREF) grant DMR-1234096. The research at University of NebraskaLincoln was supported by NSF through the Materials Research Science and Engineering Center (MRSEC) under grant DMR-1420645. S.Y.C. acknowledges the support of the Global Frontier Hybrid Interface Materials of the National Research Foundation of Korea funded by the Korea Government 2013M3A6B1078872). The work at Penn State is partially supported by Penn State NSF-MRSEC Center for Nanoscale Science grant DMR-1420620 and by NSF grant DMR-1410714. The work at Temple University was supported as part of the Center for the Computational Design of Functional Layered Materials, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences under award DE-SC0012575 and used resources of the National Energy Research Scientific Computing Center (NERSC), a User Facility supported by the DOE Office of Science. S.H.O. and K.S. acknowledge the support of the Asian Office of Aerospace Research and Development (AOARD) under grant FA2386-15-1-4046, Brain Korea 21 PLUS project for Center for Creative Industrial Materials (grant F14SN02D1707), and the National Research Foundation (NRF) of Korea funded by the Korean Government (grant 2015R1A2A2A01007904). Raman studies at Boise State University have been supported by NSF under grant DMR-1006136. The work at University of CaliforniaSanta Barbara was partially supported by the MRSEC Program of the National Science Foundation under award DMR-1121053.	Ahn CH, 2004, SCIENCE, V303, P488, DOI 10.1126/science.1092508; Ashcroft N.W., 1976, SOLID STATE PHYS; BIANCHI U, 1995, PHYS REV B, V51, P8737, DOI 10.1103/PhysRevB.51.8737; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; BURNS G, 1983, PHYS REV B, V28, P2527, DOI 10.1103/PhysRevB.28.2527; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Choi M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.185502; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Durgun E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.247601; EOM CB, 1992, SCIENCE, V258, P1766, DOI 10.1126/science.258.5089.1766; Garcia V, 2010, SCIENCE, V327, P1106, DOI 10.1126/science.1184028; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Gruverman A, 2009, NANO LETT, V9, P3539, DOI 10.1021/nl901754t; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Ishikawa R, 2011, NAT MATER, V10, P278, DOI 10.1038/NMAT2957; Jang HW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.197601; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Lichtensteiger C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047603; Liu B, 2014, PHYS CHEM CHEM PHYS, V16, P15590, DOI 10.1039/c4cp01510j; Lu H, 2012, SCIENCE, V336, P59, DOI 10.1126/science.1218693; Lu H, 2012, ADV MATER, V24, P1209, DOI 10.1002/adma.201104398; Mannhart J, 2010, SCIENCE, V327, P1607, DOI 10.1126/science.1181862; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Pantel D, 2012, NAT MATER, V11, P289, DOI [10.1038/NMAT3254, 10.1038/nmat3254]; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; SCOTT JF, 1988, J APPL PHYS, V64, P787, DOI 10.1063/1.341925; Stengel M, 2009, NAT MATER, V8, P392, DOI [10.1038/NMAT2429, 10.1038/nmat2429]; Tenne DA, 2006, SCIENCE, V313, P1614, DOI 10.1126/science.1130306; Tenne DA, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499273; UDAYAKUMAR KR, 1989, J PHYS CHEM SOLIDS, V50, P55, DOI 10.1016/0022-3697(89)90473-3; Urban KW, 2008, SCIENCE, V321, P506, DOI 10.1126/science.1152800; Warusawithana MP, 2009, SCIENCE, V324, P367, DOI 10.1126/science.1169678; ZHONG WL, 1994, PHYS REV B, V50, P698, DOI 10.1103/PhysRevB.50.698; Zhuravlev MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246802	38	207	212	20	455	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1314	1317		10.1126/science.aaa6442	http://dx.doi.org/10.1126/science.aaa6442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383947				2022-12-28	WOS:000361357700043
J	He, MG; Xiang, F; Zeng, YF; Mai, JC; Chen, QY; Zhang, J; Smith, WN; Rose, K; Morgan, IG				He, Mingguang; Xiang, Fan; Zeng, Yangfa; Mai, Jincheng; Chen, Qianyun; Zhang, Jian; Smith, Wayne; Rose, Kathryn; Morgan, Ian G.			Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; PROGRESSION; ATROPINE; ONSET	IMPORTANCE Myopia has reached epidemic levels in parts of East and Southeast Asia. However, there is no effective intervention to prevent the development of myopia. OBJECTIVE To assess the efficacy of increasing time spent outdoors at school in preventing incident myopia. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized trial of children in grade 1 from 12 primary schools in Guangzhou, China, conducted between October 2010 and October 2013. INTERVENTIONS For 6 intervention schools (n = 952 students), 1 additional 40-minute class of outdoor activities was added to each school day, and parents were encouraged to engage their children in outdoor activities after school hours, especially during weekends and holidays. Children and parents in the 6 control schools (n = 951 students) continued their usual pattern of activity. MAIN OUTCOMES AND MEASURES The primary outcome measurewas the 3-year cumulative incidence rate of myopia (defined using the Refractive Error Study in Children spherical equivalent refractive error standard of <= -0.5 diopters [D]) among the students without established myopia at baseline. Secondary outcome measures were changes in spherical equivalent refraction and axial length among all students, analyzed using mixed linear models and intention-to-treat principles. Data from the right eyes were used for the analysis. RESULTS There were 952 children in the intervention group and 951 in the control group with a mean (SD) age of 6.6 (0.34) years. The cumulative incidence rate of myopia was 30.4% in the intervention group (259 incident cases among 853 eligible participants) and 39.5%(287 incident cases among 726 eligible participants) in the control group (difference of -9.1% [95% CI, -14.1% to -4.1%]; P <.001). There was also a significant difference in the 3-year change in spherical equivalent refraction for the intervention group (-1.42 D) compared with the control group (-1.59 D) (difference of 0.17 D [95% CI, 0.01 to 0.33 D]; P =.04). Elongation of axial length was not significantly different between the intervention group (0.95 mm) and the control group (0.98 mm) (difference of -0.03 mm[95% CI, -0.07 to 0.003 mm]; P =.07). CONCLUSIONS AND RELEVANCE Among 6-year-old children in Guangzhou, China, the addition of 40 minutes of outdoor activity at school compared with usual activity resulted in a reduced incidence rate of myopia over the next 3 years. Further studies are needed to assess long-term follow-up of these children and the generalizability of these findings.	[He, Mingguang; Xiang, Fan; Zeng, Yangfa; Chen, Qianyun; Zhang, Jian; Morgan, Ian G.] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [He, Mingguang] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Australia; [Xiang, Fan] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Mai, Jincheng] Guangdong City Dept Educ, Guangzhou Students Hlth Care Inst, Guangzhou, Guangdong, Peoples R China; [Smith, Wayne] NSW Dept Hlth, Environm Hlth Branch, Sydney, NSW, Australia; [Rose, Kathryn] Univ Sydney, Discipline Orthopt, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Rose, Kathryn] Univ Technol Sydney, Discipline Orthopt, Grad Sch Hlth, Sydney, NSW 2007, Australia; [Morgan, Ian G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Sun Yat Sen University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Australian National University; University of Sydney; University of Technology Sydney; Australian National University	He, MG (corresponding author), Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China.	mingguang_he@yahoo.com	He, Mingguang/AAY-5239-2020; Morgan, Ian G/D-1190-2009; Rose, Kathryn/B-4981-2009	He, Mingguang/0000-0002-6912-2810; Morgan, Ian G/0000-0002-4548-3574; Rose, Kathryn/0000-0003-2851-4145	Fundamental Research Funds of the State Key Laboratory in Ophthalmology; National Natural Science [81125007]	Fundamental Research Funds of the State Key Laboratory in Ophthalmology; National Natural Science(National Natural Science Foundation of China (NSFC))	Funding for this trial was provided by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology and by grant 81125007 from the National Natural Science	Bar Dayan Y, 2005, INVEST OPHTH VIS SCI, V46, P2760, DOI 10.1167/iovs.04-0260; Chia A, 2012, OPHTHALMOLOGY, V119, P347, DOI 10.1016/j.ophtha.2011.07.031; Fang PC, 2010, J OCUL PHARMACOL TH, V26, P341, DOI 10.1089/jop.2009.0135; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gwiazda J, 2003, INVEST OPHTH VIS SCI, V44, P1492, DOI 10.1167/iovs.02-0816; Holden B, 2014, EYE, V28, P142, DOI 10.1038/eye.2013.256; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Spaide RF, 2014, PATHOLOGICMYOPIA; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Xiang F, 2013, EYE, V27, P1353, DOI 10.1038/eye.2013.194; Yi Jun-Hui, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P32	18	436	492	18	151	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1142	1148		10.1001/jama.2015.10803	http://dx.doi.org/10.1001/jama.2015.10803			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372583	Bronze			2022-12-28	WOS:000361284500025
J	Lasker, M				Lasker, Mary			Lasker Awards Statement by the Albert and Mary Lasker Foundation (Reprinted from JAMA, vol 222, pg 1160, 1972)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Albert & Mary Lasker Fdn, New York, NY 10017 USA		Lasker, M (corresponding author), Albert & Mary Lasker Fdn, New York, NY 10017 USA.							1972, JAMA, V222, P1160	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1182	1182		10.1001/jama.2014.11986	http://dx.doi.org/10.1001/jama.2014.11986			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372599				2022-12-28	WOS:000361284500040
J	Naylor, CD; Bell, JI				Naylor, C. David; Bell, John I.			On the Recognition of Global Excellence in Medical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Naylor, C. David] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England	University of Toronto; University of Oxford	Naylor, CD (corresponding author), 4 Shorncliffe Ave, Toronto, ON M4V 1T1, Canada.	david.naylor@utoronto.ca						[Anonymous], FULL TEXT A NOB WILL; [Anonymous], CHEM LAUR FIELDS; Casadevall A, 2013, FASEB J, V27, P4682, DOI 10.1096/fj.13-238758; Landau E., 2014, YOUR LIFE CHANGES YO; Weisse Allen B, 2015, Proc (Bayl Univ Med Cent), V28, P404	5	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1125	1126		10.1001/jama.2015.10696	http://dx.doi.org/10.1001/jama.2015.10696			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372575				2022-12-28	WOS:000361284500017
J	Johnston, AJ; Murphy, KT; Jenkinson, L; Laine, D; Emmrich, K; Faou, P; Weston, R; Jayatilleke, KM; Schloegel, J; Talbo, G; Casey, JL; Levina, V; Wong, WWL; Dillon, H; Sahay, T; Hoogenraad, J; Anderton, H; Hall, C; Schneider, P; Tanzer, M; Foley, M; Scott, AM; Gregorevic, P; Liu, SYC; Burkly, LC; Lynch, GS; Silke, J; Hoogenraad, NJ				Johnston, Amelia J.; Murphy, Kate T.; Jenkinson, Laura; Laine, David; Emmrich, Kerstin; Faou, Pierre; Weston, Ross; Jayatilleke, Krishnath M.; Schloegel, Jessie; Talbo, Gert; Casey, Joanne L.; Levina, Vita; Wong, W. Wei-Lynn; Dillon, Helen; Sahay, Tushar; Hoogenraad, Joan; Anderton, Holly; Hall, Cathrine; Schneider, Pascal; Tanzer, Maria; Foley, Michael; Scott, Andrew M.; Gregorevic, Paul; Liu, Spring Yingchun; Burkly, Linda C.; Lynch, Gordon S.; Silke, John; Hoogenraad, Nicholas J.			Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival	CELL			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; SKELETAL-MUSCLE; WEAK INDUCER; TNF-ALPHA; CELL-DEATH; TWEAK; RECEPTOR; ACTIVATION; GROWTH	The cytokine TWEAK and its cognate receptor Fn14 are members of the TNF/TNFR superfamily and are upregulated in tumors. We found that Fn14, when expressed in tumors, causes cachexia and that antibodies against Fn14 dramatically extended lifespan by inhibiting tumor-induced weight loss although having only moderate inhibitory effects on tumor growth. Anti-Fn14 antibodies prevented tumorinduced inflammation and loss of fat and muscle mass. Fn14 signaling in the tumor, rather than host, is responsible for inducing this cachexia because tumors in Fn14- andTWEAK-deficient hosts developed cachexia that was comparable to that of wild-type mice. These results extend the role of Fn14 in wound repair and muscle development to involvement in the etiology of cachexia and indicate that Fn14 antibodies may be a promising approach to treat cachexia, thereby extending lifespan and improving quality of life for cancer patients.	[Johnston, Amelia J.; Jenkinson, Laura; Laine, David; Emmrich, Kerstin; Faou, Pierre; Weston, Ross; Jayatilleke, Krishnath M.; Schloegel, Jessie; Talbo, Gert; Casey, Joanne L.; Levina, Vita; Dillon, Helen; Sahay, Tushar; Hoogenraad, Joan; Anderton, Holly; Foley, Michael; Scott, Andrew M.; Silke, John; Hoogenraad, Nicholas J.] La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Murphy, Kate T.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Wong, W. Wei-Lynn] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Anderton, Holly; Hall, Cathrine; Tanzer, Maria; Silke, John] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Anderton, Holly; Hall, Cathrine; Tanzer, Maria; Silke, John] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Scott, Andrew M.] Olivia Newton John Canc Res Inst, Melbourne, Vic 3084, Australia; [Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Liu, Spring Yingchun] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Immunol, Cambridge, MA 02142 USA	La Trobe University; University of Melbourne; University of Zurich; Walter & Eliza Hall Institute; University of Melbourne; University of Lausanne; La Trobe University; Olivia Newton-John Cancer Research Institute; Baker Heart and Diabetes Institute; Monash University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Biogen	Johnston, AJ (corresponding author), La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia.	a.johnston@latrobe.edu.au; n.hoogenraad@latrobe.edu.au	Lynch, Gordon/G-9553-2015; Gregorevic, Paul/AAH-6040-2021; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015	Lynch, Gordon/0000-0001-9220-9810; Gregorevic, Paul/0000-0002-7418-8945; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Foley, Michael/0000-0003-1349-4698; Murphy, Kate/0000-0003-1993-4367; Anderton, Holly/0000-0003-3913-9686; Scott, Andrew/0000-0002-6656-295X; Johnston, Amelia/0000-0003-4289-3516; Schneider, Pascal/0000-0003-0677-9409	Cooperative Research Centre for Biomarker Translation; NHMRC [541901, 1058190]; NHMRC Career Development Fellowship; Swiss National Science Foundation grants; NHMRC Development Grant [1075504]	Cooperative Research Centre for Biomarker Translation(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation grants(Swiss National Science Foundation (SNSF)); NHMRC Development Grant(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge financial support from the Cooperative Research Centre for Biomarker Translation and the NHMRC. We thank Timur Naim, Annabel Chee, and Jennifer Trieu for expert technical assistance. We acknowledge the provision of the activin construct, AAV vectors, and technical assistance by Craig Harrison, Hongwei Qian, and Justin Chen. We also acknowledge Stephen Wilcox for MEF tumor cell line genome DNA sequencing. J. Silke is supported by NHMRC grants #541901 and 1058190. K.T.M. is supported by an NHMRC Career Development Fellowship. P.S. is supported by Swiss National Science Foundation grants. N.J.H., J. Silke, and A.M.S. are supported by an NHMRC Development Grant #1075504. L.C.B. is an employee and stockholder of Biogen, Inc.	Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2004, FRONT BIOSCI-LANDMRK, V9, P2273, DOI 10.2741/1395; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Galfre G, 1981, Methods Enzymol, V73, P3; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Islam-Ali BS, 2001, BRIT J CANCER, V84, P1648, DOI 10.1054/bjoc.2001.1834; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Maccio A, 2012, EXPERT OPIN PHARMACO, V13, P2453, DOI 10.1517/14656566.2012.734297; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Murphy KT, 2012, DIS MODEL MECH, V5, P533, DOI 10.1242/dmm.008839; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Murphy KT, 2009, EXPERT OPIN EMERG DR, V14, P619, DOI 10.1517/14728210903369351; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Russell ST, 2005, BRIT J CANCER, V92, P876, DOI 10.1038/sj.bjc.6602404; Salzmann S, 2013, J BIOL CHEM, V288, P13455, DOI 10.1074/jbc.M112.435917; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Tajrishi MM, 2014, CYTOKINE GROWTH F R, V25, P215, DOI 10.1016/j.cytogfr.2013.12.004; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Vince JE, 2006, CELL DEATH DIFFER, V13, P1842, DOI 10.1038/sj.cdd.4402027; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wallengren O, 2013, SUPPORT CARE CANCER, V21, P1569, DOI 10.1007/s00520-012-1697-z; Walsh D, 2000, SUPPORT CARE CANCER, V8, P175, DOI 10.1007/s005200050281; Warren S, 1932, AM J MED SCI, V184, P610, DOI 10.1097/00000441-193211000-00002; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	41	86	89	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1365	1378		10.1016/j.cell.2015.08.031	http://dx.doi.org/10.1016/j.cell.2015.08.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359988	Green Accepted, Bronze			2022-12-28	WOS:000361247900024
J	Wallace, EWJ; Kear-Scott, JL; Pilipenko, EV; Schwartz, MH; Laskowski, PR; Rojek, AE; Katanski, CD; Riback, JA; Dion, MF; Franks, AM; Airoldi, EM; Pan, T; Budnik, BA; Drummond, DA				Wallace, Edward W. J.; Kear-Scott, Jamie L.; Pilipenko, Evgeny V.; Schwartz, Michael H.; Laskowski, Pawel R.; Rojek, Alexandra E.; Katanski, Christopher D.; Riback, Joshua A.; Dion, Michael F.; Franks, Alexander M.; Airoldi, Edoardo M.; Pan, Tao; Budnik, Bogdan A.; Drummond, D. Allan			Reversible, Specific, Active Aggregates of Endogenous Proteins Assemble upon Heat Stress	CELL			English	Article							QUALITY-CONTROL DEGRADATION; MESSENGER-RNA; DAMAGED PROTEINS; BUDDING YEAST; SHOCK; GRANULES; TRANSLATION; HSP70; CHAPERONES; NUCLEAR	Heat causes protein misfolding and aggregation and, in eukaryotic cells, triggers aggregation of proteins and RNA into stress granules. We have carried out extensive proteomic studies to quantify heat-triggered aggregation and subsequent disaggregation in budding yeast, identifying >170 endogenous proteins aggregating within minutes of heat shock in multiple subcellular compartments. We demonstrate that these aggregated proteins are not misfolded and destined for degradation. Stable-isotope labeling reveals that even severely aggregated endogenous proteins are disaggregated without degradation during recovery from shock, contrasting with the rapid degradation observed for many exogenous thermolabile proteins. Although aggregation likely inactivates many cellular proteins, in the case of a heterotrimeric aminoacyl-tRNA synthetase complex, the aggregated proteins remain active with unaltered fidelity. We propose that most heat-induced aggregation of mature proteins reflects the operation of an adaptive, autoregulatory process of functionally significant aggregate assembly and disassembly that aids cellular adaptation to thermal stress.	[Wallace, Edward W. J.; Kear-Scott, Jamie L.; Pilipenko, Evgeny V.; Schwartz, Michael H.; Laskowski, Pawel R.; Rojek, Alexandra E.; Katanski, Christopher D.; Riback, Joshua A.; Pan, Tao; Drummond, D. Allan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Rojek, Alexandra E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dion, Michael F.; Airoldi, Edoardo M.; Budnik, Bogdan A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Franks, Alexander M.; Airoldi, Edoardo M.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA	University of Chicago; Harvard University; Harvard University; Harvard University	Drummond, DA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.	dadrummond@uchicago.edu	Budnik, Bogdan/AAH-9987-2019; Budnik, Bogdan/AGG-8824-2022; Drummond, D. Allan/A-1250-2015	Budnik, Bogdan/0000-0003-3622-2003; Wallace, Edward/0000-0001-8025-6361; Laskowski, Pawel/0000-0002-8118-9030; Katanski, Christopher/0000-0002-1707-081X; Franks, Alexander/0000-0002-9329-206X; Dion, Michael/0000-0002-0434-4236; Riback, Joshua/0000-0002-1516-4484; Drummond, D. Allan/0000-0001-7018-7059	Alfred P. Sloan Foundation; National Institutes of Health [GM105816, GM096193]; Pew Charitable Trusts; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096193, T32GM007183, U54GM105816] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Drummond lab for critical comments on the manuscript. This work was funded by grants from the Alfred P. Sloan Foundation to D.A.D. and E.M.A., the National Institutes of Health (GM105816 via the Protein Translation Research Network, and GM096193), and the Pew Charitable Trusts. D.A.D. is a Pew Scholar in the Biomedical Sciences. Imaging was performed at the University of Chicago Integrated Light Microscopy Facility; we thank V. Bindokas and C. Labno for their help. We thank B. Glick and K. Day for assistance with image processing, E. Craig for the generous gift of the Ssz1 antibody, Y. Gilad and B. Engelmann for use of computing resources, J. Piccirilli and B. Weissman for scintillation counting assistance, and T. Sosnick for assistance with absorbance and scattering measurements. Some computations were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BARNES CA, 1995, MOL GEN GENET, V246, P619, DOI 10.1007/BF00298969; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; Fredrickson EK, 2013, J BIOL CHEM, V288, P6130, DOI 10.1074/jbc.M112.406710; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grousl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057083; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; HOLMGREN R, 1981, P NATL ACAD SCI-BIOL, V78, P3775, DOI 10.1073/pnas.78.6.3775; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LINDQUIST S, 1990, ENZYME, V44, P147, DOI 10.1159/000468754; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Martinez-Alonso M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-4; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rhoads RE, 1995, CURR TOP MICROBIOL, V203, P131; Samanfar B, 2014, MOL BIOSYST, V10, P916, DOI 10.1039/c3mb70501c; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	50	273	275	7	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1286	1298		10.1016/j.cell.2015.08.041	http://dx.doi.org/10.1016/j.cell.2015.08.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359986	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000361247900018
J	Schiffman, M; Wentzensen, N				Schiffman, Mark; Wentzensen, Nicolas			Towards therapeutic vaccination against cervical precancer?	LANCET			English	Editorial Material							INTRAEPITHELIAL NEOPLASIA; FOLLOW-UP; CANCER; COLPOSCOPY; RISK; INFECTION		[Schiffman, Mark; Wentzensen, Nicolas] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schiffman, M (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	schiffmm@mail.nih.gov	Wentzensen, Nicolas/AAG-8522-2019; Schiffman, Mark/B-9766-2015		NATIONAL CANCER INSTITUTE [ZIACP010206] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; Heinonen A, 2013, OBSTET GYNECOL, V121, P1063, DOI 10.1097/AOG.0b013e31828caa31; HELLBERG D, 1990, GYNECOL ONCOL, V38, P166, DOI 10.1016/0090-8258(90)90034-I; Kadish AS, 2002, CANCER EPIDEM BIOMAR, V11, P483; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS69, DOI 10.1097/LGT.0b013e31828543b1; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Schiffman M, 2015, GYNECOL ONCOL, V136, P175, DOI 10.1016/j.ygyno.2015.01.538; Trimble CL, 2015, LANCET; Wentzensen N, 2015, J CLIN ONCOL, V33, P83, DOI 10.1200/JCO.2014.55.9948	12	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2036	2038		10.1016/S0140-6736(15)00240-8	http://dx.doi.org/10.1016/S0140-6736(15)00240-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26386539				2022-12-28	WOS:000365987600007
J	Sharfstein, JM; Charo, A				Sharfstein, Joshua M.; Charo, Alta			The Promotion of Medical Products in the 21st Century Off-label Marketing and First Amendment Concerns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Charo, Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Charo, Alta] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 624 N Broadway St,Room 484, Baltimore, MD 21205 USA.	Joshua.Sharfstein@jhu.edu						[Anonymous], 1969, DRUG EFF STUD FIN RE; Food and Drug Administration, 2013, END MET DRUGS ADV CO; Kesselheim AS, 2015, FDA 21 CENTURY CHALL, P184; Sharfstein JM, 2015, MILBANK Q, V93, P459, DOI 10.1111/1468-0009.12130	4	11	12	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1795	1796		10.1001/jama.2015.12045	http://dx.doi.org/10.1001/jama.2015.12045			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26367520	Bronze			2022-12-28	WOS:000363960200007
J	Barends, TRM; Foucar, L; Ardevol, A; Nass, K; Aquila, A; Botha, S; Doak, RB; Falahati, K; Hartmann, E; Hilpert, M; Heinz, M; Hoffmann, MC; Kofinger, J; Koglin, JE; Kovacsova, G; Liang, M; Milathianaki, D; Lemke, HT; Reinstein, J; Roome, CM; Shoeman, RL; Williams, GJ; Burghardt, I; Hummer, G; Boutet, S; Schlichting, I				Barends, Thomas R. M.; Foucar, Lutz; Ardevol, Albert; Nass, Karol; Aquila, Andrew; Botha, Sabine; Doak, R. Bruce; Falahati, Konstantin; Hartmann, Elisabeth; Hilpert, Mario; Heinz, Marcel; Hoffmann, Matthias C.; Koefinger, Juergen; Koglin, Jason E.; Kovacsova, Gabriela; Liang, Mengning; Milathianaki, Despina; Lemke, Henrik T.; Reinstein, Jochen; Roome, Christopher M.; Shoeman, Robert L.; Williams, Garth J.; Burghardt, Irene; Hummer, Gerhard; Boutet, Sebastien; Schlichting, Ilme			Direct observation of ultrafast collective motions in CO myoglobin upon ligand dissociation	SCIENCE			English	Article							FREE-ELECTRON LASER; MOLECULAR-DYNAMICS SIMULATION; NORMAL MODE ANALYSIS; HEME-PROTEINS; CARBONMONOXY MYOGLOBIN; STRUCTURAL DYNAMICS; HEMOGLOBIN; CRYSTALLOGRAPHY; RELAXATION; RESOLUTION	The hemoprotein myoglobin is a model system for the study of protein dynamics. We used time-resolved serial femtosecond crystallography at an x-ray free-electron laser to resolve the ultrafast structural changes in the carbonmonoxy myoglobin complex upon photolysis of the Fe-CO bond. Structural changes appear throughout the protein within 500 femtoseconds, with the C, F, and H helices moving away from the heme cofactor and the E and A helices moving toward it. These collective movements are predicted by hybrid quantum mechanics/molecular mechanics simulations. Together with the observed oscillations of residues contacting the heme, our calculations support the prediction that an immediate collective response of the protein occurs upon ligand dissociation, as a result of heme vibrational modes coupling to global modes of the protein.	[Barends, Thomas R. M.; Foucar, Lutz; Nass, Karol; Botha, Sabine; Doak, R. Bruce; Hartmann, Elisabeth; Hilpert, Mario; Kovacsova, Gabriela; Reinstein, Jochen; Roome, Christopher M.; Shoeman, Robert L.; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Ardevol, Albert; Heinz, Marcel; Koefinger, Juergen; Hummer, Gerhard] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Aquila, Andrew] European XFEL GmbH, D-22761 Hamburg, Germany; [Falahati, Konstantin; Heinz, Marcel; Burghardt, Irene] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Hoffmann, Matthias C.; Koglin, Jason E.; Liang, Mengning; Milathianaki, Despina; Lemke, Henrik T.; Williams, Garth J.; Boutet, Sebastien] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA	Max Planck Society; Max Planck Society; European XFEL; Goethe University Frankfurt; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Barends, TRM (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	thomas.barends@mpimf-heidelberg.mpg.de; ilme.schlichting@mpimf-heidelberg.mpg.de	Lemke, Henrik Till T/N-7419-2016; Schlichting, Ilme/I-1339-2013; Ardevol, Albert/I-4401-2012; Falahati, Konstantin/AAN-2857-2020; Hummer, Gerhard/A-2546-2013; Nass, Karol/K-1970-2012; Milathianaki, Despina/AAG-5381-2021; Hoffmann, Matthias C./N-1082-2019; Hoffmann, Matthias C/B-3893-2009	Lemke, Henrik Till T/0000-0003-1577-8643; Falahati, Konstantin/0000-0003-1897-1916; Hummer, Gerhard/0000-0001-7768-746X; Nass, Karol/0000-0001-8843-1566; Hoffmann, Matthias C./0000-0002-3596-9853; Hoffmann, Matthias C/0000-0002-3596-9853; Ardevol, Albert/0000-0003-2614-5526; Kofinger, Jurgen/0000-0001-8367-1077; Aquila, Andrew/0000-0003-0358-2774; Heinz, Marcel/0000-0002-0354-0550	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Max Planck Society; European Union [317079]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	Use of the LCLS, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-76SF00515. We acknowledge support from the Max Planck Society. G.K. was supported by the European Union under the program FP7-PEOPLE-2011-ITN NanoMem (project number 317079). We thank R. J. D. Miller for discussions and for pointing out the complications in the high-excitation regime, as discussed in (15); P. M. Champion and M. Huix-Rotllant for valuable discussions; C. Zeymer for assistance with the samples; G. M. Stewart, T. Anderson, and SLAC Infomedia for preparing fig. S1; and T. Mueller for help in preparing Fig. 4C. T.R.M.B., L.F., K.N., A.Aq., S.Bot., R.B.D., M.C.H., E.H., M.Hi., J.E.K., G.K., M.L., D.M., H.L., C.M.R., R.L.S., G.J.W., S.Bou., and I. S. performed the experiment; T.R.M.B., L.F., K.N., J.R., and I. S. analyzed the data; A.Ar., K.F., M.He., J.K., I.B., and G.H. performed simulations; and T.R.M.B. and I. S. wrote the manuscript, with contributions from all authors. Structures and diffraction data have been deposited in the PDB under accession numbers 5CMV, 5CN4, 5CN5, 5CN6, 5CN7, 5CN8, 5CN9, 5CNB, 5CNC, 5CND, 5CNE, 5CNF, 5CNG, and 5D5R. Raw diffraction data will be made available at cxidb.org.	ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; Armstrong MR, 2003, P NATL ACAD SCI USA, V100, P4990, DOI 10.1073/pnas.0936507100; Arnlund D, 2014, NAT METHODS, V11, P923, DOI [10.1038/nmeth.3067, 10.1038/NMETH.3067]; Bionta MR, 2011, OPT EXPRESS, V19, P21855, DOI 10.1364/OE.19.021855; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Champion PM, 2004, FARADAY DISCUSS, V127, P123, DOI 10.1039/b316440c; Chu K, 2000, NATURE, V403, P921, DOI 10.1038/35002641; Deak J, 1998, J PHYS CHEM B, V102, P6621, DOI 10.1021/jp980492q; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Foucar L, 2012, COMPUT PHYS COMMUN, V183, P2207, DOI 10.1016/j.cpc.2012.04.023; FRANZEN S, 1995, J BIOL CHEM, V270, P1718, DOI 10.1074/jbc.270.4.1718; FRANZEN S, 1995, BIOCHEMISTRY-US, V34, P1224, DOI 10.1021/bi00004a016; Fujisaki H, 2005, P NATL ACAD SCI USA, V102, P6726, DOI 10.1073/pnas.0409083102; Goodno GD, 1999, J PHYS CHEM A, V103, P10630, DOI 10.1021/jp993559y; Guallar V, 2006, J AM CHEM SOC, V128, P5427, DOI 10.1021/ja057318h; HENRY ER, 1985, P NATL ACAD SCI USA, V82, P2034, DOI 10.1073/pnas.82.7.2034; Kitagawa T, 2002, BIOPOLYMERS, V67, P207, DOI 10.1002/bip.10096; KUCZERA K, 1993, P NATL ACAD SCI USA, V90, P5805, DOI 10.1073/pnas.90.12.5805; Levantino M, 2015, STRUCT DYNAM-US, V2, DOI 10.1063/1.4921907; Levantino M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7772; Li GF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4100; MARTIN JL, 1983, EMBO J, V2, P1815, DOI 10.1002/j.1460-2075.1983.tb01663.x; MILLER RJD, 1994, ACCOUNTS CHEM RES, V27, P145, DOI 10.1021/ar00041a005; Nagy AM, 2005, BBA-PROTEINS PROTEOM, V1749, P148, DOI 10.1016/j.bbapap.2005.02.005; PETRICH JW, 1987, BIOCHEMISTRY-US, V26, P7914, DOI 10.1021/bi00398a056; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Rosca F, 2002, J PHYS CHEM A, V106, P3540, DOI 10.1021/jp0129277; Rosca F, 2000, J PHYS CHEM A, V104, P4280, DOI 10.1021/jp993617f; Sage JT, 2001, PHYS REV LETT, V86, P4966, DOI 10.1103/PhysRevLett.86.4966; Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; SCHAAD O, 1993, P NATL ACAD SCI USA, V90, P9547, DOI 10.1073/pnas.90.20.9547; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Schramm VL, 2015, ACCOUNTS CHEM RES, V48, P1032, DOI 10.1021/acs.accounts.5b00002; SENO Y, 1990, J MOL BIOL, V216, P111, DOI 10.1016/S0022-2836(05)80064-6; SENO Y, 1990, J MOL BIOL, V216, P95, DOI 10.1016/S0022-2836(05)80063-4; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; White TA, 2013, ACTA CRYSTALLOGR D, V69, P1231, DOI 10.1107/S0907444913013620; ZHU LY, 1994, SCIENCE, V266, P629, DOI 10.1126/science.7939716	40	269	272	8	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					445	450		10.1126/science.aac5492	http://dx.doi.org/10.1126/science.aac5492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26359336				2022-12-28	WOS:000363213400043
J	Borghaei, H; Paz-Ares, L; Horn, L; Spigel, DR; Steins, M; Ready, NE; Chow, LQ; Vokes, EE; Felip, E; Holgado, E; Barlesi, F; Kohlhaufl, M; Arrieta, O; Burgio, MA; Fayette, J; Lena, H; Poddubskaya, E; Gerber, DE; Gettinger, SN; Rudin, CM; Rizvi, N; Crino, L; Blumenschein, GR; Antonia, SJ; Dorange, C; Harbison, CT; Finckenstein, FG; Brahmer, JR				Borghaei, H.; Paz-Ares, L.; Horn, L.; Spigel, D. R.; Steins, M.; Ready, N. E.; Chow, L. Q.; Vokes, E. E.; Felip, E.; Holgado, E.; Barlesi, F.; Kohlhaeufl, M.; Arrieta, O.; Burgio, M. A.; Fayette, J.; Lena, H.; Poddubskaya, E.; Gerber, D. E.; Gettinger, S. N.; Rudin, C. M.; Rizvi, N.; Crino, L.; Blumenschein, G. R.; Antonia, S. J.; Dorange, C.; Harbison, C. T.; Finckenstein, F. Graf; Brahmer, J. R.			Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; ANTI-PD-1 ANTIBODY; SAFETY; ERLOTINIB; BLOCKADE	BACKGROUND Nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, disrupts PD-1-mediated signaling and may restore antitumor immunity. METHODS In this randomized, open-label, international phase 3 study, we assigned patients with nonsquamous non-small-cell lung cancer (NSCLC) that had progressed during or after platinum-based doublet chemotherapy to receive nivolumab at a dose of 3 mg per kilogram of body weight every 2 weeks or docetaxel at a dose of 75 mg per square meter of body-surface area every 3 weeks. The primary end point was overall survival. RESULTS Overall survival was longer with nivolumab than with docetaxel. The median overall survival was 12.2 months (95% confidence interval [CI], 9.7 to 15.0) among 292 patients in the nivolumab group and 9.4 months (95% CI, 8.1 to 10.7) among 290 patients in the docetaxel group (hazard ratio for death, 0.73; 96% CI, 0.59 to 0.89; P = 0.002). At 1 year, the overall survival rate was 51% (95% CI, 45 to 56) with nivolumab versus 39% (95% CI, 33 to 45) with docetaxel. With additional follow-up, the overall survival rate at 18 months was 39% (95% CI, 34 to 45) with nivolumab versus 23% (95% CI, 19 to 28) with docetaxel. The response rate was 19% with nivolumab versus 12% with docetaxel (P = 0.02). Although progression-free survival did not favor nivolumab over docetaxel (median, 2.3 months and 4.2 months, respectively), the rate of progression-free survival at 1 year was higher with nivolumab than with docetaxel (19% and 8%, respectively). Nivolumab was associated with even greater efficacy than docetaxel across all end points in subgroups defined according to prespecified levels of tumor-membrane expression (>= 1%, >= 5%, and >= 10%) of the PD-1 ligand. Treatment-related adverse events of grade 3 or 4 were reported in 10% of the patients in the nivolumab group, as compared with 54% of those in the docetaxel group. CONCLUSIONS Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (Funded by Bristol-Myers Squibb; CheckMate 057 ClinicalTrials.gov number, NCT01673867.)	[Borghaei, H.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Paz-Ares, L.] Hosp Univ Virgen del Rocio, Seville, Spain; [Felip, E.] Vall dHebron Univ Hosp, Barcelona, Spain; [Felip, E.] Vall dHebron Inst Oncol, Barcelona, Spain; [Holgado, E.] Hosp Madrid, Madrid, Spain; [Horn, L.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Spigel, D. R.] Sarah Cannon Res Inst, Nashville, TN USA; [Spigel, D. R.] Tennessee Oncol, Nashville, TN USA; [Steins, M.] Univ Heidelberg Hosp, Thoraxklin, Heidelberg, Germany; [Kohlhaeufl, M.] Robert Bosch Krankenhaus Stuttgart, Gerlingen, Germany; [Ready, N. E.] Duke Univ, Med Ctr, Durham, NC USA; [Chow, L. Q.] Univ Washington, Seattle, WA 98195 USA; [Vokes, E. E.] Univ Chicago Med & Biol Sci, Chicago, IL USA; [Barlesi, F.] Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille, France; [Fayette, J.] Ctr Leon Berard, F-69373 Lyon, France; [Lena, H.] Ctr Hosp Univ Rennes, Rennes, France; [Arrieta, O.] Inst Nacl Cancerol, Mexico City, DF, Mexico; [Burgio, M. A.] Ist Sci Romagnolo Studio Cura Tumori IRCCS, Meldola, Forli Cesena, Italy; [Crino, L.] Osped Perugia, Perugia, Italy; [Poddubskaya, E.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Gerber, D. E.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Gettinger, S. N.] Yale Comprehens Canc Ctr, New Haven, CT USA; [Rudin, C. M.; Rizvi, N.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Blumenschein, G. R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Antonia, S. J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Dorange, C.; Harbison, C. T.; Finckenstein, F. Graf] Bristol Myers Squibb Co, Princeton, NJ USA; [Brahmer, J. R.] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Fox Chase Cancer Center; Virgen del Rocio University Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Vanderbilt University; Sarah Cannon Research Institute; Tennessee Oncology; Ruprecht Karls University Heidelberg; Bosch; Robert Bosch Krankenhaus; Duke University; University of Washington; University of Washington Seattle; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Centre Leon Berard; CHU Rennes; Universite de Rennes; Instituto Nacional de Cancerologia (INCAN); IRCCS Meldola (IRST); University of Perugia; Azienda Ospedaliera di Perugia; N.N. Blokhin Russian Cancer Research Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Bristol-Myers Squibb; Johns Hopkins University; Johns Hopkins Medicine	Borghaei, H (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	hossein.borghaei@fccc.edu	FELIP, ENRIQUETA/AAG-6316-2019; Vokes, Everett/Q-2146-2019; Miquel, Josep Maria/AAG-3508-2019; Rudin, Charles/R-2530-2019; Poddubskaya, Elena/AAU-9664-2020; Paz-Ares, Luis/AAH-2750-2019; Arrieta, Oscar/ABH-6022-2020; Poddubskaya, Elena/AAK-7600-2021	Rudin, Charles/0000-0001-5204-3465; Poddubskaya, Elena/0000-0001-6476-6337; FELIP, ENRIQUETA/0000-0002-7620-0098; Gerber, David/0000-0002-7812-6741; Arrieta, Oscar/0000-0002-1164-3779; Balmana, Judith/0000-0002-0762-6415	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Bristol-Myers Squibb; CheckMate 057 ClinicalTrials.gov number, NCT01673867.	Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Champiat S, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27817; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Khozin S, 2015, CLIN CANCER RES, V21, P2436, DOI 10.1158/1078-0432.CCR-14-3157; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040	20	6264	6518	52	520	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1627	1639		10.1056/NEJMoa1507643	http://dx.doi.org/10.1056/NEJMoa1507643			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU1YH	26412456	Green Accepted, Bronze			2022-12-28	WOS:000363317800008
J	Cassidy, LD; Narita, M				Cassidy, Liam D.; Narita, Masashi			GATA get a hold on senescence	SCIENCE			English	Editorial Material							SECRETORY PHENOTYPE; AUTOPHAGY; REGULATOR; CANCER; MTOR		[Cassidy, Liam D.; Narita, Masashi] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Cassidy, LD (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	masashi.narita@cruk.cam.ac.uk		Cassidy, Liam/0000-0002-9312-6256; Narita, Masashi/0000-0001-7764-577X	Cancer Research UK [15890] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shembade N, 2011, CELL MOL IMMUNOL, V8, P447, DOI 10.1038/cmi.2011.44; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	12	13	14	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1448	1449		10.1126/science.aad2501	http://dx.doi.org/10.1126/science.aad2501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404812				2022-12-28	WOS:000361707000022
J	Shiota, T; Imai, K; Qiu, J; Hewitt, VL; Tan, K; Shen, HH; Sakiyama, N; Fukasawa, Y; Hayat, S; Kamiya, M; Elofsson, A; Tomii, K; Horton, P; Wiedemann, N; Pfanner, N; Lithgow, T; Endo, T				Shiota, Takuya; Imai, Kenichiro; Qiu, Jian; Hewitt, Victoria L.; Tan, Khershing; Shen, Hsin-Hui; Sakiyama, Noriyuki; Fukasawa, Yoshinori; Hayat, Sikander; Kamiya, Megumi; Elofsson, Arne; Tomii, Kentaro; Horton, Paul; Wiedemann, Nils; Pfanner, Nikolaus; Lithgow, Trevor; Endo, Toshiya			Molecular architecture of the active mitochondrial protein gate	SCIENCE			English	Article							OUTER-MEMBRANE; IMPORT CHANNEL; CROSS-LINKING; TOM COMPLEX; TRANSLOCATION; YEAST	Mitochondria fulfill central functions in cellular energetics, metabolism, and signaling. The outer membrane translocator complex (the TOM complex) imports most mitochondrial proteins, but its architecture is unknown. Using a cross-linking approach, we mapped the active translocator down to single amino acid residues, revealing different transport paths for preproteins through the Tom40 channel. An N-terminal segment of Tom40 passes from the cytosol through the channel to recruit chaperones fromthe intermembrane space that guide the transfer of hydrophobic preproteins. The translocator contains three Tom40 beta-barrel channels sandwiched between a central alpha-helical Tom22 receptor cluster and external regulatory Tom proteins. The preprotein-translocating trimeric complex exchanges with a dimeric isoform to assemble new TOM complexes. Dynamic coupling of alpha-helical receptors, beta-barrel channels, and chaperones generates a versatile machinery that transports about 1000 different proteins.	[Shiota, Takuya; Hewitt, Victoria L.; Tan, Khershing; Shen, Hsin-Hui; Lithgow, Trevor] Monash Univ, Biomed Discovery Inst, Melbourne, Vic 3800, Australia; [Shiota, Takuya; Hewitt, Victoria L.; Tan, Khershing; Shen, Hsin-Hui; Lithgow, Trevor] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Shiota, Takuya; Kamiya, Megumi; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Imai, Kenichiro; Sakiyama, Noriyuki; Fukasawa, Yoshinori; Tomii, Kentaro; Horton, Paul] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Koto Ku, Tokyo 1350064, Japan; [Qiu, Jian; Wiedemann, Nils; Pfanner, Nikolaus] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Hayat, Sikander; Elofsson, Arne] Stockholm Univ, Dept Biochem & Biophys, S-17121 Solna, Sweden; [Hayat, Sikander; Elofsson, Arne] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Wiedemann, Nils; Pfanner, Nikolaus] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Endo, Toshiya] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan	Monash University; Monash University; Nagoya University; National Institute of Advanced Industrial Science & Technology (AIST); University of Freiburg; Stockholm University; Stockholm University; University of Freiburg; Kyoto Sangyo University	Lithgow, T (corresponding author), Monash Univ, Biomed Discovery Inst, Melbourne, Vic 3800, Australia.	trevor.lithgow@monash.edu; tendo@cc.kyoto-su.ac.jp	Fukasawa, Yoshinori/A-5582-2017; Tomii, Kentaro/B-1135-2017; Imai, Kenichiro/A-5694-2017; Pfanner, Nikolaus/AAV-7878-2021; Lithgow, Trevor J/H-5925-2017; Qiu, Jian/ABD-2260-2020; Tomii, Kentaro/AAK-6940-2021	Fukasawa, Yoshinori/0000-0002-0882-4392; Tomii, Kentaro/0000-0002-4567-4768; Imai, Kenichiro/0000-0001-5664-0566; Lithgow, Trevor J/0000-0002-0102-7884; Qiu, Jian/0000-0001-7873-0722; Tomii, Kentaro/0000-0002-4567-4768; Shen, Hsin-Hui/0000-0002-8541-4370; Hayat, Sikander/0000-0001-5919-8371; Shiota, Takuya/0000-0003-3004-4541; Wiedemann, Nils/0000-0001-8305-6728; Hewitt, Victoria/0000-0003-2997-6499	Japan Society for the Promotion of Science (JSPS); CREST Grant from the Japan Science and Technology Agency (JST); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development; Strategic Japanese-Swedish Cooperative Program on "Multidisciplinary BIO" (JST-Verket For Innovationssystem/Swedish Foundation for Strategic Research); Deutsche Forschungsgemeinschaft [PF 202/8-1, Sonderforschungsbereiche 746, 1140]; Excellence Initiative of the German federal government; Excellence Initiative of the German state government; Toyobo Bio Foundation;  [3308]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST Grant from the Japan Science and Technology Agency (JST); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Strategic Japanese-Swedish Cooperative Program on "Multidisciplinary BIO" (JST-Verket For Innovationssystem/Swedish Foundation for Strategic Research); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German federal government; Excellence Initiative of the German state government; Toyobo Bio Foundation; 	We thank C. Stubenrauch, M. Belousoff, A. Traven, and the members of the Endo lab for discussions and critical comments on the manuscript. We are grateful to P. G. Schultz for the materials for in vivo cross-linking. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) and a CREST Grant from the Japan Science and Technology Agency (JST) (T.E.); the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology and Japan Agency for Medical Research and Development (K.T., K.I., and Y.F.); Grants-in-Aid for Scientific Research on Innovative Areas ("Matryoshka-type evolution," no. 3308) (K.I., K.T., and Y.F.); the Strategic Japanese-Swedish Cooperative Program on "Multidisciplinary BIO" (JST-Verket For Innovationssystem/Swedish Foundation for Strategic Research) (K.I., N.S., Y.F., S.H., A.E., K.T., P.H., and T.E.); the Deutsche Forschungsgemeinschaft (PF 202/8-1), Sonderforschungsbereiche 746 and 1140; and the Excellence Initiative of the German federal and state governments (EXC 294 BIOSS, GSC-4 Spemann Graduate School) (N.W., N. P., and J.Q.). T.S. is a Research Fellow of the JSPS and was supported by the Toyobo Bio Foundation, H.S.S. is an Australian Research Council (ARC) Super Science Fellow (FS110200015), and T.L. is an ARC Australian Laureate Fellow (FL130100038). The data presented in this paper are tabulated in the main paper and the supplementary materials.	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Esaki M, 2003, NAT STRUCT BIOL, V10, P988, DOI 10.1038/nsb1008; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Harner M, 2011, EMBO J, V30, P3232, DOI 10.1038/emboj.2011.235; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lackey SWK, 2014, J BIOL CHEM, V289, P21640, DOI 10.1074/jbc.M114.578765; Meng GY, 2009, MOL MEMBR BIOL, V26, P136, DOI 10.1080/09687680802712422; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Shiota T, 2013, METHODS MOL BIOL, V1033, P207, DOI 10.1007/978-1-62703-487-6_14; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951	21	127	127	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1544	1548		10.1126/science.aac6428	http://dx.doi.org/10.1126/science.aac6428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404837	Green Submitted			2022-12-28	WOS:000361707000049
J	Parr, BT; Economou, C; Herzon, SB				Parr, Brendan T.; Economou, Christos; Herzon, Seth B.			A concise synthesis of (+)-batzelladine B from simple pyrrole-based starting materials	NATURE			English	Article							ENANTIOSELECTIVE TOTAL-SYNTHESIS; ASYMMETRIC-SYNTHESIS; BATZELLADINE ALKALOIDS; ABSOLUTE-CONFIGURATION; ORGANIC-SYNTHESIS; (-)-BATZELLADINE-D; DERIVATIVES; STRATEGY; REVISION; COMPLEX	Alkaloids, secondary metabolites that contain basic nitrogen atoms, are some of the most well-known biologically active natural products in chemistry and medicine(1). Although efficient laboratory synthesis of alkaloids would enable the study and optimization of their biological properties(2), their preparation is often complicated by the basicity and nucleophilicity of nitrogen, its susceptibility to oxidation, and its ability to alter reaction outcomes in unexpected ways-for example, through stereochemical instability and neighbouring group participation. Efforts to address these issues have led to the invention of a large number of protecting groups that temper the reactivity of nitrogen3; however, the use of protecting groups typically introduces additional steps and obstacles into the synthetic route. Alternatively, the use of aromatic nitrogen heterocycles as synthetic precursors can attenuate the reactivity of nitrogen and streamline synthetic strategies(4). Here we use such an approach to achieve a synthesis of the complex anti-HIV alkaloid (1)-batzelladine B in nine steps (longest linear sequence) from simple pyrrole-based starting materials. The route uses several key transformations that would be challenging or impossible to implement using saturated nitrogen heterocycles and highlights some of the advantages of beginning with aromatic reagents.	[Parr, Brendan T.; Economou, Christos; Herzon, Seth B.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Herzon, SB (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	seth.herzon@yale.edu	Ruggeri, Fabrizio/A-9383-2012	Ruggeri, Fabrizio/0000-0002-7655-6254	National Institutes of Health (NRSA fellowship) [GM110898-01A1]; National Institutes of Health (Chemistry Biology Interface Training Program) [T32GM067543]; Yale University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067543] Funding Source: NIH RePORTER	National Institutes of Health (NRSA fellowship)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Chemistry Biology Interface Training Program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support from the National Institutes of Health (NRSA fellowship GM110898-01A1 to B.T.P, Chemistry Biology Interface Training Program T32GM067543 to C.E.) and Yale University is acknowledged. We thank B. Mercado for X-ray crystallographic analysis of 19 and K.-p. Wang for assistance with HPLC purification of 1.	Arnold MA, 2006, J AM CHEM SOC, V128, P13255, DOI 10.1021/ja063860+; Aron ZD, 2004, CHEM COMMUN, P253, DOI 10.1039/b309910e; Babij NR, 2012, ANGEW CHEM INT EDIT, V51, P4128, DOI 10.1002/anie.201201001; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Butters M, 2009, ORG BIOMOL CHEM, V7, P5001, DOI 10.1039/b914744f; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Cohen F, 2006, J AM CHEM SOC, V128, P2594, DOI 10.1021/ja0574320; Cohen F, 2006, J AM CHEM SOC, V128, P2604, DOI 10.1021/ja057433s; Crampton R. M., 1997, J CHEM RES SYNOPSES, P22; Davies HML, 1996, J AM CHEM SOC, V118, P10774, DOI 10.1021/ja962081y; Duron SG, 2001, ORG LETT, V3, P1551, DOI 10.1021/ol015848m; Evans PA, 2007, ANGEW CHEM INT EDIT, V46, P7417, DOI 10.1002/anie.200700840; Franklin AS, 1999, J ORG CHEM, V64, P1512, DOI 10.1021/jo981971o; Gainer MJ, 2011, ANGEW CHEM INT EDIT, V50, P684, DOI 10.1002/anie.201006087; Gonzalez DF, 2010, CHEM-EUR J, V16, P9457, DOI 10.1002/chem.201001539; Green T.W., 1999, PROTECTIVE GROUPS OR; Hua HM, 2007, TETRAHEDRON, V63, P11179, DOI 10.1016/j.tet.2007.08.005; Laville R, 2009, J NAT PROD, V72, P1589, DOI 10.1021/np900244g; LIPSHUTZ BH, 1986, CHEM REV, V86, P795, DOI 10.1021/cr00075a005; MASAMUNE S, 1985, ANGEW CHEM INT EDIT, V24, P1, DOI 10.1002/anie.198500013; Mayr H, 2005, PURE APPL CHEM, V77, P1807, DOI 10.1351/pac200577111807; PATIL AD, 1995, J ORG CHEM, V60, P1182, DOI 10.1021/jo00110a021; Patil AD, 1997, J ORG CHEM, V62, P1814, DOI 10.1021/jo962084t; Reddy RP, 2007, J AM CHEM SOC, V129, P10312, DOI 10.1021/ja072936e; Roberts M. F., 1998, ALKALOIDS BIOCH ECOL; Shimokawa J, 2004, ANGEW CHEM INT EDIT, V43, P1559, DOI 10.1002/anie.200353200; Snider BB, 1996, TETRAHEDRON LETT, V37, P6977, DOI 10.1016/0040-4039(96)01575-4; Tang TP, 2002, J ORG CHEM, V67, P7819, DOI 10.1021/jo025957u; Wender PA, 2009, NATURE, V460, P197, DOI 10.1038/460197a; Zeng MS, 2014, J AM CHEM SOC, V136, P7058, DOI 10.1021/ja501738a	30	40	40	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					507	510		10.1038/nature14902	http://dx.doi.org/10.1038/nature14902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26375010	Green Accepted			2022-12-28	WOS:000361599900048
J	Sohn, E				Sohn, Emily			Israel: Research without prejudice	NATURE			English	Editorial Material																		CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089	2	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S12	S13		10.1038/525S12a	http://dx.doi.org/10.1038/525S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398732	Bronze			2022-12-28	WOS:000361599900005
J	Fumagalli, M; Moltke, I; Grarup, N; Racimo, F; Bjerregaard, P; Jorgensen, ME; Korneliussen, TS; Gerbault, P; Skotte, L; Linneberg, A; Christensen, C; Brandslund, I; Jorgensen, T; Huerta-Sanchez, E; Schmidt, EB; Pedersen, O; Hansen, T; Albrechtsen, A; Nielsen, R				Fumagalli, Matteo; Moltke, Ida; Grarup, Niels; Racimo, Fernando; Bjerregaard, Peter; Jorgensen, Marit E.; Korneliussen, Thorfinn S.; Gerbault, Pascale; Skotte, Line; Linneberg, Allan; Christensen, Cramer; Brandslund, Ivan; Jorgensen, Torben; Huerta-Sanchez, Emilia; Schmidt, Erik B.; Pedersen, Oluf; Hansen, Torben; Albrechtsen, Anders; Nielsen, Rasmus			Greenlandic Inuit show genetic signatures of diet and climate adaptation	SCIENCE			English	Article							POLYUNSATURATED FATTY-ACIDS; VARIANTS; PLASMA; COMMON; FOOD; CLUSTER; FADS1	The indigenous people of Greenland, the Inuit, have lived for a long time in the extreme conditions of the Arctic, including low annual temperatures, and with a specialized diet rich in protein and fatty acids, particularly omega-3 polyunsaturated fatty acids (PUFAs). A scan of Inuit genomes for signatures of adaptation revealed signals at several loci, with the strongest signal located in a cluster of fatty acid desaturases that determine PUFA levels. The selected alleles are associated with multiple metabolic and anthropometric phenotypes and have large effect sizes for weight and height, with the effect on height replicated in Europeans. By analyzing membrane lipids, we found that the selected alleles modulate fatty acid composition, which may affect the regulation of growth hormones. Thus, the Inuit have genetic and physiological adaptations to a diet rich in PUFAs.	[Fumagalli, Matteo; Gerbault, Pascale] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Fumagalli, Matteo; Racimo, Fernando; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Moltke, Ida; Skotte, Line; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark; [Bjerregaard, Peter; Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Bjerregaard, Peter] Univ Greenland, Greenland Ctr Hlth Res, Nuuk, Greenland; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Korneliussen, Thorfinn S.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Gerbault, Pascale] UCL, Dept Anthropol, London WC1H 0BW, England; [Linneberg, Allan; Jorgensen, Torben] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Christensen, Cramer] Lillebaelt Hosp, Dept Med, Vejle, Denmark; [Brandslund, Ivan] Lillebaelt Hosp, Dept Clin Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben; Schmidt, Erik B.] Aalborg Univ, Fac Med, Aalborg, Denmark; [Huerta-Sanchez, Emilia] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Schmidt, Erik B.] Aalborg Univ Hosp, Dept Cardiol, DK-9100 Aalborg, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of London; University College London; University of California System; University of California Berkeley; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; Steno Diabetes Center; University of Copenhagen; University of London; University College London; Rigshospitalet; University of Copenhagen; University of Southern Denmark; University of Copenhagen; Aalborg University; University of California System; University of California Merced; Aalborg University; Aalborg University Hospital; University of California System; University of California Berkeley	Hansen, T (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark.	torben.hansen@sund.ku.dk; albrecht@binf.ku.dk; rasmus_nielsen@berkeley.edu	Nielsen, Rasmus/D-4405-2009; Grarup, Niels/K-2807-2015; Bjerregaard, Peter/ABD-8894-2020; Fumagalli, Matteo/H-6448-2019; Pedersen, Oluf/Z-1731-2019; Albrechtsen, Anders/K-4281-2013; Moltke, Ida/C-6158-2011; Jørgensen, Torben/Z-1335-2018; Korneliussen, Thorfinn Sand/F-6421-2014; Pedersen, Oluf/AAG-8015-2020; Dina, Christian R/D-3535-2015; Korneliussen, Thorfinn Sand/ABB-7656-2021; Skotte, Line/F-7359-2014	Nielsen, Rasmus/0000-0003-0513-6591; Grarup, Niels/0000-0001-5526-1070; Bjerregaard, Peter/0000-0001-7153-8447; Fumagalli, Matteo/0000-0002-4084-2953; Pedersen, Oluf/0000-0002-3321-3972; Albrechtsen, Anders/0000-0001-7306-031X; Moltke, Ida/0000-0001-7052-8554; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Dina, Christian R/0000-0002-7722-7348; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Brandslund, Ivan/0000-0002-4203-5442; Skotte, Line/0000-0002-7398-1271; Jorgensen, Torben/0000-0001-9453-2830; Gerbault, Pascale/0000-0003-3824-0870; Schmidt, Erik Berg/0000-0002-0623-5666; Racimo, Fernando/0000-0002-5025-2607; Linneberg, Allan/0000-0002-0994-0184; Jorgensen, Marit Eika/0000-0001-8356-5565	Human Frontiers in Science Program Organization [LT00320/2014]; Danish Council for Independent Research [DFF-YDUN]; Villum Foundation; Steno Diabetes Center; NIH [R01-HG003229]; Leverhulme Programme Grant [RP2011-R-045]; University of California-Merced startup funds; Karen Elise Jensen's Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Vejle Hospital; Villum Fonden [00007171] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Human Frontiers in Science Program Organization(Human Frontier Science Program); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Foundation(Villum Fonden); Steno Diabetes Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leverhulme Programme Grant; University of California-Merced startup funds; Karen Elise Jensen's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Vejle Hospital; Villum Fonden(Villum Fonden); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Greenlandic participants and the funding agencies and research centers that made this study possible: the Human Frontiers in Science Program Organization (grant LT00320/2014); the Danish Council for Independent Research (grant DFF-YDUN); the Villum Foundation; the Steno Diabetes Center; NIH (grant R01-HG003229); the Leverhulme Programme Grant (grant RP2011-R-045); the University of California-Merced startup funds; Karen Elise Jensen's Foundation and NunaFonden, which supported the collection of data from the Greenlandic cohorts; and the Novo Nordisk Foundation Center for Basic Metabolic Research, which is an independent research center at the University of Copenhagen and is partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). We also thank T. Lauritzen and A. Sandbaek for the use of the ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment In People with Screen Detected Diabetes in Primary Care) cohort. The Vejle Diabetes Biobank was funded by the Danish Medical Research Council and Vejle Hospital. The genotyping and exome sequencing data from this project are available to researchers who have received ethics approval from the Greenland Research Ethics Committee (nun@nanoq.gl) and can be obtained by contacting T.H.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ameur A, 2012, AM J HUM GENET, V90, P809, DOI 10.1016/j.ajhg.2012.03.014; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Campuzano O, 2013, EUR J MED GENET, V56, P541, DOI 10.1016/j.ejmg.2013.08.001; Clemente FJ, 2014, AM J HUM GENET, V95, P584, DOI 10.1016/j.ajhg.2014.09.016; Collard FO, 2003, DIABETES, V52, P2888, DOI 10.2337/diabetes.52.12.2888; Damsgaard CT, 2012, PEDIATR RES, V71, P713, DOI 10.1038/pr.2012.28; Deutch B, 2007, SCI TOTAL ENVIRON, V384, P106, DOI 10.1016/j.scitotenv.2007.05.042; Gburcik V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1053, DOI 10.1152/ajpendo.00104.2012; Gullov H. C., 2004, GRONLANDS FORHISTORI; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Jenkinson A, 1999, EUR J CLIN NUTR, V53, P523, DOI 10.1038/sj.ejcn.1600783; Jeppesen C, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18361; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Mirzaei K, 2011, MINERVA ENDOCRINOL, V36, P13; Moltke I, 2015, AM J HUM GENET, V96, P54, DOI 10.1016/j.ajhg.2014.11.012; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; QUABBE HJ, 1972, J CLIN INVEST, V51, P2388, DOI 10.1172/JCI107051; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voruganti V. Saroja, 2012, Frontiers in Genetics, V3, P86, DOI 10.3389/fgene.2012.00086; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	29	278	290	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1343	1347		10.1126/science.aab2319	http://dx.doi.org/10.1126/science.aab2319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383953	Green Submitted			2022-12-28	WOS:000361357700050
J	Zhen, B; Hsu, CW; Igarashi, Y; Lu, L; Kaminer, I; Pick, A; Chua, SL; Joannopoulos, JD; Soljacic, M				Zhen, Bo; Hsu, Chia Wei; Igarashi, Yuichi; Lu, Ling; Kaminer, Ido; Pick, Adi; Chua, Song-Liang; Joannopoulos, John D.; Soljacic, Marin			Spawning rings of exceptional points out of Dirac cones	NATURE			English	Article							PARITY-TIME SYMMETRY; MICROCAVITIES; PHYSICS; LASERS	The Dirac cone underlies many unique electronic properties of graphene(1) and topological insulators, and its band structure-two conical bands touching at a single point-has also been realized for photons in waveguide arrays(2), atoms in optical lattices(3), and through accidental degeneracy(4,5). Deformation of the Dirac cone often reveals intriguing properties; an example is the quantum Hall effect, where a constant magnetic field breaks the Dirac cone into isolated Landau levels. A seemingly unrelated phenomenon is the exceptional point(6,7), also known as the parity-time symmetry breaking point(8-11), where two resonances coincide in both their positions and widths. Exceptional points lead to counter-intuitive phenomena such as loss-induced transparency(12), unidirectional transmission or reflection(11,13,14), and lasers with reversed pump dependence(15) or single-mode operation(16,17). Dirac cones and exceptional points are connected: it was theoretically suggested that certain non-Hermitian perturbations can deform a Dirac cone and spawn a ring of exceptional points(18-20). Here we experimentally demonstrate such an 'exceptional ring' in a photonic crystal slab. Angle-resolved reflection measurements of the photonic crystal slab reveal that the peaks of reflectivity follow the conical band structure of a Dirac cone resulting from accidental degeneracy, whereas the complex eigenvalues of the system are deformed into a two-dimensional flat band enclosed by an exceptional ring. This deformation arises from the dissimilar radiation rates of dipole and quadrupole resonances, which play a role analogous to the loss and gain in parity-time symmetric systems. Our results indicate that the radiation existing in any open system can fundamentally alter its physical properties in ways previously expected only in the presence of material loss and gain.	[Zhen, Bo; Hsu, Chia Wei; Igarashi, Yuichi; Lu, Ling; Kaminer, Ido; Pick, Adi; Joannopoulos, John D.; Soljacic, Marin] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Hsu, Chia Wei] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Igarashi, Yuichi] NEC Corp Ltd, Smart Energy Res Labs, Tsukuba, Ibaraki 3058501, Japan; [Pick, Adi] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Chua, Song-Liang] DSO Natl Labs, Singapore 118230, Singapore	Massachusetts Institute of Technology (MIT); Yale University; NEC Corporation; Harvard University	Zhen, B (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	bozhen@mit.edu; chiawei.hsu@yale.edu	Joannopoulos, John D/E-6401-2013; Soljacic, Marin/AAA-4868-2019; Hsu, Chia Wei (Wade)/G-5486-2011; Lu, Ling/E-1324-2017	Hsu, Chia Wei (Wade)/0000-0002-9609-7155; 	Army Research Office through Institute for Soldier Nanotechnologies [W911NF-07-D0004, W911NF-13-D-0001]; S3TEC, an Energy Frontier Research Center - US Department of Energy [DE-SC0001299]; Materials Research Science and Engineering Center of the National Science Foundation [DMR-1419807]; Marie Curie grant [328853-MC-BSiCS]	Army Research Office through Institute for Soldier Nanotechnologies; S3TEC, an Energy Frontier Research Center - US Department of Energy(United States Department of Energy (DOE)); Materials Research Science and Engineering Center of the National Science Foundation(National Science Foundation (NSF)); Marie Curie grant(European Commission)	We thank T. Savas for fabrication of the samples, and F. Wang, Y. Yang, N. Rivera, S. Skirlo, O. Miller and S. G. Johnson for discussions. This work was partly supported by the Army Research Office through the Institute for Soldier Nanotechnologies under contract nos W911NF-07-D0004 and W911NF-13-D-0001. B.Z., L.L. and M.S. were partly supported by S3TEC, an Energy Frontier Research Center funded by the US Department of Energy under grant no. DE-SC0001299. L.L. was supported in part by the Materials Research Science and Engineering Center of the National Science Foundation (award no. DMR-1419807). I.K. was supported in part by Marie Curie grant no. 328853-MC-BSiCS.	Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Berry MV, 2004, CZECH J PHYS, V54, P1039, DOI 10.1023/B:CJOP.0000044002.05657.04; Cao H, 2015, REV MOD PHYS, V87, P61, DOI 10.1103/RevModPhys.87.61; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chan CT, 2012, ADV OPTOELECTRON, V2012, DOI 10.1155/2012/313984; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; Chua SL, 2014, OPT LETT, V39, P2072, DOI 10.1364/OL.39.002072; Dembowski C, 2001, PHYS REV LETT, V86, P787, DOI 10.1103/PhysRevLett.86.787; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Hsu CW, 2014, NANO LETT, V14, P2783, DOI 10.1021/nl500340n; Hsu CW, 2013, NATURE, V499, P188, DOI 10.1038/nature12289; Huang XQ, 2011, NAT MATER, V10, P582, DOI [10.1038/NMAT3030, 10.1038/nmat3030]; Lee J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.067401; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Moiseyev N., 2011, NONHERMITIAN QUANTUM; Moitra P, 2013, NAT PHOTONICS, V7, P791, DOI [10.1038/NPHOTON.2013.214, 10.1038/nphoton.2013.214]; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Rechtsman MC, 2013, NAT PHOTONICS, V7, P153, DOI [10.1038/NPHOTON.2012.302, 10.1038/nphoton.2012.302]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Rotter I, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/15/153001; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Sakoda K, 2012, OPT EXPRESS, V20, P25181, DOI 10.1364/OE.20.025181; Suh W, 2004, IEEE J QUANTUM ELECT, V40, P1511, DOI 10.1109/JQE.2004.834773; Szameit A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.021806; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871	30	446	453	30	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					354	358		10.1038/nature14889	http://dx.doi.org/10.1038/nature14889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26352476	Green Submitted, Green Published			2022-12-28	WOS:000361297900038
J	Masterson, L; Vallis, M; Quinlivan, R; Prinsley, P				Masterson, Liam; Vallis, Martin; Quinlivan, Ros; Prinsley, Peter			Assessment and management of facial nerve palsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BELLS-PALSY; PREDNISOLONE		[Masterson, Liam] Cambridge Univ Hosp NHS Trust, Dept Ear Nose & Throat, Ear Nose & Throat Surg, Cambridge CB2 0QQ, England; [Vallis, Martin] NHS Great Yarmouth & Waveney Clin Commissioning G, Rosedale Surg, Lowestoft, Suffolk, England; [Quinlivan, Ros] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, Neuromuscular Dis, London WC1N 3BG, England; [Prinsley, Peter] Norfolk & Norwich Univ Hosp NHS Trust, Dept Ear Nose & Throat, Norwich, Norfolk, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospitals NHS Foundation Trust	Masterson, L (corresponding author), Cambridge Univ Hosp NHS Trust, Dept Ear Nose & Throat, Ear Nose & Throat Surg, Cambridge CB2 0QQ, England.	lmm398@doctors.org.uk	masterson, liam/GQQ-9472-2022	prinsley, peter/0000-0002-4119-0598; Quinlivan, Rosaline/0000-0002-2306-4782; Masterson, Liam/0000-0001-7214-030X				Baugh RF, 2013, OTOLARYNG HEAD NECK, V149, P656, DOI 10.1177/0194599813506835; Browning GG, 2010, CLIN OTOLARYNGOL, V35, P56, DOI 10.1111/j.1749-4486.2010.02084.x; Buchanan M, 2010, CLIN REV BELLS PALSY; Coulson SE, 2004, OTOL NEUROTOL, V25, P1014, DOI 10.1097/00129492-200411000-00026; de Almeida JR, 2009, JAMA-J AM MED ASSOC, V302, P985, DOI 10.1001/jama.2009.1243; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Engstrom M, 2008, LANCET NEUROL, V7, P993, DOI 10.1016/S1474-4422(08)70221-7; HOBSON CE, 2014, OTOLARYNG HEAD NECK, V151, P112, DOI DOI 10.1177/0194599814528301; Holland NJ, 2014, BMJ CLIN EVID 2014; Kamerer DB, 2001, HEAD NECK SURG OTOLA, P1108; Kenny T, 2013, BELLS PALSY; Kosins Aaron M, 2007, Can J Plast Surg, V15, P77; Lockhart P, 2009, COCHRANE DB SYST REV, V4; May M, 2001, FACIAL NERVE; Peitersen E, 2002, ACTA OTO-LARYNGOL, V122, P4, DOI 10.1080/000164802320401694; Pretto Flores L, 2000, J Neurosurg Sci, V44, P77; Rafii B, 2014, LARYNGOSCOPE, V124, P1668, DOI 10.1002/lary.24556; Salinas RA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001942.pub4; Sharp MC, 2005, BRIT J NEUROSURG, V19, P122, DOI 10.1080/02688690500145480; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006; TAVERNER D, 1954, LANCET, V2, P1052; Teixeira LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006283.pub3; Walker DT, 2012, CLIN OTOLARYNGOL, V37, P474, DOI 10.1111/coa.12026	25	15	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h3725	10.1136/bmj.h3725	http://dx.doi.org/10.1136/bmj.h3725			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26378061				2022-12-28	WOS:000361678800001
J	Minami, CA; Yang, AD; Szmuilowicz, E				Minami, Christina A.; Yang, Anthony D.; Szmuilowicz, Eytan			Negotiating the Tensions in Patient-Centered Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Minami, Christina A.; Yang, Anthony D.] Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Minami, Christina A.; Yang, Anthony D.] NW Mem Hosp, Chicago, IL 60611 USA; [Minami, Christina A.] Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, 633 N St Clair,20th Floor, Chicago, IL 60611 USA; [Yang, Anthony D.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Szmuilowicz, Eytan] Northwestern Univ, Div Hosp Med, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Minami, CA (corresponding author), Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, 633 N St Clair,20th Floor, Chicago, IL 60611 USA.	christina-minami@northwestern.edu						American Society of Clinical Oncology, SUMM CURR QOPI MEAS; Apatira L, 2008, ANN INTERN MED, V149, P861, DOI 10.7326/0003-4819-149-12-200812160-00005; Parker SM, 2007, J PAIN SYMPTOM MANAG, V34, P81, DOI 10.1016/j.jpainsymman.2006.09.035; Tanco K, 2015, JAMA ONCOL, V1, P176, DOI 10.1001/jamaoncol.2014.297; Tucker JL, 1998, MIL MED, V163, P754, DOI 10.1093/milmed/163.11.754	5	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1167	+		10.1001/jama.2015.10112	http://dx.doi.org/10.1001/jama.2015.10112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372586				2022-12-28	WOS:000361284500028
J	Zehr, JP				Zehr, Jonathan P.			How single cells work together	SCIENCE			English	Editorial Material							CYANOBACTERIUM; SYMBIOSIS; GENOME		Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Zehr, Jonathan P/B-3513-2014	Zehr, Jonathan P/0000-0002-5691-5408				Bentzon-Tilia M, 2015, ISME J, V9, P273, DOI 10.1038/ismej.2014.119; Bombar D, 2014, ISME J, V8, P2530, DOI 10.1038/ismej.2014.167; Cabello AM, 2016, ISME J, V10, P693, DOI 10.1038/ismej.2015.147; Hagino K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081749; Kiers ET, 2015, SCIENCE, V348, P392, DOI 10.1126/science.aaa9605; Kneip C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-30; Nakayama T, 2014, P NATL ACAD SCI USA, V111, P11407, DOI 10.1073/pnas.1405222111; Nowack ECM, 2012, P NATL ACAD SCI USA, V109, P5340, DOI 10.1073/pnas.1118800109; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; VILLAREAL TA, 1990, MAR ECOL-P S Z N I, V11, P117, DOI 10.1111/j.1439-0485.1990.tb00233.x; VILLAREAL TA, 1989, BRIT PHYCOL J, V24, P357, DOI 10.1080/00071618900650371; Wouters J, 2009, SYMBIOSIS, V49, P61, DOI 10.1007/s13199-009-0020-3; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444	15	15	17	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1163	1164		10.1126/science.aac9752	http://dx.doi.org/10.1126/science.aac9752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359387				2022-12-28	WOS:000360968400020
J	Russell, LM				Russell, Lynn M.			ATMOSPHERIC SCIENCE Sea-spray particles cause freezing in clouds	NATURE			English	Editorial Material									Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Russell, LM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	lmrussell@ucsd.edu		Russell, Lynn/0000-0002-6108-2375				Burrows SM, 2013, ATMOS CHEM PHYS, V13, P245, DOI 10.5194/acp-13-245-2013; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Wendisch M., 2013, AIRBORNE MEASUREMENT; Wilson TW, 2015, NATURE, V525, P234, DOI 10.1038/nature14986	6	5	5	0	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					194	195		10.1038/525194a	http://dx.doi.org/10.1038/525194a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354479				2022-12-28	WOS:000360927400023
J	Duley, L; Dorling, J; Gyte, G				Duley, Lelia; Dorling, Jon; Gyte, Gill			UNCERTAINTIES PAGE When should the umbilical cord be clamped?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACENTAL TRANSFUSION; CONTROLLED-TRIAL; WEEKS GESTATION; BIRTH; RESUSCITATION; IMMEDIATE; VOLUME		[Duley, Lelia] Queens Med Ctr, Nottingham Clin Trials Unit, Nottingham NG7 2UH, England; [Dorling, Jon] Univ Nottingham, Sch Med, Queens Med Ctr, Neonatol Unit, Liverpool, Merseyside, England; [Gyte, Gill] Univ Liverpool, Liverpool Womens NHS Fdn, Dept Womens & Childrens Hlth, Cochrane Pregnancy & Childbirth Grp, Liverpool L69 3BX, Merseyside, England	University of Nottingham; University of Nottingham; University of Liverpool	Duley, L (corresponding author), Queens Med Ctr, Nottingham Clin Trials Unit, Nottingham NG7 2UH, England.	lelia.duley@nottingham.ac.uk	Dorling, Jon/B-7409-2015; Duley, Lelia/E-8107-2015	Dorling, Jon/0000-0002-1691-3221; Duley, Lelia/0000-0001-6721-5178	National Institute for Health Research [RP-PG-0609-10107] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Aladangady N, 2006, PEDIATRICS, V117, P93, DOI 10.1542/peds.2004-1773; Andersson O, 2014, JAMA PEDIATR, V168, P547, DOI 10.1001/jamapediatrics.2013.4639; Backes CH, 2011, PEDIATRIC ACADEMIC S; Boere I, 2014, ARCH DIS CHILD SUPPL, V99, pA225; Dawes GS, 1968, FOETAL AND NEONATAL; Duley L, 2014, ARCH DIS CHILD-FETAL, V99, pA76; Elimian A, 2013, AM J OBSTET GYNECOL, V208, pS22, DOI 10.1016/j.ajog.2012.10.209; Farrar D, 2011, BJOG-INT J OBSTET GY, V118, P70, DOI 10.1111/j.1471-0528.2010.02781.x; Ghavam S, 2014, TRANSFUSION, V54, P1192, DOI 10.1111/trf.12469; Gokmen Z, 2011, J PERINAT MED, V39, P323, DOI [10.1515/JPM.2011.021, 10.1515/jpm.2011.021]; GUNTHER M, 1957, LANCET, V1, P1277, DOI 10.1016/S0140-6736(57)92302-4; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; McDonald S, 2013, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003526.PUB2; National Institute for Health and Care Excellence, 2014, INTRAPARTUM CARE CAR; Oh W, 2011, J PERINATOL, V31, pS68, DOI 10.1038/jp.2010.186; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Pushpa-Rajah A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-258; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Royal College of Obstetricians and Gynaecologists, 2009, GREEN TOP GUIDELINE; Schoonakker B, 2013, 54TH ANNUAL MEETING, P430; Strauss RG, 2007, TRANSFUSION, V47, p20A; Tabatabaii A, 2008, J MATERNAL FETAL S1, V21, P181; Thomas MR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-135; Vain NE, 2014, LANCET, V384, P235, DOI 10.1016/S0140-6736(14)60197-5; Weeks A, 2007, BRIT MED J, V335, P312, DOI 10.1136/bmj.39282.440787.80; WHO, 2012, WHO RECOMMENDATIONS; Windrim R, 2011, AM J OBSTET GYNECOL, V204, pS201	27	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2015	351								h4206	10.1136/bmj.h4206	http://dx.doi.org/10.1136/bmj.h4206			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CY	26353791				2022-12-28	WOS:000361280600001
J	Pournaras, DJ; le Roux, CW				Pournaras, Dimitri J.; le Roux, Carel W.			Type 2 diabetes: multimodal treatment of a complex disease	LANCET			English	Editorial Material							BARIATRIC SURGERY; FOLLOW-UP; REMISSION		[Pournaras, Dimitri J.; le Roux, Carel W.] Univ London Imperial Coll Sci Technol & Med, Invest Sci, London, England; [le Roux, Carel W.] Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst, Diabet Complicat Res Ctr, Dublin 4, Ireland	Imperial College London; University College Dublin	le Roux, CW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Invest Sci, London, England.	carel.leroux@ucd.ie		Le Roux, Carel/0000-0001-5521-5445				Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Miras AD, 2015, DIABETOLOGIA, V58, P1443, DOI 10.1007/s00125-015-3595-7; Pournaras DJ, 2012, BRIT J SURG, V99, P100, DOI 10.1002/bjs.7704; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; The United Kingdom National Bariatric Surgery Registry, 2014, 2 REG REP 2014	11	18	18	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					936	937		10.1016/S0140-6736(15)00132-4	http://dx.doi.org/10.1016/S0140-6736(15)00132-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369451				2022-12-28	WOS:000361182700006
J	Pittet, LF; Siebert, JN; Lacroix, LE				Pittet, Laure F.; Siebert, Johan N.; Lacroix, Laurence E.			Striking but benign: acute haemorrhagic oedema of infancy	LANCET			English	Editorial Material									[Pittet, Laure F.] Univ Hosp Geneva, Childrens Hosp, Div Gen Paediat, Geneva, Switzerland; [Siebert, Johan N.; Lacroix, Laurence E.] Univ Hosp Geneva, Childrens Hosp, Div Paediat Emergency Med, Geneva, Switzerland	University of Geneva; University of Geneva	Pittet, LF (corresponding author), Univ Hosp Geneva, Childrens Hosp, CH-1211 Geneva 14, Switzerland.	laure.pittet@hcuge.ch	Lacroix-Ducardonnoy, Laurence/HDN-9583-2022; Siebert, Johan N./ABF-6115-2020; Lacroix, Laurence/ABF-5052-2021	Lacroix-Ducardonnoy, Laurence/0000-0002-6636-3344; Siebert, Johan N./0000-0002-2871-3382; Lacroix, Laurence/0000-0002-6636-3344; Pittet, Laure/0000-0002-2395-4574					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2022	399	10336					E41	E41		10.1016/S0140-6736(15)00318-9	http://dx.doi.org/10.1016/S0140-6736(15)00318-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1K4GY	26411985				2022-12-28	WOS:000798562500002
J	Schmoller, KM; Turner, JJ; Koivomagi, M; Skotheim, JM				Schmoller, Kurt M.; Turner, J. J.; Koivomaegi, M.; Skotheim, Jan M.			Dilution of the cell cycle inhibitor Whi5 controls budding-yeast cell size	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; G(1) CYCLIN; CLN3; GROWTH; TRANSCRIPTION; CDK; G1; DIVISION; GENES; PHOSPHORYLATION	Cell size fundamentally affects all biosynthetic processes by determining the scale of organelles and influencing surface transport(1,2). Although extensive studies have identified many mutations affecting cell size, the molecular mechanisms underlying size control have remained elusive(3). In the budding yeast Saccharomyces cere-visiae, size control occurs in G1 phase before Start, the point of irreversible commitment to cell division(4,5). It was previously thought that activity of the G1 cyclin Cln3 increased with cell size to trigger Start by initiating the inhibition of the transcriptional inhibitor Whi5 (refs 6-8). Here we show that although Cln3 concentration does modulate the rate at which cells pass Start, its synthesis increases in proportion to cell size so that its total concentration is nearly constant during pre-Start G1. Rather than increasing Cln3 activity, we identify decreasing Whi5 activity-due to the dilution of Whi5 by cell growth-as a molecular mechanism through which cell size controls proliferation. Whi5 is synthesized in S/G2/M phases of the cell cycle in a largely size-independent manner. This results in smaller daughter cells being born with higher Whi5 concentrations that extend their pre-Start G1 phase. Thus, at its most fundamental level, size control in budding yeast results from the differential scaling of Cln3 and Whi5 synthesis rates with cell size. More generally, our work shows that differential size-dependency of protein synthesis can provide an elegant mechanism to coordinate cellular functions with growth.	[Schmoller, Kurt M.; Turner, J. J.; Koivomaegi, M.; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Skotheim, JM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skotheim@stanford.edu	; Skotheim, Jan/C-3238-2015	Schmoller, Kurt/0000-0001-5790-5204; Turner, Jonathan/0000-0001-7311-0313; Skotheim, Jan/0000-0001-8420-6820	Burroughs Wellcome Fund (CASI); National Science Foundation (CAREER); National Institutes of Health [GM007276]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, P50GM107615] Funding Source: NIH RePORTER	Burroughs Wellcome Fund (CASI); National Science Foundation (CAREER)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Atay and J. Feldman for reagents, R. de Bruin, A. Gladfelter, M. Cyert, and M. Loog for comments on the manuscript, the Burroughs Wellcome Fund (CASI), the National Science Foundation (CAREER), National Institutes of Health training grant GM007276 (to J.J.T.), and Human Frontier Science Program (postdoctoral fellowships to K.M.S. and M.K.) for funding.	Bastajian N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003507; Bhaduri S, 2011, CURR BIOL, V21, P1615, DOI 10.1016/j.cub.2011.08.033; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Doncic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057970; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; EPSTEIN CB, 1994, MOL CELL BIOL, V14, P2041, DOI 10.1128/MCB.14.3.2041; FANTES PA, 1975, J THEOR BIOL, V50, P213, DOI 10.1016/0022-5193(75)90034-X; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Landry BD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002851; Liu XL, 2015, ELIFE, V4, DOI 10.7554/eLife.03977; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Menoyo S, 2013, MOL CELL BIOL, V33, P1273, DOI 10.1128/MCB.01556-12; Miller ME, 2005, YEAST, V22, P1021, DOI 10.1002/yea.1292; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Ottoz DSM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku616; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Schneider BL, 2004, MOL CELL BIOL, V24, P10802, DOI 10.1128/MCB.24.24.10802-10813.2004; Shi L, 2013, P NATL ACAD SCI USA, V110, P7318, DOI 10.1073/pnas.1302490110; Thorburn RR, 2013, MOL BIOL CELL, V24, P1274, DOI 10.1091/mbc.E12-07-0520; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000189; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523; Yahya G, 2014, MOL CELL, V53, P115, DOI 10.1016/j.molcel.2013.11.015	37	159	160	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					268	+		10.1038/nature14908	http://dx.doi.org/10.1038/nature14908			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26390151	Green Accepted			2022-12-28	WOS:000362399000050
J	Geschwind, DH; Flint, J				Geschwind, Daniel H.; Flint, Jonathan			Genetics and genomics of psychiatric disease	SCIENCE			English	Review							AUTISM SPECTRUM DISORDER; DE-NOVO MUTATIONS; BIPOLAR DISORDER; NEURODEVELOPMENTAL PATHWAYS; FUNCTIONAL IMPACT; WIDE ASSOCIATION; COMPLEX TRAITS; SCHIZOPHRENIA; RARE; RISK	Large-scale genomic investigations have just begun to illuminate the molecular genetic contributions to major psychiatric illnesses, ranging from small-effect-size common variants to larger-effect-size rare mutations. The findings provide causal anchors from which to understand their neurobiological basis. Although these studies represent enormous success, they highlight major challenges reflected in the heterogeneity and polygenicity of all of these conditions and the difficulty of connecting multiple levels of molecular, cellular, and circuit functions to complex human behavior. Nevertheless, these advances place us on the threshold of a new frontier in the pathophysiological understanding, diagnosis, and treatment of psychiatric disease.	[Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford; Wellcome Centre for Human Genetics	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	dhg@mednet.ucla; jf@well.ox.ac.uk		Flint, Jonathan/0000-0002-9427-4429	National Institute of Mental Health [5R01 MH100027, 5R01 MH094714]; Simons Foundation [206744]; Wellcome Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100027, R01MH094714] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Ruzzo, V. Leppa, G. Coppola, M. Gandal, and J. Stein for their helpful comments on the manuscript and for their contributions to figure content and design and to table S1. Figure 1 was produced by D.H.G. and V. Leppa based on data in table S1; Fig. 2 was produced by J.F.; Fig. 3 was produced by D.H.G. and N. Parikshak; and Fig. 4 was produced by G. Coppola and D.H.G. We gratefully acknowledge funding support from the National Institute of Mental Health (grants 5R01 MH100027 and 5R01 MH094714 to D.H.G.), the Simons Foundation (grant 206744 to D.H.G.), and the Wellcome Trust (J.F.) for our research. We apologize to our colleagues whose primary work we were not able to cite due to space limitations and instead refer to reviews where many of the primary references can be found. D.H.G. has consulted for Synapdx and Roche.	Bearden CE, 2006, TRENDS GENET, V22, P306, DOI 10.1016/j.tig.2006.04.004; Bettelheim B., 1972, EMPTY FORTRESS INFAN; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Chaste P, 2015, BIOL PSYCHIAT, V77, P775, DOI 10.1016/j.biopsych.2014.09.017; Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405; CONVERGE Consortium, 2015, NATURE; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Evans DM, 2015, ANNU REV GENOM HUM G, V16, P327, DOI 10.1146/annurev-genom-090314-050016; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind D.H., 2015, LANCET NEUROL; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood TA, 2013, AM J PSYCHIAT, V170, P521, DOI 10.1176/appi.ajp.2012.12020186; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Levinson DF, 2002, SCIENCE, V296, P739, DOI 10.1126/science.1069914; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lowe JK, 2015, AM J PSYCHIAT, V172, P266, DOI 10.1176/appi.ajp.2014.14050576; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maier R, 2015, AM J HUM GENET, V96, P283, DOI 10.1016/j.ajhg.2014.12.006; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium, 2015, NAT NEUROSCI, V18, P199; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823	69	226	233	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1489	1494		10.1126/science.aaa8954	http://dx.doi.org/10.1126/science.aaa8954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404826	Green Accepted			2022-12-28	WOS:000361707000036
J	Davies, DR; Rawlinson, N; Iaffaldano, G; Campbell, IH				Davies, D. R.; Rawlinson, N.; Iaffaldano, G.; Campbell, I. H.			Lithospheric controls on magma composition along Earth's longest continental hotspot track	NATURE			English	Article							SEISMOLOGICAL REFERENCE MODEL; MANTLE PLUMES; AUSTRALIAN LITHOSPHERE; FLOOD BASALTS; VOLCANISM; TOMOGRAPHY; CONVECTION; COMPONENT; ORIGIN; MARGIN	Hotspots are anomalous regions of volcanism at Earth's surface that show no obvious association with tectonic plate boundaries. Classic examples include the Hawaiian-Emperor chain and the Yellowstone-Snake River Plain province. The majority are believed to form as Earth's tectonic plates move over long-lived mantle plumes: buoyant upwellings that bring hot material from Earth's deep mantle to its surface(1). It has long been recognized that lithospheric thickness limits the rise height of plumes(2-4) and, thereby, their minimum melting pressure. It should, therefore, have a controlling influence on the geochemistry of plume-related magmas, although unambiguous evidence of this has, so far, been lacking. Here we integrate observational constraints from surface geology, geochronology, plate-motion reconstructions, geochemistry and seismology to ascertain plume melting depths beneath Earth's longest continental hotspot track, a 2,000-kilometre-long track in eastern Australia that displays a record of volcanic activity between 33 and 9 million years ago(5,6), which we call the Cosgrove track. Our analyses highlight a strong correlation between lithospheric thickness and magma composition along this track, with: (1) standard basaltic compositions in regions where lithospheric thickness is less than 110 kilometres; (2) volcanic gaps in regions where lithospheric thickness exceeds 150 kilometres; and (3) lowvolume, leucitite-bearing volcanism in regions of intermediate lithospheric thickness. Trace-element concentrations from samples along this track support the notion that these compositional variations result from different degrees of partial melting, which is controlled by the thickness of overlying lithosphere. Our results place the first observational constraints on the sub-continental melting depth of mantle plumes and provide direct evidence that lithospheric thickness has a dominant influence on the volume and chemical composition of plume-derived magmas.	[Davies, D. R.; Iaffaldano, G.; Campbell, I. H.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Rawlinson, N.] Univ Aberdeen, Sch Geosci, Aberdeen AB24 3UE, Scotland	Australian National University; University of Aberdeen	Davies, DR (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia.	rhodri.davies@anu.edu.au	Davies, David Rhodri/G-1551-2015; Campbell, Ian/A-4941-2008	Davies, David Rhodri/0000-0002-7662-9468; Campbell, Ian/0000-0001-8578-0154; Iaffaldano, Giampiero/0000-0003-1750-1576; Rawlinson, Nicholas/0000-0002-6977-291X	Australian Research Council Future Fellowship [FT140101262]; Ringwood Fellowship at the Australian National University; NERC [NE/H015329/1] Funding Source: UKRI; Natural Environment Research Council [NE/H015329/1] Funding Source: researchfish	Australian Research Council Future Fellowship(Australian Research Council); Ringwood Fellowship at the Australian National University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.R.D. is funded by an Australian Research Council Future Fellowship (FT140101262). G.I. acknowledges support from the Ringwood Fellowship at the Australian National University. Digital geological data were provided by Geosciences Australia.	Antretter M, 2002, EARTH PLANET SC LETT, V203, P635, DOI 10.1016/S0012-821X(02)00841-5; CAMPBELL IH, 1992, J GEOL, V100, P497, DOI 10.1086/629605; Cohen BE, 2008, AUST J EARTH SCI, V55, P407, DOI 10.1080/08120090701769514; Cohen BE, 2013, TECTONICS, V32, P1371, DOI 10.1002/tect.20084; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Davies DR, 2009, EARTH PLANET SC LETT, V278, P50, DOI 10.1016/j.epsl.2008.11.027; Davies DR, 2014, GEOLOGY, V42, P1031, DOI 10.1130/G36093.1; DAVIES GF, 1994, J GEOPHYS RES-SOL EA, V99, P15709, DOI 10.1029/94JB00119; DUNCAN RA, 1991, REV GEOPHYS, V29, P31, DOI 10.1029/90RG02372; Ewart A., 1988, J PETROL, P225, DOI DOI 10.1093/PETR0L0GY/SPECIAL_; Farnetani C.G., 1995, EARTH PLANET SC LETT, V136, P251, DOI DOI 10.1016/0012-821X(95)00158-9; Farrington RJ, 2010, TECTONOPHYSICS, V483, P20, DOI 10.1016/j.tecto.2009.10.008; Fishwick S, 2012, AUST J EARTH SCI, V59, P809, DOI 10.1080/08120099.2012.702319; Fishwick S, 2008, TECTONICS, V27, DOI 10.1029/2007TC002116; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; Kennett BLN, 2013, GEOPHYS J INT, V192, P871, DOI 10.1093/gji/ggs065; Kennett BLN, 2012, AUST J EARTH SCI, V59, P1091, DOI 10.1080/08120099.2012.736406; King SD, 1998, EARTH PLANET SC LETT, V160, P289, DOI 10.1016/S0012-821X(98)00089-2; Knesel KM, 2008, NATURE, V454, P754, DOI 10.1038/nature07138; Leitch AM, 2001, J GEOPHYS RES-SOL EA, V106, P2047, DOI 10.1029/2000JB900307; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Montelli R, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001248; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; NELSON DR, 1986, GEOCHIM COSMOCHIM AC, V50, P231, DOI 10.1016/0016-7037(86)90172-9; Paul B, 2005, AUST J EARTH SCI, V52, P243, DOI 10.1080/08120090500139448; Rawlinson N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028105; Rawlinson N, 2015, SPRINGER GEOPHYS, P47, DOI 10.1007/978-3-319-15627-9_2; Rawlinson N, 2014, LITHOS, V189, P65, DOI 10.1016/j.lithos.2013.06.001; Rawlinson N, 2010, AUST J EARTH SCI, V57, P381, DOI 10.1080/08120099.2010.481325; Rawlinson N, 2014, GEOLOGY, V42, P783, DOI 10.1130/G35766.1; Ringwood A.E, 1975, COMPOSITION PETROLOG; Simons FJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014962; Sleep NH, 1996, J GEOPHYS RES-SOL EA, V101, P28065, DOI 10.1029/96JB02463; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; Sutherland FL, 2012, AUST J EARTH SCI, V59, P983, DOI 10.1080/08120099.2012.688293; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Tarduno J, 2009, SCIENCE, V324, P50, DOI 10.1126/science.1161256; Torsvik TH, 2010, EARTH PLANET SC LETT, V291, P106, DOI 10.1016/j.epsl.2009.12.055; WELLMAN P, 1974, TECTONOPHYSICS, V23, P49, DOI 10.1016/0040-1951(74)90110-3; WHITE RS, 1995, J GEOPHYS RES-SOL EA, V100, P17543, DOI 10.1029/95JB01585; Yoshizawa K, 2014, PHYS EARTH PLANET IN, V235, P33, DOI 10.1016/j.pepi.2014.07.008	42	103	104	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					511	+		10.1038/nature14903	http://dx.doi.org/10.1038/nature14903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26367795				2022-12-28	WOS:000361599900049
J	Kind, J; Pagie, L; de Vries, SS; Nahidiazar, L; Dey, SS; Bienko, M; Zhan, Y; Lajoie, B; de Graaf, CA; Amendola, M; Fudenberg, G; Imakaev, M; Mirny, LA; Jalink, K; Dekker, J; van Oudenaarden, A; van Steensel, B				Kind, Jop; Pagie, Ludo; de Vries, Sandra S.; Nahidiazar, Leila; Dey, Siddharth S.; Bienko, Magda; Zhan, Ye; Lajoie, Bryan; de Graaf, Carolyn A.; Amendola, Mario; Fudenberg, Geoffrey; Imakaev, Maxim; Mirny, Leonid A.; Jalink, Kees; Dekker, Job; van Oudenaarden, Alexander; van Steensel, Bas			Genome-wide Maps of Nuclear Lamina Interactions in Single Human Cells	CELL			English	Article							HI-C; DOMAIN ORGANIZATION; CHROMATIN; COMPARTMENTALIZATION; CHROMOSOMES; CONFORMATION; ARCHITECTURE; PRINCIPLES; DYNAMICS; SEQUENCE	Mammalian interphase chromosomes interact with the nuclear lamina (NL) through hundreds of large lamina-associated domains (LADs). We report a method to map NL contacts genome-wide in single human cells. Analysis of nearly 400 maps reveals a core architecture consisting of gene-poor LADs that contact the NL with high cell-to-cell consistency, interspersed by LADs with more variable NL interactions. The variable contacts tend to be cell-type specific and are more sensitive to changes in genome ploidy than the consistent contacts. Single-cell maps indicate that NL contacts involve multivalent interactions over hundreds of kilobases. Moreover, we observe extensive intra-chromosomal coordination of NL contacts, even over tens of megabases. Such coordinated loci exhibit preferential interactions as detected by Hi-C. Finally, the consistency of NL contacts is inversely linked to gene activity in single cells and correlates positively with the heterochromatic histone modification H3K9me3. These results highlight fundamental principles of single-cell chromatin organization.	[Kind, Jop; Pagie, Ludo; de Vries, Sandra S.; de Graaf, Carolyn A.; Amendola, Mario; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Kind, Jop; Dey, Siddharth S.; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Kind, Jop; Dey, Siddharth S.; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Nahidiazar, Leila; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol 1, NL-1066 CX Amsterdam, Netherlands; [Zhan, Ye; Lajoie, Bryan] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01605 USA; [Fudenberg, Geoffrey] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Imakaev, Maxim; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Bienko, Magda] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden; [Mirny, Leonid A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Howard Hughes Med Inst,Program Syst Biol, Worcester, MA 01605 USA	Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Karolinska Institutet; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.kind@hubrecht.eu; b.v.steensel@nki.nl	Bienko, Magda/AAM-8867-2020; amendola, mario/I-1728-2017; Mirny, Leonid/ABE-8083-2020; van Oudenaarden, Alexander/AAA-1705-2019	Bienko, Magda/0000-0002-6499-9082; amendola, mario/0000-0002-1188-8856; Mirny, Leonid/0000-0002-0785-5410; Dey, Siddharth S./0000-0002-1161-1654; Jalink, Kees/0000-0001-7019-3440; Fudenberg, Geoffrey/0000-0001-5905-6517	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); NHMRC Early Career Fellowship; NWO ZonMW-TOP; STW grant [12150]; ERC [AdG 294325-GeneNoiseControl]; NWO VICI Award; NIH [R01 GM114190]; National Human Genome Research Institute grant [R01 HG003143]; European Research Council (ERC) [AdG 293662-CHROMATINPRINCIPLES]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114190] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NWO ZonMW-TOP; STW grant; ERC(European Research Council (ERC)European Commission); NWO VICI Award(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute grant; European Research Council (ERC)(European Research Council (ERC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NKI Genomics Core Facility for technical assistance, Thijn Brummelkamp for help with KBM7 cells, Erik Wernersson for FISH image analysis, and members of the B.v.S. lab for helpful comments. This study was supported by a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) ALW-VENI fellowship (to J.K.), an NHMRC Early Career Fellowship (to C.A.d.G.), an NWO ZonMW-TOP and European Research Council (ERC) Advanced Grant AdG 293662-CHROMATINPRINCIPLES (to B.v.S.), a STW grant (12150) (to K.J.), an ERC Advanced Grant AdG 294325-GeneNoiseControl and NWO VICI Award (to S.S.D., M.B., and A.v.O.), a NIH grant (R01 GM114190) (to L.A.M., M.I., and G.F.), and a National Human Genome Research Institute grant (R01 HG003143) (to J.D., L.A.M., M.I., and G.F.).	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Bian Q, 2013, J CELL BIOL, V203, P767, DOI 10.1083/jcb.201305027; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; MANUELIDIS L, 1988, CHROMOSOMA, V96, P397, DOI 10.1007/BF00303033; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; OCHS RL, 1992, EXP CELL RES, V200, P339, DOI 10.1016/0014-4827(92)90181-7; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	43	273	278	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					134	147		10.1016/j.cell.2015.08.040	http://dx.doi.org/10.1016/j.cell.2015.08.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26365489	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000361846500027
J	Carlson, EW				Carlson, Erica W.			CONDENSED-MATTER PHYSICS Charge topology in superconductors	NATURE			English	Editorial Material							ORDER		Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Carlson, EW (corresponding author), Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA.	ewcarlson@purdue.edu		Carlson, Erica W./0000-0003-2162-5301				Campi G, 2015, NATURE, V525, P359, DOI 10.1038/nature14987; Carlson EW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1375; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Senthil T, 2001, PHYS REV LETT, V86, P292, DOI 10.1103/PhysRevLett.86.292; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0	8	13	14	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					329	330		10.1038/525329a	http://dx.doi.org/10.1038/525329a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381980				2022-12-28	WOS:000361297900032
J	Rylance, R				Rylance, Rick			Grant giving: Global funders to focus on interdisciplinarity	NATURE			English	Editorial Material									[Rylance, Rick] Arts & Humanities Res Council, Swindon, Wilts, England; [Rylance, Rick] Res Councils UK, Dublin, Ireland	UK Research & Innovation (UKRI); Arts & Humanities Research Council (AHRC)	Rylance, R (corresponding author), Arts & Humanities Res Council, Swindon, Wilts, England.	r.rylance@ahrc.ac.uk		Rylance, Rick/0000-0002-0042-0609				Bruce A, 2004, FUTURES, V36, P457, DOI 10.1016/j.futures.2003.10.003; Department for Business Innovation & Skills, 2014, TRIENN REV RES COUNC; Elsevier, 2015, REV UKS INT RES US C; German Research Foundation, 2013, INT REV PROC STRUCT; Klein J.T., 2010, OXFORD HDB INTERDISC, DOI DOI 10.1093/OXFORDHB/9780198733522.001.0001; Lakhani KR., 2007, VALUE OPENNESS SCI P; McLeish T., 2014, LEADING INTERDISCIPL; Whitfield J, 2008, NATURE, V451, P872, DOI 10.1038/451872a	8	67	68	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					313	315		10.1038/525313a	http://dx.doi.org/10.1038/525313a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR4JL	26381969	Bronze			2022-12-28	WOS:000361297900018
J	Allen, K; Pearson-Stuttard, J; Hooton, W; Diggle, P; Capewell, S; O'Flaherty, M				Allen, Kirk; Pearson-Stuttard, Jonathan; Hooton, William; Diggle, Peter; Capewell, Simon; O'Flaherty, Martin			Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACID CONTENT; SURVIVAL; TRENDS; AGE	OBJECTIVES To determine health and equity benefits and cost effectiveness of policies to reduce or eliminate trans fatty acids from processed foods, compared with consumption remaining at most recent levels in England. DESIGN Epidemiological modelling study. SETTING Data from National Diet and Nutrition Survey, Low Income Diet and Nutrition Survey, Office of National Statistics, and health economic data from other published studies. PARTICIPANTS Adults aged >= 25, stratified by fifths of socioeconomic circumstance. INTERVENTIONS Total ban on trans fatty acids in processed foods; improved labelling of trans fatty acids; bans on trans fatty acids in restaurants and takeaways. MAIN OUTCOME MEASURES Deaths from coronary heart disease prevented or postponed; life years gained; quality adjusted life years gained. Policy costs to government and industry; policy savings from reductions in direct healthcare, informal care, and productivity loss. RESULTS A total ban on trans fatty acids in processed foods might prevent or postpone about 7200 deaths (2.6%) from coronary heart disease from 2015-20 and reduce inequality in mortality from coronary heart disease by about 3000 deaths (15%). Policies to improve labelling or simply remove trans fatty acids from restaurants/fast food could save between 1800 (0.7%) and 3500 (1.3%) deaths from coronary heart disease and reduce inequalities by 600 (3%) to 1500 (7%) deaths, thus making them at best half as effective. A total ban would have the greatest net cost savings of about 265m pound ((sic)361m, $415m) excluding reformulation costs, or 64m pound if substantial reformulation costs are incurred outside the normal cycle. CONCLUSIONS A regulatory policy to eliminate trans fatty acids from processed foods in England would be the most effective and equitable policy option. Intermediate policies would also be beneficial. Simply continuing to rely on industry to voluntary reformulate products, however, could have negative health and economic outcomes.	[Allen, Kirk; Diggle, Peter] Univ Lancaster, Lancaster Med Sch, Lancaster LA1 4YW, England; [Allen, Kirk; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England; [Pearson-Stuttard, Jonathan] Univ Oxford, Div Med Sci, Oxford OX3 9DU, England; [Hooton, William] Univ Oxford, Oxford OX1 1DW, England	Lancaster University; University of Liverpool; University of Oxford; University of Oxford	Allen, K (corresponding author), Univ Lancaster, Lancaster Med Sch, Lancaster LA1 4YW, England.	allenk@liverpool.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131	National Institute for Health Research's School for Public Health Research (NIHR SPHR); National Institute for Health Research (NIHR); MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish; National Institute for Health Research [ACF-2015-21-015] Funding Source: researchfish	National Institute for Health Research's School for Public Health Research (NIHR SPHR); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research's School for Public Health Research (NIHR SPHR). The SPHR is funded by the National Institute for Health Research (NIHR). SPHR is a partnership between the Universities of Sheffield, Bristol, Cambridge, Exeter, UCL; London School for Hygiene and Tropical Medicine; LiLaC collaboration between the Universities of Liverpool and Lancaster and Fuse; Centre for Translational Research in Public Health, a collaboration between Newcastle, Durham, Northumbria, Sunderland, and Teesside Universities. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2014, J EPIDEMIOL COMMUN H, V68, pA35, DOI 10.1136/jech-2014-204726.72; Angell SY, 2012, ANN INTERN MED, V157, P81, DOI 10.7326/0003-4819-157-2-201207170-00004; Bajekal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059608; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Brouwer IA, 2013, EUR J CLIN NUTR, V67, P541, DOI 10.1038/ejcn.2013.43; Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Clapp J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140161; CLARK CE, 1962, OPER RES, V10, P405, DOI 10.1287/opre.10.3.405; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Coombes R, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5567; Department for Communities and Local Government, 2010, ENGL IND DEPR 2010; Department for Environment Food and Rural Affairs, 2014, FAM FOOD 2013; Department of Health, 2012, REV ART TRANS FATS R; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Food and Drug Administration, 2013, FED REGISTER, V78, P67169; Food Standard Agency, 2006, REG IMP ASS SETT TAR; Food Standards Agency, 2006, NAT DIET NUTR SURV R; Food Standards Agency, 2007, LOW INC DIET NUTR SU; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521; Gillespie DOS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127927; Hawkins NM, 2013, CIRC-CARDIOVASC QUAL, V6, P208, DOI 10.1161/CIRCOUTCOMES.111.000058; Kiage JN, 2013, AM J CLIN NUTR, V97, P1121, DOI 10.3945/ajcn.112.049064; KOOPMANSCHAP MA, 1992, SOC SCI MED, V34, P1005, DOI 10.1016/0277-9536(92)90131-9; L'Abbe MR, 2009, EUR J CLIN NUTR, V63, pS50, DOI 10.1038/ejcn.2009.14; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; McGill R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1781-7; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; NICE, 2011, COST EFF AN PHARM TR; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; O'Keeffe C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002837; Office for National Statistics, 2014, CONS PRIC INFL; Office of National Statistics, 2012, FAM SPEND; Office of National Statistics, 2013, IN DIS FREE LIF EXP; Otite FO, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120198; Pearson-Stuttard J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132524; Personal Social Services Research Unit, 2011, UNIT COSTS HLTH SOCI; Pot GK, 2012, BRIT J NUTR, V107, P405, DOI 10.1017/S0007114511002911; Public Health England, 2014, NATL DIET NUTR SURVE; R Development Core Team, 2009, R LANG ENV STAT COMP; Smolina K, 2012, CIRC-CARDIOVASC QUAL, V5, P532, DOI 10.1161/CIRCOUTCOMES.111.964700; Stender S., 2006, Scandinavian Journal of Food & Nutrition, V50, P155, DOI 10.1080/17482970601069458; Stender S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005218; Stender Steen, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1651; Stender S, 2009, NEW ENGL J MED, V361, P314, DOI 10.1056/NEJMc0903380; Townsend N, 2012, CORONARY HEART DIS S; Tugwell P, 2006, BMJ-BRIT MED J, V332, P358, DOI 10.1136/bmj.332.7537.358; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; UK Faculty of Public Health/ Royal Society for Public Health, 12 STEPS BETT PUBL H; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; World Cancer Research Fund International, 2015, IMPR FOOD SUPPL; World Health Organization, 2004, GLOB STRAT DIET PHYS	59	37	37	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2015	351								h4583	10.1136/bmj.h4583	http://dx.doi.org/10.1136/bmj.h4583			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9LZ	26374614	hybrid, Green Published			2022-12-28	WOS:000361678600002
J	Disis, ML				Disis, Mary L.			The Lasker Awards-Recognizing and Highlighting Oncology Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER		Univ Washington, Tumor Vaccine Grp, Ctr Translat Med Womens Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Disis, ML (corresponding author), Univ Washington, Tumor Vaccine Grp, Ctr Translat Med Womens Hlth, 850 Republican St,POB 358050, Seattle, WA 98195 USA.	ndisis@uw.edu						Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Schilsky RL, 2006, CLIN CANCER RES, V12, p3553S, DOI 10.1158/1078-0432.CCR-06-9000; Thaxton L, 2015, MED CLIN N AM, V99, P469, DOI 10.1016/j.mcna.2015.01.003	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1123	1124		10.1001/jama.2015.10964	http://dx.doi.org/10.1001/jama.2015.10964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372574				2022-12-28	WOS:000361284500016
J	Kularatne, SAM				Kularatne, Senanayake A. M.			Dengue fever	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEMORRHAGIC-FEVER; CONTROLLED-TRIAL; PHASE-II; VACCINE; IMMUNOGENICITY; PATHOGENESIS; RECOMBINANT; CHILDREN; EFFICACY; SAFETY		[Kularatne, Senanayake A. M.] Univ Peradeniya, Dept Med, Fac Med, Peradeniya, Sri Lanka	University of Peradeniya	Kularatne, SAM (corresponding author), Univ Peradeniya, Dept Med, Fac Med, Peradeniya, Sri Lanka.	samkul@sltnet.lk						Ashley EA, 2011, TRENDS ANAESTH CRIT, V1, P39, DOI 10.1016/j.tacc.2010.10.002; Baldacchino F, 2015, PEST MANAG SCI; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Centers for Disease Control and Prevention, 2014, CLIN GUID DENG VIR; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Kalayanarooj S., 1999, Dengue Bulletin, V23, P1; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kularatne SAM, 2008, T ROY SOC TROP MED H, V102, P1053, DOI 10.1016/j.trstmh.2008.06.001; Kularatne SAM, 2007, T ROY SOC TROP MED H, V101, P804, DOI 10.1016/j.trstmh.2007.02.021; Kularatne SAM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-141; Lanata CF, 2012, VACCINE, V30, P5935, DOI 10.1016/j.vaccine.2012.07.043; Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Ministry of Health Sri Lanka, 2012, GUID MAN DENG FEV DE; Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; Pichainarong Natchaporn, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P283; Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc; Premaratna R, 2009, T ROY SOC TROP MED H, V103, P127, DOI 10.1016/j.trstmh.2008.07.024; Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738; Rajapakse S, 2009, T ROY SOC TROP MED H, V103, P122, DOI 10.1016/j.trstmh.2008.07.022; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sawasdivorn Siraporn, 2001, Dengue Bulletin, V25, P56; Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308; Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655; Teixeira MG, 2009, BMJ-BRIT MED J, V339, P1189; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2011, COMPR GUID PREV CONT; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Zhang F, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003488.pub3	40	71	76	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2015	351								h4661	10.1136/bmj.h4661	http://dx.doi.org/10.1136/bmj.h4661			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LZ	26374064				2022-12-28	WOS:000361678600003
J	Moye, MS; Swick, BL; Wanat, KA				Moye, Molly S.; Swick, Brian L.; Wanat, Karolyn A.			A Growing Scar on the Abdomen of a Middle-aged Woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CUTANEOUS ANGIOSARCOMA; SOFT-TISSUE; PACLITAXEL		[Moye, Molly S.] Univ Iowa Hosp & Clin, Dept Dermatol, Iowa City, IA 52242 USA; [Swick, Brian L.; Wanat, Karolyn A.] Univ Iowa Hosp & Clin, Dept Dermatol, Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Swick, Brian L.; Wanat, Karolyn A.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Wanat, KA (corresponding author), 200 Hawkins Dr,40027 PFP, Iowa City, IA 52242 USA.	karolyn-wanat@uiowa.edu		Swick, Brian/0000-0002-8201-0389				Albores-Saavedra J, 2011, ANN DIAGN PATHOL, V15, P93, DOI 10.1016/j.anndiagpath.2010.07.012; Donghi D, 2010, BRIT J DERMATOL, V162, P697, DOI 10.1111/j.1365-2133.2009.09607.x; Farid M, 2013, ONCOLOGY-BASEL, V85, P182, DOI 10.1159/000354215; Fujisawa Y, 2014, BRIT J DERMATOL, V171, P1493, DOI 10.1111/bjd.13110; Morgan EA, 2012, ANN SURG ONCOL, V19, P3801, DOI 10.1245/s10434-012-2563-4; Patel RM, 2012, ADV ANAT PATHOL, V19, P320, DOI 10.1097/PAP.0b013e31826661d1; Perez MC, 2013, ANN SURG ONCOL, V20, P3391, DOI 10.1245/s10434-013-3083-6; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Schlemmer M, 2008, EUR J CANCER, V44, P2433, DOI 10.1016/j.ejca.2008.07.037; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1169	1170		10.1001/jama.2015.4082	http://dx.doi.org/10.1001/jama.2015.4082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372587				2022-12-28	WOS:000361284500029
J	Winawer, SJ				Winawer, Sidney J.			The Joy of Discovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Winawer, Sidney J.] Mem Sloan Kettering Canc Ctr, Serv Gastroenterol & Nutr, Dept Med, New York, NY 10021 USA; [Winawer, Sidney J.] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Winawer, SJ (corresponding author), Mem Sloan Kettering Canc Ctr, Serv Gastroenterol & Nutr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	winawers@mskcc.org						Gillen A, 2012, A VANLEEUWENHOEK CRE; SCHATZKI R, 1953, AM J ROENTGENOL, V70, P911; Winawer SJ, 2015, DIGEST DIS SCI, V60, P596, DOI 10.1007/s10620-014-3466-y	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1131	1132		10.1001/jama.2015.3388	http://dx.doi.org/10.1001/jama.2015.3388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372578				2022-12-28	WOS:000361284500020
J	Chung, KF				Chung, Kian Fan			Targeting the interleukin pathway in the treatment of asthma	LANCET			English	Article							THYMIC STROMAL LYMPHOPOIETIN; ALPHA MONOCLONAL-ANTIBODY; NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; PERSISTENT ASTHMA; EOSINOPHILIC ASTHMA; AIRWAY INFLAMMATION; CRTH2 ANTAGONIST; CXCR2 ANTAGONIST; CLUSTER-ANALYSIS	Asthma is a common heterogeneous disease with a complex pathophysiology. Current therapies based on inhaled corticosteroids and longacting beta(2) agonists are effective in controlling asthma in most, but not all patients, with a few patients falling into the severe asthma category. Severe asthma is characterised by poor asthma control, recurrent exacerbations, and chronic airflow obstruction despite adequate and, in many cases, high-dose treatments. There is strong evidence supporting the role for interleukins derived from T-helper-2 (Th2) cells and innate lymphoid cells, such as interleukins 4, 5, and 13, as underlying the eosinophilic and allergic inflammatory processes in nearly half of these patients. An anti-IgE antibody, omalizumab, which binds to circulating IgE, a product of B cells from the actions of interleukin 4 and interleukin 13, is used as treatment for severe allergic asthma. Studies examining cytokine blockers such as anti-interleukin-5, anti-interleukin-4R alpha, and anti-interleukin-13 monoclonal antibodies in patients with severe asthma with recurrent exacerbations and high blood eosinophil counts despite use of inhaled corticosteroids have reported improved outcomes in terms of exacerbations, asthma control, and forced expiratory volume in 1 s. The US Food and Drug Administration's recommendation to use an anti-interleukin-5 antibody for the treatment of severe eosinophilic asthma suggests that there will be a therapeutic place for these anti-Th2 agents. Biomarkers should be used to identify the right patients for such targeted approaches. More guidance will be needed as to which patients should receive each of these classes of selective antibody-based treatments. Currently, there is no treatment that targets the cytokines driving asthma associated with non-eosinophilic inflammation and low Th2 expression.	[Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Expt Studies, Airway Dis Sect, London SW3 6LY, England; [Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, Natl Inst Hlth Res NIHR, Resp Biomed Res Unit, London, England; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, London SW3 6LY, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426	National Institute for Health Research [NF-SI-0509-10080] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Accordini S, 2013, INT ARCH ALLERGY IMM, V160, P93, DOI 10.1159/000338998; Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Arm JP, 2014, CLIN EXP ALLERGY, V44, P1371, DOI 10.1111/cea.12400; Barnes N, 2012, CLIN EXP ALLERGY, V42, P38, DOI 10.1111/j.1365-2222.2011.03813.x; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Berair RGS, 2015, 2015 M AM THOR SOC D; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bleck B, 2013, J IMMUNOL, V190, P3757, DOI 10.4049/jimmunol.1201165; Borish LC, 2001, J ALLERGY CLIN IMMUN, V107, P963, DOI 10.1067/mai.2001.115624; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Brightling CE, 2015, LANCET RESP MED; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Busse WW, 2013, J ALLERGY CLIN IMMUN, V131, P339, DOI 10.1016/j.jaci.2012.10.013; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Castro M, 2014, LANCET RESP MED, V2, P879, DOI 10.1016/S2213-2600(14)70201-2; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Chung KF, 2016, J INTERN MED, V279, P192, DOI 10.1111/joim.12382; Chung Kian Fan, 2013, Ann Am Thorac Soc, V10 Suppl, pS109, DOI 10.1513/AnnalsATS.201304-087AW; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; DJUKANOVIC R, 2003, AM THOR SOC 99 INT C; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Gauvreau GM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008961; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Global Asthma Network, GLOB ASTHM REP 2014; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hall IP, 2015, PULM PHARMACOL THER, V32, P37, DOI 10.1016/j.pupt.2015.03.003; Halwani R, 2013, CHEST, V143, P494, DOI 10.1378/chest.12-0598; Hanania NA, 2015, THORAX, V70, P748, DOI 10.1136/thoraxjnl-2014-206719; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Katz Lynn E, 2014, Ann Am Thorac Soc, V11, P531, DOI 10.1513/AnnalsATS.201310-354OC; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lloyd CM, 2015, CURR OPIN IMMUNOL, V34, P52, DOI 10.1016/j.coi.2015.02.001; Maes T, 2012, AM J RESP CELL MOL, V47, P261, DOI 10.1165/rcmb.2012-0080TR; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Morjaria JB, 2008, THORAX, V63, P584, DOI 10.1136/thx.2007.086314; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Nair P, 2014, NEW ENGL J MED, V371, P1249, DOI 10.1056/NEJMe1408614; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Noonan M, 2013, J ALLERGY CLIN IMMUN, V132, P567, DOI 10.1016/j.jaci.2013.03.051; Normansell R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub4; Nowak RM, 2015, AM J EMERG MED, V33, P14, DOI 10.1016/j.ajem.2014.09.036; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Scheerens H, 2014, CLIN EXP ALLERGY, V44, P38, DOI 10.1111/cea.12220; Schleich F, 2014, RESP MED, V108, P1723, DOI 10.1016/j.rmed.2014.10.007; Schuijs MJ, 2013, CURR OPIN PHARMACOL, V13, P351, DOI 10.1016/j.coph.2013.03.013; Slager RE, 2012, J ALLERGY CLIN IMMUN, V130, P516, DOI 10.1016/j.jaci.2012.03.030; Rensen ELJ, 2009, ALLERGY, V64, P72, DOI 10.1111/j.1398-9995.2008.01881.x; Vroman H, 2015, IMMUNOBIOLOGY, V220, P254, DOI 10.1016/j.imbio.2014.09.016; Wagener AH, 2015, THORAX, V70, P115, DOI 10.1136/thoraxjnl-2014-205634; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wenzel SE, 2015, 2015 M AM THOR SOC D; Wenzel SEIP, 2010, ERS ANN C 2010 BARC; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wu JX, 2013, CELL BIOCHEM FUNCT, V31, P496, DOI 10.1002/cbf.2926; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790	87	181	191	1	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1086	1096		10.1016/S0140-6736(15)00157-9	http://dx.doi.org/10.1016/S0140-6736(15)00157-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26383000				2022-12-28	WOS:000361189200029
J	Burgmann, R				Buergmann, Roland			Weak subduction makes great quakes	SCIENCE			English	Editorial Material							FAULT; STRENGTH; FRICTION					burgmann@seismo.berkeley.edu	Burgmann, Roland/AAE-5138-2022	Burgmann, Roland/0000-0002-3560-044X				Anderson E. M., 1951, DYNAMICS FAULTING DY; Audet P, 2009, NATURE, V457, P76, DOI 10.1038/nature07650; Brudy M, 1997, J GEOPHYS RES-SOL EA, V102, P18453, DOI 10.1029/96JB02942; Burgmann R, 2014, ANNU REV EARTH PL SC, V42, P509, DOI 10.1146/annurev-earth-060313-054953; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Gao X, 2014, SCIENCE, V345, P1038, DOI 10.1126/science.1255487; Hardebeck JL, 2015, SCIENCE, V349, P1213, DOI 10.1126/science.aac5625; Hardebeck JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053438; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Lin WR, 2013, SCIENCE, V339, P687, DOI 10.1126/science.1229379; MAGEE ME, 1993, GEOLOGY, V21, P809, DOI 10.1130/0091-7613(1993)021<0809:EFAWIT>2.3.CO;2; Moore DE, 2007, NATURE, V448, P795, DOI 10.1038/nature06064	14	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1162	1163		10.1126/science.aac9625	http://dx.doi.org/10.1126/science.aac9625			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359386				2022-12-28	WOS:000360968400019
J	Kleffel, S; Posch, C; Barthel, SR; Mueller, H; Schlapbach, C; Guenova, E; Elco, CP; Lee, N; Juneja, VR; Zhan, Q; Lian, CG; Thomi, R; Hoetzenecker, W; Cozzio, A; Dummer, R; Mihm, MC; Flaherty, KT; Frank, MH; Murphy, GF; Sharpe, AH; Kupper, TS; Schatton, T				Kleffel, Sonja; Posch, Christian; Barthel, Steven R.; Mueller, Hansgeorg; Schlapbach, Christoph; Guenova, Emmanuella; Elco, Christopher P.; Lee, Nayoung; Juneja, Vikram R.; Zhan, Qian; Lian, Christine G.; Thomi, Rahel; Hoetzenecker, Wolfram; Cozzio, Antonio; Dummer, Reinhard; Mihm, Martin C., Jr.; Flaherty, Keith T.; Frank, Markus H.; Murphy, George F.; Sharpe, Arlene H.; Kupper, Thomas S.; Schatton, Tobias			Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth	CELL			English	Article							BLOCKADE; ACTIVATION; EXPRESSION; NIVOLUMAB; RESPONSES; ANTI-PD-1; PATHWAYS; ANTIBODY; SAFETY; TIM-3	Therapeutic antibodies targeting programmed cell death 1 (PD-1) activate tumor-specific immunity and have shown remarkable efficacy in the treatment of melanoma. Yet, little is known about tumor cell-intrinsic PD-1 pathway effects. Here, we show that murine and human melanomas contain PD-1-expressing cancer subpopulations and demonstrate that melanoma cell-intrinsic PD-1 promotes tumorigenesis, even in mice lacking adaptive immunity. PD-1 inhibition on melanoma cells by RNAi, blocking antibodies, or mutagenesis of melanoma-PD-1 signaling motifs suppresses tumor growth in immunocompetent, immunocompromised, and PD-1-deficient tumor graft recipient mice. Conversely, melanoma-specific PD-1 overexpression enhances tumorigenicity, as does engagement of melanoma-PD-1 by its ligand, PD-L1, whereas melanoma-PD-L1 inhibition or knockout of host-PD-L1 attenuate growth of PD-1-positive melanomas. Mechanistically, themelanoma-PD-1 receptor modulates downstream effectors of mTOR signaling. Our results identify melanoma cell-intrinsic functions of the PD-1:PD-L1 axis in tumor growth and suggest that blocking melanoma-PD-1 might contribute to the striking clinical efficacy of anti-PD-1 therapy.	[Kleffel, Sonja; Posch, Christian; Barthel, Steven R.; Mueller, Hansgeorg; Elco, Christopher P.; Lee, Nayoung; Mihm, Martin C., Jr.; Frank, Markus H.; Kupper, Thomas S.; Schatton, Tobias] Harvard Univ, Sch Med, Dept Dermatol, Harvard Skin Dis Res Ctr,Brigham & Womens Hosp, Boston, MA 02115 USA; [Posch, Christian] Rudolfstiftung Hosp, Dept Dermatol, A-1030 Vienna, Austria; [Mueller, Hansgeorg] Med Univ Innsbruck, Dept Dermatol, A-6020 Innsbruck, Austria; [Schlapbach, Christoph; Thomi, Rahel] Univ Bern, Dept Dermatol, CH-3010 Bern, Switzerland; [Guenova, Emmanuella; Hoetzenecker, Wolfram; Cozzio, Antonio; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Elco, Christopher P.; Zhan, Qian; Lian, Christine G.; Murphy, George F.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Juneja, Vikram R.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Flaherty, Keith T.] Harvard Univ, Sch Med, Div Med Oncol, Massachusetts Gen Hosp,Canc Ctr, Boston, MA 02114 USA; [Frank, Markus H.; Schatton, Tobias] Harvard Univ, Sch Med, Dept Med, Childrens Hosp Boston, Boston, MA 02115 USA; [Frank, Markus H.] Edith Cowan Univ, Sch Med Sci, Joondalup, WA 6027, Australia; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rudolfstiftung Hospital; Medical University of Innsbruck; University of Bern; University of Zurich; University Zurich Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Edith Cowan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Schatton, T (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Harvard Skin Dis Res Ctr,Brigham & Womens Hosp, Boston, MA 02115 USA.	tschatton@bwh.harvard.edu	Schlapbach, Christoph/I-4608-2019; Kupper, Thomas/O-4962-2019; Guenova, Emmanuella/G-7441-2017; Schatton, Tobias/N-9898-2018; Frank, Markus/O-1625-2014	Schlapbach, Christoph/0000-0003-0258-1243; Guenova, Emmanuella/0000-0001-5478-8735; Schatton, Tobias/0000-0003-1386-680X; Lee, Nayoung/0000-0002-1594-267X; Frank, Markus/0000-0002-1312-0488; Posch, Christian/0000-0003-0296-3567	Melanoma International Foundation; Brigham Research Institute; Brigham and Women's Hospital, Department of Dermatology; Swiss National Science Foundation [PMDPP3_151326]; NIH/NCI [1R01CA158467, U54 CA163125]; Dermatology Foundation; Austrian Society of Dermatology and Venereology; Fondation Rene Touraine; Outrun the Sun Melanoma Foundation; American Skin Association; Department of Defense through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; NATIONAL CANCER INSTITUTE [R01CA158467, U54CA163125, R01CA113796, R01CA138231] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299] Funding Source: NIH RePORTER	Melanoma International Foundation; Brigham Research Institute; Brigham and Women's Hospital, Department of Dermatology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation; Austrian Society of Dermatology and Venereology; Fondation Rene Touraine; Outrun the Sun Melanoma Foundation; American Skin Association; Department of Defense through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Joubert, I. Portugal, C. Correia, and C. Lee for technical assistance. This work was supported by an Innovative Research Grant from the Melanoma International Foundation, a Fund to Sustain Research Excellence from the Brigham Research Institute, Brigham and Women's Hospital, Department of Dermatology funding for new investigators (to T.S.), a Swiss National Science Foundation grant PMDPP3_151326 (to E.G.), and NIH/NCI grants 1R01CA158467 (to M.H.F. and G.F.M.), and U54 CA163125 (to A.H.S.). T.S. is the recipient of a Research Career Development award from the Dermatology Foundation. C.P. and H.M. are recipients of a Klaus Wolff Fellowship by the Austrian Society of Dermatology and Venereology and received salary support from the Fondation Rene Touraine. C.P. was awarded a Melanoma Research Scholar Award from the Outrun the Sun Melanoma Foundation. N.L. is the recipient of a Medical Student Grant from the American Skin Association. V.R.J. is supported by the Department of Defense through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program. The authors declare that there are no conflicts of interest.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Liu KW, 2011, J CLIN INVEST, V121, P905, DOI 10.1172/JCI43690; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	29	387	418	27	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1242	1256		10.1016/j.cell.2015.08.052	http://dx.doi.org/10.1016/j.cell.2015.08.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359984	Bronze, Green Accepted			2022-12-28	WOS:000361247900015
J	Ball, JR; Balogh, E				Ball, John R.; Balogh, Erin			Improving Diagnosis in Health Care: Highlights of a Report From the National Academies of Sciences, Engineering, and Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Natl Acad Sci, Washington, DC 20418 USA; Natl Acad Engn, Washington, DC 20418 USA; Natl Acad Med, Washington, DC USA	National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Balogh, E (corresponding author), Board Hlth Care Serv, Inst Med, 500 Fifth St NW, Washington, DC 20001 USA.	ebalogh@nas.edu						Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; National Academies of Sciences E and Medicine-Committee on Diagnostic Error in Health Care, 2015, IMPR DIAGN HLTH CAR	3	45	45	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					59	+		10.7326/M15-2256	http://dx.doi.org/10.7326/M15-2256			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26414299				2022-12-28	WOS:000367801700012
J	Connor, JP; Hall, W				Connor, Jason P.; Hall, Wayne			Alcohol burden in low-income and middle-income countries	LANCET			English	Editorial Material							CONSUMPTION; DISEASE		[Connor, Jason P.; Hall, Wayne] Univ Queensland, Ctr Youth Subst Abuse Res, Herston, Qld 4029, Australia; [Connor, Jason P.] Univ Queensland, Discipline Psychiat, Herston, Qld 4029, Australia; [Hall, Wayne] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England	University of Queensland; University of Queensland; University of London; King's College London	Hall, W (corresponding author), Univ Queensland, Ctr Youth Subst Abuse Res, Herston, Qld 4029, Australia.	w.hall@uq.edu.au	Hall, Wayne D/A-3283-2008; Connor, Jason/F-7040-2010	Hall, Wayne D/0000-0003-1984-0096; Connor, Jason/0000-0002-7020-1196				Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Smyth A, 2015, LANCET; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007	7	13	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1922	1924		10.1016/S0140-6736(15)00236-6	http://dx.doi.org/10.1016/S0140-6736(15)00236-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26386542				2022-12-28	WOS:000364763200009
J	Raja, AS; Greenberg, JO; Qaseem, A; Denberg, TD; Fitterman, N; Schuur, JD				Raja, Ali S.; Greenberg, Jeffrey O.; Qaseem, Amir; Denberg, Thomas D.; Fitterman, Nick; Schuur, Jeremiah D.		Clinical Guidelines Comm Amer Coll	Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RULE-OUT CRITERIA; DEEP VENOUS THROMBOSIS; EMERGENCY-DEPARTMENT PATIENTS; ENHANCED COMPUTED-TOMOGRAPHY; CONTRAST-INDUCED NEPHROPATHY; D-DIMER ASSAY; DECISION-SUPPORT; PRETEST PROBABILITY; RANDOMIZED-TRIAL; RADIATION-EXPOSURE	Description: Pulmonary embolism (PE) can be a severe disease and is difficult to diagnose, given its nonspecific signs and symptoms. Because of this, testing patients with suspected acute PE has increased dramatically. However, the overuse of some tests, particularly computed tomography (CT) and plasma D-dimer measurement, may not improve care while potentially leading to patient harm and unnecessary expense. Methods: The literature search encompassed studies indexed by MEDLINE (1966-2014; English-language only) and included all clinical trials and meta-analyses on diagnostic strategies, decision rules, laboratory tests, and imaging studies for the diagnosis of PE. This document is not based on a formal systematic review, but instead seeks to provide practical advice based on the best available evidence and recent guidelines. The target audience for this paper is all clinicians; the target patient population is all adults, both inpatient and outpatient, suspected of having acute PE. Best Practice Advice 1: Clinicians should use validated clinical prediction rules to estimate pretest probability in patients in whom acute PE is being considered. Best Practice Advice 2: Clinicians should not obtain D-dimer measurements or imaging studies in patients with a low pretest probability of PE and who meet all Pulmonary Embolism Rule-Out Criteria. Best Practice Advice 3: Clinicians should obtain a high-sensitivity D-dimer measurement as the initial diagnostic test in patients who have an intermediate pretest probability of PE or in patients with low pretest probability of PE who do not meet all Pulmonary Embolism Rule-Out Criteria. Clinicians should not use imaging studies as the initial test in patients who have a low or intermediate pretest probability of PE. Best Practice Advice 4: Clinicians should use age-adjusted D-dimer thresholds (age x 10 ng/mL rather than a generic 500 ng/mL) in patients older than 50 years to determine whether imaging is warranted. Best Practice Advice 5: Clinicians should not obtain any imaging studies in patients with a D-dimer level below the age-adjusted cutoff. Best Practice Advice 6: Clinicians should obtain imaging with CT pulmonary angiography (CTPA) in patients with high pretest probability of PE. Clinicians should reserve ventilation-perfusion scans for patients who have a contraindication to CTPA or if CTPA is not available. Clinicians should not obtain a D-dimer measurement in patients with a high pretest probability of PE.	[Raja, Ali S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Greenberg, Jeffrey O.; Schuur, Jeremiah D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Fitterman, Nick] Hofstra North Shore Long Isl Jewish Sch Med, Huntington, NY 11743 USA; [Denberg, Thomas D.] Caril Clin, Roanoke, VA 24036 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; American College of Physicians; Hofstra University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.		Raja, Ali S./AAE-5103-2019		ACP operating budget	ACP operating budget	Financial support for the development of this paper comes exclusively from the ACP operating budget.	Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Baumann BM, 2011, ANN EMERG MED, V58, P1, DOI 10.1016/j.annemergmed.2010.10.018; Bokobza J, 2014, AM J EMERG MED, V32, P609, DOI 10.1016/j.ajem.2014.03.008; Boone John M, 2008, J Am Coll Radiol, V5, P132, DOI 10.1016/j.jacr.2007.07.008; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Brotman DJ, 2003, AM J MED, V114, P276, DOI 10.1016/S0002-9343(02)01520-6; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; Corwin MT, 2009, AM J ROENTGENOL, V192, P1319, DOI 10.2214/AJR.08.1346; Costantino MM, 2008, AM J ROENTGENOL, V191, P471, DOI 10.2214/AJR.07.2552; De Monye W, 2002, AM J RESP CRIT CARE, V165, P345, DOI 10.1164/ajrccm.165.3.2104099; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Duriseti RS, 2010, ANN EMERG MED, V56, P321, DOI 10.1016/j.annemergmed.2010.03.029; Epstein RM, 2005, ANN FAM MED, V3, P415, DOI 10.1370/afm.348; Fanikos J, 2013, AM J MED, V126, P127, DOI 10.1016/j.amjmed.2012.07.025; Feng LB, 2013, ACAD EMERG MED, V20, P1033, DOI 10.1111/acem.12221; Fesmire FM, 2011, ANN EMERG MED, V57, P628, DOI 10.1016/j.annemergmed.2011.01.020; Fisher ES, 2004, HLTH AFF MILLWOOD; Geyer BC, 2014, AM J EMERG MED, V32, P233, DOI 10.1016/j.ajem.2013.11.019; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Gupta RT, 2009, AM J ROENTGENOL, V193, P425, DOI 10.2214/AJR.08.2186; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kabrhel C, 2005, CHEST, V127, P1627, DOI 10.1378/chest.127.5.1627; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Kline JA, 2012, J THROMB HAEMOST, V10, P572, DOI 10.1111/j.1538-7836.2012.04647.x; Kline JA, 2004, ANN EMERG MED, V44, P490, DOI 10.1016/j.annemergmed.2004.03.018; Kline JA, 2008, ANN EMERG MED, V52, P437, DOI 10.1016/j.annemergmed.2008.05.023; Kline JA, 2014, ACAD EMERG MED, V21, P949, DOI 10.1111/acem.12471; Kline JA, 2014, ANN EMERG MED, V63, P275, DOI 10.1016/j.annemergmed.2013.08.023; Kline JA, 2014, CIRC-CARDIOVASC IMAG, V7, P66, DOI 10.1161/CIRCIMAGING.113.001080; Kline JA, 2010, ACAD EMERG MED, V17, P1016, DOI 10.1111/j.1553-2712.2010.00826.x; Kline JA, 2009, ANN INTERN MED, V150, DOI 10.7326/0003-4819-150-6-200903170-02015; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Levine MB, 2013, AM J EMERG MED, V31, P1437, DOI 10.1016/j.ajem.2013.07.003; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Minges KE, 2013, J AM COLL CARDIOL, V61, pE2070, DOI 10.1016/S0735-1097(13)62070-7; Mitchell AM, 2012, ACAD EMERG MED, V19, P618, DOI 10.1111/j.1553-2712.2012.01374.x; Mitchell AM, 2010, CLIN J AM SOC NEPHRO, V5, P4, DOI 10.2215/CJN.05200709; MOSER KM, 1994, JAMA-J AM MED ASSOC, V271, P223, DOI 10.1001/jama.271.3.223; Ong CW, 2013, INTERN MED J, V43, P169, DOI 10.1111/j.1445-5994.2012.02926.x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Penaloza A, 2012, THROMB RES, V129, pE189, DOI 10.1016/j.thromres.2012.02.016; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Prevedello LM, 2013, AM J MED, V126, P975, DOI 10.1016/j.amjmed.2013.04.018; Prevedello LM, 2012, AM J MED, V125, P356, DOI 10.1016/j.amjmed.2011.06.023; Raja AS, 2014, ACAD RADIOL, V21, P378, DOI 10.1016/j.acra.2013.10.017; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Revel MP, 2012, J THROMB HAEMOST, V10, P743, DOI 10.1111/j.1538-7836.2012.04652.x; Revel MP, 2013, EUR RADIOL, V23, P2374, DOI 10.1007/s00330-013-2852-8; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Rodger MA, 2005, THROMB RES, V116, P101, DOI 10.1016/j.thromres.2004.10.011; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Roy PM, 2009, ANN INTERN MED, V151, P677, DOI 10.7326/0003-4819-151-10-200911170-00003; Salaun PY, 2011, CHEST, V139, P1294, DOI 10.1378/chest.10-1209; Schissler AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065669; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Schrecengost JE, 2003, CLIN CHEM, V49, P1483, DOI 10.1373/49.9.1483; Schuur J, 2014, EMERGENCY MED QUALIT; Schuur JD, 2014, JAMA INTERN MED, V174, P509, DOI 10.1001/jamainternmed.2013.12688; Segal JB, 2007, ANN FAM MED, V5, P63, DOI 10.1370/afm.648; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Singh B, 2013, EMERG MED J, V30, P701, DOI 10.1136/emermed-2012-201730; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Teismann NA, 2009, ANN EMERG MED, V54, P442, DOI 10.1016/j.annemergmed.2009.03.017; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278; Venkatesh AK, 2012, ARCH INTERN MED, V172, P1028, DOI 10.1001/archinternmed.2012.1804; Ward MJ, 2011, ACAD EMERG MED, V18, P22, DOI 10.1111/j.1553-2712.2010.00957.x; Warren DJ, 2012, BRIT J RADIOL, V85, P37, DOI 10.1259/bjr/17451818; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Winer-Muram HT, 2002, RADIOLOGY, V224, P487, DOI 10.1148/radiol.2242011581; Winkler RL, 2001, INT J TECHNOL ASSESS, V17, P56, DOI 10.1017/S026646230110406X; Yin F, 2012, AM J MED QUAL, V27, P74, DOI 10.1177/1062860611407907	84	181	194	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					701	+		10.7326/M14-1772	http://dx.doi.org/10.7326/M14-1772			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26414967				2022-12-28	WOS:000365610600007
J	Wu, CY; Roybal, KT; Puchner, EM; Onuffer, J; Lim, WA				Wu, Chia-Yung; Roybal, Kole T.; Puchner, Elias M.; Onuffer, James; Lim, Wendell A.			Remote control of therapeutic T cells through a small molecule-gated chimeric receptor	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; PROLIFERATION; RECOGNITION; LYMPHOCYTES; EXPRESSION; MOTILITY; LIGANDS; SYNAPSE; TRIAL; LOGIC	There is growing interest in using engineered cells as therapeutic agents. For example, synthetic chimeric antigen receptors (CARs) can redirect T cells to recognize and eliminate tumor cells expressing specific antigens. Despite promising clinical results, these engineered T cells can exhibit excessive activity that is difficult to control and can cause severe toxicity. We designed "ON-switch" CARs that enable small-molecule control over T cell therapeutic functions while still retaining antigen specificity. In these split receptors, antigen-binding and intracellular signaling components assemble only in the presence of a heterodimerizing small molecule. This titratable pharmacologic regulation could allow physicians to precisely control the timing, location, and dosage of T cell activity, thereby mitigating toxicity. This work illustrates the potential of combining cellular engineering with orthogonal chemical tools to yield safer therapeutic cells that tightly integrate cell-autonomous recognition and user control.	[Wu, Chia-Yung; Roybal, Kole T.; Puchner, Elias M.; Onuffer, James; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Wu, Chia-Yung; Roybal, Kole T.; Onuffer, James; Lim, Wendell A.] Cell Prop Lab, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Onuffer, J (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	jamesonuffer@gmail.com; wendell.lim@ucsf.edu		Puchner, Elias M./0000-0002-7129-2309	Jane Coffin Childs Memorial Fund [A121505]; NIH [PN2 EY016546, P50 GM081879, R01 GM055040, R01 CA196277, F32 GM101782]; HHMI; NATIONAL CANCER INSTITUTE [R01CA196277] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM055040, F32GM101782] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.-Y.W., J.O., W.A.L., and the Regents of the University of California have filed a patent application (WO2014127261) that relates to the ON-switch CAR. We thank the Preclinical Therapeutics Core at UCSF for helping with in vivo studies; K. McNally, S. Johnston, D. Ng, D. Nunez, H. Yan, and S. Zorn for technical assistance; B. Huang for providing a custom-built microscope for PALM imaging; Y. Huang for mass spectroscopy-based pharmacokinetic analysis; M. Milone, C. June, D. Campana, I. Pastan, T. Meyer, and T. Inoue for providing materials; and A. Weiss, J. Bluestone, Q. Tang, A. Marson, L. Lanier, and members of the Lim Lab, Cell Propulsion Lab, and Weiss Lab for advice and feedback. Supported by NIH grant F32 GM101782 (C.-Y.W.), Jane Coffin Childs Memorial Fund grant A121505 (K.T.R.), and NIH grants PN2 EY016546, P50 GM081879, R01 GM055040, and R01 CA196277 and HHMI (W.A.L.).	Bacchus W, 2012, CURR OPIN BIOTECH, V23, P695, DOI 10.1016/j.copbio.2011.12.004; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bluestone JA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007542; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Byrne JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3009951; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; Lim W, 2014, CELL SIGNALING; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Park JS, 2014, P NATL ACAD SCI USA, V111, P5896, DOI 10.1073/pnas.1402087111; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Puchner EM, 2013, P NATL ACAD SCI USA, V110, P16015, DOI 10.1073/pnas.1309676110; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; ROBERTS MR, 1994, BLOOD, V84, P2878; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sato T, 2007, MOL THER, V15, P962, DOI 10.1038/mt.sj.6300122; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006	57	415	494	9	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258							aab4077	10.1126/science.aab4077	http://dx.doi.org/10.1126/science.aab4077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26405231	Green Accepted			2022-12-28	WOS:000362838700033
J	Nishi, A; Shirado, H; Rand, DG; Christakis, NA				Nishi, Akihiro; Shirado, Hirokazu; Rand, David G.; Christakis, Nicholas A.			Inequality and visibility of wealth in experimental social networks	NATURE			English	Article							HUNTER-GATHERERS; PROMOTE COOPERATION; HUMANS; PREFERENCES; AVERSION	Humans prefer relatively equal distributions of resources(1-5), yet societies have varying degrees of economic inequality(6). To investigate some of the possible determinants and consequences of inequality, here we perform experiments involving a networked public goods game in which subjects interact and gain or lose wealth. Subjects (n =1,462) were randomly assigned to have higher or lower initial endowments, and were embedded within social networks with three levels of economic inequality (Gini coefficient=0.0, 0.2, and 0.4). In addition, we manipulated the visibility of the wealth of network neighbours. We show that wealth visibility facilitates the downstream consequences of initial inequality-in initially more unequal situations, wealth visibility leads to greater inequality than when wealth is invisible. This result reflects a heterogeneous response to visibility in richer versus poorer subjects. We also find that making wealth visible has adverse welfare consequences, yielding lower levels of overall cooperation, inter-connectedness, and wealth. High initial levels of economic inequality alone, however, have relatively few deleterious welfare effects.	[Nishi, Akihiro; Shirado, Hirokazu; Rand, David G.; Christakis, Nicholas A.] Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA; [Nishi, Akihiro; Shirado, Hirokazu; Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Christakis, Nicholas A.] Yale Univ, Dept Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Christakis, NA (corresponding author), Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA.	nicholas.christakis@yale.edu		Nishi, Akihiro/0000-0003-1629-5985; Rand, David/0000-0001-8975-2783	Japan Society for the Promotion of Science (JSPS); Robert Wood Johnson Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	We thank C. Apicella, D. G. Alvarez, A. A. Arechar, D. Bergemann, G. Iosifidis, J. Jordan, J. H. Fowler, O. Moav, and A. Zaslavsky for comments. M. McKnight provided expert programming assistance and P. Treut provided technical support. The data reported in this paper are archived at Yale Institute for Network Science and are available upon request. A.N. was supported by the Japan Society for the Promotion of Science (JSPS). Support for this research was provided by a grant from the Robert Wood Johnson Foundation.	Abou Chakra M, 2014, J THEOR BIOL, V341, P123, DOI 10.1016/j.jtbi.2013.10.004; ALLISON PD, 1978, AM SOCIOL REV, V43, P865, DOI 10.2307/2094626; Apicella CL, 2014, AM ECON REV, V104, P1793, DOI 10.1257/aer.104.6.1793; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Calvo-Armengol A, 2004, AM ECON REV, V94, P426, DOI 10.1257/0002828041464542; Chan K. S., 1999, Experimental Economics, V2, P5; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Dawes CT, 2012, P NATL ACAD SCI USA, V109, P6479, DOI 10.1073/pnas.1118653109; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; HACKETT S, 1994, J ENVIRON ECON MANAG, V27, P99, DOI 10.1006/jeem.1994.1029; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; Kun A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3453; Kuziemko I, 2014, Q J ECON, V129, P105, DOI 10.1093/qje/qjt035; Loughnan S, 2011, PSYCHOL SCI, V22, P1254, DOI 10.1177/0956797611417003; Moav O, 2012, ECON J, V122, P933, DOI 10.1111/j.1468-0297.2012.02516.x; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Sadrieh A, 2006, EUR ECON REV, V50, P1197, DOI 10.1016/j.euroecorev.2005.01.009; Shirado H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3814; Smith EA, 2010, CURR ANTHROPOL, V51, P19, DOI 10.1086/648530; TESTART A, 1982, CURR ANTHROPOL, V23, P523, DOI 10.1086/202894; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; VEBLEN T, 1999, THEORY LEISURE CLASS; Wang J., 2010, PHYS REV E, V82	30	172	177	9	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					426	+		10.1038/nature15392	http://dx.doi.org/10.1038/nature15392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT3TQ	26352469				2022-12-28	WOS:000362730200050
J	Dhruva, SS; Ross, JS; Gariepy, AM				Dhruva, Sanket S.; Ross, Joseph S.; Gariepy, Aileen M.			Revisiting Essure - Toward Safe and Effective Sterilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dhruva, Sanket S.; Ross, Joseph S.] Yale Univ, Sch Med, Clin Scholars Program, Robert Wood Johnson Fdn, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT USA; [Gariepy, Aileen M.] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT USA; [Ross, Joseph S.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Dhruva, Sanket S.] Vet Affairs Connecticut Hlth Syst, West Haven, CT USA	Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Dhruva, SS (corresponding author), Yale Univ, Sch Med, Clin Scholars Program, Robert Wood Johnson Fdn, New Haven, CT 06520 USA.			Gariepy, Aileen/0000-0003-3866-9757; Ross, Joseph/0000-0002-9218-3320				Chudnoff SG, 2015, J MINIM INVAS GYN, V22, P951, DOI 10.1016/j.jmig.2015.04.017; Food and Drug Administration, ESS SUMM STUD RES EX; Gariepy AM, 2014, CONTRACEPTION, V90, P174, DOI 10.1016/j.contraception.2014.03.010; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761	4	44	45	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15							e17	10.1056/NEJMp1510514	http://dx.doi.org/10.1056/NEJMp1510514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8XI	26397951				2022-12-28	WOS:000362372800005
J	Farokhzad, OC				Farokhzad, Omid C.			NANOTECHNOLOGY Platelet mimicry	NATURE			English	Editorial Material							NANOPARTICLES; VACCINATION; TOXINS		[Farokhzad, Omid C.] Brigham & Womens Hosp, Lab Nanomed & Biomat, Boston, MA 02115 USA; [Farokhzad, Omid C.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Farokhzad, OC (corresponding author), Brigham & Womens Hosp, Lab Nanomed & Biomat, Boston, MA 02115 USA.	ofarokhzad@bwh.harvard.edu		Farokhzad, Omid/0000-0003-2009-270X				Anselmo AC, 2014, ACS NANO, V8, P11243, DOI 10.1021/nn503732m; Cho WK, 2012, P NATL ACAD SCI USA, V109, P21289, DOI 10.1073/pnas.1216441109; Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Prendergast BD, 2010, CIRCULATION, V121, P1141, DOI 10.1161/CIRCULATIONAHA.108.773598; Pridgen EM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007049; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104	13	30	32	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					47	48		10.1038/nature15218	http://dx.doi.org/10.1038/nature15218			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26375011				2022-12-28	WOS:000362095100029
J	Keenan, TF				Keenan, Trevor F.			PHENOLOGY Spring greening in a warming world	NATURE			English	Editorial Material									Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Keenan, TF (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	trevor.keenan@mq.edu.au	Keenan, Trevor/AAY-7786-2020; Keenan, Trevor F./B-2744-2010	Keenan, Trevor/0000-0002-3347-0258; Keenan, Trevor F./0000-0002-3347-0258				Bostock J., 1857, NATURAL HIST PLINY; Friedl MA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054006; Fu YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028006, 10.1371/journal.pone.0047324]; Fu YSH, 2015, NATURE, V526, P104, DOI 10.1038/nature15402; Laube J, 2014, GLOBAL CHANGE BIOL, V20, P170, DOI 10.1111/gcb.12360; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lieth H., 2013, PHENOLOGY SEASONALIT; Luo YQ, 2015, GLOBAL CHANGE BIOL, V21, P1737, DOI 10.1111/gcb.12766; Pachauri R.K., 2014, CLIMATE CHANGE 2014, VI; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Reaumur RAF, 1735, MEMOIRES ACAD ROYALE, V1735, P545; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Zohner C. M., 2015, NEW PHYTOL	15	16	17	6	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					48	49		10.1038/nature15633	http://dx.doi.org/10.1038/nature15633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416739				2022-12-28	WOS:000362095100030
J	Bukhman, G; Mocumbi, AO; Horton, R				Bukhman, Gene; Mocumbi, Ana Olga; Horton, Richard			Reframing NCDs and injuries for the poorest billion: a Lancet Commission	LANCET			English	Editorial Material									[Bukhman, Gene] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Mocumbi, Ana Olga] Inst Nacl Saude, Minist Saude, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Horton, Richard] Lancet, London, England	Harvard University; Harvard Medical School; Eduardo Mondlane University	Bukhman, G (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	NCDIpoverty@gmail.com		Mocumbi, Ana/0000-0002-9564-2860				Alkire S, 2015, DESTITUTION WHO ARE; [Anonymous], 2011, LONG TAIL GLOB HLTH; Binagwaho A, 2014, LANCET, V383, P3, DOI 10.1016/S0140-6736(13)62423-X; Desalegn H, 2015, LANCET, V386, P105, DOI 10.1016/S0140-6736(15)61224-7; Institute for Health Metrics and Evaluation, 2015, GLOB BURD DIS DAT VI; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2015, LANCET; Trowell H.C., 1960, NONINFECTIVE DIS AFR; WHO, 2002, MACR HLTH INV HLTH E; World Bank, 2015, END POV SHAR PROSP G; World Health Organization, 2013, 66 WORLD HLTH ASS PR; World Health Organization Global Coordination Mechanism on non-communicable diseases, 2015, REP 1 DIAL CONV WHO; World Health Organization Regional Office for South-East Asia, 2013, TECHN WORK GROUP M R; Yudhoyono SB, 2013, NEW GLOB PARTN ER PO	14	41	41	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1221	1222		10.1016/S0140-6736(15)00278-0	http://dx.doi.org/10.1016/S0140-6736(15)00278-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9TQ	26403914				2022-12-28	WOS:000361700100009
J	Sedgwick, P				Sedgwick, Philip			Randomised controlled trials: understanding confounding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				El-Khoury F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3830; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h978; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h681; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8145	5	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2015	351								h5119	10.1136/bmj.h5119	http://dx.doi.org/10.1136/bmj.h5119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GR	26408098				2022-12-28	WOS:000361960500006
J	Shannon, RM; Ravi, V; Lentati, LT; Lasky, PD; Hobbs, G; Kerr, M; Manchester, RN; Coles, WA; Levin, Y; Bailes, M; Bhat, NDR; Burke-Spolaor, S; Dai, S; Keith, MJ; Oslowski, S; Reardon, DJ; van Straten, W; Toomey, L; Wang, JB; Wen, L; Wyithe, JSB; Zhu, XJ				Shannon, R. M.; Ravi, V.; Lentati, L. T.; Lasky, P. D.; Hobbs, G.; Kerr, M.; Manchester, R. N.; Coles, W. A.; Levin, Y.; Bailes, M.; Bhat, N. D. R.; Burke-Spolaor, S.; Dai, S.; Keith, M. J.; Oslowski, S.; Reardon, D. J.; van Straten, W.; Toomey, L.; Wang, J. -B.; Wen, L.; Wyithe, J. S. B.; Zhu, X. -J.			Gravitational waves from binary supermassive black holes missing in pulsar observations	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; TIMING ARRAYS; LIMITS; EVOLUTION; ACCRETION; GALAXIES; MERGERS	Gravitational waves are expected to be radiated by supermassive black hole binaries formed during galaxy mergers. A stochastic superposition of gravitational waves from all such binary systems would modulate the arrival times of pulses from radio pulsars. Using observations of millisecond pulsars obtained with the Parkes radio telescope, we constrained the characteristic amplitude of this background, A(c,yr), to be <1.0 x 10(-15) with 95% confidence. This limit excludes predicted ranges for A(c,yr) from current models with 91 to 99.7% probability. We conclude that binary evolution is either stalled or dramatically accelerated by galactic-center environments and that higher-cadence and shorter-wavelength observations would be more sensitive to gravitational waves.	[Shannon, R. M.; Hobbs, G.; Kerr, M.; Manchester, R. N.; Dai, S.; Toomey, L.] Australia Telescope Natl Facil, Commonwealth Sci & Ind Res Org CSIRO Astron & Spa, POB 76, Epping, NSW 1710, Australia; [Shannon, R. M.; Bhat, N. D. R.] Curtin Univ, Int Ctr Radio Astron Res, Bentley, WA 6102, Australia; [Ravi, V.; Bailes, M.; van Straten, W.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Lentati, L. T.] Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England; [Lasky, P. D.; Levin, Y.; Reardon, D. J.] Monash Univ, Monash Ctr Astrophys, Sch Phys & Astron, Clayton, Vic 3800, Australia; [Coles, W. A.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Burke-Spolaor, S.] Natl Radio Astron Observ, Array Operat Ctr, Socorro, NM 87801 USA; [Dai, S.] Peking Univ, Sch Phys, Dept Astron, Beijing 100871, Peoples R China; [Keith, M. J.] Univ Manchester, Ctr Astrophys, Jodrell Bank, Manchester M13 9PL, Lancs, England; [Oslowski, S.] Univ Bielefeld, Dept Phys, D-33615 Bielefeld, Germany; [Oslowski, S.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Wang, J. -B.] Chinese Acad Sci, Xinjiang Astron Observ, Urumqi 830011, Xinjiang, Peoples R China; [Wen, L.; Zhu, X. -J.] Univ Western Australia, Sch Phys, Crawley, WA 6009, Australia; [Wyithe, J. S. B.] Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Curtin University; Swinburne University of Technology; University of Cambridge; Monash University; University of California System; University of California San Diego; National Radio Astronomy Observatory (NRAO); Peking University; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Bielefeld; Max Planck Society; Chinese Academy of Sciences; Xinjiang Astronomy Observatory, NACO, CAS; University of Western Australia; University of Melbourne	Shannon, RM (corresponding author), Australia Telescope Natl Facil, Commonwealth Sci & Ind Res Org CSIRO Astron & Spa, POB 76, Epping, NSW 1710, Australia.	ryan.shannon@csiro.au; v.vikram.ravi@gmail.com	Bulik, Tomasz/AAJ-6742-2020; Shannon, Ryan/AAW-8522-2020; Hobbs, George/AAS-5025-2020; Shannon, Ryan/ABD-6796-2021; Keith, Michael/AAH-2606-2019; Zhu, Xingjiang/E-1501-2016; Oslowski, Stefan/AAI-7959-2021	Shannon, Ryan/0000-0002-7285-6348; Shannon, Ryan/0000-0002-7285-6348; Keith, Michael/0000-0001-5567-5492; Zhu, Xingjiang/0000-0001-7049-6468; Oslowski, Stefan/0000-0003-0289-0732; Manchester, Richard/0000-0001-9445-5732; Spolaor, Sarah/0000-0003-4052-7838; Wen, Linqing/0000-0001-7987-295X; Toomey, Lawrence/0000-0003-3186-3266; Lasky, Paul/0000-0003-3763-1386; Wyithe, Stuart/0000-0001-7956-9758; van Straten, Willem/0000-0003-2519-7375; Bhat, Ramesh/0000-0002-8383-5059; Reardon, Daniel/0000-0002-2035-4688; Bailes, Matthew/0000-0003-3294-3081; Kerr, Matthew/0000-0002-0893-4073; Dai, Shi/0000-0002-9618-2499; Hobbs, George/0000-0003-1502-100X	Commonwealth of Australia; Australian Research Council (ARC) Federation Fellowship [FF0348478]; CSIRO; ARC [DP0985272, DP140102578, FT120100595, FT110100384]; Curtin University research fellowship; Alexander von Humboldt Foundation; Science and Technology Facilities Council [ST/L000768/1] Funding Source: researchfish; STFC [ST/L000768/1] Funding Source: UKRI	Commonwealth of Australia(Australian Government); Australian Research Council (ARC) Federation Fellowship(Australian Research Council); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); ARC(Australian Research Council); Curtin University research fellowship; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the observers, engineers, and Parkes Observatory staff members who have assisted with the observations reported in this paper. We thank R. van Haasteren for assistance with the use of the code piccard, E. Thomas for comments on the manuscript, and I. Mandel for discussions on model selection. The Parkes radio telescope is part of the Australia Telescope National Facility, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. The PPTA project was initiated with support from R.N.M.'s Australian Research Council (ARC) Federation Fellowship (grant FF0348478) and from CSIRO under that fellowship program. The PPTA project has also received support from ARC through Discovery Project grants DP0985272 and DP140102578. N.D.R.B. acknowledges support from a Curtin University research fellowship. G.H. and Y.L. are recipients of ARC Future Fellowships (respectively, grants FT120100595 and FT110100384). S.O. is supported by the Alexander von Humboldt Foundation. R.M.S. acknowledges travel support from CSIRO through a John Philip Award for excellence in early-career research. The authors declare no conflicts of interest. Data used in this analysis can be accessed via the Australian National Data Service (www.ands.org.au).	BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Colpi M, 2014, SPACE SCI REV, V183, P189, DOI 10.1007/s11214-014-0067-1; Conselice CJ, 2014, ANNU REV ASTRON ASTR, V52, P291, DOI 10.1146/annurev-astro-081913-040037; Demorest PB, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/94; Eracleous M, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/23; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Gerosa D, 2015, MON NOT R ASTRON SOC, V446, P38, DOI 10.1093/mnras/stu2049; HELLINGS RW, 1983, ASTROPHYS J, V265, pL39, DOI 10.1086/183954; Janssen G., 2015, ADV ASTROPHYSICS SQU; Keith MJ, 2013, MON NOT R ASTRON SOC, V429, P2161, DOI 10.1093/mnras/sts486; Kocsis B, 2011, MON NOT R ASTRON SOC, V411, P1467, DOI 10.1111/j.1365-2966.2010.17782.x; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Kulier A, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/178; Lentati L, 2015, MON NOT R ASTRON SOC, V453, P2576, DOI 10.1093/mnras/stv1538; Lentati L, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.104021; Manchester RN, 2013, PUBL ASTRON SOC AUST, V30, DOI 10.1017/pasa.2012.017; McWilliams ST, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/156; Menou K, 2001, ASTROPHYS J, V558, P535, DOI 10.1086/322310; Ravi V, 2015, MON NOT R ASTRON SOC, V447, P2772, DOI 10.1093/mnras/stu2659; Ravi V, 2014, MON NOT R ASTRON SOC, V442, P56, DOI 10.1093/mnras/stu779; Sampson L, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.084055; Sesana A, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224014; Shankar F, 2013, MON NOT R ASTRON SOC, V428, P421, DOI 10.1093/mnras/sts026; Shannon RM, 2013, SCIENCE, V342, P334, DOI 10.1126/science.1238012; Siemens X, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224015; Tanaka TL, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/24/244005; Wyithe JSB, 2003, ASTROPHYS J, V590, P691, DOI 10.1086/375187	28	311	315	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1522	1525		10.1126/science.aab1910	http://dx.doi.org/10.1126/science.aab1910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404832	Green Submitted, Green Accepted			2022-12-28	WOS:000361707000043
J	Dave, R				Dave, Romeel			COMPUTATIONAL ASTROPHYSICS Monstrous galaxies unmasked	NATURE			English	Editorial Material							COSMOLOGICAL HYDRODYNAMIC SIMULATIONS; SUBMILLIMETER GALAXIES		[Dave, Romeel] Univ Western Cape, Dept Phys, ZA-7535 Cape Town, South Africa; [Dave, Romeel] S African Astron Observ, Cape Town, South Africa; [Dave, Romeel] African Inst Math Sci, Muizenberg, South Africa	University of the Western Cape; National Research Foundation - South Africa; South African Astronomical Observatory	Dave, R (corresponding author), Univ Western Cape, Dept Phys, ZA-7535 Cape Town, South Africa.	romeeld@gmail.com		Dave, Romeel/0000-0003-2842-9434				Baugh CM, 2005, MON NOT R ASTRON SOC, V356, P1191, DOI 10.1111/j.1365-2966.2004.08553.x; Blain AW, 2002, PHYS REP, V369, P111, DOI 10.1016/S0370-1573(02)00134-5; Dave R, 2010, MON NOT R ASTRON SOC, V404, P1355, DOI 10.1111/j.1365-2966.2010.16395.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Finlator K, 2006, ASTROPHYS J, V639, P672, DOI 10.1086/499349; Narayanan D, 2015, NATURE, V525, P496, DOI 10.1038/nature15383; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168	8	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					465	466		10.1038/525465a	http://dx.doi.org/10.1038/525465a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399827				2022-12-28	WOS:000361599900039
J	Dey, N; Wagner, VE; Blanton, LV; Cheng, JY; Fontana, L; Haque, R; Ahmed, T; Gordon, JI				Dey, Neelendu; Wagner, Vitas E.; Blanton, Laura V.; Cheng, Jiye; Fontana, Luigi; Haque, Rashidul; Ahmed, Tahmeed; Gordon, Jeffrey I.			Regulators of Gut Motility Revealed by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel	CELL			English	Article							INNATE LYMPHOID-CELLS; RET PROTOONCOGENE; BILE-ACID; GASTROINTESTINAL TRANSIT; MYOELECTRIC ACTIVITY; EXPRESSION; HISTORY; AVAILABILITY; MICROFLORA; MUTATIONS	To understand how different diets, the consumers' gut microbiota, and the enteric nervous system (ENS) interact to regulate gut motility, we developed a gnotobiotic mouse model that mimics short-term dietary changes that happen when humans are traveling to places with different culinary traditions. Studying animals transplanted with the microbiota from humans representing diverse culinary traditions and fed a sequence of diets representing those of all donors, we found that correlations between bacterial species abundances and transit times are diet dependent. However, the levels of unconjugated bile acids-generated by bacterial bile salt hydrolases (BSH)-correlated with faster transit, including during consumption of a Bangladeshi diet. Mice harboring a consortium of sequenced cultured bacterial strains from the Bangladeshi donor's microbiota and fed a Bangladeshi diet revealed that the commonly used cholekinetic spice, turmeric, affects gut motility through a mechanism that reflects bacterial BSH activity and Ret signaling in the ENS. These results demonstrate how a single food ingredient interacts with a functional microbiota trait to regulate host physiology.	[Dey, Neelendu; Wagner, Vitas E.; Blanton, Laura V.; Cheng, Jiye; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Dey, Neelendu; Wagner, Vitas E.; Blanton, Laura V.; Cheng, Jiye; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63108 USA; [Dey, Neelendu; Fontana, Luigi] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA; [Haque, Rashidul; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka 1212, Bangladesh	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); International Centre for Diarrhoeal Disease Research (ICDDR)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu		Fontana, Luigi/0000-0001-8500-5537; Dey, Neelendu/0000-0001-8825-5689	NIH [DK30292, DK70977, DK078669, P30 DK052574]; Bill and Melinda Gates Foundation; Crohn's and Colitis Foundation of America; Global Probiotics Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, P30DK052574, P30DK056341, R01DK070977, R01DK030292, R37DK030292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Crohn's and Colitis Foundation of America; Global Probiotics Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Robert Heuckeroth (University of Pennsylvania) for generously providing Ret+/- mice; Maria Gloria Dominguez-Bello (New York University) for her leadership in obtaining fecal samples from Amerindians in an earlier collaborative study; Andreea Soare for her assistance in obtaining fecal samples and diet records from individuals consuming a primal diet; David O'Donnell and Maria Karlsson for their assistance with gnotobiotic husbandry; Sabrina Wagoner, Janaki Lelwala-Guruge, Martin Meier, and Jessica Hoisington-Lopez for their invaluable technical assistance; and Vanessa Ridaura, Sathish Subramanian, Ansel Hsiao, Matthew Hibberd, Nicholas Griffin, Nathan McNulty, Philip Ahern, and other members of the Gordon lab for their helpful suggestions. This work was supported by grants from the NIH (DK30292, DK70977, DK078669, and P30 DK052574), the Bill and Melinda Gates Foundation, and the Crohn's and Colitis Foundation of America. N.D. is the recipient of a Young Investigator Grant for Probiotics Research from the Global Probiotics Council. J.I.G. is cofounder of Matatu Inc., a company characterizing the role of diet-by-microbiota interactions in animal health.	Alemi F, 2013, GASTROENTEROLOGY, V144, P145, DOI 10.1053/j.gastro.2012.09.055; [Anonymous], 2013, J LIPID RES; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; BURKITT DP, 1972, LANCET, V1, P1408; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45; CUMMINGS JH, 1978, J CLIN INVEST, V61, P953, DOI 10.1172/JCI109020; CUMMINGS JH, 1976, GUT, V17, P210, DOI 10.1136/gut.17.3.210; DRASAR BS, 1966, LANCET, V1, P1237; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; FALANY CN, 1994, J BIOL CHEM, V269, P19375; Falany CN, 1997, J LIPID RES, V38, P1139; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Hurd EA, 2004, INFECT IMMUN, V72, P4279, DOI 10.1128/IAI.72.7.4279-4281.2004; HUSEBYE E, 1994, DIGEST DIS SCI, V39, P946, DOI 10.1007/BF02087542; Husebye E, 2001, AM J PHYSIOL-GASTR L, V280, pG368, DOI 10.1152/ajpgi.2001.280.3.G368; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Knott ML, 2007, INT J PARASITOL, V37, P1367, DOI 10.1016/j.ijpara.2007.04.006; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Levy RL, 2000, AM J GASTROENTEROL, V95, P451, DOI 10.1111/j.1572-0241.2000.01766.x; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Nadkarni K.M, 1976, INDIAN MAT MED; Odunsi-Shiyanbade ST, 2010, CLIN GASTROENTEROL H, V8, P159, DOI 10.1016/j.cgh.2009.10.020; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Rao AS, 2010, GASTROENTEROLOGY, V139, P1549, DOI 10.1053/j.gastro.2010.07.052; Rasyid A, 1999, ALIMENT PHARM THERAP, V13, P245; Rasyid A, 2002, ASIA PAC J CLIN NUTR, V11, P314, DOI 10.1046/j.1440-6047.2002.00296.x; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shimouchi A, 2009, DIGEST DIS SCI, V54, P1725, DOI 10.1007/s10620-008-0550-1; Soret R, 2010, GASTROENTEROLOGY, V138, P1772, DOI 10.1053/j.gastro.2010.01.053; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Tong M, 2014, ISME J, V8, P2193, DOI 10.1038/ismej.2014.64; TSUZUKI T, 1995, ONCOGENE, V10, P191; WHORWELL PJ, 1986, GUT, V27, P37, DOI 10.1136/gut.27.1.37; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	54	118	123	5	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					95	107		10.1016/j.cell.2015.08.059	http://dx.doi.org/10.1016/j.cell.2015.08.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406373	Green Accepted, Bronze			2022-12-28	WOS:000361846500024
J	Fendler, TJ; Spertus, JA; Kennedy, KF; Chen, LM; Perman, SM; Chan, PS				Fendler, Timothy J.; Spertus, John A.; Kennedy, Kevin F.; Chen, Lena M.; Perman, Sarah M.; Chan, Paul S.		Amer Heart Assoc Get Guidelines	Alignment of Do-Not-Resuscitate Status With Patients' Likelihood of Favorable Neurological Survival After In-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; HEALTH-CARE-PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; SOUTHERN-AFRICA; ORDERS; STATEMENT; COUNCILS; OUTCOMES; IMPACT	IMPORTANCE After patients survive an in-hospital cardiac arrest, discussions should occur about prognosis and preferences for future resuscitative efforts. OBJECTIVE To assess whether patients' decisions for do-not-resuscitate (DNR) orders after a successful resuscitation from in-hospital cardiac arrest are aligned with their expected prognosis. DESIGN, SETTING, AND PARTICIPANTS Within Get With The Guidelines-Resuscitation, we identified 26 327 patients with return of spontaneous circulation (ROSC) after in-hospital cardiac arrest between April 2006 and September 2012 at 406 US hospitals. Using a previously validated prognostic tool, each patient's likelihood of favorable neurological survival (ie, without severe neurological disability) was calculated. The proportion of patients with DNR orders within each prognosis score decile and the association between DNR status and actual favorable neurological survival were examined. EXPOSURES Do-not-resuscitate orders within 12 hours of ROSC. MAIN OUTCOMES AND MEASURES Likelihood of favorable neurological survival. RESULTS Overall, 5944 (22.6%[95% CI, 22.1%-23.1%]) patients had DNR orders within 12 hours of ROSC. This group was older and had higher rates of comorbidities (all P < .05) than patients without DNR orders. Among patients with the best prognosis (decile 1), 7.1% (95% CI, 6.1%-8.1%) had DNR orders even though their predicted rate of favorable neurological survival was 64.7%(95% CI, 62.8%-66.6%). Among patients with the worst expected prognosis (decile 10), 36.0%(95% CI, 34.2%-37.8%) had DNR orders even though their predicted rate for favorable neurological survival was 4.0%(95% CI, 3.3%-4.7%) (P for both trends <. 001). This pattern was similar when DNR orders were redefined as within 24 hours, 72 hours, and 5 days of ROSC. The actual rate of favorable neurological survival was higher for patients without DNR orders (30.5%[95% CI, 29.9%-31.1%]) than it was for those with DNR orders (1.8%[95% CI, 1.6%-2.0%]). This pattern of lower survival among patients with DNR orders was seen in every decile of expected prognosis. CONCLUSIONS AND RELEVANCE Although DNR orders after in-hospital cardiac arrest were generally aligned with patients' likelihood of favorable neurological survival, only one-third of patients with the worst prognosis had DNR orders. Patients with DNR orders had lower survival than those without DNR orders, including those with the best prognosis.	[Fendler, Timothy J.; Spertus, John A.; Kennedy, Kevin F.; Chan, Paul S.] St Lukes Mid Amer Heart Inst, Dept Cardiol, Kansas City, MO 64111 USA; [Chen, Lena M.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Perman, Sarah M.] Univ Colorado, Sch Med, Dept Emergency Med, Denver, CO USA	Saint Luke's Mid America Heart Institute; University of Michigan System; University of Michigan; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Fendler, TJ (corresponding author), St Lukes Mid Amer Heart Inst, Cardiovasc Outcomes Res, 4401 Wornall Rd,Fifth Floor,Ste 5603, Kansas City, MO 64111 USA.	fendlert@umkc.edu	Spertus, John/ABD-3075-2021		National Heart, Lung, and Blood Institute (NHLBI); NHLBI [1R01HL123980]; Agency for Healthcare Research and Quality [K08 HS020671]; American Heart Association; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020671] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110837, R01HL123980] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American Heart Association(American Heart Association); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Fendler is supported by grant T32HL110837 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Chan is funded by grant 1R01HL123980 from the NHLBI. Dr Chen is supported by grant K08 HS020671 from Agency for Healthcare Research and Quality. Outcome, a Quintiles Company, is the data collection coordination center for the American Heart Association/American Stroke Association Get With the Guidelines programs.; The sponsors, including the American Heart Association, had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2014, CIRC-CARDIOVASC QUAL, V7, P889, DOI 10.1161/CIRCOUTCOMES.114.000925; Chan PS, 2013, NEW ENGL J MED, V368, P1019, DOI 10.1056/NEJMoa1200657; Chan PS, 2012, ARCH INTERN MED, V172, P947, DOI 10.1001/archinternmed.2012.2050; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Ebell MH, 2013, JAMA INTERN MED, V173, P1872, DOI 10.1001/jamainternmed.2013.10037; EBELL MH, 1992, J FAM PRACTICE, V34, P551; GEORGE AL, 1989, AM J MED, V87, P28; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Goldstein H, MULTILEVEL STAT MODE; Jackson EA, 2004, ARCH INTERN MED, V164, P776, DOI 10.1001/archinte.164.7.776; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kelly AG, 2014, STROKE, V45, P822, DOI 10.1161/STROKEAHA.113.004573; KELSEY SF, 1986, AM J EMERG MED, V4, P72; Larkin GL, 2010, RESUSCITATION, V81, P302, DOI 10.1016/j.resuscitation.2009.11.021; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Marrie TJ, 2002, J AM GERIATR SOC, V50, P290, DOI 10.1046/j.1532-5415.2002.50061.x; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Niemann JT, 2001, RESUSCITATION, V51, P233, DOI 10.1016/S0300-9572(01)00425-7; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; R Development Core Team, R LANG ENV STAT COMP; Richardson DK, 2013, RESUSCITATION, V84, P483, DOI 10.1016/j.resuscitation.2012.08.327; Shepardson LB, 1997, ARCH INTERN MED, V157, P1841, DOI 10.1001/archinte.157.16.1841; Topjian AA, 2010, CRIT CARE MED, V38, P1254, DOI 10.1097/CCM.0b013e3181d8ca43	27	20	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1264	1271		10.1001/jama.2015.11069	http://dx.doi.org/10.1001/jama.2015.11069			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393849	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000362110700015
J	Lagreze, WA; Schaber, M				Lagreze, Wolf A.; Schaber, Matthias			Ptosis after Swimming in the Red Sea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lagreze, Wolf A.] Univ Freiburg, D-79106 Freiburg, Germany; [Schaber, Matthias] Thunen Inst Sea Fisheries, Hamburg, Germany	University of Freiburg; Johann Heinrich von Thunen Institute	Lagreze, WA (corresponding author), Univ Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	wolf.lagreze@uniklinik-freiburg.de							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1153	1153		10.1056/NEJMicm1411119	http://dx.doi.org/10.1056/NEJMicm1411119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26376138				2022-12-28	WOS:000361556400010
J	Pettitt, C				Pettitt, Clare			ANTHROPOLOGY One-man multidisciplinarian	NATURE			English	Editorial Material									Kings Coll London, Nineteenth Century Literature & Culture, London WC2R 2LS, England	University of London; King's College London	Pettitt, C (corresponding author), Kings Coll London, Nineteenth Century Literature & Culture, London WC2R 2LS, England.	clare.pettitt@kcl.ac.uk		Pettitt, Clare Jane/0000-0002-0676-9692					0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					319	320		10.1038/525319a	http://dx.doi.org/10.1038/525319a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CR4JL	26381972	Bronze			2022-12-28	WOS:000361297900021
J	Cole, TB				Cole, Thomas B.			Falling Stars as Seen From the Balloon Albert Tissandier	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1100	1101		10.1001/jama.2014.11979	http://dx.doi.org/10.1001/jama.2014.11979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372562				2022-12-28	WOS:000361284500041
J	Ioannidis, JPA				Ioannidis, John P. A.			Is It Possible to Recognize a Major Scientific Discovery?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICINE; SCIENCE; DISEASE		[Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Atala A, 2015, JAMA-J AM MED ASSOC, V313, P1413, DOI 10.1001/jama.2015.1492; Bargmann CI, 2015, JAMA-J AM MED ASSOC, V314, P221, DOI 10.1001/jama.2015.3298; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Collins FS, 2015, JAMA-J AM MED ASSOC, V313, P131, DOI 10.1001/jama.2014.16736; COMROE JH, 1976, SCIENCE, V192, P105, DOI 10.1126/science.769161; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Deisseroth K, 2015, JAMA-J AM MED ASSOC, V313, P2019, DOI 10.1001/jama.2015.2544; Fontanarosa PB, 2015, JAMA-J AM MED ASSOC, V313, P145, DOI 10.1001/jama.2014.17937; Joyner MJ, JAMA; Langer R, 2015, JAMA-J AM MED ASSOC, V313, P135, DOI 10.1001/jama.2014.16315; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Rogers JA, 2015, JAMA-J AM MED ASSOC, V313, P561, DOI 10.1001/jama.2014.17915; SMITH R, 1987, BRIT MED J, V295, P1404, DOI 10.1136/bmj.295.6610.1404; Spier RE, 2002, SCI ENG ETHICS, V8, P99, DOI 10.1007/s11948-002-0035-0; Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125	16	10	10	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1135	1137		10.1001/jama.2015.9629	http://dx.doi.org/10.1001/jama.2015.9629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372580				2022-12-28	WOS:000361284500022
J	Stanbrook, MB				Stanbrook, Matthew B.			Review: Influenza vaccination and inhaled therapies prevent acute exacerbations in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							Global Initiative for Asthma (GINA), DIAGN DIS CHRON AIRF; GOLD, GLOB STRAT DIAGN MAN	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC3	10.7326/ACPJC-2015-163-6-003	http://dx.doi.org/10.7326/ACPJC-2015-163-6-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370030				2022-12-28	WOS:000361365900003
J	Hardebeck, JL				Hardebeck, Jeanne L.			Stress orientations in subduction zones and the strength of subduction megathrust faults	SCIENCE			English	Article							EARTHQUAKE; JAPAN; CHILE; FLOW	Subduction zone megathrust faults produce most of the world's largest earthquakes. Although the physical properties of these faults are difficult to observe directly, their frictional strength can be estimated indirectly by constraining the orientations of the stresses that act on them. A global investigation of stress orientations in subduction zones finds that the maximum compressive stress axis plunges systematically trenchward, consistently making an angle of 45 degrees to 60 degrees with respect to the subduction megathrust fault. These angles indicate that the megathrust fault is not substantially weaker than its surroundings. Together with several other lines of evidence, this implies that subduction zone megathrusts are weak faults in a low-stress environment. The deforming outer accretionary wedge may decouple the stress state along the megathrust from the constraints of the free surface.	US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Hardebeck, JL (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	jhardebeck@usgs.gov		Hardebeck, Jeanne/0000-0002-6737-7780				Anderson E. M., 1951, DYNAMICS FAULTING DY; Audet P, 2009, NATURE, V457, P76, DOI 10.1038/nature07650; Celerier B, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000240; Eberhart-Phillips D, 1999, GEOPHYS RES LETT, V26, P2565, DOI 10.1029/1999GL900567; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Gao X, 2014, SCIENCE, V345, P1038, DOI 10.1126/science.1255487; Ghimire S, 2011, TECTONOPHYSICS, V511, P1, DOI 10.1016/j.tecto.2011.08.004; Hardebeck JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053438; Hardebeck JL, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003239; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Heuret A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050712; Husen S, 2001, GEOLOGY, V29, P847, DOI 10.1130/0091-7613(2001)029<0847:PFFATL>2.0.CO;2; Kubo A, 2002, TECTONOPHYSICS, V356, P23, DOI 10.1016/S0040-1951(02)00375-X; MAGEE ME, 1993, GEOLOGY, V21, P809, DOI 10.1130/0091-7613(1993)021<0809:EFAWIT>2.3.CO;2; MOLNAR P, 1978, EARTH PLANET SC LETT, V41, P330, DOI 10.1016/0012-821X(78)90187-5; Pardo M, 2002, J S AM EARTH SCI, V15, P11, DOI 10.1016/S0895-9811(02)00003-2; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; Scholz CH, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009003; SIBSON RH, 1985, J STRUCT GEOL, V7, P751, DOI 10.1016/0191-8141(85)90150-6; Sibson RH, 2013, TECTONOPHYSICS, V600, P142, DOI 10.1016/j.tecto.2013.02.035; Toda S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047834; Twiss R.J., 2007, STRUCTURAL GEOLOGY, V2nd; Wang KL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004094	25	44	45	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1213	1216		10.1126/science.aac5625	http://dx.doi.org/10.1126/science.aac5625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359399				2022-12-28	WOS:000360968400040
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: What to do about end of life scare stories	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Borland S, 2015, DAILY MAIL; Clark D, 2014, PALLIATIVE MED, V28, P474, DOI 10.1177/0269216314526443; Dreaper J., 2015, BBC HLTH NEWS   0904; Henry C, 2015, OBSERVER; National Institute for Health and Care Excellence, 2015, END LIF CAR DRAFT GU; Nuffield Trust, 2012, IMP M CUR NURS SERV; Office for National Statistics, 2015, NAT SURV BER PEOPL V; Parliamentary and Health Service Ombudsman, 2015, DYING DIGN INV COMPL; Pullicino P, 2015, DAILY TELEGRAPH; Regnard C, 2014, AGE AGEING, V43, P171, DOI 10.1093/ageing/aft195; The Gold Standards framework, 2013, ADV CAR PLANN	11	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2015	351								h4846	10.1136/bmj.h4846	http://dx.doi.org/10.1136/bmj.h4846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EA	26362213	Bronze			2022-12-28	WOS:000361283400002
J	Boyce, N				Boyce, Niall			The art of medicine Dora in the 21st century	LANCET			English	Editorial Material									Lancet Psychiat, London EC2Y 5AS, England		Boyce, N (corresponding author), Lancet Psychiat, London EC2Y 5AS, England.	niall.boyce@lancet.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					948	949		10.1016/S0140-6736(15)00111-7	http://dx.doi.org/10.1016/S0140-6736(15)00111-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR2TE	26369462				2022-12-28	WOS:000361182700016
J	Kivimaki, M; Vineis, P; Brunner, EJ				Kivimaeki, Mika; Vineis, Paolo; Brunner, Eric J.			How can we reduce the global burden of disease?	LANCET			English	Editorial Material							MORTALITY; PREVENTION		[Kivimaeki, Mika; Brunner, Eric J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England	University of London; University College London; Imperial College London	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Brunner, Eric/H-2114-2011; Kivimaki, Mika/B-3607-2012	Brunner, Eric/0000-0002-0595-4474; Kivimaki, Mika/0000-0002-4699-5627	Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098, PG/11/63/29011] Funding Source: Medline; Medical Research Council [MR/K013351/1] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainsworth JD, 2011, METHOD INFORM MED, V50, P454, DOI 10.3414/ME11-02-0006; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; GBD 2013 Risk Factors Collaborators, 2015, LANCET; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pearce N, 2014, LANCET GLOB HEALTH, V2, pE126, DOI 10.1016/S2214-109X(14)70015-4; Rees K., 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002128.PUB4	11	7	8	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2235	2237		10.1016/S0140-6736(15)00129-4	http://dx.doi.org/10.1016/S0140-6736(15)00129-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26364543	Bronze			2022-12-28	WOS:000365993200011
J	Lynn, J; McKethan, A; Jha, AK				Lynn, Joanne; McKethan, Aaron; Jha, Ashish K.			Value-Based Payments Require Valuing What Matters to Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAY-FOR-PERFORMANCE		[Lynn, Joanne] Altarum Inst, Ctr Elder Care & Adv Illness, Ann Arbor, MI USA; [McKethan, Aaron] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Jha, Ashish K.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Cambridge, MA 02138 USA.	ajha@hsph.harvard.edu						Crimmins EM, 2009, DEMOGRAPHY, V46, P627, DOI 10.1353/dem.0.0070; Cutler DM, 2015, JAMA-J AM MED ASSOC, V313, P1606, DOI 10.1001/jama.2015.1926; McKethan A, 2014, JAMA-J AM MED ASSOC, V312, P2617, DOI 10.1001/jama.2014.15398; Naci H, 2015, JAMA-J AM MED ASSOC, V314, P121, DOI 10.1001/jama.2015.6160; Robinson JC, 2004, JAMA-J AM MED ASSOC, V291, P1880, DOI 10.1001/jama.291.15.1880; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740	7	39	39	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2015	314	14					1445	1446		10.1001/jama.2015.8909	http://dx.doi.org/10.1001/jama.2015.8909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2QI	26378889				2022-12-28	WOS:000362647800006
J	Hige, T; Aso, Y; Rubin, GM; Turner, GC				Hige, Toshihide; Aso, Yoshinori; Rubin, Gerald M.; Turner, Glenn C.			Plasticity-driven individualization of olfactory coding in mushroom body output neurons	NATURE			English	Article							EXTRINSIC NEURONS; SPATIAL REPRESENTATION; DROSOPHILA; BODIES; POPULATION; INFORMATION; BEHAVIOR; SPARSE; EXPRESSION; CODE	Although all sensory circuits ascend to higher brain areas where stimuli are represented in sparse, stimulus-specific activity patterns, relatively little is known about sensory coding on the descending side of neural circuits, as a network converges. In insects, mushroom bodies have been an important model system for studying sparse coding in the olfactory system(1-3), where this format is important for accurate memory formation(4-6). In Drosophila, it has recently been shown that the 2,000 Kenyon cells of the mushroom body converge onto a population of only 34 mushroom body output neurons (MBONs), which fall into 21 anatomically distinct cell types(7,8). Here we provide the first, to our knowledge, comprehensive view of olfactory representations at the fourth layer of the circuit, where we find a clear transition in the principles of sensory coding. We show that MBON tuning curves are highly correlated with one another. This is in sharp contrast to the process of progressive decorrelation of tuning in the earlier layers of the circuit(2,9). Instead, at the population level, odour representations are reformatted so that positive and negative correlations arise between representations of different odours. At the single-cell level, we show that uniquely identifiable MBONs display profoundly different tuning across different animals, but that tuning of the same neuron across the two hemispheres of an individual fly was nearly identical. Thus, individualized coordination of tuning arises at this level of the olfactory circuit. Furthermore, we find that this individualization is an active process that requires a learning-related gene, rutabaga. Ultimately, neural circuits have to flexibly map highly stimulus-specific information in sparse layers onto a limited number of different motor outputs. The reformatting of sensory representations we observe here may mark the beginning of this sensory-motor transition in the olfactory system.	[Hige, Toshihide; Turner, Glenn C.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Aso, Yoshinori; Rubin, Gerald M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Turner, GC (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	turner@cshl.edu	Aso, Yoshinori/ACJ-9439-2022	Turner, Glenn/0000-0002-5341-2784; Hige, Toshihide/0000-0002-0007-3192; Rubin, Gerald/0000-0001-8762-8703	NIH [R01 DC010403-01A1]; Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank V. Jayaraman, J. Dubnau and K. Ito for fly strains. We are grateful to H. Kazama, W. Li and J. Dubnau for helpful advice, and to V. Jayaraman, G. Otazu and the members of the Turner laboratory for valuable comments on the manuscript. This work was supported by NIH grant R01 DC010403-01A1 to G.C.T.; T.H. was partially supported by a Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science and a Postdoctoral Fellowship from the Uehara Memorial Foundation.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Barlow H. B., 1961, P331; Brooks ES, 2011, NEURON, V72, P316, DOI 10.1016/j.neuron.2011.08.032; Campbell RAA, 2013, J NEUROSCI, V33, P10568, DOI 10.1523/JNEUROSCI.0682-12.2013; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Fisek M, 2014, NAT NEUROSCI, V17, P280, DOI 10.1038/nn.3613; GORCZYCA MG, 1987, J NEUROSCI, V7, P1361; Gruntman E, 2013, NAT NEUROSCI, V16, P1821, DOI 10.1038/nn.3547; Gupta N, 2014, CURR BIOL, V24, P2247, DOI 10.1016/j.cub.2014.08.021; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Houk J. C., 1994, MODELS INFORM PROCES, P3; Ito K, 1998, LEARN MEMORY, V5, P52; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Li YS, 1997, J COMP NEUROL, V387, P631; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YANG MY, 1995, NEURON, V15, P45; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	45	81	81	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					258	+		10.1038/nature15396	http://dx.doi.org/10.1038/nature15396			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416731	Green Accepted			2022-12-28	WOS:000362399000048
J	Sano, T; Huang, WD; Hall, JA; Yang, Y; Chen, A; Gavzy, SJ; Lee, JY; Ziel, JW; Miraldi, ER; Domingos, AI; Bonneau, R; Littman, DR				Sano, Teruyuki; Huang, Wendy; Hall, Jason A.; Yang, Yi; Chen, Alessandra; Gavzy, Samuel J.; Lee, June-Yong; Ziel, Joshua W.; Miraldi, Emily R.; Domingos, Ana I.; Bonneau, Richard; Littman, Dan R.			An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses	CELL			English	Article							TOLL-LIKE RECEPTOR; RHEUMATOID-ARTHRITIS; GUT MICROBIOTA; DOUBLE-BLIND; CELLS; GAMMA; DIFFERENTIATION; COMMENSAL; DISEASE; INFLAMMATION	ROR gamma t(+) Th17 cells are important for mucosal defenses but also contribute to autoimmune disease. They accumulate in the intestine in response to microbiota and produce IL-17 cytokines. Segmented filamentous bacteria (SFB) are Th17-inducing commensals that potentiate autoimmunity in mice. ROR gamma t(+) T cells were induced in mesenteric lymph nodes early after SFB colonization and distributed across different segments of the gastrointestinal tract. However, robust IL-17A production was restricted to the ileum, where SFB makes direct contact with the epithelium and induces serum amyloid A proteins 1 and 2 (SAA1/2), which promote local IL-17A expression in ROR gamma t(+) T cells. We identified an SFB-dependent role of type 3 innate lymphoid cells (ILC3), which secreted IL-22 that induced epithelial SAA production in a Stat3-dependent manner. This highlights the critical role of tissue microenvironment in activating effector functions of committed Th17 cells, which may have important implications for how these cells contribute to inflammatory disease.	[Sano, Teruyuki; Huang, Wendy; Hall, Jason A.; Yang, Yi; Chen, Alessandra; Gavzy, Samuel J.; Lee, June-Yong; Ziel, Joshua W.; Miraldi, Emily R.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Chen, Alessandra; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Miraldi, Emily R.; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Miraldi, Emily R.; Bonneau, Richard] NYU, Dept Comp Sci, Courant Inst Math Sci, New York, NY 10003 USA; [Miraldi, Emily R.; Bonneau, Richard] Simons Fdn, Simons Ctr Data Anal, New York, NY 10010 USA; [Domingos, Ana I.] Inst Gulbenkian Ciencias, Obes Lab, P-2780156 Oeiras, Portugal	New York University; Howard Hughes Medical Institute; New York University; New York University; New York University; Instituto Gulbenkian de Ciencia	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA.	dan.littman@med.nyu.edu	Bonneau, Richard/GZL-2900-2022; Huang, Wendy Jia Men/AAF-2030-2021; Bonneau, Richard/ABD-6737-2021	Huang, Wendy Jia Men/0000-0001-7425-8280; Domingos, Ana/0000-0002-7938-4814; Gavzy, Samuel/0000-0002-4880-0301; Lee, June-Yong/0000-0002-4476-725X	TOYOBO Bioscience foundation; Human Frontier Science Program; Cancer Research Institute; NIH [T32 CA009161_Levy]; Dale and Betty Frey Fellowship of the Damon Runyon Cancer Research Foundation [2105-12]; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health [R01DK103358]; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103358] Funding Source: NIH RePORTER	TOYOBO Bioscience foundation; Human Frontier Science Program(Human Frontier Science Program); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dale and Betty Frey Fellowship of the Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Sebastian Amigorena, Kenneth Cadwell, Suzan R. Schwab, and Sang V. Kim for valuable discussion, Wenjun Ouyang for providing control and anti-IL-22 neutralizing antibody, Jeffrey M. Friedman for the EF1-lox-stop-lox-GFP-L10 mice, and Frederick De Beer for providing the Saa mutant mice. We thank Maria Ciofani for her contributions to the RNA-seq studies. We thank Richard M. Myers at HudsonAlpha Institute for Biotechnology for RNA-seq and TRAP-seq studies. This work was supported by fellowships from the TOYOBO Bioscience foundation (T.S.), Human Frontier Science Program (T.S.), Cancer Research Institute (W.H.), and NIH T32 CA009161_Levy (W.H.), and Dale and Betty Frey Fellowship of the Damon Runyon Cancer Research Foundation 2105-12 (J.A.H); and by the Howard Hughes Medical Institute (D.R.L.), the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.), and National Institutes of Health grant R01DK103358 (R.B. and D.R.L.).	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Chien YH, 2013, TRENDS IMMUNOL, V34, P151, DOI 10.1016/j.it.2012.11.004; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cray C, 2009, COMPARATIVE MED, V59, P517; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martineau AR, 2015, LANCET RESP MED, V3, P120, DOI 10.1016/S2213-2600(14)70255-3; Neufert C, 2010, CELL CYCLE, V9, P652, DOI 10.4161/cc.9.4.10615; O'Donnell H, 2014, IMMUNITY, V40, P213, DOI 10.1016/j.immuni.2013.12.013; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	52	329	336	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					381	393		10.1016/j.cell.2015.08.061	http://dx.doi.org/10.1016/j.cell.2015.08.061			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26411290	Bronze, Green Accepted			2022-12-28	WOS:000362952700015
J	Cracraft, J; Houde, P; Ho, SYW; Mindell, DP; Fjeldsa, J; Lindow, B; Edwards, SV; Rahbek, C; Mirarab, S; Warnow, T; Gilbert, MTP; Zhang, GJ; Braun, EL; Jarvis, ED				Cracraft, Joel; Houde, Peter; Ho, Simon Y. W.; Mindell, David P.; Fjeldsa, Jon; Lindow, Bent; Edwards, Scott V.; Rahbek, Carsten; Mirarab, Siavash; Warnow, Tandy; Gilbert, M. Thomas P.; Zhang, Guojie; Braun, Edward L.; Jarvis, Erich D.			Response to Comment on "Whole-genome analyses resolve early branches in the tree of life of modern birds"	SCIENCE			English	Editorial Material							RADIATION; RECORD; CLOCK; CHINA	Mitchell et al. argue that divergence- time estimates for our avian phylogeny were too young because of an " inappropriate" maximum age constraint for the most recent common ancestor of modern birds and that, as a result, most modern bird orders diverged before the Cretaceous- Paleogene mass extinction event 66 million years ago instead of after. However, their interpretations of the fossil record and timetrees are incorrect.	[Cracraft, Joel] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA; [Houde, Peter] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Mindell, David P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fjeldsa, Jon; Rahbek, Carsten] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Lindow, Bent; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Edwards, Scott V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Rahbek, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Mirarab, Siavash; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Warnow, Tandy] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Warnow, Tandy] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6102, Australia; [Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Braun, Edward L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Braun, Edward L.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Jarvis, Erich D.] Duke Univ, Dept Neurobiol, Med Ctr, Durham, NC 27710 USA; [Jarvis, Erich D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	American Museum of Natural History (AMNH); New Mexico State University; University of Sydney; University of California System; University of California San Francisco; University of Copenhagen; University of Copenhagen; Harvard University; Harvard University; Imperial College London; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Curtin University; Beijing Genomics Institute (BGI); University of Copenhagen; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; Howard Hughes Medical Institute	Cracraft, J (corresponding author), Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA.	jlc@amnh.org; ebraun68@ufl.edu; jarvis@neuro.duke.edu	Zhang, Guojie/B-6188-2014; Rahbek, Carsten/GVQ-0752-2022; Jarvis, Erich D/A-2319-2008; Zhang, Guojie/J-7273-2019; Edwards, Scott V./D-9071-2018; Ho, Simon YW/A-8417-2008; Gilbert, Marcus/A-8936-2013	Zhang, Guojie/0000-0001-6860-1521; Rahbek, Carsten/0000-0003-4585-0300; Jarvis, Erich D/0000-0001-8931-5049; Zhang, Guojie/0000-0001-6860-1521; Edwards, Scott V./0000-0003-2535-6217; Ho, Simon YW/0000-0002-0361-2307; Braun, Edward/0000-0003-1643-5212; Gilbert, Marcus/0000-0002-5805-7195; Mirarab, Siavash/0000-0001-5410-1518	Direct For Biological Sciences [1241066, 1118823, 1461364] Funding Source: National Science Foundation; Division Of Environmental Biology [1146248] Funding Source: National Science Foundation; Howard Hughes Medical Institute Funding Source: Medline	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Agnolin FL, 2012, PALAEONTOL Z, V86, P85, DOI 10.1007/s12542-011-0112-2; Benton Michael J., 2009, P35; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Dos Reis M, 2014, SYST BIOL, V63, P555, DOI 10.1093/sysbio/syu020; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Ho SYW, 2014, TRENDS ECOL EVOL, V29, P496, DOI 10.1016/j.tree.2014.07.004; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mitchell KJ, 2015, SCIENCE, V349, P1460, DOI 10.1126/science.aab1062; Myers TS, 2010, J PALEONTOL, V84, P1071, DOI 10.1666/09-082.1; O'Connor JK, 2013, J SYST PALAEONTOL, V11, P889, DOI 10.1080/14772019.2012.690455; O'connor PM, 2010, J VERTEBR PALEONTOL, V30, P1178, DOI 10.1080/02724634.2010.483544; Walker Cyril A., 2009, Irish Journal of Earth Sciences, V27, P15; Wang M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7987; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377	20	34	35	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255								10.1126/science.aab1578	http://dx.doi.org/10.1126/science.aab1578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404820				2022-12-28	WOS:000361707000032
J	Kang, C; Xu, QK; Martin, TD; Li, MZ; Demaria, M; Aron, L; Lu, T; Yankner, BA; Campisi, J; Elledge, SJ				Kang, Chanhee; Xu, Qikai; Martin, Timothy D.; Li, Mamie Z.; Demaria, Marco; Aron, Liviu; Lu, Tao; Yankner, Bruce A.; Campisi, Judith; Elledge, Stephen J.			The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4	SCIENCE			English	Article							CELLULAR SENESCENCE; SECRETORY PHENOTYPE; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTORS; TRIGGERS SENESCENCE; P53; CELLS; CANCER; CLEARANCE; INDUCTION	Cellular senescence is a terminal stress-activated program controlled by the p53 and p16(INK4a) tumor suppressor proteins. A striking feature of senescence is the senescence-associated secretory phenotype (SASP), a pro-inflammatory response linked to tumor promotion and aging. We have identified the transcription factor GATA4 as a senescence and SASP regulator. GATA4 is stabilized in cells undergoing senescence and is required for the SASP. Normally, GATA4 is degraded by p62-mediated selective autophagy, but this regulation is suppressed during senescence, thereby stabilizing GATA4. GATA4 in turn activates the transcription factor NF-kB to initiate the SASP and facilitate senescence. GATA4 activation depends on the DNA damage response regulators ATM and ATR, but not on p53 or p16INK4a. GATA4 accumulates in multiple tissues, including the aging brain, and could contribute to aging and its associated inflammation.	[Kang, Chanhee; Xu, Qikai; Martin, Timothy D.; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Div Genet,Brigham & Womens Hosp,Howard Hughes Med, Boston, MA 02115 USA; [Demaria, Marco; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Aron, Liviu; Lu, Tao; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Buck Institute for Research on Aging; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Div Genet,Brigham & Womens Hosp,Howard Hughes Med, Boston, MA 02115 USA.	sellege@genetics.med.harvard.edu	Kang, Chanhee/AAS-1323-2021; Demaria, Marco/AAH-9235-2019; Aron, LIviu/E-5192-2013	Demaria, Marco/0000-0002-8429-4813; Kang, Chanhee/0000-0003-4350-5706; lu, tao/0000-0002-8247-8387	NIH [GM44664, AG009909, AG017242, DP1OD006849, AG046174]; Glenn Foundation for Medical Research; American Cancer Society; American-Italian Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009909, P01AG017242, RF1AG048056, R01AG046174, R56AG009909, R37AG009909, DP1AG044161] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; American Cancer Society(American Cancer Society); American-Italian Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Materials are available under a material transfer agreement from Howard Hughes Medical Institute. We thank A. Ciccia, T. Davoli, I. Koren, E. Wooten, R. Patel, and members of the Elledge lab for helpful discussions and critical comments on this manuscript; E. Wooten and B. H. Kim for help with the gene expression profiling analyses; X. Li for help with the ChIP-qPCR experiment; and M. Hayano and D. Sinclair for providing aging mouse tissues. Supported by NIH grants GM44664 (S.J.E.), AG009909 and AG017242 (J.C.), and DP1OD006849 and AG046174 (B.A.Y.); a grant from the Glenn Foundation for Medical Research (B.A.Y.); an American Cancer Society postdoctoral fellowship (Q.X.); and the American-Italian Cancer Foundation (M.D.). C.K. is the HHMI fellow of the Jane Coffin Childs Memorial Fund for Medical Research. T.D.M. is a fellow of the Damon Runyon Cancer Research Foundation. S.J.E. is an investigator of the Howard Hughes Medical Institute.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	62	519	540	15	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255							aaa5612	10.1126/science.aaa5612	http://dx.doi.org/10.1126/science.aaa5612			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404840	Green Accepted			2022-12-28	WOS:000361707000038
J	Creixell, P; Palmeri, A; Miller, CJ; Lou, HJ; Santini, CC; Nielsen, M; Turk, BE; Linding, R				Creixell, Pau; Palmeri, Antonio; Miller, Chad J.; Lou, Hua Jane; Santini, Cristina C.; Nielsen, Morten; Turk, Benjamin E.; Linding, Rune			Unmasking Determinants of Specificity in the Human Kinome	CELL			English	Article							PROTEIN-KINASES; SUBSTRATE RECOGNITION; POSITIVE SELECTION; METAZOAN EVOLUTION; TYROSINE KINASES; DOMAIN-STRUCTURE; STRUCTURAL BASIS; ACTIVATION; RECEPTOR; NETWORK	Protein kinases control cellular responses to environmental cues by swift and accurate signal processing. Breakdowns in this high-fidelity capability are a driving force in cancer and other diseases. Thus, our limited understanding of which amino acids in the kinase domain encode substrate specificity, the so-called determinants of specificity (DoS), constitutes a major obstacle in cancer signaling. Here, we systematically discover several DoS and experimentally validate three of them, named the alpha C1, alpha C3, and APE-7 residues. We demonstrate that DoS form sparse networks of non-conserved residues spanning distant regions. Our results reveal a likely role for inter-residue allostery in specificity and an evolutionary decoupling of kinase activity and specificity, which appear loaded on independent groups of residues. Finally, we uncover similar properties driving SH2 domain specificity and demonstrate how the identification of DoS can be utilized to elucidate a greater understanding of the role of signaling networks in cancer (Creixell et al., 2015 [this issue of Cell]).	[Creixell, Pau; Santini, Cristina C.; Nielsen, Morten; Linding, Rune] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Palmeri, Antonio] Univ Roma Tor Vergata, Ctr Mol Bioinformat, I-00133 Rome, Italy; [Miller, Chad J.; Lou, Hua Jane; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Santini, Cristina C.; Linding, Rune] Univ Copenhagen UCPH, BRIC, DK-2200 Copenhagen, Denmark	Technical University of Denmark; University of Rome Tor Vergata; Yale University; University of Copenhagen	Creixell, P (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	creixell@mit.edu; linding@lindinglab.org	Nielsen, Morten/E-7754-2011; Nielsen, Morten/AAL-8700-2020	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Santini, Cristina/0000-0002-8645-2707; Linding, Rune/0000-0003-0420-4839; Palmeri, Antonio/0000-0002-2559-8833; Miller, Chad/0000-0002-2087-6566	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant (KINOMEDRIFT); Lundbeck Foundation Fellow; Human Frontier Science Program; Ludwig Fund Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324, R01GM104047] Funding Source: NIH RePORTER	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant (KINOMEDRIFT); Lundbeck Foundation Fellow; Human Frontier Science Program(Human Frontier Science Program); Ludwig Fund Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Manning for providing access to unpublished data, T. Gibson for critical assistance in the generation of the kinase domain alignment, and J. Erler, M. Sommer, and J. Saez-Rodriguez for helpful discussions in preparation of this manuscript. We thank members of R.L.'s laboratory and the Erler laboratory for advice and critical review of the manuscript, in particular, J. Longden, T. Cox, and J. Erler for assistance with the figures and text of this manuscript and J. Ferkinghoff-Borg for fruitful discussions and computational advice. We are especially indebted to J.D. Sorensen for technical assistance when deploying supercomputing infrastructures (SGI UV 2000). This work has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant (KINOMEDRIFT). R.L. is funded as a Lundbeck Foundation Fellow. This work has also been supported by a Career Development Award from the Human Frontier Science Program to R.L. P.C. is currently funded by a Ludwig Fund Postdoctoral Fellowship. The algorithms and software developed in this work will be released under the Creative Commons licensing schemes at the websites http://KinomeXplorer.science and http://KINspect.science. For further information, see also http://lindinglab.science.	Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Borrello MG, 1995, ONCOGENE, V11, P2419; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Chen C, 2014, MOL CELL, V53, P140, DOI 10.1016/j.molcel.2013.11.013; Cheng KY, 2006, J BIOL CHEM, V281, P23167, DOI 10.1074/jbc.M600480200; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Davis TL, 2009, FEBS J, V276, P4395, DOI 10.1111/j.1742-4658.2009.07147.x; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Ellis JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021169; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Goldman A, 2014, MOL CELL, V55, P422, DOI 10.1016/j.molcel.2014.05.012; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lanzi P.L., 2000, LEARNING CLASSIFIER; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Tan CSH, 2011, SCIENCE, V332, P917, DOI 10.1126/science.1188535; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Turk BE, 2008, CURR OPIN CHEM BIOL, V12, P4, DOI 10.1016/j.cbpa.2008.01.018; Wu JH, 2008, NAT STRUCT MOL BIOL, V15, P251, DOI 10.1038/nsmb.1388; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	52	51	51	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					187	201		10.1016/j.cell.2015.08.057	http://dx.doi.org/10.1016/j.cell.2015.08.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26388442	Green Published, hybrid			2022-12-28	WOS:000361846500031
J	De Sanctis, MC; Capaccioni, F; Ciarniello, M; Filacchione, G; Formisano, M; Mottola, S; Raponi, A; Tosi, F; Bockelee-Morvan, D; Erard, S; Leyrat, C; Schmitt, B; Ammannito, E; Arnold, G; Barucci, MA; Combi, M; Capria, MT; Cerroni, P; Ip, WH; Kuehrt, E; McCord, TB; Palomba, E; Beck, P; Quirico, E				De Sanctis, M. C.; Capaccioni, F.; Ciarniello, M.; Filacchione, G.; Formisano, M.; Mottola, S.; Raponi, A.; Tosi, F.; Bockelee-Morvan, D.; Erard, S.; Leyrat, C.; Schmitt, B.; Ammannito, E.; Arnold, G.; Barucci, M. A.; Combi, M.; Capria, M. T.; Cerroni, P.; Ip, W-H; Kuehrt, E.; McCord, T. B.; Palomba, E.; Beck, P.; Quirico, E.		VIRTIS Team	The diurnal cycle of water ice on comet 67P/Churyumov-Gerasimenko	NATURE			English	Article							OPTICAL-CONSTANTS; CRYSTALLINE H2O-ICE; THERMAL EVOLUTION; SURFACE; SPECTROMETER; NUCLEI; IMPACT	Observations of cometary nuclei have revealed a very limited amount of surface water ice(1-7), which is insufficient to explain the observed water outgassing. This was clearly demonstrated on comet 9P/Tempel 1, where the dust jets (driven by volatiles) were only partially correlated with the exposed ice regions(8). The observations(6,7) of 67P/Churyumov-Gerasimenko have revealed that activity has a diurnal variation in intensity arising from changing insolation conditions. It was previously concluded that water vapour was generated in ice-rich subsurface layers with a transport mechanism linked to solar illumination(1-3,5), but that has not hitherto been observed. Periodic condensations of water vapour very close to, or on, the surface were suggested(3,9) to explain short-lived outbursts seen near sunrise on comet 9P/Tempel 1. Here we report observations of water ice on the surface of comet 67P/ChuryumovGerasimenko, appearing and disappearing in a cyclic pattern that follows local illumination conditions, providing a source of localized activity. This water cycle appears to be an important process in the evolution of the comet, leading to cyclical modification of the relative abundance of water ice on its surface.	[De Sanctis, M. C.; Capaccioni, F.; Ciarniello, M.; Filacchione, G.; Formisano, M.; Raponi, A.; Tosi, F.; Ammannito, E.; Capria, M. T.; Cerroni, P.; Palomba, E.] Ist Astrofis & Planetol Spaziali INAF, Via Fosso Cavaliere 100, I-00133 Rome, Italy; [Mottola, S.; Arnold, G.; Kuehrt, E.] DLR, Inst Planetary Res, D-12489 Berlin, Germany; [Bockelee-Morvan, D.; Erard, S.; Leyrat, C.; Barucci, M. A.] Univ Paris 06, Univ Paris Diderot, LESIA Observ Paris, CNRS, F-92195 Meudon, France; [Schmitt, B.; Beck, P.; Quirico, E.] Univ Grenoble Alpes, CNRS, Inst Planetol & Astrophys Grenoble, F-38041 Grenoble 9, France; [Ammannito, E.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Combi, M.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Ip, W-H] Natl Cent Univ, Taoyuan 32001, Taiwan; [McCord, T. B.] Bear Fight Inst, Winthrop, WA 98862 USA	Istituto Nazionale Astrofisica (INAF); Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; National Central University	De Sanctis, MC (corresponding author), Ist Astrofis & Planetol Spaziali INAF, Via Fosso Cavaliere 100, I-00133 Rome, Italy.	mariacristina.desanctis@iaps.inaf.it	Beck, Pierre/F-3149-2011; Palomba, Ernesto/E-8287-2017; Stephan, Katrin/U-2524-2018; Piccioni, Giuseppe/T-9272-2017; Formisano, Michelangelo/AAJ-2719-2020; Gudipati, Murthy S/F-7575-2011; Schmitt, Bernard/A-1064-2009; Bellucci, Giancarlo/ABA-9201-2020; Filacchione, Gianrico/S-2320-2017; Tosi, Federico/F-2321-2018; quirico, eric/K-9650-2013; Frigeri, Alessandro/F-2151-2010; Frigeri, Alessandro/K-9679-2019; Combi, Michael/J-1697-2012; De Sanctis, Maria Cristina/G-5232-2013; Grassi, Davide/B-7916-2018	Palomba, Ernesto/0000-0002-9101-6774; Piccioni, Giuseppe/0000-0002-7893-6808; Formisano, Michelangelo/0000-0003-3236-1604; Gudipati, Murthy S/0000-0001-5992-373X; Schmitt, Bernard/0000-0002-1230-6627; Bellucci, Giancarlo/0000-0003-0867-8679; Filacchione, Gianrico/0000-0001-9567-0055; Tosi, Federico/0000-0003-4002-2434; quirico, eric/0000-0003-2768-0694; Frigeri, Alessandro/0000-0002-9140-3977; Frigeri, Alessandro/0000-0002-9140-3977; Combi, Michael/0000-0002-9805-0078; De Sanctis, Maria Cristina/0000-0002-3463-4437; Erard, Stephane/0000-0002-9099-8366; Mennella, Vito/0000-0001-9525-895X; Cerroni, Priscilla/0000-0003-0239-2741; Giuppi, Stefano/0000-0001-6900-3427; Migliorini, Alessandra/0000-0001-7386-9215; Ciarniello, Mauro/0000-0002-7498-5207; Longobardo, Andrea/0000-0002-1797-2741; Noschese, Raffaella/0000-0003-0502-0337; Politi, Romolo/0000-0002-9793-9780; Rinaldi, Giovanna/0000-0002-2968-0455; Grassi, Davide/0000-0003-1653-3066; Colangeli, Luigi/0000-0001-6801-9152; Raponi, Andrea/0000-0003-4996-0099; Cartacci, Marco/0000-0001-9825-1817; capria, maria teresa/0000-0002-9814-9588; Capaccioni, Fabrizio/0000-0003-1631-4314	Italian Space Agency (ASI, Italy); Centre National d'Etudes Spatiales (CNES, France); Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany); National Aeronautic and Space Administration (NASA, USA); ASI; CNES (France); DLR (Germany); STFC [ST/K00106X/1] Funding Source: UKRI	Italian Space Agency (ASI, Italy)(Agenzia Spaziale Italiana (ASI)); Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany); National Aeronautic and Space Administration (NASA, USA); ASI(Agenzia Spaziale Italiana (ASI)); CNES (France)(Centre National D'etudes Spatiales); DLR (Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the following institutions and agencies, which supported this work: the Italian Space Agency (ASI, Italy), Centre National d'Etudes Spatiales (CNES, France), Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany), and the National Aeronautic and Space Administration (NASA, USA). VIRTIS was built by a consortium from Italy, France and Germany, under the scientific responsibility of the Istituto di Astrofisica e Planetologia Spaziali of the INAF (Italy), which also guides the scientific operations. The VIRTIS instrument development for ESA has been funded and managed by ASI, with contributions from Observatoire de Meudon financed by CNES (France), and from DLR (Germany). We also thank the Rosetta Science Ground Segment and the Rosetta Mission Operations. The VIRTIS calibrated data will be available through the ESA's Planetary Science Archive (PSA) website.	A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Capria MT, 2001, PLANET SPACE SCI, V49, P907, DOI 10.1016/S0032-0633(01)00050-2; Ciarniello M, 2011, ICARUS, V214, P541, DOI 10.1016/j.icarus.2011.05.010; Clark RN, 2012, ICARUS, V218, P831, DOI 10.1016/j.icarus.2012.01.008; Coradini A, 2007, SPACE SCI REV, V128, P529, DOI 10.1007/s11214-006-9127-5; Crifo JF, 2003, ICARUS, V163, P479, DOI 10.1016/S0019-1035(03)00041-1; De Sanctis MC, 2010, ASTRON J, V140, P1, DOI 10.1088/0004-6256/140/1/1; De Sanctis MC, 2010, ICARUS, V207, P341, DOI 10.1016/j.icarus.2009.11.009; De Sanctis MC, 2005, ASTRON ASTROPHYS, V444, P605, DOI 10.1051/0004-6361:20053036; Farnham T. L., 2007, Icarus, V191, P146, DOI 10.1016/j.icarus.2006.10.038; Feaga LM, 2007, ICARUS, V190, P345, DOI [10.1016/j.icarus.2007.04.009, 10.1016/j.icarus.2007.04.038]; Filacchione G, 2012, ICARUS, V220, P1064, DOI 10.1016/j.icarus.2012.06.040; Fray N, 2009, PLANET SPACE SCI, V57, P2053, DOI 10.1016/j.pss.2009.09.011; Gulkis S, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0709; Hapke B., 2012, THEORY REFLECTANCE E; JPL Small-Body Database Browser, 67P CHUR GER; Mastrapa RM, 2008, ICARUS, V197, P307, DOI 10.1016/j.icarus.2008.04.008; Mastrapa RM, 2009, ASTROPHYS J, V701, P1347, DOI 10.1088/0004-637X/701/2/1347; Mottola S, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424590; Prialnik D, 2008, MON NOT R ASTRON SOC, V388, pL20, DOI 10.1111/j.1745-3933.2008.00491.x; Rosenberg ED, 2010, ICARUS, V209, P753, DOI 10.1016/j.icarus.2010.03.037; Rubin M, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/168; Sierk H., 2015, SCIENCE, V347; Soderblom LA, 2002, SCIENCE, V296, P1087, DOI 10.1126/science.1069527; Sunshine J. M., 2011, EPSC DPS JOINT M 201, P1345; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Tosi F, 2014, ICARUS, V240, P36, DOI 10.1016/j.icarus.2014.03.017; Vincent JB, 2015, NATURE, V523, P63, DOI 10.1038/nature14564; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206	30	128	128	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					500	+		10.1038/nature14869	http://dx.doi.org/10.1038/nature14869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399830				2022-12-28	WOS:000361599900046
J	Resnik, DB; McCann, DJ				Resnik, David B.; McCann, David J.			Deception by Research Participants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLINICAL-TRIALS		[Resnik, David B.] NIEHS, NIH, Bethesda, MD 20892 USA; [McCann, David J.] NIDA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Resnik, DB (corresponding author), NIEHS, NIH, Bethesda, MD 20892 USA.							Devine EG, 2013, CLIN TRIALS, V10, P935, DOI 10.1177/1740774513492917; Dresser R, 2013, J LAW MED ETHICS, V41, P829, DOI 10.1111/jlme.12093; KOLATA GB, 1980, HASTINGS CENT REP, V10, P5, DOI 10.2307/3560443; McCann DJ, 2015, J CLIN PSYCHOPHARMAC; Resnik DB, 2011, JAMA-J AM MED ASSOC, V305, P1236, DOI 10.1001/jama.2011.354	5	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1192	1193		10.1056/NEJMp1506985	http://dx.doi.org/10.1056/NEJMp1506985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR8WP	26398069				2022-12-28	WOS:000361635200004
J	Nanus, DM; Giannakakou, P				Nanus, David M.; Giannakakou, Paraskevi			Cancer therapies that are gone with the Wnt	SCIENCE			English	Editorial Material							PROSTATE-CANCER; PATHWAY		[Nanus, David M.] Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10021 USA; Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10021 USA	Cornell University; Cornell University	Nanus, DM (corresponding author), Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10021 USA.							Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Li J, 2015, CRIT REV CL LAB SCI, V52, P191, DOI 10.3109/10408363.2015.1023430; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Thadani-Mulero M, 2014, CANCER RES, V74, P2270, DOI 10.1158/0008-5472.CAN-13-2876; Xu D, 2015, CANCER RES, V75, P3663, DOI 10.1158/0008-5472.CAN-15-0381; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yokoyama NN, 2014, AM J CLIN EXP UROL, V2, P27	12	4	4	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1283	1284		10.1126/science.aad2448	http://dx.doi.org/10.1126/science.aad2448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383936				2022-12-28	WOS:000361357700021
J	Lie, GSS; Soucat, ALB; Basu, S				Lie, Geir Solve Sande; Soucat, Agnes L. B.; Basu, Suprotik			Financing women's, children's, and adolescents' health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lie, Geir Solve Sande] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland		Lie, GSS (corresponding author), Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland.	lieg@who.int						G8 Information Centre, METH CALC BAS COMM G; Global Development Incubator, 2014, INN FIN DEV SCAL BUS; Guttmacher Institute, ADD COSTS BEN INV SE; Heckman JJ, 4 BIG BENEFITS INVES; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Salvado R, DPAF WORKING PAPER S, V2013/05; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO, GLOB HLTH EXP DAT; World Bank, 2015, GLOB FIN FAC BUS PLA; World Health Organization, PMNCH 14 ACC REP TRA; Xu K, 2011, DETERMINANTS HLTH EX	12	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4267					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371223	hybrid			2022-12-28	WOS:000361678200011
J	Allison, JP				Allison, James P.			Checkpoints	CELL			English	Editorial Material									[Allison, James P.] Circa, Berkeley, CA USA					Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	22	23	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1203	1205		10.1016/j.cell.2015.08.047	http://dx.doi.org/10.1016/j.cell.2015.08.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359978	Bronze			2022-12-28	WOS:000361247900007
J	Newton, JN; Briggs, ADM; Murray, CJL; Dicker, D; Foreman, KJ; Wang, HD; Naghavi, M; Forouzanfar, MH; Ohno, SL; Barber, RM; Vos, T; Stanaway, JRD; Schmidt, JC; Hughes, AJ; Fay, DFJ; Ecob, R; Gresser, C; McKee, M; Rutter, H; Abubakar, I; Ali, R; Anderson, HR; Banerjee, A; Bennett, DA; Bernabe, E; Bhui, KS; Biryukov, SM; Bourne, RR; Brayne, CEG; Bruce, NG; Brugha, TS; Burch, M; Capewell, S; Casey, D; Chowdhury, R; Coates, MM; Cooper, C; Critchley, JA; Dargan, PI; Dherani, MK; Elliott, P; Ezzati, M; Fenton, KA; Fraser, MS; Furst, T; Greaves, F; Green, MA; Gunnell, DJ; Hannigan, BM; Hay, RJ; Hay, SI; Hemingway, H; Larson, HJ; Looker, KJ; Lunevicius, R; Lyons, RA; Marcenes, W; Mason-Jones, AJ; Matthews, FE; Moller, H; Murdoch, ME; Newton, CR; Pearce, N; Piel, FB; Pope, D; Rahimi, K; Rodriguez, A; Scarborough, P; Schumacher, AE; Shiue, I; Smeeth, L; Tedstone, A; Valabhji, J; Williams, HC; Wolfe, CDA; Woolf, AD; Davis, ACJ				Newton, John N.; Briggs, Adam D. M.; Murray, Christopher J. L.; Dicker, Daniel; Foreman, Kyle J.; Wang, Haidong; Naghavi, Mohsen; Forouzanfar, Mohammad H.; Ohno, Summer Lockett; Barber, Ryan M.; Vos, Theo; Stanaway, Jeff Rey D.; Schmidt, Juergen C.; Hughes, Andrew J.; Fay, Derek F. J.; Ecob, Russell; Gresser, Charis; McKee, Martin; Rutter, Harry; Abubakar, Ibrahim; Ali, Raghib; Anderson, H. Ross; Banerjee, Amitava; Bennett, Derrick A.; Bernabe, Eduardo; Bhui, Kamaldeep S.; Biryukov, Stanley M.; Bourne, Rupert R.; Brayne, Carol E. G.; Bruce, Nigel G.; Brugha, Traolach S.; Burch, Michael; Capewell, Simon; Casey, Daniel; Chowdhury, Rajiv; Coates, Matthew M.; Cooper, Cyrus; Critchley, Julia A.; Dargan, Paul I.; Dherani, Mukesh K.; Elliott, Paul; Ezzati, Majid; Fenton, Kevin A.; Fraser, Maya S.; Fuerst, Thomas; Greaves, Felix; Green, Mark A.; Gunnell, David J.; Hannigan, Bernadette M.; Hay, Roderick J.; Hay, Simon I.; Hemingway, Harry; Larson, Heidi J.; Looker, Katharine J.; Lunevicius, Raimundas; Lyons, Ronan A.; Marcenes, Wagner; Mason-Jones, Amanda J.; Matthews, Fiona E.; Moller, Henrik; Murdoch, Michele E.; Newton, Charles R.; Pearce, Neil; Piel, Frederic B.; Pope, Daniel; Rahimi, Kazem; Rodriguez, Alina; Scarborough, Peter; Schumacher, Austin E.; Shiue, Ivy; Smeeth, Liam; Tedstone, Alison; Valabhji, Jonathan; Williams, Hywel C.; Wolfe, Charles D. A.; Woolf, Anthony D.; Davis, Adrian C. J.			Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							PRIMARY LIVER-CANCER; LIFE YEARS DALYS; ALZHEIMERS-DISEASE; INTEGRATED APPROACH; 187 COUNTRIES; MORTALITY; DEMENTIA; DEATH; PREVALENCE; EXPECTANCY	Background In the Global Burden of Disease Study 2013 (GBD 2013), knowledge about health and its determinants has been integrated into a comparable framework to inform health policy. Outputs of this analysis are relevant to current policy questions in England and elsewhere, particularly on health inequalities. We use GBD 2013 data on mortality and causes of death, and disease and injury incidence and prevalence to analyse the burden of disease and injury in England as a whole, in English regions, and within each English region by deprivation quintile. We also assess disease and injury burden in England attributable to potentially preventable risk factors. England and the English regions are compared with the remaining constituent countries of the UK and with comparable countries in the European Union (EU) and beyond. Methods We extracted data from the GBD 2013 to compare mortality, causes of death, years of life lost (YLLs), years lived with a disability (YLDs), and disability-adjusted life-years (DALYs) in England, the UK, and 18 other countries (the first 15 EU members [apart from the UK] and Australia, Canada, Norway, and the USA [EU15+]). We extended elements of the analysis to English regions, and subregional areas defined by deprivation quintile (deprivation areas). We used data split by the nine English regions (corresponding to the European boundaries of the Nomenclature for Territorial Statistics level 1 [NUTS 1] regions), and by quintile groups within each English region according to deprivation, thereby making 45 regional deprivation areas. Deprivation quintiles were defined by area of residence ranked at national level by Index of Multiple Deprivation score, 2010. Burden due to various risk factors is described for England using new GBD methodology to estimate independent and overlapping attributable risk for five tiers of behavioural, metabolic, and environmental risk factors. We present results for 306 causes and 2337 sequelae, and 79 risks or risk clusters. Findings Between 1990 and 2013, life expectancy from birth in England increased by 5.4 years (95% uncertainty interval 5.0-5.8) from 75.9 years (75.9-76.0) to 81.3 years (80.9-81.7); gains were greater for men than for women. Rates of age-standardised YLLs reduced by 41.1% (38.3-43.6), whereas DALYs were reduced by 23.8% (20.9-27.1), and YLDs by 1.4% (0.1-2.8). For these measures, England ranked better than the UK and the EU15+ means. Between 1990 and 2013, the range in life expectancy among 45 regional deprivation areas remained 8.2 years for men and decreased from 7.2 years in 1990 to 6.9 years in 2013 for women. In 2013, the leading cause of YLLs was ischaemic heart disease, and the leading cause of DALYs was low back and neck pain. Known risk factors accounted for 39.6% (37.7-41.7) of DALYs; leading behavioural risk factors were suboptimal diet (10.8% [9.1-12.7]) and tobacco (10.7% [9.4-12.0]). Interpretation Health in England is improving although substantial opportunities exist for further reductions in the burden of preventable disease. The gap in mortality rates between men and women has reduced, but marked health inequalities between the least deprived and most deprived areas remain. Declines in mortality have not been matched by similar declines in morbidity, resulting in people living longer with diseases. Health policies must therefore address the causes of ill health as well as those of premature mortality. Systematic action locally and nationally is needed to reduce risk exposures, support healthy behaviours, alleviate the severity of chronic disabling disorders, and mitigate the effects of socioeconomic deprivation.	[Newton, John N.; Schmidt, Juergen C.; Hughes, Andrew J.; Fay, Derek F. J.; Ecob, Russell; Gresser, Charis; Abubakar, Ibrahim; Fenton, Kevin A.; Greaves, Felix; Hannigan, Bernadette M.; Tedstone, Alison; Davis, Adrian C. J.] Publ Hlth England, Wellington House, London SE1 8UG, England; [Davis, Adrian C. J.] London Sch Econ, London WC2A 2AE, England; [Murray, Christopher J. L.; Dicker, Daniel; Foreman, Kyle J.; Wang, Haidong; Naghavi, Mohsen; Forouzanfar, Mohammad H.; Ohno, Summer Lockett; Barber, Ryan M.; Vos, Theo; Stanaway, Jeff Rey D.; Biryukov, Stanley M.; Casey, Daniel; Coates, Matthew M.; Fraser, Maya S.; Hay, Simon I.; Larson, Heidi J.; Schumacher, Austin E.] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Newton, John N.] Univ Manchester, Manchester, Lancs, England; [Abubakar, Ibrahim] Ctr Infect Dis Epidemiol, London, England; [Abubakar, Ibrahim] MRC Clin Trials Unit, London, England; [Ali, Raghib] INDOX Canc Res Network, Oxford, England; [Ali, Raghib] John Radcliffe Hosp, Oxford OX3 9DU, England; [Ali, Raghib] Univ Oxford, Green Templeton Coll, Oxford, England; [Anderson, H. Ross] Publ Hlth Res Inst, Hamilton, ON, Canada; [Anderson, H. Ross] MRC PHE Ctr Environm & Hlth, London, England; [Anderson, H. Ross; Critchley, Julia A.] Univ London, St Georges, London, England; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Bennett, Derrick A.] Univ Oxford, Clin Trials Serv Unit, Oxford, England; [Bennett, Derrick A.] Univ Oxford, Epidemiol Studies Unit, Nuffield Dept Populat Hlth, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Bhui, Kamaldeep S.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med, London, England; [Bourne, Rupert R.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Brayne, Carol E. G.; Matthews, Fiona E.] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Briggs, Adam D. M.; Newton, Charles R.] Univ Oxford, Oxford, England; [Bruce, Nigel G.; Capewell, Simon; Dherani, Mukesh K.; Lunevicius, Raimundas; Pope, Daniel] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Chowdhury, Rajiv] Univ Cambridge, Cambridge, England; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, England; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England; [Hemingway, Harry; Davis, Adrian C. J.] UCL, London, England; [Elliott, Paul; Rodriguez, Alina] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Populat Hlth, London, England; [Fuerst, Thomas] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Greaves, Felix] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Green, Mark A.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Gunnell, David J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hannigan, Bernadette M.] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland; [Hay, Roderick J.] Int Fdn Dermatol, London, England; [Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hemingway, Harry; Smeeth, Liam] Farr Inst Hlth Informat Res, London, England; [Larson, Heidi J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Looker, Katharine J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Lunevicius, Raimundas] Univ Liverpool, Aintree Univ Hosp NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England; [Marcenes, Wagner] Queen Mary Univ London, London, England; [Mason-Jones, Amanda J.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Mason-Jones, Amanda J.] Univ Cape Town, Adolescent Hlth Res Unit, ZA-7925 Cape Town, South Africa; [Matthews, Fiona E.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Moller, Henrik] Kings Coll London, Canc Epidemiol & Populat Hlth, London, England; [Murdoch, Michele E.] West Hertfordshire Hosp NHS Trust, Watford, Herts, England; [Rutter, Harry; Pearce, Neil; Smeeth, Liam] Univ Oxford, London Sch Hyg & Trop Med, Oxford, England; [Rahimi, Kazem] Univ Oxford, George Inst Global Hlth, Oxford, England; [Rahimi, Kazem] Univ Oxford, Oxford Martin Sch, Div Cardiovasc Med, Oxford, England; [Valabhji, Jonathan] NHS England, Leeds, W Yorkshire, England; [Valabhji, Jonathan] Imperial Coll Healthcare NHS Trust, London, England; [Valabhji, Jonathan] Univ London Imperial Coll Sci Technol & Med, London, England; [Shiue, Ivy] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Wolfe, Charles D. A.] Kings Coll London, London WC2R 2LS, England; [Woolf, Anthony D.] Royal Cornwall Hosp, Treliske, Cornwall, England; [Rodriguez, Alina] Mid Sweden Univ, Sundsvall, Sweden; [Scarborough, Peter] Univ Oxford, British Heart Fdn Ctr Populat Approaches NCD Prev, Oxford, England; [Shiue, Ivy] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Lyons, Ronan A.] Swansea Univ, Coll Med, Farr Inst, Swansea, W Glam, Wales	Public Health England; University of London; London School Economics & Political Science; Institute for Health Metrics & Evaluation; University of Manchester; Medical Research Council Clinical Trials Unit; University of Oxford; University of Oxford; University of London; University of Birmingham; University of Oxford; University of Oxford; University of London; King's College London; University of London; Queen Mary University London; Anglia Ruskin University; University of Cambridge; University of Oxford; University of Liverpool; University of Leicester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Cambridge; University of Southampton; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of Sheffield; University of Bristol; Ulster University; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Aintree University Hospitals NHS Foundation Trust; University of Liverpool; University of London; Queen Mary University London; University of York - UK; University of Cape Town; Newcastle University - UK; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; University of Oxford; Imperial College London; Imperial College London; University of Edinburgh; University of Nottingham; University of London; King's College London; Royal Cornwall Hospital; Mid-Sweden University; University of Oxford; Northumbria University; Swansea University	Newton, JN (corresponding author), Publ Hlth England, Wellington House, London SE1 8UG, England.	john.newton@phe.gov.uk	Banerjee, Amitava/D-4381-2014; Bernabe, Eduardo/R-3441-2017; Matthews, Fiona/O-6932-2015; Chowdhury, Rajiv/AHB-1253-2022; Bennett, Derrick/AFL-9254-2022; Gunnell, David/ABE-6653-2020; Newton, Charles RJC/B-7578-2014; McKee, Marc D/E-2187-2011; Anderson, Hugh R/A-7417-2016; Newton, John/HCH-8693-2022; Scarborough, Peter/ABD-6111-2021; Rodriguez, Alina/B-3541-2015; Brayne, Carol/AAA-4285-2020; Davis, Adrian C/E-6022-2015; Bennett, Derrick/AAH-1220-2022; Rahimi, Kazem/AAA-4250-2022; Mason-Jones, Amanda/ABF-1565-2020; Greaves, Felix/A-1324-2012; Lunevicius, Raimundas/B-2528-2018; Brugha, Traolach/T-9326-2019; Hay, Simon Iain/F-8967-2015; Mckee, Martin/E-6673-2018; , Bennett/O-7998-2019; Rutter, Harry/HCI-8765-2022; Greaves, Felix/AAL-5891-2021; Hemingway, Harry/C-1219-2009; Larson, Heidi J./N-1018-2017; Smeeth, Liam/X-5862-2018; Rahimi, Kazem/Q-1279-2015	Banerjee, Amitava/0000-0001-8741-3411; Bernabe, Eduardo/0000-0002-1858-3713; Matthews, Fiona/0000-0002-1728-2388; Bennett, Derrick/0000-0002-9170-8447; Gunnell, David/0000-0002-0829-6470; Newton, Charles RJC/0000-0002-6999-5507; McKee, Marc D/0000-0001-8349-965X; Scarborough, Peter/0000-0002-2378-2944; Rodriguez, Alina/0000-0003-1209-8802; Brayne, Carol/0000-0001-5307-663X; Davis, Adrian C/0000-0001-7134-7528; Bennett, Derrick/0000-0002-9170-8447; Mason-Jones, Amanda/0000-0002-4292-3183; Greaves, Felix/0000-0001-9393-3122; Lunevicius, Raimundas/0000-0003-3295-0142; Brugha, Traolach/0000-0002-9786-9591; Hay, Simon Iain/0000-0002-0611-7272; Mckee, Martin/0000-0002-0121-9683; Greaves, Felix/0000-0001-9393-3122; Newton, John/0000-0002-5641-6457; Bhui, Kamaldeep/0000-0002-9205-2144; Pearce, Neil/0000-0002-9938-7852; Dargan, Paul/0000-0002-3433-9622; Green, Mark/0000-0002-0942-6628; williams, hywel/0000-0002-5646-3093; Hannigan, Bernie/0000-0001-9314-6049; Hemingway, Harry/0000-0003-2279-0624; Coates, Matthew/0000-0002-8474-4992; Elliott, Paul/0000-0002-7511-5684; Dherani, Mukesh/0000-0002-3055-9636; Moller, Henrik/0000-0001-8200-5929; Piel, Frederic B./0000-0001-8131-7728; Stanaway, Jeffrey/0000-0003-2209-8478; Larson, Heidi J./0000-0002-8477-7583; Pope, Daniel/0000-0003-2694-5478; Smeeth, Liam/0000-0002-9168-6022; Rahimi, Kazem/0000-0002-4807-4610; Woolf, Anthony/0000-0001-8482-8056; Critchley, Julia/0000-0002-5248-4188; Shiue, Ivy/0000-0003-1788-3009; Abubakar, Ibrahim/0000-0002-0370-1430; Cooper, Cyrus/0000-0003-3510-0709; Lyons, Ronan/0000-0001-5225-000X; Briggs, Adam/0000-0002-2314-1039; Valabhji, Jonathan/0000-0001-9756-4061	Bill AMP; Melinda Gates Foundation; Public Health England; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U147585819, G0900847, MC_U147585824, G0400491, MR/L003120/1, MC_U147585827, MC_UP_A620_1014, MR/K023233/1, MC_UU_12011/1, MR/L01341X/1, U1475000001, MR/K006584/1, MR/K006525/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090, NF-SI-0611-10084, CL-2010-09-002, NF-SI-0513-10085, CDF-2013-06-012, ACF-2009-21-030, NF-SI-0508-10082, NF-SI-0512-10165, RP-PG-0407-10184, NF-SI-0510-10060] Funding Source: researchfish; MRC [MC_U147585827, G0400491, MR/K006525/1, MR/L003120/1, MR/L01341X/1, MR/K023233/1, MC_U147585819, G0900847] Funding Source: UKRI	Bill AMP; Melinda Gates Foundation; Public Health England; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation and Public Health England.	Adams J, 2006, J PUBLIC HEALTH, V28, P379, DOI 10.1093/pubmed/fdl061; Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Bennett JE, 2015, LANCET, V386, P163, DOI 10.1016/S0140-6736(15)60296-3; Bongaarts J, 2014, POPUL DEV REV, V40, P189, DOI 10.1111/j.1728-4457.2014.00670.x; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Buszewicz MJ, 2011, BRIT J GEN PRACT, V61, P489, DOI 10.3399/bjgp11X588259; Butterfield R, 2009, 4 DEP HLTH; Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045; Davidson JR, 2010, PRIM CARE COMPANION, V12; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Fleming KM, 2008, J HEPATOL, V49, P732, DOI 10.1016/j.jhep.2008.05.023; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Global Burden of Disease Study Collaborators, 2015, LANCET; Green M., 2013, THESIS; Green MA, 2014, HEALTH PLACE, V30, P196, DOI 10.1016/j.healthplace.2014.09.011; Greer SL, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2616; Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4; Haan MN, 2004, ANNU REV PUBL HEALTH, V25, P1, DOI 10.1146/annurev.publhealth.25.101802.122951; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042325; Hoy D, 2014, ANN RHEUM DIS, V73, pE49, DOI 10.1136/annrheumdis-2014-205633; Kessler D, 2002, BRIT MED J, V325, P1016, DOI 10.1136/bmj.325.7371.1016; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mclennan D, 2011, TECHNICAL REPORT; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National End of Life Care Intelligence Network, 2010, DEATHS ALZH DIS DEM; NHS, 2014, NHS 5 YEAR FORW VIEW; Office for National Statistics, 2012, MORT UK 2010; Office for National Statistics, 2014, STAT B; Office of National Statistics, STAT B; Office of National Statistics, 2015, SUIC UK 2013 REG; Preston S, 2000, DEMOGRAPHY MEASURING; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rasulo Domenica, 2007, Health Stat Q, P35; Ratib S, 2014, AM J GASTROENTEROL, V109, P190, DOI 10.1038/ajg.2013.405; Rienzo C., 2012, MIGRANTS UK LABOUR M; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Salomon JA, 2013, LANCET GLOB IN PRESS; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Smith AD, 2014, J ALZHEIMERS DIS, V38, P699, DOI 10.3233/JAD-132372; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	60	273	274	4	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2257	2274		10.1016/S0140-6736(15)00195-6	http://dx.doi.org/10.1016/S0140-6736(15)00195-6			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26382241	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000365993200029
J	Canver, MC; Smith, EC; Sher, F; Pinello, L; Sanjana, NE; Shalem, O; Chen, DD; Schupp, PG; Vinjamur, DS; Garcia, SP; Luc, S; Kurita, R; Nakamura, Y; Fujiwara, Y; Maeda, T; Yuan, GC; Zhang, F; Orkin, SH; Bauer, DE				Canver, Matthew C.; Smith, Elenoe C.; Sher, Falak; Pinello, Luca; Sanjana, Neville E.; Shalem, Ophir; Chen, Diane D.; Schupp, Patrick G.; Vinjamur, Divya S.; Garcia, Sara P.; Luc, Sidinh; Kurita, Ryo; Nakamura, Yukio; Fujiwara, Yuko; Maeda, Takahiro; Yuan, Guo-Cheng; Zhang, Feng; Orkin, Stuart H.; Bauer, Daniel E.			BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis	NATURE			English	Article							BETA-GLOBIN GENE; HISTONE MODIFICATIONS; TRANSCRIPTION FACTORS; EXPRESSION; DISEASE; CAS9; VECTORS; MICE	Enhancers, critical determinants of cellular identity, are commonly recognized by correlative chromatin marks and gain-of-function potential, although only loss-of-function studies can demonstrate their requirement in the native genomic context. Previously, we identified an erythroid enhancer of human BCL11A, subject to common genetic variation associated with the fetal haemoglobin level, the mouse orthologue of which is necessary for eiythroid BCL11A expression. Here we develop pooled clustered regularly interspaced paiindromic repeat (CRISPR)-Cas9 guide RNA libraries to perform in situ saturating mutagenesis of the human and mouse enhancers. This approach reveals critical minimal features and discrete vulnerabilities of these enhancers. Despite conserved function of the composite enhancers, their architecture diverges. The crucial human sequences appear to be primate-specific. Through editing of primary human progenitors and mouse transgenesis, we validate the BCL11A erythroid enhancer as a target for fetal haemoglobin reinduction. The detailed enhancer map will inform therapeutic genome editing, and the screening approach described here is generally applicable to functional interrogation of non-coding genomic elements	[Canver, Matthew C.; Smith, Elenoe C.; Sher, Falak; Chen, Diane D.; Schupp, Patrick G.; Vinjamur, Divya S.; Luc, Sidinh; Fujiwara, Yuko; Orkin, Stuart H.; Bauer, Daniel E.] Harvard Univ, Boston Childrens Hosp, Dana Farber Canc Inst,Div Hematol Oncol,Med Sch, Harvard Stem Cell Inst,Dept Pediat,Dept Pediat On, Boston, MA 02115 USA; [Pinello, Luca; Garcia, Sara P.; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Pinello, Luca; Garcia, Sara P.; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sanjana, Neville E.; Shalem, Ophir; Zhang, Feng] MIT, Broad Inst MIT & Harvard, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Shalem, Ophir; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Kurita, Ryo; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki 3050074, Japan; [Nakamura, Yukio] Univ Tsukuba, Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Maeda, Takahiro] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of Tsukuba; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bauer, DE (corresponding author), Harvard Univ, Boston Childrens Hosp, Dana Farber Canc Inst,Div Hematol Oncol,Med Sch, Harvard Stem Cell Inst,Dept Pediat,Dept Pediat On, Boston, MA 02115 USA.	zhang@broadinstitute.org; stuart_orkin@dfci.harvard.edu; daniel.bauer@childrens.harvard.edu	Nakamura, Yukio/A-5263-2016; Macrae, Rhiannon/AAX-1536-2020; Maeda, Takahiro/AAC-4563-2019	Nakamura, Yukio/0000-0001-8056-4946; Maeda, Takahiro/0000-0003-4530-6460; Pinello, Luca/0000-0003-1109-3823; Sanjana, Neville/0000-0002-1504-0027; Shalem, Ophir/0000-0002-2267-0801; Sher, Falak/0000-0002-4429-0084; Luc, Sidinh/0000-0001-7006-6169; Vinjamur, Divya/0000-0002-9369-0412; Canver, Matthew/0000-0002-8146-3992	Jane Coffin Childs Memorial Fund for Medical Research Fellowship; NHGRI Career Development Award [K99HG008399]; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI [K99-HG008171]; Klarman Family Foundation; Leukemia & Lymphoma Society Fellow Award; NIH [R01 A1084905, R01HL119099, R01HG005085]; NIMH [5DP1-MH100706]; NIDDK [5R01-DK097768]; Waterman award from the National Science Foundation; Keck Foundation; McKnight Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; Simons Foundation; Bob Metcalfe; Center of Excellence in Molecular Hematology [P01HL032262, P30DK049216]; NIDDK Career Development Award [K08DK093705]; Doris Duke Charitable Foundation Innovations in Clinical Research Award [2013137]; Charles H. Hood Foundation Child Health Research Award;  [F30DK103359-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119099, R01HL032259, P01HL032262] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008399, R01HG005085, K99HG008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, R01DK097768, K08DK093705, F30DK103359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research Fellowship; NHGRI Career Development Award; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Klarman Family Foundation; Leukemia & Lymphoma Society Fellow Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Waterman award from the National Science Foundation; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; Simons Foundation; Bob Metcalfe; Center of Excellence in Molecular Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK Career Development Award; Doris Duke Charitable Foundation Innovations in Clinical Research Award; Charles H. Hood Foundation Child Health Research Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Hughes and D. Higgs for assistance with analysis of ChIP-seq; R. Mathieu and the Boston Children's Hospital Hematology/Oncology-HSCI Flow Cytometry Research Facility for cell sorting; Z. Herbert and F. Abderazzaq at the Dana-Farber Cancer Institute Molecular Biology Core Facility and Center for Cancer Computational Biology, respectively, for sequencing; J. Doench for providing TALENs; C. Peng for advice with MEL reporter cell generation; F. Godinho and M. Nguyen for technical help with ESCs and transgenic mice; A. Dass, C. Lin and S. Kamran for general technical assistance; C. Brendel and D. Williams for input regarding lentiviral transduction of HSPCs; J. Desimini for graphical assistance; and J. Xu and G. Lettre for insightful discussions. M.C.C. is supported by F30DK103359-01A1. E.C.S. is supported by a Jane Coffin Childs Memorial Fund for Medical Research Fellowship. L.P. is supported by NHGRI Career Development Award K99HG008399. N.E.S. is supported by a Simons Center for the Social Brain Postdoctoral Fellowship and NIH NHGRI award K99-HG008171. O.S. is supported by a fellowship from the Klarman Family Foundation. S.L. is supported by a Leukemia & Lymphoma Society Fellow Award. T.M. is supported by NIH R01 A1084905. G.-C.Y. is supported by NIH R01HL119099 and R01HG005085. F.Z. is supported by the NIMH (5DP1-MH100706) and NIDDK (5R01-DK097768), a Waterman award from the National Science Foundation, the Keck, McKnight, Damon Runyon, Searle Scholars, Merkin, Vallee, and Simons Foundations, and Bob Metcalfe. S.H.O. is supported by P01HL032262 and P30DK049216 (Center of Excellence in Molecular Hematology). D.E.B. is supported by an NIDDK Career Development Award K08DK093705, Doris Duke Charitable Foundation Innovations in Clinical Research Award (2013137), and Charles H. Hood Foundation Child Health Research Award. Computational tools and instructions for designing CRISPR-Cas9 sgRNA libraries for conducting non-coding screening can be found at the Zhang laboratory website http://www.genome-engineering.org.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Basak A, 2015, J CLIN INVEST, V125, P2363, DOI 10.1172/JCI81163; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dogan N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0009-5; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Funnell APW, 2015, BLOOD, V126, P89, DOI 10.1182/blood-2015-04-638528; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hardison RC, 2013, SCIENCE, V342, P206, DOI 10.1126/science.1245813; Hardison RC, 2010, NAT GENET, V42, P734, DOI 10.1038/ng0910-734; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; John A, 2012, DEVELOPMENT, V139, P1831, DOI 10.1242/dev.072850; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	60	503	581	4	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					192	+		10.1038/nature15521	http://dx.doi.org/10.1038/nature15521			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26375006	Green Accepted, Green Submitted			2022-12-28	WOS:000364396700036
J	Klein, HG; Flegel, WA; Natanson, C				Klein, Harvey G.; Flegel, Willy A.; Natanson, Charles			Red Blood Cell Transfusion Precision vs Imprecision Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGERY; TRIALS		[Klein, Harvey G.; Flegel, Willy A.] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Natanson, Charles] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Klein, HG (corresponding author), NIH, Dept Transfus Med, Bldg 10,Room 1C-711, Bethesda, MD 20892 USA.	hklein@dtm.cc.nih.gov	Flegel, Willy A/H-7404-2019	Flegel, Willy A/0000-0002-1631-7198	Intramural NIH HHS [Z99 CL999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Deans KJ, 2010, VOX SANG, V99, P16, DOI 10.1111/j.1423-0410.2010.01325.x; Flegel WA, 2015, LANCET HAEMATOL, V2, pE282, DOI 10.1016/S2352-3026(15)00090-3; FRIEDMAN BA, 1980, TRANSFUSION, V20, P179, DOI 10.1046/j.1537-2995.1980.20280169958.x; Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Ottenberg R, 1908, ANN SURG, V47, P486, DOI 10.1097/00000658-190804000-00002; Sim V, 2015, AM J SURG, V210, P45, DOI 10.1016/j.amjsurg.2014.08.024	8	28	29	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1557	1558		10.1001/jama.2015.10890	http://dx.doi.org/10.1001/jama.2015.10890			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26355383	Green Accepted			2022-12-28	WOS:000363028500010
J	Atarashi, K; Tanoue, T; Ando, M; Kamada, N; Nagano, Y; Narushima, S; Suda, W; Imaoka, A; Setoyama, H; Nagamori, T; Ishikawa, E; Shima, T; Hara, T; Kado, S; Jinnohara, T; Ohno, H; Kondo, T; Toyooka, K; Watanabe, E; Yokoyama, S; Tokoro, S; Mori, H; Noguchi, Y; Morita, H; Ivanov, II; Sugiyama, T; Nunez, G; Camp, JG; Hattori, M; Umesaki, Y; Honda, K				Atarashi, Koji; Tanoue, Takeshi; Ando, Minoru; Kamada, Nobuhiko; Nagano, Yuji; Narushima, Seiko; Suda, Wataru; Imaoka, Akemi; Setoyama, Hiromi; Nagamori, Takashi; Ishikawa, Eiji; Shima, Tatsuichiro; Hara, Taeko; Kado, Shoichi; Jinnohara, Toshi; Ohno, Hiroshi; Kondo, Takashi; Toyooka, Kiminori; Watanabe, Eiichiro; Yokoyama, Shin-ichiro; Tokoro, Shunji; Mori, Hiroshi; Noguchi, Yurika; Morita, Hidetoshi; Ivanov, Ivaylo I.; Sugiyama, Tsuyoshi; Nunez, Gabriel; Camp, J. Gray; Hattori, Masahira; Umesaki, Yoshinori; Honda, Kenya			Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells	CELL			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ESCHERICHIA-COLI O157-H7; IMMUNE-SYSTEM; T(H)17 CELLS; DIFFERENTIATION; HOST; COLONIZATION; ATTACHMENT; MATURATION; SEQUENCES	Intestinal Th17 cells are induced and accumulate in response to colonization with a subgroup of intestinal microbes such as segmented filamentous bacteria (SFB) and certain extracellular pathogens. Here, we show that adhesion of microbes to intestinal epithelial cells (ECs) is a critical cue for Th17 induction. Upon monocolonization of germ-free mice or rats with SFB indigenous to mice (M-SFB) or rats (R-SFB), M-SFB and R-SFB showed host-specific adhesion to small intestinal ECs, accompanied by host-specific induction of Th17 cells. Citrobacter rodentium and Escherichia coli O157 triggered similar Th17 responses, whereas adhesion-defective mutants of these microbes failed to do so. Moreover, a mixture of 20 bacterial strains, which were selected and isolated from fecal samples of a patient with ulcerative colitis on the basis of their ability to cause a robust induction of Th17 cells in the mouse colon, also exhibited EC-adhesive characteristics.	[Ando, Minoru; Imaoka, Akemi; Setoyama, Hiromi; Nagamori, Takashi; Ishikawa, Eiji; Shima, Tatsuichiro; Hara, Taeko; Kado, Shoichi; Umesaki, Yoshinori] Yakult Cent Inst, Kunitachi, Tokyo 1868650, Japan; [Atarashi, Koji; Tanoue, Takeshi; Nagano, Yuji; Narushima, Seiko; Jinnohara, Toshi; Ohno, Hiroshi; Kondo, Takashi; Watanabe, Eiichiro; Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Toyooka, Kiminori] CSRS, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji; Suda, Wataru; Hattori, Masahira; Honda, Kenya] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Suda, Wataru; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Nagamori, Takashi; Noguchi, Yurika; Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2525201, Japan; [Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Yokoyama, Shin-ichiro; Tokoro, Shunji; Mori, Hiroshi; Sugiyama, Tsuyoshi] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Lab Microbiol & Immunol, Gifu 5011196, Japan; [Camp, J. Gray] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Morita, Hidetoshi; Honda, Kenya] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Yakult Honsha Company, Limited; RIKEN; Keio University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tokyo; Azabu University; Columbia University; Gifu Pharmaceutical University; Max Planck Society; Japan Science & Technology Agency (JST)	Umesaki, Y (corresponding author), Yakult Cent Inst, 5-11 Izumi, Kunitachi, Tokyo 1868650, Japan.	yoshinori-umesaki@yakult.co.jp; kenya@keio.jp	Hattori, Masahira/C-6958-2016; Atarashi, Koji/I-5363-2014; Kamada, Nobuhiko/AAW-3299-2020; Honda, Kenya/N-5297-2015; Suda, Wataru/AAF-4469-2019; Hattori, Masahira/AAD-3785-2019; Toyooka, Kiminori/B-5027-2011; Ohno, Hiroshi/L-7899-2014; Nuñez, Gabriel/A-7160-2014	Hattori, Masahira/0000-0001-9467-0344; Atarashi, Koji/0000-0001-5422-0736; Kamada, Nobuhiko/0000-0002-1980-4178; Ohno, Hiroshi/0000-0001-8776-9661; jin teng, long/0000-0002-1948-9331; Yokoyama, Shin-ichiro/0000-0001-5413-2090; Ishikawa, Eiji/0000-0002-4179-9010	Japan Society for the Promotion of Science NEXT program, Health Labor Sciences Research Grant; Waksman Foundation of Japan; Suzuken Memorial Foundation; Uehara Memorial Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098378, P30DK034933] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science NEXT program, Health Labor Sciences Research Grant; Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Suzuken Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Japan Society for the Promotion of Science NEXT program, Health Labor Sciences Research Grant, the Waksman Foundation of Japan, Suzuken Memorial Foundation, and the Uehara Memorial Foundation. We thank the animal care staff at the Yakult Central Institute, Osamu Ohara, Mayuko Sato, and Kei Hashimoto at RIKEN for their technical supports, Hiroyuki Nobusue and Hideyuki Saya at Keio University for data discussion, and Mamoru Totsuka at the University of Tokyo for providing the aMoS7 cell line.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Camp JG, 2014, GENOME RES, V24, P1504, DOI 10.1101/gr.165845.113; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; JEPSON MA, 1993, INFECT IMMUN, V61, P4001, DOI 10.1128/IAI.61.9.4001-4004.1993; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nagano K, 2003, MICROBIOL IMMUNOL, V47, P125, DOI 10.1111/j.1348-0421.2003.tb02795.x; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pamp SJ, 2012, GENOME RES, V22, P1107, DOI 10.1101/gr.131482.111; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stanley A, 2014, ANTIOXID REDOX SIGN, V20, P2026, DOI 10.1089/ars.2013.5713; Talham GL, 1999, INFECT IMMUN, V67, P1992; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yokoyama S, 2001, J CLIN BIOCHEM NUTR, V30, P33	36	608	663	12	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					367	380		10.1016/j.cell.2015.08.058	http://dx.doi.org/10.1016/j.cell.2015.08.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26411289	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000362952700014
J	Rosa, A; Chande, A; Ziglio, S; De Sanctis, V; Bertorelli, R; Goh, SL; McCauley, SM; Nowosielska, A; Antonarakis, SE; Luban, J; Santoni, FA; Pizzato, M				Rosa, Annachiara; Chande, Ajit; Ziglio, Serena; De Sanctis, Veronica; Bertorelli, Roberto; Goh, Shih Lin; McCauley, Sean M.; Nowosielska, Anetta; Antonarakis, Stylianos E.; Luban, Jeremy; Santoni, Federico Andrea; Pizzato, Massimo			HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation	NATURE			English	Article							OPTIMAL VIRAL INFECTIVITY; VIRUS TYPE-1 INFECTIVITY; CD4 DOWN-REGULATION; T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS; SYNCYTIUM FORMATION; GLYCOSYLATED-GAG; PORE EXPANSION; FUSION; GENE	HIV-1 Nef, a protein important for the development of AIDS, has well-characterized effects on host membrane trafficking and receptor downregulation. By an unidentified mechanism, Nef increases the intrinsic infectivity of HIV-1 virions in a host-cell-dependent manner. Here we identify the host transmembrane protein SERINC5, and to a lesser extent SERINC3, as a potent inhibitor of HIV-1 particle infectivity that is counteracted by Nef. SERINC5 localizes to the plasma membrane, where it is efficiently incorporated into budding HIV-1 virions and impairs subsequent virion penetration of susceptible target cells. Nef redirects SERINC5 to a Rab7-positive endosomal compartment and thereby excludes it from HIV-1 particles. The ability to counteract SERINC5 was conserved in Nef encoded by diverse primate immunodeficiency viruses, as well as in the structurally unrelated glycosylated Gag from murine leukaemia virus. These examples of functional conservation and convergent evolution emphasize the fundamental importance of SERINC5 as a potent anti-retroviral factor.	[Rosa, Annachiara; Chande, Ajit; Ziglio, Serena; Pizzato, Massimo] Univ Trent, Ctr Integrat Biol, I-38123 Trento, Italy; [De Sanctis, Veronica; Bertorelli, Roberto] Univ Trent, Lab Biomol Sequence & Struct Anal Hlth, NGS Facil, I-38123 Trento, Italy; [Goh, Shih Lin; McCauley, Sean M.; Nowosielska, Anetta; Luban, Jeremy] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Antonarakis, Stylianos E.; Santoni, Federico Andrea] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Antonarakis, Stylianos E.] IGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland	University of Trento; University of Trento; University of Massachusetts System; University of Massachusetts Worcester; University of Geneva	Pizzato, M (corresponding author), Univ Trent, Ctr Integrat Biol, I-38123 Trento, Italy.	massimo.pizzato@unitn.it	Antonarakis, Stylianos E/N-8866-2014; Pizzato, Massimo/AFL-0051-2022; Chande, Ajit/K-5031-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Pizzato, Massimo/0000-0002-9491-1483; Luban, Jeremy/0000-0001-5650-4054; Chande, Ajit/0000-0003-2210-5180; Santoni, Federico/0000-0002-3258-4747; De Sanctis, Veronica/0000-0002-9791-5316; Rosa, Annachiara/0000-0001-7433-6357	University of Trento; FP7 Marie Curie Career Integration grant [322130]; Caritro 'Ricerca Biomedica' grant [2013.0248]; National Institute of Health [DP1DA034990]; European Research Council [249968]; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034990] Funding Source: NIH RePORTER	University of Trento; FP7 Marie Curie Career Integration grant; Caritro 'Ricerca Biomedica' grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Centre for AIDS Reagents, NIBSC, and NIH AIDS Research and Reference Reagent Program, Division of AIDS, for cell lines, plasmids and antibodies. We thank V. Adami and the CIBIO high-throughput screening and the Advanced Imaging facilities staff for technical assistance, G. De Silvestro, G. Mattiuzzo, C. Reinhard and L. Conti for reagents, G. Melikian, S. Basmaciogullari, P. Cherepanov, O. Fackler, N. Segata, F. Demichelis, A. Marcello, T. Fedrizzi and A. Helander for critical discussions. This work was supported by the Biotechnology Program of University of Trento, FP7 Marie Curie Career Integration grant number 322130 and Caritro 'Ricerca Biomedica' grant number 2013.0248 to M.P., National Institute of Health grant DP1DA034990 to J.L. and European Research Council grant 249968 to S.E.A.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Alexander L, 1997, J VIROL, V71, P6094, DOI 10.1128/JVI.71.8.6094-6099.1997; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Ciechonska M, 2014, J VIROL, V88, P6528, DOI 10.1128/JVI.00314-14; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Grossman TR, 2000, J EXP BIOL, V203, P447; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Landi A, 2011, CURR HIV RES, V9, P496, DOI 10.2174/157016211798842116; Luo TC, 1998, VIROLOGY, V241, P224, DOI 10.1006/viro.1997.8966; MILLER MD, 1995, J VIROL, V69, P579, DOI 10.1128/JVI.69.1.579-584.1995; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Pizzato M, 2008, J VIROL, V82, P10811, DOI 10.1128/JVI.01150-08; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Pizzato M, 2010, P NATL ACAD SCI USA, V107, P9364, DOI 10.1073/pnas.1001554107; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Razinkov VI, 2000, BIOCHEMISTRY-US, V39, P13462, DOI 10.1021/bi0012078; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Usami Y, 2014, J VIROL, V88, P3443, DOI 10.1128/JVI.01933-13; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Xu J, 2003, MOL BIOL REP, V30, P47, DOI 10.1023/A:1022250428015; Zhou J, 2001, J VIROL, V75, P5851, DOI 10.1128/JVI.75.13.5851-5859.2001; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	277	287	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					212	+		10.1038/nature15399	http://dx.doi.org/10.1038/nature15399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416734	Green Accepted			2022-12-28	WOS:000362399000038
J	Birkeland, P; Hogedal, L; Poulsen, F				Birkeland, Peter; Hogedal, Lisbeth; Poulsen, Frantz			CASE REVIEW An expanding intracerebral haematoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INITIAL CONSERVATIVE TREATMENT; EARLY SURGERY; HEMORRHAGE; EXPANSION; TRIAL; STICH		[Birkeland, Peter] Kings Coll Hosp London, Dept Neurosurg, London SE5 9RS, England; [Birkeland, Peter] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark; [Hogedal, Lisbeth] Odense Univ Hosp, Dept Radiol, DK-5000 Odense, Denmark; [Poulsen, Frantz] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	King's College Hospital NHS Foundation Trust; King's College Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Birkeland, P (corresponding author), Kings Coll Hosp London, Dept Neurosurg, London SE5 9RS, England.	Peter@Birkeland.dk		Poulsen, Frantz Rom/0000-0001-5715-6901				Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brouwers HB, 2013, CEREBROVASC DIS, V35, P195, DOI 10.1159/000346599; Brouwers HB, 2012, STROKE, V43, P3427, DOI 10.1161/STROKEAHA.112.664003; FISHER CM, 1971, J NEUROPATH EXP NEUR, V30, P536, DOI 10.1097/00005072-197107000-00015; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Meretoja A, 2014, INT J STROKE, V9, P519, DOI 10.1111/ijs.12132; Ovesen C, 2014, STROKE, V45, P994, DOI 10.1161/STROKEAHA.113.003608; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Sprigg N, 2014, J STROKE CEREBROVASC, V23, P1312, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.007; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708	14	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2015	351								h5014	10.1136/bmj.h5014	http://dx.doi.org/10.1136/bmj.h5014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GR	26407579	Green Published			2022-12-28	WOS:000361960500004
J	Clark, CW; Barankov, R; Huber, MG; Arif, M; Cory, DG; Pushin, DA				Clark, Charles W.; Barankov, Roman; Huber, Michael G.; Arif, Muhammad; Cory, David G.; Pushin, Dmitry A.			Controlling neutron orbital angular momentum	NATURE			English	Article							BEAMS	The quantized orbital angular momentum (OAM) of photons1 offers an additional degree of freedom and topological protection from noise. Photonic OAM states have therefore been exploited in various applications(2,3) ranging from studies of quantum entanglement and quantuminformation science(4-7) to imaging(8-12). TheOAM states of electron beams(13-15) have been shown to be similarly useful, for example in rotating nanoparticles and determining the chirality of crystals(16-19). However, although neutrons-as massive, penetrating and neutral particles-are important in materials characterization, quantum information and studies of the foundations of quantum mechanics, OAM control of neutrons has yet to be achieved. Here, we demonstrate OAM control of neutrons using macroscopic spiral phase plates that apply a ` twist' to an input neutron beam. The twisted neutron beams are analysed with neutron interferometry. Our techniques, applied to spatially incoherent beams, demonstrate both the addition of quantum angular momenta along the direction of propagation, effected by multiple spiral phase plates, and the conservation of topological charge with respect to uniform phase fluctuations. Neutron-based studies of quantum information science(20,21), the foundations of quantum mechanics(22,23), and scattering and imaging(24) of magnetic, superconducting and chiral materials have until now been limited to three degrees of freedom: spin, path and energy. The optimization of OAMcontrol, leading to well defined values ofOAM, would provide an additional quantized degree of freedom for such studies.	[Clark, Charles W.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Clark, Charles W.] Univ Maryland, Gaithersburg, MD 20899 USA; [Barankov, Roman] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Barankov, Roman] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Huber, Michael G.; Arif, Muhammad] NIST, Gaithersburg, MD 20899 USA; [Cory, David G.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Cory, David G.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Cory, David G.; Pushin, Dmitry A.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Cory, David G.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Pushin, Dmitry A.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Boston University; Boston University; National Institute of Standards & Technology (NIST) - USA; University of Waterloo; Perimeter Institute for Theoretical Physics; University of Waterloo; Canadian Institute for Advanced Research (CIFAR); University of Waterloo	Pushin, DA (corresponding author), Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada.	dmitry.pushin@uwaterloo.ca	Clark, Charles W/A-8594-2009	Clark, Charles W/0000-0001-8724-9885; Huber, Michael/0000-0002-3795-8445; Pushin, Dmitry/0000-0002-4594-3403	NSERC; CERC; NIST	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CERC; NIST(National Institute of Standards & Technology (NIST) - USA)	Financial support provided by the NSERC 'Create' and 'Discovery' programmes, CERC and the NIST Quantum Information Program is acknowledged. We appreciate discussions with B. McMorran, D. Sarenac, S. Werner and K. Wright.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; ARIF M, 1994, P SOC PHOTO-OPT INS, V2264, P20, DOI 10.1117/12.188872; BAHRDT J, 2013, PHYS REV SPEC TOP-AC, V16, DOI DOI 10.1103/PHYSREVLETT.111.034801; Cardano F, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500087; Dietze M, 1996, NUCL INSTRUM METH A, V377, P320, DOI 10.1016/0168-9002(96)00203-3; Fischer P, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2014.2363054; Gariepy G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.153901; Granada JR, 2000, J NUCL MATER, V277, P346, DOI 10.1016/S0022-3115(99)00156-7; Grunzweig C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2975848; Hasegawa Y, 2003, NATURE, V425, P45, DOI 10.1038/nature01881; Hasegawa Y, 2009, NUCL INSTRUM METH A, V611, P310, DOI 10.1016/j.nima.2009.07.060; Hasegawa Y, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.032121; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Juchtmans R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.094112; Kardjilov N, 2008, NAT PHYS, V4, P399, DOI 10.1038/nphys912; Kardjilov N, 2011, MATER TODAY, V14, P248, DOI 10.1016/S1369-7021(11)70139-0; Klepp J, 2014, PROG THEOR EXP PHYS, V2014, DOI 10.1093/ptep/ptu085; Liu D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804178; Liu D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3556; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Manke I, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1125; McMorran BJ, 2011, SCIENCE, V331, P192, DOI 10.1126/science.1198804; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Peele AG, 2004, J OPT SOC AM A, V21, P1575, DOI 10.1364/JOSAA.21.001575; Pfeiffer F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.215505; Pfeiffer F, 2009, NEUTRON SCATT APPL T, P129, DOI 10.1007/978-0-387-78693-3_8; Pushin DA, 2015, ADV HIGH ENERGY PHYS, V2015, DOI 10.1155/2015/687480; Pushin DA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.150401; Pushin DA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2737390; Pushin DA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.250404; Rauch H., 2015, NEUTRON INTERFEROMET, V12; Rusz J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.134428; Schattschneider P, 2014, ULTRAMICROSCOPY, V136, P81, DOI 10.1016/j.ultramic.2013.07.012; Shiloh R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.096102; Sponar S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053032; Sponar S, 2012, J PHYS CONF SER, V340, DOI 10.1088/1742-6596/340/1/012044; Sponar S, 2010, PHYS LETT A, V374, P431, DOI 10.1016/j.physleta.2009.11.017; Strobl M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.123902; Takahashi Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.121201; Torres J. P., 2011, TWISTED PHOTONS APPL; Treimer W, 2014, J MAGN MAGN MATER, V350, P188, DOI 10.1016/j.jmmm.2013.09.032; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Vallone G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.060503; Verbeeck J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662012; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Wood CJ, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.032315; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161; Yu SY, 2015, OPT EXPRESS, V23, P3075, DOI 10.1364/OE.23.003075	49	115	117	1	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					504	+		10.1038/nature15265	http://dx.doi.org/10.1038/nature15265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399831				2022-12-28	WOS:000361599900047
J	Hill, M				Hill, Matthew			Perspective: Be clear about the real risks	NATURE			English	Editorial Material							CANNABIS; SCHIZOPHRENIA; PSYCHOSIS		Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	University of Calgary	Hill, M (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada.	mnhill@ucalgary.ca						ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Di Forti M, 2015, LANCET PSYCHIAT, V2, P233, DOI 10.1016/S2215-0366(14)00117-5; Di Forti M, 2012, BIOL PSYCHIAT, V72, P811, DOI 10.1016/j.biopsych.2012.06.020; Hall W, 2008, WORLD PSYCHIATRY, V7, P68; Kolliakou A, 2011, INT J DEV NEUROSCI, V29, P335, DOI 10.1016/j.ijdevneu.2010.11.006; Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5; Power RA, 2014, MOL PSYCHIATR, V19, P1201, DOI 10.1038/mp.2014.51; WARNER R, 1995, SCHIZOPHRENIA BULL, V21, P483, DOI 10.1093/schbul/21.3.483	8	16	16	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S14	S14		10.1038/525S14a	http://dx.doi.org/10.1038/525S14a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398733	Bronze			2022-12-28	WOS:000361599900006
J	Mozdiak, E; O'Malley, J; Arasaradnam, R				Mozdiak, Ella; O'Malley, John; Arasaradnam, Ramesh			EASILY MISSED Inflammatory bowel disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSTIC DELAY		[Mozdiak, Ella] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, W Midlands, England; [Arasaradnam, Ramesh] Univ Warwick, Coventry CV2 2DX, W Midlands, England	University of Warwick; University of Warwick	Arasaradnam, R (corresponding author), Univ Warwick, Coventry CV2 2DX, W Midlands, England.	r.arasaradnam@warwick.ac.uk		Arasaradnam, Ramesh/0000-0002-2231-3062				Bercik P, 2005, GASTROENTEROL CLIN N, V34, P235, DOI 10.1016/j.gtc.2005.02.007; Burgmann T, 2006, CLIN GASTROENTEROL H, V4, P614, DOI 10.1016/j.cgh.2006.03.003; Card TR, 2014, UNITED EUR GASTROENT, V2, P505, DOI 10.1177/2050640614554217; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; National Institute for Health and Care Excellence, 2013, FAEC CALPR DIAGN TES; Ricart E, 2008, WORLD J GASTROENTERO, V14, P5523, DOI 10.3748/wjg.14.5523; Schoepfer AM, 2013, AM J GASTROENTEROL, V108, P1744, DOI 10.1038/ajg.2013.248; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Waugh N, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17550; Zippi M, 2014, WORLD J GASTROENTERO, V20, P17463, DOI 10.3748/wjg.v20.i46.17463	14	10	10	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2015	351								h4416	10.1136/bmj.h4416	http://dx.doi.org/10.1136/bmj.h4416			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GE	26403642				2022-12-28	WOS:000361959200001
J	Valley, TS; Sjoding, MW; Ryan, AM; Iwashyna, TJ; Cooke, CR				Valley, Thomas S.; Sjoding, Michael W.; Ryan, Andrew M.; Iwashyna, Theodore J.; Cooke, Colin R.			Association of Intensive Care Unit Admission With Mortality Among Older Patients With Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INSTRUMENTAL VARIABLE METHODS; 30-DAY MORTALITY; ICU ADMISSION; RISK; OUTCOMES; ADULTS; VOLUME; RATES; HOSPITALS	IMPORTANCE Among patients whose need for intensive care is uncertain, the relationship of intensive care unit (ICU) admission with mortality and costs is unknown. OBJECTIVE To estimate the relationship between ICU admission and outcomes for elderly patients with pneumonia. DESIGN, SETTING, AND PATIENTS Retrospective cohort study of Medicare beneficiaries (aged >64 years) admitted to 2988 acute care hospitals in the United States with pneumonia from 2010 to 2012. EXPOSURES ICU admission vs general ward admission. MAIN OUTCOMES AND MEASURES Primary outcomewas 30-day all-cause mortality. Secondary outcomes included Medicare spending and hospital costs. Patient and hospital characteristics were adjusted to account for differences between patients with and without ICU admission. To account for unmeasured confounding, an instrumental variable was used-the differential distance to a hospital with high ICU admission (defined as any hospital in the upper 2 quintiles of ICU use). RESULTS Among 1 112 394 Medicare beneficiaries with pneumonia, 328 404 (30%) were admitted to the ICU. In unadjusted analyses, patients admitted to the ICU had significantly higher 30-day mortality, Medicare spending, and hospital costs than patients admitted to a general hospital ward. Patients (n = 553 597) living closer than the median differential distance (<3.3 miles) to a hospital with high ICU admission were significantly more likely to be admitted to the ICU than patients living farther away (n = 558 797) (36% for patients living closer vs 23% for patients living farther, P < .001). In adjusted analyses, for the 13% of patients whose ICU admission decision appeared to be discretionary (dependent only on distance), ICU admission was associated with a significantly lower adjusted 30-day mortality (14.8% for ICU admission vs 20.5% for general ward admission, P = .02; absolute decrease, -5.7%[95% CI, -10.6%, -0.9%]), yet there were no significant differences in Medicare spending or hospital costs for the hospitalization. CONCLUSIONS AND RELEVANCE Among Medicare beneficiaries hospitalized with pneumonia, ICU admission of patients for whom the decision appeared to be discretionary was associated with improved survival and no significant difference in costs. A randomized trial may be warranted to assess whether more liberal ICU admission policies improve mortality for patients with pneumonia.	[Valley, Thomas S.; Sjoding, Michael W.; Iwashyna, Theodore J.; Cooke, Colin R.] Univ Michigan, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Valley, Thomas S.; Sjoding, Michael W.; Iwashyna, Theodore J.; Cooke, Colin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Ryan, Andrew M.; Cooke, Colin R.] Univ Michigan, Ctr Hlth Outcomes & Policy, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Iwashyna, Theodore J.] Monash Univ, Dept Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Cooke, Colin R.] Univ Michigan, Inst Healthcare Innovat & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Monash University; University of Michigan System; University of Michigan	Valley, TS (corresponding author), Univ Michigan, Div Pulm & Crit Care Med, 1500 Med Ctr Dr,3916 Taubman Ctr, Ann Arbor, MI 48109 USA.	valleyt@umich.edu	Valley, Thomas/ABC-7960-2020	Valley, Thomas/0000-0002-5766-4970	National Institutes of Health [T32HL007749]; Department of Veterans Affairs Health Services Research and Development Service [11-109]; Agency for Healthcare Research and Quality [K08HS020672]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant T32HL007749 from the National Institutes of Health (Drs Valley and Sjoding), grant 11-109 from the Department of Veterans Affairs Health Services Research and Development Service (Dr Iwashyna), and grant K08HS020672 from Agency for Healthcare Research and Quality (Dr Cooke).	Admon AJ, 2014, CHEST, V146, P1452, DOI 10.1378/chest.14-0059; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baiocchi M, 2014, STAT MED, V33, P2297, DOI 10.1002/sim.6128; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escher M, 2004, BRIT MED J, V329, P425, DOI 10.1136/bmj.329.7463.425; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Gabler NB, 2013, AM J RESP CRIT CARE, V188, P800, DOI 10.1164/rccm.201304-0622OC; Gershengorn HB, 2012, CRIT CARE MED, V40, P2009, DOI 10.1097/CCM.0b013e31824e9eae; Gooch RA, 2014, JAMA-J AM MED ASSOC, V311, P567, DOI 10.1001/jama.2013.283800; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Harris KM, 1998, HEALTH SERV RES, V33, P1337; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Kahn JM, 2006, CURR OPIN CRIT CARE, V12, P399, DOI 10.1097/01.ccx.0000244117.08753.38; Kahn JM, 2013, INTENS CARE MED, V39, P1635, DOI 10.1007/s00134-013-2992-y; Kahn JM, 2009, HEALTH SERV RES, V44, P862, DOI 10.1111/j.1475-6773.2009.00959.x; Kelly DM, 2014, CRIT CARE MED, V42, P1089, DOI 10.1097/CCM.0000000000000127; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Lee SJ, 2014, CHEST, V146, P908, DOI 10.1378/chest.13-2702; Lin HC, 2008, AM J RESP CRIT CARE, V177, P989, DOI 10.1164/rccm.200706-813OC; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Merchant S, 2003, CLIN THER, V25, P593, DOI 10.1016/S0149-2918(03)80099-1; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Oster Gerry, 2013, J Med Econ, V16, P809, DOI 10.3111/13696998.2013.794805; Pirracchio R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-132; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1233, DOI 10.1016/j.jclinepi.2008.12.006; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Rothberg MB, 2014, ANN INTERN MED, V160, P380, DOI 10.7326/M13-1419; Safavi KC, 2013, CIRCULATION, V127, P923, DOI 10.1161/CIRCULATIONAHA.112.001088; Sales A, 2008, MED CARE, V46, P938, DOI 10.1097/MLR.0b013e3181791a0a; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Sjoding MW, 2015, CRIT CARE MED, V43, P1178, DOI 10.1097/CCM.0000000000000925; Sjoding MW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0923-8; Sjoding MW, 2015, CRIT CARE MED, V43, P989, DOI 10.1097/CCM.0000000000000862; Sun HK, 2006, CHEST, V130, P807, DOI 10.1378/chest.130.3.807; Wallace DJ, 2015, AM J RESP CRIT CARE, V191, P410, DOI 10.1164/rccm.201409-1746OC; Wunsch H, 2012, CHEST, V141, P1393, DOI 10.1378/chest.11-2819	40	86	87	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1272	1279		10.1001/jama.2015.11068	http://dx.doi.org/10.1001/jama.2015.11068			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS5IE	26393850	Green Accepted, Bronze			2022-12-28	WOS:000362110700016
J	Miyamoto, DT; Zheng, Y; Wittner, BS; Lee, RJ; Zhu, HL; Broderick, KT; Desai, R; Fox, DB; Brannigan, BW; Trautwein, J; Arora, KS; Desai, N; Dahl, DM; Sequist, LV; Smith, MR; Kapur, R; Wu, CL; Shioda, T; Ramaswamy, S; Ting, DT; Toner, M; Maheswaran, S; Haber, DA				Miyamoto, David T.; Zheng, Yu; Wittner, Ben S.; Lee, Richard J.; Zhu, Huili; Broderick, Katherine T.; Desai, Rushil; Fox, Douglas B.; Brannigan, Brian W.; Trautwein, Julie; Arora, Kshitij S.; Desai, Niyati; Dahl, Douglas M.; Sequist, Lecia V.; Smith, Matthew R.; Kapur, Ravi; Wu, Chin-Lee; Shioda, Toshi; Ramaswamy, Sridhar; Ting, David T.; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.			RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance	SCIENCE			English	Article							CIRCULATING TUMOR-CELLS; CANCER; PATHWAY; ENZALUTAMIDE	Prostate cancer is initially responsive to androgen deprivation, but the effectiveness of androgen receptor (AR) inhibitors in recurrent disease is variable. Biopsy of bone metastases is challenging; hence, sampling circulating tumor cells (CTCs) may reveal drug-resistance mechanisms. We established single-cell RNA-sequencing (RNA-Seq) profiles of 77 intact CTCs isolated from 13 patients (mean six CTCs per patient), by using microfluidic enrichment. Single CTCs from each individual display considerable heterogeneity, including expression of AR gene mutations and splicing variants. Retrospective analysis of CTCs from patients progressing under treatment with an AR inhibitor, compared with untreated cases, indicates activation of noncanonical Wnt signaling (P = 0.0064). Ectopic expression of Wnt5a in prostate cancer cells attenuates the antiproliferative effect of AR inhibition, whereas its suppression in drug-resistant cells restores partial sensitivity, a correlation also evident in an established mouse model. Thus, single-cell analysis of prostate CTCs reveals heterogeneity in signaling pathways that could contribute to treatment failure.	[Miyamoto, David T.; Zheng, Yu; Wittner, Ben S.; Lee, Richard J.; Zhu, Huili; Broderick, Katherine T.; Desai, Rushil; Fox, Douglas B.; Brannigan, Brian W.; Trautwein, Julie; Arora, Kshitij S.; Desai, Niyati; Dahl, Douglas M.; Sequist, Lecia V.; Smith, Matthew R.; Wu, Chin-Lee; Shioda, Toshi; Ramaswamy, Sridhar; Ting, David T.; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Massachusetts Gen Canc Ctr, Charlestown, MA 02129 USA; [Miyamoto, David T.] Harvard Univ, Massachusetts Gen Hosp, Dept Radiat Oncol, Sch Med, Charlestown, MA 02129 USA; [Zheng, Yu; Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wittner, Ben S.; Lee, Richard J.; Sequist, Lecia V.; Smith, Matthew R.; Ramaswamy, Sridhar; Ting, David T.; Haber, Daniel A.] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Sch Med, Charlestown, MA 02129 USA; [Arora, Kshitij S.; Desai, Niyati; Wu, Chin-Lee] Harvard Univ, Massachusetts Gen Hosp, Dept Pathol, Sch Med, Charlestown, MA 02129 USA; [Dahl, Douglas M.] Harvard Univ, Massachusetts Gen Hosp, Dept Urol, Sch Med, Charlestown, MA 02129 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Ctr Bioengn Med, Sch Med, Charlestown, MA 02129 USA; [Maheswaran, Shyamala] Harvard Univ, Massachusetts Gen Hosp, Dept Surg, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Haber, DA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Massachusetts Gen Canc Ctr, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu; smaheswaran@mgh.harvard.edu	Ting, David/F-4389-2017	Ting, David/0000-0002-3261-2322	Prostate Cancer Foundation; Charles Evans Foundation; Department of Defense; Stand Up to Cancer; Howard Hughes Medical Institute; National Institute of Biomedical Imaging and Bioengineering (NIBIB); NIH [EB008047]; NCI [2RO1CA129933]; National Cancer Institute, NCI; Federal Share Program and Income; Affymetrix, Inc.; Mazzone Program-Dana-Farber Harvard Cancer Center; Burroughs Wellcome Fund; Massachusetts General Hospital-Johnson & Johnson Center for Excellence in CTC Technologies; Janssen LLC.; NATIONAL CANCER INSTITUTE [R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008047, U01EB012493] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Charles Evans Foundation; Department of Defense(United States Department of Defense); Stand Up to Cancer; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal Share Program and Income; Affymetrix, Inc.; Mazzone Program-Dana-Farber Harvard Cancer Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Massachusetts General Hospital-Johnson & Johnson Center for Excellence in CTC Technologies; Janssen LLC.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank C. Sawyers for helpful discussions; A. McGovern, E. Stadtmueller, and B. Abebe for clinical trial support; and L. Libby and L. Nieman for technical assistance. This work was supported by grants from the Prostate Cancer Foundation (D.A.H., S.M., M.T., M.R.S., and R.J.L.), Charles Evans Foundation (D.A.H.), Department of Defense (D.T.M., R.J.L., and D.T.T.), Stand Up to Cancer (D.A.H., M.T., S.M., and L.V.S.), Howard Hughes Medical Institute (D.A.H.), National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH, EB008047 (M.T.), NCI 2RO1CA129933 (D.A.H.), National Cancer Institute, NCI, Federal Share Program and Income (S.M. and D.T.M.), Affymetrix, Inc. (D.T.T., K.A., and N.D.), Mazzone Program-Dana-Farber Harvard Cancer Center (D.T.M.), Burroughs Wellcome Fund (D.T.T.), and the Massachusetts General Hospital-Johnson & Johnson Center for Excellence in CTC Technologies (D.A.H., M.T., and S.M.). D.T.T. is a paid consultant for Affymetrix, Inc.; R.J.L. is a paid consultant for Janssen LLC. The Massachusetts General Hospital has filed for patent protection for the CTC-iChip technology. RNA-sequencing data have been deposited in GEO under accession number GSE67980.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Lu CX, 2013, TRANSL ANDROL UROL, V2, P178, DOI 10.3978/j.issn.2223-4683.2013.09.08; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Scher HI, 2013, NAT REV CLIN ONCOL, V10, P225, DOI 10.1038/nrclinonc.2013.30; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sharpe B, 2013, STEM CELL REV REP, V9, P721, DOI 10.1007/s12015-013-9453-4; Takahashi S, 2011, P NATL ACAD SCI USA, V108, P4938, DOI 10.1073/pnas.1014850108; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Ting DT, 2014, CELL REP, V8, P1905, DOI 10.1016/j.celrep.2014.08.029; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253; Zheng DL, 2013, MOL CANCER RES, V11, P482, DOI 10.1158/1541-7786.MCR-12-0520	30	490	510	8	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1351	1356		10.1126/science.aab0917	http://dx.doi.org/10.1126/science.aab0917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383955	Green Accepted			2022-12-28	WOS:000361357700052
J	Chen, H				Chen, Hao			An uncomfortable hip exacerbated by exercise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Radiol, Sch Med, Shanghai 201999, Peoples R China	Shanghai Jiao Tong University	Chen, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Radiol, Sch Med, Shanghai 201999, Peoples R China.	poetyoung@163.com						Davies AM, 2005, IMAGING HIP BONY PEL	1	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4750	10.1136/bmj.h4750	http://dx.doi.org/10.1136/bmj.h4750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26378069				2022-12-28	WOS:000361678800008
J	Sedgwick, P; Marston, L				Sedgwick, Philip; Marston, Louise			How to read a funnel plot in a meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STATISTICAL QUESTION; BIAS		[Sedgwick, Philip] Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England; [Marston, Louise] UCL, Dept Primary Care & Populat Hlth, London WC1E 6BT, England; [Marston, Louise] UCL, Priment Clin Trials Unit, London WC1E 6BT, England	University of London; University of London; University College London; University of London; University College London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Marston, Louise/A-8535-2012; Sedgwick, Philip/C-6997-2019	Marston, Louise/0000-0002-9973-1131; Sedgwick, Philip/0000-0001-8859-2175				Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4419; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3869; Sedgwick Philip, 2015, BMJ, V350, ph3078, DOI 10.1136/bmj.h3078	4	131	134	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4718	10.1136/bmj.h4718	http://dx.doi.org/10.1136/bmj.h4718			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26377337				2022-12-28	WOS:000361678800007
J	Fekete, T				Fekete, Thomas			In non-ICU suspected CAP, beta-lactam was noninferior to beta-lactam-macrolide or fluoroquinolone for 90-d mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA		Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022					Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mills GD, 2005, BMJ-BRIT MED J, V330, P456, DOI 10.1136/bmj.38334.591586.82	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							ACPJC-2015-163-6-005	10.7326/ACPJC-2015-163-6-005	http://dx.doi.org/10.7326/ACPJC-2015-163-6-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370032				2022-12-28	WOS:000361365900005
J	Jena, AB; Khullar, D; Ho, O; Olenski, AR; Blumenthal, DM				Jena, Anupam B.; Khullar, Dhruv; Ho, Oliver; Olenski, Andrew R.; Blumenthal, Daniel M.			Sex Differences in Academic Rank in US Medical Schools in 2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENDER-DIFFERENCES; PHYSICIAN-RESEARCHERS; CAREER SATISFACTION; WOMEN PHYSICIANS; FACULTY; PRODUCTIVITY; TRENDS; MEN; RESPONSIBILITIES; ADVANCEMENT	IMPORTANCE The proportion of women at the rank of full professor in US medical schools has not increased since 1980 and remains below that of men. Whether differences in age, experience, specialty, and research productivity between sexes explain persistent disparities in faculty rank has not been studied. OBJECTIVE To analyze sex differences in faculty rank among US academic physicians. DESIGN, SETTING, AND PARTICIPANTS We analyzed sex differences in faculty rank using a cross-sectional comprehensive database of US physicians with medical school faculty appointments in 2014 (91 073 physicians; 9.1% of all US physicians), linked to information on physician sex, age, years since residency, specialty, authored publications, National Institutes of Health (NIH) funding, and clinical trial investigation. We estimated sex differences in full professorship, as well as a combined outcome of associate or full professorship, adjusting for these factors in a multilevel (hierarchical) model. We also analyzed how sex differences varied with specialty and whether differences were more prevalent at schools ranked highly in research. EXPOSURES Physician sex. MAIN OUTCOMES AND MEASURES Academic faculty rank. RESULTS In all, there were 30 464 women who were medical faculty vs 60 609 men. Of those, 3623 women (11.9%) vs 17 354 men (28.6%) had full-professor appointments, for an absolute difference of -16.7%(95% CI, -17.3% to -16.2%). Women faculty were younger and disproportionately represented in internal medicine and pediatrics. The mean total number of publications for women was 11.6 vs 24.8 for men, for a difference of -13.2 (95% CI, -13.6 to -12.7); the mean first-or last-author publications for women was 5.9 vs 13.7 for men, for a difference of -7.8 (95% CI, -8.1 to -7.5). Among 9.1% of medical faculty with an NIH grant, 6.8%(2059 of 30 464) were women and 10.3%(6237 of 60 609) were men, for a difference of -3.5%(95% CI, -3.9% to -3.1%). In all, 6.4% of women vs 8.8% of men had a trial registered on ClinicalTrials.gov, for a difference of -2.4%(95% CI, -2.8% to -2.0%). After multivariable adjustment, women were less likely than men to have achieved full-professor status (absolute adjusted difference in proportion, -3.8%; 95% CI, -4.4% to -3.3%). Sex-differences in full professorship were present across all specialties and did not vary according to whether a physician's medical school was ranked highly in terms of research funding. CONCLUSIONS AND RELEVANCE Among physicians with faculty appointments at US medical schools, there were sex differences in academic faculty rank, with women substantially less likely than men to be full professors, after accounting for age, experience, specialty, and measures of research productivity.	[Jena, Anupam B.; Ho, Oliver; Olenski, Andrew R.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Khullar, Dhruv] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Khullar, Dhruv; Blumenthal, Daniel M.] Harvard Univ, Sch Med, Boston, MA USA; [Blumenthal, Daniel M.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu		Olenski, Andrew/0000-0002-7461-0536	Office of the Director, National Institutes of Health [1DP5OD017897-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors report funding grant 1DP5OD017897-01 Early Independence Award from the Office of the Director, National Institutes of Health (Dr Jena).	Association of American Medical Colleges, 2005, CHANG REPR MEN WOM A; Association of American Medical Colleges, 2012, US MED SCH APPL STUD; Bland KI, 2002, ARCH SURG-CHICAGO, V137, P259, DOI 10.1001/archsurg.137.3.259; Carnes M, 2008, J WOMENS HEALTH, V17, P1453, DOI 10.1089/jwh.2007.0688; CARR P, 1992, J GEN INTERN MED, V7, P418, DOI 10.1007/BF02599159; Carr PL, 1998, ANN INTERN MED, V129, P532, DOI 10.7326/0003-4819-129-7-199810010-00004; CARR PL, 1993, ANN INTERN MED, V119, P908, DOI 10.7326/0003-4819-119-9-199311010-00008; Danva, 2012, WAT NUMB DANVA BENCH; DeCastro R, 2014, ACAD MED, V89, P301, DOI 10.1097/ACM.0000000000000109; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Eloy JA, 2013, LARYNGOSCOPE, V123, P1865, DOI 10.1002/lary.24039; Fried LP, 1996, JAMA-J AM MED ASSOC, V276, P898, DOI 10.1001/jama.276.11.898; Hamel MB, 2006, NEW ENGL J MED, V355, P310, DOI 10.1056/NEJMe068143; Holliday E, 2015, J GEN INTERN MED, V30, P401, DOI 10.1007/s11606-014-2988-5; Holliday EB, 2014, ACAD MED, V89, P767, DOI 10.1097/ACM.0000000000000229; Hoss MAK, 2011, J HEALTHC LEADERSH, V3, P59, DOI 10.2147/JHL.S16315; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Jagsi R, 2013, ACAD MED, V88, P1689, DOI 10.1097/ACM.0b013e3182a71519; Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Jolly S, 2014, ANN INTERN MED, V160, P344, DOI 10.7326/M13-0974; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; Lautenberger DM, 2014, STATE WOMEN ACAD MED; Nattinger AB, 2007, ARCH INTERN MED, V167, P323, DOI 10.1001/archinte.167.4.323; NICKERSON KG, 1990, JAMA-J AM MED ASSOC, V264, P1813, DOI 10.1001/jama.264.14.1813; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Reed DA, 2011, ACAD MED, V86, P43, DOI 10.1097/ACM.0b013e3181ff9ff2; Rubin D. B., 2004, MULTIPLE IMPUTATION; Seabury SA, 2013, JAMA INTERN MED, V173, P1748; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; Thomas PA, 2004, ACAD MED, V79, P258, DOI 10.1097/00001888-200403000-00013; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; WALLIS LA, 1981, JAMA-J AM MED ASSOC, V246, P2350, DOI 10.1001/jama.246.20.2350; Yedidia MJ, 2001, ACAD MED, V76, P453, DOI 10.1097/00001888-200105000-00017	33	364	367	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1149	1158		10.1001/jama.2015.10680	http://dx.doi.org/10.1001/jama.2015.10680			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372584	Green Accepted, Bronze			2022-12-28	WOS:000361284500026
J	Mukherjee, D				Mukherjee, Debabrata			Review: After coronary DES placement, longer vs shorter DAPT increases major bleeding and death and reduces MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DUAL ANTIPLATELET THERAPY; INTERVENTION; METAANALYSIS; DURATION; TRIALS		Texas Tech Univ, Hlth Sci Ctr, El Paso, TX 79409 USA	Texas Tech University System; Texas Tech University	Mukherjee, D (corresponding author), Texas Tech Univ, Hlth Sci Ctr, El Paso, TX 79409 USA.		Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC6	10.7326/ACPJC-2015-163-6-006	http://dx.doi.org/10.7326/ACPJC-2015-163-6-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370033				2022-12-28	WOS:000361365900006
J	Campbell, J; Cometto, G; Rasanathan, K; Kelley, E; Syed, S; Zurn, P; de Bernis, L; Matthews, Z; Benton, D; Frank, O; Nove, A				Campbell, James; Cometto, Giorgio; Rasanathan, Kumanan; Kelley, Edward; Syed, Shamsuzzoha; Zurn, Pascal; de Bernis, Luc; Matthews, Zoe; Benton, David; Frank, Odile; Nove, Andrea			Improving the resilience and workforce of health systems for women's, children's, and adolescents' health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN-RESOURCES; CARE; WORKERS; MANAGEMENT; COVERAGE; ILLNESS; EQUITY		[Campbell, James] WHO, Hlth Workforce, CH-1207 Geneva, Switzerland; [Cometto, Giorgio] WHO, Global Hlth Workforce Alliance, CH-1207 Geneva, Switzerland; [Kelley, Edward; Syed, Shamsuzzoha] WHO, Serv Delivery & Safety, CH-1207 Geneva, Switzerland; [Rasanathan, Kumanan] Unicef, New York, NY USA; [Zurn, Pascal] WHO, Country Off India, Hlth Syst Evidence & Policy, New Delhi, India; [de Bernis, Luc; Matthews, Zoe] United Nations Populat Fund, New York, NY USA; [Benton, David] Int Council Nurses, CH-1201 Geneva, Switzerland; [Frank, Odile] Publ Serv Int, F-01211 Ferney Voltaire, France; [Nove, Andrea] ICS Integrare, Barcelona, Spain	World Health Organization; World Health Organization; World Health Organization; UNICEF; World Health Organization; United Nations Population Fund	Campbell, J (corresponding author), WHO, Hlth Workforce, Ave Appia 20, CH-1207 Geneva, Switzerland.	campbellj@who.int	benton, david/AAC-5298-2020; Matthews, Zoe/HGD-0506-2022	benton, david/0000-0001-8418-8618; Matthews, Zoe/0000-0003-1533-6618				Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], 2013, B WORLD HEALTH ORGAN, V91, P797; Binagwaho A, 2014, LANCET, V384, P371, DOI 10.1016/S0140-6736(14)60574-2; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Eurofound, EMPL POL JOB QUAL CR; Global Health Workforce Alliance, 2015, BUILD CAP HLTH SECT; Global Health Workforce Alliance, 2010, GLOBAL EXPERIENCE CO; Global Health Workforce Alliance, 2014, EC DEM EP TRANS FUT; Global Health Workforce Alliance WHO. Synthesis paper of the thematic working groups, 2015, SYNTH PAP THEM WORK; Global Health Workforce Alliance World Health Organization, 2013, UN HLTH NO HLTH WORK; Hollnagel E, 2006, RESILIENCE ENG CONCE; Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278; Lassi ZS, 2013, B WORLD HEALTH ORGAN, V91, P824, DOI 10.2471/BLT.13.118786; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Lie GSS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4267; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Nefdt R, 2014, ETHIOP MED J S3, V52, P1630; Rasanathan K, 2014, J GLOB HEALTH, V4, P43, DOI 10.7189/jogh.04.020304; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Shapovalova ND, 2015, LANCET GLOB HEALTH, V3, pE249, DOI 10.1016/S2214-109X(15)70104-X; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; The Partnership for Maternal Newborn and Child Health, PARTNERSHIP MATEMAL; Tulenko K, 2013, B WORLD HEALTH ORGAN, V91, P847, DOI 10.2471/BLT.13.118745; UN, 2014, ROAD DIGN 2030 END P; UNFPA, 2014, STAT WORLDS MIDW 201; United Nations, 2015, SAV LIV PROT FUT PRO; United Nations Division for Sustainable Development, OP WORK GROUP PROP S; Vasan A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-6; WHO, 2007, EV BUS STRENGTH HLTH; Witter S, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0023-5; World Health Organization, 2006, WORLD HLTH REP 2006; World Health Organization, 2015, WHO GLOB STRAT PEOPL; World Health Organization, 2014, EV WOM EV CHILD POST	34	22	22	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4148					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371216	hybrid, Green Accepted			2022-12-28	WOS:000361678200004
J	Biddinger, PD; Hooper, DC; Shenoy, ES; Bajwa, EK; Robbins, GK; Branda, JA				Biddinger, Paul D.; Hooper, David C.; Shenoy, Erica S.; Bajwa, Ednan K.; Robbins, Gregory K.; Branda, John A.			Case 28-2015: A 32-Year-Old Man with Fever, Headache, and Myalgias after Traveling from Liberia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EBOLA-VIRUS DISEASE; MALARIA; ILLNESS		[Biddinger, Paul D.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Hooper, David C.; Shenoy, Erica S.; Robbins, Gregory K.] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA; [Bajwa, Ednan K.] Massachusetts Gen Hosp, Dept Pulm & Crit Care, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hooper, David C.; Shenoy, Erica S.] Massachusetts Gen Hosp, Infect Control Unit, Boston, MA 02114 USA; [Biddinger, Paul D.] Harvard Univ, Dept Emergency Med, Sch Med, Boston, MA USA; [Hooper, David C.; Shenoy, Erica S.; Bajwa, Ednan K.; Robbins, Gregory K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Biddinger, PD (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.		Shenoy, Erica/AAD-7521-2021; Branda, John/ABD-5620-2020	Robbins, Gregory/0000-0001-7545-5817; Bajwa, Ednan/0000-0001-9026-1009				[Anonymous], 2014, MMWR MORB MORTAL WKL, V63, P1175; [Anonymous], 2014, APIC EB READ POLL RE; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074; Centers for Disease Control and Prevention, 2015, CAS DEF EB VIR DIS E; Centers for Disease Control and Prevention, 2014, GUID PERS PROT EQ BE; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Firgir J., 2014, CBS NEWS        1031; Hladky GB., 2014, HOSP HAVE SPENT 5 MI; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Weber EJ, 2014, EMERG MED J, V31, P950, DOI 10.1136/emermed-2014-204433; West T Eoin, 2014, Ann Am Thorac Soc, V11, P1341, DOI 10.1513/AnnalsATS.201410-481PS; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	13	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1060	1067		10.1056/NEJMcpc1503828	http://dx.doi.org/10.1056/NEJMcpc1503828			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352818				2022-12-28	WOS:000360959000013
J	Garon, JR; Orenstein, WA				Garon, Julie R.; Orenstein, Walter A.			A worldwide shift in polio vaccines for routine immunisation	LANCET			English	Editorial Material							POLIOMYELITIS		[Garon, Julie R.; Orenstein, Walter A.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University	Orenstein, WA (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.	worenst@emory.edu						Deshpande JM, 2003, INDIAN J MED RES, V118, P217; Global Polio Eradication Initiative, 2013, POL ER ENDG STRAT PL; Patel M, 2015, EXPERT REV VACCINES, V14, P749, DOI 10.1586/14760584.2015.1001750; Platt LR, 2014, J INFECT DIS, V210, pS380, DOI 10.1093/infdis/jiu184; Sutter RW, 2015, LANCET, V386, P2413, DOI 10.1016/S0140-6736(15)00237-8; WHO, STAT COUNTR PLANN IP; World Health Organization, WHOPOLIO0502; World Health Organization, 2014, WKLY EPIDEMIOL REC, V89, P73	8	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2375	2377		10.1016/S0140-6736(15)00243-3	http://dx.doi.org/10.1016/S0140-6736(15)00243-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26388533				2022-12-28	WOS:000366290400012
J	Massironi, M; Simioni, E; Marzari, F; Cremonese, G; Giacomini, L; Pajola, M; Jorda, L; Naletto, G; Lowry, S; El-Maarry, MR; Preusker, F; Scholten, F; Sierks, H; Barbieri, C; Lamy, P; Rodrigo, R; Koschny, D; Rickman, H; Keller, HU; A'Hearn, MF; Agarwal, J; Auger, AT; Barucci, MA; Bertaux, JL; Bertini, I; Besse, S; Bodewits, D; Capanna, C; Da Deppo, V; Davidsson, B; Debei, S; De Cecco, ML; Ferri, F; Fornasier, S; Fulle, M; Gaskell, R; Groussin, O; Gutierrez, PJ; Guttler, C; Hviid, SF; Ip, WH; Knollenberg, J; Kovacs, G; Kramm, R; Kuhrt, E; Kuppers, M; La Forgia, F; Lara, LM; Lazzarin, M; Lin, ZY; Moreno, JJL; Magrin, S; Michalik, H; Mottola, S; Oklay, N; Pommerol, A; Thomas, N; Tubiana, C; Vincent, JB				Massironi, Matteo; Simioni, Emanuele; Marzari, Francesco; Cremonese, Gabriele; Giacomini, Lorenza; Pajola, Maurizio; Jorda, Laurent; Naletto, Giampiero; Lowry, Stephen; El-Maarry, Mohamed Ramy; Preusker, Frank; Scholten, Frank; Sierks, Holger; Barbieri, Cesare; Lamy, Philippe; Rodrigo, Rafael; Koschny, Detlef; Rickman, Hans; Keller, Horst Uwe; A'Hearn, Michael F.; Agarwal, Jessica; Auger, Anne-Therese; Barucci, M. Antonella; Bertaux, Jean-Loup; Bertini, Ivano; Besse, Sebastien; Bodewits, Dennis; Capanna, Claire; Da Deppo, Vania; Davidsson, Bjoern; Debei, Stefano; De Cecco, Mario Lino; Ferri, Francesca; Fornasier, Sonia; Fulle, Marco; Gaskell, Robert; Groussin, Olivier; Gutierrez, Pedro J.; Guettler, Carsten; Hviid, Stubbe F.; Ip, Wing-Huen; Knollenberg, Joerg; Kovacs, Gabor; Kramm, Rainer; Kuehrt, Ekkehard; Kueppers, Michael; La Forgia, Fiorangela; Lara, Luisa M.; Lazzarin, Monica; Lin, Zhong-Yi; Lopez Moreno, Jose J.; Magrin, Sara; Michalik, Harald; Mottola, Stefano; Oklay, Nilda; Pommerol, Antoine; Thomas, Nicolas; Tubiana, Cecilia; Vincent, Jean-Baptiste			Two independent and primitive envelopes of the bilobate nucleus of comet 67P	NATURE			English	Article							DEEP IMPACT; GEOLOGY; SHAPE; SURFACE	The factors shaping cometary nuclei are still largely unknown, but could be the result of concurrent effects of evolutionary(1,2) and primordial processes(3,4). The peculiar bilobed shape of comet 67P/Churyumov-Gerasimenko may be the result of the fusion of two objects that were once separate or the result of a localized excavation by outgassing at the interface between the two lobes(5). Here we report that the comet's major lobe is enveloped by a nearly continuous set of strata, up to 650 metres thick, which are independent of an analogous stratified envelope on the minor lobe. Gravity vectors computed for the two lobes separately are closer to perpendicular to the strata than those calculated for the entire nucleus and adjacent to the neck separating the two lobes. Therefore comet 67P/Churyumov-Gerasimenko is an accreted body of two distinct objects with 'onion-like' stratification, which formed before they merged. We conclude that gentle, low-velocity collisions occurred between two fully formed kilometre-sized cometesimals in the early stages of the Solar System. The notable structural similarities between the two lobes of comet 67P/Churyumov-Gerasimenko indicate that the early-forming cometesimals experienced similar primordial stratified accretion, even though they formed independently.	[Massironi, Matteo; Giacomini, Lorenza] Univ Padua, Dipartimento Geosci, Via G Gradenigo 6, I-35131 Padua, Italy; [Massironi, Matteo; Pajola, Maurizio; Naletto, Giampiero; Bertini, Ivano; Ferri, Francesca] Univ Padua, Ctr Ateneo Studi & Attivita Spaziali Giuseppe Col, I-35131 Padua, Italy; [Simioni, Emanuele; Naletto, Giampiero; Da Deppo, Vania] CNR INFN UOS Padova LUXOR, I-35131 Padua, Italy; [Marzari, Francesco; Barbieri, Cesare; La Forgia, Fiorangela; Lazzarin, Monica; Magrin, Sara] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Cremonese, Gabriele] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Jorda, Laurent; Lamy, Philippe; Auger, Anne-Therese; Capanna, Claire; Groussin, Olivier] Aix Marseille Univ, CNRS, UMR 7326, LAM, F-13388 Marseille, France; [Naletto, Giampiero] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Lowry, Stephen] Univ Kent, Sch Phys Sci, Canterbury CT2 7NZ, Kent, England; [El-Maarry, Mohamed Ramy; Pommerol, Antoine; Thomas, Nicolas] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Preusker, Frank; Scholten, Frank; Hviid, Stubbe F.; Knollenberg, Joerg; Kuehrt, Ekkehard; Mottola, Stefano] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetenforsch, D-12489 Berlin, Germany; [Sierks, Holger; A'Hearn, Michael F.; Agarwal, Jessica; Guettler, Carsten; Hviid, Stubbe F.; Kovacs, Gabor; Kramm, Rainer; Oklay, Nilda; Tubiana, Cecilia; Vincent, Jean-Baptiste] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Rodrigo, Rafael] CSIC INTA, Ctr Astrobiol, Madrid 28850, Spain; [Rodrigo, Rafael] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Koschny, Detlef; Besse, Sebastien] European Space Res & Technol Ctr ESA, Sci Support Off, NL-2201 AZ Noordwijk, Netherlands; [Rickman, Hans] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Rickman, Hans] PAS Space Res Ctr, PL-00716 Warsaw, Poland; [Keller, Horst Uwe] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys IGEP, D-38106 Braunschweig, Germany; [A'Hearn, Michael F.; Bodewits, Dennis] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [A'Hearn, Michael F.] Akad Wissensch Gottingen, D-37077 Gottingen, Germany; [Barucci, M. Antonella; Fornasier, Sonia] Univ Paris Diderot, Univ Paris 06, CNRS, LESIA,Observ Paris, F-92195 Meudon, France; [Bertaux, Jean-Loup] UVSQ, CNRS, IPSL, LATMOS, F-78280 Guyancourt, France; [Davidsson, Bjoern] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Debei, Stefano] Univ Padua, Dept Ind Engn, I-35131 Padua, Italy; [De Cecco, Mario Lino] Univ Trent, I-38100 Trento, Italy; [Fulle, Marco] Osserv Astron Trieste, INAF, I-34014 Trieste, Italy; [Gaskell, Robert] Planetary Sci Inst, Tucson, AZ 85719 USA; [Gutierrez, Pedro J.; Lara, Luisa M.; Lopez Moreno, Jose J.] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Ip, Wing-Huen; Lin, Zhong-Yi] Natl Cent Univ, Grad Inst Astron, Chungli 32054, Taiwan; [Kueppers, Michael] European Space Astron Ctr ESA, Operat Dept, Madrid 28691, Spain; [Michalik, Harald] TU Braunschweig, Inst Datentech & Kommunikat, D-38106 Braunschweig, Germany	University of Padua; University of Padua; University of Padua; Istituto Nazionale Astrofisica (INAF); University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Padua; University of Kent; University of Bern; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Uppsala University; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Braunschweig University of Technology; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Uppsala University; University of Padua; University of Trento; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); National Central University; European Space Agency; Braunschweig University of Technology	Massironi, M (corresponding author), Univ Padua, Dipartimento Geosci, Via G Gradenigo 6, I-35131 Padua, Italy.	matteo.massironi@unipd.it	Naletto, Giampiero/S-6329-2016; Da Deppo, Vania/D-2897-2012; Kovacs, Gabor/H-5819-2012; El-Maarry, M. Ramy/K-1360-2018; Jorda, Laurent/AAA-1718-2021; Gutiérrez, Pedro J/AAJ-6177-2020; Tubiana, Cecilia/AAG-8209-2019; Marzari, Francesco/X-2440-2019; Lara, Luisa M/F-5614-2012; Pajola, Maurizio/N-5574-2018; Moreno, Jose Juan Lopez/M-5537-2019; La Forgia, Fiorangela/AAD-7477-2019; Kovacs, Gabor/E-4688-2010; Rickman, Hans/X-7631-2018; Thomas, Nicolas/G-4693-2015	Naletto, Giampiero/0000-0003-2007-3138; Da Deppo, Vania/0000-0001-6273-8738; Kovacs, Gabor/0000-0002-6431-0556; El-Maarry, M. Ramy/0000-0002-8262-0320; Gutiérrez, Pedro J/0000-0002-7332-6269; Tubiana, Cecilia/0000-0001-8475-9898; Lara, Luisa M/0000-0002-7184-920X; Pajola, Maurizio/0000-0002-3144-1277; Moreno, Jose Juan Lopez/0000-0002-7946-2624; La Forgia, Fiorangela/0000-0003-3924-1867; Kovacs, Gabor/0000-0002-6431-0556; Rickman, Hans/0000-0002-9603-6619; Besse, Sebastien/0000-0002-1052-5439; Debei, Stefano/0000-0002-6757-6616; Lowry, Stephen/0000-0002-5605-4329; Simioni, Emanuele/0000-0001-5993-0868; fulle, marco/0000-0001-8435-5287; De Cecco, Mariolino/0000-0003-1562-0328; Thomas, Nicolas/0000-0002-0146-0071; JORDA, Laurent/0000-0001-8735-3308; Cremonese, Gabriele/0000-0001-9021-1140; Bertini, Ivano/0000-0002-0616-2444; Massironi, Matteo/0000-0002-7757-8818; Ferri, Francesca/0000-0003-2395-5275	national funding agency of Germany (DLR); national funding agency of France (CNES); national funding agency of Italy (ASI); national funding agency of Spain (MEC); national funding agency of Sweden (SNSB); ESA Technical Directorate	national funding agency of Germany (DLR); national funding agency of France (CNES); national funding agency of Italy (ASI)(Agenzia Spaziale Italiana (ASI)); national funding agency of Spain (MEC); national funding agency of Sweden (SNSB); ESA Technical Directorate	OSIRIS was built by a consortium of the Max-Planck-Institut fur Sonnensystemforschung (in Gottingen, Germany), CISAS-University of Padova (Italy), the Laboratoire d'Astrophysique de Marseille (France), the Instituto de Astrofisica de Andalucia, CSIC (Granada, Spain), the Research and Scientific Support Department of the European Space Agency (Noordwijk, The Netherlands), the Instituto Nacional de Tecnica Aeroespacial (Madrid, Spain), the Universidad Politehnica de Madrid (Spain), the Department of Physics and Astronomy of Uppsala University (Sweden), and the Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig (Germany). The support of the national funding agencies of Germany (DLR), France (CNES), Italy (ASI), Spain (MEC), Sweden (SNSB), and the ESA Technical Directorate is gratefully acknowledged. We thank the ESA teams at ESAC, ESOC and ESTEC for their work in support of the Rosetta mission.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Basilevsky AT, 2006, PLANET SPACE SCI, V54, P808, DOI 10.1016/j.pss.2006.05.001; Belton MJS, 2007, ICARUS, V187, P332, DOI 10.1016/j.icarus.2006.09.005; Belton MJS, 2009, ICARUS, V200, P280, DOI 10.1016/j.icarus.2008.11.012; Bistacchi A, 2008, COMPUT GEOSCI-UK, V34, P351, DOI 10.1016/j.cageo.2007.04.002; Britt DT, 2004, ICARUS, V167, P45, DOI 10.1016/j.icarus.2003.09.004; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; El-Maarry M., 2015, ASTRON ASTROPHYS; Groshong R. H., 2008, 3 D STRUCTURAL GEOLG; Jansson KW, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424369; Jutzi M, 2015, SCIENCE, V348, P1355, DOI 10.1126/science.aaa4747; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; Lasue J, 2009, ICARUS, V203, P599, DOI 10.1016/j.icarus.2009.05.013; Preusker F, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526349; Schiavo A, 2015, J MAPS, V11, P201, DOI 10.1080/17445647.2014.980337; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Strahler AN, 1975, PHYS GEOGRAPHY; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Thomas P, 2013, ICARUS, V222, P453, DOI 10.1016/j.icarus.2012.02.037; Thomas PC, 2007, ICARUS, V187, P4, DOI 10.1016/j.icarus.2006.12.013; Werner R. A., 1996, Celestial Mechanics and Dynamical Astronomy, V65, P313, DOI 10.1007/BF00053511	23	128	130	1	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					402	+		10.1038/nature15511	http://dx.doi.org/10.1038/nature15511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26416730				2022-12-28	WOS:000362730200045
J	Acar, M; Kocherlakota, KS; Murphy, MM; Peyer, JG; Oguro, H; Inra, CN; Jaiyeola, C; Zhao, ZY; Luby-Phelps, K; Morrison, SJ				Acar, Melih; Kocherlakota, Kiranmai S.; Murphy, Malea M.; Peyer, James G.; Oguro, Hideyuki; Inra, Christopher N.; Jaiyeola, Christabel; Zhao, Zhiyu; Luby-Phelps, Katherine; Morrison, Sean J.			Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal	NATURE			English	Article							HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; PROGENITOR CELLS; MOUSE-BRAIN; NICHE; MAINTENANCE; MICROENVIRONMENT; SINUSOIDS; MICE	Haematopoietic stem cells (HSCs) reside in a perivascular niche but the specific location of this niche remains controversial(1). HSCs are rare and few can be found in thin tissue sections(2,3) or upon live imaging(4), making it difficult to comprehensively localize dividing and non-dividing HSCs. Here, using a green fluorescent protein (GFP) knock-in for the gene Ctnnal1 in mice (hereafter denoted as alpha-catulin(GFP)), we discover that alpha-catulin(GFP) is expressed by only 0.02% of bone marrow haematopoietic cells, including almost all HSCs. We find that approximately 30% of alpha-catulin-GFP(+)c-kit(+) cells give long-term multilineage reconstitution of irradiated mice, indicating that alpha-catulin-GFP(+)c-kit(+) cells are comparable in HSC purity to cells obtained using the best markers currently available. We optically cleared the bone marrow to perform deep confocal imaging, allowing us to image thousands of alpha-catulin-GFP(+)c-kit(+) cells and to digitally reconstruct large segments of bone marrow. The distribution of alpha-catulin-GFP(+)c-kit(+) cells indicated that HSCs were more common in central marrow than near bone surfaces, and in the diaphysis relative to the metaphysis. Nearly all HSCs contacted leptin receptor positive (Lepr(+)) and Cxcl12(high) niche cells, and approximately 85% of HSCs were within 10 mm of a sinusoidal blood vessel. Most HSCs, both dividing (Ki-67(+)) and non-dividing (Ki-67(-)), were distant from arterioles, transition zone vessels, and bone surfaces. Dividing and non-dividing HSCs thus reside mainly in perisinusoidal niches with Lepr(+)Cxcl12(high) cells throughout the bone marrow.	[Kocherlakota, Kiranmai S.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Acar, Melih; Kocherlakota, Kiranmai S.; Murphy, Malea M.; Peyer, James G.; Oguro, Hideyuki; Inra, Christopher N.; Jaiyeola, Christabel; Zhao, Zhiyu; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Acar, Melih; Kocherlakota, Kiranmai S.; Murphy, Malea M.; Peyer, James G.; Oguro, Hideyuki; Inra, Christopher N.; Jaiyeola, Christabel; Zhao, Zhiyu; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Oguro, Hideyuki/Q-5478-2019; Morrison, Sean/ABD-5326-2021	Oguro, Hideyuki/0000-0002-9070-4575; Luby-Phelps, Katherine/0000-0002-8378-1409; Morrison, Sean/0000-0003-1587-8329; Murphy, Malea/0000-0001-7071-6862	National Research Service Award from NIH; NIH NHLBI [HL097760]; NIH Shared Instrumentation grant [NIH S10RR029731]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760, F32HL124947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100848] Funding Source: NIH RePORTER	National Research Service Award from NIH; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Shared Instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S.J.M. is a Howard Hughes Medical Institute investigator, the Mary McDermott Cook Chair in Pediatric Genetics, the director of the Hamon Laboratory for Stem Cells and Cancer, and a Cancer Prevention and Research Institute of Texas Scholar. J.G.P. is a National Science Foundation Graduate Research Fellow. M.M.M. was supported by a National Research Service Award from NIH. This work was supported by the NIH NHLBI (HL097760) and NIH Shared Instrumentation grant NIH S10RR029731. We thank K. Correll and M. Gross for mouse colony management; N. Loof and the Moody Foundation Flow Cytometry Facility; and A. Bugde of the University of Texas Southwestern Live Cell Imaging Facility; and Y. Liu from the Baylor College of Dentistry microCT facility. We also gratefully acknowledge D. Miranda and A. Tully from Bitplane, S. Terclavers from Zeiss, and L. Smith and H. Pudavar from Leica.	Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P743, DOI 10.1101/pdb.prot076521; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Draenert K, 1980, SCANNING ELECT MICRO, V4, P113; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Inoue S, 2001, ANAT RECORD, V264, P294, DOI 10.1002/ar.1166; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kopp HG, 2009, ANN NY ACAD SCI, V1176, P47, DOI 10.1111/j.1749-6632.2009.04964.x; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu D, 2013, LASER PHOTONICS REV, V7, P732, DOI 10.1002/lpor.201200056; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	46	424	433	11	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					126	+		10.1038/nature15250	http://dx.doi.org/10.1038/nature15250			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416744	Green Accepted			2022-12-28	WOS:000362095100047
J	Mancini, M; Pagano, G; Cappellini, G; Livi, L; Rider, M; Catani, J; Sias, C; Zoller, P; Inguscio, M; Dalmonte, M; Fallani, L				Mancini, M.; Pagano, G.; Cappellini, G.; Livi, L.; Rider, M.; Catani, J.; Sias, C.; Zoller, P.; Inguscio, M.; Dalmonte, M.; Fallani, L.			Observation of chiral edge states with neutral fermions in synthetic Hall ribbons	SCIENCE			English	Article							MAGNETIC-FIELDS; QUANTUM; REALIZATION; ATOMS; MODEL; GAS	Chiral edge states are a hallmark of quantum Hall physics. In electronic systems, they appear as a macroscopic consequence of the cyclotron orbits induced by a magnetic field, which are naturally truncated at the physical boundary of the sample. Here we report on the experimental realization of chiral edge states in a ribbon geometry with an ultracold gas of neutral fermions subjected to an artificial gauge field. By imaging individual sites along a synthetic dimension, encoded in the nuclear spin of the atoms, we detect the existence of the edge states and observe the edge-cyclotron orbits induced during quench dynamics. The realization of fermionic chiral edge states opens the door for edge state interferometry and the study of non-Abelian anyons in atomic systems.	[Mancini, M.; Pagano, G.; Inguscio, M.; Fallani, L.] Univ Florence, Dept Phys & Astron, I-50019 Sesto Fiorentino, Italy; [Cappellini, G.; Livi, L.; Catani, J.; Sias, C.; Inguscio, M.; Fallani, L.] European Lab Nonlinear Spect LENS, I-50019 Sesto Fiorentino, Italy; [Rider, M.; Zoller, P.; Dalmonte, M.] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria; [Rider, M.; Zoller, P.; Dalmonte, M.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Catani, J.] CNR, INO, Sez Sesto Fiorentino, I-50019 Sesto Fiorentino, Italy; [Sias, C.; Inguscio, M.] Ist Nazl Ric Metrol INRIM, I-10135 Turin, Italy	University of Florence; Austrian Academy of Sciences; University of Innsbruck; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); Istituto Nazionale di Ricerca Metrologica (INRIM)	Fallani, L (corresponding author), Univ Florence, Dept Phys & Astron, I-50019 Sesto Fiorentino, Italy.	fallani@lens.unifi.it	Fallani, Leonardo/C-5347-2008; Sias, Carlo/D-1317-2014; Zoller, Peter/O-1639-2014; Pagano, Guido/B-1750-2018; Pagano, Guido/ACJ-0744-2022; Fallani, Leonardo/GXN-0557-2022; Cappellini, Giacomo/AAU-9911-2021; Rider, Marie/AAQ-1153-2021	Fallani, Leonardo/0000-0001-5327-3254; Sias, Carlo/0000-0002-5390-8288; Zoller, Peter/0000-0003-4014-1505; Pagano, Guido/0000-0002-6760-4015; Pagano, Guido/0000-0002-6760-4015; Fallani, Leonardo/0000-0001-5327-3254; Cappellini, Giacomo/0000-0003-4730-3941; Rider, Marie/0000-0001-5130-1901; Catani, Jacopo/0000-0002-2951-7041; dalmonte, marcello/0000-0001-5338-4181; Inguscio, Massimo/0000-0001-8152-8103; LIVI, LORENZO FRANCESCO/0000-0002-1704-4072	European Union (EU) SIQS; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) PRIN AQUASIM; European Research Council (ERC) DISQUA; ERC UQUAM; SFB FoQuS of the Austrian Science Fund; EU SIQS	European Union (EU) SIQS; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) PRIN AQUASIM; European Research Council (ERC) DISQUA(European Research Council (ERC)); ERC UQUAM; SFB FoQuS of the Austrian Science Fund; EU SIQS	We thank A. Celi and P. Massignan for early stimulating discussions on the synthetic dimension approach. M.D. and M.R. thank C. Laflamme and A. Sterdyniak for discussions. The experimental work in Florence, Italy, was supported by European Union (EU) grant FP7 SIQS, Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) grant PRIN2012 AQUASIM, and European Research Council (ERC) Advanced Grant DISQUA. The theoretical work in Innsbruck, Austria, was supported by ERC Synergy Grant UQUAM, SFB FoQuS of the Austrian Science Fund, and EU grant FP7 SIQS.	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Atala M, 2014, NAT PHYS, V10, P588, DOI 10.1038/NPHYS2998; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Boada O, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.133001; Cazalilla MA, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/124401; Celi A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043001; Cheuk LW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095302; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Duca L, 2015, SCIENCE, V347, P288, DOI 10.1126/science.1259052; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Lewenstein M, 2012, ULTRACOLD ATOMS IN OPTICAL LATTICES: SIMULATING QUANTUM MANY-BODY SYSTEMS, P1, DOI 10.1093/acprof:oso/9780199573127.001.0001; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lindner NH, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041002; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Pagano G, 2014, NAT PHYS, V10, P198, DOI [10.1038/nphys2878, 10.1038/NPHYS2878]; Prange R. E., 1990, QUANTUM HALL EFFECT; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; Taie S, 2012, NAT PHYS, V8, P825, DOI [10.1038/NPHYS2430, 10.1038/nphys2430]; Wang PJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095301; Wen X.G., 2004, QUANTUM FIELD THEORY; Yao NY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2531	26	461	465	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1510	1513		10.1126/science.aaa8736	http://dx.doi.org/10.1126/science.aaa8736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404829	Green Submitted			2022-12-28	WOS:000361707000040
J	Rao, RT				Rao, Rahul T.			PERSONAL VIEW Guidelines on safe alcohol drinking are probably about right	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTOR; CONSUMPTION		South London & Maudsley NHS Fdn Trust, Old Age Psychiat, London SE5 8RS, England	South London & Maudsley NHS Trust	Rao, RT (corresponding author), South London & Maudsley NHS Fdn Trust, Old Age Psychiat, London SE5 8RS, England.	tony.rao@kcl.ac.uk		Rao, Rahul/0000-0002-0262-5122				Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Crome I, 2012, ADDICTION, V107, P1541, DOI 10.1111/j.1360-0443.2012.03854.x; Department of Veterans' Affairs Australian Government, 2009, ALC OLD PEOPL; Johansen D, 2005, EUR J EPIDEMIOL, V20, P29, DOI 10.1007/s10654-004-2172-z; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Rehm J, 2015, LIFETIME RISK ALCOHO; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Stockwell T, 2013, ADDICTION, V108, P428, DOI 10.1111/j.1360-0443.2012.04076.x; U.S. Department of Agriculture, 2021, YOUR RIGHTS HIPAA	12	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2015	351								h5082	10.1136/bmj.h5082	http://dx.doi.org/10.1136/bmj.h5082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3GE	26403832				2022-12-28	WOS:000361959200016
J	Zhang, DC; Chen, G; Manwani, D; Mortha, A; Xu, CL; Faith, JJ; Burk, RD; Kunisaki, Y; Jang, JE; Scheiermann, C; Merad, M; Frenette, PS				Zhang, Dachuan; Chen, Grace; Manwani, Deepa; Mortha, Arthur; Xu, Chunliang; Faith, Jeremiah J.; Burk, Robert D.; Kunisaki, Yuya; Jang, Jung-Eun; Scheiermann, Christoph; Merad, Miriam; Frenette, Paul S.			Neutrophil ageing is regulated by the microbiome	NATURE			English	Article							BONE-MARROW; GRANULOPOIESIS; MICRODOMAINS; HOMEOSTASIS	Blood polymorphonuclear neutrophils provide immune protection against pathogens, but may also promote tissue injury in inflammatory diseases(1,2). Although neutrophils are generally considered to be a relatively homogeneous population, evidence for heterogeneity is emerging(3,4). Under steady-state conditions, neutrophil heterogeneity may arise from ageing and replenishment by newly released neutrophils from the bone marrow(5). Aged neutrophils upregulate CXCR4, a receptor allowing their clearance in the bone marrow(6,7), with feedback inhibition of neutrophil production via the IL-17/G-CSF axis8, and rhythmic modulation of the haematopoietic stem-cell niche(5). The aged subset also expresses low levels of L-selectin(5,9). Previous studies have suggested that in vitro-aged neutrophils exhibit impaired migration and reduced pro-inflammatory properties(6,10). Here, using in vivo ageing analyses in mice, we show that neutrophil pro-inflammatory activity correlates positively with their ageing whilst in circulation. Aged neutrophils represent an overly active subset exhibiting enhanced alpha(M)beta(2) integrin activation and neutrophil extracellular trap formation under inflammatory conditions. Neutrophil ageing is driven by the microbiota via Toll-like receptor and myeloid differentiation factor 88-mediated signalling pathways. Depletion of the microbiota significantly reduces the number of circulating aged neutrophils and dramatically improves the pathogenesis and inflammation-related organ damage inmodels of sickle-cell disease or endotoxin-induced septic shock. These results identify a role for the microbiota in regulating a disease-promoting neutrophil subset.	[Zhang, Dachuan; Chen, Grace; Xu, Chunliang; Kunisaki, Yuya; Jang, Jung-Eun; Scheiermann, Christoph; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Zhang, Dachuan; Chen, Grace; Xu, Chunliang; Kunisaki, Yuya; Jang, Jung-Eun; Scheiermann, Christoph; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Manwani, Deepa; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Mortha, Arthur; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Mortha, Arthur; Faith, Jeremiah J.; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Faith, Jeremiah J.] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Scheiermann, Christoph/B-8261-2014; Frenette, Paul S/J-8272-2012; Xu, Chunliang/R-7065-2018; Mortha, Arthur/ABE-6250-2020; Zhang, Dachuan/GZA-8781-2022	Scheiermann, Christoph/0000-0002-9212-0995; Frenette, Paul S/0000-0003-0862-9922; Zhang, Dachuan/0000-0002-1746-275X; Mortha, Arthur/0000-0003-2673-0485	American Heart Association [15PRE23010014]; National Institutes of Health [HL069438, DK056638, HL116340]; New York State Stem Cell Science (NYSTEM) Program; NATIONAL CANCER INSTITUTE [R01CA190400, R01CA173861, R01CA154947] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL116340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638, P30DK041296] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K15364] Funding Source: KAKEN	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM) Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to C. Prophete and P. Ciero for expert technical assistance. We also thank E. Pamer (Memorial Sloan Kettering Cancer Center) for the gift of Tlr2<SUP>-/-</SUP> and Tlr4<SUP>-/-</SUP> mice; K. Ireland for assistance with the SCD patient study; Z. Chen for the taxonomic microbiota analysis; R. Ng for assistance with the germ-free mice; O. Uche and G. Wang for assistance in cell sorting; D. Reynolds and W. Tran for the microarray assay; and R. Sellers for histopathological analyses. This work was supported by a predoctoral fellowship from the American Heart Association (15PRE23010014 to D.Z.) and R01 grants from the National Institutes of Health (HL069438, DK056638, HL116340 to P.S.F.). Flow cytometry and cell sorting was supported by a Shared Facilities Award from the New York State Stem Cell Science (NYSTEM) Program.	Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chen G, 2014, BLOOD, V123, P3818, DOI 10.1182/blood-2013-10-529982; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Hang J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-31; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; ROTHE G, 1994, METHOD ENZYMOL, V233, P539; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; SCHNITT SJ, 1993, CIRC RES, V72, P914, DOI 10.1161/01.RES.72.4.914; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanji-Matsuba K, 1998, CIRCULATION, V97, P91, DOI 10.1161/01.CIR.97.1.91; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062	34	446	453	5	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					528	+		10.1038/nature15367	http://dx.doi.org/10.1038/nature15367			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26374999	Green Accepted			2022-12-28	WOS:000361599900052
J	Ko, TM; Tsai, CY; Chen, SY; Chen, KS; Yu, KH; Chu, CS; Huang, CM; Wang, CR; Weng, CT; Yu, CL; Hsieh, SC; Tsai, JC; Lai, WT; Tsai, WC; Yin, GD; Ou, TT; Cheng, KH; Yen, JH; Liou, TL; Lin, TH; Chen, DY; Hsiao, PJ; Weng, MY; Chen, YM; Chen, CH; Liu, MF; Yen, HW; Lee, JJ; Kuo, MC; Wu, CC; Hung, SY; Luo, SF; Yang, YH; Chuang, HP; Chou, YC; Liao, HT; Wang, CW; Huang, CL; Chang, CS; Lee, MTM; Chen, P; Wong, CS; Chen, CH; Wu, JY; Chen, YT; Shen, CY				Ko, Tai-Ming; Tsai, Chang-Youh; Chen, Shih-Yang; Chen, Kuo-Shu; Yu, Kuang-Hui; Chu, Chih-Sheng; Huang, Chung-Ming; Wang, Chrong-Reen; Weng, Chia-Tse; Yu, Chia-Li; Hsieh, Song-Chou; Tsai, Jer-Chia; Lai, Wen-Ter; Tsai, Wen-Chan; Yin, Guang-Dar; Ou, Tsan-Teng; Cheng, Kai-Hung; Yen, Jeng-Hsien; Liou, Teh-Ling; Lin, Tsung-Hsien; Chen, Der-Yuan; Hsiao, Pi-Jung; Weng, Meng-Yu; Chen, Yi-Ming; Chen, Chen-Hung; Liu, Ming-Fei; Yen, Hsueh-Wei; Lee, Jia-Jung; Kuo, Mei-Chuan; Wu, Chen-Ching; Hung, Shih-Yuan; Luo, Shue-Fen; Yang, Ya-Hui; Chuang, Hui-Ping; Chou, Yi-Chun; Liao, Hung-Ting; Wang, Chia-Wen; Huang, Chun-Lin; Chang, Chia-Shuo; Lee, Ming-Ta Michael; Chen, Pei; Wong, Chih-Shung; Chen, Chien-Hsiun; Wu, Jer-Yuarn; Chen, Yuan-Tsong; Shen, Chen-Yang		Taiwan Allopurinol-SCAR Consortium	Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; HLA-B; RISK; ASSOCIATION; MANAGEMENT; ALLELE; GOUT; HYPERSENSITIVITY; GUIDELINES	OBJECTIVE To evaluate the use of prospective screening for the HLA-B*58:01 allele to identify Taiwanese individuals at risk of severe cutaneous adverse reactions (SCARs) induced by allopurinol treatment. DESIGN National prospective cohort study. SETTING 15 medical centres in different regions of Taiwan, from July 2009 to August 2014. PARTICIPANTS 2926 people who had an indication for allopurinol treatment but had not taken allopurinol previously. Participants were excluded if they had undergone a bone marrow transplant, were not of Han Chinese descent, and had a history of allopurinol induced hypersensitivity. DNA purified from 2910 participants' peripheral blood was used to assess the presence of HLA-B*58:01. MAIN OUTCOME MEASURES Incidence of allopurinol induced SCARs with and without screening. RESULTS Participants who tested positive for HLA-B*58:01 (19.6%, n=571) were advised to avoid allopurinol, and were referred to an alternate drug treatment or advised to continue with their prestudy treatment. Participants who tested negative (80.4%, n=2339) were given allopurinol. Participants were interviewed once a week for two months to monitor symptoms. The historical incidence of allopurinol induced SCARs, estimated by the National Health Insurance research database of Taiwan, was used for comparison. Mild, transient rash without blisters developed in 97 (3%) participants during follow-up. None of the participants was admitted to hospital owing to adverse drug reactions. SCARs did not develop in any of the participants receiving allopurinol who screened negative for HLA-B* 58: 01. By contrast, seven cases of SCARs were expected, based on the estimated historical incidence of allopurinol induced SCARs nationwide (0.30% per year, 95% confidence interval 0.28% to 0.31%; P=0.0026; two side one sample binomial test). CONCLUSIONS Prospective screening of the HLA-B*58:01 allele, coupled with an alternative drug treatment for carriers, significantly decreased the incidence of allopurinol induced SCARs in Taiwanese medical centres.	[Ko, Tai-Ming; Chuang, Hui-Ping; Chou, Yi-Chun; Liao, Hung-Ting; Wang, Chia-Wen; Huang, Chun-Lin; Chang, Chia-Shuo; Lee, Ming-Ta Michael; Chen, Pei; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Ko, Tai-Ming; Huang, Chung-Ming] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Tsai, Chang-Youh; Liou, Teh-Ling] Taipei Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Tsai, Chang-Youh; Chen, Der-Yuan; Chen, Yi-Ming] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Shih-Yang] Country Hosp, Ctr Gout, Taipei, Taiwan; [Chen, Kuo-Shu] Tungs Taichung MetroHarbor Hosp, Taichung, Taiwan; [Yu, Kuang-Hui] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Chu, Chih-Sheng; Tsai, Jer-Chia; Lai, Wen-Ter; Tsai, Wen-Chan; Ou, Tsan-Teng; Cheng, Kai-Hung; Yen, Jeng-Hsien; Lin, Tsung-Hsien; Hsiao, Pi-Jung; Yen, Hsueh-Wei; Lee, Jia-Jung; Wu, Chen-Ching] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chu, Chih-Sheng; Tsai, Jer-Chia; Lai, Wen-Ter; Tsai, Wen-Chan; Ou, Tsan-Teng; Cheng, Kai-Hung; Yen, Jeng-Hsien; Lin, Tsung-Hsien; Hsiao, Pi-Jung; Yen, Hsueh-Wei; Lee, Jia-Jung; Kuo, Mei-Chuan; Wu, Chen-Ching] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Chu, Chih-Sheng; Tsai, Jer-Chia; Lai, Wen-Ter; Tsai, Wen-Chan; Ou, Tsan-Teng; Cheng, Kai-Hung; Yen, Jeng-Hsien; Hsiao, Pi-Jung; Yen, Hsueh-Wei; Wu, Chen-Ching] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan; [Chu, Chih-Sheng; Tsai, Jer-Chia; Lai, Wen-Ter; Tsai, Wen-Chan; Ou, Tsan-Teng; Cheng, Kai-Hung; Yen, Jeng-Hsien; Hsiao, Pi-Jung; Yen, Hsueh-Wei; Wu, Chen-Ching] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Huang, Chung-Ming] China Med Univ Hosp, Taichung, Taiwan; [Wang, Chrong-Reen; Weng, Chia-Tse; Liu, Ming-Fei] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yin, Guang-Dar] Far Eastern Polyclin, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan; [Chen, Chen-Hung] Tri Serv Gen Hosp, Taipei, Taiwan; [Kuo, Mei-Chuan] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Hung, Shih-Yuan] E Da Hosp, Div Nephrol, Kaohsiung, Taiwan; [Hung, Shih-Yuan] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Luo, Shue-Fen] Chang Gung Univ, Taoyuan, Taiwan; [Yang, Ya-Hui] Fooyin Univ, Dept Occupat Safety & Hyg, Kaohsiung, Taiwan; [Yang, Ya-Hui] Kaohsiung Vet Gen Hosp, Dept Educ & Res, Kaohsiung, Taiwan; [Lee, Ming-Ta Michael] RIKEN, Ctr Integrat Med Sci, Lab Int Alliance Genom Res, Core Genom Med, Yokohama, Kanagawa, Japan; [Wong, Chih-Shung] Cathay Gen Hosp, Dept Anaesthesiol, Taipei, Taiwan; [Wong, Chih-Shung] PharmiGene, Taipei, Taiwan; [Chen, Chien-Hsiun; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Shen, Chen-Yang] China Med Univ Hosp, Coll Publ Hlth, Taichung, Taiwan; [Shen, Chen-Yang] Acad Sinica, Taiwan Biobank, Taipei 11529, Taiwan	Academia Sinica - Taiwan; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Tungs' Taichung MetroHarbor Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Tri-Service General Hospital; Kaohsiung Medical University; E-Da Hospital; I Shou University; Chang Gung University; Fooyin University; Kaohsiung Veterans General Hospital; RIKEN; Cathay General Hospital; China Medical University Taiwan; Duke University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan	Shen, CY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	bmcys@ibms.sin.ca.edu.tw	Tsai, Chang-Youh/G-1747-2013; Wu, Jer-Yuarn/S-7010-2018; Chen, Yi-Ming/AAV-3806-2021; Chen, Chien Hsiun/Q-3826-2018; Yen, Jeng-Hsien/A-1335-2010; Ko, Tai-Ming/ABB-3384-2020	Tsai, Chang-Youh/0000-0002-4154-4018; Chen, Yi-Ming/0000-0001-7593-3065; Yen, Jeng-Hsien/0000-0002-1291-1739; Lin, Tsung-Hsien/0000-0002-7226-8730; Yang, Ya-Hui/0000-0002-1785-5123; Chang, Joshua/0000-0003-3591-602X; Wang, Chrong-Reen/0000-0001-9881-7024; Cheng, Kai-Hung/0000-0003-1066-9499	Academia Sinica Genomic Medicine Multicenter, Taiwan [40-05-GMM]; Taiwan Biobank, Academia Sinica, Taiwan; National Health Research Institutes, Taiwan [NHIRD-102-066]	Academia Sinica Genomic Medicine Multicenter, Taiwan; Taiwan Biobank, Academia Sinica, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the Academia Sinica Genomic Medicine Multicenter Study (40-05-GMM), Taiwan Biobank, Academia Sinica, and the National Health Research Institutes (NHIRD-102-066). All three funders are from Taiwan.	Cao ZH, 2012, PHARMACOGENOMICS, V13, P1193, DOI [10.2217/pgs.12.89, 10.2217/PGS.12.89]; Chao Jeannie, 2009, Curr Rheumatol Rep, V11, P135; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chiu MLS, 2012, BRIT J DERMATOL, V167, P44, DOI 10.1111/j.1365-2133.2012.10894.x; Chung WH, 2007, CURR OPIN ALLERGY CL, V7, P317, DOI 10.1097/ACI.0b013e3282370c5f; Chung WH, 2015, ANN RHEUM DIS, V74, P2157, DOI 10.1136/annrheumdis-2014-205577; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Fam AG, 2001, ARTHRITIS RHEUM-US, V44, P231, DOI 10.1002/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7; Fritsch P O, 2000, Am J Clin Dermatol, V1, P349, DOI 10.2165/00128071-200001060-00003; Ghislain Pierre-Dominique, 2002, Dermatol Online J, V8, P5; Goncalo M, 2013, BRIT J DERMATOL, V169, P660, DOI 10.1111/bjd.12389; Greenberger PA, 2006, J ALLERGY CLIN IMMUN, V117, pS464, DOI 10.1016/j.jaci.2005.11.002; Halevy S, 2008, J AM ACAD DERMATOL, V58, P25, DOI 10.1016/j.jaad.2007.08.036; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hershfield MS, 2013, CLIN PHARMACOL THER, V93, P153, DOI 10.1038/clpt.2012.209; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kang HR, 2011, PHARMACOGENET GENOM, V21, P303, DOI 10.1097/FPC.0b013e32834282b8; Kaniwa N, 2008, PHARMACOGENOMICS, V9, P1617, DOI 10.2217/14622416.9.11.1617; Kim SC, 2013, ARTHRIT CARE RES, V65, P578, DOI 10.1002/acr.21817; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Lin CH, 2015, J ALLERGY CLIN IMMUN, V135, P1063, DOI 10.1016/j.jaci.2014.09.041; Lin HW, 2011, LANCET ONCOL, V12, P900, DOI 10.1016/S1470-2045(11)70165-6; Lonjou C, 2008, PHARMACOGENET GENOM, V18, P99, DOI 10.1097/FPC.0b013e3282f3ef9c; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Markel A, 2005, ISR MED ASSOC J, V7, P656; Mini E, 2009, CLIN CASES MINER BON, V6, P17; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Nuki G, 2014, CURR OPIN RHEUMATOL, V26, P152, DOI 10.1097/BOR.0000000000000034; Park DJ, 2015, ARTHRIT CARE RES, V67, P280, DOI 10.1002/acr.22409; Ramasamy SN, 2013, DRUG SAFETY, V36, P953, DOI 10.1007/s40264-013-0084-0; Saokaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094294; Schneider G, 2012, PHARMACOEPIDEM DR S, V21, P236, DOI 10.1002/pds.2331; Sivera F, 2014, ANN RHEUM DIS, V73, P328, DOI 10.1136/annrheumdis-2013-203325; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yun J, 2013, CLIN EXP ALLERGY, V43, P1246, DOI 10.1111/cea.12184; Yun J, 2014, J IMMUNOL, V192, P2984, DOI 10.4049/jimmunol.1302306	39	135	140	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4848	10.1136/bmj.h4848	http://dx.doi.org/10.1136/bmj.h4848			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26399967	Green Published, hybrid			2022-12-28	WOS:000361957200008
J	Dohner, H; Weisdorf, DJ; Bloomfield, CD				Doehner, Hartmut; Weisdorf, Daniel J.; Bloomfield, Clara D.			Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; 1ST COMPLETE REMISSION; UMBILICAL-CORD BLOOD; MINIMAL RESIDUAL DISEASE; NEWLY-DIAGNOSED AML; MYELODYSPLASTIC SYNDROME; OLDER PATIENTS; CLONAL HEMATOPOIESIS; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE		[Doehner, Hartmut] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Weisdorf, Daniel J.] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN USA; [Bloomfield, Clara D.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Ulm University; University of Minnesota System; University of Minnesota Twin Cities; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Bloomfield, CD (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, C933,460 W 10th Ave, Columbus, OH 43210 USA.	clara.bloomfield@osumc.edu	Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536	Celgene; Astellas; Eli Lilly; Bristol-Myers Squibb; GlaxoSmithKline; Astex Pharmaceuticals; Roche; Celator Pharmaceuticals; Agios Pharmaceuticals; Seattle Genetics; Tolero Pharmaceuticals; Sunesis Pharmaceuticals; Amgen; Alexion; Pharmacyclics; Therakos	Celgene(Bristol-Myers SquibbCelgene Corporation); Astellas(Astellas Pharmaceuticals); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Astex Pharmaceuticals; Roche(Roche Holding); Celator Pharmaceuticals; Agios Pharmaceuticals; Seattle Genetics; Tolero Pharmaceuticals; Sunesis Pharmaceuticals; Amgen(Amgen); Alexion; Pharmacyclics; Therakos	Dr. Dohner reports receiving fees for serving on advisory boards from Celgene, Astellas, Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Astex Pharmaceuticals, Roche, Celator Pharmaceuticals, Agios Pharmaceuticals, Seattle Genetics, Tolero Pharmaceuticals, Sunesis Pharmaceuticals, and Amgen, honoraria for scientific presentations from Celgene, and fees for chairing a symposium from Amgen; and Dr. Weisdorf, receiving consulting fees from Alexion, Amgen, and Pharmacyclics, honoraria for study planning from Pharmacyclics and Enlivex Therapeutics, lecture fees from Therakos, travel support from Millennium, and grant support from Alexion. No other potential conflict of interest relevant to this article was reported.	Abdel-Wahab O, 2013, BLOOD, V121, P3563, DOI 10.1182/blood-2013-01-451781; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Ballen KK, 2012, BLOOD, V119, P1972, DOI 10.1182/blood-2011-11-354563; Bashey A, 2013, J CLIN ONCOL, V31, P1310, DOI 10.1200/JCO.2012.44.3523; Bornhauser M, 2012, LANCET ONCOL, V13, P1035, DOI 10.1016/S1470-2045(12)70349-2; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Burnett AK, 2015, BLOOD, V125, P3878, DOI 10.1182/blood-2015-01-623447; Burnett AK, 2013, J CLIN ONCOL, V31, P3360, DOI 10.1200/JCO.2012.47.4874; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Chan SM, 2015, NAT MED, V21, P178, DOI 10.1038/nm.3788; Cooley S, 2014, J IMMUNOL, V192, P4592, DOI 10.4049/jimmunol.1302517; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; de Lima M, 2014, BIOL BLOOD MARROW TR, V20, P4, DOI 10.1016/j.bbmt.2013.08.012; de Lima M, 2010, CANCER-AM CANCER SOC, V116, P5420, DOI 10.1002/cncr.25500; Di Stasi A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00036; DiNardo CD, 2015, EXPERT OPIN PHARMACO, V16, P95, DOI 10.1517/14656566.2015.981527; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dombret H, 2014, BLOOD, V124, P117, DOI [10.1182/blood.V124.21.117.117, DOI 10.1182/BLOOD.V124.21.117.117]; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Eapen M, 2011, LANCET ONCOL, V12, P1214, DOI 10.1016/S1470-2045(11)70260-1; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Farag SS, 2011, BIOL BLOOD MARROW TR, V17, P1796, DOI 10.1016/j.bbmt.2011.06.005; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Gasiorowski RE, 2014, BRIT J HAEMATOL, V164, P481, DOI 10.1111/bjh.12691; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gill S, 2014, BLOOD, V123, P2343, DOI 10.1182/blood-2013-09-529537; Godley LA, 2014, SEMIN HEMATOL, V51, P306, DOI 10.1053/j.seminhematol.2014.08.001; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; Grimwade D, 2014, BLOOD, V124, P3345, DOI [10.1182/blood-2014-05-577593, 10.1182/asheducation-2014.1.222]; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Gupta V, 2011, BLOOD, V117, P2307, DOI 10.1182/blood-2010-10-265603; Gupta V, 2010, BLOOD, V116, P1839, DOI 10.1182/blood-2010-04-278317; Hills RK, 2014, LANCET ONCOL, V15, P986, DOI 10.1016/S1470-2045(14)70281-5; Hills RK, 2011, BLOOD, V118, P2389, DOI 10.1182/blood-2011-02-337261; Issa JJ, 2015, LANCET ONCOL; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Lancet JE, 2014, BLOOD, V123, P3239, DOI 10.1182/blood-2013-12-540971; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Litzow MR, 2010, BLOOD, V115, P1850, DOI 10.1182/blood-2009-10-249128; Lowenberg B, 2013, BLOOD, V121, P26, DOI 10.1182/blood-2012-07-444851; Lynn RC, 2015, BLOOD, V125, P3466, DOI 10.1182/blood-2014-11-612721; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; McClune BL, 2010, J CLIN ONCOL, V28, P1878, DOI 10.1200/JCO.2009.25.4821; McCurdy SR, 2015, BLOOD, V125, P3024, DOI 10.1182/blood-2015-01-623991; Mendler JH, 2012, J CLIN ONCOL, V30, P3109, DOI 10.1200/JCO.2011.40.6652; Meyer SC, 2014, LANCET ONCOL, V15, pE382, DOI 10.1016/S1470-2045(14)70008-7; Nacheva EP, 2013, BRIT J HAEMATOL, V161, P541, DOI 10.1111/bjh.12301; Othus M, 2014, LEUKEMIA, V28, P289, DOI 10.1038/leu.2013.176; Pasquini MC, 2012, J CLIN ONCOL, V30, P3194, DOI 10.1200/JCO.2012.41.7071; Petersdorf SH, 2013, BLOOD, V121, P4854, DOI 10.1182/blood-2013-01-466706; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Rasche L, 2015, BLOOD, V126; Ravandi F, 2014, BLOOD, V124; Schlenk RF, 2014, HAEMATOLOGICA, V99, P1663, DOI 10.3324/haematol.2014.114611; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sorror ML, 2014, J CLIN ONCOL, V32, P3249, DOI 10.1200/JCO.2013.53.8157; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takahashi Y, 2015, INT J RADIAT ONCOL, V91, P30, DOI 10.1016/j.ijrobp.2014.09.014; Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280; Thol F, 2015, BLOOD, V126, P319, DOI 10.1182/blood-2014-10-551911; Vellenga E, 2011, BLOOD, V118, P6037, DOI 10.1182/blood-2011-07-370247; Walter RB, 2015, LEUKEMIA; Walter RB, 2013, BLOOD, V122, P1813, DOI 10.1182/blood-2013-06-506725; Wander SA, 2014, THER ADV HEMATOL, V5, P65, DOI 10.1177/2040620714532123; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Williams DM, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.115.115; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177	77	1710	1780	40	393	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1136	1152		10.1056/NEJMra1406184	http://dx.doi.org/10.1056/NEJMra1406184			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR7UG	26376137				2022-12-28	WOS:000361556400009
J	Rajniak, J; Barco, B; Clay, NK; Sattely, ES				Rajniak, Jakub; Barco, Brenden; Clay, Nicole K.; Sattely, Elizabeth S.			A new cyanogenic metabolite in Arabidopsis required for inducible pathogen defence	NATURE			English	Article							FLAGELLIN PERCEPTION; PLANTS; INDOLE-3-ACETALDOXIME; BIOSYNTHESIS; RESISTANCE; CONVERSION; CATALYZES; THALIANA; PATHWAY	Thousands of putative biosynthetic genes in Arabidopsis thaliana have no known function, which suggests that there are numerous molecules contributing to plant fitness that have not yet been discovered(1,2). Prime among these uncharacterized genes are cytochromes P450 upregulated in response to pathogens(3,4). Here we start with a single pathogen-induced P450 (ref. 5), CYP82C2, and use a combination of untargeted metabolomics and coexpression analysis to uncover the complete biosynthetic pathway to 4-hydroxyindole-3-carbonyl nitrile (4-OH-ICN), a previously unknown Arabidopsis metabolite. This metabolite harbours cyanogenic functionality that is unprecedented in plants and exceedingly rare in nature(6,7); furthermore, the aryl cyanohydrin intermediate in the 4-OH-ICN pathway reveals a latent capacity for cyanogenic glucoside biosynthesis(8,9) in Arabidopsis. By expressing 4-OH-ICN biosynthetic enzymes in Saccharomyces cerevisiae and Nicotiana benthamiana, we reconstitute the complete pathway in vitro and in vivo and validate the functions of its enzymes. Arabidopsis 4-OH-ICN pathway mutants show increased susceptibility to the bacterial pathogen Pseudomonas syringae, consistent with a role in inducible pathogen defence. Arabidopsis has been the pre-eminent model system(10,11) for studying the role of small molecules in plant innate immunity(12); our results uncover a new branch of indole metabolism distinct from the canonical camalexin pathway, and support a role for this pathway in the Arabidopsis defence response(13). These results establish a more complete framework for understanding how the model plant Arabidopsis uses small molecules in pathogen defence.	[Rajniak, Jakub; Sattely, Elizabeth S.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Barco, Brenden; Clay, Nicole K.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Stanford University; Yale University	Sattely, ES (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	nicole.clay@yale.edu; sattely@stanford.edu		Rajniak, Jakub/0000-0003-2124-0647; Barco, Brenden/0000-0002-6298-9593	National Science Foundation [MCB-0519898]; National Institutes of Health [R37 GM 48707];  [R00 GM089985];  [DP2 AT008321];  [T32 GM008412-20];  [T32 GM007499-38]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [DP2AT008321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048707, T32GM007499, T32GM008412, R00GM089985, R37GM048707] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Ausubel, M. B. Mudgett, C. Khosla, A. Saghatelian, Y. Millet, C. Danna, S. Galanie, and members of the Sattely and Clay laboratories for advice on experiments and comments on the manuscript. We thank the Salk Institute Genomic Analysis Laboratory for providing the sequence-indexed Arabidopsis transfer-DNA insertion mutants. We thank G. Lomonossoff (John Innes Centre) for providing plasmid pEAQ. This work was supported by R00 GM089985 and DP2 AT008321 (to E.S.S.), T32 GM008412-20 (to J.R.), and T32 GM007499-38 (to B.B.). The early stages of this work were supported by National Science Foundation grant MCB-0519898 and National Institutes of Health grant R37 GM 48707 (awarded to Fred Ausubel, Massachusetts General Hospital, Boston, Massachusetts, USA).	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Bottcher C, 2014, PLANT PHYSIOL, V165, P841, DOI 10.1104/pp.114.235630; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Jones TH, 1976, J CHEM ECOL, V2, P421, DOI 10.1007/BF00988807; Liu F, 2010, CELL RES, V20, P539, DOI 10.1038/cr.2010.36; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Peyret H, 2013, PLANT MOL BIOL, V83, P51, DOI 10.1007/s11103-013-0036-1; Rauhut T, 2009, PHYTOCHEMISTRY, V70, P1638, DOI 10.1016/j.phytochem.2009.05.002; Tattersall DB, 2001, SCIENCE, V293, P1826, DOI 10.1126/science.1062249; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Vinayavekhin N, 2010, CURRENT PROTOCOLS MO, V30, P1, DOI 10.1002/0471142727.mb3001s90; Zagrobelny M, 2008, PHYTOCHEMISTRY, V69, P1457, DOI 10.1016/j.phytochem.2008.02.019; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	28	132	142	10	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					376	+		10.1038/nature14907	http://dx.doi.org/10.1038/nature14907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26352477	Green Accepted			2022-12-28	WOS:000361297900043
J	Woolston, C				Woolston, Chris			WORK ENVIRONMENT When labs go bad	NATURE			English	Editorial Material																			0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					413	415		10.1038/nj7569-413a	http://dx.doi.org/10.1038/nj7569-413a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR4JL	26397002				2022-12-28	WOS:000361297900051
J	Feinberg, AP; Fallin, MD				Feinberg, Andrew P.; Fallin, M. Daniele			Epigenetics at the Crossroads of Genes and the Environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DNA METHYLATION		[Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Fallin, M. Daniele] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Ctr Epigenet, 720 Rutland Ave,Ross 1064, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NHGRI NIH HHS [P50 HG003233] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Multhaup ML, 2015, CELL METAB, V21, P138, DOI 10.1016/j.cmet.2014.12.014; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	10	54	55	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1129	1130		10.1001/jama.2015.10414	http://dx.doi.org/10.1001/jama.2015.10414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372577	Green Accepted			2022-12-28	WOS:000361284500019
J	Peterson, ED				Peterson, Eric D.			The Lasker Awards-Recognizing and Valuing Investments in Cardiovascular Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA	Duke University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, POB 17969, Durham, NC 27715 USA.	eric.peterson@duke.edu	Peterson, Eric David/ABF-5033-2021					Altman LK, PAGE IS DEAD 90 PION; Fleishman JL, CASEBOOK FDN GREAT A; KATZ LN, 1952, CIRCULATION, V5, P101, DOI 10.1161/01.CIR.5.1.101; Lasker Foundation, THE LASK LEG; Levitan D, PAUL KNOCKS FLIES NI; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; US National Library of Medicine, M LASK PAP	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1121	1122		10.1001/jama.2015.10486	http://dx.doi.org/10.1001/jama.2015.10486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372573				2022-12-28	WOS:000361284500015
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: For better primary care, pay GPs for service	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4839	10.1136/bmj.h4839	http://dx.doi.org/10.1136/bmj.h4839			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371079	Bronze			2022-12-28	WOS:000361678200020
J	Poccia, N; Baturina, TI; Coneri, F; Molenaar, CG; Wang, XR; Bianconi, G; Brinkman, A; Hilgenkamp, H; Golubov, AA; Vinokur, VM				Poccia, Nicola; Baturina, Tatyana I.; Coneri, Francesco; Molenaar, Cor G.; Wang, X. Renshaw; Bianconi, Ginestra; Brinkman, Alexander; Hilgenkamp, Hans; Golubov, Alexander A.; Vinokur, Valerii M.			Critical behavior at a dynamic vortex insulator-to-metal transition	SCIENCE			English	Article							TEMPERATURE MOTT TRANSITION; SUPERCONDUCTING FILMS; ARRAYS; ELECTRONS; DEFECTS	An array of superconducting islands placed on a normal metal film offers a tunable realization of nanopatterned superconductivity. This system enables investigation of the nature of competing vortex states and phase transitions between them. A square array creates the eggcrate potential in which magnetic field-induced vortices are frozen into a vortex insulator. We observed a vortex insulator-vortex metal transition driven by the applied electric current and determined critical exponents that coincided with those for thermodynamic liquid-gas transition. Our findings offer a comprehensive description of dynamic critical behavior and establish a deep connection between equilibrium and nonequilibrium phase transitions.	[Poccia, Nicola; Coneri, Francesco; Molenaar, Cor G.; Wang, X. Renshaw; Brinkman, Alexander; Hilgenkamp, Hans; Golubov, Alexander A.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Poccia, Nicola] Rome Int Ctr Mat Sci Superstripes RICMASS, I-00185 Rome, Italy; [Baturina, Tatyana I.] Russian Acad Sci, Siberian Branch, AV Rzhanov Inst Semicond Phys, Novosibirsk 630090, Russia; [Baturina, Tatyana I.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Baturina, Tatyana I.; Vinokur, Valerii M.] Argonne Natl Lab, Div Mat Sci, Chicago, IL 60637 USA; [Bianconi, Ginestra] Queen Mary Univ London, Sch Math Sci, London E1 4NS, England; [Golubov, Alexander A.] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow District, Russia	University of Twente; Russian Academy of Sciences; Omsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences; Rzhanov Institute of Semiconductor Physics, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University; United States Department of Energy (DOE); Argonne National Laboratory; University of London; Queen Mary University London; Moscow Institute of Physics & Technology	Vinokur, VM (corresponding author), Argonne Natl Lab, Div Mat Sci, Chicago, IL 60637 USA.	vinokour@anl.gov	Poccia, Nicola/L-1130-2016; Golubov, Alexander A/J-8233-2013; Baturina, Tatyana/AAA-1588-2022; Golubov, Alexander/N-4720-2019; Renshaw Wang, Xiao/I-5352-2012; Bianconi, Ginestra/I-5742-2018; Vinokur, Valerii M/J-7299-2013; Bianconi, Ginestra/AAE-4114-2020	Poccia, Nicola/0000-0001-7982-0113; Renshaw Wang, Xiao/0000-0002-5503-9899; Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Hilgenkamp, Hans/0000-0001-6109-8804	Dutch FOM foundation; Dutch NWO foundation; U.S. Department of Energy, Office of Science, Materials Sciences and Engineering Division; Ministry of Education and Science of the Russian Federation [14.Y26.31.0007]; Marie Curie IEF; Alexander von Humboldt Foundation	Dutch FOM foundation; Dutch NWO foundation; U.S. Department of Energy, Office of Science, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Marie Curie IEF(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank M. Lankhorst, F. Roesthuis, and D. Veldhuis for help during the experiments. Supported by the Dutch FOM and NWO foundations; the U.S. Department of Energy, Office of Science, Materials Sciences and Engineering Division; and Ministry of Education and Science of the Russian Federation grant 14.Y26.31.0007. N.P. and T.I.B. acknowledge for financial support the Marie Curie IEF and the Alexander von Humboldt Foundation, respectively. All data are available in the supplementary materials. Author contributions: N.P. conceived and designed the experiment; N.P., F.C., C.G.M., and X.R.W. performed the experiments; V.M.V. conceived the theoretical concept; T.I.B. and V.M.V. analyzed experimental data and developed a theory; A.A.G., A.B., G.B., and H.H. contributed to the theoretical description; and all authors contributed in writing the manuscript.	BAERT M, 1995, PHYS REV LETT, V74, P3269, DOI 10.1103/PhysRevLett.74.3269; Baturina TI, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/47002; Baturina TI, 2005, JETP LETT+, V81, P10, DOI 10.1134/1.1881727; BENZ SP, 1990, PHYS REV B, V42, P6165, DOI 10.1103/PhysRevB.42.6165; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Eley S, 2012, NAT PHYS, V8, P59, DOI 10.1038/nphys2154; FISHER ME, 1974, REV MOD PHYS, V46, P597, DOI 10.1103/RevModPhys.46.597; Goldberg S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.064523; Harada K, 1996, SCIENCE, V274, P1167, DOI 10.1126/science.274.5290.1167; HARPER PG, 1955, P PHYS SOC LOND A, V68, P874, DOI 10.1088/0370-1298/68/10/304; Henkel M, 2008, THEOR MATH PHYS SER, P1; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Jiang Z, 2004, APPL PHYS LETT, V84, P5371, DOI 10.1063/1.1767278; KADANOFF LP, 1967, REV MOD PHYS, V39, P395, DOI 10.1103/RevModPhys.39.395; Kierfeld J, 2000, PHYS REV LETT, V85, P4948, DOI 10.1103/PhysRevLett.85.4948; Kotliar G, 2000, PHYS REV LETT, V84, P5180, DOI 10.1103/PhysRevLett.84.5180; Lifshitz EM., 1977, QUANTUM MECH, V3rd; Limelette P, 2003, SCIENCE, V302, P89, DOI 10.1126/science.1088386; NELSON DR, 1993, PHYS REV B, V48, P13060, DOI 10.1103/PhysRevB.48.13060; Newrock RS, 2000, SOLID STATE PHYS, V54, P263; Rozenberg MJ, 1999, PHYS REV LETT, V83, P3498, DOI 10.1103/PhysRevLett.83.3498; TINKHAM M, 1983, PHYS REV B, V28, P6578, DOI 10.1103/PhysRevB.28.6578	22	37	37	2	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1202	1205		10.1126/science.1260507	http://dx.doi.org/10.1126/science.1260507			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359398	Green Submitted			2022-12-28	WOS:000360968400037
J	Sarewitz, D				Sarewitz, Daniel			Reproducibility will not cure what ails science	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA.	daniel.sarewitz@asu.edu						Alberts B, 2015, SCIENCE, V348, P1420, DOI 10.1126/science.aab3847	1	15	15	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					159	159		10.1038/525159a	http://dx.doi.org/10.1038/525159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9IM	26354448	Bronze			2022-12-28	WOS:000360927400004
J	Sukumar, M; Roychoudhuri, R; Restifo, NP				Sukumar, Madhusudhanan; Roychoudhuri, Rahul; Restifo, Nicholas P.			Nutrient Competition: A New Axis of Tumor Immunosuppression	CELL			English	Editorial Material								It is thought that cancer cells engage in Warburg metabolism to meet intrinsic biosynthetic requirements of cell growth and proliferation. Papers by Chang et al. and Ho et al. show that Warburg metabolism enables tumor cells to restrict glucose availability to T cells, suppressing anti-tumor immunity.	[Sukumar, Madhusudhanan; Roychoudhuri, Rahul; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Restifo, NP (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	restifo@nih.gov	Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019; Roychoudhuri, Rahul/A-7442-2010	Roychoudhuri, Rahul/0000-0002-5392-1853; Restifo, Nicholas P./0000-0003-4229-4580	Intramural NIH HHS [Z01 BC010763-03] Funding Source: Medline; Wellcome Trust [105663] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	10	77	83	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1206	1208		10.1016/j.cell.2015.08.064	http://dx.doi.org/10.1016/j.cell.2015.08.064			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359979	Green Accepted, Bronze			2022-12-28	WOS:000361247900008
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			Lancet	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	1	1	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					945	945		10.1016/S0140-6736(15)00108-7	http://dx.doi.org/10.1016/S0140-6736(15)00108-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR2TE	26369459				2022-12-28	WOS:000361182700014
J	Mingrone, G; Panunzi, S; De Gaetano, A; Guidone, C; Iaconelli, A; Nanni, G; Castagneto, M; Bornstein, S; Rubino, F				Mingrone, Geltrude; Panunzi, Simona; De Gaetano, Andrea; Guidone, Caterina; Iaconelli, Amerigo; Nanni, Giuseppe; Castagneto, Marco; Bornstein, Stefan; Rubino, Francesco			Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial	LANCET			English	Article							Y GASTRIC BYPASS; THERAPY; DISEASE; PLASMA; MODEL	Background Randomised controlled trials have shown that bariatric surgery is more effective than conventional treatment for the short-term control of type-2 diabetes. However, published studies are characterised by a relatively short follow-up. We aimed to assess 5 year outcomes from our randomised trial designed to compare surgery with conventional medical treatment for the treatment of type 2 diabetes in obese patients. Methods We did our open-label, randomised controlled trial at one diabetes centre in Italy. Patients aged 30-60 years with a body-mass index of 35 kg/m(2) or more and a history of type 2 diabetes lasting at least 5 years were randomly assigned (1: 1: 1), via a computer-generated randomisation procedure, to receive either medical treatment or surgery by Roux-en-Y gastric bypass or biliopancreatic diversion. Participants were aware of treatment allocation before the operation and study investigators were aware from the point of randomisation. The primary endpoint was the rate of diabetes remission at 2 years, defined as a glycated haemaglobin A(1c) (HbA(1c)) concentration of 6.5% or less (<= 47.5 mmol/mol) and a fasting glucose concentration of 5.6 mmol/L or less without active pharmacological treatment for 1 year. Here we analyse glycaemic and metabolic control, cardiovascular risk, medication use, quality of life, and long-term complications 5 years after randomisation. Analysis was by intention to treat for the primary endpoint and by per protocol for the 5 year follow-up. This study is registered with ClinicalTrials.gov, number NCT00888836. Findings Between April 27, 2009, and Oct 31, 2009, we randomly assigned 60 patients to receive either medical treatment (n=20) or surgery by gastric bypass (n=20) or biliopancreatic diversion (n=20); 53 (88%) patients completed 5 years' follow-up. Overall, 19 (50%) of the 38 surgical patients (seven [37%] of 19 in the gastric bypass group and 12 [63%] of 19 in the bilipancreatic diversion group) maintained diabetes remission at 5 years, compared with none of the 15 medically treated patients (p=0.0007). We recorded relapse of hyperglycaemia in eight (53%) of the 15 patients who achieved 2 year remission in the gastric bypass group and seven (37%) of the 19 patients who achieved 2 year remission in the biliopancreatic diversion group. Eight (42%) patients who underwent gastric bypass and 13 (68%) patients who underwent biliopancreatic diversion had an HbA(1c) concentration of 6.5% or less (<= 47.5 mmol/mol) with or without medication, compared with four (27%) medically treated patients (p=0.0457). Surgical patients lost more weight than medically treated patients, but weight changes did not predict diabetes remission or relapse after surgery. Both surgical procedures were associated with significantly lower plasma lipids, cardiovascular risk, and medication use. Five major complications of diabetes (including one fatal myocardial infarction) arose in four (27%) patients in the medical group compared with only one complication in the gastric bypass group and no complications in the biliopancreatic diversion group. No late complications or deaths occurred in the surgery groups. Nutritional side-effects were noted mainly after biliopancreatic diversion. Interpretation Surgery is more effective than medical treatment for the long-term control of obese patients with type 2 diabetes and should be considered in the treatment algorithm of this disease. However, continued monitoring of glycaemic control is warranted because of potential relapse of hyperglycaemia.	[Mingrone, Geltrude; Guidone, Caterina; Iaconelli, Amerigo] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy; [Nanni, Giuseppe; Castagneto, Marco] Univ Cattolica Sacro Cuore, Dept Surg, I-00168 Rome, Italy; [Panunzi, Simona; De Gaetano, Andrea] CNR, Inst Syst Anal & Comp Sci, BioMatLab, Rome, Italy; [Bornstein, Stefan] Univ Carl Gustav Carus Dresden, Dept Med 3, Dresden, Germany; [Mingrone, Geltrude; Bornstein, Stefan] Kings Coll London, Diabet & Nutr Sci, London WC2R 2LS, England; [Rubino, Francesco] Kings Coll London, Metab & Bariatr Surg, London WC2R 2LS, England	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; King's College London; University of London; King's College London	Mingrone, G (corresponding author), Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy.	gmingrone@rm.unicatt.it	Guidone, Caterina/ABG-6508-2021; De Gaetano, Andrea/AAC-4805-2021; Panunzi, Simona/AAK-9337-2020; Mingrone, Geltrude/AAB-9681-2019	De Gaetano, Andrea/0000-0001-7712-056X; Panunzi, Simona/0000-0003-0956-8578; Mingrone, Geltrude/0000-0003-2021-528X; Guidone, Caterina/0000-0002-0241-7083	Catholic University of Rome; Catholic University of Rome, Italy	Catholic University of Rome; Catholic University of Rome, Italy	Catholic University of Rome.; This study was funded by the Catholic University of Rome, Italy. We thank Anna Caprodossi for technical assistance.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Childs BP, 2005, DIABETES CARE, V28, P1245; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; DYCK PJ, 1988, MUSCLE NERVE, V11, P21, DOI 10.1002/mus.880110106; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Pinheiro JS, 2008, SURG OBES RELAT DIS, V4, P521, DOI 10.1016/j.soard.2007.12.016; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; R Development Core Team, 2009, R LANG ENV STAT COMP; Rubino F, 2002, ANN SURG, V236, P554, DOI 10.1097/00000658-200211000-00003; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Salinari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056258; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Wentworth JM, 2014, LANCET DIABETES ENDO, V2, P545, DOI 10.1016/S2213-8587(14)70066-X; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	29	756	788	4	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					964	973		10.1016/S0140-6736(15)00075-6	http://dx.doi.org/10.1016/S0140-6736(15)00075-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369473				2022-12-28	WOS:000361182700028
J	Weidinger, S; Novak, N				Weidinger, Stephan; Novak, Natalija			Atopic dermatitis	LANCET			English	Review							THYMIC STROMAL LYMPHOPOIETIN; GENOME-WIDE ASSOCIATION; STRATUM-CORNEUM LIPIDS; INNATE LYMPHOID-CELLS; OF-FUNCTION MUTATIONS; SKIN BARRIER; FILAGGRIN MUTATIONS; FOOD ALLERGY; TOPICAL CORTICOSTEROIDS; STAPHYLOCOCCUS-AUREUS	Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. Although it most often starts in infancy and affects two of ten children, it is also highly prevalent in adults. It is the leading non-fatal health burden attributable to skin diseases, inflicts a substantial psychosocial burden on patients and their relatives, and increases the risk of food allergy, asthma, allergic rhinitis, other immune-mediated inflammatory diseases, and mental health disorders. Originally regarded as a childhood disorder mediated by an imbalance towards a T-helper-2 response and exaggerated IgE responses to allergens, it is now recognised as a lifelong disposition with variable clinical manifestations and expressivity, in which defects of the epidermal barrier are central. Present prevention and treatment focus on restoration of epidermal barrier function, which is best achieved through the use of emollients. Topical corticosteroids are still the first-line therapy for acute flares, but they are also used proactively along with topical calcineurin inhibitors to maintain remission. Non-specific immunosuppressive drugs are used in severe refractory cases, but targeted disease-modifying drugs are being developed. We need to improve understanding of the heterogeneity of the disease and its subtypes, the role of atopy and autoimmunity, the mechanisms behind disease-associated itch, and the comparative effectiveness and safety of therapies.	[Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Campus Kiel, D-24105 Kiel, Germany; [Novak, Natalija] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Bonn	Weidinger, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Campus Kiel, D-24105 Kiel, Germany.	sweidinger@dermatology.uni-kiel.de	Weidinger, Stephan/C-8461-2011	Weidinger, Stephan/0000-0003-3944-252X	German National Research Council (DFG); Cluster of Excellence "Inflammation at Interfaces" [EXC306/2]; German Federal Ministry of Education and Research (BMBF) [01ZX1306A]; DFG [SFB704]; Cluster of Excellence "ImmunoSensation"; Christine Kuhne Stiftung Center for Allergy Research and Education (CK-CARE)	German National Research Council (DFG)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Cluster of Excellence "ImmunoSensation"; Christine Kuhne Stiftung Center for Allergy Research and Education (CK-CARE)	We thank Thomas Schwarz for review of the manuscript and helpful discussion, and Lennart Lenk, Thomas Heller, Arne Voss, Dagmar Blankenburg, Heidi Ponicke, and Hansjorg Schutze for help with the clinical pictures and illustrations. We acknowledge researchers whose work we could not cite because of space limitations. SW's research group received support from the German National Research Council (DFG) through individual grants and the Cluster of Excellence "Inflammation at Interfaces" (grant EXC306/2), and the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (sysINFLAME, grant 01ZX1306A). NN's research group received support from the DFG through grant SFB704, the Cluster of Excellence "ImmunoSensation", and the Christine Kuhne Stiftung Center for Allergy Research and Education (CK-CARE).	Apfelbacher CJ, 2011, ALLERGY, V66, P206, DOI 10.1111/j.1398-9995.2010.02464.x; Aschoff R, 2011, EXP DERMATOL, V20, P832, DOI 10.1111/j.1600-0625.2011.01335.x; Ashcroft DM, 2005, BMJ-BRIT MED J, V330, P516, DOI 10.1136/bmj.38376.439653.D3; Aubert-Wastiaux H, 2011, BRIT J DERMATOL, V165, P808, DOI 10.1111/j.1365-2133.2011.10449.x; Bae JM, 2013, J ALLERGY CLIN IMMUN, V132, P110, DOI 10.1016/j.jaci.2013.02.044; Balaji H, 2011, J ALLERGY CLIN IMMUN, V128, P92, DOI 10.1016/j.jaci.2011.02.043; Ballardini N, 2013, BRIT J DERMATOL, V168, P588, DOI 10.1111/bjd.12196; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; Bath-Hextall F, 2009, ALLERGY, V64, P258, DOI 10.1111/j.1398-9995.2008.01917.x; Bath-Hextall FJ, 2010, BRIT J DERMATOL, V163, P12, DOI 10.1111/j.1365-2133.2010.09743.x; Bath-Hextall FJ, 2012, COCHRANE DB SYST REV, V2; Batista DIS, 2015, J EUR ACAD DERMATOL, V29, P1091, DOI 10.1111/jdv.12753; Beattie PE, 2006, BRIT J DERMATOL, V155, P145, DOI 10.1111/j.1365-2133.2006.07185.x; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, pe7; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Belgrave DCM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001748; Bin LH, 2014, J ALLERGY CLIN IMMUN, V134, P848, DOI 10.1016/j.jaci.2014.07.018; Boyle RJ, 2008, COCHRANE DB SYST REV, V4; Brenninkmeijer EEA, 2008, BRIT J DERMATOL, V158, P754, DOI 10.1111/j.1365-2133.2007.08412.x; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Buddenkotte J, 2010, ALLERGY, V65, P805, DOI 10.1111/j.1398-9995.2010.01995.x; Castela E, 2012, J EUR ACAD DERMATOL, V26, P47, DOI 10.1111/j.1468-3083.2012.04523.x; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chen SL, 2010, J DERMATOL TREAT, V21, P144, DOI 10.3109/09546630903401470; Chen XY, 2013, LANCET INFECT DIS, V13, P877, DOI 10.1016/S1473-3099(13)70109-9; Cornelissen C, 2012, J ALLERGY CLIN IMMUN, V129, P426, DOI 10.1016/j.jaci.2011.10.042; Dalgard FJ, 2015, J INVEST DERMATOL, V135, P984, DOI 10.1038/jid.2014.530; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Darabi K, 2009, J AM ACAD DERMATOL, V60, P125, DOI 10.1016/j.jaad.2008.07.058; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; de Benedictis FM, 2009, ALLERGY, V64, P295, DOI 10.1111/j.1398-9995.2008.01779.x; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Deckert S, 2014, ALLERGY, V69, P37, DOI 10.1111/all.12246; El-Khalawany MA, 2013, EUR J PEDIATR, V172, P351, DOI 10.1007/s00431-012-1893-3; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Eller E, 2009, ALLERGY, V64, P1023, DOI 10.1111/j.1398-9995.2009.01952.x; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Ersser SJ, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004054.PUB3; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Flohr C, 2011, CURR PROBL DERMATOL, V41, P1, DOI 10.1159/000323290; Foisy Michelle, 2011, Evid Based Child Health, V6, P1322; Fuggle NR, 2015, J AM ACAD DERMATOL, V72, P108, DOI 10.1016/j.jaad.2014.08.048; Ganem MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066244; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Garmhausen D, 2013, ALLERGY, V68, P498, DOI 10.1111/all.12112; Garritsen FM, 2014, BRIT J DERMATOL, V170, P501, DOI 10.1111/bjd.12645; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Green C, 2004, HEALTH TECHNOL ASSES, V8, P1; Green C, 2004, Health Technol Assess, V8, P1; Green C, 2004, HEALTH TECHNOL ASSES, V8, piv; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; Haeck IM, 2011, J AM ACAD DERMATOL, V64, P1074, DOI 10.1016/j.jaad.2010.04.027; Heine G, 2006, ALLERGY, V61, P611, DOI 10.1111/j.1398-9995.2006.01029.x; Heratizadeh A, 2011, BRIT J DERMATOL, V164, P316, DOI 10.1111/j.1365-2133.2010.10090.x; Hirasawa Y, 2010, J INVEST DERMATOL, V130, P614, DOI 10.1038/jid.2009.257; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hoare C, 2000, Health Technol Assess, V4, P1; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Ishikawa J, 2010, J INVEST DERMATOL, V130, P2511, DOI 10.1038/jid.2010.161; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Janmohamed SR, 2014, J AM ACAD DERMATOL, V70, P1076, DOI 10.1016/j.jaad.2014.01.898; Janssens M, 2012, J LIPID RES, V53, P2755, DOI 10.1194/jlr.P030338; Jungersted JM, 2010, ALLERGY, V65, P911, DOI 10.1111/j.1398-9995.2010.02326.x; Kaffenberger BH, 2014, J AM ACAD DERMATOL, V71, P480, DOI 10.1016/j.jaad.2014.04.045; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kezic S, 2014, FRONT BIOSCI-LANDMRK, V19, P541, DOI 10.2741/4225; Kezic S, 2012, J ALLERGY CLIN IMMUN, V129, P1031, DOI 10.1016/j.jaci.2011.12.989; Khattri S, 2014, J ALLERGY CLIN IMMUN, V133, P1626, DOI 10.1016/j.jaci.2014.03.003; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kopfnagel V, 2013, CURR OPIN ALLERGY CL, V13, P531, DOI 10.1097/ACI.0b013e328364ddfd; Langan SM, 2006, BRIT J DERMATOL, V155, P504, DOI 10.1111/j.1365-2133.2006.07381.x; Langan SM, 2009, BRIT J DERMATOL, V161, P640, DOI 10.1111/j.1365-2133.2009.09320.x; Langan SM, 2007, ARCH DERMATOL, V143, P1570, DOI 10.1001/archderm.143.12.1570; Leung DYM, 2011, J ALLERGY CLIN IMMUN, V127, P965, DOI 10.1016/j.jaci.2011.02.010; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Longo G, 2013, LANCET, V382, P1656, DOI 10.1016/S0140-6736(13)60309-8; Lopes C, 2013, PEDIAT ALLERG IMM-UK, V24, P603, DOI 10.1111/pai.12111; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; Miajlovic H, 2010, J ALLERGY CLIN IMMUN, V126, P1184, DOI 10.1016/j.jaci.2010.09.015; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Mohan GC, 2015, JAMA DERMATOL, V151, P522, DOI 10.1001/jamadermatol.2014.3324; Morizane S, 2012, J ALLERGY CLIN IMMUN, V130, P259, DOI 10.1016/j.jaci.2012.03.006; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nankervis H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008426.pub2; Ng JPX, 2015, J EUR ACAD DERMATOL, V29, P854, DOI 10.1111/jdv.12864; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Novak N, 2012, J ALLERGY CLIN IMMUN, V129, P879, DOI 10.1016/j.jaci.2012.01.062; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Oh MH, 2013, J IMMUNOL, V191, P5371, DOI 10.4049/jimmunol.1300300; Omori-Miyake M, 2014, J INVEST DERMATOL, V134, P1342, DOI 10.1038/jid.2013.503; Otsuka A, 2014, J ALLERGY CLIN IMMUN, V133, P139, DOI 10.1016/j.jaci.2013.07.027; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, pe5; Paternoster L, NAT GENET IN PRESS; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pendaries V, 2014, J INVEST DERMATOL, V134, P2938, DOI 10.1038/jid.2014.259; Peters AS, 2010, J ALLERGY CLIN IMMUN, V126, P590, DOI 10.1016/j.jaci.2010.06.020; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Reuter J, 2010, AM J CLIN DERMATOL, V11, P247, DOI 10.2165/11533220-000000000-00000; Ricci Giampaolo, 2006, J Pediatr Health Care, V20, P311, DOI 10.1016/j.pedhc.2006.04.009; Roekevisch E, 2014, J ALLERGY CLIN IMMUN, V133, P429, DOI 10.1016/j.jaci.2013.07.049; Roggenkamp D, 2013, J INVEST DERMATOL, V133, P1620, DOI 10.1038/jid.2012.464; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Samuelov L, 2014, J ALLERGY CLIN IMMUN, V134, P808, DOI 10.1016/j.jaci.2014.07.061; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; Schmitt J, 2007, J EUR ACAD DERMATOL, V21, P606, DOI 10.1111/j.1468-3083.2006.02023.x; Schmitt J, 2011, BRIT J DERMATOL, V164, P415, DOI 10.1111/j.1365-2133.2010.10030.x; Schmitt J, 2010, ALLERGY, V65, P1506, DOI 10.1111/j.1398-9995.2010.02449.x; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schmitt J, 2016, J ALLERGY CLIN IMMUN, V137, P130, DOI 10.1016/j.jaci.2015.06.029; Schmitt J, 2015, J INVEST DERMATOL, V135, P24, DOI 10.1038/jid.2014.320; Schram ME, 2011, J ALLERGY CLIN IMMUN, V128, P353, DOI 10.1016/j.jaci.2011.03.024; Shlivko IL, 2014, SKIN RES TECHNOL, V20, P136, DOI 10.1111/srt.12095; Sigurgeirsson B, 2015, PEDIATRICS, V135, P597, DOI 10.1542/peds.2014-1990; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Simon D, 2014, ALLERGY, V69, P125, DOI 10.1111/all.12351; Simonart T, 2011, BRIT J DERMATOL, V165, P897, DOI 10.1111/j.1365-2133.2011.10457.x; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Simpson EL, 2012, J ALLERGY CLIN IMMUN, V130, P137, DOI 10.1016/j.jaci.2012.01.075; Simpson EL, 2010, J AM ACAD DERMATOL, V63, P587, DOI 10.1016/j.jaad.2009.11.011; Sonesson A, 2013, ACTA DERM-VENEREOL, V93, P340, DOI 10.2340/00015555-1465; Stout TE, 2014, J INVEST DERMATOL, V134, P423, DOI 10.1038/jid.2013.284; Stutte S, 2010, P NATL ACAD SCI USA, V107, P8736, DOI 10.1073/pnas.0906126107; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Suh DC, 2007, J MANAGE CARE PHARM, V13, P778, DOI 10.18553/jmcp.2007.13.9.778; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang TS, 2012, J ALLERGY CLIN IMMUN, V129, P1209, DOI 10.1016/j.jaci.2012.02.002; Thomsen SF, 2007, ALLERGY ASTHMA PROC, V28, P535, DOI 10.2500/aap2007.28.3041; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Tominaga M, 2014, J DERMATOL, V41, P205, DOI 10.1111/1346-8138.12317; Travers JB, 2012, PEDIATR DERMATOL, V29, P289, DOI 10.1111/j.1525-1470.2011.01661.x; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; van Drongelen V, 2014, CLIN EXP ALLERGY, V44, P1515, DOI 10.1111/cea.12443; van Zuuren EJ, 2014, EUR THYROID J, V3, P25, DOI 10.1159/000356040; Vavrova K, 2014, J INVEST DERMATOL, V134, P746, DOI 10.1038/jid.2013.402; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wallach D, 2014, CHEM IMMUNOL ALLERGY, V100, P81, DOI 10.1159/000358606; Williams H, 2008, J ALLERGY CLIN IMMUN, V121, P947, DOI 10.1016/j.jaci.2007.11.004; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Wisniewski JA, 2013, CLIN EXP ALLERGY, V43, P1160, DOI 10.1111/cea.12169; Worm M, 2006, ACTA DERM-VENEREOL, V86, P119, DOI 10.2340/00015555-0028; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Zeller S, 2009, J ALLERGY CLIN IMMUN, V124, P278, DOI 10.1016/j.jaci.2009.05.015; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010; Zutavern A, 2008, PEDIATRICS, V121, pE44, DOI 10.1542/peds.2006-3553	161	1041	1111	23	386	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1109	1122		10.1016/S0140-6736(15)00149-X	http://dx.doi.org/10.1016/S0140-6736(15)00149-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26377142				2022-12-28	WOS:000371775000030
J	Boat, TF; Buka, SL; Perrin, JM				Boat, Thomas F.; Buka, Stephen L.; Perrin, James M.			Children With Mental Disorders Who Receive Disability Benefits A Report From the IOM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Boat, Thomas F.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Boat, Thomas F.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Buka, Stephen L.] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA; [Perrin, James M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Perrin, James M.] MassGen Hosp Children, Boston, MA USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Brown University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Boat, TF (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	thomas.boat@cchmc.org	; Buka, Stephen/H-7335-2014	Perrin, James/0000-0002-1810-3708; Buka, Stephen/0000-0002-8578-9308				Government Accountability Office, 2012, GAO12497; Houtrow AJ, 2014, PEDIATRICS, V134, P530, DOI 10.1542/peds.2014-0594; National Academies of Sciences Engineering and Medicine, 2015, MENT DIS DIS LOW INC; Pulcini CD, 2012, ACAD PEDIATR, V12, P489, DOI 10.1016/j.acap.2012.07.001; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; Wen P., 2010, BOSTON GLOBE	6	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2019	2020		10.1001/jama.2015.12445	http://dx.doi.org/10.1001/jama.2015.12445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PR	26361217	Bronze			2022-12-28	WOS:000364764200011
J	Hu, CMJ; Fang, RH; Wang, KC; Luk, BT; Thamphiwatana, S; Dehaini, D; Nguyen, P; Angsantikul, P; Wen, CH; Kroll, AV; Carpenter, C; Ramesh, M; Qu, V; Patel, SH; Zhu, J; Shi, W; Hofman, FM; Chen, TC; Gao, WW; Zhang, K; Chien, S; Zhang, LF				Hu, Che-Ming J.; Fang, Ronnie H.; Wang, Kuei-Chun; Luk, Brian T.; Thamphiwatana, Soracha; Dehaini, Diana; Phu Nguyen; Angsantikul, Pavimol; Wen, Cindy H.; Kroll, Ashley V.; Carpenter, Cody; Ramesh, Manikantan; Qu, Vivian; Patel, Sherrina H.; Zhu, Jie; Shi, William; Hofman, Florence M.; Chen, Thomas C.; Gao, Weiwei; Zhang, Kang; Chien, Shu; Zhang, Liangfang			Nanoparticle biointerfacing by platelet membrane cloaking	NATURE			English	Article							POLYMERIC NANOPARTICLES; BACTERIAL PATHOGENS; BLOOD-PLATELETS; SURFACE; COMPLEMENT; DELIVERY; EXPRESSION; BINDING; PROTEIN; TOXINS	Development of functional nanoparticles can be encumbered by unanticipated material properties and biological events, which can affect nanoparticle effectiveness in complex, physiologically relevant systems(1-3). Despite the advances in bottom-up nanoengineering and surface chemistry, reductionist functionalization approaches remain inadequate in replicating the complex interfaces present in nature and cannot avoid exposure of foreign materials. Here we report on the preparation of polymeric nanoparticles enclosed in the plasma membrane of human platelets, which are a unique population of cellular fragments that adhere to a variety of disease-relevant substrates(4-7). The resulting nanoparticles possess a right-side-out unilamellar membrane coating functionalized with immunomodulatory and adhesion antigens associated with platelets. Compared to uncoated particles, the platelet membrane-cloaked nanoparticles have reduced cellular uptake by macrophage-like cells and lack particle-induced complement activation in autologous human plasma. The cloaked nanoparticles also display platelet-mimicking properties such as selective adhesion to damaged human and rodent vasculatures as well as enhanced binding to platelet-adhering pathogens. In an experimental rat model of coronary restenosis and a mouse model of systemic bacterial infection, docetaxel and vancomycin, respectively, show enhanced therapeutic efficacy when delivered by the platelet-mimetic nanoparticles. The multifaceted biointerfacing enabled by the platelet membrane cloaking method provides a new approach in developing functional nanoparticles for disease-targeted delivery.	[Hu, Che-Ming J.; Fang, Ronnie H.; Thamphiwatana, Soracha; Dehaini, Diana; Angsantikul, Pavimol; Kroll, Ashley V.; Carpenter, Cody; Ramesh, Manikantan; Qu, Vivian; Gao, Weiwei; Zhang, Kang; Zhang, Liangfang] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Hu, Che-Ming J.; Fang, Ronnie H.; Luk, Brian T.; Thamphiwatana, Soracha; Dehaini, Diana; Angsantikul, Pavimol; Kroll, Ashley V.; Gao, Weiwei; Zhang, Liangfang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Wang, Kuei-Chun; Luk, Brian T.; Phu Nguyen; Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wang, Kuei-Chun; Phu Nguyen; Zhang, Kang; Chien, Shu; Zhang, Liangfang] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Wen, Cindy H.; Patel, Sherrina H.; Zhu, Jie; Zhang, Kang] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Hofman, Florence M.; Chen, Thomas C.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Southern California	Zhang, LF (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.	kang.zhang@gmail.com; shuchien@ucsd.edu; zhang@ucsd.edu	Hu, Che-Ming/N-7674-2018; Wang, Kuei-Chun (Mark)/N-3419-2017; Wang, Kuei-Chun/N-3089-2017; Angsantikul, Pavimol/AAS-7240-2020; Zhu, Jie/AAD-1330-2022; Thamphiwatana, Soracha D./B-5338-2017; Zhang, Kang/Y-2740-2019	Hu, Che-Ming/0000-0002-0988-7029; Angsantikul, Pavimol/0000-0002-1671-9373; Zhu, Jie/0000-0001-6862-9022; Thamphiwatana, Soracha D./0000-0003-3664-9488; Zhang, Kang/0000-0002-4549-1697; Shi, William/0000-0001-5452-2902	National Institutes of Health [R01DK095168, R01HL108735, R01EY25090]; Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense [HDTRA1-14-1-0064]; National Institutes of Health from the National Cancer Institute [R25CA153915]; NATIONAL CANCER INSTITUTE [R25CA153915] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY025090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM112584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health under Award Numbers R01DK095168 (L.Z.), R01HL108735 (S.C.) and R01EY25090 (K.Z.), and partially by the Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense under Grant Number HDTRA1-14-1-0064 (L.Z.). R.H.F. is supported by a National Institutes of Health R25CA153915 training grant from the National Cancer Institute.	Andersen AJ, 2009, J BIOMED NANOTECHNOL, V5, P364, DOI 10.1166/jbn.2009.1045; Anselmo AC, 2014, ACS NANO, V8, P11243, DOI 10.1021/nn503732m; Bertram JP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000397; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Chan JM, 2010, P NATL ACAD SCI USA, V107, P2213, DOI 10.1073/pnas.0914585107; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; GACHET C, 1993, J CELL BIOL, V120, P1021, DOI 10.1083/jcb.120.4.1021; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; Hu CMJ, 2013, NANOSCALE, V5, P2664, DOI 10.1039/c3nr00015j; Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; Law SKA, 1997, PROTEIN SCI, V6, P263; Luk BT, 2014, NANOSCALE, V6, P2730, DOI 10.1039/c3nr06371b; Modery-Pawlowski CL, 2013, BIOMATERIALS, V34, P526, DOI 10.1016/j.biomaterials.2012.09.074; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Pelaz B, 2013, SMALL, V9, P1573, DOI 10.1002/smll.201201229; Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; SIMS PJ, 1989, J BIOL CHEM, V264, P19228; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; TERSTAPPEN LWMM, 1992, J LEUKOCYTE BIOL, V52, P652, DOI 10.1002/jlb.52.6.652; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4	30	918	945	62	1125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					118	+		10.1038/nature15373	http://dx.doi.org/10.1038/nature15373			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26374997	Green Accepted			2022-12-28	WOS:000362095100045
J	Wu, ZX; Curtin, WA				Wu, Zhaoxuan; Curtin, W. A.			The origins of high hardening and low ductility in magnesium	NATURE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; SINGLE-CRYSTAL MAGNESIUM; NONBASAL SLIP SYSTEMS; MINIMUM ENERGY PATHS; ELASTIC BAND METHOD; ALUMINUM-ALLOYS; AUTOMOTIVE INDUSTRY; ROOM-TEMPERATURE; SADDLE-POINTS; HCP METALS	Magnesium is a lightweight structural metal but it exhibits low ductility-connected with unusual, mechanistically unexplained, dislocation and plasticity phenomena-which makes it difficult to form and use in energy-saving lightweight structures. We employ long-time molecular dynamics simulations utilizing a density-functional-theory-validated interatomic potential, and reveal the fundamental origins of the previously unexplained phenomena. Here we show that the key < c+alpha > dislocation (where < c+alpha > indicates the magnitude and direction of slip) is metastable on easy-glide pyramidal II planes; we find that it undergoes a thermally activated, stress-dependent transition to one of three lower-energy, basal-dissociated immobile dislocation structures, which cannot contribute to plastic straining and that serve as strong obstacles to the motion of all other dislocations. This transition is intrinsic to magnesium, driven by reduction in dislocation energy and predicted to occur at very high frequency at room temperature, thus eliminating all major dislocation slip systems able to contribute to c-axis strain and leading to the high hardening and low ductility of magnesium. Enhanced ductility can thus be achieved by increasing the time and temperature at which the transition from the easy-glide metastable dislocation to the immobile basal-dissociated structures occurs. Our results provide the underlying insights needed to guide the design of ductile magnesium alloys.	[Wu, Zhaoxuan; Curtin, W. A.] Ecole Polytech Fed Lausanne, Inst Engn Mech, CH-1015 Lausanne, Switzerland; [Wu, Zhaoxuan] Inst High Performance Comp, Singapore 138632, Singapore	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC)	Curtin, WA (corresponding author), Ecole Polytech Fed Lausanne, Inst Engn Mech, CH-1015 Lausanne, Switzerland.	william.curtin@epfl.ch	Wu, Zhaoxuan/A-2097-2012	Wu, Zhaoxuan/0000-0002-4739-1139	Agency for Science, Technology and Research (A*STAR), Singapore; European Research Council, ERC [339081 - PreCoMet]	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); European Research Council, ERC(European Research Council (ERC)European Commission)	Z.W. acknowledges financial support from the Agency for Science, Technology and Research (A*STAR), Singapore. W.A.C. acknowledges support of this work through a European Research Council Advanced Grant, 'Predictive Computational Metallurgy', ERC grant agreement no. 339081 - PreCoMet. W.A.C. also acknowledges earlier long-term support of Mg research from General Motors Corporation that provided the basis for research reported here.	Agnew SR, 2012, WOODHEAD PUBL MATER, P63; Agnew SR, 2002, METALL MATER TRANS A, V33, P851, DOI 10.1007/s11661-002-0154-x; Ando S, 2000, MATER SCI FORUM, V350-3, P43, DOI 10.4028/www.scientific.net/MSF.350-351.43; Bertin N, 2014, INT J PLASTICITY, V62, P72, DOI 10.1016/j.ijplas.2014.06.010; Bettles CJ, 2009, MAT SCI ENG A-STRUCT, V505, P6, DOI 10.1016/j.msea.2008.11.004; Byer CM, 2010, SCRIPTA MATER, V62, P536, DOI 10.1016/j.scriptamat.2009.12.017; Devincre B, 2008, SCIENCE, V320, P1745, DOI 10.1126/science.1156101; EDELIN G, 1973, PHILOS MAG, V28, P1203, DOI 10.1080/14786437308227994; Faken D., 1994, Computational Materials Science, V2, P279, DOI 10.1016/0927-0256(94)90109-0; Geng J, 2014, PHIL MAG LETT, V94, P377, DOI 10.1080/09500839.2014.916423; Heinz A, 2000, MAT SCI ENG A-STRUCT, V280, P102, DOI 10.1016/S0921-5093(99)00674-7; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hidalgo-Manrique P, 2015, ACTA MATER, V92, P265, DOI 10.1016/j.actamat.2015.03.053; Hirth J. P., 1972, THEORY DISLOCATIONS; Kang F, 2009, SCRIPTA MATER, V61, P844, DOI 10.1016/j.scriptamat.2009.07.011; Kitahara T, 2007, KEY ENG MATER, V345-346, P129, DOI 10.4028/www.scientific.net/KEM.345-346.129; KOCKS UF, 1975, PROG MATER SCI, V19, P1; Koike J, 2003, ACTA MATER, V51, P2055, DOI 10.1016/S1359-6454(03)00005-3; Kulekci MK, 2008, INT J ADV MANUF TECH, V39, P851, DOI 10.1007/s00170-007-1279-2; Leyson GPM, 2010, NAT MATER, V9, P750, DOI [10.1038/NMAT2813, 10.1038/nmat2813]; Miller WS, 2000, MAT SCI ENG A-STRUCT, V280, P37, DOI 10.1016/S0921-5093(99)00653-X; OBARA T, 1973, ACTA METALL MATER, V21, P845, DOI 10.1016/0001-6160(73)90141-7; Pollock TM, 2010, SCIENCE, V328, P986, DOI 10.1126/science.1182848; Price P. B., 1961, J APPL PHYS, V32, P1750, DOI DOI 10.1063/1.1728430; PRICE PB, 1960, PHILOS MAG, V5, P873, DOI 10.1080/14786436008238307; Sandlobes S, 2014, ACTA MATER, V70, P92, DOI 10.1016/j.actamat.2014.02.011; Sandlobes S, 2012, ACTA MATER, V60, P3011, DOI 10.1016/j.actamat.2012.02.006; Sandlobes S, 2013, MAT SCI ENG A-STRUCT, V576, P61, DOI 10.1016/j.msea.2013.03.006; STOHR JF, 1972, PHILOS MAG, V25, P1313, DOI 10.1080/14786437208223856; Syed B, 2012, SCRIPTA MATER, V67, P700, DOI 10.1016/j.scriptamat.2012.06.036; Tonda H, 2002, METALL MATER TRANS A, V33, P831, DOI 10.1007/s11661-002-0152-z; Wu Z, 2015, ACTA MATER, V88, P1, DOI 10.1016/j.actamat.2015.01.023; Wu Z, 2015, MODEL SIMUL MATER SC, V23, DOI 10.1088/0965-0393/23/1/015004; Yang ZQ, 2013, ACTA MATER, V61, P350, DOI 10.1016/j.actamat.2012.09.067; Yoo MH, 2001, MAT SCI ENG A-STRUCT, V319, P87, DOI 10.1016/S0921-5093(01)01027-9; Yu Q, 2013, P NATL ACAD SCI USA, V110, P13289, DOI 10.1073/pnas.1306371110	37	357	364	36	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					62	+		10.1038/nature15364	http://dx.doi.org/10.1038/nature15364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26390153	Green Submitted			2022-12-28	WOS:000362095100035
J	Celi, A; Tarruell, L				Celi, Alessio; Tarruell, Leticia			Probing the edge with cold atoms	SCIENCE			English	Editorial Material									[Celi, Alessio; Tarruell, Leticia] ICFO Inst Ciencies Fotoniques, Barcelona Inst Sci & Technol, Barcelona 08860, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Celi, A (corresponding author), ICFO Inst Ciencies Fotoniques, Barcelona Inst Sci & Technol, Barcelona 08860, Spain.	alessio.celi@icfo.es; leticia.tarruell@icfo.es	Tarruell, Leticia/I-8152-2012; Celi, Alessio/I-8079-2012	Tarruell, Leticia/0000-0002-0564-1435; Celi, Alessio/0000-0003-4939-084X				Boada O, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.133001; Celi A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043001; Greiner M, 2008, NATURE, V453, P736, DOI 10.1038/453736a; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515	8	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1450	1451		10.1126/science.aac7605	http://dx.doi.org/10.1126/science.aac7605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404814				2022-12-28	WOS:000361707000024
J	Baum, M				Baum, Michael			Why Does the Weeping Willow Weep? Reconceptualizing Oncogenesis in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baum, Michael] UCL, Dept Surg, London, England; [Baum, Michael] Royal Free & Univ Coll, Sch Med, Clin Trials Grp, London, England	University of London; University College London; University of London; University College London; UCL Medical School	Baum, M (corresponding author), UCL, Dept Surg, London, England.							Baum M, 2005, EUR J CANCER, V41, P508, DOI 10.1016/j.ejca.2004.09.031; Baum M, 1999, EUR J CANCER, V35, P886, DOI 10.1016/S0959-8049(99)00067-2; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Lin J, 2007, TREE PHYSIOL, V27, P1575, DOI 10.1093/treephys/27.11.1575; Retsky M, 2013, CURR MED CHEM, V20, P4163; Schwartz L., 2004, CANC GLYCOLYSIS PHYS	6	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1267	1269		10.1056/NEJMms1505722	http://dx.doi.org/10.1056/NEJMms1505722			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398075				2022-12-28	WOS:000361635200015
J	Goedert, M				Goedert, Michel			Fibril features	NATURE			English	News Item									MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Goedert, M (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk		Cheng, Yifan/0000-0001-9535-0369	Medical Research Council [MC_U105184291] Funding Source: Medline; MRC [MC_U105184291] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					458	458		10.1038/nature15630	http://dx.doi.org/10.1038/nature15630			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26352470				2022-12-28	WOS:000361599900033
J	Ong-Abdullah, M; Ordway, JM; Jiang, N; Ooi, SE; Kok, SY; Sarpan, N; Azimi, N; Hashim, AT; Ishak, Z; Rosli, SK; Malike, FA; Abu Bakar, NA; Marjuni, M; Abdullah, N; Yaakub, Z; Amiruddin, MD; Nookiah, R; Singh, R; Low, ETL; Chan, KL; Azizi, N; Smith, SW; Bacher, B; Budiman, MA; Van Brunt, A; Wischmeyer, C; Beil, M; Hogan, M; Lakey, N; Lim, CC; Arulandoo, X; Wong, CK; Choo, CN; Wong, WC; Kwan, YY; Alwee, SSRS; Sambanthamurthi, R; Martienssen, RA				Ong-Abdullah, Meilina; Ordway, Jared M.; Jiang, Nan; Ooi, Siew-Eng; Kok, Sau-Yee; Sarpan, Norashikin; Azimi, Nuraziyan; Hashim, Ahmad Tarmizi; Ishak, Zamzuri; Rosli, Samsul Kamal; Malike, Fadila Ahmad; Abu Bakar, Nor Azwani; Marjuni, Marhalil; Abdullah, Norziha; Yaakub, Zulkifli; Amiruddin, Mohd Din; Nookiah, Rajanaidu; Singh, Rajinder; Low, Eng-Ti Leslie; Chan, Kuang-Lim; Azizi, Norazah; Smith, Steven W.; Bacher, Blaire; Budiman, Muhammad A.; Van Brunt, Andrew; Wischmeyer, Corey; Beil, Melissa; Hogan, Michael; Lakey, Nathan; Lim, Chin-Ching; Arulandoo, Xaviar; Wong, Choo-Kien; Choo, Chin-Nee; Wong, Wei-Chee; Kwan, Yen-Yen; Alwee, Sharifah Shahrul Rabiah Syed; Sambanthamurthi, Ravigadevi; Martienssen, Robert A.			Loss of Karma transposon methylation underlies the mantled somaclonal variant of oil palm	NATURE			English	Article							ELAEIS-GUINEENSIS JACQ.; MADS BOX GENES; EPIGENETIC MUTATION; FLOWER STRUCTURE; ARABIDOPSIS; ELEMENTS; GENOME; MAIZE; RETROTRANSPOSON; PARAMUTATION	Somaclonal variation arises in plants and animals when differentiated somatic cells are induced into a pluripotent state, but the resulting clones differ from each other and from their parents. In agriculture, somaclonal variation has hindered the micropropagation of elite hybrids and genetically modified crops, but the mechanism responsible remains unknown(1). The oil palm fruit 'mantled' abnormality is a somaclonal variant arising from tissue culture that drastically reduces yield, and has largely halted efforts to clone elite hybrids for oil production(2-4). Widely regarded as an epigenetic phenomenon(5), 'mantling' has defied explanation, but here we identify the MANTLED locus using epigenome-wide association studies of the African oil palm Elaeis guineensis. DNA hypomethylation of a LINE retrotransposon related to rice Karma, in the intron of the homeotic gene DEFICIENS, is common to all mantled clones and is associated with alternative splicing and premature termination. Dense methylation near the Karma splice site (termed the Good Karma epiallele) predicts normal fruit set, whereas hypomethylation (the Bad Karma epiallele) predicts homeotic transformation, parthenocarpy and marked loss of yield. Loss of Karma methylation and of small RNA in tissue culture contributes to the origin of mantled, while restoration in spontaneous revertants accounts for non-Mendelian inheritance. The ability to predict and cull mantling at the plantlet stage will facilitate the introduction of higher performing clones and optimize environmentally sensitive land resources.	[Ong-Abdullah, Meilina; Ooi, Siew-Eng; Kok, Sau-Yee; Sarpan, Norashikin; Azimi, Nuraziyan; Hashim, Ahmad Tarmizi; Ishak, Zamzuri; Rosli, Samsul Kamal; Malike, Fadila Ahmad; Abu Bakar, Nor Azwani; Marjuni, Marhalil; Abdullah, Norziha; Yaakub, Zulkifli; Amiruddin, Mohd Din; Nookiah, Rajanaidu; Singh, Rajinder; Low, Eng-Ti Leslie; Chan, Kuang-Lim; Azizi, Norazah] Malaysian Palm Oil Board, Persiaran Inst, Kajang 43000, Selangor, Malaysia; [Ordway, Jared M.; Jiang, Nan; Smith, Steven W.; Bacher, Blaire; Budiman, Muhammad A.; Van Brunt, Andrew; Wischmeyer, Corey; Beil, Melissa; Hogan, Michael; Lakey, Nathan] Orion Genom, St Louis, MO 63108 USA; [Lim, Chin-Ching; Arulandoo, Xaviar] United Plantat Berhad, Teluk Intan 36009, Perak, Malaysia; [Wong, Choo-Kien; Choo, Chin-Nee; Wong, Wei-Chee] Appl Agr Resources Sdn Bhd, Petaling Jaya 47810, Selangor, Malaysia; [Kwan, Yen-Yen; Alwee, Sharifah Shahrul Rabiah Syed] Lengkuk Teknol, FELDA Global Ventures R&D Sdn Bhd, FELDA Biotechnol Ctr, Bandar Enstek 71760, Negeri Sembilan, Malaysia; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Malaysian Palm Oil Board; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA.	raviga@mpob.gov.my; martiens@cshl.edu	Singh, Rajinder/P-9179-2015; R., Samsul/E-9197-2014; Low, Eng Ti Leslie/AHD-7011-2022; JIANG, NAN/AHB-1945-2022	Singh, Rajinder/0000-0001-9933-4884; R., Samsul/0000-0003-0497-3005; Low, Eng Ti Leslie/0000-0003-3414-8401; , Kok/0000-0001-5314-3521; Ong-Abdullah, Meilina/0000-0003-4825-5021; Ooi, Siew-Eng/0000-0002-6621-5456; Yaakub, Zulkifli/0000-0001-9174-271X; Sambanthamurthi, Ravi/0000-0003-3023-9306; Chan, Kuang-Lim/0000-0002-8419-0432; Abdullah, Norziha/0000-0002-4693-7558; Wong, Wei Chee/0000-0002-9226-5545	NIGMS NIH HHS [R01 GM067014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam H, 2007, ANN BOT-LONDON, V100, P1, DOI 10.1093/aob/mcm027; Adam H, 2007, J EXP BOT, V58, P1245, DOI 10.1093/jxb/erl263; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Alwee SS, 2006, PLANT CELL TISS ORG, V85, P331, DOI 10.1007/s11240-006-9084-4; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Baubec T, 2014, EMBO REP, V15, P446, DOI 10.1002/embr.201337915; Chan PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099774; Corley R.H.V., 1997, PLANTATION MANAGEMEN, P279; Corley R. H. V, 1986, CRC HDB FRUIT SET DE, P253; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Cui XK, 2013, P NATL ACAD SCI USA, V110, P1953, DOI 10.1073/pnas.1217020110; Durand-Gasselin T., 1990, OLEAGINEUX, V45, P10; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Jaligot E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091896; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Jones L. H., 1974, Oil Palm News, P1; Komatsu M, 2003, PLANT CELL, V15, P1934, DOI 10.1105/tpc.011809; Kubis SE, 2003, PLANT MOL BIOL, V52, P69, DOI 10.1023/A:1023942309092; Kushairi A., 2006, P CLON QUAL REPL MAT; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; MARTIENSSEN R, 1990, GENE DEV, V4, P331, DOI 10.1101/gad.4.3.331; Matthes M, 2001, THEOR APPL GENET, V102, P971, DOI 10.1007/s001220000491; Mgbeze G. C., 2014, African Journal of Biotechnology, V13, P989; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Perbal MC, 1996, DEVELOPMENT, V122, P3433; RABECHAULT H, 1976, CR ACAD SCI D NAT, V283, P1735; Rao V., 1990, ELAEIS, V2, P199; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; ROHANI O, 2000, ADV OIL PALM RES, P238; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Stewart FJ, 1998, BIOL CHEM, V379, P611; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; ZEVEN A C, 1973, Journal of the Nigerian Institute for Oil Palm Research, V5, P31	40	284	292	8	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					533	+		10.1038/nature15365	http://dx.doi.org/10.1038/nature15365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26352475	Green Accepted			2022-12-28	WOS:000361599900053
J	Page, J; Ware, M				Page, Jonathan; Ware, Mark			Perspective: Close the knowledge gap	NATURE			English	Editorial Material							CANNABIS		[Page, Jonathan] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Ware, Mark] McGill Univ, Ctr Hlth, Alan Edwards Pain Management Unit, Montreal, PQ, Canada	University of British Columbia; McGill University	Page, J (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	jon.page@botany.ubc.ca; mark.ware@mcgill.ca		Ware, Mark/0000-0002-1286-1719				Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Ware M. A., J PAIN IN THE PRESS; Ware MA, 2010, CAN MED ASSOC J, V182, DOI [DOI 10.1503/cmaj.091414, 10.1503/cmaj.091414]; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358	4	3	3	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S9	S9		10.1038/525S9a	http://dx.doi.org/10.1038/525S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398739				2022-12-28	WOS:000361599900004
J	Palter, J				Palter, Jaime			MARINE SCIENCE Storms bring ocean nutrients to light	NATURE			English	Editorial Material									Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Palter, J (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett Bay Campus, Narragansett, RI 02882 USA.	jpalter@uri.edu		Palter, Jaime/0000-0002-2656-8062				Cabre A, 2015, CLIM DYNAM, V45, P1253, DOI 10.1007/s00382-014-2374-3; Foltz GR, 2015, GEOPHYS RES LETT, V42, P1158, DOI 10.1002/2015GL063222; Hanshaw MN, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031862; IPCC, 2013, CLIMATE CHANGE 2022; Jochum M, 2013, J CLIMATE, V26, P2833, DOI 10.1175/JCLI-D-12-00181.1; Lozier MS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049414; Redfield AC, 1936, NATURE, V138, P1013, DOI 10.1038/1381013a0; Rudnick DL, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006849; Rumyantseva A., 2015, GLOBAL BIOGEOCHEM CY; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134	10	4	4	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					460	461		10.1038/525460a	http://dx.doi.org/10.1038/525460a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399823				2022-12-28	WOS:000361599900035
J	Edmond, H; Hillman, T				Edmond, Holly; Hillman, Toby			CASE SCENARIO Life threatening complication of intramuscular injections for musculoskeletal back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edmond, Holly; Hillman, Toby] Univ Coll Hosp, Acute Med Unit, London NW1 2BU, England	University of London; University College London	Edmond, H (corresponding author), Univ Coll Hosp, Acute Med Unit, London NW1 2BU, England.	holly.edmond@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4638	10.1136/bmj.h4638	http://dx.doi.org/10.1136/bmj.h4638			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26399702				2022-12-28	WOS:000361957200005
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC NHS truths that dare not speak their name	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SAVE					nigel.hawkes1@btinternet.com						Davis K, 2014, MIRROR WALL PERFORMA; Hawkes N, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1505; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4951; White C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3228	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2015	351								h4983	10.1136/bmj.h4983	http://dx.doi.org/10.1136/bmj.h4983			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3EO	26395189				2022-12-28	WOS:000361954700003
J	Lelieveld, J; Evans, JS; Fnais, M; Giannadaki, D; Pozzer, A				Lelieveld, J.; Evans, J. S.; Fnais, M.; Giannadaki, D.; Pozzer, A.			The contribution of outdoor air pollution sources to premature mortality on a global scale	NATURE			English	Article							FINE PARTICULATE MATTER; CIRCULATION MODEL ECHAM5/MESSY1; ATMOSPHERIC CHEMISTRY; TECHNICAL NOTE; CLIMATE-CHANGE; RISK-FACTORS; HUMAN HEALTH; BURDEN; EMISSIONS; SUBMODEL	Assessment of the global burden of disease is based on epidemiological cohort studies that connect premature mortality to a wide range of causes(1-5), including the long-term health impacts of ozone and fine particulate matter with a diameter smaller than 2.5 micrometres (PM2.5)(3-9). It has proved difficult to quantify premature mortality related to air pollution, notably in regions where air quality is not monitored, and also because the toxicity of particles from various sources may vary(10). Here we use a global atmospheric chemistry model to investigate the link between prematuremortality and seven emission source categories in urban and rural environments. In accord with the global burden of disease for 2010 (ref. 5), we calculate that outdoor air pollution, mostly by PM2.5, leads to 3.3 (95 per cent confidence interval 1.61-4.81) million premature deaths per year worldwide, predominantly in Asia. We primarily assume that all particles are equally toxic(5), but also include a sensitivity study that accounts for differential toxicity. We find that emissions from residential energy use such as heating and cooking, prevalent in India and China, have the largest impact on premature mortality globally, being even more dominant if carbonaceous particles are assumed to be most toxic. Whereas in much of the USA and in a few other countries emissions from traffic and power generation are important, in eastern USA, Europe, Russia and East Asia agricultural emissions make the largest relative contribution to PM2.5, with the estimate of overall health impact depending on assumptions regarding particle toxicity. Model projections based on a business-as-usual emission scenario indicate that the contribution of outdoor air pollution to premature mortality could double by 2050.	[Lelieveld, J.; Pozzer, A.] Max Planck Inst Chem, Atmospher Chem Dept, D-55128 Mainz, Germany; [Lelieveld, J.; Giannadaki, D.] Cyprus Inst, Energy Environm & Water Res Ctr, CY-1645 Nicosia, Cyprus; [Evans, J. S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Evans, J. S.] Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, CY-3041 Limassol, Cyprus; [Fnais, M.] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Max Planck Society; Harvard University; Harvard T.H. Chan School of Public Health; Cyprus International Institute for Environmental & Public Health; Cyprus University of Technology; King Saud University	Lelieveld, J (corresponding author), Max Planck Inst Chem, Atmospher Chem Dept, D-55128 Mainz, Germany.	jos.lelieveld@mpic.de	Reid, David W/B-3263-2011; Pozzer, Andrea/L-4872-2013; Fnais, Mohammed/GYJ-2383-2022; Lelieveld, Jos/A-1986-2013	Pozzer, Andrea/0000-0003-2440-6104; Lelieveld, Jos/0000-0001-6307-3846; Evans, John/0000-0001-9837-1026	Distinguished Scientist Fellowship Program at the King Saud University, Riyadh; European Research Council under European Union/ERC [226144]	Distinguished Scientist Fellowship Program at the King Saud University, Riyadh; European Research Council under European Union/ERC(European Research Council (ERC))	We are grateful to the EDGAR team of the Joint Research Centre in Ispra, Italy, for the emission data. We acknowledge support from the Distinguished Scientist Fellowship Program at the King Saud University, Riyadh. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 226144.	Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220; [Anonymous], WHO STAT INF SYST WH; Astitha M, 2012, ATMOS CHEM PHYS, V12, P11057, DOI 10.5194/acp-12-11057-2012; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Blanchard CL, 2008, J AIR WASTE MANAGE, V58, P1598, DOI 10.3155/1047-3289.58.12.1598; Bouwman AF., 2006, INTEGRATED MODELLING, P1; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cao J, 2011, J HAZARD MATER, V186, P1594, DOI 10.1016/j.jhazmat.2010.12.036; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Christoudias T, 2013, ATMOS CHEM PHYS, V13, P1425, DOI 10.5194/acp-13-1425-2013; Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166; de Meij A, 2012, ATMOS RES, V114, P38, DOI 10.1016/j.atmosres.2012.05.014; Doering U., 2010, 62957 JRC; Duncan BN, 2008, ATMOS CHEM PHYS, V8, P2267, DOI 10.5194/acp-8-2267-2008; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fang YY, 2013, CLIMATIC CHANGE, V121, P239, DOI 10.1007/s10584-013-0847-8; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Giannadaki D, 2014, ATMOS CHEM PHYS, V14, P957, DOI 10.5194/acp-14-957-2014; Ginoux P, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000388; Gurjar BR, 2010, ATMOS ENVIRON, V44, P4606, DOI 10.1016/j.atmosenv.2010.08.011; Harrison RM, 2012, ATMOS ENVIRON, V46, P115, DOI 10.1016/j.atmosenv.2011.10.028; Hedegaard GB, 2013, ATMOS CHEM PHYS, V13, P3569, DOI 10.5194/acp-13-3569-2013; Hurrell JW, 2008, J CLIMATE, V21, P5145, DOI 10.1175/2008JCLI2292.1; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jacob DJ, 2009, ATMOS ENVIRON, V43, P51, DOI 10.1016/j.atmosenv.2008.09.051; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Jockel P, 2005, ATMOS CHEM PHYS, V5, P433; Jockel P, 2006, ATMOS CHEM PHYS, V6, P5067; Jones AM, 2008, ATMOS ENVIRON, V42, P4467, DOI 10.1016/j.atmosenv.2008.02.001; Kerkweg A, 2006, ATMOS CHEM PHYS, V6, P4617, DOI 10.5194/acp-6-4617-2006; Kinney PL, 2010, ENVIRON SCI POLICY, V13, P434, DOI 10.1016/j.envsci.2010.05.002; Lelieveld J, 2013, ATMOS CHEM PHYS, V13, P7023, DOI 10.5194/acp-13-7023-2013; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lippmann Morton, 2013, Res Rep Health Eff Inst, P5; Liu JF, 2009, ATMOS ENVIRON, V43, P4339, DOI 10.1016/j.atmosenv.2009.05.032; Megaritis AG, 2013, ATMOS CHEM PHYS, V13, P3423, DOI 10.5194/acp-13-3423-2013; Moussiopoulos N, 2012, INT J ENVIRON POLLUT, V50, P376, DOI 10.1504/IJEP.2012.051208; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; Ostro B., 2004, OUTDOOR AIR POLLUTIO; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pozzer A, 2007, ATMOS CHEM PHYS, V7, P2527, DOI 10.5194/acp-7-2527-2007; Pozzer A, 2006, ATMOS CHEM PHYS, V6, P5435, DOI 10.5194/acp-6-5435-2006; Pozzer A, 2012, ATMOS CHEM PHYS, V12, P6915, DOI 10.5194/acp-12-6915-2012; Pozzer A, 2012, ATMOS CHEM PHYS, V12, P961, DOI 10.5194/acp-12-961-2012; Pozzer A, 2011, GEOSCI MODEL DEV, V4, P771, DOI 10.5194/gmd-4-771-2011; Pozzer A, 2009, ATMOS CHEM PHYS, V9, P9417, DOI 10.5194/acp-9-9417-2009; Pringle KJ, 2010, GEOSCI MODEL DEV, V3, P391, DOI 10.5194/gmd-3-391-2010; Pringle KJ, 2010, ATMOS CHEM PHYS, V10, P5241, DOI 10.5194/acp-10-5241-2010; Pruss-Ustun A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-7; Pye HOT, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010701; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Roman HA, 2008, ENVIRON SCI TECHNOL, V42, P2268, DOI 10.1021/es0713882; Russ P., 2007, 23032 JRC EUR EN; Russell AG, 2009, ENVIRON SCI TECHNOL, V43, P4620, DOI 10.1021/es9005459; Sander R, 2005, ATMOS CHEM PHYS, V5, P445, DOI 10.5194/acp-5-445-2005; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005; Tager I., 2010, 17 HLTH EFF I; Taylor K. E., 2000, 60 PCMDI LAW LIV NAT; Thurston G.D., 2013, NATL PARTICLE COMPON, P127; Timmermans RMA, 2013, URBAN CLIM, V6, P44, DOI 10.1016/j.uclim.2013.10.004; Tost H, 2007, ATMOS CHEM PHYS, V7, P2733, DOI 10.5194/acp-7-2733-2007; Tost H, 2006, ATMOS CHEM PHYS, V6, P565, DOI 10.5194/acp-6-565-2006; Tuomisto JT, 2008, RELIAB ENG SYST SAFE, V93, P732, DOI 10.1016/j.ress.2007.03.002; UN Department of Economic and Social Affairs Population Division, 2005, WORLD POP PROSP 2004; Van Aardenne J., 2010, 61281 JRC, P71; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Vedal Sverre, 2013, Res Rep Health Eff Inst, P5; West JJ, 2006, P NATL ACAD SCI USA, V103, P3988, DOI 10.1073/pnas.0600201103; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang R, 2014, ATMOS CHEM PHYS, V14, P175, DOI 10.5194/acp-14-175-2014	73	2935	3076	209	2638	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					367	+		10.1038/nature15371	http://dx.doi.org/10.1038/nature15371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381985				2022-12-28	WOS:000361297900041
J	Fauci, AS; Morens, DM; Marston, HD				Fauci, Anthony S.; Morens, David M.; Marston, Hilary D.			Vaccination and the Lasker Awards Enduring Legacies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLIOMYELITIS		[Fauci, Anthony S.; Morens, David M.; Marston, Hilary D.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 31 Ctr Dr,MSC 2520,Bldg 31,Room 7A-03, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Centers for Disease Control and Prevention, HAEM INFL DIS INCL H; ENDERS JF, 1980, REV INFECT DIS, V2, P493; Francis T, 1955, AM J PUBLIC HEALTH N, V45, P1; Jackson S, 2013, J CLIN INVEST, V123, P4107, DOI 10.1172/JCI72874; SABIN AB, 1965, J AMER MED ASSOC, V194, P872, DOI 10.1001/jama.194.8.872; SALK JE, 1955, JAMA-J AM MED ASSOC, V158, P1239, DOI 10.1001/jama.1955.02960140001001; WHO, POL CAS COUNT	7	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1119	1120		10.1001/jama.2015.9807	http://dx.doi.org/10.1001/jama.2015.9807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372572				2022-12-28	WOS:000361284500014
J	van Opstal, EJ; Bordenstein, SR				van Opstal, Edward J.; Bordenstein, Seth R.			Rethinking heritability of the microbiome	SCIENCE			English	Editorial Material							GUT MICROBIOME; BACTERIAL; CONSEQUENCES; COMMUNITY; GENETICS		[van Opstal, Edward J.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	van Opstal, EJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.	s.bordenstein@vanderbilt.edu		van Opstal, Edward/0000-0002-2973-6308	Direct For Biological Sciences [1046149] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Lewis ND, 2011, J IMMUNOL, V186, P3632, DOI 10.4049/jimmunol.1003431; Palmer GH, 2013, CELL MICROBIOL, V15, P1969, DOI 10.1111/cmi.12182; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	15	73	76	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1172	1173		10.1126/science.aab3958	http://dx.doi.org/10.1126/science.aab3958			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359393				2022-12-28	WOS:000360968400026
J	Valluru, B; Raj, R				Valluru, Balakrishna; Raj, Ray			Arachnoid Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Valluru, Balakrishna; Raj, Ray] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Valluru, B (corresponding author), Royal Liverpool Univ Hosp, Liverpool, Merseyside, England.	bavalluru@msn.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11							e13	10.1056/NEJMicm1413067	http://dx.doi.org/10.1056/NEJMicm1413067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352828				2022-12-28	WOS:000360959000012
J	Bhatnagar, R; Maskell, N				Bhatnagar, Rahul; Maskell, Nick			The modern diagnosis and management of pleural effusions	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TALC PLEURODESIS; PARAPNEUMONIC EFFUSIONS; CATHETER; DISEASE; COST; ACCURACY; FLUID; CT		[Bhatnagar, Rahul] Univ Bristol, Southmead Hosp, Acad Resp Unit, Bristol BS10 5NB, Avon, England; [Maskell, Nick] Southmead Hosp North Bristol NHS Trust, North Bristol Lung Ctr, Bristol, Avon, England	Southmead Hospital; University of Bristol; North Bristol NHS Trust	Bhatnagar, R (corresponding author), Univ Bristol, Southmead Hosp, Acad Resp Unit, Bristol BS10 5NB, Avon, England.	Rahul.Bhatnagar@Bristol.ac.uk		maskell, nick/0000-0002-1276-6500; Bhatnagar, Rahul/0000-0003-3906-1997	National Institute for Health Research [CL-2014-25-502] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ahmed L, 2014, CHEST, V146, pE190, DOI 10.1378/chest.14-0394; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; Astoul P, 2013, EUR RESP J S57, V42, pP3081; Bintcliffe OJ, 2014, CURR PULMONOL REP, V3, P61, DOI 10.1007/s13665-014-0073-5; Clive AO, 2014, THORAX, V69, P1098, DOI 10.1136/thoraxjnl-2014-205285; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; Department of Health Payment by Results team, 2013, PAYM RES GUID 2013 2; Diacon AH, 2003, CHEST, V123, P436, DOI 10.1378/chest.123.2.436; Ekstrom MP, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7617; Fysh ETH, 2013, CHEST, V144, P1597, DOI 10.1378/chest.12-3103; Havelock T, 2010, THORAX, V65, P61, DOI 10.1136/thx.2010.137026; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Hooper CE, 2010, RESPIROLOGY, V15, P1028, DOI 10.1111/j.1440-1843.2010.01832.x; Janda S, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-58; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; LEUNG AN, 1990, AM J ROENTGENOL, V154, P487, DOI 10.2214/ajr.154.3.2106209; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; MACHA HN, 1993, EUR J CARDIO-THORAC, V7, P19, DOI 10.1016/1010-7940(93)90142-X; MAREL M, 1993, CHEST, V104, P1486, DOI 10.1378/chest.104.5.1486; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; Menzies SM, 2011, THORAX, V66, P658, DOI 10.1136/thx.2010.157842; Mercaldi CJ, 2013, CHEST, V143, P532, DOI 10.1378/chest.12-0447; Morel A, 2011, THORAX, V66, P448, DOI 10.1136/thx.2009.133504; Penz ED, 2014, CHEST, V146, P991, DOI 10.1378/chest.13-2481; Puri V, 2012, ANN THORAC SURG, V94, P374, DOI 10.1016/j.athoracsur.2012.02.100; Reddy C, 2011, CHEST, V139, P1419, DOI 10.1378/chest.10-1868; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Sahn SA, 2008, TXB PLEURAL DIS, P209; Shaw P., 2004, COCHRANE DB SYST REV; TARYLE DA, 1978, CHEST, V74, P170, DOI 10.1378/chest.74.2.170; Tremblay A, 2012, EXP LUNG RES, V38, P475, DOI 10.3109/01902148.2012.731715; Van Meter MEM, 2011, J GEN INTERN MED, V26, P70, DOI 10.1007/s11606-010-1472-0; Young RL, 2013, THORAX, V68, pA42, DOI 10.1136/thoraxjnl-2013-204457.85	34	23	24	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2015	351								h4520	10.1136/bmj.h4520	http://dx.doi.org/10.1136/bmj.h4520			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CS	26350935	Green Submitted			2022-12-28	WOS:000361280000002
J	Menke, A; Casagrande, S; Geiss, L; Cowie, CC				Menke, Andy; Casagrande, Sarah; Geiss, Linda; Cowie, Catherine C.			Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; HEALTH-INSURANCE COVERAGE; FASTING PLASMA-GLUCOSE; NATIONAL-HEALTH; US ADULTS; OBESITY; POPULATION; OVERWEIGHT; CUTOFFS	IMPORTANCE Previous studies have shown increasing prevalence of diabetes in the United States. New US data are available to estimate prevalence of and trends in diabetes. OBJECTIVE To estimate the recent prevalence and update US trends in total diabetes, diagnosed diabetes, and undiagnosed diabetes using National Health and Nutrition Examination Survey (NHANES) data. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional surveys conducted between 1988-1994 and 1999-2012 of nationally representative samples of the civilian, noninstitutionalized US population; 2781 adults from 2011-2012 were used to estimate recent prevalence and an additional 23 634 adults from 1988-2010 were used to estimate trends. MAIN OUTCOMES AND MEASURES The prevalence of diabetes was defined using a previous diagnosis of diabetes or, if diabetes was not previously diagnosed, by (1) a hemoglobin A(1c) level of 6.5% or greater or a fasting plasma glucose (FPG) level of 126 mg/dL or greater (hemoglobin A1c or FPG definition) or (2) additionally including 2-hour plasma glucose (2-hour PG) level of 200mg/dL or greater (hemoglobin A1c, FPG, or 2-hour PG definition). Prediabetes was defined as a hemoglobin A1c level of 5.7% to 6.4%, an FPG level of 100 mg/dL to 125 mg/dL, or a 2-hour PG level of 140 mg/dL to 199 mg/dL. RESULTS In the overall 2011-2012 population, the unadjusted prevalence (using the hemoglobin A1c, FPG, or 2-hour PG definitions for diabetes and prediabetes) was 14.3%(95% CI, 12.2%-16.8%) for total diabetes, 9.1% (95% CI, 7.8%-10.6%) for diagnosed diabetes, 5.2% (95% CI, 4.0%-6.9%) for undiagnosed diabetes, and 38.0%(95% CI, 34.7%-41.3%) for prediabetes; among those with diabetes, 36.4%(95% CI, 30.5%-42.7%) were undiagnosed. The unadjusted prevalence of total diabetes (using the hemoglobin A1c or FPG definition) was 12.3%(95% CI, 10.8%-14.1%); among those with diabetes, 25.2%(95% CI, 21.1%-29.8%) were undiagnosed. Compared with non-Hispanic white participants (11.3%[95% CI, 9.0%-14.1%]), the age-standardized prevalence of total diabetes (using the hemoglobin A1c, FPG, or 2-hour PG definition) was higher among non-Hispanic black participants (21.8%[95% CI, 17.7%-26.7%]; P < .001), non-Hispanic Asian participants (20.6%[95% CI, 15.0%-27.6%]; P = .007), and Hispanic participants (22.6%[95% CI, 18.4%-27.5%]; P < .001). The age-standardized percentage of cases that were undiagnosed was higher among non-Hispanic Asian participants (50.9%[95% CI, 38.3%-63.4%]; P = .004) and Hispanic participants (49.0% [95% CI, 40.8%-57.2%]; P = .02) than all other racial/ethnic groups. The age-standardized prevalence of total diabetes (using the hemoglobin A1c or FPG definition) increased from 9.8%(95% CI, 8.9%-10.6%) in 1988-1994 to 10.8%(95% CI, 9.5%-12.0%) in 2001-2002 to 12.4%(95% CI, 10.8%-14.2%) in 2011-2012 (P < .001 for trend) and increased significantly in every age group, in both sexes, in every racial/ethnic group, by all education levels, and in all poverty income ratio tertiles. CONCLUSIONS AND RELEVANCE In 2011-2012, the estimated prevalence of diabetes was 12% to 14% among US adults, depending on the criteria used, with a higher prevalence among participants who were non-Hispanic black, non-Hispanic Asian, and Hispanic. Between 1988-1994 and 2011-2012, the prevalence of diabetes increased in the overall population and in all subgroups evaluated.	[Menke, Andy; Casagrande, Sarah] Social & Sci Syst Inc, Silver Spring, MD 20910 USA; [Geiss, Linda] US Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Cowie, Catherine C.] NIDDK, NIH, Bethesda, MD USA	Social & Scientific Systems; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Menke, A (corresponding author), Social & Sci Syst Inc, 8757 Georgia Ave, Silver Spring, MD 20910 USA.	amenke@s-3.com			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [GS10F0381L]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by contract GS10F0381L from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Casagrande SS, 2012, DIABETES CARE, V35, P2243, DOI 10.2337/dc12-0257; Christophi CA, 2013, J DIABETES COMPLICAT, V27, P150, DOI 10.1016/j.jdiacomp.2012.09.012; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Menke A, 2013, EPIDEMIOLOGY, V24, P773, DOI 10.1097/EDE.0b013e31829ef01a; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; Nelson KM, 2005, HEALTH SERV RES, V40, P361, DOI 10.1111/j.1475-6773.2005.0d362.x; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Staimez LR, 2013, CURR DIABETES REV, V9, P312, DOI 10.2174/15733998113099990061; Stevens J, 2003, INT J OBESITY, V27, P287, DOI 10.1038/sj.ijo.0802255; Zipf G, 2013, VITAL HLTH STAT, V56, P1	23	1187	1201	5	112	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1021	1029		10.1001/jama.2015.10029	http://dx.doi.org/10.1001/jama.2015.10029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348752	Bronze			2022-12-28	WOS:000360840700014
J	Liu, L; Black, RE				Liu, Li; Black, Robert E.			Child survival in 2015: much accomplished, but more to do	LANCET			English	Editorial Material							COUNTDOWN		[Liu, Li; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA.	rblack1@jhu.edu	liu, li/HGC-0900-2022					Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lorenzetti L., 2015, WORLDS 1 MALARIA VAC; United Nations Inter-agency Group for Child Mortality Estimation, LEV TRENDS IN PRESS; WHO, 2014, WORLD MAL REP 2014, P242; World Health Organization, 2015, GUID MAN POSS SER BA; You D, 2015, LANCET	10	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2234	2235		10.1016/S0140-6736(15)00193-2	http://dx.doi.org/10.1016/S0140-6736(15)00193-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26361943				2022-12-28	WOS:000365993200010
J	Siu, AL				Siu, Albert L.		US Preventive Services Task Force	Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC CIGARETTES; UNITED-STATES; NICOTINE PATCHES; SMOKERS; TRENDS; POLICY; TRIAL	Description: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on counseling and interventions to prevent tobacco use and tobacco-related disease in adults, including pregnant women. Methods: The USPSTF reviewed the evidence on interventions for tobacco smoking cessation that are relevant to primary care (behavioral interventions, pharmacotherapy, and complementary or alternative therapy) in adults, including pregnant women. Population: This recommendation applies to adults aged 18 years or older, including pregnant women. Recommendations: The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and U.S. Food and Drug Administration-approved pharmacotherapy for cessation to adults who use tobacco. (A recommendation) The USPSTF recommends that clinicians ask all pregnant women about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant women who use tobacco. (A recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant women. (I statement) The USPSTF concludes that the current evidence is insufficient to recommend electronic nicotine delivery systems for tobacco cessation in adults, including pregnant women. The USPSTF recommends that clinicians direct patients who smoke tobacco to other cessation interventions with established effectiveness and safety (previously stated). (I statement)	[Siu, Albert L.; US Preventive Services Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		Siu, AL (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.							Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P542; American Academy of Family Physicians, 2008, CLIN PRACT GUID TOB; American College of Physicians, 2010, TOB CONT PREV; [Anonymous], 2011, Obstet Gynecol, V118, P746, DOI 10.1097/AOG.0b013e3182310ca9; Berlin I, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1622; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Centers for Disease Control and Prevention, TOB US PREGN; Chamberlain Catherine, 2013, Cochrane Database Syst Rev, pCD001055, DOI 10.1002/14651858.CD001055.pub4; Chatham-Stephens K, 2014, MMWR-MORBID MORTAL W, V63, P292; Cooper S, 2014, LANCET RESP MED, V2, P728, DOI 10.1016/S2213-2600(14)70157-2; Dempsey DA, 2001, DRUG SAFETY, V24, P277, DOI 10.2165/00002018-200124040-00005; Fiore MC, 2008, CLIN PRACTICE GUIDEL; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Hartmann-Boyce J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001118.pub3; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Kandra KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103462; Kattapong VJ, 1998, AM J PREV MED, V15, P160, DOI 10.1016/S0749-3797(98)00036-1; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Mills EJ, 2014, CIRCULATION, V129, P28, DOI 10.1161/CIRCULATIONAHA.113.003961; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Office on Smoking and Health (US), 2010, TOB SMOK CAUS DIS BI; Oncken C, 2008, OBSTET GYNECOL, V112, P859, DOI 10.1097/AOG.0b013e318187e1ec; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171; Rice VH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001188.pub4; ROSE G, 1992, J EPIDEMIOL COMMUN H, V46, P75, DOI 10.1136/jech.46.1.75; Schmidt L, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140283; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1; U.S. Department of Health and Human Services, 2001, 2001 SURG GEN REP WO; U.S. Food and Drug Administration, 2012, CHANT VAR SAF COMM U; U.S. Food and Drug Administration, 2015, CHANT VAR DRUG SAF C; US Preventive Serv Task Force, 2009, ANN INTERN MED, V150, P551, DOI 10.7326/0003-4819-150-8-200904210-00009; White AR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000009.pub4; World Health Organization, 2013, WHO REC PREV MAN TOB	45	308	309	1	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					622	+		10.7326/M15-2023	http://dx.doi.org/10.7326/M15-2023			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26389730				2022-12-28	WOS:000363737400020
J	Hofmann, J; Hahm, HS; Seeberger, PH; Pagel, K				Hofmann, J.; Hahm, H. S.; Seeberger, P. H.; Pagel, K.			Identification of carbohydrate anomers using ion mobility-mass spectrometry	NATURE			English	Article							COLLISION CROSS-SECTIONS; SOLID-PHASE SYNTHESIS; ISOMERIC OLIGOSACCHARIDES; AUTOMATED SYNTHESIS; N-GLYCANS; SEPARATION; MS	Carbohydrates are ubiquitous biological polymers that are important in a broad range of biological processes(1-3). However, owing to their branched structures and the presence of stereogenic centres at each glycosidic linkage between monomers, carbohydrates are harder to characterize than are peptides and oligonucleotides(4). Methods such as nuclear magnetic resonance spectroscopy can be used to characterize glycosidic linkages, but this technique requires milligram amounts of material and cannot detect small amounts of coexisting isomers(5). Mass spectrometry, on the other hand, can provide information on carbohydrate composition and connectivity for even small amounts of sample, but it cannot be used to distinguish between stereoisomers(6). Here, we demonstrate that ion mobility-mass spectrometry-a method that separates molecules according to their mass, charge, size, and shape-can unambiguously identify carbohydrate linkage-isomers and stereoisomers. We analysed six synthetic carbohydrate isomers that differ in composition, connectivity, or configuration. Our data show that coexisting carbohydrate isomers can be identified, and relative concentrations of the minor isomer as low as 0.1 per cent can be detected. In addition, the analysis is rapid, and requires no derivatization and only small amounts of sample. These results indicate that ion-mobility-mass spectrometry is an effective tool for the analysis of complex carbohydrates. This method could have an impact on the field of carbohydrate synthesis similar to that of the advent of high-performance liquid chromatography on the field of peptide assembly in the late 1970s.	[Hofmann, J.; Pagel, K.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Hofmann, J.; Hahm, H. S.; Seeberger, P. H.; Pagel, K.] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Hahm, H. S.; Seeberger, P. H.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, D-14476 Potsdam, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Free University of Berlin; Max Planck Society	Seeberger, PH (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Muhlenberg 1, D-14476 Potsdam, Germany.	peter.seeberger@mpikg.mpg.de; kevin.pagel@fu-berlin.de	Pagel, Kevin/C-5533-2019; Hahm, Heung Sik/A-8809-2014	Pagel, Kevin/0000-0001-8054-4718; Hahm, Heung Sik/0000-0003-2326-7923	Free University Berlin; Max Planck Society	Free University Berlin; Max Planck Society(Max Planck Society)	We thank the Free University Berlin and the Max Planck Society for financial support. J.H. and K.P. thank G. von Helden, J.L.P. Benesch and W.B. Struwe for comments.	Bertozzi C.R., 2009, ESSENTIALS GLYCOBIOL; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Bohrer BC, 2008, ANNU REV ANAL CHEM, V1, P293, DOI 10.1146/annurev.anchem.1.031207.113001; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]; Both P, 2014, NAT CHEM, V6, P65, DOI [10.1038/NCHEM.1817, 10.1038/nchem.1817]; Daikoku S, 2009, RAPID COMMUN MASS SP, V23, P3713, DOI 10.1002/rcm.4303; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Eller S, 2013, ANGEW CHEM INT EDIT, V52, P5858, DOI 10.1002/anie.201210132; Fenn LS, 2011, PHYS CHEM CHEM PHYS, V13, P2196, DOI 10.1039/c0cp01414a; Gabryelski W, 2003, J AM SOC MASS SPECTR, V14, P265, DOI 10.1016/S1044-0305(03)00002-3; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Hofmann J, 2014, ANAL CHEM, V86, P10789, DOI 10.1021/ac5028353; Krock L, 2012, CHEM SCI, V3, P1617, DOI 10.1039/c2sc00940d; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Martin CE, 2011, CHEM COMMUN, V47, P10260, DOI 10.1039/c1cc13614c; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Pagel K, 2013, ANAL CHEM, V85, P5138, DOI 10.1021/ac400403d; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Plasencia MD, 2008, J AM SOC MASS SPECTR, V19, P1706, DOI 10.1016/j.jasms.2008.07.020; Prien JM, 2009, J AM SOC MASS SPECTR, V20, P539, DOI 10.1016/j.jasms.2008.11.012; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Service RF, 2012, SCIENCE, V338, P321, DOI 10.1126/science.338.6105.321; Uetrecht C, 2010, CHEM SOC REV, V39, P1633, DOI 10.1039/b914002f; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Z, 2013, SCIENCE, V341, P379, DOI 10.1126/science.1236231; Werz DB, 2007, J AM CHEM SOC, V129, P2770, DOI 10.1021/ja069218x; Williams JP, 2010, INT J MASS SPECTROM, V298, P119, DOI 10.1016/j.ijms.2009.08.006; Zhu ML, 2009, ANAL BIOANAL CHEM, V394, P1853, DOI 10.1007/s00216-009-2865-y	33	220	225	6	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					241	+		10.1038/nature15388	http://dx.doi.org/10.1038/nature15388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416727	Green Submitted			2022-12-28	WOS:000362399000044
J	Diamond, MP; Legro, RS; Coutifaris, C; Alvero, R; Robinson, RD; Casson, P; Christman, GM; Ager, J; Huang, H; Hansen, KR; Baker, V; Usadi, R; Seungdamrong, A; Bates, GW; Rosen, RM; Haisenleder, D; Krawetz, SA; Barnhart, K; Trussell, JC; Ohl, D; Jin, Y; Santoro, N; Eisenberg, E; Zhang, H				Diamond, M. P.; Legro, R. S.; Coutifaris, C.; Alvero, R.; Robinson, R. D.; Casson, P.; Christman, G. M.; Ager, J.; Huang, H.; Hansen, K. R.; Baker, V.; Usadi, R.; Seungdamrong, A.; Bates, G. W.; Rosen, R. M.; Haisenleder, D.; Krawetz, S. A.; Barnhart, K.; Trussell, J. C.; Ohl, D.; Jin, Y.; Santoro, N.; Eisenberg, E.; Zhang, H.		NICHD Reprod Med Network	Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; MULTIPLE INTRAUTERINE GESTATIONS; OVARIAN STIMULATION; AROMATASE INHIBITORS; FERTILITY TREATMENTS; OVULATION INDUCTION; RANDOMIZED-TRIAL; INSEMINATION; CITRATE; SUPEROVULATION	BACKGROUND The standard therapy for women with unexplained infertility is gonadotropin or clomiphene citrate. Ovarian stimulation with letrozole has been proposed to reduce multiple gestations while maintaining live birth rates. METHODS We enrolled couples with unexplained infertility in a multicenter, randomized trial. Ovulatory women 18 to 40 years of age with at least one patent fallopian tube were randomly assigned to ovarian stimulation (up to four cycles) with gonadotropin (301 women), clomiphene (300), or letrozole (299). The primary outcome was the rate of multiple gestations among women with clinical pregnancies. RESULTS After treatment with gonadotropin, clomiphene, or letrozole, clinical pregnancies occurred in 35.5%, 28.3%, and 22.4% of cycles, and live birth in 32.2%, 23.3%, and 18.7%, respectively; pregnancy rates with letrozole were significantly lower than the rates with standard therapy (gonadotropin or clomiphene) (P = 0.003) or gonadotropin alone (P<0.001) but not with clomiphene alone (P = 0.10). Among ongoing pregnancies with fetal heart activity, the multiple gestation rate with letrozole (9 of 67 pregnancies, 13%) did not differ significantly from the rate with gonadotropin or clomiphene (42 of 192, 22%; P = 0.15) or clomiphene alone (8 of 85, 9%; P = 0.44) but was lower than the rate with gonadotropin alone (34 of 107, 32%; P = 0.006). All multiple gestations in the clomiphene and letrozole groups were twins, whereas gonadotropin treatment resulted in 24 twin and 10 triplet gestations. There were no significant differences among groups in the frequencies of congenital anomalies or major fetal and neonatal complications. CONCLUSIONS In women with unexplained infertility, ovarian stimulation with letrozole resulted in a significantly lower frequency of multiple gestation but also a lower frequency of live birth, as compared with gonadotropin but not as compared with clomiphene. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT01044862.)	[Diamond, M. P.] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Diamond, M. P.; Ager, J.; Krawetz, S. A.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Legro, R. S.] Penn State Univ, Dept Obstet & Gynecol, Hershey, PA USA; [Coutifaris, C.; Barnhart, K.] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Alvero, R.; Santoro, N.] Univ Colorado, Dept Obstet & Gynecol, Denver, CO 80202 USA; [Robinson, R. D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Casson, P.] Univ Vermont, Dept Obstet & Gynecol, Burlington, VT 05405 USA; [Christman, G. M.; Ohl, D.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Huang, H.; Jin, Y.; Zhang, H.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Hansen, K. R.] Univ Oklahoma, Coll Med, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Baker, V.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Usadi, R.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Seungdamrong, A.] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Bates, G. W.] Univ Alabama Birmingham, Birmingham, AL 35487 USA; [Rosen, R. M.] Univ Calif San Francisco, Dept Reprod Endocrinol & Infertil, San Francisco, CA 94143 USA; [Haisenleder, D.] Univ Virginia, Ctr Res Reprod, Ligand Core Lab, Charlottesville, VA USA; [Trussell, J. C.] Upstate Univ Hosp, Syracuse, NY USA; [Eisenberg, E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Fertil & Infertil Branch, Rockville, MD USA	University System of Georgia; Augusta University; Wayne State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; University of Colorado System; University of Colorado Denver; University of Texas System; University of Texas Health San Antonio; University of Vermont; University of Michigan System; University of Michigan; Yale University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University; Carolinas Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; University of Virginia; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Diamond, MP (corresponding author), Georgia Regents Univ, Dept Obstet & Gynecol, 1120 15th St,Rm BA-7313, Augusta, GA 30912 USA.	michael.diamond@gru.edu	krawetz, stephen/GQQ-3308-2022; Huang, Huang/AAN-5671-2020	Alvero, Ruben/0000-0001-6542-710X; Legro, Richard/0000-0001-9927-7584; Diamond, Michael/0000-0001-6353-4489	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934, U10HD039005, P50HD028934, U10HD077680, U10HD055936, U10HD055925, U10HD038992, U10HD055942, U10HD027049, U10HD038998, U10HD055944] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the National Institutes of Health and others	Al-Fadhli R, 2006, FERTIL STERIL, V85, P161, DOI 10.1016/j.fertnstert.2005.07.1283; Al-Fozan H, 2004, FERTIL STERIL, V82, P1561, DOI 10.1016/j.fertnstert.2004.04.070; Badawy A, 2009, FERTIL STERIL, V92, P1355, DOI 10.1016/j.fertnstert.2008.06.013; Bayar U, 2006, FERTIL STERIL, V85, P1045, DOI 10.1016/j.fertnstert.2005.09.045; Cook JL, 2011, J OBSTET GYNAECOL CA, V33, P609, DOI 10.1016/S1701-2163(16)34909-X; Diamond MP, 2015, FERTIL STERIL, V103, P962, DOI 10.1016/j.fertnstert.2014.12.130; Diamond MP, 2011, CONTEMP CLIN TRIALS, V32, P902, DOI 10.1016/j.cct.2011.07.009; Dickey RP, 1999, FERTIL STERIL, V71, P684, DOI 10.1016/S0015-0282(98)00519-6; FISCH P, 1989, FERTIL STERIL, V51, P828; Fouda UM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-84; Ghesquiere SL, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.016; Gregoriou O, 2008, FERTIL STERIL, V90, P678, DOI 10.1016/j.fertnstert.2007.06.099; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Kulkarni AD, 2013, NEW ENGL J MED, V369, P2218, DOI 10.1056/NEJMoa1301467; Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517; McClamrock HD, 2012, FERTIL STERIL, V97, P802, DOI 10.1016/j.fertnstert.2012.02.031; Mitwally MFM, 2003, HUM REPROD, V18, P1588, DOI 10.1093/humrep/deg311; Pavone ME, 2013, J CLIN ENDOCR METAB, V98, P1838, DOI 10.1210/jc.2013-1328; Pfeifer S, 2012, FERTIL STERIL, V97, P825, DOI 10.1016/j.fertnstert.2011.11.048; Polyzos NP, 2009, REPROD BIOMED ONLINE, V19, P456, DOI 10.1016/j.rbmo.2009.06.008; Quintero RB, 2007, FERTIL STERIL, V88, P879, DOI 10.1016/j.fertnstert.2006.11.166; Reynolds MA, 2003, PEDIATRICS, V111, P1159; Samani FG, 2009, ARCH GYNECOL OBSTET, V280, P201, DOI 10.1007/s00404-008-0888-9; Schieve LA, 2009, AM J EPIDEMIOL, V170, P1396, DOI 10.1093/aje/kwp281; Tulandi T, 2006, FERTIL STERIL, V85, P1761, DOI 10.1016/j.fertnstert.2006.03.014	25	167	177	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1230	1240		10.1056/NEJMoa1414827	http://dx.doi.org/10.1056/NEJMoa1414827			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398071	Green Accepted, Bronze			2022-12-28	WOS:000361635200008
J	Gould, J				Gould, Julie			THE CANNABIS CROP	NATURE			English	Editorial Material																		Brown TT, 2002, J CLIN PHARMACOL, V42, p90S, DOI 10.1002/j.1552-4604.2002.tb06008.x; Johnson R., 2015, JAMA-J AM MED ASSOC, V313, P2456; Pertwee RG., 2014, HDB CANNABIS; United Nations Office on Drugs and Crime, 2014, UN OFF DRUG CRIM WOR, P3	4	44	46	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S2	S3		10.1038/525S2a	http://dx.doi.org/10.1038/525S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0LE	26398736	Bronze			2022-12-28	WOS:000426170100001
J	Wheeler, TM; Baker, JN; Chad, DA; Zilinski, JL; Verzosa, S; Mordes, DA				Wheeler, Thurman M.; Baker, Joshua N.; Chad, David A.; Zilinski, Jodi L.; Verzosa, Stacey; Mordes, Daniel A.			Case 30-2015: A 50-Year-Old Man with Cardiogenic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; MYOTONIC-DYSTROPHY TYPE-1; EFFECTIVE ANTIMYOTONIA TREATMENT; ADULT PATIENTS; ABNORMALITIES; EXPERIENCE; MEXILETINE; EXPANSION; SUPPORT; MUSCLE		[Wheeler, Thurman M.; Chad, David A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Verzosa, Stacey] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mordes, Daniel A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Baker, Joshua N.] Massachusetts Gen Hosp, Div Cardiac Surg, Boston, MA 02114 USA; [Zilinski, Jodi L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Wheeler, Thurman M.; Chad, David A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Baker, Joshua N.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Zilinski, Jodi L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Verzosa, Stacey] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mordes, Daniel A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wheeler, TM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.							Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bird T.D., 2013, GENEREVIEWS; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Combes A, 2008, CRIT CARE MED, V36, P1404, DOI 10.1097/CCM.0b013e31816f7cf7; Formica F, 2008, ASAIO J, V54, P89, DOI 10.1097/MAT.0b013e31815ff27e; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Griggs RC, 1995, EVALUATION TREATMENT; Groh WJ, 2008, NEW ENGL J MED, V358, P2688, DOI 10.1056/NEJMoa062800; Groh WJ, 2011, NEUROLOGY, V76, P409, DOI 10.1212/WNL.0b013e3181fe72d7; HUYGEN PLM, 1994, AUDIOLOGY, V33, P73; KWIECINSKI H, 1988, MUSCLE NERVE, V11, P576, DOI 10.1002/mus.880110609; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Logigian EL, 2010, NEUROLOGY, V74, P1441, DOI 10.1212/WNL.0b013e3181dc1a3a; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; Magovern GJ, 1999, ANN THORAC SURG, V68, P655, DOI 10.1016/S0003-4975(99)00581-0; Muehrcke DD, 1996, ANN THORAC SURG, V61, P684, DOI 10.1016/0003-4975(95)01042-4; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; NGUYEN HH, 1988, J AM COLL CARDIOL, V11, P662, DOI 10.1016/0735-1097(88)91547-1; Riggs JE, 1999, CLIN NEUROPHARMACOL, V22, P180; SONODA Y, 1994, MUSCLE NERVE, V17, P891, DOI 10.1002/mus.880170808; Wheeler TM, 2007, NEUROMUSCULAR DISORD, V17, P242, DOI 10.1016/j.nmd.2006.12.015; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362	23	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1251	1261		10.1056/NEJMcpc1415169	http://dx.doi.org/10.1056/NEJMcpc1415169			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398074				2022-12-28	WOS:000361635200012
J	Fortescue, EB				Fortescue, Elizabeth B.			Mercy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02452 USA	Harvard University; Harvard Medical School	Fortescue, EB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02452 USA.	elizabeth.fortescue@gmail.com						Brown B., LISTENING TO SHAME; Egan J., THE THIN RED LINE; Favazza ArmandoR., 1996, BODIES SIEGE SELF MU; Gerson Jessica, 2002, Curr Psychiatry Rep, V4, P30, DOI 10.1007/s11920-002-0009-6; Sacks O., 2015, NEW YORKER, P26; Stanley B, 2001, AM J PSYCHIAT, V158, P427, DOI 10.1176/appi.ajp.158.3.427; Strong M, 1998, BRIGHT RED SCREAM SE	7	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1231	1232		10.1001/jama.2015.7653	http://dx.doi.org/10.1001/jama.2015.7653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393842				2022-12-28	WOS:000362110700008
J	[Anonymous]				[Anonymous]			Current Comment Counting the World's Cost (Reprinted from JAMA, vol 65, pg 1117, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1915, JAMA, V65, P1117	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1298	1298		10.1001/jama.2014.12000	http://dx.doi.org/10.1001/jama.2014.12000			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393862				2022-12-28	WOS:000362110700027
J	Fisman, R; Jakiela, P; Kariv, S; Markovits, D				Fisman, Raymond; Jakiela, Pamela; Kariv, Shachar; Markovits, Daniel			The distributional preferences of an elite	SCIENCE			English	Article							BEHAVIOR; TESTS	We studied the distributional preferences of an elite cadre of Yale Law School students, a group that will assume positions of power in U.S. society. Our experimental design allows us to test whether redistributive decisions are consistent with utility maximization and to decompose underlying preferences into two qualitatively different tradeoffs: fair-mindedness versus self-interest, and equality versus efficiency. Yale Law School subjects are more consistent than subjects drawn from the American Life Panel, a diverse sample of Americans. Relative to the American Life Panel, Yale Law School subjects are also less fair-minded and substantially more efficiency-focused. We further show that our measure of equality-efficiency tradeoffs predicts Yale Law School students' career choices: Equality-minded subjects are more likely to be employed at nonprofit organizations.	[Fisman, Raymond] Boston Univ, Dept Econ, Boston, MA 02215 USA; Univ Maryland, Dept Agr & Resource Econ, College Pk, MD 20742 USA; Univ Calif Berkeley, Dept Econ, Berkeley, CA USA; Yale Univ, Sch Law, New Haven, CT 06520 USA	Boston University; University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley; Yale University	Fisman, R (corresponding author), Boston Univ, Dept Econ, Boston, MA 02215 USA.	rfisman@bu.edu			Columbia University Graduate School of Business; Center for Equitable Growth at UCB, YLS; Oscar M. Reubhausen Fund; National Science Foundation; Multidisciplinary University Research Initiative (MURI)	Columbia University Graduate School of Business; Center for Equitable Growth at UCB, YLS; Oscar M. Reubhausen Fund; National Science Foundation(National Science Foundation (NSF)); Multidisciplinary University Research Initiative (MURI)(MURI)	We are grateful to J. Andreoni, D. Bernheim, S. DellaVigna, C. Jolls, D. Kahan, B. Polak, M. Rabin, E. Saez and A. Schwartz for helpful discussions and comments. This paper has also benefitted from suggestions by the participants of seminars at several universities and conferences. The experiments reported in this paper were funded by the Columbia University Graduate School of Business, the Center for Equitable Growth at UCB, YLS, and the Oscar M. Reubhausen Fund. S.K. acknowledges the National Science Foundation and the Multidisciplinary University Research Initiative (MURI) for financial support. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of any funding agency. Replication data files are available online at https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi%3A10.7910%2FDVN%2FJYHMRA.	Afriat S.N., 1972, INT ECON REV, V13, P568, DOI [10.2307/2525845, DOI 10.2307/2525845]; Afriat S.N, 1967, INT ECON REV, V8, P67, DOI [DOI 10.2307/2525382, 10.2307/2525382]; Altonji JG, 2005, J POLIT ECON, V113, P151, DOI 10.1086/426036; Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; BECKER GS, 1962, J POLIT ECON, V70, P1, DOI 10.1086/258584; BRONARS SG, 1987, ECONOMETRICA, V55, P693, DOI 10.2307/1913608; Choi S, 2007, AM ECON REV, V97, P153, DOI 10.1257/aer.97.2.153; Fisman R., 2014, NATL BUREAU EC RES; Fisman R, 2007, AM ECON REV, V97, P1858, DOI 10.1257/aer.97.5.1858; Fisman R, 2015, J PUBLIC ECON, V128, P84, DOI 10.1016/j.jpubeco.2015.06.001; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Okun A.M., 2015, EQUALITY EFFICIENCY; Piff PK, 2014, PERS SOC PSYCHOL B, V40, P34, DOI 10.1177/0146167213501699; Stancheva S., 2013, NATL BUREAU EC RES; VARIAN HR, 1982, ECONOMETRICA, V50, P945, DOI 10.2307/1912771; VARIAN HR, 1983, REV ECON STUD, V50, P99, DOI 10.2307/2296957	16	62	63	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254							aab0096	10.1126/science.aab0096	http://dx.doi.org/10.1126/science.aab0096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR5CR	26383958				2022-12-28	WOS:000361357700039
J	D'Orazio, DJ; Haiman, Z; Schiminovich, D				D'Orazio, Daniel J.; Haiman, Zoltan; Schiminovich, David			Relativistic boost as the cause of periodicity in a massive black-hole binary candidate	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; ACCRETION DISKS; CENTRAL CAVITY; QUASAR; VARIABILITY; SIMULATION; DYNAMICS; SYSTEMS; MODELS; DRIVEN	Because most large galaxies contain a central black hole, and galaxies often merge(1), black-hole binaries are expected to be common in galactic nuclei(2). Although they cannot be imaged, periodicities in the light curves of quasars have been interpreted as evidence for binaries(3-5), most recently in PG 1302-102, which has a short rest-frame optical period of four years (ref. 6). If the orbital period of the black-hole binary matches this value, then for the range of estimated black-hole masses, the components would be separated by 0.007-0.017 parsecs, implying relativistic orbital speeds. There has been much debate over whether black-hole orbits could be smaller than one parsec (ref. 7). Here we report that the amplitude and the sinusoid-like shape of the variability of the light curve of PG 1302-102 can be fitted by relativistic Doppler boosting of emission from a compact, steadily accreting, unequal-mass binary. We predict that brightness variations in the ultraviolet light curve track those in the optical, but with a two to three times larger amplitude. This prediction is relatively insensitive to the details of the emission process, and is consistent with archival ultraviolet data. Follow-up ultraviolet and optical observations in the next few years can further test this prediction and confirm the existence of a binary black hole in the relativistic regime.	[D'Orazio, Daniel J.; Haiman, Zoltan; Schiminovich, David] Columbia Univ, Dept Astron, New York, NY 10027 USA	Columbia University	Haiman, Z (corresponding author), Columbia Univ, Dept Astron, 550 West 120th St, New York, NY 10027 USA.	zoltan@astro.columbia.edu		D'Orazio, Daniel/0000-0002-1271-6247; Haiman, Zoltan/0000-0003-3633-5403	National Science Foundation Graduate Research Fellowship [DGE1144155]; NASA [NNX11AE05G]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	The authors thank M. Graham, J. Halpern, A. Price-Whelan, J. Andrews, M. Charisi, E. Quataert, and B. Kocsis for discussions. We also thank M. Graham for providing the optical data in electronic form. This work was supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE1144155 (D.J.D.) and by the NASA grant NNX11AE05G (Z.H.).	Andrae R., 2013, Astronomy & Astrophysics, V554, DOI 10.1051/0004-6361/201321335; ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Charisi M., MON NOT R A IN PRESS; Cooksey KL, 2008, ASTROPHYS J, V676, P262, DOI 10.1086/528704; D'Orazio DJ, 2015, MON NOT R ASTRON SOC, V452, P2540, DOI 10.1093/mnras/stv1457; D'Orazio DJ, 2013, MON NOT R ASTRON SOC, V436, P2997, DOI 10.1093/mnras/stt1787; Djorgovski S. G., 2010, 1 YEAR MAXI MONITORI, P32; Dunhill AC, 2015, MON NOT R ASTRON SOC, V448, P3545, DOI 10.1093/mnras/stv284; Evans IN, 2004, ASTROPHYS J SUPPL S, V150, P73, DOI 10.1086/379649; Farris BD, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/134; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Graham MJ, 2015, NATURE, V518, P74, DOI 10.1038/nature14143; Hayasaki K, 2008, ASTROPHYS J, V682, P1134, DOI 10.1086/588837; HUTCHINGS JB, 1994, PUBL ASTRON SOC PAC, V106, P642, DOI 10.1086/133425; Jiang YF, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/106; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kelly BC, 2009, ASTROPHYS J, V698, P895, DOI 10.1088/0004-637X/698/1/895; Komossa S., 2006, MEM SOC ASTRON ITAL, V77, P733; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Kozlowski S, 2010, ASTROPHYS J, V708, P927, DOI 10.1088/0004-637X/708/2/927; Lai D, 2014, MON NOT R ASTRON SOC, V440, P3532, DOI 10.1093/mnras/stu485; Liu TT, 2015, ASTROPHYS J LETT, V803, DOI 10.1088/2041-8205/803/2/L16; Loeb A, 2003, ASTROPHYS J, V588, pL117, DOI 10.1086/375551; MacFadyen AI, 2008, ASTROPHYS J, V672, P83, DOI 10.1086/523869; Mazeh T, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015550; Milosavljevic M, 2003, AIP CONF PROC, V686, P201; Narayan R., 1998, THEORY BLACK HOLE AC, P148; Narayan R, 2008, NEW ASTRON REV, V51, P733, DOI 10.1016/j.newar.2008.03.002; Nixon C, 2013, MON NOT R ASTRON SOC, V434, P1946, DOI 10.1093/mnras/stt1136; Richards GT, 2006, ASTROPHYS J SUPPL S, V166, P470, DOI 10.1086/506525; Roedig C, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219986; Roedig C, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/115; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Shi JM, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/131; Shi JM, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/118; Shporer A, 2010, ASTROPHYS J LETT, V725, pL200, DOI 10.1088/2041-8205/725/2/L200; Tanaka T, 2010, ASTROPHYS J, V714, P404, DOI 10.1088/0004-637X/714/1/404; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896; van Kerkwijk MH, 2010, ASTROPHYS J, V715, P51, DOI 10.1088/0004-637X/715/1/51; Volonteri M, 2003, ASTROPHYS J, V582, P559, DOI 10.1086/344675; Wang JM, 2003, ASTRON ASTROPHYS, V409, P887, DOI 10.1051/0004-6361:20031218; Wright J. T., 2013, PLANETS STARS STELLA, P489; Yu QJ, 2002, MON NOT R ASTRON SOC, V335, P965, DOI 10.1046/j.1365-8711.2002.05532.x	45	98	98	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					351	+		10.1038/nature15262	http://dx.doi.org/10.1038/nature15262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381982	Green Submitted			2022-12-28	WOS:000361297900037
J	Mishra, CK; Thomas, J; Kumar, R; Basavaraj, T; James, AJ; Mohan, A; Kuruvilla, S; Basavaraj, S				Mishra, C. K.; Thomas, Joe; Kumar, Rakesh; Basavaraj, Trupthi; James, A. J.; Mohan, Anshu; Kuruvilla, Shyama; Basavaraj, S.			National leadership: driving forward the updated Global Strategy for Women's, Children's and Adolescents' Health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kuruvilla, Shyama] WHO, Family Womens & Childrens Hlth, Geneva, Switzerland	World Health Organization		mishrack@nic.in	Thomas, Joe/AAV-8878-2021	Thomas, Joe/0000-0002-0275-6640; Kuruvilla, Shyama/0000-0002-0327-4467				Ansell C., 2012, OXFORD HDB GOVERNANC, DOI [DOI 10.1093/OXFORDHB/9780199560530.013.0035, 10.1093/oxfordhb/9780199560530.013.0035]; Bouman S, 2013, PUBLIC PRIVATE PARTN; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Dasandi N., 2014, POLITICS BUREAUCRACY; Pinzon-Florez CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120747; Every Woman Every Child, 2015, STAK CONS M UPD GLOB; Every Woman Every Child, 2015, SAV LIV PROT FUT PRO; Hellowell M., 2012, COMMONWEALTH HLTH PA; International Health Partnership (IHP+), 2014, PROGR INT PARTN REL; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Keefer Philip, 2011, ASIAN DEV REV, V28, P94; Kennedy F, 2014, ANAL LEADERSHIP DEV; Kuruvilla Shyama, 2014, Bull World Health Organ, V92, P533, DOI 10.2471/BLT.14.138131; Ministry of Health Ethiopia PMNCH WHO World Bank AHPSR, 2015, SUCC FACT WOM CHILDR; Ministry of Health Rwanda PMNCH WHO World Bank AHPSR, 2015, SUCC FACT WOM CHILDR; Partnership for Maternal Newborn and Child Health (PMNCH), 2012, NAT ACC MECH WOM CHI; Rauch JE, 2000, J PUBLIC ECON, V75, P49, DOI 10.1016/S0047-2727(99)00044-4; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tembo F, 2012, CIT VOIC STAT ACC TH; UN Women, 2011, PROGR WORLDS WOM PUR; World Health Organization, 2012, WHO HLTH SYST FRAM; World Health Organization; Partnership for Maternal Newborn and Child Health (PMNCH), 2013, PMNCH 2013 REP	23	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4282					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9LW	26371224	hybrid			2022-12-28	WOS:000361678200012
J	Nagarajan, N; Smart, B; Nwadiuko, J				Nagarajan, Neeraja; Smart, Blair; Nwadiuko, Joseph			Diaspora engagement in humanitarian emergencies and beyond	LANCET			English	Editorial Material							BRAIN-DRAIN		[Nagarajan, Neeraja] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Smart, Blair] Rush Univ, Rush Med Sch, Chicago, IL 60612 USA; [Nwadiuko, Joseph] Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD USA	Johns Hopkins University; Rush University; Johns Hopkins University; Johns Hopkins Medicine	Nagarajan, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA.	nnagara2@jhu.edu		Nwadiuko, Joseph/0000-0002-2498-2972				ANMF, 2015, AM NEP MED FDN EARTH; Bhargava A, 2011, ECON HUM BIOL, V9, P172, DOI 10.1016/j.ehb.2010.12.004; Busse H, 2013, ACAD EMERG MED, V20, P1310, DOI 10.1111/acem.12265; Duckenfield D, 2015, ENGAGING AFRICAN DIA; Erikson Daniel P., 2014, DIASPORA LOBBIES US, P185; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1853, DOI 10.1001/jama.298.16.1853; Licuanan V, 2015, WORLD DEV, V65, P94, DOI 10.1016/j.worlddev.2014.05.010; Mahroum S., 2006, INT J MULTICULTURAL, V8, P25; Malla RB, 2015, EARTHQUAKE PREPAREDN; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Naik Stigter, 2007, INT ORG MIGRATION; Semple K, 2015, NY TIMES, pA18; Woo G., 2008, 14 WORLD C EARTHQ EN; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	14	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1015	1016		10.1016/S0140-6736(15)00071-9	http://dx.doi.org/10.1016/S0140-6736(15)00071-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR2VQ	26382979				2022-12-28	WOS:000361189200004
J	Haber, JE				Haber, James E.			Deciphering the DNA Damage Response	CELL			English	Editorial Material							ESCHERICHIA-COLI B; PROTEIN-KINASE; ULTRAVIOLET MUTAGENESIS; CHECKPOINT; YEAST; CHK1; REPAIR; LINKAGE; RAD53; ATM	This year's Albert Lasker Basic Medical Research Award honors Evelyn Witkin and Stephen J. Elledge, two pioneers in elucidating the DNA damage response, whose contributions span more than 40 years.	[Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	haber@brandeis.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020056, R01GM061766, R01GM076020] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM020056, R01 GM076020, R01 GM061766] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ELLEDGE SJ, 1983, J MOL BIOL, V164, P175, DOI 10.1016/0022-2836(83)90074-8; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Liu QH, 2000, GENE DEV, V14, P1448; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; TOBEY RA, 1975, NATURE, V254, P245, DOI 10.1038/254245a0; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WITKIN EM, 1973, GENETICS, V73, P91; WITKIN EM, 1967, P NATL ACAD SCI USA, V57, P1275, DOI 10.1073/pnas.57.5.1275; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	15	15	15	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1183	1185		10.1016/j.cell.2015.08.034	http://dx.doi.org/10.1016/j.cell.2015.08.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359974	Bronze			2022-12-28	WOS:000361247900003
J	Sparano, JA; Gray, RJ; Makower, DF; Pritchard, KI; Albain, KS; Hayes, DF; Geyer, CE; Dees, EC; Perez, EA; Olson, JA; Zujewski, JA; Lively, T; Badve, SS; Saphner, TJ; Wagner, LI; Whelan, TJ; Ellis, MJ; Paik, S; Wood, WC; Ravdin, P; Keane, MM; Moreno, HLG; Reddy, PS; Goggins, TF; Mayer, IA; Brufsky, AM; Toppmeyer, DL; Kaklamani, VG; Atkins, JN; Berenberg, JL; Sledge, GW				Sparano, J. A.; Gray, R. J.; Makower, D. F.; Pritchard, K. I.; Albain, K. S.; Hayes, D. F.; Geyer, C. E., Jr.; Dees, E. C.; Perez, E. A.; Olson, J. A., Jr.; Zujewski, J. A.; Lively, T.; Badve, S. S.; Saphner, T. J.; Wagner, L. I.; Whelan, T. J.; Ellis, M. J.; Paik, S.; Wood, W. C.; Ravdin, P.; Keane, M. M.; Gomez Moreno, H. L.; Reddy, P. S.; Goggins, T. F.; Mayer, I. A.; Brufsky, A. M.; Toppmeyer, D. L.; Kaklamani, V. G.; Atkins, J. N.; Berenberg, J. L.; Sledge, G. W.			Prospective Validation of a 21-Gene Expression Assay in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADJUVANT CHEMOTHERAPY; CLINICAL-PRACTICE; AMERICAN SOCIETY; GENE-EXPRESSION; TAMOXIFEN; TRIAL; EFFICACY; RECOMMENDATIONS; RECURRENCE; MARKERS	BACKGROUND Prior studies with the use of a prospective-retrospective design including archival tumor samples have shown that gene-expression assays provide clinically useful prognostic information. However, a prospectively conducted study in a uniformly treated population provides the highest level of evidence supporting the clinical validity and usefulness of a biomarker. METHODS We performed a prospective trial involving women with hormone-receptor-positive, human epidermal growth factor receptor type 2 (HER2)-negative, axillary node-negative breast cancer with tumors of 1.1 to 5.0 cm in the greatest dimension (or 0.6 to 1.0 cm in the greatest dimension and intermediate or high tumor grade) who met established guidelines for the consideration of adjuvant chemotherapy on the basis of clinicopathologic features. A reverse-transcriptase-polymerase-chain-reaction assay of 21 genes was performed on the paraffin-embedded tumor tissue, and the results were used to calculate a score indicating the risk of breast-cancer recurrence; patients were assigned to receive endocrine therapy without chemotherapy if they had a recurrence score of 0 to 10, indicating a very low risk of recurrence (on a scale of 0 to 100, with higher scores indicating a greater risk of recurrence). RESULTS Of the 10,253 eligible women enrolled, 1626 women (15.9%) who had a recurrence score of 0 to 10 were assigned to receive endocrine therapy alone without chemotherapy. At 5 years, in this patient population, the rate of invasive disease-free survival was 93.8% (95% confidence interval [CI], 92.4 to 94.9), the rate of freedom from recurrence of breast cancer at a distant site was 99.3% (95% CI, 98.7 to 99.6), the rate of freedom from recurrence of breast cancer at a distant or local-regional site was 98.7% (95% CI, 97.9 to 99.2), and the rate of overall survival was 98.0% (95% CI, 97.1 to 98.6). CONCLUSIONS Among patients with hormone-receptor-positive, HER2-negative, axillary node-negative breast cancer who met established guidelines for the recommendation of adjuvant chemotherapy on the basis of clinicopathologic features, those with tumors that had a favorable gene-expression profile had very low rates of recurrence at 5 years with endocrine therapy alone. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT00310180.)	[Sparano, J. A.; Makower, D. F.] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Gray, R. J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pritchard, K. I.] Sunnybrook Res Inst, Toronto, ON, Canada; [Whelan, T. J.] Juravinski Canc Ctr, Hamilton, ON, Canada; [Albain, K. S.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Wagner, L. I.; Kaklamani, V. G.] Northwestern Univ, Chicago, IL 60611 USA; [Hayes, D. F.] Univ Michigan, Ann Arbor, MI 48109 USA; [Geyer, C. E., Jr.] Virginia Commonwealth Univ, Sch Med, Richmond, NC USA; [Geyer, C. E., Jr.] Massey Canc Ctr, Richmond, NC USA; [Dees, E. C.] Univ N Carolina, Chapel Hill, NC USA; [Olson, J. A., Jr.] Duke Univ, Med Ctr, Durham, NC USA; [Wagner, L. I.] Wake Forest Univ Hlth Serv, Winston Salem, NC USA; [Atkins, J. N.] Southeast Clin Oncol Res Consortium, Goldsboro, NC USA; [Perez, E. A.] Mayo Clin, Jacksonville, FL 32224 USA; [Olson, J. A., Jr.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Zujewski, J. A.; Lively, T.] NIH, Bethesda, MD 20892 USA; [Badve, S. S.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Sledge, G. W.] Indiana Univ Hosp, Indianapolis, IN 46202 USA; [Saphner, T. J.] Vince Lombardi Canc Clin, Two Rivers, WI USA; [Goggins, T. F.] Fox Valley Hematol & Oncol, Appleton, WI USA; [Ellis, M. J.] Baylor Coll Med, Houston, TX 77030 USA; [Ravdin, P.] Univ Texas San Antonio, San Antonio, TX USA; [Ellis, M. J.] Washington Univ, St Louis, MO USA; [Paik, S.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Brufsky, A. M.] Univ Pittsburgh, Pittsburgh, PA USA; [Paik, S.] Yonsei Univ, Dept Med Oncol, Coll Med, Seoul, South Korea; [Paik, S.] Yonsei Univ, Breast Ctr, Coll Med, Seoul, South Korea; [Wood, W. C.] Emory Univ, Atlanta, GA 30322 USA; [Keane, M. M.] Irish Clin Oncol Res Grp, Dublin, Ireland; [Gomez Moreno, H. L.] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Reddy, P. S.] Canc Ctr Kansas, Wichita, KS USA; [Mayer, I. A.] Vanderbilt Univ, Nashville, TN 37235 USA; [Toppmeyer, D. L.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Berenberg, J. L.] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Sledge, G. W.] Stanford Univ, Stanford, CA 94305 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Loyola University Chicago; Northwestern University; University of Michigan System; University of Michigan; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Wake Forest University; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; Indiana University System; Indiana University Bloomington; Indiana University System; Baylor College of Medicine; University of Texas System; University of Texas at San Antonio (UTSA); Washington University (WUSTL); Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Emory University; All-Ireland Cooperative Oncology Research Group; Instituto Nacional de Enfermedades Neoplasicas; Cancer Center of Kansas; Vanderbilt University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Cancer Research Center of Hawaii; University of Hawaii System; Stanford University	Sparano, JA (corresponding author), Montefiore Med Ctr, Dept Oncol, 1695 Eastchester Rd, Bronx, NY 10461 USA.	jsparano@montefiore.org	Evans, Diane/F-9258-2017; Whelan, Timothy/D-3185-2017; Geyer, Charles/AGY-0119-2022; Hayes, Daniel/ABE-1129-2020; Brufsky, Adam/AAE-7470-2020	Whelan, Timothy/0000-0001-9844-2023; Geyer, Charles/0000-0002-2379-5702; Sparano, Joseph/0000-0002-9031-2010; Gomez, Henry/0000-0003-2660-1843; Paik, Soonmyung/0000-0001-9688-6480; Badve, Sunil/0000-0001-8861-9980; Brufsky, Adam/0000-0001-8080-7960	National Cancer Institute; NATIONAL CANCER INSTITUTE [U10CA037403, U10CA180820, U10CA180857, P50CA121973, U10CA066636, U10CA023318, UG1CA189858, P30CA047904, U10CA180847, U10CA180868, U24CA196172, U10CA180794, U10CA180821, U10CA021115, U10CA180888, U10CA180864, UG1CA189867, U10CA180822, U10CA180838, UG1CA189869, U10CA180816, U10CA180844, U10CA180799, U10CA077202, UG1CA189808, UG1CA190140, P30CA013330, U10CA180790, UG1CA189859, UG1CA189804, U10CA086802, U10CA180801, U10CA180833, U10CA180795] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT00310180.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abrams J S, 2001, Breast Cancer, V8, P298, DOI 10.1007/BF02967528; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; [Anonymous], 2007, LANCET ONCOL, V8, P1079, DOI 10.1016/S1470-2045(07)70346-7; Bartlett J, 2013, CLIN ONCOL-UK, V25, P109, DOI 10.1016/j.clon.2012.10.005; Cardoso F, 2007, MOL ONCOL, V1, P246, DOI 10.1016/j.molonc.2007.10.004; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 1, pS1; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Duffy MJ, 2015, CLIN CHEM, V61, P809, DOI 10.1373/clinchem.2015.239863; Fisher B, 1997, JNCI-J NATL CANCER I, V89, P1673, DOI 10.1093/jnci/89.22.1673; Goldstein LJ, 2008, J CLIN ONCOL, V26, P4063, DOI 10.1200/JCO.2007.14.4501; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hayes Daniel, 2011, Clin Adv Hematol Oncol, V9, P130; Hayes DF, 2015, MOL ONCOL, V9, P960, DOI 10.1016/j.molonc.2014.10.004; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; MANSOUR EG, 1989, NEW ENGL J MED, V320, P485, DOI 10.1056/NEJM198902233200803; Mansour EG, 1998, J CLIN ONCOL, V16, P3486, DOI 10.1200/JCO.1998.16.11.3486; Munoz D, 2014, JNCI-J NATL CANCER I, V106; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sestak I, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0516-0; Sgroi DC, 2013, LANCET ONCOL, V14, P1067, DOI 10.1016/S1470-2045(13)70387-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Sparano JA, 2015, J CLIN ONCOL, V33, P2353, DOI 10.1200/JCO.2015.60.9271; Sparano JA, 2010, SURG ONCOL CLIN N AM, V19, P581, DOI 10.1016/j.soc.2010.03.008; Tang G, 2011, BREAST CANCER RES TR, V127, P133, DOI 10.1007/s10549-010-1331-z; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong WB, 2012, CONTEMP CLIN TRIALS, V33, P1117, DOI 10.1016/j.cct.2012.08.006	37	851	872	2	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2005	2014		10.1056/NEJMoa1510764	http://dx.doi.org/10.1056/NEJMoa1510764			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4JN	26412349	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000364957700006
J	Cappola, AR; FitzGerald, GA				Cappola, Anne R.; FitzGerald, Garret A.			Confluence, Not Conflict of Interest Name Change Necessary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cappola, Anne R.; FitzGerald, Garret A.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Smilow Ctr Translat Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Cappola, AR (corresponding author), Univ Penn, Perelman Sch Med, Translat Res Ctr, 12th Floor,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	acappola@mail.med.upenn.edu			NCATS NIH HHS [UL1 TR000003] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Gino F, 2011, ORGAN BEHAV HUM DEC, V114, P104, DOI 10.1016/j.obhdp.2010.10.002; University of Pennsylvania Perelman School of Medicine, ITMAT CONFL INT SCI	2	62	62	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1791	1792		10.1001/jama.2015.12020	http://dx.doi.org/10.1001/jama.2015.12020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26402846				2022-12-28	WOS:000363960200005
J	Jacobs, JZ; Rosado-Lugo, JD; Cranz-Mileva, S; Ciccaglione, KM; Tournier, V; Zaratiegui, M				Jacobs, Jake Z.; Rosado-Lugo, Jesus D.; Cranz-Mileva, Susanne; Ciccaglione, Keith M.; Tournier, Vincent; Zaratiegui, Mikel			Arrested replication forks guide retrotransposon integration	SCIENCE			English	Article							ACTIVATING-PROTEIN SAP1; POL-II PROMOTERS; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; RIBOSOMAL DNA; SITES; TRANSCRIPTION; TY1; SEQUENCE; ELEMENTS	Long terminal repeat (LTR) retrotransposons are an abundant class of genomic parasites that replicate by insertion of new copies into the host genome. Fungal LTR retrotransposons prevent mutagenic insertions through diverse targeting mechanisms that avoid coding sequences, but conserved principles guiding their target site selection have not been established. Here, we show that insertion of the fission yeast LTR retrotransposon Tf1 is guided by the DNA binding protein Sap1 and that the efficiency and location of the targeting depend on the activity of Sap1 as a replication fork barrier. We propose that Sap1 and the fork arrest it causes guide insertion of Tf1 by tethering the integration complex to target sites.	[Jacobs, Jake Z.; Rosado-Lugo, Jesus D.; Cranz-Mileva, Susanne; Ciccaglione, Keith M.; Tournier, Vincent; Zaratiegui, Mikel] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Zaratiegui, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson A133,604 Allison Rd, Piscataway, NJ 08854 USA.	zaratiegui@dls.rutgers.edu		Tournier, Vincent/0000-0002-3971-1972; Zaratiegui, Mikel/0000-0002-0342-0268	Searle Scholar Award; NIH [1R01GM105831]; Rutgers Biotechnology Training Program [5T32GM008339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339, R01GM105831] Funding Source: NIH RePORTER	Searle Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to H. Levin for strains, reagents, and technical advice as well as critical discussions. This work was supported by a Searle Scholar Award and NIH grant 1R01GM105831 (to M.Z.) and a Rutgers Biotechnology Training Program Grant 5T32GM008339 (to J.Z.J.). The high-throughput sequencing data reported in this paper are archived at the Gene Expression Omnibus repository (www.ncbi.nlm.nih.gov/geo) under accession no. GSE67692. The authors declare no financial conflicts of interest.	ARCANGIOLI B, 1994, NUCLEIC ACIDS RES, V22, P2930, DOI 10.1093/nar/22.15.2930; Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Bridier-Nahmias A, 2015, SCIENCE, V348, P585, DOI 10.1126/science.1259114; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Chatterjee AG, 2014, NUCLEIC ACIDS RES, V42, P8449, DOI 10.1093/nar/gku534; Curcio MJ, 2007, MOL CELL BIOL, V27, P8874, DOI 10.1128/MCB.01095-07; de Lahondes R, 2003, EUKARYOT CELL, V2, P910, DOI 10.1128/EC.2.5.910-921.2003; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Fricker AD, 2014, ANNU REV GENET, V48, P167, DOI 10.1146/annurev-genet-120213-092046; GHAZVINI M, 1995, MOL CELL BIOL, V15, P4939; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; Krings G, 2006, MOL CELL BIOL, V26, P8061, DOI 10.1128/MCB.01102-06; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Leem YE, 2008, MOL CELL, V30, P98, DOI 10.1016/j.molcel.2008.02.016; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Qi XJ, 2012, GENOME RES, V22, P681, DOI 10.1101/gr.131219.111; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Sabouri N, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0101-5; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Tsankov A, 2011, GENOME RES, V21, P1851, DOI 10.1101/gr.122267.111; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zaratiegui M, 2011, NATURE, V469, P112, DOI 10.1038/nature09608; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	27	29	29	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1549	1553		10.1126/science.aaa3810	http://dx.doi.org/10.1126/science.aaa3810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404838	Green Accepted			2022-12-28	WOS:000361707000050
J	Solow, AR				Solow, Andrew R.			Extreme weather, made by us?	SCIENCE			English	Editorial Material									Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Solow, AR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	asolow@whoi.edu						Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Field C.B., 2012, MANAGING RISKS EXTRE; Hansen G, 2014, J CLIMATE, V27, P8297, DOI 10.1175/JCLI-D-14-00399.1; Herring SC, 2015, B AM METEOROL SOC, V96, DOI 10.1175/BAMS-EEE_2014_ch1.1; Landsea CW, 2006, SCIENCE, V313, P452, DOI 10.1126/science.1128448; Lewis SC, 2013, GEOPHYS RES LETT, V40, P3705, DOI 10.1002/grl.50673; Otto FEL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050422; Williams AP, 2015, GEOPHYS RES LETT, V42, P6819, DOI 10.1002/2015GL064924	9	13	13	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1444	1445		10.1126/science.aad2132	http://dx.doi.org/10.1126/science.aad2132			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404810				2022-12-28	WOS:000361707000020
J	Jerrett, M				Jerrett, Michael			ATMOSPHERIC SCIENCE The death toll from air-pollution sources	NATURE			English	Editorial Material							COMPARATIVE RISK-ASSESSMENT; PARTICULATE MATTER; GLOBAL BURDEN; MORTALITY; POLLUTANTS; EXPOSURE; DISEASE		[Jerrett, Michael] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA 90095 USA; [Jerrett, Michael] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Ctr Occupat & Environm Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jerrett, M (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA 90095 USA.	mjerrett@ucla.edu	Jerrett, Michael/CAA-2482-2022	jerrett, michael/0000-0002-4121-0587				Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236; Baumgartner J, 2014, P NATL ACAD SCI USA, V111, P13229, DOI 10.1073/pnas.1317176111; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Thurston G. D., ENV HLTH PE IN PRESS; Wang SX, 2014, ATMOS CHEM PHYS, V14, P6571, DOI 10.5194/acp-14-6571-2014	13	93	105	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					330	331		10.1038/525330a	http://dx.doi.org/10.1038/525330a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381981				2022-12-28	WOS:000361297900033
J	Doshi, P				Doshi, Peter			No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAJOR DEPRESSION; EFFICACY					pdoshi@bmj.com						American Academy of Child and Adolescent Psychiatry, 2012, TREAS REP; American Academy of Child and Adolescent Psychiatry, 2014, TREAS REP; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; FDA, CLIN REV PAR; Jureidini J, 2010, PAXIL STUDY 329 PARO; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320	7	16	16	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4629	10.1136/bmj.h4629	http://dx.doi.org/10.1136/bmj.h4629			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26377109				2022-12-28	WOS:000361678800005
J	Arnold, RM				Arnold, Robert M.			Review: Cannabinoids may improve symptoms for some indications but increase adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Arnold, RM (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.							Elliot S., 2011, MED MARIJUANA PATIEN; Romero-Sandoval EA, 2012, 8 ANN DARTHM S SUBST	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							ACPJC-2015-163-6-004	10.7326/ACPJC-2015-163-6-004	http://dx.doi.org/10.7326/ACPJC-2015-163-6-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370031				2022-12-28	WOS:000361365900004
J	Cunningham, S; Rodriguez, A; Adams, T; Boyd, KA; Butcher, I; Enderby, B; MacLean, M; McCormick, J; Paton, JY; Wee, F; Thomas, H; Riding, K; Turner, SW; Williams, C; McIntosh, E; Lewis, SC				Cunningham, Steve; Rodriguez, Aryelly; Adams, Tim; Boyd, Kathleen A.; Butcher, Isabella; Enderby, Beth; MacLean, Morag; McCormick, Jonathan; Paton, James Y.; Wee, Fiona; Thomas, Huw; Riding, Kay; Turner, Steve W.; Williams, Chris; McIntosh, Emma; Lewis, Steff C.		Bronchiolitis Infancy Discharge	Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial	LANCET			English	Article							CHILDREN; SUPPORT	Background The American Academy of Pediatrics recommends a permissive hypoxaemic target for an oxygen saturation of 90% for children with bronchiolitis, which is consistent with the WHO recommendations for targets in children with lower respiratory tract infections. No evidence exists to support this threshold. We aimed to assess whether the 90% or higher target for management of oxygen supplementation was equivalent to a normoxic 94% or higher target for infants admitted to hospital with viral bronchiolitis. Methods We did a parallel-group, randomised, controlled, equivalence trial of infants aged 6 weeks to 12 months of age with physician-diagnosed bronchiolitis newly admitted into eight paediatric hospital units in the UK (the Bronchiolitis of Infancy Discharge Study [BIDS]). A central computer randomly allocated (1: 1) infants, in varying length blocks of four and six and without stratifi cation, to be clipped to standard oximeters (patients treated with oxygen if pulse oxygen saturation [SpO(2)] < 94%) or modified oximeters (displayed a measured value of 90% as 94%, therefore oxygen not given until SpO2 < 90%). All parents, clinical staff, and outcome assessors were masked to allocation. The primary outcome was time to resolution of cough (prespecified equivalence limits of plus or minus 2 days) in the intention-to-treat population. This trial is registered with ISRCTN, number ISRCTN28405428. Findings Between Oct 3, and March 30, 2012, and Oct 1, and March 29, 2013, we randomly assigned 308 infants to standard oximeters and 307 infants to modifi ed oximeters. Cough resolved by 15.0 days (median) in both groups (95% CI for difference -1 to 2) and so oxygen thresholds were equivalent. We recorded 35 serious adverse events in 32 infants in the standard care group and 25 serious adverse events in 24 infants in the modifi ed care group. In the standard care group, eight infants transferred to a high-dependency unit, 23 were readmitted, and one had a prolonged hospital stay. In the modifi ed care group, 12 infants were transferred to a high-dependency unit and 12 were readmitted to hospital. Recorded adverse events did not diff er significantly. Interpretation Management of infants with bronchiolitis to an oxygen saturation target of 90% or higher is as safe and clinically effective as one of 94% or higher. Future research should assess the benefits and risks of different oxygen saturation targets in acute respiratory infection in older children, particularly in developing nations where resources are scarce. Copyright (C) Cunningham et al. Open Access article distributed under the terms of CC BY-NC-ND.	[Cunningham, Steve; Riding, Kay] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh EH9 1LF, Midlothian, Scotland; [Rodriguez, Aryelly; Butcher, Isabella; Lewis, Steff C.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH9 1LF, Midlothian, Scotland; [MacLean, Morag] Univ Edinburgh, Edinburgh Clin Trials Unit, Edinburgh EH9 1LF, Midlothian, Scotland; [Adams, Tim] Crosshouse Hosp, Dept Paediat, Kilmarnock, Scotland; [Boyd, Kathleen A.; McIntosh, Emma] Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Paton, James Y.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Enderby, Beth] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [McCormick, Jonathan] Univ Dundee, Ninewells Hosp & Med Sch, Dept Paediat, Dundee DD1 9SY, Scotland; [Thomas, Huw] Bristol Childrens Hosp, Dept Resp Med, Bristol, Avon, England; [Turner, Steve W.] Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Williams, Chris] Royal Cornwall Hosp, Truro, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow; University of Exeter; University of Dundee; Bristol Royal Hospital For Children; University of Aberdeen; Royal Cornwall Hospital	Cunningham, S (corresponding author), Univ Edinburgh, Dept Child Life & Hlth, Edinburgh EH9 1LF, Midlothian, Scotland.	steve.cunningham@nhs.net		Boyd, Kathleen/0000-0002-9764-0113; Lewis, Steff/0000-0003-1210-2314; Cunningham, Steve/0000-0001-7342-251X; Lyttle, Mark/0000-0002-8634-7210; Gamble, Carrol/0000-0002-3021-1955; MacLean, Morag/0000-0002-4037-0247; McIntosh, Emma/0000-0001-6340-3083; Tonner, Sharon/0000-0002-7775-9926	National Institute for Health Research, Health Technology Assessment programme; UK National Institute for Health Research (NIHR), Health Technology Assessment (HTA) programme [09/91/16]; NHS Research Scotland (NRS), through the Edinburgh Clinical Research Facility; National Institute for Health Research [09/91/16] Funding Source: researchfish	National Institute for Health Research, Health Technology Assessment programme(National Institute for Health Research (NIHR)); UK National Institute for Health Research (NIHR), Health Technology Assessment (HTA) programme; NHS Research Scotland (NRS), through the Edinburgh Clinical Research Facility; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research, Health Technology Assessment programme.; We were funded by the UK National Institute for Health Research (NIHR), Health Technology Assessment (HTA) programme (project number 09/91/16) and will be published in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the UK Department of Health. The BIDS study team acknowledges the financial support of NHS Research Scotland (NRS), through the Edinburgh Clinical Research Facility. We also received non-financial support from the Scottish Children's Research Network (ScotCRN) and the NIHR Clinical Research Network. Masimo, CA, USA, produced oxygen saturation monitors with standard and altered algorithm to the specification required for the study, which we then bought from Masimo. We thank Michael Shields (Queen's University Belfast), Colin Powell (University of Cardiff), and Clare Murray (University of Manchester) for serving as the trial steering committee, and to Sheila McKenzie (NHS Highland), Mike McKean (Newcastle University), and Carrol Gamble (University of Liverpool) for serving as the data monitoring committee.	Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Altman DG, 1989, STAT CONFIDENCE, P19; [Anonymous], 2014, THORAX, V69, P1; Bass JL, 2007, PEDIATRICS, V119, P611, DOI 10.1542/peds.2006-3002; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Cunningham S, 2012, ARCH DIS CHILD, V97, P361, DOI 10.1136/adc.2010.205211; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hudson KL, 2013, NEW ENGL J MED, V368, P2349, DOI 10.1056/NEJMp1306986; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Macklin R, 2013, NEW ENGL J MED, V369, pE3, DOI 10.1056/NEJMc1308015; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; National Guideline Clearinghouse (NGC), GUID SYNTH PREV DIAG; Network SIG, 2006, BRONCH CHILDR SIGN 9; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; ROJAS MX, 2009, COCHRANE DB SYST REV, V1; Schuh S, 2014, JAMA-J AM MED ASSOC, V312, P712, DOI 10.1001/jama.2014.8637; Schwarze J, 2013, THORAX, V68, P108, DOI 10.1136/thoraxjnl-2012-202291; Shields Michael D, 2013, Cough, V9, P11, DOI 10.1186/1745-9974-9-11; Skjerven HO, 2013, NEW ENGL J MED, V368, P2286, DOI 10.1056/NEJMoa1301839; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Thompson M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7027; UK Department of Health, NAT SCHED REF COSTS; Unger S, 2008, PEDIATRICS, V121, P470, DOI 10.1542/peds.2007-1135; World Health Organization, 2013, POCK BOOK HOSP CAR C; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	85	87	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1041	1048		10.1016/S0140-6736(15)00163-4	http://dx.doi.org/10.1016/S0140-6736(15)00163-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26382998	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000361189200023
J	Henriksen-Lacey, M; Giner-Casares, JJ				Henriksen-Lacey, Malou; Giner-Casares, Juan J.			Nice to know you	SCIENCE			English	Editorial Material									[Henriksen-Lacey, Malou; Giner-Casares, Juan J.] CIC BiomaGUNE, San Sebastian, Spain	CIC biomaGUNE	Henriksen-Lacey, M (corresponding author), CIC BiomaGUNE, San Sebastian, Spain.		Giner-Casares, Juan J. J/N-7612-2015; Henriksen, Malou/F-7821-2014; Giner-Casares, Juan J./D-7053-2013; Giner-Casares, Juan J./ABF-2642-2020; biomaGUNE, CIC/J-9136-2014	Giner-Casares, Juan J. J/0000-0002-6673-300X; Henriksen, Malou/0000-0003-3544-5846; Giner-Casares, Juan J./0000-0002-6673-300X; Giner-Casares, Juan J./0000-0002-6673-300X; biomaGUNE, CIC/0000-0001-7690-0660					0	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1254	1254		10.1126/science.349.6253.1254	http://dx.doi.org/10.1126/science.349.6253.1254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9XH	26359404				2022-12-28	WOS:000360968400047
J	Tanno, Y; Susumu, H; Kawamura, M; Sugimura, H; Honda, T; Watanabe, Y				Tanno, Yuji; Susumu, Hiroaki; Kawamura, Miyuki; Sugimura, Haruhiko; Honda, Takashi; Watanabe, Yoshinori			RETRACTED: The inner centromere-shugoshin network prevents chromosomal instability (Retracted article. See vol. 357, pg. 981, 2017)	SCIENCE			English	Article; Retracted Publication							KINETOCHORE ORIENTATION; CHROMATID COHESION; CANCER; CELLS; HETEROCHROMATIN; ANEUPLOIDY; PHOSPHORYLATION; TUMORIGENESIS; PROTECTION; MECHANISM	Chromosomal instability (CIN) is a major trait of cancer cells and a potent driver of tumor progression. However, the molecular mechanisms underlying CIN still remain elusive. We found that a number of CIN+ cell lines have impairments in the integrity of the conserved inner centromere-shugoshin (ICS) network, which coordinates sister chromatid cohesion and kinetochore-microtubule attachment. These defects are caused mostly by the loss of histone H3 lysine 9 trimethylation at centromeres and sometimes by a reduction in chromatin-associated cohesin; both pathways separately sustain centromeric shugoshin stability. Artificial restoration of the ICS network suppresses chromosome segregation errors in a wide range of CIN+ cells, including RB- and BRCA1-deficient cells. Thus, dysfunction of the ICS network might be a key mechanism underlying CIN in human tumorigenesis.	[Tanno, Yuji; Susumu, Hiroaki; Kawamura, Miyuki; Honda, Takashi; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Susumu, Hiroaki; Kawamura, Miyuki; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan	University of Tokyo; University of Tokyo; Hamamatsu University School of Medicine	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812	JSPS KAKENHI [24770180, 26440093]; JSPS; MEXT KAKENHI grants [S-001, 25000014]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript; T. Akiyama, Y. Gotoh, K. Shirahige, T. Hirota, K. Miyagawa, A. Enomoto, M. Ohsugi, T. Kitamura, H. Suzuki, and T. Ohta for kindly providing materials; K. Funai for clinical arrangements; Y. Hirabayashi, Y. Kanki, S. Koitabashi, M. Okada, T. Kahyo, A. R. Maia, R. Nakato, and D. Izawa for valuable technical advice; and all members of our laboratory, particularly Y. Yamagishi, for their valuable support and discussions. Supported by JSPS KAKENHI grants 24770180 and 26440093 (Y.T.), a JSPS research fellowship (H. Sus.), and MEXT KAKENHI grants S-001 (H. Sug.) and 25000014 (Y.W.).	Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Salimian KJ, 2011, CURR BIOL, V21, P1158, DOI 10.1016/j.cub.2011.06.015; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Watanabe Y, 2012, NAT REV MOL CELL BIO, V13, P370, DOI 10.1038/nrm3349; Yamada HY, 2012, CELL CYCLE, V11, P479, DOI 10.4161/cc.11.3.18994; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	30	38	38	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1237	1240		10.1126/science.aaa2655	http://dx.doi.org/10.1126/science.aaa2655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359403				2022-12-28	WOS:000360968400046
J	McCarthy, M				McCarthy, Mark			Will Public Health England lead research?	LANCET			English	Editorial Material									[McCarthy, Mark] UCL, London WC1E 6BT, England	University of London; University College London	McCarthy, M (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	m.mccarthy@ucl.ac.uk						[Anonymous], 2015, DOING SUPP US PUBL H; Horton R, 2013, LANCET, V381, ps1, DOI DOI 10.1016/S0140-6736(13)61256-8; McCarthy M, 2014, J PUBLIC HEALTH-UK, V36, P325, DOI 10.1093/pubmed/fdt035; National Institute for Health Research, ANN REP 2013 14; Newton JN, 2015, LANCET; Thompson SG, 2015, LANCET, V386, P509, DOI 10.1016/S0140-6736(15)60578-5; UK Department of Business Skills and Innovation, 2011, STRAT LIF SCI; UK Department of Health, 2011, PUBL HLTH LOC GOV FA; UK Department of Health, 2015, LIV WELL LONG ON YEA; Voss M, 2013, EUR J PUBLIC HEALTH, V23, P19, DOI 10.1093/eurpub/ckt150	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2232	2234		10.1016/S0140-6736(15)00196-8	http://dx.doi.org/10.1016/S0140-6736(15)00196-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26382242	hybrid			2022-12-28	WOS:000365993200009
J	You, DZ; Hug, L; Ejdemyr, S; Idele, P; Hogan, D; Mathers, C; Gerland, P; New, JR; Alkema, L				You, Danzhen; Hug, Lucia; Ejdemyr, Simon; Idele, Priscila; Hogan, Daniel; Mathers, Colin; Gerland, Patrick; New, Jin Rou; Alkema, Leontine		United Nations Inter-Agcy Grp Chil	Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation	LANCET			English	Article							REDUCTION; COUNTDOWN; NEWBORN; HEALTH	Background In 2000, world leaders agreed on the Millennium Development Goals (MDGs). MDG 4 called for a two-thirds reduction in the under-5 mortality rate between 1990 and 2015. We aimed to estimate levels and trends in under-5 mortality for 195 countries from 1990 to 2015 to assess MDG 4 achievement and then intended to project how various post-2015 targets and observed rates of change will affect the burden of under-5 deaths from 2016 to 2030. Methods We updated the UN Inter-agency Group for Child Mortality Estimation (UN IGME) database with 5700 country-year datapoints. As of July, 2015, the database contains about 17 000 country-year datapoints for mortality of children younger than 5 years for 195 countries, and includes all available nationally-representative data from vital registration systems, population censuses, household surveys, and sample registration systems. We used these data to generate estimates, with uncertainty intervals, of under-5 (age 0-4 years) mortality using a Bayesian B-spline bias-reduction model (B3 model). This model includes a data model to adjust for systematic biases associated with different types of data sources. To provide insights into the global and regional burden of under-5 deaths associated with post-2015 targets, we constructed five scenario-based projections for under-5 mortality from 2016 to 2030 and estimated national, regional, and global under-5 mortality rates up to 2030 for each scenario. Results The global under-5 mortality rate has fallen from 90.6 deaths per 1000 live-births (90% uncertainty interval 89.3-92.2) in 1990 to 42.5 (40.9-45.6) in 2015. During the same period, the annual number of under-5 deaths worldwide dropped from 12.7 million (12.6 million-13.0 million) to 5.9 million (5.7 million-6.4 million). The global under-5 mortality rate reduced by 53% (50-55%) in the past 25 years and therefore missed the MDG 4 target. Based on point estimates, two regions-east Asia and the Pacific, and Latin America and the Caribbean-achieved the MDG 4 target. 62 countries achieved the MDG 4 target, of which 24 were low-income and lower-middle income countries. Between 2016 and 2030, 94.4 million children are projected to die before the age of 5 years if the 2015 mortality rate remains constant in each country, and 68.8 million would die if each country continues to reduce its mortality rate at the pace estimated from 2000 to 2015. If all countries achieve the Sustainable Development Goal of an under-5 mortality rate of 25 or fewer deaths per 1000 livebirths by 2030, we project 56.0 million deaths by 2030. About two-thirds of all sub-Saharan African countries need to accelerate progress to achieve this target. Interpretation Despite substantial progress in reducing child mortality, concerted efforts remain necessary to avoid preventable under-5 deaths in the coming years and to accelerate progress in improving child survival further. Urgent actions are needed most in the regions and countries with high under-5 mortality rates, particularly those in sub-Saharan Africa and south Asia.	[You, Danzhen; Hug, Lucia; Ejdemyr, Simon; Idele, Priscila] UNICEF, Div Data Res & Policy, New York, NY 10017 USA; [Hogan, Daniel; Mathers, Colin] WHO, CH-1211 Geneva, Switzerland; [Gerland, Patrick] UN, Populat Div, New York, NY 10017 USA; [New, Jin Rou] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Alkema, Leontine] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Biostat & Epidemiol, Amherst, MA 01003 USA	UNICEF; World Health Organization; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Amherst	You, DZ (corresponding author), UNICEF, Div Data Res & Policy, New York, NY 10017 USA.	dyou@unicef.org	Gerland, Patrick/F-7390-2013	Gerland, Patrick/0000-0002-2082-3122; Mathers, Colin/0000-0002-0617-6731	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		A Promise Renewed, 2012, COMM CHILD SURV PROM; Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Alkema L, 2014, ANN APPL STAT, V8, P2122, DOI 10.1214/14-AOAS768; Alkema L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101112; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], 2013, POPDBWMDI2013; [Anonymous], 2015, ATT SPANK; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Centers for Disease Control and Prevention, DET TABL NAT VIT STA; Chiang CL, 1984, LIFE TABLE ITS APPL; Child Trends, 2013, FAM LIF DIFF CENTR S; Ethiopia Public Health Institute Federal Democratic Republic of Ethiopia Ministry of Health Countdown to 2015 and UNICEF, 2015, COUNTD HLTH ETH BUIL; Hill K, 1999, TRENDS CHILD MORTALI; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McArthur JW, 2014, 78 BROOK GLOB EC DEV; Ministry of Health Brazil, DATASUS C 16 STAT CH; Murray C, 2015, LANCET, V386, P3, DOI 10.1016/S0140-6736(15)61171-0; PMNCH WHO World Bank and AHPSR, 2013, SUCC FACT WOM CHILDR; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; UN Inter-Agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; UNICEF, 2015, ECA25ANOS EST CRIANC; United Nations, 2015, ESAPWP241 UN; United Nations General Assembly, 2014, REP OP WORK GROUP GE; United Nations Secretary-General Ban Ki-moon, 2010, GLOB STRAT WOM CHILD; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	27	403	406	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2275	2286		10.1016/S0140-6736(15)00120-8	http://dx.doi.org/10.1016/S0140-6736(15)00120-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26361942				2022-12-28	WOS:000365993200030
J	Hamilton, DF; Howie, CR				Hamilton, David F.; Howie, Colin R.			Knee arthroscopy: influence of systems for delivering healthcare on procedure rates	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMBULATORY SURGERY; POPULATION		[Hamilton, David F.; Howie, Colin R.] Univ Edinburgh, Orthopaed, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh	Howie, CR (corresponding author), Univ Edinburgh, Orthopaed, Edinburgh EH16 4SB, Midlothian, Scotland.	colin.howie@ed.ac.uk	Hamilton, David F/J-7186-2019	Hamilton, David F/0000-0001-9060-9255				Addicott R, 2014, COMMISSIONING FUNDIN; Addicott R., 2014, COMMISSIONING CONTRA; Appleby J, 2012, PAYMENT RESULTS CAN; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Carr A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2983; Dearing J, 2010, SURG-J R COLL SURG E, V8, P144, DOI 10.1016/j.surge.2009.11.010; Felson DT, 2010, BEST PRACT RES CL RH, V24, P47, DOI 10.1016/j.berh.2009.08.002; Gauffin H, 2014, OSTEOARTHR CARTILAGE, V22, P1808, DOI 10.1016/j.joca.2014.07.017; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Harris IA, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-143; Hollenbeck BK, 2010, SURG INNOV, V17, P340, DOI 10.1177/1553350610377211; Holmes R, 2013, AM J SPORT MED, V41, P1039, DOI 10.1177/0363546513479771; Jarvinen TLN, 2014, ACTA ORTHOP, V85, P684; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; Laupattarakasem W, 2009, COCHRANE DB SYST REV, V1; Lazic S, 2014, KNEE, V21, P631, DOI 10.1016/j.knee.2014.02.014; Leach W, 2013, REFERRAL PATHWAYS PA; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; MITCHELL JM, 1992, JAMA-J AM MED ASSOC, V268, P2055, DOI 10.1001/jama.268.15.2055; Monitor NHS England, 2014, REF PAYM SYST NHS SE; National Institute for Health and Care Excellence, 2014, GC177 NICE; NHS England, 2014, NHS STAND CONTR; NHS Right Care, 2011, NHS ATL VAR HEALTHC; Reichenbach S, 2010, COCHRANE DB SYST REV, V5; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747	26	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2015	351								h4720	10.1136/bmj.h4720	http://dx.doi.org/10.1136/bmj.h4720			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GE	26405226				2022-12-28	WOS:000361959200002
J	Parienti, JJ; Mongardon, N; Megarbane, B; Mira, JP; Kalfon, P; Gros, A; Marque, S; Thuong, M; Pottier, V; Ramakers, M; Savary, B; Seguin, A; Valette, X; Terzi, N; Sauneuf, B; Cattoir, V; Mermel, LA; du Cheyron, D				Parienti, Jean-Jacques; Mongardon, Nicolas; Megarbane, Bruno; Mira, Jean-Paul; Kalfon, Pierre; Gros, Antoine; Marque, Sophie; Thuong, Marie; Pottier, Veronique; Ramakers, Michel; Savary, Benoit; Seguin, Amelie; Valette, Xavier; Terzi, Nicolas; Sauneuf, Bertrand; Cattoir, Vincent; Mermel, Leonard A.; du Cheyron, Damien		3SITES Study Grp	Intravascular Complications of Central Venous Catheterization by Insertion Site	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; CARE-ASSOCIATED INFECTIONS; BLOOD-STREAM INFECTION; INTERNAL JUGULAR-VEIN; POVIDONE-IODINE; RISK-FACTORS; METAANALYSIS; COLONIZATION; PREVENTION	BACKGROUND Three anatomical sites are commonly used to insert central venous catheters, but insertion at each site has the potential for major complications. METHODS In this multicenter trial, we randomly assigned nontunneled central venous catheterization in patients in the adult intensive care unit (ICU) to the subclavian, jugular, or femoral vein (in a 1: 1: 1 ratio if all three insertion sites were suitable [three-choice scheme] and in a 1: 1 ratio if two sites were suitable [two-choice scheme]). The primary outcome measure was a composite of catheter-related bloodstream infection and symptomatic deep-vein thrombosis. RESULTS A total of 3471 catheters were inserted in 3027 patients. In the three-choice comparison, there were 8, 20, and 22 primary outcome events in the subclavian, jugular, and femoral groups, respectively (1.5, 3.6, and 4.6 per 1000 catheter-days; P = 0.02). In pairwise comparisons, the risk of the primary outcome was significantly higher in the femoral group than in the subclavian group (hazard ratio, 3.5; 95% confidence interval [CI], 1.5 to 7.8; P = 0.003) and in the jugular group than in the subclavian group (hazard ratio, 2.1; 95% CI, 1.0 to 4.3; P = 0.04), whereas the risk in the femoral group was similar to that in the jugular group (hazard ratio, 1.3; 95% CI, 0.8 to 2.1; P = 0.30). In the three-choice comparison, pneumothorax requiring chest-tube insertion occurred in association with 13 (1.5%) of the sub-clavian-vein insertions and 4 (0.5%) of the jugular-vein insertions. CONCLUSIONS In this trial, subclavian-vein catheterization was associated with a lower risk of bloodstream infection and symptomatic thrombosis and a higher risk of pneumothorax than jugular-vein or femoral-vein catheterization. (Funded by the Hospital Program for Clinical Research, French Ministry of Health; ClinicalTrials.gov number, NCT01479153.)	[Parienti, Jean-Jacques] CHU Caen, Dept Biostat & Clin Res, F-14000 Caen, France; [Parienti, Jean-Jacques] CHU Caen, Dept Infect Dis, F-14000 Caen, France; [Pottier, Veronique] CHU Caen, Dept Surg Intens Care, F-14000 Caen, France; [Seguin, Amelie; Valette, Xavier; Terzi, Nicolas; Sauneuf, Bertrand; du Cheyron, Damien] CHU Caen, Dept Med Intens Care, F-14000 Caen, France; [Cattoir, Vincent] CHU Caen, Dept Microbiol, F-14000 Caen, France; [Terzi, Nicolas] INSERM, Unite Mixte Rech Sci 1075, COMETE, Caen, France; [Parienti, Jean-Jacques; Cattoir, Vincent; du Cheyron, Damien] Univ Caen Normandie, Risques Microbiens EA4655, Caen, France; [Mongardon, Nicolas; Mira, Jean-Paul] CHU Cochin, Dept Med Intens Care, Paris, France; [Megarbane, Bruno] CHU Lariboisiere, Dept Med & Toxicol Intens Care, Paris, France; [Mongardon, Nicolas] CHU Mondor, Dept Anesthesiol & Surg Intens Care, Creteil, France; [Kalfon, Pierre] Ctr Hosp Gen, Dept Intens Care Med, Chartres, France; [Gros, Antoine] Ctr Hosp Gen, Dept Intens Care Med, Versailles, France; [Marque, Sophie] Ctr Hosp Gen, Dept Intens Care Med, Corbeil Essonnes, France; [Marque, Sophie] Ctr Hosp Gen, Dept Intens Care Med, Pontoise, France; [Ramakers, Michel; Savary, Benoit] Ctr Hosp Gen, Dept Intens Care Med, St Lo, France; [Mermel, Leonard A.] Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis,Dept Med, Providence, RI 02903 USA	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre Hospitalier de Versailles; Centre Hospitalier Sud Francilien; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Parienti, JJ (corresponding author), CHU Caen, Dept Biostat & Clin Res, Ave Cote de Nacre, F-14000 Caen, France.	parienti-jj@chu-caen.fr	Luque, Yosu/AAE-8565-2021; Parienti, Jean-Jacques/AAD-1701-2021; Morichau-Beauchant, Tristan/AAK-9832-2020; Mermel, Leonard/Z-1475-2019; TERZI, Nicolas/AAD-4348-2019; Griffin, Jeff/AAH-6994-2020; Legouis, David/ABF-8069-2020; Cattoir, Vincent/AAD-8353-2019	Luque, Yosu/0000-0002-3172-6571; Parienti, Jean-Jacques/0000-0002-4774-5590; Morichau-Beauchant, Tristan/0000-0001-9890-4590; TERZI, Nicolas/0000-0003-4036-6245; Mongardon, Nicolas/0000-0003-2756-4052; Vodovar, Dominique/0000-0002-8196-5511; KANTOR, ELIE/0000-0002-9888-3280; Megarbane, Bruno/0000-0002-2522-2764; Legouis, David/0000-0002-2924-9737; VALETTE, Xavier/0000-0001-5049-9186	Hospital Program for Clinical Research, French Ministry of Health	Hospital Program for Clinical Research, French Ministry of Health	Funded by the Hospital Program for Clinical Research, French Ministry of Health	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P243; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Cartier V, 2014, J HOSP INFECT, V87, P103, DOI 10.1016/j.jhin.2014.03.009; Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cook DJ, 2010, CRIT CARE MED, V38, pS76, DOI 10.1097/CCM.0b013e3181c9e344; Eisen Lewis A, 2006, J Intensive Care Med, V21, P40, DOI 10.1177/0885066605280884; Fragou M, 2011, CRIT CARE MED, V39, P1607, DOI 10.1097/CCM.0b013e318218a1ae; French Haute Autorite de Sante, CHECK LIST POS CATH; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Kwakman PH, 2012, CRIT CARE, V16, DOI 10.1186/cc11849; Law MG, 2003, STAT MED, V22, P19, DOI 10.1002/sim.1308; Maiwald M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044277; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2000, ANN INTERN MED, V133, P395; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Mermel LA, 2011, CLIN INFECT DIS, V52, P211, DOI 10.1093/cid/ciq108; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Minet C, 2012, CRIT CARE MED, V40, P3202, DOI 10.1097/CCM.0b013e318265e461; MORO ML, 1994, INFECT CONT HOSP EP, V15, P253; Noto MJ, 2015, JAMA-J AM MED ASSOC, V313, P369, DOI 10.1001/jama.2014.18400; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; O'Leary R, 2012, BRIT J ANAESTH, V109, P762, DOI 10.1093/bja/aes262; Parienti JJ, 2008, JAMA-J AM MED ASSOC, V299, P2413, DOI 10.1001/jama.299.20.2413; Parienti JJ, 2002, JAMA-J AM MED ASSOC, V288, P722, DOI 10.1001/jama.288.6.722; Parienti JJ, 2004, CRIT CARE MED, V32, P708, DOI 10.1097/01.CCM.0000115265.05604.7B; RAAD II, 1994, JAMA-J AM MED ASSOC, V271, P1014, DOI 10.1001/jama.271.13.1014; Siempos II, 2009, CRIT CARE MED, V37, P2283, DOI 10.1097/CCM.0b013e3181a02a67; Souweine B, 2008, INTENS CARE MED, V34, P286, DOI 10.1007/s00134-007-0849-y; Timsit JF, 2012, CRIT CARE MED, V40, P1707, DOI 10.1097/CCM.0b013e31824e0d46; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	36	333	364	5	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1220	1229		10.1056/NEJMoa1500964	http://dx.doi.org/10.1056/NEJMoa1500964			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398070				2022-12-28	WOS:000361635200007
J	Aiga, H				Aiga, Hirotsugu			PERSONAL VIEW Hidden out-of-pocket payments can burden patients' families but are under-recognised	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aiga, Hirotsugu] Japan Int Cooperat Agcy, Dept Human Dev, Hlth & Nutr, Chiyoda Ku, Tokyo 1028012, Japan; [Aiga, Hirotsugu] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Global Hlth, Washington, DC 20052 USA	George Washington University	Aiga, H (corresponding author), Japan Int Cooperat Agcy, Dept Human Dev, Hlth & Nutr, Chiyoda Ku, 3rd Floor,Nibancho Ctr Bldg 5-25,Niban Cho, Tokyo 1028012, Japan.	aiga.hirotsugu@jica.go.jp						DiFazio R, 2011, J PEDIATR NURS, V26, P78, DOI 10.1016/j.pedn.2010.01.010; EPI Join Stock Company Baomoi, 2013, GREET NEW YEAR SUN S; Gandon Julien, 2013, Rev Infirm, P38; Johnson A, 2012, SOC SCI MED, V75, P1786, DOI 10.1016/j.socscimed.2012.07.015; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; Tien N, 2012, SOHA NEWS       1212; World Bank, 2014, MOV UN COV SOC HLTH; World Health Organization, 2014, MON PROGR UN HLTH CO; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Zing.vn, 2014, ZING            0630	11	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4990	10.1136/bmj.h4990	http://dx.doi.org/10.1136/bmj.h4990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26400068				2022-12-28	WOS:000361957200011
J	Wang, B; Kesselheim, AS				Wang, Bo; Kesselheim, Aaron S.			Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS	OBJECTIVE To characterize the types of comparators and endpoints used in efficacy trials for approvals of supplemental indications, compared with the data supporting these drugs' originally approved indications. DESIGN Systematic review. SETTING Publicly accessible data on supplemental indications approved by the US Food and Drug Administration from 2005 to 2014. MAIN OUTCOME MEASURES Types of comparators (active, placebo, historical, none) and endpoints (clinical outcomes, clinical scales, surrogate) in the efficacy trials for these drugs' supplemental and original indication approvals. RESULTS The cohort included 295 supplemental indications. Thirty per cent (41/136) of supplemental approvals for new indications were supported by efficacy trials with active comparators, compared with 51% (47/93) of modified use approvals and 11% (7/65) of approvals expanding the patient population (P<0.001), almost all of which related to pediatric patients (61/65; 94%). Trials using clinical outcome endpoints led to approval for 32% (44/137) of supplemental approvals for new indications, 30% (28/93) of modified indication approvals, and 22% (14/65) of expanded population approvals (P=0.29). Orphan drugs had supplemental approvals for 40 non-orphan indications, which were supported by similar proportions of trials using active comparators (28% (11/40) for non-orphan supplemental indications versus 24% (10/42) for original orphan indications; P=0.70) and clinical outcome endpoints (25% (10/40) versus 31% (13/42); P=0.55). CONCLUSIONS Wide variations were seen in the evidence supporting approval of supplemental indications, with the fewest active comparators and clinical outcome endpoints used in trials leading to supplemental approvals that expanded the patient population.	[Wang, Bo; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 1620 Tremont St, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Greenwall faculty scholars program in bioethics; Harvard program in therapeutic science	Greenwall faculty scholars program in bioethics; Harvard program in therapeutic science	This investigator initiated study was not funded by industry. ASK's work is supported by the Greenwall faculty scholars program in bioethics and the Harvard program in therapeutic science. The funders had no role in the conception, writing, or review of the manuscript.	Anderson J, 2012, ARTHRIT CARE RES, V64, P640, DOI 10.1002/acr.21649; Berndt Ernst R, 2006, Pharmacoeconomics, V24 Suppl 2, P69, DOI 10.2165/00019053-200624002-00008; Darrow JJ, 2014, NEW ENGL J MED, V370, P1252, DOI 10.1056/NEJMhle1311493; DIMASI JA, 1991, J CLIN PHARMACOL, V31, P205, DOI 10.1002/j.1552-4604.1991.tb04963.x; DiMasi JA, 1996, DRUG INF J, V30, P315; DiMasi JA, 2013, CLIN THER, V35, P808, DOI 10.1016/j.clinthera.2013.04.004; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; GlaxoSmithKline, 2012, PROM PRESCR INF; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539; Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Ku LC, 2015, PEDIATR RES, V77, P2, DOI 10.1038/pr.2014.143; Li JS, 2007, JAMA-J AM MED ASSOC, V297, P480, DOI 10.1001/jama.297.5.480; Moore T, 2015, DRUG SAFETY, V38, P601, DOI 10.1007/s40264-015-0305-9; Munos B., 2015, 2014 NEW DRUG APPROV; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; US Food and Drug Administration, FDAS SENT IN; US Food and Drug Administration, SEARCH ORPH DRUG DES; US Food and Drug Administration, 2010, SENT IN ACC EL HEALT; US Food and Drug Administration, DRUGS FDA FDA APPR D; US Food and Drug Administration Center for Drug Evaluation and Research, 2002, 21335S001 NDA US FOO; US Food and Drug Administration Center for Drug Evaluation and Research, 2013, 021588S037 NDA US FO; US Food and Drug Administration Center for Drug Evaluation and Research, 1030005251 SBLA US F; Vestal RE, 2000, CANCER, V80, P1302	27	24	24	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4679	10.1136/bmj.h4679	http://dx.doi.org/10.1136/bmj.h4679			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26400844	Green Published, hybrid			2022-12-28	WOS:000361957200006
J	Chowdhury, TA; Shah, R				Chowdhury, Tahseen Ahmad; Shah, Rupal			10-MINUTE CONSULTATION Reducing the risk of diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chowdhury, Tahseen Ahmad] Royal London Hosp Whitechapel, Dept Diabet & Metab, London E1 1BB, England; [Shah, Rupal] Bridge Lane Grp Practice, London SW11 3AD, England	Barts Health NHS Trust; Royal London Hospital	Shah, R (corresponding author), Bridge Lane Grp Practice, London SW11 3AD, England.	RShahroo_tindall@hotmail.com						Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; National Institute for Health and Care Excellence, 2012, PREV TYP 2 DIAB RISK; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2015	351								h4595	10.1136/bmj.h4595	http://dx.doi.org/10.1136/bmj.h4595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3EO	26394768				2022-12-28	WOS:000361954700001
J	Laanait, N; Callagon, EBR; Zhang, Z; Sturchio, NC; Lee, SS; Fenter, P				Laanait, Nouamane; Callagon, Erika B. R.; Zhang, Zhan; Sturchio, Neil C.; Lee, Sang Soo; Fenter, Paul			X-ray-driven reaction front dynamics at calcite-water interfaces	SCIENCE			English	Article							DISSOLUTION KINETICS; ELECTRON-MICROSCOPY; LIQUID; SYSTEMS; PHASE	The interface between minerals and aqueous solutions hosts globally important biogeochemical processes such as the growth and dissolution of carbonate minerals. Understanding such processes requires spatially and temporally resolved observations and experimental controls that precisely manipulate the interfacial thermodynamic state. Using the intense radiation fields of a focused synchrotron x-ray beam, we drove dissolution at the calcite/water interface and simultaneously probed the dynamics of the propagating reaction fronts using surface x-ray microscopy. Evolving surface structures were controlled by the time-dependent solution composition, as characterized by a kinetic reaction model. At extreme disequilibria, we observed the onset of reaction front instabilities with velocities of > 30 nanometers per second. These instabilities serve as a signature of transport-limited dissolution of calcite under extreme disequilibrium.	[Laanait, Nouamane; Lee, Sang Soo; Fenter, Paul] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Laanait, Nouamane; Callagon, Erika B. R.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Callagon, Erika B. R.] Univ Illinois, Dept Earth & Environm Sci, Chicago, IL USA; [Zhang, Zhan] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Sturchio, Neil C.] Univ Delaware, Dept Geol Sci, Newark, DE USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory; University of Delaware	Laanait, N (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.	laanaitn@ornl.gov; fenter@anl.gov	, Paul/AFZ-1599-2022; Laanait, Nouamane/A-2498-2016; Fenter, Paul/ABE-6009-2020; Zhang, Zhan/A-9830-2008	, Paul/0000-0002-6672-9748; Laanait, Nouamane/0000-0001-7100-4250; Fenter, Paul/0000-0002-6672-9748; Zhang, Zhan/0000-0002-7618-6134; Sturchio, Neil/0000-0002-7581-9585	Geosciences Research Program of the Office of Basic Energy Sciences, U.S. Department of Energy (DOE), at Argonne National Laboratory (ANL); University of Illinois at Chicago; University of Delaware	Geosciences Research Program of the Office of Basic Energy Sciences, U.S. Department of Energy (DOE), at Argonne National Laboratory (ANL); University of Illinois at Chicago; University of Delaware	This work was supported by the Geosciences Research Program of the Office of Basic Energy Sciences, U.S. Department of Energy (DOE), at Argonne National Laboratory (ANL), the University of Illinois at Chicago, and the University of Delaware. The x-ray data were collected at the Advanced Photon Source (33-ID-D), a U.S. DOE Office of Science User Facility at ANL. A portion of this research was performed by N.L. as a staff member at the Center for Nanophase Materials Sciences, a U.S DOE Office of Science User Facility at Oak Ridge National Laboratory. Primary data for this report are uncompressed video files that are available upon request from N.L and P.F. N.L. and P.F. designed the research and wrote the manuscript with input from all authors. N.L. analyzed the x-ray data and performed modeling and computations. E.B.C. and P.F. prepared the samples. All authors participated in x-ray imaging experiments.	Brantley S. L., 2008, KINETICS WATER ROCK, P152; CHOU L, 1989, CHEM GEOL, V78, P269, DOI 10.1016/0009-2541(89)90063-6; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Dove PM, 2005, P NATL ACAD SCI USA, V102, P15357, DOI 10.1073/pnas.0507777102; Elliot J. A., 1990, FUSION ENG DES, V13, P21; Fenter P, 2006, NAT PHYS, V2, P700, DOI 10.1038/nphys419; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Laanait N, 2014, J SYNCHROTRON RADIAT, V21, P1252, DOI 10.1107/S1600577514016555; Lasaga AC, 2001, SCIENCE, V291, P2400, DOI 10.1126/science.1058173; Nielsen MH, 2014, SCIENCE, V345, P1158, DOI 10.1126/science.1254051; PLUMMER LN, 1978, AM J SCI, V278, P179, DOI 10.2475/ajs.278.2.179; Pokrovsky OS, 2005, CHEM GEOL, V217, P239, DOI 10.1016/j.chemgeo.2004.12.012; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; SAMUEL AH, 1953, J CHEM PHYS, V21, P1080, DOI 10.1063/1.1699113; Schneider NM, 2014, J PHYS CHEM C, V118, P22373, DOI 10.1021/jp507400n; Shiraki R, 2000, AQUAT GEOCHEM, V6, P87, DOI 10.1023/A:1009656318574; Steefel C.I., 2008, KINETICS WATER ROCK, P545; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915	20	45	45	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1330	1334		10.1126/science.aab3272	http://dx.doi.org/10.1126/science.aab3272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383950				2022-12-28	WOS:000361357700047
J	North, MP; Stephens, SL; Collins, BM; Agee, JK; Aplet, G; Franklin, JF; Fule, PZ				North, M. P.; Stephens, S. L.; Collins, B. M.; Agee, J. K.; Aplet, G.; Franklin, J. F.; Fule, P. Z.			Reform forest fire management	SCIENCE			English	Editorial Material							SIERRA-NEVADA; WILDFIRE; SUPPRESSION; CALIFORNIA; POLICY		[North, M. P.; Collins, B. M.] USFS Pacific Southwest Res Stn, Davis, CA 95618 USA; [North, M. P.] Univ Calif Davis, Davis, CA 95616 USA; [Stephens, S. L.; Collins, B. M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Agee, J. K.; Franklin, J. F.] Univ Washington, Seattle, WA 98195 USA; [Aplet, G.] Wilderness Soc, Denver, CO 80202 USA; [Fule, P. Z.] No Arizona Univ, Flagstaff, AZ 86011 USA	University of California System; University of California Davis; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Northern Arizona University	North, MP (corresponding author), USFS Pacific Southwest Res Stn, Davis, CA 95618 USA.	mpnorth@ucdavis.edu	North, Malcolm/AAW-8897-2020	North, Malcolm/0000-0002-9090-784X				[Anonymous], 2014, NAT COH WILDL FIR MA; Bennett J., 2012, WILDFIRE POLICY LAW, P142; Calkin DE, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0033-8; Calkin DE, 2005, J FOREST, V103, P179, DOI 10.1093/jof/103.4.179; Cantwell M., 2015, WILDFIRE MANAGEMENT; Dombeck MP, 2004, CONSERV BIOL, V18, P883, DOI 10.1111/j.1523-1739.2004.00491.x; Finney MA, 2005, FOREST ECOL MANAG, V211, P97, DOI 10.1016/j.foreco.2005.02.010; Lydersen JM, 2014, FOREST ECOL MANAG, V328, P326, DOI 10.1016/j.foreco.2014.06.005; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; National Interagency Fire Center, 2015, STATISTICS; North M, 2015, J FOREST, V113, P40, DOI 10.5849/jof.14-058; Quinn-Davidson LN, 2012, INT J WILDLAND FIRE, V21, P210, DOI 10.1071/WF11017; Schweizer D, 2014, J ENVIRON MANAGE, V144, P265, DOI 10.1016/j.jenvman.2014.06.007; Sneeuwjagt RJ, 2013, FIRE ECOL, V9, P14, DOI 10.4996/fireecology.0902014; Snider G, 2006, J FOREST, V104, P431; Stephens SL, 2014, FRONT ECOL ENVIRON, V12, P115, DOI 10.1890/120332	16	292	301	8	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1280	1281		10.1126/science.aab2356	http://dx.doi.org/10.1126/science.aab2356			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR5CR	26383934				2022-12-28	WOS:000361357700019
J	Jaunmuktane, Z; Mead, S; Ellis, M; Wadsworth, JDF; Nicoll, AJ; Kenny, J; Launchbury, F; Linehan, J; Richard-Loendt, A; Walker, AS; Rudge, P; Collinge, J; Brandner, S				Jaunmuktane, Zane; Mead, Simon; Ellis, Matthew; Wadsworth, Jonathan D. F.; Nicoll, Andrew J.; Kenny, Joanna; Launchbury, Francesca; Linehan, Jacqueline; Richard-Loendt, Angela; Walker, A. Sarah; Rudge, Peter; Collinge, John; Brandner, Sebastian			Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy	NATURE			English	Article							CREUTZFELDT-JAKOB-DISEASE; HUMAN PRION DISEASE; ALZHEIMER-TYPE NEUROPATHOLOGY; PITUITARY GROWTH-HORMONE; TRANSGENIC MICE; INDUCTION; BRAIN; RISK; DEPOSITION; RECIPIENTS	More than two hundred individuals developed Creutzfeldt-Jakob disease (CJD) worldwide as a result of treatment, typically in childhood, with human cadaveric pituitary-derived growth hormone contaminated with prions(1,2). Although such treatment ceased in 1985, iatrogenic CJD (iCJD) continues to emerge because of the prolonged incubation periods seen in human prion infections. Unexpectedly, in an autopsy study of eight individuals with iCJD, aged 36-51 years, in four we found moderate to severe grey matter and vascular amyloid-beta (A beta) pathology. The A beta deposition in the grey matter was typical of that seen in Alzheimer's disease and A beta in the blood vessel walls was characteristic of cerebral amyloid angiopathy(3) and did not co-localize with prion protein deposition. None of these patients had pathogenic mutations, APOE epsilon 4 or other high-risk alleles(4) associated with early-onset Alzheimer's disease. Examination of a series of 116 patients with other prion diseases from a prospective observational cohort study(5) showed minimal or no A beta pathology in cases of similar age range, or a decade older, without APOE epsilon 4 risk alleles. We also analysed pituitary glands from individuals with A beta pathology and found marked A beta deposition in multiple cases. Experimental seeding of A beta pathology has been previously demonstrated in primates and transgenic mice by central nervous system or peripheral inoculation with Alzheimer's disease brain homogenate(6-11). The marked deposition of parenchymal and vascular A beta in these relatively young patients with iCJD, in contrast with other prion disease patients and population controls, is consistent with iatrogenic transmission of A beta pathology in addition to CJD and suggests that healthy exposed individuals may also be at risk of iatrogenic Alzheimer's disease and cerebral amyloid angiopathy. These findings should also prompt investigation of whether other known iatrogenic routes of prion transmission may also be relevant to A beta and other proteopathic seeds associated with neurodegenerative and other human diseases.	[Jaunmuktane, Zane; Brandner, Sebastian] Natl Hosp Neurol & Neurosurg, Div Neuropathol, London WC1N 3BG, England; [Mead, Simon; Wadsworth, Jonathan D. F.; Nicoll, Andrew J.; Kenny, Joanna; Linehan, Jacqueline; Rudge, Peter; Collinge, John; Brandner, Sebastian] MRC, Prion Unit, London WC1 3BG, England; [Mead, Simon; Ellis, Matthew; Wadsworth, Jonathan D. F.; Nicoll, Andrew J.; Launchbury, Francesca; Richard-Loendt, Angela; Collinge, John; Brandner, Sebastian] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Mead, Simon; Kenny, Joanna; Rudge, Peter; Collinge, John] Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London WC1N 3BG, England; [Walker, A. Sarah] UCL, MRC Clin Trials Unit, London WC2B 6NH, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Medical Research Council Clinical Trials Unit; University of London; University College London	Brandner, S (corresponding author), Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk; s.brandner@ucl.ac.uk	Walker, Sarah/HDM-8717-2022; Jaunmuktane, Zane/ABC-9039-2020; Brandner, Sebastian/J-4562-2014	Jaunmuktane, Zane/0000-0001-7738-8881; Brandner, Sebastian/0000-0002-9821-0342; Mead, Simon/0000-0002-4326-1468; Wadsworth, Jonathan/0000-0002-4797-2259; Kenny, Joanna/0000-0002-2271-1941; Ellis, Matthew/0000-0002-5264-0531	UK Medical Research Council; National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre; Dementia Biomedical Research Unit; Medical Research Council [MC_UU_12023/22, MC_U123192748, MC_U123160657, MC_U123160655] Funding Source: researchfish; MRC [MC_U123192748, MC_UU_12023/22, MC_U123160655, MC_U123160657] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre; Dementia Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council and the National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre and Dementia Biomedical Research Unit. We are grateful to all patients and their relatives and carers for their participation in the National Prion Monitoring Cohort and for consent to autopsy and use of tissues for this research. We thank all physicians who contributed information and the National CJD Research and Surveillance Unit for coordination of patient referral and tissue sharing under the National referral scheme. We also thank J. Broni, L. Brock and T. Wilkins for histological assistance and B. Peters, R. Sinclair, C.-W. Lok and M. Karseras for support with post mortem examinations at UCLH. We thank G. Adamson, T. Campbell, J. Uphill and R. Druyeh for assistance with genetic analyses.	Abrams JY, 2011, J CLIN ENDOCR METAB, V96, pE1666, DOI 10.1210/jc.2011-1357; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Beck J, 2014, NEUROBIOL AGING, V35, P261, DOI 10.1016/j.neurobiolaging.2013.07.017; Beekes M, 2014, ACTA NEUROPATHOL, V128, P463, DOI 10.1007/s00401-014-1324-9; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brandner S, 2008, PHILOS T R SOC B, V363, P3755, DOI 10.1098/rstb.2008.0091; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Ellison D., 2012, NEUROPATHOLOGY REFER; Fritschi SK, 2014, ACTA NEUROPATHOL, V128, P477, DOI 10.1007/s00401-014-1339-2; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Heyman A, 1990, Aging (Milano), V2, P415; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Isaacs AM, 2008, NEUROPATH APPL NEURO, V34, P446, DOI 10.1111/j.1365-2990.2008.00963.x; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; OMeara ES, 1997, NEUROEPIDEMIOLOGY, V16, P86, DOI 10.1159/000109675; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Preusser M, 2006, J NEUROL NEUROSUR PS, V77, P413, DOI 10.1136/jnnp.2005.070805; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rudge P, 2015, BRAIN; Swerdlow AJ, 2003, NEUROLOGY, V61, P783, DOI 10.1212/01.WNL.0000084000.27403.15; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; van der Laak JAWM, 2000, CYTOMETRY, V39, P275; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wadsworth Jonathan D. F., 2008, V459, P197, DOI 10.1007/978-1-59745-234-2_14	39	306	313	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					247	+		10.1038/nature15369	http://dx.doi.org/10.1038/nature15369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354483	Bronze			2022-12-28	WOS:000360927400038
J	Kelly, RJ; Hochsmann, B; Szer, J; Kulasekararaj, A; Path, FRC; de Guibert, S; Roth, A; Weitz, IC; Armstrong, E; Risitano, AM; Patriquin, CJ; Terriou, L; Muus, P; Hill, A; Turner, MP; Schrezenmeier, H; de Latour, RP				Kelly, Richard J.; Hoechsmann, Britta; Szer, Jeff; Kulasekararaj, Austin; Path, F. R. C.; de Guibert, Sophie; Roeth, Alexander; Weitz, Ilene C.; Armstrong, Elina; Risitano, Antonio M.; Patriquin, Christopher J.; Terriou, Louis; Muus, Petra; Hill, Anita; Turner, Michelle P.; Schrezenmeier, Hubert; de latour, Regis Peffault			Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; NATURAL-HISTORY; MANAGEMENT; ACTIVATION; SYSTEM	BACKGROUND Eculizumab, a humanized monoclonal antibody against complement protein C5 that inhibits terminal complement activation, has been shown to prevent complications of paroxysmal nocturnal hemoglobinuria (PNH) and improve quality of life and overall survival, but data on the use of eculizumab in women during pregnancy are scarce. METHODS We designed a questionnaire to solicit data on pregnancies in women with PNH and sent it to the members of the International PNH Interest Group and to the physicians participating in the International PNH Registry. We assessed the safety and efficacy of eculizumab in pregnant patients with PNH by examining the birth and developmental records of the children born and adverse events in the mothers. RESULTS Of the 94 questionnaires that were sent out, 75 were returned, representing a response rate of 80%. Data on 75 pregnancies in 61 women with PNH were evaluated. There were no maternal deaths and three fetal deaths (4%). Six miscarriages (8%) occurred during the first trimester. Requirements for transfusion of red cells increased during pregnancy, from a mean of 0.14 units per month in the 6 months before pregnancy to 0.92 units per month during pregnancy. Platelet transfusions were given in 16 pregnancies. In 54% of pregnancies that progressed past the first trimester, the dose or the frequency of use of eculizumab had to be increased. Low-molecular-weight heparin was used in 88% of the pregnancies. Ten hemorrhagic events and 2 thrombotic events were documented; both thrombotic events occurred during the postpartum period. A total of 22 births (29%) were premature. Twenty cord-blood samples were examined for the presence of eculizumab; the drug was detected in 7 of the samples. A total of 25 babies were breast-fed, and in 10 of these cases, breast milk was examined for the presence of eculizumab; the drug was not detected in any of the 10 breast-milk samples. CONCLUSIONS Eculizumab provided benefit for women with PNH during pregnancy, as evidenced by a high rate of fetal survival and a low rate of maternal complications. (ClinicalTrials.gov number, NCT01374360.)	[Kelly, Richard J.; Hill, Anita] St James Univ Hosp, Dept Haematol, Leeds LS17 7PU, W Yorkshire, England; [Kulasekararaj, Austin] Kings Coll Hosp London, Haematol Med, London, England; [Hoechsmann, Britta; Schrezenmeier, Hubert] Univ Ulm, D-89069 Ulm, Germany; [Hoechsmann, Britta; Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv Baden Wurtt, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Roeth, Alexander] Univ Hosp Essen, Dept Hematol, Essen, Germany; [Hoechsmann, Britta; Kulasekararaj, Austin; Risitano, Antonio M.; Terriou, Louis; Schrezenmeier, Hubert; de latour, Regis Peffault] European Grp Blood & Marrow Transplantat, PNH Subcomm Severe Aplast Anemia Working Party, Leiden, Netherlands; [Muus, Petra] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Szer, Jeff] Royal Melbourne Hosp, Dept Clin Haematol, Parkville, Vic 3050, Australia; [Szer, Jeff] Univ Melbourne, Parkville, Vic 3052, Australia; [de Guibert, Sophie] Univ Hosp, Dept Hematol, Rennes, France; [Terriou, Louis] Univ Hosp Lille, Dept Internal Med, Clin Immunol, Lille, France; [de latour, Regis Peffault] Univ Paris Diderot, Hop St Louis, Assistance Publ Hop Paris, Serv Hematol Greffe,Ctr Reference Aplasie Med HPN, Paris, France; [de latour, Regis Peffault] Filiere Sante Maladie Rare Immunohematol MARIH, Paris, France; [Weitz, Ilene C.] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA; [Armstrong, Elina] Univ Helsinki, Cent Hosp, Dept Hematol, Helsinki, Finland; [Risitano, Antonio M.] Univ Naples Federico II, Dept Clin Med & Surg, Hematol, Federico 2, Naples, Italy; [Patriquin, Christopher J.] McMaster Univ, Hematol & Thromboembolism, Hamilton, ON, Canada; [Turner, Michelle P.] ICON Clin Res, San Francisco, CA USA	Saint James's University Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; Ulm University; University of Duisburg Essen; Radboud University Nijmegen; Royal Melbourne Hospital; University of Melbourne; CHU Rennes; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Southern California; University of Helsinki; Helsinki University Central Hospital; University of Naples Federico II; McMaster University; ICON plc	Kelly, RJ (corresponding author), St James Univ Hosp, Dept Haematol, Level 3 Beckett St, Leeds LS17 7PU, W Yorkshire, England.	richardkelly@nhs.net; peffaultdelatour@-aphp.fr	Muus, P./L-4539-2015; terriou, louis/S-2830-2018	terriou, louis/0000-0001-5919-9956; Patriquin, Christopher/0000-0002-2089-8650				Ando Yayoi, 2014, Rinsho Ketsueki, V55, P2288; BAIS J, 1994, EUR J OBSTET GYN R B, V53, P211, DOI 10.1016/0028-2243(94)90121-X; Bjorge L, 2003, ACTA OBSTET GYN SCAN, V82, P1067, DOI 10.1046/j.1600-0412.2003.00337.x; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Burwick RM, 2013, PLACENTA, V34, P201, DOI 10.1016/j.placenta.2012.11.014; Danilov AV, 2010, LEUKEMIA RES, V34, P566, DOI 10.1016/j.leukres.2009.10.025; de Guibert S, 2011, HAEMATOL-HEMATOL J, V96, P1276, DOI 10.3324/haematol.2010.037531; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; Dmytrijuk A, 2008, ONCOLOGIST, V13, P993, DOI 10.1634/theoncologist.2008-0086; Fieni S, 2006, OBSTET GYNECOL SURV, V61, P593, DOI 10.1097/01.ogx.0000234794.27485.59; Girardi G, 2008, IMMUNOL INVEST, V37, P645, DOI 10.1080/08820130802191615; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Hallstensen RF, 2015, IMMUNOBIOLOGY, V220, P452, DOI 10.1016/j.imbio.2014.11.003; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kelly R, 2010, BRIT J HAEMATOL, V149, P446, DOI 10.1111/j.1365-2141.2010.08099.x; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Marasca R, 2010, BRIT J HAEMATOL, V150, P707, DOI 10.1111/j.1365-2141.2010.08258.x; National Institute for Health and Care Excellence, 2013, ECT PREGN MISC DIAGN; Nishimura JI, 2004, MEDICINE, V83, P193, DOI 10.1097/01.md.0000126763.68170.46; Office for National Statistics, 2012, GEST SPEC INF MORT 2; Patriquin C, 2015, CLIN CASE REP, V3, P88, DOI 10.1002/ccr3.161; Ray JG, 2000, HAEMOSTASIS, V30, P103; Schrezenmeier H, 2014, HAEMATOLOGICA, V99, P922, DOI 10.3324/haematol.2013.093161; SPENCER JAD, 1980, BRIT J OBSTET GYNAEC, V87, P246, DOI 10.1111/j.1471-0528.1980.tb04528.x; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Tichelli A, 2002, ANN INTERN MED, V137, P164, DOI 10.7326/0003-4819-137-3-200208060-00008	29	142	148	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1032	1039		10.1056/NEJMoa1502950	http://dx.doi.org/10.1056/NEJMoa1502950			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352814	Bronze, Green Published			2022-12-28	WOS:000360959000008
J	Owens, B				Owens, Brian			George King: research leader at the Joslin Diabetes Center	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					947	947		10.1016/S0140-6736(15)00110-5	http://dx.doi.org/10.1016/S0140-6736(15)00110-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369461	Bronze			2022-12-28	WOS:000361182700015
J	Tiacci, E; Park, JH; De Carolis, L; Chung, SS; Broccoli, A; Scott, S; Zaja, F; Devlin, S; Pulsoni, A; Chung, YR; Cimminiello, M; Kim, E; Rossi, D; Stone, RM; Motta, G; Saven, A; Varettoni, M; Altman, JK; Anastasia, A; Grever, MR; Ambrosetti, A; Rai, KR; Fraticelli, V; Lacouture, ME; Carella, AM; Levine, RL; Leoni, P; Rambaldi, A; Falzetti, F; Ascani, S; Capponi, M; Martelli, MP; Park, CY; Pileri, SA; Rosen, N; Foa, R; Berger, MF; Zinzani, PL; Abdel-Wahab, O; Falini, B; Tallman, MS				Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; Cimminiello, M.; Kim, E.; Rossi, D.; Stone, R. M.; Motta, G.; Saven, A.; Varettoni, M.; Altman, J. K.; Anastasia, A.; Grever, M. R.; Ambrosetti, A.; Rai, K. R.; Fraticelli, V.; Lacouture, M. E.; Carella, A. M.; Levine, R. L.; Leoni, P.; Rambaldi, A.; Falzetti, F.; Ascani, S.; Capponi, M.; Martelli, M. P.; Park, C. Y.; Pileri, S. A.; Rosen, N.; Foa, R.; Berger, M. F.; Zinzani, P. L.; Abdel-Wahab, O.; Falini, B.; Tallman, M. S.			Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEK INHIBITION; ACTIVATION; MUTATIONS; MELANOMA; RAF; SURVIVAL; VEMURAFENIB; CLADRIBINE; PHENOTYPE; SIGNATURE	BACKGROUND BRAF V600E is the genetic lesion underlying hairy-cell leukemia. We assessed the safety and activity of the oral BRAF inhibitor vemurafenib in patients with hairy-cell leukemia that had relapsed after treatment with a purine analogue or who had disease that was refractory to purine analogues. METHODS We conducted two phase 2, single-group, multicenter studies of vemurafenib (at a dose of 960 mg twice daily) - one in Italy and one in the United States. The therapy was administered for a median of 16 weeks in the Italian study and 18 weeks in the U.S. study. Primary end points were the complete response rate (in the Italian trial) and the overall response rate (in the U.S. trial). Enrollment was completed (28 patients) in the Italian trial in April 2013 and is still open (26 of 36 planned patients) in the U.S. trial. RESULTS The overall response rates were 96% (25 of 26 patients who could be evaluated) after a median of 8 weeks in the Italian study and 100% (24 of 24) after a median of 12 weeks in the U.S. study. The rates of complete response were 35% (9 of 26 patients) and 42% (10 of 24) in the two trials, respectively. In the Italian trial, after a median follow-up of 23 months, the median relapse-free survival was 19 months among patients with a complete response and 6 months among those with a partial response; the median treatment-free survival was 25 months and 18 months, respectively. In the U.S. trial, at 1 year, the progression-free survival rate was 73% and the overall survival rate was 91%. Drug-related adverse events were usually of grade 1 or 2, and the events most frequently leading to dose reductions were rash and arthralgia or arthritis. Secondary cutaneous tumors (treated with simple excision) developed in 7 of 50 patients. The frequent persistence of phosphorylated ERK-positive leukemic cells in bone marrow at the end of treatment suggests bypass reactivation of MEK and ERK as a resistance mechanism. CONCLUSIONS A short oral course of vemurafenib was highly effective in patients with relapsed or refractory hairy-cell leukemia. (Funded by the Associazione Italiana per la Ricerca sul Cancro and others; EudraCT number, 2011-005487-13; ClinicalTrials.gov number NCT01711632.)	[Tiacci, E.; De Carolis, L.; Falzetti, F.; Ascani, S.; Capponi, M.; Martelli, M. P.; Falini, B.] Univ Perugia, Inst Hematol, Dept Med, I-06100 Perugia, Italy; [Tiacci, E.; De Carolis, L.; Falzetti, F.; Ascani, S.; Capponi, M.; Martelli, M. P.; Falini, B.] Univ Perugia, CREO, I-06100 Perugia, Italy; [Tiacci, E.; De Carolis, L.; Falzetti, F.; Ascani, S.; Capponi, M.; Martelli, M. P.; Falini, B.] Osped Santa Maria Misericordia, Perugia, Italy; [Broccoli, A.; Pileri, S. A.; Zinzani, P. L.] Univ Bologna, Sch Med, Units Hematol & Hematopathol, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Zaja, F.] Azienda Ospedaliero Univ, Dipartimento Sci Med Sperimentali & Clin, Ctr Trapianti & Terapie Cellulari Carlo Melzi, Hematol Unit, Udine, Italy; [Pulsoni, A.; Foa, R.] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Capponi, M.] Azienda Osped Regionale San Carlo, Hematol & Bone Marrow Transplant Unit, Potenza, Italy; [Rossi, D.] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy; [Motta, G.] Osped Ferrarotto, Hematol Unit, Catania, Italy; [Varettoni, M.] Policlin San Matteo, Fdn IRCCS, Dept Onco Hematol, Pavia, Italy; [Anastasia, A.] Spedali Civil Brescia, Hematol Unit, I-25125 Brescia, Italy; [Ambrosetti, A.] Univ Verona, Sect Hematol, Dept Med, I-37100 Verona, Italy; [Fraticelli, V.] Fdn Ric & Cura SS Giovanni Paolo II, Onco Hematol Unit, Campobasso, Italy; [Carella, A. M.] Univ San Martino, Azienda Osped, IRCCS, Ist Nazl Ric Cancro,Inst Hematol 1, Genoa, Italy; [Leoni, P.] Univ Osped Riuniti, Azienda Osped, Dept Hematol, Ancona, Italy; [Rambaldi, A.] Azienda Osped Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy; [Park, J. H.; Chung, S. S.; Levine, R. L.; Abdel-Wahab, O.; Tallman, M. S.] Leukemia Serv, New York, NY USA; [Lacouture, M. E.] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA; [Scott, S.; Chung, Y. R.; Kim, E.; Levine, R. L.; Park, C. Y.; Berger, M. F.; Abdel-Wahab, O.] Human Oncol & Pathogenesis Program, Dept Med, New York, NY USA; [Devlin, S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Park, C. Y.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Rosen, N.] Mem Sloan Kettering Canc Ctr, Dept Pharmacol, New York, NY 10021 USA; [Berger, M. F.] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10021 USA; [Rai, K. R.] Hofstra North Shore Long Isl Jewish Sch Med, Div Hematol Oncol, New York, NY USA; [Stone, R. M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Saven, A.] Scripps Clin, Div Hematol & Oncol, La Jolla, CA 92037 USA; [Altman, J. K.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Grever, M. R.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH USA	University of Perugia; University of Perugia; Hospital Santa Maria della Misericordia; University of Bologna; Sapienza University Rome; University of Eastern Piedmont Amedeo Avogadro; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; Hospital Spedali Civili Brescia; University of Verona; University of Genoa; IRCCS AOU San Martino IST; ASST Papa Giovanni XXIII; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hofstra University; Harvard University; Dana-Farber Cancer Institute; Scripps Research Institute; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Falini, B (corresponding author), Univ Perugia, Osped Santa Maria Misericordia, Inst Hematol, CREO, I-06132 Perugia, Italy.	brunangelo.falini@unipg.it	Broccoli, Alessandro/K-1558-2016; Pileri, Stefano/AAP-6337-2020; Zinzani, Pier Luigi/J-9182-2016; Kim, Eunhee/AAK-3650-2020; levine, ross/AAE-7658-2019; Kim, Eunhee/Q-9162-2016; Martelli, Maria Paola/ABH-3300-2021; VARETTONI, MARZIA/AAC-1867-2019; Rambaldi, Alessandro/M-6172-2019; Rambaldi, Alessandro/P-2603-2018; Rosen, Neal/ABF-2677-2020	Broccoli, Alessandro/0000-0001-5633-7313; Zinzani, Pier Luigi/0000-0002-2112-2651; Kim, Eunhee/0000-0001-7143-7769; Martelli, Maria Paola/0000-0001-9139-1729; VARETTONI, MARZIA/0000-0001-7304-1629; Rambaldi, Alessandro/0000-0002-3739-7502; Rambaldi, Alessandro/0000-0002-3739-7502; Zaja, Francesco/0000-0003-3995-8817; Fraticelli, Vincenzo/0000-0002-3983-8113; FALINI, Brunangelo/0000-0002-7198-5965; Chung, Young Rock/0000-0001-5752-8322; Lacouture, Mario/0000-0002-4818-3710	Associazione Italiana per la Ricerca sul Cancro; EudraCT [2011-005487-13]; NATIONAL CANCER INSTITUTE [P30CA008748, K08CA160647] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); EudraCT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Associazione Italiana per la Ricerca sul Cancro and others; EudraCT number, 2011-005487-13	Abdel-Wahab O, 2014, CANCER DISCOV, V4, P538, DOI 10.1158/2159-8290.CD-13-1038; Barak V, 1998, EUR CYTOKINE NETW, V9, P33; Basso K, 2004, J EXP MED, V199, P59, DOI 10.1084/jem.20031175; Blachly JS, 2015, J NATL COMPR CANC NE, V13, P9, DOI 10.6004/jnccn.2015.0004; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Else M, 2009, BRIT J HAEMATOL, V145, P733, DOI 10.1111/j.1365-2141.2009.07668.x; Falini B, 2004, LANCET, V363, P1869, DOI 10.1016/S0140-6736(04)16356-3; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Foucar K, 2008, WHO CLASSIFICATION T, P188; Gibney GT, 2013, NAT REV CLIN ONCOL, V10, P390, DOI 10.1038/nrclinonc.2013.83; Grever MR, 2010, BLOOD, V115, P21, DOI 10.1182/blood-2009-06-195370; Holderfield M, 2014, BRIT J CANCER, V111, P640, DOI 10.1038/bjc.2014.139; Kamiguti AS, 2003, ONCOGENE, V22, P2272, DOI 10.1038/sj.onc.1206398; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kitagawa Y, 2012, LEUKEMIA, V26, P2564, DOI 10.1038/leu.2012.149; Maevis V, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.3; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pettirossi V, 2015, BLOOD, V125, P1207, DOI 10.1182/blood-2014-10-603100; Ravandi F, 2006, BLOOD, V107, P4658, DOI 10.1182/blood-2005-11-4590; Rosenberg JD, 2014, BLOOD, V123, P177, DOI 10.1182/blood-2013-06-508754; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; STEIS RG, 1988, BLOOD, V71, P1304; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tiacci E, 2006, NAT REV CANCER, V6, P437, DOI 10.1038/nrc1888; Tiacci E, 2013, HAEMATOLOGICA, V98, P635, DOI 10.3324/haematol.2012.078071; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Vergote V, 2014, ANN HEMATOL, V93, P2087, DOI 10.1007/s00277-014-2104-2; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Warden DW, 2013, AM J SURG PATHOL, V37, P305, DOI 10.1097/PAS.0b013e3182712481	40	199	205	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1733	1747		10.1056/NEJMoa1506583	http://dx.doi.org/10.1056/NEJMoa1506583			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26352686	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000363514100009
J	Nicolai, T; Fuchs, O; von Mutius, E				Nicolai, Thomas; Fuchs, Oliver; von Mutius, Erika			Caring for the Wave of Refugees in Munich	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														von Mutius, Erika/0000-0002-8893-4515					0	37	37	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2015	373	17					1593	1595		10.1056/NEJMp1512139	http://dx.doi.org/10.1056/NEJMp1512139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU1YH	26397950				2022-12-28	WOS:000363317800004
J	Berchowitz, LE; Kabachinski, G; Walker, MR; Carlile, TM; Gilbert, WV; Schwartz, TU; Amon, A				Berchowitz, Luke E.; Kabachinski, Greg; Walker, Margaret R.; Carlile, Thomas M.; Gilbert, Wendy V.; Schwartz, Thomas U.; Amon, Angelika			Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis	CELL			English	Article							RNA-BINDING PROTEINS; AGGREGATES IN-VITRO; SACCHAROMYCES-CEREVISIAE; PRION; GENE; GRANULES; MEIOSIS; OLIGOMERS; DOMAINS; DISEASE	Message-specific translational control is required for gametogenesis. In yeast, the RNA-binding protein Rim4 mediates translational repression of numerous mRNAs, including the B-type cyclin CLB3, which is essential for establishing the meiotic chromosome segregation pattern. Here, we show that Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein. Our data further show that Rim4 aggregation is a developmentally regulated process. Starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation. At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence. Although amyloids are best known for their role in the etiology of diseases such as Alzheimer's, Parkinson's, and diabetes by forming toxic protein aggregates, our findings show that cells can utilize amyloid-like protein aggregates to function as central regulators of gametogenesis.	[Berchowitz, Luke E.; Walker, Margaret R.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Berchowitz, Luke E.; Walker, Margaret R.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Kabachinski, Greg; Carlile, Thomas M.; Gilbert, Wendy V.; Schwartz, Thomas U.; Amon, Angelika] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Berchowitz, Luke/0000-0002-3388-7723; /0000-0003-2807-9657; Carlile, Thomas/0000-0002-7699-9354; Amon, Angelika/0000-0001-9837-0314	American Cancer Society; Charles King Trust; NIH; American Cancer Society fellowship; NIH [GM62207, GM77537, GM094303]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537, R01GM094303, R01GM062207] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Charles King Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steven McKnight and Doug Frantz for providing the b-isox reagent and Susan Lindquist for providing the alpha-Sup35 antibody. We thank Kristin Knouse for help with DAZL analysis, Arzu Sandikci for development and troubleshooting microfluidics and help with live imaging analysis, and Matthew Webber for help with CD. We thank Amanda Del Rosario for mass spectrometry and Dong Soo Yun for TEM at the Koch Cancer Institute Core Facilities. We thank Wendy Salmon and Nikki Watson at the Whitehead Institute for help with FRAP and TEM. We thank members of the Amon lab for critical reading of the manuscript. All animal procedures were approved by the Massachusetts Institute of Technology Committee on Animal Care. L.E.B. is supported by American Cancer Society and Charles King Trust post-doctoral fellowships. G.L.K. is supported by an NIH grant to T.U.S. T.M.C. is supported by an American Cancer Society fellowship. This research was supported by NIH grants GM62207 to A. A., GM77537 to T.U.S., and GM094303 to W.V.G. A.A. is also an investigator of the Howard Hughes Medical Institute.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Berchowitz LE, 2013, GENE DEV, V27, P2147, DOI 10.1101/gad.224253.113; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2007, PRION, V1, P161, DOI 10.4161/pri.1.3.4837; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Haag ES, 2001, P NATL ACAD SCI USA, V98, P6983, DOI 10.1073/pnas.141237898; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Miller MP, 2012, ELIFE, V1, DOI 10.7554/eLife.00117; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Soushko M, 2000, YEAST, V16, P631, DOI 10.1002/(SICI)1097-0061(200005)16:7<631::AID-YEA559>3.3.CO;2-L; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; XU LZ, 1995, MOL CELL BIOL, V15, P6572	37	98	98	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 8	2015	163	2					406	418		10.1016/j.cell.2015.08.060	http://dx.doi.org/10.1016/j.cell.2015.08.060			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CT6WE	26411291	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000362952700017
J	Chokshi, DA; El-Sayed, AM; Stine, NW				Chokshi, Dave A.; El-Sayed, Abdulrahman M.; Stine, Nicholas W.			J-Shaped Curves and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; METAANALYSIS; ADULTS		[Chokshi, Dave A.; Stine, Nicholas W.] NYC Hlth & Hosp Corp, New York, NY 10013 USA; [Chokshi, Dave A.; Stine, Nicholas W.] NYU, Langone Med Ctr, New York, NY USA; [El-Sayed, Abdulrahman M.] City Detroit Dept Hlth & Wellness Promot, Detroit, MI USA	New York University; NYU Langone Medical Center	Chokshi, DA (corresponding author), NYC Hlth & Hosp Corp, 125 Worth St,Room 410, New York, NY 10013 USA.	dave.chokshi@nychhc.org		Stine, Nicholas/0000-0001-8811-259X; Chokshi, Dave/0000-0001-7467-4591				Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Congressional Budget Office, 2013, INCR ALL TAX ALC BEV; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Dwyer-Lindgren L, 2015, AM J PUBLIC HEALTH, V105, P1120, DOI 10.2105/AJPH.2014.302313; Garmendia ML, 2013, EUR J CLIN NUTR, V67, P513, DOI 10.1038/ejcn.2012.190; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Sim JJ, 2014, J AM COLL CARDIOL, V64, P588, DOI 10.1016/j.jacc.2014.04.065	8	21	21	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2015	314	13					1339	1340		10.1001/jama.2015.9566	http://dx.doi.org/10.1001/jama.2015.9566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT2PH	26390229				2022-12-28	WOS:000362644700009
J	Martincorena, I; Campbell, PJ				Martincorena, Inigo; Campbell, Peter J.			Somatic mutation in cancer and normal cells	SCIENCE			English	Review							TERT PROMOTER MUTATIONS; CLONAL HEMATOPOIESIS; PROGENITOR CELLS; DISTINCT PATTERNS; TUMOR TYPES; GENOME; REARRANGEMENT; EVOLUTION; SELECTION; LEUKEMIA	Spontaneously occurring mutations accumulate in somatic cells throughout a person's lifetime. The majority of these mutations do not have a noticeable effect, but some can alter key cellular functions. Early somatic mutations can cause developmental disorders, whereas the progressive accumulation of mutations throughout life can lead to cancer and contribute to aging. Genome sequencing has revolutionized our understanding of somatic mutation in cancer, providing a detailed view of the mutational processes and genes that drive cancer. Yet, fundamental gaps remain in our knowledge of how normal cells evolve into cancer cells. We briefly summarize a number of the lessons learned over 5 years of cancer genome sequencing and discuss their implications for our understanding of cancer progression and aging.	[Martincorena, Inigo; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England.	pc8@sanger.ac.uk		Martincorena, Inigo/0000-0003-1122-4416	14M Genomics Ltd.	14M Genomics Ltd.	We thank L. B. Alexandrov (Los Alamos National Laboratory, USA) for sharing data before publication (Fig. 1A) and the TCGA team for their invaluable public resource. Figures 1 and 2 are largely based on data generated by TCGA (http://cancergenome.nih.gov/). P.J.C. is a Wellcome Trust Senior Clinical Fellow, and I.M. is a fellow of Queens' College, Cambridge. P.J.C. holds equity in and is a paid consultant for 14M Genomics Ltd.	Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Brash DE, 1998, CANCER SURV, V32, P69; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Larson PS, 2005, J CLIN ONCOL, V23, P8613, DOI 10.1200/JCO.2005.02.1451; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leroi AM, 2003, NAT REV CANCER, V3, P226, DOI 10.1038/nrc1016; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; McDermott DH, 2015, CELL, V160, P686, DOI 10.1016/j.cell.2015.01.014; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nord KH, 2014, NAT GENET, V46, P474, DOI 10.1038/ng.2927; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poon SL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0161-3; Preston SL, 2003, CANCER RES, V63, P3819; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yang AH, 2003, J NEUROSCI, V23, P10454; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	60	624	642	6	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1483	1489		10.1126/science.aab4082	http://dx.doi.org/10.1126/science.aab4082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404825				2022-12-28	WOS:000361707000035
J	Creixell, P; Schoof, EM; Simpson, CD; Longden, J; Miller, CJ; Lou, HJ; Perryman, L; Cox, TR; Zivanovic, N; Palmeri, A; Wesolowska-Andersen, A; Helmer-Citterich, M; Ferkinghoff-Borg, J; Itamochi, H; Bodenmiller, B; Erler, JT; Turk, BE; Linding, R				Creixell, Pau; Schoof, Erwin M.; Simpson, Craig D.; Longden, James; Miller, Chad J.; Lou, Hua Jane; Perryman, Lara; Cox, Thomas R.; Zivanovic, Nevena; Palmeri, Antonio; Wesolowska-Andersen, Agata; Helmer-Citterich, Manuela; Ferkinghoff-Borg, Jesper; Itamochi, Hiroaki; Bodenmiller, Bernd; Erler, Janine T.; Turk, Benjamin E.; Linding, Rune			Kinome-wide Decoding of Network-Attacking Mutations Rewiring Cancer Signaling	CELL			English	Article							PROTEIN-KINASE D1; SH2 DOMAIN; SOMATIC MUTATION; SPECIFICITY; GENE; ACTIVATION; INHIBITOR; SEQUENCE; GROWTH; COMPLEMENT	Cancer cells acquire pathological phenotypes through accumulation of mutations that perturb signaling networks. However, global analysis of these events is currently limited. Here, we identify six types of network-attacking mutations (NAMs), including changes in kinase and SH2 modulation, network rewiring, and the genesis and extinction of phosphorylation sites. We developed a computational platform (ReKINect) to identify NAMs and systematically interpreted the exomes and quantitative (phospho-)proteomes of five ovarian cancer cell lines and the global cancer genome repository. We identified and experimentally validated several NAMs, including PKC gamma M501I and PKD1 D665N, which encode specificity switches analogous to the appearance of kinases de novo within the kinome. We discover mutant molecular logic gates, a drift toward phospho-threonine signaling, weakening of phosphorylation motifs, and kinase-inactivating hotspots in cancer. Our method pinpoints functional NAMs, scales with the complexity of cancer genomes and cell signaling, and may enhance our capability to therapeutically target tumor-specific networks.	[Creixell, Pau; Schoof, Erwin M.; Wesolowska-Andersen, Agata; Linding, Rune] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Simpson, Craig D.; Longden, James; Perryman, Lara; Cox, Thomas R.; Ferkinghoff-Borg, Jesper; Erler, Janine T.; Linding, Rune] Univ Copenhagen UCPH, BRIC, DK-2200 Copenhagen, Denmark; [Miller, Chad J.; Lou, Hua Jane; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Zivanovic, Nevena; Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Palmeri, Antonio; Helmer-Citterich, Manuela] Univ Roma Tor Vergata, Ctr Mol Bioinformat, I-00133 Rome, Italy; [Itamochi, Hiroaki] Tottori Univ, Sch Med, Yonago, Tottori 6838504, Japan	Technical University of Denmark; University of Copenhagen; Yale University; University of Zurich; University of Rome Tor Vergata; Tottori University	Linding, R (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	linding@lindinglab.org		Helmer-Citterich, Manuela/0000-0001-9530-7504; Palmeri, Antonio/0000-0002-2559-8833; Linding, Rune/0000-0003-0420-4839; Erler, Janine/0000-0001-8675-6527; Cox, Thomas/0000-0001-9294-1745; Schoof, Erwin Marten/0000-0002-3117-7832; Miller, Chad/0000-0002-2087-6566	Lundbeck Foundation; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC grant (KINOMEDRIFT); VKR [VKR 022758]; Novo Nordisk Foundation; NIH [R01 GM104047, T32 GM007324]; Ludwig Fund Postdoctoral Fellowship; Novo Nordisk Fonden [NNF12OC1015992] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104047, T32GM007324] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); European Research Council under the European Union's Seventh Framework Programme (FP)/ERC grant (KINOMEDRIFT); VKR; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Fund Postdoctoral Fellowship; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This article is dedicated to the memory of late Tony Pawson, whose ground-breaking research represented a fundamental foundation to this work. We thank T. Gibson for technical assistance with sequence alignments, S. Knapp's group and the Structural Genomics Consortium for providing plasmids, G. Manning for sharing unpublished data, and members of the R.L. laboratory for critical reading of this manuscript, particularly C. Santini. We are further indebted to J. Kim for assistance with NetworKIN, NetPhorest, and KinomeXplorer and X. Robin for assisting in developing and maintaining the ReKINect website. We are also indebted to several members of the Pawson laboratory, especially A. Pasculescu for his assistance in collecting phosphorylation site information, G. Gish for discussions on potentially essential SH2 residues, and B. Larsen for his suggestions on MS spectra annotation. Similarly, we thank members of the Yaffe laboratory for discussions on critical parts of this manuscript. This work was funded by The Lundbeck Foundation and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant (KINOMEDRIFT) and was conducted using the VKR funded Instrument Center for Systems Proteomics (VKR 022758). J.T.E. and L.P. are supported by a Hallas Moller Stipend from the Novo Nordisk Foundation. Work in the B.E.T. laboratory was partly supported by NIH grant R01 GM104047, and C.J.M. was supported by NIH training grant T32 GM007324. P.C. is currently funded by a Ludwig Fund Postdoctoral Fellowship. The algorithms and software developed in this work will be released under the Creative Commons licensing schemes at the websites http://KinomeXplorer.science, http://ReKINect.science, and http://KINspect.science. For further information see also http://lindinglab.science.	Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Andreadi C, 2012, GENE DEV, V26, P1945, DOI 10.1101/gad.193458.112; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Borrello MG, 1995, ONCOGENE, V11, P2419; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chen C, 2014, MOL CELL, V53, P140, DOI 10.1016/j.molcel.2013.11.013; Creixell P, 2015, CELL, V163, P187, DOI 10.1016/j.cell.2015.08.057; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Creixell P, 2012, PHILOS T R SOC B, V367, P2584, DOI 10.1098/rstb.2012.0076; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hassan S, 2009, ONCOGENE, V28, P4386, DOI 10.1038/onc.2009.291; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Mazzoni E, 2003, MOL CANCER RES, V1, P776; Mehenni H, 1998, AM J HUM GENET, V63, P1641, DOI 10.1086/302159; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Sundram V, 2011, MOL CANCER RES, V9, P985, DOI 10.1158/1541-7786.MCR-10-0365; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Weinberg RA, 2014, CELL, V157, P267, DOI 10.1016/j.cell.2014.03.004; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yaffe MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003684; Yang J, 2014, TRAFFIC, V15, P861, DOI 10.1111/tra.12179; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	58	109	110	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					202	217		10.1016/j.cell.2015.08.056	http://dx.doi.org/10.1016/j.cell.2015.08.056			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26388441	Green Published, hybrid			2022-12-28	WOS:000361846500032
J	Laursen, L				Laursen, Lucas			Botany: The cultivation of weed	NATURE			English	Editorial Material							CANNABIS CANNABACEAE; SATIVA											Clarke RC, 2013, CANNABIS: EVOLUTION AND ETHNOBOTANY, P1; de Meijer EPM, 2003, GENETICS, V163, P335; Hillig KW, 2005, GENET RESOUR CROP EV, V52, P161, DOI 10.1007/s10722-003-4452-y; Hillig KW, 2004, AM J BOT, V91, P966, DOI 10.3732/ajb.91.6.966; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102	6	11	12	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S4	S5		10.1038/525S4a	http://dx.doi.org/10.1038/525S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398737	Bronze			2022-12-28	WOS:000361599900002
J	Nielsen, MW				Nielsen, Mathias Wullum			Make academic job advertisements fair to all	NATURE			English	Editorial Material									Aarhus Univ, Danish Ctr Studies Res & Res Policy, DK-8000 Aarhus C, Denmark	Aarhus University	Nielsen, MW (corresponding author), Aarhus Univ, Danish Ctr Studies Res & Res Policy, DK-8000 Aarhus C, Denmark.	mwn@ps.au.dk		Nielsen, Mathias Wullum/0000-0001-8759-7150				NIELSEN MW, 2015, SCI PUBLIC POLICY; 2013, NATURE, V495, P35	2	1	1	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					427	427		10.1038/525427a	http://dx.doi.org/10.1038/525427a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KI	26399792	Bronze, Green Published			2022-12-28	WOS:000361599900013
J	Chow, CK; Redfern, J; Hillis, GS; Thakkar, J; Santo, K; Hackett, ML; Jan, S; Graves, N; de Keizer, L; Barry, T; Bompoint, S; Stepien, S; Whittaker, R; Rodgers, A; Thiagalingam, A				Chow, Clara K.; Redfern, Julie; Hillis, Graham S.; Thakkar, Jay; Santo, Karla; Hackett, Maree L.; Jan, Stephen; Graves, Nicholas; de Keizer, Laura; Barry, Tony; Bompoint, Severine; Stepien, Sandrine; Whittaker, Robyn; Rodgers, Anthony; Thiagalingam, Aravinda			Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; CARDIAC REHABILITATION; PREVENTION; METAANALYSIS; MULTICENTER; TECHNOLOGY; PROGRAM; PEOPLE; INCOME; MIDDLE	IMPORTANCE Cardiovascular disease prevention, including lifestyle modification, is important but underutilized. Mobile health strategies could address this gap but lack evidence of therapeutic benefit. OBJECTIVE To examine the effect of a lifestyle-focused semipersonalized support program delivered by mobile phone text message on cardiovascular risk factors. DESIGN AND SETTING The Tobacco, Exercise and Diet Messages (TEXT ME) trial was a parallel-group, single-blind, randomized clinical trial that recruited 710 patients (mean age, 58 [SD, 9.2] years; 82% men; 53% current smokers) with proven coronary heart disease (prior myocardial infarction or proven angiographically) between September 2011 and November 2013 from a large tertiary hospital in Sydney, Australia. INTERVENTIONS Patients in the intervention group (n =352) received 4 text messages per week for 6 months in addition to usual care. Text messages provided advice, motivational reminders, and support to change lifestyle behaviors. Patients in the control group (n=358) received usual care. Messages for each participant were selected from a bank of messages according to baseline characteristics (eg, smoking) and delivered via an automated computerized message management system. The program was not interactive. MAIN OUTCOMES AND MEASURES The primary end point was low-density lipoprotein cholesterol (LDL-C) level at 6 months. Secondary end points included systolic blood pressure, body mass index (BMI), physical activity, and smoking status. RESULTS At 6 months, levels of LDL-C were significantly lower in intervention participants, with concurrent reductions in systolic blood pressure and BMI, significant increases in physical activity, and a significant reduction in smoking. The majority reported the text messages to be useful (91%), easy to understand (97%), and appropriate in frequency (86%). [GRAPHICS] CONCLUSIONS AND RELEVANCE Among patients with coronary heart disease, the use of a lifestyle-focused text messaging service compared with usual care resulted in a modest improvement in LDL-C level and greater improvement in other cardiovascular disease risk factors. The duration of these effects and hence whether they result in improved clinical outcomes remain to be determined.	[Chow, Clara K.; Redfern, Julie] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chow, Clara K.; Thakkar, Jay; Barry, Tony; Thiagalingam, Aravinda] Westmead Hosp, Sydney, NSW, Australia; [Hillis, Graham S.; Thakkar, Jay; Santo, Karla; Hackett, Maree L.; Jan, Stephen; de Keizer, Laura; Bompoint, Severine; Stepien, Sandrine; Rodgers, Anthony] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Hillis, Graham S.] Royal Perth Hosp, Perth, WA 6001, Australia; [Hillis, Graham S.] Univ Western Australia, Perth, WA 6009, Australia; [Graves, Nicholas] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Whittaker, Robyn] Univ Auckland, Auckland 1, New Zealand; [Thiagalingam, Aravinda] Univ Sydney, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney; Royal Perth Hospital; University of Western Australia; University of Western Australia; Queensland University of Technology (QUT); University of Auckland; University of Sydney	Chow, CK (corresponding author), George Inst Global Hlth, Cardiovasc Div, POB M201,Missenden Rd, Camperdown, NSW 2050, Australia.	cchow@georgeinstitute.org.au	Redfern, Julie/AAM-8617-2020; Hackett, Maree L/O-8752-2016; Jan, Stephen/AAG-3333-2021; Thakkar, Jay/H-1723-2017; Santo, Karla/L-2889-2016	Redfern, Julie/0000-0001-8707-5563; Hackett, Maree L/0000-0003-1211-9087; Bompoint, Severine/0000-0001-5226-4321; Thakkar, Jay/0000-0002-5509-6009; Graves, Nicholas/0000-0002-5559-3267; Jan, Stephen/0000-0003-2839-1405; Rodgers, Anthony/0000-0003-1282-1896; Santo, Karla/0000-0001-9047-8865	National Heart Foundation of Australia [G10S5110]; BUPA Foundation Grant; Career Development Fellowship; National Health and Medical Research Council (NHMRC) [1033478]; National Heart Foundation [11S6016]; Sydney Medical Foundation Chapman Fellowship; NHMRC Career Development Fellowship [1061793]; National Heart Foundation Future Fellowship [G160523]; University of Sydney International Postgraduate Research Scholarship; National Heart Foundation Future Leader Fellowship [100034: 2014-17]; NHMRC Senior Research Fellowship	National Heart Foundation of Australia(National Heart Foundation of Australia); BUPA Foundation Grant; Career Development Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia); Sydney Medical Foundation Chapman Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Future Fellowship(National Heart Foundation of Australia); University of Sydney International Postgraduate Research Scholarship(University of Sydney); National Heart Foundation Future Leader Fellowship(National Heart Foundation of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by peer-reviewed grants from the National Heart Foundation of Australia Grant-in-Aid (G10S5110) and a BUPA Foundation Grant. Dr Chow is funded by a Career Development Fellowship cofunded by the National Health and Medical Research Council (NHMRC) (1033478) and National Heart Foundation (11S6016) and Sydney Medical Foundation Chapman Fellowship. Dr Redfern is funded by an NHMRC Career Development Fellowship (1061793) cofunded with a National Heart Foundation Future Fellowship (G160523). Dr Santo is funded by a University of Sydney International Postgraduate Research Scholarship. Dr Hackett is funded by a National Heart Foundation Future Leader Fellowship, Level 2 (100034: 2014-17). Dr Jan is funded by an NHMRC Senior Research Fellowship.	Bethell HJN, 2007, J PUBLIC HEALTH, V29, P57, DOI 10.1093/pubmed/fdl091; Chow CK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000606; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Cunnington AJ, 2002, POSTGRAD MED J, V78, P233, DOI 10.1136/pmj.78.918.233; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Franklin NC, 2015, POSTGRAD MED, V127, P150, DOI 10.1080/00325481.2015.1015396; Franklin VL, 2006, DIABETIC MED, V23, P1332, DOI 10.1111/j.1464-5491.2006.01989.x; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194; Hurling R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e7; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lozano R, 2013, LANCET, V381, P628; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marquez Contreras E, 2004, Aten Primaria, V34, P399, DOI 10.1157/13068215; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Miloh T, 2009, PEDIATRICS, V124, pE844, DOI 10.1542/peds.2009-0415; National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand, 2012, RED RISK HEART DIS E; Neal B, 2000, LANCET, V356, P1955; Patrick K, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1100; Petrie KJ, 2012, BRIT J HEALTH PSYCH, V17, P74, DOI 10.1111/j.2044-8287.2011.02033.x; Redfern J, 2014, EUR J PREV CARDIOL, V21, P492, DOI 10.1177/2047487312449416; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Tonkin Andrew, 2005, Heart Lung Circ, V14, P275; Vale MJ, 2003, ARCH INTERN MED, V163, P2775, DOI 10.1001/archinte.163.22.2775; Western Sydney Local Health District, 2013, EP PROF WSLHD RES; Whittaker R, 2012, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858; World Health Organization, GLOB PHYS ACT QUEST; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	31	392	403	6	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1255	1263		10.1001/jama.2015.10945	http://dx.doi.org/10.1001/jama.2015.10945			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393848	Bronze			2022-12-28	WOS:000362110700014
J	D'Amico, AV; Chen, MH; Renshaw, A; Loffredo, M; Kantoff, PW				D'Amico, Anthony V.; Chen, Ming-Hui; Renshaw, Andrew; Loffredo, Marian; Kantoff, Philip W.			Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[D'Amico, Anthony V.; Loffredo, Marian] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; [Chen, Ming-Hui] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Renshaw, Andrew] Miami Baptist Hosp, Dept Pathol, Miami, FL USA; [Kantoff, Philip W.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of Connecticut; Baptist Hospital Miami; Harvard University; Dana-Farber Cancer Institute	D'Amico, AV (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.	adamico@partners.org		Kantoff, Philip/0000-0001-7275-0597	NCI NIH HHS [P30 CA008748] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein JP, 2003, SURVIVAL ANAL TECHNI, P243; Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745	6	99	100	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1291	1293		10.1001/jama.2015.8577	http://dx.doi.org/10.1001/jama.2015.8577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393854	Bronze			2022-12-28	WOS:000362110700020
J	[Anonymous]				[Anonymous]			Alirocumab (Praluent) to Lower LDL-Cholesterol (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 57, pg 113-115, 2015)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Bays H, 2015, J CLIN ENDOCR METAB, V100, P3140, DOI 10.1210/jc.2015-1520; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Robinson JG, 2011, J CLIN LIPIDOL, V5, pS18, DOI 10.1016/j.jacl.2011.03.451; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; 2015, MED LETT DRUGS THERA, V57, P113	5	3	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1284	1285		10.1001/jama.2015.11372	http://dx.doi.org/10.1001/jama.2015.11372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393853				2022-12-28	WOS:000362110700019
J	Tidey, JW; Miller, ME				Tidey, Jennifer W.; Miller, Mollie E.			Smoking cessation and reduction in people with chronic mental illness	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSTTRAUMATIC-STRESS-DISORDER; BUPROPION SUSTAINED-RELEASE; PLACEBO-CONTROLLED TRIAL; NICOTINIC ACETYLCHOLINE-RECEPTORS; CIGARETTE-SMOKING; BIPOLAR DISORDER; PSYCHIATRIC-DISORDERS; TOBACCO DEPENDENCE; ANXIETY DISORDERS; DOUBLE-BLIND	The high prevalence of cigarette smoking and tobacco related morbidity and mortality in people with chronic mental illness is well documented. This review summarizes results from studies of smoking cessation treatments in people with schizophrenia, depression, anxiety disorders, and post-traumatic stress disorder. It also summarizes experimental studies aimed at identifying biopsychosocial mechanisms that underlie the high smoking rates seen in people with these disorders. Research indicates that smokers with chronic mental illness can quit with standard cessation approaches with minimal effects on psychiatric symptoms. Although some studies have noted high relapse rates, longer maintenance on pharmacotherapy reduces rates of relapse without untoward effects on psychiatric symptoms. Similar biopsychosocial mechanisms are thought to be involved in the initiation and persistence of smoking in patients with different disorders. An appreciation of these common factors may aid the development of novel tobacco treatments for people with chronic mental illness. Novel nicotine and tobacco products such as electronic cigarettes and very low nicotine content cigarettes may also be used to improve smoking cessation rates in people with chronic mental illness.	[Tidey, Jennifer W.; Miller, Mollie E.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA	Brown University	Tidey, JW (corresponding author), Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA.	Jennifer_Tidey@brown.edu			National Institute on Drug Abuse [U54DA031659, P50DA036114]; FDA Center for Tobacco Products; National Institute of General Medical Sciences [P20GM103644]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA031659, P50DA036114] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FDA Center for Tobacco Products; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The preparation of this paper was supported by grants U54DA031659 and P50DA036114 from the National Institute on Drug Abuse and the FDA Center for Tobacco Products, and grant P20GM103644 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the FDA.	Addington J, 1998, AM J PSYCHIAT, V155, P974, DOI 10.1176/ajp.155.7.974; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Asfar T, 2011, ADDICT BEHAV, V36, P764, DOI 10.1016/j.addbeh.2011.02.003; Ashare RL, 2014, NEUROPHARMACOLOGY, V76, P581, DOI 10.1016/j.neuropharm.2013.04.034; Bacher I, 2011, ARCH GEN PSYCHIAT, V68, P817, DOI 10.1001/archgenpsychiatry.2011.82; Baker A, 2006, AM J PSYCHIAT, V163, P1934, DOI 10.1176/appi.ajp.163.11.1934; Baker A, 2010, AUST NZ J PSYCHIAT, V44, P342, DOI 10.3109/00048670903489841; Barr RS, 2008, NEUROPSYCHOPHARMACOL, V33, P480, DOI 10.1038/sj.npp.1301423; Beckham JC, 1997, ADDICT BEHAV, V22, P637, DOI 10.1016/S0306-4603(96)00071-8; BECKHAM JC, 1995, J TRAUMA STRESS, V8, P461, DOI 10.1002/jts.2490080308; Beckham JC, 2013, NICOTINE TOB RES, V15, P1122, DOI 10.1093/ntr/nts252; Benowitz NL, 2013, TOB CONTROL, V22, P14, DOI 10.1136/tobaccocontrol-2012-050860; Beratis S, 2001, COMPR PSYCHIAT, V42, P393, DOI 10.1053/comp.2001.26273; Berk M, 2008, J AFFECT DISORDERS, V110, P126, DOI 10.1016/j.jad.2008.01.018; BRESLAU N, 1992, AM J PSYCHIAT, V149, P464; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P161, DOI 10.1001/archpsyc.55.2.161; Brody AL, 2009, BIOL PSYCHIAT, V66, P898, DOI 10.1016/j.biopsych.2009.06.011; Brown RA, 1996, J AM ACAD CHILD PSY, V35, P1602, DOI 10.1097/00004583-199612000-00011; Brown RA, 2007, NICOTINE TOB RES, V9, P721, DOI 10.1080/14622200701416955; Brunzell DH, 2012, NEUROPSYCHOPHARMACOL, V37, P1134, DOI 10.1038/npp.2011.299; Buckner JD, 2014, EXP CLIN PSYCHOPHARM, V22, P341, DOI 10.1037/a0037206; Burgess ES, 2002, J CONSULT CLIN PSYCH, V70, P356, DOI 10.1037//0022-006X.70.2.356; Cahill K, 2014, JAMA-J AM MED ASSOC, V311, P193, DOI 10.1001/jama.2013.283787; Calhoun PS, 2011, J TRAUMA STRESS, V24, P303, DOI 10.1002/jts.20634; Callaghan RC, 2014, J PSYCHIATR RES, V48, P102, DOI 10.1016/j.jpsychires.2013.09.014; Caponnetto P, 2013, INT J ENV RES PUB HE, V10, P446, DOI 10.3390/ijerph10020446; Carmody TP, 2012, NICOTINE TOB RES, V14, P919, DOI 10.1093/ntr/ntr304; Carroll FI, 2014, ADV PHARMACOL, V69, P177, DOI 10.1016/B978-0-12-420118-7.00005-6; Cather C, 2013, J DUAL DIAGN, V9, P87, DOI 10.1080/15504263.2012.749559; Cavazos-Rehg PA, 2014, PSYCHOL MED, V44, P2523, DOI 10.1017/S0033291713003206; Chambers RA, 2001, BIOL PSYCHIAT, V50, P71, DOI 10.1016/S0006-3223(01)01134-9; Chengappa KNR, 2014, J CLIN PSYCHIAT, V75, P765, DOI 10.4088/JCP.13m08756; Chou KR, 2004, INT J NURS STUD, V41, P321, DOI 10.1016/j.ijnurstu.2003.07.001; Cook J, 2010, NICOTINE TOB RES, V12, P978, DOI 10.1093/ntr/ntq118; Cook JW, 2007, PSYCHOPHARMACOLOGY, V192, P87, DOI 10.1007/s00213-006-0688-5; Cox LS, 2004, J GEN INTERN MED, V19, P828, DOI 10.1111/j.1525-1497.2004.30423.x; D'Souza DC, 2012, AM J PSYCHIAT, V169, P326, DOI 10.1176/appi.ajp.2011.11020189; Dalack GW, 1999, NEUROPSYCHOPHARMACOL, V21, P195, DOI 10.1016/S0893-133X(98)00121-3; Dalack GW, 1998, AM J PSYCHIAT, V155, P1490, DOI 10.1176/ajp.155.11.1490; Dedert EA, 2014, NICOTINE TOB RES, V16, P430, DOI 10.1093/ntr/ntt167; Dedert EA, 2012, NICOTINE TOB RES, V14, P372, DOI 10.1093/ntr/ntr142; DHAENEN HA, 1994, BIOL PSYCHIAT, V35, P128, DOI 10.1016/0006-3223(94)91202-5; Donny EC, 2014, PREV MED, V68, P17, DOI 10.1016/j.ypmed.2014.06.020; Esterlis I, 2014, BIOL PSYCHIAT, V76, P495, DOI 10.1016/j.biopsych.2013.11.001; Evins A E, 2001, Nicotine Tob Res, V3, P397, DOI 10.1080/14622200110073920; Evins AE, 2008, J CLIN PSYCHOPHARM, V28, P660, DOI 10.1097/JCP.0b013e31818ad7d6; Evins AE, 2007, J CLIN PSYCHOPHARM, V27, P380, DOI 10.1097/01.jcp.0b013e3180ca86fa; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Evins AE, 2005, J CLIN PSYCHOPHARM, V25, P218, DOI 10.1097/01.jcp.0000162802.54076.18; Evins AE, 2004, J CLIN PSYCHIAT, V65, P307; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Feldner MT, 2007, ADDICT BEHAV, V32, P214, DOI 10.1016/j.addbeh.2006.03.032; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Frye MA, 2013, J CLIN PSYCHOPHARM, V33, P821, DOI 10.1097/JCP.0b013e31829cc3cd; Gallagher SM, 2007, J PSYCHOACTIVE DRUGS, V39, P487, DOI 10.1080/02791072.2007.10399888; George TP, 2008, BIOL PSYCHIAT, V63, P1092, DOI 10.1016/j.biopsych.2007.11.002; George TP, 2002, BIOL PSYCHIAT, V52, P53, DOI 10.1016/S0006-3223(02)01339-2; George TP, 2002, NEUROPSYCHOPHARMACOL, V26, P75, DOI 10.1016/S0893-133X(01)00296-2; George TP, 2000, AM J PSYCHIAT, V157, P1835, DOI 10.1176/appi.ajp.157.11.1835; Gierisch JM, 2012, J GEN INTERN MED, V27, P351, DOI 10.1007/s11606-011-1915-2; Goelz PM, 2014, DRUG ALCOHOL DEPEN, V138, P67, DOI 10.1016/j.drugalcdep.2014.02.007; Goldstein BI, 2008, AM J ADDICTION, V17, P364, DOI 10.1080/10550490802266151; Goodwin RD, 2014, ANN EPIDEMIOL, V24, P493, DOI 10.1016/j.annepidem.2014.01.014; Hahn B, 2013, BIOL PSYCHIAT, V74, P436, DOI 10.1016/j.biopsych.2013.03.017; Hall SM, 1998, ARCH GEN PSYCHIAT, V55, P683, DOI 10.1001/archpsyc.55.8.683; Hartz SM, 2014, JAMA PSYCHIAT, V71, P248, DOI 10.1001/jamapsychiatry.2013.3726; Hartz SM, 2011, PSYCHIAT GENET, V21, P77, DOI 10.1097/YPG.0b013e32834135eb; Hatsukami DK, 2010, ADDICTION, V105, P343, DOI 10.1111/j.1360-0443.2009.02780.x; Heffner JL, 2013, PSYCHIAT RES, V210, P857, DOI 10.1016/j.psychres.2013.04.010; Heffner JL, 2008, BIPOLAR DISORD, V10, P838, DOI 10.1111/j.1399-5618.2008.00630.x; Hertzberg JS, 2013, NICOTINE TOB RES, V15, P1934, DOI 10.1093/ntr/ntt060; Hertzberg MA, 2001, J CLIN PSYCHOPHARM, V21, P94, DOI 10.1097/00004714-200102000-00017; Hitsman B, 2013, ADDICTION, V108, P294, DOI 10.1111/add.12009; Horst W, 2005, NEUROPSYCH DIS TREAT, V1, P349; Hughes JR, 2006, NICOTINE TOB RES, V8, P739, DOI 10.1080/14622200600789726; HUGHES JR, 1986, AM J PSYCHIAT, V143, P993; Jiang F, 2014, DRUG ALCOHOL DEPEN, V145, P69, DOI 10.1016/j.drugalcdep.2014.10.022; Kelly Deanna L, 2011, Schizophr Bull, V37, P832, DOI 10.1093/schbul/sbp152; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kimbrel NA, 2014, DRUG ALCOHOL DEPEN, V135, P59, DOI 10.1016/j.drugalcdep.2013.11.002; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Leventhal AM, 2015, PSYCHOL BULL, V141, P176, DOI 10.1037/bul0000003; Leventhal AM, 2009, NICOTINE TOB RES, V11, P1047, DOI 10.1093/ntr/ntp098; Malpass D, 2007, PSYCHOPHARMACOLOGY, V190, P363, DOI 10.1007/s00213-006-0612-z; Marshall EC, 2008, J ANXIETY DISORD, V22, P1214, DOI 10.1016/j.janxdis.2008.01.003; Marshall EC, 2009, EXP CLIN PSYCHOPHARM, V17, P356, DOI 10.1037/a0016883; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Martinez-Ortega JM, 2013, J PSYCHIATR RES, V47, P858, DOI 10.1016/j.jpsychires.2013.03.012; McChargue DE, 2002, ADDICTION, V97, P785, DOI 10.1046/j.1360-0443.2002.00064.x; McFall M, 2005, AM J PSYCHIAT, V162, P1311, DOI 10.1176/appi.ajp.162.7.1311; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Mineur YS, 2010, TRENDS PHARMACOL SCI, V31, P580, DOI 10.1016/j.tips.2010.09.004; Morisano D, 2013, AM J ADDICTION, V22, P46, DOI 10.1111/j.1521-0391.2013.00313.x; Moss TG, 2009, DRUG ALCOHOL DEPEN, V104, P94, DOI 10.1016/j.drugalcdep.2009.04.005; Moylan S, 2013, BRAIN BEHAV, V3, P302, DOI 10.1002/brb3.137; Moylan S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-123; Olincy A, 1997, BIOL PSYCHIAT, V42, P1, DOI 10.1016/S0006-3223(96)00302-2; Ostacher MJ, 2006, J CLIN PSYCHIAT, V67, P1907, DOI 10.4088/JCP.v67n1210; Perkins KA, 2010, PSYCHOPHARMACOLOGY, V210, P25, DOI 10.1007/s00213-010-1811-1; Philip NS, 2010, PSYCHOPHARMACOLOGY, V212, P1, DOI 10.1007/s00213-010-1932-6; Piper ME, 2011, ADDICTION, V106, P418, DOI 10.1111/j.1360-0443.2010.03173.x; Piper ME, 2010, J CONSULT CLIN PSYCH, V78, P13, DOI 10.1037/a0018065; Prochaska JJ, 2011, BIPOLAR DISORD, V13, P466, DOI 10.1111/j.1399-5618.2011.00944.x; Riala K, 2005, J PSYCHIATR NEUROSCI, V30, P26; Roll JM, 1998, EXP CLIN PSYCHOPHARM, V6, P157, DOI 10.1037/1064-1297.6.2.157; Royal Australian College of General Practitioners, 2021, RACGP; Secretariat of the WHO Framework Convention on Tobacco Control, 2019, INF NOT CLASS NOV EM; Shah PJ, 1997, PSYCHOL MED, V27, P1247, DOI 10.1017/S0033291797005382; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Siru R, 2009, ADDICTION, V104, P719, DOI 10.1111/j.1360-0443.2009.02545.x; Smith PH, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2013-051466; Smith PH, 2014, AM J PUBLIC HEALTH, V104, pE127, DOI 10.2105/AJPH.2013.301502; Spring B, 2003, AM J PSYCHIAT, V160, P316, DOI 10.1176/appi.ajp.160.2.316; Steinberg ML, 2012, PSYCHOL ADDICT BEHAV, V26, P850, DOI 10.1037/a0028375; Steinberg ML, 2004, J CONSULT CLIN PSYCH, V72, P723, DOI 10.1037/0022-006X.72.4.723; Strong DR, 2010, DRUG ALCOHOL DEPEN, V109, P90, DOI 10.1016/j.drugalcdep.2009.12.020; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Thornton LK, 2012, ADDICT BEHAV, V37, P427, DOI 10.1016/j.addbeh.2011.11.039; Tidey JW, 2014, NICOTINE TOB RES, V16, P326, DOI 10.1093/ntr/ntt152; Tidey JW, 2013, NICOTINE TOB RES, V15, P121, DOI 10.1093/ntr/nts098; Tidey JW, 2011, PSYCHOPHARMACOLOGY, V217, P279, DOI 10.1007/s00213-011-2282-8; Tidey JW, 2005, DRUG ALCOHOL DEPEN, V80, P259, DOI 10.1016/j.drugalcdep.2005.04.002; Tidey JW, 2002, EXP CLIN PSYCHOPHARM, V10, P241, DOI 10.1037//1064-1297.10.3.241; Tsoi DT, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007253.pub3; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vrana SR, 2013, PSYCHOPHARMACOLOGY, V230, P477, DOI 10.1007/s00213-013-3181-y; Watson NL, 2012, ADDICT BEHAV, V37, P986, DOI 10.1016/j.addbeh.2012.03.025; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Weinberger AH, 2008, J CLIN PSYCHOPHARM, V28, P584, DOI 10.1097/JCP.0b013e318184ba3c; Weinberger AH, 2013, NICOTINE TOB RES, V15, P1014, DOI 10.1093/ntr/nts213; Weinberger AH, 2012, ADDICTION, V107, P1847, DOI 10.1111/j.1360-0443.2012.03889.x; Weinberger AH, 2011, ADDICT BEHAV, V36, P434, DOI 10.1016/j.addbeh.2010.12.024; Weinberger AH, 2010, DRUG ALCOHOL DEPEN, V108, P7, DOI 10.1016/j.drugalcdep.2009.11.004; Weinberger AH, 2009, AM J ADDICTION, V18, P140, DOI 10.1080/10550490802544888; Weiner E, 2001, AM J PSYCHIAT, V158, P635, DOI 10.1176/appi.ajp.158.4.635; Weiner E, 2012, J CLIN PSYCHIAT, V73, P95, DOI 10.4088/JCP.10m06143gre; Weiner E, 2011, SCHIZOPHR RES, V129, P94, DOI 10.1016/j.schres.2011.02.003; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; Williams JM, 2011, DRUG ALCOHOL DEPEN, V118, P313, DOI 10.1016/j.drugalcdep.2011.04.009; Williams JM, 2010, J SUBST ABUSE TREAT, V38, P384, DOI 10.1016/j.jsat.2010.03.006; Wing VC, 2012, ANN NY ACAD SCI, V1248, P89, DOI 10.1111/j.1749-6632.2011.06261.x; Wu BS, 2012, J DUAL DIAGN, V8, P131, DOI 10.1080/15504263.2012.671067; Zehe JM, 2013, ADDICT BEHAV, V38, P1931, DOI 10.1016/j.addbeh.2012.11.013; Ziedonis DM, 1997, SCHIZOPHRENIA BULL, V23, P247, DOI 10.1093/schbul/23.2.247; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569; Zvolensky MJ, 2007, NICOTINE TOB RES, V9, P965, DOI 10.1080/14622200701540812; Zvolensky Michael J., 2004, Cognitive Behaviour Therapy, V33, P114, DOI 10.1080/16506070310016969; Zvolensky MJ, 2005, J ANXIETY DISORD, V19, P673, DOI 10.1016/j.janxdis.2004.07.001	154	103	103	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2015	351								h4065	10.1136/bmj.h4065	http://dx.doi.org/10.1136/bmj.h4065			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3ED	26391240	Green Published			2022-12-28	WOS:000361953500001
J	Kaw, R				Kaw, Roop			Obstructive sleep apnea in US veterans was associated with increased mortality and morbidity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Kaw, R (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Kaw, Roop/A-7877-2009	Kaw, Roop/0000-0001-7712-7729					0	1	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC12	10.7326/ACPJC-2015-163-6-012	http://dx.doi.org/10.7326/ACPJC-2015-163-6-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370027				2022-12-28	WOS:000361365900012
J	Schafer, AI				Schafer, Andrew I.			Thrombocytosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PLATELET COUNT; POLYCYTHEMIA-VERA; ETHNICITY; SEX; AGE		Weill Cornell Med Coll, Richard T Silver MD Myeloproliferat Neoplasms Ctr, New York, NY 10021 USA	Cornell University	Schafer, AI (corresponding author), Weill Cornell Med Coll, Richard T Silver MD Myeloproliferat Neoplasms Ctr, 1305 York Ave,WGC Eighth Floor,POB 403, New York, NY 10021 USA.	ais2007@med.cornell.edu						Balduini CL, 2014, HAEMATOLOGICA, V99, P953, DOI 10.3324/haematol.2014.106260; Biino G, 2012, BRIT J HAEMATOL, V157, P384, DOI 10.1111/j.1365-2141.2011.08981.x; Briggs C, 2007, INT J LAB HEMATOL, V29, P77, DOI 10.1111/j.1751-553X.2007.00909.x; Griesshammer M, 1999, J INTERN MED, V245, P295, DOI 10.1046/j.1365-2796.1999.00452.x; Lin RJ, 2014, BLOOD, V124, P184, DOI 10.1182/blood-2014-03-562538; Michiels JJ, 2015, ACTA HAEMATOL-BASEL, V133, P56, DOI 10.1159/000360388; Ruggeri M, 2003, ANN INTERN MED, V139, P470, DOI 10.7326/0003-4819-139-6-200309160-00009; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Viny AD, 2014, CANCER J, V20, P61, DOI 10.1097/PPO.0000000000000013	10	5	5	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1171	1172		10.1001/jama.2015.8515	http://dx.doi.org/10.1001/jama.2015.8515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372588				2022-12-28	WOS:000361284500030
J	Sanghera, J; Gentile, L; Barragues, A; Guerras-Delgado, I; O'Hanlon, L; Hinton, RL; Rasanathan, K; Stahlhofer, M; Khosla, R				Sanghera, Jyoti; Gentile, Lynn; Barragues, Alfonso; Guerras-Delgado, Imma; O'Hanlon, Lucinda; Hinton, Rachel Louise; Rasanathan, Kumanan; Stahlhofer, Marcus; Khosla, Rajat		Global Strategy Women's Children's	Human rights in the new Global Strategy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sanghera, Jyoti; Gentile, Lynn; Guerras-Delgado, Imma] United Nations, Off High Commissioner Human Rights, Human Rights & Econ & Social Issues Sect, Geneva, Switzerland; [O'Hanlon, Lucinda] United Nations, Off High Commissioner Human Rights, Womens Rights & Gender Sect, Geneva, Switzerland; [Barragues, Alfonso] United Nations Populat Fund, Human Rights, New York, NY USA; [Hinton, Rachel Louise] WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva, Switzerland; [Khosla, Rajat] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Rasanathan, Kumanan] United Nations Childrens Fund, New York, NY USA; [Stahlhofer, Marcus] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Child & Adolescent Rights, Geneva, Switzerland; [Stahlhofer, Marcus] WHO, Cluster Family Womens & Childrens Hlth, Geneva, Switzerland	United Nations Population Fund; World Health Organization; World Health Organization; UNICEF; World Health Organization; World Health Organization	Sanghera, J (corresponding author), United Nations, Off High Commissioner Human Rights, Human Rights & Econ & Social Issues Sect, Geneva, Switzerland.	jsanghera@ohchr.org						Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES R; Committee on Economic Social and Cultural Rights (CESCR), 2000, GEN COMM NO 14 RIGHT; Every Woman Every Child Technical Content Workstream Working Group on Determinants, 2015, SOC POL ENV DET DRAF; Every Woman Every Child Technical Content Workstream Working Group on Early Child Development, 2015, EFF INT STRAT IMPR E; Office of the United Nations High Commissioner for Human Rights World Health Organization, 2012, TECHN GUID APPL HUM; Office of the United Nations High Commissioner for Human Rights World Health Organization, 2014, TECHN GUID APPL HUM; United Nations Committee on the Rights of the Child, 2013, GEN COMM NO 15 RIGHT; United Nations Committee on the Rights of the Child, 2005, GEN COMM NO 7 IMPL C; United Nations Committee on the Rights of the Child, 2013, GEN COMM NO 14 RIGHT; United Nations Committee on the Rights of the Child, 2005, GEN COMM NO 7 IMPL C; World Health Organization, AD PREGN	11	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4184	10.1136/bmj.h4184	http://dx.doi.org/10.1136/bmj.h4184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371219	hybrid, Green Published			2022-12-28	WOS:000361678200007
J	Boyle, P; Smith, LK; Cooper, NJ; Williams, KS; O'Connor, H				Boyle, Paul; Smith, Lucy K.; Cooper, Nicola J.; Williams, Kate S.; O'Connor, Henrietta			Gender balance: Women are funded more fairly in social science	NATURE			English	Editorial Material							JOB		[Boyle, Paul] Univ Leicester, Leicester LE1 7RH, Leics, England; [Boyle, Paul] United Kingdoms Econ, London, England; [Boyle, Paul] Social Res Council, London, England; [Smith, Lucy K.; Cooper, Nicola J.] Univ Leicester, Health Care Evaluat Res, Leicester LE1 7RH, Leics, England; [Williams, Kate S.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [O'Connor, Henrietta] Univ Leicester, Dept Sociol, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester; University of Leicester; University of Leicester	Boyle, P (corresponding author), Univ Leicester, Leicester LE1 7RH, Leics, England.		Smith, Lucy K/I-6300-2018; Smith, Lucy K/S-6593-2019	Smith, Lucy K/0000-0001-9470-0793; Smith, Lucy K/0000-0001-9470-0793; O'Connor, Henrietta/0000-0003-1851-6307	National Institute for Health Research [CDF-2013-06-018] Funding Source: researchfish; Department of Health [CDF-2013-06-018] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		[Anonymous], 2015, NATURE, V522, P255; Bedi G, 2012, LANCET, V380, P474, DOI 10.1016/S0140-6736(12)61292-6; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; Glass JL, 2013, SOC FORCES, V92, P723, DOI 10.1093/sf/sot092; Mauthner NS, 2010, GENDER WORK ORGAN, V17, P481, DOI 10.1111/j.1468-0432.2010.00522.x; Morgan D., 1981, DOING FEMINIST RES; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Pohlhaus JR, 2011, ACAD MED, V86, P759, DOI 10.1097/ACM.0b013e31821836ff; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; Steinpreis RE, 1999, SEX ROLES, V41, P509, DOI 10.1023/A:1018839203698	10	34	34	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					181	183		10.1038/525181a	http://dx.doi.org/10.1038/525181a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9IM	26354468	Bronze, Green Published			2022-12-28	WOS:000360927400012
J	Nathan, DM				Nathan, David M.			Diabetes Advances in Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LIFE-STYLE INTERVENTION; BETA-CELL FUNCTION; GLYCEMIC CONTROL; INTENSIVE TREATMENT; INSULIN ANALOGS; GLUCOSE CONTROL; BLADDER-CANCER; FOLLOW-UP; CARDIOVASCULAR OUTCOMES; EUROPEAN ASSOCIATION	IMPORTANCE Chronic diseases have overtaken acute diseases, such as infections, as the major cause of premature mortality worldwide. Diabetes mellitus, a chronic degenerative metabolic disease, has reached epidemic proportions in the past 30 years, with worldwide prevalence approaching 400 million people. OBSERVATIONS AND ADVANCES The epidemic is largely secondary to an increasing sedentary lifestyle and highly prevalent overweight and obesity contributing to the development of type 2 diabetes. Clinical research efforts have developed and demonstrated effective strategies for prevention, and the annual incidence of diabetes in the United States may be decreasing for the first time in 3 decades. The long-term complications of diabetes cause severe morbidity and mortality. Here too the means of reducing the burden of microvascular and cardiovascular disease have been proved. CONCLUSIONS AND RELEVANCE Improved glycemic control and better management of other identified risk factors for the complications of diabetes and more effective treatment of cardiovascular disease and microvascular complications have resulted in a more optimistic outlook for people with diabetes. This review focuses on recent advances in diagnosis and management and the remaining challenges in the prevention and treatment of diabetes mellitus.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Diabet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Nathan, DM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Diabet, 50 Staniford St,Ste 340, Boston, MA 02114 USA.	dnathan@MGH.Harvard.edu						Aiello LP, 2015, NEW ENGL J MED, V372, P1722, DOI 10.1056/NEJMoa1409463; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; [Anonymous], 2011, NAT DIAB FACT SHEET; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Basu Ananda, 2015, J Diabetes Sci Technol, V9, P63, DOI 10.1177/1932296814554797; Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bolli GB, 2009, DIABETES CARE, V32, P1170, DOI 10.2337/dc08-1874; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Canadian Diabetes Association, 2013, CAN J DIABETES S1, V37, pS61; Ceglia L, 2006, ANN INTERN MED, V145, P665, DOI 10.7326/0003-4819-145-9-200611070-00009; Centers for Disease Control and Prevention, NAT DIAB STAT REP 20; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; Damiano Edward R, 2014, J Diabetes Sci Technol, V8, P699, DOI 10.1177/1932296814532203; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P978; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Golagiuri S, 2002, DIABETES CARE, V25, P1410; GOLDSTEIN DE, 1995, DIABETES CARE, V18, P896, DOI 10.2337/diacare.18.6.896; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gruessner AC, 2012, CURR OPIN ORGAN TRAN, V17, P100, DOI 10.1097/MOT.0b013e32834ee700; Hagopian W, 2013, DIABETES, V62, P3901, DOI 10.2337/db13-0236; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Heller S, 2012, LANCET, V379, P1489, DOI 10.1016/S0140-6736(12)60204-9; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hu Y, 2011, DIABETES CARE, V34, P1848, DOI 10.2337/dc10-2105; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Ji LN, 2015, J DIABETES, V7, P166, DOI 10.1111/1753-0407.12165; Klonoff David C, 2015, J Diabetes Sci Technol, V9, P895, DOI 10.1177/1932296815584797; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Li L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2366; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Lodwig Volker, 2014, J Diabetes Sci Technol, V8, P390; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Monami M, 2009, DIABETES OBES METAB, V11, P372, DOI 10.1111/j.1463-1326.2008.00976.x; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Porcellati F, 2007, DIABETES CARE, V30, P2447, DOI 10.2337/dc07-0002; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Segre AV, 2015, DIABETES, V64, P1470, DOI 10.2337/db14-0703; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Singh SR, 2009, CAN MED ASSOC J, V180, P385, DOI 10.1503/cmaj.081041; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Smith RJ, 2010, J CLIN ENDOCR METAB, V95, P1566, DOI 10.1210/jc.2009-1966; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Taylor SI, 2015, J CLIN ENDOCR METAB, V100, P2849, DOI 10.1210/jc.2015-1884; Tricco AC, 2014, BMJ-BRIT MED J, V349, P5459; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Food and Drug Administration, FDA REQ REM SOM PRES; Walford GA, 2014, DIABETES CARE, V37, P2508, DOI 10.2337/dc14-0560; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wei N, 2014, DIABETES CARE, V37, P1048, DOI 10.2337/dc13-2173; Whittemore R, 2011, TRANSL BEHAV MED, V1, P480, DOI 10.1007/s13142-011-0062-y; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang Q, 2014, DIABETES RES CLIN PR, V105, P313, DOI 10.1016/j.diabres.2014.06.006; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	102	247	258	10	187	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1052	1062		10.1001/jama.2015.9536	http://dx.doi.org/10.1001/jama.2015.9536			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348754				2022-12-28	WOS:000360840700017
J	George, JN				George, James N.			Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised?	LANCET			English	Editorial Material									[George, James N.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Dept Med,Coll Med,Coll Publ Hlth, Oklahoma City, OK 73126 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	George, JN (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Coll Publ Hlth,Hematol Sect,Dept Med,Coll Med, Oklahoma City, OK 73126 USA.	james-george@ouhsc.ed						Clark WF, 2003, JAMA-J AM MED ASSOC, V290, P1351, DOI 10.1001/jama.290.10.1351; Gall ECL, 2014, AM J KIDNEY DIS, V63, P119, DOI 10.1053/j.ajkd.2013.08.031; George JN, 2014, NEW ENGL J MED, V371, P654, DOI 10.1056/NEJMra1312353; Grange S, 2015, LANCET, V386, P1011, DOI 10.1016/S0140-6736(15)00076-8; Pollack A, 2015, NY TIMES, pB2	5	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					1012	1012		10.1016/S0140-6736(15)00077-X	http://dx.doi.org/10.1016/S0140-6736(15)00077-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369475				2022-12-28	WOS:000361182700035
J	Brown, ECF				Brown, Erin C. Fuse			The Blind Spot in the Patient Protection and Affordable Care Act's Cost-Control Policies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MARKET; RATES		[Brown, Erin C. Fuse] Georgia State Univ, Coll Law, Law, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Brown, ECF (corresponding author), Georgia State Univ, Coll Law, Law, POB 4037, Atlanta, GA 30302 USA.	efusebrown@gsu.edu		Fuse Brown, Erin/0000-0002-6821-5345				Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Dafny L, 2014, NEW ENGL J MED, V370, P198, DOI 10.1056/NEJMp1313948; Feldman R, 2015, J HLTH POLIT POLICY; Ginsburg PB, 2014, HEALTH AFFAIR, V33, P1067, DOI 10.1377/hlthaff.2013.0810; Greaney Thomas L., 2014, ARIZ ST LJ, V46, P1; Murray R, 2009, HEALTH AFFAIR, V28, P1395, DOI 10.1377/hlthaff.28.5.1395; Vladeck BC, 2014, HEALTH AFFAIR, V33, P1083, DOI 10.1377/hlthaff.2014.0336; Wennberg JE, 2002, HLTH AFF MILLWOOD, DOI 10.1377/hlthaff.w2.96; White C, 2013, HEALTH AFFAIR, V32, P935, DOI 10.1377/hlthaff.2012.0332	9	3	3	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					871	+		10.7326/M15-1386	http://dx.doi.org/10.7326/M15-1386			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26390146				2022-12-28	WOS:000365866500011
J	Tokar, JL; Allen, JI; Kochman, ML				Tokar, Jeffrey L.; Allen, John I.; Kochman, Michael L.			Getting to Zero: Reducing the Risk for Duodenoscope-Related Infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESISTANT ESCHERICHIA-COLI		[Tokar, Jeffrey L.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA; [Kochman, Michael L.] Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; [Allen, John I.] Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06510 USA	Fox Chase Cancer Center; University of Pennsylvania; Yale University	Tokar, JL (corresponding author), Fox Chase Canc Ctr, Dept Med, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jeffrey.Tokar@fccc.edu						ALLEN JI, 1987, GASTROENTEROLOGY, V92, P759, DOI 10.1016/0016-5085(87)90029-1; [Anonymous], INT DUOD SURV PROT; Chandrasekhara V, 2015, GASTROINTEST ENDOSC, V82, P203, DOI 10.1016/j.gie.2015.04.022; Chathadi KV, 2015, GASTROINTEST ENDOSC, V81, P795, DOI 10.1016/j.gie.2014.11.019; Epstein L, 2014, JAMA-J AM MED ASSOC, V312, P1447, DOI 10.1001/jama.2014.12720; Kola A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0049-4; Ross AS, 2015, GASTROINTEST ENDOSC, V82, P477, DOI 10.1016/j.gie.2015.04.036; Spaulding EH, 1971, P INT C NOS INF ATL, P254; US Food and Drug Administration, 2015, SUPPL MEAS ENH DUOD; Wendorf KA, 2015, INFECT CONT HOSP EP, V36, P634, DOI 10.1017/ice.2015.66	10	13	13	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					873	+		10.7326/M15-1719	http://dx.doi.org/10.7326/M15-1719			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26390309				2022-12-28	WOS:000365866500012
J	Hung, T; Pratt, GA; Sundararaman, B; Townsend, MJ; Chaivorapol, C; Bhangale, T; Graham, RR; Ortmann, W; Criswell, LA; Yeo, GW; Behrens, TW				Hung, T.; Pratt, G. A.; Sundararaman, B.; Townsend, M. J.; Chaivorapol, C.; Bhangale, T.; Graham, R. R.; Ortmann, W.; Criswell, L. A.; Yeo, G. W.; Behrens, T. W.			The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NUCLEOTIDE RESOLUTION; HEART-BLOCK; ACTIVATION; DISEASE; PROTEIN; CELLS; ANTIBODIES; ELEMENTS; PATHWAY	Autoantibodies target the RNA binding protein Ro60 in systemic lupus erythematosus (SLE) and Sjogren's syndrome. However, it is unclear whether Ro60 and its associated RNAs contribute to disease pathogenesis. We catalogued the Ro60-associated RNAs in human cell lines and found that among other RNAs, Ro60 bound an RNA motif derived from endogenous Alu retroelements. Alu transcripts were induced by type I interferon and stimulated proinflammatory cytokine secretion by human peripheral blood cells. Ro60 deletion resulted in enhanced expression of Alu RNAs and interferon-regulated genes. Anti-Ro60-positive SLE immune complexes contained Alu RNAs, and Alu transcripts were up-regulated in SLE whole blood samples relative to controls. These findings establish a link among the lupus autoantigen Ro60, Alu retroelements, and type I interferon.	[Hung, T.; Townsend, M. J.; Chaivorapol, C.; Bhangale, T.; Graham, R. R.; Ortmann, W.; Behrens, T. W.] Genentech Inc, San Francisco, CA 94080 USA; [Pratt, G. A.; Sundararaman, B.; Yeo, G. W.] Univ Calif San Diego, Sanford Consortium Regenerat Med, Inst Genom Med, Dept Cellular & Mol Med,Stem Cell Program, La Jolla, CA 92037 USA; [Criswell, L. A.] Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Res, San Francisco, CA 94143 USA; [Yeo, G. W.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Yeo, G. W.] Agcy Sci Technol & Res, Genome Inst Singapore & Mol Engn Lab, Singapore, Singapore	Roche Holding; Genentech; University of California System; University of California San Diego; University of California System; University of California San Francisco; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Hung, T (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	hungt2@gene.com; geneyeo@ucsd.edu; behrens.tim@gene.com	Sundararaman, Balaji/GWQ-5695-2022; Yeo, Gene/AAE-7676-2019	Sundararaman, Balaji/0000-0001-8559-1660; Yeo, Gene/0000-0002-0799-6037	Alfred P. Sloan research fellowship; NIH [HG004659, NS075449, HG007005]; NSF [DGE-1144086]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007005, R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	Alfred P. Sloan research fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Lowe, E. Brown and V. Dixit for their critical review of the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. A material transfer agreement is required for access to the GM12878 Ro60 KO cell lines. Sequencing data are available at NCBI GEO, accession number GSE72420. Supported by an Alfred P. Sloan research fellowship and NIH grants HG004659, NS075449, and HG007005 (G.W.Y.) and by NSF graduate research fellowship grant DGE-1144086 (G.A.P.).	ALSPAUGH M, 1979, ARTHRITIS RHEUM, V22, P796, DOI 10.1002/art.1780220719; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; BENCHETRIT E, 1988, J EXP MED, V167, P1560, DOI 10.1084/jem.167.5.1560; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; Clancy RM, 2010, J IMMUNOL, V184, P2148, DOI 10.4049/jimmunol.0902248; CLARK G, 1969, J IMMUNOL, V102, P117; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Green NM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383000; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Kalunian KC, 2016, ANN RHEUM DIS, V75, P196, DOI 10.1136/annrheumdis-2014-206090; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee LA, 2005, AUTOIMMUN REV, V4, P207, DOI 10.1016/j.autrev.2004.11.003; MARAIA RJ, 1994, NUCLEIC ACIDS RES, V22, P3045, DOI 10.1093/nar/22.15.3045; Migliorini P, 2005, AUTOIMMUNITY, V38, P47, DOI 10.1080/08916930400022715; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schulte-Pelkum J, 2009, AUTOIMMUN REV, V8, P632, DOI 10.1016/j.autrev.2009.02.010; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Xue DH, 2003, P NATL ACAD SCI USA, V100, P7503, DOI 10.1073/pnas.0832411100; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486	26	140	141	6	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					455	459		10.1126/science.aac7442	http://dx.doi.org/10.1126/science.aac7442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26382853	Green Accepted			2022-12-28	WOS:000363213400045
J	Aguirre, A; Nugent, CA				Aguirre, Alfredo; Nugent, Colleen A.			Oral Manifestation of Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aguirre, Alfredo] SUNY Buffalo, Sch Dent Med, Buffalo, NY 14260 USA; [Nugent, Colleen A.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Aguirre, A (corresponding author), SUNY Buffalo, Sch Dent Med, Buffalo, NY 14260 USA.	aguirr@buffalo.edu							0	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1250	1250		10.1056/NEJMicm1413715	http://dx.doi.org/10.1056/NEJMicm1413715			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398073				2022-12-28	WOS:000361635200010
J	Wei, K; Serpooshan, V; Hurtado, C; Diez-Cunado, M; Zhao, MM; Maruyama, S; Zhu, WH; Fajardo, G; Noseda, M; Nakamura, K; Tian, XY; Liu, QZ; Wang, A; Matsuura, Y; Bushway, P; Cai, WQ; Savchenko, A; Mahmoudi, M; Schneider, MD; van den Hoff, MJB; Butte, MJ; Yang, PC; Walsh, K; Zhou, B; Bernstein, D; Mercola, M; Ruiz-Lozano, P				Wei, Ke; Serpooshan, Vahid; Hurtado, Cecilia; Diez-Cunado, Marta; Zhao, Mingming; Maruyama, Sonomi; Zhu, Wenhong; Fajardo, Giovanni; Noseda, Michela; Nakamura, Kazuto; Tian, Xueying; Liu, Qiaozhen; Wang, Andrew; Matsuura, Yuka; Bushway, Paul; Cai, Wenqing; Savchenko, Alex; Mahmoudi, Morteza; Schneider, Michael D.; van den Hoff, Maurice J. B.; Butte, Manish J.; Yang, Phillip C.; Walsh, Kenneth; Zhou, Bin; Bernstein, Daniel; Mercola, Mark; Ruiz-Lozano, Pilar			Epicardial FSTL1 reconstitution regenerates the adult mammalian heart	NATURE			English	Review							FOLLISTATIN-LIKE 1; DIFFERENTIATION; EXPRESSION; RECEPTOR; GROWTH; INJURY; CELLS; CARDIOMYOCYTES; IDENTIFICATION; CANDIDATE	The elucidation of factors that activate the regeneration of the adult mammalian heart is of major scientific and therapeutic importance. Herewe found that epicardial cells contain a potent cardiogenic activity identified as follistatin-like 1 (Fstl1). Epicardial Fstl1 declines following myocardial infarction and is replaced by myocardial expression. Myocardial Fstl1 does not promote regeneration, either basally or upon transgenic overexpression. Application of the human Fstl1 protein (FSTL1) via an epicardial patch stimulates cell cycle entry and division of pre-existing cardiomyocytes, improving cardiac function and survival in mouse and swine models of myocardial infarction. The data suggest that the loss of epicardial FSTL1 is a maladaptive response to injury, and that its restoration would be an effective way to reverse myocardial death and remodelling following myocardial infarction in humans.	[Wei, Ke; Hurtado, Cecilia; Diez-Cunado, Marta; Zhu, Wenhong; Bushway, Paul; Cai, Wenqing; Savchenko, Alex; Mercola, Mark] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [Wei, Ke; Hurtado, Cecilia; Diez-Cunado, Marta; Zhu, Wenhong; Bushway, Paul; Cai, Wenqing; Savchenko, Alex; Mercola, Mark] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Serpooshan, Vahid; Diez-Cunado, Marta; Zhao, Mingming; Fajardo, Giovanni; Wang, Andrew; Matsuura, Yuka; Mahmoudi, Morteza; Butte, Manish J.; Yang, Phillip C.; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Serpooshan, Vahid; Diez-Cunado, Marta; Zhao, Mingming; Fajardo, Giovanni; Wang, Andrew; Matsuura, Yuka; Mahmoudi, Morteza; Butte, Manish J.; Yang, Phillip C.; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Maruyama, Sonomi; Nakamura, Kazuto; Walsh, Kenneth] Boston Univ, Whitaker Cardiovasc Inst, Sch Med, Boston, MA 02118 USA; [Noseda, Michela; Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Fac Med, London W12 0NN, England; [Tian, Xueying; Liu, Qiaozhen; Zhou, Bin] Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Tian, Xueying; Liu, Qiaozhen; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Mahmoudi, Morteza] Univ Tehran Med Sci, Nanotechnol Res Ctr, Fac Pharm, Tehran 1417613151, Iran; [van den Hoff, Maurice J. B.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Excellence Brain Sci, Shanghai 200031, Peoples R China	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Stanford University; Boston University; Imperial College London; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tehran University of Medical Sciences; University of Amsterdam; Academic Medical Center Amsterdam; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ruiz-Lozano, P (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, 300 Pasteur Dr, Stanford, CA 94305 USA.	prlozano@stanford.edu	Butte, Manish/T-8860-2019; Mahmoudi, Morteza/F-3432-2011; Mahmoudi, Morteza/L-5332-2017; Butte, Manish/AAM-8604-2020; Cai, Wenqing/AAS-2248-2021	Butte, Manish/0000-0002-4490-5595; Mahmoudi, Morteza/0000-0002-2575-9684; Mahmoudi, Morteza/0000-0002-2575-9684; Butte, Manish/0000-0002-4490-5595; Bernstein, Daniel/0000-0001-7761-5853; Serpooshan, Vahid/0000-0002-5304-095X; van den Hoff, Maurice/0000-0002-3837-8055; Zhou, Bin/0000-0001-5278-5522; Noseda, Michela/0000-0002-9553-5029	NIH [HL065484, R01 HL086879, HL113601, HL108176, P01 HL098053, P30 AR061303, P30 CA030199, K08 AI079268]; California Institute for Regenerative Medicine (CIRM) [RC1-00132, TG2-0116]; NIH/NHLBI [5UM1 HL113456, HL116591]; Stanford BioX Interdisciplinary Initiatives Program; NSF NSEC [PHY-0830228]; National Basic Research Program of China [2013CB945302, 2012CB945102]; National Natural Science Foundation of China [91339104, 31271552, 31222038]; Stanford Cardiovascular Institute; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116591, UM1HL113456, R56HL065484, R01HL086879, R01HL108176, R01HL113601, R01HL065484, P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110482] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/007/25296, RG/15/1/31165] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford BioX Interdisciplinary Initiatives Program; NSF NSEC(National Science Foundation (NSF)); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Stanford Cardiovascular Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation)	We thank L. M. Brill for spectrometry, F. Cerignolli for providing valuable cells, S. Metzler and P. Kim for help with imaging, and P. Shah for assistance in mouse and pig experiments. This work was supported by NIH grants to P. R.-L. (HL065484 and R01 HL086879); M. Me. (HL113601, HL108176, P01 HL098053); P30 AR061303 and P30 CA030199 for shared services and by the California Institute for Regenerative Medicine (CIRM, RC1-00132) to M. Me. K. We. and C.H. were SBMRI CIRM postdoctoral fellows (TG2-0116). V.S. was an Oak Foundation postdoctoral fellow. Support was also provided by NIH/NHLBI 5UM1 HL113456 to P.C.Y; HL116591 to K.Wa., M.J.B. was supported by the NIH (K08 AI079268) and the Stanford BioX Interdisciplinary Initiatives Program and NSF NSEC(PHY-0830228). B.Z. was supported by the National Basic Research Program of China (2013CB945302 and 2012CB945102) and the National Natural Science Foundation of China (91339104, 31271552, and 31222038). A Seed Grant to P.R.-L. from the Stanford Cardiovascular Institute supported the swine study.	Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g; Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Brade T, 2011, DEVELOPMENT, V138, P139, DOI 10.1242/dev.054239; Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042; Bushway PJ, 2006, METHOD ENZYMOL, V414, P300, DOI 10.1016/S0076-6879(06)14017-3; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cerignoli F, 2012, J PHARMACOL TOX MET, V66, P246, DOI 10.1016/j.vascn.2012.08.167; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; EID H, 1992, CIRC RES, V71, P40, DOI 10.1161/01.RES.71.1.40; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Fajardo G, 2013, J MOL CELL CARDIOL, V63, P155, DOI 10.1016/j.yjmcc.2013.07.016; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Lavine KJ, 2007, TRENDS CARDIOVAS MED, V17, P77, DOI 10.1016/j.tcm.2007.01.002; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017; Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008; Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028; Shimano M, 2011, P NATL ACAD SCI USA, V108, pE899, DOI 10.1073/pnas.1108559108; Smart N, 2012, ANN NY ACAD SCI, V1269, P92, DOI 10.1111/j.1749-6632.2012.06708.x; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301; Widera C, 2012, CLIN CHEM, V58, P1233, DOI 10.1373/clinchem.2012.182816; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	38	305	324	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					479	+		10.1038/nature15372	http://dx.doi.org/10.1038/nature15372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26375005	Green Accepted, Green Submitted			2022-12-28	WOS:000361599900042
J	Kesselheim, AS; Wang, B; Franklin, JM; Darrow, JJ				Kesselheim, Aaron S.; Wang, Bo; Franklin, Jessica M.; Darrow, Jonathan J.			Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCELERATED APPROVAL; CLINICAL-TRIALS; FOOD; SAFETY; ACT	OBJECTIVE To evaluate the use of special expedited development and review pathways at the US Food and Drug Administration over the past two decades. DESIGN Cohort study. SETTING FDA approved novel therapeutics between 1987 and 2014. POPULATION Publicly available sources provided each drug's year of approval, their innovativeness (first in class versus not first in class), World Health Organization Anatomic Therapeutic Classification, and which (if any) of the FDA's four primary expedited development and review programs or designations were associated with each drug: orphan drug, fast track, accelerated approval, and priority review. MAIN OUTCOME MEASURES Logistic regression models evaluated trends in the proportion of drugs associated with each of the four expedited development and review programs. To evaluate the number of programs associated with each approved drug over time, Poisson models were employed, with the number of programs as the dependent variable and a linear term for year of approval. The difference in trends was compared between drugs that were first in class and those that were not. RESULTS The FDA approved 774 drugs during the study period, with one third representing first in class agents. Priority review (43%) was the most prevalent of the four programs, with accelerated approval (9%) the least common. There was a significant increase of 2.6% per year in the number of expedited review and approval programs granted to each newly approved agent (incidence rate ratio 1.026, 95% confidence interval 1.017 to 1.035, P<0.001), and a 2.4% increase in the proportion of drugs associated with at least one such program (odds ratio 1.024, 95% confidence interval 1.006 to 1.043, P=0.009). Driving this trend was an increase in the proportion of approved, non-first in class drugs associated with at least one program for drugs (P=0.03 for interaction). CONCLUSIONS In the past two decades, drugs newly approved by the FDA have been associated with an increasing number of expedited development or review programs. Though expedited programs should be strictly limited to drugs providing noticeable clinical advances, this trend is being driven by drugs that are not first in class and thus potentially less innovative.	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017; Darrow, J J/R-8365-2019	Kesselheim, Aaron/0000-0002-8867-2666; Darrow, J J/0000-0002-7351-4243	Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science	Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science	This investigator initiated study was not funded by industry. ASK's work is supported by the Greenwall Faculty Scholars Program in Bioethics and the Harvard Program in Therapeutic Science. The funders had no role in the conception, writing, or review of the manuscript.	[Anonymous], 2013, WHO COLLABORATING CT; [Anonymous], 2014, HLTH AFF MILLWOOD; Avorn J, 2015, NEW ENGL J MED, V372, P2473, DOI 10.1056/NEJMp1506964; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; CRAWFORD SY, 1992, AM J HOSP PHARM, V49, P2383, DOI 10.1093/ajhp/49.10.2383; Darrow Jonathan J, 2014, N Engl J Med, V370, pe39, DOI 10.1056/NEJMp1402114; Darrow JJ, 2014, NEW ENGL J MED, V370, P1252, DOI 10.1056/NEJMhle1311493; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Food and Drug Administration, 2010, MYL GEMT OZ MARK WIT; Food and Drug Administration DHHS, 2015, SEARCH ORPH DRUG DES; Food and Drug Administration DHHS, 2014, EXP PROGR SER COND D; Food and Drug Administration DHHS, 1985, FED REGISTER, V240, P51002; Food and Drug Administration DHHS, 2014, ACC RESTR APPR SUBP; Food and Drug Administration DHHS, 2010, CDER FAST TRACK PROD; Food and Drug Administration DHHS, 1988, FED REGISTER, V53, P41516; Food and Drug Administration DHHS, 2011, CDER DRUG BIOL ACC A; Food and Drug Administration DHHS, 1992, FED REGISTER, V57, P58942; Government Accountability Office, 2012, FDA HAS MET MOST PER; HALPERIN JA, 1981, FOOD DRUG LAW J, V36, P166; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Kesselheim AS, 2015, CLIN PHARMACOL THER, V97, P29, DOI 10.1002/cpt.1; Kesselheim AS, 2015, HEALTH AFFAIR, V34, P286, DOI 10.1377/hlthaff.2014.1038; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Lanthier M, 2013, HEALTH AFFAIR, V32, P1433, DOI 10.1377/hlthaff.2012.0541; Lexchin J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006816; Lexchin J, 2012, ARCH INTERN MED, V172, P1680, DOI 10.1001/archinternmed.2012.4444; Light DW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2068; McCrimmon KK, 2013, HLTH NEWS COLOR 0515; NELSON RJ, 1988, GEORGETOWN LAW J, V77, P463; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Prasad V, 2014, JAMA-J AM MED ASSOC, V311, P353, DOI 10.1001/jama.2013.284531; Sanger-Katz M, 2015, NY TIMES; Shulman SR, 1995, FOOD DRUG LAW J, V50, P503; Svensson S, 2013, JAMA INTERN MED, V173, P611, DOI 10.1001/jamainternmed.2013.3037; Temple R, 2000, MYLOTARG GEMTUZUMAB	35	93	93	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4633	10.1136/bmj.h4633	http://dx.doi.org/10.1136/bmj.h4633			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3FL	26400751	hybrid, Green Published			2022-12-28	WOS:000361957200004
J	Teicholz, N				Teicholz, Nina			NUTRITION The scientific report guiding the US dietary guidelines: is it scientific?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; MEDITERRANEAN-STYLE DIET; BLOOD-PRESSURE; PROSPECTIVE COHORT; SATURATED FAT; PATTERN; ASSOCIATION; CARBOHYDRATE; METAANALYSIS					teicholz@gmail.com						Adamsson V, 2011, J INTERN MED, V269, P150, DOI 10.1111/j.1365-2796.2010.02290.x; Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; [Anonymous], 1968, LANCET, V2, P693; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bao Y, 2013, NEW ENGL J MED, V369, P2001, DOI 10.1056/NEJMoa1307352; Beresford SAA, 2006, JAMA-J AM MED ASSOC, V295, P643, DOI 10.1001/jama.295.6.643; Blumenthal JA, 2010, HYPERTENSION, V55, P1199, DOI 10.1161/HYPERTENSIONAHA.109.149153; Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Center for Nutrition Policy and Promotion, 1980, DIET GUID AM; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Cope MB, 2010, INT J OBESITY, V34, P84, DOI 10.1038/ijo.2009.239; Dietary Guidelines Advisory Committee, 2015, SCI REPORT; Dietary Guidelines Advisory Committee, SCI REP B; Dietary Guidelines Advisory Committee, SCI REP D; Dietary Guidelines Advisory Committee, SCI REP C; Dietary Guidelines Advisory Committee, SCI REP D; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; Harrington E., 2015, WASHINGTON FREE 0610; Hering G., 2015, GUARDIAN; Herman J, 2010, FOOD DRUG LAW J, V65, P285; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Jacobs DR, 2009, AM J CLIN NUTR, V89, P509, DOI 10.3945/ajcn.2008.26371; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jalonick MC, 2015, ASS PRESS; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; Knopp RH, 1997, JAMA-J AM MED ASSOC, V278, P1509, DOI 10.1001/jama.278.18.1509; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Leren P, 1966, Acta Med Scand Suppl, V466, P1; MARGETTS BM, 1985, CLIN EXP PHARMACOL P, V12, P263, DOI 10.1111/j.1440-1681.1985.tb02644.x; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Evidence Library, WHAT IS EFF SAT FAT; National Research Council Food and Nutrition Board National Academy of Sciences, 1980, HEALTHF DIETS; Nutrition Evidence Library, MEAT SYST REV QUEST; Nutrition Evidence Library, WHAT IS REL ADH DIET; Nutrition Evidence Library, VEG FRUIT SYST REV Q; Nutrition Evidence Library, FREQ ASK QUEST; Nutrition Evidence Library, DO HLTH OUTC VEG DIE; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Prentice RL, 2007, JNCI-J NATL CANCER I, V99, P1534, DOI 10.1093/jnci/djm159; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Santos FL, 2012, OBES REV, V13, P1048, DOI 10.1111/j.1467-789X.2012.01021.x; Seymour D, 1969, CIRCULATION       S2, V40, P1, DOI DOI 10.1161/01.CIR.40.1S2.II-1; Shi YK, 2014, LANCET, V383, P1947, DOI 10.1016/S0140-6736(14)60886-2; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; TURPEINEN O, 1979, INT J EPIDEMIOL, V8, P99, DOI 10.1093/ije/8.2.99; US Department of Agriculture, 2015, FOOD ASS LANDSC; Walden CE, 2000, ARTERIOSCL THROM VAS, V20, P1580, DOI 10.1161/01.ATV.20.6.1580	62	40	41	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4962	10.1136/bmj.h4962	http://dx.doi.org/10.1136/bmj.h4962			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26400973	Green Published, Bronze			2022-12-28	WOS:000361957200010
J	Feske, SK; Goldberg, M; Dudzinski, DM; Gonzalez, RG; Kovach, AE				Feske, Steven K.; Goldberg, Marcia; Dudzinski, David M.; Gonzalez, Ramon Gilberto; Kovach, Alexandra E.			Case 29-2015: A 38-Year-Old Pregnant Woman with Headache and Visual Symptoms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOMYOCARDIAL FIBROSIS; HYPEREOSINOPHILIC SYNDROME; EPIDEMIOLOGY; MYOCARDITIS; STROKE; SYSTEM; WOMEN; PICA; RISK		[Feske, Steven K.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Goldberg, Marcia] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Dudzinski, David M.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Gonzalez, Ramon Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kovach, Alexandra E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Feske, Steven K.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Goldberg, Marcia; Dudzinski, David M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gonzalez, Ramon Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kovach, Alexandra E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Feske, SK (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.		Goldberg, Marcia/U-8604-2019; Kovach, Alexandra/AAP-7332-2020; Kovach, Alexandra Elizabeth/ABC-4382-2021	Kovach, Alexandra Elizabeth/0000-0002-6742-6749				Barbosa MM, 1998, AM J TROP MED HYG, V58, P26, DOI 10.4269/ajtmh.1998.58.26; Barton James C, 2010, BMC Blood Disord, V10, P9, DOI 10.1186/1471-2326-10-9; Borczuk AC, 1997, CARDIOVASC RES, V33, P527, DOI 10.1016/S0008-6363(96)00257-X; BRABIN BJ, 1985, REV INFECT DIS, V7, P579; Branda JA, 2006, CLIN INFECT DIS, V42, P972, DOI 10.1086/500937; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cunningham FG., 2010, PROTOCOLS HIGH RISK, P587; DAVIES JNP, 1960, AM HEART J, V59, P600, DOI 10.1016/0002-8703(60)90464-6; ELLRODT A, 1987, ARCH NEUROL-CHICAGO, V44, P432, DOI 10.1001/archneur.1987.00520160064016; Feske SK, 2009, STROKE, V40, pE183; FOURESTIE V, 1993, BRAIN, V116, P603, DOI 10.1093/brain/116.3.603; GOKA AKJ, 1990, T ROY SOC TROP MED H, V84, P829, DOI 10.1016/0035-9203(90)90098-Y; Grear KE, 2013, CLIN OBSTET GYNECOL, V56, P350, DOI 10.1097/GRF.0b013e31828f25fa; Kittner SJ, 1996, NEW ENGL J MED, V335, P768, DOI 10.1056/NEJM199609123351102; Loeffler W., 1936, SCHWEIZ MED WSCHR, V66, P817; Lopez LB, 2012, J OBSTET GYNAECOL, V32, P150, DOI 10.3109/01443615.2011.638093; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; RASHWAN MA, 1995, BRIT HEART J, V73, P284; ROCHE M, 1966, AM J TROP MED HYG, V15, P1032, DOI 10.4269/ajtmh.1966.15.1032; Sarazin M, 2004, J NEUROL NEUROSUR PS, V75, P305; SESHADRI S, 1991, INT J CARDIOL, V31, P348, DOI 10.1016/0167-5273(91)90387-5; Simon HU, 2010, J ALLERGY CLIN IMMUN, V126, P45, DOI 10.1016/j.jaci.2010.03.042; Thihalolipavan S, 2013, MATERN CHILD HLTH J, V17, P49, DOI 10.1007/s10995-012-0947-5	23	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1154	1164		10.1056/NEJMcpc1404335	http://dx.doi.org/10.1056/NEJMcpc1404335			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR7UG	26376139				2022-12-28	WOS:000361556400012
J	Ramirez-Lafita, F				Ramirez-Lafita, Francisco			Disease activity-guided TNF inhibitor dose reduction was noninferior to continuing TNF inhibitors for RA flares	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Viamed Monegal Hosp, Tarragona, Spain		Ramirez-Lafita, F (corresponding author), Viamed Monegal Hosp, Tarragona, Spain.							Ostergaard M, 2015, ANN RHEUM DIS; Tanaka Y, 2012, CURR OPIN RHEUMATOL, V24, P319, DOI 10.1097/BOR.0b013e3283524e4c; van Herwaarden N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010455.pub2	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC9	10.7326/ACPJC-2015-163-6-009	http://dx.doi.org/10.7326/ACPJC-2015-163-6-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370036				2022-12-28	WOS:000361365900009
J	Turecki, G; Brent, DA				Turecki, Gustavo; Brent, David A.			Suicide and suicidal behaviour	LANCET			English	Review							MAJOR DEPRESSIVE DISORDER; RANDOMIZED CLINICAL-TRIAL; PRIMARY-CARE PATIENTS; EARLY-LIFE ADVERSITY; RISK-FACTORS; MOOD DISORDERS; MENTAL-HEALTH; FOLLOW-UP; PSYCHOLOGICAL AUTOPSY; EPIGENETIC REGULATION	Suicide is a complex public health problem of global importance. Suicidal behaviour differs between sexes, age groups, geographic regions, and sociopolitical settings, and variably associates with different risk factors, suggesting aetiological heterogeneity. Although there is no effective algorithm to predict suicide in clinical practice, improved recognition and understanding of clinical, psychological, sociological, and biological factors might help the detection of high-risk individuals and assist in treatment selection. Psychotherapeutic, pharmacological, or neuromodulatory treatments of mental disorders can often prevent suicidal behaviour; additionally, regular follow-up of people who attempt suicide by mental health services is key to prevent future suicidal behaviour.	[Turecki, Gustavo] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Brent, David A.] Western Psychiat Inst & Clin, Pittsburgh, PA USA	McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Turecki, G (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca		Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research [MOP93775, MOP11260, MOP119429, MOP119430]; US National Institutes of Health [1R01DA033684]; Fonds de Recherche du Quebec - Sante through a Chercheur National salary award; Fonds de Recherche du Quebec - Sante through the Quebec Network on Suicide, Mood Disorders and Related Disorders; US National Institutes of Mental Health [MH056612, MH100451, MH104311]; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH100451, R01MH056612, R10MH056612, U01MH104311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033684] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de Recherche du Quebec - Sante through a Chercheur National salary award; Fonds de Recherche du Quebec - Sante through the Quebec Network on Suicide, Mood Disorders and Related Disorders; US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	GT is supported by grants from the Canadian Institute of Health Research (MOP93775, MOP11260, MOP119429, and MOP119430), from the US National Institutes of Health (1R01DA033684), and by the Fonds de Recherche du Quebec - Sante through a Chercheur National salary award and through the Quebec Network on Suicide, Mood Disorders and Related Disorders. DAB is supported by grants from the US National Institutes of Mental Health (MH056612, MH100451, and MH104311). We are indebted to Sylvanne Daniels for essential help in the preparation of this seminar.	Afifi TO, 2008, AM J PUBLIC HEALTH, V98, P946, DOI 10.2105/AJPH.2007.120253; Ahmedani BK, 2014, J GEN INTERN MED, V29, P870, DOI 10.1007/s11606-014-2767-3; Akechi T, 2006, BRIT J PSYCHIAT, V188, P231, DOI 10.1192/bjp.188.3.231; Alexopoulos GS, 2009, AM J PSYCHIAT, V166, P882, DOI 10.1176/appi.ajp.2009.08121779; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; Arango V, 2002, PROG BRAIN RES, V136, P443; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; ASBERG M, 1976, SCIENCE, V191, P478; AVERY D, 1978, ARCH GEN PSYCHIAT, V35, P749; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; Black C, 2015, BIOL PSYCHIAT, V78, P28, DOI 10.1016/j.biopsych.2014.10.014; Bolton J. M., 2014, PSYCHOL MED, P1; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Brent DA, 2008, PSYCHIAT CLIN N AM, V31, P157, DOI 10.1016/j.psc.2008.02.001; Brent DA, 2015, JAMA PSYCHIAT, V72, P160, DOI 10.1001/jamapsychiatry.2014.2141; Brezo J, 2010, MOL PSYCHIATR, V15, P831, DOI 10.1038/mp.2009.19; Brezo J, 2008, BRIT J PSYCHIAT, V193, P134, DOI 10.1192/bjp.bp.107.037994; Brezo J, 2007, PSYCHOL MED, V37, P1563, DOI 10.1017/S003329170700058X; Carroll R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089944; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Christodoulou C, 2012, ACTA PSYCHIAT SCAND, V125, P127, DOI 10.1111/j.1600-0447.2011.01750.x; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Conner KR, 2011, SUICIDE LIFE-THREAT, V41, P594, DOI 10.1111/j.1943-278X.2011.00057.x; Conwell Y, 1996, AM J PSYCHIAT, V153, P1001; Conwell Y, 2011, PSYCHIAT CLIN N AM, V34, P451, DOI 10.1016/j.psc.2011.02.002; EGELAND JA, 1985, JAMA-J AM MED ASSOC, V254, P915, DOI 10.1001/jama.254.7.915; Ernst C, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-7; Ernst C, 2011, BIOL PSYCHIAT, V70, P312, DOI 10.1016/j.biopsych.2011.03.038; Ernst C, 2009, ARCH GEN PSYCHIAT, V66, P22, DOI 10.1001/archpsyc.66.1.22; Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Fink M, 2014, J ECT, V30, P5, DOI 10.1097/YCT.0b013e3182a6ad0d; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Fond G, 2014, PSYCHOPHARMACOLOGY, V231, P3663, DOI 10.1007/s00213-014-3664-5; Fountoulakis KN, 2014, BRIT J PSYCHIAT, V205, P486, DOI 10.1192/bjp.bp.114.147454; Fu Q, 2002, PSYCHOL MED, V32, P11, DOI 10.1017/S0033291701004846; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P580, DOI 10.1001/archgenpsychiatry.2011.2048; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gould MS, 2001, ANN NY ACAD SCI, V932, P200; Grover KE, 2009, J CLIN PSYCHOL, V65, P1281, DOI 10.1002/jclp.20632; Grunebaum MF, 2012, NEUROPSYCHOPHARMACOL, V37, P697, DOI 10.1038/npp.2011.247; Haas AP, 2010, J HOMOSEXUAL, V58, P10, DOI 10.1080/00918369.2011.534038; Hadley D, 2011, J ECT, V27, P18, DOI 10.1097/YCT.0b013e3181ce1a8c; Harrod CS, 2014, COCHRANE DB SYST REV, V10; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; Hennen J, 2005, SCHIZOPHR RES, V73, P139, DOI 10.1016/j.schres.2004.05.015; Hoertel N, 2015, MOL PSYCHIATR, V20, P718, DOI 10.1038/mp.2015.19; Holma KM, 2014, BIPOLAR DISORD, V16, P652, DOI 10.1111/bdi.12195; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Ilgen MA, 2013, JAMA PSYCHIAT, V70, P692, DOI 10.1001/jamapsychiatry.2013.908; Inagaki M, 2015, J AFFECT DISORDERS, V175, P66, DOI 10.1016/j.jad.2014.12.048; Jeon HJ, 2010, J NERV MENT DIS, V198, P643, DOI 10.1097/NMD.0b013e3181ef3ecf; Johnston AK, 2009, AUST NZ J PSYCHIAT, V43, P635, DOI 10.1080/00048670902970874; Jollant F, 2014, PSYCHOL MED, V17, P1; Katz C, 2013, DEPRESS ANXIETY, V30, P1030, DOI 10.1002/da.22114; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Kim CD, 2005, AM J PSYCHIAT, V162, P1017, DOI 10.1176/appi.ajp.162.5.1017; Kim CD, 2003, PSYCHOL MED, V33, P1299, DOI 10.1017/S0033291703008146; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Knox KL, 2010, AM J PUBLIC HEALTH, V100, P2457, DOI 10.2105/AJPH.2009.159871; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Lapierre S, 2011, CRISIS, V32, P88, DOI 10.1027/0227-5910/a000076; Lee FS, 2014, SCIENCE, V346, P547, DOI 10.1126/science.1260497; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lieb R, 2005, AM J PSYCHIAT, V162, P1665, DOI 10.1176/appi.ajp.162.9.1665; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002; Luxton DD, 2013, CRISIS, V34, P32, DOI 10.1027/0227-5910/a000158; Mann JJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0537; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; McGirr A, 2008, PSYCHOL MED, V38, P407, DOI 10.1017/S0033291707001419; McGirr A, 2010, J PSYCHIATR NEUROSCI, V35, P399, DOI 10.1503/jpn.090121; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Melhem NM, 2007, AM J PSYCHIAT, V164, P1364, DOI 10.1176/appi.ajp.2007.06091522; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nock MK, 2007, AM J PSYCHIAT, V164, P820, DOI 10.1176/appi.ajp.164.5.820; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Nordentoft M, 2011, PROG NEURO-PSYCHOPH, V35, P848, DOI 10.1016/j.pnpbp.2010.11.038; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; O'Donnell KC, 2007, NEUROSCI BIOBEHAV R, V31, P932, DOI 10.1016/j.neubiorev.2007.04.002; Ougrin D, 2015, J AM ACAD CHILD PSY, V54, P97, DOI 10.1016/j.jaac.2014.10.009; Park JE, 2014, J AFFECT DISORDERS, V162, P96, DOI 10.1016/j.jad.2014.03.012; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Pirkis J, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P531; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkumar R, 2015, PHARMACOL RES, V99, P23, DOI 10.1016/j.phrs.2015.05.003; Reeves A, 2014, BRIT J PSYCHIAT, V205, P246, DOI 10.1192/bjp.bp.114.144766; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Rudd MD, 2015, AM J PSYCHIAT, V172, P441, DOI 10.1176/appi.ajp.2014.14070843; RUTZ W, 1992, ACTA PSYCHIAT SCAND, V85, P83, DOI 10.1111/j.1600-0447.1992.tb01448.x; Schulsinger F., 1979, ORIGIN PREVENTION TR, P277; Scott KM, 2012, BRIT J PSYCHIAT, V200, P469, DOI 10.1192/bjp.bp.111.103267; Seguin M, 2014, BRIT J PSYCHIAT, V205, P120, DOI 10.1192/bjp.bp.113.139949; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Sharifi V, 2015, BRIT J PSYCHIAT, V207, P30, DOI 10.1192/bjp.bp.113.143198; Sikorski C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-10; Sinclair JMA, 2007, J AFFECT DISORDERS, V102, P11, DOI 10.1016/j.jad.2006.12.006; Sondergard L, 2008, BIPOLAR DISORD, V10, P87, DOI 10.1111/j.1399-5618.2008.00464.x; Spallek J, 2015, EUR J PUBLIC HEALTH, V25, P63, DOI 10.1093/eurpub/cku121; Statham DJ, 1998, PSYCHOL MED, V28, P839, DOI 10.1017/S0033291798006916; Stoffers JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005652.pub2; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Sullivan GM, 2015, JAMA PSYCHIAT, V72, P169, DOI 10.1001/jamapsychiatry.2014.2406; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; Szekely A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075081; Tarrier N, 2008, BEHAV MODIF, V32, P77, DOI 10.1177/0145445507304728; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Turecki G, 2013, MOL PSYCHIATR, V18, P1242, DOI 10.1038/mp.2013.153; Turecki G, 2016, BIOL PSYCHIAT, V79, P87, DOI 10.1016/j.biopsych.2014.11.022; Turecki G, 2014, NAT REV NEUROSCI, V15, P802, DOI 10.1038/nrn3839; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; Tyrer P, 2015, LANCET, V385, P717, DOI 10.1016/S0140-6736(14)61995-4; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Vita A, 2015, INT CLIN PSYCHOPHARM, V30, P1, DOI 10.1097/YIC.0000000000000048; Vitiello B, 2011, J CLIN PSYCHIAT, V72, P388, DOI 10.4088/JCp.09m05885blu; Wanner B, 2012, PSYCHOL MED, V42, P2373, DOI 10.1017/S0033291712000438; Wasserman D, 2015, LANCET, V385, P1536, DOI 10.1016/S0140-6736(14)61213-7; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Weinberg I, 2010, J CLIN PSYCHIAT, V71, P699, DOI 10.4088/JCP.08m04840blu; Weissman MM, 1999, PSYCHOL MED, V29, P9, DOI 10.1017/S0033291798007867; While D, 2012, LANCET, V379, P1005, DOI 10.1016/S0140-6736(11)61712-1; WHO, 2014, MENT HLTH SUIC PREV; Williams JMG, 2005, J ABNORM PSYCHOL, V114, P421, DOI 10.1037/0021-843X.114.3.421; Yang B, 2000, SUICIDE LIFE-THREAT, V30, P183; Yanowitch R, 2011, ADV GENET, V75, P151, DOI 10.1016/B978-0-12-380858-5.00005-8; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	141	904	920	21	252	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1227	1239		10.1016/S0140-6736(15)00234-2	http://dx.doi.org/10.1016/S0140-6736(15)00234-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG9OB	26385066	Green Accepted			2022-12-28	WOS:000372412000034
J	Haberle, V; Stark, A				Haberle, Vanja; Stark, Alexander			Coordinating the Human Looks	CELL			English	Editorial Material							ENHANCER ACTIVITY; EVOLUTION	Prescott et al. take a step forward in studying primate morphological evolution by a cellular anthropology approach. Through epigenomic profiling of in-vitro-derived cells, the authors identify and characterize candidate cis-regulatory elements underlying divergence in facial morphology between human and chimp, shedding new light on what makes us (look) human.	[Haberle, Vanja; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012	Stark, Alexander/0000-0003-2611-0841; Haberle, Vanja/0000-0003-4191-3714				Arnold CD, 2014, NAT GENET, V46, P685, DOI 10.1038/ng.3009; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006	10	0	0	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					24	26		10.1016/j.cell.2015.09.010	http://dx.doi.org/10.1016/j.cell.2015.09.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406365	Bronze			2022-12-28	WOS:000361846500015
J	Pollen, AA; Nowakowski, TJ; Chen, JD; Retallack, H; Sandoval-Espinosa, C; Nicholas, CR; Shuga, J; Liu, SJ; Oldham, MC; Diaz, A; Lim, DA; Leyrat, AA; West, JA; Kriegstein, AR				Pollen, Alex A.; Nowakowski, Tomasz J.; Chen, Jiadong; Retallack, Hanna; Sandoval-Espinosa, Carmen; Nicholas, Cory R.; Shuga, Joe; Liu, Siyuan John; Oldham, Michael C.; Diaz, Aaron; Lim, Daniel A.; Leyrat, Anne A.; West, Jay A.; Kriegstein, Arnold R.			Molecular Identity of Human Outer Radial Glia during Cortical Development	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SUBVENTRICULAR ZONE; TENASCIN-C; EXTRACELLULAR-MATRIX; CEREBRAL-CORTEX; STEM-CELLS; ADULT HIPPOCAMPUS; MOUSE NEOCORTEX; GROWTH-FACTOR; NEUROGENESIS	Radial glia, the neural stem cells of the neocortex, are located in two niches: the ventricular zone and outer subventricular zone. Although outer subventricular zone radial glia may generate the majority of human cortical neurons, their molecular features remain elusive. By analyzing gene expression across single cells, we find that outer radial glia preferentially express genes related to extracellular matrix formation, migration, and stemness, including TNC, PTPRZ1, FAM107A, HOPX, and LIFR. Using dynamic imaging, immunostaining, and clonal analysis, we relate these molecular features to distinctive behaviors of outer radial glia, demonstrate the necessity of STAT3 signaling for their cell cycle progression, and establish their extensive proliferative potential. These results suggest that outer radial glia directly support the subventricular niche through local production of growth factors, potentiation of growth factor signals by extracellular matrix proteins, and activation of self-renewal pathways, thereby enabling the developmental and evolutionary expansion of the human neocortex.	[Pollen, Alex A.; Nowakowski, Tomasz J.; Chen, Jiadong; Retallack, Hanna; Sandoval-Espinosa, Carmen; Nicholas, Cory R.; Liu, Siyuan John; Oldham, Michael C.; Diaz, Aaron; Lim, Daniel A.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Pollen, Alex A.; Nowakowski, Tomasz J.; Chen, Jiadong; Retallack, Hanna; Sandoval-Espinosa, Carmen; Liu, Siyuan John; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Shuga, Joe; Leyrat, Anne A.; West, Jay A.] Fluidigm Corp, San Francisco, CA 94080 USA; [Diaz, Aaron; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollen, AA (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	alex.pollen@gmail.com; kriegsteina@stemcell.ucsf.edu		Lim, Daniel/0000-0001-7221-3425	Damon Runyon Cancer Research Foundation [DRG-2166-13]; UCSF-CTSI [UL1 TR000004]; NIH [U01 MH105989, R01NS075998]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075998] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; UCSF-CTSI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Stephen Noctor, Marc Unger, Bob Jones, Beatriz Alvarado, Tricia Sun, Mercedes Paredes, Becky Anderson, Raphael Kohler, Jerry Wang, Shaohui Wang, Yingying Wang, and Simone Mayer for providing resources, suggestions, and technical assistance and the staff at the San Francisco General Hospital for providing access to donated tissue samples. A.A.P. is supported by a Damon Runyon Cancer Research Foundation postdoctoral fellowship (DRG-2166-13). A.D. is partially supported by UCSF-CTSI UL1 TR000004. This research was supported by NIH awards U01 MH105989 and R01NS075998 to A.R.K.A.A.L., J.A.W., and J.S. have a financial interest in Fluidigm Corporation as employees and/or stockholders.	Autelitano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110316; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Besser M, 2012, DEV BIOL, V369, P163, DOI 10.1016/j.ydbio.2012.05.020; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Bianchi A, 2010, CELL CYCLE, V9, P1647, DOI 10.4161/cc.9.8.11517; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garwood J, 2004, EUR J NEUROSCI, V20, P2524, DOI 10.1111/j.1460-9568.2004.03727.x; Gertz CC, 2014, J NEUROSCI, V34, P2559, DOI 10.1523/JNEUROSCI.2645-13.2014; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hong S, 2015, J NEUROSCI, V35, P1011, DOI 10.1523/JNEUROSCI.2119-14.2015; Huang GY, 2014, STEM CELLS, V32, P1149, DOI 10.1002/stem.1609; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Katoh D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.27; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kyuno D, 2013, CARCINOGENESIS, V34, P1232, DOI 10.1093/carcin/bgt057; Le PU, 2010, ONCOGENE, V29, P4636, DOI 10.1038/onc.2010.216; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030178, 10.1371/journal.pone.0041386]; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Nie S, 2015, J PROTEOME RES, V14, P814, DOI 10.1021/pr5008653; Ostrem BEL, 2014, CELL REP, V8, P656, DOI 10.1016/j.celrep.2014.06.058; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vasistha NA, 2014, CEREB CORTEX; von Holst A, 2008, CELLS TISSUES ORGANS, V188, P170, DOI 10.1159/000112848; Wang WZ, 2011, CEREB CORTEX, V21, P2187, DOI 10.1093/cercor/bhq278; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714	52	445	450	4	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					55	67		10.1016/j.cell.2015.09.004	http://dx.doi.org/10.1016/j.cell.2015.09.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406371	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000361846500021
J	Andersen, K; Rasmussen, F; Held, C; Neovius, M; Tynelius, P; Sundstrom, J				Andersen, Kasper; Rasmussen, Finn; Held, Claes; Neovius, Martin; Tynelius, Per; Sundstrom, Johan			Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY LEVELS; CORONARY-HEART-DISEASE; BONE-MINERAL DENSITY; ATRIAL-FIBRILLATION; ALL-CAUSE; CARDIOVASCULAR MORTALITY; INSULIN SENSITIVITY; ENDURANCE SPORT; LEISURE-TIME; BODY-MASS	OBJECTIVE To investigate the associations of exercise capacity and muscle strength in late adolescence with risk of vascular disease and arrhythmia. DESIGN Cohort study. SETTING General population in Sweden. PARTICIPANTS 1.1 million men who participated in mandatory military conscription between 1 August 1972 and 31 December 1995, at a median age of 18.2 years. Participants were followed until 31 December 2010. MAIN OUTCOMES Associations between exercise capacity and muscle strength with risk of vascular disease and subgroups (ischaemic heart disease, heart failure, stroke, and cardiovascular death) and risk of arrhythmia and subgroups (atrial fibrillation or flutter, bradyarrhythmia, supraventricular tachycardia, and ventricular arrhythmia or sudden cardiac death). Maximum exercise capacity was estimated by the ergometer bicycle test, and muscle strength was measured as handgrip strength by a hand dynamometer. High exercise capacity or muscle strength was deemed as above the median level. RESULTS During a median follow-up of 26.3 years, 26 088 vascular disease events and 17 312 arrhythmia events were recorded. Exercise capacity was inversely associated with risk of vascular disease and its subgroups. Muscle strength was also inversely associated with vascular disease risk, driven by associations of higher muscle strength with lower risk of heart failure and cardiovascular death. Exercise capacity had a U shaped association with risk of arrhythmia, driven by a direct association with risk of atrial fibrillation and a U shaped association with bradyarrhythmia. Higher muscle strength was associated with lower risk of arrhythmia (specifically, lower risk of bradyarrhythmia and ventricular arrhythmia). The combination of high exercise capacity and high muscle strength was associated with a hazard ratio of 0.67 (95% confidence interval 0.65 to 0.70) for vascular events and 0.92 (0.88 to 0.97) for arrhythmia compared with the combination of low exercise capacity and low muscle strength. CONCLUSIONS Exercise capacity and muscle strength in late adolescence are independently and jointly associated with long term risk of vascular disease and arrhythmia. The health benefit of lower risk of vascular events with higher exercise capacity was not outweighed by higher risk of arrhythmia.	[Andersen, Kasper; Held, Claes; Sundstrom, Johan] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Andersen, Kasper; Held, Claes; Sundstrom, Johan] Univ Uppsala Hosp, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Rasmussen, Finn; Tynelius, Per] Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Unit, Stockholm, Sweden; [Neovius, Martin] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska Institutet	Andersen, K (corresponding author), Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden.	kasper.andersen@medsci.uu.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009; Held, Claes/AAA-3973-2021	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Held, Claes/0000-0001-9402-7404; Neovius, Martin/0000-0003-2300-3055; Rasmussen, Finn/0000-0001-7915-7809	Swedish Research Council [2007-5942, 2010-1078, K2014-99X-22495-01-3]; Geriatric Fund, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Geriatric Fund, Sweden	JS was funded by the Swedish Research Council (grants 2007-5942 and 2010-1078). KA received a grant from the Geriatric Fund, Sweden. MN was funded by the Swedish Research Council (grant K2014-99X-22495-01-3). All researchers were independent from funders.	Andersen K, 2008, HORM METAB RES, V40, P635, DOI 10.1055/s-0028-1083810; Andersen K, 2013, EUR HEART J, V34, P3624, DOI 10.1093/eurheartj/eht188; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Baturova MA, 2014, EUROPACE, V16, P1714, DOI 10.1093/europace/euu165; Berman LJ, 2012, DIABETES-METAB RES, V28, P395, DOI 10.1002/dmrr.2292; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Claessen G, 2011, HEART, V97, P918, DOI 10.1136/hrt.2010.216150; Corrado D, 2011, EUR HEART J, V32, P934, DOI 10.1093/eurheartj/ehq482; Drca N, 2014, HEART, V100, P1037, DOI 10.1136/heartjnl-2013-305304; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Heimburger O, 2000, AM J KIDNEY DIS, V36, P1213, DOI 10.1053/ajkd.2000.19837; Held C, 2012, EUR HEART J, V33, P452, DOI 10.1093/eurheartj/ehr432; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lee S, 2006, OBESITY, V14, P1579, DOI 10.1038/oby.2006.182; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mont L, 2009, EUROPACE, V11, P11, DOI 10.1093/europace/eun289; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; Shin H, 2014, J GERIATR PHYS THER, V37, P7, DOI 10.1519/JPT.0b013e31828af203; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244	33	59	59	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4543	10.1136/bmj.h4543	http://dx.doi.org/10.1136/bmj.h4543			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26378015	Green Published, hybrid			2022-12-28	WOS:000361678800003
J	Le Manach, Y; Collins, G; Bhandari, M; Bessissow, A; Boddaert, J; Khiami, F; Chaudhry, H; De Beer, J; Riou, B; Landais, P; Winemaker, M; Boudemaghe, T; Devereaux, PJ				Le Manach, Yannick; Collins, Gary; Bhandari, Mohit; Bessissow, Amal; Boddaert, Jacques; Khiami, Frederic; Chaudhry, Harman; De Beer, Justin; Riou, Bruno; Landais, Paul; Winemaker, Mitchell; Boudemaghe, Thierry; Devereaux, P. J.			Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; NECK; ARTHROPLASTY; ASSOCIATION; BALANCE; TRAUMA	IMPORTANCE Patients undergoing surgery for a hip fracture have a higher risk of mortality and major complications compared with patients undergoing an elective total hip replacement (THR) operation. The effect of older age and comorbidities associated with hip fracture on this increased perioperative risk is unknown. OBJECTIVE To determine if there was a difference in hospital mortality among patients who underwent hip fracture surgery relative to an elective THR, after adjustment for age, sex, and preoperative comorbidities. DESIGN, SETTING, AND PARTICIPANTS Using the French National Hospital Discharge Database from January 2010 to December 2013, patients older than 45 years undergoing hip surgery at French hospitals were included. The International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), codes were used to determine patients' comorbidities and complications after surgery. A population matched for age, sex, and preoperative comorbidities of patients who underwent elective THR or hip fracture surgery was created using a multivariable logistic model and a greedy matching algorithm with a 1: 1 ratio. EXPOSURE Hip fracture. MAIN OUTCOMES AND MEASURES Postoperative in-hospital mortality. RESULTS A total of 690 995 eligible patients were included from 864 centers in France. Patients undergoing elective THR surgery (n = 371 191) were younger, more commonly men, and had less comorbidity compared with patients undergoing hip fracture surgery. Following hip fracture surgery (n = 319 804), 10 931 patients (3.42%) died before hospital discharge and 669 patients (0.18%) died after elective THR. Multivariable analysis of the matched populations (n = 234 314) demonstrated a higher risk of mortality (1.82% for hip fracture surgery vs 0.31% for elective THR; absolute risk increase, 1.51% [95% CI, 1.46%-1.55%]; relative risk [RR], 5.88 [95% CI, 5.26-6.58]; P <.001) and of major postoperative complications (5.88% for hip fracture surgery vs 2.34% for elective THR; absolute risk increase, 3.54%[95% CI, 3.50%-3.59%]; RR, 2.50 [95% CI, 2.40-2.62]; P <.001) among patients undergoing hip fracture surgery. CONCLUSIONS AND RELEVANCE In a large cohort of French patients, hip fracture surgery compared with elective THR was associated with a higher risk of in-hospital mortality after adjustment for age, sex, and measured comorbidities. Further studies are needed to define the causes for these differences.	[Le Manach, Yannick] McMaster Univ, Dept Anesthesia, Michael DeGroote Sch Med, Hamilton, ON, Canada; [Le Manach, Yannick; Bhandari, Mohit; Devereaux, P. J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Michael DeGroote Sch Med, Hamilton, ON, Canada; [Le Manach, Yannick; Bhandari, Mohit; Bessissow, Amal; Chaudhry, Harman; Devereaux, P. J.] Hamilton Hlth Sci, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Hamilton, ON, Canada; [Le Manach, Yannick; Bhandari, Mohit; Bessissow, Amal; Chaudhry, Harman; Devereaux, P. J.] McMaster Univ, Hamilton, ON, Canada; [Collins, Gary] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England; [Bhandari, Mohit; Chaudhry, Harman; De Beer, Justin; Winemaker, Mitchell] McMaster Univ, Dept Surg, Michael DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada; [Bessissow, Amal] McGill Univ, Div Gen Internal Med, Montreal, PQ, Canada; [Boddaert, Jacques] Grp Hosp Pitie Salpetriere, AP HP, Dept Geriatr, F-75634 Paris, France; [Boddaert, Jacques] Univ Paris 06, Dept Hosp Univ Fight Stress & Aging, Sorbonne Univ, Paris, France; [Khiami, Frederic] Grp Hosp Pitie Salpetriere, Dept Orthoped Surg, AP HP, F-75634 Paris, France; [Riou, Bruno; Landais, Paul; Boudemaghe, Thierry] Univ Montpellier, Unite Propre Rech Enseignement Super, Equipe Acceuil 2415, Clin Res Inst,Fac Med, F-34059 Montpellier, France; [Riou, Bruno] Grp Hosp Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, F-75634 Paris, France; [Riou, Bruno] Univ Paris 06, Inst Cardiovasc Metab & Nutr, Univ Paris 04, Paris, France; [Riou, Bruno] INSERM, Unite Mixte Rech 1166, Paris, France; [Landais, Paul; Boudemaghe, Thierry] Nimes Univ Hosp, Dept Biostat Clin Res & Med Informat, Nimes, France; [Devereaux, P. J.] McMaster Univ, Dept Med, Michael DeGroote Sch Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; University of Oxford; McMaster University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; McMaster University	Le Manach, Y (corresponding author), Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yannick.lemanach@phri.ca	Collins, Gary Stephen/A-2258-2014; Devereaux, PJ/AAY-1757-2021; Winemaker, Mitchell/AAQ-5131-2021; Boudemaghe, Thierry/AAA-2607-2019; Le Manach, Yannick/AAE-5700-2019; Devereaux, PJ/AAF-2862-2019; Bhandari, Mohit/AAQ-1675-2021	Collins, Gary Stephen/0000-0002-2772-2316; Boudemaghe, Thierry/0000-0003-4768-2267; Le Manach, Yannick/0000-0003-0474-8545; Devereaux, PJ/0000-0003-2935-637X	Hamilton Anesthesia Associates; Canadian Network and Centre for Trials Internationally; United Kingdom Medical Research Council [G1100513]; Heart and Stroke Foundation of Ontario Career Investigator Award; MRC [G1100513] Funding Source: UKRI; Medical Research Council [G1100513] Funding Source: researchfish	Hamilton Anesthesia Associates; Canadian Network and Centre for Trials Internationally; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heart and Stroke Foundation of Ontario Career Investigator Award(Heart & Stroke Foundation of Ontario); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Hamilton Anesthesia Associates (Dr Le Manach) and the Canadian Network and Centre for Trials Internationally (Dr Le Manach), by grant G1100513 from the United Kingdom Medical Research Council (Dr Collins), and by a Heart and Stroke Foundation of Ontario Career Investigator Award (Dr Devereaux).	Agence Technique de l'Information Sur l'Hospitalisation, CLASS GROUP HOM MAL; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Beloosesky Y, 2007, J GERONTOL A-BIOL, V62, P420, DOI 10.1093/gerona/62.4.420; Bessissow A, 2014, J COMP EFFECT RES, V3, P115, DOI 10.2217/cer.14.5; Boddaert J, 2014, ANESTHESIOLOGY, V121, P1336, DOI 10.1097/ALN.0000000000000478; Boddaert J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083795; Buse GL, 2014, CAN MED ASSOC J, V186, pE52, DOI 10.1503/cmaj.130901; Chuang D, 2005, ANZ J SURG, V75, P813, DOI 10.1111/j.1445-2197.2005.03530.x; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Ford S, 2014, ANAESTHESIA, V69, P643, DOI 10.1111/anae.12722; Franklin JM, 2014, STAT MED, V33, P1685, DOI 10.1002/sim.6058; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Landais P, 2014, HEALTH INFORM SER, P191, DOI 10.1007/978-2-8178-0478-1_9; LeBlanc ES, 2011, ARCH INTERN MED, V171, P1831, DOI 10.1001/archinternmed.2011.447; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lunt M, 2014, AM J EPIDEMIOL, V179, P226, DOI 10.1093/aje/kwt212; Miller RR, 2008, J AM GERIATR SOC, V56, P1050, DOI 10.1111/j.1532-5415.2008.01708.x; O'Brien J, 2000, LANCET, V355, P1295; Onuoha GN, 2000, NEUROPEPTIDES, V34, P116, DOI 10.1054/npep.2000.0803; Robinson RP, 2007, CLIN ORTHOP RELAT R, P196, DOI 10.1097/BLO.0b013e3181576006; Sassoon A, 2013, J ARTHROPLASTY, V28, P1659, DOI 10.1016/j.arth.2013.01.027; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Svensen CH, 2004, J CLIN ANESTH, V16, P435, DOI 10.1016/j.jclinane.2003.12.008; Tsangari H, 2004, BONE, V35, P334, DOI 10.1016/j.bone.2004.02.006; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; White SM, 2014, ANAESTHESIA, V69, P224, DOI 10.1111/anae.12542; Woolson ST, 2007, J BONE JOINT SURG AM, V89A, P601, DOI 10.2106/JBJS.F.00584; World Health Organization, INT CLASS DIS ICD	32	105	106	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1159	1166		10.1001/jama.2015.10842	http://dx.doi.org/10.1001/jama.2015.10842			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372585	Bronze			2022-12-28	WOS:000361284500027
J	Wilcken, N; Lee, CI				Wilcken, Nicholas; Lee, Clara Inkyung			In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wilcken, Nicholas; Lee, Clara Inkyung] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia	University of Sydney	Wilcken, N (corresponding author), Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia.							Amgen, STUD DEN ADJ TREATM; Coleman R, 2015, LANCET IN PRESS; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC11	10.7326/ACPJC-2015-163-6-011	http://dx.doi.org/10.7326/ACPJC-2015-163-6-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370026				2022-12-28	WOS:000361365900011
J	Rasanathan, K; Damji, N; Atsbeha, T; Drisse, MNB; Davis, A; Dora, C; Karam, A; Kuruvilla, S; Mahon, J; Neira, M; Montesinos, EV; von Zinkernagel, D; Webb, D				Rasanathan, Kumanan; Damji, Nazneen; Atsbeha, Tesmerelna; Drisse, Marie-Noel Brune; Davis, Austen; Dora, Carlos; Karam, Azza; Kuruvilla, Shyama; Mahon, Jacqueline; Neira, Maria; Montesinos, Eugenio Villar; von Zinkernagel, Deborah; Webb, Douglas			Ensuring multisectoral action on the determinants of reproductive, maternal, newborn, child, and adolescent health in the post-2015 era	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPMENT GOALS; UNDER-5 MORTALITY; COUNTRIES; INCOME		[Rasanathan, Kumanan; Damji, Nazneen; Atsbeha, Tesmerelna; Drisse, Marie-Noel Brune; Davis, Austen; Dora, Carlos; Karam, Azza; Kuruvilla, Shyama; Mahon, Jacqueline; Neira, Maria; Montesinos, Eugenio Villar; von Zinkernagel, Deborah; Webb, Douglas] Unicef, Hlth Sect, Every Woman Every Child Determinants Hlth Working, New York, NY 10017 USA; [Rasanathan, Kumanan] Unicef, Hlth Sect, New York, NY 10017 USA; [Damji, Nazneen; Atsbeha, Tesmerelna] United Nations Women, New York, NY USA; [Drisse, Marie-Noel Brune; Dora, Carlos; Neira, Maria] WHO, Dept Publ Hlth Social & Environm Determinants Hlt, CH-1211 Geneva, Switzerland; [Davis, Austen] Norad, Oslo, Norway; [Karam, Azza; Mahon, Jacqueline] United Nations Populat Fund, New York, NY USA; [Kuruvilla, Shyama] WHO, Cluster Family & Community Hlth, Geneva, Switzerland; [Montesinos, Eugenio Villar] WHO, Social Determinants Hlth Unit, Geneva, Switzerland; [von Zinkernagel, Deborah] UNAIDS, Geneva, Switzerland; [Webb, Douglas] United Nations Dev Programme, New York, NY USA	UNICEF; UNICEF; World Health Organization; United Nations Population Fund; World Health Organization; World Health Organization; UNAIDS	Rasanathan, K (corresponding author), Unicef, Hlth Sect, Every Woman Every Child Determinants Hlth Working, New York, NY 10017 USA.	krasanathan@unicef.org		Kuruvilla, Shyama/0000-0002-0327-4467				Banati P, 2012, EXPERT WORKING GROUP; Bircher J, 2014, J PUBLIC HEALTH POL, V35, P363, DOI 10.1057/jphp.2014.19; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8; Cohen RL, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0067-7; Committee on Economic Social and Cultural Rights, 2000, SUBST ISS AR IMPL IC; El-Noush H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4151; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kickbusch I., 2010, IMPLEMENTING HLTH AL; Kuruvilla Shyama, 2014, Bull World Health Organ, V92, P533, DOI 10.2471/BLT.14.138131; Legge D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1893; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Partnership for Maternal Newborn and Child Health WHO, 2014, POL GUID IMPL ESS IN; Pruss-Ustun A, 2006, PREVENTING DIS HLTH; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Robeyns I, 2011, STANFORD ENCY PHILOS; Silver KL, 2014, LANCET, V384, P1093, DOI 10.1016/S0140-6736(14)61667-6; Solar O., 2010, CONCEPTUAL FRAMEWORK, DOI DOI 10.13016/17CR-AQB9; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; United Nations, 2010, GLOB STRAT WOM CHILD; United Nations Children?s Fund (UNICEF), 2015, INV CAS ED EQ; Verguet S, 2014, HEALTH POLICY PLANN, V29, P151, DOI 10.1093/heapol/czs143; Victora CG, 2010, INT J EPIDEMIOL, V39, P650, DOI 10.1093/ije/dyq097; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2011, SOC DET HLTH SECT BR, V2; WHO Unicef, 2015, WAT SAN HYG HLTH CAR; WHO Unicef Government of Sweden and Government of Botswana, 2013, HLTH POST 2015 AG; Women and Gender Equity Knowledge Network, 2007, UNE UNF IN IN GEND I; World Bank, 2014, GLOB FIN FAC SUPP EV; World Health Organization, 2015, HLTH ALL POL TRAIN M	33	21	21	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4213					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371220	hybrid			2022-12-28	WOS:000361678200008
J	Farez, MF; Mascanfroni, ID; Mendez-Huergo, SP; Yeste, A; Murugaiyan, G; Garo, LP; Aguirre, MEB; Patel, B; Ysrraelit, MC; Zhu, C; Kuchroo, VK; Rabinovich, GA; Quintana, FJ; Correale, J				Farez, Mauricio F.; Mascanfroni, Ivan D.; Mendez-Huergo, Santiago P.; Yeste, Ada; Murugaiyan, Gopal; Garo, Lucien P.; Balbuena Aguirre, Maria E.; Patel, Bonny; Ysrraelit, Maria C.; Zhu, Chen; Kuchroo, Vijay K.; Rabinovich, Gabriel A.; Quintana, Francisco J.; Correale, Jorge			Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses	CELL			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; PATHOGENIC T(H)17 CELLS; VITAMIN-D; TRANSCRIPTION FACTORS; NUCLEAR RECEPTORS; MESSENGER-RNA; IMMUNE CELLS; RISK; DIFFERENTIATION	Seasonal changes in disease activity have been observed in multiple sclerosis, an autoimmune disorder that affects the CNS. These epidemiological observations suggest that environmental factors influence the disease course. Here, we report that melatonin levels, whose production is modulated by seasonal variations in night length, negatively correlate with multiple sclerosis activity in humans. Treatment with melatonin ameliorates disease in an experimental model of multiple sclerosis and directly interferes with the differentiation of human and mouse T cells. Melatonin induces the expression of the repressor transcription factor Nfil3, blocking the differentiation of pathogenic Th17 cells and boosts the generation of protective Tr1 cells via Erk1/2 and the transactivation of the IL-10 promoter by ROR-alpha. These results suggest that melatonin is another example of how environmental-driven cues can impact T cell differentiation and have implications for autoimmune disorders such as multiple sclerosis.	[Farez, Mauricio F.; Balbuena Aguirre, Maria E.; Ysrraelit, Maria C.; Correale, Jorge] Raul Carrea Inst Neurol Res FLENI, Ctr Res Neuroimmunol Dis CIEN, RA-1428 Buenos Aires, DF, Argentina; [Mascanfroni, Ivan D.; Yeste, Ada; Murugaiyan, Gopal; Garo, Lucien P.; Patel, Bonny; Zhu, Chen; Kuchroo, Vijay K.; Quintana, Francisco J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Mendez-Huergo, Santiago P.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn IBYME CONICET, Inst Biol & Med Expt, Lab Inmunopatol, RA-1428 Buenos Aires, DF, Argentina; [Balbuena Aguirre, Maria E.] Hosp Clin Jose San Martin, Dept Neurol, RA-1428 Buenos Aires, DF, Argentina; [Zhu, Chen; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Hospital de Clinicas Jose de San Martin; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Buenos Aires	Farez, MF (corresponding author), Raul Carrea Inst Neurol Res FLENI, Ctr Res Neuroimmunol Dis CIEN, RA-1428 Buenos Aires, DF, Argentina.	mfarez@fleni.org.ar; fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020; Ysrraelit, Maria Celica Celica/AAX-4454-2021; Correale, Jorge/AAG-4245-2020	Ysrraelit, Maria Celica Celica/0000-0003-0846-5825; 	Allende Foundation; MSIF Du-Pree grant; Biogen Idec; Novartis Argentina; Merck Serono Argentina; NIH [AI093903, NS087867]; National Multiple Sclerosis Society [RG4111A1, JF2161-A-5]; International Progressive MS Alliance [PA0069]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093903, R01AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087867] Funding Source: NIH RePORTER	Allende Foundation; MSIF Du-Pree grant; Biogen Idec(Biogen); Novartis Argentina(Novartis); Merck Serono Argentina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); International Progressive MS Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Allende Foundation and the MSIF Du-Pree grant (to M.F.F.), a grant from Biogen Idec and Novartis Argentina (to M.F.F. and J.C.) and Merck Serono Argentina (to J.C.), AI093903 and NS087867 from the NIH, RG4111A1 and JF2161-A-5 from the National Multiple Sclerosis Society, and PA0069 from the International Progressive MS Alliance to F.J.Q. We would like to thank Drs. Lora Hooper, Bart Staels, Vincent Laudent, Mitch Lazar, and Daniel Tenen for generously providing reagents used in these studies. We would also like to thank Jessica Kenison-White for technical assistance with mice colonies.	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Baeten DLP, 2013, NAT MED, V19, P824, DOI 10.1038/nm.3268; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Farez M. F., 2014, J NEUROL NEUROSURG P; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Fassi J, 2003, MEDICINA-BUENOS AIRE, V63, P215; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Graham C, 1998, J PINEAL RES, V24, P230, DOI 10.1111/j.1600-079X.1998.tb00538.x; Hedstrom AK, 2011, ANN NEUROL, V70, P733, DOI 10.1002/ana.22597; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Hickie IB, 2011, LANCET, V378, P621, DOI 10.1016/S0140-6736(11)60095-0; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jin YP, 2000, J NEUROL SCI, V181, P56, DOI 10.1016/S0022-510X(00)00408-1; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Karim A, 2006, J CLIN PHARMACOL, V46, P140, DOI 10.1177/0091270005283461; Kobayashi T, 2014, J IMMUNOL, V192, P1918, DOI 10.4049/jimmunol.1301819; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Loken-Amsrud KI, 2012, NEUROLOGY, V79, P267, DOI 10.1212/WNL.0b013e31825fdf01; Macchi MM, 2004, FRONT NEUROENDOCRIN, V25, P177, DOI 10.1016/j.yfrne.2004.08.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Morera AL, 2007, J PINEAL RES, V43, P313, DOI 10.1111/j.1600-079X.2007.00467.x; Pevet P, 2003, J NEUROENDOCRINOL, V15, P422, DOI 10.1046/j.1365-2826.2003.01017.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pozo D, 2004, J PINEAL RES, V37, P48, DOI 10.1111/j.1600-079X.2004.00135.x; Pozo D, 1997, FASEB J, V11, P466, DOI 10.1096/fasebj.11.6.9194527; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rosecrans R, 2014, CLIN BIOCHEM, V47, P670, DOI 10.1016/j.clinbiochem.2014.02.004; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schernhammer ES, 2004, CANCER EPIDEM BIOMAR, V13, P936; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spelman T, 2014, ANN NEUROL, V76, P880, DOI 10.1002/ana.24287; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Ueno-Towatari Tomoko, 2007, Journal of Physiological Anthropology, V26, P209, DOI 10.2114/jpa2.26.209; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	62	191	197	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1338	1352		10.1016/j.cell.2015.08.025	http://dx.doi.org/10.1016/j.cell.2015.08.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359987	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000361247900022
J	Friedman, D; Devinsky, O				Friedman, Daniel; Devinsky, Orrin			Cannabinoids in the Treatment of Epilepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MEDICAL MARIJUANA; ENDOCANNABINOID SYSTEM; PLANT CANNABINOIDS; STATUS EPILEPTICUS; OROMUCOSAL SPRAY; DOUBLE-BLIND; CANNABIDIOL; RECEPTOR; CB1; ANTICONVULSANT		[Friedman, Daniel; Devinsky, Orrin] NYU, Langone Sch Med, Dept Neurol, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Friedman, D (corresponding author), NYU, Langone Sch Med, Dept Neurol, 223 E 34th St, New York, NY 10016 USA.	daniel.friedman@nyumc.org		Devinsky, Orrin/0000-0003-0044-4632	GW Pharmaceuticals; Novartis; Marinus Pharmaceuticals; Eisai; SK Biopharmaceuticals; Upsher-Smith Laboratories; Pfizer	GW Pharmaceuticals; Novartis(Novartis); Marinus Pharmaceuticals; Eisai(Eisai Co Ltd); SK Biopharmaceuticals; Upsher-Smith Laboratories; Pfizer(Pfizer)	Dr. Devinsky reports receiving grant support from GW Pharmaceuticals and Novartis and serving on the scientific advisory board of MiaMed; and Dr. Friedman, receiving fees for serving on an advisory board for Marinus Pharmaceuticals and consulting fees from Eisai, Marinus Pharmaceuticals, SK Biopharmaceuticals, Upsher-Smith Laboratories, and Pfizer, all of which were paid to the Epilepsy Study Consortium. No other potential conflict of interest relevant to this article was reported.	AMES FR, 1986, S AFR MED J, V69, P14; [Anonymous], 2014, HDB OF CANNABIS, DOI DOI 10.1093/ACPROF:OSO/9780199662685.003.0007; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Bergamaschi MM, 2011, CURR DRUG SAF, V6, P237, DOI 10.2174/157488611798280924; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Brust J C, 1992, Trans Am Clin Climatol Assoc, V103, P176; Campos AC, 2012, J PSYCHIATR RES, V46, P1501, DOI 10.1016/j.jpsychires.2012.08.012; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; CHAN HSL, 1987, PEDIATRICS, V79, P946; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; CONSROE PF, 1975, JAMA-J AM MED ASSOC, V234, P306, DOI 10.1001/jama.234.3.306; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; DAVIS JP, 1949, FED PROC, V8, P284; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Deshpande LS, 2007, EUR J PHARMACOL, V558, P52, DOI 10.1016/j.ejphar.2006.11.030; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Devinsky O, 2015, ANN M AM AC NEUR WAS; Devinsky O, 2015, EPILEPSIA, V56, P7, DOI 10.1111/epi.12853; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Drug Enforcement Agency, DRUG SCHED DRUG SCHE; ELLISON JM, 1990, J CLIN PSYCHIAT, V51, P439; ElSohly M, 2014, HDB OF CANNABIS, P1093, DOI DOI 10.1093/ACPROF:OSO/9780199662685.003.0001; FEENEY DM, 1976, JAMA-J AM MED ASSOC, V235, P1105, DOI 10.1001/jama.1976.03260370015003; Friedman D., 2014, AES M SEATTL WA AES; Gloss D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009270.pub3; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Gowers WR, 1881, EPILEPSY OTHER CHRON; Gross DW, 2004, NEUROLOGY, V62, P2095, DOI 10.1212/01.WNL.0000127623.03766.75; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; Hamerle M, 2014, EUR J NEUROL, V21, P167, DOI 10.1111/ene.12081; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Healy J, 2015, NY TIMES, pA1; Hegde M, 2012, EPILEPSY BEHAV, V25, P563, DOI 10.1016/j.yebeh.2012.09.024; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Hill TDM, 2013, BRIT J PHARMACOL, V170, P679, DOI 10.1111/bph.12321; Iannotti FA, 2014, ACS CHEM NEUROSCI, V5, P1131, DOI 10.1021/cn5000524; Jatoi A, 2002, J CLIN ONCOL, V20, P567, DOI 10.1200/JCO.20.2.567; Karanian DA, 2007, J PHARMACOL EXP THER, V322, P1059, DOI 10.1124/jpet.107.120147; KEELER MH, 1967, DIS NERV SYST, V28, P474; Koppel BS, 2014, NEUROLOGY, V82, P1556, DOI 10.1212/WNL.0000000000000363; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lorenzetti V, 2015, BRIT J PSYCHIAT, V206, P77, DOI 10.1192/bjp.bp.114.151407; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Maa E, 2014, EPILEPSIA, V55, P783, DOI 10.1111/epi.12610; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mathern GW, 2015, EPILEPSIA, V56, P1, DOI 10.1111/epi.12843; MECHOULAM R, 1978, NATURWISSENSCHAFTEN, V65, P174, DOI 10.1007/BF00450585; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mortati Katherine, 2007, Rev Neurol Dis, V4, P103; Ng YT, 2011, NEUROLOGY, V77, P1473, DOI 10.1212/WNL.0b013e318232de76; Patsalos PN, 2003, LANCET NEUROL, V2, P347, DOI 10.1016/S1474-4422(03)00409-5; Pertwee R, 2014, HDB CANNABIS; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Perucca P, 2012, LANCET NEUROL, V11, P792, DOI 10.1016/S1474-4422(12)70153-9; Porter BE, 2013, EPILEPSY BEHAV, V29, P574, DOI 10.1016/j.yebeh.2013.08.037; Press CA, 2015, EPILEPSY BEHAV, V45, P49, DOI 10.1016/j.yebeh.2015.02.043; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Robson P, 2011, EXPERT OPIN DRUG SAF, V10, P675, DOI 10.1517/14740338.2011.575778; Rogeberg O, 2013, P NATL ACAD SCI USA, V110, P4251, DOI 10.1073/pnas.1215678110; Romigi A, 2010, EPILEPSIA, V51, P768, DOI 10.1111/j.1528-1167.2009.02334.x; Schoedel KA, 2011, HUM PSYCHOPHARM CLIN, V26, P224, DOI 10.1002/hup.1196; SCHULTES RE, 1973, NAT HIST, V82, P59; Stout SM, 2014, DRUG METAB REV, V46, P86, DOI 10.3109/03602532.2013.849268; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; Tofighi B, 2012, J ADDICT MED, V6, P240, DOI 10.1097/ADM.0b013e3182619004; Trembly B, 1990, MAR 90 INT C CANN C; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140; Weimer K, 2013, PEDIATR RES, V74, P96, DOI 10.1038/pr.2013.66; Whalley BJ., 2013, ENDOCANNABINOIDS MOL, P164; Zajicek JP, 2005, J NEUROL NEUROSUR PS, V76, P1664, DOI 10.1136/jnnp.2005.070136	76	171	179	1	126	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1048	1058		10.1056/NEJMra1407304	http://dx.doi.org/10.1056/NEJMra1407304			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352816				2022-12-28	WOS:000360959000010
J	Miligkos, M; Bannuru, RR; Alkofide, H; Kher, SR; Schmid, CH; Balk, EM				Miligkos, Michael; Bannuru, Raveendhara R.; Alkofide, Hadeel; Kher, Sucharita R.; Schmid, Christopher H.; Balk, Ethan M.			Leukotriene-Receptor Antagonists Versus Placebo in the Treatment of Asthma in Adults and Adolescents A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; EOSINOPHILIC CATIONIC PROTEIN; TO-MODERATE ASTHMA; ADD-ON THERAPY; INHALED CORTICOSTEROIDS; ORAL MONTELUKAST; BRONCHIAL HYPERRESPONSIVENESS; ALLERGIC RHINITIS; LUNG-FUNCTION	Background: Leukotriene-receptor antagonists (LTRAs) are recommended as an alternative treatment in patients with mild asthma, but their effect compared with placebo is unclear. Purpose: To determine the benefits and harms of LTRAs as monotherapy or in combination with inhaled corticosteroids compared with placebo in adults and adolescents with asthma. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials from inception through June 2015. Study Selection: Peer-reviewed, English-language, randomized, controlled trials in patients with asthma that reported the effect of LTRAs versus placebo on measures of asthma control. Data Extraction: Three researchers extracted data on study population, interventions, outcome measures, and adverse events. One researcher assessed risk of bias. Data Synthesis: Of the 2008 abstracts that were screened, 50 trials met eligibility criteria. Random-effects meta-analyses of 6 trials of LTRA monotherapy showed that LTRAs reduced the risk for an exacerbation (summary risk ratio [RR], 0.60 [95% CI, 0.44 to 0.81]). In 4 trials of LTRAs as add-on therapy to inhaled corticosteroids, the summary RR for exacerbation was 0.80 (CI, 0.60 to 1.07). Leukotriene-receptor antagonists either as monotherapy or as add-on therapy to inhaled corticosteroids increased FEV1, whereas FEV1 percentage of predicted values was improved only in trials of LTRA monotherapy. Adverse event rates were similar in the intervention and comparator groups. Limitation: Variation in definitions and reporting of outcomes, high risk of bias in some studies, heterogeneity of findings, possible selective outcome reporting bias, and inability to assess the effect of asthma severity on summary estimates. Conclusion: Leukotriene-receptor antagonists as monotherapy improved asthma control compared with placebo, but which patients are most likely to respond to treatment with LTRAs remains unclear. Primary Funding Source: National Institutes of Health.	[Miligkos, Michael] Univ Thessaly, Sch Med, Lab Biomath, Larisa 41222, Greece; [Bannuru, Raveendhara R.] Tufts Med Ctr, CTCIA, Boston, MA 02111 USA; [Alkofide, Hadeel] Tufts Univ, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Kher, Sucharita R.] Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA; [Schmid, Christopher H.; Balk, Ethan M.] Brown Univ, Ctr Evidence Based Med, Sch Publ Hlth, Providence, RI 02912 USA	University of Thessaly; Tufts Medical Center; Tufts University; Brown University	Miligkos, M (corresponding author), Univ Thessaly, Sch Med, Lab Biomath, 22 Papakyriazi St, Larisa 41222, Greece.	mmiligkos@med.uth.gr	Balk, Ethan/AAJ-2547-2020; Kher, Sucharita/AAV-7566-2020; Bannuru, Raveendhara/G-2601-2011; Schmid, Christopher H./J-2398-2014	Kher, Sucharita/0000-0002-3051-6441; Bannuru, Raveendhara/0000-0002-8069-5783; Schmid, Christopher H./0000-0002-0855-5313; Miligkos, Michael/0000-0001-8021-2780	National Institutes of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS021396] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000073, UL1TR001064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Altman LC, 1998, J ALLERGY CLIN IMMUN, V102, P50, DOI 10.1016/S0091-6749(98)70054-5; Asthma and Allergy Foundation of America, COST OF ASTHMA; Awad N, 2002, INDIAN PRACT, V55, P303; Baena-Cagnani CE, 2003, INT ARCH ALLERGY IMM, V130, P307, DOI 10.1159/000070218; Balk EM., 2012, METHODS RES REPORTS, V12, pEHC141; Barnes NC, 1997, THORAX, V52, P523, DOI 10.1136/thx.52.6.523; Baumgartner RA, 2003, EUR RESPIR J, V21, P123, DOI 10.1183/09031936.03.00028803; Busse W, 2001, J FAM PRACTICE, V50, P595; Cakmak G, 2004, TOHOKU J EXP MED, V204, P249, DOI 10.1620/tjem.204.249; Hulett AC, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-20; Currie GP, 2002, CHEST, V122, P146, DOI 10.1378/chest.122.1.146; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Ducharme FM, 2002, BMJ-BRIT MED J, V324, P1545, DOI 10.1136/bmj.324.7353.1545; Fish JE, 1997, CLIN THER, V19, P675, DOI 10.1016/S0149-2918(97)80092-6; Gao JM, 2013, CHINESE MED J-PEKING, V126, P2229, DOI 10.3760/cma.j.issn.0366-6999.20121888; Green RH, 2006, EUR RESPIR J, V27, P1144, DOI 10.1183/09031936.06.00102605; HANANIA NA, 1995, AM J MED, V98, P196, DOI 10.1016/S0002-9343(99)80404-5; Helenius I, 2004, ALLERGY, V59, P39, DOI 10.1046/j.1398-9995.2003.00353.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Chung-Jen, 2003, Chang Gung Med J, V26, P554; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-15; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; Israel E, 2002, J ALLERGY CLIN IMMUN, V110, P847, DOI 10.1067/mai.2002.129413; Jayaram L, 2005, EUR RESPIR J, V25, P41, DOI 10.1183/09031936.04.00008104; Jayaram L, 2005, THORAX, V60, P100, DOI 10.1136/thx.2004.021634; Joos S, 2008, THORAX, V63, P453, DOI 10.1136/thx.2007.081596; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kanazawa H, 2004, CHEST, V125, P1700, DOI 10.1378/chest.125.5.1700; Kanniess F, 2002, EUR RESPIR J, V20, P1080, DOI 10.1183/09031936.02.00304202; Kraft M, 2006, CHEST, V130, P1726, DOI 10.1378/chest.130.6.1726; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Lofdahl CG, 1999, BMJ-BRIT MED J, V319, P87, DOI 10.1136/bmj.319.7202.87; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Minoguchi K, 2002, CHEST, V121, P732, DOI 10.1378/chest.121.3.732; Murphy S, 2007, NIH PUBLICATION; Nakamura Y, 1998, THORAX, V53, P835, DOI 10.1136/thx.53.10.835; Nathan RA, 2005, CHEST, V128, P1910, DOI 10.1378/chest.128.4.1910; Nathan RA, 1998, J ALLERGY CLIN IMMUN, V102, P935, DOI 10.1016/S0091-6749(98)70331-8; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P497, DOI 10.1016/S1081-1206(10)62728-7; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Orwin R.G., 1994, HDB RES SYNTHESIS; Philip G, 2004, CURR MED RES OPIN, V20, P1549, DOI 10.1185/030079904X3348; Pizzichini E, 1999, EUR RESPIR J, V14, P12, DOI 10.1034/j.1399-3003.1999.14a04.x; Price D, 2013, J ALLERGY CLIN IMMUN, V131, P763, DOI 10.1016/j.jaci.2012.12.673; Raudenbush SW., 1985, J EDUC STATIST, V10, P75, DOI DOI 10.3102/10769986010002075; Reid DW, 2008, J NEGAT RESULTS BIOM, V7, DOI 10.1186/1477-5751-7-3; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; Schaper C, 2011, J INVEST ALLERG CLIN, V21, P51; Spahn JD, 2006, ANN ALLERG ASTHMA IM, V96, P541, DOI 10.1016/S1081-1206(10)63548-X; Spector SL, 2004, ANN ALLERG ASTHMA IM, V93, P232, DOI 10.1016/S1081-1206(10)61493-7; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618, DOI 10.1164/ajrccm.150.3.8087328; Stelmach I, 2002, CLIN EXP ALLERGY, V32, P264, DOI 10.1046/j.1365-2222.2002.01286.x; Stelmach I, 2002, J ALLERGY CLIN IMMUN, V109, P257, DOI 10.1067/mai.2002.121456; Stelmach I, 2007, PULM PHARMACOL THER, V20, P691, DOI 10.1016/j.pupt.2006.08.003; Storms W, 2004, RESP MED, V98, P1051, DOI 10.1016/j.rmed.2004.05.008; Storms W, 2001, CLIN EXP ALLERGY, V31, P77, DOI 10.1046/j.1365-2222.2001.00969.x; Strunk RC, 2008, J ALLERGY CLIN IMMUN, V122, P1138, DOI 10.1016/j.jaci.2008.09.028; Tohda Y, 2002, CLIN EXP ALLERGY, V32, P1180, DOI 10.1046/j.1365-2745.2002.01440.x; Ulrik CS, 2009, ALLERGY ASTHMA PROC, V30, P64, DOI 10.2500/aap.2009.30.3196; Vaquerizo MJ, 2003, THORAX, V58, P204, DOI 10.1136/thorax.58.3.204; Wallace B.C., 2012, P ACM INT HLTH INF S, P819, DOI DOI 10.1145/2110363.2110464; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041; Yoo S H, 2001, Respirology, V6, P15; Yoshida S, 2000, CLIN EXP ALLERGY, V30, P1008; Zeidler MR, 2006, EUR RESPIR J, V27, P307, DOI 10.1183/09031936.06.00005605	72	27	30	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					756	U245		10.7326/M15-1059	http://dx.doi.org/10.7326/M15-1059			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26390230	Green Accepted			2022-12-28	WOS:000365746400018
J	McGlynn, SE; Chadwick, GL; Kempes, CP; Orphan, VJ				McGlynn, Shawn E.; Chadwick, Grayson L.; Kempes, Christopher P.; Orphan, Victoria J.			Single cell activity reveals direct electron transfer in methanotrophic consortia	NATURE			English	Article							SULFATE-REDUCING BACTERIA; ANAEROBIC OXIDATION; METHANE OXIDATION; SPATIAL STRUCTURE; ANME-2 ARCHAEA; MODEL; REDUCTION; SEDIMENT	Multicellular assemblages of microorganisms are ubiquitous in nature, and the proximity afforded by aggregation is thought to permit intercellular metabolic coupling that can accommodate otherwise unfavourable reactions. Consortia of methane-oxidizing archaea and sulphate-reducing bacteria are a well-known environmental example of microbial co-aggregation; however, the coupling mechanisms between these paired organisms is not well understood, despite the attention given them because of the global significance of anaerobic methane oxidation. Here we examined the influence of interspecies spatial positioning as it relates to biosynthetic activity within structurally diverse uncultured methane-oxidizing consortia by measuring stable isotope incorporation for individual archaeal and bacterial cells to constrain their potential metabolic interactions. In contrast to conventional models of syntrophy based on the passage of molecular intermediates, cellular activities were found to be independent of both species intermixing and distance between syntrophic partners within consortia. A generalized model of electric conductivity between co-associated archaea and bacteria best fit the empirical data. Combined with the detection of large multi-haem cytochromes in the genomes of methanotrophic archaea and the demonstration of redox-dependent staining of the matrix between cells in consortia, these results provide evidence for syntrophic coupling through direct electron transfer.	[McGlynn, Shawn E.; Chadwick, Grayson L.; Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Kempes, Christopher P.] NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA; [Kempes, Christopher P.] CALTECH, Control & Dynam Syst, Pasadena, CA 91125 USA; [Kempes, Christopher P.] SETI Inst, Mountain View, CA 94034 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology	Orphan, VJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	vorphan@gps.caltech.edu	Orphan, Victoria/AAS-5989-2020; McGlynn, Shawn/Y-5831-2019; Chadwick, Grayson/AAE-1585-2019	Orphan, Victoria/0000-0002-5374-6178; McGlynn, Shawn/0000-0002-8199-7011; Chadwick, Grayson/0000-0003-0700-9350	US Department of Energy, Office of Science, Office of Biological Environmental Research [DE-SC0004949, DE-SC0010574]; Gordon and Betty Moore foundation Marine Microbiology Initiative [3780]; DOE-BER [DE-SC0003940]; Agouron Geobiology Option post-doctoral fellowship in the Division of Geological and Planetary Sciences at Caltech; NASA Astrobiology Institute [NNA13AA92A]	US Department of Energy, Office of Science, Office of Biological Environmental Research(United States Department of Energy (DOE)); Gordon and Betty Moore foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); DOE-BER(United States Department of Energy (DOE)); Agouron Geobiology Option post-doctoral fellowship in the Division of Geological and Planetary Sciences at Caltech; NASA Astrobiology Institute	We are grateful for the use of the facilities of the Beckman Resource Center for Transmission Electron Microscopy at Caltech (BRCem) and advice provided by A. McDowall, our collaborators T. Deerinck and M. Ellisman from the National Center for Microscopy and Imaging Research (NCMIR), C. Miele (UGA) and M. El-Naggar at USC. Metagenomic binning of ANME-2b was conducted by C. Skennerton and M. Haroonin collaboration with G. Tyson and M. Imelfort (University of Queensland). This work was supported by the US Department of Energy, Office of Science, Office of Biological Environmental Research under award numbers (DE-SC0004949 and DE-SC0010574) and a grant from the Gordon and Betty Moore foundation Marine Microbiology Initiative (grant number 3780). V.J.O. is supported by a DOE-BER early career grant (DE-SC0003940). S.E.M. acknowledges support from an Agouron Geobiology Option post-doctoral fellowship in the Division of Geological and Planetary Sciences at Caltech and C.P.K. was supported by the NASA Astrobiology Institute (award number NNA13AA92A). This is NAI-Life Underground Publication 049.	Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; DOLFING J, 1992, FEMS MICROBIOL ECOL, V101, P183, DOI 10.1016/0168-6496(92)90034-Q; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Kempes CP, 2014, P NATL ACAD SCI USA, V111, P208, DOI 10.1073/pnas.1315521110; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kletzin A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00439; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Krueger M, 2008, FEMS MICROBIOL ECOL, V63, P401, DOI 10.1111/j.1574-6941.2007.00431.x; LITWIN JA, 1982, ACTA HISTOCHEM, V71, P111, DOI 10.1016/S0065-1281(82)80023-8; Lovley DR, 2012, ANNU REV MICROBIOL, V66, P391, DOI 10.1146/annurev-micro-092611-150104; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Meysman FJR, 2015, GEOCHIM COSMOCHIM AC, V152, P122, DOI 10.1016/j.gca.2014.12.014; Michelusi N, 2014, IEEE J SEL AREA COMM, V32, P2402, DOI 10.1109/JSAC.2014.2367666; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00230; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nielsen AT, 2000, ENVIRON MICROBIOL, V2, P59, DOI 10.1046/j.1462-2920.2000.00084.x; Okamoto A, 2012, BIOELECTROCHEMISTRY, V85, P61, DOI 10.1016/j.bioelechem.2011.12.003; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2009, ENVIRON MICROBIOL, V11, P1777, DOI 10.1111/j.1462-2920.2009.01903.x; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Richardson DJ, 2012, MOL MICROBIOL, V85, P201, DOI 10.1111/j.1365-2958.2012.08088.x; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rotaru AE, 2014, APPL ENVIRON MICROB, V80, P4599, DOI 10.1128/AEM.00895-14; Schink B., 2013, PROKARYOTES PROKARYO, P471, DOI DOI 10.1007/978-3-642-30123-0_59; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Wang FP, 2014, ISME J, V8, P1069, DOI 10.1038/ismej.2013.212; Welte C, 2014, BBA-BIOENERGETICS, V1837, P1130, DOI 10.1016/j.bbabio.2013.12.002; Wessel AK, 2013, NAT REV MICROBIOL, V11, P337, DOI 10.1038/nrmicro3010; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210	41	358	381	25	541	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					531	U146		10.1038/nature15512	http://dx.doi.org/10.1038/nature15512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26375009				2022-12-28	WOS:000364026100041
J	Bhatt, S; Weiss, DJ; Cameron, E; Bisanzio, D; Mappin, B; Dalrymple, U; Battle, KE; Moyes, CL; Henry, A; Eckhoff, PA; Wenger, EA; Briet, O; Penny, MA; Smith, TA; Bennett, A; Yukich, J; Eisele, TP; Griffin, JT; Fergus, CA; Lynch, M; Lindgren, F; Cohen, JM; Murray, CLJ; Smith, DL; Hay, SI; Cibulskis, RE; Gething, PW				Bhatt, S.; Weiss, D. J.; Cameron, E.; Bisanzio, D.; Mappin, B.; Dalrymple, U.; Battle, K. E.; Moyes, C. L.; Henry, A.; Eckhoff, P. A.; Wenger, E. A.; Briet, O.; Penny, M. A.; Smith, T. A.; Bennett, A.; Yukich, J.; Eisele, T. P.; Griffin, J. T.; Fergus, C. A.; Lynch, M.; Lindgren, F.; Cohen, J. M.; Murray, C. L. J.; Smith, D. L.; Hay, S. I.; Cibulskis, R. E.; Gething, P. W.			The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015	NATURE			English	Article							IMPACT; ENDEMICITY; INFECTION; DISEASE; BURDEN; RISK	Since the year 2000, a concerted campaign against malaria has led to unprecedented levels of intervention coverage across sub-Saharan Africa. Understanding the effect of this control effort is vital to inform future control planning. However, the effect of malaria interventions across the varied epidemiological settings of Africa remains poorly understood owing to the absence of reliable surveillance data and the simplistic approaches underlying current disease estimates. Here we link a large database of malaria field surveys with detailed reconstructions of changing intervention coverage to directly evaluate trends from 2000 to 2015, and quantify the attributable effect of malaria disease control efforts. We found that Plasmodium falciparum infection prevalence in endemic Africa halved and the incidence of clinical disease fell by 40% between 2000 and 2015. We estimate that interventions have averted 663 (542753 credible interval) million clinical cases since 2000. Insecticide-treated nets, the most widespread intervention, were by far the largest contributor (68% of cases averted). Although still below target levels, current malaria interventions have substantially reduced malaria disease incidence across the continent. Increasing access to these interventions, and maintaining their effectiveness in the face of insecticide and drug resistance, should form a cornerstone of post-2015 control strategies.	[Bhatt, S.; Weiss, D. J.; Cameron, E.; Bisanzio, D.; Mappin, B.; Dalrymple, U.; Battle, K. E.; Moyes, C. L.; Henry, A.; Smith, D. L.; Gething, P. W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Eckhoff, P. A.; Wenger, E. A.] Intellectual Ventures, Inst Dis Modeling, Bellevue, WA 98005 USA; [Briet, O.; Penny, M. A.; Smith, T. A.] Swiss Trop & Publ Hlth Inst, Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Briet, O.; Penny, M. A.; Smith, T. A.] Univ Basel, CH-4001 Basel, Switzerland; [Bennett, A.] Univ Calif San Francisco, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Yukich, J.; Eisele, T. P.] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, New Orleans, LA 70112 USA; [Cohen, J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Fergus, C. A.; Lynch, M.; Cibulskis, R. E.] WHO, Global Malaria Programme, CH-1211 Geneva 27, Switzerland; [Lindgren, F.] Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England; [Cohen, J. M.] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Murray, C. L. J.; Smith, D. L.; Hay, S. I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Smith, D. L.] Sanaria Inst Global Hlth & Trop Med, Rockville, MD 20850 USA; [Smith, D. L.; Hay, S. I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Hay, S. I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Intellectual Ventures; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of California System; University of California San Francisco; Tulane University; Imperial College London; World Health Organization; University of Bath; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; Wellcome Centre for Human Genetics	Gething, PW (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.	peter.gething@zoo.ox.ac.uk	Eisele, Thom/AAE-8958-2020; Penny, Melissa A/N-6838-2015; Hay, Simon Iain/F-8967-2015; Smith, David L/L-8850-2013; Bhatt, Samir/ABE-7938-2020; Smith, Thomas/B-5569-2015; Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022; Smith, David/GQQ-8257-2022; Briet, Olivier/K-1917-2015	Penny, Melissa A/0000-0002-4972-593X; Hay, Simon Iain/0000-0002-0611-7272; Smith, David L/0000-0003-4367-3849; Smith, Thomas/0000-0002-3650-9381; Gething, Peter/0000-0001-6759-5449; Battle, Katherine/0000-0003-2401-2615; /0000-0002-6175-5648; Cohen, Justin/0000-0003-4481-6784; Lindgren, Finn/0000-0002-5833-2011; Bhatt, Samir/0000-0002-0891-4611; Moyes, Catherine/0000-0002-8028-4079; Fergus, Cristin Alexis/0000-0002-7819-2087; Cameron, Ewan/0000-0002-8842-3811; Briet, Olivier/0000-0003-1186-2688; Mappin, Bonnie/0000-0002-1205-719X	UK Medical Research Council (MRC) [K00669X]; UK Department for International Development (DFID) MRC/DFID [K00669X]; Bill and Melinda Gates Foundation (BMGF) [OPP1068048, OPP1106023]; BMGF [OPP1106023, OPP1032350, OPP1110495, OPP1119467, OPP1093011]; Wellcome Trust [095066]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; MRC Fellowship [G1002284]; Global Good Fund; Medical Research Council [MR/K00669X/1, G1002284, MR/K010174/1B] Funding Source: researchfish; MRC [G1002284, MR/K00669X/1] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); BMGF; Wellcome Trust(Wellcome TrustEuropean Commission); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Global Good Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge assistance from M. Renshaw in providing information from the Roll Back Malaria Harmonization Working Group Programmatic Gap Analysis and other guidance in the interpretation of our results. We thank members of the Roll Back Malaria Monitoring and Evaluation Reference Group and the World Health Organization Surveillance Monitoring and Evaluation Technical expert Group for their feedback and suggestions. We thank C. Burgert of the DHS (Demographic and Health Surveys) Program for her assistance with DHS Survey access and interpretation. P.W.G. is a Career Development Fellow(no. K00669X) jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and receives support from the Bill and Melinda Gates Foundation (BMGF; nos OPP1068048, OPP1106023). These grants also support E.C., S.B., B.M., U.D., D.J.W., D.B. and A.H. The Swiss TPH component was supported through the project no. OPP1032350 funded by the BMGF. D.L.S. is funded by the BMGF (OPP1110495). S.I.H. is funded by a Senior Research Fellowship from the Wellcome Trust (no. 095066), which also supports K.E.B., and grants from the BMGF (nos. OPP1119467, OPP1106023 and OPP1093011). S.I.H. and D.L.S. also acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. J.T.G. is funded by an MRC Fellowship (no. G1002284). E.A.W. and P.A.E. are funded by the Global Good Fund.	Battle KE, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.12; Cameron E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9170; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Giardina F, 2014, LANCET GLOB HEALTH, V2, pE601, DOI 10.1016/S2214-109X(14)70300-6; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Lengeler C, 2004, COCHRANE DATABASE SY; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; Roll Back Malaria Partnership Secretariat, 2015, ACT INV DEF MAL 2016; Roll Back Malaria Partnership/World Health Organization, 2008, GLOB MAL ACT PLAN 1; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001157; Weiss DJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0574-x; Wenger EA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-126; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, GLOB TECHN STRAT MAL; WorldPop, 2015, GRIDD POP DISTR	26	1431	1442	10	224	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					207	+		10.1038/nature15535	http://dx.doi.org/10.1038/nature15535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26375008	Green Submitted, Green Accepted			2022-12-28	WOS:000362399000037
J	Zheng, HF; Forgetta, V; Hsu, YH; Estrada, K; Rosello-Diez, A; Leo, PJ; Dahia, CL; Park-Min, KH; Tobias, JH; Kooperberg, C; Kleinman, A; Styrkarsdottir, U; Liu, CT; Uggla, C; Evans, DS; Nielson, CM; Walter, K; Pettersson-Kymmer, U; McCarthy, S; Eriksson, J; Kwan, T; Jhamai, M; Trajanoska, K; Memari, Y; Min, J; Huang, J; Danecek, P; Wilmot, B; Li, R; Chou, WC; Mokry, LE; Moayyeri, A; Claussnitzer, M; Cheng, CH; Cheung, W; Medina-Gomez, C; Ge, B; Chen, SH; Choi, K; Oei, L; Fraser, J; Kraaij, R; Hibbs, MA; Gregson, CL; Paquette, D; Hofman, A; Wibom, C; Tranah, GJ; Marshall, M; Gardiner, BB; Cremin, K; Auer, P; Hsu, L; Ring, S; Tung, JY; Thorleifsson, G; Enneman, AW; van Schoor, NM; de Groot, LCPGM; van der Velde, N; Melin, B; Kemp, JP; Christiansen, C; Sayers, A; Zhou, YH; Calderari, S; van Rooij, J; Carlson, C; Peters, U; Berlivet, S; Dostie, J; Uitterlinden, AG; Williams, SR; Farber, C; Grinberg, D; LaCroix, AZ; Haessler, J; Chasman, DI; Giulianini, F; Rose, LM; Ridker, PM; Eisman, JA; Nguyen, TV; Center, JR; Nogues, X; Garcia-Giralt, N; Launer, LL; Gudnason, V; Mellstrom, D; Vandenput, L; Amin, N; van Duijn, CM; Karlsson, MK; Ljunggren, O; Svensson, O; Hallmans, G; Rousseau, F; Giroux, S; Bussiere, J; Arp, PP; Koromani, F; Prince, RL; Lewis, JR; Langdahl, BL; Hermann, AP; Jensen, JEB; Kaptoge, S; Khaw, KT; Reeve, J; Formosa, MM; Xuereb-Anastasi, A; Akesson, K; McGuigan, FE; Garg, G; Olmos, JM; Zarrabeitia, MT; Riancho, JA; Ralston, SH; Alonso, N; Jiang, X; Goltzman, D; Pastinen, T; Grundberg, E; Gauguier, D; Orwoll, ES; Karasik, D; Davey-Smith, G; Smith, AV; Siggeirsdottir, K; Harris, TB; Zillikens, MC; van Meurs, JBJ; Thorsteinsdottir, U; Maurano, MT; Timpson, NJ; Soranzo, N; Durbin, R; Wilson, S; Ntzani, EE; Brown, MA; Stefansson, K; Hinds, DA; Spector, T; Cupples, LA; Ohlsson, C; Greenwood, CMT; Jackson, RD; Rowe, DW; Loomis, CA; Evans, DM; Ackert-Bicknell, CL; Joyner, AL; Duncan, EL; Kiel, DP; Rivadeneira, F; Richards, JB				Zheng, Hou-Feng; Forgetta, Vincenzo; Hsu, Yi-Hsiang; Estrada, Karol; Rosello-Diez, Alberto; Leo, Paul J.; Dahia, Chitra L.; Park-Min, Kyung Hyun; Tobias, Jonathan H.; Kooperberg, Charles; Kleinman, Aaron; Styrkarsdottir, Unnur; Liu, Ching-Ti; Uggla, Charlotta; Evans, Daniel S.; Nielson, Carrie M.; Walter, Klaudia; Pettersson-Kymmer, Ulrika; McCarthy, Shane; Eriksson, Joel; Kwan, Tony; Jhamai, Mila; Trajanoska, Katerina; Memari, Yasin; Min, Josine; Huang, Jie; Danecek, Petr; Wilmot, Beth; Li, Rui; Chou, Wen-Chi; Mokry, Lauren E.; Moayyeri, Alireza; Claussnitzer, Melina; Cheng, Chia-Ho; Cheung, Warren; Medina-Gomez, Carolina; Ge, Bing; Chen, Shu-Huang; Choi, Kwangbom; Oei, Ling; Fraser, James; Kraaij, Robert; Hibbs, Matthew A.; Gregson, Celia L.; Paquette, Denis; Hofman, Albert; Wibom, Carl; Tranah, Gregory J.; Marshall, Mhairi; Gardiner, Brooke B.; Cremin, Katie; Auer, Paul; Hsu, Li; Ring, Sue; Tung, Joyce Y.; Thorleifsson, Gudmar; Enneman, Anke W.; van Schoor, Natasja M.; de Groot, Lisette C. P. G. M.; van der Velde, Nathalie; Melin, Beatrice; Kemp, John P.; Christiansen, Claus; Sayers, Adrian; Zhou, Yanhua; Calderari, Sophie; van Rooij, Jeroen; Carlson, Chris; Peters, Ulrike; Berlivet, Soizik; Dostie, Josee; Uitterlinden, Andre G.; Williams, Stephen R.; Farber, Charles; Grinberg, Daniel; LaCroix, Andrea Z.; Haessler, Jeff; Chasman, Daniel I.; Giulianini, Franco; Rose, Lynda M.; Ridker, Paul M.; Eisman, John A.; Nguyen, Tuan V.; Center, Jacqueline R.; Nogues, Xavier; Garcia-Giralt, Natalia; Launer, Lenore L.; Gudnason, Vilmunder; Mellstrom, Dan; Vandenput, Liesbeth; Amin, Najaf; van Duijn, Cornelia M.; Karlsson, Magnus K.; Ljunggren, Osten; Svensson, Olle; Hallmans, Goran; Rousseau, Francois; Giroux, Sylvie; Bussiere, Johanne; Arp, Pascal P.; Koromani, Fjorda; Prince, Richard L.; Lewis, Joshua R.; Langdahl, Bente L.; Hermann, A. Pernille; Jensen, Jens-Erik B.; Kaptoge, Stephen; Khaw, Kay-Tee; Reeve, Jonathan; Formosa, Melissa M.; Xuereb-Anastasi, Angela; Akesson, Kristina; McGuigan, Fiona E.; Garg, Gaurav; Olmos, Jose M.; Zarrabeitia, Maria T.; Riancho, Jose A.; Ralston, Stuart H.; Alonso, Nerea; Jiang, Xi; Goltzman, David; Pastinen, Tomi; Grundberg, Elin; Gauguier, Dominique; Orwoll, Eric S.; Karasik, David; Davey-Smith, George; Smith, Albert V.; Siggeirsdottir, Kristin; Harris, Tamara B.; Zillikens, M. Carola; van Meurs, Joyce B. J.; Thorsteinsdottir, Unnur; Maurano, Matthew T.; Timpson, Nicholas J.; Soranzo, Nicole; Durbin, Richard; Wilson, ScottG.; Ntzani, Evangelia E.; Brown, Matthew A.; Stefansson, Kari; Hinds, David A.; Spector, Tim; Cupples, L. Adrienne; Ohlsson, Claes; Greenwood, Celia M. T.; Jackson, Rebecca D.; Rowe, David W.; Loomis, Cynthia A.; Evans, David M.; Ackert-Bicknell, Cheryl L.; Joyner, Alexandra L.; Duncan, Emma L.; Kiel, Douglas P.; Rivadeneira, Fernando; Richards, J. Brent		AOGC Consortium; UK10K Consortium	Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture	NATURE			English	Article							WIDE ASSOCIATION LOCI; MINERAL DENSITY; HUMAN-DISEASES; VARIANTS; ENGRAILED-1; OSTEOPOROSIS; GENE	The extent to which low-frequency (minor allele frequency (MAF) between 1-5%) and rare (MAF <= 1%) variants contribute to complex traits and disease in the general population is mainly unknown. Bone mineral density (BMD) is highly heritable, a major predictor of osteoporotic fractures, and has been previously associated with common genetic variants(1-8), as well as rare, population specific, coding variants(9). Here we identify novel non-coding genetic variants with large effects on BMD (n(total) = 53,236) and fracture (n(total) = 508,253) in individuals of European ancestry from the general population. Associations for BMD were derived from whole-genome sequencing (n = 2,882 from UK10K (ref. 10); a population-based genome sequencing consortium), whole-exome sequencing (n = 3,549), deep imputation of genotyped samples using a combined UK10K/1000 Genomes reference panel (n = 26,534), and de novo replication genotyping (n = 20,271). We identified a low-frequency non-coding variant near a novel locus, EN1, with an effect size fourfold larger than the mean of previously reported common variants for lumbar spine BMD8 (rs11692564(T), MAF51.6%, replication effect size510.20 s.d., P-meta = 2 x 10(-14)), which was also associated with a decreased risk of fracture (odds ratio = 0.85; P = 2 x 10(-11); ncases = 98,742 and ncontrols = 409,511). Using an En1cre/flox mouse model, we observed that conditional loss of En1 results in low bone mass, probably as a consequence of high bone turnover. We also identified a novel low frequency non-coding variant with large effects on BMD near WNT16 (rs148771817(T), MAF = 1.2%, replication effect size +10.41 s.d., P-meta = 1 x 10(-11)). In general, there was an excess of association signals arising from deleterious coding and conserved non-coding variants. These findings provide evidence that low-frequency non-coding variants have large effects on BMD and fracture, thereby providing rationale for whole-genome sequencing and improved imputation reference panels to study the genetic architecture of complex traits and disease in the general population.	[Zheng, Hou-Feng; Forgetta, Vincenzo; Li, Rui; Richards, J. Brent] McGill Univ, Dept Med, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Forgetta, Vincenzo; Li, Rui; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Forgetta, Vincenzo; Li, Rui; Richards, J. Brent] McGill Univ, Dept Epidemiol, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Forgetta, Vincenzo; Li, Rui; Richards, J. Brent] McGill Univ, Dept Biostat, Montreal, PQ H3A 1A2, Canada; [Zheng, Hou-Feng; Forgetta, Vincenzo; Li, Rui; Mokry, Lauren E.; Greenwood, Celia M. T.; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada; [Hsu, Yi-Hsiang; Chou, Wen-Chi; Claussnitzer, Melina; Cheng, Chia-Ho; Karasik, David; Kiel, Douglas P.] Hebrew SeniorLife, Inst Aging Res, Boston, MA 02131 USA; [Hsu, Yi-Hsiang; Estrada, Karol; Chou, Wen-Chi; Claussnitzer, Melina; Chasman, Daniel I.; Ridker, Paul M.; Kiel, Douglas P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hsu, Yi-Hsiang; Estrada, Karol; Claussnitzer, Melina; Kiel, Douglas P.] Broad Inst MIT & Harvard, Boston, MA 02115 USA; [Estrada, Karol; Jhamai, Mila; Trajanoska, Katerina; Medina-Gomez, Carolina; Oei, Ling; Kraaij, Robert; Enneman, Anke W.; van der Velde, Nathalie; van Rooij, Jeroen; Uitterlinden, Andre G.; Arp, Pascal P.; Koromani, Fjorda; Zillikens, M. Carola; van Meurs, Joyce B. J.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Estrada, Karol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Rosello-Diez, Alberto; Joyner, Alexandra L.] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Leo, Paul J.; Marshall, Mhairi; Gardiner, Brooke B.; Cremin, Katie; Kemp, John P.; Brown, Matthew A.; Evans, David M.; Duncan, Emma L.] Univ Queensland, Diamantina Inst, Translat Res Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Dahia, Chitra L.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Dahia, Chitra L.] Hosp Special Surg, Tissue Engn Regenerat & Repair Program, New York, NY 10021 USA; [Park-Min, Kyung Hyun] Hosp Special Surg, Rheumatol Div, New York, NY 10021 USA; [Tobias, Jonathan H.] Univ Bristol, Sch Clin Sci, Bristol BS10 5NB, Avon, England; [Tobias, Jonathan H.; Min, Josine; Kemp, John P.; Davey-Smith, George; Timpson, Nicholas J.; Evans, David M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Kooperberg, Charles; Hsu, Li; Carlson, Chris; Peters, Ulrike; Haessler, Jeff] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Kleinman, Aaron; Tung, Joyce Y.; Hinds, David A.] 23andMe, Res Dept, Mountain View, CA 94041 USA; [Styrkarsdottir, Unnur; Thorsteinsdottir, Unnur] deCODE Genet, Dept Populat Genom, IS-101 Reykjavik, Iceland; [Liu, Ching-Ti; Zhou, Yanhua; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Uggla, Charlotta; Eriksson, Joel; Mellstrom, Dan; Vandenput, Liesbeth; Ohlsson, Claes] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [Evans, Daniel S.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94158 USA; [Nielson, Carrie M.; Tranah, Gregory J.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Nielson, Carrie M.; Tranah, Gregory J.; Orwoll, Eric S.] Oregon Hlth & Sci Univ, Bone Mineral Unit, Portland, OR 97239 USA; [Walter, Klaudia; McCarthy, Shane; Memari, Yasin; Huang, Jie; Danecek, Petr; Soranzo, Nicole; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Pettersson-Kymmer, Ulrika] Umea Univ, Dept Pharmacol, S-90187 Umea, Sweden; [Pettersson-Kymmer, Ulrika] Umea Univ, Dept Clin Neurosci, S-90187 Umea, Sweden; [Pettersson-Kymmer, Ulrika; Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, SE-90187 Umea, Sweden; [Eriksson, Joel] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, S-41345 Gothenburg, Sweden; [Kwan, Tony; Cheung, Warren; Ge, Bing; Chen, Shu-Huang; Pastinen, Tomi; Grundberg, Elin] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Kwan, Tony; Cheung, Warren; Ge, Bing; Chen, Shu-Huang; Pastinen, Tomi; Grundberg, Elin] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Trajanoska, Katerina; Medina-Gomez, Carolina; Oei, Ling; Kraaij, Robert; Hofman, Albert; Uitterlinden, Andre G.; Koromani, Fjorda; van Meurs, Joyce B. J.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Wilmot, Beth] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97239 USA; [Wilmot, Beth] Oregon Hlth & Sci Univ, Dept Med & Clin Informat, Portland, OR 97239 USA; [Moayyeri, Alireza; Kaptoge, Stephen] UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England; [Moayyeri, Alireza; Wilson, ScottG.; Spector, Tim; Richards, J. Brent] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Claussnitzer, Melina; Kiel, Douglas P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Cheung, Warren; Pastinen, Tomi; Grundberg, Elin; Greenwood, Celia M. T.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Medina-Gomez, Carolina; Oei, Ling; Kraaij, Robert; Hofman, Albert; van Rooij, Jeroen; Uitterlinden, Andre G.; Rivadeneira, Fernando] NCHA, NGI, NL-2300 RC Leiden, Netherlands; [Choi, Kwangbom; Hibbs, Matthew A.; Ackert-Bicknell, Cheryl L.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Fraser, James; Paquette, Denis; Berlivet, Soizik; Dostie, Josee] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Fraser, James; Paquette, Denis; Berlivet, Soizik; Dostie, Josee] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Hibbs, Matthew A.] Trinity Univ, Dept Comp Sci, San Antonio, TX 78212 USA; [Gregson, Celia L.; Sayers, Adrian] Univ Bristol, Musculoskeletal Res Unit, Bristol BS10 5NB, Avon, England; [Wibom, Carl; Melin, Beatrice] Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden; [Auer, Paul] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53726 USA; [Ring, Sue] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Thorleifsson, Gudmar] deCODE Genet, Dept Stat, IS-101 Reykjavik, Iceland; [van Schoor, Natasja M.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; [van Schoor, Natasja M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, NL-1007 MB Amsterdam, Netherlands; [de Groot, Lisette C. P. G. M.] Wageningen Univ, Dept Human Nutr, NL-6700 EV Wageningen, Netherlands; [van der Velde, Nathalie] Acad Med Ctr, Sect Geriatr, Dept Internal Med, NL-1105 Amsterdam, Netherlands; [Christiansen, Claus] Nord Biosci, DK-2730 Herlev, Denmark; [Calderari, Sophie; Gauguier, Dominique] INSERM, UMRS 1138, Cordeliers Res Ctr, F-75006 Paris, France; [Calderari, Sophie; Gauguier, Dominique] Univ Paris 06, Inst Cardiometab & Nutr, F-75013 Paris, France; [Williams, Stephen R.; Farber, Charles; Nogues, Xavier] Univ Virginia, Ctr Publ Hlth Genom, Dept Med, Charlottesville, VA 22908 USA; [Williams, Stephen R.; Farber, Charles; Nogues, Xavier] Univ Virginia, Ctr Publ Hlth Genom, Dept Cardiovasc Med, Charlottesville, VA 22908 USA; [Grinberg, Daniel] Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; [Grinberg, Daniel] Ctr Biomed Network Res Rare Dis CIBERER, U720, Barcelona 28029, Spain; [Grinberg, Daniel] Univ Barcelona, Inst Biomed, Dept Human Mol Genet, E-08028 Barcelona, Spain; [LaCroix, Andrea Z.] Univ Calif San Diego, Womens Hlth Ctr Excellence Family Med & Publ Hlth, San Diego, CA 92103 USA; [Chasman, Daniel I.; Giulianini, Franco; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Eisman, John A.; Nguyen, Tuan V.; Center, Jacqueline R.] Garvan Inst Med Res, Osteoporosis & Bone Biol Program, Sydney, NSW 2010, Australia; [Eisman, John A.] Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW 6959, Australia; [Eisman, John A.; Nguyen, Tuan V.; Center, Jacqueline R.] NSW Univ, St Vincents Hosp, Sydney, NSW 2010, Australia; [Eisman, John A.; Nguyen, Tuan V.; Center, Jacqueline R.] NSW Univ, Sch Clin, Sydney, NSW 2010, Australia; [Nogues, Xavier; Garcia-Giralt, Natalia] Inst Hosp Mar Invest Med, Musculoskeletal Res Grp, Barcelona 08003, Spain; [Garcia-Giralt, Natalia] Inst Hlth Carlos III, Cooperat Res Network Aging & Fragil RETICEF, Madrid 28029, Spain; [Nogues, Xavier] Univ Autonoma Barcelona, Hosp Mar, Dept Internal Med, E-08193 Barcelona, Spain; [Launer, Lenore L.] NIA, Neuroepidemiol Sect, NIH, Bethesda, MD 20892 USA; [Gudnason, Vilmunder; Smith, Albert V.; Siggeirsdottir, Kristin] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Gudnason, Vilmunder; Smith, Albert V.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [Karlsson, Magnus K.; Akesson, Kristina] Skane Univ Hosp, Dept Orthopaed, S-20502 Malmo, Sweden; [Ljunggren, Osten] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Svensson, Olle] Umea Univ, Dept Surg & Perioperat Sci, S-90185 Umea, Sweden; [Rousseau, Francois] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1V 0A6, Canada; [Rousseau, Francois; Giroux, Sylvie; Bussiere, Johanne] CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ G1V 4G2, Canada; [Prince, Richard L.; Lewis, Joshua R.; Wilson, ScottG.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Prince, Richard L.; Lewis, Joshua R.] Univ Western Australia, Dept Med, Perth, WA 6009, Australia; [Langdahl, Bente L.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus C, Denmark; [Hermann, A. Pernille] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense C, Denmark; [Jensen, Jens-Erik B.] Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge CB2 2QQ, England; [Reeve, Jonathan] Univ Cambridge, Med & Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Reeve, Jonathan] Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; [Formosa, Melissa M.; Xuereb-Anastasi, Angela] Univ Malta, Dept Appl Biomed Sci, Fac Hlth Sci, MSD-2080 Msida, Malta; [Akesson, Kristina; McGuigan, Fiona E.; Garg, Gaurav] Lund Univ, Clin & Mol Osteoporosis Res Unit, Dept Clin Sci Malmo, S-20502 Lund, Sweden; [Olmos, Jose M.; Riancho, Jose A.] Univ Cantabria, Dept Med & Psychiat, Santander 39011, Spain; [Olmos, Jose M.; Riancho, Jose A.] Hosp UM Valdecilla IDIVAL, Dept Internal Med, Santander 39008, Spain; [Zarrabeitia, Maria T.] Univ Cantabria, Dept Legal Med, Santander 39011, Spain; [Ralston, Stuart H.; Alonso, Nerea] Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Jiang, Xi; Rowe, David W.] Univ Connecticut, Ctr Hlth, Coll Dent Med, Dept Reconstruct Sci, Farmington, CT 06030 USA; [Goltzman, David] McGill Univ, Dept Med & Physiol, Montreal, PQ H4A 3J1, Canada; [Orwoll, Eric S.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Karasik, David] Bar Ilan Univ, Fac Med Galilee, IL-13010 Safed, Israel; [Harris, Tamara B.] NIA, Lab Epidemiol, NIH, Bethesda, MD 20892 USA; [Maurano, Matthew T.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wilson, ScottG.] Univ Western Australia, Sch Med & Pharmacol, Crawley 6009, Australia; [Ntzani, Evangelia E.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ntzani, Evangelia E.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02903 USA; [Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Greenwood, Celia M. T.] McGill Univ, Gerald Bronfman Ctr, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Jackson, Rebecca D.] Ohio State Univ, Dept Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Loomis, Cynthia A.] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Loomis, Cynthia A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Diabet & Endocrinol, Brisbane, Qld 4029, Australia	McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; University of Queensland; Cornell University; University of Bristol; University of Bristol; Fred Hutchinson Cancer Center; Boston University; University of Gothenburg; California Pacific Medical Center; California Pacific Medical Center Research Institute; Oregon Health & Science University; Oregon Health & Science University; Wellcome Trust Sanger Institute; Umea University; Umea University; Umea University; University of Gothenburg; McGill University; Erasmus University Rotterdam; Erasmus MC; Oregon Health & Science University; Oregon Health & Science University; University of London; University College London; University of London; King's College London; Harvard University; Beth Israel Deaconess Medical Center; McGill University; University of Rochester; McGill University; McGill University; Trinity University; University of Bristol; Umea University; University of Wisconsin System; University of Wisconsin Milwaukee; University of Bristol; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research; Nordic Bioscience; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Virginia; University of Virginia; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Garvan Institute of Medical Research; University of Notre Dame Australia; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icelandic Heart Association; University of Iceland; Erasmus University Rotterdam; Erasmus MC; Lund University; Skane University Hospital; Uppsala University; Umea University; Laval University; Laval University; University of Western Australia; University of Western Australia; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Cambridge; University of Cambridge; University of Oxford; University of Malta; Lund University; Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Edinburgh; University of Connecticut; McGill University; Oregon Health & Science University; Bar Ilan University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Western Australia; University of Ioannina; Brown University; Framingham Heart Study; McGill University; McGill University; University System of Ohio; Ohio State University; New York University; New York University; Royal Brisbane & Women's Hospital	Richards, JB (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3A 1A2, Canada.	brent.richards@mcgill.ca	Evans, David M/H-6325-2013; lewis, josh/GZG-7164-2022; Stefansson, Kari/AAE-7187-2019; Rivadeneira, Fernando/O-5385-2015; Auer, Paul/AAC-5060-2019; Gardiner, Brooke B/C-7773-2011; Fox, Laura J/C-6249-2016; Vandenput, Liesbeth/AAI-4100-2021; Khaw, Kay-Tee/AAZ-3209-2021; Garcia-Giralt, Natalia/AAA-7588-2021; Richards, J Brent/AAF-4225-2019; Ntzani, Evangelina E./K-1565-2019; Zheng, Houfeng/K-4424-2012; Sayers, Adrian/AAU-8134-2020; Attrill, Lauren/V-1688-2018; Brown, Matthew A/E-5749-2010; Ohlsson, Claes/HIR-6959-2022; Durbin, Richard/AAE-7178-2019; Ackert-Bicknell, Cheryl/AAC-6833-2019; Reeve, Jonathan/C-7551-2012; Gauguier, Dominique/G-2190-2016; Gudnason, Vilmundur/AAE-7126-2019; Gregson, Celia/AAE-1216-2021; Medina-Gomez, Carolina/I-1725-2019; Leo, Paul/R-4464-2019; Center, Jacqueline/AAY-8712-2021; Grinberg, Daniel/F-3641-2010; Roselló-Díez, Alberto/K-7295-2016; Timpson, Nicholas John/O-7548-2015; Kemp, John P./R-3091-2018; Ohlsson, Claes/AGP-3544-2022; Davey Smith, George/A-7407-2013; Oei, Ling/E-8163-2013; Vandenput, Liesbeth/AAP-3655-2020; Koromani, Fjorda/AAY-3529-2021; Tobias, Jon/E-2832-2014; Moayyeri, Alireza/N-3332-2014; Smith, Albert Vernon/K-5150-2015; Duncan, Emma/L-1224-2013	Evans, David M/0000-0003-0663-4621; Rivadeneira, Fernando/0000-0001-9435-9441; Gardiner, Brooke B/0000-0003-3740-3244; Vandenput, Liesbeth/0000-0002-1712-6131; Garcia-Giralt, Natalia/0000-0001-6507-0147; Richards, J Brent/0000-0002-3746-9086; Zheng, Houfeng/0000-0001-5681-8598; Sayers, Adrian/0000-0001-7452-5043; Brown, Matthew A/0000-0003-0538-8211; Ohlsson, Claes/0000-0002-9633-2805; Durbin, Richard/0000-0002-9130-1006; Ackert-Bicknell, Cheryl/0000-0003-4253-4775; Reeve, Jonathan/0000-0002-4364-2682; Gauguier, Dominique/0000-0001-6156-9530; Gudnason, Vilmundur/0000-0001-5696-0084; Gregson, Celia/0000-0001-6414-0529; Medina-Gomez, Carolina/0000-0001-7999-5538; Center, Jacqueline/0000-0002-5278-4527; Grinberg, Daniel/0000-0001-9859-2590; Roselló-Díez, Alberto/0000-0002-5550-9846; Timpson, Nicholas John/0000-0002-7141-9189; Kemp, John P./0000-0002-9105-2249; Ohlsson, Claes/0000-0002-9633-2805; Davey Smith, George/0000-0002-1407-8314; Oei, Ling/0000-0003-3523-458X; Vandenput, Liesbeth/0000-0002-1712-6131; Nogues, Xavier/0000-0002-5537-1859; van Meurs, Joyce/0000-0001-6245-2123; Wilson, Scott/0000-0002-0357-1373; Cheung, Warren/0000-0003-0267-7464; Calderari, Sophie/0000-0002-9669-681X; Ntzani, Evangelia/0000-0003-3712-4181; Tobias, Jon/0000-0002-7475-3932; Chou, Wen-Chi/0000-0001-8408-3533; van der Velde, Nathalie/0000-0002-6477-6209; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Olmos, Jose M./0000-0002-7765-0891; Karasik, David/0000-0002-8826-0530; Kelly, Kirsten/0000-0003-4234-543X; Hinds, David/0000-0002-4911-803X; Van Duijn, Cornelia/0000-0002-2374-9204; Styrkarsdottir, Unnur/0000-0001-8146-8278; Moayyeri, Alireza/0000-0002-9143-2161; Zarrabeitia, Maria T./0000-0002-2836-7766; Liu, Ching-Ti/0000-0002-0703-0742; Li, Rui/0000-0001-8353-6772; Cupples, L. Adrienne/0000-0003-0273-7965; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; McCarthy, Shane/0000-0002-2715-4187; Nogues, Xavier/0000-0001-8201-9933; de Groot, Lisette/0000-0003-2778-2789; Amin, Najaf/0000-0002-8944-1771; Soranzo, Nicole/0000-0003-1095-3852; Smith, Albert Vernon/0000-0003-1942-5845; s, hema/0000-0002-3440-9475; Memari, Yasin/0000-0002-1747-542X; Trajanoska, Katerina/0000-0002-3792-4296; Greenwood, Celia/0000-0002-2427-5696; van Schoor, Natasja/0000-0002-0870-0795; Kiel, Douglas/0000-0001-8474-0310; Koromani, Fjorda/0000-0002-6942-5889; Xuereb-Anastasi, Angela/0000-0001-6361-6345; Farber, Charles/0000-0002-6748-4711; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Duncan, Emma/0000-0002-8143-4403; McKechanie, Andrew/0000-0003-4273-9906; Formosa, Melissa/0000-0002-7852-2701; Williams, Stephen/0000-0003-2108-2757; Forgetta, Vincenzo/0000-0002-6061-4720; Mellstrom, Dan/0000-0003-2761-3723	MRC [MC_UU_12013/4, MC_UU_12013/3, MR/L003120/1, MC_UU_12013/1] Funding Source: UKRI; Arthritis Research UK [20000] Funding Source: Medline; British Heart Foundation [RG/08/014/24067] Funding Source: Medline; Canadian Institutes of Health Research [119462-1] Funding Source: Medline; Medical Research Council [MC_UU_12013/1, MC_PC_15018, G0401527, MC_UU_12013/4, MR/L003120/1, G1000143, MC_UU_12013/3] Funding Source: Medline; NCI NIH HHS [P30 CA008748, UM1 CA182913, P30 CA015704] Funding Source: Medline; NIAMS NIH HHS [R01 AR063702, K01 AR062655, R01 AR035583, R00 AR061430, R01 AR065530, U01 AR045632, U01 AR066160, U01 AR045580, P30 AR057235, R01 AR035582, RC2 AR058973, U01 AR045647, U01 AR045583, U01 AR045654, U01 AR045614] Funding Source: Medline; NIA NIH HHS [R01 AG027576, U01 AG042143, R01 AG005394, R01 AG027574, U01 AG042140, U01 AG018197, R01 AG005407] Funding Source: Medline; NIH HHS [S10 OD020069] Funding Source: Medline; Versus Arthritis [20000] Funding Source: Medline; Wellcome Trust [102215] Funding Source: Medline; NATIONAL CANCER INSTITUTE [UM1CA182913, P30CA015704, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045632, R00AR061430, U01AR045647, R01AR063702, U01AR045583, K01AR062655, R01AR035582, U01AR045614, U01AR045580, P30AR057235, U01AR066160, R01AR035583, U01AR045654, RC2AR058973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005394, R01AG005407, U01AG042143, R01AG027574, R01AG027576, U01AG042140, U01AG018197] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER; Cancer Research UK [20000] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10165, NF-SI-0510-10268] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0004839, NNF14OC0009883, NNF13OC0005785] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)		Ackert-Bicknell CL, 2010, J BONE MINER RES, V25, P1808, DOI 10.1002/jbmr.72; Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Deckelbaum RA, 2006, DEVELOPMENT, V133, P63, DOI 10.1242/dev.02171; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koller DL, 2010, J CLIN ENDOCR METAB, V95, P1802, DOI 10.1210/jc.2009-1903; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Matise MP, 1997, J NEUROSCI, V17, P7805; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sgaier SK, 2007, DEVELOPMENT, V134, P2325, DOI 10.1242/dev.000620; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Voorman A. A., 2013, R PACKAGE META ANAL; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745	38	313	322	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					112	+		10.1038/nature14878	http://dx.doi.org/10.1038/nature14878			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26367794	Green Accepted, Green Submitted			2022-12-28	WOS:000362095100044
J	Agrawal, AF				Agrawal, Aneil F.			EVOLUTIONARY BIOLOGY Infection elevates diversity	NATURE			English	Editorial Material							DNA REARRANGEMENTS; SHORT-TERM; RECOMBINATION; SELECTION; PARASITE; TRIGGERS; SEX		Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Toronto	Agrawal, AF (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada.	a.agrawal@utoronto.ca						Agrawal AF, 2005, GENETICS, V171, P803, DOI 10.1534/genetics.105.041301; Agrawal AF, 2009, EVOLUTION, V63, P2131, DOI 10.1111/j.1558-5646.2009.00695.x; Andronic L, 2012, CAN J PLANT SCI, V92, P1083, DOI [10.4141/CJPS2011-197, 10.4141/cjps2011-197]; BELL G, 1987, NATURE, V328, P66, DOI 10.1038/328066a0; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Singh ND, 2015, SCIENCE, V349, P747, DOI 10.1126/science.aab1768	10	1	1	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					464	465		10.1038/525464a	http://dx.doi.org/10.1038/525464a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399826				2022-12-28	WOS:000361599900038
J	Stehr, N				Stehr, Nico			Climate policy: Democracy is not an inconvenience	NATURE			English	Editorial Material									Zeppelin Univ, European Ctr Sustainabil Res, Friedrichshafen, Germany	Zeppelin University	Stehr, N (corresponding author), Zeppelin Univ, European Ctr Sustainabil Res, Friedrichshafen, Germany.	nico.stehr@t-online.de						Adam D, 2009, **DROPPED REF**; Beeson M, 2010, ENVIRON POLIT, V19, P276, DOI 10.1080/09644010903576918; Gamble A., 2000, DEBATING GOVERNANCE; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hayek FA, 1941, NATURE, V148, P580, DOI 10.1038/148580a0; Hayek FriedrichA., 1960, CONSTITUTION LIBERTY; REN, 2015, REN 2015 GLOB STAT R; Rosanvallon Pierre, 2013, SOC EQUALS; Runciman David, 2013, CONFIDENCE TRAP HIST; Stehr, 2015, INFORM POWER DEMOCRA	10	24	24	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					449	+		10.1038/525449a	http://dx.doi.org/10.1038/525449a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KI	26399814	Bronze			2022-12-28	WOS:000361599900024
J	Liu, HR; Cheng, LP				Liu, Hongrong; Cheng, Lingpeng			Cryo-EM shows the polymerase structures and a nonspooled genome within a dsRNA virus	SCIENCE			English	Article							CYTOPLASMIC POLYHEDROSIS-VIRUS; CRYOELECTRON MICROSCOPY; MESSENGER-RNA; REOVIRUS POLYMERASE-LAMBDA-3; MECHANISM; PROTEIN; VISUALIZATION; RESOLUTION; PARTICLES; CYPOVIRUS	Double-stranded RNA (dsRNA) viruses possess a segmented dsRNA genome and a number of RNA-dependent RNA polymerases (RdRps) enclosed in a capsid. Until now, the precise structures of genomes and RdRps within the capsids have been unknown. Here we report the structures of RdRps and associated RNAs within nontranscribing and transcribing cypoviruses (NCPV and TCPV, respectively), using a combination of cryo-electron microscopy (cryo-EM) and a symmetry-mismatch reconstruction method. The RdRps and associated RNAs appear to exhibit a pseudo-D-3 symmetric organization in both NCPV and TCPV. However, the molecular interactions between RdRps and the genomic RNA were found to differ in these states. Our work provides insight into the mechanisms of the replication and transcription in dsRNA viruses and paves a way for structural determination of lower-symmetry complexes enclosed in higher-symmetry structures.	[Liu, Hongrong] Hunan Normal Univ, Coll Phys & Informat Sci, Changsha 410081, Hunan, Peoples R China; [Cheng, Lingpeng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Hunan Normal University; Tsinghua University	Liu, HR (corresponding author), Hunan Normal Univ, Coll Phys & Informat Sci, Changsha 410081, Hunan, Peoples R China.	hrliu@hunnu.edu.cn; lingpengcheng@mail.tsinghua.edu.cn	Cheng, Lingpeng/AAG-9934-2020	Cheng, Lingpeng/0000-0002-9148-0550	National Natural Science Foundation of China [91230116, 31170697, 31370736, 31000333]; National Basic Research Program of China [2010CB912403]; Program for New Century Excellent Talents [NCET-13-0787]; Hunan Provincial NSF [13JJ1017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Hunan Provincial NSF	We thank H. Wang for critical discussion of the manuscript, B. Zhu and X. Li for assistance with computer programming, X. Gong for help with model refinement, T. Juelich for language editing, C. Yang for discussion on sample preparation, G. Ji and X. Huang for assistance with cryo-EM, and P. Zhu for support. This research was supported by the National Natural Science Foundation of China (91230116, 31170697, 31370736, and 31000333), the National Basic Research Program of China (2010CB912403), the Program for New Century Excellent Talents (NCET-13-0787), and the Hunan Provincial NSF (13JJ1017). All EM data were collected at the Center for Biological Imaging, Institute of Biophysics, Chinese Academy of Sciences. We declare no competing financial interests. The electron density maps and C alpha models have been deposited in the EM Data Bank and the Protein Data Bank (PDB) under EM accession numbers EMD-6321 and EMD-6322 and PDB IDs 3JA4 and 3JA5, respectively. L.C. and H.L. designed the reconstruction algorithm, analyzed the data, and contributed to the writing of the manuscript.	Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cheng LP, 2011, P NATL ACAD SCI USA, V108, P1373, DOI 10.1073/pnas.1014995108; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Duquerroy S, 2009, EMBO J, V28, P1655, DOI 10.1038/emboj.2009.109; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Makeyev EV, 2004, VIRUS RES, V101, P45, DOI 10.1016/j.virusres.2003.12.005; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Pesavento JB, 2001, P NATL ACAD SCI USA, V98, P1381, DOI 10.1073/pnas.98.4.1381; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Xia Q, 2003, J BIOL CHEM, V278, P1094, DOI 10.1074/jbc.M205964200; Yang CW, 2012, P NATL ACAD SCI USA, V109, P6118, DOI 10.1073/pnas.1200206109; YAZAKI K, 1980, VIROLOGY, V105, P467, DOI 10.1016/0042-6822(80)90047-1; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009; Zhu B, 2014, J MOL BIOL, V426, P2167, DOI 10.1016/j.jmb.2014.03.013	25	55	62	21	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1347	1350		10.1126/science.aaa4938	http://dx.doi.org/10.1126/science.aaa4938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383954				2022-12-28	WOS:000361357700051
J	Romero, NA; Margrey, KA; Tay, NE; Nicewicz, DA				Romero, Nathan A.; Margrey, Kaila A.; Tay, Nicholas E.; Nicewicz, David A.			Site-selective arene C-H amination via photoredox catalysis	SCIENCE			English	Article							N BOND FORMATION; ORGANIC-SYNTHESIS; IMIDATION; FUNCTIONALIZATION; HETEROARENES; DERIVATIVES; AMIDATION; HETEROCYCLES; ARYLAMINES; MOLECULES	Over the past several decades, organometallic cross-coupling chemistry has developed into one of the most reliable approaches to assemble complex aromatic compounds from preoxidized starting materials. More recently, transition metal-catalyzed carbon-hydrogen activation has circumvented the need for preoxidized starting materials, but this approach is limited by a lack of practical amination protocols. Here, we present a blueprint for aromatic carbon-hydrogen functionalization via photoredox catalysis and describe the utility of this strategy for arene amination. An organic photoredox-based catalyst system, consisting of an acridinium photooxidant and a nitroxyl radical, promotes site-selective amination of a variety of simple and complex aromatics with heteroaromatic azoles of interest in pharmaceutical research. We also describe the atom-economical use of ammonia to form anilines, without the need for prefunctionalization of the aromatic component.	[Romero, Nathan A.; Margrey, Kaila A.; Tay, Nicholas E.; Nicewicz, David A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Nicewicz, DA (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	nicewicz@unc.edu	, UNC Chemistry NMR/AGR-7635-2022; Tay, Nicholas/AAW-5242-2021	Tay, Nicholas/0000-0002-4063-8880; Romero, Nathan/0000-0001-8127-4617	David and Lucile Packard Foundation; Merck; Amgen Young Investigator Award; Francis Preston Venable Graduate Fellowship	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Merck(Merck & Company); Amgen Young Investigator Award(Amgen); Francis Preston Venable Graduate Fellowship	Financial support was provided by the David and Lucile Packard Foundation, Merck, and an Amgen Young Investigator Award. N.A.R is grateful for an NSF Graduate Fellowship, and K.A.M. was supported by a Francis Preston Venable Graduate Fellowship. A provisional patent has been filed on the methods presented here (U.S. patent application no. 62/170,632).	Allen LJ, 2014, J AM CHEM SOC, V136, P5607, DOI 10.1021/ja501906x; Baur JE, 1996, ANAL CHEM, V68, P3815, DOI 10.1021/ac960603m; BORDWELL FG, 1989, J AM CHEM SOC, V111, P1792, DOI 10.1021/ja00187a036; Boursalian GB, 2013, J AM CHEM SOC, V135, P13278, DOI 10.1021/ja4064926; Brachet E, 2015, CHEM SCI, V6, P987, DOI 10.1039/c4sc02365j; Foo K, 2014, J AM CHEM SOC, V136, P5279, DOI 10.1021/ja501879c; Hartwig JF, 1998, ACCOUNTS CHEM RES, V31, P852, DOI 10.1021/ar970282g; HESS WP, 1989, J PHYS CHEM-US, V93, P1944, DOI 10.1021/j100342a049; Kantak AA, 2011, J AM CHEM SOC, V133, P19960, DOI 10.1021/ja2087085; Kawakami T, 2015, J AM CHEM SOC, V137, P2460, DOI 10.1021/ja5130012; Kim HJ, 2011, J AM CHEM SOC, V133, P16382, DOI 10.1021/ja207296y; Lam PYS, 2001, TETRAHEDRON LETT, V42, P3415, DOI 10.1016/S0040-4039(01)00510-X; Tran LD, 2013, ANGEW CHEM INT EDIT, V52, P6043, DOI 10.1002/anie.201300135; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Matsubara T, 2014, J AM CHEM SOC, V136, P646, DOI 10.1021/ja412521k; Morofuji T, 2015, CHEM-EUR J, V21, P3211, DOI 10.1002/chem.201406398; Morofuji T, 2014, J AM CHEM SOC, V136, P4496, DOI 10.1021/ja501093m; Morofuji T, 2013, J AM CHEM SOC, V135, P5000, DOI 10.1021/ja402083e; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Nguyen TM, 2014, ANGEW CHEM INT EDIT, V53, P6198, DOI 10.1002/anie.201402443; Nicewicz DA, 2014, ACS CATAL, V4, P355, DOI 10.1021/cs400956a; Ohkubo K, 2013, J PHYS CHEM A, V117, P10719, DOI 10.1021/jp408315a; Ohkubo K, 2011, CHEM SCI, V2, P715, DOI 10.1039/c0sc00535e; Ohkubo K, 2010, CHEM COMMUN, V46, P601, DOI 10.1039/b920606j; PAN XM, 1993, J CHEM SOC PERK T, V2, P289; PANDEY G, 1990, TETRAHEDRON LETT, V31, P5373, DOI 10.1016/S0040-4039(00)98075-4; Pesco, 1977, U.S. Patent, Patent No. [4,031,106, 4031106]; Pesco TWD, 1977, U.S. Patent, Patent No. [4001260, 4,001,260]; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qin QX, 2014, ORG LETT, V16, P3504, DOI 10.1021/ol501457s; Rao KS, 2012, TETRAHEDRON, V68, P7735, DOI 10.1016/j.tet.2012.06.015; Ritchie TJ, 2012, MEDCHEMCOMM, V3, P1062, DOI 10.1039/c2md20111a; Schmittel M, 1997, ANGEW CHEM INT EDIT, V36, P2550, DOI 10.1002/anie.199725501; Shul'pin G. B., 2004, TRANSITION METALS OR, P215; Tsang WCP, 2008, J ORG CHEM, V73, P7603, DOI 10.1021/jo801273q; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Vo GD, 2009, J AM CHEM SOC, V131, P11049, DOI 10.1021/ja903049z; Wolfe JP, 1998, ACCOUNTS CHEM RES, V31, P805, DOI 10.1021/ar9600650; Xu H, 2014, J ORG CHEM, V79, P4414, DOI 10.1021/jo5003592	39	532	533	14	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1326	1330		10.1126/science.aac9895	http://dx.doi.org/10.1126/science.aac9895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383949				2022-12-28	WOS:000361357700046
J	Armstrong, S				Armstrong, Stephen			HEALTH AND TECHNOLOGY Which app should I use?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						[Anonymous], 2015, EHEALTH NEWS    0209; Belsey J., 2009, WHAT IS EVIDENCE BAS; BSI, 2015, HLTH WELLN APPS QUAL; Carter T, 2014, J MOB TECHNOL MED, V3, P2, DOI [10.7309/jmtm.3.2.2, DOI 10.7309/JMTM.3.2.2]; Cox A., 2011, SMARTPHONE APPS MONI; Dolan B, 2012, MOBIHEALTHNEWS  0322; European Commission, REV MED DEV DIR; European Commission, PUBL CONS GREEN PAP; Franko OI, 2012, J MED SYST, V36, P3135, DOI 10.1007/s10916-011-9798-7; Medicines and Healthcare Products Regulatory Agency, 2014, MED DEV STAND AL SOF; National Information Board, 2014, INTR PERS HLTH CAR 2; National Information Board, PERS HLTH CAR 2020 W; Sharpe R., 2012, WASHINGTON POST	13	14	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2015	351								h4597	10.1136/bmj.h4597	http://dx.doi.org/10.1136/bmj.h4597			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CY	26353800				2022-12-28	WOS:000361280600003
J	Grande, I; Berk, M; Birmaher, B; Vieta, E				Grande, Iria; Berk, Michael; Birmaher, Boris; Vieta, Eduard			Bipolar disorder	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE DISORDER; WEEKLY SYMPTOMATIC STATUS; INTERNATIONAL SOCIETY; MAINTENANCE TREATMENT; I DISORDER; COMPARATIVE EFFICACY; TASK-FORCE; GROUP PSYCHOEDUCATION; ANTIMANIC TREATMENTS	Bipolar disorder is a recurrent chronic disorder characterised by fluctuations in mood state and energy. It affects more than 1% of the world's population irrespective of nationality, ethnic origin, or socioeconomic status. Bipolar disorder is one of the main causes of disability among young people, leading to cognitive and functional impairment and raised mortality, particularly death by suicide. A high prevalence of psychiatric and medical comorbidities is typical in affected individuals. Accurate diagnosis of bipolar disorder is difficult in clinical practice because onset is most commonly a depressive episode and looks similar to unipolar depression. Moreover, there are currently no valid biomarkers for the disorder. Therefore, the role of clinical assessment remains key. Detection of hypomanic periods and longitudinal assessment are crucial to differentiate bipolar disorder from other conditions. Current knowledge of the evolving pharmacological and psychological strategies in bipolar disorder is of utmost importance.	[Grande, Iria; Vieta, Eduard] Univ Barcelona, IDIBAPS, Clin Inst Neurosci, Bipolar Disorders Unit,Hosp Clin,CIBERSAM, Barcelona, Spain; [Berk, Michael] Deakin Univ, IMPACT Strateg Res Ctr, Sch Med, Geelong, Vic 3217, Australia; [Berk, Michael] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Orygen, Natl Ctr Excellence Youth Mental Hlth, Parkville, Vic 3052, Australia; [Berk, Michael] Univ Melbourne, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Berk, Michael] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Birmaher, Boris] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Deakin University; Florey Institute of Neuroscience & Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Melbourne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Vieta, E (corresponding author), Hosp Clin Barcelona, Clin Inst Neurosci, Bipolar Disorders Unit, E-08036 Barcelona, Spain.	evieta@clinic.ub.es	Vieta, Eduard/Y-2919-2019; Grande, Iria/AAF-9342-2021; Berk, Michael/M-7891-2013	Vieta, Eduard/0000-0002-0548-0053; Berk, Michael/0000-0002-5554-6946	Rio Hortega Contracts [CM12/00062]; Juan Rodes Contracts (Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain) [JR15/00012]; NHMRC [1059660]; Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, CIBERSAM [PI12/00912]; Grups Consolidats de Recerca [SGR 398]; Seventh European Framework Programme (ENBREC); Stanley Medical Research Institute	Rio Hortega Contracts; Juan Rodes Contracts (Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, CIBERSAM; Grups Consolidats de Recerca; Seventh European Framework Programme (ENBREC); Stanley Medical Research Institute	IG has received a research grant from Rio Hortega Contracts (CM12/00062) and Juan Rodes Contracts (JR15/00012; Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain). MB is supported by an NHMRC Senior Principal Research Fellowship (1059660). EV thanks the Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, CIBERSAM (PI12/00912), Grups Consolidats de Recerca 2014 (SGR 398), Seventh European Framework Programme (ENBREC), and the Stanley Medical Research Institute for their support.	Akiskal HS, 2000, J AFFECT DISORDERS, V59, pS5, DOI 10.1016/S0165-0327(00)00203-2; AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1; Angst J, 1966, AETIOLOGIE NOSOLOGIE; Angst J, 2011, ARCH GEN PSYCHIAT, V68, P791, DOI 10.1001/archgenpsychiatry.2011.87; Axelson DA, 2011, J AM ACAD CHILD PSY, V50, P1001, DOI 10.1016/j.jaac.2011.07.005; Baldessarini RJ, 2012, ACTA PSYCHIAT SCAND, V125, P293, DOI 10.1111/j.1600-0447.2011.01818.x; Berk L, 2010, HUM PSYCHOPHARM CLIN, V25, P1, DOI 10.1002/hup.1081; Berk M, 2007, J AFFECT DISORDERS, V103, P181, DOI 10.1016/j.jad.2007.01.027; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Berk M, 2007, BIPOLAR DISORD, V9, P671, DOI 10.1111/j.1399-5618.2007.00484.x; Berk M, 2011, J AFFECT DISORDERS, V135, P389, DOI 10.1016/j.jad.2011.06.005; Berk M, 2009, INT J NEUROPSYCHOPH, V12, P441, DOI 10.1017/S1461145708009498; Birmaher B, 2013, CHILD ADOL MENT H-UK, V18, P140, DOI 10.1111/camh.12021; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Birnbaum R, 2014, NEW ENGL J MED, V370, P1855, DOI 10.1056/NEJMc1401817; Boden Robert, 2012, BMJ, V345, pe7085, DOI 10.1136/bmj.e7085; Bonnin CM, 2012, J AFFECT DISORDERS, V136, P650, DOI 10.1016/j.jad.2011.10.012; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Calabrese JR, 2004, BIOL PSYCHIAT, V56, P957, DOI 10.1016/j.biopsych.2004.09.022; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Colom F, 2006, J AFFECT DISORDERS, V93, P13, DOI 10.1016/j.jad.2006.01.032; Colom F, 2009, BRIT J PSYCHIAT, V194, P260, DOI 10.1192/bjp.bp.107.040485; Colom F, 1998, PSYCHOTHER PSYCHOSOM, V67, P3, DOI 10.1159/000012252; Colom F, 2003, ARCH GEN PSYCHIAT, V60, P402, DOI 10.1001/archpsyc.60.4.402; CORYELL W, 1995, AM J PSYCHIAT, V152, P385; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139; Dean OM, 2015, REV BRAS PSIQUIATR, V37, P3, DOI 10.1590/1516-4446-2013-1341; Dodd Seetal, 2004, Expert Opin Drug Saf, V3, P221; Duffy A, 2009, J CAN ACAD CHILD ADO, V18, P200; Fagiolini A, 2003, AM J PSYCHIAT, V160, P112, DOI 10.1176/appi.ajp.160.1.112; Fiedorowicz JG, 2008, ANN CLIN PSYCHIATRY, V20, P131, DOI 10.1080/10401230802177722; Forty L, 2008, BRIT J PSYCHIAT, V192, P388, DOI 10.1192/bjp.bp.107.045294; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P1053; Frey BN, 2013, AUST NZ J PSYCHIAT, V47, P321, DOI 10.1177/0004867413478217; Gardner HH, 2006, J CLIN PSYCHIAT, V67, P1209, DOI 10.4088/JCP.v67n0806; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Geller B, 2012, ARCH GEN PSYCHIAT, V69, P515, DOI 10.1001/archgenpsychiatry.2011.1508; Gibbons RD, 2009, ARCH GEN PSYCHIAT, V66, P1354, DOI 10.1001/archgenpsychiatry.2009.159; Goikolea JM, 2013, EUR NEUROPSYCHOPHARM, V23, P305, DOI 10.1016/j.euroneuro.2012.05.017; Goikolea JM, 2013, J AFFECT DISORDERS, V144, P191, DOI 10.1016/j.jad.2012.07.038; Goldberg JF, 2001, AM J PSYCHIAT, V158, P1265, DOI 10.1176/appi.ajp.158.8.1265; Gonda X, 2012, J AFFECT DISORDERS, V143, P16, DOI 10.1016/j.jad.2012.04.041; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; Goodwin GM, 2008, EUR NEUROPSYCHOPHARM, V18, P535, DOI 10.1016/j.euroneuro.2008.03.003; Grande I, 2015, EUR PSYCHIAT, V30, P528, DOI 10.1016/j.eurpsy.2015.01.003; Grande I, 2014, ACTA PSYCHIAT SCAND, V129, P437, DOI 10.1111/acps.12268; Grande I, 2014, ACTA PSYCHIAT SCAND, V129, P393, DOI 10.1111/acps.12192; Grande I, 2013, ACTA PSYCHIAT SCAND, V127, P403, DOI 10.1111/acps.12003; Grande I, 2012, J AFFECT DISORDERS, V143, P102, DOI 10.1016/j.jad.2012.05.035; Grande I, 2015, CNS DRUGS, V29, P221, DOI 10.1007/s40263-015-0235-1; Grande I, 2014, INT J NEUROPSYCHOPH, V17, P497, DOI 10.1017/S1461145713001168; Grande I, 2013, INT J NEUROPSYCHOPH, V16, P513, DOI 10.1017/S1461145712000405; Grande I, 2012, PHYSIOL BEHAV, V106, P46, DOI 10.1016/j.physbeh.2011.10.029; Grande I, 2010, PSYCHIAT INVEST, V7, P243, DOI 10.4306/pi.2010.7.4.243; Grunze H, 2013, WORLD J BIOL PSYCHIA, V14, P154, DOI 10.3109/15622975.2013.770551; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hantouche EG, 2005, J AFFECT DISORDERS, V84, P127, DOI 10.1016/j.jad.2004.01.017; Henin A, 2005, BIOL PSYCHIAT, V58, P554, DOI 10.1016/j.biopsych.2005.06.010; Hoertel N, 2013, J AFFECT DISORDERS, V146, P338, DOI 10.1016/j.jad.2012.09.016; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Canales-Rodriguez EJ, 2014, BIOL PSYCHIAT, V76, P239, DOI 10.1016/j.biopsych.2013.09.027; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Kapczinski F, 2014, ACTA PSYCHIAT SCAND, V130, P354, DOI 10.1111/acps.12305; Kapczinski F, 2008, NEUROSCI BIOBEHAV R, V32, P675, DOI 10.1016/j.neubiorev.2007.10.005; Kapczinski F, 2009, EXPERT REV NEUROTHER, V9, P957, DOI [10.1586/ern.09.31, 10.1586/ERN.09.31]; Kessing LV, 2013, BRIT J PSYCHIAT, V202, P212, DOI 10.1192/bjp.bp.112.113548; Kilbourne AM, 2004, BIPOLAR DISORD, V6, P368, DOI 10.1111/j.1399-5618.2004.00138.x; Konopaske GT, 2014, JAMA PSYCHIAT, V71, P1323, DOI 10.1001/jamapsychiatry.2014.1582; Kraepelin E, 1920, Z GESAMTE NEUROL PSY, V62, P1, DOI 10.1007/BF02887354; Lauder S, 2015, J AFFECT DISORDERS, V171, P13, DOI 10.1016/j.jad.2014.08.008; Leonhard K, 1957, AUFTEILUNG ENDOGENEN; Macneil CA, 2012, EARLY INTERV PSYCHIA, V6, P380, DOI 10.1111/j.1751-7893.2011.00336.x; Malhi GS, 2012, CURR PSYCHIAT REP, V14, P676, DOI 10.1007/s11920-012-0324-5; Martinez-Aran A, 2007, BIPOLAR DISORD, V9, P103, DOI 10.1111/j.1399-5618.2007.00327.x; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Martinez-Aran A, 2015, EUR NEUROPSYCHOPHARM, V25, P151, DOI 10.1016/j.euroneuro.2015.01.007; Martinowich K, 2009, J CLIN INVEST, V119, P726, DOI 10.1172/JCI37703; McClellan J, 2007, J AM ACAD CHILD ADOL, V46, P107, DOI DOI 10.1097/01.CHI.0000242240.69678.C4; McDonald WM, 1996, B MENNINGER CLIN, V60, P174; McElroy SL, 2001, AM J PSYCHIAT, V158, P420, DOI 10.1176/appi.ajp.158.3.420; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Miklowitz DJ, 2008, ARCH GEN PSYCHIAT, V65, P1053, DOI 10.1001/archpsyc.65.9.1053; Mitchell PB, 2004, BIPOLAR DISORD, V6, P530, DOI 10.1111/j.1399-5618.2004.00137.x; Miura T, 2014, LANCET PSYCHIAT, V1, P351, DOI 10.1016/S2215-0366(14)70314-1; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moreno C, 2007, ARCH GEN PSYCHIAT, V64, P1032, DOI 10.1001/archpsyc.64.9.1032; Munk-Olsen T, 2014, BIPOLAR DISORD, V16, P300, DOI 10.1111/bdi.12145; National Collaborative Centre for Mental Health, 2014, NIC CLIN GUID 185; Ng F, 2009, BIPOLAR DISORD, V11, P559, DOI 10.1111/j.1399-5618.2009.00737.x; Nivoli AMA, 2011, J AFFECT DISORDERS, V133, P443, DOI 10.1016/j.jad.2011.04.055; Pacchiarotti I, 2013, AM J PSYCHIAT, V170, P1249, DOI 10.1176/appi.ajp.2013.13020185; Perlis RH, 2006, AM J PSYCHIAT, V163, P225, DOI 10.1176/appi.ajp.163.2.225; PERRIS C, 1966, ACTA PSYCHIAT SCAND, VS 42, P9; Phillips Mary L, 2013, Lancet, V381, P1663, DOI 10.1016/S0140-6736(13)60989-7; Pomarol-Clotet E, 2015, BRIT J PSYCHIAT, V206, P136, DOI 10.1192/bjp.bp.114.152033; Pompili M, 2013, BIPOLAR DISORD, V15, P457, DOI 10.1111/bdi.12087; Popovic D, 2012, EUR NEUROPSYCHOPHARM, V22, P339, DOI 10.1016/j.euroneuro.2011.09.008; POST RM, 1992, AM J PSYCHIAT, V149, P999; Rosa AR, 2012, ACTA PSYCHIAT SCAND, V125, P335, DOI 10.1111/j.1600-0447.2011.01830.x; Saunders KEA, 2013, BIPOLAR DISORD, V15, P575, DOI 10.1111/bdi.12065; Schaffer A, 2015, BIPOLAR DISORD, V17, P1, DOI 10.1111/bdi.12271; Schaffer A, 2010, J AFFECT DISORDERS, V125, P103, DOI 10.1016/j.jad.2010.02.118; Schoeyen HK, 2015, AM J PSYCHIAT, V172, P41, DOI 10.1176/appi.ajp.2014.13111517; Scott J, 2006, BRIT J PSYCHIAT, V188, P488, DOI 10.1192/bjp.188.5.488; Shine B, 2015, LANCET, V386, P461, DOI 10.1016/S0140-6736(14)61842-0; Sole B, 2015, EUR NEUROPSYCHOPHARM, V25, P257, DOI 10.1016/j.euroneuro.2014.05.010; Tiihonen J, 2005, AM J PSYCHIAT, V162, P1904, DOI 10.1176/appi.ajp.162.10.1904; Tobia A, 2014, ACTA PSYCHIAT SCAND, V130, P238, DOI 10.1111/acps.12302; Tohen M, 2000, AM J PSYCHIAT, V157, P220, DOI 10.1176/appi.ajp.157.2.220; Tondo L, 2003, CNS DRUGS, V17, P491, DOI 10.2165/00023210-200317070-00003; Tondo L, 2010, ACTA PSYCHIAT SCAND, V121, P446, DOI 10.1111/j.1600-0447.2009.01523.x; Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971; Valenti M, 2015, BIPOLAR DISORD, V17, P549, DOI 10.1111/bdi.12288; Vieta E, 2014, ACTA PSYCHIAT SCAND, V129, P323, DOI 10.1111/acps.12270; Vieta E, 2008, BIPOLAR DISORD, V10, P163, DOI 10.1111/j.1399-5618.2007.00561.x; Vieta E, 2007, SCHIZOPHRENIA BULL, V33, P886, DOI 10.1093/schbul/sbm057; Vieta E, 2014, AM J PSYCHIAT, V171, P1023, DOI 10.1176/appi.ajp.2014.14070826; Vieta E, 2013, INT J NEUROPSYCHOPH, V16, P1719, DOI 10.1017/S1461145713000278; Vieta E, 2013, J AFFECT DISORDERS, V148, P28, DOI 10.1016/j.jad.2013.03.007; Vieta E, 2011, INT J NEUROPSYCHOPH, V14, P1029, DOI 10.1017/S1461145711000885; Vieta E, 2010, J CLIN PSYCHOPHARM, V30, P579, DOI 10.1097/JCP.0b013e3181f15849; Winokur G., 1969, MANIC DEPRESSIVE ILL; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025; Yildiz A, 2015, PSYCHOL MED, V45, P299, DOI 10.1017/S0033291714001305; Yildiz A, 2011, NEUROPSYCHOPHARMACOL, V36, P375, DOI 10.1038/npp.2010.192; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zimmerman M, 2012, J CLIN PSYCHIAT, V73, P437, DOI 10.4088/JCP.11com07288; ZORNBERG GL, 1993, J CLIN PSYCHOPHARM, V13, P397	140	727	735	16	300	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1561	1572		10.1016/S0140-6736(15)00241-X	http://dx.doi.org/10.1016/S0140-6736(15)00241-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26388529				2022-12-28	WOS:000373741600032
J	Sutter, RW; Bahl, S; Deshpande, JM; Verma, H; Ahmad, M; Venugopal, P; Rao, JV; Agarkhedkar, S; Lalwani, SK; Kunwar, A; Sethi, R; Takane, M; Mohanty, L; Chatterjee, A; John, TJ; Jafari, H; Aylward, RB				Sutter, Roland W.; Bahl, Sunil; Deshpande, Jagadish M.; Verma, Harish; Ahmad, Mohammad; Venugopal, P.; Rao, J. Venkateswara; Agarkhedkar, Sharad; Lalwani, Sanjay K.; Kunwar, Abhishek; Sethi, Raman; Takane, Marina; Mohanty, Lalitendu; Chatterjee, Arani; John, T. Jacob; Jafari, Hamid; Aylward, R. Bruce			Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial	LANCET			English	Article							ORAL POLIOVIRUS VACCINE; EPIDEMIOLOGY; CHILDREN	Background Polio eradication needs a new routine immunisation schedule-three or four doses of bivalent type 1 and type 3 oral poliovirus vaccine (bOPV) and one dose of inactivated poliovirus vaccine (IPV), but no immunogenicity data are available for this schedule. We aimed to assess immunogenicity of this vaccine schedule. Methods We did an open-label, randomised controlled trial in four centres in India. After informed consent was obtained from a parent or legally acceptable representative, healthy newborn babies were randomly allocated to one of five groups: trivalent OPV (tOPV); tOPV plus IPV; bOPV; bOPV plus IPV; or bOPV plus two doses of IPV (2IPV). The key eligibility criteria were: full-term birth (>= 37 weeks of gestation); birthweight >= 2.5 kg; and Apgar score of 9 or more. OPV was administered at birth, 6 weeks, 10 weeks, and 14 weeks; IPV was administered intramuscularly at 14 weeks. The primary study objective was to investigate immunogenicity of the new vaccine schedule, assessed by seroconversion against poliovirus types 1, 2, and 3 between birth and 18 weeks in the per-protocol population (all participants with valid serology results on cord blood and at 18 weeks). Neutralisation assays tested cord blood and sera collected at 14 weeks, 18 weeks, 19 weeks, and 22 weeks by investigators masked to group allocation. This trial was registered with the India Clinical Trials Registry, number CTRI/2013/06/003722. Findings Of 900 newborn babies enrolled between June 13 and Aug 29, 2013, 782 (87%) completed the per-protocol requirements. Between birth and age 18 weeks, seroconversion against poliovirus type 1 in the tOPV group occurred in 162 of 163 (99.4%, 95% CI 96.6-100), in 150 (98.0%, 94.4-99.6) of 153 in the tOPV plus IPV group, in 153 (98.7%, 95.4-99.8) of 155 in the bOPV group, in 155 (99.4%, 96.5-100) of 156 in the bOPV plus IPV group, and in 154 (99.4%, 96.5-100) of 155 in the bOPV plus 2IPV group. Seroconversion against poliovirus type 2 occurred in 157 (96.3%, 92.2-98.6) of 163 in the tOPV group, 153 (100%, 97.6-100.0) of 153 in the tOPV plus IPV group, 29 (18.7%, 12.9-25.7) of 155 in the bOPV group, 107 (68.6%, 60.7-75.8) of 156 in the bOPV plus IPV group, and in 121 (78.1%, 70.7-84.3) of 155 in the bOPV plus 2IPV group. Seroconversion against poliovirus type 3 was achieved in 147 (90.2%, 84.5-94.3) of 163 in the tOPV group, 152 (99.3%, 96.4-100) of 153 in the tOPV plus IPV group, 151 (97.4%, 93.5-99.3) of 155 in the bOPV group, 155 (99.4%, 96.5-100) of 156 in the bOPV plus IPV group, and 153 (98.7%, 95.4-99.8) of 155 in the bOPV plus 2IPV group. Superiority was achieved for vaccine regimens including IPV against poliovirus type 3 compared with those not including IPV (tOPV plus IPV vs tOPV alone, p=0.0008; and bOPV plus IPV vs bOPV alone, p=0.0153). 12 serious adverse events occurred (six in the tOPV group, one in the tOPV plus IPV group, three in the bOPV group, zero in the bOPV plus IPV group, and two in the bOPV plus 2IPV group), none of which was attributed to the trial intervention. Interpretation The new vaccination schedule improves immunogenicity against polioviruses, especially against poliovirus type 3.	[Sutter, Roland W.; Verma, Harish; Takane, Marina; Jafari, Hamid; Aylward, R. Bruce] WHO, CH-1211 Geneva, Switzerland; [Bahl, Sunil; Ahmad, Mohammad; Kunwar, Abhishek; Sethi, Raman] WHO, India Natl Polio Surveillance Project, New Delhi, India; [Bahl, Sunil] WHO, Reg Off South East Asia, New Delhi, India; [Deshpande, Jagadish M.] Enterovirus Res Ctr, Haffkine Inst Compound, Bombay, Maharashtra, India; [Venugopal, P.] Andhra Med Coll, Visakhapatnam, Andhra Pradesh, India; [Rao, J. Venkateswara] Gandhi Med Coll & Hosp, Secunderabad, India; [Agarkhedkar, Sharad] Dr DY Patil Med Coll, Pune, Maharashtra, India; [Lalwani, Sanjay K.] Bharati Vidyapeeth Deemed Univ Med Coll, Pune, Maharashtra, India; [Mohanty, Lalitendu; Chatterjee, Arani] Panacea Biotec Ltd, New Delhi, India; [Chatterjee, Arani] Biol E Ltd, Hyderabad, Andhra Pradesh, India; [John, T. Jacob] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	World Health Organization; World Health Organization; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; Andhra Medical College; Gandhi Medical College & Hospital, Hyderabad; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre; Bharati Vidyapeeth Deemed University; Christian Medical College & Hospital (CMCH) Vellore	Sutter, RW (corresponding author), WHO, Ave Appia, CH-1211 Geneva, Switzerland.	sutterr@who.int		Lalwani, Sanjay/0000-0003-4446-2357; Deshpande, Jagadish/0000-0001-5194-0375	WHO, through a grant from Rotary International [59735]	WHO, through a grant from Rotary International	WHO, through a grant from Rotary International (grant number 59735).	Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P1; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P253; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P73; [Anonymous], 2005, VIENN R FDN STAT COM; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Chandir S, 2014, J INFECT DIS, V210, pS390, DOI 10.1093/infdis/jiu378; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Department of Immunization Vaccines and Biologicals, 2004, POL LAB MAN; Effron B, 1993, INTRO BOOTSTRAP; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Expanded Programme on Immunization, 1991, WHOEPIRD913; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Global Polio Eradication Initiative, 2013, POL ER ENDG STRAT PL; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Habib MA, 2015, VACCINE, V33, P819, DOI 10.1016/j.vaccine.2014.12.001; Immunization Systems Management Group of the Global Polio Eradication Initiative, 2015, Weekly Epidemiological Record, V90, P337; Iwarson S, 2004, J TRAVEL MED, V11, P120, DOI 10.2310/7060.2004.17079; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; Mir F, 2015, LANCET INFECT DIS, V15, P889, DOI 10.1016/S1473-3099(15)00093-6; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Platt LR, 2014, J INFECT DIS, V210, pS380, DOI 10.1093/infdis/jiu184; Resik S, 2015, VACCINE, V33, P307, DOI 10.1016/j.vaccine.2014.11.025; Resik S, 2013, NEW ENGL J MED, V368, P416, DOI 10.1056/NEJMoa1202541; SAS, 1989, SAS STAT US GUID VER, V1; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Sutter RW, 2013, VACCINE, P574; Vidor E, 2013, POLIOVIRUS VACCINE I	30	44	45	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2413	2421		10.1016/S0140-6736(15)00237-8	http://dx.doi.org/10.1016/S0140-6736(15)00237-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26388534				2022-12-28	WOS:000366290400035
J	Summers, LH				Summers, Lawrence H.		267 Signatories	Economists' declaration on universal health coverage	LANCET			English	Editorial Material									[Summers, Lawrence H.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Summers, LH (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	Lawrence_Summers@harvard.edu						Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kydland FE, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P701; Save the Children, 2015, WAK UP CALL LESS EB; Schaferhoff M, 2015, LANCET; Sen A., 2015, GUARDIAN LONDON 0106; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; WHO Commission on Macroeconomics and Health, 2002, HLTH EC GROWTH POV R; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	8	29	29	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2112	2113		10.1016/S0140-6736(15)00242-1	http://dx.doi.org/10.1016/S0140-6736(15)00242-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26388531				2022-12-28	WOS:000365987600032
J	Kim, JJ; Campos, NG; Sy, S; Burger, EA; Cuzick, J; Castle, PE; Hunt, WC; Waxman, A; Wheeler, CM				Kim, Jane J.; Campos, Nicole G.; Sy, Stephen; Burger, Emily A.; Cuzick, Jack; Castle, Philip E.; Hunt, William C.; Waxman, Alan; Wheeler, Cosette M.		New Mexico HPV Pap Registry	Inefficiencies and High-Value Improvements in US Cervical Cancer Screening Practice A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; NATURAL-HISTORY MODEL; UNITED-STATES; FOLLOW-UP; WOMEN; PREVENTION; NEOPLASIA; INFECTION; TIME; GUANACASTE	Background: Studies suggest that cervical cancer screening practice in the United States is inefficient. The cost and health implications of nonadherence in the screening process compared with recommended guidelines are uncertain. Objective: To estimate the benefits, costs, and cost-effectiveness of current cervical cancer screening practice and assess the value of screening improvements. Design: Model-based cost-effectiveness analysis. Data Sources: New Mexico HPV Pap Registry; medical literature. Target Population: Cohort of women eligible for routine screening. Time Horizon: Lifetime. Perspective: Societal. Intervention: Current cervical cancer screening practice; improved adherence to guidelines-based screening interval, triage testing, diagnostic referrals, and precancer treatment referrals. Outcome Measures: Reductions in lifetime cervical cancer risk, quality-adjusted life-years (QALYs), lifetime costs, incremental cost-effectiveness ratios, and incremental net monetary benefits (INMBs). Results of Base-Case Analysis: Current screening practice was associated with lower health benefit and was not cost-effective relative to guidelines-based strategies. Improvements in the screening process were associated with higher QALYs and small changes in costs. Perfect adherence to screening every 3 years with cytologic testing and adherence to colposcopy/biopsy referrals were associated with the highest INMBs ($759 and $741, respectively, at a willingness-to-pay threshold of $100 000 per QALY gained); together, the INMB increased to $1645. Results of Sensitivity Analysis: Current screening practice was inefficient in 100% of simulations. The rank ordering of screening improvements according to INMBs was stable over a range of screening inputs and willingness-to-pay thresholds. Limitation: The effect of human papillomavirus vaccination was not considered. Conclusion: The added health benefit of improving adherence to guidelines, especially the 3-year interval for cytologic screening and diagnostic follow-up, may justify additional investments in interventions to improve U.S. cervical cancer screening practice.	Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; Univ Oslo, Oslo, Norway; Queen Mary Univ London, London, England; Albert Einstein Coll Med, Bronx, NY 10467 USA; Global Coalit Cerv Canc, Arlington, VA USA; Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; University of London; Queen Mary University London; Yeshiva University; Albert Einstein College of Medicine; University of New Mexico; University of New Mexico's Health Sciences Center	Kim, JJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	jkim@hsph.harvard.edu	Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554	U.S. National Cancer Institute; NATIONAL CANCER INSTITUTE [U54CA164336] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	U.S. National Cancer Institute.	[Anonymous], CAN FACTS FIG 2014; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Bratti MC, 2004, REV PANAM SALUD PUBL, V15, P75; Burger EA, 2014, INT J CANCER, V135, P1931, DOI 10.1002/ijc.28838; Campos NG, 2014, AM J EPIDEMIOL, V180, P545, DOI 10.1093/aje/kwu159; Cantor SB, 2006, MED DECIS MAKING, V26, P265, DOI 10.1177/027298906288679; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Centers for Medicare & Medicaid Services, 2012 CLIN LAB FEE SC; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Cuzick J, 2015, INT J CANCER, V136, P2854, DOI 10.1002/ijc.29337; Cuzick J, 2014, CANCER EPIDEM BIOMAR, V23, P765, DOI 10.1158/1055-9965.EPI-13-0973; Downs LS, 2008, GYNECOL ONCOL, V109, pS22, DOI 10.1016/j.ygyno.2008.01.003; Eltoum IA, 2007, CANCER CYTOPATHOL, V111, P34, DOI 10.1002/cncr.22487; Gold MR, 1996, COST EFFECTIVENESS H; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; Howlader N, 2014, SEER CANCER STAT REV; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Kim JJ, 2013, JAMA INTERN MED, V173, P241, DOI 10.1001/2013.jamainternmed.1034; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; Kinney W, 2014, GYNECOL ONCOL, V132, P628, DOI 10.1016/j.ygyno.2013.12.037; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Rauh-Hain JA, 2013, CANCER-AM CANCER SOC, V119, P3644, DOI 10.1002/cncr.28261; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Saslow D, 2012, J LOW GENIT TRACT DI, V16, P175, DOI 10.1097/LGT.0b013e31824ca9d5; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; U.S. Bureau of Labor Statistics, 2012 CONS PRIC IND M; US Census Bureau, AM COMM SURV ACS 200; Wheeler CM, 2014, INT J CANCER, V135, P624, DOI 10.1002/ijc.28605; Wheeler CM, 2013, INT J CANCER, V132, P198, DOI 10.1002/ijc.27608; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510	37	50	51	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					589	+		10.7326/M15-0420	http://dx.doi.org/10.7326/M15-0420			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26414147	Green Accepted			2022-12-28	WOS:000363737400017
J	Murray, CJL				Murray, Christopher J. L.			Shifting to Sustainable Development Goals - Implications for Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.							[Anonymous], 2001, MACR HLTH INV HLTH E; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJ, 2015, LANCET, V386, P2145, DOI DOI 10.1016/S0140-6736(15)61340-X; United Nations, 2015, MILL DEV GOALS REP 2	5	57	59	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1390	1393		10.1056/NEJMp1510082	http://dx.doi.org/10.1056/NEJMp1510082			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8XI	26376045				2022-12-28	WOS:000362372800003
J	Lemmon, JP				Lemmon, John P.			Reimagine fuel cells	NATURE			English	Editorial Material							ENERGY-STORAGE		US Dept Energy Adv Res Projects Agcy Energy ARPA, Washington, DC 20585 USA		Lemmon, JP (corresponding author), US Dept Energy Adv Res Projects Agcy Energy ARPA, Washington, DC 20585 USA.	john.lemmon@hq.doe.gov						Chartouni D, 2002, INT J HYDROGEN ENERG, V27, P945, DOI 10.1016/S0360-3199(01)00186-0; Duan CC, 2015, SCIENCE, V349, P1321, DOI 10.1126/science.aab3987; Federal Energy Regulatory Commission et al, 2012, ASS DEM RESP ADV MET; Jacobs T., 2013, J PET TECHNOL, V65, P4135; Lew D., 2013, W WIND SOLAR INTEGRA; Schroder C., 2012, SPIEGEL ENERGY REVOL; US Energy Information Administration, 2013, MOD DISTR GEN BUILD; Van Overmeere Q, 2012, NANO LETT, V12, P3756, DOI 10.1021/nl301601y; Wang CS, 2004, J ELECTROCHEM SOC, V151, pA260, DOI 10.1149/1.1640627; Weiss J., 2015, INTEGRATING RENEWABL	10	60	61	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					447	449		10.1038/525447a	http://dx.doi.org/10.1038/525447a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399813	Bronze			2022-12-28	WOS:000361599900023
J	Barontini, G; Hohmann, L; Haas, F; Esteve, J; Reichel, J				Barontini, Giovanni; Hohmann, Leander; Haas, Florian; Esteve, Jerome; Reichel, Jakob			Deterministic generation of multiparticle entanglement by quantum Zeno dynamics	SCIENCE			English	Article							STATE; ATOMS; MODE; BITS	Multiparticle entangled quantum states, a key resource in quantum-enhanced metrology and computing, are usually generated by coherent operations exclusively. However, unusual forms of quantum dynamics can be obtained when environment coupling is used as part of the state generation. In this work, we used quantum Zeno dynamics (QZD), based on nondestructive measurement with an optical microcavity, to deterministically generate different multiparticle entangled states in an ensemble of 36 qubit atoms in less than 5 microseconds. We characterized the resulting states by performing quantum tomography, yielding a time-resolved account of the entanglement generation. In addition, we studied the dependence of quantum states on measurement strength and quantified the depth of entanglement. Our results show that QZD is a versatile tool for fast and deterministic entanglement generation in quantum engineering applications.	[Barontini, Giovanni; Hohmann, Leander; Haas, Florian; Esteve, Jerome; Reichel, Jakob] Univ Paris 06, Ecole Normale Super, Lab Kastler Brossel, Coll France, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Reichel, J (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Kastler Brossel, Coll France, 24 Rue Lhomond, F-75005 Paris, France.	jakob.reichel@ens.fr	Reichel, Jakob/AAW-1107-2021; Barontini, Giovanni/B-7714-2015; Esteve, Jerome/G-1084-2014	Reichel, Jakob/0000-0003-3420-4178; Barontini, Giovanni/0000-0003-1464-562X; Esteve, Jerome/0000-0002-1556-8120	European Union Information and Communication Technologies project QIBEC (Quantum Interferometry with Bose-Einstein Condensates) [GA 284584]; Institut Francilien pour la Recherche sur les Atomes Froids (IFRAF)	European Union Information and Communication Technologies project QIBEC (Quantum Interferometry with Bose-Einstein Condensates); Institut Francilien pour la Recherche sur les Atomes Froids (IFRAF)	This work was supported by the European Union Information and Communication Technologies project QIBEC (Quantum Interferometry with Bose-Einstein Condensates) (GA 284584) and by the Institut Francilien pour la Recherche sur les Atomes Froids (IFRAF). We thank J. Volz, R. Gehr, and G. Dubois for their contributions to early stages of this experiment. G.B. and L.H. performed the experiment; F.H. contributed to the experimental setup; and G.B., L.H., J.E., and J. R. contributed to data analysis and interpretation, as well as to writing the manuscript.	Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Brandstatter B, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4838696; Bretheau L, 2015, SCIENCE, V348, P776, DOI 10.1126/science.1259345; Chandrashekar CM, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.052108; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Facchi P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.080401; Facchi P, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/49/493001; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Lin Y, 2013, NATURE, V504, P415, DOI 10.1038/nature12801; Maniscalco S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.090503; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; Muller A, 2010, OPT LETT, V35, P2293, DOI 10.1364/OL.35.002293; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Raimond JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.213601; Rossi R, 2009, PHYS LETT A, V374, P158, DOI 10.1016/j.physleta.2009.10.086; Schafer F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4194; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Shankar S, 2013, NATURE, V504, P419, DOI 10.1038/nature12802; Shao XQ, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/16/165507; Shi ZC, 2012, EUR PHYS J D, V66, DOI 10.1140/epjd/e2012-20733-1; Signoles A, 2014, NAT PHYS, V10, P715, DOI [10.1038/nphys3076, 10.1038/NPHYS3076]; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Uphoff M, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/013053; Verstraete F, 2009, NAT PHYS, V5, P633, DOI 10.1038/NPHYS1342; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225; Wang XB, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.062339	30	78	78	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1317	1321		10.1126/science.aaa0754	http://dx.doi.org/10.1126/science.aaa0754			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383948	Green Submitted			2022-12-28	WOS:000361357700044
J	Sege, R; Nykiel-Bub, L; Selk, S				Sege, Robert; Nykiel-Bub, Linley; Selk, Sabrina			Sex Differences in Institutional Support for Junior Biomedical Researchers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							FACULTY; GENDER		[Sege, Robert; Nykiel-Bub, Linley] Hlth Resources Act, Med Fdn Div, Boston, MA 02116 USA; [Selk, Sabrina] Natl Inst Child Healthcare Qual, Boston, MA USA		Sege, R (corresponding author), Hlth Resources Act, 95 Berkeley St, Boston, MA 02116 USA.	rsege@hria.org		Sege, Robert/0000-0003-1260-4787				Barnett RC, 1998, ACAD MED, V73, P180, DOI 10.1097/00001888-199802000-00017; Holliday EB, 2014, ACAD MED, V89, P767, DOI 10.1097/ACM.0000000000000229; Mayer AP, 2014, ACAD MED, V89, P312, DOI 10.1097/ACM.0000000000000089; NIH, BIOM RES WORKF WORK; Rockey S, WOMEN BIOMEDICAL RES	5	140	140	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1175	1177		10.1001/jama.2015.8517	http://dx.doi.org/10.1001/jama.2015.8517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26372589	Bronze			2022-12-28	WOS:000361284500031
J	Chinthapalli, K				Chinthapalli, Krishna			HEADS UP The billion dollar business of being smart	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MODAFINIL		Royal N Shore Hosp, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney	Chinthapalli, K (corresponding author), Royal N Shore Hosp, Sydney, NSW, Australia.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Allaire JC, 2014, SCIENCEINSIDER; BALZAC HD, 1996, MICH QUART REV, V35, P273; Centers for Disease Control and Prevention, 2015, ATTENTION DEFICIT HY; Duke University, AC DISH; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Hawkes N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4573; Miech R. A., 2015, MONITORING FUTURE NA, V1; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Musso MW, 2014, J ATTEN DISORD, V18, P186, DOI 10.1177/1087054712441970; Pringle E., 2010, RISE FALL PROVIGIL; Singh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105969; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Talbot M., 2009, NEW YORKER	13	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4829	10.1136/bmj.h4829	http://dx.doi.org/10.1136/bmj.h4829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26370589				2022-12-28	WOS:000361678200019
J	Wainwright, CE; Kapur, N				Wainwright, Claire E.; Kapur, Nitin			Oxygen saturation targets in infants with bronchiolitis	LANCET			English	Editorial Material							COUGH		[Wainwright, Claire E.; Kapur, Nitin] Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, Brisbane, Qld 4101, Australia		Wainwright, CE (corresponding author), Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, Brisbane, Qld 4101, Australia.	claire.wainwright@health.qld.gov.au	Wainwright, Claire E/G-4218-2013; Kapur, Nitin/H-2003-2013	Wainwright, Claire E/0000-0001-8389-3809; Kapur, Nitin/0000-0002-8423-0596				Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bass JL, 2007, PEDIATRICS, V119, P611, DOI 10.1542/peds.2006-3002; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Cunningham S, 2012, ARCH DIS CHILD, V97, P361, DOI 10.1136/adc.2010.205211; Hay AD, 2003, FAM PRACT, V20, P696, DOI 10.1093/fampra/cmg613; Hunt CE, 1999, J PEDIATR-US, V135, P580, DOI 10.1016/S0022-3476(99)70056-9; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Mason NP, 1999, EUR RESPIR J, V13, P508, DOI 10.1183/09031936.99.13350899; Network SIG, 2006, BRONCH CHILDR SIGN 9; Schuh S, 2014, JAMA-J AM MED ASSOC, V312, P712, DOI 10.1001/jama.2014.8637; Sundar Krishna M, 2010, Cough, V6, P2, DOI 10.1186/1745-9974-6-2; Unger S, 2008, PEDIATRICS, V121, P470, DOI 10.1542/peds.2007-1135; Walsh P, 2015, WEST J EMERG MED, V16, P85, DOI 10.5811/westjem.2015.1.24930	13	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1016	1018		10.1016/S0140-6736(15)00155-5	http://dx.doi.org/10.1016/S0140-6736(15)00155-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26382980	hybrid			2022-12-28	WOS:000361189200005
J	Taylor-Weiner, H; Zivin, JG				Taylor-Weiner, Hermes; Zivin, Joshua Graff			Medicine's Wild West - Unlicensed Stem-Cell Clinics in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Taylor-Weiner, Hermes] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Zivin, Joshua Graff] Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA; [Zivin, Joshua Graff] Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA; [Taylor-Weiner, Hermes] Sanford Consortium Regenerat Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor-Weiner, H (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.		Zivin, Joshua Graff/ABF-1697-2020					[Anonymous], 2014, HUM CELLS TISS CELL; Connolly R, 2014, TRAVEL MED INFECT DI, V12, P695, DOI 10.1016/j.tmaid.2014.09.008; Food and Drug Administration, 2014, MIN MAN HUM CELLS TI; Hanke W, 2004, DERMATOL SURG, V30, P967, DOI 10.1111/j.1524-4725.2004.30300.x	4	39	40	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					985	987		10.1056/NEJMp1504560	http://dx.doi.org/10.1056/NEJMp1504560			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ9TV	26352811				2022-12-28	WOS:000360959000001
J	Takwoingi, Y; Abba, K; Garner, P				Takwoingi, Yemisi; Abba, Katharine; Garner, Paul			Rapid Diagnostic Testing for Plasmodium vivax and Nonfalciparum Malaria in Endemic Areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Takwoingi, Yemisi] Univ Birmingham, Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Abba, Katharine; Garner, Paul] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England	University of Birmingham; Liverpool School of Tropical Medicine	Takwoingi, Y (corresponding author), Univ Birmingham, Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England.	y.takwoingi@bham.ac.uk	Garner, Paul/Y-8385-2019; Garner, Paul/HII-5856-2022	Garner, Paul/0000-0002-0607-6941; Takwoingi, Yemisi/0000-0002-5828-9746	UK Aid from the UK government [PO 5242]; Department for International Development (DFID) [201400] Funding Source: researchfish	UK Aid from the UK government(CGIAR); Department for International Development (DFID)	The Cochrane review was funded by UK Aid (HRPC09 Evidence Building and Synthesis Research, Department for International Development [contract PO 5242]) from the UK government for the benefit of developing countries.	[Anonymous], 2011, COCHRANE DATABASE SY; [Anonymous], COCHRANE DATABASE SY; [Anonymous], GUID TREATM MAL; Chong CK, 2014, KOREAN J PARASITOL, V52, P501, DOI 10.3347/kjp.2014.52.5.501; Herrera S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-87; Kumari P. R., 2014, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V5, P1428; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Vyas S, 2014, E MEDITERR HEALTH J, V20, P236, DOI 10.26719/2014.20.4.236	8	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1065	1066		10.1001/jama.2015.6719	http://dx.doi.org/10.1001/jama.2015.6719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348756	Green Accepted			2022-12-28	WOS:000360840700019
J	Williams, B; MacDonald, TM; Morant, S; Webb, DJ; Sever, P; McInnes, G; Ford, I; Cruickshank, JK; Caulfield, MJ; Salsbury, J; Mackenzie, I; Padmanabhan, S; Brown, MJ				Williams, Bryan; MacDonald, Thomas M.; Morant, Steve; Webb, David J.; Sever, Peter; McInnes, Gordon; Ford, Ian; Cruickshank, J. Kennedy; Caulfield, Mark J.; Salsbury, Jackie; Mackenzie, Isla; Padmanabhan, Sandosh; Brown, Morris J.		British Hypertension Soc PATHWAY S	Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial	LANCET			English	Article							BLOOD-PRESSURE; ARTERIAL-HYPERTENSION; GUIDELINES; MANAGEMENT; METAANALYSIS; RENIN	Background Optimal drug treatment for patients with resistant hypertension is undefined. We aimed to test the hypotheses that resistant hypertension is most often caused by excessive sodium retention, and that spironolactone would therefore be superior to non-diuretic add-on drugs at lowering blood pressure. Methods In this double-blind, placebo-controlled, crossover trial, we enrolled patients aged 18-79 years with seated clinic systolic blood pressure 140 mm Hg or greater (or >= 135 mm Hg for patients with diabetes) and home systolic blood pressure (18 readings over 4 days) 130 mm Hg or greater, despite treatment for at least 3 months with maximally tolerated doses of three drugs, from 12 secondary and two primary care sites in the UK. Patients rotated, in a preassigned, randomised order, through 12 weeks of once daily treatment with each of spironolactone (25-50 mg), bisoprolol (5-10 mg), doxazosin modified release (4-8 mg), and placebo, in addition to their baseline blood pressure drugs. Random assignment was done via a central computer system. Investigators and patients were masked to the identity of drugs, and to their sequence allocation. The dose was doubled after 6 weeks of each cycle. The hierarchical primary endpoints were the difference in averaged home systolic blood pressure between spironolactone and placebo, followed (if significant) by the difference in home systolic blood pressure between spironolactone and the average of the other two active drugs, followed by the difference in home systolic blood pressure between spironolactone and each of the other two drugs. Analysis was by intention to treat. The trial is registered with EudraCT number 2008-007149-30, and ClinicalTrials. gov number, NCT02369081. Findings Between May 15, 2009, and July 8, 2014, we screened 436 patients, of whom 335 were randomly assigned. After 21 were excluded, 285 patients received spironolactone, 282 doxazosin, 285 bisoprolol, and 274 placebo; 230 patients completed all treatment cycles. The average reduction in home systolic blood pressure by spironolactone was superior to placebo (-8.70 mm Hg [95% CI -9.72 to -7.69]; p<0.0001), superior to the mean of the other two active treatments (doxazosin and bisoprolol; -4.26 [-5.13 to -3.38]; p<0.0001), and superior when compared with the individual treatments; versus doxazosin (-4.03 [-5.04 to -3.02]; p<0.0001) and versus bisoprolol (-4.48 [-5.50 to -3.46]; p<0.0001). Spironolactone was the most effective blood pressure-lowering treatment, throughout the distribution of baseline plasma renin; but its margin of superiority and likelihood of being the best drug for the individual patient were many-fold greater in the lower than higher ends of the distribution. All treatments were well tolerated. In six of the 285 patients who received spironolactone, serum potassium exceeded 6.0 mmol/L on one occasion. Interpretation Spironolactone was the most effective add-on drug for the treatment of resistant hypertension. The superiority of spironolactone supports a primary role of sodium retention in this condition. Copyright (C) Williams et al. Open Access article distributed under the terms of CC BY.	[Williams, Bryan] UCL, Inst Cardiovasc Sci, London, England; [Williams, Bryan] UCL UCL Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England; [MacDonald, Thomas M.; Morant, Steve; Mackenzie, Isla] Univ Dundee, Med Res Inst, Med Monitoring Unit, Dundee, Scotland; [Webb, David J.] Univ Edinburgh, Clin Pharmacol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [McInnes, Gordon; Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Cruickshank, J. Kennedy] Kings Coll London, Cardiovasc Med & Diabet, London WC2R 2LS, England; [Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Salsbury, Jackie; Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 1TN, England	University of London; University College London; University of London; University College London; University of Dundee; University of Edinburgh; Imperial College London; University of Glasgow; University of Glasgow; University of London; King's College London; University of London; Queen Mary University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Williams, B (corresponding author), Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 0QQ, England.	bryan.williams@ucl.ac.uk; m.j.brown@cai.cam.ac.uk	Ford, Ian/ABE-6145-2020; Padmanabhan, Sandosh/S-3963-2016	MacDonald, Thomas/0000-0001-5189-6669; Caulfield, Mark/0000-0001-9295-3594; Mackenzie, Isla/0000-0002-3680-7127; Padmanabhan, Sandosh/0000-0003-3869-5808; McCallum, Linsay/0000-0001-6596-647X; Williams, Bryan/0000-0002-8094-1841; Morant, Steven/0000-0001-5674-3784	British Heart Foundation; National Institute for Health Research; British Heart Foundation [FS/14/52/30901, FS/14/12/30540, FS/14/75/31134, SP/08/002/24118, FS/11/35/28871, PG/07/085/23349] Funding Source: researchfish; Medical Research Council [MR/K006584/1, G9521010] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10059, NF-SI-0611-10273, NF-SI-0512-10113, NF-SI-0514-10011, NF-SI-0512-10052] Funding Source: researchfish; MRC [G9521010] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The British Heart Foundation and National Institute for Health Research.	Achelrod D, 2015, AM J HYPERTENS, V28, P355, DOI 10.1093/ajh/hpu151; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Brown MJ, 2007, HEART, V93, P1026, DOI 10.1136/hrt.2006.107706; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Dahal K, 2015, AM J HYPERTENS, V28, P1376, DOI 10.1093/ajh/hpv031; ESH/ESC, 2013, BLOOD PRESSURE, V22, P193, DOI DOI 10.3109/08037051.2013.812549; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Kjeldsen S, 2014, DRUGS, V74, P2033, DOI 10.1007/s40265-014-0306-5; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Morganti A, 2010, J HYPERTENS, V28, P1307, DOI 10.1097/HJH.0b013e32833857ad; Myat A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7473; Nishizaka MK, 2003, AM J HYPERTENS, V16, P925, DOI 10.1016/S0895-7061(03)01032-X; Oxlund CS, 2013, J HYPERTENS, V31, P2094, DOI 10.1097/HJH.0b013e3283638b1a; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Taler SJ, 2002, HYPERTENSION, V39, P982, DOI 10.1161/01.HYP.0000016176.16042.2F; Tomaszewski M, 2014, HEART, V100, P855, DOI 10.1136/heartjnl-2013-305063; Vaclavik J, 2011, HYPERTENSION, V57, P1069, DOI 10.1161/HYPERTENSIONAHA.111.169961; Wei L, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1768; Williams B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008951; Williams B, 2009, LANCET, V374, P1396, DOI 10.1016/S0140-6736(09)61600-7	21	607	643	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2059	2068		10.1016/S0140-6736(15)00257-3	http://dx.doi.org/10.1016/S0140-6736(15)00257-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26414968	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000365987600027
J	Ge, JP; Li, WQ; Zhao, QC; Li, NN; Chen, MF; Zhi, P; Li, RC; Gao, N; Xiao, BL; Yang, MJ				Ge, Jingpeng; Li, Wanqiu; Zhao, Qiancheng; Li, Ningning; Chen, Maofei; Zhi, Peng; Li, Ruochong; Gao, Ning; Xiao, Bailong; Yang, Maojun			Architecture of the mammalian mechanosensitive Piezol channel	NATURE			English	Article							ACTIVATED ION-CHANNEL; OF-FUNCTION MUTATIONS; GATED SODIUM-CHANNEL; CRYSTAL-STRUCTURE; DISTAL ARTHROGRYPOSIS; MERKEL CELLS; MECHANOTRANSDUCTION; RECEPTORS; MECHANISM; STATE	Piezo proteins are evolutionarily conserved and functionally diverse mechanosensitive cation channels. However, the overall structural architecture and gating mechanisms of Piezo channels have remained unknown. Here we determine the cryo-electron microscopy structure of the full-length (2,547 amino acids) mouse Piezol (Piezol) at a resolution of 4.8 angstrom. Piezol forms a trimeric propeller-like structure (about 900 kilodalton), with the extracellular domains resembling three distal blades and a central cap. The transmembrane region has 14 apparently resolved segments per subunit. These segments form three peripheral wings and a central pore module that encloses a potential ion-conducting pore. The rather flexible extracellular blade domains are connected to the central intracellular domain by three long beam-like structures. This trimeric architecture suggests that Piezol may use its peripheral regions as force sensors to gate the central ion-conducting pore.	[Ge, Jingpeng; Zhao, Qiancheng; Chen, Maofei; Li, Ruochong; Xiao, Bailong; Yang, Maojun] Tsinghua Univ, Sch Life Sci Med, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Ge, Jingpeng; Li, Wanqiu; Li, Ningning; Chen, Maofei; Li, Ruochong; Gao, Ning; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci, Minist Educ, Beijing 100084, Peoples R China; [Zhao, Qiancheng; Zhi, Peng; Xiao, Bailong] Tsinghua Univ, Sch Med, Dept Pharmacol & Pharmaceut Sci, Beijing 100084, Peoples R China; [Xiao, Bailong] Tsinghua Univ, IDG McGovern Inst Brain Res, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Gao, N (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci, Minist Educ, Beijing 100084, Peoples R China.	ninggao@tsinghua.edu.cn; xbailong@biomed.tsinghua.edu.cn; maojunyang@tsinghua.edu.cn	Ge, Jingpeng/AGG-3471-2022; Gao, Ning/AAK-2214-2020; Gao, Ning/J-9623-2012; Zhao, Qiancheng/AAY-6658-2021; Gai, Jingpeng/AAT-9369-2021	Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Gai, Jingpeng/0000-0001-6164-1221; Li, Ningning/0000-0001-8601-5171; Yang, Maojun/0000-0002-6798-3094; Li, Wanqiu/0000-0002-9227-3246	Ministry of Science and Technology [2012CB911101, 2011CB910502, 2015CB910102, 2013CB910404]; National Natural Science Foundation of China [21532004, 31570733, 31030020, 31170679, 31422016, 31422027]; Ministry of Education	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	We thank H. Yu and J. Chai for discussion and proofreading of the manuscript. We thank the staff at beamline BL17U of the Shanghai Synchrotron Radiation Facility (SSRF) and beamline 3W1A of the Beijing Synchrotron Radiation, Facility (BSRF) for their assistance in data collection. K. Wu and H. Wang are acknowledged for technique.help. We also thank the National Center for Protein Sciences (Beijing, China) for technical support with cryo-electron microscopy data collection and for computation resources. This work was supported by grants from the Ministry of Science and Technology (2012CB911101 and 2011CB910502 to M.Y., 2015CB910102 to B.X. and 2013CB910404 to N.G.), the National Natural Science Foundation of China (21532004, 31570733, 31030020 and 31170679 to M.Y., 31422016 to N.G. and 31422027 to B.X.) and the Ministry of Education (the Young Thousand Talent program to B.X.).	Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Bae C, 2013, BIOPHYS J, V105, P880, DOI 10.1016/j.bpj.2013.07.019; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beneteau C, 2014, CLIN GENET, V85, P293, DOI 10.1111/cge.12147; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Faucherre A, 2014, HAEMATOLOGICA, V99, P70, DOI 10.3324/haematol.2013.086090; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gottlieb PA, 2012, CHANNELS, V6, P214, DOI 10.4161/chan.21050; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Kamajaya A, 2014, STRUCTURE, V22, P1520, DOI 10.1016/j.str.2014.08.009; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prole DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066068; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Schneider ER, 2014, P NATL ACAD SCI USA, V111, P14941, DOI 10.1073/pnas.1413656111; Schrenk-Siemens K, 2015, NAT NEUROSCI, V18, P10, DOI 10.1038/nn.3894; Shmukler BE, 2014, BLOOD CELL MOL DIS, V52, P53, DOI 10.1016/j.bcmd.2013.07.015; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	48	233	255	17	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					64	69		10.1038/nature15247	http://dx.doi.org/10.1038/nature15247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26390154				2022-12-28	WOS:000364270700043
J	Basu, S; Phillips, RS; Bitton, A; Song, ZR; Landon, BE				Basu, Sanjay; Phillips, Russell S.; Bitton, Asaf; Song, Zirui; Landon, Bruce E.			Medicare Chronic Care Management Payments and Financial Returns to Primary Care Practices A Modeling Study	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL ADMISSIONS; GLOBAL PAYMENT; COMMUNITY CARE; HOME PILOT; PATIENT; HEALTH; COST; QUALITY; ORGANIZATIONS; IMPACT	Background: Physicians have traditionally been reimbursed for face-to-face visits. A new non-visit-based payment for chronic care management (CCM) of Medicare patients took effect in January 2015. Objective: To estimate financial implications of CCM payment for primary care practices. Design: Microsimulation model incorporating national data on primary care use, staffing, expenditures, and reimbursements. Data Sources: National Ambulatory Medical Care Survey and other published sources. Target Population: Medicare patients. Time Horizon: 10 years. Perspective: Practice-level. Intervention: Comparison of CCM delivery approaches by staff and physicians. Outcome Measures: Net revenue per full-time equivalent (FTE) physician; time spent delivering CCM services. Results of Base-Case Analysis: If nonphysician staff were to deliver CCM services, net revenue to practices would increase despite opportunity and staffing costs. Practices could expect approximately $332 per enrolled patient per year (95% CI, $234 to $429) if CCM services were delivered by registered nurses RNs), approximately $372 (CI, $276 to $468) if services were delivered by licensed practical nurses, and approximately $385 (CI, $286 to $485) if services were delivered by medical assistants. For a typical practice, this equates to more than $75 000 of net annual revenue per FTE physician and 12 hours of nursing service time per week if 50% of eligible patients enroll. At a minimum, 131 Medicare patients (CI, 115 to 140 patients) must enroll for practices to recoup the salary and overhead costs of hiring a full-time RN to provide CCM services. Results of Sensitivity Analysis: If physicians were to deliver all CCM services, approximately 25% of practices nationwide could expect net revenue losses due to opportunity costs of face-to-face visit time. Limitation: The CCM program may alter long-term primary care use, which is difficult to predict. Conclusion: Practices that rely on nonphysician team members to deliver CCM services will probably experience substantial net revenue gains but must enroll a sufficient number of eligible patients to recoup costs.	[Basu, Sanjay] Stanford Univ, Sch Med, Stanford, CA 94305 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Basu, S (corresponding author), Stanford Univ, Sch Med, Med Sch Off Build X322,1265 Welch Rd, Stanford, CA 94305 USA.				Center for Medicare & Medicaid Innovation	Center for Medicare & Medicaid Innovation	Dr. Bitton reports that he received personal fees from the Center for Medicare & Medicaid Innovation for serving as a part-time senior advisor to the Comprehensive Primary Care initiative at the Center for Medicare & Medicaid Innovation and that he participated in a technical expert panel convened by Mathematica Policy Research that advised the Assistant Secretary for Planning and Evaluation of Health and Human Services on the chronic care management fee. Dr. Landon reports personal fees from United Biosource and Research Triangle Institute outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-2677.	American Academy of Family Physicians, 2014, FPM SER DIR OBS PRIM; [Anonymous], 2013, MED EXP PAN SURV; Basu S, 2015, MED CARE, V53, P125, DOI 10.1097/MLR.0000000000000278; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540; Bielaszka-DuVernay C, 2011, HEALTH AFFAIR, V30, P383, DOI 10.1377/hlthaff.2011.0169; Bureau of Labor Statistics, 2014, OCC OUTL HDB; Bureau of Labor Statistics, 2015, CONS PRIC IND; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Centers for Disease Control and Prevention, 2014, NAT AMB MED CAR SURV; Centers for Medicare & Medicaid Services, 2015, CHR CAR MAN SERV FAC; Centers for Medicare & Medicaid Services, 2014, POL PAYM CHANG MED P; Centers for Medicare & Medicaid Services, 2011, ANN WELLN VIS AWV IN; Centers for Medicare & Medicaid Services, 2014, MED MOV FORW 2014; Centers for Medicare & Medicaid Services (CMS). HHS, 2014, FED REGISTER, V79, P67547; Christensen EW, 2013, MIL MED, V178, P135, DOI 10.7205/MILMED-D-12-00220; Coleman K, 2010, ANN FAM MED, V8, P493, DOI 10.1370/afm.1190; Cuenca Arnold E, 2012, Fam Pract Manag, V19, P11; Design Cost Data, 2007, NHBC DAT; DeVries A, 2012, AM J MANAG CARE, V18, P534; Driscoll DL, 2013, ANN FAM MED, V11, pS41, DOI 10.1370/afm.1474; Epstein AM, 2014, HEALTH AFFAIR, V33, P95, DOI 10.1377/hlthaff.2013.1063; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; Fillmore H, 2014, POPUL HEALTH MANAG, V17, P141, DOI 10.1089/pop.2013.0055; Flottemesch TJ, 2012, AM J MANAG CARE, V18, P677; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Grumbach K, 2013, JAMA INTERN MED, V173, P1913, DOI 10.1001/jamainternmed.2013.7652; Harbrecht MG, 2012, HEALTH AFFAIR, V31, P2010, DOI 10.1377/hlthaff.2012.0359; Hofert M, 2011, J STAT SOFTW, V39, P1; Husereau D, 2013, BJOG-INT J OBSTET GY, V120, P765, DOI 10.1111/1471-0528.12241; IBM, 2015, IBM KEN COMPANALYST; Landon BE, 2014, JAMA-J AM MED ASSOC, V312, P1633, DOI 10.1001/jama.2014.9529; Landon BE, 2012, NEW ENGL J MED, V366, P393, DOI 10.1056/NEJMp1112637; Lewis VA, 2013, HEALTH SERV RES, V48, P1840, DOI 10.1111/1475-6773.12102; Maeng DD, 2012, AM J MANAG CARE, V18, P149; Mathematica Policy Research, 2015, EV COMPR PRIM CAR IN; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; Medical Group, 2015, DATADIVE; Medical Group Management Association, 2014, COST SURV SINGL SPEC; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Moore Kent J, 2015, Fam Pract Manag, V22, P7; Patel MS, 2013, AM J MANAG CARE, V19, P509; Phillips RL, 2011, J AMBUL CARE MANAG, V34, P67, DOI 10.1097/JAC.0b013e3181ffc342; Raskas RS, 2012, HEALTH AFFAIR, V31, P2002, DOI 10.1377/hlthaff.2012.0364; Reid RJ, 2013, ANN FAM MED, V11, pS19, DOI 10.1370/afm.1476; Roby DH, 2010, MED CARE RES REV, V67, P412, DOI 10.1177/1077558710368682; Rosenberg CN, 2012, HEALTH AFFAIR, V31, P2423, DOI 10.1377/hlthaff.2011.1002; Schillinger D, 2000, J GEN INTERN MED, V15, P329, DOI 10.1046/j.1525-1497.2000.07010.x; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026; Song ZR, 2012, NEW ENGL J MED, V366, P1560, DOI 10.1056/NEJMp1201261; Steiner BD, 2008, ANN FAM MED, V6, P361, DOI 10.1370/afm.866; Taha H. A., 2010, OPERATIONS RES INTRO; Takach M, 2011, HEALTH AFFAIR, V30, P1325, DOI 10.1377/hlthaff.2011.0170; U.S. Census Bureau, 2019, CURRENT POPULATION S	55	34	34	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					580	+		10.7326/M14-2677	http://dx.doi.org/10.7326/M14-2677			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU7QV	26389533				2022-12-28	WOS:000363737400016
J	Mitchell, KJ; Cooper, A; Phillips, MJ				Mitchell, Kieren J.; Cooper, Alan; Phillips, Matthew J.			Comment on "Whole-genome analyses resolve early branches in the tree of life of modern birds"	SCIENCE			English	Editorial Material							CRETACEOUS ORIGIN; SUPPORT	Jarvis et al. (Research Articles, 12 December 2014, p. 1320) presented molecular clock analyses that suggested that most modern bird orders diverged just after the mass extinction event at the Cretaceous-Paleogene boundary (about 66 million years ago). We demonstrate that this conclusion results from the use of a single inappropriate maximum bound, which effectively precludes the Cretaceous diversification overwhelmingly supported by previous molecular studies.	[Mitchell, Kieren J.; Cooper, Alan] Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Phillips, Matthew J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia	University of Adelaide; Queensland University of Technology (QUT)	Mitchell, KJ (corresponding author), Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia.	kieren.mitchell@adelaide.edu.au	Phillips, Matthew J/J-1365-2012	Phillips, Matthew J/0000-0003-1532-449X; Mitchell, Kieren/0000-0002-3921-0262; Cooper, Alan/0000-0002-7738-7851				Agnolin FL, 2006, AMEGHINIANA, V43, P245; Barnett R, 2005, CURR BIOL, V15, pR589, DOI 10.1016/j.cub.2005.07.052; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Ksepka DT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0677; Mayr G, 2014, PALAEONTOLOGY, V57, P231, DOI 10.1111/pala.12103; Myers TS, 2010, J PALEONTOL, V84, P1071, DOI 10.1666/09-082.1; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Phillips MJ, 2015, PALAEONTOL ELECTRON, V18; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007	14	28	29	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1460	U52		10.1126/science.aab1062	http://dx.doi.org/10.1126/science.aab1062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404819				2022-12-28	WOS:000361707000031
J	Mutti, FG; Knaus, T; Scrutton, NS; Breuer, M; Turner, NJ				Mutti, Francesco G.; Knaus, Tanja; Scrutton, Nigel S.; Breuer, Michael; Turner, Nicholas J.			Conversion of alcohols to enantiopure amines through dual-enzyme hydrogen-borrowing cascades	SCIENCE			English	Article							CRYSTAL-STRUCTURE; CHIRAL AMINES; DEHYDROGENASE; AMINATION; SPECIFICITY; SUBSTRATE; ACID	alpha-Chiral amines are key intermediates for the synthesis of a plethora of chemical compounds at industrial scale. We present a biocatalytic hydrogen-borrowing amination of primary and secondary alcohols that allows for the efficient and environmentally benign production of enantiopure amines. The method relies on a combination of two enzymes: an alcohol dehydrogenase (from Aromatoleum sp., Lactobacillus sp., or Bacillus sp.) operating in tandem with an amine dehydrogenase (engineered from Bacillus sp.) to aminate a structurally diverse range of aromatic and aliphatic alcohols, yielding up to 96% conversion and 99% enantiomeric excess. Primary alcohols were aminated with high conversion (up to 99%). This redox self-sufficient cascade possesses high atom efficiency, sourcing nitrogen from ammonium and generating water as the sole by-product.	[Mutti, Francesco G.; Turner, Nicholas J.] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England; [Mutti, Francesco G.; Knaus, Tanja; Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Breuer, Michael] BASF SE, White Biotechnol Res, D-67056 Ludwigshafen, Germany	University of Manchester; University of Manchester; BASF	Mutti, FG (corresponding author), Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	f.mutti@uva.nl; nicholas.turner@manchester.ac.uk		Knaus, Tanja/0000-0001-9942-9226; Breuer, Michael/0000-0002-6683-4003; Turner, Nicholas/0000-0002-8708-0781	European Union [266025]; European Research Council under the European Union [638271]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K0017802/1]; Royal Society; BBSRC [BB/K00199X/1, BB/M017702/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K00199X/1, BB/M017702/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish	European Union(European Commission); European Research Council under the European Union(European Research Council (ERC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research leading to these results received funding from the European Union's Seventh Framework Programme FP7/2007-2013 under grant agreement 266025 (BIONEXGEN). The project leading to this application has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement no. 638271, BioSusAmin). T.K. and N.S.S. received funding from UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/K0017802/1). N.J.T. is grateful to the Royal Society for a Wolfson Research Merit Award. Some aspects of the results reported here are the subject of a provisional patent application. Author contributions: F.G.M. and N.J.T. conceived the project andwrote the manuscript; F.G.M. planned the experiments, expressed and purified the AmDHs, performed the biocatalytic reactions, and analyzed the data; T.K. performed the gene cloning of all AmDHs and purified the ADHs; N.S.S. and M.B. provided intellectual and technical support; and M.B. and BASF provided the ADHs. We thank R. Heath for a preliminary kinetic assay of the Ph-AmDH.	Abrahamson MJ, 2013, ADV SYNTH CATAL, V355, P1780, DOI 10.1002/adsc.201201030; Abrahamson MJ, 2012, ANGEW CHEM INT EDIT, V51, P3969, DOI 10.1002/anie.201107813; Arpe H J, 2010, IND ORGANIC CHEM; Au SK, 2014, ACS CATAL, V4, P4021, DOI 10.1021/cs4012167; Balkenhohl F, 1997, J PRAK CHEM-CHEM ZTG, V339, P381, DOI 10.1002/prac.19973390166; Bommarius BR, 2014, CHEM COMMUN, V50, P14953, DOI 10.1039/c4cc06527a; CANNIO R, 1994, EUR J BIOCHEM, V222, P345, DOI 10.1111/j.1432-1033.1994.tb18873.x; FABIANO E, 1987, SYNTHESIS-STUTTGART, P190; Hoffken HW, 2006, BIOCHEMISTRY-US, V45, P82, DOI 10.1021/bi051596b; Hummel W., 1999, PCT Int. Appl. WO, Patent No. 9947684; Imm S, 2011, ANGEW CHEM INT EDIT, V50, P7599, DOI 10.1002/anie.201103199; Knaus T, 2015, ORG BIOMOL CHEM, V13, P223, DOI 10.1039/c4ob02282c; Musa MM, 2011, CATAL SCI TECHNOL, V1, P1311, DOI 10.1039/c1cy00160d; Niefind K, 2003, J MOL BIOL, V327, P317, DOI 10.1016/S0022-2836(03)00081-0; Oldenhuis NJ, 2014, J AM CHEM SOC, V136, P12548, DOI 10.1021/ja5058482; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Resch V, 2010, ADV SYNTH CATAL, V352, P993, DOI 10.1002/adsc.200900891; Royer J., 2010, CHIRAL AMINE SYNTHES, DOI 10.1002/anie.201005721; Sattler JH, 2012, ANGEW CHEM INT EDIT, V51, P9156, DOI 10.1002/anie.201204683; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Schrittwieser JH, 2011, CURR OPIN CHEM BIOL, V15, P249, DOI 10.1016/j.cbpa.2010.11.010; Sheldon R. A., 2007, GREEN CHEM CATALYSIS; Sterling D. I., 1992, CHIRALITY IND, P209; Tauber K, 2013, CHEM-EUR J, V19, P4030, DOI 10.1002/chem.201202666; Wittcoff H. A., 2013, IND ORGANIC CHEM, V3; Zhang Y., 2014, ANGEW CHEM, V126, P1423	27	250	257	16	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1525	1529		10.1126/science.aac9283	http://dx.doi.org/10.1126/science.aac9283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404833	Green Accepted			2022-12-28	WOS:000361707000044
J	Gupta, V; Kerry, VB; Goosby, E; Yates, R				Gupta, Vin; Kerry, Vanessa B.; Goosby, Eric; Yates, Robert			Politics and Universal Health Coverage - The Post-2015 Global Health Agenda	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Vin] Univ Cambridge, Dept Polit & Int Studies, Cambridge, England; [Yates, Robert] Royal Inst Int Affairs, London, England; [Gupta, Vin; Kerry, Vanessa B.] Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Kerry, Vanessa B.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Kerry, Vanessa B.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kerry, Vanessa B.] Seed Global Hlth, Boston, MA USA; [Goosby, Eric] Univ Calif San Francisco, Ctr Implementat Sci, San Francisco, CA 94143 USA	University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Gupta, V (corresponding author), Univ Cambridge, Dept Polit & Int Studies, Cambridge, England.			Yates, Robert/0000-0002-6149-7335				Institute for Economics and Peace, GLOB PEAC IND; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; OTTEN AL, 1992, HEALTH AFFAIR, V11, P111, DOI 10.1377/hlthaff.11.4.111; Stuckler D, 2010, PUBLIC HEALTH REV, V32, P213, DOI 10.1007/BF03391599; Wyden R, 2008, HEALTH AFFAIR, V27, P689, DOI 10.1377/hlthaff.27.3.689	5	16	16	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1189	1192		10.1056/NEJMp1508807	http://dx.doi.org/10.1056/NEJMp1508807			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR8WP	26376044				2022-12-28	WOS:000361635200003
J	Kwok, R				Kwok, Roberta			Creative writing: A world of pure imagination	NATURE			English	Editorial Material																			0	0	0	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					553	555		10.1038/nj7570-553a	http://dx.doi.org/10.1038/nj7570-553a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26405723	Bronze			2022-12-28	WOS:000361599900058
J	Postma, DS; Rabe, KF				Postma, Dirkje S.; Rabe, Klaus F.			The Asthma-COPD Overlap Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; EOSINOPHILIC AIRWAY INFLAMMATION; LUNG-FUNCTION; RESPIRATORY SYMPTOMS; HYPERRESPONSIVENESS; DECLINE; REVERSIBILITY; TRIAL; TIME; HYPERREACTIVITY		[Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen Res Inst Asthma, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, COPD, Groningen, Netherlands; [Rabe, Klaus F.] German Ctr Lung Res, LungenClin Grosshansdorf, Airway Re Ctr North, Grosshansdorf, Germany; [Rabe, Klaus F.] Univ Kiel, Dept Med, Kiel, Germany	University of Groningen; University of Groningen; Grosshansdorf Hospital; University of Kiel	Postma, DS (corresponding author), Univ Med Ctr Groningen, Dept Pulmonol, Hanzepl 1 AA11, Groningen, Netherlands.	d.s.postma@umcg.nl	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401	Chiesi; Boehringer Ingelheim; Teva; Takeda; AstraZeneca; Novartis; GlaxoSmithKline; InterMune; AstraZeneca/Pearl; Sandoz International; Berlin-Chemie	Chiesi(Chiesi Pharmaceuticals Inc); Boehringer Ingelheim(Boehringer Ingelheim); Teva(Teva Pharmaceutical Industries); Takeda(Takeda Pharmaceutical Company Ltd); AstraZeneca(AstraZeneca); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); InterMune; AstraZeneca/Pearl; Sandoz International(Novartis); Berlin-Chemie	Dr. Postma reports consulting fees paid to her institution by Chiesi, Boehringer Ingelheim, Teva, Takeda, AstraZeneca, Novartis, and GlaxoSmithKline. Dr. Rabe reports receiving consulting fees from InterMune, Chiesi, GlaxoSmithKline, AstraZeneca/Pearl, Novartis, Takeda, Teva, Sandoz International, Berlin-Chemie, and Boehringer Ingelheim and grant support from InterMune. No other potential conflict of interest relevant to this article was reported.	Altose MD, 2000, NEW ENGL J MED, V343, P1902; Barker BL, 2013, CLIN SCI, V124, P371, DOI 10.1042/CS20120340; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Bleecker ER, 2008, PULM PHARMACOL THER, V21, P682, DOI 10.1016/j.pupt.2008.04.003; Boros PW, 2012, COPD, V9, P213, DOI 10.3109/15412555.2012.669434; Brown RH, 2006, J APPL PHYSIOL, V101, P30, DOI 10.1152/japplphysiol.01190.2005; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Fattahi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-10; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOBAL STRATEGY DIAG; Grootendorst Diana C, 2004, Proc Am Thorac Soc, V1, P77, DOI 10.1513/pats.2306025; Gunst SJ, 2012, J APPL PHYSIOL, V113, P837, DOI 10.1152/japplphysiol.00483.2012; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Jamieson DB, 2013, AM J RESP CRIT CARE, V188, P187, DOI 10.1164/rccm.201211-2103OC; KERSTJENS HAM, 1992, NEW ENGL J MED, V327, P1413, DOI 10.1056/NEJM199211123272003; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Lancas T, 2011, RESPIRATION, V82, P177, DOI 10.1159/000326897; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Mauad T, 2008, CURR OPIN PULM MED, V14, P31, DOI 10.1097/MCP.0b013e3282f19846; Orie NGM, 1962, BRONCHITIS; Pignatti P, 2011, REJUV RES, V14, P365, DOI 10.1089/rej.2010.1150; Postma DS, 2014, CLIN CHEST MED, V35, P143, DOI 10.1016/j.ccm.2013.09.010; Postma DS, 1998, AM J RESP CRIT CARE, V158, pS187, DOI 10.1164/ajrccm.158.supplement_2.13tac170; POSTMA DS, 1986, AM REV RESPIR DIS, V134, P276; Prosperini G, 2002, J ALLERGY CLIN IMMUN, V110, P855, DOI 10.1067/mai.2002.130050; Ravensberg AJ, 2013, RESP MED, V107, P959, DOI 10.1016/j.rmed.2013.03.018; RIJCKEN B, 1995, AM J RESP CRIT CARE, V151, P1377, DOI 10.1164/ajrccm.151.5.7735588; Rutgers SR, 1998, AM J RESP CRIT CARE, V157, P880, DOI 10.1164/ajrccm.157.3.9709100; SAHN SA, 1978, CHEST, V73, P389, DOI 10.1378/chest.73.3.389; Singh D, 2014, EUR RESPIR J, V44, P1697, DOI 10.1183/09031936.00162414; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; SPARROW D, 1988, EPIDEMIOL REV, V10, P29, DOI 10.1093/oxfordjournals.epirev.a036027; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tashkin DP, 2013, CURR OPIN PULM MED, V19, P116, DOI 10.1097/MCP.0b013e32835d8ea4; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; TASHKIN DP, 1992, AM REV RESPIR DIS, V145, P301, DOI 10.1164/ajrccm/145.2_Pt_1.301; van den Berge M, 2012, EUR RESPIR J, V40, P1098, DOI 10.1183/09031936.00169711; Verbanck S, 1999, AM J RESP CRIT CARE, V159, P1545, DOI 10.1164/ajrccm.159.5.9809017; Verbanck S, 1998, AM J RESP CRIT CARE, V157, P1573, DOI 10.1164/ajrccm.157.5.9710042; Vestbo J, 2001, THORAX, V56, P11; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; VILLAR MTA, 1995, AM J RESP CRIT CARE, V151, P656, DOI 10.1164/ajrccm/151.3_Pt_1.656; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	49	363	371	5	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1241	1249		10.1056/NEJMra1411863	http://dx.doi.org/10.1056/NEJMra1411863			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398072				2022-12-28	WOS:000361635200009
J	Prescott, SL; Srinivasan, R; Marchetto, MC; Grishina, I; Narvaiza, I; Selleri, L; Gage, FH; Swigut, T; Wysocka, J				Prescott, Sara L.; Srinivasan, Rajini; Marchetto, Maria Carolina; Grishina, Irina; Narvaiza, Inigo; Selleri, Licia; Gage, Fred H.; Swigut, Tomek; Wysocka, Joanna			Enhancer Divergence and cis-Regulatory Evolution in the Human and Chimp Neural Crest	CELL			English	Article							TRANSCRIPTION FACTOR-BINDING; HUMAN GENOME; DROSOPHILA; DNA; CHIMPANZEES; MORPHOLOGY; CHROMATIN; ELEMENTS; PATTERNS; POSITION	cis-regulatory changes play a central role in morphological divergence, yet the regulatory principles underlying emergence of human traits remain poorly understood. Here, we use epigenomic profiling from human and chimpanzee cranial neural crest cells to systematically and quantitatively annotate divergence of craniofacial cis-regulatory landscapes. Epigenomic divergence is often attributable to genetic variation within TF motifs at orthologous enhancers, with a novel motif being most predictive of activity biases. We explore properties of this cis-regulatory change, revealing the role of particular retroelements, uncovering broad clusters of species-biased enhancers near genes associated with human facial variation, and demonstrating that cis-regulatory divergence is linked to quantitative expression differences of crucial neural crest regulators. Our work provides a wealth of candidates for future evolutionary studies and demonstrates the value of "cellular anthropology,'' a strategy of using in-vitro-derived embryonic cell types to elucidate both fundamental and evolving mechanisms underlying morphological variation in higher primates.	[Prescott, Sara L.; Srinivasan, Rajini; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Prescott, Sara L.; Srinivasan, Rajini; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Marchetto, Maria Carolina; Narvaiza, Inigo; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA; [Grishina, Irina; Selleri, Licia] Cornell Univ, Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Gage, Fred H.] Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92093 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Salk Institute; Cornell University; University of California System; University of California San Diego; Howard Hughes Medical Institute; Stanford University; Stanford University	Swigut, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	swigut@stanford.edu; wysocka@stanford.edu	wang, edwin/G-5372-2010	Prescott, Sara/0000-0003-4348-9021; Swigut, Tomek/0000-0002-7649-6781	W.M. Keck Foundation; Stanford School of Medicine Innovation Fund; NIH [R01 GM095555, U01 DE024430, TR01 MH095741]; CIRM training grant [TG2-01159]; Helmsley Charitable Fund; Mathers Foundation; JPB Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE024430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095741] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); Stanford School of Medicine Innovation Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM training grant; Helmsley Charitable Fund; Mathers Foundation; JPB Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Kingsley, R. Greenberg, J. Buenrostro, and Wysocka lab members for comments on the manuscript. We also thank R. Aho and J.D. Benazet for help with imaging of mouse transgenic embryos and interpretation of staining patterns, as well as P. Nano and E. Grow for help generating reporter reagents. This work was supported by W.M. Keck Foundation, Stanford School of Medicine Innovation Fund, and NIH R01 GM095555 (J.W.) and U01 DE024430 (J.W. and L.S.), as well as CIRM training grant (TG2-01159) (S.L.P.). This work was also partially supported by funds from NIH TR01 MH095741, the Helmsley Charitable Fund, the Mathers Foundation, and the JPB Foundation (F.H.G.).	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; BILSBOROUGH A, 1988, AM J PHYS ANTHROPOL, V76, P61, DOI 10.1002/ajpa.1330760107; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cain CE, 2011, GENETICS, V187, P1225, DOI 10.1534/genetics.110.126177; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fish JL, 2014, DEVELOPMENT, V141, P674, DOI 10.1242/dev.100107; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gronau I, 2013, MOL BIOL EVOL, V30, P1159, DOI 10.1093/molbev/mst019; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hubisz MJ, 2014, CURR OPIN GENET DEV, V29, P15, DOI 10.1016/j.gde.2014.07.005; Jheon AH, 2009, J DENT RES, V88, P12, DOI 10.1177/0022034508327757; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Mansouri A, 1996, DEVELOPMENT, V122, P831; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Satija R, 2012, GENOME RES, V22, P656, DOI 10.1101/gr.130682.111; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; TREMBLAY P, 1995, DEV BIOL, V171, P317, DOI 10.1006/dbio.1995.1284; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wong E.S., 2014, GENOME RES; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhou X, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0547-3	54	176	178	1	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					68	83		10.1016/j.cell.2015.08.036	http://dx.doi.org/10.1016/j.cell.2015.08.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26365491	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000361846500022
J	Rathert, P; Roth, M; Neumann, T; Muerdter, F; Roe, JS; Muhar, M; Deswal, S; Cerny-Reiterer, S; Peter, B; Jude, J; Hoffmann, T; Boryn, LM; Axelsson, E; Schweifer, N; Tontsch-Grunt, U; Dow, LE; Gianni, D; Pearson, M; Valent, P; Stark, A; Kraut, N; Vakoc, CR; Zuber, J				Rathert, Philipp; Roth, Mareike; Neumann, Tobias; Muerdter, Felix; Roe, Jae-Seok; Muhar, Matthias; Deswal, Sumit; Cerny-Reiterer, Sabine; Peter, Barbara; Jude, Julian; Hoffmann, Thomas; Boryn, Lukasz M.; Axelsson, Elin; Schweifer, Norbert; Tontsch-Grunt, Ulrike; Dow, Lukas E.; Gianni, Davide; Pearson, Mark; Valent, Peter; Stark, Alexander; Kraut, Norbert; Vakoc, Christopher R.; Zuber, Johannes			Transcriptional plasticity promotes primary and acquired resistance to BET inhibition	NATURE			English	Article							BROMODOMAIN INHIBITION; SELECTIVE-INHIBITION; READ ALIGNMENT; SELF-RENEWAL; C-MYC; LEUKEMIA; TARGET; RNA; CLASSIFICATION; ACTIVATION	Following the discovery of BRD4 as a non-oncogene addiction target in acute myeloid leukaemia (AML)(1,2), bromodomain and extra terminal protein (BET) inhibitors are being explored as a promising therapeutic avenue in numerous cancers(3-5). While clinical trials have reported single-agent activity in advanced haematological malignancies(6), mechanisms determining the response to BET inhibition remain poorly understood. To identify factors involved in primary and acquired BET resistance in leukaemia, here we perform a chromatin-focused RNAi screen in a sensitive MLL-AF9; Nras(G12D)-driven AML mouse model, and investigate dynamic transcriptional profiles in sensitive and resistantmouse and human leukaemias. Our screen shows that suppression of the PRC2 complex, contrary to effects in other contexts, promotes BET inhibitor resistance in AML. PRC2 suppression does not directly affect the regulation of Brd4-dependent transcripts, but facilitates the remodelling of regulatory pathways that restore the transcription of key targets such as Myc. Similarly, while BET inhibition triggers acute MYC repression in human leukaemias regardless of their sensitivity, resistant leukaemias are uniformly characterized by their ability to rapidly restore MYC transcription. This process involves the activation and recruitment of WNT signalling components, which compensate for the loss of BRD4 and drive resistance in various cancer models. Dynamic chromatin immunoprecipitation sequencing and self-transcribing active regulatory region sequencing of enhancer profiles reveal that BET-resistant states are characterized by remodelled regulatory landscapes, involving the activation of a focal MYC enhancer that recruits WNT machinery in response to BET inhibition. Together, our results identify and validate WNT signalling as a driver and candidate biomarker of primary and acquired BET resistance in leukaemia, and implicate the rewiring of transcriptional programs as an important mechanism promoting resistance to BET inhibitors and, potentially, other chromatin-targeted therapies.	[Rathert, Philipp; Roth, Mareike; Neumann, Tobias; Muerdter, Felix; Muhar, Matthias; Deswal, Sumit; Jude, Julian; Hoffmann, Thomas; Boryn, Lukasz M.; Axelsson, Elin; Stark, Alexander; Zuber, Johannes] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Roe, Jae-Seok; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Cerny-Reiterer, Sabine; Peter, Barbara; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, A-1090 Vienna, Austria; [Cerny-Reiterer, Sabine; Peter, Barbara; Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, A-1090 Vienna, Austria; [Schweifer, Norbert; Tontsch-Grunt, Ulrike; Gianni, Davide; Pearson, Mark; Kraut, Norbert] Boehringer Ingelheim Reg Ctr Vienna GmbH, A-1121 Vienna, Austria; [Dow, Lukas E.] Weill Cornell Med Coll, Dept Med Hematol & Med Oncol, New York, NY 10065 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Cold Spring Harbor Laboratory; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Boehringer Ingelheim; Cornell University	Zuber, J (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	zuber@imp.ac.at	Zuber, Johannes/E-7517-2011; Gamperl, Susi/V-2715-2019; Test, PV/U-9451-2019; Valent, Peter/B-8533-2016; Stark, Alexander/D-1473-2012; Test, Test/Y-7921-2019; Peter, Barbara/O-8110-2018	Zuber, Johannes/0000-0001-8810-6835; Gamperl, Susi/0000-0003-0456-5095; Valent, Peter/0000-0003-0456-5095; Stark, Alexander/0000-0003-2611-0841; Peter, Barbara/0000-0001-5701-5412; Dow, Lukas/0000-0001-7048-1418; Muerdter, Felix/0000-0002-0840-2544; Muhar, Matthias/0000-0002-3018-9698; Jude, Julian/0000-0002-9091-9867; Neumann, Tobias/0000-0003-3908-4224; Axelsson, Elin/0000-0003-4382-1880; Rathert, Philipp/0000-0003-1477-136X; Roe, Jae-Seok/0000-0002-9994-3062	European Research Council (ERC) [336860]; SFB of the Austrian Science Fund (FWF) [F4704, F4710]; European Union; ERC [242922]; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [P30CA045508, K22CA181280, R01CA174793] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); SFB of the Austrian Science Fund (FWF); European Union(European Commission); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Weissenbock, B. Hopfgartner and M. Fellner for technical support, S.-M. Kula and the IMP/IMBA Molecular Biology Service for help with library construction, G. Schmauss, T. Lendl, M. Weninger and G. Stengl and the Biooptics Service Facility for FACS; A. Sommer and his team at Campus Science Support Facilities (http://www.csf.ac.at) for Illumina sequencing, S. W. Lowe for reagents and discussions, and all members of the Zuber laboratory for reagents, protocols and discussions. This research was funded by a Starting Grant of the European Research Council (ERC no. 336860; to J.Z.), SFB grants F4704 and F4710 of the Austrian Science Fund (FWF), a Fellowship of the People Programme (Marie Curie Actions) of the European Union (to P.R.). F.M. is an EMBO long-term fellow (EMBO ALTF 491-2014) and research in the Stark laboratory is supported by an ERC Starting grant (no. 242922; to A.S.). The Zuber laboratory and research at the IMP is generously supported by Boehringer Ingelheim.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Ballare C, 2012, NAT STRUCT MOL BIOL, V19, P1257, DOI 10.1038/nsmb.2434; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong C. Y., 2015, NATURE; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herait PE, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-CT231; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	55	338	347	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					543	+		10.1038/nature14898	http://dx.doi.org/10.1038/nature14898			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26367798	Green Accepted			2022-12-28	WOS:000361599900055
J	Wang, YB; Zhang, TH; Kwiatkowski, N; Abraham, BJ; Lee, TI; Xie, SZ; Yuzugullu, H; Von, T; Li, HY; Lin, Z; Stover, DG; Lim, E; Wang, ZGC; Iglehart, JD; Young, RA; Gray, NS; Zhao, JJ				Wang, Yubao; Zhang, Tinghu; Kwiatkowski, Nicholas; Abraham, Brian J.; Lee, Tong Ihn; Xie, Shaozhen; Yuzugullu, Haluk; Thanh Von; Li, Heyuan; Lin, Ziao; Stover, Daniel G.; Lim, Elgene; Wang, Zhigang C.; Iglehart, J. Dirk; Young, Richard A.; Gray, Nathanael S.; Zhao, Jean J.			CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer	CELL			English	Article							GROWTH-FACTOR RECEPTOR; THERAPEUTIC TARGET; SUPER-ENHANCERS; CELL IDENTITY; CLAUDIN-LOW; INHIBITION; CDK7; ACTIVATION; CHROMATIN; EGFR	Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer that exhibits extremely high levels of genetic complexity and yet a relatively uniform transcriptional program. We postulate that TNBC might be highly dependent on uninterrupted transcription of a key set of genes within this gene expression program and might therefore be exceptionally sensitive to inhibitors of transcription. Utilizing kinase inhibitors and CRISPR/Cas9-mediated gene editing, we show here that triple-negative but not hormone receptor-positive breast cancer cells are exceptionally dependent on CDK7, a transcriptional cyclin-dependent kinase. TNBCcells are unique in their dependence on this transcriptional CDK and suffer apoptotic cell death upon CDK7 inhibition. An "Achilles cluster'' of TNBC-specific genes is especially sensitive to CDK7 inhibition and frequently associated with super-enhancers. We conclude that CDK7 mediates transcriptional addiction to a vital cluster of genes in TNBC and CDK7 inhibition may be a useful therapy for this challenging cancer.	[Wang, Yubao; Zhang, Tinghu; Xie, Shaozhen; Yuzugullu, Haluk; Thanh Von; Li, Heyuan; Lin, Ziao; Wang, Zhigang C.; Iglehart, J. Dirk; Gray, Nathanael S.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wang, Yubao; Zhang, Tinghu; Xie, Shaozhen; Yuzugullu, Haluk; Thanh Von; Gray, Nathanael S.; Zhao, Jean J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Abraham, Brian J.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Stover, Daniel G.; Lim, Elgene] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wang, Zhigang C.; Iglehart, J. Dirk] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	nathanael_gray@dfci.harvard.edu; jean_zhao@dfci.harvard.edu	Abraham, Brian/C-2230-2019; Young, Richard A/F-6495-2012; Lim, Elgene/AAS-7280-2020; Wang, Yubao/L-3912-2014; Li, Heyuan/ABE-3208-2021	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647; Lim, Elgene/0000-0001-8065-8838; Stover, Daniel/0000-0001-9003-8165; Li, Heyuan/0000-0003-4254-4017	NIH [R01CA179483-01]; MIT-DFCI Bridge grant; NIH/NCI [P50 CA168504]; NATIONAL CANCER INSTITUTE [R01CA179483, P50CA168504, R01CA172461, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT-DFCI Bridge grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Wiederschain and F. Zhang for sharing the plasmids. We thank the Nikon Imaging Center at Harvard Medical School, DFCI Flow Cytometry Core Facility, and Dana-Farber/Harvard Cancer Center Rodent Histopathology Core for technical assistance and the use of instruments. This study was supported by NIH R01CA179483-01 (N.S.G.), a MIT-DFCI Bridge grant (N.S.G. and R.A.Y.), and NIH/NCI P50 CA168504 (J.Z.). N.S.G., T.Z., and N.K. are inventors on a patent application covering THZ1 and THZ2. N.S.G. and R.A.Y. are scientific founders of Syros Pharmaceuticals, a company that has licensed THZ1 and THZ2 from the Dana-Farber Cancer Institute.	Abramson VG, 2015, CANCER-AM CANCER SOC, V121, P8, DOI 10.1002/cncr.28914; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brand TM, 2014, MOL CANCER THER, V13, P1356, DOI 10.1158/1535-7163.MCT-13-1021; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hsu YH, 2014, CANCER RES, V74, P4822, DOI 10.1158/0008-5472.CAN-14-0584; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu G, 2014, CANCER CELL, V26, P222, DOI 10.1016/j.ccr.2014.06.026; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Schachter MM, 2013, CELL CYCLE, V12, P3239, DOI 10.4161/cc.26355; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sohn J, 2014, J CANCER, V5, P745, DOI 10.7150/jca.9696; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Truong HH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004751; Ueno NT, 2011, J CANCER, V2, P324, DOI 10.7150/jca.2.324; Wang HY, 2013, J BIOL CHEM, V288, P6478, DOI 10.1074/jbc.M112.419184; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	55	267	281	3	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					174	186		10.1016/j.cell.2015.08.063	http://dx.doi.org/10.1016/j.cell.2015.08.063			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406377	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000361846500030
J	Katzelnick, LC; Fonville, JM; Gromowski, GD; Arriaga, JB; Green, A; James, SL; Lau, L; Montoya, M; Wang, CL; VanBlargan, LA; Russell, CA; Thu, HM; Pierson, TC; Buchy, P; Aaskov, JG; Munoz-Jordan, JL; Vasilakis, N; Gibbons, RV; Tesh, RB; Osterhaus, ADME; Fouchier, RAM; Durbin, A; Simmons, CP; Holmes, EC; Harris, E; Whitehead, SS; Smith, DJ				Katzelnick, Leah C.; Fonville, Judith M.; Gromowski, Gregory D.; Arriaga, Jose Bustos; Green, Angela; James, Sarah L.; Lau, Louis; Montoya, Magelda; Wang, Chunling; VanBlargan, Laura A.; Russell, Colin A.; Thu, Hlaing Myat; Pierson, Theodore C.; Buchy, Philippe; Aaskov, John G.; Munoz-Jordan, Jorge L.; Vasilakis, Nikos; Gibbons, Robert V.; Tesh, Robert B.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Durbin, Anna; Simmons, Cameron P.; Holmes, Edward C.; Harris, Eva; Whitehead, Stephen S.; Smith, Derek J.			Dengue viruses cluster antigenically but not as discrete serotypes	SCIENCE			English	Article							NEUTRALIZING ANTIBODY-LEVELS; HEMORRHAGIC-FEVER; INFECTION; VACCINE; IDENTIFICATION; TRANSMISSION; PROTECTION; EMERGENCE; EVOLUTION; RESPONSES	The four genetically divergent dengue virus (DENV) types are traditionally classified as serotypes. Antigenic and genetic differences among the DENV types influence disease outcome, vaccine-induced protection, epidemic magnitude, and viral evolution. We characterized antigenic diversity in the DENV types by antigenic maps constructed from neutralizing antibody titers obtained from African green monkeys and after human vaccination and natural infections. Genetically, geographically, and temporally, diverse DENV isolates clustered loosely by type, but we found that many are as similar antigenically to a virus of a different type as to some viruses of the same type. Primary infection antisera did not neutralize all viruses of the same DENV type any better than other types did up to 2 years after infection and did not show improved neutralization to homologous type isolates. That the canonical DENV types are not antigenically homogeneous has implications for vaccination and research on the dynamics of immunity, disease, and the evolution of DENV.	[Katzelnick, Leah C.; Fonville, Judith M.; James, Sarah L.; Smith, Derek J.] Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge CB2 3EJ, England; [Katzelnick, Leah C.; Fonville, Judith M.; James, Sarah L.; Smith, Derek J.] World Hlth Org WHO Collaborating Ctr Modeling Evo, Cambridge CB2 3EJ, England; [Katzelnick, Leah C.; Gromowski, Gregory D.; Arriaga, Jose Bustos; VanBlargan, Laura A.; Pierson, Theodore C.; Whitehead, Stephen S.] NIAID, NIH, Bethesda, MD 20892 USA; [Katzelnick, Leah C.; Green, Angela; Lau, Louis; Montoya, Magelda; Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Fonville, Judith M.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Russell, Colin A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Thu, Hlaing Myat] Dept Med Res, Yangon, Myanmar; [Buchy, Philippe] Reseau Int Inst Pasteur, Inst Pasteur Cambodia, Phnom Penh 12201, Cambodia; [Aaskov, John G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Aaskov, John G.] Australian Army Malaria Inst, Brisbane, Qld 4051, Australia; [Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, San Juan, PR 00971 USA; [Vasilakis, Nikos; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Vasilakis, Nikos; Tesh, Robert B.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA; [Vasilakis, Nikos; Tesh, Robert B.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Vasilakis, Nikos; Tesh, Robert B.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Gibbons, Robert V.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Durbin, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA; [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Simmons, Cameron P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Cambridge; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Berkeley; Erasmus University Rotterdam; Erasmus MC; University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; University of Oxford; University of Melbourne; University of Sydney; University of Sydney	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Downing St, Cambridge CB2 3EJ, England.	djs200@cam.ac.uk	Simmons, Cameron P/ABA-3896-2021; Vasilakis, Nikos/ABE-7318-2020; Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014; Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Lau, Louis/ABC-7288-2020; Bustos-Arriaga, Jose/AAH-3885-2019; Russell, Colin/ABE-7106-2020; Lau, Louis C/J-1480-2014; Whitehead, Stephen/AAG-2787-2019	Simmons, Cameron P/0000-0002-9039-7392; Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Holmes, Edward/0000-0001-9596-3552; Bustos-Arriaga, Jose/0000-0002-7368-6432; James, Sarah/0000-0002-6969-1167; BUCHY, Philippe/0000-0003-1372-3008	Intramural Research Program of the U.S. NIH; National Institute of Allergy and Infectious Diseases (NIAID); European Union (EU) [223498, 278976]; Human Frontier Science Program (HFSP) program grant [P0050/2008]; NIH Director's Pioneer Award [DP1-OD000490-01]; FIRST program from the Bill and Melinda Gates Foundation; Instituto Carlos Slim de la Salud; NIAID-NIH Centers of Excellence for Influenza Research and Surveillance [HHSN266200700010C, HHSN272201400008C]; Gates Cambridge Scholarship; NIH Oxford Cambridge Scholars Program; Medical Research Council Fellowship [MR/K021885/1]; Junior Research Fellowship from Homerton College Cambridge; National Health and Medical Research Council Australia Fellowship; NIH [HHSN272201000040I/HHSN27200004/D04]; GSK Pharma; GSK Vaccines; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099631, ZIAAI001022, P01AI106695, ZIAAI000891] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER; MRC [MR/K021885/1] Funding Source: UKRI; Medical Research Council [MR/K021885/1] Funding Source: researchfish	Intramural Research Program of the U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union (EU)(CGIAREuropean Commission); Human Frontier Science Program (HFSP) program grant; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIRST program from the Bill and Melinda Gates Foundation; Instituto Carlos Slim de la Salud; NIAID-NIH Centers of Excellence for Influenza Research and Surveillance; Gates Cambridge Scholarship; NIH Oxford Cambridge Scholars Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Junior Research Fellowship from Homerton College Cambridge; National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GSK Pharma; GSK Vaccines; Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We express our gratitude to the members of the Dengue Antigenic Cartography Consortium, named in the supplementary materials, for their advice and contributions to the Consortium to date. We thank D. Burke, N. Lewis, E. Selkov, E. Skepner, A. Mosterin, R. Mogling, S. Wilks, T. Kotarba, and V. Duong for their technical expertise. M. Melendrez, J. Hang, R. Jarman, S. M. Cave, S. G. Widen, T. G. Wood, and V. Duong assisted with virus sequencing. C. Firestone and M. Galvez assisted with neutralization assay titrations. This research was supported in part by the Intramural Research Program of the U.S. NIH, National Institute of Allergy and Infectious Diseases (NIAID), European Union (EU) FP7 programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science Program (HFSP) program grant P0050/2008, the NIH Director's Pioneer Award DP1-OD000490-01, the FIRST program from the Bill and Melinda Gates Foundation, and the Instituto Carlos Slim de la Salud (E.H.). The antigenic cartography toolkit was in part supported by NIAID-NIH Centers of Excellence for Influenza Research and Surveillance contracts HHSN266200700010C and HHSN272201400008C for use on influenza virus. L.C.K. was supported by the Gates Cambridge Scholarship and the NIH Oxford Cambridge Scholars Program. J.M.F. was supported by a Medical Research Council Fellowship (MR/K021885/1) and a Junior Research Fellowship from Homerton College Cambridge. E.C.H. was supported by an National Health and Medical Research Council Australia Fellowship. N.V. and R.B.T were supported by NIH contract HHSN272201000040I/HHSN27200004/D04. The viruses and sera used in this study are covered by standard material transfer agreements at the home institutions of S.S.W., C.P.S., E.H., P.B., J.G.A., J.L.M.J., N.V., and R.B.T. A.D.M.E.O. is a professor and director of Artemis One Health Utrecht, The Netherlands; Chief Scientific Officer Viroclinics Biosciences BV, the Netherlands; and a Board Member of Protein Sciences USA. P.B. performed this work while at the Institut Pasteur in Cambodia, but since June 2015, is with GlaxoSmithKline vaccines in Singapore, and has stock options with GSK. C.P.S. is a paid consultant to GSK Pharma, GSK Vaccines, and Merck and has received a grant and consulting payments to his institution from Sanofi Pasteur. The sequences used in this study are available from GenBank (http://www.ncbi.nlm.nih.gov/genbank/) and are listed in table S1. Files used for genetic analyses are available as supplementary data files. The NIH monovalent DENV vaccines trials (ClinicalTrials.gov identifiers: NCT00473135 NCT00920517, NCT00831012, NCT00831012) were performed under an investigational new drug application reviewed by the U.S. Food and Drug Administration and approved by the Institutional Review Board at the University of Vermont and Johns Hopkins University. Informed consent was obtained in accordance federal and international regulations (21CFR50, ICHE6). The Pediatric Dengue Cohort Study in Managua, Nicaragua, was approved by the Institutional Review Boards of the Nicaraguan Ministry of Health and the University of California, Berkeley. Parents or legal guardians of all subjects provided written informed consent, and subjects 6 years of age and older provided assent.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buddhari D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003230; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P785, DOI 10.1038/ni0715-785a; Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018; Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910; Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P635, DOI 10.4269/ajtmh.1980.29.635; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102; Hickey AC, 2013, AM J TROP MED HYG, V89, P1043, DOI 10.4269/ajtmh.13-0145; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kochel TJ, 2005, J INFECT DIS, V191, P1000, DOI 10.1086/427511; Kochel TJ, 2002, LANCET, V360, P310, DOI 10.1016/S0140-6736(02)09522-3; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023; Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0; Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486; Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141; VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761; Vasilakis N, 2008, AM J TROP MED HYG, V79, P128, DOI 10.4269/ajtmh.2008.79.128; WHO/TDR, 2009, DENG GUID DIAGN TREA; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	41	132	135	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1338	1343		10.1126/science.aac5017	http://dx.doi.org/10.1126/science.aac5017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383952	Green Accepted, Green Submitted			2022-12-28	WOS:000361357700049
J	Marshak, MP				Marshak, Michael P.			My trek back to science	SCIENCE			English	Editorial Material									[Marshak, Michael P.] Univ Colorado, Boulder, CO 80309 USA; [Marshak, Michael P.] Renewable & Sustainable Energy Inst, Boulder, CO USA	University of Colorado System; University of Colorado Boulder	Marshak, MP (corresponding author), Univ Colorado, Boulder, CO 80309 USA.		Marshak, Michael P/N-3213-2013	Marshak, Michael P/0000-0002-8027-2705					0	1	1	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1406	1406		10.1126/science.349.6254.1406	http://dx.doi.org/10.1126/science.349.6254.1406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR5CR	26383957				2022-12-28	WOS:000361357700055
J	El-Noush, H; Silver, KL; Pamba, AO; Singer, PA				El-Noush, Haitham; Silver, Karlee L.; Pamba, Allan O.; Singer, Peter A.			Innovating for women's, children's, and adolescents' health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Silver, Karlee L.; Singer, Peter A.] Grand Challenges Canada, Toronto, ON, Canada; [Pamba, Allan O.] GlaxoSmithKline, East Africa Cluster & African Govt Affairs, Secunderabad, Telangana, India	GlaxoSmithKline	Singer, PA (corresponding author), Grand Challenges Canada, Toronto, ON, Canada.	peter.singer@grandchallenges.ca						Every Woman Every Child, SAV LIV PROT FUT PRO; Grand Challenges Canada, 2010, INT INN; Jamison DT, 2004, 21 DIS CONTR PRIOR P; PATH, 2014, PATH ANN REP; Rodin J, 2014, INNOVATIONS FINANCE; Singer PA, 2015, MEASURING IMPACT; Singer PA, 2014, GRAND CHALLENGES APP	7	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4151					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371217	hybrid			2022-12-28	WOS:000361678200005
J	Burton, BK; Balwani, M; Feillet, F; Baric, I; Burrow, TA; Grande, CC; Coker, M; Consuelo-Sanchez, A; Deegan, P; Di Rocco, M; Enns, GM; Erbe, R; Ezgu, F; Ficicioglu, C; Furuya, KN; Kane, J; Laukaitis, C; Mengel, E; Neilan, EG; Nightingale, S; Peters, H; Scarpa, M; Schwab, KO; Smolka, V; Valayannopoulos, V; Wood, M; Goodman, Z; Yang, Y; Eckert, S; Rojas-Caro, S; Quinn, AG				Burton, B. K.; Balwani, M.; Feillet, F.; Baric, I.; Burrow, T. A.; Camarena Grande, C.; Coker, M.; Consuelo-Sanchez, A.; Deegan, P.; Di Rocco, M.; Enns, G. M.; Erbe, R.; Ezgu, F.; Ficicioglu, C.; Furuya, K. N.; Kane, J.; Laukaitis, C.; Mengel, E.; Neilan, E. G.; Nightingale, S.; Peters, H.; Scarpa, M.; Schwab, K. O.; Smolka, V.; Valayannopoulos, V.; Wood, M.; Goodman, Z.; Yang, Y.; Eckert, S.; Rojas-Caro, S.; Quinn, A. G.			A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTER STORAGE DISEASE; FATTY LIVER-DISEASE; WOLMANS DISEASE; TRANSPLANTATION; PHENOTYPE; LIPIDOSIS; FIBROSIS; CHILDREN; THERAPY; ADULT	BACKGROUND Lysosomal acid lipase is an essential lipid-metabolizing enzyme that breaks down endocytosed lipid particles and regulates lipid metabolism. We conducted a phase 3 trial of enzyme-replacement therapy in children and adults with lysosomal acid lipase deficiency, an underappreciated cause of cirrhosis and severe dyslipidemia. METHODS In this multicenter, randomized, double-blind, placebo-controlled study involving 66 patients, we evaluated the safety and effectiveness of enzyme-replacement therapy with sebelipase alfa (administered intravenously at a dose of 1 mg per kilogram of body weight every other week); the placebo-controlled phase of the study was 20 weeks long and was followed by open-label treatment for all patients. The primary end point was normalization of the alanine aminotransferase level. Secondary end points included additional disease-related efficacy assessments, safety, and side-effect profile. RESULTS Substantial disease burden at baseline included a very high level of low-density lipoprotein cholesterol (>= 190 mg per deciliter) in 38 of 66 patients (58%) and cirrhosis in 10 of 32 patients (31%) who underwent biopsy. A total of 65 of the 66 patients who underwent randomization completed the double-blind portion of the trial and continued with open-label treatment. At 20 weeks, the alanine aminotransferase level was normal in 11 of 36 patients (31%) in the sebelipase alfa group and in 2 of 30 (7%) in the placebo group (P = 0.03), with mean changes from baseline of -58 U per liter versus -7 U per liter (P<0.001). With respect to pre-specified key secondary efficacy end points, we observed improvements in lipid levels and reduction in hepatic fat content (P<0.001 for all comparisons, except P = 0.04 for triglycerides). The number of patients with adverse events was similar in the two groups; most events were mild and were considered by the investigator to be unrelated to treatment. CONCLUSIONS Sebelipase alfa therapy resulted in a reduction in multiple disease-related hepatic and lipid abnormalities in children and adults with lysosomal acid lipase deficiency. (Funded by Synageva BioPharma and others; ARISE ClinicalTrials.gov number, NCT01757184.)	[Burton, B. K.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA; [Balwani, M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Erbe, R.] Women & Childrens Hosp Buffalo, Buffalo, NY USA; [Feillet, F.] Hop Enfants, Ctr Hosp Univ Brabois, Vandoeuvre Les Nancy, France; [Valayannopoulos, V.] Univ Hosp Necker, Enfants Malades & Imagine Inst, Paris, France; [Baric, I.] Univ Hosp Ctr Zagreb, Zagreb, Croatia; [Baric, I.] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Burrow, T. A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Camarena Grande, C.] Hosp Univ La Paz, Madrid, Spain; [Coker, M.] Ege Univ, Fac Med, Izmir, Turkey; [Ezgu, F.] Gazi Univ, Fac Med, Ankara, Turkey; [Consuelo-Sanchez, A.] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [Deegan, P.] Cambridge Univ Hosp, Cambridge, England; [Di Rocco, M.] Gaslini Inst, Dept Pediat, Unit Rare Dis, Genoa, Italy; [Scarpa, M.] Univ Padua, Padua, Italy; [Enns, G. M.] Stanford Univ, Palo Alto, CA 94304 USA; [Kane, J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ficicioglu, C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Furuya, K. N.] Alfred I duPont Hosp Children, Wilmington, DE USA; [Laukaitis, C.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Mengel, E.] Johannes Gutenberg Univ Mainz, Ctr Pediat & Adolescent Med, Villa Metab, D-55122 Mainz, Germany; [Schwab, K. O.] Univ Hosp Freiburg, Freiburg, Germany; [Neilan, E. G.] Boston Childrens Hosp, Boston, MA USA; [Yang, Y.; Eckert, S.; Rojas-Caro, S.; Quinn, A. G.] Synageva BioPharma, Lexington, MA USA; [Nightingale, S.] Univ Newcastle, John Hunter Childrens Hosp, Newcastle, NSW 2300, Australia; [Nightingale, S.] Univ Newcastle, Discipline Paediat & Child Hlth, Newcastle, NSW 2300, Australia; [Peters, H.] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Wood, M.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Smolka, V.] Palacky Univ, Fac Hosp, CR-77147 Olomouc, Czech Republic; [Goodman, Z.] Inova Fairfax Hosp, Falls Church, VA USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai; Women & Children's Hospital of Buffalo; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Zagreb; University of Zagreb; Cincinnati Children's Hospital Medical Center; Hospital Universitario La Paz; Ege University; Gazi University; Hospital Infantil de Mexico Federico Gomez; University of Cambridge; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Padua; Stanford University; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Nemours Alfred I. duPont Hospital for Children; University of Arizona; Johannes Gutenberg University of Mainz; University of Freiburg; Harvard University; Boston Children's Hospital; University of Newcastle; University of Newcastle; Royal Children's Hospital Melbourne; Royal Brisbane & Women's Hospital; Palacky University Olomouc; University Hospital Olomouc; Inova Fairfax Hospital	Burton, BK (corresponding author), Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA.	bburton@luriechildrens.org	Laukaitis, Christina M/AAL-5865-2021; Scarpa, Maurizio/AAC-1467-2019; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina/ABF-1739-2021; Feillet, Francois/A-2871-2015; Valayannopoulos, Vassili/AFR-8311-2022; Feillet, Francois/A-3648-2017; Ficicioglu, Can/AAQ-8002-2020; peters, heidi/GWD-0358-2022; Scarpa, Maurizio/E-2539-2016	Laukaitis, Christina M/0000-0003-1466-7941; Feillet, Francois/0000-0002-8717-469X; Peters, Heidi/0000-0001-7189-5874; Nightingale, Scott/0000-0003-0986-7105; SCARPA, MAURIZIO/0000-0002-0382-3251; Deegan, Patrick/0000-0001-9427-9900; Ficicioglu, Can/0000-0002-8331-9804	Synageva BioPharma; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000067, UL1TR000170] Funding Source: NIH RePORTER	Synageva BioPharma; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Synageva BioPharma and others; ARISE ClinicalTrials.gov number, NCT01757184.	Alkhouri N, 2013, LIVER INT, V33, P79, DOI 10.1111/liv.12024; Alonso EM, 2008, LIVER TRANSPLANT, V14, P585, DOI 10.1002/lt.21488; Ambler GK, 2013, JIMD REP, V8, P41, DOI 10.1007/8904_2012_155; [Anonymous], 2012, ONLINE MENDELIAN INH; Balwani M, 2013, HEPATOLOGY, V58, P950, DOI 10.1002/hep.26289; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; CROCKER AC, 1965, PEDIATRICS, V35, P627; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Elleder M, 2000, J HEPATOL, V32, P528, DOI 10.1016/S0168-8278(00)80407-9; Fouchier SW, 2013, CURR OPIN LIPIDOL, V24, P332, DOI 10.1097/MOL.0b013e328361f6c6; Gasche C, 1997, J HEPATOL, V27, P744, DOI 10.1016/S0168-8278(97)80092-X; Grabowski GA., 2012, ONLINE METABOLIC MOL; Grabowski G, 2013, HEPATOLOGY, V58, P850, DOI 10.1002/hep.26366; Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; MARSHALL WC, 1969, ARCH DIS CHILD, V44, P331, DOI 10.1136/adc.44.235.331; Reiner Z, 2014, ATHEROSCLEROSIS, V235, P21, DOI 10.1016/j.atherosclerosis.2014.04.003; Sloan HR, 1972, METABOLIC BASIS INHE, P808; Thelwall PE, 2013, J HEPATOL, V59, P543, DOI 10.1016/j.jhep.2013.04.016; Todoroki T, 2000, ANN CLIN BIOCHEM, V37, P187, DOI 10.1258/0004563001899195; Valayannopoulos V, 2014, J HEPATOL, V61, P1135, DOI 10.1016/j.jhep.2014.06.022	22	147	154	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1010	1020		10.1056/NEJMoa1501365	http://dx.doi.org/10.1056/NEJMoa1501365			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352813	Green Published, Bronze			2022-12-28	WOS:000360959000006
J	Hendriksen, JMT; Geersing, GJ; Lucassen, WAM; Erkens, PMG; Stoffers, HEJH; Van Weert, HCPM; Buller, HR; Hoes, AW; Moons, KGM				Hendriksen, Janneke M. T.; Geersing, Geert-Jan; Lucassen, Wim A. M.; Erkens, Petra M. G.; Stoffers, Henri E. J. H.; Van Weert, Henk C. P. M.; Bueller, Harry R.; Hoes, Arno W.; Moons, Karel G. M.			Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSESSING CLINICAL PROBABILITY; D-DIMER; EMERGENCY-DEPARTMENT; INDIVIDUAL PROGNOSIS; COMPUTED-TOMOGRAPHY; VENOUS THROMBOSIS; DECISION RULES; WELLS RULE; IMPACT; SIMPLIFICATION	OBJECTIVE To validate all diagnostic prediction models for ruling out pulmonary embolism that are easily applicable in primary care. DESIGN Systematic review followed by independent external validation study to assess transportability of retrieved models to primary care medicine. SETTING 300 general practices in the Netherlands. PARTICIPANTS Individual patient dataset of 598 patients with suspected acute pulmonary embolism in primary care. MAIN OUTCOME MEASURES Discriminative ability of all models retrieved by systematic literature search, assessed by calculation and comparison of C statistics. After stratification into groups with high and low probability of pulmonary embolism according to pre-specified model cut-offs combined with qualitative D-dimer test, sensitivity, specificity, efficiency (overall proportion of patients with low probability of pulmonary embolism), and failure rate (proportion of pulmonary embolism cases in group of patients with low probability) were calculated for all models. RESULTS Ten published prediction models for the diagnosis of pulmonary embolism were found. Five of these models could be validated in the primary care dataset: the original Wells, modified Wells, simplified Wells, revised Geneva, and simplified revised Geneva models. Discriminative ability was comparable for all models (range of C statistic 0.75-0.80). Sensitivity ranged from 88% (simplified revised Geneva) to 96% (simplified Wells) and specificity from 48% (revised Geneva) to 53% (simplified revised Geneva). Efficiency of all models was between 43% and 48%. Differences were observed between failure rates, especially between the simplified Wells and the simplified revised Geneva models (failure rates 1.2% (95% confidence interval 0.2% to 3.3%) and 3.1% (1.4% to 5.9%), respectively; absolute difference -1.98% (-3.33% to -0.74%)). Irrespective of the diagnostic prediction model used, three patients were incorrectly classified as having low probability of pulmonary embolism; pulmonary embolism was diagnosed only after referral to secondary care. CONCLUSIONS Five diagnostic pulmonary embolism prediction models that are easily applicable in primary care were validated in this setting. Whereas efficiency was comparable for all rules, the Wells rules gave the best performance in terms of lower failure rates.	[Hendriksen, Janneke M. T.; Geersing, Geert-Jan; Hoes, Arno W.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, NL-3508 GA Utrecht, Netherlands; [Lucassen, Wim A. M.; Van Weert, Henk C. P. M.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Erkens, Petra M. G.; Stoffers, Henri E. J. H.] Maastricht Univ, CAHPRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Bueller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Hendriksen, JMT (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, NL-3508 GA Utrecht, Netherlands.	j.m.t.hendriksen-9@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021; Stoffers, Henri E.J.H./N-3785-2019	Stoffers, Henri E.J.H./0000-0002-7908-5101	Netherlands Organization for Scientific Research (ZONMW) [918.10.615, 91208004]; VENI grant from The Netherlands Organization for Scientific Research (ZONMW) [016.166.030]	Netherlands Organization for Scientific Research (ZONMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); VENI grant from The Netherlands Organization for Scientific Research (ZONMW)	KGMM received a grant from The Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). GJG is supported by a VENI grant from The Netherlands Organization for Scientific Research (ZONMW 016.166.030). All funding sources had no role in the design, conduct, analyses, or reporting of the study or in the decision to submit the manuscript for publication.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Barais M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098112; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Geersing Geert-Jan, 2012, BMJ, V345, pe6564, DOI 10.1136/bmj.e6564; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Hendriksen JMT, 2013, J THROMB HAEMOST, V11, P129, DOI 10.1111/jth.12262; Janssen KJM, 2009, CLIN CHEM, V55, P994, DOI 10.1373/clinchem.2008.115345; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kline JA, 2002, ANN EMERG MED, V39, P144, DOI 10.1067/mem.2002.121398; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Knottnerus JA, 2002, J CLIN EPIDEMIOL, V55, P1201, DOI 10.1016/S0895-4356(02)00528-0; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Lencioni R, 2010, ACTA RADIOL, V51, P741, DOI 10.3109/02841851.2010.495350; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Miniati M, 2003, AM J MED, V114, P173, DOI 10.1016/S0002-9343(02)01478-X; Miniati M, 2008, AM J RESP CRIT CARE, V178, P290, DOI 10.1164/rccm.200802-207OC; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Prasad V, 2012, ARCH INTERN MED, V172, P955, DOI 10.1001/archinternmed.2012.195; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P863, DOI 10.1016/j.jclinepi.2007.02.004; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178	40	47	53	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2015	351								h4438	10.1136/bmj.h4438	http://dx.doi.org/10.1136/bmj.h4438			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CS	26349907	Green Published, hybrid			2022-12-28	WOS:000361280000001
J	Owens, B				Owens, Brian			Profile: Joslin Diabetes Center, Boston, MA, USA	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					944	944		10.1016/S0140-6736(15)00116-6	http://dx.doi.org/10.1016/S0140-6736(15)00116-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369458	Bronze			2022-12-28	WOS:000361182700013
J	Morice, P; Leary, A; Creutzberg, C; Abu-Rustum, N; Darai, E				Morice, Philippe; Leary, Alexandra; Creutzberg, Carien; Abu-Rustum, Nadeem; Darai, Emile			Endometrial cancer	LANCET			English	Review							PHASE-II TRIAL; EXTERNAL-BEAM RADIOTHERAPY; PELVIC RADIATION-THERAPY; CLEAR-CELL CARCINOMA; SENTINEL LYMPH-NODES; BODY-MASS INDEX; MYOMETRIAL INVASION; INTERMEDIATE-RISK; STAGE-I; CLINICOPATHOLOGICAL SIGNIFICANCE	Endometrial cancer is the most common gynaecological tumour in developed countries, and its incidence is increasing. The most frequently occurring histological subtype is endometrioid adenocarcinoma. Patients are often diagnosed when the disease is still confined to the uterus. Standard treatment consists of primary hysterectomy and bilateral salpingo-oophorectomy, often using minimally invasive approaches (laparoscopic or robotic). Lymph node surgical strategy is contingent on histological factors (subtype, tumour grade, involvement of lymphovascular space), disease stage (including myometrial invasion), patients' characteristics (age and comorbidities), and national and international guidelines. Adjuvant treatment is tailored according to histology and stage. Various classifications are used to assess the risks of recurrence and to determine optimum postoperative management. 5 year overall survival ranges from 74% to 91% in patients without metastatic disease. Trials are ongoing in patients at high risk of recurrence (including chemotherapy, chemoradiation therapy, and molecular targeted therapies) to assess the modalities that best balance optimisation of survival with the lowest adverse effects on quality of life.	[Morice, Philippe] Gustave Roussy, Dept Gynecol Surg, 114 Rue Edouard Vaillant, F-94805 Villejuif, France; [Leary, Alexandra] Gustave Roussy, Dept Med Oncol, F-94805 Villejuif, France; [Leary, Alexandra] Gustave Roussy, Translat Res Lab U981, F-94805 Villejuif, France; [Morice, Philippe] Gustave Roussy, INSERM, U1030, F-94805 Villejuif, France; [Morice, Philippe] Univ Paris 11, Le Kremlin Bicetre, France; [Creutzberg, Carien] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands; [Abu-Rustum, Nadeem] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Darai, Emile] Hop Tenon, Dept Obstet & Gynaecol, F-75970 Paris, France; [Darai, Emile] INSERM, UMRS 938, Paris, France; [Darai, Emile] Univ Paris 06, Paris, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Memorial Sloan Kettering Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Morice, P (corresponding author), Gustave Roussy, Dept Gynecol Surg, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	philippe.morice@gustaveroussy.fr	Morice, Philippe/ABC-3179-2021	Creutzberg, Carien/0000-0002-7008-4321; Morice, Philippe/0000-0003-0579-9993; leary, alexandra/0000-0002-2043-2244				AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Abu-Rustum NR, 2010, GYNECOL ONCOL, V116, P399, DOI 10.1016/j.ygyno.2009.11.027; Abu-Rustum NR, 2013, ANN SURG ONCOL, V20, P353, DOI 10.1245/s10434-012-2685-8; Abu-Rustum NR, 2009, GYNECOL ONCOL, V113, P163, DOI 10.1016/j.ygyno.2009.01.003; Akbayir O, 2011, GYNECOL ONCOL, V122, P600, DOI 10.1016/j.ygyno.2011.05.041; AlHilli MM, 2013, GYNECOL ONCOL, V131, P103, DOI 10.1016/j.ygyno.2013.06.037; AlHilli MM, 2014, GYNECOL ONCOL, V133, P485, DOI 10.1016/j.ygyno.2014.03.567; Alvarez EA, 2013, GYNECOL ONCOL, V129, P22, DOI 10.1016/j.ygyno.2012.12.022; Anderson KE, 2001, CANCER EPIDEM BIOMAR, V10, P611; Andreano A, 2014, EUR RADIOL, V24, P1327, DOI 10.1007/s00330-014-3139-4; [Anonymous], 2015, Obstet Gynecol, V125, P274, DOI 10.1097/01.AOG.0000459870.06491.71; Arem H, 2013, JNCI-J NATL CANCER I, V105, P342, DOI 10.1093/jnci/djs530; Asbury RF, 2002, AM J CLIN ONCOL-CANC, V25, P557, DOI 10.1097/00000421-200212000-00004; Ballester M, 2013, ANN SURG ONCOL, V20, P407, DOI 10.1245/s10434-012-2683-x; Ballester M, 2011, LANCET ONCOL, V12, P469, DOI 10.1016/S1470-2045(11)70070-5; Ballester M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-465; Barakat RR, 1999, GYNECOL ONCOL, V75, P99, DOI 10.1006/gyno.1999.5536; Barlin JN, 2013, GYNECOL ONCOL, V130, P452, DOI 10.1016/j.ygyno.2013.06.009; Barlin JN, 2012, GYNECOL ONCOL, V125, P531, DOI 10.1016/j.ygyno.2012.02.021; Barlin JN, 2010, GYNECOL ONCOL, V118, P14, DOI 10.1016/j.ygyno.2010.04.005; Beesley VL, 2015, GYNECOL ONCOL, V136, P87, DOI 10.1016/j.ygyno.2014.11.006; Bendifallah S, 2014, BRIT J CANCER, V110, P2640, DOI 10.1038/bjc.2014.237; Bendifallah S, 2013, BRIT J CANCER, V109, P1498, DOI 10.1038/bjc.2013.500; Bendifallah S, 2015, AM J OBSTET GYNECOL, V212, pe1; Blake P, 2009, LANCET, V373, P137, DOI 10.1016/S0140-6736(08)61767-5; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Boruta DM, 2009, GYNECOL ONCOL, V115, P142, DOI 10.1016/j.ygyno.2009.06.011; Bosse T, 2014, EUR J CANCER, V50, P2602, DOI 10.1016/j.ejca.2014.07.014; Bradford LS, 2015, AM J CLIN ONCOL-CANC, V38, P206, DOI 10.1097/COC.0b013e31829a2974; Brinton LA, 2013, GYNECOL ONCOL, V129, P277, DOI 10.1016/j.ygyno.2013.02.023; Buchanan DD, 2014, J CLIN ONCOL, V32, P90, DOI 10.1200/JCO.2013.51.2129; Burke WM, 2014, GYNECOL ONCOL, V134, P385, DOI 10.1016/j.ygyno.2014.05.018; Burke WM, 2014, GYNECOL ONCOL, V134, P393, DOI 10.1016/j.ygyno.2014.06.003; Byron SA, 2009, FUTURE ONCOL, V5, P27, DOI 10.2217/14796694.5.1.27; Castonguay V, 2014, GYNECOL ONCOL, V134, P274, DOI 10.1016/j.ygyno.2014.05.016; Chang YN, 2011, FERTIL STERIL, V96, P957, DOI 10.1016/j.fertnstert.2011.07.1146; Chen LM, 2007, OBSTET GYNECOL, V110, P18, DOI 10.1097/01.AOG.0000267500.27329.85; Chicklore S, 2013, NUCL MED COMMUN, V34, P130, DOI 10.1097/MNM.0b013e32835c0964; Coleman RL, 2015, GYNECOL ONCOL, V138, P30, DOI 10.1016/j.ygyno.2015.04.005; Colombo N, 2013, BRIT J CANCER, V108, P1021, DOI 10.1038/bjc.2013.59; Creasman W T, 2006, Int J Gynaecol Obstet, V95 Suppl 1, pS105; Creutzberg CL, 2015, INT J RADIAT ONCOL, V91, P530, DOI 10.1016/j.ijrobp.2014.11.022; Creutzberg CL, 2011, INT J RADIAT ONCOL, V81, pE631, DOI 10.1016/j.ijrobp.2011.04.013; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Crosbie E., 2014, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858, DOI 10.1002/14651858]; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Despierre E, 2006, INT J GYNECOL CANCER, V16, P273, DOI 10.1111/j.1525-1438.2006.00416.x; Dijkhuizen FPHLJ, 2000, CANCER, V89, P1765, DOI 10.1002/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F; Duska LR, 2001, GYNECOL ONCOL, V83, P388, DOI 10.1006/gyno.2001.6434; Eltabbakh GH, 2005, GYNECOL ONCOL, V99, P309, DOI 10.1016/j.ygyno.2005.06.010; Emons G, 2014, GYNECOL ONCOL, V133, P427, DOI 10.1016/j.ygyno.2014.03.576; Eto T, 2013, GYNECOL ONCOL, V131, P574, DOI 10.1016/j.ygyno.2013.08.036; Eto T, 2012, GYNECOL ONCOL, V127, P338, DOI 10.1016/j.ygyno.2012.08.012; Evans-Metcalf ER, 1998, OBSTET GYNECOL, V91, P349, DOI 10.1016/S0029-7844(97)00668-6; Fadare O, 2013, MODERN PATHOL, V26, P1101, DOI 10.1038/modpathol.2013.35; Fader AN, 2009, CANCER-AM CANCER SOC, V115, P2119, DOI 10.1002/cncr.24247; Febbraro T, 2014, GYNECOL ONCOL, V135, P614, DOI 10.1016/j.ygyno.2014.10.011; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Frimer M, 2010, GYNECOL ONCOL, V119, P496, DOI 10.1016/j.ygyno.2010.08.030; Frumovitz M, 2004, GYNECOL ONCOL, V95, P463, DOI 10.1016/j.ygyno.2004.07.016; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Hoang LN, 2014, HISTOPATHOLOGY, V64, P585, DOI 10.1111/his.12286; Hogberg T, 2010, EUR J CANCER, V46, P2422, DOI 10.1016/j.ejca.2010.06.002; Hori M, 2013, EUR RADIOL, V23, P2296, DOI 10.1007/s00330-013-2815-0; Howitt BE, 2015, JAMA ONCOL, V1, P1319, DOI 10.1001/jamaoncol.2015.2151; Hussein YR, 2015, MODERN PATHOL, V28, P505, DOI 10.1038/modpathol.2014.143; Janda M, 2010, LANCET ONCOL, V11, P772, DOI 10.1016/S1470-2045(10)70145-5; Jantarasaengaram S, 2014, ULTRASOUND OBST GYN, V43, P569, DOI 10.1002/uog.13200; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Khoury-Collado F, 2011, GYNECOL ONCOL, V122, P251, DOI 10.1016/j.ygyno.2011.04.030; Khoury-Collado F, 2009, GYNECOL ONCOL, V115, P453, DOI 10.1016/j.ygyno.2009.08.026; KILGORE LC, 1995, GYNECOL ONCOL, V56, P29, DOI 10.1006/gyno.1995.1005; Kim CH, 2013, INT J GYNECOL CANCER, V23, P964, DOI 10.1097/IGC.0b013e3182954da8; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Kong A, 2012, JNCI-J NATL CANCER I, V104, P1625, DOI 10.1093/jnci/djs374; Koskas M, 2014, ANN SURG ONCOL, V21, P2376, DOI 10.1245/s10434-014-3589-6; Kuhn E, 2014, AM J SURG PATHOL, V38, P660, DOI 10.1097/PAS.0000000000000166; Kunneman M, 2014, BRIT J CANCER, V111, P674, DOI 10.1038/bjc.2014.322; Kuoppala T, 2008, GYNECOL ONCOL, V110, P190, DOI 10.1016/j.ygyno.2008.03.020; Lacey JV, 2012, INT J CANCER, V131, P1921, DOI 10.1002/ijc.27457; Lai CH, 2014, GYNECOL ONCOL, V135, P156, DOI 10.1016/j.ygyno.2014.07.092; Lancaster JM, 2007, GYNECOL ONCOL, V107, P159, DOI 10.1016/j.ygyno.2007.09.031; Landrum LM, 2009, GYNECOL ONCOL, V112, P337, DOI 10.1016/j.ygyno.2008.10.009; Lecuru F, 2008, INT J GYNECOL CANCER, V18, P1326, DOI 10.1111/j.1525-1438.2007.01183.x; Lee DO, 2011, J OBSTET GYNAECOL RE, V37, P1423, DOI 10.1111/j.1447-0756.2011.01558.x; Lee TS, 2007, GYNECOL ONCOL, V104, P52, DOI 10.1016/j.ygyno.2006.07.003; Leitao MM, 2013, GYNECOL ONCOL, V129, P38, DOI 10.1016/j.ygyno.2013.01.002; Liao CY, 2014, GYNECOL ONCOL, V135, P163, DOI 10.1016/j.ygyno.2014.07.095; Lin G, 2009, RADIOLOGY, V250, P784, DOI 10.1148/radiol.2503080874; Lindemann K, 2014, BMC CANCER, V5, P14; Liu FY, 2012, GYNECOL ONCOL, V125, P566, DOI 10.1016/j.ygyno.2012.03.021; Lu Q, 2013, J CANCER RES CLIN, V139, P1853, DOI 10.1007/s00432-013-1504-3; Luo J, 2014, BRIT J CANCER, V111, P1432, DOI 10.1038/bjc.2014.407; Maggi R, 2006, BRIT J CANCER, V95, P266, DOI 10.1038/sj.bjc.6603279; Makker V, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5513; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Matulonis U, 2015, GYNECOL ONCOL, V136, P246, DOI 10.1016/j.ygyno.2014.12.019; Mavromatis ID, 2012, ACTA OBSTET GYN SCAN, V91, P779, DOI 10.1111/j.1600-0412.2012.01406.x; McCluggage WG, 2006, J CLIN PATHOL, V59, P801, DOI 10.1136/jcp.2005.029702; McMeekin DS, 2014, GYNECOL ONCOL, V134, P438, DOI 10.1016/j.ygyno.2014.07.078; McMeekin DS, 2007, GYNECOL ONCOL, V106, P16, DOI 10.1016/j.ygyno.2007.04.032; Mendivil A, 2009, CANCER CONTROL, V16, P46, DOI 10.1177/107327480901600107; Modica I, 2007, AM J SURG PATHOL, V31, P744, DOI 10.1097/01.pas.0000213428.61374.06; Moir-Meyer GL, 2015, HUM GENET, V134, P269, DOI 10.1007/s00439-014-1507-4; MORROW CP, 1990, GYNECOL ONCOL, V36, P166, DOI 10.1016/0090-8258(90)90166-I; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; Olawaiye AB, 2009, GYNECOL ONCOL, V113, P277, DOI 10.1016/j.ygyno.2009.02.003; Onsrud M, 2013, J CLIN ONCOL, V31, P3951, DOI 10.1200/JCO.2013.48.8023; Oza AM, 2015, J CLIN ONCOL, V33, P3576, DOI 10.1200/JCO.2014.58.8871; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; Powell MA, 2014, GYNECOL ONCOL, V135, P38, DOI 10.1016/j.ygyno.2014.07.083; Purdie DM, 2001, BEST PRACT RES CL OB, V15, P341, DOI 10.1053/beog.2000.0180; Querleu D, 2011, INT J GYNECOL CANCER, V21, P945, DOI 10.1097/IGC.0b013e31821bd473; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renkonen-Sinisalo L, 2007, INT J CANCER, V120, P821, DOI 10.1002/ijc.22446; Robbins JR, 2013, GYNECOL ONCOL, V131, P593, DOI 10.1016/j.ygyno.2013.10.007; Rodolakis A, 2015, INT J GYNECOL CANCER, V25, P1258, DOI 10.1097/IGC.0000000000000493; Savelli L, 2008, ULTRASOUND OBST GYN, V31, P560, DOI 10.1002/uog.5295; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Selman Tara J, 2008, BMC Womens Health, V8, P8, DOI 10.1186/1472-6874-8-8; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Sheikh MA, 2014, FUTURE ONCOL, V10, P2561, DOI 10.2217/fon.14.192; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slomovitz BM, 2015, J CLIN ONCOL, DOI [10.1200/JCO.2014.58.3401.org, DOI 10.1200/JCO.2014.58.3401.ORG]; Slomovitz BM, 2010, CANCER-AM CANCER SOC, V116, P5415, DOI 10.1002/cncr.25515; Soini T, 2014, OBSTET GYNECOL, V124, P292, DOI 10.1097/AOG.0000000000000356; Sorbe B, 2012, INT J RADIAT ONCOL, V82, P1249, DOI 10.1016/j.ijrobp.2011.04.014; Susumu N, 2008, GYNECOL ONCOL, V108, P226, DOI 10.1016/j.ygyno.2007.09.029; Swisher EBJ, 2014, 26 EORTC NCI AACR S; Teplinsky E, 2014, GYNECOL ONCOL, V135, P364, DOI 10.1016/j.ygyno.2014.09.003; Terry P, 1999, INT J CANCER, V82, P38, DOI 10.1002/(SICI)1097-0215(19990702)82:1&lt;38::AID-IJC8&gt;3.0.CO;2-Q; Timmermans A, 2010, OBSTET GYNECOL, V116, P160, DOI 10.1097/AOG.0b013e3181e3e7e8; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Touboul C, 2014, ANTICANCER RES, V34, P5670; Trabert B, 2015, CANCER EPIDEM BIOMAR, V24, P261, DOI 10.1158/1055-9965.EPI-14-0923; Trimble CL, 2006, CANCER-AM CANCER SOC, V106, P812, DOI 10.1002/cncr.21650; Tsoref D, 2014, GYNECOL ONCOL, V135, P184, DOI 10.1016/j.ygyno.2014.06.033; Union internationale contre le cancer (UICC), 2009, TNM CLASS TUM MAL; Vergote I TM, 2013, J CLIN ONCOL S, V31, P5520, DOI DOI 10.1200/jco.2013.31.15_suppl.5520; Vidal F, 2013, INT J GYNECOL CANCER, V23, P1237, DOI 10.1097/IGC.0b013e31829b1b98; Weiderpass E, 2014, EUR J CANCER, V50, P1675, DOI 10.1016/j.ejca.2014.02.020; Werner HMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090141; Whitney CW, 2004, GYNECOL ONCOL, V92, P4, DOI 10.1016/j.ygyno.2003.09.018; Zannoni GF, 2010, VIRCHOWS ARCH, V457, P27, DOI 10.1007/s00428-010-0939-z; Zeimet AG, 2013, JNCI-J NATL CANCER I, V105, P1142, DOI 10.1093/jnci/djt144; Zhang ZM, 2014, INT J GYNECOL CANCER, V24, P534, DOI 10.1097/IGC.0000000000000092	158	918	968	17	229	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1094	1108		10.1016/S0140-6736(15)00130-0	http://dx.doi.org/10.1016/S0140-6736(15)00130-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26354523				2022-12-28	WOS:000371775000029
J	Elraiyah, T; Gionfriddo, MR; Montori, VM; Murad, MH				Elraiyah, Tarig; Gionfriddo, Michael R.; Montori, Victor M.; Murad, Mohammad Hassan			Content, Consistency, and Quality of Black Box Warnings: Time for a Change	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTIDEPRESSANTS; GUIDE		[Elraiyah, Tarig; Gionfriddo, Michael R.] Mayo Clin, Rochester, MN 55905 USA; [Montori, Victor M.; Murad, Mohammad Hassan] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Murad, MH (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, 200 First St SW, Rochester, MN 55905 USA.	Murad.mohammad@mayo.edu	Murad, M. Hassan/AAW-4367-2020; Gionfriddo, Michael R./S-8359-2016	Gionfriddo, Michael R./0000-0003-1391-7072; Murad, Mohammad Hassan/0000-0001-5502-5975; Montori, Victor/0000-0003-0595-2898	NCATS NIH HHS [TL1 TR000137] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000137] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Dorsey ER, 2010, ARCH INTERN MED, V170, P96, DOI 10.1001/archinternmed.2009.456; Elraiyah T, 2015, J CLIN EPIDEMIOL, V68, P698, DOI 10.1016/j.jclinepi.2015.01.025; Friedman RA, 2014, NEW ENGL J MED, V371, P1666, DOI 10.1056/NEJMp1408480; Karpel JP, 2009, ANN ALLERG ASTHMA IM, V103, P304, DOI 10.1016/S1081-1206(10)60529-7; Kaunitz AM, 2011, CONTRACEPTION, V84, P212, DOI 10.1016/j.contraception.2011.01.009; Murphy S, 2006, J ALLERGY CLIN IMMUN, V117, P34, DOI 10.1016/j.jaci.2005.10.031; Shulman LP, 2006, CONTRACEPTION, V73, P440, DOI 10.1016/j.contraception.2006.01.007; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; Stone MB, 2014, NEW ENGL J MED, V371, P1668, DOI 10.1056/NEJMp1411138	10	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					875	+		10.7326/M15-1097	http://dx.doi.org/10.7326/M15-1097			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26415046				2022-12-28	WOS:000365866500013
J	Pillay, J; Armstrong, MJ; Butalia, S; Donovan, LE; Sigal, RJ; Chordiya, P; Dhakal, S; Vandermeer, B; Hartling, L; Nuspl, M; Featherstone, R; Dryden, DM				Pillay, Jennifer; Armstrong, Marni J.; Butalia, Sonia; Donovan, Lois E.; Sigal, Ronald J.; Chordiya, Pritam; Dhakal, Sanjaya; Vandermeer, Ben; Hartling, Lisa; Nuspl, Megan; Featherstone, Robin; Dryden, Donna M.			Behavioral Programs for Type 1 Diabetes Mellitus A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; MOTIVATIONAL ENHANCEMENT THERAPY; PERSONAL TRAINER INTERVENTION; SELF-MANAGEMENT EDUCATION; IMPROVE REGIMEN ADHERENCE; POOR METABOLIC-CONTROL; QUALITY-OF-LIFE; GLYCEMIC CONTROL; MULTISYSTEMIC THERAPY; YOUNG-PEOPLE	Background: Whether behavioral approaches for self-management programs benefit individuals with type 1 diabetes mellitus is unclear. Purpose: To determine the effects of behavioral programs for patients with type 1 diabetes on behavioral, clinical, and health outcomes and to investigate factors that might moderate effect. Data Sources: 6 electronic databases (1993 to June 2015), trial registries and conference proceedings (2011 to 2014), and reference lists. Study Selection: 36 prospective, controlled studies involving participants of any age group that compared behavioral programs with usual care, active controls, or other programs. Data Extraction: One reviewer extracted and another verified data. Two reviewers assessed quality and strength of evidence (SOE). Data Synthesis: Moderate SOE showed reduction in glycated hemoglobin (HbA1c) at 6 months after the intervention compared with usual care (mean difference, -0.29 [95% CI, -0.45 to -0.13] percentage points) and compared with active controls (-0.44 [CI, -0.69 to -0.19] percentage points). At the end of the intervention and 12-month follow-up or longer, there were no statistically significant differences in HbA1c (low SOE) for comparisons with usual care or active control. Compared with usual care, generic quality of life at program completion did not differ (moderate SOE). Other outcomes had low or insufficient SOE. Adults appeared to benefit more for glycemic control at program completion (-0.28 [CI, -0.57 to 0.01] percentage points) than did youth (-0.12 [CI, -0.43 to 0.19] percentage points). Program intensity appeared not to influence effectiveness; some individual delivery appears beneficial. Limitations: All studies had medium or high risk of bias. There was scarce evidence for many outcomes. Conclusion: Behavioral programs for type 1 diabetes offer some benefit for glycemic control, at least at short-term followup, but improvement for other outcomes has not been shown. (PROSPERO registration number: CRD42014010515)	[Pillay, Jennifer; Chordiya, Pritam; Dhakal, Sanjaya; Vandermeer, Ben; Hartling, Lisa; Nuspl, Megan; Featherstone, Robin; Dryden, Donna M.] Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton Clin Hlth Acad, Edmonton, AB T6G 1C9, Canada; Alberta Hlth Serv, Calgary, AB, Canada; [Armstrong, Marni J.; Butalia, Sonia; Donovan, Lois E.; Sigal, Ronald J.] Univ Calgary, Div Endocrinol & Metab, Richmond Rd Diagnost & Treatment Ctr, Calgary, AB T2T 5C7, Canada	University of Alberta; Alberta Health Services (AHS); University of Calgary; University of Calgary	Pillay, J (corresponding author), Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton Clin Hlth Acad, 4th Floor,11405 87th Ave, Edmonton, AB T6G 1C9, Canada.	jpillay@ualberta.ca	Sigal, Ronald/AAU-6081-2020; Featherstone, Robin/J-5165-2014; Sigal, Ron/AAK-7627-2020	Featherstone, Robin/0000-0003-2517-2258; Butalia, Sonia/0000-0001-7865-9161	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERD registration number: CRD42014010515)	Agency for Healthcare Research and Quality, 2014, AHRQ PUBL, V10; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015; Amsberg S, 2009, DIABETES RES CLIN PR, V84, P76, DOI 10.1016/j.diabres.2008.12.011; Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713; [Anonymous], 2008, DIABETES EDUCATOR, V34, P445, DOI 10.1177/0145721708316625; Ayling K, 2015, PSYCHOL HEALTH, V30, P85, DOI 10.1080/08870446.2014.953528; BOARDWAY RH, 1993, J PEDIATR PSYCHOL, V18, P29, DOI 10.1093/jpepsy/18.1.29; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Christie D, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18200; Cook S, 2002, DIABETES EDUCATOR, V28, P115, DOI 10.1177/014572170202800113; Couch Robert, 2008, Evid Rep Technol Assess (Full Rep), P1; Couper JJ, 1999, DIABETES CARE, V22, P1933, DOI 10.2337/diacare.22.12.1933; Court JM, 2009, PEDIATR DIABETES, V10, P185, DOI 10.1111/j.1399-5448.2009.00586.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis DA, 2005, J PEDIATR PSYCHOL, V30, P656, DOI 10.1093/jpepsy/jsi052; Ellis DA, 2005, DIABETES CARE, V28, P1604, DOI 10.2337/diacare.28.7.1604; Ellis DA, 2004, J CLIN PSYCHOL MED S, V11, P315, DOI 10.1023/B:JOCS.0000045351.98563.4d; Ellis DA, 2007, J CONSULT CLIN PSYCH, V75, P168, DOI 10.1037/0022-006X.75.1.168; Ellis DA, 2012, ANN BEHAV MED, V44, P207, DOI 10.1007/s12160-012-9378-1; Forlani G, 2006, J ENDOCRINOL INVEST, V29, P405, DOI 10.1007/BF03344123; Franklin VL, 2006, DIABETIC MED, V23, P1332, DOI 10.1111/j.1464-5491.2006.01989.x; Fullerton B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009122.pub2; Funnell M, 2013, DIABETIC MED, V30, P765, DOI 10.1111/dme.12244; Griffin S, 1998, BMJ-BRIT MED J, V317, P390; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Hampson SE, 2000, DIABETES CARE, V23, P1416, DOI 10.2337/diacare.23.9.1416; Harris MA, 2015, DIABETES CARE, V38, P1427, DOI 10.2337/dc14-2469; Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holmes CS, 2014, DIABETES CARE, V37, P1535, DOI 10.2337/dc13-1053; Hood KK, 2010, DIABETES CARE, V33, P1658, DOI 10.2337/dc09-2268; Husted GR, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-321; Ingerski LM, 2010, J ADOLESCENT HEALTH, V47, P191, DOI 10.1016/j.jadohealth.2010.01.012; International Diabetes Federation, 2011, POS STAT SELF MAN ED; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-15; Ismail K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14220; Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005; Jones H, 2013, CAN J DIABETES, V37, pS26, DOI 10.1016/j.jcjd.2013.01.015; Karlsen B, 2004, PATIENT EDUC COUNS, V53, P299, DOI 10.1016/j.pec.2003.10.008; Katz ML, 2014, PEDIATR DIABETES, V15, P142, DOI 10.1111/pedi.12065; Kichler JC, 2013, FAM SYST HEALTH, V31, P280, DOI 10.1037/a0033039; Knight KM, 2006, DIABETIC MED, V23, P485, DOI 10.1111/j.1464-5491.2005.01802.x; Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138; Lehmkuhl Heather D, 2010, J Diabetes Sci Technol, V4, P199; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; Malik K, 2013, HUMAN DEV REP 2013; Mannucci E, 2005, ACTA DIABETOL, V42, P1, DOI 10.1007/s00592-005-0167-1; Mayer-Davis EJ, 2015, DIABETIC MED, V32, P829, DOI 10.1111/dme.12641; MCNABB WL, 1994, DIABETES EDUCATOR, V20, P121, DOI 10.1177/014572179402000206; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Murphy HR, 2007, DIABETIC MED, V24, P1261, DOI 10.1111/j.1464-5491.2007.02229.x; Murphy HR, 2006, DIABETIC MED, V23, P935, DOI 10.1111/j.1464-5491.2006.01816.x; Murphy HR, 2012, DIABETIC MED, V29, pE249, DOI 10.1111/j.1464-5491.2012.03683.x; Nansel TR, 2007, DIABETES CARE, V30, P2471, DOI 10.2337/dc06-2621; Nansel TR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0214-4; Nansel TR, 2012, PEDIATRICS, V129, pE866, DOI 10.1542/peds.2011-2858; Nansel TR, 2009, DIABETES CARE, V32, P807, DOI 10.2337/dc08-1968; Nansel TR, 2009, PEDIATR DIABETES, V10, P105, DOI 10.1111/j.1399-5448.2008.00448.x; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; National Institute for Health and Clinical Excellence, 2010, MAN TYP 2 DIAB; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Patel A, 2011, DIABETIC MED, V28, P470, DOI 10.1111/j.1464-5491.2010.03198.x; Perry TL, 1997, EUR J CLIN NUTR, V51, P757, DOI 10.1038/sj.ejcn.1600478; Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Pillay J, 2015, BEHAV PROGRAMS DIABE; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Ridge K, 2012, PSYCHOSOM MED, V74, P319, DOI 10.1097/PSY.0b013e31824c181b; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Schilling Lynne S, 2006, J Pediatr Nurs, V21, P412, DOI 10.1016/j.pedn.2006.01.034; Serlachius AS, 2014, J HLTH PSYCHOL; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sidik K, 2002, STAT MED, V21, P3153, DOI 10.1002/sim.1262; THOMASDOBERSEN DA, 1993, J AM DIET ASSOC, V93, P535, DOI 10.1016/0002-8223(93)91812-5; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Urban AD, 2004, J CLIN OUTCOMES MANA, V11, P299; US Department of Health and Human Services CDER, 2008, GUID IND DIAB MELL D; Viklund G, 2007, DIABETIC MED, V24, P550, DOI 10.1111/j.1464-5491.2007.02114.x; Viner RM, 2003, DIABETIC MED, V20, P739, DOI 10.1046/j.1464-5491.2003.00995.x; Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613; Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098; Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017	90	51	50	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					836	+		10.7326/M15-1399	http://dx.doi.org/10.7326/M15-1399			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26414020				2022-12-28	WOS:000365866500007
J	Romero, R; Deter, R				Romero, Roberto; Deter, Russell			Should serial fetal biometry be used in all pregnancies?	LANCET			English	Editorial Material									[Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,NIH, Bethesda, MD 20892 USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Deter, Russell] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan; Michigan State University; Wayne State University; Baylor College of Medicine	Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,NIH, Bethesda, MD 20892 USA.	prbchiefstaff@med.wayne.edu	Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	Intramural NIH HHS [Z99 HD999999] Funding Source: Medline; NICHD NIH HHS [HHSN275201300006C] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bornstein M. H., 2014, DEV INFANCY CONT INT; Bricker L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001451.pub4; Chaiworapongsa T, 2016, J MATERN-FETAL NEO M, V29, P1214, DOI 10.3109/14767058.2015.1048431; Chaiworapongsa T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.016; Deter RL, 2014, J MATERN-FETAL NEO M, V27, P543, DOI 10.3109/14767058.2013.833904; Flood K, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.008; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; National Collaborating Centre for Women's and Children's Health, 2008, NICE CLIN GUID 63 DI; National Collaborating Centre for Women's and Children's Health, 2008, NICE CLIN GUID 62 AN; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Sovio U, 2015, LANCET; WHO Department of Nutrition for Health and Development, 2006, WHO CHILD GROWTH STA	13	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2038	2040		10.1016/S0140-6736(15)00148-8	http://dx.doi.org/10.1016/S0140-6736(15)00148-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26360241	hybrid, Green Accepted			2022-12-28	WOS:000365987600008
J	Choueiri, TK; Escudier, B; Powles, T; Mainwaring, PN; Rini, BI; Donskov, F; Hammers, H; Hutson, TE; Lee, JL; Peltola, K; Roth, BJ; Bjarnason, GA; Geczi, L; Keam, B; Maroto, P; Heng, DYC; Schmidinger, M; Kantoff, PW; Borgman-Hagey, A; Hessel, C; Scheffold, C; Schwab, GM; Tannir, NM; Motzer, RJ				Choueiri, T. K.; Escudier, B.; Powles, T.; Mainwaring, P. N.; Rini, B. I.; Donskov, F.; Hammers, H.; Hutson, T. E.; Lee, J-L; Peltola, K.; Roth, B. J.; Bjarnason, G. A.; Geczi, L.; Keam, B.; Maroto, P.; Heng, D. Y. C.; Schmidinger, M.; Kantoff, P. W.; Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G. M.; Tannir, N. M.; Motzer, R. J.		METEOR Investigators	Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; PROGNOSTIC-FACTORS; HGF/C-MET; C-MET; SUNITINIB; TUMORS; METASTASIS; XL184; NEPHRECTOMY; SORAFENIB	BACKGROUND Cabozantinib is an oral, small-molecule tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR) as well as MET and AXL, each of which has been implicated in the pathobiology of metastatic renal-cell carcinoma or in the development of resistance to antiangiogenic drugs. This randomized, open-label, phase 3 trial evaluated the efficacy of cabozantinib, as compared with everolimus, in patients with renal-cell carcinoma that had progressed after VEGFR-targeted therapy. METHODS We randomly assigned 658 patients to receive cabozantinib at a dose of 60 mg daily or everolimus at a dose of 10 mg daily. The primary end point was progression-free survival. Secondary efficacy end points were overall survival and objective response rate. RESULTS Median progression-free survival was 7.4 months with cabozantinib and 3.8 months with everolimus. The rate of progression or death was 42% lower with cabozantinib than with everolimus (hazard ratio, 0.58; 95% confidence interval [CI] 0.45 to 0.75; P<0.001). The objective response rate was 21% with cabozantinib and 5% with everolimus (P<0.001). A planned interim analysis showed that overall survival was longer with cabozantinib than with everolimus (hazard ratio for death, 0.67; 95% CI, 0.51 to 0.89; P = 0.005) but did not cross the significance boundary for the interim analysis. Adverse events were managed with dose reductions; doses were reduced in 60% of the patients who received cabozantinib and in 25% of those who received everolimus. Discontinuation of study treatment owing to adverse events occurred in 9% of the patients who received cabozantinib and in 10% of those who received everolimus. CONCLUSIONS Progression-free survival was longer with cabozantinib than with everolimus among patients with renal-cell carcinoma that had progressed after VEGFR-targeted therapy.	[Choueiri, T. K.; Kantoff, P. W.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Escudier, B.] Inst Gustave Roussy, Villejuif, France; [Powles, T.] Queen Mary Univ London, Royal Free NHS Trust, Canc Res UK Expt Canc Med Ctr, Barts Canc Inst, London, England; [Mainwaring, P. N.] Icon Canc Care, South Brisbane, Qld, Australia; [Rini, B. I.] Cleveland Clin, Cleveland, OH USA; [Donskov, F.] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Hammers, H.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; [Hutson, T. E.] Baylor Univ, Charles A Sammons Canc Ctr, Texas Oncol, Dallas, TX USA; [Lee, J-L] Univ Ulsan, Coll Med, Seoul, South Korea; [Keam, B.] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Peltola, K.] Univ Helsinki, Cent Hosp, Ctr Canc, Helsinki, Finland; [Roth, B. J.] Washington Univ, St Louis, MO 63130 USA; [Bjarnason, G. A.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Heng, D. Y. C.] Tom Baker Canc Clin, Calgary, AB, Canada; [Geczi, L.] Natl Inst Oncol, Budapest, Hungary; [Maroto, P.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Schmidinger, M.] Med Univ Vienna, Vienna, Austria; [Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G. M.] Exelixis, San Francisco, CA USA; [Tannir, N. M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Motzer, R. J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; UNICANCER; Gustave Roussy; Cancer Research UK; University of London; Queen Mary University London; University College London; ICON plc; Cleveland Clinic Foundation; Aarhus University; Johns Hopkins University; Johns Hopkins Medicine; Baylor University; Baylor University Medical Center; Texas Oncology; University of Ulsan; Seoul National University (SNU); Seoul National University Hospital; University of Helsinki; Helsinki University Central Hospital; Washington University (WUSTL); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tom Baker Cancer Clinic; University of Calgary; National Institute of Oncology Hungary; Hospital of Santa Creu i Sant Pau; Medical University of Vienna; Exelixis, Inc.; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center	Choueiri, TK (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,DANA 1230, Boston, MA 02215 USA.	toni_choueiri@dfci.-harvard.edu	Gravis, Gwenaelle/CAG-3019-2022; Choueiri, Toni/K-5238-2019; Bjarnason, Georg A/L-6032-2019; Hutson, Thomas/AAS-9639-2020	Gravis, Gwenaelle/0000-0002-3127-1554; Choueiri, Toni/0000-0002-9201-3217; Bjarnason, Georg A/0000-0001-6903-5357; Hutson, Thomas/0000-0002-4529-4212; DURAN, IGNACIO/0000-0001-8571-7163; McDermott, Ray/0000-0002-8952-4315; Kantoff, Philip/0000-0001-7275-0597; Motzer, Robert/0000-0001-6925-2327; Donskov, Frede/0000-0002-8449-863X; joly, florence/0000-0001-6168-4942; OUDARD, Stephane/0000-0003-0893-285X; Cuff, Katharine/0000-0002-9261-3618; Garcia-Donas, Jesus/0000-0001-7731-3601	Exelixis; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Exelixis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Exelixis	Choueiri TK, 2014, ANN ONCOL, V25, P1603, DOI 10.1093/annonc/mdu184; Ciamporcero E, 2015, MOL CANCER THER, V14, P101, DOI 10.1158/1535-7163.MCT-14-0094; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; International Agency for Research on Cancer, 2012, GLOBOCAN KIDN CANC E; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Kroeger N, 2014, EUR UROL, V65, P1086, DOI 10.1016/j.eururo.2013.07.031; Leibovich BC, 2003, CANCER-AM CANCER SOC, V97, P1663, DOI 10.1002/cncr.11234; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Motzer R, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4506; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2014, J CLIN ONCOL, V32, P2766, DOI 10.1200/JCO.2013.54.6911; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Singh P, 2012, APPL COMPUT MATH-BAK, V1, P1, DOI DOI 10.7243/2049-7962-1-5; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Viola D, 2013, FUTURE ONCOL, V9, P1083, DOI [10.2217/fon.13.128, 10.2217/FON.13.128]; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Zhou L, 2015, ONCOGENE	29	801	819	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1814	1823		10.1056/NEJMoa1510016	http://dx.doi.org/10.1056/NEJMoa1510016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26406150	Green Accepted, Bronze			2022-12-28	WOS:000364144000005
J	Patnode, CD; Henderson, JT; Thompson, JH; Senger, CA; Fortmann, SP; Whitlock, EP				Patnode, Carrie D.; Henderson, Jillian T.; Thompson, Jamie H.; Senger, Caitlyn A.; Fortmann, Stephen P.; Whitlock, Evelyn P.			Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							NICOTINE-REPLACEMENT THERAPY; RANDOMIZED CONTROLLED TRIAL; SMOKING-CESSATION; METHODOLOGICAL QUALITY; ELECTRONIC CIGARETTES; MEASUREMENT TOOL; METAANALYSIS; SMOKERS; VARENICLINE; PATCHES	Background: Tobacco use is the leading cause of preventable death in the United States. Purpose: To review the effectiveness and safety of pharmacotherapy and behavioral interventions for tobacco cessation. Data Sources: 5 databases and 8 organizational Web sites were searched through 1 August 2014 for systematic reviews, and PubMed was searched through 1 March 2015 for trials on electronic nicotine delivery systems. Study Selection: Two reviewers examined 114 articles to identify English-language reviews that reported health, cessation, or adverse outcomes. Data Extraction: One reviewer abstracted data from good-and fair-quality reviews, and a second checked for accuracy. Data Synthesis: 54 reviews were included. Behavioral interventions increased smoking cessation at 6 months or more (physician advice had a pooled risk ratio [RR] of 1.76 [95% CI, 1.58 to 1.96]). Nicotine replacement therapy (RR, 1.60 [CI, 1.53 to 1.68]), bupropion (RR, 1.62 [CI, 1.49 to 1.76]), and varenicline (RR, 2.27 [CI, 2.02 to 2.55]) were also effective for smoking cessation. Combined behavioral and pharmacotherapy interventions increased cessation by 82% compared with minimal intervention or usual care (RR, 1.82 [CI, 1.66 to 2.00]). None of the drugs were associated with major cardiovascular adverse events. Only 2 trials addressed efficacy of electronic cigarettes for smoking cessation and found no benefit. Among pregnant women, behavioral interventions benefited cessation and perinatal health; effects of nicotine replacement therapy were not significant. Limitation: Evidence published after each review's last search date was not included. Conclusion: Behavioral and pharmacotherapy interventions improve rates of smoking cessation among the general adult population, alone or in combination. Data on the effectiveness and safety of electronic nicotine delivery systems are limited.	[Patnode, Carrie D.; Henderson, Jillian T.; Thompson, Jamie H.; Senger, Caitlyn A.; Fortmann, Stephen P.; Whitlock, Evelyn P.] Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR 97232 USA	Kaiser Permanente	Patnode, CD (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR 97232 USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P29; [Anonymous], 2014, SMOKING CESSATION IN; Banham L, 2010, ADDICTION, V105, P1176, DOI 10.1111/j.1360-0443.2010.02946.x; Barnes J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001008.pub2; Benowitz Neal L, 2014, Ann Am Thorac Soc, V11, P231, DOI 10.1513/AnnalsATS.201312-433PS; Berlin Ivan, 2014, BMJ, V348, pg1622, DOI 10.1136/bmj.g1622; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Bize R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004705.pub4; Bodner Michael E., 2009, Physiotherapy Theory and Practice, V25, P369, DOI 10.1080/09593980903011887; Bondurant S, 2009, COMBATING TOBACCO MI; Brody JS, 2014, AM J RESP CRIT CARE, V189, P379, DOI 10.1164/rccm.201312-2263ED; Brown J, 2013, WORLDV EVID-BASED NU, V10, P150, DOI 10.1111/wvn.12000; Bullen C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2008; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Cahill K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004492.pub4; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Carr AB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005084.pub3; Carson KV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009046.pub2; Chamberlain Catherine, 2013, Cochrane Database Syst Rev, pCD001055, DOI 10.1002/14651858.CD001055.pub4; Chen YF, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16380; Cheng HM, 2012, AM J CHINESE MED, V40, P429, DOI 10.1142/S0192415X12500334; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Coleman T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078; Coleman T, 2012, NEW ENGL J MED, V366, P808, DOI 10.1056/NEJMoa1109582; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Di YM, 2014, DRUG ALCOHOL DEPEN, V142, P14, DOI 10.1016/j.drugalcdep.2014.07.002; Ebbert J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004306.pub4; Filion KB, 2011, BJOG-INT J OBSTET GY, V118, P1422, DOI 10.1111/j.1471-0528.2011.03065.x; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; Fiore MC, 2008, CLIN PRACTICE GUIDEL; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Gierisch J., 2010, COMP EFFECTIVENESS S; Hartmann-Boyce J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001118.pub3; Hettema JE, 2010, J CONSULT CLIN PSYCH, V78, P868, DOI 10.1037/a0021498; Hitchman SC, 2014, ADDICTION, V109, P867, DOI 10.1111/add.12550; Huang YB, 2012, J PUBLIC HEALTH-HEID, V20, P355, DOI 10.1007/s10389-011-0476-5; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hutton HE, 2011, NICOTINE TOB RES, V13, P227, DOI 10.1093/ntr/ntq252; Johnston V, 2013, NICOTINE TOB RES, V15, P1329, DOI 10.1093/ntr/ntt022; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Lai DTC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006936.pub2, 10.1002/14651858.CD006936.pub3]; Liu JJ, 2013, PREV MED, V57, P765, DOI 10.1016/j.ypmed.2013.09.014; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Maziak W, 2014, JAMA-J AM MED ASSOC, V311, P1922, DOI 10.1001/jama.2014.2995; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; Mills EJ, 2014, CIRCULATION, V129, P28, DOI 10.1161/CIRCULATIONAHA.113.003961; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Mottillo S, 2009, EUR HEART J, V30, P718, DOI 10.1093/eurheartj/ehn552; Myung SK, 2012, BJOG-INT J OBSTET GY, V119, P1029, DOI 10.1111/j.1471-0528.2012.03408.x; Myung SK, 2009, ARCH INTERN MED, V169, P929, DOI 10.1001/archinternmed.2009.109; Nierkens V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073373; Oncken C, 2008, OBSTET GYNECOL, V112, P859, DOI 10.1097/AOG.0b013e318187e1ec; Patnode CD, 2015, BEHAV COUNSELING PHA; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Rice VH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001188.pub4; Rodgers A, 2005, TOB CONTROL, V14, P255, DOI 10.1136/tc.2005.011577; ROSE G, 1992, J EPIDEMIOL COMMUN H, V46, P75, DOI 10.1136/jech.46.1.75; ROSE G, 1978, J EPIDEMIOL COMMUN H, V32, P275, DOI 10.1136/jech.32.4.275; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Stotts AL, 2015, AM J PERINAT, V32, P351, DOI 10.1055/s-0034-1386635; Su A, 2014, MATERN CHILD HLTH J, V18, P714, DOI 10.1007/s10995-013-1298-6; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Tahiri M, 2012, AM J MED, V125, P576, DOI 10.1016/j.amjmed.2011.09.028; Tran K, 2010, PHARM BASED STRATEGI; Tsoi DT, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007253.pub3; Tzelepis F, 2011, JNCI-J NATL CANCER I, V103, P922, DOI 10.1093/jnci/djr169; U. S. Preventive Services Task Force, 2011, PROC MAN; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; US Preventive Serv Task Force, 2009, ANN INTERN MED, V150, P551, DOI 10.7326/0003-4819-150-8-200904210-00009; Ussher MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub3; van der Meer RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006102.pub2; Villanti AC, 2010, AM J PREV MED, V39, P564, DOI 10.1016/j.amepre.2010.08.009; White AR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000009.pub4; White AR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000009.pub3; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]; Wisborg K, 2000, OBSTET GYNECOL, V96, P967, DOI 10.1016/S0029-7844(00)01071-1; World Health Organization, 2013, WHO REC PREV MAN TOB; Zbikowski SM, 2012, MATURITAS, V71, P131, DOI 10.1016/j.maturitas.2011.11.019	89	116	119	1	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8					608	+		10.7326/M15-0171	http://dx.doi.org/10.7326/M15-0171			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU7QV	26389650				2022-12-28	WOS:000363737400019
J	Usami, Y; Wu, YF; Gottlinger, HG				Usami, Yoshiko; Wu, Yuanfei; Goettlinger, Heinrich G.			SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CD4 DOWN-REGULATION; OPTIMAL VIRAL INFECTIVITY; PRIMARY T-LYMPHOCYTES; CELL-SURFACE CD4; GLYCOSYLATED-GAG; CYTOPLASMIC DOMAIN; VIRION FUSION; REPLICATION	HIV-1 Nef and the unrelated mouse leukaemia virus glycosylated Gag (glycoGag) strongly enhance the infectivity of HIV-1 virions produced in certain cell types in a clathrin-dependent manner. Here we show that Nef and glycoGag prevent the incorporation of the multipass transmembrane proteins serine incorporator 3 (SERINC3) and SERINC5 into HIV-1 virions to an extent that correlates with infectivity enhancement. Silencing of both SERINC3 and SERINC5 precisely phenocopied the effects of Nef and glycoGag on HIV-1 infectivity. The infectivity of nef-deficient virions increased more than 100-fold when produced in double-knockout human CD4(+) T cells that lack both SERINC3 and SERINC5, and re-expression experiments confirmed that the absence of SERINC3 and SERINC5 accounted for the infectivity enhancement. Furthermore, SERINC3 and SERINC5 together restricted HIV-1 replication, and this restriction was evaded by Nef. SERINC3 and SERINC5 are highly expressed in primary human HIV-1 target cells, and inhibiting their downregulation by Nef is a potential strategy to combat HIV/AIDS.	[Usami, Yoshiko; Wu, Yuanfei; Goettlinger, Heinrich G.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Gottlinger, HG (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	heinrich.gottlinger@umassmed.edu		Gottlinger, Heinrich/0000-0003-4124-5824	NIAID/NIH [R01AI029873]; NIDA/NIH [DP1DA038034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA038034] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Leszyk and S. Shaffer for protein microsequencing, BGI Americas for RNA-seq, R. Maehr for sgRNA and Cas9 expression plasmids, J. Sodroski for HIVec2.GFP, T. Akagi for pCXbsr, and the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH for p89.6, indinavir, maraviroc, the monoclonal antibodies 183-H12-5C and Chessie 8, and TZM-bl cells. This work was supported by NIAID/NIH grant R01AI029873 and by NIDA/NIH grant DP1DA038034.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Brandenberg OF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004595; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Dorfman T, 2002, J VIROL, V76, P6857, DOI 10.1128/JVI.76.13.6857-6862.2002; Forshey BM, 2003, J VIROL, V77, P4409, DOI 10.1128/JVI.77.7.4409-4414.2003; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; Grossman TR, 2000, J EXP BIOL, V203, P447; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Luo TC, 1998, VIROLOGY, V241, P224, DOI 10.1006/viro.1997.8966; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; MILLER MD, 1995, J VIROL, V69, P579, DOI 10.1128/JVI.69.1.579-584.1995; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; PILLEMER EA, 1986, J VIROL, V57, P413, DOI 10.1128/JVI.57.2.413-421.1986; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Pizzato M, 2010, P NATL ACAD SCI USA, V107, P9364, DOI 10.1073/pnas.1001554107; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Usami Y, 2014, J VIROL, V88, P3443, DOI 10.1128/JVI.01933-13; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	59	272	283	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					218	+		10.1038/nature15400	http://dx.doi.org/10.1038/nature15400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416733	Green Accepted			2022-12-28	WOS:000362399000039
J	Birchler, JA				Birchler, James A.			Mendel, Mechanism, Models, Marketing, and More	CELL			English	Editorial Material								This year marks the 150th anniversary of the presentation by Gregor Mendel of his studies of plant hybridization to the Brunn Natural History Society. Their nature and meaning have been discussed many times. However, on this occasion, we reflect on the scientific enterprise and the perception of new discoveries.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Birchler, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	birchlerj@missouri.edu						Birchler JA, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.20, 10.1038/nplants.2015.20]; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Darwin C, 1877, EFFECTS CROSS SELF F; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Darwin CR, 1876, EFFECTS CROSS SELF F; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Endersby Jim, 2007, GUINEA PIGS HIST BIO; Forsdyke D.R., 2008, TREASURE YOUR EXCEPT; Galinat W.C., 1998, MAIZE GENET COOP NEW, V72, P83; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mendel G., 1866, P NATURAL HIST SOC B; Mendel G, 1870, HIERACIUM HYBRIDS OB; Ronceret A, 2015, PLANT REPROD, V28, P91, DOI [10.1007/s00497-015-0262-6, 10.1007/s00497-015-0262]	14	8	8	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					9	11		10.1016/j.cell.2015.09.008	http://dx.doi.org/10.1016/j.cell.2015.09.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406361	Bronze			2022-12-28	WOS:000361846500002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The false god of appraisal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Archer J, 2014, UNDERSTANDING RISE F; Vara V, 2015, NEW YORKER	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2015	351								h4982	10.1136/bmj.h4982	http://dx.doi.org/10.1136/bmj.h4982			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3ED	26391141	Bronze			2022-12-28	WOS:000361953500004
J	Davenport, RJ				Davenport, Richard J.			Review: Immediate vs deferred antiepileptics reduce recurrence at 1 to 2 y after an unprovoked first seizure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Edinburgh	Davenport, RJ (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.							Scottish Intercollegiate Guidelines Network (SIGN), 2015, DIAGN MAN EP AD	1	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC8	10.7326/ACPJC-2015-163-6-008	http://dx.doi.org/10.7326/ACPJC-2015-163-6-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370035				2022-12-28	WOS:000361365900008
J	Koretz, RL				Koretz, Ronald L.			Neither dabigatran nor rivaroxaban was linked to increased GI bleeding compared with warfarin	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ORAL ANTICOAGULANTS; METAANALYSIS		Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0	2	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC13	10.7326/ACPJC-2015-163-6-013	http://dx.doi.org/10.7326/ACPJC-2015-163-6-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370028				2022-12-28	WOS:000361365900013
J	Mikaloff-Fletcher, SE				Mikaloff-Fletcher, S. E.			An increasing carbon sink?	SCIENCE			English	Editorial Material									Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Mikaloff-Fletcher, SE (corresponding author), Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand.	sara.mikalof-fletcher@niwa.co.nz		Mikaloff Fletcher, Sara/0000-0003-0741-0320				Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Ito T, 2010, NATURE, V463, P80, DOI 10.1038/nature08687; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; Munro DR, 2015, GEOPHYS RES LETT, V42, P7623, DOI 10.1002/2015GL065194; Rodgers KB, 2014, BIOGEOSCIENCES, V11, P4077, DOI 10.5194/bg-11-4077-2014; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Zickfeld K, 2008, SCIENCE, V319, DOI [10.1126/science.1146886, 10.1126/science.1149077]	11	7	7	6	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1165	1165		10.1126/science.aad0912	http://dx.doi.org/10.1126/science.aad0912			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359388				2022-12-28	WOS:000360968400021
J	Schoggins, JW				Schoggins, John W.			Viruses carry antiviral cargo	SCIENCE			English	Editorial Material							GMP-AMP SYNTHASE; PROTEINS; SENSOR; CGAMP; HIV		Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Schoggins, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	john.schoggins@utsouthwestern.edu						Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Lahaye X, 2015, CURR OPIN VIROL, V11, P55, DOI 10.1016/j.coviro.2015.01.013; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458	11	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1166	1167		10.1126/science.aad0942	http://dx.doi.org/10.1126/science.aad0942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359389				2022-12-28	WOS:000360968400022
J	Gurney, KR; Romero-Lankao, P; Seto, KC; Hutyra, LR; Duren, R; Kennedy, C; Grimm, NB; Ehleringer, JR; Marcotullio, P; Hughes, S; Pincetl, S; Chester, MV; Runfola, DM; Feddema, JJ; Sperling, J				Gurney, Kevin Robert; Romero-Lankao, Paty; Seto, Karen C.; Hutyra, Lucy R.; Duren, Riley; Kennedy, Christopher; Grimm, Nancy B.; Ehleringer, Jim R.; Marcotullio, Peter; Hughes, Sara; Pincetl, Stephanie; Chester, Mikhail V.; Runfola, Daniel M.; Feddema, Johannes J.; Sperling, Joshua			Climate change: Track urban emissions on a human scale	NATURE			English	Editorial Material							URBANIZATION		[Gurney, Kevin Robert] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Gurney, Kevin Robert] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Gurney, KR (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	kevin.gurney@asu.edu	Runfola, Daniel Miller/AAI-7868-2020; Grimm, Nancy B/D-2840-2009; Seto, Karen C./C-2722-2008; /J-4400-2012	Runfola, Daniel Miller/0000-0001-5356-4676; Grimm, Nancy B/0000-0001-9374-660X; Seto, Karen C./0000-0002-4928-2446; /0000-0002-0800-0908; Hughes, Sara/0000-0002-1282-6235; Marcotullio, Peter/0000-0001-8133-1204; Kennedy, Christopher/0000-0001-8812-4451	Direct For Biological Sciences [1026865] Funding Source: National Science Foundation; Direct For Social, Behav & Economic Scie [1229429] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Chester MV, 2014, EARTHS FUTURE, V2, P533, DOI 10.1002/2014EF000253; City of Los Angeles, 2008, CLIMATELA MUNICIPAL; Erickson P, 2014, ADV CLIMATE AMBITION; Gurney K.R., 2013, EOS T AGU, V94, P199, DOI [10.1002/2013EO220003, DOI 10.1002/2013EO220003]; Hutyra LR, 2014, EARTHS FUTURE, V2, P473, DOI 10.1002/2014EF000255; Kort EA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052738; Marcotullio PJ, 2014, EARTHS FUTURE, V2, P496, DOI 10.1002/2014EF000257; McKain K, 2012, P NATL ACAD SCI USA, V109, P8423, DOI 10.1073/pnas.1116645109; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; World Bank, 2010, INDEP EVAL GROUP STU, P1, DOI 10.1596/978-0-8213-8653-8	10	90	92	4	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					179	181		10.1038/525179a	http://dx.doi.org/10.1038/525179a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354467	Bronze, Green Published			2022-12-28	WOS:000360927400011
J	Zinman, B; Wanner, C; Lachin, JM; Fitchett, D; Bluhmki, E; Hantel, S; Mattheus, M; Devins, T; Johansen, OE; Woerle, HJ; Broedl, UC; Inzucchi, SE; Aizenberg, D; Ulla, M; Waitman, J; De Loredo, L; Farias, J; Fideleff, H; Lagrutta, M; Maldonado, N; Colombo, H; Pacora, FF; Wasserman, A; Maffei, L; Lehman, R; Selvanayagam, J; d'Emden, M; Fasching, P; Paulweber, B; Toplak, H; Luger, A; Drexel, H; Prager, R; Schnack, C; Schernthaner, G; Fliesser-Gorzer, E; Kaser, S; Scheen, A; Van Gaal, L; Hollanders, G; Kockaerts, Y; Capiau, L; Chachati, A; Persu, A; Hermans, M; Vantroyen, D; Vercammen, C; Van de Borne, P; Mathieu, C; Benhalima, K; Lienart, F; Mortelmans, J; Strivay, M; Vereecken, G; Keymeulen, B; Lamkanfi, F; Chacra, A; Eliaschewitz, F; Zanella, M; Faludi, A; Bertolami, M; Hayashida, C; Salles, JN; Monte, O; Dinato, M; Manenti, E; Rassi, N; Halpern, A; Lima, M; Ayoub, J; Felicio, J; Borges, J; Gross, J; Sgarbi, J; Betti, R; Tiburcio, A; Purisch, S; Schmid, H; Takahashi, M; Castro, M; Rea, R; Hissa, M; Neto, BG; Saraiva, J; Henein, S; Lochnan, H; Imran, SA; Clayton, D; Bayly, K; Berlingieri, J; Boucher, P; Chan, Y; Gupta, M; Chehayeb, R; Ouellett, A; Ur, E; Woo, V; Zinman, B; St Amour, E; Lozano, MT; Lozno, HY; Urina, M; Jaramillo, PL; Jaramillo, N; Sanchez, G; Perez, G; Tusek, S; Mirosevic, G; Goldoni, V; Jurisic-Erzen, D; Balasko, A; Balic, S; Drvodelic-Sunic, E; Varzic, SC; Machkova, M; Weiner, P; Lastuvka, J; Olsovsky, J; Krarup, T; Ridderstrale, M; Tarnow, L; Boesgaard, TW; Lihn, AS; Christensen, P; Juhl, H; Urhammer, S; Lund, P; Adojaan, B; Jakovlev, U; Lanno, R; Lubi, M; Marandi, T; Gouet, D; Courreges, J; Zaoui, P; Choukroun, G; Petit, C; Formagne, L; Estour, B; Mabire, P; Daugenet, C; Lemarie, B; Clavel, S; Aure, P; Remaud, P; Halimi, J; Hadjadj, S; Couffinhal, T; Glonti, S; Metreveli, D; Lominadze, Z; Giorgadze, E; Burtchuladze, T; Javashvili, L; Kurashvili, G; Kurashvili, R; Virsaladze, D; Nadareishvili, L; Khomasuridze, A; Cahill, T; Green, F; MacRury, S; Waldron, M; Middleton, A; McKnight, J; Pearson, E; Butler, M; Choksi, M; Caldwell, I; Farmer, I; Wyatt, N; Patrick, J; O'Brien, I; Devers, M; Bousboulas, S; Pappas, S; Piaditis, G; Vryonidou, A; Tentolouris, N; Karamitsos, K; Manes, C; Benroubi, M; Avramidis, I; Ozaki, R; Tan, K; Siu, S; Tsang, C; Dudas, M; Nagy, K; Salamon, C; Ip, T; Geroo, L; Patkay, J; Tabak, A; Juhasz, F; Szentpeteri, I; Tamas, G; Ghaisas, N; Bantwal, G; Mohan, V; Gupta, J; Sadhu, N; Kulkarni, A; Garg, N; Reddy, S; Deshpande, N; Gutlapalli, K; Pillai, M; Premchand, R; Badgandi, M; Jain, S; Aravind, S; Shamanna, P; Pandey, A; Gupta, S; Pramono, B; Saksono, HD; Agung, P; Wahono, SD; Suastika, K; Tanggo, Y; Juwana, Y; Siswanto, B; Adawi, F; Efrati, S; Mazen, E; Bashkin, A; Herskovits, T; Jaffe, A; Schiff, E; Wainstein, J; Taddei, S; Aiello, A; Arca, M; Calabro, P; Cignarelli, M; Fioretto, P; Reggiani, GM; Gnasso, A; Marchionni, N; Marsilii, A; Bucci, M; Mezzetti, A; Pozzilli, P; Colivicchi, F; Santini, M; Moro, E; Toscano, V; Fucili, A; Semplicini, A; Monno, S; Furui, K; Higashiue, S; Hiramatsu, N; Kawamitsu, K; Takenaka, T; Takahashi, H; Hojo, F; Onishi, Y; Izumino, K; Okubo, M; Wakida, Y; Kondo, Y; Hieshima, K; Jinnouchi, H; Suzuki, A; Ito, M; Park, S; Kim, Y; Hong, T; Park, H; Gwon, H; Kim, H; Kang, K; Jeong, M; Seung, K; Lim, D; Rha, S; Tahk, S; Yang, J; Yoon, J; Shin, M; Kim, D; Jeong, J; Ahmad, NN; Mustafa, N; Mohamed, WW; Fung, Y; Ghani, RA; Chandramouli, A; Chee, K; Kadir, KA; Ling, K; Abu Hassan, M; Foo, S; Lee, S; Hernandez, PG; Aguilar-Salinas, C; Velazquez, MV; Flores, F; Salazar, MA; Escalante, DM; Soria, MG; Munoz, EC; Storms, G; Schaper, N; Kooy, A; Krekels, M; van Bemmel, T; Verhoeven, R; Mulder, H; Oldenburg-Ligtenberg, P; Gonkel, F; de Jong, A; van Soest, J; Viergever, P; Mevissen, H; Lochorn, G; Zwiers, G; Hoogslag, P; Ronner, E; Nierop, P; Al-Windy, N; Kragten, J; Dekelver, P; Benatar, J; Krebs, J; Scott, R; Heggen, E; Berz, A; Fossum, C; Hurtig, U; Langslet, G; Baranowski, M; Sparby, J; Karlsson, T; Karlsson, T; Torres, CD; Escudero, AR; Lisson, R; Maldonado, AA; Rojas, WG; Bravo, LG; Osores, JL; Farfan, J; Zapata, L; Junchaya, JG; Concha, YR; Calderon, JU; Sy, R; Tan, G; Aquitania, G; De Los Santos, G; Panelo, A; Roderos, O; Rosales, R; Toledo, R; Liwag, A; Ramoncito, H; Skokowska, E; Krzyzagorska, E; Ogorek, M; Wojnowski, L; Spyra, J; Konieczny, M; Piesiewicz, W; Kus, W; Ocicka-Kozakiewicz, A; Orlowska-Kunikowska, E; Zmuda, W; Duarte, S; Leitao, A; Monteiro, P; Rita, H; Salgado, V; Pinto, L; Queiros, J; Teixeira, J; Rogado, C; Duarte, R; do Rosario, FS; Silva, A; Andrade, L; Velez, M; Brazao, M; Istratoaie, O; Lichiardopol, R; Catrinoiu, D; Militaru, C; Zetu, C; Barbonta, D; Cosma, D; Crisan, C; Pop, L; Esip, V; Khetagurova, F; Petrov, A; Arutyunov, G; Boyarkin, M; Agafyina, A; Vorokhobina, N; Petunina, N; Libov, I; Zalevskaya, A; Nikolaev, K; Barbarash, O; Potemkin, V; Bystrova, A; Krasilnikova, E; Barbarich, V; Chumakova, G; Tarasov, N; Meleshkevich, T; Zateyshchikov, D; Lantseva, O; Belenkiy, D; Obrezan, A; Rossolko, L; Fillipova, E; Yakhontova, P; Khokhlov, A; Tan, R; Sum, C; Chang, H; Distiller, L; Pretorius, M; Nortje, H; Mitha, E; Burgess, L; Blignaut, S; Venter, T; Moodley, R; Lombaard, J; Govind, U; Naidoo, V; Mookadam, M; Engelbrecht, J; Omar, M; Jurgens, J; Podgorski, G; Vawda, H; Naidoo, D; Emanuel, S; Roodt, A; Amod, A; Van Zyl, L; Segura, J; Brito, M; Fernandez-Cruz, A; Artola, S; Iglesias, R; Toural, E; Garcia-Ortiz, L; Saban, J; Mesa, J; Vidal, J; Linares, J; del Canizo, F; Rigla, M; Suarez, C; Llorente, I; Moreno, B; Antoli, A; Peralta, FG; Iglesias, M; Pereg, V; de Teresa, L; Camafort, M; Trescoli, C; Satarasinghe, R; Somasundaram, N; Siyambalapitiya, S; Antonypillai, C; Bulugahapitiya, D; Medagama, U; Huang, C; Lu, Y; Hwang, J; Chiang, C; Wen, M; Chen, J; Lai, W; Chang, K; Wang, J; Yeh, H; Kriangsak, P; Deerochanawong, C; Suwanwalaikorn, S; Mangklabruks, A; Kaewsuwanna, P; Piyayotai, D; Iabluchanskyi, M; Samoylov, O; Godlevska, O; Kovalyova, O; Voloshyna, O; Tseluyko, V; Zotov, S; Vykhovanyuk, I; Dulgeroff, A; Mayfield, R; Zaniewski-Singh, M; Ullal, J; Aloi, J; De La Rosa, R; Mosely, J; Wittmer, B; Aronoff, S; Rosenfeld, J; Seidner, M; Warren, M; Fishman, N; Weiss, R; Arif, A; Sandberg, M; Lewis, D; Ball, E; Graf, R; Breton, C; Tamayo, R; Richards, R; Cefalu, W; Uwaifo, G; Zayour, D; Hoffman, J; Fitz-Patrick, D; Khan, B; Blaze, K; Bressler, P; Halpern, S; Chappell, D; Bergenstal, R; Cuddihy, R; Matfin, G; Freedman, Z; Gonzalez-Campoy, J; Lerman, S; Rendell, M; Sitar, S; Reeves, M; Howard, T; Soufer, J; Miranda-Palma, B; Laliotis, A; Shomali, M; Teltser, M; Hurley, D; Morawski, E; Cherlin, R; Houchin, V; Welch, M; Goytia-Leos, D; Syed, M; Kowaloff, E; Weinrauch, L; Peniston, J; Brockmyre, A; First, B; Feld, L; Huffman, D; Nassim, O; Gottschlich, G; Patel, A; Knopke, C; Hernandez, M; Diaz, J; Giugliano, G; Nicasio, J; Eagerton, D; Huntley, R; Reed, J; Magee, M; Hippert, R; Sofley, C; Alzohaili, O; Levins, P; Anspach, R; Shah, S; Brusco, O; Naidu, J; Lindenbaum, J; Jacks, R; Hammond, G; Arena, C; Saxman, K; Mach, M; Kerstein, H; Kereiakes, D; Wahlen, J; Wehmeier, K; Chaykin, L; Rothman, J; Fogelfeld, L; Stroger, JH; Bittar, N; Rosenstock, J; Kayne, D; Navarro, J; Colfer, H; Mokshagundam, S; Shandilya, L; Connery, L; Wysham, C; Dela Llana, A; Jardula, M; MacAdams, M; Flippo, G; Heurich, E; Curtis, C; Sanders, D; Rawls, R; Velazquez, F; Osea, E; Mahood, K; Feldman, G; Eder, F; Riley, E; Fowler, W; Jain, M; Shepard, M; Schear, M; Barker, B; Strout, C; Obiekwe, O; Shanik, M; Green, C; Blakney, E; Roberson, K; Bretton, E; Pish, R; Kaveh, K; Maynard, B; Barager, W; Soldyshev, R; Austin, B; Parmar, P; Simpson, R; Chauhan, A; Kasper, J; Burr, R; Patel, N; Mariano, H; Pluto, T; Bratcher, C; Juarez, M; Levinson, L; Awad, A; Longshaw, K; Hoffman, K; Richwine, R; Molter, D; Boscia, J; Kowalyk, S; Lemis, P; Liss, J; Orr, R; Riser, J; Wood, J; Ubani, A; Paine, W; Hassani, F; Miranda, F; Hansen, V; Hansen, VR; Farris, N; Bowden, R; Ajani, D; Maw, K; Andersen, J; Bergman, B; Dunmyer, S; Brandon, D; Anderson, M; Bononi, P; Prawer, J; Seidman, B; Cruz, H; Wilks, K; DiSanto, L; Buynak, R; Christensen, T; Denker, P; Koppel, W; Stedman, M; Lewy-Alterbaum, L; Karim, S; Shapiro, J; Gardner, T; Oskin, T; Gabra, N; Malano, J				Zinman, Bernard; Wanner, Christoph; Lachin, John M.; Fitchett, David; Bluhmki, Erich; Hantel, Stefan; Mattheus, Michaela; Devins, Theresa; Johansen, Odd Erik; Woerle, Hans J.; Broedl, Uli C.; Inzucchi, Silvio E.; Aizenberg, D.; Ulla, M.; Waitman, J.; De Loredo, L.; Farias, J.; Fideleff, H.; Lagrutta, M.; Maldonado, N.; Colombo, H.; Ferre Pacora, F.; Wasserman, A.; Maffei, L.; Lehman, R.; Selvanayagam, J.; d'Emden, M.; Fasching, P.; Paulweber, B.; Toplak, H.; Luger, A.; Drexel, H.; Prager, R.; Schnack, C.; Schernthaner, G.; Fliesser-Goerzer, E.; Kaser, S.; Scheen, A.; Van Gaal, L.; Hollanders, G.; Kockaerts, Y.; Capiau, L.; Chachati, A.; Persu, A.; Hermans, M.; Vantroyen, D.; Vercammen, C.; Van de Borne, P.; Mathieu, C.; Benhalima, K.; Lienart, F.; Mortelmans, J.; Strivay, M.; Vereecken, G.; Keymeulen, B.; Lamkanfi, F.; Chacra, A.; Eliaschewitz, F.; Zanella, M.; Faludi, A.; Bertolami, M.; Hayashida, C.; Nunes Salles, J.; Monte, O.; Dinato, M.; Manenti, E.; Rassi, N.; Halpern, A.; Lima Filho, M.; Ayoub, J.; Felicio, J.; Borges, J.; Gross, J.; Sgarbi, J.; Betti, R.; Tiburcio, A.; Purisch, S.; Schmid, H.; Takahashi, M.; Castro, M.; Rea, R.; Hissa, M.; Geloneze Neto, B.; Saraiva, J.; Henein, S.; Lochnan, H.; Imran, S. A.; Clayton, D.; Bayly, K.; Berlingieri, J.; Boucher, P.; Chan, Y.; Gupta, M.; Chehayeb, R.; Ouellett, A.; Ur, E.; Woo, V.; Zinman, B.; St Amour, E.; Terront Lozano, M.; Yupanqui Lozno, H.; Urina, M.; Lopez Jaramillo, P.; Jaramillo, N.; Sanchez, G.; Perez, G.; Tusek, S.; Mirosevic, G.; Goldoni, V.; Jurisic-Erzen, D.; Balasko, A.; Balic, S.; Drvodelic-Sunic, E.; Varzic, S. Canecki; Machkova, M.; Weiner, P.; Lastuvka, J.; Olsovsky, J.; Krarup, T.; Ridderstrale, M.; Tarnow, L.; Boesgaard, T. Wellov; Lihn, A. Saetre; Christensen, P.; Juhl, H.; Urhammer, S.; Lund, P.; Adojaan, B.; Jakovlev, U.; Lanno, R.; Lubi, M.; Marandi, T.; Gouet, D.; Courreges, J.; Zaoui, P.; Choukroun, G.; Petit, C.; Formagne, L.; Estour, B.; Mabire, P.; Daugenet, C.; Lemarie, B.; Clavel, S.; Aure, P.; Remaud, P.; Halimi, J.; Hadjadj, S.; Couffinhal, T.; Glonti, S.; Metreveli, D.; Lominadze, Z.; Giorgadze, E.; Burtchuladze, T.; Javashvili, L.; Kurashvili, G.; Kurashvili, R.; Virsaladze, D.; Nadareishvili, L.; Khomasuridze, A.; Cahill, T.; Green, F.; MacRury, S.; Waldron, M.; Middleton, A.; McKnight, J.; Pearson, E.; Butler, M.; Choksi, M.; Caldwell, I.; Farmer, I.; Wyatt, N.; Patrick, J.; O'Brien, I.; Devers, M.; Bousboulas, S.; Pappas, S.; Piaditis, G.; Vryonidou, A.; Tentolouris, N.; Karamitsos, K.; Manes, C.; Benroubi, M.; Avramidis, I.; Ozaki, R.; Tan, K.; Siu, S.; Tsang, C.; Dudas, M.; Nagy, K.; Salamon, C.; Ip, T.; Geroo, L.; Patkay, J.; Tabak, A.; Juhasz, F.; Szentpeteri, I.; Tamas, G.; Ghaisas, N.; Bantwal, G.; Mohan, V.; Gupta, J.; Sadhu, N.; Kulkarni, A.; Garg, N.; Reddy, S.; Deshpande, N.; Gutlapalli, K.; Pillai, M.; Premchand, R.; Badgandi, M.; Jain, S.; Aravind, S.; Shamanna, P.; Pandey, A.; Gupta, S.; Pramono, B.; Saksono, H. Dante; Agung, P.; Wahono, S. Djoko; Suastika, K.; Tanggo, Y.; Juwana, Y.; Siswanto, B.; Adawi, F.; Efrati, S.; Mazen, E.; Bashkin, A.; Herskovits, T.; Jaffe, A.; Schiff, E.; Wainstein, J.; Taddei, S.; Aiello, A.; Arca, M.; Calabro, P.; Cignarelli, M.; Fioretto, P.; Reggiani, G. Marchesini; Gnasso, A.; Marchionni, N.; Marsilii, A.; Bucci, M.; Mezzetti, A.; Pozzilli, P.; Colivicchi, F.; Santini, M.; Moro, E.; Toscano, V.; Fucili, A.; Semplicini, A.; Monno, S.; Furui, K.; Higashiue, S.; Hiramatsu, N.; Kawamitsu, K.; Takenaka, T.; Takahashi, H.; Hojo, F.; Onishi, Y.; Izumino, K.; Okubo, M.; Wakida, Y.; Kondo, Y.; Hieshima, K.; Jinnouchi, H.; Suzuki, A.; Ito, M.; Park, S.; Kim, Y.; Hong, T.; Park, H.; Gwon, H.; Kim, H.; Kang, K.; Jeong, M.; Seung, K.; Lim, D.; Rha, S.; Tahk, S.; Yang, J.; Yoon, J.; Shin, M.; Kim, D.; Jeong, J.; Ahmad, N. Nik; Mustafa, N.; Mohamed, W. Wan; Fung, Y.; Ghani, R. Abdul; Chandramouli, A.; Chee, K.; Kadir, K. Abdul; Ling, K.; Abu Hassan, M.; Foo, S.; Lee, S.; Garcia Hernandez, P.; Aguilar-Salinas, C.; Vidrio Velazquez, M.; Flores, F.; Alpizar Salazar, M.; Micher Escalante, D.; Garcia Soria, M.; Cardona Munoz, E.; Storms, G.; Schaper, N.; Kooy, A.; Krekels, M.; van Bemmel, T.; Verhoeven, R.; Mulder, H.; Oldenburg-Ligtenberg, P.; Gonkel, F.; de Jong, A.; van Soest, J.; Viergever, P.; Mevissen, H.; Lochorn, G.; Zwiers, G.; Hoogslag, P.; Ronner, E.; Nierop, P.; Al-Windy, N.; Kragten, J.; Dekelver, P.; Benatar, J.; Krebs, J.; Scott, R.; Heggen, E.; Berz, A.; Fossum, C.; Hurtig, U.; Langslet, G.; Baranowski, M.; Sparby, J.; Karlsson, T.; Karlsson, Thomas; Delgado Torres, C.; Rodriguez Escudero, A.; Lisson, R.; Allemant Maldonado, A.; Gallardo Rojas, W.; Gonzales Bravo, L.; Lema Osores, J.; Farfan, J.; Zapata, L.; Godoy Junchaya, J.; Roldan Concha, Y.; Urquiaga Calderon, J.; Sy, R.; Tan, G.; Aquitania, G.; De Los Santos, G.; Panelo, A.; Roderos, O.; Rosales, R.; Toledo, R.; Liwag, A.; Ramoncito, H.; Skokowska, E.; Krzyzagorska, E.; Ogorek, M.; Wojnowski, L.; Spyra, J.; Konieczny, M.; Piesiewicz, W.; Kus, W.; Ocicka-Kozakiewicz, A.; Orlowska-Kunikowska, E.; Zmuda, W.; Duarte, S.; Leitao, A.; Monteiro, P.; Rita, H.; Salgado, V.; Pinto, L.; Queiros, J.; Teixeira, J.; Rogado, C.; Duarte, R.; Sobral do Rosario, F.; Silva, A.; Andrade, L.; Velez, M.; Brazao, M.; Istratoaie, O.; Lichiardopol, R.; Catrinoiu, D.; Militaru, C.; Zetu, C.; Barbonta, D.; Cosma, D.; Crisan, C.; Pop, L.; Esip, V.; Khetagurova, F.; Petrov, A.; Arutyunov, G.; Boyarkin, M.; Agafyina, A.; Vorokhobina, N.; Petunina, N.; Libov, I.; Zalevskaya, A.; Nikolaev, K.; Barbarash, O.; Potemkin, V.; Bystrova, A.; Krasilnikova, E.; Barbarich, V.; Chumakova, G.; Tarasov, N.; Meleshkevich, T.; Zateyshchikov, D.; Lantseva, O.; Belenkiy, D.; Obrezan, A.; Rossolko, L.; Fillipova, E.; Yakhontova, P.; Khokhlov, A.; Tan, R.; Sum, C.; Chang, H.; Distiller, L.; Pretorius, M.; Nortje, H.; Mitha, E.; Burgess, L.; Blignaut, S.; Venter, T.; Moodley, R.; Lombaard, J.; Govind, U.; Naidoo, V.; Mookadam, M.; Engelbrecht, J.; Omar, M.; Jurgens, J.; Podgorski, G.; Vawda, H.; Naidoo, D.; Emanuel, S.; Roodt, A.; Amod, A.; Van Zyl, L.; Segura, J.; Brito, M.; Fernandez-Cruz, A.; Artola, S.; Iglesias, R.; Toural, E.; Garcia-Ortiz, L.; Saban, J.; Mesa, J.; Vidal, J.; Linares, J.; del Canizo, F.; Rigla, M.; Suarez, C.; Llorente, I.; Moreno, B.; Antoli, A.; Gomez Peralta, F.; Iglesias, M.; Pereg, V.; de Teresa, L.; Camafort, M.; Trescoli, C.; Satarasinghe, R.; Somasundaram, N.; Siyambalapitiya, S.; Antonypillai, C.; Bulugahapitiya, D.; Medagama, U.; Huang, C.; Lu, Y.; Hwang, J.; Chiang, C.; Wen, M.; Chen, J.; Lai, W.; Chang, K.; Wang, J.; Yeh, H.; Kriangsak, P.; Deerochanawong, C.; Suwanwalaikorn, S.; Mangklabruks, A.; Kaewsuwanna, P.; Piyayotai, D.; Iabluchanskyi, M.; Samoylov, O.; Godlevska, O.; Kovalyova, O.; Voloshyna, O.; Tseluyko, V.; Zotov, S.; Vykhovanyuk, I.; Dulgeroff, A.; Mayfield, R.; Zaniewski-Singh, M.; Ullal, J.; Aloi, J.; De La Rosa, R.; Mosely, J.; Wittmer, B.; Aronoff, S.; Rosenfeld, J.; Seidner, M.; Warren, M.; Fishman, N.; Weiss, R.; Arif, A.; Sandberg, M.; Lewis, D.; Ball, E.; Graf, R.; Breton, C.; Tamayo, R.; Richards, R.; Cefalu, W.; Uwaifo, G.; Zayour, D.; Hoffman, J.; Fitz-Patrick, D.; Khan, B.; Blaze, K.; Bressler, P.; Halpern, S.; Chappell, D.; Bergenstal, R.; Cuddihy, R.; Matfin, G.; Freedman, Z.; Gonzalez-Campoy, J.; Lerman, S.; Rendell, M.; Sitar, S.; Reeves, M.; Howard, T.; Soufer, J.; Miranda-Palma, B.; Laliotis, A.; Shomali, M.; Teltser, M.; Hurley, D.; Morawski, E.; Cherlin, R.; Houchin, V.; Welch, M.; Goytia-Leos, D.; Syed, M.; Kowaloff, E.; Weinrauch, L.; Peniston, J.; Brockmyre, A.; First, B.; Feld, L.; Huffman, D.; Nassim, O.; Gottschlich, G.; Patel, A.; Knopke, C.; Hernandez, M.; Diaz, J.; Giugliano, G.; Nicasio, J.; Eagerton, D.; Huntley, R.; Reed, J., III; Magee, M.; Hippert, R.; Sofley, C., Jr.; Alzohaili, O.; Levins, P.; Anspach, R.; Shah, S.; Brusco, O.; Naidu, J.; Lindenbaum, J.; Jacks, R.; Hammond, G.; Arena, C.; Saxman, K.; Mach, M.; Kerstein, H.; Kereiakes, D.; Wahlen, J.; Wehmeier, K.; Chaykin, L.; Rothman, J.; Fogelfeld, L.; Stroger, John H., Jr.; Bittar, N.; Rosenstock, J.; Kayne, D.; Navarro, J.; Colfer, H.; Mokshagundam, S.; Shandilya, L.; Connery, L.; Wysham, C.; Dela Llana, A.; Jardula, M.; MacAdams, M.; Flippo, G.; Heurich, E.; Curtis, C.; Sanders, D.; Rawls, R.; Velazquez, F.; Osea, E.; Mahood, K.; Feldman, G.; Eder, F.; Riley, E.; Fowler, W.; Jain, M.; Shepard, M.; Schear, M.; Barker, B.; Strout, C.; Obiekwe, O.; Shanik, M.; Green, C.; Blakney, E.; Roberson, K.; Bretton, E.; Pish, R.; Kaveh, K.; Maynard, B.; Barager, W.; Soldyshev, R.; Austin, B.; Parmar, P.; Simpson, R.; Chauhan, A.; Kasper, J.; Burr, R.; Patel, N.; Mariano, H.; Pluto, T.; Bratcher, C.; Juarez, M.; Levinson, L.; Awad, A.; Longshaw, K.; Hoffman, K.; Richwine, R.; Molter, D.; Boscia, J., III; Kowalyk, S.; Lemis, P.; Liss, J.; Orr, R.; Riser, J.; Wood, J.; Ubani, A.; Paine, W.; Hassani, F.; Miranda, F.; Hansen, V.; Hansen, Val R.; Farris, N.; Bowden, R.; Ajani, D.; Maw, K.; Andersen, J.; Bergman, B.; Dunmyer, S.; Brandon, D.; Anderson, M.; Bononi, P.; Prawer, J.; Seidman, B.; Cruz, H.; Wilks, K.; DiSanto, L.; Buynak, R.; Christensen, T.; Denker, P.; Koppel, W.; Stedman, M.; Lewy-Alterbaum, L.; Karim, S.; Shapiro, J.; Gardner, T.; Oskin, T.; Gabra, N.; Malano, J.		EMPA-REG OUTCOME Investigators	Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; ADD-ON; GLUCOSE CONTROL; RISK; METFORMIN; 24-WEEK; METAANALYSIS; SITAGLIPTIN; STIFFNESS; DISEASE	BACKGROUND The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known. METHODS We randomly assigned patients to receive 10 mg or 25 mg of empagliflozin or placebo once daily. The primary composite outcome was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, as analyzed in the pooled empagliflozin group versus the placebo group. The key secondary composite outcome was the primary outcome plus hospitalization for unstable angina. RESULTS A total of 7020 patients were treated (median observation time, 3.1 years). The primary outcome occurred in 490 of 4687 patients (10.5%) in the pooled empagliflozin group and in 282 of 2333 patients (12.1%) in the placebo group (hazard ratio in the empagliflozin group, 0.86; 95.02% confidence interval, 0.74 to 0.99; P = 0.04 for superiority). There were no significant between-group differences in the rates of myocardial infarction or stroke, but in the empagliflozin group there were significantly lower rates of death from cardiovascular causes (3.7%, vs. 5.9% in the placebo group; 38% relative risk reduction), hospitalization for heart failure (2.7% and 4.1%, respectively; 35% relative risk reduction), and death from any cause (5.7% and 8.3%, respectively; 32% relative risk reduction). There was no significant between-group difference in the key secondary outcome (P = 0.08 for superiority). Among patients receiving empagliflozin, there was an increased rate of genital infection but no increase in other adverse events. CONCLUSIONS Patients with type 2 diabetes at high risk for cardiovascular events who received empagliflozin, as compared with placebo, had a lower rate of the primary composite cardiovascular outcome and of death from any cause when the study drug was added to standard care.	[Zinman, Bernard] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5S 1A1, Canada; [Zinman, Bernard] Univ Toronto, Div Endocrinol, Toronto, ON M5S 1A1, Canada; [Fitchett, David] Univ Toronto, Div Cardiol, Toronto, ON M5S 1A1, Canada; [Wanner, Christoph] Wurzburg Univ Clin, Div Nephrol, Dept Med, Wurzburg, Germany; [Bluhmki, Erich; Hantel, Stefan] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Mattheus, Michaela; Woerle, Hans J.; Broedl, Uli C.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Lachin, John M.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Devins, Theresa] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Johansen, Odd Erik] Boehringer Ingelheim Norway, Asker, Norway; [Inzucchi, Silvio E.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA; [Aizenberg, D.] Ctr Med Viamonte, Buenos Aires, DF, Argentina; [Ulla, M.] ILAIMCEOM, Cordoba, Cba, Argentina; [Waitman, J.] Ctr Diabetol Dr Waitman, Cordoba, Cba, Argentina; [De Loredo, L.] Hosp Privado Ctr Med Cordoba SA, Cordoba, Cba, Argentina; [De Loredo, L.] Parque Velez Sarfield, Cordoba, Cba, Argentina; [Farias, J.; Fideleff, H.] Sanatorio Guemes Hosp Privado, Buenos Aires, DF, Argentina; [Lagrutta, M.] Inst Invest Clin, Rosario, Santa Fe, Argentina; [Maldonado, N.] Ctr Med Alta Complejidad, Rosario, Santa Fe, Argentina; [Colombo, H.] Clin Privada Colombo, Cordoba, Co, Argentina; [Ferre Pacora, F.] Ctr Med Colon, Cordoba, Co, Argentina; [Wasserman, A.] Fepreva, Buenos Aires, DF, Argentina; [Maffei, L.] Consultorios Asociados Endocrinol & Invest Clin, Buenos Aires, DF, Argentina; [Lehman, R.] Adelaide Med Res, Ashford, SA, Australia; [Selvanayagam, J.] Heart & Vasc Inst, Fullarton, SA, Australia; [d'Emden, M.] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Fasching, P.] Wilhelminenspital Wien, Vienna, Austria; [Paulweber, B.] LKH Salzburg, St Johanns Spital, Salzburg, Austria; [Toplak, H.] Med Univ Graz, Graz, Austria; [Luger, A.] Univ Klin Innere Med III, Vienna, Austria; [Drexel, H.] Landeskrankenhaus Feldkirch, Feldkirch, Austria; [Prager, R.] Krankenhaus Hietzing NZR, Vienna, Austria; [Schnack, C.; Schernthaner, G.] Krankenanstalt Rudolfstiftung Wien, Semmelweis Frauenklin, Vienna, Austria; [Schernthaner, G.] Univ Klin Innere Med II, Vienna, Austria; [Kaser, S.] Univ Klin Innsbruck, Innsbruck, Austria; [Scheen, A.] Ctr Hosp Univ Liege, Liege, Belgium; [Van Gaal, L.] UZA, Edegem, Belgium; [Kockaerts, Y.] Ziekenhuis Oost Limburg, Genk, Belgium; [Chachati, A.] CHR Huy, Huy, Belgium; [Persu, A.; Hermans, M.] Clin Univ St Luc, Brussels, Belgium; [Vantroyen, D.] Huisartsenpraktijk Hygeia, Hasselt, Belgium; [Vercammen, C.] Imelda ZH Bonheiden, Bonheiden, Belgium; [Van de Borne, P.] Hop Univ Erasme, Brussels, Belgium; [Mathieu, C.; Benhalima, K.] Univ Hosp Gasthuisberg, Leuven, Belgium; [Lienart, F.] CHU Tivoli, La Louviere, Belgium; [Strivay, M.] CHR Citadelle, Site Citadelle, Liege, Belgium; [Keymeulen, B.; Lamkanfi, F.] UZ Brussels, Brussels, Belgium; [Chacra, A.] Hosp Sao Paulo UNIFESP, Villa Clementino, SP, Brazil; [Eliaschewitz, F.] Ctr Pesquisas Clin Ltda, Higienopolis, SP, Brazil; [Zanella, M.] Hosp Rim Hipertensao, Vila Clementino, SP, Brazil; [Faludi, A.; Bertolami, M.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Hayashida, C.] Blumenau Serv Med SC Ltda, Vila Leopoldina, SP, Brazil; [Monte, O.] Irmandade Santa Casa Misericordia Sao Paulo, Vila Albuquerque, SP, Brazil; [Dinato, M.] Hosp Guilherme Alvaro, Ctr Pesquisas Clin, Boqueirao, ST, Brazil; [Manenti, E.] Hosp Mae Deus, Porto Alegre, RS, Brazil; [Rassi, N.] Hosp Geral Goiania, Goiania, Go, Brazil; [Halpern, A.] FMUSP, Hosp Clin Sao Paulo, Sao Paulo, Brazil; [Lima Filho, M.] Univ Ribeirao Preto, Hosp Elect Bonini, Ribeirao Preto, Brazil; [Ayoub, J.] IMC, Sao Jose Do Rio Preto, Brazil; [Felicio, J.] Hosp Univ Joao Barros Barreto, Belem, Para, Brazil; [Borges, J.] Ctr Pesquisa Clin Brasil, Brasilia, DF, Brazil; [Gross, J.] Ctr Pesquisas Diabet, Porto Alegre, RS, Brazil; [Sgarbi, J.] Hosp Clin, Fac Med Marilia, Marilia, Brazil; [Betti, R.] Inst Coracao, Sao Paulo, Brazil; [Tiburcio, A.; Purisch, S.] Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil; [Schmid, H.] Irmandade Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Takahashi, M.] Univ Estadual Maringa, Maringa, Parana, Brazil; [Castro, M.] Inst Pesquisa Clin Med Avancada, Sao Paulo, Brazil; [Rea, R.] Univ Fed Parana, Curitiba, Parana, Brazil; [Hissa, M.] Ctr Pesquisas Diabet Doencas, Fortaleza, Ceara, Brazil; [Geloneze Neto, B.] Ced Ctr Endocrinol Diabet, Campinas, Brazil; [Saraiva, J.] PUCCAMP, Hosp Maternidade Celso Peirro, Campinas, Brazil; [Henein, S.] SKDS Res Inc, Newmarket, ON, Canada; [Imran, S. A.; Clayton, D.] QEII Hlth Sci Ctr, Clin Res Ctr, Halifax, NS, Canada; [Bayly, K.] Mt Royal Family Physicians, Saskatoon, SK, Canada; [Chehayeb, R.; Ouellett, A.] ViaCar Rech Clinique Inc, Longueuil, PQ, Canada; [St Amour, E.] Q&T Res Outaouais, Gatineau, PQ, Canada; [Terront Lozano, M.] UNIENDO Unidad Integral Endocrinol, Bogota, Colombia; [Yupanqui Lozno, H.] Dexa Diab IPS, Bogota, Colombia; [Urina, M.] Fdn Caribe Investigac Biomed, Barranquilla, Colombia; [Lopez Jaramillo, P.] Fdn Oftalmolog Santander, Floridablanca, ON, Canada; [Jaramillo, N.] CEMDE, Medellin, Colombia; [Sanchez, G.] CEQUIN, Armenia, Colombia; Cardiolab Ltda, Bogota, Colombia; [Tusek, S.] Specialized Hosp Med Rehabil, Krapinske Toplice, Croatia; [Mirosevic, G.; Goldoni, V.] Univ Hosp Ctr Sestre Milosrdnice, Zagreb, Croatia; [Jurisic-Erzen, D.] Univ Hosp Ctr Rijeka, Rijeka, Croatia; [Balasko, A.; Balic, S.] Gen Hosp Sveti Duh, Zagreb, Croatia; [Drvodelic-Sunic, E.] Gen Hosp Karlovac, Karlovac, Croatia; [Varzic, S. Canecki] Clin Hosp Ctr Osijek, Osijek, Croatia; [Machkova, M.] CCBR Czech Prague Sro, Prague 3, Czech Republic; [Weiner, P.] Hosp Jindrichuv Hradec, Diabetol Out Patient Clin, Jindrichuv Hrade, Czech Republic; Masaryk Hosp, Usti Nad Labem, Czech Republic; [Olsovsky, J.] St Anna Hosp, Brno, Czech Republic; [Krarup, T.] Bispebjerg Hosp, Kobenhavn NV, Denmark; [Ridderstrale, M.; Tarnow, L.; Boesgaard, T. Wellov] Steno Diabet Ctr, Gentofte, Denmark; [Lihn, A. Saetre] Reg Hosp Randers, Randers NO, Denmark; [Christensen, P.; Juhl, H.] Slagelse Sygehus, Slagelse, Denmark; [Urhammer, S.] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Lund, P.] Forskningsctr Nordsjaellands Hosp, Helsingor, Denmark; [Adojaan, B.] Tartu Endocrinol Ctr, Tartu, Estonia; [Jakovlev, U.] East Tallinn Cent Hosp, Tallinn, Estonia; [Lanno, R.] Merelahe Family Doctors Ctr, Tallinn, Estonia; [Lubi, M.; Marandi, T.] Tartu Univ Hosp, Tartu, Estonia; [Marandi, T.] North Estonia Med Ctr Fdn, Tallinn, Estonia; [Gouet, D.] Hop St Louis, La Rochelle 1, France; [Courreges, J.] CH Narbonne, Narbonne, France; [Zaoui, P.] CHU Grenoble, Grenoble, France; [Choukroun, G.] Chu Sud, Amiens, France; [Petit, C.] Ctr Hosp Gen Sud Francilien, Corbeil Essonnes, France; [Formagne, L.] Cabinet Med, Derval, France; Hop Nord, St Priez Jarez, France; [Mabire, P.] Cabinet Med, Fleury Orne, France; [Daugenet, C.] Cabinet Med, Equeurdreville Hainevill, France; [Lemarie, B.] Cabinet Med, Bourg Des Cptes, France; [Clavel, S.] Hop Hotel Dieu, Le Creusot, France; [Aure, P.; Remaud, P.] Cabinet Med, Angers, France; [Halimi, J.] CHU Tours, Tours, France; [Hadjadj, S.] Hop Poitiers, Poitiers, France; [Couffinhal, T.] Hop Cardiol Haut Leveque, Pessac, France; [Glonti, S.] Unimed Ajara LLC, Batumi, Georgia; [Metreveli, D.] David Metreveli Med Ctr Ltd, Tbilisi, Georgia; [Lominadze, Z.] L&J Clin, Kutaisi, Georgia; [Giorgadze, E.] Natl Inst Endocrinol Ltd, Tbilisi, Georgia; [Burtchuladze, T.; Javashvili, L.] Chemotherapy & Immunotherapy Clin Medulla, Tbilisi, Georgia; [Kurashvili, G.; Kurashvili, R.] Natl Ctr Diabet Res Ltd, Tbilisi, Georgia; [Virsaladze, D.] Med Ctr Medelite Ltd, Tbilisi, Georgia; [Nadareishvili, L.; Khomasuridze, A.] Zhordania Inst Human Reprod, Tbilisi, Georgia; [Cahill, T.] Res Unit, Somerset, England; [Green, F.] NHS Dumfries Galloway, Dumfries, Scotland; [MacRury, S.] Highland Diabet Inst, Inverness, Scotland; [Waldron, M.; Middleton, A.] Fowey River Practice, Fowey, England; [McKnight, J.] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Pearson, E.] NHS Tayside, Dundee, Scotland; [Butler, M.] Waterloo Med Ctr, Blackpool, England; [Choksi, M.; Caldwell, I.] Swan Lane Med Ctr, Bolton, England; [Farmer, I.] Stanwell Rd Surg, Ashford, Kent, England; [Wyatt, N.; Patrick, J.] Ctr Hlth, Bradford, W Yorkshire, England; [O'Brien, I.] NHS Lanarkshire, Wishaw, England; [Devers, M.] NHS Lanarkshire, Airdrie, Scotland; [Bousboulas, S.; Pappas, S.] Gen Hosp Nikaia, Nikaia, Greece; [Piaditis, G.] Gen Hosp Athens G Gennimatas, Athens, Greece; [Vryonidou, A.] Korgialenio Benakio Hellen Red Cross Hosp, Athens, Greece; [Tentolouris, N.] Gen Hosp Athens Laiko, Athens, Greece; [Karamitsos, K.] Gen Hosp Larissa, Larisa, Greece; [Manes, C.] Gen Hosp Papageorgiou, Thessaloniki, Greece; [Benroubi, M.] Gen Hosp Athens Polikliniki, Athens, Greece; [Avramidis, I.] Gen Hosp Thessaloniki G Papanikolaou, Thessaloniki, Greece; [Ozaki, R.] Prince Wales Hosp, Hong Kong, Peoples R China; [Tan, K.] Queen Mary Hosp, Hong Kong, Peoples R China; [Siu, S.; Ip, T.] Tung Wah Eastern Hosp, Hong Kong, Peoples R China; [Tsang, C.] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Peoples R China; [Dudas, M.] Bekes Cty Pandy Kalman Hosp, Gyula, Hungary; [Nagy, K.] Synexus Hungary Ltd, Budapest, Hungary; [Salamon, C.] Clinfan SMO Ltd, Szekszard, Hungary; [Geroo, L.; Tabak, A.; Tamas, G.] Semmelweis Univ, Budapest, Hungary; [Patkay, J.] Szent Pantaleon Hosp, Dunaujvaros, Hungary; [Juhasz, F.] CEE Res Kft, Kisvarda, Hungary; [Szentpeteri, I.] CRU Hungary Kft, Szikszo, Hungary; [Ghaisas, N.] Shatabdi Super Special Hosp, Nasik, Maharashtra, India; [Bantwal, G.] St Johns Med Coll & Hosp, Bangalore, Karnataka, India; [Mohan, V.] Dr Mohans Diabet Special, Chennai, Tamil Nadu, India; [Gupta, J.] S R Kalla Gastroentorol & Gen Hosp, Jaipur, Rajasthan, India; [Sadhu, N.] Shree Krishna Hosp & Heart Care Ctr, Ahmadabad, Gujarat, India; [Kulkarni, A.] Deendayal Mem Hosp, Pune, Maharashtra, India; [Garg, N.] Tagore Hosp & Heart Care Ctr, Jalandhar, Punjab, India; [Reddy, S.] Sumana Hosp, Hyderabad, Telangana, India; [Deshpande, N.] Spandan Heart Inst & Res Ctr, Nagpur, Maharashtra, India; [Gutlapalli, K.] Dr Ramesh Cardiac & Multispecial Hosp Ltd, Vijaywada, Andhra Pradesh, India; [Pillai, M.] Lakshmi Hosp, Cochin, Kerala, India; [Premchand, R.] Krishna Inst Med Sci, Secunderabad, Telangana, India; [Badgandi, M.] Manipal Hosp, Bangalore, Karnataka, India; [Jain, S.] TOTAL Diabet Hormone Inst, Indore, Madhya Pradesh, India; [Aravind, S.] DIACON Hosp & Res Ctr, Bangalore, Karnataka, India; [Shamanna, P.] Bangalore Clinisearch, Bangalore, Karnataka, India; [Pandey, A.] Heritage Hosp Ltd, Varanasi, Uttar Pradesh, India; [Gupta, S.] Diabet Care N Res Ctr, Nagpur, Maharashtra, India; [Pramono, B.] Sardjito Hosp, Yogyakarta, Indonesia; [Saksono, H. Dante] Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Agung, P.] Soetomo Hosp, Surabaya, Indonesia; [Wahono, S. Djoko] Saiful Anwar Hosp, Malang, Indonesia; [Suastika, K.] Sanglah Hosp, Denpasar, Bali, Indonesia; [Tanggo, Y.] Rumah Sakit FK UKI, Jakarta, Indonesia; [Juwana, Y.] Cinere Hosp, Depok, Indonesia; [Siswanto, B.] Harapan Kita Natl Cardiovasc Ctr, Jakarta, Indonesia; [Adawi, F.] ZIV Med Ctr, Safed, Israel; [Efrati, S.] Assaf Harofeh Med Ctr, Zerifin, Israel; [Mazen, E.] Haemek Med Ctr, Afula, Israel; [Bashkin, A.; Herskovits, T.] Western Galilee Hosp, Nahariyya, Israel; [Jaffe, A.] Hillel Yaffe Med Ctr, Hadera, Israel; [Schiff, E.] Bnai Zion Med Ctr, Haifa, Israel; [Wainstein, J.] E Wolfson Med Ctr, Holon, Israel; [Taddei, S.] Dipartimento Med Interna, Pisa, Italy; [Aiello, A.] UOC Endocrinol Diabetol & Malattie Metabol, Campobasso, Italy; [Arca, M.] Dipartimento Clin & Terapia Med, Rome, Italy; [Calabro, P.] UOC Cardiol, Naples, Italy; [Cignarelli, M.] Dipartimento Sci Med, Foggia, Italy; [Fioretto, P.] Azienda Osped Padova, Padua, Italy; [Reggiani, G. Marchesini] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Gnasso, A.] A O Mater Domini, Catanzaro, Italy; [Marchionni, N.; Marsilii, A.] A O Careggi, Florence, Italy; [Bucci, M.; Mezzetti, A.] Fdn Univ G DAnnunzio, Chieti, Italy; [Pozzilli, P.] Area Endocrinol, Rome, Italy; [Colivicchi, F.; Santini, M.] Div Cardiol, Rome, Italy; [Moro, E.; Semplicini, A.] UO Med Interna, Venice, Italy; [Toscano, V.] UOC Endocrinol, Rome, Italy; [Fucili, A.] Ctr Scompenso Cardiaco, Ferrara, Italy; [Monno, S.] Chibanishi Gen Hosp, Matsudo, Chiba, Japan; [Furui, K.] Hanyu Gen Hosp, Hanyu, Saitama, Japan; [Higashiue, S.; Hiramatsu, N.] Kishiwada Tokushukai Hosp, Kishiwada, Osaka, Japan; [Kawamitsu, K.] Okinawa Tokushukai Med Corp, Yaesecho, Okinawa, Japan; [Takenaka, T.] Natl Hosp Org Hokkaido Med Ctr, Nishi Ku, Sapporo, Hokkaido, Japan; [Takahashi, H.] Iryouhouijneiwakai Minamiakatsuka Clin, Mito, Ibaraki, Japan; [Hojo, F.] Kobari Gen Hosp, Noda, Chiba, Japan; [Onishi, Y.] Inst Adult Dis, Chuo Ku, Tokyo, Japan; [Izumino, K.] Fujikoshi Hosp, Toyama, Toyama, Japan; [Okubo, M.] Gifu Heart Ctr, Gifu, Gifu, Japan; [Wakida, Y.] Daishinkai Med Corp Ookuma Hosp, Kita Ku, Nagoya, Aichi, Japan; [Kondo, Y.] Clin Horikawa, Kamigyo Ku, Kyoto, Kyoto, Japan; [Hieshima, K.; Jinnouchi, H.] Jinnouchi Diabet Ctr, Kumamoto, Kumamoto, Japan; [Suzuki, A.; Ito, M.] Fujita Hlth Univ Hosp, Toyoake, Aichi, Japan; [Park, S.] Severance Hosp, Seoul, South Korea; [Kim, Y.] Asan Med Ctr, Seoul, South Korea; [Hong, T.] Pusan Natl Univ Hosp, Pusan, South Korea; [Park, H.] Kyungpook Natl Univ Hosp, Daegu, South Korea; [Gwon, H.] Samsung Med Ctr, Seoul, South Korea; [Kim, H.] Seoul Natl Univ Hosp, Seoul, South Korea; [Kang, K.; Lee, S.] Eulji Univ Hosp, Daejeon, South Korea; [Jeong, M.] Chonnam Natl Univ Hosp, Gwangju, South Korea; [Seung, K.] Catholic Univ Korea, Seoul, South Korea; [Lim, D.] Korea Univ Anam Hosp, Seoul, South Korea; [Rha, S.] Korea Univ Guro Hosp, Seoul, South Korea; [Tahk, S.] Ajou Univ Hosp, Suwon, South Korea; [Yang, J.] Natl Hlth Insurance Serv Ilsan Hosp, Goyang, South Korea; [Yoon, J.] Wonju Severance Christian Hosp, Wonju, South Korea; [Shin, M.] Gachon Univ Gil Med Ctr, Incheon, South Korea; [Kim, D.] Inje Univ Haeundae Paik Hosp, Busan, South Korea; [Jeong, J.] Chungnam Natl Univ Hosp, Daejoen, South Korea; [Ahmad, N. Nik] Hosp Tengku Ampuan Afzan, Pahang, Malaysia; [Mustafa, N.] Pusat Perubatan Univ, Kuala Lumpur, Malaysia; [Mohamed, W. Wan] Hosp Univ Sains Malaysia, Kelantan, Malaysia; [Fung, Y.] Queen Elizabeth Hosp, Kota Kinabalu, Malaysia; [Ghani, R. Abdul; Chandramouli, A.] Univ Teknol Mara, Selangor, Malaysia; [Chee, K.] Univ Malaya Med Ctr, Kuala Lumpur, Malaysia; [Kadir, K. Abdul] Monash Univ Sunway Campus, Selangor Darul Ehsan, Malaysia; [Ling, K.] Hosp Sultanah Aminah, Johor Baharu, Malaysia; [Abu Hassan, M.] Hosp Sultanah Bahiyah, Kedah, Malaysia; [Foo, S.] Hosp Selayang, Selangor, Malaysia; [Garcia Hernandez, P.] Hosp Univ Nuevo Leon, Monterrey, Nl, Mexico; [Aguilar-Salinas, C.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Vidrio Velazquez, M.] Unidad Invest Clin Cardiometab, Colonia Americana, Gua, Mexico; [Flores, F.] Hosp Dr Angel Leano, Los Robles, Mexico; [Alpizar Salazar, M.] Ctr Especializado Diabet, Reforma Social, Mexico; [Micher Escalante, D.; Garcia Soria, M.] Clin Res Inst, San Lucas Tepetlcalco, Mexico; [Cardona Munoz, E.] ICLE SC, Ladron De Guevara, Mexico; [Storms, G.] St Antonius Hosp, Utrecht, Netherlands; [Schaper, N.] Maastricht UMC, Maastricht, Netherlands; [Kooy, A.] Bethesda Ziekenhuis, Hoogeveen, Netherlands; [Krekels, M.] Orbis Med Ctr, Geleen, Netherlands; [van Bemmel, T.; Verhoeven, R.] Gelre Ziekenhuizen Apeldoorn, Apeldoorn, Netherlands; [Mulder, H.] Rotterdam Res Inst, Rotterdam, Netherlands; [Oldenburg-Ligtenberg, P.] Meander Med Ctr, Amersfoort, Netherlands; [Gonkel, F.] Ropcke Zweers Ziekenhuis, Hardenberg, Netherlands; [de Jong, A.] Huisartsenpraktijk Hooge Boom, Hoogwoud, Netherlands; [van Soest, J.] Huisartsenmaatschap LSV, Nijverdal, Netherlands; [Viergever, P.] Gemini Ziekenhuis, Den Helder, Netherlands; [Mevissen, H.] Huisartsenpraktijk Wildervank, Wildervank, Netherlands; [Lochorn, G.] Med Ctr Gorecht, Hoogezand, Netherlands; [Zwiers, G.] Vlietland Ziekenhuis, Schiedam, Netherlands; [Hoogslag, P.] Diaconessenhuis Meppel, Meppel, Netherlands; [Ronner, E.] Reinier de Graaf Gasthuis, Delft, Netherlands; [Nierop, P.] St Franciscus Gasthuis, Rotterdam, Netherlands; [Al-Windy, N.] Gelre Ziekenhuizen Locatie Zutphen, Zutphen, Netherlands; [Kragten, J.] Atrium Med Ctr, Heerlen, Netherlands; [Dekelver, P.] Huisartsenpraktijk Dekelver, Baarle Nassau, Netherlands; [Benatar, J.] Auckland City Hosp, Auckland, New Zealand; [Krebs, J.] Wellington Hosp, Wellington, New Zealand; [Scott, R.] Christchurch Hosp Campus, Christchurch, New Zealand; [Heggen, E.; Langslet, G.] Oslo Univ Sykehus HF, Oslo, Norway; [Berz, A.] Med Senter Fornebu, Fornebu, Norway; [Fossum, C.] Sykehuset Innlandet HF, Gjovik, Norway; [Hurtig, U.] Sykehuset Innlandet HF, Avd Tynset, Tynset, Norway; [Baranowski, M.] Intern Med, Trondheim, Norway; [Sparby, J.] Sykehuset Innlandet HF, Kongsvinger, Kongvinger, Norway; [Delgado Torres, C.] Inst Delgado Invest Med, Arequipa, Peru; [Rodriguez Escudero, A.] Hosp Alberto Sabogal Sologuren, Bellavista, Peru; [Lisson, R.] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru; [Allemant Maldonado, A.] Hosp Nacl Hipolito Unanue, El Agustino, Peru; [Gallardo Rojas, W.] Inst Med Miraflores, Miraflores, Peru; [Gonzales Bravo, L.] Clin Med San Martin, Ica, Peru; [Lema Osores, J.] Hosp Nacl Arzobispo Loayza, Lima, Peru; [Farfan, J.] Inst Endocrinol Farfan, Arequipa, Peru; [Zapata, L.] Casa Diabet & Nutr, Lima, Peru; [Godoy Junchaya, J.] Hosp Nacl Daniel Alcides Carrion, Lima, Peru; [Urquiaga Calderon, J.] Ctr Invest Heart Help, Lima, LI, Peru; [Sy, R.] Cardinal Santos Med Ctr, Manila, Philippines; [Tan, G.] Cebu Doctors Univ Hosp, Cebu, Philippines; [Aquitania, G.] Philippine Nikkei Jin Kai Polyclin & Diagnost Ctr, Davao, Philippines; [De Los Santos, G.; Rosales, R.] Metropolitan Med Ctr, Manila, Philippines; [Panelo, A.] UERM Inst Studies Diabet Fdn Inc, Marikina City, Philippines; [Roderos, O.] De La Salle Univ Med Ctr, Cavite City, Philippines; [Toledo, R.] Senor Santo Nino Hosp, Tarlac, Philippines; [Liwag, A.] West Visayas State Univ Med Ctr, Jaro Iloilo City, Philippines; [Ramoncito, H.] Amang Rodriguez Med Ctr, Marikina City, Philippines; [Skokowska, E.] NZOZ Przychodnia Specjalistyczna Med, Lublin, Poland; [Ogorek, M.] NZOZ All Med Med Ctr, Lodz, Poland; [Wojnowski, L.] Citomed Sp Zoo, Torun, Poland; [Konieczny, M.] Specialized Phys Off Ko Med, Pulawy, Poland; [Piesiewicz, W.] Med Ctr Hosp Swietej Rodziny, Lodz, Poland; [Ocicka-Kozakiewicz, A.] NonPubl HealthCare Ctr Nasz Lekarz, Torun, Poland; [Orlowska-Kunikowska, E.] Univ Clin Ctr, Gdansk, Poland; [Zmuda, W.] Oswiecimskie Ctr Badan Klinicznych Medicome Sp Zo, Oswiecim, Poland; [Duarte, S.] Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Leitao, A.] Ctr Hosp Lisboa Cent, Lisbon, Portugal; [Monteiro, P.] Hosp Univ Coimbra, Coimbra, Portugal; [Rita, H.] EPE, Unidade Saude Litoral Alentejano, Santiago Do Cacem, Portugal; [Salgado, V.] Hosp Fernando Fonseca, Amadora, Portugal; [Pinto, L.] EPE, Ctr Hosp Leiria Pombal, Leiria, Portugal; [Queiros, J.] Hosp Sao Joao, Porto, Portugal; [Teixeira, J.] Unidade Local Saude Alto Minho, Viana Do Castelo, Portugal; [Rogado, C.; Duarte, R.] APDP, Lisbon, Portugal; [Sobral do Rosario, F.] Hosp Luz, Lisbon, Portugal; [Silva, A.] EPE, Ctr Hosp Algarve, Faro, Portugal; [Andrade, L.] Ctr Hosp Vila Nova De Gaia Espinho, Vila Nova De Gaia, Portugal; [Velez, M.] EPE, Ctr Hosp Medio Tejo, Torres Novas, Portugal; [Brazao, M.] EPE, Serv Regiao Autonoma Madeira, Funchal, Madeira, Portugal; [Istratoaie, O.] SC Cardioctr Dr Istratoaie SRL, Craiova, Romania; [Lichiardopol, R.; Zetu, C.] Inst Diabet Nutr & Metab Dis, Bucharest, Romania; [Catrinoiu, D.] Cty Clin Hosp, Constanta, Romania; [Militaru, C.] SC Cardiomed SRL, Craiova, Romania; [Barbonta, D.] SC Diana Barbonta SRL, Alba Iulia, Romania; [Cosma, D.] Pelican Impex SRL, Cabinet 15, Oradea, Romania; [Crisan, C.] Mediab SRL, RAI Med SRL, Targu Mures, Romania; [Esip, V.; Lantseva, O.] St Petersburg State Healthcare Inst, St Petersburg, Russia; [Khetagurova, F.; Petrov, A.] Vsevolozhsk Cent Reg Hosp, Vsevolozhsk, Russia; [Arutyunov, G.] City Clin Hosp 4, Moscow, Russia; [Boyarkin, M.] City Alexander Hosp St Petersburg, St Petersburg, Russia; [Agafyina, A.] St Petersburg GUZ City Clin Hosp 40, St Petersburg, Russia; [Vorokhobina, N.] St Petersburg GUZ City Clin Hosp St Petersburg, St Petersburg, Russia; [Petunina, N.] City Clin Hosp 67, Moscow, Russia; [Libov, I.] Moscow GUZ City Clin Hosp, Moscow, Russia; [Zalevskaya, A.] Autonomous Nonprofit Org, St Petersburg, Russia; [Nikolaev, K.] City Clin Hosp 19, Novosibirsk, Russia; [Barbarash, O.] Heart & Vessels Dis Complex Problems, Kemerovo, Russia; [Potemkin, V.] Moscow GUZ City Clin Hosp 68, Moscow, Russia; [Krasilnikova, E.] St Petersburg State Med Univ, St Petersburg, Russia; [Barbarich, V.] City Clin Hosp 1, Novosibirsk, Russia; [Chumakova, G.] Altai State Med Univ, Barnaul, Russia; [Tarasov, N.] Main Dept Internal Affairs, Medicosanit Unit, Kemerovo, Russia; [Meleshkevich, T.] Cent Clin Hosp 2, Moscow, Russia; [Zateyshchikov, D.] City Hosp 17, Moscow, Russia; [Belenkiy, D.] MUZ Novosibirsk Municipal Clin Hosp Emergency 2, Novosibirsk, Russia; [Obrezan, A.] LLC Int Med Ctr SOGAZ, St Petersburg, Russia; [Rossolko, L.] City Polyclin 120, St Petersburg, Russia; [Fillipova, E.] LLC Medinet, St Petersburg, Russia; [Yakhontova, P.] Novosibirsk Reg Clin, Novosibirsk, Russia; [Khokhlov, A.] MUZ Clin Hosp 2, Yaroslavl, Russia; [Tan, R.] Natl Heart Ctr, Singapore, Singapore; [Sum, C.] Khoo Teck Puat Hosp, Singapore, Singapore; [Chang, H.] Singapore Gen Hosp, Singapore, Singapore; [Distiller, L.] Ctr Diabet & Endocrinol, Houghton, South Africa; [Pretorius, M.] Tiervlei Trial Ctr, Bellville, South Africa; [Mitha, E.] Newtown Clin Res Ctr, Newtown, South Africa; [Burgess, L.] Tread Res, Parow, South Africa; [Blignaut, S.] Paarl Res Ctr, Paarl, South Africa; [Venter, T.] Cardiol Clin Res, Alberton, South Africa; [Moodley, R.] Dr Moodley & Dr Sarvan, Tongaa, South Africa; [Lombaard, J.] Josha Res Ctr, Bloemfontein, South Africa; [Govind, U.] Dr U Govind, Sydenham, South Africa; [Mookadam, M.] Langeberg Clin Trials, Cape Town, WC, South Africa; [Engelbrecht, J.] Vergelegen Mediclin, Somerset West, South Africa; [Omar, M.] Ctr Diabet & Endocrinol, Durban, South Africa; [Jurgens, J.] DJW Navorsing, Krugersdorp, South Africa; [Podgorski, G.] Greenacres Hosp, Port Elizabeth, South Africa; [Vawda, H.; Naidoo, D.] Cardiol Res Clin, Durban, Kzn, South Africa; [Emanuel, S.] Synopsis Res, Cape Town, Wc, South Africa; [Roodt, A.] Clinresco Ctr Pty Ltd, Kempton Pk, Gau, South Africa; [Amod, A.] Chatsworth Unit 10, Med Ctr, Kzn, South Africa; [Van Zyl, L.] Clin Projects Res, Worcester, Wc, South Africa; [Segura, J.] Hosp 12 Octubre, Madrid, Spain; [Brito, M.] Hosp Univ Puerta de Hierro, Mahadahonda, Madrid, Spain; [Fernandez-Cruz, A.] Hosp Clin Univ San Carlos, Madrid, Spain; [Artola, S.] Ctr Salud Maria Jesus Hereza, Leganest, Madrid, Spain; [Iglesias, R.] Ctr Salud Pedro Lain Entralgo, Alcorcon, Madrid, Spain; [Toural, E.] Ctr Salud Lavapies, Madrid, Spain; [Garcia-Ortiz, L.] Ctr Salud La Alamedilla, Salamanca, Spain; [Saban, J.] Hosp Univ Ramon y Cajal, Madrid, Spain; [Mesa, J.] Hosp Valle De Hebron, Barcelona, Spain; [Vidal, J.; Camafort, M.] Hosp Clin Barcelona, Barcelona, Spain; [Linares, J.] Clin Inmaculada Concepc, Granada, Spain; [del Canizo, F.] Hosp Infanta Leonor, Madrid, Spain; [Rigla, M.] Corp Sanitaria Parc Tauli, Sabadell, Barcelona, Spain; [Suarez, C.] Hosp Univ La Princesa, Madrid, Spain; [Llorente, I.] Hosp Nuestra Senora de la Candelaria, Santa Cruz De Tenerife, Spain; [Moreno, B.] Hosp Gen Univ, Madrid, Spain; [Antoli, A.; Gomez Peralta, F.] Hosp Nuestra Senora de Sonsoles, Avila, Spain; [Iglesias, M.] AP Badia del Valles, Badia Valles Barcelona, Spain; [Gomez Peralta, F.] Hosp Gen Segovia, Segovia, Spain; [Pereg, V.] Hosp Son Espases, Palma De Mallorca, Spain; [de Teresa, L.] Inst Ciencias Med, Alicante, Spain; [Trescoli, C.] Hosp Ribera, Valencia, Spain; [Satarasinghe, R.] Sri Jayewardenepura Gen Hosp & PGMI, Nugegoda, Sri Lanka; [Somasundaram, N.] Natl Hosp, Colombo, Sri Lanka; [Siyambalapitiya, S.] Colombo North Teaching Hosp, Ragama, Sri Lanka; [Antonypillai, C.] Diabet & Endocrine Unit, Kandy, Sri Lanka; [Bulugahapitiya, D.] Diabet Clin, Kalubowila, Sri Lanka; [Medagama, U.] Teaching Hosp Peradeniya, Kandy, Sri Lanka; [Huang, C.] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Lu, Y.] E Da Hosp, Kaohsiung, Taiwan; [Hwang, J.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chiang, C.] Taipei Vet Gen Hosp, Taipei, Taiwan; [Wen, M.] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Chen, J.] Natl Cheng Kung Univ Hosp, Tainan, Taiwan; [Lai, W.] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chang, K.] China Med Univ Hosp, Taichung, Taiwan; [Wang, J.] Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan; [Yeh, H.] Mackay Mem Hosp, Tamsui, Taipei County, Taiwan; [Kriangsak, P.] Udonthani Hosp, Udon Thani, Muang District, Thailand; [Deerochanawong, C.] Rajavithi Hosp, Bangkok, Thailand; [Suwanwalaikorn, S.] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Mangklabruks, A.] Maharaj Nakorn Chiangmai Hosp, Chiang Mai, Thailand; [Kaewsuwanna, P.] Maharat Nakhon Ratchasima Hosp, Nakhon Ratchasima, Thailand; [Piyayotai, D.] Thammasat Univ Hosp, Pathum Tani, Thailand; [Iabluchanskyi, M.] Clin Hosp 5, Kharkov, Ukraine; [Samoylov, O.] Sci Ctr Radiat, Kiev, Ukraine; [Godlevska, O.] City Clin Hosp Emergency Care, Kharkov, Ukraine; [Kovalyova, O.] Kharkiv City Hosp 3, Kharkov, Ukraine; [Voloshyna, O.] Odessa State Med Univ, Odessa, Ukraine; [Tseluyko, V.] City Clin Hosp 8, Kharkov, Ukraine; [Zotov, S.; Vykhovanyuk, I.] Clin Cardiol Sertse i Sudyny LTD, Kiev, Ukraine; [Dulgeroff, A.] High Desert Med Grp, Lancaster, CA USA; [Mayfield, R.] Mt View Clin Res, Greer, SC USA; [Zaniewski-Singh, M.] Michelle Zaniewski MD PA, Houston, TX USA; [Ullal, J.; Aloi, J.] Strelitz Diabet Ctr, Norfolk, VA USA; [De La Rosa, R.] Four Rivers Clin Res, Paducah, KY USA; [Mosely, J.; Wittmer, B.] Commonwealth Biomed Res LLC, Madisonville, KY USA; [Aronoff, S.] Res Inst Dallas, Dallas, TX USA; [Rosenfeld, J.; Seidner, M.] Green & Seidner Family Practice, Lansdale, PA USA; [Warren, M.] Phys East PA, Greenville, NC USA; [Fishman, N.] Diabet & Endocrine Specialists Inc, Chesterfield, MO USA; [Weiss, R.] Maine Res Associates, Auburn, ME USA; [Arif, A.] Apex Med Res, Flint, MI USA; [Sandberg, M.] Westcott Med Ctr, Flemington, NJ USA; [Lewis, D.] Arkansas Primary Care Clin, Little Rock, AK USA; [Ball, E.] Walla Walla Clin, Walla Walla, WA USA; [Graf, R.] MultiCare Specialties Res, Tacoma, WA USA; [Breton, C.] Int Res Associates LLC, Miami, FL USA; [Tamayo, R.] Genesis Res Int, Longwood, FL USA; [Richards, R.; Cefalu, W.; Uwaifo, G.] Louisiana State Univ, New Orleans, LA USA; [Zayour, D.; Hoffman, J.] Via Christi Clin PA, Wichita, KS USA; [Fitz-Patrick, D.] East West Med Res, Honolulu, HI USA; [Khan, B.] Atlanta Clin Res Ctr, Atlanta, GA USA; [Blaze, K.] South Broward Res, Pembroke Pines, FL USA; [Bressler, P.] North Texas Endocrine Ctr, Dallas, TX USA; [Halpern, S.; Chappell, D.] Radiant Res Inc, Santa Rosa, CA USA; [Bergenstal, R.; Cuddihy, R.; Matfin, G.] Int Diabet Ctr, Minneapolis, MN USA; [Freedman, Z.] Endocrine Diabet Care & Resource Ctr, Rochester, NY USA; [Gonzalez-Campoy, J.] Minnesota Ctr Obes Metab & Edocrinol PA, Eagan, MN USA; [Lerman, S.] Ctr Diabet & Endocrine Care, Ft Lauderdale, FL USA; [Rendell, M.] Creighton Univ, Sch Med, Diabet Ctr, Omaha, NE USA; [Sitar, S.] Orange Cty Res Inst, Anaheim, CA USA; [Reeves, M.] Michael L Reeves MD, Chattanooga, MD USA; [Howard, T.] Med Affiliated Res Ctr Inc, Huntsville, AL USA; [Soufer, J.] Chase Med Res LLC, Waterbury, CT USA; [Miranda-Palma, B.] Univ Miami, Diabet Res Inst, Miami, FL USA; [Laliotis, A.] Integrated Res Ctr, San Diego, CA USA; [Shomali, M.] Union Mem Hosp, Diabet & Endocrine Ctr, Baltimore, MD USA; [Teltser, M.] A&R Res Grp LLC, Pembroke Pines, FL USA; [Hurley, D.] Med Res South LLC, Charleston, SC USA; [Morawski, E.] Holston Med Grp, Kingsport, TN USA; [Cherlin, R.] Richard Cherlin MD, Los Gatos, CA USA; [Houchin, V.] Harrisburg Family Med Ctr, Harrisburg, AR USA; [Welch, M.; Goytia-Leos, D.] Consano Clin Res, San Antonio, TX USA; [Syed, M.] Ilumina Clin Associates, Indiana, PA USA; [Kowaloff, E.; Weinrauch, L.] Atlantic Clin Trials LLC, Watertown, MA USA; [Peniston, J.] Avington Mem Hosp, Feasterville Trevose, PA USA; [Brockmyre, A.] Holston Med Grp, Bristol, TN USA; [First, B.] Ritchken & First MDs, San Diegeo, CA USA; [Feld, L.] Horizon Clin Res Associates, Gilbert, AZ USA; [Huffman, D.] Univ Diabet & Endocrine Consultants Inc, Chattanooga, TN USA; [Nassim, O.] Clin Res Inc, Huntington Pk, CA USA; [Gottschlich, G.] New Horizons Clin Res, Cincinnati, OH USA; [Patel, A.; Knopke, C.] Integrated Res Grp Inc, Riverside, CA USA; [Hernandez, M.] Berma Res Grp, Hialeah, FL USA; [Diaz, J.] Community Res South Florida, Hialeah, FL USA; [Giugliano, G.; Nicasio, J.] Baystate Med Ctr, Springfield, MA USA; [Eagerton, D.] Carolina Hlth Specialists, Myrtle Beach, SC USA; [Huntley, R.] Norwalk Med, Norwalk, CT USA; [Reed, J., III] Endocrine Res Solut Inc, Roswell, GA USA; [Magee, M.] MedStar Hlth Res Inst, Washington, DC USA; [Hippert, R.] Integrated Med Grp PC, Fleetwood, PA USA; [Sofley, C., Jr.] Internal Med Associates Anderson PA, Anderson, SC USA; [Alzohaili, O.] Alzohaili Med Consultants, Dearborn, MI USA; [Levins, P.; Anspach, R.] Clin Res Adv Inc, Phoenix, AZ USA; [Shah, S.] St Josephs Med Associates, Stockton, CA USA; [Brusco, O.] Osvaldo Brusco MD, Corpus Christi, TX USA; [Naidu, J.] Naidu Clin, Odessa, TX USA; [Lindenbaum, J.] Jeffry Lindenbaum DO PC, Yardley, PA USA; [Jacks, R.] Hill Cty Med Associates, New Braunfels, TX USA; [Hammond, G.] Dormir Clin Trials Inc, Midvale, UT USA; [Arena, C.] Utah Clin Trials LLC, Salt Lake City, UT USA; [Saxman, K.] Oregon Med Grp, Adult Med Clin, Eugene, OR USA; [Mach, M.] Valley Endocrine & Diabet Consultants Inc, Valencia, CA USA; [Kerstein, H.] Howard Kerstein MD, Denver, CO USA; [Kereiakes, D.] Carl & Edyth Linder Ctr Res & Educ, Cincinnati, OH USA; [Wahlen, J.] Adv Res Inst, South Ogden, UT USA; [Wehmeier, K.] UF Endocrinol & Diabet, Jacksonville, FL USA; [Chaykin, L.] Meriden Res, Bradenton, FL USA; [Rothman, J.] Univ Phys Grp, Staten Isl, NY USA; [Fogelfeld, L.; Stroger, John H., Jr.] Cook Cty Hosp, Chicago, IL 60612 USA; [Bittar, N.] Gemini Sci LLC, Madison, WI USA; [Rosenstock, J.] Dallas Diabet & Endocrine Ctr, Dallas, TX USA; [Kayne, D.] Med Grp Encino, Encino, CA USA; [Navarro, J.] Genesis Clin Res, Tampa, FL USA; [Colfer, H.] Nisus Res, Petoskey, MI USA; [Mokshagundam, S.] Robley Rex VA Med Ctr, Louisville, KY USA; [Shandilya, L.] Ettrick Hlth Ctr PA, South Chesterfield, PA USA; [Connery, L.] Lion Res, Norman, OK USA; [Wysham, C.] Rockwood Diabet & Metab Hlth Ctr, Spokane, WA USA; [Dela Llana, A.] MediSphere Med Res Ctr LLC, Evansville, IN USA; [Jardula, M.] Desert Oasis Healthcare, Palm Springs, CA USA; [MacAdams, M.] Lubbock Diagnost Clin, Lubbock, TX USA; [Flippo, G.] Alabama Clin Therapeut LLC, Birmingham, AL USA; [Heurich, E.; Curtis, C.] Compass Res, Orlando, FL USA; [Sanders, D.; Rawls, R.] Horizan Res Grp Inc, Mobile, AL USA; [Velazquez, F.] Pioneer Res Solut Inc, Houston, TX USA; [Osea, E.] Innovat Clin Res Inc, Harbor City, CA USA; [Mahood, K.] Family Med Sayebrook, Myrtle Beach, SC USA; [Feldman, G.] South Carolina Pharmaceut Res, Spartanburg, SC USA; [Eder, F.] United Med Associates, Binghamton, NY USA; [Riley, E.; Fowler, W.] Tower Pointe Res Ctr, Hodges, SC USA; [Jain, M.] Southwest Clin Res Ctr LLC, Pearland, TX USA; [Shepard, M.] Medstar Res Inst, Hyattsville, MD USA; [Schear, M.] Dayton Clin Res, Dayton, OH USA; [Barker, B.] Delaware Res, Delaware, OH USA; [Strout, C.] Coastal Carolina Res Ctr, Mt Pleasant, SC USA; [Obiekwe, O.] Ropheka Med Ctr, Riverdale, GA USA; [Shanik, M.] Endocrine Associates Long Isl PC, Smithtown, NY USA; [Green, C.; Blakney, E.] Green Clin PC, Memphis, TN USA; [Roberson, K.] Delta Waves Inc, Colorado Springs, CO USA; [Bretton, E.] Albuquerque Clin Trials, Albuquerque, NM USA; [Pish, R.] Pish Med Associates, Uniontown, PA USA; [Kaveh, K.] Coastal Nephrol Associates Res Ctr LLC, Port Charlotte, FL USA; [Maynard, B.; Barager, W.; Soldyshev, R.] Great Falls Clin LLP, Great Falls, MT USA; [Austin, B.] Preferred Primary Care Phys Inc, Pittsburgh, PA USA; [Parmar, P.; Simpson, R.] Lynn Inst, Denver, CO USA; [Chauhan, A.] Prime Med Grp, Clairton, PA USA; [Kasper, J.; Burr, R.] Focus Clin Res, Draper, UT USA; [Patel, N.] Wells Inst Hlth Awareness, Kettering, OH USA; [Mariano, H.] Fresno Inc, Res Ctr, Fresno, CA USA; [Pluto, T.] Fay West Family Practice, Scottdale, PA USA; [Bratcher, C.] Diabet Amer, Plano, TX USA; [Juarez, M.] Panacea Clin Res, San Antonio, TX USA; [Levinson, L.] Tipton Med Diagnost Ctr, Tipton, PA USA; [Awad, A.] Clin Res Consultants LLC, Kansas City, MO USA; [Longshaw, K.] Leading Edge Res PA, Dallas, TX USA; [Hoffman, K.] TRY Res, Maitland, FL USA; [Richwine, R.] Texas Hlth Physicians Grp, Ft Worth, TX USA; [Molter, D.] North Myrtle Beach Family Practice, North Myrtle Beach, SC USA; [Boscia, J., III] CU Pharmaceut Res, Union, SC USA; [Kowalyk, S.] Endocrinol Associates, Greensburg, PA USA; [Lemis, P.] Jefferson Cardiol Assoc, Clairton, PA USA; [Liss, J.] Med Res & Hlth Educ Fdn Inc, Columbus, GA USA; [Orr, R.] Phoenix Med Grp PC, Peoria, AZ USA; [Riser, J.] Riser Med Res, Picayune, MS USA; [Wood, J.] Leading Edge Res PA INOVA, Richardson, TX USA; [Ubani, A.] Windsor Med Clin, Tampa, FL USA; [Paine, W.; Hassani, F.] Mileground Family Practice, Morgantown, WV USA; [Farris, N.] Lexington LLC, Res Grp, Lexington, KY USA; [Bowden, R.] Charleston Internal Med Res Inst, Charleston, WV USA; [Ajani, D.] Southwest Clin Trial, Houston, TX USA; [Maw, K.; Andersen, J.] Meridien Res, Brooksville, FL USA; [Bergman, B.] Benefis Hlth Grp, Great Falls, MT USA; [Dunmyer, S.] Pharmacotherapy Res Associates Inc, Zanesville, OH USA; [Brandon, D.] Calif Res Fdn, San Diego, CA USA; [Anderson, M.] Kernodle Clin, Burlington, NC USA; [Bononi, P.] Partners Nephrol Endocrinol, Pittsburgh, PA USA; [Seidman, B.] Seidman Clin Trials, Delray Beach, FL USA; [Cruz, H.] Florida Inst Clin Res, Orlando, FL USA; [Buynak, R.] Buynak Clin Res, Valparaiso, IN USA; [Christensen, T.] Calabash Med Ctr, Calabash, NC USA; [Denker, P.] Gulfcoast Endocrine & Diabet Ctr, Clearwater, FL USA; [Stedman, M.] Stedman Clin Trials, Tampa, FL USA; [Lewy-Alterbaum, L.] All Med Res LLC, Cooper City, FL USA; [Karim, S.; Shapiro, J.] Philadelphia Hlth Associates, Philadelphia, PA USA; [Gardner, T.; Oskin, T.] Northside Internal Med, Spokane, WA USA; [Gabra, N.; Malano, J.] Burke Internal Med & Res, Burke, VA USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Wurzburg; Boehringer Ingelheim; Boehringer Ingelheim; George Washington University; Boehringer Ingelheim; Boehringer Ingelheim; Yale University; Hospital Privado - Universitario de Cordoba; Royal Brisbane & Women's Hospital; Wilhelminenspital; Medical University of Graz; Rudolfstiftung Hospital; Medical University of Innsbruck; University of Liege; East Limburg Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven; Universidade Federal de Sao Paulo (UNIFESP); Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade de Ribeirao Preto; Faculdade de Medicina de Marilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Maringa; Universidade Federal do Parana; Pontificia Universidade Catolica de Campinas; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Rijeka; Masaryk Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); University of Copenhagen; Bispebjerg Hospital; Steno Diabetes Center; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Tours; CHU Poitiers; Universite de Poitiers; CHU Bordeaux; University of Edinburgh; Laiko General Hospital; Papageorgiou Hospital; George Papanikolaou General Hospital of Thessaloniki; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Alice Ho Miu Ling Nethersole Hospital; Semmelweis University; St. John's National Academy of Health Sciences; St. John's Medical College; Central General Hospital Dr. Sardjito; University of Indonesia; Sanglah General Hospital; Ziv Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Emek Medical Center; Western Galilee Hospital; Bnai Zion Medical Center; University of Padua; Azienda Ospedaliera - Universita di Padova; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; G d'Annunzio University of Chieti-Pescara; Fujita Health University; Yonsei University; Yonsei University Health System; Pusan National University; Pusan National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Eulji University; Chonnam National University; Chonnam National University Hospital; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Ajou University; Ajou University Hospital; National Health Insurance Service; Gachon University; Inje University; Chungnam National University; Chungnam National University Hospital; Universiti Malaya; Universiti Sains Malaysia; Universiti Teknologi MARA; Universiti Malaya; Monash University; Monash University Sunway; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; St. Antonius Hospital Utrecht; Maastricht University; Maastricht University Medical Centre (MUMC); Orbis Medical Center; Gelre Hospitals; Meander Medisch Centrum; Reinier de Graaf Hospital; Franciscus Gasthuis; Atrium Medical Center; Auckland City Hospital; Christchurch Hospital New Zealand; Innlandet Hospital Trust; Innlandet Hospital Trust; Innlandet Hospital Trust; Seguro Social de Salud del Peru; Cebu Doctors University; UERM Memorial Medical Center; De La Salle University; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Hospital Professor Doutor Fernando Fonseca, EPE; Sao Joao Hospital; Pavlov First Saint Petersburg State Medical University; Altai State Medical University; National Heart Centre Singapore; Singapore General Hospital; Hospital Universitario 12 de Octubre; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Ramon y Cajal; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Infanta Leonor; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital de La Princesa; Hospital Universitari Son Espases; University of Colombo; Colombo North Teaching Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; E-Da Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Mackay Memorial Hospital; Rajavithi Hospital; Chulalongkorn University; Chiang Mai University; Thammasat University; National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; Odessa National Medical University; Louisiana State University System; International Diabetes Center; Creighton University; University of Miami; Union Memorial Hospital; Baystate Medical Center; MedStar Health Research Institute; John H Stroger Junior Hospital Cook County; Diabetes & Endocrine Center	Zinman, B (corresponding author), Zinman Mt Sinai Hosp, 60 Murray St,Suite L5-024,Box 17, Toronto, ON M5T 3L9, Canada.	zinman@lunenfeld.ca	pinto, leonor/HGC-4320-2022; mathieu, chantal/ABD-5505-2021; Rigla, Mercedes/AAM-2183-2020; Camafort-Babkowski, Miguel/H-6310-2014; Babkowski, Miguel Camafort/AAE-3657-2021; Zateyshchikov, Dmitry A/D-6575-2012; Zateyshchikov, Dmitry/AGN-8590-2022; Scott, Russell/ABC-8328-2020; Trescolí, Carlos/GLQ-7462-2022; catrinoiu, doina/AAC-9317-2021; Onishi, Yukiko/AAU-9057-2021; Krarup, Thure/AHD-5424-2022; Inzucchi, Silvio/ABF-4121-2021; Khokhlov, Alexander L./E-2765-2017; Libov, Igor/GRN-8152-2022; Chee, Kok Han/I-2138-2013; Semplicini, Andrea/B-5959-2013; Salinas, Carlos A Aguilar/AAL-4491-2020; Couffinhal, Thierry/M-6857-2014; TENTOLOURIS, NIKOLAOS/AAH-6231-2019; Toplak, Hermann/ABG-3269-2020; Escudero, Alejandro/AGR-5004-2022; Calabro, Paolo/AAC-2704-2022; Woerle, Hans/ABE-1013-2021; Mirosevic, Gorana/AAK-9294-2021; Chumakova, Galina A/L-5677-2015; Uwaifo, Gabriel I/M-2361-2016; Schaper, Nicolaas C/E-7112-2014; Halimi, jean-michel/AAO-5268-2020; Geloneze, Bruno/F-4231-2010; De Jong, Audrey/AAA-8553-2020; Marchionni, Niccolò/ABE-3977-2020; fioretto, paola/AHD-4415-2022; Rha, Seung-Woon/AGE-5810-2022; Arutyunov, Gregory/K-9721-2018; Nikolaev, Konstantin/P-4750-2017; Urina, Miguel/H-2605-2016; Benhalima, Katrien/K-5800-2017	mathieu, chantal/0000-0002-4055-5233; Rigla, Mercedes/0000-0002-6691-4871; Camafort-Babkowski, Miguel/0000-0002-8669-6410; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Zateyshchikov, Dmitry/0000-0001-7065-2045; Scott, Russell/0000-0002-2107-6480; Onishi, Yukiko/0000-0003-1180-5982; Krarup, Thure/0000-0002-9152-0583; Khokhlov, Alexander L./0000-0002-0032-0341; Chee, Kok Han/0000-0002-4485-0504; Semplicini, Andrea/0000-0003-0652-0739; Couffinhal, Thierry/0000-0002-9217-2533; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Toplak, Hermann/0000-0002-7513-5167; Chumakova, Galina A/0000-0002-2810-6531; Uwaifo, Gabriel I/0000-0002-6962-9304; Geloneze, Bruno/0000-0002-0557-4578; Marchionni, Niccolò/0000-0002-8101-4695; Rha, Seung-Woon/0000-0001-9456-9852; Arutyunov, Gregory/0000-0002-6645-2515; Lochnan, Heather/0000-0002-3820-7897; schaper, nicolaas/0000-0002-2128-8029; Persu, Alexandre/0000-0002-4007-9695; Nikolaev, Konstantin/0000-0003-4601-6203; Tabak, Adam/0000-0002-6234-3936; Sgarbi, Jose/0000-0001-7187-984X; Avramidis, Iakovos/0000-0002-9114-5541; Vidal, Josep/0000-0002-4564-4518; Colivicchi, Furio/0000-0001-7187-2234; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Keymeulen, Bart/0000-0002-8671-4527; Ohneberg, Kristin/0000-0002-9724-6933; Urina, Miguel/0000-0001-6003-4622; Marchesini, Giulio/0000-0003-2407-9860; Gardner, Thomas/0000-0002-5112-5810; BUCCI, MARCO/0000-0002-5213-7768; Segura, Julian/0000-0003-4677-9526; Zanella, Maria Teresa/0000-0002-8451-8522; Lachin, John/0000-0001-9838-2841; Mulder, Hindrik/0000-0002-6593-8417; Benhalima, Katrien/0000-0002-3325-0263	Boehringer Ingelheim; Eli Lilly	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly)	Funded by Boehringer Ingelheim and Eli Lilly; EMPA-REG OUTCOME ClinicalTrials.gov number, NCT01131676.	Bakris GL, 2014, DIABETES CARE, V37, P867, DOI 10.2337/dc13-1870; Barnett AH, 2014, LANCET DIABETES ENDO, V2, P369, DOI 10.1016/S2213-8587(13)70208-0; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Beyersmann J, 2011, COMPETING RISKS MULT; Boehringer Ingelheim Pharmaceuticals, JARD EMP TABL PRES; Cardoso CRL, 2013, DIABETES CARE, V36, P3772, DOI 10.2337/dc13-0506; Cherney DZI, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-28; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Chilton RC, 2014, DIABETES OBES METAB; Department of Health and Human Services Food and Drug Administration, GUID IND DIAB MELL E; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Gallo LA, 2015, DIABETES VASC DIS RE, V12, P78, DOI 10.1177/1479164114561992; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2015, DIABETES VASC DIS RE, V12, P90, DOI 10.1177/1479164114559852; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Ridderstrale M, 2014, LANCET DIABETES ENDO, V2, P691, DOI 10.1016/S2213-8587(14)70120-2; Roden M, 2013, LANCET DIABETES ENDO, V1, P208, DOI 10.1016/S2213-8587(13)70084-6; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Rosenstock J, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12503; Rosenstock J, 2014, DIABETES CARE, V37, P1815, DOI 10.2337/dc13-3055; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Tikkanen I, 2015, DIABETES CARE, V38, P420, DOI 10.2337/dc14-1096; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zinman B, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-102	30	4540	4767	23	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2117	2128		10.1056/NEJMoa1504720	http://dx.doi.org/10.1056/NEJMoa1504720			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26378978	Green Submitted, Green Accepted			2022-12-28	WOS:000365354800006
J	Hermann, T				Hermann, Thomas			NON-CODING RNA Antibiotic tricks a switch	NATURE			English	Editorial Material									Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hermann, T (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tch@ucsd.edu	Hermann, Thomas/L-4311-2019	Hermann, Thomas/0000-0002-9855-1593				Dibrov SM, 2014, J MED CHEM, V57, P1694, DOI 10.1021/jm401312n; Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Matzner D, 2015, J MED CHEM, V58, P3275, DOI 10.1021/jm500868e; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; WAKSMAN SA, 1953, SCIENCE, V118, P259, DOI 10.1126/science.118.3062.259; WAKSMAN SA, 1947, MYCOLOGIA, V39, P565, DOI 10.2307/3755196; World Health Organization, 2016, ANTIMICROBIAL RESIST	10	4	5	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					650	651		10.1038/nature15635	http://dx.doi.org/10.1038/nature15635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26416738				2022-12-28	WOS:000363832100038
J	Bertotti, A; Papp, E; Jones, S; Adleff, V; Anagnostou, V; Lupo, B; Sausen, M; Phallen, J; Hruban, CA; Tokheim, C; Niknafs, N; Nesselbush, M; Lytle, K; Sassi, F; Cottino, F; Migliardi, G; Zanella, ER; Ribero, D; Russolillo, N; Mellano, A; Muratore, A; Paraluppi, G; Salizzoni, M; Marsoni, S; Kragh, M; Lantto, J; Cassingena, A; Li, QK; Karchin, R; Scharpf, R; Sartore-Bianchi, A; Siena, S; Diaz, LA; Trusolino, L; Velculescu, VE				Bertotti, Andrea; Papp, Eniko; Jones, Sian; Adleff, Vilmos; Anagnostou, Valsamo; Lupo, Barbara; Sausen, Mark; Phallen, Jillian; Hruban, Carolyn A.; Tokheim, Collin; Niknafs, Noushin; Nesselbush, Monica; Lytle, Karli; Sassi, Francesco; Cottino, Francesca; Migliardi, Giorgia; Zanella, Eugenia R.; Ribero, Dario; Russolillo, Nadia; Mellano, Alfredo; Muratore, Andrea; Paraluppi, Gianluca; Salizzoni, Mauro; Marsoni, Silvia; Kragh, Michael; Lantto, Johan; Cassingena, Andrea; Li, Qing Kay; Karchin, Rachel; Scharpf, Robert; Sartore-Bianchi, Andrea; Siena, Salvatore; Diaz, Luis A., Jr.; Trusolino, Livio; Velculescu, Victor E.			The genomic landscape of response to EGFR blockade in colorectal cancer	NATURE			English	Article							GENE COPY NUMBER; ACTIVATING MUTATIONS; ACQUIRED-RESISTANCE; SOMATIC MUTATION; IDENTIFICATION; PANITUMUMAB; SEQUENCE; INSIGHTS; THERAPY; BREAST	Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly used targeted therapies are the monoclonal antibodies cetuximab and panitumumab, which prevent epidermal growth factor receptor (EGFR) activation(1). Recent studies have identified alterations in KRAS(2-4) and other genes(5-13) as likely mechanisms of primary and secondary resistance to anti-EGFR antibody therapy. Despite these efforts, additional mechanisms of resistance to EGFR blockade are thought to be present in colorectal cancer and little is known about determinants of sensitivity to this therapy. To examine the effect of somatic genetic changes in colorectal cancer on response to anti-EGFR antibody therapy, here we perform complete exome sequence and copy number analyses of 129 patient-derived tumour grafts and targeted genomic analyses of 55 patient tumours, all of which were KRAS wild-type. We analysed the response of tumours to anti-EGFR antibody blockade in tumour graft models and in clinical settings and functionally linked therapeutic responses to mutational data. In addition to previously identified genes, we detected mutations in ERBB2, EGFR, FGFR1, PDGFRA, and MAP2K1 as potential mechanisms of primary resistance to this therapy. Novel alterations in the ectodomain of EGFR were identified in patients with acquired resistance to EGFR blockade. Amplifications and sequence changes in the tyrosine kinase receptor adaptor gene IRS2 were identified in tumours with increased sensitivity to anti-EGFR therapy. Therapeutic resistance to EGFR blockade could be overcome in tumour graft models through combinatorial therapies targeting actionable genes. These analyses provide a systematic approach to evaluating response to targeted therapies in human cancer, highlight new mechanisms of responsiveness to anti-EGFR therapies, and delineate new avenues for intervention in managing colorectal cancer.	[Bertotti, Andrea; Lupo, Barbara; Migliardi, Giorgia; Zanella, Eugenia R.; Trusolino, Livio] Univ Turin, Sch Med, Dept Oncol, I-10060 Turin, Italy; [Bertotti, Andrea; Lupo, Barbara; Sassi, Francesco; Cottino, Francesca; Migliardi, Giorgia; Zanella, Eugenia R.; Mellano, Alfredo; Muratore, Andrea; Marsoni, Silvia; Trusolino, Livio] Fdn Piemonte Oncol IRCCS, Candiolo Canc Inst, Translat Canc Med Surg Oncol & Clin Trials Coord, I-10060 Turin, Italy; [Bertotti, Andrea] Natl Inst Biostruct & Biosyst INBB, I-00136 Rome, Italy; [Papp, Eniko; Adleff, Vilmos; Anagnostou, Valsamo; Phallen, Jillian; Hruban, Carolyn A.; Li, Qing Kay; Karchin, Rachel; Scharpf, Robert; Diaz, Luis A., Jr.; Velculescu, Victor E.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Jones, Sian; Sausen, Mark; Nesselbush, Monica; Lytle, Karli] Personal Genome Diagnost, Baltimore, MD 21224 USA; [Tokheim, Collin; Niknafs, Noushin; Karchin, Rachel] Johns Hopkins Univ, Inst Computat Med, Dept Biomed Engn, Baltimore, MD 21204 USA; [Ribero, Dario; Russolillo, Nadia] Mauriziano Umberto Hosp, Dept Surg, I-10128 Turin, Italy; [Paraluppi, Gianluca; Salizzoni, Mauro] San Giovanni Battista Hosp, Liver Transplantat Ctr, I-10126 Turin, Italy; [Salizzoni, Mauro] Univ Turin, Sch Med, Dept Surg Sci, I-10126 Turin, Italy; [Kragh, Michael; Lantto, Johan] Symphogen AS, DK-2750 Ballerup, Denmark; [Cassingena, Andrea; Sartore-Bianchi, Andrea; Siena, Salvatore] Osped Niguarda Ca Granda, Niguarda Canc Ctr, I-20162 Milan, Italy; [Siena, Salvatore] Univ Milan, Sch Med, I-20162 Milan, Italy; [Diaz, Luis A., Jr.] Johns Hopkins, Ludwig Ctr Canc Genet & Therapeut, Swim Amer Lab, Baltimore, MD 21287 USA	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Symphogen; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Milan; Johns Hopkins University	Velculescu, VE (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.	andrea.bertotti@ircc.it; livio.trusolino@ircc.it; velculescu@jhmi.edu	SIENA, SALVATORE/AAC-5806-2019; Sartore-Bianchi, Andrea/AAB-9848-2019; Migliardi, Giorgia/AAB-6619-2020; Velculescu, Victor/ABF-4846-2020; sassi, francesco/AAB-6844-2020; Karchin, Rachel/AFO-2592-2022; Cassingena, Andrea/AGD-7137-2022; Russolillo, Nadia/AAJ-7477-2020	SIENA, SALVATORE/0000-0002-2681-2846; Sartore-Bianchi, Andrea/0000-0003-0780-0409; Velculescu, Victor/0000-0003-1195-438X; sassi, francesco/0000-0002-4741-0408; Cassingena, Andrea/0000-0003-4116-3992; Karchin, Rachel/0000-0002-5069-1239; Lupo, Barbara/0000-0002-4383-6882; Diaz, Luis/0000-0002-7079-8914; Trusolino, Livio/0000-0002-6379-3365; Tokheim, Collin/0000-0003-1395-5378; Hruban, Carolyn/0000-0001-9882-040X; Lantto, Johan/0000-0002-8650-7157; Mellano, Alfredo/0000-0002-9090-5123; Nesselbush, Monica/0000-0003-4818-2301; Migliardi, Giorgia/0000-0001-5770-8120; Zanella, Eugenia Rosalinda/0000-0002-8036-3789; Marsoni, Silvia/0000-0002-5361-7122; Sausen, Mark/0000-0002-2916-5269; Russolillo, Nadia/0000-0002-0627-186X; Cottino, Francesca/0000-0001-6715-1784	John G. Ballenger Trust; FasterCures Research Acceleration Award; European Community's Seventh Framework Programme; AIRC Italian Association for Cancer Research (Special Program Molecular Clinical Oncology) [531000, 9970]; AIRC Italian Association for Cancer Research [14205, 15571]; American Association for Cancer Research (AACR) - Fight Colorectal Cancer Career Development Award [12-20-16-BERT]; Commonwealth Foundation; Swim Across America; US National Institutes of Health [CA121113]; Fondazione Piemontese per la Ricerca sul Cancro-ONLUS (5x1000 Italian Ministry of Health); Oncologia Ca' Granda ONLUS; SU2C-DCS International Translational Cancer Research Dream Team Grant [SU2C-AACR-DT1415]; NATIONAL CANCER INSTITUTE [R01CA121113, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007057] Funding Source: NIH RePORTER	John G. Ballenger Trust; FasterCures Research Acceleration Award; European Community's Seventh Framework Programme(European Commission); AIRC Italian Association for Cancer Research (Special Program Molecular Clinical Oncology)(Fondazione AIRC per la ricerca sul cancro); AIRC Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); American Association for Cancer Research (AACR) - Fight Colorectal Cancer Career Development Award; Commonwealth Foundation; Swim Across America; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS (5x1000 Italian Ministry of Health); Oncologia Ca' Granda ONLUS; SU2C-DCS International Translational Cancer Research Dream Team Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Angiuoli, D. Riley, L. Kann, M. Shukla, and C. L. McCord for their assistance with next-generation sequencing analyses, and F. Galimi and S. M. Leto for their help with Sanger sequencing analyses and functional studies. This work was supported by the John G. Ballenger Trust, FasterCures Research Acceleration Award, the European Community's Seventh Framework Programme, the AIRC Italian Association for Cancer Research (Special Program Molecular Clinical Oncology 531000, project 9970, and Investigator Grants projects 14205 and 15571), American Association for Cancer Research (AACR) - Fight Colorectal Cancer Career Development Award in memory of Lisa Dubow (project 12-20-16-BERT), the Commonwealth Foundation, Swim Across America, US National Institutes of Health grant CA121113, Fondazione Piemontese per la Ricerca sul Cancro-ONLUS (5x1000 Italian Ministry of Health 2011), Oncologia Ca' Granda ONLUS, and the SU2C-DCS International Translational Cancer Research Dream Team Grant (SU2C-AACR-DT1415). We acknowledge Merck for a gift of cetuximab. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. A.B. and L.T. are members of the EurOPDX Consortium.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baralis E, 2012, J MED SYST, V36, pS81, DOI 10.1007/s10916-012-9891-6; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Diaz LA, 2013, ONCOTARGET, V4, P1856; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kavuri SM, 2015, CANCER DISCOV, V5, P832, DOI 10.1158/2159-8290.CD-14-1211; Koefoed K, 2011, MABS-AUSTIN, V3, P584, DOI 10.4161/mabs.3.6.17955; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Leary RJ, 2007, NAT PROTOC, V2, P1973, DOI 10.1038/nprot.2007.276; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Moroni M, 2005, ANN ONCOL, V16, P1848, DOI 10.1093/annonc/mdi356; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pavlicek A, 2013, MOL CANCER THER, V12, P2929, DOI 10.1158/1535-7163.MCT-13-0442-T; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Siena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062264; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Voigt M, 2012, NEOPLASIA, V14, P1023, DOI 10.1593/neo.121242; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zanella ER, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010445	39	301	314	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					263	+		10.1038/nature14969	http://dx.doi.org/10.1038/nature14969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416732	Green Accepted, Green Submitted			2022-12-28	WOS:000362399000049
J	Rosenthal, MB				Rosenthal, Meredith B.			Physician Payment after the SGR - The New Meritocracy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rosenthal, MB (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.							Aaron HJ, 2015, NEW ENGL J MED, V372, P1977, DOI 10.1056/NEJMp1504076	1	22	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1187	1189		10.1056/NEJMp1507757	http://dx.doi.org/10.1056/NEJMp1507757			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR8WP	26398068				2022-12-28	WOS:000361635200002
J	Varela, L; Horvath, TL				Varela, Luis; Horvath, Tamas L.			A Sympathetic View on Fat by Leptin	CELL			English	Editorial Material							WHITE ADIPOSE-TISSUE; OBESE GENE; INNERVATION; NEURONS	Zeng et al. reveal that the lipolytic effect of the hormone leptin is mediated by sympathetic nerve fibers that directly "envelope" white adipocytes. Local activation of the sympathetic input to the fat opens new venues to circumvent central leptin resistance in obesity.	[Varela, Luis; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signalling & Neurobiol Meta, New Haven, CT 06520 USA	Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signalling & Neurobiol Meta, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Varela, Luis/ABG-7581-2020	Varela, Luis/0000-0001-7794-7241				Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Diano S., 2001, NATURE, V411, P480; DICULESCU I, 1970, Journal of Neuro-Visceral Relations, V32, P25, DOI 10.1007/BF02324328; Giordano A, 2006, AM J PHYSIOL-REG I, V291, pR1243, DOI 10.1152/ajpregu.00679.2005; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Pellegrino MJ, 2014, NEUROSCI LETT, V566, P1, DOI 10.1016/j.neulet.2014.02.014; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	10	3	3	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					26	27		10.1016/j.cell.2015.09.016	http://dx.doi.org/10.1016/j.cell.2015.09.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406366	Bronze			2022-12-28	WOS:000361846500016
J	Preisler, J; Kopeika, J; Ismail, L; Vathanan, V; Farren, J; Abdallah, Y; Battacharjee, P; Van Holsbeke, C; Bottomley, C; Gould, D; Johnson, S; Stalder, C; Van Calster, B; Hamilton, J; Timmerman, D; Bourne, T				Preisler, Jessica; Kopeika, Julia; Ismail, Laure; Vathanan, Veluppillai; Farren, Jessica; Abdallah, Yazan; Battacharjee, Parijat; Van Holsbeke, Caroline; Bottomley, Cecilia; Gould, Deborah; Johnson, Susanne; Stalder, Catriona; Van Calster, Ben; Hamilton, Judith; Timmerman, Dirk; Bourne, Tom			Defining safe criteria to diagnose miscarriage: prospective observational multicentre study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL SAC; PREGNANCY; ULTRASOUND; VIABILITY; SCAN	OBJECTIVES To validate recent guidance changes by establishing the performance of cut-off values for embryo crown-rump length and mean gestational sac diameter to diagnose miscarriage with high levels of certainty. Secondary aims were to examine the influence of gestational age on interpretation of mean gestational sac diameter and crown-rump length values, determine the optimal intervals between scans and findings on repeat scans that definitively diagnose pregnancy failure.) DESIGN Prospective multicentre observational trial. SETTING Seven hospital based early pregnancy assessment units in the United Kingdom. PARTICIPANTS 2845 women with intrauterine pregnancies of unknown viability included if transvaginal ultrasonography showed an intrauterine pregnancy of uncertain viability. In three hospitals this was initially defined as an empty gestational sac <20 mm mean diameter with or without a visible yolk sac but no embryo, or an embryo with crown-rump length <6 mm with no heartbeat. Following amended guidance in December 2011 this definition changed to a gestational sac size <25 mm or embryo crown-rump length <7 mm. At one unit the definition was extended throughout to include a mean gestational sac diameter <30 mm or embryo crown-rump length <8 mm. MAIN OUTCOME MEASURES Mean gestational sac diameter, crown-rump length, and presence or absence of embryo heart activity at initial and repeat transvaginal ultrasonography around 7-14 days later. The final outcome was pregnancy viability at 11-14 weeks' gestation. RESULTS The following indicated a miscarriage at initial scan: mean gestational sac diameter >= 25 mm with an empty sac (364/364 specificity: 100%, 95% confidence interval 99.0% to 100%), embryo with crown-rump length >= 7 mm without visible embryo heart activity (110/110 specificity: 100%, 96.7% to 100%), mean gestational sac diameter >= 18 mm for gestational sacs without an embryo presenting after 70 days' gestation (907/907 specificity: 100%, 99.6% to 100%), embryo with crown-rump length >= 3 mm without visible heart activity presenting after 70 days' gestation (87/87 specificity: 100%, 95.8% to 100%). The following were indicative of miscarriage at a repeat scan: initial scan and repeat scan after seven days or more showing an embryo without visible heart activity (103/103 specificity: 100%, 96.5% to 100%), pregnancies without an embryo and mean gestational sac diameter <12 mm where the mean diameter has not doubled after 14 days or more (478/478 specificity: 100%, 99.2% to 100%), pregnancies without an embryo and mean gestational sac diameter >= 12 mm showing no embryo heartbeat after seven days or more (150/150 specificity: 100%, 97.6% to 100%). CONCLUSIONS Recently changed cut-off values of gestational sac and embryo size defining miscarriage are appropriate and not too conservative but do not take into account gestational age. Guidance on timing between scans and expected findings on repeat scans are still too liberal. Protocols for miscarriage diagnosis should be reviewed to account for this evidence to avoid misdiagnosis and the risk of terminating viable pregnancies.	[Preisler, Jessica; Ismail, Laure; Farren, Jessica; Abdallah, Yazan; Stalder, Catriona; Bourne, Tom] Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, London W12 0HS, England; [Kopeika, Julia; Hamilton, Judith] St Thomas Hosp, Early Pregnancy & Acute Gynaecol Unit, London, England; [Ismail, Laure; Gould, Deborah] St Marys Hosp, Imperial Coll NHS Trust, London, England; [Vathanan, Veluppillai; Bottomley, Cecilia] Chelsea & Westminster Hosp, London, England; [Battacharjee, Parijat] Northwick Pk Hosp & Clin Res Ctr, Harrow, Middx, England; [Van Holsbeke, Caroline; Timmerman, Dirk; Bourne, Tom] Univ Hosp Leuven, Dept Obstet & Gynaecol, Leuven, Belgium; [Johnson, Susanne] Princess Anne Hosp, Southampton, Hants, England; [Van Calster, Ben; Timmerman, Dirk; Bourne, Tom] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium	Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Imperial College London; Imperial College London; KU Leuven; University Hospital Leuven; KU Leuven	Bourne, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, London W12 0HS, England.	tbourne@imperial.ac.uk	Timmerman, Dirk/AAD-2363-2019; Van Calster, Ben/F-9150-2010; Bourne, Tom/I-6478-2012	Timmerman, Dirk/0000-0002-3707-6645; Van Calster, Ben/0000-0003-1613-7450; Bourne, Tom/0000-0003-1421-6059; Farren, Jessica/0000-0002-8082-6499	National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London	National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London	TB is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. DT is a fundamental clinical researcher at the Research Foundation-Flanders. The sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the work for publication. The researchers performed this work independently of the funding sources.	Abdallah Y, 2011, ULTRASOUND OBST GYN, V38, P497, DOI 10.1002/uog.10109; Abdallah Y, 2011, ULTRASOUND OBST GYN, V38, P503, DOI 10.1002/uog.10075; Bottomley C, 2011, ULTRASOUND OBST GYN, V37, P588, DOI 10.1002/uog.9007; Bottomley C, 2009, HUM REPROD, V24, P1811, DOI 10.1093/humrep/dep084; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Davison AZ, 2014, EUR J OBSTET GYN R B, V178, P95, DOI 10.1016/j.ejogrb.2014.04.002; Doubilet PM, 2013, NEW ENGL J MED, V369, P1443, DOI 10.1056/NEJMra1302417; FLETCHER JL, 1986, PRIMARY CARE, V13, P667; Horrow MM, 2009, AM COLL RADIOL, V6, P235; Hu MW, 2014, J ULTRAS MED, V33, P1585, DOI 10.7863/ultra.33.9.1585; Jeve Y, 2011, ULTRASOUND OBST GYN, V38, P489, DOI 10.1002/uog.10108; Lane BF, 2013, ULTRASOUND Q, V29, P91, DOI 10.1097/RUQ.0b013e31829158c2; Newbatt E, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8136; Pexsters A, 2011, ULTRASOUND OBST GYN, V38, P510, DOI 10.1002/uog.8884; Rowling SE, 1997, RADIOLOGY, V203, P211, DOI 10.1148/radiology.203.1.9122395; Royal College of Obstetricians and Gynaecologists, 2011, 25 ROYAL COLL OBST G; Royal College of Obstetricians and Gynaecologists, 2006, MAN EARL PREGAN LOSS; Westin M, 2007, ULTRASOUND OBST GYN, V30, P728, DOI 10.1002/uog.5138	18	28	28	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4579	10.1136/bmj.h4579	http://dx.doi.org/10.1136/bmj.h4579			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26400869	Green Published, hybrid			2022-12-28	WOS:000361957200002
J	Pormann, PE				Pormann, Peter E.			INTERDISCIPLINARITY Inside Manchester's 'arts lab'	NATURE			English	Editorial Material									[Pormann, Peter E.] Univ Manchester, John Rylands Res Inst, Manchester M13 9PL, Lancs, England; [Pormann, Peter E.] Syriac Galen Palimpsest Project, London, England	University of Manchester	Pormann, PE (corresponding author), Univ Manchester, John Rylands Res Inst, Manchester M13 9PL, Lancs, England.	peter.pormann@manchester.ac.uk			Arts and Humanities Research Council [AH/M005704/1] Funding Source: researchfish; AHRC [AH/M005704/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	3	3	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					318	319		10.1038/525318a	http://dx.doi.org/10.1038/525318a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CR4JL	26381971	hybrid			2022-12-28	WOS:000361297900020
J	Thomas, JM				Thomas, John Meurig			CATALYSIS Tens of thousands of atoms replaced by one	NATURE			English	Editorial Material							HYDROGENATIONS; NANOPARTICLES		[Thomas, John Meurig] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 OFS, England; [Thomas, John Meurig] Univ Cambridge, Peterhouse, Cambridge CB3 OFS, England	University of Cambridge; University of Cambridge	Thomas, JM (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 OFS, England.	jmt2@cam.ac.uk						Arrigo R, 2015, ACS CATAL, V5, P2740, DOI 10.1021/acscatal.5b00094; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Goettmann F, 2006, ANGEW CHEM INT EDIT, V45, P4467, DOI 10.1002/anie.200600412; Groenewolt M, 2005, ADV MATER, V17, P1789, DOI 10.1002/adma.200401756; Haruta M, 2011, FARADAY DISCUSS, V152, P11, DOI 10.1039/c1fd00107h; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Kyriakou G, 2012, SCIENCE, V335, P1209, DOI 10.1126/science.1215864; LINDLAR H, 1952, HELV CHIM ACTA, V35, P446, DOI 10.1002/hlca.19520350205; Midgley PA, 2001, CHEM COMMUN, P907, DOI 10.1039/b101819c; PALCZEWSKA W, 1984, J MOL CATAL, V25, P307, DOI 10.1016/0304-5102(84)80053-X; Peters B, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4914145; Serna P, 2011, TOP CATAL, V54, P439, DOI 10.1007/s11244-011-9668-z; Thomas J. M., PHIL T R SO IN PRESS; Thomas J. M., 2012, DESIGN APPL SINGLE S; Thomas JM, 2003, ACCOUNTS CHEM RES, V36, P20, DOI 10.1021/ar990017q; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Vile G, 2015, ANGEW CHEM INT EDIT, V54, P11265, DOI 10.1002/anie.201505073; Wei HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6634; Yang M, 2015, J AM CHEM SOC, V137, P3470, DOI 10.1021/ja513292k	20	98	100	4	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					325	326		10.1038/525325a	http://dx.doi.org/10.1038/525325a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381979				2022-12-28	WOS:000361297900029
J	Viseu, A				Viseu, Ana			Integration of social science into research is crucial	NATURE			English	Editorial Material									Univ Europeia, Lisbon, Portugal	Universidade Europeia	Viseu, A (corresponding author), Univ Europeia, Lisbon, Portugal.	ana@anaviseu.org		Viseu, Ana/0000-0001-5450-2338					0	73	73	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					291	291		10.1038/525291a	http://dx.doi.org/10.1038/525291a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR4JL	26381948	Bronze			2022-12-28	WOS:000361297900006
J	Dehorter, N; Ciceri, G; Bartolini, G; Lim, L; del Pino, I; Marin, O				Dehorter, Nathalie; Ciceri, Gabriele; Bartolini, Giorgia; Lim, Lynette; del Pino, Isabel; Marin, Oscar			Tuning of fast-spiking interneuron properties by an activity-dependent transcriptional switch	SCIENCE			English	Article							EXCITATORY-INHIBITORY BALANCE; CEREBELLAR GRANULE CELLS; GABAERGIC INTERNEURONS; CORTICAL INTERNEURONS; SENSORY AFFERENTS; GENE-REGULATION; VISUAL-CORTEX; K+ CHANNELS; NEURONS; EXPRESSION	The function of neural circuits depends on the generation of specific classes of neurons. Neural identity is typically established near the time when neurons exit the cell cycle to become postmitotic cells, and it is generally accepted that, once the identity of a neuron has been established, its fate is maintained throughout life. Here, we show that network activity dynamically modulates the properties of fast-spiking (FS) interneurons through the postmitotic expression of the transcriptional regulator Er81. In the adult cortex, Er81 protein levels define a spectrum of FS basket cells with different properties, whose relative proportions are, however, continuously adjusted in response to neuronal activity. Our findings therefore suggest that interneuron properties are malleable in the adult cortex, at least to a certain extent.	[Dehorter, Nathalie; Bartolini, Giorgia; Lim, Lynette; del Pino, Isabel; Marin, Oscar] Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; [Dehorter, Nathalie; Ciceri, Gabriele; Bartolini, Giorgia; Lim, Lynette; del Pino, Isabel; Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Dehorter, Nathalie; Ciceri, Gabriele; Bartolini, Giorgia; Lim, Lynette; del Pino, Isabel; Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain	University of London; King's College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Marin, O (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House,Guys Campus, London SE1 1UL, England.	oscar.marin@kcl.ac.uk	del Pino, Isabel/A-6072-2018; Marin, Oscar/F-3856-2012	del Pino, Isabel/0000-0002-8672-926X; Marin, Oscar/0000-0001-6264-7027; Lim, Lynette/0000-0003-4179-8373; Dehorter, Nathalie/0000-0001-7599-2866; Ciceri, Gabriele/0000-0002-8481-9771	Spanish Ministry of Science and Innovation [SAF2011-28845]; European Research Council [ERC-2011-AdG 293683]; Wellcome Trust [103714MA]; EMBO postdoctoral fellowships	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); EMBO postdoctoral fellowships(European Molecular Biology Organization (EMBO))	We thank M. Fernandez and C. Serra for excellent technical assistance; T. Gil and A. Dopplapudi for lab support; C. Garcia-Frigola for help with ChIP experiments; T. Jessell for antibodies; and S. Arber, Z. J. Huang, and K. Nave for reagents and mouse lines. We are grateful to J. Burrone, N. Flames, C. Houart, M. Maravall, and B. Rico for critical reading of the manuscript, and members of the Marin and Rico laboratories for stimulating discussions and ideas. The data presented in this paper are tabulated in the supplementary materials. This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF2011-28845), the European Research Council (ERC-2011-AdG 293683), and the Wellcome Trust (103714MA) to O.M. N.D. and L.L. were supported by EMBO postdoctoral fellowships. O.M. is a Wellcome Trust Investigator.	Abe H, 2012, P NATL ACAD SCI USA, V109, P8734, DOI 10.1073/pnas.1206418109; Abe H, 2011, P NATL ACAD SCI USA, V108, P12497, DOI 10.1073/pnas.1109940108; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Campanac E, 2013, NEURON, V77, P712, DOI 10.1016/j.neuron.2012.12.020; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cave JW, 2010, J NEUROSCI, V30, P4717, DOI 10.1523/JNEUROSCI.0419-10.2010; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Helm J, 2013, J NEUROPHYSIOL, V109, P1600, DOI 10.1152/jn.00782.2012; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Li P, 2014, NEUROSCIENCE, V265, P60, DOI 10.1016/j.neuroscience.2014.01.033; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	35	89	93	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1216	1220		10.1126/science.aab3415	http://dx.doi.org/10.1126/science.aab3415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359400	Green Accepted, Green Submitted			2022-12-28	WOS:000360968400041
J	Meckling, J; Kelsey, N; Biber, E; Zysman, J				Meckling, Jonas; Kelsey, Nina; Biber, Eric; Zysman, John			Winning coalitions for climate policy	SCIENCE			English	Editorial Material									[Meckling, Jonas] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Meckling, Jonas; Kelsey, Nina; Biber, Eric; Zysman, John] Univ Calif Berkeley, Berkeley Roundtable Int Econ, Berkeley, CA 94720 USA; [Kelsey, Nina; Zysman, John] Univ Calif Berkeley, Ctr Informat Technol Res Interest Soc, Berkeley, CA 94720 USA; [Kelsey, Nina] Univ Calif Berkeley, Inst Govt Studies, Berkeley, CA 94720 USA; [Biber, Eric] Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA; [Zysman, John] Univ Calif Berkeley, Dept Polit Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meckling, J (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	meckling@berkeley.edu						Aklin M, 2013, AM J POLIT SCI, V57, P643, DOI 10.1111/ajps.12002; [Anonymous], 2014, REN 2014 GLOB STAT R; Biber E, 2013, VANDERBILT LAW REV, V66, P399; Calel R., 2015, REV EC STAT; Fischer C, 2008, J ENVIRON ECON MANAG, V55, P142, DOI 10.1016/j.jeem.2007.11.001; International Energy Agency, 2014, WORLD EN OUTL 2014; Kelsey N., 2014, GREEN SPIRAL POLICY; Laird FN, 2009, ENERG POLICY, V37, P2619, DOI 10.1016/j.enpol.2009.02.027; Levin K, 2012, POLICY SCI, V45, P123, DOI 10.1007/s11077-012-9151-0; Meckling J, 2014, WIRES CLIM CHANGE, V5, P569, DOI 10.1002/wcc.293; Newell P., 2010, CLIMATE CAPITALISM G; OYE KA, 1994, J THEOR POLIT, V6, P593, DOI 10.1177/0951692894006004008; Rodrik D, 2014, OXFORD REV ECON POL, V30, P469, DOI 10.1093/oxrep/gru025; Victor DG, 2005, SCIENCE, V309, P1820, DOI 10.1126/science.1113180; World Bank, 2022, STATE TRENDS CARBON; ZYSMAN J, 2014, CAN GREEN SUSTAIN GR; [No title captured]	17	147	147	5	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1170	1171		10.1126/science.aab1336	http://dx.doi.org/10.1126/science.aab1336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9XH	26359392				2022-12-28	WOS:000360968400025
J	Steculorum, SM; Paeger, L; Bremser, S; Evers, N; Hinze, Y; Idzko, M; Kloppenburg, P; Bruning, JC				Steculorum, Sophie M.; Paeger, Lars; Bremser, Stephan; Evers, Nadine; Hinze, Yvonne; Idzko, Marco; Kloppenburg, Peter; Bruening, Jens C.			Hypothalamic UDP Increases in Obesity and Promotes Feeding via P2Y6-Dependent Activation of AgRP Neurons	CELL			English	Article							INSULIN-RESISTANCE; SYMPATHETIC NEURONS; ENERGY HOMEOSTASIS; EXPRESSING NEURONS; P2Y(6) RECEPTOR; URIDINE; LEPTIN; STIMULATION; BEHAVIOR; PROTEIN	Activation of orexigenic AgRP-expressing neurons in the arcuate nucleus of the hypothalamus potently promotes feeding, thus defining new regulators of AgRP neuron activity could uncover potential novel targets for obesity treatment. Here, we demonstrate that AgRP neurons express the purinergic receptor 6 (P2Y6), which is activated by uridine-diphosphate (UDP). In vivo, UDP induces ERK phosphorylation and cFos expression in AgRP neurons and promotes action potential firing of these neurons in brain slice recordings. Consequently, central application of UDP promotes feeding, and this response is abrogated upon pharmacologic or genetic inhibition of P2Y6 as well as upon pharmacogenetic inhibition of AgRP neuron activity. In obese animals, hypothalamic UDP content is elevated as a consequence of increased circulating uridine concentrations. Collectively, these experiments reveal a potential regulatory pathway in obesity, where peripheral uridine increases hypothalamic UDP concentrations, which in turn can promote feeding via PY6-dependent activation of AgRP neurons.	[Steculorum, Sophie M.; Evers, Nadine; Bruening, Jens C.] Max Planck Inst Metab Res, Dept Neuronal Control Metab, D-50931 Cologne, Germany; [Steculorum, Sophie M.; Evers, Nadine; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50924 Cologne, Germany; [Steculorum, Sophie M.; Paeger, Lars; Bremser, Stephan; Evers, Nadine; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Steculorum, Sophie M.; Paeger, Lars; Bremser, Stephan; Evers, Nadine; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Paeger, Lars; Bremser, Stephan; Kloppenburg, Peter] Univ Cologne, Inst Zool, Bioctr, D-50674 Cologne, Germany; [Hinze, Yvonne] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Idzko, Marco] Univ Freiburg, Med Ctr, Dept Pneumol, D-79106 Freiburg, Germany; [Bruening, Jens C.] Natl Ctr Diabet Res DZD, D-85764 Neuherberg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; University of Freiburg	Bruning, JC (corresponding author), Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany.	bruening@sf.mpg.de	; Steculorum, Sophie/R-2704-2017	Paeger, Lars/0000-0001-8716-3483; Steculorum, Sophie/0000-0002-5665-2732	DFG [BR 1492/7-1, TRR134]; Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Networking Fund of the Helmholtz Association; European Union Seventh Framework Programme (FP7) [266408]; Humboldt-Bayer program of the Alexander Von Humboldt foundation; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD)	DFG(German Research Foundation (DFG)); Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Networking Fund of the Helmholtz Association; European Union Seventh Framework Programme (FP7); Humboldt-Bayer program of the Alexander Von Humboldt foundation(Alexander von Humboldt Foundation); Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD)	We are grateful to A Anne Lautenschlager and Helmut Wratil for outstanding technical assistance. We thank Joel Elmquist and Brad B. Lowell for providing the AgRP<SUP>Cre</SUP> mice used in this study. This work was supported by a grant from the DFG (BR 1492/7-1) to J.C.B. and received funding by the DFG within the framework of the TRR134 and within the Excellence Initiative by German Federal and State Governments (CECAD). This work was funded (in part) by the Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Networking Fund of the Helmholtz Association. Moreover, the research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 266408. S.M.S. was funded by the Humboldt-Bayer program of the Alexander Von Humboldt foundation and received a grant from the Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD). Images from the illustration were used and adapted from Servier Medical Art.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; ANDERSON EP, 1964, BIOCHIM BIOPHYS ACTA, V91, P380, DOI 10.1016/0926-6550(64)90067-2; Andrews ZB, 2011, PEPTIDES, V32, P2248, DOI 10.1016/j.peptides.2011.05.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balasubramanian R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116203; Balasubramanian R, 2013, BIOCHEM PHARMACOL, V85, P991, DOI 10.1016/j.bcp.2012.11.029; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Belgardt BF, 2010, ANN NY ACAD SCI, V1212, P97, DOI 10.1111/j.1749-6632.2010.05799.x; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Brunschweiger A, 2006, CURR MED CHEM, V13, P289, DOI 10.2174/092986706775476052; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Cansev M, 2006, BRAIN RES REV, V52, P389, DOI 10.1016/j.brainresrev.2006.05.001; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dobolyi A, 2011, CURR TOP MED CHEM, V11, P1058, DOI 10.2174/156802611795347618; Dudzinska W, 2013, PHYSIOL RES, V62, P163, DOI 10.33549/physiolres.932355; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hamada T, 2007, CIRC J, V71, P354, DOI 10.1253/circj.71.354; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Kittner H, 2006, EUR J NEUROSCI, V24, P2049, DOI 10.1111/j.1460-9568.2006.05071.x; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Konner AC, 2012, CELL METAB, V16, P144, DOI 10.1016/j.cmet.2012.07.004; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Norenberg W, 2000, BRIT J PHARMACOL, V129, P709, DOI 10.1038/sj.bjp.0703096; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Sohn JW, 2013, TRENDS NEUROSCI, V36, P504, DOI 10.1016/j.tins.2013.05.003; Steculorum SM, 2015, J CLIN INVEST, V125, P846, DOI 10.1172/JCI73688; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Urasaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099728; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; VonKugelgen I, 1997, NEUROSCIENCE, V78, P935; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yamamoto T, 2010, NUCLEOS NUCLEOT NUCL, V29, P504, DOI 10.1080/15257771003740986	48	48	51	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1404	1417		10.1016/j.cell.2015.08.032	http://dx.doi.org/10.1016/j.cell.2015.08.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359991	Bronze			2022-12-28	WOS:000361247900027
J	Wilson, TW; Ladino, LA; Alpert, PA; Breckels, MN; Brooks, IM; Browse, J; Burrows, SM; Carslaw, KS; Huffman, JA; Judd, C; Kilthau, WP; Mason, RH; McFiggans, G; Miller, LA; Najera, JJ; Polishchuk, E; Rae, S; Schiller, CL; Si, M; Temprado, JV; Whale, TF; Wong, JPS; Wurl, O; Yakobi-Hancock, JD; Abbatt, JPD; Aller, JY; Bertram, AK; Knopf, DA; Murray, BJ				Wilson, Theodore W.; Ladino, Luis A.; Alpert, Peter A.; Breckels, Mark N.; Brooks, Ian M.; Browse, Jo; Burrows, Susannah M.; Carslaw, Kenneth S.; Huffman, J. Alex; Judd, Christopher; Kilthau, Wendy P.; Mason, Ryan H.; McFiggans, Gordon; Miller, Lisa A.; Najera, Juan J.; Polishchuk, Elena; Rae, Stuart; Schiller, Corinne L.; Si, Meng; Temprado, Jesus Vergara; Whale, Thomas F.; Wong, Jenny P. S.; Wurl, Oliver; Yakobi-Hancock, Jacqueline D.; Abbatt, Jonathan P. D.; Aller, Josephine Y.; Bertram, Allan K.; Knopf, Daniel A.; Murray, Benjamin J.			A marine biogenic source of atmospheric ice-nucleating particles	NATURE			English	Article							TRANSMISSION X-RAY; SEA-SURFACE MICROLAYER; TRANSPARENT EXOPOLYMER PARTICLES; SPRAY AEROSOL COMPOSITION; DISSOLVED ORGANIC-CARBON; FORMING NUCLEI; MINERAL DUST; ARCTIC-OCEAN; MATTER; WATER	The amount of ice present in clouds can affect cloud lifetime, precipitation and radiative properties(1,2). The formation of ice in clouds is facilitated by the presence of airborne ice-nucleating particles(1,2). Sea spray is one of the major global sources of atmospheric particles, but it is unclear to what extent these particles are capable of nucleating ice(3-11). Sea-spray aerosol contains large amounts of organic material that is ejected into the atmosphere during bubble bursting at the organically enriched sea-air interface or sea surface microlayer(12-19). Here we show that organic material in the sea surface microlayer nucleates ice under conditions relevant for mixed-phase cloud and high-altitude ice cloud formation. The ice-nucleating material is probably biogenic and less than approximately 0.2 micrometres in size. We find that exudates separated from cells of the marine diatom Thalassiosira pseudonana nucleate ice, and propose that organic material associated with phytoplankton cell exudates is a likely candidate for the observed ice-nucleating ability of the microlayer samples. Global model simulations of marine organic aerosol, in combination with our measurements, suggest that marine organic material may be an important source of ice-nucleating particles in remote marine environments such as the Southern Ocean, North Pacific Ocean and North Atlantic Ocean.	[Wilson, Theodore W.; Brooks, Ian M.; Browse, Jo; Carslaw, Kenneth S.; Judd, Christopher; Temprado, Jesus Vergara; Whale, Thomas F.; Murray, Benjamin J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Ladino, Luis A.; Wong, Jenny P. S.; Yakobi-Hancock, Jacqueline D.; Abbatt, Jonathan P. D.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Alpert, Peter A.; Knopf, Daniel A.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Terr & Planetary Atmospheres, Stony Brook, NY 11794 USA; [Breckels, Mark N.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Burrows, Susannah M.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA; [Huffman, J. Alex] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA; [Kilthau, Wendy P.; Aller, Josephine Y.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Mason, Ryan H.; Polishchuk, Elena; Si, Meng; Bertram, Allan K.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [McFiggans, Gordon; Najera, Juan J.; Rae, Stuart] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Miller, Lisa A.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Schiller, Corinne L.] Environm Canada, Air Qual Sci Unit, Vancouver, BC V6C 3S5, Canada; [Wurl, Oliver] Leibniz Inst Balt Sea Res Warnemunde, Dept Biol Oceanog, D-18119 Rostock, Germany	University of Leeds; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Essex; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Denver; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of British Columbia; University of Manchester; Fisheries & Oceans Canada; Environment & Climate Change Canada; Leibniz Institut fur Ostseeforschung Warnemunde	Wilson, TW (corresponding author), Univ Leeds, Sch Earth & Environm, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	theo.w.wilson@gmail.com; luis.ladinomoreno@utoronto.ca	Wurl, Oliver/AAQ-9972-2021; McFiggans, Gordon B/B-8689-2011; Huffman, J. Alex/A-7449-2010; Ladino, Luis Antonio./AAF-7614-2019; Vergara Temprado, Jesús/T-9569-2018; Murray, Benjamin/C-1219-2010; Brooks, Ian M/E-1378-2012; Alpert, Peter Aaron/R-9776-2019; Carslaw, Ken S/C-8514-2009; Knopf, Daniel A/F-2040-2011; Whale, Thomas/C-6205-2015; Burrows, Susannah M./A-7429-2011; Wong, Jenny/GQP-8042-2022; Wilson, Theodore/H-2793-2015	McFiggans, Gordon B/0000-0002-3423-7896; Huffman, J. Alex/0000-0002-5363-9516; Ladino, Luis Antonio./0000-0002-4941-7945; Vergara Temprado, Jesús/0000-0002-3105-0946; Murray, Benjamin/0000-0002-8198-8131; Brooks, Ian M/0000-0002-5051-1322; Carslaw, Ken S/0000-0002-6800-154X; Knopf, Daniel A/0000-0001-7732-3922; Whale, Thomas/0000-0002-1062-2685; Burrows, Susannah M./0000-0002-0745-7252; Wilson, Theodore/0000-0001-9168-5487; Wong, Jenny Pui Shan/0000-0002-8729-8166; Alpert, Peter/0000-0002-7582-9206; Abbatt, Jonathan/0000-0002-3372-334X; Bertram, Allan K./0000-0002-5621-2323; Aller, Josephine/0000-0003-1549-1108	Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231 (ALS-05955)]; Natural Environment Research Council [NE/K004417/1, NE/I020059/1, NE/I013466/1, NE/I028696/1, NE/I019057/1, NE/H009485/1]; European Research Council [240449, 603445]; UK Aerosol Society; National Science Foundation [AGS-1232203]; German Research Foundation [WU585/6-1]; Climate Change and Atmospheric Research Program of the Natural Sciences and Engineering Research Council of Canada; Fisheries and Oceans Canada; Environment Canada; NOAA's Climate Program Office; DOE Office of Science (BER) Earth System Modeling Program; Natural Environment Research Council [NE/L007827/1, 1230241, 1047972, NE/I028858/1] Funding Source: researchfish; NERC [NE/I020059/1, NE/H009485/1, NE/K004417/1, NE/L007827/1, NE/I028858/1, NE/I013466/1, NE/I028696/1] Funding Source: UKRI	Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); UK Aerosol Society; National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Climate Change and Atmospheric Research Program of the Natural Sciences and Engineering Research Council of Canada; Fisheries and Oceans Canada; Environment Canada(CGIAR); NOAA's Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); DOE Office of Science (BER) Earth System Modeling Program(United States Department of Energy (DOE)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	T.W.W., B.J.M. and T.F.W. acknowledge the assistance provided by the crew and other scientists onboard the R/V Knorr and the RRS James Clark Ross, the British Antarctic Survey, K. Baustian, J. McQuaid, A. Windross, J. Knulst, J. F. Wilson, A. M. Booth, R. Chance, L. J. Carpenter, S. Peppe, D. O'Sullivan, N. Umo, I. Cotton, H. Pearce, H. Price and M. J. Callaghan. The STXM/NEXAFS analysis was performed at the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231 (user award to D.A.K./J.Y.A. ALS-05955). STXM analyses were facilitated by A. L. D. Kilcoyne and M. K. Gilles. L. A. L. acknowledges assistance from R. Leaitch, E. Mungall, R. Christensen and J. Li, and the Pacific region Department of Fisheries and Oceans staff. The Marine Boundary Layer sampling site in Ucluelet is jointly supported and maintained by Environment Canada, the British Columbia Ministry of the Environment and Metro Vancouver. We acknowledge funding from the Natural Environment Research Council (NE/K004417/1, NE/I020059/1, NE/I013466/1, NE/I028696/1, NE/I019057/1, NE/H009485/1), the European Research Council (FP7, 240449 ICE, BACCHUS 603445), the UK Aerosol Society, National Science Foundation (AGS-1232203), German Research Foundation (WU585/6-1), the Climate Change and Atmospheric Research Program of the Natural Sciences and Engineering Research Council of Canada (for NETCARE), Fisheries and Oceans Canada, Environment Canada, NOAA's Climate Program Office (for WACS II), and the DOE Office of Science (BER) Earth System Modeling Program.	Abramson L, 2009, DEEP-SEA RES PT II, V56, P1369, DOI 10.1016/j.dsr2.2008.11.031; Aller JY, 2005, J AEROSOL SCI, V36, P801, DOI 10.1016/j.jaerosci.2004.10.012; Alpert PA, 2011, ATMOS CHEM PHYS, V11, P5539, DOI 10.5194/acp-11-5539-2011; Alpert PA, 2011, PHYS CHEM CHEM PHYS, V13, P19882, DOI 10.1039/c1cp21844a; Alvain S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003154; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Augustin S, 2013, ATMOS CHEM PHYS, V13, P10989, DOI 10.5194/acp-13-10989-2013; Ault AP, 2013, ENVIRON SCI TECHNOL, V47, P5603, DOI 10.1021/es400416g; Bigg EK, 1996, TELLUS B, V48, P223, DOI 10.1034/j.1600-0889.1996.t01-1-00007.x; BIGG EK, 1973, J ATMOS SCI, V30, P1153, DOI 10.1175/1520-0469(1973)030<1153:INCIRA>2.0.CO;2; Brandes JA, 2004, MAR CHEM, V92, P107, DOI 10.1016/j.marchem.2004.06.020; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Burrows SM, 2013, ATMOS CHEM PHYS, V13, P245, DOI 10.5194/acp-13-245-2013; Cunliffe M, 2013, PROG OCEANOGR, V109, P104, DOI 10.1016/j.pocean.2012.08.004; Cziczo DJ, 2013, SCIENCE, V340, P1320, DOI 10.1126/science.1234145; Engel A, 2004, DEEP-SEA RES PT I, V51, P83, DOI 10.1016/j.dsr.2003.09.001; Engel A., 2009, PRACTICAL GUIDELINES, P125, DOI DOI 10.1201/9781420073072.CH7; FALL R, 1985, J MAR RES, V43, P257, DOI 10.1357/002224085788437370; FISHER NS, 1993, DEEP-SEA RES PT I, V40, P671, DOI 10.1016/0967-0637(93)90065-B; Frohlich-Nowoisky J, 2015, BIOGEOSCIENCES, V12, P1057, DOI 10.5194/bg-12-1057-2015; Fuentes E, 2011, ATMOS CHEM PHYS, V11, P2585, DOI 10.5194/acp-11-2585-2011; Gantt B, 2013, ATMOS CHEM PHYS, V13, P3979, DOI 10.5194/acp-13-3979-2013; Ghorai S, 2011, J PHYS CHEM A, V115, P4373, DOI 10.1021/jp112360x; Ghorai S, 2010, ANAL CHEM, V82, P9289, DOI 10.1021/ac101797k; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hawkins LN, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/612132; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Hopkins RJ, 2007, J AEROSOL SCI, V38, P573, DOI 10.1016/j.jaerosci.2007.03.009; Huneeus N, 2011, ATMOS CHEM PHYS, V11, P7781, DOI 10.5194/acp-11-7781-2011; Kanji ZA, 2013, ATMOS CHEM PHYS, V13, P9097, DOI 10.5194/acp-13-9097-2013; Kanji ZA, 2009, AEROSOL SCI TECH, V43, P730, DOI 10.1080/02786820902889861; Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739; Knopf DA, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021866; Knopf DA, 2011, NAT GEOSCI, V4, P88, DOI 10.1038/NGEO1037; Knulst JC, 2003, LANGMUIR, V19, P10194, DOI 10.1021/la035069+; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; Koop T, 2009, PHYS CHEM CHEM PHYS, V11, P10839, DOI 10.1039/b914289d; Kuznetsova M, 2005, MAR CHEM, V96, P359, DOI 10.1016/j.marchem.2005.03.007; Lawrence JR, 2003, APPL ENVIRON MICROB, V69, P5543, DOI 10.1128/AEM.69.9.5543-5554.2003; Leck C, 2005, TELLUS B, V57, P305, DOI 10.1111/j.1600-0889.2005.00148.x; MacGilchrist GA, 2014, BIOGEOSCIENCES, V11, P3695, DOI 10.5194/bg-11-3695-2014; Mann GW, 2010, GEOSCI MODEL DEV, V3, P519, DOI 10.5194/gmd-3-519-2010; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Moffet R. C., 2010, FUNDAMENTALS APPL AE, P419; Moffet RC, 2010, ANAL CHEM, V82, P7906, DOI 10.1021/ac1012909; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Murray BJ, 2010, PHYS CHEM CHEM PHYS, V12, P10380, DOI 10.1039/c003297b; Nickovic S, 2012, ATMOS CHEM PHYS, V12, P845, DOI 10.5194/acp-12-845-2012; O'Sullivan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08082; Orellana MV, 2011, P NATL ACAD SCI USA, V108, P13612, DOI 10.1073/pnas.1102457108; Pan X, 2014, DEEP-SEA RES PT I, V85, P80, DOI 10.1016/j.dsr.2013.12.003; Prather KA, 2013, P NATL ACAD SCI USA, V110, P7550, DOI 10.1073/pnas.1300262110; Pummer BG, 2012, ATMOS CHEM PHYS, V12, P2541, DOI 10.5194/acp-12-2541-2012; Quinn PK, 2014, NAT GEOSCI, V7, P228, DOI [10.1038/NGEO2092, 10.1038/ngeo2092]; ROSINSKI J, 1987, J AEROSOL SCI, V18, P291, DOI 10.1016/0021-8502(87)90024-3; Russell LM, 2010, P NATL ACAD SCI USA, V107, P6652, DOI 10.1073/pnas.0908905107; Schmitt-Kopplin P, 2012, BIOGEOSCIENCES, V9, P1571, DOI 10.5194/bg-9-1571-2012; Sciare J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011998; Takahama S, 2007, ATMOS ENVIRON, V41, P9435, DOI 10.1016/j.atmosenv.2007.08.051; VALI G, 1971, J ATMOS SCI, V28, P402, DOI 10.1175/1520-0469(1971)028<0402:QEOERA>2.0.CO;2; van Pinxteren M, 2012, ENVIRON SCI TECHNOL, V46, P10455, DOI 10.1021/es204492b; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Vignati E, 2010, ATMOS ENVIRON, V44, P670, DOI 10.1016/j.atmosenv.2009.11.013; Wang XF, 2015, ACS CENTRAL SCI, V1, P124, DOI 10.1021/acscentsci.5b00148; Whale TF, 2015, ATMOS MEAS TECH, V8, P2437, DOI 10.5194/amt-8-2437-2015; Wurl O., 2009, PRACTICAL GUIDELINES, P33, DOI DOI 10.1201/9781420073072.CH2; Wurl O, 2009, MAR CHEM, V115, P1, DOI 10.1016/j.marchem.2009.04.007; Yakobi-Hancock JD, 2013, ATMOS CHEM PHYS, V13, P11175, DOI 10.5194/acp-13-11175-2013; Yun YX, 2013, GEOPHYS RES LETT, V40, P4121, DOI 10.1002/grl.50794; Zubavichus Y, 2005, J PHYS CHEM A, V109, P6998, DOI 10.1021/jp0535846; Zubkov M, 2007, J PLANKTON RES, V29, P79	72	338	343	22	472	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					234	+		10.1038/nature14986	http://dx.doi.org/10.1038/nature14986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354482	Green Submitted, Green Accepted			2022-12-28	WOS:000360927400035
J	Plourde, G; Pancholy, SB; Nolan, J; Jolly, S; Rao, SV; Amhed, I; Bangalore, S; Patel, T; Dahm, JB; Bertrand, OF				Plourde, Guillaume; Pancholy, Samir B.; Nolan, Jim; Jolly, Sanjit; Rao, Sunil V.; Amhed, Imdad; Bangalore, Sripal; Patel, Tejas; Dahm, Johannes B.; Bertrand, Olivier F.			Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; CARDIAC-CATHETERIZATION; FEMORAL APPROACH; TRANSFEMORAL APPROACH; OPERATOR; ANGIOPLASTY; SAFETY; TRIAL; FLUOROSCOPY; TRANSULNAR	Background Transradial access for cardiac catheterisation results in lower bleeding and vascular complications than the traditional transfemoral access route. However, the increased radiation exposure potentially associated with transradial access is a possible drawback of this method. Whether transradial access is associated with a clinically significant increase in radiation exposure that outweighs its benefits is unclear. Our aim was therefore to compare radiation exposure between transradial access and transfemoral access for diagnostic coronary angiograms and percutaneous coronary interventions (PCI). Methods We did a systematic review and meta-analysis of the scientific literature by searching the PubMed, Embase, and Cochrane Library databases with relevant terms, and cross-referencing relevant articles for randomised controlled trials (RCTs) that compared radiation parameters in relation to access site, published from Jan 1, 1989, to June 3, 2014. Three investigators independently sorted the potentially relevant studies, and two others extracted data. We focused on the primary radiation outcomes of fluoroscopy time and kerma-area product, and used meta-regression to assess the changes over time. Secondary outcomes were operator radiation exposure and procedural time. We used both fixed-effects and random-effects models with inverse variance weighting for the main analyses, and we did confirmatory analyses for observational studies. Findings Of 1252 records identified, we obtained data from 24 published RCTs for 19 328 patients. Our primary analyses showed that transradial access was associated with a small but significant increase in fluoroscopy time for diagnostic coronary angiograms (weighted mean difference [WMD], fixed effect: 1.04 min, 95% CI 0.84-1.24; p<0.0001) and PCI (1.15 min, 95% CI 0.96-1.33; p<0.0001), compared with transfemoral access. Transradial access was also associated with higher kerma-area product for diagnostic coronary angiograms (WMD, fixed effect: 1.72 Gy.cm(2), 95% CI -0.10 to 3.55; p=0.06), and significantly higher kerma-area product for PCI (0.55 Gy.cm(2), 95% CI 0.08-1.02; p=0.02). Mean operator radiation doses for PCI with basic protection were 107 mu Sv (SD 110) with transradial access and 74 mu Sv (68) with transfemoral access; with supplementary protection, the doses decreased to 21 mu Sv (17) with transradial access and 46 mu Sv (9) with transfemoral. Meta-regression analysis showed that the overall difference in fl uoroscopy time between the two procedures has decreased significantly by 75% over the past 20 years from 2 min in 1996 to about 30 s in 2014 (p<0.0001). In observational studies, differences and effect sizes remained consistent with RCTs. Interpretation Transradial access was associated with a small but significant increase in radiation exposure in both diagnostic and interventional procedures compared with transfemoral access. Since differences in radiation exposure narrow over time, the clinical significance of this small increase is uncertain and is unlikely to outweigh the clinical benefits of transradial access.	[Plourde, Guillaume; Bertrand, Olivier F.] Univ Laval, Quebec Heart Lung Inst, Quebec City, PQ G1K 7P4, Canada; [Pancholy, Samir B.; Amhed, Imdad] Commonwealth Med Ctr, Wright Ctr Grad Med Educ, Scranton, PA USA; [Nolan, Jim] Univ Hosp North Staffordshire, Stoke On Trent, Staffs, England; [Jolly, Sanjit] McMaster Univ, Hamilton, ON, Canada; [Jolly, Sanjit] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Rao, Sunil V.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Bangalore, Sripal] NYU, Sch Med, New York, NY USA; [Patel, Tejas] Apex Heart Inst, Ahmadabad, Gujarat, India; [Patel, Tejas] Sheth VS Gen Hosp, Dept Cardiol, Ahmadabad, Gujarat, India; [Patel, Tejas] Smt NHL Municipal Med Coll, Ahmadabad, Gujarat, India; [Dahm, Johannes B.] Heart & Vasc Ctr Neu Bethlehem, Dept Cardiol Angiol, Gottingen, Germany; [Bertrand, Olivier F.] McGill Univ, Dept Mech Engn, Montreal, PQ, Canada	Laval University; Quebec Heart & Lung Institute; McMaster University; McMaster University; Population Health Research Institute; Duke University; New York University; McGill University	Bertrand, OF (corresponding author), Quebec Heart Lung Inst, Intervent Cardiol Labs, Quebec City, PQ G1V 4G5, Canada.	olivier.bertrand@criucpq.ulaval.ca	Patel, Tejas/AAT-6528-2020	Bangalore, Sripal/0000-0001-9485-0652; Plourde, Guillaume/0000-0002-3641-6281; Dahm, Johannes B./0000-0002-0074-1162				Abdelaal E, 2014, JACC-CARDIOVASC INTE, V7, P567, DOI 10.1016/j.jcin.2014.02.005; Achenbach S, 2008, CATHETER CARDIO INTE, V72, P629, DOI 10.1002/ccd.21696; Aptecar E, 2006, CATHETER CARDIO INTE, V67, P711, DOI 10.1002/ccd.20679; Balter S, 1999, CATHETER CARDIO INTE, V47, P347, DOI 10.1002/(SICI)1522-726X(199907)47:3<347::AID-CCD23>3.0.CO;2-N; Bashore TM, 2004, AM HEART J, V147, P375, DOI 10.1016/j.ahj.2003.10.015; Bernat I, 2014, J AM COLL CARDIOL, V63, P964, DOI 10.1016/j.jacc.2013.08.1651; Bertrand OF, 2008, AM HEART J, V156, P135, DOI 10.1016/j.ahj.2008.02.006; Bertrand OF, 2012, AM HEART J, V163, P632, DOI 10.1016/j.ahj.2012.01.015; Brasselet C, 2007, HEART, V93, P1556, DOI 10.1136/hrt.2007.117309; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Cantor WJ, 2005, AM HEART J, V150, P543, DOI 10.1016/j.ahj.2004.10.043; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Chodor P, 2011, KARDIOL POL, V69, P763; Chodor P, 2009, CARDIOL J, V16, P332; Cooper CJ, 1999, AM HEART J, V138, P430, DOI 10.1016/S0002-8703(99)70143-2; Cousins C., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.09.001; Dossel O, 2009, IFMBE P; Fazel R, 2014, CIRCULATION, V130, P1730, DOI 10.1161/CIR.0000000000000048; Georges JL, 2014, CATHETER CARDIO INTE, V83, P729, DOI 10.1002/ccd.25327; Hahalis G, 2013, CIRC-CARDIOVASC INTE, V6, P252, DOI 10.1161/CIRCINTERVENTIONS.112.000150; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hildick-Smith DJR, 2004, CATHETER CARDIO INTE, V61, P60, DOI 10.1002/ccd.10708; Hou L, 2010, SAUDI MED J, V31, P158; ICRP, 1990, ANN ICRP, V60, P1991; Ingwersen M, 2013, JACC-CARDIOVASC INTE, V6, P1095, DOI 10.1016/j.jcin.2013.05.012; Jolly SS, 2013, JACC-CARDIOVASC INTE, V6, P258, DOI 10.1016/j.jcin.2012.10.016; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P1269, DOI 10.1016/S0735-1097(97)00064-8; Kim KP, 2008, HEALTH PHYS, V94, P211, DOI 10.1097/01.HP.0000290614.76386.35; Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003; Koltowski L, 2014, KARDIOL POL, V72, P604, DOI 10.5603/KP.a2014.0071; Kuon E, 2008, HEART, V94, P667, DOI 10.1136/hrt.2007.125021; Lange HW, 2012, JACC-CARDIOVASC INTE, V5, P445, DOI 10.1016/j.jcin.2011.12.013; Lange HW, 2006, CATHETER CARDIO INTE, V67, P12, DOI 10.1002/ccd.20451; Larrazet F, 2003, BRIT J RADIOL, V76, P473, DOI 10.1259/bjr/21553230; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu HL, 2014, RADIAT PROT DOSIM, V158, P412, DOI 10.1093/rpd/nct261; Lo TS, 2012, AM HEART J, V164, P455, DOI 10.1016/j.ahj.2012.06.011; Louvard Y, 2001, CATHETER CARDIO INTE, V52, P181, DOI 10.1002/1522-726X(200102)52:2<181::AID-CCD1044>3.0.CO;2-G; Mann JT, 1996, J INVASIVE CARDIOL, V8, pD40; Mann JT, 1996, J INVASIVE CARDIOL, V8, pD22; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Michael TT, 2013, JACC-CARDIOVASC INTE, V6, P1138, DOI 10.1016/j.jcin.2013.08.004; Public Health England, 2011, ION RAD DOS COMP HLT; Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007; Reddy BK, 2004, CATHETER CARDIO INTE, V62, P143, DOI 10.1002/ccd.20027; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Roussanov Oleg, 2007, J Invasive Cardiol, V19, P349; Saito S, 2003, CATHETER CARDIO INTE, V59, P26, DOI 10.1002/ccd.10493; Santas E, 2009, REV ESP CARDIOL, V62, P482, DOI 10.1016/S0300-8932(09)71028-0; Stecker MS, 2009, J VASC INTERV RADIOL, V20, pS263, DOI 10.1016/j.jvir.2009.04.037; Vazquez Rodriguez JM, 2009, COMP ACCESO RADIAL F; Wang YB, 2012, J INVASIVE CARDIOL, V24, P412; Wassef AWA, 2014, JACC-CARDIOVASC INTE, V7, P550, DOI 10.1016/j.jcin.2013.11.022; Yigit Fatma, 2006, Anadolu Kardiyol Derg, V6, P229	56	92	94	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2192	2203		10.1016/S0140-6736(15)00305-0	http://dx.doi.org/10.1016/S0140-6736(15)00305-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26411986				2022-12-28	WOS:000365992600031
J	Bateman-House, A; Kimberly, L; Redman, B; Dubler, N; Caplan, A				Bateman-House, Alison; Kimberly, Laura; Redman, Barbara; Dubler, Nancy; Caplan, Arthur			Right-to-Try Laws: Hope, Hype, and Unintended Consequences	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Langone Med Ctr, New York, NY 10016 USA; Columbia Univ, Sch Social Work, New York, NY USA	New York University; NYU Langone Medical Center; Columbia University	Bateman-House, A (corresponding author), NYU, Div Med Eth, Langone Med Ctr, 227 East 30th St, New York, NY 10016 USA.	Alison.Bateman-House@nyumc.org	Bateman-House, Alison/AAP-6213-2021	Bateman-House, Alison/0000-0001-6921-9666; Kimberly, Laura/0000-0001-6873-6266				Caplan A, 2010, AM J BIOETHICS, V10, P24, DOI 10.1080/15265161.2010.481980; Caplan AL, 2015, EXPERT OPIN PHARMACO, V16, P1275, DOI 10.1517/14656566.2015.1046837; CORIERI CHRISTINA, 2014, EVERYONE DESERVES RI; Farber David, 2015, HLTH AFFAIRS BL 0522; Forbes JB, 2015, MAN ALS WANTS EXPT D; Gaffney Alexander, 2015, 100 HOURS 1 FDA DRAM; Ginal J, HOUSE BILL 14 1281 G; Gorski D, 2014, RIGHT TRY LAWS DALLA; Lowes R, 2015, FDA SIMPLIFY COMPASS	9	26	26	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					796	U307		10.7326/M15-0148	http://dx.doi.org/10.7326/M15-0148			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26413841				2022-12-28	WOS:000365746400025
J	Smyth, A; Teo, KK; Rangarajan, S; O'Donnell, M; Zhang, XH; Rana, P; Leong, DP; Dagenais, G; Seron, P; Rosengren, A; Schutte, AE; Lopez-Jaramillo, P; Oguz, A; Chifamba, J; Diaz, R; Lear, S; Avezum, A; Kumar, R; Mohan, V; Szuba, A; Wei, L; Yang, W; Jian, B; McKee, M; Yusuf, S				Smyth, Andrew; Teo, Koon K.; Rangarajan, Sumathy; O'Donnell, Martin; Zhang, Xiaohe; Rana, Punam; Leong, Darryl P.; Dagenais, Gilles; Seron, Pamela; Rosengren, Annika; Schutte, Aletta E.; Lopez-Jaramillo, Patricio; Oguz, Ayetkin; Chifamba, Jephat; Diaz, Rafael; Lear, Scott; Avezum, Alvaro; Kumar, Rajesh; Mohan, Viswanathan; Szuba, Andrzej; Wei, Li; Yang, Wang; Jian, Bo; McKee, Martin; Yusuf, Salim		PURE Investigators	Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study	LANCET			English	Article							HIGH-INCOME COUNTRIES; ALL-CAUSE MORTALITY; RISK-FACTOR; GLOBAL BURDEN; SHAPED CURVE; DRINKING; METAANALYSIS; EVENTS; ASSOCIATION; RUSSIA	Background Alcohol consumption is proposed to be the third most important modifiable risk factor for death and disability. However, alcohol consumption has been associated with both benefits and harms, and previous studies were mostly done in high-income countries. We investigated associations between alcohol consumption and outcomes in a prospective cohort of countries at different economic levels in five continents. Methods We included information from 12 countries participating in the Prospective Urban Rural Epidemiological (PURE) study, a prospective cohort study of individuals aged 35-70 years. We used Cox proportional hazards regression to study associations with mortality (n=2723), cardiovascular disease (n=2742), myocardial infarction (n=979), stroke (n=817), alcohol-related cancer (n=764), injury (n=824), admission to hospital (n=8786), and for a composite of these outcomes (n=11 963). Findings We included 114 970 adults, of whom 12 904 (11%) were from high-income countries (HICs), 24 408 (21%) were from upper-middle-income countries (UMICs), 48 845 (43%) were from lower-middle-income countries (LMICs), and 28 813 (25%) were from low-income countries (LICs). Median follow-up was 4.3 years (IQR 3.0-6.0). Current drinking was reported by 36 030 (31%) individuals, and was associated with reduced myocardial infarction (hazard ratio [HR] 0.76 [95% CI 0.63-0.93]), but increased alcohol-related cancers (HR 1.51 [1.22-1.89]) and injury (HR 1.29 [1.04-1.61]). High intake was associated with increased mortality (HR 1.31 [1.04-1.66]). Compared with never drinkers, we identified significantly reduced hazards for the composite outcome for current drinkers in HICs and UMICs (HR 0.84 [0.77-0.92]), but not in LMICs and LICs, for which we identified no reductions in this outcome (HR 1.07 [0.95-1.21]; p(interaction) < 0.0001). Interpretation Current alcohol consumption had differing associations by clinical outcome, and differing associations by income region. However, we identified sufficient commonalities to support global health strategies and national initiatives to reduce harmful alcohol use.	[Smyth, Andrew; Teo, Koon K.; Rangarajan, Sumathy; O'Donnell, Martin; Zhang, Xiaohe; Rana, Punam; Leong, Darryl P.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Smyth, Andrew; Teo, Koon K.; Rangarajan, Sumathy; O'Donnell, Martin; Zhang, Xiaohe; Rana, Punam; Leong, Darryl P.; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Smyth, Andrew; O'Donnell, Martin] Natl Univ Ireland Galway, Res Board Clin Res Facil Galway, Galway, Ireland; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Seron, Pamela] Univ La Frontera, Fac Med, Manuel Montt, Chile; [Rosengren, Annika] Univ Hosp, Diagnosvagen, Goteburg, Sweden; [Rosengren, Annika] Ostra Hosp, Diagnosvagen, Goteburg, Sweden; [Schutte, Aletta E.] North West Univ, HART, Potchefstroom, South Africa; [Schutte, Aletta E.] North West Univ, MRC Res Unit Hypertens & Cardiovasc Dis, Potchefstroom, South Africa; [Lopez-Jaramillo, Patricio] Univ Santander, Fdn Oftalmol Santander, Res Insitute, Sch Med, Floridablanca, Bucaramanga, Colombia; [Oguz, Ayetkin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Lear, Scott] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Kumar, Rajesh] Sch Publ Hlth, Postgrad Inst Med Educ & Res, Chandigarh, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Szuba, Andrzej] Wroclaw Med Univ, Dept Internal Med, Wroclaw, Poland; [Szuba, Andrzej] 4th Mil Hosp Wroclaw, Wroclaw, Poland; [Wei, Li; Yang, Wang; Jian, Bo] Cardiovasc Acad Med Sci, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	McMaster University; Population Health Research Institute; McMaster University; Ollscoil na Gaillimhe-University of Galway; Laval University; Universidad de La Frontera; North West University - South Africa; North West University - South Africa; Universidad Industrial de Santander; Istanbul Medeniyet University; University of Zimbabwe; Simon Fraser University; Instituto Dante Pazzanese de Cardiologia; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Madras Diabetes Research Foundation; Wroclaw Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of London; London School of Hygiene & Tropical Medicine	Smyth, A (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	andrew.smyth@phri.ca	Seron, Pamela/AAN-3304-2021; Schutte, Aletta E/E-5126-2018; Chifamba, Jephat/AHE-4535-2022; Mckee, Martin/E-6673-2018; Oguz, Aytekin/AAJ-2732-2021; Avezum, Alvaro/AAP-7687-2020; Szuba, Andrzej/AAY-1162-2020; Avezum, Alvaro AA/K-6137-2016; O'Donnell, Martin/ABE-7459-2020; Kelishadi, Roya/E-6154-2012; McKee, Marc D/E-2187-2011; Gomez-Arbelaez, Diego/K-1883-2013; Igumbor, Ehimario/B-2652-2012	Seron, Pamela/0000-0003-0190-8988; Schutte, Aletta E/0000-0001-9217-4937; Chifamba, Jephat/0000-0001-8166-1182; Mckee, Martin/0000-0002-0121-9683; Oguz, Aytekin/0000-0002-2595-5167; Avezum, Alvaro AA/0000-0002-3073-6890; O'Donnell, Martin/0000-0002-7347-7761; Kelishadi, Roya/0000-0001-7455-1495; McKee, Marc D/0000-0001-8349-965X; Gulec, Sadi/0000-0002-2685-2522; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Yusuf, Salim/0000-0003-4776-5601; Szuba, Andrzej/0000-0002-7555-6201; Igumbor, Ehimario/0000-0002-6313-6031; Camacho, Paul Anthony/0000-0002-6233-9582; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Jerling, Johann/0000-0003-2600-3536; Teo, Koon/0000-0002-3731-0956; Levitt, Naomi/0000-0001-6480-8066	Population Health Research Institute; Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, AstraZeneca (Canada); Sanofi-Aventis (France and Canada); Boehringer Ingelheim (Germany and Canada); Servier; GlaxoSmithKline; Novartis; King Pharma	Population Health Research Institute; Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, AstraZeneca (Canada); Sanofi-Aventis (France and Canada); Boehringer Ingelheim (Germany and Canada); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma	Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, GlaxoSmithKline, Novartis, King Pharma, and national or local organisations in participating countries.	Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Bellavia A, 2014, ANN EPIDEMIOL, V24, P291, DOI 10.1016/j.annepidem.2013.12.012; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Huang C, 2014, MAYO CLIN PROC, V89, P1201, DOI 10.1016/j.mayocp.2014.05.014; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184; KLATSKY AL, 1993, ALCOHOL CLIN EXP RES, V17, P1156, DOI 10.1111/j.1530-0277.1993.tb05221.x; Klatsky AL, 2007, ANN EPIDEMIOL, V17, pS63, DOI 10.1016/j.annepidem.2007.01.014; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; Li Y, 2009, EUR J CANCER, V45, P843, DOI 10.1016/j.ejca.2008.11.001; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Peden M, 2002, INJURY CHART BOOK GR; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Plunk AD, 2014, ALCOHOL CLIN EXP RES, V38, P471, DOI 10.1111/acer.12250; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Rehm J, 2013, ALCOHOL RES-CURR REV, V35, P174; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; SCHOENFELD D, 1980, BIOMETRIKA, V67, P145; SHAPER AG, 1990, BRIT J ADDICT, V85, P837; SHAPER AG, 1988, LANCET, V2, P1267; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274; Wang C, 2014, J WOMENS HEALTH, V23, P373, DOI 10.1089/jwh.2013.4414; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, 2011, GLOB STAT REP ALC HL; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	30	117	123	0	63	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1945	1954		10.1016/S0140-6736(15)00235-4	http://dx.doi.org/10.1016/S0140-6736(15)00235-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PI	26386538				2022-12-28	WOS:000364763200029
J	Schindler, S; Gaillard, JM; Gruning, A; Neuhaus, P; Traill, LW; Tuljapurkar, S; Coulson, T				Schindler, Susanne; Gaillard, Jean-Michel; Gruening, Andre; Neuhaus, Peter; Traill, Lochran W.; Tuljapurkar, Shripad; Coulson, Tim			Sex-specific demography and generalization of the Trivers-Willard theory	NATURE			English	Article							COLUMBIAN GROUND-SQUIRRELS; MATERNAL CONDITION; LIFE-HISTORY; REPRODUCTIVE SUCCESS; RATIO; AGE; POPULATIONS; MANIPULATION; INVESTMENT; ALLOCATION	The Trivers-Willard theory(1) proposes that the sex ratio of offspring should vary with maternal condition when it has sex-specific influences on offspring fitness. In particular, mothers in good condition in polygynous and dimorphic species are predicted to produce an excess of sons, whereas mothers in poor condition should do the opposite. Despite the elegance of the theory, support for it has been limited(2,3). Here we extend and generalize the Trivers-Willard theory to explain the disparity between predictions and observations of offspring sex ratio. In polygynous species, males typically have higher mortality rates(4), different age-specific reproductive schedules and more risk-prone life history tactics than females; however, these differences are not currently incorporated into the Trivers-Willard theory. Using two-sex models parameterized with data from free-living mammal populations with contrasting levels of sex differences in demography, we demonstrate how sex differences in life history traits over the entire lifespan can lead to a wide range of sex allocation tactics, and show that correlations between maternal condition and offspring sex ratio alone are insufficient to conclude that mothers adaptively adjust offspring sex ratio.	[Schindler, Susanne; Coulson, Tim] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Gaillard, Jean-Michel] Univ Lyon 1, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Gruening, Andre] Univ Surrey, Dept Comp Sci, Guildford GU2 7XH, Surrey, England; [Neuhaus, Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Traill, Lochran W.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Surrey; University of Calgary; University of Witwatersrand; Stanford University	Schindler, S (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.	Susanne.Schindler@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003; Gaillard, Jean-Michel/0000-0003-0174-8451; Tuljapurkar, Shripad/0000-0001-5549-4245	ERC Advanced Grant; Swiss National Science Foundation [SNF 3100AO-109816]; European Commission (Marie Curie Fellowship) [254442]; Carnegie Corporation of New York [B8749.R01]; NERC [NE/I023783/2, NE/K014218/1] Funding Source: UKRI; Natural Environment Research Council [NE/K014218/1, NE/I023783/2] Funding Source: researchfish	ERC Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission (Marie Curie Fellowship)(European Commission); Carnegie Corporation of New York; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank Y. Vindenes, S. Cubaynes, S. West, R. K. Kanda, J. A. Deere, J. Barthold, M. Brouard, R. A. Pozo, and E. G. Simmonds for comments. We thank M. Festa-Bianchet and F. Pelletier for access to Bighorn sheep data and feedback. We acknowledge the use of the University of Oxford Advanced Research Computing facility. S. S. was funded by an ERC Advanced Grant to T.C., P.N. is funded by a Swiss National Science Foundation grant (SNF 3100AO-109816), and L.T. was funded by grants from the European Commission (Marie Curie Fellowship 254442) and the Carnegie Corporation of New York (B8749.R01).	Blanchard P, 2005, BEHAV ECOL, V16, P274, DOI 10.1093/beheco/arh153; BRONSON MT, 1979, ECOLOGY, V60, P272, DOI 10.2307/1937655; Brown GR, 2001, ANIM BEHAV, V61, P683, DOI 10.1006/anbe.2000.1659; CHARNOV E L, 1982; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Edwards AM, 2014, TRENDS ECOL EVOL, V29, P158, DOI 10.1016/j.tree.2013.12.003; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; FESTABIANCHET M, 1991, ANIM BEHAV, V42, P71, DOI 10.1016/S0003-3472(05)80607-4; Fisher R.A., 1930, GENETICAL THEORY NAT; Gedir JV, 2014, OECOLOGIA, V174, P1225, DOI 10.1007/s00442-013-2861-y; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Hewison AJM, 1996, BEHAV ECOL, V7, P461, DOI 10.1093/beheco/7.4.461; Hewison AJM, 2005, ECOL LETT, V8, P430, DOI 10.1111/j.1461-0248.2005.00743.x; Jones PH, 2012, CAN J ZOOL, V90, P736, DOI 10.1139/Z2012-042; Kappeler P., 2006, VERHALTENSBIOLOGIE; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.2307/177239; Martin JGA, 2011, ECOLOGY, V92, P441, DOI 10.1890/09-2413.1; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Murie JO, 1995, CAN J ZOOL, V73, P1819, DOI 10.1139/z95-214; Neuhaus P, 2000, BEHAV ECOL SOCIOBIOL, V48, P75, DOI 10.1007/s002650000209; Neuhaus P, 2001, CAN J ZOOL, V79, P465, DOI 10.1139/cjz-79-3-465; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Schindler S, 2013, AM NAT, V182, P28, DOI 10.1086/670753; Schwanz LE, 2006, AM NAT, V168, P521, DOI 10.1086/507993; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Steiner UK, 2014, AM NAT, V183, P771, DOI 10.1086/675894; TAYLOR PD, 1990, AM NAT, V135, P95, DOI 10.1086/285034; Traill LW, 2014, P NATL ACAD SCI USA, V111, P13223, DOI 10.1073/pnas.1407508111; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WIEBE KL, 1992, BEHAV ECOL SOCIOBIOL, V30, P379; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085	36	56	56	0	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					249	+		10.1038/nature14968	http://dx.doi.org/10.1038/nature14968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26390152				2022-12-28	WOS:000362399000046
J	Walter, K; Min, JL; Huang, J; Crooks, L; Memari, Y; McCarthy, S; Perry, JRB; Xu, C; Futema, M; Lawson, D; Iotchkova, V; Schiffels, S; Hendricks, AE; Danecek, P; Li, R; Floyd, J; Wain, LV; Barroso, I; Humphries, SE; Hurles, ME; Zeggini, E; Barrett, JC; Plagnol, V; Richards, JB; Greenwood, CMT; Timpson, NJ; Durbin, R; Soranzo, N; Bala, S; Clapham, P; Coates, G; Cox, T; Daly, A; Danecek, P; Du, Y; Durbin, R; Edkins, S; Ellis, P; Flicek, P; Guo, X; Guo, X; Huang, L; Jackson, DK; Joyce, C; Keane, T; Kolb-Kokocinski, A; Langford, C; Li, Y; Liang, J; Lin, H; Liu, R; Maslen, J; McCarthy, S; Muddyman, D; Quail, MA; Stalker, J; Sun, J; Tian, J; Wang, G; Wang, J; Wang, Y; Wong, K; Zhang, P; Barroso, I; Birney, E; Boustred, C; Chen, L; Clement, G; Cocca, M; Danecek, P; Smith, GD; Day, INM; Day-Williams, A; Down, T; Dunham, I; Durbin, R; Evans, DM; Gaunt, TR; Geihs, M; Greenwood, CMT; Hart, D; Hendricks, AE; Howie, B; Huang, J; Hubbard, T; Hysi, P; Iotchkova, V; Jamshidi, Y; Karczewski, KJ; Kemp, JP; Lachance, G; Lawson, D; Lek, M; Lopes, M; MacArthur, DG; Marchini, J; Mangino, M; Mathieson, I; McCarthy, S; Memari, Y; Metrustry, S; Min, JL; Moayyeri, A; Muddyman, D; Northstone, K; Panoutsopoulou, K; Paternoster, L; Perry, JRB; Quaye, L; Richards, JB; Ring, S; Ritchie, GRS; Schiffels, S; Shihab, HA; Shin, SY; Small, KS; Artigas, MS; Soranzo, N; Southam, L; Spector, TD; St Pourcain, B; Surdulescu, G; Tachmazidou, I; Timpson, NJ; Tobin, MD; Valdes, AM; Visscher, PM; Wain, LV; Walter, K; Ward, K; Wilson, SG; Wong, K; Yang, J; Zeggini, E; Zhang, F; Zheng, HF; Anney, R; Ayub, M; Barrett, JC; Blackwood, D; Bolton, PF; Breen, G; Collier, DA; Craddock, N; Crooks, L; Curran, S; Curtis, D; Durbin, R; Gallagher, L; Geschwind, D; Gurling, H; Holmans, P; Lee, I; Lonnqvist, J; McCarthy, S; McGuffin, P; McIntosh, AM; McKechanie, AG; McQuillin, A; Morris, J; Muddyman, D; O'Donovan, MC; Owen, MJ; Palotie, A; Parr, JR; Paunio, T; Pietilainen, O; Rehnstrom, K; Sharp, SI; Skuse, D; St Clair, D; Suvisaari, J; Walters, JTR; Williams, HJ; Barroso, I; Bochukova, E; Bounds, R; Dominiczak, A; Durbin, R; Farooqi, IS; Hendricks, AE; Keogh, J; Marenne, GL; McCarthy, S; Morris, A; Muddyman, D; O'Rahilly, S; Porteous, DJ; Smith, BH; Tachmazidou, I; Wheeler, E; Zeggini, E; Al Turki, S; Anderson, CA; Antony, D; Barroso, IS; Beales, P; Bentham, J; Bhattacharya, S; Calissano, M; Carss, K; Chatterjee, K; Cirak, S; Cosgrove, C; Durbin, R; Fitzpatrick, DR; Floyd, J; Foley, AR; Franklin, CS; Futema, M; Grozeva, D; Humphries, SE; Hurles, ME; McCarthy, S; Mitchison, HM; Muddyman, D; Muntoni, F; O'Rahilly, S; Onoufriadis, A; Parker, V; Payne, F; Plagnol, V; Raymond, FL; Roberts, N; Savage, DB; Scambler, P; Schmidts, M; Schoenmakers, N; Semple, RK; Serra, E; Spasic-Boskovic, O; Stevens, E; van Kogelenberg, M; Vijayarangakannan, P; Walter, K; Williamson, KA; Wilson, C; Whyte, T; Ciampi, A; Greenwood, CMT; Hendricks, AE; Li, R; Metrustry, S; Oualkacha, K; Tachmazidou, I; Xu, CJ; Zeggini, E; Bobrow, M; Bolton, PF; Durbin, R; Fitzpatrick, DR; Griffin, H; Hurles, ME; Kaye, J; Kennedy, K; Kent, A; Muddyman, D; Muntoni, F; Raymond, FL; Semple, RK; Smee, C; Spector, TD; Timpson, NJ; Charlton, R; Ekong, R; Futema, M; Humphries, SE; Khawaja, F; Lopes, LR; Migone, N; Payne, SJ; Plagnol, V; Pollitt, RC; Povey, S; Ridout, CK; Robinson, RL; Scott, RH; Shaw, A; Syrris, P; Taylor, R; Vandersteen, AM; Barrett, JC; Barroso, I; Smith, GD; Durbin, R; Farooqi, IS; Fitzpatrick, DR; Hurles, ME; Kaye, J; Kennedy, K; Langford, C; McCarthy, S; Muddyman, D; Owen, MJ; Palotie, A; Richards, JB; Soranzo, N; Spector, TD; Stalker, J; Timpson, NJ; Zeggini, E; Amuzu, A; Casas, JP; Chambers, JC; Cocca, M; Dedoussis, G; Gambaro, G; Gasparini, P; Gaunt, TR; Huang, J; Iotchkova, V; Isaacs, A; Johnson, J; Kleber, ME; Kooner, JS; Langenberg, C; Luan, J; Malerba, G; Marz, W; Matchan, A; Min, JL; Morris, R; Nordestgaard, BG; Benn, M; Ring, S; Scott, RA; Soranzo, N; Southam, L; Timpson, NJ; Toniolo, D; Traglia, M; Tybjaerg-Hansen, A; van Duijn, CM; van Leeuwen, EM; Varbo, A; Whincup, P; Zaza, G; Zeggini, E; Zhang, WH				Walter, Klaudia; Min, Josine L.; Huang, Jie; Crooks, Lucy; Memari, Yasin; McCarthy, Shane; Perry, John R. B.; Xu, ChangJiang; Futema, Marta; Lawson, Daniel; Iotchkova, Valentina; Schiffels, Stephan; Hendricks, Audrey E.; Danecek, Petr; Li, Rui; Floyd, James; Wain, Louise V.; Barroso, Ines; Humphries, Steve E.; Hurles, Matthew E.; Zeggini, Eleftheria; Barrett, Jeffrey C.; Plagnol, Vincent; Richards, J. Brent; Greenwood, Celia M. T.; Timpson, Nicholas J.; Durbin, Richard; Soranzo, Nicole; Bala, Senduran; Clapham, Peter; Coates, Guy; Cox, Tony; Daly, Allan; Danecek, Petr; Du, Yuanping; Durbin, Richard; Edkins, Sarah; Ellis, Peter; Flicek, Paul; Guo, Xiaosen; Guo, Xueqin; Huang, Liren; Jackson, David K.; Joyce, Chris; Keane, Thomas; Kolb-Kokocinski, Anja; Langford, Cordelia; Li, Yingrui; Liang, Jieqin; Lin, Hong; Liu, Ryan; Maslen, John; McCarthy, Shane; Muddyman, Dawn; Quail, Michael A.; Stalker, Jim; Sun, Jianping; Tian, Jing; Wang, Guangbiao; Wang, Jun; Wang, Yu; Wong, Kim; Zhang, Pingbo; Barroso, Ines; Birney, Ewan; Boustred, Chris; Chen, Lu; Clement, Gail; Cocca, Massimiliano; Danecek, Petr; Smith, George Davey; Day, Ian N. M.; Day-Williams, Aaron; Down, Thomas; Dunham, Ian; Durbin, Richard; Evans, David M.; Gaunt, Tom R.; Geihs, Matthias; Greenwood, Celia M. T.; Hart, Deborah; Hendricks, Audrey E.; Howie, Bryan; Huang, Jie; Hubbard, Tim; Hysi, Pirro; Iotchkova, Valentina; Jamshidi, Yalda; Karczewski, Konrad J.; Kemp, John P.; Lachance, Genevieve; Lawson, Daniel; Lek, Monkol; Lopes, Margarida; MacArthur, Daniel G.; Marchini, Jonathan; Mangino, Massimo; Mathieson, Iain; McCarthy, Shane; Memari, Yasin; Metrustry, Sarah; Min, Josine L.; Moayyeri, Alireza; Muddyman, Dawn; Northstone, Kate; Panoutsopoulou, Kalliope; Paternoster, Lavinia; Perry, John R. B.; Quaye, Lydia; Richards, J. Brent; Ring, Susan; Ritchie, Graham R. S.; Schiffels, Stephan; Shihab, Hashem A.; Shin, So-Youn; Small, Kerrin S.; Artigas, Maria Soler; Soranzo, Nicole; Southam, Lorraine; Spector, Timothy D.; St Pourcain, Beate; Surdulescu, Gabriela; Tachmazidou, Ioanna; Timpson, Nicholas J.; Tobin, Martin D.; Valdes, Ana M.; Visscher, Peter M.; Wain, Louise V.; Walter, Klaudia; Ward, Kirsten; Wilson, Scott G.; Wong, Kim; Yang, Jian; Zeggini, Eleftheria; Zhang, Feng; Zheng, Hou-Feng; Anney, Richard; Ayub, Muhammad; Barrett, Jeffrey C.; Blackwood, Douglas; Bolton, Patrick F.; Breen, Gerome; Collier, David A.; Craddock, Nick; Crooks, Lucy; Curran, Sarah; Curtis, David; Durbin, Richard; Gallagher, Louise; Geschwind, Daniel; Gurling, Hugh; Holmans, Peter; Lee, Irene; Lonnqvist, Jouko; McCarthy, Shane; McGuffin, Peter; McIntosh, Andrew M.; McKechanie, Andrew G.; McQuillin, Andrew; Morris, James; Muddyman, Dawn; O'Donovan, Michael C.; Owen, Michael J.; Palotie, Aarno; Parr, Jeremy R.; Paunio, Tiina; Pietilainen, Olli; Rehnstrom, Karola; Sharp, Sally I.; Skuse, David; St Clair, David; Suvisaari, Jaana; Walters, James T. R.; Williams, Hywel J.; Barroso, Ines; Bochukova, Elena; Bounds, Rebecca; Dominiczak, Anna; Durbin, Richard; Farooqi, I. Sadaf; Hendricks, Audrey E.; Keogh, Julia; Marenne, Gae Lle; McCarthy, Shane; Morris, Andrew; Muddyman, Dawn; O'Rahilly, Stephen; Porteous, David J.; Smith, Blair H.; Tachmazidou, Ioanna; Wheeler, Eleanor; Zeggini, Eleftheria; Al Turki, Saeed; Anderson, Carl A.; Antony, Dinu; Barroso, Ines; Beales, Phil; Bentham, Jamie; Bhattacharya, Shoumo; Calissano, Mattia; Carss, Keren; Chatterjee, Krishna; Cirak, Sebahattin; Cosgrove, Catherine; Durbin, Richard; Fitzpatrick, David R.; Floyd, James; Foley, A. Reghan; Franklin, Christopher S.; Futema, Marta; Grozeva, Detelina; Humphries, Steve E.; Hurles, Matthew E.; McCarthy, Shane; Mitchison, Hannah M.; Muddyman, Dawn; Muntoni, Francesco; O'Rahilly, Stephen; Onoufriadis, Alexandros; Parker, Victoria; Payne, Felicity; Plagnol, Vincent; Raymond, F. Lucy; Roberts, Nicola; Savage, David B.; Scambler, Peter; Schmidts, Miriam; Schoenmakers, Nadia; Semple, Robert K.; Serra, Eva; Spasic-Boskovic, Olivera; Stevens, Elizabeth; van Kogelenberg, Margriet; Vijayarangakannan, Parthiban; Walter, Klaudia; Williamson, Kathleen A.; Wilson, Crispian; Whyte, Tamieka; Ciampi, Antonio; Greenwood, Celia M. T.; Hendricks, Audrey E.; Li, Rui; Metrustry, Sarah; Oualkacha, Karim; Tachmazidou, Ioanna; Xu, ChangJiang; Zeggini, Eleftheria; Bobrow, Martin; Bolton, Patrick F.; Durbin, Richard; Fitzpatrick, David R.; Griffin, Heather; Hurles, Matthew E.; Kaye, Jane; Kennedy, Karen; Kent, Alastair; Muddyman, Dawn; Muntoni, Francesco; Raymond, F. Lucy; Semple, Robert K.; Smee, Carol; Spector, Timothy D.; Timpson, Nicholas J.; Charlton, Ruth; Ekong, Rosemary; Futema, Marta; Humphries, Steve E.; Khawaja, Farrah; Lopes, Luis R.; Migone, Nicola; Payne, Stewart J.; Plagnol, Vincent; Pollitt, Rebecca C.; Povey, Sue; Ridout, Cheryl K.; Robinson, Rachel L.; Scott, Richard H.; Shaw, Adam; Syrris, Petros; Taylor, Rohan; Vandersteen, Anthony M.; Barrett, Jeffrey C.; Barroso, Ines; Smith, George Davey; Durbin, Richard; Farooqi, I. Sadaf; Fitzpatrick, David R.; Hurles, Matthew E.; Kaye, Jane; Kennedy, Karen; Langford, Cordelia; McCarthy, Shane; Muddyman, Dawn; Owen, Michael J.; Palotie, Aarno; Richards, J. Brent; Soranzo, Nicole; Spector, Timothy D.; Stalker, Jim; Timpson, Nicholas J.; Zeggini, Eleftheria; Amuzu, Antoinette; Casas, Juan Pablo; Chambers, John C.; Cocca, Massimiliano; Dedoussis, George; Gambaro, Giovanni; Gasparini, Paolo; Gaunt, Tom R.; Huang, Jie; Iotchkova, Valentina; Isaacs, Aaron; Johnson, Jon; Kleber, Marcus E.; Kooner, Jaspal S.; Langenberg, Claudia; Luan, Jian'an; Malerba, Giovanni; Maerz, Winfried; Matchan, Angela; Min, Josine L.; Morris, Richard; Nordestgaard, Borge G.; Benn, Marianne; Ring, Susan; Scott, Robert A.; Soranzo, Nicole; Southam, Lorraine; Timpson, Nicholas J.; Toniolo, Daniela; Traglia, Michela; Tybjaerg-Hansen, Anne; van Duijn, Cornelia M.; van Leeuwen, Elisabeth M.; Varbo, Anette; Whincup, Peter; Zaza, Gianluigi; Zeggini, Eleftheria; Zhang, Weihua		UK10K Consortium; UCLEB Consortium	The UK10K project identifies rare variants in health and disease	NATURE			English	Article							GENOME-WIDE ASSOCIATION; LOW-FREQUENCY; INCIDENTAL FINDINGS; COMMON; HERITABILITY; EXOME; APOC3; RISK; LOCI; SNP	The contribution of rare and low-frequency variants to human traits is largely unexplored. Here we describe insights from sequencing whole genomes (low read depth, 7x) or exomes (high read depth, 80x) of nearly 10,000 individuals from population-based and disease collections. In extensively phenotyped cohorts we characterize over 24 million novel sequence variants, generate a highly accurate imputation reference panel and identify novel alleles associated with levels of triglycerides (APOB), adiponectin (ADIPOQ) and low-density lipoprotein cholesterol (LDLR and RGAG1) from single-marker and rare variant aggregation tests. We describe population structure and functional annotation of rare and low-frequency variants, use the data to estimate the benefits of sequencing for association studies, and summarize lessons from disease-specific collections. Finally, we make available an extensive resource, including individual-level genetic and phenotypic data and web-based tools to facilitate the exploration of association results.	[Walter, Klaudia; Huang, Jie; Crooks, Lucy; Memari, Yasin; McCarthy, Shane; Iotchkova, Valentina; Hendricks, Audrey E.; Danecek, Petr; Floyd, James; Barroso, Ines; Hurles, Matthew E.; Zeggini, Eleftheria; Barrett, Jeffrey C.; Durbin, Richard; Soranzo, Nicole; Bala, Senduran; Coates, Guy; Cox, Tony; Daly, Allan; Edkins, Sarah; Ellis, Peter; Flicek, Paul; Jackson, David K.; Joyce, Chris; Keane, Thomas; Kolb-Kokocinski, Anja; Langford, Cordelia; Maslen, John; Muddyman, Dawn; Quail, Michael A.; Stalker, Jim; Wong, Kim; Chen, Lu; Day-Williams, Aaron; Down, Thomas; Geihs, Matthias; Hubbard, Tim; Lopes, Margarida; Panoutsopoulou, Kalliope; Ritchie, Graham R. S.; Southam, Lorraine; Tachmazidou, Ioanna; Morris, James; Palotie, Aarno; Pietilainen, Olli; Rehnstrom, Karola; Marenne, Gae Lle; Wheeler, Eleanor; Anderson, Carl A.; Carss, Keren; Foley, A. Reghan; Franklin, Christopher S.; Payne, Felicity; Serra, Eva; van Kogelenberg, Margriet; Vijayarangakannan, Parthiban; Smee, Carol; Barrett, Jeffrey C.; Barroso, Ines; Matchan, Angela] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1HH, England; [Soranzo, Nicole; Chen, Lu] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Min, Josine L.; Timpson, Nicholas J.; Smith, George Davey; Evans, David M.; Gaunt, Tom R.; Northstone, Kate; Paternoster, Lavinia; Shihab, Hashem A.; Shin, So-Youn; St Pourcain, Beate] Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Crooks, Lucy] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Perry, John R. B.; Richards, J. Brent; Clement, Gail; Hart, Deborah; Hysi, Pirro; Lachance, Genevieve; Mangino, Massimo; Metrustry, Sarah; Moayyeri, Alireza; Quaye, Lydia; Small, Kerrin S.; Spector, Timothy D.; Surdulescu, Gabriela; Valdes, Ana M.; Ward, Kirsten; Wilson, Scott G.; Zhang, Feng] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Perry, John R. B.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,Epidemiol Unit, Cambridge CB2 0QQ, England; [Xu, ChangJiang; Li, Rui; Greenwood, Celia M. T.; Sun, Jianping; Richards, J. Brent; Zheng, Hou-Feng; Foley, A. Reghan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Xu, ChangJiang; Greenwood, Celia M. T.; Sun, Jianping; Richards, J. Brent; Ciampi, Antonio] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Futema, Marta; Humphries, Steve E.] UCL, BHF Labs, Cardiovasc Genet, Inst Cardiovasc Sci, London WC1E 6JJ, England; [Lawson, Daniel] Univ Bristol, Sch Math, Bristol BS8 2BN, Avon, England; [Lawson, Daniel] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Iotchkova, Valentina; Flicek, Paul; Birney, Ewan; Dunham, Ian; Ritchie, Graham R. S.] European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Colorado, Dept Math & Stat Sci, Denver, CO 80204 USA; [Li, Rui; Richards, J. Brent; Zheng, Hou-Feng] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3A 1B1, Canada; [Richards, J. Brent; Morris, Richard] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Floyd, James] Univ London, John Vane Sci Ctr, Genome Ctr, London EC1M 6BQ, England; [Wain, Louise V.; Artigas, Maria Soler; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Artigas, Maria Soler; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Barroso, Ines; Bochukova, Elena; Bounds, Rebecca; Farooqi, I. Sadaf; Keogh, Julia; O'Rahilly, Stephen; Chatterjee, Krishna; Parker, Victoria; Savage, David B.; Schoenmakers, Nadia; Semple, Robert K.; Barroso, Ines] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Barroso, Ines; Bochukova, Elena; Bounds, Rebecca; Keogh, Julia; Chatterjee, Krishna; Parker, Victoria; Savage, David B.; Schoenmakers, Nadia; Barroso, Ines] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Plagnol, Vincent] UCL, Genet Inst UGI, London WC1E 6BT, England; McGill Univ, Dept Oncol, Quebec City, PQ H2W 1S6, Canada; [Du, Yuanping; Guo, Xiaosen; Guo, Xueqin; Huang, Liren; Li, Yingrui; Liang, Jieqin; Lin, Hong; Tian, Jing; Wang, Guangbiao; Wang, Jun; Wang, Yu; Zhang, Pingbo] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Guo, Xiaosen; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Liu, Ryan] BGI Europe, London EC2M 4YE, England; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China; [Boustred, Chris] Great Ormond St Hosp NHS Fdn Trust, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Cocca, Massimiliano; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet, I-34100 Trieste, Italy; [Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, I-34100 Trieste, Italy; [Day, Ian N. M.] Univ Bristol, Sch Social & Community Med, Bristol Genet Epidemiol Labs, Bristol BS8 2BN, Avon, England; [Day-Williams, Aaron] Biogen Idec Inc, Computat Biol & Genom, Cambridge, MA 02142 USA; [Down, Thomas; Hubbard, Tim; Onoufriadis, Alexandros] Kings Coll London, Div Genet & Mol Med, Dept Med & Mol Genet, Sch Med,Guys Hosp, London SE1 9RT, England; [Evans, David M.; Kemp, John P.; Visscher, Peter M.; Yang, Jian] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Howie, Bryan] Adapt Biotechnol Corp, Seattle, WA 98102 USA; [Jamshidi, Yalda] St Georges Univ London, Human Genet Res Ctr, London SW17 0RE, England; [Karczewski, Konrad J.; Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Karczewski, Konrad J.; MacArthur, Daniel G.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lopes, Margarida; Marchini, Jonathan; Southam, Lorraine] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lopes, Margarida] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr, London SE1 9RT, England; [Mathieson, Iain] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Moayyeri, Alireza] UCL, Farr Inst Hlth Informat Res, Inst Hlth Informat, London NW1 2DA, England; [Ring, Susan] Univ Bristol, ALSPAC, Bristol BS8 2BN, Avon, England; [Ring, Susan] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Expt Psychol, Bristol BS8 1TU, Avon, England; [Tobin, Martin D.] Glenfield Gen Hosp, Natl Inst Hlth Res NIHR Leicester Resp Biomed Res, Leicester LE3 9QP, Leics, England; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Anney, Richard; Gallagher, Louise] St James Hosp, Trinity Ctr Hlth Sci, Dept Psychiat, Dublin 8, Ireland; [Ayub, Muhammad] Queens Univ, Dept Psychiat, Div Dev Disabil, Kingston, ON N6C 0A7, Canada; [Blackwood, Douglas; McIntosh, Andrew M.; McKechanie, Andrew G.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Bolton, Patrick F.; Curran, Sarah] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child Psychiat, London SE5 8AF, England; [Bolton, Patrick F.; Breen, Gerome] Kings Coll London, Inst Psychiat Psychol & Neurosci, NIHR BRC Mental Hlth, London SE5 8AF, England; [Breen, Gerome] Kings Coll London, SLaM NHS Trust, London SE5 8AF, England; [Breen, Gerome; Collier, David A.; McGuffin, Peter] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Collier, David A.] Eli Lilly & Co Ltd, Lilly Res Labs, Windlesham GU20 6PH, Surrey, England; [Craddock, Nick; Holmans, Peter; O'Donovan, Michael C.; Owen, Michael J.; Walters, James T. R.; Williams, Hywel J.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF24 4HQ, S Glam, Wales; [Curran, Sarah] Univ Sussex, Brighton BN1 9RH, E Sussex, England; [Curran, Sarah] Sussex Partnership NHS Fdn Trust, Worthing BN13 3EP, England; [Curtis, David] UCL, UCL Genet Inst, London WC1E 6BT, England; [Geschwind, Daniel] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Gurling, Hugh; McQuillin, Andrew; Sharp, Sally I.] UCL, Mol Psychiat Lab, Div Psychiat, London WC1E 6BT, England; [Lee, Irene; Skuse, David] UCL Inst Child Hlth, Behav & Brain Sci Unit, London WC1N 1EH, England; [Lonnqvist, Jouko; Paunio, Tiina; Pietilainen, Olli; Suvisaari, Jaana] Natl Inst Hlth & Welf THL, FI-00271 Helsinki, Finland; [McKechanie, Andrew G.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh EH10 5HF, Midlothian, Scotland; [Pietilainen, Olli] Univ Helsinki, Inst Mol Med Finland FIMM, FI-00014 Helsinki, Finland; Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02132 USA; Broad Inst MIT & Harvard, Genet Anal Platform, Cambridge, MA 02132 USA; [Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, FI-00014 Helsinki, Finland; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Williams, Hywel J.] UCL Inst Child Hlth, Ctr Translat Omics GOSgene, London WC1N 1EH, England; [Dominiczak, Anna] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Morris, Andrew] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH16 4UX, Midlothian, Scotland; [Porteous, David J.] Univ Edinburgh, Inst Genet & Expt Med, Western Gen Hosp, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Smith, Blair H.] Ninewells Hosp & Med Sch, Dundee DD2 4RB, Scotland; [Al Turki, Saeed] King Abdul Aziz Med City, Dept Pathol, Riyadh 11426, Saudi Arabia; [Antony, Dinu; Beales, Phil; Mitchison, Hannah M.; Scambler, Peter; Schmidts, Miriam; Scott, Richard H.] UCL Inst Child Hlth, Genet & Genom Med & Birth Defects Res Ctr, London WC1N 1EH, England; [Bentham, Jamie; Bhattacharya, Shoumo; Cosgrove, Catherine] Dept Cardiovasc Med, Oxford OX3 7BN, England; [Bentham, Jamie; Bhattacharya, Shoumo; Cosgrove, Catherine] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Calissano, Mattia; Cirak, Sebahattin; Foley, A. Reghan; Muntoni, Francesco; Stevens, Elizabeth; Whyte, Tamieka] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Calissano, Mattia; Cirak, Sebahattin; Foley, A. Reghan; Stevens, Elizabeth; Whyte, Tamieka] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [Cirak, Sebahattin] Uniklin Koln, Inst Humangenet, D-50931 Cologne, Germany; [Fitzpatrick, David R.; Williamson, Kathleen A.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Grozeva, Detelina; Raymond, F. Lucy; Roberts, Nicola; Spasic-Boskovic, Olivera; Wilson, Crispian; Bobrow, Martin] Addenbrookes Hosp, Acad Lab Med Genet, Lv Addenbrookes Treatment Ctr 6, Cambridge CB2 0QQ, England; [Schmidts, Miriam] Radboudumc, Human Genet Dept, NL-6525 HP Nijmegen, Netherlands; [Schmidts, Miriam] RIMLS, NL-6525 HP Nijmegen, Netherlands; [Oualkacha, Karim] Univ Quebec, Dept Math, Montreal, PQ H3C 3P8, Canada; [Griffin, Heather; Kaye, Jane; Kaye, Jane] Univ Oxford, HeLEX Ctr Hlth Law & Emerging Technol, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Kennedy, Karen] Natl Canc Res Inst, London EC1V 4AD, England; [Kent, Alastair] Genet Alliance UK, London N1 3QP, England; [Charlton, Ruth; Robinson, Rachel L.] St James Univ Hosp, Leeds Genet Lab, Leeds LS9 7TF, W Yorkshire, England; [Ekong, Rosemary; Povey, Sue] UCL, Dept Genet Evolut & Environm GEE, London WC1E 6BT, England; [Khawaja, Farrah; Taylor, Rohan] St Georges Univ, SW Thames Reg Genet Lab, London SW17 0RE, England; [Lopes, Luis R.; Syrris, Petros; Casas, Juan Pablo] UCL, Inst Cardiovasc Sci, London WC1E 6BT, England; [Lopes, Luis R.] Univ Lisbon, Fac ofMedicine, Cardiovasc Ctr, P-1649028 Lisbon, Portugal; [Migone, Nicola] Univ Torino, Dept Med Sci, I-10124 Turin, Italy; [Payne, Stewart J.] Northwick Pk Hosp & Clin Res Ctr, Kennedy Galton Ctr, North West Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Pollitt, Rebecca C.] Sheffield Childrens NHS Fdn Trust, Connect Tissue Disorders Serv, Sheffield Diagnost Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Ridout, Cheryl K.] Guys Hosp, Viapath, Mol Genet, London SE1 9RT, England; [Scott, Richard H.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Shaw, Adam] Guys & St Thomas NHS Fdn Trust, Clin Genet, London SE1 9RT, England; [Vandersteen, Anthony M.] Maritime Med Genet Serv, Halifax, NS B3K 6R8, Canada; [Amuzu, Antoinette; Casas, Juan Pablo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Chambers, John C.; Zhang, Weihua] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Dedoussis, George] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens 17671, Greece; [Gambaro, Giovanni] Univ Cattolica Sacro Cuore, Columbus Gemelli Univ Hosp, Inst Internal Med, Div Nephrol & Dialysis,Renal Program, I-00168 Rome, Italy; [Gasparini, Paolo] Sidra, Expt Genet Div, Doha, Qatar; [Isaacs, Aaron; van Duijn, Cornelia M.; van Leeuwen, Elisabeth M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [Johnson, Jon] UCL, UCL Inst Educ, Dept Quantitat Social Sci, London WC1H 0AL, England; [Kleber, Marcus E.] Fac Med, Dept Med 5, D-68167 Mannheim, Germany; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Langenberg, Claudia; Luan, Jian'an; Scott, Robert A.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Malerba, Giovanni] Univ Verona, Dept Life & Reprod Sci, Biol & Genet, I-37134 Verona, Italy; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, D-68161 Mannheim, Germany; [Maerz, Winfried] Heidelberg Univ, Mannheim Med Fac, Med Clin Nephrol 5, Hypertensiol,Rheumatol,Endocrinolgy,Diabetol, D-68167 Mannheim, Germany; [Morris, Richard] Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Nordestgaard, Borge G.; Benn, Marianne; Varbo, Anette] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Nordestgaard, Borge G.; Benn, Marianne; Varbo, Anette] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne; Varbo, Anette] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Toniolo, Daniela; Traglia, Michela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem KB3011, DK-2100 Copenhagen, Denmark; [Whincup, Peter] St Georges Univ London, Populat Hlth Res Inst, London SW17 0RE, England; [Zaza, Gianluigi] Univ Verona, Dept Med, Renal Unit, I-37126 Verona, Italy	Wellcome Trust Sanger Institute; University of Cambridge; University of Bristol; Sheffield Children's NHS Foundation Trust; University of London; King's College London; University of Cambridge; Lady Davis Institute; McGill University; McGill University; University of London; University College London; University of Bristol; University of Bristol; European Molecular Biology Laboratory (EMBL); University of Colorado System; University of Colorado Denver; McGill University; McGill University; University of London; Queen Mary University London; University of Leicester; University of Leicester; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; McGill University; Beijing Genomics Institute (BGI); University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; IRCCS Burlo Garofolo; University of Trieste; University of Bristol; Biogen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Queensland; St Georges University London; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Wellcome Centre for Human Genetics; Illumina; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Harvard University; Harvard Medical School; University of London; University College London; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Queensland; University of Western Australia; University of Western Australia; Trinity College Dublin; Queens University - Canada; Royal Infirmary of Edinburgh; University of Edinburgh; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; Eli Lilly; Cardiff University; University of Sussex; University of London; University College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; University of London; University College London; Finland National Institute for Health & Welfare; University of Edinburgh; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Newcastle University - UK; University of Helsinki; University of Aberdeen; University of London; University College London; University of Glasgow; University of Edinburgh; University of Edinburgh; University of Dundee; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Cologne; University of Edinburgh; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Radboud University Nijmegen; University of Quebec; University of Quebec Montreal; University of Oxford; Saint James's University Hospital; University of London; University College London; St Georges University London; University of London; University College London; Universidade de Lisboa; University of Turin; Imperial College London; Sheffield Children's NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Harokopio University Athens; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sidra Medical & Research Center; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; UCL Institute of Education; Imperial College London; University of Verona; Medical University of Graz; SYNLAB Group; Ruprecht Karls University Heidelberg; University of Bristol; University of Copenhagen; University of Copenhagen; University of Copenhagen; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Rigshospitalet; University of Copenhagen; St Georges University London; University of Verona	Soranzo, N (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1HH, England.	rd@sanger.ac.uk; ns6@sanger.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; Zheng, Houfeng/K-4424-2012; O'Rahilly, Stephen/ABF-6509-2020; Visscher, Peter/ABB-6151-2020; zhang, weihua/GXV-1334-2022; Walters, James/HCH-8835-2022; Gaunt, Tom R/O-3918-2014; Gasparini, Paolo/B-6173-2014; Sharp, Sally/AAG-2005-2019; Scambler, Peter/AAZ-6026-2020; Kaye, Jane/AAG-4679-2020; Cirak, Sebahattin/AAX-9593-2020; McQuillin, Andrew/C-1623-2008; McIntosh, Andrew M/B-9379-2008; Yang, Jian/A-5852-2010; Traglia, Michela/AAX-5816-2020; Hendricks, Audrey/I-4127-2016; Benn, Marianne/O-4164-2019; Curtis, David/HGB-3921-2022; Hubbard, Tim J.P./AAT-4571-2020; Breen, Gerome/Y-2706-2019; SYRRIS, PETROS/C-1703-2008; Kemp, John P./R-3091-2018; Dedoussis, George/AAN-7252-2021; Northstone, Kate/A-8165-2011; van Leeuwen, Elisabeth/G-3382-2017; Artigas, María Soler/L-6529-2013; Guo, Xueqin/AAZ-9936-2020; Lopes, Luis/K-7527-2019; Bhattacharya, Shoumo/F-4127-2010; Schiffels, Stephan/D-5675-2018; Timpson, Nicholas John/O-7548-2015; Jamshidi, Yalda/AAL-1377-2020; Richards, J Brent/AAF-4225-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Evans, David M/H-6325-2013; Marenne, Gaelle/AAU-8338-2020; O'Donovan, Michael C/P-7005-2018; Malerba, Giovanni/T-3278-2019; Attrill, Lauren/V-1688-2018; Mangino, Massimo/F-5134-2011; Porteous, David/AAA-3446-2021; Zaza, Gianluigi/K-3827-2018; Toniolo, Daniela/AAE-2969-2019; Williams, Hywel/AAL-2440-2021; Davey Smith, George/A-7407-2013; Semple, Robert/AAB-2948-2019; St Clair, David/AAN-2412-2021; St Pourcain, Beate/K-8004-2017; Quail, michael/ABE-6131-2020; Marchini, Jonathan/ABE-9024-2020; Durbin, Richard/AAE-7178-2019; Dominiczak, Anna F/P-9390-2017; Cirak, Sebahattin/AAZ-6829-2020; Schmidts, Miriam/A-3777-2012; Collier, David A/D-1649-2011; Futema, Marta/AAD-7557-2022; Payne, Felicity/GKF-2573-2022; Hubbard, Tim J/C-2567-2008; Cocca, Massimiliano/J-2951-2018; Moayyeri, Alireza/N-3332-2014; Paternoster, Lavinia/C-1292-2015; Karczewski, Jakub/L-7326-2018; Wang, Jun/B-9503-2016; Lawson, Daniel/A-8550-2011; Wang, Jun/C-8434-2016	Zheng, Houfeng/0000-0001-5681-8598; O'Rahilly, Stephen/0000-0003-2199-4449; Visscher, Peter/0000-0002-2143-8760; Gaunt, Tom R/0000-0003-0924-3247; Sharp, Sally/0000-0003-1363-5219; Scambler, Peter/0000-0002-1487-4628; Kaye, Jane/0000-0002-7311-4725; McQuillin, Andrew/0000-0003-1567-2240; McIntosh, Andrew M/0000-0002-0198-4588; Yang, Jian/0000-0003-2001-2474; Hendricks, Audrey/0000-0002-7152-0287; Benn, Marianne/0000-0002-1701-595X; Curtis, David/0000-0002-4089-9183; Hubbard, Tim J.P./0000-0002-1767-9318; Breen, Gerome/0000-0003-2053-1792; SYRRIS, PETROS/0000-0002-2363-8758; Kemp, John P./0000-0002-9105-2249; Dedoussis, George/0000-0002-7798-6221; Northstone, Kate/0000-0002-0602-1983; Artigas, María Soler/0000-0002-3213-1107; Lopes, Luis/0000-0002-6408-4667; Bhattacharya, Shoumo/0000-0002-5571-0478; Schiffels, Stephan/0000-0002-1017-9150; Timpson, Nicholas John/0000-0002-7141-9189; Jamshidi, Yalda/0000-0003-0151-6482; Richards, J Brent/0000-0002-3746-9086; Evans, David M/0000-0003-0663-4621; Marenne, Gaelle/0000-0002-4363-7170; O'Donovan, Michael C/0000-0001-7073-2379; Mangino, Massimo/0000-0002-2167-7470; Porteous, David/0000-0003-1249-6106; Toniolo, Daniela/0000-0001-9545-6032; Williams, Hywel/0000-0001-7758-0312; Davey Smith, George/0000-0002-1407-8314; St Pourcain, Beate/0000-0002-4680-3517; Marchini, Jonathan/0000-0003-0610-8322; Durbin, Richard/0000-0002-9130-1006; Dominiczak, Anna F/0000-0003-4913-3608; Schmidts, Miriam/0000-0002-1714-6749; Collier, David A/0000-0003-4087-1559; Payne, Felicity/0000-0003-4228-581X; Hubbard, Tim J/0000-0002-1767-9318; Cocca, Massimiliano/0000-0002-1127-7596; Van Duijn, Cornelia/0000-0002-2374-9204; Savage, David Bousfield/0000-0002-7857-7032; Gasparini, Paolo/0000-0002-0859-0856; Valdes, Ana M./0000-0003-1141-4471; Mitchison, Hannah/0000-0002-3163-6293; Johnson, Jon/0000-0001-8482-1620; Pollitt, Rebecca/0000-0002-8864-397X; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Semple, Robert Kenneth/0000-0001-6539-3069; Grozeva, Detelina/0000-0003-3239-8415; Edkins, Sarah/0000-0003-0717-1972; Humphries, Stephen E/0000-0002-8221-6547; McKechanie, Andrew/0000-0003-4273-9906; Iotchkova, Valentina/0000-0001-5057-0210; Coates, Guy/0000-0002-8055-4796; Ekong, Rosemary/0000-0002-5984-7893; Walter, Klaudia/0000-0003-4448-0301; Greenwood, Celia/0000-0002-2427-5696; Kelly, Kirsten/0000-0003-4234-543X; Moayyeri, Alireza/0000-0002-9143-2161; Barroso, Ines/0000-0001-5800-4520; Morris, Richard/0000-0001-7240-4563; Wong, Kim/0000-0002-0984-1477; Lachance, Genevieve/0000-0001-7523-8329; Venkatasubramanian, Siddharth/0000-0002-5860-0768; FitzPatrick, David R./0000-0003-4861-969X; Birney, Ewan/0000-0001-8314-8497; Paternoster, Lavinia/0000-0003-2514-0889; Karczewski, Jakub/0000-0001-9322-7842; Wheeler, Eleanor/0000-0002-8616-6444; Kivimaki, Mika/0000-0002-4699-5627; Zeggini, Eleftheria/0000-0003-4238-659X; Li, Rui/0000-0001-8353-6772; Barrett, Jeffrey/0000-0002-1152-370X; Palotie, Aarno/0000-0002-2527-5874; Plagnol, Vincent/0000-0002-5597-9215; Huang, Jie/0000-0002-9036-4304; Wilson, Scott/0000-0002-0357-1373; Gambaro, Giovanni/0000-0001-5733-2370; McCarthy, Shane/0000-0002-2715-4187; Malerba, Giovanni/0000-0001-8705-8560; Wang, Jun/0000-0002-2113-5874; Dunham, Ian/0000-0003-2525-5598; Soranzo, Nicole/0000-0003-1095-3852; Lee, Irene O./0000-0003-0004-6802; Whincup, Peter/0000-0002-5589-4107; Anderson, Carl/0000-0003-1719-7009; Gallagher, Louise/0000-0001-9462-2836; Anney, Richard/0000-0002-6083-407X; Walters, James/0000-0002-6980-4053; s, hema/0000-0002-3440-9475; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Flicek, Paul/0000-0002-3897-7955; Nordestgaard, Borge/0000-0002-1954-7220; Zaza, Gianluigi/0000-0002-6004-6196; Farooqi, Sadaf/0000-0001-7609-3504; Tobin, Martin/0000-0002-3596-7874; Memari, Yasin/0000-0002-1747-542X; Schoenmakers, Nadia/0000-0002-0847-2884; MacArthur, Daniel/0000-0002-5771-2290; Bochukova, Elena/0000-0003-0275-1548; Lawson, Daniel/0000-0002-5311-6213; Hysi, Pirro/0000-0001-5752-2510; Futema, Marta/0000-0002-2120-2088; Karczewski, Konrad/0000-0003-2878-4671; Wain, Louise/0000-0003-4951-1867; Suvisaari, Jaana/0000-0001-7167-0990; Wang, Jun/0000-0002-8540-8931; Small, Kerrin/0000-0003-4566-0005	Wellcome Trust [WT091310]; BBSRC [BB/M020991/1, BB/K015427/1] Funding Source: UKRI; ESRC [ES/M001660/1, ES/J023299/1] Funding Source: UKRI; MRC [G0500870, G0800509, MC_UU_12015/1, G0801843, G0902313, MC_U106179472, MR/J012165/1, MR/K013351/1, MC_UU_12013/3, MC_UU_12013/1, MC_UU_12013/4, MC_UU_12015/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K015427/1, BB/M020991/1] Funding Source: researchfish; British Heart Foundation [RG/10/13/28570, RG/10/17/28553, RG/08/008/25291, PG/07/045/22690] Funding Source: researchfish; Economic and Social Research Council [ES/M001660/1, ES/J023299/1] Funding Source: researchfish; Medical Research Council [MC_PC_13048, MC_UU_12013/3, MR/K013351/1, MR/L010305/1, G0801843, MC_UU_12015/2, MC_UU_12012/5/B, MC_UU_12015/1, G9817803B, G0902313, G0500870, MR/K000608/1, MC_U106179472, MC_PC_13046, MC_UU_12013/4, MC_PC_15018, MC_UU_12013/1, MR/J012165/1, G0800509] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10198, NF-SI-0514-10176, NF-SI-0510-10268, NF-SI-0514-10027, NF-SI-0507-10380, NF-SI-0513-10109] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4, SCD/12] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; Great Ormond Street Hospital Childrens Charity	This study makes use of data generated by the UK10K Consortium. The Wellcome Trust provided funding for UK10K (WT091310). Additional grant support and acknowledgements can be found in the Supplementary Information.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Geihs M., 2015, BIOINFORMATICS; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kaye J, 2014, EUR J HUM GENET, V22, P1100, DOI 10.1038/ejhg.2013.290; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Taylor PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6681; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timpson NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5871; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Whittall R A, 2002, J Med Genet, V39, pe57, DOI 10.1136/jmg.39.9.e57; Williams FMK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003095; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	49	612	618	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					82	+		10.1038/nature14962	http://dx.doi.org/10.1038/nature14962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26367797	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000362095100038
J	Chung, HS; Piana-Agostinetti, S; Shaw, DE; Eaton, WA				Chung, Hoi Sung; Piana-Agostinetti, Stefano; Shaw, David E.; Eaton, William A.			Structural origin of slow diffusion in protein folding	SCIENCE			English	Article							SINGLE-MOLECULE FRET; 3-HELIX BUNDLE PROTEIN; TRANSITION PATH TIMES; INTERNAL-FRICTION; REACTION COORDINATE; CHEMICAL-REACTIONS; ENERGY LANDSCAPE; CHAIN DYNAMICS; VISCOSITY; KINETICS	Experimental, theoretical, and computational studies of small proteins suggest that interresidue contacts not present in the folded structure play little or no role in the self-assembly mechanism. Non-native contacts can, however, influence folding kinetics by introducing additional local minima that slow diffusion over the global free-energy barrier between folded and unfolded states. Here, we combine single-molecule fluorescence with all-atom molecular dynamics simulations to discover the structural origin for the slow diffusion that markedly decreases the folding rate for a designed a-helical protein. Our experimental determination of transition path times and our analysis of the simulations point to non-native salt bridges between helices as the source, which provides a quantitative glimpse of how specific intramolecular interactions influence protein folding rates by altering dynamics and not activation free energies.	[Chung, Hoi Sung; Eaton, William A.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Piana-Agostinetti, Stefano; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); D. E. Shaw Research; Columbia University	Chung, HS (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	chunghoi@niddk.nih.gov; stefano.piana-agostinetti@DEShawResearch.com; david.shaw@DEShawResearch.com; eaton@helix.nih.gov	Chung, Hoi Sung/C-2624-2009	Chung, Hoi Sung/0000-0001-6897-4969	NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029055] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Best and A. Szabo for many helpful and insightful discussions. Work at NIH was supported by the Intramural Research Program of the NIDDK. We are also thank J. M. Louis for the preparation, dye labeling, and purification of the protein used in this work, with technical assistance from A. Aniana.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Borgia A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2204; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chung HS, 2014, PHYS CHEM CHEM PHYS, V16, P18644, DOI 10.1039/c4cp02489c; Chung HS, 2013, NATURE, V502, P685, DOI 10.1038/nature12649; Chung HS, 2013, CHEM PHYS, V422, P229, DOI 10.1016/j.chemphys.2012.08.005; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Chung HS, 2011, J PHYS CHEM A, V115, P3642, DOI 10.1021/jp1009669; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; CICCOTTI G, 1990, J CHEM PHYS, V93, P7137, DOI 10.1063/1.459437; de Sancho D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5307; Echeverria I, 2014, J AM CHEM SOC, V136, P8708, DOI 10.1021/ja503069k; Ferreiro DU, 2014, Q REV BIOPHYS, V47, P285, DOI 10.1017/S0033583514000092; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Jas GS, 2001, J PHYS CHEM B, V105, P261, DOI 10.1021/jp0022048; Klimov DK, 1997, PHYS REV LETT, V79, P317, DOI 10.1103/PhysRevLett.79.317; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Mullen RG, 2014, J CHEM THEORY COMPUT, V10, P659, DOI 10.1021/ct4009798; NORTHRUP SH, 1980, J CHEM PHYS, V73, P2700, DOI 10.1063/1.440484; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Piana S, 2012, P NATL ACAD SCI USA, V109, P17845, DOI 10.1073/pnas.1201811109; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Portman JJ, 2001, J CHEM PHYS, V114, P5082, DOI 10.1063/1.1334663; Sagnella DE, 2000, J CHEM PHYS, V113, P7702, DOI 10.1063/1.1313554; Schulz JCF, 2012, J AM CHEM SOC, V134, P6273, DOI 10.1021/ja211494h; Shaw D.E., 2009, SC 09; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Walsh STR, 1999, P NATL ACAD SCI USA, V96, P5486, DOI 10.1073/pnas.96.10.5486; Wensley BG, 2012, P NATL ACAD SCI USA, V109, P17795, DOI 10.1073/pnas.1201793109; Wensley BG, 2012, J MOL BIOL, V423, P273, DOI 10.1016/j.jmb.2012.08.003; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Zheng WW, 2015, J AM CHEM SOC, V137, P3283, DOI 10.1021/ja511609u; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100	42	148	148	2	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1504	1510		10.1126/science.aab1369	http://dx.doi.org/10.1126/science.aab1369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404828	Green Accepted			2022-12-28	WOS:000361707000039
J	Gould, J				Gould, J.			Cannabis: 4 big questions	NATURE			English	Article																			0	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S18	S18		10.1038/525S18a	http://dx.doi.org/10.1038/525S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398735	Bronze			2022-12-28	WOS:000361599900062
J	Wolf, G; Macfarlan, TS				Wolf, Gernot; Macfarlan, Todd S.			Revealing the Complexity of Retroviral Repression	CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; ENDOGENOUS RETROVIRUSES; ZFP809	Retroviral restriction is a complex phenomenon that, despite remarkable recent progress, is far from being well understood. In this Preview, we introduce an insightful study by Yang et al. that represents the first attempt to identify the global determinants of retroviral repression in pluripotent mammalian cells.	[Wolf, Gernot; Macfarlan, Todd S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Macfarlan, TS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	todd.macfarlan@nih.gov	Macfarlan, Todd/S-3750-2017	Macfarlan, Todd/0000-0003-2495-9809; Wolf, Gernot/0000-0002-3943-8662	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008933] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD008933-03, ZIA HD008933-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Yang BX, 2015, CELL, V163, P230, DOI 10.1016/j.cell.2015.08.037; Yu ZS, 2015, CELL MOL LIFE SCI, V72, P327, DOI 10.1007/s00018-014-1748-3	10	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					30	32		10.1016/j.cell.2015.09.014	http://dx.doi.org/10.1016/j.cell.2015.09.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406368	Green Accepted, Bronze			2022-12-28	WOS:000361846500018
J	Qureshi, ZU; Millum, J; Blencowe, H; Kelley, M; Fottrell, E; Lawn, JE; Costello, A; Colbourn, T				Qureshi, Zeshan U.; Millum, Joseph; Blencowe, Hannah; Kelley, Maureen; Fottrell, Edward; Lawn, Joy E.; Costello, Anthony; Colbourn, Tim			Stillbirth should be given greater priority on the global health agenda	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEONATAL DEATH; VERBAL AUTOPSY; MORTALITY; PREGNANCY; ANXIETY; BABIES; RATES		[Qureshi, Zeshan U.; Fottrell, Edward; Costello, Anthony; Colbourn, Tim] UCL, Inst Global Hlth, London, England; [Millum, Joseph] NIH, Clin Ctr Dept Bioeth, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Blencowe, Hannah; Lawn, Joy E.] London Sch Hyg & Trop Med, Maternal Adolescent Reprod & Child Hlth Ctr, London WC1, England; [Kelley, Maureen] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England	University of London; University College London; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH Fogarty International Center (FIC); University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Qureshi, ZU (corresponding author), UCL, Inst Global Hlth, London, England.	zeshan.u.qureshi@gmail.com	Lawn, Joy/ABE-6382-2020; Colbourn, Tim/AAE-6645-2019	Lawn, Joy/0000-0002-4573-1443; Colbourn, Tim/0000-0002-6917-6552; Fottrell, Edward/0000-0003-0518-7161; Qureshi, Zeshan/0000-0001-5755-6032; Kelley, Maureen/0000-0001-8230-5315; Blencowe, Hannah/0000-0003-1556-3159				Badenhorst W, 2006, J PSYCHOSOM OBST GYN, V27, P245, DOI 10.1080/01674820600870327; Bapat U, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-39; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bonnette S, 2012, J SOCIOL, V48, P248, DOI 10.1177/1440783311413485; Cacciatore J, 2008, BIRTH-ISS PERINAT C, V35, P313, DOI 10.1111/j.1523-536X.2008.00258.x; Colbourn T, 2015, COST EFFECT RESOUR A, V13, DOI 10.1186/s12962-014-0028-2; Conde-Agudelo A, 2005, OBSTET GYNECOL, V106, P359, DOI 10.1097/01.AOG.0000171118.79529.a3; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Department of Health, 2013, AB STAT ENGL WAL 201; Dolea C, 2000, GLOBAL BURDEN OBSTRU; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Goldenberg RL, 2013, INT J GYNECOL OBSTET, V123, P252, DOI 10.1016/j.ijgo.2013.06.020; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hamid S, 2014, J PAK MED ASSOC, V64, P331; Harper Mairi, 2011, BMJ Support Palliat Care, V1, P306, DOI 10.1136/bmjspcare-2011-000025; Hoj L, 2002, BJOG-INT J OBSTET GY, V109, P792, DOI 10.1111/j.1471-0528.2002.01259.x; Hossain MB, 2007, DEMOGRAPHY, V44, P771, DOI 10.1353/dem.2007.0047; Hughes PM, 1999, BRIT MED J, V318, P1721, DOI 10.1136/bmj.318.7200.1721; Kassebaum NJ, 2014, LANCET, V384, P956; Kelley M, 2011, LANCET, V377, P1636, DOI 10.1016/S0140-6736(11)60279-1; Kelley MC, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-137; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; LITHELL UB, 1992, LANCET, V339, P377, DOI 10.1016/0140-6736(92)91704-C; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Phillips J, 2015, BIOETHICS, V29, P413, DOI 10.1111/bioe.12120; Scott J, 2011, LANCET, V377, P1386, DOI 10.1016/S0140-6736(11)60107-4; Simon J, 2009, HEALTH ECON, V18, P487, DOI 10.1002/hec.1375; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Sumner L., 1981, ABORTION MORAL THEOR; Tooley Michael, 1983, ABORTION INFANTICIDE; Turton P, 2001, BRIT J PSYCHIAT, V178, P556, DOI 10.1192/bjp.178.6.556; UN Inter-agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; United Nations, OP WORK GROUP PROP S; Vergnano S, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-48; WHO, 2012, DEP REPROD HEAL RES, P1	40	17	17	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4620	10.1136/bmj.h4620	http://dx.doi.org/10.1136/bmj.h4620			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3FL	26400645	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000361957200003
J	Edenhofer, O				Edenhofer, Ottmar			King Coal and the queen of subsidies	SCIENCE			English	Editorial Material									Tech Univ Berlin, Mercator Res Inst Global Commons & Climate Change, Potsdam Inst Climate Impact Res, Berlin, Germany	Potsdam Institut fur Klimafolgenforschung; Technical University of Berlin	Edenhofer, O (corresponding author), Tech Univ Berlin, Mercator Res Inst Global Commons & Climate Change, Potsdam Inst Climate Impact Res, Berlin, Germany.	ottmar.edenhofer@pik-potsdam.de	Edenhofer, Ottmar/E-1886-2013	Edenhofer, Ottmar/0000-0001-6029-5208				Coady MrDavid., 2015, LARGE ARE GLOBAL ENE, V15, DOI [10.5089/9781513532196.001, DOI 10.5089/9781513532196.001]; Del Granado FJA, 2012, WORLD DEV, V40, P2234, DOI 10.1016/j.worlddev.2012.05.005; Hirth L, 2015, RENEW ENERG, V74, P925, DOI 10.1016/j.renene.2014.08.065; IEA, 2014, WORLD EN OUTL 2014; International Energy Agency (IEA), 2020, OIL GAS IND EN TRANS; IPCC, 2011, SPEC REP REN EN SOUR; IRENA, 2015, REN POW GEN COSTS 20; Jakob M, 2015, NAT CLIM CHANGE, V5, P709, DOI 10.1038/nclimate2679; McJeon H, 2014, NATURE, V514, P482, DOI 10.1038/nature13837; Shearer Christine, 2015, BOOM BUST TRACKING G; Steckel JC, 2015, P NATL ACAD SCI USA, V112, pE3775, DOI 10.1073/pnas.1422722112; U.S. Environmental Protection Agency, 2015, CLEAN POW PLAN EX PO; White House, 2014, US CHIN JOINT ANN CL	13	40	40	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1286	1287		10.1126/science.aad0674	http://dx.doi.org/10.1126/science.aad0674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR5CR	26383938				2022-12-28	WOS:000361357700023
J	Landolt, HP				Landolt, Hans Peter			Caffeine, the circadian clock, and sleep	SCIENCE			English	Editorial Material							RECEPTORS; ADENOSINE		[Landolt, Hans Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Landolt, Hans Peter] Univ Zurich, Zurich Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University of Zurich	Landolt, HP (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	landolt@pharma.uzh.ch	Landolt, Hans-Peter/H-6951-2016	Landolt, Hans-Peter/0000-0003-0887-9403				Alhaider IA, 2011, MOL CELL NEUROSCI, V46, P742, DOI 10.1016/j.mcn.2011.02.006; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Burke TM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5125; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; Elmenhorst D, 2012, J NUCL MED, V53, P1723, DOI 10.2967/jnumed.112.105114; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; Lazar AS, 2015, NEUROIMAGE, V116, P123, DOI 10.1016/j.neuroimage.2015.05.012; Lewy AJ, 1999, J BIOL RHYTHM, V14, P227, DOI 10.1177/074873099129000641; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012	15	10	11	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1289	1289		10.1126/science.aad2958	http://dx.doi.org/10.1126/science.aad2958			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383940				2022-12-28	WOS:000361357700025
J	Tishkoff, S				Tishkoff, Sarah			Strength in small numbers	SCIENCE			English	Editorial Material									[Tishkoff, Sarah] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tishkoff, Sarah] Univ Penn, Dept Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Tishkoff, S (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113657] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK104339] Funding Source: Medline; NIEHS NIH HHS [P30 ES013508] Funding Source: Medline; NIGMS NIH HHS [R01 GM113657] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Cohen JC, 2013, SCIENCE, V340, P689, DOI 10.1126/science.1239101; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Perry GH, 2014, P NATL ACAD SCI USA, V111, pE3596, DOI 10.1073/pnas.1402875111; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Sheridan C, 2015, NAT BIOTECHNOL, V33, P785, DOI 10.1038/nbt0815-785; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	10	13	13	4	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1282	1283		10.1126/science.aad0584	http://dx.doi.org/10.1126/science.aad0584			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383935	Green Accepted			2022-12-28	WOS:000361357700020
J	Fessenden, M				Fessenden, Marissa			THE CELL MENAGERIE: HUMAN IMMUNE PROFILING	NATURE			English	Editorial Material							HEAVY											Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Yamanaka YJ, 2012, INTEGR BIOL-UK, V4, P1175, DOI [10.1039/c2ib20167d, 10.1039/c2ib200157d]	7	9	9	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					409	411		10.1038/525409a	http://dx.doi.org/10.1038/525409a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381986				2022-12-28	WOS:000361297900050
J	Mandal, P; Pitcher, MJ; Alaria, J; Niu, H; Borisov, P; Stamenov, P; Claridge, JB; Rosseinsky, MJ				Mandal, P.; Pitcher, M. J.; Alaria, J.; Niu, H.; Borisov, P.; Stamenov, P.; Claridge, J. B.; Rosseinsky, M. J.			Designing switchable polarization and magnetization at room temperature in an oxide	NATURE			English	Article							PHASE-TRANSITIONS; BOUNDARY	Ferroelectric and ferromagnetic materials exhibit long-range order of atomic-scale electric or magnetic dipoles that can be switched by applying an appropriate electric or magnetic field, respectively. Both switching phenomena form the basis of non-volatile random access memory(1), but in the ferroelectric case, this involves destructive electrical reading and in the magnetic case, a high writing energy is required(2). In principle, low-power and high-density information storage that combines fast electrical writing and magnetic reading can be realized with magnetoelectric multiferroic materials(3). These materials not only simultaneously display ferroelectricity and ferromagnetism, but also enable magnetic moments to be induced by an external electric field, or electric polarization by a magnetic field(4,5). However, synthesizing bulk materials with both long-range orders at room temperature in a single crystalline structure is challenging because conventional ferroelectricity requires closed-shell d(0) or s(2) cations, whereas ferromagnetic order requires open-shell d(n) configurations with unpaired electrons(6). These opposing requirements pose considerable difficulties for atomic-scale design strategies such as magnetic ion substitution into ferroelectrics(7,8). One material that exhibits both ferroelectric and magnetic order is BiFeO3, but its cycloidal magnetic structure(9) precludes bulk magnetization and linear magnetoelectric coupling(10). A solid solution of a ferroelectric and a spin-glass perovskite combines switchable polarization(11) with glassy magnetization, although it lacks long-range magnetic order(12). Crystal engineering of a layered perovskite has recently resulted in room-temperature polar ferromagnets(13), but the electrical polarization has not been switchable. Here we combine ferroelectricity and ferromagnetism at room temperature in a bulk perovskite oxide, by constructing a percolating network of magnetic ions with strong superexchange interactions within a structural scaffold exhibiting polar lattice symmetries at a morphotropic phase boundary(14) (the compositional boundary between two polar phases with different polarization directions, exemplified by the PbZrO3-PbTiO3 system) that both enhances polarization switching and permits canting of the ordered magnetic moments. We expect this strategy to allow the generation of a range of tunable multiferroic materials.	[Mandal, P.; Pitcher, M. J.; Niu, H.; Borisov, P.; Claridge, J. B.; Rosseinsky, M. J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Alaria, J.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Stamenov, P.] Univ Dublin Trinity Coll, CRANN, Dublin 2, Ireland	University of Liverpool; University of Liverpool; Trinity College Dublin	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	j.b.claridge@liv.ac.uk; m.j.rosseinsky@liv.ac.uk	Borisov, Pavel/A-6218-2015; Claridge, John B/I-7395-2012; Pitcher, Michael J/B-7157-2019	Borisov, Pavel/0000-0003-1464-6999; Claridge, John B/0000-0003-4849-6714; Pitcher, Michael J/0000-0003-2044-6774; Alaria, Jonathan/0000-0001-5868-0318; Stamenov, Plamen/0000-0002-8132-3033	EPSRC [EP/H000925/1]; Engineering and Physical Sciences Research Council [EP/H000925/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC under EP/H000925/1. M.J.R. is a Royal Society Research Professor.	Arnold DC, 2015, IEEE T ULTRASON FERR, V62, P62, DOI 10.1109/TUFFC.2014.006668; Bibes M, 2012, NAT MATER, V11, P354, DOI 10.1038/nmat3318; Borisov P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2793500; Chen X, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388149; Chillal S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174418; Damjanovic D, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3479479; Evans DM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2548; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Filoti G, 1997, J ALLOY COMPD, V256, P86, DOI 10.1016/S0925-8388(96)03110-6; Heron JT, 2014, NATURE, V516, P370, DOI 10.1038/nature14004; Heron JT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217202; Hill NA, 2000, J PHYS CHEM B, V104, P6694, DOI [10.1021/jp000114x, 10.1021/jpc00114x]; Khomchenko VA, 2011, CRYST RES TECHNOL, V46, P238, DOI 10.1002/crat.201100040; Mandal P, 2015, ADV MATER, V27, P2883, DOI 10.1002/adma.201405452; Nan CW, 2008, J APPL PHYS, V103, DOI 10.1063/1.2836410; Noheda B, 2006, PHASE TRANSIT, V79, P5, DOI 10.1080/01411590500467262; Pitcher MJ, 2015, SCIENCE, V347, P420, DOI 10.1126/science.1262118; POPOV YF, 1993, JETP LETT+, V57, P69; Schmid H, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434201; Scott JF, 2007, NAT MATER, V6, P256, DOI 10.1038/nmat1868; SHTRIKMAN S, 1963, PHYS REV, V130, P986, DOI 10.1103/PhysRev.130.986; Smolenskii G. A., 1982, Soviet Physics - Uspekhi, V25, P475, DOI 10.1070/PU1982v025n07ABEH004570; SOSNOWSKA I, 1982, J PHYS C SOLID STATE, V15, P4835, DOI 10.1088/0022-3719/15/23/020; Weisheit M, 2007, SCIENCE, V315, P349, DOI 10.1126/science.1136629; WHITE RL, 1969, J APPL PHYS, V40, P1061, DOI 10.1063/1.1657530; Yuan GL, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220642; Zhang N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6231; Zhang SX, 2012, J APPL PHYS, V111, DOI 10.1063/1.3702405; Zhu JG, 2008, P IEEE, V96, P1786, DOI 10.1109/JPROC.2008.2004313	29	106	108	9	554	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					363	+		10.1038/nature14881	http://dx.doi.org/10.1038/nature14881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381984				2022-12-28	WOS:000361297900040
J	Eigenmann, F				Eigenmann, Franz			Multidisciplinary team meetings encourage overtreatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kantonsspital, CH-5400 Baden, Switzerland	Kantonsspital Aarau AG (KSA)	Eigenmann, F (corresponding author), Kantonsspital, CH-5400 Baden, Switzerland.	franz.eigenmann@ksb.ch						El Saghir Nagi S, 2014, Am Soc Clin Oncol Educ Book, pe461, DOI 10.14694/EdBook_AM.2014.34.e461; Freeman RK, 2010, EUR J CARDIO-THORAC, V38, P1, DOI 10.1016/j.ejcts.2010.01.051; Keating NL, 2013, JNCI-J NATL CANCER I, V105, P113, DOI 10.1093/jnci/djs502; MOSCOVIC.S, 1969, J PERS SOC PSYCHOL, V12, P125, DOI 10.1037/h0027568; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083, DOI 10.6004/jnccn.2014.0106	6	8	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2015	351								h4630	10.1136/bmj.h4630	http://dx.doi.org/10.1136/bmj.h4630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9MB	26378062				2022-12-28	WOS:000361678800006
J	McDougall, L; Sharma, A; Franz-Vasdeki, J; Beattie, AE; Toure, K; Afsana, K; Boldosser-Boesch, A; Dare, L; Draganus, F; Eardley, K; Ruiz, CG; Gronseth, L; Iversen, K; Kuruvilla, S; Marshall, A; McCallon, B; Papp, S				McDougall, Lori; Sharma, Anita; Franz-Vasdeki, Jennifer; Beattie, Allison Eva; Toure, Kadidiatou; Afsana, Kaosar; Boldosser-Boesch, Amy; Dare, Lola; Draganus, Flavia; Eardley, Kate; Garcia Ruiz, Cecilia; Gronseth, Lars; Iversen, Katja; Kuruvilla, Shyama; Marshall, Allison; McCallon, Betsy; Papp, Susan			Prioritising women's, children's, and adolescents' health in the post-2015 world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBAL HEALTH		[McDougall, Lori] WHO, Partnership Maternal Newborn & Child Hlth, Policy & Advocacy, CH-1211 Geneva 27, Switzerland; [Franz-Vasdeki, Jennifer; Beattie, Allison Eva; Toure, Kadidiatou] WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland; [Sharma, Anita] UN Fdn, Millennium Dev Goals Initiat, Washington, DC 20006 USA; [Afsana, Kaosar] BRAC, Hlth Nutr & Populat, Dhaka, Bangladesh; [Boldosser-Boesch, Amy] Family Care Int, New York, NY 10006 USA; [Dare, Lola] CHESTRAD Int, Ibadan, Nigeria; [Draganus, Flavia] UN Fdn, Every Woman Every Child, Geneva, Switzerland; [Eardley, Kate] World Vis Int, Uxbridge UB11 1FG, Middx, England; [Garcia Ruiz, Cecilia] Espolea, Gender Programmes, Mexico City, DF, Mexico; [Gronseth, Lars] Norad, Global Hlth Educ & Res, Oslo, Norway; [Iversen, Katja] Women Deliver, New York, NY 10012 USA; [Papp, Susan] Women Deliver, Policy & Advocacy, New York, NY 10012 USA; [Kuruvilla, Shyama] WHO, Family Womens & Childrens Hlth, Geneva, Switzerland; [Marshall, Allison] Int Planned Parenthood Federat, London SE1 3UZ, England; [McCallon, Betsy] White Ribbon Alliance, Washington, DC 20036 USA	World Health Organization; World Health Organization; Bangladesh Rural Advancement Committee BRAC; World Health Organization	McDougall, L (corresponding author), WHO, Partnership Maternal Newborn & Child Hlth, Policy & Advocacy, CH-1211 Geneva 27, Switzerland.	mcdougalll@who.int		Kuruvilla, Shyama/0000-0002-0327-4467; McDougall, Lori/0000-0002-1885-5344; Afsana, Kaosar/0000-0002-5197-8151; Iversen, Kasper/0000-0003-0504-8487				Abroms LC, 2008, ANNU REV PUBL HEALTH, V29, P219, DOI 10.1146/annurev.publhealth.29.020907.090824; Government of Canada, MUSK IN BACKGR; Harvard Family Research Project, GUID MEAS ADV POL; Papp SA, 2013, GLOB PUBLIC HEALTH, V8, P449, DOI 10.1080/17441692.2012.748085; Partnership for Maternal Newborn & Child Health, 2013, PMNCH 2013 REP AN PR; Partnership for Maternal Newborn & Child Health, CONS UPD GLOB STRAT; Partnership for Maternal Newborn & Child Health, PMNCH 2014 REP TRACK; Partnership for Maternal Newborn & Child Health, 2013, STRENGTH NAT ADV COA; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman J, 2009, B WORLD HEALTH ORGAN, V87, P608, DOI 10.2471/BLT.08.060749; The partnership for Maternal Newborn & Child Health WHO The World Bank Alliance for Health Policy and Systems Research, 2014, SUCC FACT WOM CHILDR; United Nations, GLOB STRAT LAUNCH UN; United Nations, SAV LIV PROT FUT PRO; World Bank, 2014, DEV PARTN SUPP CREAT; World Bank, 2015, GOLB FIN FAC SUPP EV	16	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4327					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371226	hybrid			2022-12-28	WOS:000361678200014
J	Beasley, R; Semprini, A; Mitchell, EA				Beasley, Richard; Semprini, Alex; Mitchell, Edwin A.			Risk factors for asthma: is prevention possible?	LANCET			English	Article							NEWLY-DIAGNOSED ASTHMA; ALLERGIC SENSITIZATION; LUNG-FUNCTION; BRONCHIAL HYPERREACTIVITY; INHALED CORTICOSTEROIDS; ATOPIC SENSITIZATION; CONTROLLED-TRIAL; ONSET ASTHMA; CHILDREN; CHILDHOOD	Asthma is one of the most common diseases in the world, resulting in a substantial burden of disease. Although rates of deaths due to asthma worldwide have reduced greatly over the past 25 years, no available therapeutic regimens can cure asthma, and the burden of asthma will continue to be driven by increasing prevalence. The reasons for the increase in asthma prevalence have not been defined, which limits the opportunities to develop targeted primary prevention measures. Although associations are reported between a wide range of risk factors and childhood asthma, substantiation of causality is inherently difficult from observational studies, and few risk factors have been assessed in primary prevention studies. Furthermore, none of the primary prevention intervention strategies that have undergone scrutiny in randomised controlled trials has provided sufficient evidence to lead to widespread implementation in clinical practice. A better understanding of the factors that cause asthma is urgently needed, and this knowledge could be used to develop public health and pharmacological primary prevention measures that are effective in reducing the prevalence of asthma worldwide. To achieve this it will be necessary to think outside the box, not only in terms of risk factors for the causation of asthma, but also the types of novel primary prevention strategies that are developed, and the research methods used to provide the evidence base for their implementation. In the interim, public health efforts should remain focused on measures with the potential to improve lung and general health, such as: reducing tobacco smoking and environmental tobacco smoke exposure; reducing indoor and outdoor air pollution and occupational exposures; reducing childhood obesity and encouraging a diet high in vegetables and fruit; improving feto-maternal health; encouraging breastfeeding; promoting childhood vaccinations; and reducing social inequalities.	[Beasley, Richard; Semprini, Alex] Med Res Inst New Zealand, Wellington 6242, New Zealand; [Mitchell, Edwin A.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland 1, New Zealand	Medical Research Institute Of New Zealand; University of Auckland	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6242, New Zealand.	Richard.Beasley@mrinz.ac.nz	Semprini, Alex/AAX-1214-2021; Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X; Semprini, Alex/0000-0003-0949-0555				Aligne CA, 2000, AM J RESP CRIT CARE, V162, P873; Anderson GP, 2010, RESPIROLOGY, V15, P902, DOI 10.1111/j.1440-1843.2010.01820.x; Anderson HR, 2010, OCCUP ENVIRON MED, V67, P293, DOI 10.1136/oem.2009.048785; [Anonymous], 2004, GLOBAL BURDEN ASTHMA; Azad MB, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6471; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barr RG, 2007, AM J RESP CRIT CARE, V175, P120, DOI 10.1164/rccm.200603-411OC; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Boulet LP, 2011, EXPERT REV RESP MED, V5, P377, DOI [10.1586/ERS.11.34, 10.1586/ers.11.34]; Brunekreef B, 2012, EPIDEMIOLOGY, V23, P742, DOI 10.1097/EDE.0b013e318261f040; Brunekreef B, 2009, ENVIRON HEALTH PERSP, V117, P1791, DOI 10.1289/ehp.0800467; Chiu YHM, 2012, AM J RESP CRIT CARE, V186, P147, DOI 10.1164/rccm.201201-0162OC; Crider KS, 2013, AM J CLIN NUTR, V98, P1272, DOI 10.3945/ajcn.113.065623; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; D'Vaz N, 2012, PEDIATRICS, V130, P674, DOI 10.1542/peds.2011-3104; de Groot EP, 2010, EUR RESPIR J, V36, P671, DOI 10.1183/09031936.00185709; Dick S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003827; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Farquhar H, 2009, J ALLERGY CLIN IMMUN, V124, P649, DOI 10.1016/j.jaci.2009.07.037; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Gehring U, 2008, CLIN EXP ALLERGY, V38, P1911, DOI 10.1111/j.1365-2222.2008.03087.x; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Genuneit J, 2012, PEDIAT ALLERG IMM-UK, V23, P509, DOI 10.1111/j.1399-3038.2012.01312.x; Gilliland FD, 2006, AM J RESP CRIT CARE, V174, P1092, DOI 10.1164/rccm.200605-722OC; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Guerra S, 2008, ANNU REV MED, V59, P327, DOI 10.1146/annurev.med.59.060406.213232; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Holt PG, 2013, J ALLERGY CLIN IMMUN, V132, P991, DOI 10.1016/j.jaci.2013.04.049; International Labour Office, 2013, MARK PROGR CHILD LAB; Jackson Daniel J, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS139, DOI 10.1513/AnnalsATS.201312-448LD; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010909.pub2; Klemens CM, 2011, BJOG-INT J OBSTET GY, V118, P916, DOI 10.1111/j.1471-0528.2010.02846.x; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; Kramer MS, 2007, BMJ-BRIT MED J, V335, P815, DOI 10.1136/bmj.39304.464016.AE; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; LILJA G, 1989, CLIN EXP ALLERGY, V19, P473, DOI 10.1111/j.1365-2222.1989.tb02416.x; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Maas T, 2009, COCHRANE DB SYST REV, V5; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020; McEvoy CT, 2014, JAMA-J AM MED ASSOC, V311, P2074, DOI 10.1001/jama.2014.5217; McKeever TM, 2004, AM J RESP CRIT CARE, V170, P725, DOI 10.1164/rccm.200405-611PP; Melgert BN, 2007, CURR ALLERGY ASTHM R, V7, P143, DOI 10.1007/s11882-007-0012-4; Mitchell EA, 2013, CLIN EXP ALLERGY, V43, P73, DOI 10.1111/cea.12024; MITCHELL EA, 1989, THORAX, V44, P81, DOI 10.1136/thx.44.2.81; Mitchell EA, 2012, THORAX, V67, P941, DOI 10.1136/thoraxjnl-2011-200901; Nagel G, 2009, EUR RESPIR J, V33, P993, DOI 10.1183/09031936.00075708; Nagel G, 2012, PEDIAT ALLERG IMM-UK, V23, P737, DOI 10.1111/pai.12007; Nagel G, 2010, THORAX, V65, P516, DOI 10.1136/thx.2009.128256; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006475.pub2; Osborn DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub3; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; Penders J, 2011, EUR RESPIR J, V38, P295, DOI 10.1183/09031936.00105010; Rantala A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027912; Razi CH, 2010, J ALLERGY CLIN IMMUN, V126, P763, DOI 10.1016/j.jaci.2010.07.038; Robinson CL, 2011, THORAX, V66, P1051, DOI 10.1136/thx.2011.158956; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; Simpson A, 2009, CURR ALLERGY ASTHM R, V9, P363, DOI 10.1007/s11882-009-0053-y; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; Strachan DP, 2015, CLIN EXP ALLERGY, V45, P126, DOI 10.1111/cea.12349; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Toelle BG, 2013, J ALLERGY CLIN IMMUN, V132, P1220, DOI 10.1016/j.jaci.2013.06.005; van Schayck OCP, 2007, J ALLERGY CLIN IMMUN, V119, P1323, DOI 10.1016/j.jaci.2007.02.024; Varghese J., OM 85 PREVENTION AST; VATHENEN AS, 1988, LANCET, V1, P554; von Berg A, 2007, J ALLERGY CLIN IMMUN, V119, P718, DOI 10.1016/j.jaci.2006.11.017; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Warner JO, 2001, J ALLERGY CLIN IMMUN, V108, P929, DOI 10.1067/mai.2001.120015; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; Weinmayr G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113996; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wong GWK, 2013, LANCET RESP MED, V1, P386, DOI 10.1016/S2213-2600(13)70073-0; Woodcock A, 2004, AM J RESP CRIT CARE, V170, P433, DOI 10.1164/rccm.200401-083OC; World Health Organization, 2012, BURD DIS AMB HOUS AI; Yoshihara S, 2009, PEDIAT ALLERG IMM-UK, V20, P486, DOI 10.1111/j.1399-3038.2008.00807.x	94	294	302	6	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1075	1085		10.1016/S0140-6736(15)00156-7	http://dx.doi.org/10.1016/S0140-6736(15)00156-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26382999				2022-12-28	WOS:000361189200028
J	Watts, G				Watts, Geoff			Donald Lloyd Rasmussen Obituary	LANCET			English	Biographical-Item																		RASMUSSEN DL, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1034	1034		10.1016/S0140-6736(15)00162-2	http://dx.doi.org/10.1016/S0140-6736(15)00162-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26382986				2022-12-28	WOS:000361189200012
J	Snyder, A				Snyder, Alison			Jules Hirsch Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					950	950		10.1016/S0140-6736(15)00112-9	http://dx.doi.org/10.1016/S0140-6736(15)00112-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369463	Bronze			2022-12-28	WOS:000361182700017
J	Forouzanfar, MH; Alexander, L; Anderson, HR; Bachman, VF; Biryukov, S; Brauer, M; Burnett, R; Casey, D; Coates, MM; Cohen, A; Delwiche, K; Estep, K; Frostad, JJ; Astha, KC; Kyu, HH; Moradi-Lakeh, M; Ng, M; Slepak, EL; Thomas, BA; Wagner, J; Aasvang, GM; Abbafati, C; Ozgoren, AA; Abd-Allah, F; Abera, SF; Aboyans, V; Abraham, B; Abraham, JP; Abubakar, I; Abu-Rmeileh, NME; Aburto, TC; Achoki, T; Adelekan, A; Adofo, K; Adou, AK; Adsuar, JC; Afshin, A; Agardh, EE; Al Khabouri, MJ; Al Lami, FH; Alam, SS; Alasfoor, D; Albittar, MI; Alegretti, MA; Aleman, AV; Alemu, ZA; Alfonso-Cristancho, R; Alhabib, S; Ali, R; Ali, MK; Alla, F; Allebeck, P; Allen, PJ; Alsharif, U; Alvarez, E; Alvis-Guzman, N; Amankwaa, AA; Amare, AT; Ameh, EA; Ameli, O; Amini, H; Ammar, W; Anderson, BO; Antonio, CAT; Anwari, P; Cunningham, SA; Arnlov, J; Arsenijevic, VSA; Artaman, A; Asghar, RJ; Assadi, R; Atkins, LS; Atkinson, C; Avila, MA; Awuah, B; Badawi, A; Bahit, MC; Bakfalouni, T; Balakrishnan, K; Balalla, S; Balu, RK; Banerjee, A; Barber, RM; Barker-Collo, SL; Barquera, S; Barregard, L; Barrero, LH; Barrientos-Gutierrez, T; Basto-Abreu, AC; Basu, A; Basu, S; Basulaiman, MO; Ruvalcaba, CB; Beardsley, J; Bedi, N; Bekele, T; Bell, ML; Benjet, C; Bennett, DA; Benzian, H; Bernabe, E; Beyene, TJ; Bhala, N; Bhalla, A; Bhutta, ZQA; Bikbov, B; Bin Abdulhak, AA; Blore, JD; Blyth, FM; Bohensky, MA; Basara, BB; Borges, G; Bornstein, NM; Bose, D; Boufous, S; Bourne, RR; Brainin, M; Brazinova, A; Breitborde, NJ; Brenner, H; Briggs, ADM; Broday, DM; Brooks, PM; Bruce, NG; Brugha, TS; Brunekreef, B; Buchbinder, R; Bui, LN; Bukhman, G; Bulloch, AG; Burch, M; Burney, PGJ; Campos-Nonato, IR; Campuzano, JC; Cantoral, AJ; Caravanos, J; Cardenas, R; Cardis, E; Carpenter, DO; Caso, V; Castaneda-Orjuela, CA; Castro, RE; Catala-Lopez, F; Cavalleri, F; Cavlin, A; Chadha, VK; Chang, JC; Charlson, FJ; Chen, HL; Chen, WQ; Chen, ZM; Chiang, PP; Chimed-Ochir, O; Chowdhury, R; Christophi, CA; Chuang, TW; Chugh, SS; Cirillo, M; Classen, TKD; Colistro, V; Colomar, M; Colquhoun, SM; Contreras, AG; Cooper, C; Cooperrider, K; Cooper, LT; Coresh, J; Courville, KJ; Criqui, MH; Cuevas-Nasu, L; Damsere-Derry, J; Danawi, H; Dandona, L; Dandona, R; Dargan, PI; Davis, A; Davitoiu, DV; Dayama, A; de Castro, EF; De la Cruz-Gongora, V; De Leo, D; de Lima, G; Degenhardt, L; del Pozo-Cruz, B; Dellavalle, RP; Deribe, K; Derrett, S; Jarlais, DCD; Dessalegn, M; deVeber, GA; Devries, KM; Dharmaratne, SD; Dherani, MK; Dicker, D; Ding, EL; Dokova, K; Dorsey, ER; Driscoll, TR; Duan, L; Durrani, AM; Ebel, BE; Ellenbogen, RG; Elshrek, YM; Endres, M; Ermakov, SP; Erskine, HE; Eshrati, B; Esteghamati, A; Fahimi, S; Faraon, EJA; Farzadfar, F; Fay, DFJ; Feigin, VL; Feigl, AB; Fereshtehnejad, SM; Ferrari, AJ; Ferri, CP; Flaxman, AD; Fleming, TD; Foigt, N; Foreman, KJ; Paleo, UF; Franklin, RC; Gabbe, B; Gaffikin, L; Gakidou, E; Gamkrelidze, A; Gankpe, FG; Gansevoort, RT; Garcia-Guerra, FA; Gasana, E; Geleijnse, JM; Gessner, BD; Gething, P; Gibney, KB; Gillum, RF; Ginawi, IAM; Giroud, M; Giussani, G; Goenka, S; Goginashvili, K; Dantes, HG; Gona, P; de Cosio, TG; Gonzalez-Castell, D; Gotay, CC; Goto, A; Gouda, HN; Guerrant, RL; Gugnani, HC; Guillemin, F; Gunnell, D; Gupta, R; Gupta, R; Gutierrez, RA; Hafezi-Nejad, N; Hagan, H; Hagstromer, M; Halasa, YA; Hamadeh, RR; Hammami, M; Hankey, GJ; Hao, YT; Harb, HL; Haregu, TN; Haro, JM; Havmoeller, R; Hay, SI; Hedayati, MT; Heredia-Pi, IB; Hernandez, L; Heuton, KR; Heydarpour, P; Hijar, M; Hoek, HW; Man, HJH; Hornberger, JC; Hosgood, HD; Hoy, DG; Hsairi, M; Hu, GQ; Hu, H; Huang, C; Huang, JJ; Hubbell, BJ; Huiart, L; Husseini, A; Iannarone, ML; Iburg, KM; Idrisov, BT; Ikeda, N; Innos, K; Inoue, M; Islami, F; Ismayilova, S; Jacobsen, KH; Jansen, HA; Jarvis, DL; Jassal, SK; Jauregui, A; Jayaraman, S; Jeemon, P; Jensen, PN; Jha, V; Jiang, F; Jiang, GH; Jiang, Y; Jonas, JB; Juel, K; Kan, HD; Roseline, SSK; Karam, NE; Karch, A; Karema, CK; Karthikeyan, G; Kaul, A; Kawakami, N; Kazi, DS; Kemp, AH; Kengne, AP; Keren, A; Khader, YS; Khalifa, SEAH; Khan, EA; Khang, YH; Khatibzadeh, S; Khonelidze, I; Kieling, C; Kim, D; Kim, S; Kim, Y; Kimokoti, RW; Kinfu, Y; Kinge, JM; Kissela, BM; Kivipelto, M; Knibbs, LD; Knudsen, AK; Kokubo, Y; Kose, MR; Kosen, S; Kraemer, A; Kravchenko, M; Krishnaswami, S; Kromhout, H; Ku, T; Defo, BK; Bicer, BK; Kuipers, EJ; Kulkarni, C; Kulkarni, VS; Kumar, GA; Kwan, GF; Lai, T; Balaji, AL; Lalloo, R; Lallukka, T; Lam, H; Lan, Q; Lansingh, VC; Larson, HJ; Larsson, A; Laryea, DO; Lavados, PM; Lawrynowicz, AE; Leasher, JL; Lee, JT; Leigh, J; Leung, R; Levi, M; Li, Y; Li, Y; Liang, J; Liang, XF; Lim, SS; Lindsay, MP; Lipshultz, SE; Liu, SW; Liu, Y; Lloyd, BK; Logroscino, G; London, SJ; Lopez, N; Lortet-Tieulent, J; Lotufo, PA; Lozano, R; Lunevicius, R; Ma, JX; Ma, S; Machado, VMP; MacIntyre, MF; Magis-Rodriguez, C; Mahdi, AA; Majdan, M; Malekzadeh, R; Mangalam, S; Mapoma, CC; Marape, M; Marcenes, W; Margolis, DJ; Margono, C; Marks, GB; Martin, RV; Marzan, MB; Mashal, MT; Masiye, F; Mason-Jones, AJ; Matsushita, K; Matzopoulos, R; Mayosi, BM; Mazorodze, TT; Mckay, AC; Mckee, M; McLain, A; Meaney, PA; Medina, C; Mehndiratta, MM; Mejia-Rodriguez, F; Mekonnen, W; Melaku, YA; Meltzer, M; Memish, ZA; Mendoza, W; Mensah, GA; Meretoja, A; Mhimbira, FA; Micha, R; Miller, TR; Mills, EJ; Misganaw, A; Mishra, S; Ibrahim, NM; Mohammad, KA; Mokdad, AH; Mola, GL; Monasta, L; Hernandez, JCM; Montico, M; Moore, AR; Morawska, L; Mori, R; Moschandreas, J; Moturi, WN; Arian, DM; Mueller, UO; Mukaigawara, M; Mullany, EC; Murthy, KS; Naghavi, M; Nahas, Z; Naheed, A; Naidoo, KS; Naldi, L; Nand, D; Nangia, V; Narayan, KMV; Nash, D; Neal, B; Nejjari, C; Neupane, SP; Newton, CR; Ngalesoni, FN; Ngirabega, JD; Nguyen, G; Nguyen, NT; Nieuwenhuijsen, MJ; Nisar, MI; Nogueira, JR; Nolla, JM; Nolte, S; Norheim, OF; Norman, RE; Norrving, B; Nyakarahuka, L; Oh, IH; Ohkubo, T; Olusanya, BO; Omer, SB; Opio, JN; Orozco, R; Pagcatipunan, RS; Pain, AW; Pandian, JD; Panelo, CIA; Papachristou, C; Park, EK; Parry, CD; Caicedo, AJP; Patten, SB; Paul, VK; Pavlin, BI; Pearce, N; Pedraza, LS; Pedroza, A; Stokic, LP; Pekericli, A; Pereira, DM; Perez-Padilla, R; Perez-Ruiz, F; Perico, N; Perry, SAL; Pervaiz, A; Pesudovs, K; Peterson, CB; Petzold, M; Phillips, MR; Phua, HP; Plass, D; Poenaru, D; Polanczyk, GV; Polinder, S; Pond, CD; Pope, CA; Pope, D; Popova, S; Pourmalek, F; Powles, J; Prabhakaran, D; Prasad, NM; Qato, DM; Quezada, AD; Quistberg, DAA; Racape, L; Rafay, A; Rahimi, K; Rahimi-Movaghar, V; Rahman, SU; Raju, M; Rakovac, I; Rana, SM; Rao, M; Razavi, H; Reddy, KS; Refaat, AH; Rehm, J; Remuzzi, G; Ribeiro, AL; Riccio, PM; Richardson, L; Riederer, A; Robinson, M; Roca, A; Rodriguez, A; Rojas-Rueda, D; Romieu, I; Ronfani, L; Room, R; Roy, N; Ruhago, GM; Rushton, L; Sabin, N; Sacco, RL; Saha, S; Sahathevan, R; Sahraian, MA; Salomon, JA; Salvo, D; Sampson, UK; Sanabria, JR; Sanchez, LM; Sanchez-Pimienta, TG; Sanchez-Riera, L; Sandar, L; Santos, IS; Sapkota, A; Satpathy, M; Saunders, JE; Sawhney, M; Saylan, MI; Scarborough, P; Schmidt, JC; Schneider, IJC; Schottker, B; Schwebel, DC; Scott, JG; Seedat, S; Sepanlou, SG; Serdar, B; Servan-Mori, EE; Shaddick, G; Shahraz, S; Levy, TS; Shangguan, S; She, J; Sheikhbahaei, S; Shibuya, K; Shin, HH; Shinohara, Y; Shiri, R; Shishani, K; Shiue, I; Sigfusdottir, ID; Silberberg, DH; Simard, EP; Sindi, S; Singh, A; Singh, GM; Singh, JA; Skirbekk, V; Sliwa, K; Soljak, M; Soneji, S; Soreide, K; Soshnikov, S; Sposato, LA; Sreeramareddy, CT; Stapelberg, NJC; Stathopoulou, V; Steckling, N; Stein, DJ; Stein, MB; Stephens, N; Stockl, H; Straif, K; Stroumpoulis, K; Sturua, L; Sunguya, BF; Swaminathan, S; Swaroop, M; Sykes, BL; Tabb, KM; Takahashi, K; Talongwa, RT; Tandon, N; Tanne, D; Tanner, M; Tavakkoli, M; Ao, BJT; Teixeira, CM; Rojo, MMT; Terkawi, AS; Texcalac-Sangrador, JL; Thackway, SV; Thomson, B; Thorne-Lyman, AL; Thrift, AG; Thurston, GD; Tillmann, T; Tobollik, M; Tonelli, M; Topouzis, F; Towbin, JRA; Toyoshima, H; Traebert, JE; Tran, BX; Trasande, L; Trillini, M; Trujillo, U; Dimbuene, ZT; Tsilimbaris, M; Tuzcu, EM; Uchendu, US; Ukwaja, KN; Uzun, SB; van de Vijver, S; Van Dingenen, R; Van Gool, CH; Van Os, J; Varakin, YY; Vasankari, TJ; Vasconcelos, AMN; Vavilala, MS; Veerman, LJ; Velasquez-Melendez, G; Venketasubramanian, N; Vijayakumar, L; Villalpando, S; Violante, FS; Vlassov, VV; Vollset, SE; Wagner, GR; Waller, SG; Wallin, MT; Wan, X; Wang, HD; Wang, JL; Wang, LH; Wang, WZ; Wang, YP; Warouw, TS; Watts, CH; Weichenthal, S; Weiderpass, E; Weintraub, RG; Werdecker, A; Wessells, KR; Westerman, R; Whiteford, HA; Wilkinson, JD; Williams, HC; Williams, TN; Woldeyohannes, SM; Wolfe, CDA; Wong, JQ; Woolf, AD; Wright, JL; Wurtz, B; Xu, G; Yan, LJL; Yang, GH; Yano, Y; Ye, PP; Yenesew, M; Yentur, GK; Yip, P; Yonemoto, N; Yoon, SJ; Younis, MZ; Younoussi, Z; Yu, CH; Zaki, ME; Zhao, Y; Zheng, YF; Zhou, MG; Zhu, J; Zhu, SK; Zou, XN; Zunt, JR; Lopez, AD; Vos, T; Murray, CJ				Forouzanfar, Mohammad H.; Alexander, Lily; Anderson, H. Ross; Bachman, Victoria F.; Biryukov, Stan; Brauer, Michael; Burnett, Richard; Casey, Daniel; Coates, Matthew M.; Cohen, Aaron; Delwiche, Kristen; Estep, Kara; Frostad, Joseph J.; Astha, K. C.; Kyu, Hmwe H.; Moradi-Lakeh, Maziar; Ng, Marie; Slepak, Erica Leigh; Thomas, Bernadette A.; Wagner, Joseph; Aasvang, Gunn Marit; Abbafati, Cristiana; Ozgoren, Ayse Abbasoglu; Abd-Allah, Foad; Abera, Semaw F.; Aboyans, Victor; Abraham, Biju; Abraham, Jerry Puthenpurakal; Abubakar, Ibrahim; Abu-Rmeileh, Niveen M. E.; Aburto, Tania C.; Achoki, Tom; Adelekan, Ademola; Adofo, Koranteng; Adou, Arsene K.; Adsuar, Jose C.; Afshin, Ashkan; Agardh, Emilie E.; Al Khabouri, Mazin J.; Al Lami, Faris H.; Alam, Sayed Saidul; Alasfoor, Deena; Albittar, Mohammed I.; Alegretti, Miguel A.; Aleman, Alicia V.; Alemu, Zewdie A.; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Raghib; Ali, Mohammed K.; Alla, Francois; Allebeck, Peter; Allen, Peter J.; Alsharif, Ubai; Alvarez, Elena; Alvis-Guzman, Nelson; Amankwaa, Adansi A.; Amare, Azmeraw T.; Ameh, Emmanuel A.; Ameli, Omid; Amini, Heresh; Ammar, Walid; Anderson, Benjamin O.; Antonio, Carl Abelardo T.; Anwari, Palwasha; Cunningham, Solveig Argeseanu; Arnlov, Johan; Arsenijevic, Valentina S. Arsic; Artaman, Al; Asghar, Rana J.; Assadi, Reza; Atkins, Lydia S.; Atkinson, Charles; Avila, Marco A.; Awuah, Baffour; Badawi, Alaa; Bahit, Maria C.; Bakfalouni, Talal; Balakrishnan, Kalpana; Balalla, Shivanthi; Balu, Ravi Kumar; Banerjee, Amitava; Barber, Ryan M.; Barker-Collo, Suzanne L.; Barquera, Simon; Barregard, Lars; Barrero, Lope H.; Barrientos-Gutierrez, Tonatiuh; Basto-Abreu, Ana C.; Basu, Arindam; Basu, Sanjay; Basulaiman, Mohammed O.; Ruvalcaba, Carolina Batis; Beardsley, Justin; Bedi, Neeraj; Bekele, Tolesa; Bell, Michelle L.; Benjet, Corina; Bennett, Derrick A.; Benzian, Habib; Bernabe, Eduardo; Beyene, Tariku J.; Bhala, Neeraj; Bhalla, Ashish; Bhutta, Zulfi Qar A.; Bikbov, Boris; Bin Abdulhak, Aref A.; Blore, Jed D.; Blyth, Fiona M.; Bohensky, Megan A.; Basara, Berrak Bora; Borges, Guilherme; Bornstein, Natan M.; Bose, Dipan; Boufous, Soufiane; Bourne, Rupert R.; Brainin, Michael; Brazinova, Alexandra; Breitborde, Nicholas J.; Brenner, Hermann; Briggs, Adam D. M.; Broday, David M.; Brooks, Peter M.; Bruce, Nigel G.; Brugha, Traolach S.; Brunekreef, Bert; Buchbinder, Rachelle; Bui, Linh N.; Bukhman, Gene; Bulloch, Andrew G.; Burch, Michael; Burney, Peter G. J.; Campos-Nonato, Ismael R.; Campuzano, Julio C.; Cantoral, Alejandra J.; Caravanos, Jack; Cardenas, Rosario; Cardis, Elisabeth; Carpenter, David O.; Caso, Valeria; Castaneda-Orjuela, Carlos A.; Castro, Ruben E.; Catala-Lopez, Ferran; Cavalleri, Fiorella; Cavlin, Alanur; Chadha, Vineet K.; Chang, Jung-chen; Charlson, Fiona J.; Chen, Honglei; Chen, Wanqing; Chen, Zhengming; Chiang, Peggy P.; Chimed-Ochir, Odgerel; Chowdhury, Rajiv; Christophi, Costas A.; Chuang, Ting-Wu; Chugh, Sumeet S.; Cirillo, Massimo; Classen, Thomas K. D.; Colistro, Valentina; Colomar, Mercedes; Colquhoun, Samantha M.; Contreras, Alejandra G.; Cooper, Cyrus; Cooperrider, Kimberly; Cooper, Leslie T.; Coresh, Josef; Courville, Karen J.; Criqui, Michael H.; Cuevas-Nasu, Lucia; Damsere-Derry, James; Danawi, Hadi; Dandona, Lalit; Dandona, Rakhi; Dargan, Paul I.; Davis, Adrian; Davitoiu, Dragos V.; Dayama, Anand; de Castro, E. Filipa; De la Cruz-Gongora, Vanessa; De Leo, Diego; de Lima, Graca; Degenhardt, Louisa; del Pozo-Cruz, Borja; Dellavalle, Robert P.; Deribe, Kebede; Derrett, Sarah; Jarlais, Don C. Des; Dessalegn, Muluken; deVeber, Gabrielle A.; Devries, Karen M.; Dharmaratne, Samath D.; Dherani, Mukesh K.; Dicker, Daniel; Ding, Eric L.; Dokova, Klara; Dorsey, E. Ray; Driscoll, Tim R.; Duan, Leilei; Durrani, Adnan M.; Ebel, Beth E.; Ellenbogen, Richard G.; Elshrek, Yousef M.; Endres, Matthias; Ermakov, Sergey P.; Erskine, Holly E.; Eshrati, Babak; Esteghamati, Alireza; Fahimi, Saman; Faraon, Emerito Jose A.; Farzadfar, Farshad; Fay, Derek F. J.; Feigin, Valery L.; Feigl, Andrea B.; Fereshtehnejad, Seyed-Mohammad; Ferrari, Alize J.; Ferri, Cleusa P.; Flaxman, Abraham D.; Fleming, Thomas D.; Foigt, Nataliya; Foreman, Kyle J.; Paleo, Urbano Fra; Franklin, Richard C.; Gabbe, Belinda; Gaffikin, Lynne; Gakidou, Emmanuela; Gamkrelidze, Amiran; Gankpe, Fortune G.; Gansevoort, Ron T.; Garcia-Guerra, Francisco A.; Gasana, Evariste; Geleijnse, Johanna M.; Gessner, Bradford D.; Gething, Pete; Gibney, Katherine B.; Gillum, Richard F.; Ginawi, Ibrahim A. M.; Giroud, Maurice; Giussani, Giorgia; Goenka, Shifalika; Goginashvili, Ketevan; Dantes, Hector Gomez; Gona, Philimon; de Cosio, Teresita Gonzalez; Gonzalez-Castell, Dinorah; Gotay, Carolyn C.; Goto, Atsushi; Gouda, Hebe N.; Guerrant, Richard L.; Gugnani, Harish C.; Guillemin, Francis; Gunnell, David; Gupta, Rahul; Gupta, Rajeev; Gutierrez, Reyna A.; Hafezi-Nejad, Nima; Hagan, Holly; Hagstromer, Maria; Halasa, Yara A.; Hamadeh, Randah R.; Hammami, Mouhanad; Hankey, Graeme J.; Hao, Yuantao; Harb, Hilda L.; Haregu, Tilahun Nigatu; Haro, Josep Maria; Havmoeller, Rasmus; Hay, Simon I.; Hedayati, Mohammad T.; Heredia-Pi, Ileana B.; Hernandez, Lucia; Heuton, Kyle R.; Heydarpour, Pouria; Hijar, Martha; Hoek, Hans W.; Man, Howard J. Hoff; Hornberger, John C.; Hosgood, H. Dean; Hoy, Damian G.; Hsairi, Mohamed; Hu, Guoqing; Hu, Howard; Huang, Cheng; Huang, John J.; Hubbell, Bryan J.; Huiart, Laetitia; Husseini, Abdullatif; Iannarone, Marissa L.; Iburg, Kim M.; Idrisov, Bulat T.; Ikeda, Nayu; Innos, Kaire; Inoue, Manami; Islami, Farhad; Ismayilova, Samaya; Jacobsen, Kathryn H.; Jansen, Henrica A.; Jarvis, Deborah L.; Jassal, Simerjot K.; Jauregui, Alejandra; Jayaraman, Sudha; Jeemon, Panniyammakal; Jensen, Paul N.; Jha, Vivekanand; Jiang, Fan; Jiang, Guohong; Jiang, Ying; Jonas, Jost B.; Juel, Knud; Kan, Haidong; Roseline, Sidibe S. Kany; Karam, Nadim E.; Karch, Andre; Karema, Corine K.; Karthikeyan, Ganesan; Kaul, Anil; Kawakami, Norito; Kazi, Dhruv S.; Kemp, Andrew H.; Kengne, Andre P.; Keren, Andre; Khader, Yousef S.; Khalifa, Shams Eldin Ali Hassan; Khan, Ejaz A.; Khang, Young-Ho; Khatibzadeh, Shahab; Khonelidze, Irma; Kieling, Christian; Kim, Daniel; Kim, Sungroul; Kim, Yunjin; Kimokoti, Ruth W.; Kinfu, Yohannes; Kinge, Jonas M.; Kissela, Brett M.; Kivipelto, Miia; Knibbs, Luke D.; Knudsen, Ann Kristin; Kokubo, Yoshihiro; Kose, M. Rifat; Kosen, Soewarta; Kraemer, Alexander; Kravchenko, Michael; Krishnaswami, Sanjay; Kromhout, Hans; Ku, Tiffany; Defo, Barthelemy Kuate; Bicer, Burcu Kucuk; Kuipers, Ernst J.; Kulkarni, Chanda; Kulkarni, Veena S.; Kumar, G. Anil; Kwan, Gene F.; Lai, Taavi; Balaji, Arjun Lakshmana; Lalloo, Ratilal; Lallukka, Tea; Lam, Hilton; Lan, Qing; Lansingh, Van C.; Larson, Heidi J.; Larsson, Anders; Laryea, Dennis O.; Lavados, Pablo M.; Lawrynowicz, Alicia E.; Leasher, Janet L.; Lee, Jong-Tae; Leigh, James; Leung, Ricky; Levi, Miriam; Li, Yichong; Li, Yongmei; Liang, Juan; Liang, Xiaofeng; Lim, Stephen S.; Lindsay, M. Patrice; Lipshultz, Steven E.; Liu, Shiwei; Liu, Yang; Lloyd, Belinda K.; Logroscino, Giancarlo; London, Stephanie J.; Lopez, Nancy; Lortet-Tieulent, Joannie; Lotufo, Paulo A.; Lozano, Rafael; Lunevicius, Raimundas; Ma, Jixiang; Ma, Stefan; Machado, Vasco M. P.; MacIntyre, Michael F.; Magis-Rodriguez, Carlos; Mahdi, Abbas A.; Majdan, Marek; Malekzadeh, Reza; Mangalam, Srikanth; Mapoma, Christopher C.; Marape, Marape; Marcenes, Wagner; Margolis, David J.; Margono, Christopher; Marks, Guy B.; Martin, Randall V.; Marzan, Melvin B.; Mashal, Mohammad T.; Masiye, Felix; Mason-Jones, Amanda J.; Matsushita, Kunihiro; Matzopoulos, Richard; Mayosi, Bongani M.; Mazorodze, Tasara T.; Mckay, Abigail C.; Mckee, Martin; McLain, Abigail; Meaney, Peter A.; Medina, Catalina; Mehndiratta, Man Mohan; Mejia-Rodriguez, Fabiola; Mekonnen, Wubegzier; Melaku, Yohannes A.; Meltzer, Michele; Memish, Ziad A.; Mendoza, Walter; Mensah, George A.; Meretoja, Atte; Mhimbira, Francis Apolinary; Micha, Renata; Miller, Ted R.; Mills, Edward J.; Misganaw, Awoke; Mishra, Santosh; Ibrahim, Norlinah Mohamed; Mohammad, Karzan A.; Mokdad, Ali H.; Mola, Glen L.; Monasta, Lorenzo; Hernandez, Julio C. Montaez; Montico, Marcella; Moore, Ami R.; Morawska, Lidia; Mori, Rintaro; Moschandreas, Joanna; Moturi, Wilkister N.; Arian, Dariush Mozaff; Mueller, Ulrich O.; Mukaigawara, Mitsuru; Mullany, Erin C.; Murthy, Kinnari S.; Naghavi, Mohsen; Nahas, Ziad; Naheed, Aliya; Naidoo, Kovin S.; Naldi, Luigi; Nand, Devina; Nangia, Vinay; Narayan, K. M. Venkat; Nash, Denis; Neal, Bruce; Nejjari, Chakib; Neupane, Sudan P.; Newton, Charles R.; Ngalesoni, Frida N.; Ngirabega, Jean de Dieu; Nguyen, Grant; Nguyen, Nhung T.; Nieuwenhuijsen, Mark J.; Nisar, Muhammad I.; Nogueira, Jose R.; Nolla, Joan M.; Nolte, Sandra; Norheim, Ole F.; Norman, Rosana E.; Norrving, Bo; Nyakarahuka, Luke; Oh, In-Hwan; Ohkubo, Takayoshi; Olusanya, Bolajoko O.; Omer, Saad B.; Opio, John Nelson; Orozco, Ricardo; Pagcatipunan, Rodolfo S., Jr.; Pain, Amanda W.; Pandian, Jeyaraj D.; Panelo, Carlo Irwin A.; Papachristou, Christina; Park, Eun-Kee; Parry, Charles D.; Caicedo, Angel J. Paternina; Patten, Scott B.; Paul, Vinod K.; Pavlin, Boris I.; Pearce, Neil; Pedraza, Lilia S.; Pedroza, Andrea; Stokic, Ljiljana Pejin; Pekericli, Ayfer; Pereira, David M.; Perez-Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Perry, Samuel A. L.; Pervaiz, Aslam; Pesudovs, Konrad; Peterson, Carrie B.; Petzold, Max; Phillips, Michael R.; Phua, Hwee Pin; Plass, Dietrich; Poenaru, Dan; Polanczyk, Guilherme V.; Polinder, Suzanne; Pond, Constance D.; Pope, C. Arden; Pope, Daniel; Popova, Svetlana; Pourmalek, Farshad; Powles, John; Prabhakaran, Dorairaj; Prasad, Noela M.; Qato, Dima M.; Quezada, Amado D.; Quistberg, D. Alex A.; Racape, Lionel; Rafay, Anwar; Rahimi, Kazem; Rahimi-Movaghar, Vafa; Rahman, Sajjad Ur; Raju, Murugesan; Rakovac, Ivo; Rana, Saleem M.; Rao, Mayuree; Razavi, Homie; Reddy, K. Srinath; Refaat, Amany H.; Rehm, Juergen; Remuzzi, Giuseppe; Ribeiro, Antonio L.; Riccio, Patricia M.; Richardson, Lee; Riederer, Anne; Robinson, Margaret; Roca, Anna; Rodriguez, Alina; Rojas-Rueda, David; Romieu, Isabelle; Ronfani, Luca; Room, Robin; Roy, Nobhojit; Ruhago, George M.; Rushton, Lesley; Sabin, Nsanzimana; Sacco, Ralph L.; Saha, Sukanta; Sahathevan, Ramesh; Sahraian, Mohammad Ali; Salomon, Joshua A.; Salvo, Deborah; Sampson, Uchechukwu K.; Sanabria, Juan R.; Sanchez, Luz Maria; Sanchez-Pimienta, Tania G.; Sanchez-Riera, Lidia; Sandar, Logan; Santos, Itamar S.; Sapkota, Amir; Satpathy, Maheswar; Saunders, James E.; Sawhney, Monika; Saylan, Mete I.; Scarborough, Peter; Schmidt, Juergen C.; Schneider, Ione J. C.; Schoettker, Ben; Schwebel, David C.; Scott, James G.; Seedat, Soraya; Sepanlou, Sadaf G.; Serdar, Berrin; Servan-Mori, Edson E.; Shaddick, Gavin; Shahraz, Saeid; Levy, Teresa Shamah; Shangguan, Siyi; She, Jun; Sheikhbahaei, Sara; Shibuya, Kenji; Shin, Hwashin H.; Shinohara, Yukito; Shiri, Rahman; Shishani, Kawkab; Shiue, Ivy; Sigfusdottir, Inga D.; Silberberg, Donald H.; Simard, Edgar P.; Sindi, Shireen; Singh, Abhishek; Singh, Gitanjali M.; Singh, Jasvinder A.; Skirbekk, Vegard; Sliwa, Karen; Soljak, Michael; Soneji, Samir; Soreide, Kjetil; Soshnikov, Sergey; Sposato, Luciano A.; Sreeramareddy, Chandrashekhar T.; Stapelberg, Nicolas J. C.; Stathopoulou, Vasiliki; Steckling, Nadine; Stein, Dan J.; Stein, Murray B.; Stephens, Natalie; Stoeckl, Heidi; Straif, Kurt; Stroumpoulis, Konstantinos; Sturua, Lela; Sunguya, Bruno F.; Swaminathan, Soumya; Swaroop, Mamta; Sykes, Bryan L.; Tabb, Karen M.; Takahashi, Ken; Talongwa, Roberto T.; Tandon, Nikhil; Tanne, David; Tanner, Marcel; Tavakkoli, Mohammad; Ao, Braden J. Te; Teixeira, Carolina M.; Rojo, Martha M. Tellez; Terkawi, Abdullah S.; Texcalac-Sangrador, Jose Luis; Thackway, Sarah V.; Thomson, Blake; Thorne-Lyman, Andrew L.; Thrift, Amanda G.; Thurston, George D.; Tillmann, Taavi; Tobollik, Myriam; Tonelli, Marcello; Topouzis, Fotis; Towbin, Jeff Rey A.; Toyoshima, Hideaki; Traebert, Jeff Erson; Tran, Bach X.; Trasande, Leonardo; Trillini, Matias; Trujillo, Ulises; Dimbuene, Zacharie Tsala; Tsilimbaris, Miltiadis; Tuzcu, Emin Murat; Uchendu, Uche S.; Ukwaja, Kingsley N.; Uzun, Selen B.; van de Vijver, Steven; Van Dingenen, Rita; Van Gool, Coen H.; Van Os, Jim; Varakin, Yuri Y.; Vasankari, Tommi J.; Vasconcelos, Ana Maria N.; Vavilala, Monica S.; Veerman, Lennert J.; Velasquez-Melendez, Gustavo; Venketasubramanian, N.; Vijayakumar, Lakshmi; Villalpando, Salvador; Violante, Francesco S.; Vlassov, Vasiliy Victorovich; Vollset, Stein Emil; Wagner, Gregory R.; Waller, Stephen G.; Wallin, Mitchell T.; Wan, Xia; Wang, Haidong; Wang, JianLi; Wang, Linhong; Wang, Wenzhi; Wang, Yanping; Warouw, Tati S.; Watts, Charlotte H.; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Werdecker, Andrea; Wessells, K. Ryan; Westerman, Ronny; Whiteford, Harvey A.; Wilkinson, James D.; Williams, Hywel C.; Williams, Thomas N.; Woldeyohannes, Solomon M.; Wolfe, Charles D. A.; Wong, John Q.; Woolf, Anthony D.; Wright, Jonathan L.; Wurtz, Brittany; Xu, Gelin; Yan, Lijing L.; Yang, Gonghuan; Yano, Yuichiro; Ye, Pengpeng; Yenesew, Muluken; Yentuer, Goekalp K.; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Younis, Mustafa Z.; Younoussi, Zourkaleini; Yu, Chuanhua; Zaki, Maysaa El Sayed; Zhao, Yong; Zheng, Yingfeng; Zhou, Maigeng; Zhu, Jun; Zhu, Shankuan; Zou, Xiaonong; Zunt, Joseph R.; Lopez, Alan D.; Vos, Theo; Murray, Christopher J.		GBD 2013 Risk Factors	Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; FINE PARTICULATE MATTER; ALL-CAUSE MORTALITY; LONG-TERM EXPOSURE; AIR-POLLUTION; TOBACCO SMOKING; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HOUSEHOLD COOKING	Background The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the first of a series of annual updates of the GBD. Risk factor quantification, particularly of modifiable risk factors, can help to identify emerging threats to population health and opportunities for prevention. The GBD 2013 provides a timely opportunity to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate counterfactual risk distribution. Methods Attributable deaths, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) have been estimated for 79 risks or clusters of risks using the GBD 2010 methods. Risk-outcome pairs meeting explicit evidence criteria were assessed for 188 countries for the period 1990-2013 by age and sex using three inputs: risk exposure, relative risks, and the theoretical minimum risk exposure level (TMREL). Risks are organised into a hierarchy with blocks of behavioural, environmental and occupational, and metabolic risks at the first level of the hierarchy. The next level in the hierarchy includes nine clusters of related risks and two individual risks, with more detail provided at levels 3 and 4 of the hierarchy. Compared with GBD 2010, six new risk factors have been added: handwashing practices, occupational exposure to trichloroethylene, childhood wasting, childhood stunting, unsafe sex, and low glomerular filtration rate. For most risks, data for exposure were synthesised with a Bayesian meta-regression method, DisMod-MR 2.0, or spatial-temporal Gaussian process regression. Relative risks were based on meta-regressions of published cohort and intervention studies. Attributable burden for clusters of risks and all risks combined took into account evidence on the mediation of some risks such as high body-mass index (BMI) through other risks such as high systolic blood pressure and high cholesterol. Findings All risks combined account for 57.2% (95% uncertainty interval [UI] 55.8-58.5) of deaths and 41.6% (40.1-43.0) of DALYs. Risks quantified account for 87.9% (86.5-89.3) of cardiovascular disease DALYs, ranging to a low of 0% for neonatal disorders and neglected tropical diseases and malaria. In terms of global DALYs in 2013, six risks or clusters of risks each caused more than 5% of DALYs: dietary risks accounting for 11.3 million deaths and 241.4 million DALYs, high systolic blood pressure for 10.4 million deaths and 208.1 million DALYs, child and maternal malnutrition for 1.7 million deaths and 176.9 million DALYs, tobacco smoke for 6.1 million deaths and 143.5 million DALYs, air pollution for 5.5 million deaths and 141.5 million DALYs, and high BMI for 4.4 million deaths and 134.0 million DALYs. Risk factor patterns vary across regions and countries and with time. In sub-Saharan Africa, the leading risk factors are child and maternal malnutrition, unsafe sex, and unsafe water, sanitation, and handwashing. In women, in nearly all countries in the Americas, north Africa, and the Middle East, and in many other high-income countries, high BMI is the leading risk factor, with high systolic blood pressure as the leading risk in most of Central and Eastern Europe and south and east Asia. For men, high systolic blood pressure or tobacco use are the leading risks in nearly all high-income countries, in north Africa and the Middle East, Europe, and Asia. For men and women, unsafe sex is the leading risk in a corridor from Kenya to South Africa. Interpretation Behavioural, environmental and occupational, and metabolic risks can explain half of global mortality and more than one-third of global DALYs providing many opportunities for prevention. Of the larger risks, the attributable burden of high BMI has increased in the past 23 years. In view of the prominence of behavioural risk factors, behavioural and social science research on interventions for these risks should be strengthened. Many prevention and primary care policy options are available now to act on key risks.	[Forouzanfar, Mohammad H.; Alexander, Lily; Bachman, Victoria F.; Biryukov, Stan; Brauer, Michael; Casey, Daniel; Coates, Matthew M.; Cohen, Aaron; Delwiche, Kristen; Estep, Kara; Frostad, Joseph J.; Kyu, Hmwe H.; Moradi-Lakeh, Maziar; Ng, Marie; Slepak, Erica Leigh; Thomas, Bernadette A.; Wagner, Joseph; Achoki, Tom; Atkinson, Charles; Barber, Ryan M.; Cooperrider, Kimberly; Dandona, Lalit; Dicker, Daniel; Flaxman, Abraham D.; Fleming, Thomas D.; Foreman, Kyle J.; Gakidou, Emmanuela; Hay, Simon I.; Heuton, Kyle R.; Iannarone, Marissa L.; Ku, Tiffany; Larson, Heidi J.; Lim, Stephen S.; Lozano, Rafael; MacIntyre, Michael F.; Margono, Christopher; McLain, Abigail; Mokdad, Ali H.; Mullany, Erin C.; Naghavi, Mohsen; Nguyen, Grant; Pain, Amanda W.; Richardson, Lee; Robinson, Margaret; Sandar, Logan; Stephens, Natalie; Thomson, Blake; Wan, Xia; Wurtz, Brittany; Lopez, Alan D.; Vos, Theo; Murray, Christopher J.] Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA; [Ebel, Beth E.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Harborview UW Med, Seattle, WA 98195 USA; [Wright, Jonathan L.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Jensen, Paul N.; Quistberg, D. Alex A.; Riederer, Anne; Vavilala, Monica S.; Zunt, Joseph R.] Univ Washington, Seattle, WA 98195 USA; [Anderson, H. Ross] Univ London, St Georges, London, England; [Pourmalek, Farshad] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brauer, Michael; Gotay, Carolyn C.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Burnett, Richard; Shin, Hwashin H.; Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Dept Community Med, Tehran, Iran; [Knudsen, Ann Kristin] Norwegian Inst Publ Hlth, Dept Hlth Registries, Oslo, Norway; [Aasvang, Gunn Marit; Kinge, Jonas M.; Skirbekk, Vegard; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Oslo, Norway; [Abbafati, Cristiana] Univ Roma La Sapienza, I-00185 Rome, Italy; [Ozgoren, Ayse Abbasoglu; Cavlin, Alanur] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey; [Bicer, Burcu Kucuk] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey; [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt; [Abera, Semaw F.] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Melaku, Yohannes A.] Mekelle Univ, Mekelle, Ethiopia; [Abera, Semaw F.] Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia; [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France; [Abraham, Biju] Govt Coll Munnar, Munnar, India; [Abraham, Jerry Puthenpurakal] Univ So Calif, Calif Hosp, Family Med Residency Program, Los Angeles, CA USA; [Abraham, Jerry Puthenpurakal] Harvard Univ, Inst Global Hlth, Boston, MA 02115 USA; [Thorne-Lyman, Andrew L.] Harvard Univ, Dept Nutr, Boston, MA 02115 USA; [Ding, Eric L.; Fahimi, Saman; Khatibzadeh, Shahab; Wagner, Gregory R.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Bukhman, Gene] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Campos-Nonato, Ismael R.; Feigl, Andrea B.; Salomon, Joshua A.] Harvard Univ, Boston, MA 02115 USA; [Benzian, Habib] UCL, Dept Epidemiol & Publ Hlth, London, England; [Abubakar, Ibrahim] UCL, London, England; [Abu-Rmeileh, Niveen M. E.] Birzeit Univ, Inst Community & Publ Hlth, Ramallah, Pakistan; [Aburto, Tania C.; Avila, Marco A.; Barquera, Simon; Barrientos-Gutierrez, Tonatiuh; Campos-Nonato, Ismael R.; Campuzano, Julio C.; Cantoral, Alejandra J.; Contreras, Alejandra G.; Cuevas-Nasu, Lucia; De la Cruz-Gongora, Vanessa; Garcia-Guerra, Francisco A.; Dantes, Hector Gomez; de Cosio, Teresita Gonzalez; Gonzalez-Castell, Dinorah; Heredia-Pi, Ileana B.; Hernandez, Lucia; Jauregui, Alejandra; Lozano, Rafael; Medina, Catalina; Mejia-Rodriguez, Fabiola; Hernandez, Julio C. Montaez; Pedraza, Lilia S.; Pedroza, Andrea; Quezada, Amado D.; Salvo, Deborah; Sanchez, Luz Maria; Sanchez-Pimienta, Tania G.; Servan-Mori, Edson E.; Levy, Teresa Shamah; Rojo, Martha M. Tellez; Villalpando, Salvador] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbo, Nigeria; [Adofo, Koranteng] Kwame Nkrumah Univ Sci, Kumasi, Ghana; [Adou, Arsene K.] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Adsuar, Jose C.; Paleo, Urbano Fra] Univ Extremadura, Caceres, Spain; [Afshin, Ashkan; Micha, Renata; Arian, Dariush Mozaff] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA USA; [Shahraz, Saeid; Shangguan, Siyi] Tufts Univ, Tufts Med Ctr, Boston, MA USA; [Agardh, Emilie E.] Inst Publ Hlth Sci, Stockholm, Sweden; [Al Khabouri, Mazin J.] Minist Hlth, Muscat, Oman; [Al Lami, Faris H.] Baghdad Coll Med, Baghdad, Iraq; [Alam, Sayed Saidul; Naheed, Aliya] icddr b, Dhaka, Bangladesh; [Alasfoor, Deena] Minist Hlth, Al Khuwair, Oman; [Albittar, Mohammed I.] Independent, Damascus, Syria; [Alegretti, Miguel A.] Univ Republica, Dept Prevent & Social Med, Montevideo, Uruguay; [Cavalleri, Fiorella] Univ Republica, Fac Med, Montevideo, Uruguay; [Alemu, Zewdie A.] Debre Markos Univ, Addis Ababa, Ethiopia; [Alhabib, Samia] King Abdullah Bin Abdulaziz Univ Hosp, Riyadh, Saudi Arabia; [Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Gething, Pete] Univ Oxford, Dept Zool, Oxford, England; [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D. M.; Hay, Simon I.; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England; [Singh, Gitanjali M.] Tufts Univ, Boston, MA USA; [Aleman, Alicia V.; Colistro, Valentina] Univ Republica, Montevideo, Uruguay; [Simard, Edgar P.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA; [Ali, Mohammed K.; Cunningham, Solveig Argeseanu; Liu, Yang; Narayan, K. M. Venkat; Omer, Saad B.] Emory Univ, Atlanta, GA USA; [Alla, Francois; Guillemin, Francis] Univ Lorraine, Nancy, France; [Allebeck, Peter; Roy, Nobhojit] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden; [Allen, Peter J.] Minist Hlth, Belmopan, Belize; [Alsharif, Ubai; Endres, Matthias; Nolte, Sandra; Papachristou, Christina] Charite, Berlin, Germany; [Alvarez, Elena] Govt, Madrid, Spain; [Alvis-Guzman, Nelson; Caicedo, Angel J. Paternina] Univ Cartagena, Cartagena De Indias, Colombia; [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA; [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Yenesew, Muluken] Bahir Dar Univ, Bahir Dar, Ethiopia; [Ameh, Emmanuel A.] Ahmadu Bello Univ, Zaria, Nigeria; [Ameli, Omid] Boston Univ, Boston, MA USA; [Amini, Heresh] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Iran; [Amini, Heresh] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Amini, Heresh] Univ Basel, Basel, Switzerland; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Faraon, Emerito Jose A.] Univ Philippines Manila, Coll Publ Hlth, Manila, Philippines; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines; [Panelo, Carlo Irwin A.] Univ Philippines Manila, Manila, Philippines; [Arnlov, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Falun, Sweden; [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Inst Microbiol & Immunol, Sch Med, Belgrade, Serbia; [Arsenijevic, Valentina S. Arsic] Univ Childrens Hosp Belgrade, Belgrade, Serbia; [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran; [Atkins, Lydia S.] Minist Hlth, Wellness Human Serv & Gender Relat, St Lucia, Qld, Australia; [Awuah, Baffour; Laryea, Dennis O.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Bahit, Maria C.] INECO Neurociencias, Rosario, Argentina; [Bakfalouni, Talal] Minist Hlth, Damascus, Syria; [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India; [Balalla, Shivanthi; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ao, Braden J. Te] Auckland Univ Technol, Auckland, New Zealand; [Balu, Ravi Kumar; Dandona, Lalit; Dandona, Rakhi; Goenka, Shifalika; Kumar, G. Anil; Murthy, Kinnari S.; Reddy, K. Srinath] Publ Hlth Fdn India, Delhi, India; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [del Pozo-Cruz, Borja] Univ Auckland, Auckland, New Zealand; [Barregard, Lars] Univ Gothenburg, Dept Occupat & Environm Hlth, Gothenburg, Sweden; [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Basto-Abreu, Ana C.; Ruvalcaba, Carolina Batis; de Castro, E. Filipa; Lopez, Nancy; Texcalac-Sangrador, Jose Luis] Natl Inst Publ Hlth, Mexico City, DF, Mexico; [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand; [Gaffikin, Lynne] Stanford Univ, Sch Med, Stanford, CA USA; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Basulaiman, Mohammed O.; Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia; [Beardsley, Justin] Univ Oxford, Ho Hi Minh City, Vietnam; [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia; [Bekele, Tolesa] Madawalabu Univ, Bale Robe, Ethiopia; [Bell, Michelle L.] Yale Univ, New Haven, CT USA; [Benjet, Corina; Borges, Guilherme; Gutierrez, Reyna A.; Orozco, Ricardo] Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF, Mexico; [Benzian, Habib] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY 10003 USA; [Trasande, Leonardo] NYU, Sch Med, New York, NY USA; [Hagan, Holly] NYU, New York, NY 10003 USA; [Bernabe, Eduardo; Wolfe, Charles D. A.] Kings Coll London, London, England; [Beyene, Tariku J.] Addis Ababa Univ, Debre Zeyit, Ethiopia; [Bhala, Neeraj] Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Bhala, Neeraj] Univ Otago, Capital & Coast District Hlth Board, Wellington, New Zealand; [Derrett, Sarah] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Wellington, New Zealand; [Bhalla, Ashish; Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh, India; [Bhutta, Zulfi Qar A.] Aga Khan Univ, Med Ctr, Karachi, Pakistan; [Nisar, Muhammad I.] Aga Khan Univ, Karachi, Pakistan; [Bikbov, Boris] AI Evdokimov Moscow State Univ Med & Dent, Moscow, Russia; [Bikbov, Boris] Acad VI Shumakov Fed Res Ctr Transplantol & Artif, Moscow, Russia; [Bin Abdulhak, Aref A.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Vijayakumar, Lakshmi] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Chiang, Peggy P.] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Blore, Jed D.; Brooks, Peter M.; Colquhoun, Samantha M.; Balaji, Arjun Lakshmana; Weintraub, Robert G.; Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Blyth, Fiona M.] Univ Sydney, Concord, NSW, Australia; [Meretoja, Atte] Univ Melbourne, Dept Florey, Parkville, Vic, Australia; [Meretoja, Atte] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Bohensky, Megan A.] Univ Melbourne, Parkville, Vic, Australia; [Basara, Berrak Bora; Yentuer, Goekalp K.] Minist Hlth, Gen Directorate Hlth Res, Ankara, Turkey; [Kose, M. Rifat; Pekericli, Ayfer; Uzun, Selen B.] Minist Hlth, Ankara, Turkey; [Bornstein, Natan M.] Tel Aviv Saurasky Med Ctr, Tel Aviv, Israel; [Bose, Dipan] World Bank, Washington, DC USA; [Boufous, Soufiane] Univ New S Wales, Transport & Rd Safety, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert R.] Anglia Ruskin Univ, Cambridge, England; [Brainin, Michael] Danube Univ Krems, Krems, Austria; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia; [Breitborde, Nicholas J.] Ohio State Univ, Columbus, OH USA; [Breitborde, Nicholas J.] Univ Arizona, Tucson, AZ USA; [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Broday, David M.] Technion, Haifa, Israel; [Lunevicius, Raimundas] Univ Liverpool, Sch Med, Liverpool, Merseyside, England; [Bruce, Nigel G.; Dherani, Mukesh K.; Pope, Daniel] Univ Liverpool, Liverpool, Merseyside, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Brunekreef, Bert; Kromhout, Hans] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Gabbe, Belinda; Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Melbourne, Vic, Australia; [Bui, Linh N.; Nguyen, Nhung T.] Hanoi Sch Publ Hlth, Hanoi, Vietnam; [Bulloch, Andrew G.; Patten, Scott B.; Tonelli, Marcello; Wang, JianLi] Univ Calgary, Calgary, AB, Canada; [Burch, Michael] Great Ormond St Hosp Sick Children, London, England; [Burney, Peter G. J.; Foreman, Kyle J.; Jarvis, Deborah L.; Rodriguez, Alina; Rushton, Lesley; Soljak, Michael; Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, London, England; [Caravanos, Jack; Nash, Denis] CUNY, Sch Publ Hlth, New York, NY USA; [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Cardis, Elisabeth; Nieuwenhuijsen, Mark J.; Rojas-Rueda, David] Ctr Res Environm Epidemiol, Barcelona, Spain; [Carpenter, David O.; Leung, Ricky] SUNY Albany, Rensselaer, NY USA; [Caso, Valeria] Univ Perugia, Stroke Unit, Perugia, Italy; [Castaneda-Orjuela, Carlos A.] Colombian Natl Hlth Observ, Inst Nacl Salud, Bogota, Colombia; [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Dept Publ Hlth, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Castro, Ruben E.] Univ Diego Portales, Santiago, Chile; [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy, Minist Hlth, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Catala-Lopez, Ferran] Univ Valencia, Dept Med, CIBERSAM, Valencia, Spain; [Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India; [Chang, Jung-chen] Natl Taiwan Univ, Taipei, Taiwan; [Scott, James G.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Knibbs, Luke D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Charlson, Fiona J.; Erskine, Holly E.; Ferrari, Alize J.; Gouda, Hebe N.; Veerman, Lennert J.; Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia; [Chen, Wanqing; Zou, Xiaonong] Chinese Acad Med Sci, Canc Inst, Beijing, Peoples R China; [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing, Peoples R China; [Chen, Honglei; London, Stephanie J.] NIEHS, Div Intramural Res, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC USA; [Jiang, Ying] Univ Occupat & Environm Hlth, Dept Hlth Dev, Kitakyushu, Fukuoka 807, Japan; [Takahashi, Ken] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Chimed-Ochir, Odgerel] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Chowdhury, Rajiv; Powles, John] Univ Cambridge, Cambridge, England; [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus; [Chuang, Ting-Wu] Taipei Med Univ, Taipei, Taiwan; [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA USA; [Cirillo, Massimo] Univ Salerno, Baronissi, Italy; [Classen, Thomas K. D.] Univ Bielefeld, Dept Environm & Hlth, Bielefeld, Germany; [Kraemer, Alexander; Tobollik, Myriam] Univ Bielefeld, Sch Publ Hlth, Bielefeld, Germany; [Colomar, Mercedes] UNICEM, Montevideo, Uruguay; [Colquhoun, Samantha M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Cooper, Leslie T.] Mayo Clin, Rochester, MN USA; [Coresh, Josef; Matsushita, Kunihiro] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Tran, Bach X.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Courville, Karen J.] Hosp Dr Gustavo N Collado, Chitre, Panama; [Criqui, Michael H.; Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Danawi, Hadi; Refaat, Amany H.] Walden Univ, Minneapolis, MN USA; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England; [Davis, Adrian; Fay, Derek F. J.; Schmidt, Juergen C.] Publ Hlth England, London, England; [Davitoiu, Dragos V.] Univ Med & Pharm Bucharest, Bucharest, Romania; [Dayama, Anand] Jacobi Med Ctr, Dept Surg, Atlanta, GA USA; [De Leo, Diego] Griffith Univ, Brisbane, Qld, Australia; [de Lima, Graca] Local Hlth Unit Matosinhos, Matosinhos, Portugal; [de Lima, Graca; Machado, Vasco M. P.] Northern Reg Hlth Adm, Dept Publ Hlth, Porto, Portugal; [Nogueira, Jose R.; Teixeira, Carolina M.] Northern Reg Hlth Adm, Porto, Portugal; [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, US Dept Vet Affairs, Denver, CO USA; [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Deribe, Kebede] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Mekonnen, Wubegzier] Univ Addis Ababa, Addis Ababa, Ethiopia; [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Publ Hlth, Palmerston North, New Zealand; [Jarlais, Don C. Des] Mt Sinai Beth Israel, New York, NY USA; [Jarlais, Don C. Des] Icahn Sch Med Mt Sinai, New York, NY USA; [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia; [deVeber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Lindsay, M. Patrice] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hu, Howard] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Devries, Karen M.; Larson, Heidi J.; Mckee, Martin; Pearce, Neil; Stoeckl, Heidi; Tillmann, Taavi; Watts, Charlotte H.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria; [Dorsey, E. Ray] Univ Rochester, Med Ctr, Rochester, NY USA; [Driscoll, Tim R.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia; [Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia; [Duan, Leilei; Li, Yichong; Liu, Shiwei; Ma, Jixiang; Wang, Linhong; Ye, Pengpeng; Zhou, Maigeng] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Durrani, Adnan M.] Natl Inst Hlth, Montgomery Village, MD USA; [Elshrek, Yousef M.] Univ Tripoli, Fac Agr, Dept Food Sci, Tripoli, Libya; [Ermakov, Sergey P.] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Ermakov, Sergey P.; Soshnikov, Sergey] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Liang, Xiaofeng] China CDC, Beijing, Peoples R China; [Eshrati, Babak] Arak Univ Med Sci & Hlth Affairs, Arak, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, NonCommunicable Dis Res Ctr, Tehran, Iran; [Heydarpour, Pouria; Sahraian, Mohammad Ali] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Neurosci Inst, Tehran, Iran; [Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Ferri, Cleusa P.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine; [Franklin, Richard C.] James Cook Univ, Townsville, Qld, Australia; [Gamkrelidze, Amiran; Khonelidze, Irma; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Gankpe, Fortune G.] Leras Afrique, Cotonou, Benin; [Gankpe, Fortune G.] CHU Hassan II, Fes, Morocco; [Gasana, Evariste] Rwanda Biomed Ctr, TB & Other Respir Dis Div, Kigali, Rwanda; [Sabin, Nsanzimana] Rwanda Biomed Ctr, Kigali, Rwanda; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Gibney, Katherine B.] Melbourne Hlth, Parkville, Vic, Australia; [Gillum, Richard F.] Howard Univ, Washington, DC USA; [Ginawi, Ibrahim A. M.] Univ Hail, Coll Med, Hailsham, E Sussex, England; [Giroud, Maurice] Univ Hosp Dijon, Dijon, France; [Giussani, Giorgia] IRCCS Mario Negri Inst Pharmacol Res, Milan, Italy; [Goginashvili, Ketevan] Minist Labour Hlth & Social Affairs, Tbilisi, Georgia; [Esteghamati, Alireza; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Tehran, Iran; [Gona, Philimon] Univ Massachusetts Boston, Boston, MA USA; [Goto, Atsushi] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan; [Guerrant, Richard L.] Univ Virginia, Sch Med, Charlottesville, VA USA; [Terkawi, Abdullah S.] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Gugnani, Harish C.] St James Sch Med, Kralendijk, Netherlands; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Gupta, Rahul] West Virginia Bur Publ Hlth, Charleston, WV USA; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Hagstromer, Maria] Karolinska Inst, Huddinge, Sweden; [Halasa, Yara A.; Idrisov, Bulat T.] Brandeis Univ, Waltham, MA USA; [Hamadeh, Randah R.] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA; [Hankey, Graeme J.] Univ Western Australia, Perth, WA, Australia; [Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Haregu, Tilahun Nigatu; van de Vijver, Steven] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Haro, Josep Maria] CIBERSAM, Parc Sanitari St Joan de Deu, Sant Boi De Llobregat, Spain; [Haro, Josep Maria] Univ Barcelona, Barcelona, Spain; [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran; [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico; [Hoek, Hans W.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Man, Howard J. Hoff] Natl Inst Deafness & Other Commun Disorders, Epidemiol & Stat Program, NIH, Bethesda, MD USA; [Mensah, George A.] NIH, Ctr Translat Res & Implementat Sci, Bethesda, MD USA; [Sampson, Uchechukwu K.] NIH, NHLBI, Bethesda, MD USA; [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY USA; [Hsairi, Mohamed] Natl Inst Publ Hlth, Tunis, Tunisia; [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia; [Hu, Guoqing] Cent S Univ, Changsha, Peoples R China; [Huang, Cheng] George Washington Univ, Washington, DC USA; [Hubbell, Bryan J.] US EPA, Res Triangle Pk, NC USA; [Huiart, Laetitia; Racape, Lionel] CHU La Reunion, Saint Denis, France; [Husseini, Abdullatif] Qatar Univ, Doha, Qatar; [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark; [Ikeda, Nayu] Natl Inst Hlth Nutr, Tokyo, Japan; [Innos, Kaire] Natl Inst Hlth Dev, Tallinn, Estonia; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Islami, Farhad] Amer Canc Soc, New York, NY USA; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA USA; [Jansen, Henrica A.] UNFPA Asia & Pacific Reg Off, Bangkok, Thailand; [Jassal, Simerjot K.] Univ Calif San Diego, San Diego, CA USA; [Jayaraman, Sudha] Virginia Commonwealth Univ, Richmond, VA USA; [Jeemon, Panniyammakal; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Jiang, Fan] Shanghai Childrens Med Ctr, Tianjin, Peoples R China; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Kan, Haidong] Fudan Univ, Shanghai, Peoples R China; [Roseline, Sidibe S. Kany] MARIKANI, Bamako, Mali; [Karam, Nadim E.] Univ Balamand, Beirut, Lebanon; [Karch, Andre] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany; [Karch, Andre] German Ctr Infect Res, Hannover Braunschweig Site, Braunschweig, Germany; [Karema, Corine K.] Minist Hlth, Malaria & Other Parasit Dis Div, Kigali City, Rwanda; [Karthikeyan, Ganesan; Paul, Vinod K.; Satpathy, Maheswar; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India; [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA; [Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA USA; [Kemp, Andrew H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil; [Kemp, Andrew H.] Univ Sydney, Camperdown, NSW, Australia; [Kengne, Andre P.; Matzopoulos, Richard; Parry, Charles D.] South African Med Res Council, Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa; [Matzopoulos, Richard] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Kengne, Andre P.; Mayosi, Bongani M.; Stein, Dan J.] Univ Cape Town, Cape Town, South Africa; [Keren, Andre] Hadassah Kerem Univ Hosp, Cardiol, Jerusalem, Israel; [Khader, Yousef S.] Jordan Univ Sci & Technol, Irbid, Jordan; [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar; [Khan, Ejaz A.] Hlth Serv Acad, Islamabad, Pakistan; [Khan, Ejaz A.] Expanded Programme Immunizat, Islamabad, Pakistan; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kieling, Christian] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Kim, Daniel] Northeastern Univ, Boston, MA USA; [Kim, Sungroul] Soonchunhyang Univ, Seoul, South Korea; [Kim, Yunjin] Southern Univ Coll, Johor Baharu, Malaysia; [Kimokoti, Ruth W.] Simmons Coll, Boston, MA USA; [Kinfu, Yohannes] Univ Canberra, Canberra, ACT, Australia; [Kissela, Brett M.] Univ Cincinnati, Cincinnati, OH USA; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Kosen, Soewarta] Minist Hlth Indonesia, NIHRD, Ctr Community Empowerment Hlth Policy & Human, Jakarta, Indonesia; [Warouw, Tati S.] Minist Hlth Indonesia, NIHRD, Jakarta, Indonesia; [Kravchenko, Michael] Res Ctr Neurol, Moscow, Russia; [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR USA; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Kuipers, Ernst J.] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Kulkarni, Chanda] Rajrajeswari Med Coll & Hosp, Bangalore, Karnataka, India; [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR USA; [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Gold Coast, Qld, Australia; [Lalloo, Ratilal] Univ Adelaide, Sch Dent, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia; [Lallukka, Tea] Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lallukka, Tea] Univ Helsinki, Fac Med, Helsinki, Finland; [Lam, Hilton] NIH, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Lan, Qing] NCI, Rockville, MD USA; [Lansingh, Van C.] Help Me See Inc, New York, NY USA; [Lansingh, Van C.] Inst Mexicano Oftalmol, Queretaro, Mexico; [Lavados, Pablo M.] Univ Desarrollo, Serv Neurol, Clin Alemana, Santiago, Chile; [Lawrynowicz, Alicia E.] Inst Nacl Epidemiol Dr Juan H Jara, Mar Del Plata, Buenos Aires, Argentina; [Leasher, Janet L.] Nova SE Univ, Coll Optometry, Ft Lauderdale, FL USA; [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea; [Levi, Miriam] Tuscany Reg Ctr Occupat Injuries & Dis, Florence, Italy; [Li, Yichong] Anolinx LLC, Salt Lake City, UT USA; [Liang, Juan; Wang, Yanping; Zhu, Jun] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu, Peoples R China; [Lindsay, M. Patrice] Heart & Stroke Fdn Canada, Ottawa, ON, Canada; [Lipshultz, Steven E.] Wayne State Univ, Detroit, MI USA; [Lloyd, Belinda K.] Monash Univ, Eastern Hlth Clin Sch, Fitzroy, Vic, Australia; [Lloyd, Belinda K.; Room, Robin] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Fitzroy, Vic, Australia; [Logroscino, Giancarlo] Univ Bari, Bari, Italy; [Lortet-Tieulent, Joannie] Amer Canc Soc, Atlanta, GA USA; [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Ma, Stefan; Phua, Hwee Pin] Minist Hlth Singapore, Singapore, Singapore; [Ma, Stefan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Magis-Rodriguez, Carlos] Secretaria Salud Mexico, Ctr Nacl Prevenc & Control VIH SIDA, Mexico City, DF, Mexico; [Mahdi, Abbas A.] King Georges Med Univ, Lucknow, Uttar Pradesh, India; [Malekzadeh, Reza] Shariati Hosp, Digest Dis Reseach Inst, Tehran, Iran; [Malekzadeh, Reza] Shiraz Univ Med Sci, Shiraz, Iran; [Mangalam, Srikanth] Tech Stand & Safety Author, Toronto, ON, Canada; [Masiye, Felix] Univ Zambia, Lusaka, Zambia; [Marape, Marape] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Marcenes, Wagner] Queen Mary Univ London, London, England; [Meaney, Peter A.] Univ Penn, Pereleman Sch Med, Philadelphia, PA USA; [Martin, Randall V.] Dalhousie Univ, Halifax, NS, Canada; [Marzan, Melvin B.] Univ East Ramon Magsaysay Memorial, Med Ctr, Quezon City, Philippines; [Mashal, Mohammad T.] Minist Publ Hlth, Kabul, Afghanistan; [Mason-Jones, Amanda J.] Univ York, York, N Yorkshire, England; [Mazorodze, Tasara T.] Automot Ind Dev Ctr Eastern Cape, Port Elizabeth, South Africa; [Mckay, Abigail C.] EmergentCorp, Belize City, Belize; [Meaney, Peter A.] Childrens Hosp Philadelphia, Philadelphia, PA USA; [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, New Delhi, India; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA USA; [Mendoza, Walter] United Nations Populat Fund, Lima, Peru; [Meretoja, Atte] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Mhimbira, Francis Apolinary] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth, Perth, WA, Australia; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Margolis, David J.; Silberberg, Donald H.] Univ Penn, Philadelphia, PA USA; [Mishra, Santosh] SNDT Womens Univ, Populat Educ Resource Ctr, Dept Continuing & Adult Educ & Extens, Bombay, Maharashtra, India; [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Bandar Tun Razak, Malaysia; [Mohammad, Karzan A.] Univ Salahaddin, Erbil, Iraq; [Mola, Glen L.] Univ Papua New Guinea, Boroko, Papua N Guinea; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] Inst Maternal & Child Hlth, IRCCS Burlo Garofolo, Trieste, Italy; [Moore, Ami R.] Univ N Texas, Denton, TX USA; [Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia; [Norman, Rosana E.] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan; [Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece; [Moschandreas, Joanna] Univ Crete, Iraklion, Greece; [Moturi, Wilkister N.] Egerton Univ, Egerton, Kenya; [Werdecker, Andrea] Competence Ctr Mortal Follow Up German Natl Cohor, Heidelberg, Germany; [Mueller, Ulrich O.; Westerman, Ronny] Fed Inst Populat Res, Wiesbaden, Germany; [Mukaigawara, Mitsuru] Okinawa Chubu Hosp, Okinawa, Japan; [Nahas, Ziad] Amer Univ Beirut, Med Ctr, Beirut, Lebanon; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, South Africa; [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Nand, Devina] Minist Hlth Fiji, Suva, Fiji; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Neal, Bruce] George Inst Global Hlth, Sydney, NSW, Australia; [Nejjari, Chakib] Fac Med, Fes, Morocco; [Neupane, Sudan P.] Univ Oslo, Oslo, Norway; [Ngalesoni, Frida N.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Ngirabega, Jean de Dieu] East African Community Hlth Res Commiss, Kigali, Rwanda; [Nolla, Joan M.] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain; [Nolte, Sandra] Deakin Univ, Melbourne, Vic, Australia; [Vollset, Stein Emil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Norheim, Ole F.] Univ Bergen, Bergen, Norway; [Norrving, Bo] Lund Univ, Dept Clin Sci, Lund, Sweden; [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Oh, In-Hwan] Kyung Hee Univ, Seoul, South Korea; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo, Japan; [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Ikoyi, Nigeria; [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Lira, Uganda; [Pagcatipunan, Rodolfo S., Jr.] United Lab Inc, Mandaluyong City, Philippines; [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India; [Park, Eun-Kee] Kosin Univ, Coll Med, Busan, South Korea; [Stein, Dan J.] South African Med Res Council, Unit Anxiety & Stress Disorders, Cape Town, South Africa; [Parry, Charles D.] South African Med Res Council, Cape Town, South Africa; [Parry, Charles D.; Seedat, Soraya] Univ Stellenbosch, Cape Town, South Africa; [Stokic, Ljiljana Pejin] Econ Inst, Belgrade, Serbia; [Pereira, David M.] Univ Porto, REQUIMTE, Fac Farm, Dept Quim,Lab Farmacognosia, Oporto, Portugal; [Perez-Padilla, Rogelio] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, OSI EE Cruces, Baracaldo, Spain; [Perez-Ruiz, Fernando] Biocruces Hlth Res Inst, Baracaldo, Spain; [Perico, Norberto; Remuzzi, Giuseppe; Trillini, Matias] IRCCS Mario Negri Inst Pharmacol Res, Bergamo, Italy; [Perry, Samuel A. L.] Washington State Dept Hlth, Kent, WA USA; [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Pakistan; [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA, Australia; [Peterson, Carrie B.] Aalborg Univ, Aalborg Esst, Denmark; [Petzold, Max] Hlth Metr Unit, Gothenburg, Sweden; [Petzold, Max] Univ Witwatersrand, Johannesburg, South Africa; [Phillips, Michael R.] Emory Univ, Atlanta, GA USA; [Plass, Dietrich] Fed Environm Agcy, Sect Exposure Assessment & Environm Hlth Indicato, Berlin, Germany; [Poenaru, Dan] McGill Univ, Montreal Childrens Hosp, Montreal, PQ, Canada; [Poenaru, Dan] MyungSung Med Coll, Addis Ababa, Ethiopia; [Pond, Constance D.] Univ Newcastle, Callaghan, NSW 2308, Australia; [Pope, C. Arden] Brigham Young Univ, Provo, UT USA; [Popova, Svetlana; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Prasad, Noela M.] Fred Hollows Fdn, Sydney, NSW, Australia; [Qato, Dima M.] Univ Illinois, Coll Pharm, Chicago, IL USA; [Rafay, Anwar; Rana, Saleem M.] Contech Int Hlth Consultants, Lahore, Pakistan; [Rafay, Anwar; Rana, Saleem M.] Contech Sch Publ Hlth, Lahore, Pakistan; [Rahman, Sajjad Ur] Hamad Med Corp, Doha, Qatar; [Raju, Murugesan] Univ Missouri, Columbia, MO USA; [Rakovac, Ivo] WHO Reg Off Europe, Copenhagen, Denmark; [Rao, Mayuree] Brown Univ, Warren Alpert Med Sch, Providence, RI USA; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Refaat, Amany H.] Suez Canal Univ, Ismailia, Egypt; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Escola Enfermagem, Belo Horizonte, MG, Brazil; [Riccio, Patricia M.; Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada; [Riederer, Anne] George Washington Univ, Washington, DC USA; [Roca, Anna] MRC Unit, Fajara, Gambia; [Rodriguez, Alina] Mid Sweden Univ, Stersund, Sweden; [Romieu, Isabelle; Straif, Kurt] WHO, IARC, Lyon, France; [Roy, Nobhojit] HBNI Univ, BARC Hosp, Bombay, Maharashtra, India; [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Miami, FL USA; [Saha, Sukanta] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Sahathevan, Ramesh] Univ Kebangsaan Malaysia, Med Ctr, Kuala Lumpur, Malaysia; [Sahathevan, Ramesh] Calvary Healthcare Bruce, Canberra, ACT, Australia; [Sanabria, Juan R.] Case Western Reserve Univ, Cleveland, OH USA; [Sanabria, Juan R.] RFU Chicago Med Sch, Canc Treatment Ctr Amer, N Chicago, IL USA; [Sanchez-Riera, Lidia] Univ Zurich, Ctr Ageing & Mobil, Zurich, Switzerland; [Sanchez-Riera, Lidia] City Hosp Waid, Zurich, Switzerland; [Sapkota, Amir] Univ Maryland, Sch Publ Hlth, College Pk, MD USA; [Saunders, James E.] Dartmouth Coll, Dartmouth Hitchcock Med Ctr, Lebanon, NH USA; [Soneji, Samir] Dartmouth Coll, Lebanon, NH USA; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [Saylan, Mete I.] Novartis Turkey, Istanbul, Turkey; [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Serdar, Berrin] Univ Colorado, Aurora, CO USA; [Shaddick, Gavin] Univ Bath, Bath BA2 7AY, Avon, England; [Shangguan, Siyi] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan; [Shiri, Rahman] Univ Tampere, Sch Hlth Sci, Tampere, Finland; [Shishani, Kawkab] Washington State Univ, Spokane, WA USA; [Shiue, Ivy] Northumbria Univ, Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Shiue, Ivy] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Sigfusdottir, Inga D.] Reykjavik Univ, Reykjavik, Iceland; [Singh, Abhishek] Int Inst Populat Sci, Bombay, Maharashtra, India; [Soreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway; [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Kajang, Cheras, Malaysia; [Stapelberg, Nicolas J. C.] Griffith Univ, Southport, Qld, Australia; [Stathopoulou, Vasiliki] Attikon Univ Hosp, Athens, Greece; [Steckling, Nadine] Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, Athens, Greece; [Stroumpoulis, Konstantinos] Ctr Hosp Publ Cotentin, Cherbourg, France; [Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Swaroop, Mamta; Yano, Yuichiro] Northwestern Univ, Chicago, IL USA; [Sykes, Bryan L.] Univ Calif Irvine, Irvine, CA USA; [Tabb, Karen M.] Univ Illinois, Champaign, IL USA; [Talongwa, Roberto T.] Minist Hlth, MINSANTE, Yaounde, Cameroon; [Tanne, David] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Tanne, David] Tel Aviv Univ, Tel Hashomer, Israel; [Tavakkoli, Mohammad] Westchester Med Ctr, Valhalla, NY USA; [Terkawi, Abdullah S.] Outcomes Res Consortium, Cleveland, OH USA; [Terkawi, Abdullah S.] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thackway, Sarah V.] New South Wales Hlth, Sydney, NSW, Australia; [Thurston, George D.] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Topouzis, Fotis] Aristotle Univ Thessaloniki, Thessaloniki, Greece; [Towbin, Jeff Rey A.] Bonheur Childrens Hosp, Memphis, TN USA; [Towbin, Jeff Rey A.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN USA; [Toyoshima, Hideaki] Anjo Kosei Hosp, Hlth Care Ctr, Anjo City, Japan; [Traebert, Jeff Erson] Univ Southern Santa Catarina, Palhoca, Brazil; [Tran, Bach X.] Hanoi Med Univ, Hanoi, Vietnam; [Trujillo, Ulises] Serv Canario Salud, Tenerife, Spain; [Dimbuene, Zacharie Tsala] Univ Kinshasa, Fac Econ & Management, Dept Populat Sci & Dev, Kinshasa, DEM REP CONGO; [Tuzcu, Emin Murat] Cleveland Clin, Cleveland, OH USA; [Uchendu, Uche S.] Dept Vet Affairs, Washington, DC USA; [Ukwaja, Kingsley N.] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria; [Van Dingenen, Rita] European Commiss, Joint Res Ctr, Ispra, Italy; [Van Gool, Coen H.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Van Os, Jim] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Vasconcelos, Ana Maria N.] Univ Brasilia, Brasilia, DF, Brazil; [Vijayakumar, Lakshmi] VHS SNEHA, Madras, Tamil Nadu, India; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Vlassov, Vasiliy Victorovich] Higher Sch Econ, Moscow, Russia; [Wagner, Gregory R.] Natl Inst Occupat Safety & Hlth, Washington, DC USA; [Waller, Stephen G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Wallin, Mitchell T.] Georgetown Univ, Dept Neurol, Arlington, VA USA; [Wallin, Mitchell T.] VA Med Ctr, Washington, DC USA; [Wang, Wenzhi] Beijing Neurosurg Inst, Beijing, Peoples R China; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Wessells, K. Ryan] Univ Calif Davis, Davis, CA USA; [Westerman, Ronny] German Natl Cohort Consortium, Heidelberg, Germany; [Wilkinson, James D.] Wayne State Univ, Detroit, MI USA; [Williams, Hywel C.] Univ Nottingham, Nottingham, England; [Woldeyohannes, Solomon M.] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Wong, John Q.] Manila Univ, Ateneo Sch Med & Publ Hlth, Pasig, Philippines; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, Cornwall, England; [Xu, Gelin] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing, Peoples R China; [Yan, Lijing L.] Duke Kunshan Univ, Kunshan, Peoples R China; [Yang, Gonghuan] Peking Union Med Coll, Beijing, Peoples R China; [Yano, Yuichiro] Jichi Med Sch, Tochigi, Japan; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA; [Younoussi, Zourkaleini] Univ Niamey, Niamey, Niger; [Yu, Chuanhua] Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan, Peoples R China; [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China; [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Hangzhou, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; University of British Columbia; University of British Columbia; Health Canada; Health Effects Institute (HEI); Iran University of Medical Sciences; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Sapienza University Rome; Hacettepe University; Hacettepe University; Egyptian Knowledge Bank (EKB); Cairo University; Mekelle University; Mekelle University; CHU Limoges; University of Southern California; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; University of London; University College London; University of London; University College London; Instituto Nacional de Salud Publica; Universidad de Extremadura; Tufts University; Tufts Medical Center; Tufts University; International Centre for Diarrhoeal Disease Research (ICDDR); Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Oxford; University of Oxford; University of Oxford; Tufts University; Universidad de la Republica, Uruguay; Emory University; Rollins School Public Health; Emory University; Universite de Lorraine; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena; University System of Georgia; Albany State University; University of Groningen; University of Groningen; University of Groningen; Bahir Dar University; Bahir Dar University; Ahmadu Bello University; Boston University; Kurdistan University of Medical Sciences; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Uppsala University; Uppsala University; Dalarna University; University of Belgrade; Mashhad University Medical Science; Kwame Nkrumah University Science & Technology; Public Health Agency of Canada; Sri Ramachandra Institute of Higher Education & Research; Auckland University of Technology; Auckland University of Technology; Public Health Foundation of India; University of Birmingham; University of Auckland; University of Auckland; University of Gothenburg; Pontificia Universidad Javeriana; Instituto Nacional de Salud Publica; University of Canterbury; Stanford University; Stanford University; Ministry of Health - Saudi Arabia; University of Oxford; Yale University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; New York University; New York University; New York University; University of London; King's College London; Addis Ababa University; University of Birmingham; University of Otago; University of Otago; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; Aga Khan University; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; University of Iowa; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Sydney; University of Melbourne; University of Melbourne; University of Melbourne; Ministry of Health - Turkey; Ministry of Health - Turkey; Tel Aviv University; Sackler Faculty of Medicine; The World Bank; University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; Danube University Krems; University of Trnava; University System of Ohio; Ohio State University; University of Arizona; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Liverpool; University of Liverpool; University of Leicester; Utrecht University; Cabrini Health; Monash University; Monash University; Monash University; Hanoi University of Public Health; University of Calgary; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Imperial College London; City University of New York (CUNY) System; Universidad Autonoma Metropolitana - Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Perugia; Instituto Nacional de Salud (Colombia); Universidad Nacional de Colombia; University Diego Portales; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; National Taiwan University; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Cambridge; Cyprus University of Technology; Taipei Medical University; Cedars Sinai Medical Center; University of Salerno; University of Bielefeld; University of Bielefeld; Murdoch Children's Research Institute; University of Southampton; Mayo Clinic; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of California System; University of California San Diego; Walden University; Guy's & St Thomas' NHS Foundation Trust; Public Health England; Carol Davila University of Medicine & Pharmacy; Griffith University; US Department of Veterans Affairs; University of Brighton; University of Sussex; Addis Ababa University; Addis Ababa University; Massey University; Icahn School of Medicine at Mount Sinai; African Medical & Research Foundation (AMREF); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; University of Peradeniya; Medical University Varna; University of Rochester; University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; National Institutes of Health (NIH) - USA; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Ministry of Health of the Russian Federation; Chinese Center for Disease Control & Prevention; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; James Cook University; National Center for Disease Control & Public Health - Georgia; Hassan II University Hospital Center of Fez; Rwanda Biomedical Center; Rwanda Biomedical Center; Wageningen University & Research; Agence de Medecine Preventive; Howard University; CHU Dijon Bourgogne; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Tehran University of Medical Sciences; University of Massachusetts System; University of Massachusetts Boston; Tokyo Women's Medical University; University of Virginia; University of Virginia; University of Bristol; Fortis Escorts Hospital; Karolinska Institutet; Brandeis University; Arabian Gulf University; University of Western Australia; Sun Yat Sen University; Sun Yat Sen University; African Population & Health Research Centre; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Mazandaran University Medical Sciences; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yeshiva University; Albert Einstein College of Medicine; Central South University; George Washington University; United States Environmental Protection Agency; CHU Reunion; Qatar University; Aarhus University; National Institute of Health & Nutrition - Japan; National Institute for Health Development - Estonia; University of Tokyo; University of Tokyo; University of Tokyo; American Cancer Society; George Mason University; United Nations Population Fund; University of California System; University of California San Diego; Virginia Commonwealth University; Tianjin Center for Disease Control & Prevention; Shanghai Jiao Tong University; Ruprecht Karls University Heidelberg; Fudan University; Fudan University; University Balamand; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; All India Institute of Medical Sciences (AIIMS) New Delhi; University of California System; University of California San Francisco; Universidade de Sao Paulo; University of Sydney; South African Medical Research Council; University of Cape Town; University of Cape Town; University of Cape Town; Jordan University of Science & Technology; Health Services Academy; Seoul National University (SNU); Universidade Federal do Rio Grande do Sul; Northeastern University; Soonchunhyang University; Simmons University; University of Canberra; University System of Ohio; University of Cincinnati; National Cerebral & Cardiovascular Center - Japan; Ministry of Health - Indonesia; National Institute of Health Research & Development (NIHRD); Ministry of Health - Indonesia; National Institute of Health Research & Development (NIHRD); Research Center of Neurology; Oregon Health & Science University; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC; Arkansas State University; Boston Medical Center; Griffith University; University of Adelaide; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clinica Alemana; Universidad del Desarrollo; Nova Southeastern University; Korea University; Sichuan University; Wayne State University; Monash University; Turning Point Alcohol & Drug Centre - Australia; Universita degli Studi di Bari Aldo Moro; American Cancer Society; Aintree University Hospitals NHS Foundation Trust; Ministry of Health-Singapore; National University of Singapore; King George's Medical University; Tehran University of Medical Sciences; Shiraz University of Medical Science; University of Zambia; Baylor College of Medicine; University of London; Queen Mary University London; University of Pennsylvania; Dalhousie University; UERM Memorial Medical Center; University of York - UK; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; United Nations Population Fund; University of Helsinki; Helsinki University Central Hospital; Ifakara Health Institute; Pacific Institute for Research & Evaluation (PIRE); Curtin University; University of Ottawa; University of Pennsylvania; Universiti Kebangsaan Malaysia; Salahaddin University; University of Papua New Guinea; IRCCS Burlo Garofolo; University of North Texas System; University of North Texas Denton; Queensland University of Technology (QUT); Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; University of Crete; University of Crete; Egerton University; Okinawa Chubu Central Hospital; American University of Beirut; University of Kwazulu Natal; ASST Papa Giovanni XXIII; Suraj Eye Institute; George Institute for Global Health; University of Sydney; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; University of Oslo; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Deakin University; University of Bergen; University of Bergen; Lund University; Makerere University; Kyung Hee University; Teikyo University; South African Medical Research Council; South African Medical Research Council; Stellenbosch University; Universidade do Porto; Hospital Universitario Cruces; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Flinders University South Australia; Aalborg University; University of Witwatersrand; Emory University; McGill University; University of Newcastle; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hamad Medical Corporation; University of Missouri System; University of Missouri Columbia; World Health Organization; Brown University; Egyptian Knowledge Bank (EKB); Suez Canal University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; London Health Sciences Centre; Western University (University of Western Ontario); George Washington University; University of London; London School of Hygiene & Tropical Medicine; Mid-Sweden University; World Health Organization; International Agency for Research on Cancer (IARC); Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute; Muhimbili University of Health & Allied Sciences; University of Miami; Queensland Centre for Mental Health Research; Universiti Kebangsaan Malaysia; Case Western Reserve University; Chicago Medical School; University of Zurich; University System of Maryland; University of Maryland College Park; Dartmouth College; Dartmouth College; Marshall University; Novartis; Novartis Turkey; Universidade Federal de Santa Catarina (UFSC); University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Bath; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tachikawa Hospital; Tampere University; Washington State University; Northumbria University; University of Edinburgh; Reykjavik University; International Institute for Population Sciences; Stavanger University Hospital; Universiti Tunku Abdul Rahman (UTAR); Griffith University; University Hospital Attikon; University of Munich; Alexandra Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Northwestern University; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign; Chaim Sheba Medical Center; Tel Aviv University; Westchester Medical Center; King Fahad Medical City; New York University; Aristotle University of Thessaloniki; University of Tennessee System; University of Tennessee Health Science Center; Universidade do Sul de Santa Catarina; Hanoi Medical University; Universite de Kinshasa; Cleveland Clinic Foundation; European Commission Joint Research Centre; EC JRC ISPRA Site; Netherlands National Institute for Public Health & the Environment; Maastricht University; UKK Institute; Universidade de Brasilia; University of Bologna; HSE University (National Research University Higher School of Economics); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Uniformed Services University of the Health Sciences - USA; Georgetown University; Beijing Neurosurgical Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of California System; University of California Davis; Wayne State University; University of Nottingham; University of Gondar; Royal Cornwall Hospital; Nanjing University; Duke Kunshan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jichi Medical University; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Jackson State University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Chongqing Medical University; Zhejiang University	Murray, CJ (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Lotufo, Paulo/A-9843-2008; Idrisov, Bulat/A-8271-2018; Kemp, Andrew Haddon/C-7984-2012; Nyakarahuka, Luke/AGH-2432-2022; Wallin, Mitchell T./J-8190-2019; saylan, Mete/B-5648-2008; Rojas-Rueda, David/AAK-2184-2020; Kaul, Anil/B-2075-2016; Castro, Ruben E/J-1948-2015; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Defo, Barthelemy Kuate/I-4818-2017; Jiang, Fan/AGX-9052-2022; Prabhakaran, Dorairaj/B-4147-2011; Karch, André/D-6973-2017; Terkawi, Abdullah Suleiman/AAC-1113-2019; Mahdi, Abbas Ali/AAB-2293-2021; Brenner, Hermann/B-4627-2017; Varakin, Yuriy Ya/C-8634-2012; Bose, Dipan/GRS-0467-2022; Schwebel, David/GXH-9944-2022; Singh, Jasvinder/R-6172-2019; A, Naheed/AHB-2941-2022; wang, lin/HHM-2225-2022; Martin, Randall/C-1205-2014; Alsharif, Ubai/AAK-2088-2021; Soshnikov, Sergey/AAG-9739-2020; Geleijnse, Johanna Marianna M/B-5749-2012; Medina, Catalina/AAT-6316-2020; Rana, Saleem M/Y-9791-2018; Moradi-Lakeh, Maziar/ABC-9793-2021; Ribeiro, Ana Cristina/HHN-7466-2022; Oh, In Hwan/AAI-9070-2020; Pereira, David/M-9286-2013; Polanczyk, Guilherme V./AAF-6142-2021; Kengne, Andre Pascal/ABB-3696-2020; Montico, Marcella/B-5290-2013; Melaku, Yohannes Adama/S-2451-2019; CT, Sreeramareddy/I-1203-2019; Hay, Simon Iain/F-8967-2015; GANKPE, GBETOHO FORTUNE/GLT-4476-2022; Ikeda, Nayu/J-9890-2019; Neupane, Sudan Prasad/C-8056-2011; Matzopoulos, Richard/AAL-9965-2021; Khan, Ejaz A/B-9340-2016; Vasconcelos, Ana Maria Nogales/AAL-9776-2020; Pope, C. Arden/ABD-5522-2021; Sepanlou, Sadaf G/H-9343-2016; Perico, Norberto/ABH-3222-2020; Kinfu, Yohannes/AAC-8054-2020; Marks, Guy B./F-5058-2013; Santos, Itamar/M-2208-2019; Brugha, Traolach/T-9326-2019; Tillmann, Taavi/R-6026-2016; Gona, Philimon/K-1477-2019; Brenner, Hermann/ABE-6383-2020; Castañeda-Orjuela, Carlos/N-2601-2017; Matsushita, Kunihiro/B-1021-2018; Zhou, Maigeng/HCH-7703-2022; Courville, Karen/AAW-1462-2021; Gething, Peter/ABD-2110-2020; Lopez, Alan/AAA-2734-2022; Hu, Howard/AAV-5360-2021; Heredia-Pi, Ileana Beatriz/L-4247-2019; Room, Robin/ABF-7460-2021; Deribe, Kebede/K-7055-2019; Nash, Denis/AFI-7485-2022; Newton, Charles RJC/B-7578-2014; Lee, Jong-Tae/AAF-5746-2020; Beyene, Tariku Jibat/A-6875-2017; Rodriguez, Alina/B-3541-2015; Salomon, Joshua/S-1929-2019; Takahashi, Ken/AAX-7705-2020; Deribe, Kebede/I-5422-2019; Schöttker, Ben/F-8183-2014; Lozano, Rafael/T-5352-2018; Room, Robin/ABH-8505-2020; Zheng, Yingfeng/AAE-2983-2022; McKee, Marc D/E-2187-2011; Ronfani, Luca/B-6668-2013; Satpathy, Maheswar/J-3135-2017; Matsushita, Kunihiro/AAJ-5817-2020; assadi, reza/AAI-1124-2021; Charlson, Fiona/R-8963-2019; Bernabe, Eduardo/R-3441-2017; Jayaraman, Sudha/AAH-3059-2019; Li, Yichong/A-3559-2019; Villalpando, Salvador/AAS-3874-2021; Saylan, Mete/AAP-1195-2020; Giussani, Giorgia/AAA-8029-2020; Bicer, Burcu Kucuk/G-4922-2017; Stein, Dan/A-1752-2008; RUIZ, FERNANDO PEREZ/X-1980-2019; Sposato, Luciano A/D-7782-2012; Weiderpass, Elisabete/M-4029-2016; Bin Abdulhak, Aref/AAK-4348-2020; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Broday, David/AAE-7108-2019; Riederer, Anne/HHN-1303-2022; Majdan, Marek/K-5017-2012; Bell, Michelle/Y-4608-2018; Poenaru, Dan/S-2562-2017; Kivipelto, Miia/AAS-3557-2021; Hankey, Graeme J/H-4968-2014; Gunnell, David/ABE-6653-2020; abbafati, cristiana/AAD-7511-2022; Mapoma, Christopher Chabila/AAX-3368-2020; Lunevicius, Raimundas/B-2528-2018; Azage, Muluken/AAF-6515-2020; Ermakov, Sergey/G-1709-2016; Bedi, Neeraj/H-2838-2019; Malekzadeh, Reza/U-1382-2017; Ribeiro, Antonio L/C-2707-2009; Rahimi, Kazem/AAA-4250-2022; Foigt, Nataliya/AAU-5229-2020; Hubbell, Bryan/AAA-2511-2020; Cardis, Elisabeth/C-3904-2017; , Bennett/O-7998-2019; Søreide, Kjetil/A-9797-2010; Tanne, David/F-2560-2010; Radfar, Amir/I-8057-2019; Thrift, Amanda/I-6251-2012; Sacco, Ralph/Y-9278-2019; Whiteford, Harvey A/A-4840-2009; Asghar, Rana Jawad/AAF-7634-2021; Juel, Knud/C-8916-2013; Dokova, Klara/N-2448-2016; Karthikeyan, Ganesan/D-5767-2012; Adsuar, Jose C/C-6558-2008; Degenhardt, Louisa J/D-4515-2012; Pond, Constance Dimity/I-1390-2019; Vasconcelos, Ana/AAK-4526-2020; Ginawi, Ibrahim Abdelmageed Mohamed/H-3260-2012; Boothapati, Anil Kumar/HHS-1813-2022; van Os, Jim/C-2113-2014; Ali, Mohammed K/N-9833-2013; PEREZ-RUIZ, FERNANDO/E-4844-2012; Salomon, Joshua A/D-3898-2009; LOGROSCINO, GIANCARLO/K-5148-2016; Liu, Yang/AAA-7224-2019; Jacobsen, Kathryn H./B-5857-2008; Alsharif, Ubai/C-6527-2017; Levi, Miriam/AAR-8512-2020; London, Stephanie/C-3734-2019; Ärnlöv, Johan/AAF-2746-2019; Davis, Adrian C/E-6022-2015; Lalloo, Ratilal/O-5624-2014; wang, YA XING/K-9671-2016; Schneider, Ione J.C./J-8762-2013; Devries, Karen/K-1083-2016; assadi, reza/AAT-6629-2020; Phillips, Michael Robert/AAE-7585-2021; Sahathevan, Ramesh/S-9302-2019; Khan, Prof Dr Ejaz/GNP-1245-2022; Gething, Peter/GQR-1884-2022; Quistberg, D Alex/P-3538-2019; Trasande, Leonardo/ABE-6339-2020; Woldeyohannes, Solomon Meseret/E-5783-2012; Hedayati, Mohammad T./E-2304-2017; Husseini, Abdullatif/E-8377-2015; Kravchenko, Michael A/B-2596-2012; Rahimi-Movaghar, Vafa/L-6339-2019; Mukaigawara, Mitsuru/L-2144-2016; Ukwaja, Kingsley N./A-7794-2013; Cunningham, Solveig/W-2672-2019; Bennett, Derrick/AAH-1220-2022; Balakrishnan, Kalpana/B-6653-2015; Kuipers, Ernst J/H-3293-2019; Feigin, Valery/AAF-2313-2019; Cunningham, Solveig A/K-6760-2012; Lortet-Tieulent, Joannie/AAE-9099-2019; Memish, Ziad Ahmed/AEJ-9424-2022; Catalá-López, Ferrán/N-6018-2018; Naldi, Luigi/AFM-8982-2022; Santos, Itamar S/K-7055-2012; Parry, Charles/A-2906-2009; de la cruz, vanessa/AAH-5999-2020; Waller, Stephen/AAI-1787-2020; Jiang, Fan/AHA-6297-2022; Zheng, Yingfeng/CAE-9225-2022; Refaat, Amany/AAA-8470-2021; Rakovac, Ivo/A-7678-2013; Mckee, Martin/E-6673-2018; ABRAHAM, BIJU/AAK-2461-2020; Brauer, Michael/Y-2810-2019; CASO, VALERIA/AAC-5156-2022; Bikbov, Boris/I-4594-2013; Newton, Charles/V-7872-2019; Aboyans, Victor/AAN-8308-2020; Polanczyk, Guilherme V/C-2345-2012; Weiderpass, Elisabete/AAP-2747-2021; KUMAR, ANIL/ACD-8340-2022; Naohiro, Yonemoto/Y-3761-2019; Meretoja, Atte/H-6531-2019; Ding, Eric L./K-1118-2019; Giussani, Giorgia/E-8057-2017; Ferri, Cleusa Pinheiro/B-2922-2010; wang, lin/GSE-3040-2022; Traebert, Jefferson/R-8699-2016; Sapkota, Amir/A-5968-2011; Amini, Heresh/B-3076-2010; Trillini, Matias/ABA-7075-2020; Chowdhury, Rajiv/AHB-1253-2022; Kan, Haidong/AGU-0328-2022; Kieling, Christian/U-3905-2019; van Os, Jim/V-8884-2019; Scott, James G/D-5900-2012; Tonelli, Marcello/B-3028-2009; Thurston, George/ABB-1359-2021; Cantoral, Alejandra/AAA-3615-2021; Van Dingenen, Rita/AAI-3197-2021; Alvis-Guzman, Nelson/D-4913-2013; Lopez, Alan D/F-1487-2010; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Soshnikov, Sergey/R-7352-2016; Olusanya, Bolajoko O./F-4504-2012; Nyakarahuka, Luke/W-8164-2019; Kromhout, Hans/A-9159-2008; Pesudovs, Konrad/T-9403-2019; Franklin, Richard Charles/H-1731-2012; Antonio, Carl Abelardo/AAP-4280-2020; Badawi, Alaa/ABC-1300-2021; Amare, Azmeraw T./B-9487-2018; A, Naheed/AHB-2940-2022; Pourmalek, Farshad/A-8188-2010; Zaki, Maysaa El Sayed/C-1522-2013; Violante, Francesco S/A-6934-2009; Hornberger, John/M-4932-2019; Papachristou, Christina/AAR-2187-2021; Dimbuene, Zacharie Tsala/H-3029-2019; ABBASOGLU OZGOREN, AYSE/I-8707-2013; Zhao, Yong/Z-3231-2019; PACELLA, ROSANA E./F-2774-2010; Hamadeh, Randah R./AAE-9720-2020; Pandian, Jeyaraj Durai/AAV-5591-2020; Bennett, Derrick/AFL-9254-2022; Nieuwenhuijsen, Mark J/C-3914-2017; Mason-Jones, Amanda/ABF-1565-2020; Monasta, Lorenzo/B-1388-2012; Charlson, Fiona J/F-5290-2011; Marzan, Melvin/AAP-8443-2020; Buchbinder, Rachelle/G-2952-2011; Naidoo, Kovin Shunmugam/AAF-5914-2020; Mokdad, Ali H./AAD-1232-2022; Fra.Paleo, Urbano/B-8088-2016; SHIN, HS/AAE-5381-2022; Wagner, Gregory R/B-1014-2009; alla, francois/D-2295-2014; Haro, Josep Maria/D-1423-2011; Benzian, Habib/AAN-5866-2020; Brazinova, Alexandra/C-4265-2016; Scarborough, Peter/ABD-6111-2021; Zunt, Joseph/ABD-2886-2021; Zaki, Maysaa El Sayed/H-3049-2019; Khader, Yousef/AAE-9620-2019; Kim, Yun Jin/AAE-8281-2019; Narayan, K.M. Venkat/J-9819-2012; Shiri, Rahman/ABB-1780-2021; Broday, David/CAG-3728-2022; Soshnikov, Sergey/AAV-8566-2020; Leung, Ricky/P-3702-2015; Patten, Scott/B-4434-2011; Nolte, Sandra/B-7498-2008; wang, lili/HDL-7210-2022; Bin Abdulhak, Aref/AAM-9492-2020; Alvarez, Elena/S-1068-2019; Anderson, Hugh R/A-7417-2016; Norheim, Ole Frithjof/AAC-8771-2020; Knudsen, Ann Kristin/AAB-2465-2019; Banerjee, Amitava/D-4381-2014; Heydarpour, Pouria/J-7330-2019; Vasconcelos, Ana Maria Nogales/E-1935-2019; Ferrari, Alize J/G-1746-2011; Naldi, Luigi/K-6343-2016; Knibbs, Luke/C-7865-2012; Bedi, Neeraj/AGR-0606-2022; Ameli, Omid/G-1583-2013; Refaat, Amany/K-5419-2016; Davitoiu, Dragos/P-9703-2017; Vlassov, Vasiliy/B-4036-2014; Larson, Heidi J./N-1018-2017; Cirillo, Massimo/G-5480-2018; Vlassov, Valentin/F-4720-2013; Rahimi-Movaghar, Vafa/T-7816-2017; Erskine, Holly/K-5244-2012; Lansingh, Van/C-8672-2018; Paternina-Caicedo, Angel/N-4496-2015; Leasher, Janet/B-8889-2016; Remuzzi, Giuseppe/V-9766-2017; Morawska, Lidia/B-4140-2011; Rahimi, Kazem/Q-1279-2015; Veerman, Lennert/A-9973-2011	Lotufo, Paulo/0000-0002-4856-8450; Kemp, Andrew Haddon/0000-0003-1146-3791; Nyakarahuka, Luke/0000-0002-2944-9157; Wallin, Mitchell T./0000-0003-1061-5714; saylan, Mete/0000-0002-8917-1775; Rojas-Rueda, David/0000-0001-5854-2484; Castro, Ruben E/0000-0002-7289-9081; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Defo, Barthelemy Kuate/0000-0002-6589-0564; Jiang, Fan/0000-0003-0634-101X; Prabhakaran, Dorairaj/0000-0002-3172-834X; Karch, André/0000-0003-3014-8543; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Brenner, Hermann/0000-0002-6129-1572; Singh, Jasvinder/0000-0003-3485-0006; A, Naheed/0000-0002-6016-5603; Martin, Randall/0000-0003-2632-8402; Alsharif, Ubai/0000-0002-4024-3950; Soshnikov, Sergey/0000-0002-6983-7066; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Rana, Saleem M/0000-0001-6479-9235; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Ribeiro, Ana Cristina/0000-0002-0493-8376; Oh, In Hwan/0000-0002-5450-9887; Pereira, David/0000-0003-0384-7592; Polanczyk, Guilherme V./0000-0003-2311-3289; Montico, Marcella/0000-0003-0377-8232; Melaku, Yohannes Adama/0000-0002-3051-7313; CT, Sreeramareddy/0000-0002-5693-7631; Hay, Simon Iain/0000-0002-0611-7272; GANKPE, GBETOHO FORTUNE/0000-0002-1242-9686; Ikeda, Nayu/0000-0002-3424-1991; Matzopoulos, Richard/0000-0001-9063-6210; Khan, Ejaz A/0000-0002-7072-8035; Vasconcelos, Ana Maria Nogales/0000-0001-7589-107X; Sepanlou, Sadaf G/0000-0002-3669-5129; Perico, Norberto/0000-0002-3147-4327; Kinfu, Yohannes/0000-0001-9607-6891; Marks, Guy B./0000-0002-8976-8053; Santos, Itamar/0000-0003-3212-8466; Brugha, Traolach/0000-0002-9786-9591; Tillmann, Taavi/0000-0002-8428-3719; Brenner, Hermann/0000-0002-6129-1572; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Matsushita, Kunihiro/0000-0002-7179-718X; Courville, Karen/0000-0002-4182-6736; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Room, Robin/0000-0002-5618-385X; Newton, Charles RJC/0000-0002-6999-5507; Lee, Jong-Tae/0000-0002-8510-3054; Beyene, Tariku Jibat/0000-0002-7474-1966; Rodriguez, Alina/0000-0003-1209-8802; Salomon, Joshua/0000-0003-3929-5515; Takahashi, Ken/0000-0002-7310-2257; Deribe, Kebede/0000-0002-8526-6996; Schöttker, Ben/0000-0002-1217-4521; Lozano, Rafael/0000-0002-7356-8823; McKee, Marc D/0000-0001-8349-965X; Ronfani, Luca/0000-0001-5710-3914; Satpathy, Maheswar/0000-0003-3521-4781; Matsushita, Kunihiro/0000-0002-7179-718X; Charlson, Fiona/0000-0003-2876-5040; Bernabe, Eduardo/0000-0002-1858-3713; Jayaraman, Sudha/0000-0003-1094-5836; Li, Yichong/0000-0003-3842-475X; Villalpando, Salvador/0000-0001-6429-3816; Giussani, Giorgia/0000-0003-2460-3095; Bicer, Burcu Kucuk/0000-0002-5615-264X; Stein, Dan/0000-0001-7218-7810; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Sposato, Luciano A/0000-0001-6425-9343; Weiderpass, Elisabete/0000-0003-2237-0128; Broday, David/0000-0002-6525-3979; Majdan, Marek/0000-0001-8037-742X; Bell, Michelle/0000-0002-3965-1359; Poenaru, Dan/0000-0002-6267-6140; Hankey, Graeme J/0000-0002-6044-7328; Gunnell, David/0000-0002-0829-6470; Mapoma, Christopher Chabila/0000-0001-9233-5462; Lunevicius, Raimundas/0000-0003-3295-0142; Azage, Muluken/0000-0003-3222-0158; Ermakov, Sergey/0000-0003-1072-1162; Bedi, Neeraj/0000-0003-4709-8423; Malekzadeh, Reza/0000-0002-9820-6335; Ribeiro, Antonio L/0000-0002-2740-0042; Foigt, Nataliya/0000-0002-3613-5965; Hubbell, Bryan/0000-0002-7963-3438; Cardis, Elisabeth/0000-0003-0999-6839; Søreide, Kjetil/0000-0001-7594-4354; Tanne, David/0000-0002-6699-2220; Radfar, Amir/0000-0001-6177-3048; Thrift, Amanda/0000-0001-8533-4170; Whiteford, Harvey A/0000-0003-4667-6623; Karthikeyan, Ganesan/0000-0002-2073-2917; Adsuar, Jose C/0000-0001-7203-3168; Degenhardt, Louisa J/0000-0002-8513-2218; Pond, Constance Dimity/0000-0001-6520-4213; Ginawi, Ibrahim Abdelmageed Mohamed/0000-0001-8628-1840; Salomon, Joshua A/0000-0003-3929-5515; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Liu, Yang/0000-0001-5477-2186; Jacobsen, Kathryn H./0000-0002-4198-6246; Alsharif, Ubai/0000-0002-4024-3950; Levi, Miriam/0000-0002-0086-3952; London, Stephanie/0000-0003-4911-5290; Ärnlöv, Johan/0000-0002-6933-4637; Davis, Adrian C/0000-0001-7134-7528; Lalloo, Ratilal/0000-0001-5822-1269; wang, YA XING/0000-0003-2749-7793; Schneider, Ione J.C./0000-0001-6339-7832; Devries, Karen/0000-0001-8935-2181; Phillips, Michael Robert/0000-0002-5973-2439; Sahathevan, Ramesh/0000-0001-7643-0961; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Gething, Peter/0000-0001-6759-5449; Quistberg, D Alex/0000-0001-9730-2686; Hedayati, Mohammad T./0000-0001-6415-4648; Husseini, Abdullatif/0000-0001-8767-5956; Kravchenko, Michael A/0000-0001-5187-5518; Mukaigawara, Mitsuru/0000-0001-6530-2083; Ukwaja, Kingsley N./0000-0002-1974-8735; Bennett, Derrick/0000-0002-9170-8447; Balakrishnan, Kalpana/0000-0002-5905-1801; Kuipers, Ernst J/0000-0002-0633-3098; Cunningham, Solveig A/0000-0002-2354-1526; Lortet-Tieulent, Joannie/0000-0002-8816-7475; Memish, Ziad Ahmed/0000-0002-5099-0714; Catalá-López, Ferrán/0000-0002-3833-9312; Naldi, Luigi/0000-0002-3160-2835; Santos, Itamar S/0000-0003-3212-8466; Parry, Charles/0000-0001-9787-2785; Zheng, Yingfeng/0000-0002-0914-7864; Rakovac, Ivo/0000-0003-3462-2636; Mckee, Martin/0000-0002-0121-9683; Brauer, Michael/0000-0002-9103-9343; CASO, VALERIA/0000-0002-2020-8891; Bikbov, Boris/0000-0002-1925-7506; Newton, Charles/0000-0002-6999-5507; Polanczyk, Guilherme V/0000-0003-2311-3289; Weiderpass, Elisabete/0000-0003-2237-0128; Meretoja, Atte/0000-0001-6433-1931; Ding, Eric L./0000-0002-5881-8097; Giussani, Giorgia/0000-0003-2460-3095; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Amini, Heresh/0000-0002-4825-1322; Trillini, Matias/0000-0003-1859-1729; Kieling, Christian/0000-0001-7691-4149; van Os, Jim/0000-0002-7245-1586; Scott, James G/0000-0002-0744-0688; Tonelli, Marcello/0000-0002-0846-3187; Cantoral, Alejandra/0000-0002-1397-8476; Van Dingenen, Rita/0000-0003-2521-4972; Alvis-Guzman, Nelson/0000-0001-9458-864X; Lopez, Alan D/0000-0001-5818-6512; Soshnikov, Sergey/0000-0002-6983-7066; Olusanya, Bolajoko O./0000-0002-3826-0583; Nyakarahuka, Luke/0000-0002-2944-9157; Kromhout, Hans/0000-0002-4233-1890; Pesudovs, Konrad/0000-0002-6322-9369; Franklin, Richard Charles/0000-0003-1864-4552; Antonio, Carl Abelardo/0000-0001-7476-0553; Amare, Azmeraw T./0000-0002-7940-0335; A, Naheed/0000-0002-6016-5603; Pourmalek, Farshad/0000-0002-2134-0771; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Violante, Francesco S/0000-0003-4084-2782; Dimbuene, Zacharie Tsala/0000-0002-7977-1689; ABBASOGLU OZGOREN, AYSE/0000-0002-6106-4839; Zhao, Yong/0000-0001-9290-109X; PACELLA, ROSANA E./0000-0002-9742-1957; Hamadeh, Randah R./0000-0002-4205-1354; Bennett, Derrick/0000-0002-9170-8447; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Mason-Jones, Amanda/0000-0002-4292-3183; Monasta, Lorenzo/0000-0001-7774-548X; Charlson, Fiona J/0000-0003-2876-5040; Marzan, Melvin/0000-0003-2696-7335; Buchbinder, Rachelle/0000-0002-0597-0933; Mokdad, Ali H./0000-0002-4994-3339; Fra.Paleo, Urbano/0000-0001-6192-7684; SHIN, HS/0000-0002-7263-6257; Haro, Josep Maria/0000-0002-3984-277X; Benzian, Habib/0000-0003-3692-4849; Brazinova, Alexandra/0000-0003-0625-256X; Scarborough, Peter/0000-0002-2378-2944; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Khader, Yousef/0000-0002-7830-6857; Kim, Yun Jin/0000-0001-8853-6587; Narayan, K.M. Venkat/0000-0001-8621-5405; Shiri, Rahman/0000-0002-9312-3100; Leung, Ricky/0000-0002-2852-6771; Patten, Scott/0000-0001-9871-4041; Nolte, Sandra/0000-0001-6185-9423; Bin Abdulhak, Aref/0000-0001-9988-8609; Alvarez, Elena/0000-0002-9679-2721; Norheim, Ole Frithjof/0000-0002-5748-5956; Banerjee, Amitava/0000-0001-8741-3411; Heydarpour, Pouria/0000-0001-5644-7555; Ferrari, Alize J/0000-0002-7863-9117; Naldi, Luigi/0000-0002-3160-2835; Bedi, Neeraj/0000-0003-4709-8423; LARYEA, DENNIS/0000-0003-2212-084X; Derrett, Sarah/0000-0003-2867-0498; Sanchez Riera, Lidia/0000-0003-0774-2480; Ameli, Omid/0000-0001-7878-0551; Quezada-Sanchez, Amado D./0000-0003-3258-8198; Sunguya, Bruno/0000-0003-3625-0725; Al Asfoor, Deena/0000-0002-7973-1935; Trasande, Leonardo/0000-0002-1928-597X; Innos, Kaire/0000-0003-0120-2213; /0000-0002-9584-0576; Refaat, Amany/0000-0002-0501-6146; Davitoiu, Dragos/0000-0002-4493-6754; Goto, Atsushi/0000-0003-0669-654X; Rocha Nogueira, Jose/0000-0002-8316-710X; Nisar, Muhammad Imran/0000-0002-2378-4720; Xu, Gelin/0000-0002-6194-0341; Seedat, Soraya/0000-0002-5118-786X; Nash, Denis/0000-0002-3280-5386; Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106; Mahdi, Abbas Ali/0000-0002-8580-9911; Khang, Young-Ho/0000-0002-9585-8266; Meaney, Peter/0000-0001-9898-6928; Abubakar, Ibrahim/0000-0002-0370-1430; Vlassov, Vasiliy/0000-0001-5203-549X; Thomson, Blake/0000-0002-6433-0338; Endres, Matthias/0000-0001-6520-3720; Knudsen, Ann Kristin/0000-0002-1218-798X; shishani, kawkab/0000-0002-7792-6456; alla, francois/0000-0002-5793-7190; Sahraian, Mohammad Ali/0000-0002-3224-8807; Bhala, Neeraj/0000-0003-2502-1177; FARAON, EMERITO JOSE A./0000-0001-6157-5930; Ali, Mohammed/0000-0001-7266-2503; Larson, Heidi J./0000-0002-8477-7583; Aboyans, Victor/0000-0002-0322-9818; Magis-Rodriguez, Carlos/0000-0001-5481-1253; Feigin, Valery L./0000-0002-6372-1740; Shiue, Ivy/0000-0003-1788-3009; Ruhago, George Mugambage/0000-0001-7469-7822; Nahas, Ziad/0000-0002-8391-5673; Stockl, Heidi/0000-0002-0907-8483; Shibuya, Kenji/0000-0003-2528-7530; Dherani, Mukesh/0000-0002-3055-9636; Sanchez Pimienta, Tania Georgina/0000-0002-7743-0047; Cooper, Leslie/0000-0003-1002-3313; Razavi, Homie/0000-0002-2658-6930; Gouda, Hebe/0000-0002-5709-4509; Neal, Bruce/0000-0002-0490-7465; WILKINSON, JAMES/0000-0003-1945-5622; Balalla, Shivanthi/0000-0001-5320-753X; Mhimbira, Francis/0000-0001-8989-6832; Coates, Matthew/0000-0002-8474-4992; Cirillo, Massimo/0000-0002-6409-3504; Yoon, Seok-Jun/0000-0003-3297-0071; Ye, Pengpeng/0000-0002-2924-1436; Dandona, Rakhi/0000-0003-0926-788X; Moturi, Wilkister Nyaora/0000-0001-6620-4856; Topouzis, Fotis/0000-0002-8966-537X; Jarvis, Deborah/0000-0002-1753-3896; Basto Abreu, Ana/0000-0003-1600-4797; Tabb Dina, Karen/0000-0002-4722-9502; Texcalac Sangrador, Jose Luis/0000-0003-4507-9237; williams, hywel/0000-0002-5646-3093; Pandian, Jeyaraj/0000-0003-0028-1968; Aburto, Tania/0000-0002-6932-9344; Rakovac, Ivo/0000-0002-6815-5274; Mori, Rintaro/0000-0001-7656-6156; Islami, Farhad/0000-0002-7357-5994; Kim, Daniel/0000-0001-8907-6420; Kengne, Andre Pascal/0000-0002-5183-131X; Te Ao, Braden/0000-0002-1050-200X; Vlassov, Valentin/0000-0003-2845-2992; Woolf, Anthony/0000-0001-8482-8056; Barrero, Lope/0000-0003-1503-0264; Colquhoun, Samantha/0000-0002-6750-1147; Chen, Honglei/0000-0003-3446-7779; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Jeemon, Panniyammakal/0000-0003-4172-4307; Boufous, Soufiane/0000-0002-5686-1729; Kwan, Gene/0000-0002-0929-6800; Servan-Mori, Edson/0000-0001-9820-8325; Salvo, Deborah/0000-0002-9726-0882; Juel, Knud/0000-0002-4134-1173; van Gool, Coen H/0000-0001-7170-0563; Contreras, Alejandra/0000-0003-1576-5922; Pope, Daniel/0000-0003-2694-5478; Dargan, Paul/0000-0002-3433-9622; Colistro, Valentina/0000-0002-5727-4980; Dokova, Klara/0000-0002-0164-4903; Benjet, Corina/0000-0002-4569-6094; Cavlin, Alanur/0000-0001-9714-9984; Ohkubo, Takayoshi/0000-0002-3283-8196; Jha, Vivekanand/0000-0002-8015-9470; CHANG, JUNG-CHEN/0000-0001-8651-2602; Lallukka, Tea/0000-0003-3841-3129; Assadi, Reza/0000-0002-5016-2994; , Borja/0000-0003-3944-2212; Erskine, Holly/0000-0003-3119-9211; Knibbs, Luke/0000-0002-0399-2370; Lansingh, Van/0000-0002-0090-4195; Qato, Dima/0000-0001-5411-6998; ABRAHAM, BIJU/0000-0002-3586-2589; Idrisov, Bulat/0000-0002-1971-2572; Paternina-Caicedo, Angel/0000-0002-6332-5174; Batis, Carolina/0000-0002-2823-6651; Leasher, Janet/0000-0002-8779-5162; Riccio, Patricia/0000-0002-5561-5278; Blyth, Fiona/0000-0003-1128-6756; Miller, Ted/0000-0002-0958-2639; Tellez Rojo, Martha/0000-0003-3322-3334; Phillips, Michael/0000-0002-0252-9085; Stroumpoulis, Konstantinos/0000-0003-3234-3772; Achoki, Tom/0000-0001-6309-8904; Farzadfar, Farshad/0000-0001-8288-4046; Pedraza, Lilia S/0000-0001-9975-7035; Sindi, Shireen/0000-0002-3786-0552; Kissela, Brett/0000-0002-9773-4013; Abd-Allah, Foad/0000-0001-8308-5756; Goenka, Shifalika/0000-0001-6993-2883; Remuzzi, Giuseppe/0000-0002-6194-3446; Kimokoti, Ruth/0000-0002-4980-3256; Briggs, Adam/0000-0002-2314-1039; Gabbe, Belinda/0000-0001-7096-7688; Esteghamati, Alireza/0000-0001-5114-3982; Morawska, Lidia/0000-0002-0594-9683; Borges, Guilherme/0000-0002-3269-0507; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Woldeyohannes, Solomon/0000-0003-2431-2730; Reddy, K Srinath/0000-0003-3416-3548; Soljak, Michael/0000-0002-0303-1617; Neupane, Sudan Prasad/0000-0002-7389-4178; Aasvang, Gunn Marit/0000-0002-3592-4831; Rahimi, Kazem/0000-0002-4807-4610; Veerman, Lennert/0000-0002-3206-8232; Burney, Peter/0000-0001-8635-5678; Roy, Nobhojit/0000-0003-2022-7416; Hu, Howard/0000-0002-3676-2707; Hoek, Hans/0000-0001-6353-5465; Pearce, Neil/0000-0002-9938-7852	Bill AMP; Melinda Gates Foundation; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0400491, U1475000001, MR/L003120/1, MC_U147585819, MR/K006525/1, MC_U137686851, MC_UU_12011/1, MC_U147585827, MC_U147585824, MC_UP_A620_1014] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, RP-PG-0407-10184, NF-SI-0510-10060, NF-SI-0513-10085, ACF-2011-13-012, NF-SI-0512-10165] Funding Source: researchfish; MRC [MC_U137686851, MR/K006525/1, MC_U147585827, G0400491, MR/L003120/1, MC_U147585819] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR001079, KL2TR001088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, ZIAES043012, R01ES021446] Funding Source: NIH RePORTER	Bill AMP; Melinda Gates Foundation; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Bill & Melinda Gates Foundation.	Abrams DI, 2014, J CLIN ONCOL, V32, P2290, DOI 10.1200/JCO.2014.56.6299; Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA111, DOI 10.1289/ehp.122-A111; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607; Banks E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0281-z; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bloomberg Philanthropies, 2011, ACC WORLDW MOV RED T; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brumback B A, 2000, Biostatistics, V1, P203, DOI 10.1093/biostatistics/1.2.203; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Carey IM, 2013, AM J RESP CRIT CARE, V187, P1226, DOI 10.1164/rccm.201210-1758OC; Chafe ZA, 2014, ENVIRON HEALTH PERSP, V122, P1314, DOI 10.1289/ehp.1206340; Chan M, 2012, LANCET, V380, P2054, DOI 10.1016/S0140-6736(12)62135-7; Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Cook RJ, 2001, BIOMETRICS, V57, P671, DOI 10.1111/j.0006-341X.2001.00671.x; Crouse DL, 2012, ENVIRON HEALTH PERSP, V120, P708, DOI 10.1289/ehp.1104049; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dye C, 2013, NATURE, V502, pS13, DOI 10.1038/502S13a; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Guasch-Ferre M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-164; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6; He F. J., 2013, BMJ, V346; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Hebert JR, 2014, ADV NUTR, V5, P447, DOI 10.3945/an.114.006189; Hystad P, 2013, EPIDEMIOLOGY, V24, P762, DOI 10.1097/EDE.0b013e3182949ae7; Institute of Medicine of the National Academies, 2013, SOD INT POP ASEV; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Jackson CL, 2014, AM J CLIN NUTR, V100, p408S, DOI 10.3945/ajcn.113.071332; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098; Kim JY, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62162-X; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Masters RK, 2013, AM J PUBLIC HEALTH, V103, P1895, DOI 10.2105/AJPH.2013.301379; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Mente A, 2014, CAN J CARDIOL, V30, P507, DOI 10.1016/j.cjca.2014.02.003; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400; Naveedullah, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/590306; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Donnell M, 2014, NEW ENGL J MED, V371, P2137, DOI 10.1056/NEJMc1412113; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Olofin I, 2013, PLOS ONE, V8; Patel SR, 2012, SLEEP, V35, P97, DOI 10.5665/sleep.1594; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pope CA, 2015, J AIR WASTE MANAGE, V65, P516, DOI 10.1080/10962247.2014.993004; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Preston SH, 2013, EPIDEMIOLOGY, V24, P158, DOI 10.1097/EDE.0b013e3182770217; Preston SH, 1980, POPULATION EC CHANGE, P289; Rehm J, 2013, INT J ALCOHOL DRUG R, V2, P1, DOI 10.7895/ijadr.v2il.132; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rhodes HG, MEAS RISKS CAUS PREM; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rouhani MH, 2014, OBES REV, V15, P740, DOI 10.1111/obr.12172; Saint-Jacques N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-44; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Stokes A, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-6; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vander Hoorn S, 2004, COMP QUANTIFICATION; Villeneuve PJ, 1999, CANCER CAUSE CONTROL, V10, P355, DOI 10.1023/A:1008958103865; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Watts C, 2012, LANCET, V380, P2060, DOI 10.1016/S0140-6736(12)62121-7; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organization, 2008, MPOWER POL PACK REV; Zhao XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110131	86	1725	1795	34	377	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2287	2323		10.1016/S0140-6736(15)00128-2	http://dx.doi.org/10.1016/S0140-6736(15)00128-2			37	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26364544	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000365993200031
J	Nomura, N; Verdon, G; Kang, HJ; Shimamura, T; Nomura, Y; Sonoda, Y; Hussien, SA; Qureshi, AA; Coincon, M; Sato, Y; Abe, H; Nakada-Nakura, Y; Hino, T; Arakawa, T; Kusano-Arai, O; Iwanari, H; Murata, T; Kobayashi, T; Hamakubo, T; Kasahara, M; Iwata, S; Drew, D				Nomura, Norimichi; Verdon, Gregory; Kang, Hae Joo; Shimamura, Tatsuro; Nomura, Yayoi; Sonoda, Yo; Hussien, Saba Abdul; Qureshi, Aziz Abdul; Coincon, Mathieu; Sato, Yumi; Abe, Hitomi; Nakada-Nakura, Yoshiko; Hino, Tomoya; Arakawa, Takatoshi; Kusano-Arai, Osamu; Iwanari, Hiroko; Murata, Takeshi; Kobayashi, Takuya; Hamakubo, Takao; Kasahara, Michihiro; Iwata, So; Drew, David			Structure and mechanism of the mammalian fructose transporter GLUT5	NATURE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; GLUCOSE-TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; SMALL-INTESTINE; HEXOSE TRANSPORTER; SUGAR-TRANSPORT; MEMBRANE; FAMILY; SEQUENCE	The altered activity of the fructose transporter GLUT5, an isoform of the facilitated-diffusion glucose transporter family, has been linked to disorders such as type 2 diabetes and obesity. GLUT5 is also overexpressed in certain tumour cells, and inhibitors are potential drugs for these conditions. Here we describe the crystal structures of GLUT5 from Rattus norvegicus and Bos taurus in open outward-and open inward-facing conformations, respectively. GLUT5 has a major facilitator superfamily fold like other homologous monosaccharide transporters. On the basis of a comparison of the inward-facing structures of GLUT5 and human GLUT1, a ubiquitous glucose transporter, we show that a single point mutation is enough to switch the substrate-binding preference of GLUT5 from fructose to glucose. A comparison of the substrate-free structures of GLUT5 with occluded substrate-bound structures of Escherichia coli XylE suggests that, in addition to global rocker-switch-like re-orientation of the bundles, local asymmetric rearrangements of carboxy-terminal transmembrane bundle helices TM7 and TM10 underlie a 'gated-pore' transport mechanism in such monosaccharide transporters.	[Nomura, Norimichi; Shimamura, Tatsuro; Nomura, Yayoi; Sato, Yumi; Abe, Hitomi; Nakada-Nakura, Yoshiko; Hino, Tomoya; Arakawa, Takatoshi; Murata, Takeshi; Kobayashi, Takuya; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Nomura, Norimichi; Shimamura, Tatsuro; Nomura, Yayoi; Hino, Tomoya; Arakawa, Takatoshi; Murata, Takeshi; Kobayashi, Takuya; Iwata, So] Japan Sci & Technol Agcy, ERATO, Iwata Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Nomura, Norimichi; Shimamura, Tatsuro; Nomura, Yayoi; Nakada-Nakura, Yoshiko; Murata, Takeshi; Kobayashi, Takuya; Iwata, So] Japan Sci & Technol Agcy, Res Accelerat Program, Membrane Prot Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Verdon, Gregory; Kang, Hae Joo; Sonoda, Yo; Iwata, So; Drew, David] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Verdon, Gregory; Kang, Hae Joo; Iwata, So] Diamond Light Source, Membrane Prot Lab, Chilton OX11 0DE, Oxon, England; [Verdon, Gregory; Kang, Hae Joo; Iwata, So] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Hussien, Saba Abdul; Qureshi, Aziz Abdul; Coincon, Mathieu; Drew, David] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Kusano-Arai, Osamu; Hamakubo, Takao] Univ Tokyo, Dept Quantitat Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Murata, Takeshi; Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kasahara, Michihiro] Teikyo Univ, Sch Med, Biophys Lab, Hachioji, Tokyo 1920395, Japan	Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Imperial College London; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Stockholm University; University of Tokyo; RIKEN; Teikyo University	Nomura, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Konoe Cho, Kyoto 6068501, Japan.	nnomura@mfour.med.kyoto-u.ac.jp; s.iwata@mfour.med.kyoto-u.ac.jp; ddrew@dbb.su.se	Murata, Takeshi/J-6181-2017; Drew, David/AAY-3455-2020; Drew, David/D-3243-2018; Arakawa, Takatoshi/K-9739-2013	Murata, Takeshi/0000-0002-5748-4670; Arakawa, Takatoshi/0000-0001-6496-5440; Drew, David/0000-0001-8866-6349; Verdon, Gregory/0000-0002-9788-4361	Knut and Alice Wallenberg Foundation; Royal Society; BBSRC [BB/G02325/1]; ERATO Human Receptor Crystallography Project of the Japan Science and Technology Agency (JST); Research Acceleration Program of the JST; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT [22570114]; MEXT; Wellcome Trust at the Diamond Light Source Limited [062164/Z/00/Z]; Centre for Biomembrane Research (CBR) - Swedish Foundation for Strategic Research; Human Frontiers Postdoctoral fellowship; EMBO through Young Investigator Program (YIP); BBSRC [BB/G023425/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERATO Human Receptor Crystallography Project of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Research Acceleration Program of the JST; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wellcome Trust at the Diamond Light Source Limited(Wellcome Trust); Centre for Biomembrane Research (CBR) - Swedish Foundation for Strategic Research; Human Frontiers Postdoctoral fellowship; EMBO through Young Investigator Program (YIP); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to D. Slotboom, A. Cameron and S. Newstead for discussions and comments, and J. Mansfield for assistance with large-scale yeast fermentations and H. Unno with rGLUT5 crystallization. Data were collected at the European Synchrotron Radiation Facility, Diamond Light Source, and SPring-8 (proposal numbers 2011A1393, 2011B1229, 2012A1184, 2012B1253, 2013A1241, 2013B1237, 2014A1348 and 2014B1407), with assistance from beamline scientists. This work was funded by the Knut and Alice Wallenberg Foundation (D. D), The Royal Society through the University Research Fellow scheme (D. D), the BBSRC (BB/G02325/1 to S. I.), the ERATO Human Receptor Crystallography Project of the Japan Science and Technology Agency (JST) (S. I.), by the Research Acceleration Program of the JST (S. I.), by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (S. I.), and by Grants-in-Aids for Scientific Research from the MEXT (No. 22570114 to N.N.), and by the Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT (T.K.). The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/Z/00/Z) at the Diamond Light Source Limited, and The Centre for Biomembrane Research (CBR), supported by the Swedish Foundation for Strategic Research. H.J.K. was a recipient of a Human Frontiers Postdoctoral fellowship and D. D. acknowledges support from EMBO through the Young Investigator Program (YIP).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson M, 2012, STRUCTURE, V20, P1893, DOI 10.1016/j.str.2012.08.021; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; BLAKEMORE SJ, 1995, BIOCHEM J, V309, P7, DOI 10.1042/bj3090007; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Fukuda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8097; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Karpowich NK, 2008, SCIENCE, V321, P781, DOI 10.1126/science.1161495; Kasahara T, 2009, BBA-BIOMEMBRANES, V1788, P1051, DOI 10.1016/j.bbamem.2009.01.014; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KAYANO T, 1990, J BIOL CHEM, V265, P13276; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Li Q, 2004, AM J PHYSIOL-GASTR L, V287, pG236, DOI 10.1152/ajpgi.00396.2003; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; RAND EB, 1993, AM J PHYSIOL, V264, pG1169, DOI 10.1152/ajpgi.1993.264.6.G1169; SARKAR HK, 1988, P NATL ACAD SCI USA, V85, P5463, DOI 10.1073/pnas.85.15.5463; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; SHEPHERD PR, 1992, DIABETES, V41, P1360, DOI 10.2337/diabetes.41.10.1360; SIMPSON IA, 1994, BIOCHEM SOC T, V22, P671, DOI 10.1042/bst0220671; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Sonoda Y, 2010, FEBS LETT, V584, P2539, DOI 10.1016/j.febslet.2010.04.015; Suharni, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P378, DOI 10.1089/mab.2014.0041; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WARBURG O, 1956, SCIENCE, V124, P269; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	55	150	156	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					397	+		10.1038/nature14909	http://dx.doi.org/10.1038/nature14909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26416735	Green Accepted, Green Submitted			2022-12-28	WOS:000362730200044
J	Huang, X; Chen, H; Michelsen, K; Schneider, S; Shaffer, PL				Huang, Xin; Chen, Hao; Michelsen, Klaus; Schneider, Stephen; Shaffer, Paul L.			Crystal structure of human glycine receptor-alpha 3 bound to antagonist strychnine	NATURE			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTORS; FUNCTIONAL EXPRESSION; GATING MECHANISM; BINDING-PROTEIN; LIGAND; COMPLEXES; ACTIVATION; ANALOGS	Neurotransmitter-gated ion channels of the Cys-loop receptor family are essential mediators of fast neurotransmission throughout the nervous system and are implicated in many neurological disorders. Available X-ray structures of prokaryotic and eukaryotic Cys-loop receptors provide tremendous insights into the binding of agonists, the subsequent opening of the ion channel, and the mechanism of channel activation(1-8). Yet the mechanism of inactivation by antagonists remains unknown. Here we present a 3.0 angstrom X-ray structure of the human glycine receptor-alpha 3 homopentamer in complex with a high affinity, high-specificity antagonist, strychnine. Our structure allows us to explore in detail the molecular recognition of antagonists. Comparisons with previous structures reveal a mechanism for antagonist-induced inactivation of Cys-loop receptors, involving an expansion of the orthosteric binding site in the extracellular domain that is coupled to closure of the ion pore in the transmembrane domain.	[Huang, Xin; Michelsen, Klaus; Shaffer, Paul L.] Amgen Inc, Dept Mol Struct & Characterizat, Cambridge, MA 02142 USA; [Chen, Hao] Amgen Inc, Dept Prot Technol, Cambridge, MA 02142 USA; [Schneider, Stephen] Amgen Inc, Dept Neurosci, Cambridge, MA 02142 USA	Amgen; Amgen; Amgen	Huang, X (corresponding author), Amgen Inc, Dept Mol Struct & Characterizat, 360 Binney St, Cambridge, MA 02142 USA.	hxin@amgen.com; pshaffer@amgen.com						Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P1789, DOI 10.1016/j.bcp.2003.12.037; Jensen AA, 2006, EUR J PHARMACOL, V539, P27, DOI 10.1016/j.ejphar.2006.04.010; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mohsen AMY, 2014, CHEM BIODIVERS, V11, P1256, DOI 10.1002/cbdv.201400110; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f	41	167	170	4	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					277	+		10.1038/nature14972	http://dx.doi.org/10.1038/nature14972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416729				2022-12-28	WOS:000362399000052
J	Yoho, R				Yoho, Rachel			How science fairs shaped my career	SCIENCE			English	Editorial Material									[Yoho, Rachel] Arizona State Univ, Biol Design Program, Tempe, AZ USA; [Yoho, Rachel] Arizona State Univ, Swette Ctr Environm Biotechnol, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Yoho, R (corresponding author), Arizona State Univ, Biol Design Program, Tempe, AZ USA.								0	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1578	1578		10.1126/science.349.6255.1578	http://dx.doi.org/10.1126/science.349.6255.1578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404839				2022-12-28	WOS:000361707000051
J	Alexander, JM; Diez, JM; Levine, JM				Alexander, Jake M.; Diez, Jeffrey M.; Levine, Jonathan M.			Novel competitors shape species' responses to climate change	NATURE			English	Article							BIOTIC INTERACTIONS; PLANT-RESPONSE; GLOBAL CHANGE; DISPERSAL; RANGE; COMMUNITIES; FUTURE; SHIFTS	Understanding how species respond to climate change is critical for forecasting the future dynamics and distribution of pests, diseases and biological diversity(1-3). Although ecologists have long acknowledged species' direct physiological and demographic responses to climate, more recent work suggests that these direct responses can be overwhelmed by indirect effects mediated via other interacting community members(2-7). Theory suggests that some of the most dramatic impacts of community change will probably arise through the assembly of novel species combinations after asynchronous migrations with climate(8-10). Empirical tests of this prediction are rare, as existing work focuses on the effects of changing interactions between competitors that co-occur today(7,11-15). To explore how species' responses to climate warming depend on how their competitors migrate to track climate, we transplanted alpine plant species and intact plant communities along a climate gradient in the Swiss Alps. Here we show that when alpine plants were transplanted to warmer climates to simulate a migration failure, their performance was strongly reduced by novel competitors that could migrate upwards from lower elevation; these effects generally exceeded the impact of warming on competition with current competitors. In contrast, when we grew the focal plants under their current climate to simulate climate tracking, a shift in the competitive environment to novel high-elevation competitors had little to no effect. This asymmetry in the importance of changing competitor identity at the leading versus trailing range edges is best explained by the degree of functional similarity between current and novel competitors. We conclude that accounting for novel competitive interactions may be essential to predict species' responses to climate change accurately.	[Alexander, Jake M.; Levine, Jonathan M.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Diez, Jeffrey M.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Riverside	Alexander, JM (corresponding author), ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland.	jake.alexander@usys.ethz.ch	Levine, Jonathan/A-7167-2014; Diez, Jeffrey/AAD-5956-2019; Alexander, Jake/P-2580-2014	Alexander, Jake/0000-0003-2226-7913; Levine, Jonathan/0000-0003-2857-7904; Diez, Jeffrey/0000-0002-4279-1838	ETH Zurich	ETH Zurich(ETH Zurich)	We thank M.-J. Machler, D. Righetti, C. Schmid, P. Stettler, R. Guidon, A. Vitra, S. Minneboo, J. Leuenberger and other members of the Plant Ecology group for assistance with field work, and the community of Haldenstein for providing field sites. S. Gusewell provided statistical advice. We thank P. Adler, J. HilleRisLambers and the Plant Ecology group for reading and commenting on the manuscript. ETH Zurich funding to the Plant Ecology group supported the project.	Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Adler PB, 2012, J ECOL, V100, P478, DOI 10.1111/j.1365-2745.2011.01930.x; Adler PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006887; Auguie B, 2017, GRIDEXTRA MISCELLANE; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; CH2011, 2011, CH2011 SWISS CLIM CH; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Elmendorf SC, 2015, P NATL ACAD SCI USA, V112, P448, DOI 10.1073/pnas.1410088112; Farrer EC, 2014, GLOBAL CHANGE BIOL, V20, P1238, DOI 10.1111/gcb.12401; Freckleton RP, 2001, ECOL LETT, V4, P348, DOI 10.1046/j.1461-0248.2001.00231.x; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gonzalez-Megias A, 2012, PHILOS T R SOC B, V367, P3115, DOI 10.1098/rstb.2011.0346; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; HilleRisLambers J, 2013, ANN NY ACAD SCI, V1297, P112, DOI 10.1111/nyas.12182; Hintze C, 2013, PERSPECT PLANT ECOL, V15, P180, DOI 10.1016/j.ppees.2013.02.001; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Levine JM, 2010, ECOLOGY, V91, P130, DOI 10.1890/08-2039.1; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Milazzo M, 2013, J ANIM ECOL, V82, P468, DOI 10.1111/j.1365-2656.2012.02034.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Svenning JC, 2014, ECOGRAPHY, V37, P1198, DOI 10.1111/j.1600-0587.2013.00574.x; Tamme R, 2014, ECOLOGY, V95, P505, DOI 10.1890/13-1000.1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Williams JW, 2013, ANN NY ACAD SCI, V1297, P29, DOI 10.1111/nyas.12226; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zimmermann NE, 1999, J VEG SCI, V10, P469, DOI 10.2307/3237182	30	353	361	21	471	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					515	+		10.1038/nature14952	http://dx.doi.org/10.1038/nature14952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26374998				2022-12-28	WOS:000361599900050
J	Owens, B				Owens, Brian			Drug development: The treasure chest	NATURE			English	Editorial Material																		GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Musty R. E., 2006, P S INT CANNABINOID, V32; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Vinals X., 2015, PLOS BIOL, V13	6	20	20	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S6	S8		10.1038/525S6a	http://dx.doi.org/10.1038/525S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398738	Bronze			2022-12-28	WOS:000361599900003
J	Paszkowski, J				Paszkowski, Jerzy			EPIGENETICS The karma of oil palms	NATURE			English	Editorial Material									Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England	University of Cambridge	Paszkowski, J (corresponding author), Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England.	jerzy.paszkowski@slcu.cam.ac.uk						Adam H, 2007, J EXP BOT, V58, P1245, DOI 10.1093/jxb/erl263; [Anonymous], CONTR EL COLD SPRING; Jaligot E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091896; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354	8	4	5	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					466	467		10.1038/nature15216	http://dx.doi.org/10.1038/nature15216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26352472				2022-12-28	WOS:000361599900040
J	Stelzer, Y; Shivalila, CS; Soldner, F; Markoulaki, S; Jaenisch, R				Stelzer, Yonatan; Shivalila, Chikdu Shakti; Soldner, Frank; Markoulaki, Styliani; Jaenisch, Rudolf			Tracing Dynamic Changes of DNA Methylation at Single-Cell Resolution	CELL			English	Article							IMPRINTING CENTER; SUPER-ENHANCERS; SOMATIC-CELLS; GENOME-WIDE; CPG ISLAND; METHYLOME; IDENTITY; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION	Mammalian DNA methylation plays an essential role in development. To date, only snapshots of different mouse and human cell types have been generated, providing a static view on DNA methylation. To enable monitoring of methylation status as it changes over time, we establish a reporter of genomic methylation (RGM) that relies on a minimal imprinted gene promoter driving a fluorescent protein. We show that insertion of RGM proximal to promoter-associated CpG islands reports the gain or loss of DNA methylation. We further utilized RGM to report endogenous methylation dynamics of non-coding regulatory elements, such as the pluripotency-specific super enhancers of Sox2 and miR290. Loci-specific DNA methylation changes and their correlation with transcription were visualized during cell-state transition following differentiation of mouse embryonic stem cells and during reprogramming of somatic cells to pluripotency. RGM will allow the investigation of dynamic methylation changes during development and disease at single-cell resolution.	[Stelzer, Yonatan; Shivalila, Chikdu Shakti; Soldner, Frank; Markoulaki, Styliani; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shivalila, Chikdu Shakti; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	t, lf/AAJ-4924-2020		NIH [HD 045022]; Human Frontier Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Thorold W. Theunissen, Patti Wisniewski, and Colin Zollo for FACS analyses and cell sorting, Denes Hnisz for providing ChIP-seq tracks, Kibibi Ganz for mouse injections, Huijing Yu for help in cloning, and Stefan Semrau for help with the RA differentiation and comments on the manuscript. This study was supported by NIH grant HD 045022. Y.S. is supported by a Human Frontier Postdoctoral Fellowship and. R.J. is co-founder of Fate Therapeutics and an adviser to Stemgent.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Gingold JA, 2014, MOL CELL, V56, P140, DOI 10.1016/j.molcel.2014.08.014; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Kantor B, 2004, HUM MOL GENET, V13, P2767, DOI 10.1093/hmg/ddh290; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; MUMMANENI P, 1995, J BIOL CHEM, V270, P788, DOI 10.1074/jbc.270.2.788; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Sabag O, 2014, NAT STRUCT MOL BIOL, V21, P110, DOI 10.1038/nsmb.2734; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vidal SE, 2014, STEM CELL REP, V3, P574, DOI 10.1016/j.stemcr.2014.08.003; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhou HY, 2014, GENE DEV, V28, P2699, DOI 10.1101/gad.248526.114; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	44	92	93	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					218	229		10.1016/j.cell.2015.08.046	http://dx.doi.org/10.1016/j.cell.2015.08.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406378	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000361846500033
J	Barrett, MP; McDonnell, SM				Barrett, Michael P.; McDonnell, Stephen M.			Hip pain after a fall	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTURES; FIXATION		[Barrett, Michael P.] Ipswich Hosp NHS Trust, Ipswich IP4 5PD, Suffolk, England; [McDonnell, Stephen M.] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	Ipswich Hospital NHS Trust; Ipswich Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Barrett, MP (corresponding author), Ipswich Hosp NHS Trust, Ipswich IP4 5PD, Suffolk, England.	m.barrett1@nhs.net		McDonnell, Stephen/0000-0002-3181-4192				British Orthopaedic Association, 2012, STAND TRAUM HIP FRAC; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; HOWE WW, 1950, J BONE JOINT SURG AM, V32-A, P856, DOI 10.2106/00004623-195032040-00015; Ly TV, 2008, J BONE JOINT SURG AM, V90A, P2254; National Institute for Health and Care Excellence, 2011, HIP FRACT MAN HIP FR, V124; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203, DOI 10.1302/0301-620X.74B2.1544952; Parker MJ, 2002, J BONE JOINT SURG BR, V84B, P1150, DOI 10.1302/0301-620X.84B8.13522; VILLAR RN, 1986, BRIT MED J, V293, P1203, DOI 10.1136/bmj.293.6556.1203	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2015	351								h4785	10.1136/bmj.h4785	http://dx.doi.org/10.1136/bmj.h4785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3EO	26396152				2022-12-28	WOS:000361954700002
J	Ni, XJ; Wong, ZJ; Mrejen, M; Wang, Y; Zhang, X				Ni, Xingjie; Wong, Zi Jing; Mrejen, Michael; Wang, Yuan; Zhang, Xiang			An ultrathin invisibility skin cloak for visible light	SCIENCE			English	Article							BROAD-BAND; METASURFACE HOLOGRAMS; REFLECTION	Metamaterial-based optical cloaks have thus far used volumetric distribution of the material properties to gradually bend light and thereby obscure the cloaked region. Hence, they are bulky and hard to scale up and, more critically, typical carpet cloaks introduce unnecessary phase shifts in the reflected light, making the cloaks detectable. Here, we demonstrate experimentally an ultrathin invisibility skin cloak wrapped over an object. This skin cloak conceals a three-dimensional arbitrarily shaped object by complete restoration of the phase of the reflected light at 730-nanometer wavelength. The skin cloak comprises a metasurface with distributed phase shifts rerouting light and rendering the object invisible. In contrast to bulky cloaks with volumetric index variation, our device is only 80 nanometer (about one-ninth of the wavelength) thick and potentially scalable for hiding macroscopic objects.	[Ni, Xingjie; Wong, Zi Jing; Mrejen, Michael; Wang, Yuan; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr NSEC, Berkeley, CA 94720 USA; [Wang, Yuan; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Zhang, Xiang] King Abdulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia	National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; King Abdulaziz University	Zhang, X (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr NSEC, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Wang, Yuan/F-7211-2011; Ni, Xingjie/I-2235-2012; Wong, Zi Jing/AGP-9517-2022; Zhang, Xiang/F-6905-2011	Wang, Yuan/0000-0001-7892-2812; Ni, Xingjie/0000-0001-7405-5678; Zhang, Xiang/0000-0002-3272-894X; Wong, Zi Jing/0000-0003-0746-3473	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	The work was supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division under contract no. DE-AC02-05CH11231.	Aieta F, 2012, NANO LETT, V12, P4932, DOI 10.1021/nl302516v; Alu A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245115; Brun M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3068491; Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Chen XZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1176; Ergin T, 2010, SCIENCE, V328, P337, DOI 10.1126/science.1186351; Estakhri NM, 2014, IEEE ANTENN WIREL PR, V13, P1775, DOI 10.1109/LAWP.2014.2371894; Fan PY, 2012, NAT PHOTONICS, V6, P380, DOI [10.1038/NPHOTON.2012.108, 10.1038/nphoton.2012.108]; Farhat M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.024301; Fleury R, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045423; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Gharghi M, 2011, NANO LETT, V11, P2825, DOI 10.1021/nl201189z; Han TC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.054302; Hsu LY, 2015, PROG ELECTROMAGN RES, V152, P33, DOI 10.2528/PIER15032005; Huang LL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3808; Huang LL, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.26; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Lee J, 2014, NATURE, V511, P65, DOI 10.1038/nature13455; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Ma HF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1023; Milton GW, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/248; Ni XJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3807; Ni XJ, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.28; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pors A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02155; Pors A, 2013, OPT LETT, V38, P513, DOI 10.1364/OL.38.000513; Sanchis L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.124301; Schittny R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195901; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Selvanayagam M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041011; Shitrit N, 2013, SCIENCE, V340, P724, DOI 10.1126/science.1234892; Sun SL, 2012, NANO LETT, V12, P6223, DOI 10.1021/nl3032668; Sun SL, 2012, NAT MATER, V11, P426, DOI [10.1038/nmat3292, 10.1038/NMAT3292]; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; Xu HY, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.054301; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]; Yu NF, 2012, NANO LETT, V12, P6328, DOI 10.1021/nl303445u; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhang BL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.033901; Zhang S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.123002; Zheng GX, 2015, NAT NANOTECHNOL, V10, P308, DOI [10.1038/nnano.2015.2, 10.1038/NNANO.2015.2]	45	736	770	64	881	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1310	1314		10.1126/science.aac9411	http://dx.doi.org/10.1126/science.aac9411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383946				2022-12-28	WOS:000361357700042
J	Gallus, A				Gallus, Alexander			In unexplained recurrent pregnancy loss, daily LMWH did not improve ongoing pregnancy or live birth rates	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gallus, Alexander] Flinders Med Ctr, Adelaide, SA, Australia; [Gallus, Alexander] Flinders Univ S Australia, Adelaide, SA 5001, Australia	Flinders Medical Centre; Flinders University South Australia	Gallus, A (corresponding author), Flinders Med Ctr, Adelaide, SA, Australia.			Gallus, Alexander/0000-0001-7347-9989				Duffett L, 2015, BRIT J HAEMATOL, V168, P619, DOI 10.1111/bjh.13209; Pasquier E, 2015, BLOOD, V125, P2200, DOI 10.1182/blood-2014-11-610857; Rodger MA, 2014, LANCET, V384, P1673, DOI 10.1016/S0140-6736(14)60793-5	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC10	10.7326/ACPJC-2015-163-6-010	http://dx.doi.org/10.7326/ACPJC-2015-163-6-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370025				2022-12-28	WOS:000361365900010
J	Hussain, T; Jan, RA				Hussain, Tajamul; Jan, Rafi A.			A Viper Bite	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hussain, Tajamul; Jan, Rafi A.] Sherikashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India	Sher-i-Kashmir Institute of Medical Sciences	Hussain, T (corresponding author), Sherikashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India.	salimtajamul@gmail.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1059	1059		10.1056/NEJMicm1410237	http://dx.doi.org/10.1056/NEJMicm1410237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352817				2022-12-28	WOS:000360959000011
J	Scharf, L; Wang, HQ; Gao, H; Chen, SY; McDowall, AW; Bjorkman, PJ				Scharf, Louise; Wang, Haoqing; Gao, Han; Chen, Songye; McDowall, Alasdair W.; Bjorkman, Pamela J.			Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env	CELL			English	Article							CRYO-EM STRUCTURE; MOLECULAR ARCHITECTURE; CRYSTAL-STRUCTURE; GLYCOPROTEIN; POTENT; CD4; VISUALIZATION; QUATERNARY; REVEALS; EPITOPE	The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs); thus, most neutralizing antibodies are strain specific. The 8ANC195 epitope, defined by crystal and electron microscopy (EM) structures of bNAb 8ANC195 complexed with monomeric gp120 and trimeric Env, respectively, spans the gp120 and gp41 Env subunits. To investigate 8ANC195' s gp41 epitope at higher resolution, we solved a 3.58 angstrom crystal structure of 8ANC195 complexed with fully glycosylated Env trimer, revealing 8ANC195 insertion into a glycan shield gap to contact gp120 and gp41 glycans and protein residues. To determine whether 8ANC195 recognizes the CD4-bound open Env conformation that leads to co-receptor binding and fusion, one of several known conformations of virion-associated Env, we solved EM structures of an Env/CD4/CD4-induced antibody/8ANC195 complex. 8ANC195 binding partially closed the CD4-bound trimer, confirming structural plasticity of Env by revealing a previously unseen conformation. 8ANC195' s ability to bind different Env conformations suggests advantages for potential therapeutic applications.	[Scharf, Louise; Wang, Haoqing; Gao, Han; Chen, Songye; McDowall, Alasdair W.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [McDowall, Alasdair W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bjorkman@caltech.edu			National Institute Of Allergy and Infectious Diseases of the National Institutes of Health [HIVRAD P01 AI100148]; Bill and Melinda Gates Foundation [1040753]; National Institutes of Health [2 P50 GM082545-06]; American Cancer Society [PF-13-076-01-MPC]; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	National Institute Of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute Of Allergy and Infectious Diseases of the National Institutes of Health Grant HIVRAD P01 AI100148 (P.J.B.) (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health), the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Grant 1040753 [P.J.B.]), the National Institutes of Health Grant 2 P50 GM082545-06 (P.J.B.), the American Cancer Society Grant PF-13-076-01-MPC (L.S.), and the Molecular Observatory at Caltech supported by the Gordon and Betty Moore Foundation. We thank the Gordon and Betty Moore and Beckman Foundations for gifts to Caltech that helped support electron microscopy; Grant Jensen for advice and support for EM; Jost Vielmetter and the Caltech Protein Expression Center for producing proteins and use of the Biacore T200; Priyanthi Gnanapragasam and ReneMares for performing neutralization assays; the beamline staff at the Advanced Photon Source GM/CA-CAT for use and support for beamline 23ID-D; Marta Murphy and Rachel Galimidi for assistance with figures; and Michel Nussenzweig, Johannes Scheid, and Anthony West for helpful discussions and critical reading of the manuscript.	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; White TA, 2011, J VIROL, V85, P12114, DOI 10.1128/JVI.05297-11; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	45	100	102	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1379	1390		10.1016/j.cell.2015.08.035	http://dx.doi.org/10.1016/j.cell.2015.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359989	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000361247900025
J	Gahl, WA; Wise, AL; Ashley, EA				Gahl, William A.; Wise, Anastasia L.; Ashley, Euan A.			The Undiagnosed Diseases Network of the National Institutes of Health A National Extension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROGRAM		[Gahl, William A.; Wise, Anastasia L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Ashley, Euan A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ashley, Euan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Stanford University	Ashley, EA (corresponding author), Stanford Univ, Dept Med, Falk CVRB, 870 Quarry Rd, Stanford, CA 94305 USA.	euan@stanford.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007942, U01HG007690, U01HG007709, U01HG007703, U01HG007672, U01HG007674, U01HG007530, ZIDHG200352, ZIAHG000215, U01HG007943, U01HG007708] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG007943, U01 HG007708, U01 HG007690, U01 HG007703, U01 HG007674, U01 HG007709, U01 HG007672, U01 HG007942, U01 HG007530] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Gahl WA, 2012, GENET MED, V14, P51; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Manoli I, 2013, MOL GENET METAB, V108, P249, DOI 10.1016/j.ymgme.2013.01.015; National Technical Information Services, 1989, REP NAT COMM ORPH DI, P17; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Tifft CJ, 2014, CURR OPIN PEDIATR, V26, P626, DOI 10.1097/MOP.0000000000000155	7	67	67	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1797	1798		10.1001/jama.2015.12249	http://dx.doi.org/10.1001/jama.2015.12249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26375289				2022-12-28	WOS:000363960200008
J	Mayo-Wilson, E; Doshi, P; Dickersin, K				Mayo-Wilson, Evan; Doshi, Peter; Dickersin, Kay			Are manufacturers sharing data as promised?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIVIDUAL PATIENT DATA; WASTE		[Doshi, Peter] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore		evan.mayo-wilson@jhu.edu	Mayo-Wilson, Evan/J-6289-2019	Mayo-Wilson, Evan/0000-0001-6126-2459	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], 2015, WHO STAT PUBL DISCL; AstraZeneca, 2015, DISCL COMM; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Doshi P, 2014, BMJ-BRIT MED J, V2014, P348, DOI 10.1136; Drazen JM, 2015, NEW ENGL J MED, V372, P201, DOI 10.1056/NEJMp1415160; Ebrahim S, 2014, JAMA-J AM MED ASSOC, V312, P1024, DOI 10.1001/jama.2014.9646; Goodman S, 2011, ANN INTERN MED, V155, P61, DOI 10.7326/0003-4819-155-1-201107050-00010; Hughes S, 2014, PHARM STAT, V13, P179, DOI 10.1002/pst.1615; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Moorthy VS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001819; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794	13	18	18	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2015	351								h4169	10.1136/bmj.h4169	http://dx.doi.org/10.1136/bmj.h4169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GR	26407814	Green Published			2022-12-28	WOS:000361960500001
J	Fong, CY; Gilan, O; Lam, EYN; Rubin, AF; Ftouni, S; Tyler, D; Stanley, K; Sinha, D; Yeh, P; Morison, J; Giotopoulos, G; Lugo, D; Jeffrey, P; Lee, SCW; Carpenter, C; Gregory, R; Ramsay, RG; Lane, SW; Abdel-Wahab, O; Kouzarides, T; Johnstone, RW; Dawson, SJ; Huntly, BJP; Prinjha, RK; Papenfuss, AT; Dawson, MA				Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.			BET inhibitor resistance emerges from leukaemia stem cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; SELECTIVE-INHIBITION; DRUG-RESISTANCE; SEQUENCING DATA; CANCER; MUTATIONS; DISCOVERY; CHROMATIN; MECHANISM; ACCURATE	Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a newtherapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks(1,2). Early clinical trials have shown promise, especially in acute myeloid leukaemia(3), and therefore the evaluation of resistance mechanismsis crucial to optimize the clinical efficacy of these drugs. Here we use primary mouse haematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET. Resistance to I-BET confers cross-resistance to chemically distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins. Resistance is notmediated through increased drug efflux or metabolism, but is shown to emerge from leukaemia stem cells both ex vivo and in vivo. Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription. We demonstrate that resistance to BET inhibitors, in human and mouse leukaemia cells, is in part a consequence of increasedWnt/beta-catenin signalling, and negative regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo. Together, these findings provide new insights into the biology of acute myeloid leukaemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clinical utility of these unique targeted therapies.	[Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Ramsay, Robert G.; Johnstone, Ricky W.; Dawson, Sarah-Jane; Papenfuss, Anthony T.; Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, East Melbourne, Vic 3002, Australia; [Fong, Chun Yew; Gilan, Omer; Tyler, Dean; Yeh, Paul; Ramsay, Robert G.; Johnstone, Ricky W.; Dawson, Sarah-Jane; Papenfuss, Anthony T.; Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, East Melbourne, Vic 3002, Australia; [Fong, Chun Yew; Yeh, Paul; Dawson, Mark A.] Peter MacCallum Canc Ctr, Dept Haematol, East Melbourne, Vic 3002, Australia; [Rubin, Alan F.; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Rubin, Alan F.; Papenfuss, Anthony T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Morison, Jessica; Giotopoulos, George; Huntly, Brian J. P.] Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 OXY, England; [Morison, Jessica; Giotopoulos, George; Huntly, Brian J. P.] Wellcome Trust MRC Stem Cell Inst, Cambridge CB2 0XY, England; [Lugo, Dave; Jeffrey, Philip; Gregory, Richard; Prinjha, Rab K.] GlaxoSmithKline, Epinova DPU, Immunoinflammat Ctr Excellence Drug Discovery, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Lee, Stanley Chun-Wei; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Carpenter, Christopher] GlaxoSmithKline, Canc Epigenet DPU, Oncol R&D, Collegeville, PA 19426 USA; [Lane, Steven W.] Univ Queensland, QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Kouzarides, Tony] Gurdon Inst, Cambridge CB2 1QN, England; [Kouzarides, Tony] Dept Pathol, Cambridge CB2 1QN, England	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Walter & Eliza Hall Institute; University of Melbourne; GlaxoSmithKline; Memorial Sloan Kettering Cancer Center; GlaxoSmithKline; QIMR Berghofer Medical Research Institute; University of Queensland	Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Canc Res Div, East Melbourne, Vic 3002, Australia.	mark.dawson@petermac.org	Dawson, Mark A/B-9317-2017; Johnstone, Ricky w/H-3748-2014; Ramsay, Robert G/C-3291-2015; Papenfuss, Anthony T/C-6297-2008; huntly, brian/E-6725-2014	Dawson, Mark A/0000-0002-5464-5029; Johnstone, Ricky w/0000-0001-7053-9237; Ramsay, Robert G/0000-0001-5003-0433; Papenfuss, Anthony T/0000-0002-1102-8506; Giotopoulos, George/0000-0003-1390-6592; YEH, PAUL/0000-0002-4172-3614; Lam, Enid Yi Ni/0000-0001-5843-7836; huntly, brian/0000-0003-0312-161X; Dawson, Sarah-Jane/0000-0002-8276-0374; Kouzarides, Tony/0000-0002-8918-4162; Lee, Stanley/0000-0001-7110-2416; Rubin, Alan/0000-0003-1474-605X	Leukaemia Foundation Australia; Haematology Society of Australia; Haematology Society of New Zealand; Royal Australasian College of Physicians; Victorian Comprehensive Cancer Centre; NATIONAL CANCER INSTITUTE [P30CA006516, K08CA160647, P30CA008748] Funding Source: NIH RePORTER; Cancer Research UK [10827, 17001] Funding Source: researchfish; Medical Research Council [MR/M010392/1] Funding Source: researchfish; Worldwide Cancer Research [14-1069] Funding Source: researchfish; MRC [MR/M010392/1] Funding Source: UKRI	Leukaemia Foundation Australia; Haematology Society of Australia; Haematology Society of New Zealand; Royal Australasian College of Physicians(General Electric); Victorian Comprehensive Cancer Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Bannister for critical reading of the manuscript. The Leukaemia Foundation Australia, Haematology Society of Australia and New Zealand, Royal Australasian College of Physicians and the Victorian Comprehensive Cancer Centre have supported CYF with PhD scholarships. M.A.D. is a Senior Leukaemia Foundation Australia Fellow, VESKI Innovation Fellow and Herman Clinical Fellow. The National Health and Medical Research Council of Australia (1085015; 1066545) and Leukaemia Foundation Australia fund the Dawson laboratory.	Amarasinghe KC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S2; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dawson MA, 2014, LEUKEMIA, V28, P311, DOI 10.1038/leu.2013.338; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Herait PE, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-CT231; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Rathert P, 2015, NATURE; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tsirigos A, 2012, BIOINFORMATICS, V28, P282, DOI 10.1093/bioinformatics/btr646; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	42	352	361	6	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					538	+		10.1038/nature14888	http://dx.doi.org/10.1038/nature14888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26367796	Green Accepted			2022-12-28	WOS:000361599900054
J	Jiang, H; Wang, SS; Huang, YJ; He, XN; Cui, HG; Zhu, XL; Zheng, YX				Jiang, Hao; Wang, Shusheng; Huang, Yuejia; He, Xiaonan; Cui, Honggang; Zhu, Xueliang; Zheng, Yixian			Phase Transition of Spindle-Associated Protein Regulate Spindle Apparatus Assembly	CELL			English	Article							XENOPUS EGG EXTRACTS; CHROMOSOME ALIGNMENT; SELF-ORGANIZATION; BUB3 STABILITY; MATRIX; MITOSIS; MEGATOR; SKELETOR; DOMAINS; KINESIN	Spindle assembly required during mitosis depends on microtubule polymerization. We demonstrate that the evolutionarily conserved low-complexity protein, BuGZ, undergoes phase transition or coacervation to promote assembly of both spindles and their associated components. BuGZ forms temperature-dependent liquid droplets alone or on microtubules in physiological buffers. Coacervation in vitro or in spindle and spindle matrix depends on hydrophobic residues in BuGZ. BuGZ coacervation and its binding to microtubules and tubulin are required to promote assembly of spindle and spindle matrix in Xenopus egg extract and in mammalian cells. Since several previously identified spindle-associated components also contain low-complexity regions, we propose that coacervating proteins may be a hallmark of proteins that comprise a spindle matrix that functions to promote assembly of spindles by concentrating its building blocks.	[Jiang, Hao; He, Xiaonan; Zhu, Xueliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Jiang, Hao; Wang, Shusheng; Huang, Yuejia; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Cui, Honggang] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Cui, Honggang] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Carnegie Institution for Science; Johns Hopkins University; Johns Hopkins University	Zhu, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	xlzhu@sibcb.ac.cn; zheng@ciwemb.edu	Cui, Honggang/E-8012-2010		Chinese Academy of Sciences [XDA01010107]; Ministry of Science and Technology of China [2014CB964803]; National Science Foundation of China [31420103916, GM056312, GM106023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106023, R01GM056312] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Andreas Merdes for the NuMA antibody, Ona Martin for proof reading, Ona Martin and Lynne Hugendubler for technical support, Dr. Pengcheng Zhang for help with the turbidity assay, and the Y.Z. lab for critical reading. Supported by the Chinese Academy of Sciences (XDA01010107 to X.Z.), Ministry of Science and Technology of China (2014CB964803 to X.Z.), National Science Foundation of China (31420103916 to X.Z. and Y.Z.), and GM056312 and GM106023 (to Y.Z.).	Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Caudron N, 2000, J MOL BIOL, V297, P211, DOI 10.1006/jmbi.2000.3554; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Civelekoglu-Scholey G, 2010, J CELL BIOL, V188, P49, DOI 10.1083/jcb.200908150; Fabian L, 2007, J CELL SCI, V120, P2190, DOI 10.1242/jcs.03465; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gatlin JC, 2010, J CELL BIOL, V188, P481, DOI 10.1083/jcb.200907110; GOLDMAN RD, 1969, J CELL SCI, V4, P179; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Hayashi H, 2012, MOL BIOL CELL, V23, P1688, DOI 10.1091/mbc.E11-09-0815; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Johansen KM, 2011, CHROMOSOME RES, V19, P345, DOI 10.1007/s10577-011-9187-6; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; LESLIE RJ, 1987, P NATL ACAD SCI USA, V84, P2771, DOI 10.1073/pnas.84.9.2771; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Lukacs D, 1981, Orv Hetil, V122, P349; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Oakley BR, 2000, TRENDS CELL BIOL, V10, P537, DOI 10.1016/S0962-8924(00)01857-2; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Pickett-Heaps J, 2009, PROTOPLASMA, V235, P91, DOI 10.1007/s00709-009-0030-2; PICKETTHEAPS J, 1984, J CELL BIOL, V99, pS137, DOI 10.1083/jcb.99.1.137s; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; SCHIBLER MJ, 1980, EUR J CELL BIOL, V22, P687; Scholey JM, 2001, J CELL BIOL, V154, P261, DOI 10.1083/jcb.200101097; Schweizer N, 2014, CURR OPIN CELL BIOL, V28, P1, DOI 10.1016/j.ceb.2014.01.002; Shimamoto Y, 2011, CELL, V145, P1062, DOI 10.1016/j.cell.2011.05.038; Toledo CM, 2014, DEV CELL, V28, P282, DOI 10.1016/j.devcel.2013.12.014; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wein H, 1998, CELL MOTIL CYTOSKEL, V41, P214; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yao CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103855; Yao CF, 2012, MOL BIOL CELL, V23, P3532, DOI 10.1091/mbc.E12-06-0429; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zheng YX, 2006, CELL CYCLE, V5, P2345, DOI 10.4161/cc.5.20.3365; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	51	175	186	4	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					108	122		10.1016/j.cell.2015.08.010	http://dx.doi.org/10.1016/j.cell.2015.08.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26388440	Green Accepted, Bronze			2022-12-28	WOS:000361846500025
J	Chou, D; Daelmans, B; Jolivet, RR; Kinney, M; Say, L				Chou, Doris; Daelmans, Bernadette; Jolivet, R. Rima; Kinney, Mary; Say, Lale			Ending preventable maternal and newborn mortality and stillbirths	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROGRESS; DEATHS; CARE		[Chou, Doris; Say, Lale] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; [Daelmans, Bernadette] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva 27, Switzerland; [Jolivet, R. Rima] Harvard Univ, TH Chan Sch Publ Hlth, Maternal Hlth Task Force, Boston, MA USA; [Kinney, Mary] Save Children, Global Evidence & Advocacy, Washington, DC USA	World Health Organization; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Save the Children	Chou, D (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	choud@who.int	Kinney, Mary V/M-6952-2013; , lalesay/AAG-1912-2021; Lawn, Joy/ABE-6382-2020; Vogel, Joshua/K-7649-2019; Souza, Joao Paulo/G-1982-2010	Kinney, Mary V/0000-0002-2903-0161; Lawn, Joy/0000-0002-4573-1443; Vogel, Joshua/0000-0002-3214-7096; Souza, Joao Paulo/0000-0002-2288-4244; McDougall, Lori/0000-0002-1885-5344				Agarwal S, 2009, SCALING SOCIAL ACCOU; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Harrison MS, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S9; IEG World Bank IFC MIGA, 2013, DEL MILL DEV GOALS R; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kassebaum NJ, 2014, LANCET, V384, P956; Kuruvilla Shyama, 2014, Bull World Health Organ, V92, P533, DOI 10.2471/BLT.14.138131; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Mehl G, 2014, SCIENCE, V345, P1284, DOI 10.1126/science.1258926; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Reichenheim ME, 2009, ARCH GYNECOL OBSTET, V280, P337, DOI 10.1007/s00404-008-0891-1; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Sheikh Kabir, 2011, PLoS Med, V8, pe1001073, DOI 10.1371/journal.pmed.1001073; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; The Lancet, 2014, LANCET; The Lancet, 2011, LANCET; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; UN Inter-agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; UNFPA, STAT WORLDS MIDW 201; UNFPA UNIFEM OSAGI, 2005, COMB GEND BAS VIOL K; WHO, 2015, WHO REC HLTH PROM IN; WHO, 2012, ICD 10 CLASS MENT BE; WHO, 2013, MAT DEATH SURV RESP; WHO, HLTH SYST FIN PATH U; WHO Aga Khan University PMNCH, 2011, ESS INT COMM GUID RE; WHO Unicef UNFPA The World Bank United Nations Population Division, 2014, TRENDS; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Bank, 2015, GLOB FIN FAC SUPP EV; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2014, PREVENTION ELIMINATI; World Health Organization, WORLD HLTH STAT 2014; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization, 2014, WHO REC COMM MOB FAC	40	99	99	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4255	10.1136/bmj.h4255	http://dx.doi.org/10.1136/bmj.h4255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371222	hybrid			2022-12-28	WOS:000361678200010
J	Janvier, C; Tosi, L; Bretheau, L; Girit, CO; Stern, M; Bertet, P; Joyez, P; Vion, D; Esteve, D; Goffman, MF; Pothier, H; Urbina, C				Janvier, C.; Tosi, L.; Bretheau, L.; Girit, C. Oe.; Stern, M.; Bertet, P.; Joyez, P.; Vion, D.; Esteve, D.; Goffman, M. F.; Pothier, H.; Urbina, C.			Coherent manipulation of Andreev states in superconducting atomic contacts	SCIENCE			English	Article							QUBIT	Coherent control of quantum states has been demonstrated in a variety of superconducting devices. In all of these devices, the variables that are manipulated are collective electromagnetic degrees of freedom: charge, superconducting phase, or flux. Here we demonstrate the coherent manipulation of a quantum system based on Andreev bound states, which are microscopic quasi-particle states inherent to superconducting weak links. Using a circuit quantum electrodynamics setup, we performed single-shot readout of this Andreev qubit. We determined its excited-state lifetime and coherence time to be in the microsecond range. Quantum jumps and parity switchings were observed in continuous measurements. In addition to having possible quantum information applications, such Andreev qubits are a test-bed for the physics of single elementary excitations in superconductors.	[Janvier, C.; Tosi, L.; Bretheau, L.; Girit, C. Oe.; Stern, M.; Bertet, P.; Joyez, P.; Vion, D.; Esteve, D.; Goffman, M. F.; Pothier, H.; Urbina, C.] CEA Saclay, Quantron Grp, Serv Phys Etat Condense, IRAMIS,CNRS UMR 3680, F-91191 Gif Sur Yvette, France; [Tosi, L.] Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Tosi, L.] Comis Nacl Energia Atom, Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Urbina, C (corresponding author), CEA Saclay, Quantron Grp, Serv Phys Etat Condense, IRAMIS,CNRS UMR 3680, F-91191 Gif Sur Yvette, France.	cristian.urbina@cea.fr	Girit, Çağlar/AFT-1507-2022; Pothier, Hugues/D-1151-2014; Urbina, Cristian/M-6412-2015; Girit, Çağlar/D-4845-2014; Tosi, Leandro/A-4953-2018; Bretheau, Landry/Q-5468-2018; Goffman, Marcelo F/S-1751-2016	Girit, Çağlar/0000-0001-8953-9261; Pothier, Hugues/0000-0002-0601-6885; Urbina, Cristian/0000-0001-9145-8081; Girit, Çağlar/0000-0001-8953-9261; Bretheau, Landry/0000-0001-5628-934X; Janvier, Camille/0000-0003-4759-8380; Goffman, Marcelo/0000-0002-0357-3555	European Union [PIIF-GA-2011-298415]; ECOS-SUD (France-Argentina) [A11E04]; CONICET (Argentina);  [ANR-12-BS04-0016-MASH]	European Union(European Commission); ECOS-SUD (France-Argentina); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); 	We thank P. Senat and P.-F. Orfila for technical assistance and G. Catelani, V. Shumeiko, and A. Levy Yeyati for discussions. We acknowledge financial support by contract ANR-12-BS04-0016-MASH. C.O.G. was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency grant agreement PIIF-GA-2011-298415. L.T. was supported by ECOS-SUD (France-Argentina) grant A11E04 and a scholarship from CONICET (Argentina). C.J., M.F.G., H.P., and C.U. took part in all aspects of this work. L.T., L.B., C.O.G., and D.E. participated in the design of the experiment. M.S. and D.V. helped with microwave setup. L.T. and D.V. participated in running the experiment. All authors participated in interpreting the data and writing the manuscript.	BEENAKKER CWJ, 1991, PHYS REV LETT, V66, P3056, DOI 10.1103/PhysRevLett.66.3056; Bretheau L, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041034; Bretheau L, 2013, NATURE, V499, P312, DOI 10.1038/nature12315; CAROLI C, 1964, PHYS LETT, V9, P307, DOI 10.1016/0031-9163(64)90375-0; Catelani G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064517; Chang W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217005; Chevallier D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165401; Chtchelkatchev NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.226806; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; de Visser PJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.167004; Desposito MA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.140511; Franke KJ, 2011, SCIENCE, V332, P940, DOI 10.1126/science.1202204; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Janvier C, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/47/474208; Kos F, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174521; Levenson-Falk EM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047002; Makhlin Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178301; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Olivares DG, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.104504; Padurariu C, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/57006; Pillet JD, 2010, NAT PHYS, V6, P965, DOI 10.1038/NPHYS1811; Pop IM, 2014, NATURE, V508, P369, DOI 10.1038/nature13017; Riste D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2936; Romero G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180506; Scheer E, 1997, PHYS REV LETT, V78, P3535, DOI 10.1103/PhysRevLett.78.3535; vanRuitenbeek JM, 1996, REV SCI INSTRUM, V67, P108, DOI 10.1063/1.1146558; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Vool U, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.247001; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6836; Zazunov A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.214505; Zazunov A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.104508; Zazunov A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.087003; Zgirski M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.257003	35	114	115	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1199	1202		10.1126/science.aab2179	http://dx.doi.org/10.1126/science.aab2179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359397	Green Submitted, Green Published			2022-12-28	WOS:000360968400036
J	Menon, AK; Levine, TP				Menon, Anant K.; Levine, Tim P.			CELL BIOLOGY Countercurrents in lipid flow	NATURE			English	Editorial Material							OXYSTEROL-BINDING PROTEINS; MEMBRANE CONTACT SITES; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PHOSPHATIDYLSERINE TRANSPORT; METABOLISM; EXCHANGE; REVEALS; DRIVEN; GOLGI		[Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Levine, Tim P.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England	Cornell University; University of London; University College London	Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	akm2003@med.cornell.edu; tim.levine@ucl.ac.uk	Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; Levine, Timothy/0000-0002-7231-0775				Beh CT, 2001, GENETICS, V157, P1117; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Pagano RE, 1990, CURR OPIN CELL BIOL, V2, P652, DOI 10.1016/0955-0674(90)90107-P; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671	15	5	5	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					191	192		10.1038/525191a	http://dx.doi.org/10.1038/525191a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354476				2022-12-28	WOS:000360927400021
J	Yatim, N; Jusforgues-Saklani, H; Orozco, S; Schulz, O; da Silva, RB; Sousa, CRE; Green, DR; Oberst, A; Albert, ML				Yatim, Nader; Jusforgues-Saklani, Helene; Orozco, Susana; Schulz, Oliver; da Silva, Rosa Barreira; Reis e Sousa, Caetano; Green, Douglas R.; Oberst, Andrew; Albert, Matthew L.			RIPK1 and NF-kappa B signaling in dying cells determines cross-priming of CD8(+) T cells	SCIENCE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; APOPTOTIC CELLS; DEATH PATHWAYS; PROTEIN; IMMUNOGENICITY; IDENTIFICATION; RIPOPTOSOME; TOLERANCE; CASPASE-8; EXPOSURE	Dying cells initiate adaptive immunity by providing both antigens and inflammatory stimuli for dendritic cells, which in turn activate CD8(+) T cells through a process called antigen cross-priming. To define how different forms of programmed cell death influence immunity, we established models of necroptosis and apoptosis, in which dying cells are generated by receptor-interacting protein kinase-3 and caspase-8 dimerization, respectively. We found that the release of inflammatory mediators, such as damage-associated molecular patterns, by dying cells was not sufficient for CD8(+) T cell cross-priming. Instead, robust cross-priming required receptor-interacting protein kinase-1 (RIPK1) signaling and nuclear factor kappa B (NF-kappa B)-induced transcription within dying cells. Decoupling NF-kappa B signaling from necroptosis or inflammatory apoptosis reduced priming efficiency and tumor immunity. Our results reveal that coordinated inflammatory and cell death signaling pathways within dying cells orchestrate adaptive immunity.	[Yatim, Nader; Jusforgues-Saklani, Helene; da Silva, Rosa Barreira; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Lab Dendrit Cell Biol, F-75015 Paris, France; [Yatim, Nader; Jusforgues-Saklani, Helene; da Silva, Rosa Barreira; Albert, Matthew L.] INSERM, U818, F-75015 Paris, France; [Yatim, Nader] Univ Paris 07, Frontieres Vivant Doctoral Sch, EcoleDoctorale 474, F-75004 Paris, France; [Orozco, Susana; Oberst, Andrew] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Schulz, Oliver; Reis e Sousa, Caetano] Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, London WC2A 3LY, England; [Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle; Francis Crick Institute; St Jude Children's Research Hospital	Albert, ML (corresponding author), Inst Pasteur, Dept Immunol, Lab Dendrit Cell Biol, 25 Rue Docteur Roux, F-75015 Paris, France.	albertm@pasteur.fr	Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Green, Douglas R/N-8083-2018; Albert, Matthew L/C-9782-2009	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Green, Douglas R/0000-0002-7332-1417; OROZCO, SUSANA L./0000-0003-1741-6275; Yatim, Nader/0000-0001-5326-1624; Schulz, Oliver/0000-0002-1493-3341	Agence Nationale de Recherches sur le Sida et les Hepatitis; Agence Nationale de la Recherche [ANR-12-BSV3-0011-01]; Laboratories of Excellence Immuno-Onco grant [ANR-11-IDEX-0005-02]; French National Cancer Institute (INCa); Ecole de l'Inserm Liliane Bettencourt; NIH [R21CA185681, R01AI108685, AI44848, 5R01AI108685-02]; Cancer Research UK; Francis Crick Institute; European Research Council; Genomics Platform of the Department of Translational Research at Institut Curie [INCa-DGOS-4654, SIRIC11-002, ANR-10-IDEX-0001-02 PSL, ANR-11-LBX-0044]; NATIONAL CANCER INSTITUTE [R21CA185681, R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108685, T32AI106677, R01AI044828] Funding Source: NIH RePORTER; Cancer Research UK [15689] Funding Source: researchfish; The Francis Crick Institute [10136] Funding Source: researchfish	Agence Nationale de Recherches sur le Sida et les Hepatitis(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Laboratories of Excellence Immuno-Onco grant; French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); Ecole de l'Inserm Liliane Bettencourt; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Francis Crick Institute; European Research Council(European Research Council (ERC)European Commission); Genomics Platform of the Department of Translational Research at Institut Curie; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	The authors thank S. Zelenay for the LA-Delta OVA-mCherry and Delta OVA-mCherry constructs; R. Weil for the dominant negative NF-kappa B plasmid; P.O. Vidalain for the NF-kappa B-Luciferase reporter plasmid; P. Fitzgerald for cell lines; and. M.A. Ingersoll, D. Duffy, O. Schwartz, J. Boussier, and A. Yatim for their critical reading of the manuscript and advice. We also thank M. A. Ingersoll for mouse protocols, M. Fontes for assistance with Qlucore Omics software, and the Centre for Human Immunology for providing technical support and project management. The data from this study are tabulated here and in the supplementary materials. Dimerizable RIPK3 and caspase-8 constructs are available from D.O. under a materials transfer agreement with the University of Washington. U.S. Patent PCT/US2014/036196 has been filed by St. Jude Children's Research Hospital, covering the induction of necroptosis using RIPK3 oligomerization. Funding for the work was provided by the Agence Nationale de Recherches sur le Sida et les Hepatitis; Projet ANUBIS of the Agence Nationale de la Recherche (ANR-12-BSV3-0011-01) and a Laboratories of Excellence Immuno-Onco grant (ANR-11-IDEX-0005-02) (M.L.A., N.Y., H.J.-S., and R.B.d.S.); the French National Cancer Institute (INCa) (Plan Cancer 2014-2019) and the Ecole de l'Inserm Liliane Bettencourt (N.Y.); NIH grants R21CA185681 and R01AI108685 (A.O.); NIH grant AI44848 (D.R.G.); and NIH award 5R01AI108685-02 (S.O.). C.R.S. and O.S. were supported by grants from Cancer Research UK, The Francis Crick Institute, and the European Research Council. The authors thank the Genomics Platform of the Department of Translational Research at Institut Curie for experiments conducted using Nanostring tools (grants INCa-DGOS-4654, SIRIC11-002, ANR-10-IDEX-0001-02 PSL, and ANR-11-LBX-0044).	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gamrekelashvili J, 2013, J CLIN INVEST, V123, P4755, DOI 10.1172/JCI65698; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Yatim N, 2011, IMMUNITY, V35, P478, DOI 10.1016/j.immuni.2011.10.010	39	332	348	7	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					328	+		10.1126/science.aad0395	http://dx.doi.org/10.1126/science.aad0395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26405229	Green Accepted, Green Submitted			2022-12-28	WOS:000362838700043
J	Chen, TY; Robinson, LF; Burke, A; Southon, J; Spooner, P; Morris, PJ; Ng, HC				Chen, Tianyu; Robinson, Laura F.; Burke, Andrea; Southon, John; Spooner, Peter; Morris, Paul J.; Ng, Hong Chin			Synchronous centennial abrupt events in the ocean and atmosphere during the last deglaciation	SCIENCE			English	Article							HIGH-RESOLUTION RECORD; NORTH-ATLANTIC; OVERTURNING CIRCULATION; TROPICAL ATLANTIC; SOUTHERN-OCEAN; HULU CAVE; DEEP-SEA; CARBON; CO2; CLIMATE	Antarctic ice-core data reveal that the atmosphere experienced abrupt centennial increases in CO2 concentration during the last deglaciation (similar to 18 thousand to 11 thousand years ago). Establishing the role of ocean circulation in these changes requires high-resolution, accurately dated marine records. Here, we report radiocarbon data from uranium-thorium-dated deep-sea corals in the Equatorial Atlantic and Drake Passage over the past 25,000 years. Two major deglacial radiocarbon shifts occurred in phase with centennial atmospheric CO2 rises at 14.8 thousand and 11.7 thousand years ago. We interpret these radiocarbon-enriched signals to represent two short-lived (less than 500 years) "overshoot" events, with Atlantic meridional overturning stronger than that of the modern era. These results provide compelling evidence for a close coupling of ocean circulation and centennial climate events during the last deglaciation.	[Chen, Tianyu; Robinson, Laura F.; Spooner, Peter; Morris, Paul J.; Ng, Hong Chin] Univ Bristol, Bristol Isotope Grp, Sch Earth Sci, Bristol, Avon, England; [Burke, Andrea] Univ St Andrews, Dept Earth & Environm Sci, St Andrews, Fife, Scotland; [Southon, John] Univ Calif Irvine, Sch Phys Sci, Irvine, CA USA	University of Bristol; University of St Andrews; University of California System; University of California Irvine	Chen, TY (corresponding author), IAEA, Dept Nucl Sci & Applicat, Monaco, Monaco.	tc14502@bristol.ac.uk		Burke, Andrea/0000-0002-3754-1498; Ng, Hong Chin/0000-0002-2707-8372; Robinson, Laura/0000-0001-6811-0140	European Research Council; Philip Leverhulme Trust; U.S. National Science Foundation [0636787, 0944474, 0902957, 1234664]; Marie Curie Reintegration Grant; Natural Environment Research Council [NE/M004619/1] Funding Source: researchfish; NERC [NE/M004619/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Philip Leverhulme Trust; U.S. National Science Foundation(National Science Foundation (NSF)); Marie Curie Reintegration Grant(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the European Research Council, the Philip Leverhulme Trust, the U.S. National Science Foundation (grants 0636787, 0944474, 0902957, and 1234664), and a Marie Curie Reintegration Grant. All the data reported in this paper are available in the supplementary materials. We acknowledge the crew and science parties of RRS James Cook cruise JC094 and RV Nathaniel B. Palmer cruise NBP1103 who made this study possible. We also thank J. F. McManus and K. R. Hendry for the helpful comments during the preparation of this manuscript and C. D. Coath, C. A. Taylor, S. Lucas, and C. Bertrand for help with sample preparation and analyses. Comments from two anonymous reviewers helped to improve the manuscript, inspiring us to look at the deglacial ventilation and circulation events from a more broadened view.	Allen KA, 2015, QUATERNARY SCI REV, V122, P180, DOI 10.1016/j.quascirev.2015.05.007; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2010, NAT GEOSCI, V3, P567, DOI [10.1038/ngeo921, 10.1038/NGEO921]; Bradtmiller LI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6817; Broecker W, 2012, QUATERNARY SCI REV, V57, P17, DOI 10.1016/j.quascirev.2012.09.024; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Bryan SP, 2010, EARTH PLANET SC LETT, V298, P244, DOI 10.1016/j.epsl.2010.08.025; Buizert C, 2014, SCIENCE, V345, P1177, DOI 10.1126/science.1254961; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Cheng H, 2000, GEOCHIM COSMOCHIM AC, V64, P2401, DOI 10.1016/S0016-7037(99)00422-6; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Cleroux C, 2011, QUATERNARY SCI REV, V30, P1875, DOI 10.1016/j.quascirev.2011.04.015; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; De Pol-Holz R, 2010, NAT GEOSCI, V3, P192, DOI 10.1038/NGEO745; Huang KF, 2014, EARTH PLANET SC LETT, V389, P200, DOI 10.1016/j.epsl.2013.12.037; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kohler P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6520; Lippold J, 2012, NAT GEOSCI, V5, P813, DOI [10.1038/NGEO1608, 10.1038/ngeo1608]; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Lund DC, 2015, PALEOCEANOGRAPHY, V30, P477, DOI 10.1002/2014PA002657; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Martinez-Boti MA, 2015, NATURE, V518, P219, DOI 10.1038/nature14155; Matsumoto K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031301; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Oppo DW, 2015, PALEOCEANOGRAPHY, V30, P353, DOI 10.1002/2014PA002667; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts NL, 2010, SCIENCE, V327, P75, DOI 10.1126/science.1178068; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Schmittner A, 2015, CLIM PAST, V11, P135, DOI 10.5194/cp-11-135-2015; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Thornalley DJR, 2011, SCIENCE, V331, P202, DOI 10.1126/science.1196812; Toggweiler JR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001758; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221	39	73	82	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1537	1541		10.1126/science.aac6159	http://dx.doi.org/10.1126/science.aac6159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404835	Green Submitted			2022-12-28	WOS:000361707000047
J	Miller-Struttmann, NE; Geib, JC; Franklin, JD; Kevan, PG; Holdo, RM; Ebert-May, D; Lynn, AM; Kettenbach, JA; Hedrick, E; Galen, C				Miller-Struttmann, Nicole E.; Geib, Jennifer C.; Franklin, James D.; Kevan, Peter G.; Holdo, Ricardo M.; Ebert-May, Diane; Lynn, Austin M.; Kettenbach, Jessica A.; Hedrick, Elizabeth; Galen, Candace			Functional mismatch in a bumble bee pollination mutualism under climate change	SCIENCE			English	Article							ABUNDANCE; PATTERNS; SHIFTS; COMPETITION; PHENOLOGY; DECLINE	Ecological partnerships, or mutualisms, are globally widespread, sustaining agriculture and biodiversity. Mutualisms evolve through the matching of functional traits between partners, such as tongue length of pollinators and flower tube depth of plants. Long-tongued pollinators specialize on flowers with deep corolla tubes, whereas shorter-tongued pollinators generalize across tube lengths. Losses of functional guilds because of shifts in global climate may disrupt mutualisms and threaten partner species. We found that in two alpine bumble bee species, decreases in tongue length have evolved over 40 years. Co-occurring flowers have not become shallower, nor are small-flowered plants more prolific. We argue that declining floral resources because of warmer summers have favored generalist foraging, leading to a mismatch between shorter-tongued bees and the longer-tubed plants they once pollinated.	[Miller-Struttmann, Nicole E.] SUNY Coll Old Westbury, Dept Biol Sci, Old Westbury, NY 11568 USA; [Miller-Struttmann, Nicole E.; Franklin, James D.; Holdo, Ricardo M.; Lynn, Austin M.; Kettenbach, Jessica A.; Galen, Candace] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Geib, Jennifer C.] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Kevan, Peter G.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Ebert-May, Diane] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Kettenbach, Jessica A.] N Carolina State Univ, Dept Biol Sci, Zool Program, Raleigh, NC 27695 USA; [Hedrick, Elizabeth] Lincoln Univ, Dept Life & Phys Sci, Jefferson City, MO 65101 USA	State University of New York (SUNY) System; SUNY Old Westbury; University of Missouri System; University of Missouri Columbia; University of North Carolina; Appalachian State University; University of Guelph; Michigan State University; University of North Carolina; North Carolina State University; Lincoln University - Missouri	Miller-Struttmann, NE (corresponding author), SUNY Coll Old Westbury, Dept Biol Sci, Nat Sci Bldg Rm NS247, Old Westbury, NY 11568 USA.	nmillstrutt@gmail.com	Miller-Struttmann, Nicole/AAZ-1535-2020	Miller-Struttmann, Nicole/0000-0002-4799-4802	Arapaho National Forest, Niwot Ridge Long-Term Ecological Research (NSF) [DEB-1027341]; NSF [DEB-79-10786, 1045322]; Division Of Environmental Biology [1027341] Funding Source: National Science Foundation	Arapaho National Forest, Niwot Ridge Long-Term Ecological Research (NSF); NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge L. W. Macior and P. A. Byron for their meticulous work on Rocky Mountain bumble bees; J. Myrick, J. Guinnup, A. Drew, L. Rimmer, J. Stoehr, M. Pallo, L. Hesh, and B. Lubinski for laboratory and fieldwork; and the Mountain Research Station, University of Colorado and Mount Evans Field Station, Denver University for research facilities. The Arapaho National Forest, Niwot Ridge Long-Term Ecological Research (NSF grant DEB-1027341) and Mountain Area Land Trust (Pennsylvania Mountain) provided access to research sites. The Canadian National Collection of Insects; Rocky Mountain Herbarium, University of Wyoming; Kathryn Kalmbach Herbarium, Denver Botanic Garden; University of Colorado Herbarium; Colorado State University Herbarium; and the Missouri Botanical Garden loaned specimens. Research was supported by NSF (grants DEB-79-10786 and 1045322). Data and specific code are archived at DOI: 10.5061/dryad.10278 PRISM Climate Group data for Mount Evans and Pennsylvania Mountain are from www.prism.oregonstate.edu.	Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Byron P.A., 1980, DISSERTATION; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Essenberg CJ, 2012, AM NAT, V180, P153, DOI 10.1086/666610; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Geib JC, 2015, ECOL APPL, V25, P768, DOI 10.1890/14-0151.1; GILBERT FS, 1981, ECOL ENTOMOL, V6, P245, DOI 10.1111/j.1365-2311.1981.tb00612.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; GRANT V, 1992, P NATL ACAD SCI USA, V89, P9400, DOI 10.1073/pnas.89.20.9400; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; Hoye TT, 2013, NAT CLIM CHANGE, V3, P759, DOI [10.1038/nclimate1909, 10.1038/NCLIMATE1909]; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Kopp CW, 2014, J VEG SCI, V25, P135, DOI 10.1111/jvs.12072; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACIOR L W, 1974, Melanderia, V15, P1; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; McGuire CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044370; MILLER RB, 1981, EVOLUTION, V35, P763, DOI [10.1111/j.1558-5646.1981.tb04936.x, 10.2307/2408246]; Miller-Rushing AJ, 2009, AM J BOT, V96, P1821, DOI 10.3732/ajb.0800411; Miller-Struttmann NE, 2014, OECOLOGIA, V176, P1033, DOI 10.1007/s00442-014-3066-8; Muchhala N, 2009, P R SOC B, V276, P2147, DOI 10.1098/rspb.2009.0102; Ploquin EF, 2013, OECOLOGIA, V173, P1649, DOI 10.1007/s00442-013-2731-7; Pyke GH, 2012, ENVIRON ENTOMOL, V41, P1332, DOI 10.1603/EN11284; Rodriguez-Girones MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002992; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057	30	133	140	18	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1541	1544		10.1126/science.aab0868	http://dx.doi.org/10.1126/science.aab0868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404836				2022-12-28	WOS:000361707000048
J	Stuhl, BK; Lu, HI; Aycock, LM; Genkina, D; Spielman, IB				Stuhl, B. K.; Lu, H. -I.; Aycock, L. M.; Genkina, D.; Spielman, I. B.			Visualizing edge states with an atomic Bose gas in the quantum Hall regime	SCIENCE			English	Article							MAGNETIC-FIELDS; OPTICAL LATTICES; NEUTRAL ATOMS; ELECTRONS; FERMIONS	Bringing ultracold atomic gases into the quantum Hall regime is challenging. We engineered an effective magnetic field in a two-dimensional lattice with an elongated-strip geometry, consisting of the sites of an optical lattice in the long direction and of three internal atomic spin states in the short direction. We imaged the localized states of atomic Bose-Einstein condensates in this strip; via excitation dynamics, we further observed both the skipping orbits of excited atoms traveling down the system's edges, analogous to edge magnetoplasmons in two-dimensional electron systems, and a dynamical Hall effect for bulk excitations. Our technique involves minimal heating, which will be important for spectroscopic measurements of the Hofstadter butterfly and realizations of Laughlin's charge pump.	[Stuhl, B. K.; Lu, H. -I.; Aycock, L. M.; Genkina, D.; Spielman, I. B.] NIST, JQI, Gaithersburg, MD 20899 USA; [Stuhl, B. K.; Lu, H. -I.; Aycock, L. M.; Genkina, D.; Spielman, I. B.] Univ Maryland, Gaithersburg, MD 20899 USA; [Aycock, L. M.] Cornell Univ, Dept Phys, Ithaca, NY 14850 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Cornell University	Spielman, IB (corresponding author), NIST, JQI, Gaithersburg, MD 20899 USA.	ian.spielman@nist.gov			Army Research Office's Atomtronics Multidisciplinary University Research Initiative (MURI); Air Force Office of Scientific Research's Quantum Matter MURI; NIST; NSF through the Physics Frontier Center at the JQI; NSF Graduate Research Fellowship Program; Direct For Mathematical & Physical Scien [1430094] Funding Source: National Science Foundation	Army Research Office's Atomtronics Multidisciplinary University Research Initiative (MURI); Air Force Office of Scientific Research's Quantum Matter MURI; NIST(National Institute of Standards & Technology (NIST) - USA); NSF through the Physics Frontier Center at the JQI(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by the Army Research Office's Atomtronics Multidisciplinary University Research Initiative (MURI), the Air Force Office of Scientific Research's Quantum Matter MURI, NIST, and NSF (through the Physics Frontier Center at the JQI). B.K.S. is a NIST-National Research Council Postdoctoral Research Associate. L.M.A. was supported by the NSF Graduate Research Fellowship Program. All authors except I.B.S contributed to the data collection effort. B.K.S. and L.M.A. configured the apparatus for this experiment. H.-I.L. led the team on all aspects of the edge-current and skipping-orbit measurements. H.-I.L., L.M.A., and B.K.S. analyzed data. B.K.S., H.-I.L., L.M.A, and I.B.S. performed numerical and analytical calculations. All authors contributed to writing the manuscript. I.B.S. proposed the initial experiment.	Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; ASHOORI RC, 1992, PHYS REV B, V45, P3894, DOI 10.1103/PhysRevB.45.3894; Atala M, 2014, NAT PHYS, V10, P588, DOI 10.1038/NPHYS2998; Beugeling W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075118; Boada O, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.133001; Boada O, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/045007; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Celi A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043001; Geisler MC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256801; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; HARPER PG, 1955, P PHYS SOC LOND A, V68, P879, DOI 10.1088/0370-1298/68/10/305; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Hugel D, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023619; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; KERN K, 1991, PHYS REV LETT, V66, P1618, DOI 10.1103/PhysRevLett.66.1618; LAUGHLIN RB, 1981, PHYS REV B, V23, P5632, DOI 10.1103/PhysRevB.23.5632; LeBlanc LJ, 2012, P NATL ACAD SCI USA, V109, P10811, DOI 10.1073/pnas.1202579109; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lin YJ, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063631; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Montambaux G, 2011, EUR PHYS J B, V79, P215, DOI 10.1140/epjb/e2010-10584-y; Morsch O, 2006, REV MOD PHYS, V78, P179, DOI 10.1103/RevModPhys.78.179; Petrescu A, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.054520; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494	32	405	408	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1514	1517		10.1126/science.aaa8515	http://dx.doi.org/10.1126/science.aaa8515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404830	Green Submitted			2022-12-28	WOS:000361707000041
J	Brodsky, JL; Frizzell, RA				Brodsky, Jeffrey L.; Frizzell, Raymond A.			A Combination Therapy for Cystic Fibrosis	CELL			English	Editorial Material									[Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			NIDDK NIH HHS [P30 DK079307] Funding Source: Medline; NIGMS NIH HHS [R01 GM075061] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	11	13	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					17	17		10.1016/j.cell.2015.09.003	http://dx.doi.org/10.1016/j.cell.2015.09.003			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406363	Green Accepted, Bronze			2022-12-28	WOS:000361846500004
J	Molliex, A; Temirov, J; Lee, J; Coughlin, M; Kanagaraj, AP; Kim, HJ; Mittag, T; Taylor, JP				Molliex, Amandine; Temirov, Jamshid; Lee, Jihun; Coughlin, Maura; Kanagaraj, Anderson P.; Kim, Hong Joo; Mittag, Tanja; Taylor, J. Paul			Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization	CELL			English	Article							INTRINSICALLY DISORDERED PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; RNA GRANULES; NUCLEAR IMPORT; HNRNP A1; MUTATIONS; BINDING; ALS; SPECIFICITY; TRANSITION	Stress granules are membrane-less organelles composed of RNA-binding proteins (RBPs) and RNA. Functional impairment of stress granules has been implicated in amyotrophic lateral sclerosis, frontotemporal dementia, and multisystem proteinopathy-diseases that are characterized by fibrillar inclusions of RBPs. Genetic evidence suggests a link between persistent stress granules and the accumulation of pathological inclusions. Here, we demonstrate that the disease-related RBP hnRNPA1 undergoes liquid-liquid phase separation (LLPS) into protein-rich droplets mediated by a low complexity sequence domain (LCD). While the LCD of hnRNPA1 is sufficient to mediate LLPS, the RNA recognition motifs contribute to LLPS in the presence of RNA, giving rise to several mechanisms for regulating assembly. Importantly, while not required for LLPS, fibrillization is enhanced in protein-rich droplets. We suggest that LCD-mediated LLPS contributes to the assembly of stress granules and their liquid properties and provides a mechanistic link between persistent stress granules and fibrillar protein pathology in disease.	[Molliex, Amandine; Coughlin, Maura; Kanagaraj, Anderson P.; Kim, Hong Joo; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Temirov, Jamshid] St Jude Childrens Res Hosp, Cell & Tissue Imaging Ctr, Memphis, TN 38105 USA; [Lee, Jihun; Mittag, Tanja] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Howard Hughes Med Inst, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Mittag, T (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	tanja.mittag@stjude.org; jpaul.taylor@stjude.org	Taylor, J. Paul/N-2482-2018; KANAGARAJ, A/GZG-4720-2022	Taylor, J. Paul/0000-0002-5794-0349; Lee, Jihun/0000-0002-8803-7689; , Palsamy Kanagaraj/0000-0003-3297-3125; Mittag, Tanja/0000-0002-1827-3811; Kim, Hong Joo/0000-0002-9157-1612	Muscular Dystrophy Association; Packard Center for ALS Research; Target ALS; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Packard Center for ALS Research; Target ALS; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Peng for his help in estimating the intracellular hnRNPA1 concentrations. We thank V. Frohlich and the St. Jude Cell and Tissue Imaging Shared Resource for extended access to their microscopes. We thank M. Rosen and R. Parker for comments on our manuscript and for sharing data prior to publication. We thank M. Marzahn for scientific input and E. Enemark for sharing reagents. We thank J. Parobek and A-M. Hedges in St. Jude Biomedical Communications for photography of the test tubes. This work was supported by funding from the Muscular Dystrophy Association, the Packard Center for ALS Research, Target ALS, and ALSAC.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bernis C, 2014, MOL BIOL CELL, V25, P992, DOI 10.1091/mbc.E13-08-0506; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Das RK, 2015, CURR OPIN STRUC BIOL, V32, P102, DOI 10.1016/j.sbi.2015.03.008; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Figley MD, 2014, J NEUROSCI, V34, P8083, DOI 10.1523/JNEUROSCI.0543-14.2014; Flory PJ, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Hackman P, 2013, ANN NEUROL, V73, P500, DOI 10.1002/ana.23831; Hormoz S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02919; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Huggins ML, 1942, J PHYS CHEM-US, V46, P151, DOI 10.1021/j150415a018; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Klar J, 2013, HUM MUTAT, V34, P572, DOI 10.1002/humu.22282; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Muschol M, 1997, J CHEM PHYS, V107, P1953, DOI 10.1063/1.474547; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Sengers J.V, 1980, PHASE TRANSIT, P95; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Vieira NM, 2014, HUM MOL GENET, V23, P4103, DOI 10.1093/hmg/ddu127; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033	48	1312	1324	27	269	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					123	133		10.1016/j.cell.2015.09.015	http://dx.doi.org/10.1016/j.cell.2015.09.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406374	Bronze, Green Accepted			2022-12-28	WOS:000361846500026
J	Gorte, RJ				Gorte, Raymond J.			Cooling down ceramic fuel cells	SCIENCE			English	Editorial Material									Univ Penn, Chem & Biomol Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Gorte, RJ (corresponding author), Univ Penn, Chem & Biomol Engn, Philadelphia, PA 19104 USA.	gorte@seas.upenn.edu						Duan CC, 2015, SCIENCE, V349, P1321, DOI 10.1126/science.aab3987; Friebe S, 2015, ANGEW CHEM INT EDIT, V54, P7790, DOI 10.1002/anie.201500751; Haile SM, 2001, NATURE, V410, P910, DOI 10.1038/35073536; Kim J, 2014, CHEMSUSCHEM, V7, P2811, DOI 10.1002/cssc.201402351; McIntosh S, 2004, CHEM REV, V104, P4845, DOI 10.1021/cr020725g; Wachsman ED, 2011, SCIENCE, V334, P935, DOI 10.1126/science.1204090	6	18	18	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1290	1290		10.1126/science.aad0432	http://dx.doi.org/10.1126/science.aad0432			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383941				2022-12-28	WOS:000361357700026
J	Wolthers, M				Wolthers, Mariette			How minerals dissolve	SCIENCE			English	Editorial Material							ATOMIC-FORCE MICROSCOPY; CALCITE; DISSOLUTION		[Wolthers, Mariette] Univ Utrecht, Dept Earth Sci Geochem, Fac Geosci, NL-3508 TC Utrecht, Netherlands; [Wolthers, Mariette] UCL, Dept Chem, London, England	Utrecht University; University of London; University College London	Wolthers, M (corresponding author), Univ Utrecht, Dept Earth Sci Geochem, Fac Geosci, NL-3508 TC Utrecht, Netherlands.	m.wolthers@uu.nl	Wolthers, Mariette/V-7994-2017	Wolthers, Mariette/0000-0003-3908-5622	Natural Environment Research Council [NE/J018856/1] Funding Source: researchfish; NERC [NE/J018856/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; BOYLE EA, 1981, EARTH PLANET SC LETT, V53, P11, DOI 10.1016/0012-821X(81)90022-4; Fischer C, 2014, APPL GEOCHEM, V43, P132, DOI 10.1016/j.apgeochem.2014.02.002; Laanait N, 2015, SCIENCE, V349, P1330, DOI 10.1126/science.aab3272; Liang Y, 1996, GEOCHIM COSMOCHIM AC, V60, P4883, DOI 10.1016/S0016-7037(96)00337-7; Luquot L, 2009, CHEM GEOL, V265, P148, DOI 10.1016/j.chemgeo.2009.03.028; Luttge A, 2003, GEOCHIM COSMOCHIM AC, V67, P1099; Morse JW, 2007, CHEM REV, V107, P342, DOI 10.1021/cr050358j; Ruiz-Agudo E, 2012, MINERAL MAG, V76, P227, DOI 10.1180/minmag.2012.076.1.227; STIPP SLS, 1994, GEOCHIM COSMOCHIM AC, V58, P3023, DOI 10.1016/0016-7037(94)90176-7; Teng HH, 2004, GEOCHIM COSMOCHIM AC, V68, P253, DOI 10.1016/S0016-7037(03)00423-X; WILLERT CE, 1991, EXP FLUIDS, V10, P181	12	11	11	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1288	1288		10.1126/science.aad0852	http://dx.doi.org/10.1126/science.aad0852			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383939				2022-12-28	WOS:000361357700024
J	Ma, DL; Vano-Galvan, S				Ma, Dong-Lai; Vano-Galvan, Sergio			Cutaneous Collagenous Vasculopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ma, Dong-Lai] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Vano-Galvan, Sergio] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Hospital Universitario Ramon y Cajal	Ma, DL (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	mdonglai@sohu.com		Vano-Galvan, Sergio/0000-0003-2773-7494					0	3	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12							e14	10.1056/NEJMicm1408473	http://dx.doi.org/10.1056/NEJMicm1408473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26376155				2022-12-28	WOS:000361556400011
J	Fordyce, CB; Granger, CB				Fordyce, Christopher B.; Granger, Christopher B.			Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							STATIN THERAPY; METAANALYSIS		[Fordyce, Christopher B.; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Fordyce, CB (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.							Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Mills EJ, 2011, EUR HEART J, V32, P1409, DOI 10.1093/eurheartj/ehr035; Rosenson RS, 2015, J AM COLL CARDIOL, V65, P270, DOI 10.1016/j.jacc.2014.09.088	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC7	10.7326/ACPJC-2015-163-6-007	http://dx.doi.org/10.7326/ACPJC-2015-163-6-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370034				2022-12-28	WOS:000361365900007
J	Jucker, M; Walker, LC				Jucker, Mathias; Walker, Lary C.			NEURODEGENERATION Amyloid-beta-pathology induced in humans	NATURE			English	Editorial Material							PRION DISEASE; ALZHEIMER		[Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Jucker, Mathias] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Emory University; Emory University	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de; lary.walker@emory.edu	Walker, L C/J-6541-2015	Walker, L C/0000-0001-9166-3261				Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; PRUSINER SB, 1984, NEW ENGL J MED, V310, P661, DOI 10.1056/NEJM198403083101021; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Tousseyn T, 2015, J NEUROPATH EXP NEUR, V74, P873, DOI 10.1097/NEN.0000000000000228; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Ye L., 2015, NATURE NEUROSCI	12	29	31	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					193	194		10.1038/525193a	http://dx.doi.org/10.1038/525193a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354478	Bronze			2022-12-28	WOS:000360927400022
J	Pencina, MJ; D'Agostino, RB				Pencina, Michael J.; D'Agostino, Ralph B.			Evaluating Discrimination of Risk Prediction Models The C Statistic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AREA		[Pencina, Michael J.] Duke Univ, Duke Clin Res Inst, Biostat & Bioinformat, Durham, NC 27705 USA; [D'Agostino, Ralph B.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Duke University; Boston University	Pencina, MJ (corresponding author), Duke Univ, Duke Clin Res Inst, Biostat & Bioinformat, 2400 Pratt St, Durham, NC 27705 USA.	michael.pencina@duke.edu						Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Melgaard L, 2015, JAMA-J AM MED ASSOC, V314, P1030, DOI 10.1001/jama.2015.10725; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe M., 2013, RISK ASSESSMENT EVAL, P107; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	8	196	197	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1063	1064		10.1001/jama.2015.11082	http://dx.doi.org/10.1001/jama.2015.11082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348755				2022-12-28	WOS:000360840700018
J	Ratwani, RM; Benda, NC; Hettinger, AZ; Fairbanks, RJ				Ratwani, Raj M.; Benda, Natalie C.; Hettinger, A. Zachary; Fairbanks, Rollin J.			Electronic Health Record Vendor Adherence to Usability Certification Requirements and Testing Standards	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ratwani, Raj M.; Benda, Natalie C.; Hettinger, A. Zachary; Fairbanks, Rollin J.] MedStar Hlth, Natl Ctr Human Factors Healthcare, Washington, DC 20008 USA		Ratwani, RM (corresponding author), MedStar Hlth, 3007 Tilden St, Washington, DC 20008 USA.	raj.ratwani@medicalhfe.org		Hettinger, Aaron/0000-0003-0483-5788	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022542] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Institute of Medicine, 2012, HLTH IT PAT SAF BUIL; International Organization for Standardization, ERG REQ OFF WORK VIS; Magrabi F, 2010, J AM MED INFORM ASSN, V17, P663, DOI 10.1136/jamia.2009.002444; National Institute of Standards and Technology US Department of Commerce, 7804 NISTIR; Office of the National Coordinator for Health Information Technology, CERT HLTH IT PROD LI	5	55	55	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1070	1071		10.1001/jama.2015.8372	http://dx.doi.org/10.1001/jama.2015.8372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348757	Bronze			2022-12-28	WOS:000360840700020
J	Haas, AL; Wilkinson, K				Haas, Arthur L.; Wilkinson, Keith			Irwin (Ernie) Allen Rose (1926-2015) Obituary	CELL			English	Biographical-Item									[Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70130 USA; [Wilkinson, Keith] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Louisiana State University System; Emory University	Haas, AL (corresponding author), Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70130 USA.	ahaas@lsuhsc.edu						ROSE I, PUBLICATION LIST	1	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					233	234		10.1016/j.cell.2015.06.066	http://dx.doi.org/10.1016/j.cell.2015.06.066			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26397005	Bronze			2022-12-28	WOS:000358087700002
J	Thabit, H; Tauschmann, M; Allen, JM; Leelarathna, L; Hartnell, S; Wilinska, ME; Acerini, CL; Dellweg, S; Benesch, C; Heinemann, L; Mader, JK; Holzer, M; Kojzar, H; Exall, J; Yong, J; Pichierri, J; Barnard, KD; Kollman, C; Cheng, P; Hindmarsh, PC; Campbell, FM; Arnolds, S; Pieber, TR; Evans, ML; Dunger, DB; Hovorka, R				Thabit, H.; Tauschmann, M.; Allen, J. M.; Leelarathna, L.; Hartnell, S.; Wilinska, M. E.; Acerini, C. L.; Dellweg, S.; Benesch, C.; Heinemann, L.; Mader, J. K.; Holzer, M.; Kojzar, H.; Exall, J.; Yong, J.; Pichierri, J.; Barnard, K. D.; Kollman, C.; Cheng, P.; Hindmarsh, P. C.; Campbell, F. M.; Arnolds, S.; Pieber, T. R.; Evans, M. L.; Dunger, D. B.; Hovorka, R.		APCam Consortium; AP home Consortium	Home Use of an Artificial Beta Cell in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOOP INSULIN DELIVERY; OVERNIGHT GLUCOSE CONTROL; GLYCEMIC CONTROL; PUMP THERAPY; CONTROL 1ST; OPEN-LABEL; PANCREAS; HYPOGLYCEMIA; CHILDREN; SYSTEM	BACKGROUND The feasibility, safety, and efficacy of prolonged use of an artificial beta cell (closed-loop insulin-delivery system) in the home setting have not been established. METHODS In two multicenter, crossover, randomized, controlled studies conducted under free-living home conditions, we compared closed-loop insulin delivery with sensor-augmented pump therapy in 58 patients with type 1 diabetes. The closed-loop system was used day and night by 33 adults and overnight by 25 children and adolescents. Participants used the closed-loop system for a 12-week period and sensor-augmented pump therapy (control) for a similar period. The primary end point was the proportion of time that the glucose level was between 70 mg and 180 mg per deciliter for adults and between 70 mg and 145 mg per deciliter for children and adolescents. RESULTS Among adults, the proportion of time that the glucose level was in the target range was 11.0 percentage points (95% confidence interval [CI], 8.1 to 13.8) greater with the use of the closed-loop system day and night than with control therapy (P<0.001). The mean glucose level was lower during the closed-loop phase than during the control phase (difference, -11 mg per deciliter; 95% CI, -17 to -6; P<0.001), as were the area under the curve for the period when the glucose level was less than 63 mg per deciliter (39% lower; 95% CI, 24 to 51; P<0.001) and the mean glycated hemoglobin level (difference, -0.3%; 95% CI, -0.5 to -0.1; P = 0.002). Among children and adolescents, the proportion of time with the nighttime glucose level in the target range was higher during the closed-loop phase than during the control phase (by 24.7 percentage points; 95% CI, 20.6 to 28.7; P<0.001), and the mean nighttime glucose level was lower (difference, -29 mg per deciliter; 95% CI, -39 to -20; P<0.001). The area under the curve for the period in which the day-and-night glucose levels were less than 63 mg per deciliter was lower by 42% (95% CI, 4 to 65; P = 0.03). Three severe hypoglycemic episodes occurred during the closed-loop phase when the closed-loop system was not in use. CONCLUSIONS Among patients with type 1 diabetes, 12-week use of a closed-loop system, as compared with sensor-augmented pump therapy, improved glucose control, reduced hypoglycemia, and, in adults, resulted in a lower glycated hemoglobin level.	[Thabit, H.; Tauschmann, M.; Allen, J. M.; Leelarathna, L.; Wilinska, M. E.; Evans, M. L.; Dunger, D. B.; Hovorka, R.] Univ Cambridge, Wellcome Trust Med Res Council Inst Metab Sci, Cambridge, England; [Thabit, H.; Leelarathna, L.; Hartnell, S.; Wilinska, M. E.] Cambridge Univ Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Cambridge, England; [Tauschmann, M.; Allen, J. M.; Wilinska, M. E.; Acerini, C. L.; Dunger, D. B.; Hovorka, R.] Univ Cambridge, Dept Paediat, Cambridge, England; [Exall, J.; Yong, J.; Campbell, F. M.] Leeds Childrens Hosp, Leeds, W Yorkshire, England; [Pichierri, J.; Hindmarsh, P. C.] Univ Coll London Hosp, Inst Child Hlth, London, England; [Barnard, K. D.] Bournemouth Univ, Fac Hlth & Social Sci, Bournemouth, Dorset, England; [Dellweg, S.; Benesch, C.; Heinemann, L.; Arnolds, S.] Profil, Neuss, Germany; [Allen, J. M.; Holzer, M.; Kojzar, H.; Pieber, T. R.] Med Univ Graz, Dept Internal Med, Graz, Austria; [Kollman, C.; Cheng, P.] Jaeb Ctr Hlth Res, Tampa, FL USA	University of Cambridge; University of Cambridge; University of Cambridge; University College London Hospitals NHS Foundation Trust; University of London; University College London; Bournemouth University; Profil; Medical University of Graz; JAEB Center For Health Research	Hovorka, R (corresponding author), Univ Cambridge, Metab Res Labs, NIHR Cambridge Biomed Res Ctr, Wellcome Trust MRC Inst Metab Sci, Box 289,Addenbrookes Hosp,Hills Rd, Cambridge CB2 0QQ, England.	rh347@cam.ac.uk	Hovorka, Roman/J-4123-2016; Tauschmann, Martin/GLN-8103-2022; Hovorka, Roman/O-1116-2019; Leelarathna, Lalantha/HDL-7345-2022	Hovorka, Roman/0000-0003-2901-461X; Hovorka, Roman/0000-0003-2901-461X; Leelarathna, Lalantha/0000-0001-9602-1962; Pieber, Thomas/0000-0003-3554-0405; Dunger, Professor David/0000-0002-2566-9304; Acerini, Carlo/0000-0003-2121-5871; Mader, Julia/0000-0001-7854-4233; Thabit, Hood/0000-0001-6076-6997; DeVries, J. Hans/0000-0001-9196-9906; Tauschmann, Martin/0000-0002-2305-2490; Evans, Mark/0000-0001-8122-8987; Murphy, Helen/0000-0002-5489-0614	JDRF; Medical Research Council [G0600717] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10274, NF-SI-0513-10012] Funding Source: researchfish; MRC [G0600717] Funding Source: UKRI	JDRF(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the JDRF and others; AP@home04 and APCam08 ClinicalTrials.gov numbers, NCT01961622 and NCT01778348.	Atlas E, 2010, DIABETES CARE, V33, P1072, DOI 10.2337/dc09-1830; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Breton M, 2012, DIABETES, V61, P2230, DOI 10.2337/db11-1445; Buckingham BA, 2015, DIABETES CARE, V38, P1197, DOI 10.2337/dc14-3053; Castle JR, 2010, DIABETES CARE, V33, P1282, DOI 10.2337/dc09-2254; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Davis EA, 1997, DIABETES CARE, V20, P22, DOI 10.2337/diacare.20.1.22; Haidar A, 2015, LANCET DIABETES ENDO, V3, P595, DOI 10.1016/S2213-8587(15)00141-2; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Hovorka R, 2015, DIABETIC MED, V32, P987, DOI 10.1111/dme.12766; Hovorka R, 2014, DIABETES CARE, V37, P1204, DOI 10.2337/dc13-2644; Hovorka R, 2011, NAT REV ENDOCRINOL, V7, P385, DOI 10.1038/nrendo.2011.32; Johnson SR, 2013, DIABETIC MED, V30, P1126, DOI 10.1111/dme.12247; Kovatchev BP, 2014, DIABETES CARE, V37, P1789, DOI 10.2337/dc13-2076; Kovatchev BP, 2013, DIABETES CARE, V36, P1851, DOI 10.2337/dc12-1965; Leelarathna L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006075; Leelarathna L, 2014, DIABETES CARE, V37, P1931, DOI 10.2337/dc13-2911; Ly TT, 2015, DIABETES CARE, V38, P1205, DOI 10.2337/dc14-3073; Ly TT, 2014, DIABETES CARE, V37, P2310, DOI 10.2337/dc14-0147; Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; Phillip M, 2013, NEW ENGL J MED, V368, P824, DOI 10.1056/NEJMoa1206881; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Russell SJ, 2012, DIABETES CARE, V35, P2148, DOI 10.2337/dc12-0071; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Thabit H, 2014, LANCET DIABETES ENDO, V2, P701, DOI 10.1016/S2213-8587(14)70114-7; Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959	29	281	282	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2129	2140		10.1056/NEJMoa1509351	http://dx.doi.org/10.1056/NEJMoa1509351			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26379095	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000365354800007
J	Filippon, J				Filippon, Jonathan			PERSONAL VIEW Slow and costly access to anonymised patient data impedes academic research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Mary Univ London, London E1 2AB, England	University of London; Queen Mary University London	Filippon, J (corresponding author), Queen Mary Univ London, London E1 2AB, England.	jonathanfilippon@gmail.com	Filippon, Jonathan/X-7795-2019; Filippon, Jonathan G/A-4917-2013	Filippon, Jonathan/0000-0003-3907-1992				Pollock AM, 2014, LANCET, V383, P1523, DOI 10.1016/S0140-6736(14)60727-3	1	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2015	351								h5087	10.1136/bmj.h5087	http://dx.doi.org/10.1136/bmj.h5087			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GR	26408001				2022-12-28	WOS:000361960500005
J	Mughal, F; Rashid, A; Mishra, RC				Mughal, Faraz; Rashid, Ahmed; Mishra, Rajnish C.			CASE REVIEW A case of unusual hand pain in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOTONIC-DYSTROPHY		[Mughal, Faraz; Mishra, Rajnish C.] Dove Med Practice, Birmingham B23 5DD, W Midlands, England; [Rashid, Ahmed] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Cambridge	Mughal, F (corresponding author), Dove Med Practice, Birmingham B23 5DD, W Midlands, England.	farazm@doctors.org.uk	Mughal, Faraz/AAF-6073-2019	Mughal, Faraz/0000-0002-5437-5962				Gomes L, 2014, REV PORT CARDIOL, V33, P765, DOI 10.1016/j.repc.2014.06.003; Groh WJ, 2008, NEW ENGL J MED, V358, P2688, DOI 10.1056/NEJMoa062800; Heatwole C, 2012, NEUROLOGY, V79, P348, DOI 10.1212/WNL.0b013e318260cbe6; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Timman R, 2010, J REHABIL MED, V42, P823, DOI 10.2340/16501977-0598; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2015	351								h5005	10.1136/bmj.h5005	http://dx.doi.org/10.1136/bmj.h5005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GR	26407679				2022-12-28	WOS:000361960500003
J	Carter, J; Wiedenheft, B				Carter, Joshua; Wiedenheft, Blake			SnapShot: CRISPR-RNA-Guided Adaptive Immune Systems	CELL			English	Editorial Material							CAS ADAPTATION		[Carter, Joshua; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59715 USA	Montana State University System; Montana State University Bozeman	Carter, J (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59715 USA.			Carter, Joshua/0000-0002-9194-7966	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474, R01GM108888, P20GM103500] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [52006931] Funding Source: Medline; NIGMS NIH HHS [R01 GM108888, 5P20GM103474, P20GM103500, R01GM108888] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bondy-Denomy J., 2015, NATURE; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114	9	12	20	10	111	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					260	U284		10.1016/j.cell.2015.09.011	http://dx.doi.org/10.1016/j.cell.2015.09.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406380	Bronze, Green Accepted			2022-12-28	WOS:000361846500038
J	De Los Angeles, A; Ferrari, F; Xi, RB; Fujiwara, Y; Benvenisty, N; Deng, HK; Hochedlinger, K; Jaenisch, R; Lee, S; Leitch, HG; Lensch, MW; Lujan, E; Pei, DQ; Rossant, J; Wernig, M; Park, PJ; Daley, GQ				De Los Angeles, Alejandro; Ferrari, Francesco; Xi, Ruibin; Fujiwara, Yuko; Benvenisty, Nissim; Deng, Hongkui; Hochedlinger, Konrad; Jaenisch, Rudolf; Lee, Soohyun; Leitch, Harry G.; Lensch, M. William; Lujan, Ernesto; Pei, Duanqing; Rossant, Janet; Wernig, Marius; Park, Peter J.; Daley, George Q.			Hallmarks of pluripotency	NATURE			English	Review							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; PRIMORDIAL GERM-CELLS; GROUND-STATE; DNA METHYLATION; TRANSCRIPTIONAL NETWORK; REGULATORY CIRCUITRY; ISOLATED BLASTOMERES; MOUSE EPIBLAST; SOMATIC-CELLS	Stem cells self-renew and generate specialized progeny through differentiation, but vary in the range of cells and tissues they generate, a property called developmental potency. Pluripotent stem cells produce all cells of an organism, while multipotent or unipotent stem cells regenerate only specific lineages or tissues. Defining stem-cell potency relies upon functional assays and diagnostic transcriptional, epigenetic and metabolic states. Here we describe functional and molecular hallmarks of pluripotent stem cells, propose a checklist for their evaluation, and illustrate how forensic genomics can validate their provenance.	[De Los Angeles, Alejandro; Fujiwara, Yuko; Lensch, M. William; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [De Los Angeles, Alejandro; Fujiwara, Yuko; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [De Los Angeles, Alejandro; Fujiwara, Yuko; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [De Los Angeles, Alejandro; Fujiwara, Yuko; Hochedlinger, Konrad; Lensch, M. William; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [De Los Angeles, Alejandro; Fujiwara, Yuko; Hochedlinger, Konrad; Lensch, M. William; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ferrari, Francesco; Xi, Ruibin; Hochedlinger, Konrad; Lee, Soohyun; Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA; [Xi, Ruibin] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Xi, Ruibin] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China; [Benvenisty, Nissim] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Leitch, Harry G.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; [Lujan, Ernesto; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Rossant, Janet] Hosp Sick Children, Res Inst, Toronto, ON M5G 0A4, Canada	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Peking University; Peking University; Hebrew University of Jerusalem; Peking University; Peking University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Imperial College London; Stanford University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Daley, GQ (corresponding author), Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Ferrari, Francesco/H-5007-2012; Leitch, Harry/I-3357-2019	Ferrari, Francesco/0000-0002-9811-3753; Leitch, Harry/0000-0002-3486-8962; Park, Peter/0000-0001-9378-960X; Rossant, Janet/0000-0002-3731-5466; Lee, Soohyun/0000-0002-3594-6213; Xi, Ruibin/0000-0001-7545-7361	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Conrad S, 2014, NATURE, V512, P338, DOI 10.1038/nature13661; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; International Cell Line Authentication Committee, 2012, GUID HUM CELL LIN AU; *ISSCR, 2006, GUID COND HUM EMBR S; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; KELLY SJ, 1977, J EXP ZOOL, V200, P365, DOI 10.1002/jez.1402000307; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Ko K, 2010, NATURE, V465, pE1, DOI 10.1038/nature09089; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitalipov SM, 2002, BIOL REPROD, V66, P1449, DOI 10.1095/biolreprod66.5.1449; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Narasimha M, 1997, CURR BIOL, V7, P881, DOI 10.1016/S0960-9822(06)00377-0; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nicholas JS, 1942, J EXP ZOOL, V90, P441, DOI 10.1002/jez.1400900307; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Ohtsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045220; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; RIKEN, 2014, REP STAP CELL RES PA; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; Roy S, 2013, P NATL ACAD SCI USA, V110, P4598, DOI 10.1073/pnas.1218682110; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; STEVENS LC, 1958, J NATL CANCER I, V20, P1257, DOI 10.1093/jnci/20.6.1257; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Van de Velde H, 2008, HUM REPROD, V23, P1742, DOI 10.1093/humrep/den190; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; WILLADSEN SM, 1981, VET REC, V108, P211, DOI 10.1136/vr.108.10.211; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	112	248	254	7	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					469	478		10.1038/nature15515	http://dx.doi.org/10.1038/nature15515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26399828				2022-12-28	WOS:000361599900041
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Stand with junior doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, EUR WORK TIM DIR HEL; BMA, 2013, DEBT RIDD STUD FORC; Ercolani MG, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007335; Royal College of Obstetricians and Gynaecologists, 2015, RCOG STAT NEW CONTR; Tugendhat T., 2015, DAILY TELEGRAPH	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2015	351								h5132	10.1136/bmj.h5132	http://dx.doi.org/10.1136/bmj.h5132			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3GE	26404659	Bronze			2022-12-28	WOS:000361959200022
J	Pain, S				Pain, Stephanie			A potted history	NATURE			English	Editorial Material																			0	33	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S10	S11		10.1038/525S10a	http://dx.doi.org/10.1038/525S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0LD	26398731	Bronze			2022-12-28	WOS:000426167700001
J	Serrels, A; Lund, T; Serrels, B; Byron, A; McPherson, RC; von Kriegsheim, A; Gomez-Cuadrado, L; Canel, M; Muir, M; Ring, JE; Maniati, E; Sims, AH; Pachter, JA; Brunton, VG; Gilbert, N; Anderton, SM; Nibbs, RJB; Frame, MC				Serrels, Alan; Lund, Tom; Serrels, Bryan; Byron, Adam; McPherson, Rhoanne C.; von Kriegsheim, Alexander; Gomez-Cuadrado, Laura; Canel, Marta; Muir, Morwenna; Ring, Jennifer E.; Maniati, Eleni; Sims, Andrew H.; Pachter, Jonathan A.; Brunton, Valerie G.; Gilbert, Nick; Anderton, Stephen M.; Nibbs, Robert J. B.; Frame, Margaret C.			Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity	CELL			English	Article							FOCAL-ADHESION KINASE; REGULATORY T-CELLS; EPITHELIAL-SPECIFIC DISRUPTION; TUMOR-FORMATION; CANCER; EXPRESSION; BLOCKADE; PD-1; DIFFERENTIATION; HETEROCHROMATIN	Focal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase activity of nuclear-targeted FAK in squamous cell carcinoma (SCC) cells drives exhaustion of CD8(+) T cells and recruitment of regulatory T cells (Tregs) in the tumor microenvironment by regulating chemokine/cytokine and ligand-receptor networks, including via transcription of Ccl5, which is crucial. These changes inhibit antigen-primed cytotoxic CD8(+) T cell activity, permitting growth of FAK-expressing tumors. Mechanistically, nuclear FAK is associated with chromatin and exists in complex with transcription factors and their upstream regulators that control Ccl5 expression. Furthermore, FAK's immuno-modulatory nuclear activities may be specific to cancerous squamous epithelial cells, as normal keratinocytes do not have nuclear FAK. Finally, we show that a small-molecule FAK kinase inhibitor, VS-4718, which is currently in clinical development, also drives depletion of Tregs and promotes a CD8(+) T cell-mediated anti-tumor response. Therefore, FAK inhibitors may trigger immune-mediated tumor regression, providing previously unrecognized therapeutic opportunities.	[Serrels, Alan; Lund, Tom; Serrels, Bryan; Byron, Adam; von Kriegsheim, Alexander; Gomez-Cuadrado, Laura; Canel, Marta; Muir, Morwenna; Sims, Andrew H.; Brunton, Valerie G.; Frame, Margaret C.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [McPherson, Rhoanne C.; Anderton, Stephen M.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [Ring, Jennifer E.; Pachter, Jonathan A.] Verastem Inc, Needham, MA 02494 USA; [Maniati, Eleni] Univ London, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Gilbert, Nick] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Nibbs, Robert J. B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of London; University of Edinburgh; University of Glasgow	Serrels, A (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XR, Midlothian, Scotland.	a.serrels@ed.ac.uk; m.frame@ed.ac.uk	Maniati, Eleni/ABC-4551-2020; Muir, Morwenna/N-5448-2019; Byron, Adam/C-4871-2008; Byron, Adam/AID-5111-2022; von Kriegsheim, Alex/C-2371-2016; Sims, Andrew/E-4819-2012	Muir, Morwenna/0000-0001-5835-3886; Byron, Adam/0000-0002-5939-9883; von Kriegsheim, Alex/0000-0002-4952-8573; Frame, Margaret/0000-0001-5882-1942; Sims, Andrew/0000-0001-9082-3665; Gomez-Cuadrado, Laura/0000-0002-4754-2582; Gilbert, Nick/0000-0003-0505-6081; Nibbs, Robert/0000-0002-8150-0044	Cancer Research UK [C157/A15703]; European Research Council [29440]; Medical Research Council [G1100084]; Cancer Research UK [15703] Funding Source: researchfish; Medical Research Council [G0900992] Funding Source: researchfish; MRC [G1100084, G0900992] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK (Grant no. C157/A15703 to M.C.F.), European Research Council (Grant no. 29440 Cancer Innovation to M.C.F.) and Medical Research Council (Grant no. G1100084 to S.M.A.). We thank Frederic Li Mow Chee for help with transcriptomic analysis, Amaya Garcia-Munoz for help with mass spectrometry, Elisabeth Freyer for help with FACS, and Arkadiusz Welman for help with manuscript preparation. J.E.R. and J.A.P. are employees of Verastem Inc.	Albasri A, 2014, ANTICANCER RES, V34, P3969; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Biragyn A, 2012, SEMIN CANCER BIOL, V22, P50, DOI 10.1016/j.semcancer.2012.01.005; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Darrasse-Jeze G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00292; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Goldstein JD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00155; Kono K, 2006, CANCER IMMUNOL IMMUN, V55, P1064, DOI 10.1007/s00262-005-0092-8; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim STS, 2013, MOL CELLS, V36, P1, DOI 10.1007/s10059-013-0139-1; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Ondondo B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00197; Onizuka S, 1999, CANCER RES, V59, P3128; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Serrels A, 2012, INT J CANCER, V131, P287, DOI 10.1002/ijc.26351; Shah W, 2011, CELL MOL IMMUNOL, V8, P59, DOI 10.1038/cmi.2010.56; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Shimizu J, 1999, J IMMUNOL, V163, P5211; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Slack-Davis JK, 2009, MOL CANCER THER, V8, P2470, DOI 10.1158/1535-7163.MCT-09-0262; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	50	233	249	4	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					160	173		10.1016/j.cell.2015.09.001	http://dx.doi.org/10.1016/j.cell.2015.09.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406376	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000361846500029
J	Takahashi, N; Hirata, Y; Aihara, K; Mas, P				Takahashi, Nozomu; Hirata, Yoshito; Aihara, Kazuyuki; Mas, Paloma			A Hierarchical Multi-oscillator Network Orchestrates the Arabidopsis Circadian System	CELL			English	Article							GENE-EXPRESSION; MESOPHYLL PROTOPLASTS; APRR1/TOC1 QUINTET; CLOCK; RHYTHMS; THALIANA; TOC1; SYNCHRONIZATION; CHROMATIN; PROTEIN	Short- and long-distance circadian communication is essential for integration of temporal information. However, a major challenge in plant biology is to decipher how individual clocks are interconnected to sustain rhythms in the whole plant. Here we show that the shoot apex is composed of an ensemble of coupled clocks that influence rhythms in roots. Live-imaging of single cells, desynchronization of dispersed protoplasts, and mathematical analysis using barycentric coordinates for high-dimensional space show a gradation in the strength of circadian communication in different tissues, with shoot apex clocks displaying the highest coupling. The increased synchrony confers robustness of morning and evening oscillations and particular capabilities for phase readjustments. Rhythms in roots are altered by shoot apex ablation and micrografting, suggesting that signals from the shoot apex are able to synchronize distal organs. Similarly to themammalian suprachiasmatic nucleus, shoot apexes play a dominant role within the plant hierarchical circadian structure.	[Takahashi, Nozomu; Mas, Paloma] CSIC IRTA UAB UB, CRAG, Barcelona 08193, Spain; [Hirata, Yoshito; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Mas, Paloma] CSIC, E-08028 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC)	Mas, P (corresponding author), CSIC IRTA UAB UB, CRAG, Campus UAB, Barcelona 08193, Spain.	paloma.mas@cragenomica.es	Hirata, Yoshito/L-9297-2018; Mas, Paloma/B-8215-2016	Hirata, Yoshito/0000-0002-9245-2543; Mas, Paloma/0000-0002-3780-8041	Spanish Ministry of Economy and Competitiveness; Generalitat de Catalunya (AGAUR); Global Research Network of the National Research Foundation of Korea; European Commission Marie Curie Research Training Network (ChIP-ET); Ministry of Education, Culture, Sports, Science (MEXT); Japan Agency for Medical Research and development (AMED); CREST, JST, Japan; CRAG fellowship	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Global Research Network of the National Research Foundation of Korea(National Research Foundation of Korea); European Commission Marie Curie Research Training Network (ChIP-ET); Ministry of Education, Culture, Sports, Science (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); CREST, JST, Japan(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); CRAG fellowship	We thank Professor Y. Helariutta for the cals3 seeds, Professor K. Kornacker for help with the JTK_CYCLE algorithm, Professor R. Green for CCA1-HA-EYP plants, and M. Amenos for help with the confocal microscope. This work was supported by research grants to P.M. from the Spanish Ministry of Economy and Competitiveness, from the Generalitat de Catalunya (AGAUR), from the Global Research Network of the National Research Foundation of Korea, and from the European Commission Marie Curie Research Training Network (ChIP-ET). Y.H. and K.A. are supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science (MEXT) and Japan Agency for Medical Research and development (AMED). K.A. is also partially supported by CREST, JST, Japan. N.T. is supported by a CRAG fellowship.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Bainbridge K, 2014, METHODS MOL BIOL, V1062, P155, DOI 10.1007/978-1-62703-580-4_7; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Endo M, 2014, NATURE, V515, P419, DOI 10.1038/nature13919; Evans JA, 2012, J BIOL RHYTHM, V27, P443, DOI 10.1177/0748730412461246; Fukuda H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098102; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Harrington M, 2010, J CLIN INVEST, V120, P2265, DOI 10.1172/JCI43632; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hirata Y, 2015, CHAOS, V25, DOI 10.1063/1.4906746; Holbrook NM, 2002, J EXP BOT, V53, P1503, DOI 10.1093/jexbot/53.373.1503; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Kinmonth-Schultz HA, 2013, SEMIN CELL DEV BIOL, V24, P407, DOI 10.1016/j.semcdb.2013.02.006; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Malapeira J, 2012, P NATL ACAD SCI USA, V109, P21540, DOI 10.1073/pnas.1217022110; Mas P, 1998, PLANT J, V15, P835, DOI 10.1046/j.1365-313X.1998.00253.x; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nakamichi N, 2003, PLANT CELL PHYSIOL, V44, P360, DOI 10.1093/pcp/pcg039; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Portoles S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001201; Rascher U, 2001, P NATL ACAD SCI USA, V98, P11801, DOI 10.1073/pnas.191169598; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Sai J, 1999, P NATL ACAD SCI USA, V96, P11659, DOI 10.1073/pnas.96.20.11659; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Stratmann T, 2008, SEMIN CELL DEV BIOL, V19, P554, DOI 10.1016/j.semcdb.2008.07.012; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wenden B, 2012, P NATL ACAD SCI USA, V109, P6757, DOI 10.1073/pnas.1118814109; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x; Yakir E, 2011, PLANT J, V68, P520, DOI 10.1111/j.1365-313X.2011.04707.x; Yakir E, 2009, PLANT PHYSIOL, V150, P844, DOI 10.1104/pp.109.137414; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	54	93	99	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					148	159		10.1016/j.cell.2015.08.062	http://dx.doi.org/10.1016/j.cell.2015.08.062			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406375	Bronze, Green Published			2022-12-28	WOS:000361846500028
J	Vunjak-Novakovic, G				Vunjak-Novakovic, Gordana			CARDIAC BIOLOGY A protein for healing infarcted hearts	NATURE			English	Editorial Material							FOLLISTATIN-LIKE 1; REGENERATION		[Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA; [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Vunjak-Novakovic, G (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.	gv2131@columbia.edu		Vunjak-Novakovic, Gordana/0000-0002-9382-1574				Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Menasche P, 2015, EUR HEART J, V36, P2011, DOI 10.1093/eurheartj/ehv189; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Sylva M, 2013, BIRTH DEFECTS RES C, V99, P61, DOI 10.1002/bdrc.21030; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372	10	1	1	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					461	462		10.1038/nature15217	http://dx.doi.org/10.1038/nature15217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26375007				2022-12-28	WOS:000361599900036
J	Campi, G; Bianconi, A; Poccia, N; Bianconi, G; Barba, L; Arrighetti, G; Innocenti, D; Karpinski, J; Zhigadlo, ND; Kazakov, SM; Burghammer, M; Zimmermann, MV; Sprung, M; Ricci, A				Campi, G.; Bianconi, A.; Poccia, N.; Bianconi, G.; Barba, L.; Arrighetti, G.; Innocenti, D.; Karpinski, J.; Zhigadlo, N. D.; Kazakov, S. M.; Burghammer, M.; Zimmermann, M. V.; Sprung, M.; Ricci, A.			Inhomogeneity of charge-density-wave order and quenched disorder in a high-T-c superconductor	NATURE			English	Article							LOCAL LATTICE-DISTORTIONS; PHASE; TEMPERATURE; INSTABILITY; COMPLEXITY; NEMATICITY; EVOLUTION; QUANTUM; GLASS	It has recently been established that the high-transition-temperature (high-T-c) superconducting state coexists with short-range charge-density-wave order(1-11) and quenched disorder(12,13) arising from dopants and strain(14-17). This complex, multiscale phase separation(18-21) invites the development of theories of high-temperature superconductivity that include complexity(22-25). The nature of the spatial interplay between charge and dopant order that provides a basis for nanoscale phase separation remains a key open question, because experiments have yet to probe the unknown spatial distribution at both the nanoscale and mesoscale (between atomic and macroscopic scale). Here we report micro X-ray diffraction imaging of the spatial distribution of both short-range charge-density-wave 'puddles' (domains with only a few wavelengths) and quenched disorder in HgBa2CuO4+y, the single-layer cuprate with the highest T-c, 95 kelvin (refs 26-28). We found that the charge-density-wave puddles, like the steam bubbles in boiling water, have a fat-tailed size distribution that is typical of self-organization near a critical point(19). However, the quenched disorder, which arises from oxygen interstitials, has a distribution that is contrary to the usually assumed random, uncorrelated distribution(12,13). The interstitial-oxygen-rich domains are spatially anticorrelated with the charge-density-wave domains, because higher doping does not favour the stripy charge-density-wave puddles, leading to a complex emergent geometry of the spatial landscape for superconductivity.	[Campi, G.; Bianconi, A.] CNR, Inst Crystallog, I-00015 Monterotondo Roma, Italy; [Campi, G.; Bianconi, A.; Poccia, N.; Innocenti, D.; Ricci, A.] RICMASS, Superstripes, Rome Int Ctr Mat Sci, I-00185 Rome, Italy; [Poccia, N.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Bianconi, G.] Queen Mary Univ London, Sch Math, London E1 4SN, England; [Barba, L.; Arrighetti, G.] Sincrotrone Elettra UOS Trieste, Inst Crystallog, I-34149 Trieste, Italy; [Innocenti, D.; Karpinski, J.] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, CH-1015 Lausanne, Switzerland; [Karpinski, J.; Zhigadlo, N. D.; Kazakov, S. M.] ETH, Swiss Fed Inst Technol Zurich, Solid State Phys Lab, CH-8093 Zurich, Switzerland; [Kazakov, S. M.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia; [Burghammer, M.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Burghammer, M.] Univ Ghent, Dept Analyt Chem, B-9000 Ghent, Belgium; [Zimmermann, M. V.; Sprung, M.; Ricci, A.] Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Twente; University of London; Queen Mary University London; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Lomonosov Moscow State University; European Synchrotron Radiation Facility (ESRF); Ghent University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Bianconi, A (corresponding author), CNR, Inst Crystallog, Via Salaria Km 29-300, I-00015 Monterotondo Roma, Italy.	antonio.bianconi@ricmass.eu	Poccia, Nicola/L-1130-2016; Bianconi, Antonio/J-3997-2013; Bianconi, Ginestra/AAE-4114-2020; Bianconi, Ginestra/I-5742-2018; Barba, Luisa/D-3162-2012; Kazakov, Sergey M./A-4139-2014; innocenti, davide/H-7786-2012; Arrighetti, Gianmichele/B-9452-2015; Campi, Gaetano/H-1981-2018	Poccia, Nicola/0000-0001-7982-0113; Bianconi, Antonio/0000-0001-9795-3913; Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Barba, Luisa/0000-0001-8832-7056; Kazakov, Sergey M./0000-0002-0553-7881; innocenti, davide/0000-0002-0465-3039; Arrighetti, Gianmichele/0000-0001-9423-899X; Zhigadlo, Nikolai/0000-0001-7322-5874; Campi, Gaetano/0000-0001-9845-9394	Superstripes Institute; Marie Curie Intra-European Fellowship	Superstripes Institute; Marie Curie Intra-European Fellowship(European Commission)	We acknowledge the ESRF, ELETTRA and DESY synchrotron facilities for radiation-beam time and support. We thank the beamline scientists for help with experiments. We acknowledge the Calypso programme for travel support. We acknowledge support from the Superstripes Institute. N.P. acknowledges financial support from a Marie Curie Intra-European Fellowship for career development.	Alvarez G, 2006, LOW TEMP PHYS+, V32, P290, DOI 10.1063/1.2199428; Bianconi A, 1996, PHYS REV LETT, V76, P3412, DOI 10.1103/PhysRevLett.76.3412; Bianconi A, 2013, NAT PHYS, V9, P536, DOI 10.1038/nphys2738; Bianconi G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061113; Comin R, 2015, SCIENCE, V347, P1335, DOI 10.1126/science.1258399; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Croft TP, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.224513; Davison RA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245116; Drees Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6731; Fratini M, 2010, NATURE, V466, P841, DOI 10.1038/nature09260; Gabovich AM, 2001, SUPERCOND SCI TECH, V14, pR1, DOI 10.1088/0953-2048/14/4/201; Gor'kov LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08524; IMRY Y, 1975, PHYS REV LETT, V35, P1399, DOI 10.1103/PhysRevLett.35.1399; Izquierdo M, 2011, J PHYS CHEM SOLIDS, V72, P545, DOI 10.1016/j.jpcs.2010.10.055; Karpinski J, 1999, SUPERCOND SCI TECH, V12, pR153, DOI 10.1088/0953-2048/12/9/201; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Kresin VZ, 2007, PHYS REP, V437, P233, DOI 10.1016/j.physrep.2006.10.001; Lucas A, 2015, NUCL PHYS B, V892, P239, DOI 10.1016/j.nuclphysb.2015.01.017; Mesaros A, 2011, SCIENCE, V333, P426, DOI 10.1126/science.1201082; Phillabaum B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1920; Poccia N, 2012, P NATL ACAD SCI USA, V109, P15685, DOI 10.1073/pnas.1208492109; Poccia N, 2011, NAT MATER, V10, P733, DOI [10.1038/NMAT3088, 10.1038/nmat3088]; Ricci A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02383; She JH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.184518; Tabis W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6875; Vojta T, 2006, J PHYS A-MATH GEN, V39, pR143, DOI 10.1088/0305-4470/39/22/R01; Wagner JL, 2001, FUNDMAT RES, P331; Wu ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10073; Zeng W, 2010, INFOCOM 2010 P IEEE, P1	30	215	217	10	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					359	+		10.1038/nature14987	http://dx.doi.org/10.1038/nature14987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26381983	Green Submitted			2022-12-28	WOS:000361297900039
J	Lee, JS; Cua, DJ				Lee, Jacob S.; Cua, Daniel J.			Melatonin Lulling Th17 Cells to Sleep	CELL			English	Editorial Material							MULTIPLE-SCLEROSIS; DIFFERENTIATION		[Lee, Jacob S.; Cua, Daniel J.] Merck Res Lab, IMR Pathway Biol, Palo Alto, CA 94304 USA	Merck & Company	Lee, JS (corresponding author), Merck Res Lab, IMR Pathway Biol, 901 Calif Ave, Palo Alto, CA 94304 USA.	jacob.lee@merck.com; daniel.cua@merck.com						Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	9	12	13	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1212	1214		10.1016/j.cell.2015.08.054	http://dx.doi.org/10.1016/j.cell.2015.08.054			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359982	Bronze			2022-12-28	WOS:000361247900011
J	Rubio, M; Elmegreen, BG; Hunter, DA; Brinks, E; Cortes, JR; Cigan, P				Rubio, Monica; Elmegreen, Bruce G.; Hunter, Deidre A.; Brinks, Elias; Cortes, Juan R.; Cigan, Phil			Dense cloud cores revealed by CO in the low metallicity dwarf galaxy WLM	NATURE			English	Article							GALACTIC MOLECULAR CLOUDS; STAR-FORMATION; IRREGULAR GALAXIES; MILKY-WAY; GAS; CLUSTERS; STELLAR; CARBON; THINGS; MASS	Understanding stellar birth requires observations of the clouds in which they form. These clouds are dense and self-gravitating, and in all existing observations they are molecular, with H-2 the dominant species and carbon monoxide (CO) the best available tracer(1,2). When the abundances of carbon and oxygen are low compared with that of hydrogen, and the opacity from dust is also low, as in primeval galaxies and local dwarf irregular galaxies(3), CO forms slowly and is easily destroyed, so it is difficult for it to accumulate inside dense clouds(4). Here we report interferometric observations of CO clouds in the local group dwarf irregular galaxy Wolf-Lundmark-Melotte (WLM)(5), which has a metallicity that is 13 per cent of the solar value(6,7) and 50 per cent lower than the previous CO detection threshold. The clouds are tiny compared to the surrounding atomic and H-2 envelopes, but they have typical densities and column densities for CO clouds in the Milky Way. The normal CO density explains why star clusters forming in dwarf irregulars have similar densities to star clusters in giant spiral galaxies. The low cloud masses suggest that these clusters will also be low mass, unless some galaxy-scale compression occurs, such as an impact from a cosmic cloud or other galaxy. If the massive metal-poor globular clusters in the halo of the Milky Way formed in dwarf galaxies, as is commonly believed, then they were probably triggered by such an impact.	[Rubio, Monica] Univ Chile, Dept Astron, Santiago 8320000, Chile; [Elmegreen, Bruce G.] IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Hunter, Deidre A.] Lowell Observ, Flagstaff, AZ 86001 USA; [Brinks, Elias] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Cortes, Juan R.] Joint ALMA Observ, Santiago 7630355, Chile; [Cortes, Juan R.] Natl Radio Astron Observ, Santiago 7630197, Chile; [Cigan, Phil] New Mexico Inst Min & Technol, Socorro, NM 87801 USA	Universidad de Chile; International Business Machines (IBM); University of Hertfordshire; National Radio Astronomy Observatory (NRAO); New Mexico Institute of Mining Technology	Elmegreen, BG (corresponding author), IBM Corp, Div Res, TJ Watson Res Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	bge@us.ibm.com	Rubio, Monica/J-3384-2016	Brinks, Elias/0000-0002-7758-9699; Cigan, Phil/0000-0002-8736-2463	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) through FONDECYT [1140839]; CONICYT [BASAL PFB-06]; Lowell Observatory Research Fund; NASA (National Aeronautics and Space Administration) JPL RSA [1433776, 1456896]; STFC [ST/M001008/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/M001008/1] Funding Source: researchfish	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) through FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Lowell Observatory Research Fund; NASA (National Aeronautics and Space Administration) JPL RSA; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We wish to thank P. Massey and the Local Group Survey team for the use of their Ha image of WLM. L. Hill made the colour composite inset in Fig. 1. M.R. would like to thank C. Herrera and J. Garcia for support with the CASA implementation to reduce the raw data and A. Rojas for support in the ALMA data reduction. M.R. is grateful to A. Leroy for providing the galaxy data to produce Fig. 3. M.R. thanks the ALMA Director for the invitation to spend her 2015 sabbatical leave at the Joint ALMA Observatory (JAO) in Santiago, where this article was finished. P. C. is grateful to L. Young and S. Madden for invaluable guidance on Herschel data reduction. M.R. wishes to acknowledge support from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) through FONDECYT grant no. 1140839. M.R. is partially supported by CONICYT project BASAL PFB-06. The contributions from D.A.H. were funded by the Lowell Observatory Research Fund. P.C. acknowledges support from NASA (National Aeronautics and Space Administration) JPL RSA grant 1433776 to L. Young and grant 1456896 to D.A.H. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. NRAO is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bekki K, 2008, MON NOT R ASTRON SOC, V388, pL10, DOI 10.1111/j.1745-3933.2008.00489.x; Beuther H, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201424757; Billett OH, 2002, ASTRON J, V123, P1454, DOI 10.1086/339181; Bolatto AD, 2008, ASTROPHYS J, V686, P948, DOI 10.1086/591513; Chomiuk L, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/197; Cigan P., ASTRON J UNPUB; Elmegreen BG, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/145; Elmegreen BG, 2013, NATURE, V495, P487, DOI 10.1038/nature11933; Elmegreen BG, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/9; Glover SCO, 2012, MON NOT R ASTRON SOC, V421, P116, DOI 10.1111/j.1365-2966.2011.20260.x; Glover SCO, 2012, MON NOT R ASTRON SOC, V421, P9, DOI 10.1111/j.1365-2966.2011.19648.x; Heyer M, 2009, ASTROPHYS J, V699, P1092, DOI 10.1088/0004-637X/699/2/1092; Hunter DA, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/134; Hunter DA, 2010, ASTRON J, V139, P447, DOI 10.1088/0004-6256/139/2/447; Johnson M, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/152; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Krumholz MR, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/9; Leaman R, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/33; Lee H, 2005, ASTROPHYS J, V620, P223, DOI 10.1086/427019; Massey P, 2007, ASTRON J, V133, P2393, DOI 10.1086/513319; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; McMillan PJ, 2011, MON NOT R ASTRON SOC, V414, P2446, DOI 10.1111/j.1365-2966.2011.18564.x; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Remy-Ruyer A, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321602; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Tan J. C., 2013, IAU S, V292, P19; Turner JL, 2015, NATURE, V519, P331, DOI 10.1038/nature14218; Wong T, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/16; Zhang HX, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/47	30	50	50	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					218	+		10.1038/nature14901	http://dx.doi.org/10.1038/nature14901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354481	Green Submitted			2022-12-28	WOS:000360927400031
J	Mwangi, MN; Roth, JM; Smit, MR; Trijsburg, L; Mwangi, AM; Demir, AY; Wielders, JPM; Mens, PF; Verweij, JJ; Cox, SE; Prentice, AM; Brouwer, ID; Savelkoul, HFJ; Andang'o, PEA; Verhoef, H				Mwangi, Martin N.; Roth, Johanna M.; Smit, Menno R.; Trijsburg, Laura; Mwangi, Alice M.; Demir, Ayse Y.; Wielders, Jos P. M.; Mens, Petra F.; Verweij, Jaco J.; Cox, Sharon E.; Prentice, Andrew M.; Brouwer, Inge D.; Savelkoul, Huub F. J.; Andang'o, Pauline E. A.; Verhoef, Hans			Effect of Daily Antenatal Iron Supplementation on Plasmodium Infection in Kenyan Women A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT; MALARIA; PREGNANCY; GESTATION; ANEMIA; MEDICATION; MORTALITY; GROWTH; RISK	IMPORTANCE Anemia affects most pregnant African women and is predominantly due to iron deficiency, but antenatal iron supplementation has uncertain health benefits and can increase the malaria burden. OBJECTIVE To measure the effect of antenatal iron supplementation on maternal Plasmodium infection risk, maternal iron status, and neonatal outcomes. DESIGN, SETTING, AND PARTICIPANTS Randomized placebo-controlled trial conducted October 2011 through April 2013 in a malaria endemic area among 470 rural Kenyan women aged 15 to 45 years with singleton pregnancies, gestational age of 13 to 23 weeks, and hemoglobin concentration of 9 g/dL or greater. All women received 5.7 mg iron/day through flour fortification during intervention, and usual intermittent preventive treatment against malaria was given. INTERVENTIONS Supervised daily supplementation with 60 mg of elemental iron (as ferrous fumarate, n = 237 women) or placebo (n = 233) from randomization until 1 month postpartum. MAIN OUTCOMES AND MEASURES Primary outcome was maternal Plasmodium infection at birth. Predefined secondary outcomes were birth weight and gestational age at delivery, intrauterine growth, and maternal and infant iron status at 1 month after birth. RESULTS Among the 470 participating women, 40 women (22 iron, 18 placebo) were lost to follow-up or excluded at birth; 12 mothers were lost to follow-up postpartum (5 iron, 7 placebo). At baseline, 190 of 318 women (59.7%) were iron-deficient. In intention-to-treat analysis, comparison of women who received iron vs placebo, respectively, yielded the following results at birth: Plasmodium infection risk: 50.9% vs 52.1% (crude difference, -1.2%, 95% CI, -11.8% to 9.5%; P = .83); birth weight: 3202 g vs 3053 g (crude difference, 150 g, 95% CI, 56 to 244; P = .002); birth-weight-for-gestational-age z score: 0.52 vs 0.31 (crude difference, 0.21, 95% CI, -0.11 to 0.52; P = .20); and at 1 month after birth: maternal hemoglobin concentration: 12.89 g/dL vs 11.99 g/dL (crude difference, 0.90 g/dL, 95% CI, 0.61 to 1.19; P < .001); geometric mean maternal plasma ferritin concentration: 32.1 mu g/L vs 14.4 mu g/L (crude difference, 123.4%, 95% CI, 85.5% to 169.1%; P < .001); geometric mean neonatal plasma ferritin concentration: 163.0 mu g/L vs 138.7 mu g/L (crude difference, 17.5%, 95% CI, 2.4% to 34.8%; P = .02). Serious adverse events were reported for 9 and 12 women who received iron and placebo, respectively. There was no evidence that intervention effects on Plasmodium infection risk were modified by intermittent preventive treatment use. CONCLUSIONS AND RELEVANCE Among rural Kenyan women with singleton pregnancies, administration of daily iron supplementation, compared with administration of placebo, resulted in no significant differences in overall maternal Plasmodium infection risk. Iron supplementation led to increased birth weight.	[Mwangi, Martin N.; Roth, Johanna M.; Smit, Menno R.; Trijsburg, Laura; Savelkoul, Huub F. J.; Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AH Wageningen, Netherlands; [Mwangi, Martin N.; Andang'o, Pauline E. A.] Maseno Univ, Sch Publ Hlth & Community Dev, Maseno, Kenya; [Roth, Johanna M.; Mens, Petra F.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Mwangi, Alice M.] Univ Nairobi, Appl Nutr Programme, Nairobi, Kenya; [Demir, Ayse Y.; Wielders, Jos P. M.] Meander Med Ctr, Clin Chem Lab, Amersfoort, Netherlands; [Verweij, Jaco J.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Cox, Sharon E.; Prentice, Andrew M.; Verhoef, Hans] London Sch Hyg & Trop Med, MRC Int Nutr Programme, London, England; [Cox, Sharon E.; Prentice, Andrew M.; Verhoef, Hans] MRC, MRC Int Nutr Programme, Keneba, Gambia; [Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, NL-6700 AH Wageningen, Netherlands	Wageningen University & Research; Maseno University; University of Nairobi; Meander Medisch Centrum; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wageningen University & Research	Mwangi, MN (corresponding author), Wageningen Univ, Cell Biol & Immunol Grp, POB 338, NL-6700 AH Wageningen, Netherlands.	mart.mwangi@gmail.com	Cox, Sharon E/ABA-7986-2020; Smit, Menno R./J-7153-2019; Mwangi, Martin/Q-5821-2017; Prentice, Andrew/AAG-1961-2019; Demir, Ayse Yasemin/GPF-7965-2022; Verhoef, Hans/AGD-5388-2022; Savelkoul, Huub FJ/F-6026-2012; Brouwer, Inge D/K-8455-2013; Verhoef, Hans/L-3024-2015	Cox, Sharon E/0000-0002-9908-2936; Smit, Menno R./0000-0003-3405-6638; Verhoef, Hans/0000-0002-9346-9689; Verweij, Jaco J./0000-0001-8553-931X; Brouwer, Inge/0000-0002-2554-7227; Mwangi, Martin/0000-0002-8358-4448	INSTAPA project - European Union [211484]; Medical Research Council [MC_U123292701, MC_U123292699] Funding Source: researchfish; MRC [MC_U123292699, MC_U123292701] Funding Source: UKRI	INSTAPA project - European Union; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the INSTAPA project, which received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 211484. Fortitech and Swiss Precision Diagnostics donated fortification premix and urine pregnancy tests, respectively. Laboratory and Allied, Nairobi, prepared supplemental capsules (without financial compensation).	[Anonymous], 1958, IR DEF AN REP STUD G; [Anonymous], 2008, KEN NAT TECHN GUID M; Beaton GH, 2000, AM J CLIN NUTR, V72, p265S, DOI 10.1093/ajcn/72.1.265S; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Clark MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5446; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; Cottrell G, 2006, ACTA TROP, V98, P255, DOI 10.1016/j.actatropica.2006.05.009; CRAMER JA, 1989, JAMA-J AM MED ASSOC, V261, P3273, DOI 10.1001/jama.261.22.3273; De Benois B., 2008, WORLDWIDE PREVALENCE; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Kenya National Bureau of Statistics and ICF Macro, 2010, KEN DEM HLTH SURV 20; Mason J., 2001, MICRONUTRIENT REPORT; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1841; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Ministry of Public Health and Sanitation M.o.M.S., 2010, GUID DET REG PROC GE; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; OLIVIERI NF, 1991, ARCH DIS CHILD, V66, P1399, DOI 10.1136/adc.66.12.1399; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Othoro C, 2006, CLIN VACCINE IMMUNOL, V13, P568, DOI 10.1128/CVI.13.5.568-574.2006; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Prentice AM, 2012, ADV NUTR, V3, P583, DOI 10.3945/an.111.001230; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Price C., 2009, 20090049 NCEE US DEP; Sangare L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087743; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Scholl TO, 2011, NUTR REV, V69, pS23, DOI 10.1111/j.1753-4887.2011.00429.x; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; US Institute of Medicine, 2001, DIET REF INT VIT A V; Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125; Vucic V, 2013, NUTR REV, V71, P386, DOI 10.1111/nure.12037; World Health Organization, GUID DAIL IR FOL AC; Zeng LX, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2001	37	49	49	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1009	1020		10.1001/jama.2015.9496	http://dx.doi.org/10.1001/jama.2015.9496			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348751	Green Accepted, Bronze			2022-12-28	WOS:000360840700013
J	Thornicroft, G; Mehta, N; Clement, S; Evans-Lacko, S; Doherty, M; Rose, D; Koschorke, M; Shidhaye, R; O'Reilly, C; Henderson, C				Thornicroft, Graham; Mehta, Nisha; Clement, Sarah; Evans-Lacko, Sara; Doherty, Mary; Rose, Diana; Koschorke, Mirja; Shidhaye, Rahul; O'Reilly, Claire; Henderson, Claire			Evidence for effective interventions to reduce mental-health-related stigma and discrimination	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; SELF-STIGMA; ILLNESS STIGMA; HELP-SEEKING; STUDENTS ATTITUDES; PUBLIC-ATTITUDES; HUMAN-RIGHTS; PEOPLE; SCHIZOPHRENIA; IMPACT	Stigma and discrimination in relation to mental illnesses have been described as having worse consequences than the conditions themselves. Most medical literature in this area of research has been descriptive and has focused on attitudes towards people with mental illness rather than on interventions to reduce stigma. In this narrative Review, we summarise what is known globally from published systematic reviews and primary data on effective interventions intended to reduce mental-illness-related stigma or discrimination. The main findings emerging from this narrative overview are that: (1) at the population level there is a fairly consistent pattern of short-term benefits for positive attitude change, and some lesser evidence for knowledge improvement; (2) for people with mental illness, some group-level anti-stigma inventions show promise and merit further assessment; (3) for specific target groups, such as students, social-contact-based interventions usually achieve short-term (but less clearly long-term) attitudinal improvements, and less often produce knowledge gains; (4) this is a heterogeneous field of study with few strong study designs with large sample sizes; (5) research from low-income and middle-income countries is conspicuous by its relative absence; (6) caution needs to be exercised in not overgeneralising lessons from one target group to another; (7) there is a clear need for studies with longer-term follow-up to assess whether initial gains are sustained or attenuated, and whether booster doses of the intervention are needed to maintain progress; (8) few studies in any part of the world have focused on either the service user's perspective of stigma and discrimination or on the behaviour domain of behavioural change, either by people with or without mental illness in the complex processes of stigmatisation. We found that social contact is the most effective type of intervention to improve stigma-related knowledge and attitudes in the short term. However, the evidence for longer-term benefit of such social contact to reduce stigma is weak. In view of the magnitude of challenges that result from mental health stigma and discrimination, a concerted effort is needed to fund methodologically strong research that will provide robust evidence to support decisions on investment in interventions to reduce stigma.	[Thornicroft, Graham; Koschorke, Mirja] Kings Coll London, Ctr Global Mental Hlth, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Mehta, Nisha; Clement, Sarah; Evans-Lacko, Sara; Doherty, Mary; Rose, Diana] Kings Coll London, Hlth Serv, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Mehta, Nisha; Clement, Sarah; Evans-Lacko, Sara; Doherty, Mary; Rose, Diana; Henderson, Claire] Kings Coll London, Populat Res Dept, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Shidhaye, Rahul] Publ Hlth Fdn India, Ctr Mental Hlth, Delhi, India; [O'Reilly, Claire] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of London; King's College London; University of London; King's College London; University of London; King's College London; Public Health Foundation of India; University of Sydney	Thornicroft, G (corresponding author), Kings Coll London, Ctr Global Mental Hlth, Inst Psychiat, Denmark Hill, London SE5 8AF, England.	graham.thornicroft@kcl.ac.uk	Evans-Lacko, Sara/F-8489-2014; Rose, Diana/HGE-8574-2022; Henderson, Claire/E-4664-2010; Rose, Diana S/D-1387-2010; Shidhaye, Rahul/I-1329-2019; Thornicroft, Graham/B-4027-2010	Evans-Lacko, Sara/0000-0003-4691-2630; Henderson, Claire/0000-0002-6998-5659; Rose, Diana S/0000-0002-6393-6389; Shidhaye, Rahul/0000-0001-9365-7164; Thornicroft, Graham/0000-0003-0662-0879; Docherty, Mary/0000-0002-5745-7613	National Institute for Health Research [RP-PG-0606-1053]; Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust; Wellcome Trust; European Union [305968]; National Institute for Health Research [CL-2012-17-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This publication is independent research funded by the National Institute for Health Research under its Programme Grants for Applied Research scheme (Improving Mental Health Outcomes by Reducing Stigma and Discrimination: RP-PG-0606-1053) (authors GT, SC, CH, and DR). GT and DR are also funded in relation to the National Institute for Health Research (NIHR) Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. GT is an Honorary Professor at the University of KwaZulu Natal, Durban; he is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) South London. MK was supported by a Wellcome Trust Clinical PhD Fellowship during her involvement in the review. The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 305968. We would also like to acknowledge our gratitude to the following colleagues for their contributions to this review: Luigi de Benedictis, Dmitry Krupchanka, Nikhil Gupta, Shinsuke Koike, Elena Marcus, Anne-Claire Stona, Jorge Palacios, and Elizabeth Barley.	Altindag A, 2006, PSYCHIAT CLIN NEUROS, V60, P283, DOI 10.1111/j.1440-1819.2006.01503.x; Ando S, 2011, SCHIZOPHR RES, V133, P8, DOI 10.1016/j.schres.2011.09.011; Angermeyer MC, 2003, SOC PSYCH PSYCH EPID, V38, P593, DOI 10.1007/s00127-003-0680-x; [Anonymous], 2013, SUIC PREV SUPRE; Arikan K, 1999, ISRAEL J PSYCHIAT, V36, P100; ARKAR H, 1992, SOC PSYCH PSYCH EPID, V27, P151; Armson, CRISP EVERY FAMILY L, P100; Armstrong G, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-17; Arvaniti A, 2009, SOC PSYCH PSYCH EPID, V44, P658, DOI 10.1007/s00127-008-0481-3; Bayar MR, 2009, ISR J PSYCHIATR REL, V46, P226; Blair Irvine A, 2012, Issues Ment Health Nurs, V33, P181, DOI 10.3109/01612840.2011.639482; Brohan E, 2013, PSYCHIAT RES, V208, P33, DOI 10.1016/j.psychres.2013.03.007; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Campbell M, 2011, PSYCHOSIS, V3, P41, DOI 10.1080/17522431003735529; Chinnayya H P, 1990, Int J Soc Psychiatry, V36, P300; Chou KL, 1998, INT J SOC PSYCHIATR, V44, P215, DOI 10.1177/002076409804400307; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; Clement S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009453.pub2; Clement S, 2012, BRIT J PSYCHIAT, V201, P57, DOI 10.1192/bjp.bp.111.093120; Clement S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-36; Clement S, 2011, J MENT HEALTH, V20, P219, DOI 10.3109/09638237.2011.579645; Clement S, 2010, EPIDEMIOL PSICHIAT S, V19, P72, DOI 10.1017/S1121189X00001627; Corker E, 2013, BRIT J PSYCHIAT, V202, pS58, DOI 10.1192/bjp.bp.112.112912; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI 10.1176/appi.ps.201100529; Corrigan PW, 2009, WORLD PSYCHIATRY, V8, P75; Corrigan PW, 2004, SCHIZOPHRENIA BULL, V30, P481, DOI 10.1093/oxfordjournals.schbul.a007096; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Corrigan PW, 2000, CLIN PSYCHOL-SCI PR, V7, P48, DOI 10.1093/clipsy/7.1.48; Couture Shannon M., 2003, J MENTAL HLTH, V12, P291, DOI [10.1080/09638231000118276, DOI 10.1080/09638231000118276]; Drew N, 2011, LANCET, V378, P1664, DOI 10.1016/S0140-6736(11)61458-X; Evans-Lacko S, 2014, EUR PSYCHIAT, V29, P381, DOI 10.1016/j.eurpsy.2014.02.007; Evans-Lacko S, 2013, BRIT J PSYCHIAT, V202, pS77, DOI 10.1192/bjp.bp.113.126672; Farrelly S, 2015, Psychol Med, V45, P2013, DOI 10.1017/S0033291714003158; Friedrich B, 2013, BRIT J PSYCHIAT, V202, pS89, DOI 10.1192/bjp.bp.112.114017; Fung KMT, 2011, PSYCHIAT RES, V189, P208, DOI 10.1016/j.psychres.2011.02.013; Gaebel W, 2008, SCHIZOPHR RES, V98, P184, DOI 10.1016/j.schres.2007.09.013; Gould M, 2007, J TRAUMA STRESS, V20, P505, DOI 10.1002/jts.20233; Gulliver Amelia, 2012, J Med Internet Res, V14, pe69, DOI 10.2196/jmir.1864; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Gutierrez-Maldonado J, 2009, SOC PSYCH PSYCH EPID, V44, P343, DOI 10.1007/s00127-008-0451-9; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Henderson C, 2013, AM J PUBLIC HEALTH, V103, P777, DOI 10.2105/AJPH.2012.301056; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hinshaw Stephen P., 2007, MARK SHAME; Holzinger A, 2008, PSYCHIAT PRAX, V35, P376, DOI 10.1055/s-2008-1067396; Jeffery D, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-120; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Jorm AF, 2005, AUST NZ J PSYCHIAT, V39, P248, DOI 10.1080/j.1440-1614.2005.01561.x; Jorm AF, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-33; Jorm AF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-51; Kassam A, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-51; Kitchener BA, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-23; Kitchener BA, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-10; Knight MTD, 2006, BEHAV COGN PSYCHOTH, V34, P305, DOI 10.1017/S1352465805002705; Kolodziej ME, 1996, J CONSULT CLIN PSYCH, V64, P1387, DOI 10.1037/0022-006X.64.6.1387; Krawitz R, 2004, AUST NZ J PSYCHIAT, V38, P554, DOI 10.1111/j.1440-1614.2004.01409.x; Lasalvia A, 2013, LANCET, V381, P55, DOI 10.1016/S0140-6736(12)61379-8; LINK B, 2001, STIGMA ITS PUBLIC HL; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Link BG, 2004, SCHIZOPHRENIA BULL, V30, P511, DOI 10.1093/oxfordjournals.schbul.a007098; Mansouri Naghmeh, 2009, Int J Ment Health Syst, V3, P15, DOI 10.1186/1752-4458-3-15; Mehta N, 2009, BRIT J PSYCHIAT, V194, P278, DOI 10.1192/bjp.bp.108.052654; Mittal D, 2012, PSYCHIAT SERV, V63, P974, DOI 10.1176/appi.ps.201100459; Morrison AP, 2013, BRIT J PSYCHIAT, V203, P140, DOI 10.1192/bjp.bp.112.123703; National Institute for Health and Clinical Excellence, 2007, BEH CHANG POP COMM I; Nordt C, 2006, SCHIZOPHRENIA BULL, V32, P709, DOI 10.1093/schbul/sbj065; O'Reilly CL, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7409167; OGEDENGBE RO, 1993, INT J NURS STUD, V30, P247, DOI 10.1016/0020-7489(93)90035-S; Padmavati R, 2005, INT J SOC PSYCHIATR, V51, P139, DOI 10.1177/0020764005056761; Paykel ES, 1998, BRIT J PSYCHIAT, V173, P519, DOI 10.1192/bjp.173.6.519; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001; Pinfold V, 2003, BRIT J PSYCHIAT, V182, P342, DOI 10.1192/bjp.182.4.342; Rahman A, 1998, LANCET, V352, P1022, DOI 10.1016/S0140-6736(98)02381-2; Randall J, 2013, EPIDEMIOL PSYCH SCI, V22, P241, DOI 10.1017/S2045796012000467; Rong Y, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-36; Schachter Howard M, 2008, Child Adolesc Psychiatry Ment Health, V2, P18, DOI 10.1186/1753-2000-2-18; Schomerus G, 2008, EPIDEMIOL PSICHIAT S, V17, P31, DOI 10.1017/S1121189X00002669; Schulze B, 2003, ACTA PSYCHIAT SCAND, V107, P142, DOI 10.1034/j.1600-0447.2003.02444.x; Schulze B, 2007, INT REV PSYCHIATR, V19, P137, DOI 10.1080/09540260701278929; SOGAARD AJ, 1995, HEALTH EDUC RES, V10, P267, DOI 10.1093/her/10.3.267; Stuart H, 2006, CURR OPIN PSYCHIATR, V19, P522, DOI 10.1097/01.yco.0000238482.27270.5d; Sumathipala Athula, 2004, BMC Med Ethics, V5, pE5; Thara R, 2003, INT J SOC PSYCHIATR, V49, P233, DOI 10.1177/00207640030493009; Thornicroft C, 2014, AUST NZ J PSYCHIAT, V48, P360, DOI 10.1177/0004867413512687; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Thornicroft G, 2008, EPIDEMIOL PSICHIAT S, V17, P14, DOI 10.1017/S1121189X00002621; Thornicroft G, 2007, LANCET, V370, P807, DOI 10.1016/S0140-6736(07)61392-0; Thornicroft G, 2007, INT REV PSYCHIATR, V19, P113, DOI 10.1080/09540260701278937; Thornicroft G, 2007, BRIT J PSYCHIAT, V190, P192, DOI 10.1192/bjp.bp.106.025791; Thornicroft G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2969; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Ucok A, 2006, PSYCHIAT CLIN NEUROS, V60, P439, DOI 10.1111/j.1440-1819.2006.01529.x; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; Worakul Puangsoi, 2007, Journal of the Medical Association of Thailand, V90, P1199; World Health Organization, 2013, GLOB MENT HLTH ACT P; Yamaguchi S, 2013, J NERV MENT DIS, V201, P490, DOI 10.1097/NMD.0b013e31829480df; Yang L., 2010, MENTAL NEUROLOGICAL	100	535	543	17	244	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1123	1132		10.1016/S0140-6736(15)00298-6	http://dx.doi.org/10.1016/S0140-6736(15)00298-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG0SD	26410341				2022-12-28	WOS:000371775000031
J	Mayer, KH; Beyrer, C				Mayer, Kenneth H.; Beyrer, Chris			Antiretroviral chemoprophylaxis: PROUD and pragmatism	LANCET			English	Editorial Material							PREEXPOSURE PROPHYLAXIS; HIV-INFECTION; PREVENTION; TRANSMISSION; WOMEN		[Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Univ, Dept Med, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Beyrer, Chris] Johns Hopkins Univ, Dept Epidemiol, Ctr Hlth & Human Rights, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Beyrer, Chris] Int AIDS Soc, Geneva, Switzerland	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mayer, KH (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.	khmayer@gmail.com						ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; AIDS Vaccine Advocacy Coalition, AVAC REP 2013 RES RE; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; McCormack S, 2015, LANCET; Molina JMCC., 2015, C RETR OPP INF 2015; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; UNAIDS, AIDS INF; van de Vijver DAMC, 2013, AIDS, V27, P2943, DOI 10.1097/01.aids.0000433237.63560.20; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225	15	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					6	7		10.1016/S0140-6736(15)00153-1	http://dx.doi.org/10.1016/S0140-6736(15)00153-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26364262	hybrid			2022-12-28	WOS:000367457300006
J	Delewi, R; Piek, JJ				Delewi, Ronak; Piek, Jan J.			Cardiac catheterisation: radiation for radialists	LANCET			English	Editorial Material							FEMORAL ACCESS; CORONARY; INTERVENTION		[Delewi, Ronak; Piek, Jan J.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Delewi, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.delewi@amc.uva.nl		Delewi, Ronak/0000-0001-6070-9423				CAMPEAU L, 1989, CATHETER CARDIO DIAG, V16, P3, DOI 10.1002/ccd.1810160103; Cooper CJ, 1999, AM HEART J, V138, P430, DOI 10.1016/S0002-8703(99)70143-2; Delewi R, 2013, CIRC-CARDIOVASC INTE, V6, P501, DOI 10.1161/CIRCINTERVENTIONS.113.000220; Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P1269, DOI 10.1016/S0735-1097(97)00064-8; Kuipers G, 2010, RADIAT PROT DOSIM, V140, P259, DOI 10.1093/rpd/ncq113; Pancholy SB, 2015, JACC-CARDIOVASC INTE, V8, P1189, DOI 10.1016/j.jcin.2015.03.026; Plourde G, 2015, LANCET, V386, P2192, DOI 10.1016/S0140-6736(15)00305-0; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2123	2124		10.1016/S0140-6736(15)00306-2	http://dx.doi.org/10.1016/S0140-6736(15)00306-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26411984				2022-12-28	WOS:000365992600010
J	Lau, L; Gray, EE; Brunette, RL; Stetson, DB				Lau, Laura; Gray, Elizabeth E.; Brunette, Rebecca L.; Stetson, Daniel B.			DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway	SCIENCE			English	Article							INTERFERON REGULATORY FACTOR-3; INNATE IMMUNITY; RECOGNITION; PROTEINS; EVASION; ADAPTER; ACIDS	Cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) detects intracellular DNA and signals through the adapter protein STING to initiate the antiviral response to DNA viruses. Whether DNA viruses can prevent activation of the cGAS-STING pathway remains largely unknown. Here, we identify the oncogenes of the DNA tumor viruses, including E7 from human papillomavirus (HPV) and E1A from adenovirus, as potent and specific inhibitors of the cGAS-STING pathway. We show that the LXCXE motif of these oncoproteins, which is essential for blockade of the retinoblastoma tumor suppressor, is also important for antagonizing DNA sensing. E1A and E7 bind to STING, and silencing of these oncogenes in human tumor cells restores the cGAS-STING pathway. Our findings reveal a host-virus conflict that may have shaped the evolution of viral oncogenes.	[Lau, Laura; Gray, Elizabeth E.; Brunette, Rebecca L.; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA.	stetson@uw.edu			Cancer Research Institute Irvington postdoctoral fellowship	Cancer Research Institute Irvington postdoctoral fellowship	We are grateful to D. DiMaio for the BPV-E2 construct; to J. Kagan for the p450 ER-targeting motif; to J. Sage for providing the Rb/p107/p130 triple-knockout MEFs; and to members of the Stetson lab for discussions. The data presented in this paper are tabulated in the main paper and in the supplementary materials. D.B.S. is a scholar of the Rita Allen Foundation and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease. E.E.G. is supported by a Cancer Research Institute Irvington postdoctoral fellowship.	AHN KS, 1993, J BIOL CHEM, V268, P18726; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; CORBEIL HB, 1994, J VIROL, V68, P6697, DOI 10.1128/JVI.68.10.6697-6709.1994; de Souza RF, 2010, BBA-GENE REGUL MECH, V1799, P302, DOI 10.1016/j.bbagrm.2009.10.006; DEVILLIERS EM, 1987, LANCET, V2, P703; Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12; Fonseca GJ, 2012, CELL HOST MICROBE, V11, P597, DOI 10.1016/j.chom.2012.05.005; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; GEY GO, 1952, CANCER RES, V12, P264; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HWANG ES, 1993, J VIROL, V67, P3720, DOI 10.1128/JVI.67.7.3720-3729.1993; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Paladino P, 2009, J INTERF CYTOK RES, V29, P599, DOI 10.1089/jir.2009.0074; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	31	262	275	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					568	571		10.1126/science.aab3291	http://dx.doi.org/10.1126/science.aab3291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26405230	Green Published			2022-12-28	WOS:000363660000050
J	Kayagaki, N; Stowe, IB; Lee, BL; O'Rourke, K; Anderson, K; Warming, S; Cuellar, T; Haley, B; Roose-Girma, M; Phung, QT; Liu, PS; Lill, JR; Li, H; Wu, JS; Kummerfeld, S; Zhang, J; Lee, WP; Snipas, SJ; Salvesen, GS; Morris, LX; Fitzgerald, L; Zhang, YF; Bertram, EM; Goodnow, CC; Dixit, VM				Kayagaki, Nobuhiko; Stowe, Irma B.; Lee, Bettina L.; O'Rourke, Karen; Anderson, Keith; Warming, Soren; Cuellar, Trinna; Haley, Benjamin; Roose-Girma, Merone; Phung, Qui T.; Liu, Peter S.; Lill, Jennie R.; Li, Hong; Wu, Jiansheng; Kummerfeld, Sarah; Zhang, Juan; Lee, Wyne P.; Snipas, Scott J.; Salvesen, Guy S.; Morris, Lucy X.; Fitzgerald, Linda; Zhang, Yafei; Bertram, Edward M.; Goodnow, Christopher C.; Dixit, Vishva M.			Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling	NATURE			English	Article							CELL-DEATH; ACTIVATION; INTERLEUKIN-1-BETA; PYROPTOSIS; EPITHELIUM; RECEPTORS; CRYSTALS; PROTEASE; RELEASE; MEMBERS	Intracellular lipopolysaccharide from Gram-negative bacteria including Escherichia colt Salmonella typhimurium, Shigella flexneri, and Burkholderia thailandensis activates mouse caspase-11, causing pyroptotic cell death, interleukin-1 beta processing, and lethal septic shock. How caspase-11 executes these downstream signalling events is largely unknown. Here we show that gasdermin D is essential for caspase-11-dependent pyroptosis and interleukin-1 beta maturation. A forward genetic screen with ethyl-N-nitrosourea-mutagenized mice links Gsdmd to the intracellular lipopolysaccharide response. Macrophages from Gsdmd(-/-) mice generated by gene targeting also exhibit defective pyroptosis and interleukin-1 beta secretion induced by cytoplasmic lipopolysaccharide or Gram-negative bacteria. In addition, Gsdmd(-1-) mice are protected from a lethal dose of lipopolysaccharide. Mechanistically, caspase-11 cleaves gasdermin D, and the resulting amino-terminal fragment promotes both pyroptosis and NLRP3-dependent activation of caspase-1 in a cell-intrinsic manner. Our data identify gasdermin D as a critical target of caspase-11 and a key mediator of the host response against Grain-negative bacteria.	[Kayagaki, Nobuhiko; Stowe, Irma B.; Lee, Bettina L.; O'Rourke, Karen; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Anderson, Keith; Warming, Soren; Cuellar, Trinna; Haley, Benjamin; Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Phung, Qui T.; Liu, Peter S.; Lill, Jennie R.; Li, Hong; Wu, Jiansheng] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Kummerfeld, Sarah] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Zhang, Juan; Lee, Wyne P.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, Program Cell Death Signaling Networks, La Jolla, CA 92037 USA; [Morris, Lucy X.; Fitzgerald, Linda; Zhang, Yafei; Bertram, Edward M.] Australian Natl Univ, John Curtin Sch Med Res, Australian Phen Facil, Canberra, ACT 2601, Australia; [Bertram, Edward M.; Goodnow, Christopher C.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia; [Goodnow, Christopher C.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Goodnow, Christopher C.] UNSW Australia, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Sanford Burnham Prebys Medical Discovery Institute; Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney	Kayagaki, N (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	kayagaki@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Wu, Jian/AAU-5221-2020; Warming, Soren/ABD-5729-2021; Goodnow, Christopher C/V-8108-2018; Wu, Jian/AAU-5221-2020	dixit, vishva m/0000-0001-6983-0326; Wu, Jian/0000-0001-9933-7364; Goodnow, Christopher C/0000-0001-5296-6155; Wu, Jian/0000-0002-3394-1507; Kummerfeld, Sarah/0000-0002-0089-2358; Warming, Soren/0000-0002-5721-0741; Cuellar, Trinna/0000-0002-9991-9505				Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Angosto D, 2012, INNATE IMMUN-LONDON, V18, P815, DOI 10.1177/1753425912441956; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fujii T, 2008, GENESIS, V46, P418, DOI 10.1002/dvg.20412; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Katoh M, 2004, INT J ONCOL, V25, P765; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ruhl S., 2015, EUR J IMMUNOL; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Xie HX, 2014, INFECT IMMUN, V82, P3436, DOI 10.1128/IAI.01065-13; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449	41	1748	1843	33	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					666	671		10.1038/nature15541	http://dx.doi.org/10.1038/nature15541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26375259				2022-12-28	WOS:000363832100041
J	Outland, B; Newman, MM; William, MJ				Outland, Brian; Newman, Mary M.; William, Margo J.			Health Policy Basics: Implementation of the International Classification of Disease, 10th Revision	ANNALS OF INTERNAL MEDICINE			English	Article								The International Classification of Diseases (ICD) standardizes diagnostic codes into meaningful criteria to enable the storage and retrieval of information regarding patient care. Whereas other countries have been using ICD, 10th Revision (ICD-10), for years, the United States will transition from ICD, Ninth Revision, Clinical Modification (ICD-9-CM), to ICD-10, on 1 October 2015. This transition is one of the largest and most technically challenging changes that the medical community has experienced in the past several decades. This article outlines the implications of moving to ICD-10 and recommends resources to facilitate the transition.	[Outland, Brian; William, Margo J.] Amer Coll Physicians, Washington, DC 20001 USA; [Newman, Mary M.] Pk Med Associates, Lutherville Timonium, MD 21093 USA	American College of Physicians	Outland, B (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.							[Anonymous], 2015, COMMUNICATION 0304; Centers for Medicare & Medicaid Services, 2014, ICD 10 BAS MED PRACT; National Center for Health Statistics, 2015, INT CLASS DIS 10 REV; Office of the Secretary HHS, 2009, Fed Regist, V74, P3328; U.S. National Center for Health Statistics, 2015, ICD 10 OFF GUID COD; World Health Organization-Family of International Classifications (WHO-FIC), 2013, INT CLASS DIS ICD ST	6	8	9	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					554	+		10.7326/M15-1933	http://dx.doi.org/10.7326/M15-1933			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26390305				2022-12-28	WOS:000362496400009
J	Lightowlers, RN; Taylor, RW; Turnbull, DM				Lightowlers, Robert N.; Taylor, Robert W.; Turnbull, Doug M.			Mutations causing mitochondrial disease: What is new and what challenges remain?	SCIENCE			English	Review							CYTOCHROME-C-OXIDASE; GENE-THERAPY; HYPERTROPHIC CARDIOMYOPATHY; GENOME TRANSFER; RIBOSOMAL-RNA; MTDNA; NUCLEAR; HETEROPLASMY; DIAGNOSIS; TRANSMISSION	Mitochondrial diseases are among the most common and most complex of all inherited genetic diseases. The involvement of both the mitochondrial and nuclear genome presents unique challenges, but despite this there have been some remarkable advances in our knowledge of mitochondrial diseases over the past few years. A greater understanding of mitochondrial genetics has led to improved diagnosis as well as novel ways to prevent transmission of severe mitochondrial disease. These and other advances have had a major impact on patient care, but considerable challenges remain, particularly in the areas of therapies for those patients manifesting clinical symptoms associated with mitochondrial dysfunction and the tissue specificity seen in many mitochondrial disorders. This review highlights some important recent advances in mitochondrial disease but also stresses the areas where progress is essential.	[Turnbull, Doug M.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	doug.turnbull@ncl.ac.uk		Turnbull, Doug/0000-0002-8878-9901	Wellcome Trust Centre for Mitochondrial Research [G906919]; Newcastle University Centre for Aging and Vitality (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Aging and Vitality (Medical Research Council) [G016354/1]; MRC Centre for Neuromuscular Disease [G000608-1]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; Medical Research Council [MR/K000608/1, G0700718, G0800674] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10187] Funding Source: researchfish; MRC [G0800674, MR/K000608/1, G0700718] Funding Source: UKRI	Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); Newcastle University Centre for Aging and Vitality (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University Centre for Aging and Vitality (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre for Neuromuscular Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by The Wellcome Trust Centre for Mitochondrial Research (G906919), Newcastle University Centre for Aging and Vitality [supported by the Biotechnology and Biological Sciences Research Council and Medical Research Council (G016354/1)], MRC Centre for Neuromuscular Disease (G000608-1), The MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) (G0800674), The Lily Foundation, the UK NIHR Biomedical Research Centre in Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation Trust and UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children" Service.	Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960; Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hagstrom E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969; Hanske J, 2012, P NATL ACAD SCI USA, V109, P125, DOI 10.1073/pnas.1112312108; Hodgkinson A, 2014, SCIENCE, V344, P413, DOI 10.1126/science.1251110; Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Lam BL, 2014, JAMA OPHTHALMOL, V132, P428, DOI 10.1001/jamaophthalmol.2013.7971; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007; McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35; Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528; Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060; Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	69	192	198	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1494	1499		10.1126/science.aac7516	http://dx.doi.org/10.1126/science.aac7516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404827				2022-12-28	WOS:000361707000037
J	Perry, ML				Perry, Mike L.			Expanding the chemical space for redox flow batteries	SCIENCE			English	Editorial Material							ENERGY-STORAGE		United Technol Res Ctr, E Hartford, CT 06108 USA	Raytheon Technologies	Perry, ML (corresponding author), United Technol Res Ctr, E Hartford, CT 06108 USA.	perryml@utrc.utc.com						Chalamala B. R., 2014, IEEE P, V102, P976; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; Darling RM, 2014, ENERG ENVIRON SCI, V7, P3459, DOI 10.1039/c4ee02158d; Lin KX, 2015, SCIENCE, V349, P1529, DOI 10.1126/science.aab3033; Soloveichik GL, 2011, ANNU REV CHEM BIOMOL, V2, P503, DOI 10.1146/annurev-chembioeng-061010-114116; US Department of Energy, 2013, GRID EN STOR	6	13	14	11	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1452	1452		10.1126/science.aad0698	http://dx.doi.org/10.1126/science.aad0698			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404815				2022-12-28	WOS:000361707000025
J	Shendure, J; Akey, JM				Shendure, Jay; Akey, Joshua M.			The origins, determinants, and consequences of human mutations	SCIENCE			English	Review							DE-NOVO MUTATIONS; HUMAN GENETIC-DISEASE; HUMAN GENOME; INHERITED MUTATIONS; MAMMALIAN EVOLUTION; HUMAN CANCER; VARIANTS; PATTERNS; SPECTRUM; GERMLINE	Germline mutations are the principal cause of heritable disease and the ultimate source of evolutionary change. Similarly, somatic mutations are the primary cause of cancer and may contribute to the burden of human disease more broadly than previously appreciated. Here, we review recent insights into the rates, spectrum, and determinants of genomic mutations and how these parameters inform our understanding of both Mendelian and complex human diseases. We also consider models for conceptualizing mutational consequences and outline several key areas for future research, including the development of new technologies to access and quantify the full spectrum of mutations, as well as to better interpret the consequences of mutations with respect to molecular functionality, evolutionary fitness, and disease pathogenicity.	[Shendure, Jay; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; akeyj@uw.edu	Shendure, Jay/AAU-3684-2021; Pinheiro, Maísa/E-7424-2012	Akey, Joshua/0000-0002-4411-1330	NIH [R01GM110068, U01HG007591, DP1HG007811]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01GM110068 and U01HG007591 to J.M.A. and DP1HG007811 to J.S. Due to space constraints, all relevant literature could not be cited, and we apologize for omissions.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altieri F, 2008, ANTIOXID REDOX SIGN, V10, P891, DOI 10.1089/ars.2007.1830; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Campbell PJ, 2009, NAT GENET, V41, P385, DOI 10.1038/ng0409-385; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COOPER DN, 1990, HUM GENET, V85, P55; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu WQ, 2013, ANNU REV GENOM HUM G, V14, P467, DOI 10.1146/annurev-genom-091212-153509; Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Green P, 2013, SCIENCE, V340, DOI 10.1126/science.1233195; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Haldane JBS, 2004, J GENET, V83, P235, DOI 10.1007/BF02717892; Harris K, 2015, P NATL ACAD SCI USA, V112, P3439, DOI 10.1073/pnas.1418652112; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Racimo F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004697; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107	60	91	94	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1478	1483		10.1126/science.aaa9119	http://dx.doi.org/10.1126/science.aaa9119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404824				2022-12-28	WOS:000361707000034
J	Oberlander, J; Laugesen, MJ				Oberlander, Jonathan; Laugesen, Miriam J.			Leap of Faith - Medicare's New Physician Payment System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC 27515 USA; [Laugesen, Miriam J.] Columbia Univ, New York, NY USA	University of North Carolina; University of North Carolina Chapel Hill; Columbia University	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.		Laugesen, Miriam J/B-9794-2009	Laugesen, Miriam J/0000-0003-4305-604X				Ikegami N, 2015, INT J HEALTH POLICY, V4, P57, DOI 10.15171/ijhpm.2015.26; Laugesen MJ, 2009, J HEALTH POLIT POLIC, V34, P157, DOI 10.1215/03616878-2008-043; Vladeck B, 2012, ROUNDTABLE MEDICARE	3	26	26	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1185	1187		10.1056/NEJMp1509154	http://dx.doi.org/10.1056/NEJMp1509154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR8WP	26398067				2022-12-28	WOS:000361635200001
J	Williams, RS; Lotia, S; Holloway, AK; Pico, AR				Williams, R. Sanders; Lotia, Samad; Holloway, Alisha K.; Pico, Alexander R.			From Scientific Discovery to Cures: Bright Stars within a Galaxy	CELL			English	Editorial Material								We propose that data mining and network analysis utilizing public databases can identify and quantify relationships between scientific discoveries and major advances in medicine (cures). Further development of such approaches could help to increase public understanding and governmental support for life science research and could enhance decision making in the quest for cures.	[Williams, R. Sanders; Lotia, Samad; Holloway, Alisha K.; Pico, Alexander R.] Gladstone Inst, San Francisco, CA 94158 USA; [Williams, R. Sanders; Holloway, Alisha K.; Pico, Alexander R.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Williams, RS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	rs.williams@gladstone.ucsf.edu	Pico, Alexander/HCH-4305-2022	Pico, Alexander/0000-0001-5706-2163				Nicholson S, 2006, INFORM PROCESS MANAG, V42, P785, DOI 10.1016/j.ipm.2005.05.008; Nishikawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00151; Sarli Cathy C, 2014, Mo Med, V111, P399; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030	4	24	25	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					21	23		10.1016/j.cell.2015.09.007	http://dx.doi.org/10.1016/j.cell.2015.09.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406364	Bronze			2022-12-28	WOS:000361846500014
J	Huang, ES				Huang, Elbert S.			Potential Overtreatment of Older, Complex Adults With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE CONTROL; TYPE-2	IMPORTANCE In older adults with multiple serious comorbidities and functional limitations, the harms of intensive glycemic control likely exceed the benefits. OBJECTIVES To examine glycemic control levels among older adults with diabetes mellitus by health status and to estimate the prevalence of potential overtreatment of diabetes. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analysis of the data on 1288 older adults (>= 65 years) with diabetes from the National Health and Nutrition Examination Survey (NHANES) from 2001 through 2010 who had a hemoglobin A(1c) (Hb(A1c)) measurement. All analyses incorporated complex survey design to produce nationally representative estimates. EXPOSURES Health status categories: very complex/poor, based on difficulty with 2 or more activities of daily living or dialysis dependence; complex/intermediate, based on difficulty with 2 or more instrumental activities of daily living or presence of 3 or more chronic conditions; and relatively healthy if none of these were present. MAIN OUTCOMES AND MEASURES Tight glycemic control (HbA(1c) level, <7%) and use of diabetes medications likely to result in hypoglycemia (insulin or sulfonylureas). RESULTS Of 1288 older adults with diabetes, 50.7%(95% CI, 46.6%-54.8%), representing 3.1 million (95% CI, 2.7-3.5), were relatively healthy, 28.1%(95% CI, 24.8%-31.5%), representing 1.7 million (95% CI, 1.4-2.0), had complex/intermediate health, and 21.2%(95% CI, 18.3%-24.4%), representing 1.3 million (95% CI, 1.1-1.5), had very complex/poor health. Overall, 61.5% (95% CI, 57.5%-65.3%), representing 3.8 million (95% CI, 3.4-4.2), had an HbA(1c) level of less than 7%; this proportion did not differ across health status categories (62.8%[95% CI, 56.9%-68.3%]) were relatively healthy, 63.0%(95% CI, 57.0%-68.6%) had complex/intermediate health, and 56.4% (95% CI, 49.7%-62.9%) had very complex/poor health (P=.26). Of the older adults with an Hb(A1c) level of less than 7%, 54.9% (95% CI, 50.4%-59.3%) were treated with either insulin or sulfonylureas; this proportion was similar across health status categories. During the 10 study years, there were no significant changes in the proportion of older adults with an Hb(A1c) level of less than 7%(P=.34), the proportion with an Hb(A1c) level of less than 7% who had complex/intermediate or very complex/poor health (P=.27), or the proportion with an Hb(A1c) level of less than 7% who were treated with insulin or sulfonylureas despite having complex/intermediate or very complex/poor health (P=.65). CONCLUSIONS AND RELEVANCE Although the harms of intensive treatment likely exceed the benefits for older patients with complex/intermediate or very complex/poor health status, most of these adults reached tight glycemic targets between 2001 and 2010. Most of them were treated with insulin or sulfonylureas, which may lead to severe hypoglycemia. Our findings suggest that a substantial proportion of older adults with diabetes were potentially overtreated.	Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago	Huang, ES (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	ehuang@medicine.bsd.uchicago.edu			AHRQ HHS [R01 HS018542] Funding Source: Medline; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NIDDK NIH HHS [R01 DK081796, P30 DK092949, K24 DK105340] Funding Source: Medline; AHRQ [5R01HS018542-03, 5R01HS018542-02] Funding Source: Federal RePORTER; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018542] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK105340, R01DK081796, P30DK092949] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cegelka A, 2013, J AM GERIATR SOC, V61, P2020, DOI 10.1111/jgs.12514; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345	7	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1280	1281		10.1001/jama.2015.9757	http://dx.doi.org/10.1001/jama.2015.9757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26393851	Green Accepted			2022-12-28	WOS:000362110700017
J	Sedgwick, P				Sedgwick, Philip			Understanding the ecological fallacy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7327; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3840; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979	4	44	46	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2015	351								h4773	10.1136/bmj.h4773	http://dx.doi.org/10.1136/bmj.h4773			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3ED	26391012				2022-12-28	WOS:000361953500002
J	Chen, DZ; Shi, CY; An, Q; Zeng, QS; Mao, WL; Goddard, WA; Greer, JR				Chen, David Z.; Shi, Crystal Y.; An, Qi; Zeng, Qiaoshi; Mao, Wendy L.; Goddard, William A., III; Greer, Julia R.			Fractal atomic-level percolation in metallic glasses	SCIENCE			English	Article							MEDIUM-RANGE ORDER; DYNAMICS; PACKING; DENSITY; MODEL; SIMULATION; LIQUIDS	Metallic glasses are metallic alloys that exhibit exotic material properties. They may have fractal structures at the atomic level, but a physical mechanism for their organization without ordering has not been identified. We demonstrated a crossover between fractal short-range (<2 atomic diameters) and homogeneous long-range structures using in situ x-ray diffraction, tomography, and molecular dynamics simulations. A specific class of fractal, the percolation cluster, explains the structural details for several metallic-glass compositions. We postulate that atoms percolate in the liquid phase and that the percolating cluster becomes rigid at the glass transition temperature.	[Chen, David Z.; Greer, Julia R.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Shi, Crystal Y.; Mao, Wendy L.] Stanford Univ, Dept Geol Sci, Stanford, CA 94305 USA; [An, Qi; Goddard, William A., III] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Zeng, Qiaoshi] Ctr High Pressure Sci & Technol Adv Res, Shanghai 201203, Peoples R China; [Zeng, Qiaoshi] Carnegie Inst Sci, Geophys Lab, High Pressure Synerget Consortium, Argonne, IL 60439 USA; [Mao, Wendy L.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Greer, Julia R.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA	California Institute of Technology; Stanford University; California Institute of Technology; Carnegie Institution for Science; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; California Institute of Technology	Chen, DZ (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	dzchen@caltech.edu	zeng, qiaoshi/V-8250-2019	zeng, qiaoshi/0000-0001-5960-1378	U.S. Department of Energy Office of Basic Energy Sciences (DOE-BES); NASA's Space Technology Research Grants Program (Early Career Faculty grants); NSF [EAR-1055454, MRI-1126249]; DOE-BES [DE-FG02-99ER45775, DE-AC02-06CH11357]; National Natural Science Foundation of China [U1530402]; DOE's National Nuclear Security Administration (NNSA) [DE-NA0001974]; NNSA Predictive Science Academic Alliance Program at Caltech [DE-FC52-08NA28613]; NSF Center for Science and Engineering of Materials computer cluster [DMR-0520565]; Defense Advanced Research Projects Agency-Army Research Office [W31P4Q-13-1-0010]; NSF Graduate Research Fellowship [DGE-1144469]; Division Of Materials Research [1436985] Funding Source: National Science Foundation	U.S. Department of Energy Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); NASA's Space Technology Research Grants Program (Early Career Faculty grants); NSF(National Science Foundation (NSF)); DOE-BES(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DOE's National Nuclear Security Administration (NNSA); NNSA Predictive Science Academic Alliance Program at Caltech; NSF Center for Science and Engineering of Materials computer cluster; Defense Advanced Research Projects Agency-Army Research Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Diffraction data and simulated RDFs are available as supplementary materials. The authors thank D. C. Hofmann for providing the Cu<INF>46</INF>Zr<INF>46</INF>Al<INF>5</INF>Be<INF>3</INF> wires and Y. Lin for her aid in sample loading. The authors acknowledge the financial support of the U.S. Department of Energy Office of Basic Energy Sciences (DOE-BES) and NASA's Space Technology Research Grants Program (Early Career Faculty grants to J.R.G.). W.L.M. and C.Y.S. acknowledge support from NSF grant EAR-1055454. Q.Z. acknowledges support from DOE-BES (grant DE-FG02-99ER45775) and the National Natural Science Foundation of China (grant U1530402). Portions of this work were performed at the High Pressure Collaborative Access Team (HPCAT) of the Advanced Photon Source (APS), Argonne National Laboratory. HPCAT operations are supported by DOE's National Nuclear Security Administration (NNSA) under award no. DE-NA0001974 and by DOE-BES under award no. DE-FG02-99ER45775, with partial instrumentation funding by NSF grant MRI-1126249. APS is supported by DOE-BES under contract no. DE-AC02-06CH11357. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for DOE by Stanford University. Some computations were carried out on the Shared Heterogeneous Cluster computers (Caltech Center for Advanced Computing Research) provided by the NNSA Predictive Science Academic Alliance Program at Caltech (grant DE-FC52-08NA28613) and on the NSF Center for Science and Engineering of Materials computer cluster (grant DMR-0520565). Q.A. and W.A.G. received support from the Defense Advanced Research Projects Agency-Army Research Office (grant W31P4Q-13-1-0010) and NSF (grant DMR-1436985). This material is based on work supported by an NSF Graduate Research Fellowship (grant DGE-1144469). Any opinions, findings, and conclusions or recommendations expressed in the material are those of the authors and do not necessarily reflect the views of NSF.	ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; Bunde A., 1991, FRACTALS DISORDERED; Cheng YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.245501; Cheng YQ, 2011, PROG MATER SCI, V56, P379, DOI 10.1016/j.pmatsci.2010.12.002; CLARKE AS, 1987, PHYS REV B, V35, P7350, DOI 10.1103/PhysRevB.35.7350; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Delogu F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.255901; Duan G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224208; Falk ML, 1999, PHYS REV B, V60, P7062, DOI 10.1103/PhysRevB.60.7062; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Hirata A, 2011, NAT MATER, V10, P28, DOI [10.1038/nmat2897, 10.1038/NMAT2897]; Keys AS, 2007, NAT PHYS, V3, P260, DOI 10.1038/nphys572; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Li Y, 2008, SCIENCE, V322, P1816, DOI 10.1126/science.1163062; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Lorenz CD, 2001, J CHEM PHYS, V114, P3659, DOI 10.1063/1.1338506; Lund AC, 2003, ACTA MATER, V51, P5399, DOI 10.1016/S1359-6454(03)00396-3; Ma D, 2009, NAT MATER, V8, P30, DOI [10.1038/nmat2340, 10.1038/NMAT2340]; Ma XF, 2012, NANO LETT, V12, P486, DOI 10.1021/nl203964z; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mendelev MI, 2009, PHILOS MAG, V89, P967, DOI 10.1080/14786430902832773; Miracle DB, 2013, ACTA MATER, V61, P3157, DOI 10.1016/j.actamat.2013.02.005; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; ORBACH R, 1986, SCIENCE, V231, P814, DOI 10.1126/science.231.4740.814; POWELL MJ, 1979, PHYS REV B, V20, P4194, DOI 10.1103/PhysRevB.20.4194; Pun GPP, 2009, PHILOS MAG, V89, P3245, DOI 10.1080/14786430903258184; Sahimi M, 1994, APPL PERCOLATION THE; SCHER H, 1970, J CHEM PHYS, V53, P3759, DOI 10.1063/1.1674565; SHANTE VKS, 1971, ADV PHYS, V20, P325, DOI 10.1080/00018737100101261; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; SIETSMA J, 1991, J NON-CRYST SOLIDS, V135, P146, DOI 10.1016/0022-3093(91)90415-3; Tallinen T, 2009, NAT MATER, V8, P25, DOI [10.1038/nmat2343, 10.1038/NMAT2343]; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Wang JF, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052107; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Yang B, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206099; Zeng QS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.185502	38	96	96	5	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1306	1310		10.1126/science.aab1233	http://dx.doi.org/10.1126/science.aab1233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383945				2022-12-28	WOS:000361357700041
J	Ascoli, GA				Ascoli, Giorgio A.			On Synaptic Circuits, Memory, and Kumquats	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	George Mason University	Ascoli, GA (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.				NINDS NIH HHS [R01 NS039600, R01 NS086082] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039600, R01NS086082] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ascoli GA, 2015, TREES OF THE BRAIN, ROOTS OF THE MIND, P1; Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Mainetti M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004155; Sadtler PT, 2014, NATURE, V512, P423, DOI 10.1038/nature13665	5	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1170	1172		10.1056/NEJMcibr1509692	http://dx.doi.org/10.1056/NEJMcibr1509692			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR7UG	26376141	Green Accepted			2022-12-28	WOS:000361556400015
J	Lu, J; Zuo, Y				Lu, Ju; Zuo, Yi			NEUROSCIENCE Forgetfulness illuminated	NATURE			English	Editorial Material							IN-VIVO; MEMORY		[Lu, Ju; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Lu, J (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	jlu39@ucsc.edu; yizuo@ucsc.edu		Zuo, Yi/0000-0001-9020-0003				Chen CC, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00028; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Semon R.W., 1904, MNEME ALS ERHALTENDE	11	2	2	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					324	325		10.1038/nature15211	http://dx.doi.org/10.1038/nature15211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26352474				2022-12-28	WOS:000361297900028
J	Daelmans, B; Black, MM; Lombardi, J; Lucas, J; Richter, L; Silver, K; Britto, P; Yoshikawa, H; Perez-Escamilla, R; MacMillan, H; Dua, T; Bouhouch, RR; Bhutta, ZA; Darmstadt, GL; Rao, N				Daelmans, Bernadette; Black, Maureen M.; Lombardi, Joan; Lucas, Jane; Richter, Linda; Silver, Karlee; Britto, Pia; Yoshikawa, Hirokazu; Perez-Escamilla, Rafael; MacMillan, Harriet; Dua, Tarun; Bouhouch, Raschida R.; Bhutta, Zulfiqar A.; Darmstadt, Gary L.; Rao, Nirmala			Effective interventions and strategies for improving early child development	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNITY-HEALTH WORKERS; NUTRITION INTERVENTIONS; STIMULATION; OUTCOMES; INCOME; PREVENTION; COUNTRIES; PROGRAMS; PAKISTAN; GROWTH		[Daelmans, Bernadette; Bouhouch, Raschida R.] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Policy Planning & Programmes, CH-1211 Geneva 27, Switzerland; [Black, Maureen M.] Univ Maryland, Sch Med, Dept Pediat, Pediat, Baltimore, MD 21201 USA; [Lombardi, Joan] Bernard van Leer Fdn, The Hague, Netherlands; [Richter, Linda] DST NRF Ctr Excellence Human Dev, Durban, South Africa; [Richter, Linda] Human Sci Res Council, Durban, South Africa; [Silver, Karlee] Grand Challenges Canada, Toronto, ON, Canada; [Britto, Pia] United Nations Childrens Fund, Early Child Dev, New York, NY USA; [Yoshikawa, Hirokazu] NYU Steinhardt, Dept Appl Physiol, Globalizat & Educ, New York, NY USA; [Perez-Escamilla, Rafael] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, Epidemiol & Publ Hlth, New Haven, CT USA; [MacMillan, Harriet] McMaster Univ, Dept Psychiat & Behav Neurosci, Psychiat & Behav Neurosci, Hamilton, ON, Canada; [MacMillan, Harriet] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Dua, Tarun] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva 27, Switzerland; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Darmstadt, Gary L.] Stanford Univ, Sch Med, Dept Pediat, Maternal & Child Hlth, Stanford, CA 94305 USA; [Darmstadt, Gary L.] Stanford Univ, Sch Med, Dept Pediat, Neonatal & Dev Pediat, Stanford, CA 94305 USA; [Rao, Nirmala] Univ Hong Kong, Fac Educ, Early Childhood Dev & Educ, Hong Kong, Hong Kong, Peoples R China	World Health Organization; University System of Maryland; University of Maryland Baltimore; Human Sciences Research Council-South Africa; UNICEF; Yale University; McMaster University; McMaster University; World Health Organization; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Stanford University; Stanford University; University of Hong Kong	Daelmans, B (corresponding author), WHO, Dept Maternal Newborn Child & Adolescent Hlth, Policy Planning & Programmes, CH-1211 Geneva 27, Switzerland.	daelmansb@who.int	MacMillan, Harriet/B-4530-2016; Darmstadt, Gary/AAU-7488-2020	MacMillan, Harriet/0000-0002-1223-706X; Darmstadt, Gary/0000-0002-7522-5824; Black, Maureen/0000-0002-6427-4639				Black MM, 2014, ANN NY ACAD SCI, V1308, P1, DOI 10.1111/nyas.12351; BOWLBY J, 1951, Bull World Health Organ, V3, P355; Britto P.R., 2013, HDB EARLY CHILDHOOD; Britto PR, 2014, ANN NY ACAD SCI, V1308, P245, DOI 10.1111/nyas.12365; Denboba AD, 2014, STEPPING EARLY CHILD; Ertem I, 2012, DEV DIFFICULTIES EAR; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Garcia M, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-8897-6; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Grantham-McGregor SM, 2014, ANN NY ACAD SCI, V1308, P11, DOI 10.1111/nyas.12284; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Heckman J, 2015, 4 BIG BENEFITS INVES; Irwin L, 2007, EARLY CHILD DEV POWE; Jayaratne K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-172; Jin X, 2007, J DEV BEHAV PEDIATR, V28, P123; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Khan NZ, 2013, CHILD CARE HLTH DEV, V39, P643, DOI 10.1111/j.1365-2214.2012.01393.x; Mikton C, 2009, B WORLD HEALTH ORGAN, V87, P353, DOI 10.2471/BLT.08.057075; Pallas SW, 2013, AM J PUBLIC HEALTH, V103, pE74, DOI 10.2105/AJPH.2012.301102; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Sandler IN, 2011, ANNU REV PSYCHOL, V62, P299, DOI 10.1146/annurev.psych.121208.131619; Shonkoff J.P., 2000, NEURONS NEIGHBORHOOD; Shonkoff JP, 2013, HDB EARLY CHILDHOOD, P24; UN, 2014, ROAD DIGN 2030 END P; UN Sustainable Development Solutions Network, 2015, KEY EL SUCC ADD AB A; Wachs TD, 2013, HDB EARLY CHILDHOOD, P85, DOI DOI 10.1093/ACPROF:OSO/9780199922994.003.0005; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2013, M REPORT NURTURING H; WHO, 2014, GLOB HLTH OBS; WHO Unicef, 2012, CAR CHILD DEV; World Health Organization, 2008, MAT MENT HLTH CHILD; Yousafzai AK, 2014, LANCET, V384, P1282, DOI 10.1016/S0140-6736(14)60455-4; Yousafzai AK, 2014, ARCH DIS CHILD, V99, P840, DOI 10.1136/archdischild-2012-302066	35	26	26	3	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4029					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR9LW	26371213	Bronze			2022-12-28	WOS:000361678200001
J	Knecht, ZA; Gaudet, R; Garrity, PA				Knecht, Zachary A.; Gaudet, Rachelle; Garrity, Paul A.			The Touching Tail of a Mechanotransduction Channel	CELL			English	Editorial Material							MECHANORECEPTORS; SUBUNIT; NOMPC		[Knecht, Zachary A.; Garrity, Paul A.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02458 USA; [Knecht, Zachary A.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02458 USA; [Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Brandeis University; Brandeis University; Harvard University	Garrity, PA (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02458 USA.	pgarrity@brandeis.edu	Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Garrity, Paul/0000-0002-8274-6564	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019929] Funding Source: NIH RePORTER; NIMH NIH HHS [T32 MH019929] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Effertz T, 2012, NAT NEUROSCI, V15, P1198, DOI 10.1038/nn.3175; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Liang X, 2013, CURR BIOL, V23, P755, DOI 10.1016/j.cub.2013.03.065; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024	9	5	5	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1214	1216		10.1016/j.cell.2015.08.049	http://dx.doi.org/10.1016/j.cell.2015.08.049			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359983	Bronze			2022-12-28	WOS:000361247900012
J	Leroy, A				Leroy, Adam			ASTROPHYSICS Glimpse into a primitive stellar nursery	NATURE			English	Editorial Material							IRREGULAR GALAXY WLM; CARBON-MONOXIDE; CLOUDS; ORION		Ohio State Univ, Dept Astron, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Leroy, A (corresponding author), Ohio State Univ, Dept Astron, 174 W 18Th Ave, Columbus, OH 43210 USA.	leroy.42@osu.edu		Leroy, Adam/0000-0002-2545-1700				Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Buckle JV, 2010, MON NOT R ASTRON SOC, V401, P204, DOI 10.1111/j.1365-2966.2009.15619.x; Elmegreen BG, 2013, NATURE, V495, P487, DOI 10.1038/nature11933; Glover SCO, 2012, MON NOT R ASTRON SOC, V426, P377, DOI 10.1111/j.1365-2966.2012.21737.x; Hunter DA, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/134; ISRAEL FP, 1986, ASTROPHYS J, V303, P186, DOI 10.1086/164065; Lee H, 2005, ASTROPHYS J, V620, P223, DOI 10.1086/427019; Rubio M, 2015, NATURE, V525, P218, DOI 10.1038/nature14901; Taylor CL, 1998, ASTRON J, V116, P2746, DOI 10.1086/300655; Wilson BA, 2005, ASTRON ASTROPHYS, V430, P523, DOI 10.1051/0004-6361:20035943	10	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					195	197		10.1038/525195a	http://dx.doi.org/10.1038/525195a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26354480				2022-12-28	WOS:000360927400024
J	Comi, G; Radaelli, M				Comi, Giancarlo; Radaelli, Marta			Oral corticosteroids for multiple sclerosis relapse	LANCET			English	Editorial Material							UNMET NEEDS TRIBUNE; INTRAVENOUS METHYLPREDNISOLONE; TREATMENT EXPERIENCE; METAANALYSIS; RECOVERY; BURDEN; MRI; MS		[Comi, Giancarlo; Radaelli, Marta] Univ Vita Salute San Raffaele, Hosp San Raffaele, Inst Expt Neurol, Dept Neurol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Comi, G (corresponding author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Inst Expt Neurol, Dept Neurol, I-20132 Milan, Italy.	comi.giancarlo@hsr.it						BARKHOF F, 1991, NEUROLOGY, V41, P1219, DOI 10.1212/WNL.41.8.1219; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Burton JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006921.pub3; Karampampa K, 2012, MULT SCLER J, V18, P7, DOI 10.1177/1352458512441566; Karampampa K, 2012, J POPUL THER CLIN PH, V19, pE11; Le Page E, 2015, LANCET, V386, P974, DOI 10.1016/S0140-6736(15)61137-0; Martinelli V, 2009, NEUROLOGY, V73, P1842, DOI 10.1212/WNL.0b013e3181c3fd5b; Miller DM, 2000, MULT SCLER, V6, P267, DOI 10.1191/135245800678827770; O'Brien JA, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-17; Ramo-Tello C, 2014, MULT SCLER J, V20, P717, DOI 10.1177/1352458513508835; Richert ND, 2001, MULT SCLER, V7, P49, DOI 10.1191/135245801669116174; Zivadinov R, 2001, NEUROLOGY, V57, P1239, DOI 10.1212/WNL.57.7.1239; Zivadinov R, 2008, J NEUROL SCI, V267, P28, DOI 10.1016/j.jns.2007.09.025	13	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					937	939		10.1016/S0140-6736(15)00072-0	http://dx.doi.org/10.1016/S0140-6736(15)00072-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26369452				2022-12-28	WOS:000361182700007
J	Djuric, PM; Benveniste, H; Wagshul, ME; Henn, F; Enikolopov, G; Maletic-Savatic, M				Djuric, Petar M.; Benveniste, Helene; Wagshul, Mark E.; Henn, Fritz; Enikolopov, Grigori; Maletic-Savatic, Mirjana			Response to comments on "magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain"	SCIENCE			English	Editorial Material							HRMAS H-1-NMR; METABOLITES; EXTRACTION; TISSUE; PROFILES		[Djuric, Petar M.; Benveniste, Helene; Wagshul, Mark E.; Maletic-Savatic, Mirjana] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Benveniste, Helene; Henn, Fritz] Brookhaven Natl Lab, Brookhaven, NY 11719 USA; [Enikolopov, Grigori; Maletic-Savatic, Mirjana] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; Cold Spring Harbor Laboratory	Djuric, PM (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	djuric@ece.sunysb.edu; Mirjana.Maletic-Savatic@stonybrook.edu	Enikolopov, Grigori/P-5731-2019; Enikolopov, Grigori N/B-7771-2009	Enikolopov, Grigori/0000-0001-8178-8917; Enikolopov, Grigori N/0000-0001-8178-8917; Djuric, Petar M./0000-0001-7791-3199; Maletic-Savatic, Mirjana/0000-0002-6548-4662	NIDDK NIH HHS [T32 DK007521] Funding Source: Medline; NINDS NIH HHS [R01 NS032764, R21 NS053875, K08 NS044276] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053875, K08NS044276] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cheng LL, 2005, CANCER RES, V65, P3030, DOI 10.1158/0008-5472.CAN-04-4106; Colombo E, 2006, STEM CELLS, V24, P825, DOI 10.1634/stemcells.2005-0313; Friedman SD, 2008, SCIENCE, V321, DOI 10.1126/science.1153484; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Jansen JFA, 2006, MAGN RESON MED, V56, P666, DOI 10.1002/mrm.20968; KATYAL SL, 1985, LIPIDS, V20, P201, DOI 10.1007/BF02534255; Kay S. M., 1988, MODERN SPECTRAL ESTI; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Millis K, 1999, MAGNET RESON MED, V41, P257, DOI 10.1002/(SICI)1522-2594(199902)41:2<257::AID-MRM8>3.0.CO;2-N; Peet AC, 2007, NMR BIOMED, V20, P692, DOI 10.1002/nbm.1181; Poullet JB, 2007, NMR BIOMED, V20, P493, DOI 10.1002/nbm.1112; Ratai EM, 2005, NMR BIOMED, V18, P242, DOI 10.1002/nbm.953; Sandgren N, 2004, J MAGN RESON, V168, P259, DOI 10.1016/j.jmr.2004.03.011; Srivastava NK, 2008, NMR BIOMED, V21, P89, DOI 10.1002/nbm.1159; Stern AS, 2002, J AM CHEM SOC, V124, P1982, DOI 10.1021/ja011669o; Stoica P, 2004, IEEE T BIO-MED ENG, V51, P1568, DOI 10.1109/TBME.2004.828031; Stoica P, 2005, SPECTRAL ANAL SIGNAL, V452; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Valonen PK, 2005, NMR BIOMED, V18, P252, DOI 10.1002/nbm.955	22	9	10	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889								10.1126/science.1156889	http://dx.doi.org/10.1126/science.1156889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	26380846	Green Accepted			2022-12-28	WOS:000258077700024
J	Pillay, J; Armstrong, MJ; Butalia, S; Donovan, LE; Sigal, RJ; Vandermeer, B; Chordiya, P; Dhakal, S; Hartling, L; Nuspl, M; Featherstone, R; Dryden, DM				Pillay, Jennifer; Armstrong, Marni J.; Butalia, Sonia; Donovan, Lois E.; Sigal, Ronald J.; Vandermeer, Ben; Chordiya, Pritam; Dhakal, Sanjaya; Hartling, Lisa; Nuspl, Megan; Featherstone, Robin; Dryden, Donna M.			Behavioral Programs for Type 2 Diabetes Mellitus A Systematic Review and Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							SELF-MANAGEMENT EDUCATION; RANDOMIZED CONTROLLED-TRIAL; AFRICAN-AMERICAN WOMEN; COMMUNITY-HEALTH WORKER; LIFE-STYLE INTERVENTION; QUALITY-OF-LIFE; WEIGHT-LOSS PROGRAM; GLYCEMIC CONTROL; MEXICAN-AMERICANS; PATIENT EDUCATION	Background: Behavioral programs may improve outcomes for individuals with type 2 diabetes mellitus, but there is a large diversity of behavioral interventions and uncertainty about how to optimize the effectiveness of these programs. Purpose: To identify factors moderating the effectiveness of behavioral programs for adults with type 2 diabetes. Data Sources: 6 databases (1993 to January 2015), conference proceedings (2011 to 2014), and reference lists. Study Selection: Duplicate screening and selection of 132 randomized, controlled trials evaluating behavioral programs compared with usual care, active controls, or other behavioral programs. Data Extraction: One reviewer extracted and another verified data. Two reviewers independently assessed risk of bias. Data Synthesis: Behavioral programs were grouped on the basis of program content and delivery methods. A Bayesian network meta-analysis showed that most lifestyle and diabetes self-management education and support programs (usually offering >= 11 contact hours) led to clinically important improvements in glycemic control (>= 0.4% reduction in hemoglobin A1c [HbA1c]), whereas most diabetes self-management education programs without added support-especially those offering 10 or fewer contact hours-provided little benefit. Programs with higher effect sizes were more often delivered in person than via technology. Lifestyle programs led to the greatest reductions in body mass index. Reductions in HbA1c seemed to be greater for participants with a baseline HbA1c level of 7.0% or greater, adults younger than 65 years, and minority persons (subgroups with >= 75% nonwhite participants). Limitations: All trials had medium or high risk of bias. Subgroup analyses were indirect, and therefore exploratory. Most outcomes were reported immediately after the interventions. Conclusion: Diabetes self-management education offering 10 or fewer hours of contact with delivery personnel provided little benefit. Behavioral programs seem to benefit persons with suboptimal or poor glycemic control more than those with good control.	Univ Alberta, Evidence Based Practice Ctr, Edmonton, AB T6G 1C9, Canada; [Pillay, Jennifer; Vandermeer, Ben; Chordiya, Pritam; Dhakal, Sanjaya; Hartling, Lisa; Nuspl, Megan; Featherstone, Robin; Dryden, Donna M.] Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton Clin Hlth Acad, Edmonton, AB T6G 1C9, Canada; Alberta Hlth Serv, Calgary Zone, AB, Canada; [Armstrong, Marni J.; Butalia, Sonia; Donovan, Lois E.; Sigal, Ronald J.] Univ Calgary, Richmond Rd Diagnost & Treatment Ctr, Div Endocrinol & Metab, Calgary, AB T2T 5C7, Canada	University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Calgary	Pillay, J (corresponding author), Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton Clin Hlth Acad, 4th Floor,11405 87th Ave, Edmonton, AB T6G 1C9, Canada.	jpillay@ualberta.ca	Sigal, Ron/AAK-7627-2020; Sigal, Ronald/AAU-6081-2020; Featherstone, Robin/J-5165-2014	Featherstone, Robin/0000-0003-2517-2258; Butalia, Sonia/0000-0001-7865-9161	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO registration number: CRD42014010515)	Adachi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-467; AgursCollins TD, 1997, DIABETES CARE, V20, P1503, DOI 10.2337/diacare.20.10.1503; Amoako E, 2008, WESTERN J NURS RES, V30, P928, DOI 10.1177/0193945908320465; Anderson DR, 2010, J GEN INTERN MED, V25, P1116, DOI 10.1007/s11606-010-1419-5; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Anderson RM, 2005, ETHNIC DIS, V15, P671; Anderson Robert M, 2009, Ther Patient Educ, V1, P3; Anderson-Loftin W, 2005, DIABETES EDUCATOR, V31, P555, DOI 10.1177/0145721705278948; [Anonymous], 2008, DIABETES EDUCATOR, V34, P445, DOI 10.1177/0145721708316625; Baksi AK, 2008, DIABETIC MED, V25, P1076, DOI 10.1111/j.1464-5491.2008.02542.x; Barratt R, 2008, BRIT J NUTR, V99, P1025, DOI 10.1017/S0007114507839018; Beverly EA, 2013, DIABETES EDUCATOR, V39, P504, DOI 10.1177/0145721713486837; Bond GE, 2007, DIABETES TECHNOL THE, V9, P52, DOI 10.1089/dia.2006.0057; Bozzetto L, 2014, ACTA DIABETOL, V51, P385, DOI 10.1007/s00592-013-0522-6; Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809; Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527; Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259; Brown SA, 2011, ETHNIC DIS, V21, P20; Castejon AM, 2013, J HEALTH CARE POOR U, V24, P48, DOI 10.1353/hpu.2014.0003; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Chan JCN, 2014, JAMA INTERN MED, V174, P972, DOI 10.1001/jamainternmed.2014.655; Chan LS, 2012, DISS ABSTR INT B, V74, P4; Cheong SH, 2009, J AM DIET ASSOC, V109, P1411, DOI 10.1016/j.jada.2009.05.012; Chlebowy DO, 2015, WESTERN J NURS RES, V37, P566, DOI 10.1177/0193945914530522; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Clark M, 2004, BRIT J HEALTH PSYCH, V9, P365, DOI 10.1348/1359107041557066; Cooper H, 2008, DIABETES RES CLIN PR, V82, P165, DOI 10.1016/j.diabres.2008.07.013; Corkery E, 1997, DIABETES CARE, V20, P254, DOI 10.2337/diacare.20.3.254; Cramer JS, 2007, DIABETES EDUCATOR, V33, P503, DOI 10.1177/0145721707301680; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; Dasgupta K, 2006, DIABETES RES CLIN PR, V72, P53, DOI 10.1016/j.diabres.2005.09.010; Davis RM, 2010, DIABETES CARE, V33, P1712, DOI 10.2337/dc09-1919; Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x; Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2; Dunstan DW, 2005, DIABETES CARE, V28, P3, DOI 10.2337/diacare.28.1.3; Dunstan DW, 1997, DIABETES CARE, V20, P913, DOI 10.2337/diacare.20.6.913; Eakin EG, 2014, DIABETES CARE, V37, P2177, DOI 10.2337/dc13-2427; Edelman D, 2015, J GEN INTERN MED, V30, P626, DOI 10.1007/s11606-014-3154-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Ettenhofer, 2002, AM J HLTH ED, V33, P161, DOI DOI 10.1080/19325037.2002.10604732; Fan LF, 2009, CAN J DIABETES, V33, P18, DOI 10.1016/S1499-2671(09)31005-9; Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493; Foster GD, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.3; Foster GD, 2009, POSTGRAD MED, V121, P113, DOI 10.3810/pgm.2009.09.2046; Frosch DL, 2011, ARCH INTERN MED, V171, P2011, DOI 10.1001/archinternmed.2011.497; Funnell M, 2013, DIABETIC MED, V30, P765, DOI 10.1111/dme.12244; Gagliardino JJ, 2013, DIABETIC MED, V30, P1102, DOI 10.1111/dme.12230; Giannopoulou I, 2005, METABOLISM, V54, P866, DOI 10.1016/j.metabol.2005.01.033; Glasgow RE, 2006, AM J MANAG CARE, V12, P137; Glasgow RE, 2006, CHRONIC ILLN, V2, P27, DOI 10.1179/174592006X93851; Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024; Glazier RH, 2006, DIABETES CARE, V29, P1675, DOI 10.2337/dc05-1942; Goudswaard AN, 2004, DIABETIC MED, V21, P491, DOI 10.1111/j.1464-5491.2004.01153.x; Hawkins SY, 2010, RES THEOR NURS PRACT, V24, P217, DOI 10.1891/1541-6577.24.4.217; Hemmingsen B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub3; Hendricks LE, 2000, DIABETES EDUCATOR, V26, P995, DOI 10.1177/014572170002600612; Hermanns N, 2012, PATIENT EDUC COUNS, V86, P226, DOI 10.1016/j.pec.2011.05.017; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hill-Briggs F, 2011, J GEN INTERN MED, V26, P972, DOI 10.1007/s11606-011-1689-6; Holmen H, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3882; Huisman S, 2009, PATIENT EDUC COUNS, V75, P84, DOI 10.1016/j.pec.2008.09.027; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-15; Izquierdo RE, 2003, DIABETES CARE, V26, P1002, DOI 10.2337/diacare.26.4.1002; Johnson ST, 2009, DIABETES OBES METAB, V11, P836, DOI 10.1111/j.1463-1326.2009.01050.x; Jones H, 2003, DIABETES CARE, V26, P732, DOI 10.2337/diacare.26.3.732; Gagliardino JJ, 2013, DIABETES-METAB RES, V29, P152, DOI 10.1002/dmrr.2368; Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576; Kim MT, 2009, DIABETES EDUCATOR, V35, P986, DOI 10.1177/0145721709345774; Kim SH, 2006, METABOLISM, V55, P1053, DOI 10.1016/j.metabol.2006.03.017; Kim SH, 2014, CLIN ENDOCRINOL, V80, P825, DOI 10.1111/cen.12249; Knight KM, 2006, DIABETIC MED, V23, P485, DOI 10.1111/j.1464-5491.2005.01802.x; Koo BK, 2010, DIABETIC MED, V27, P1088, DOI 10.1111/j.1464-5491.2010.03045.x; Kulzer B, 2007, DIABETIC MED, V24, P415, DOI 10.1111/j.1464-5491.2007.02089.x; Lee A, 2011, POSTGRAD MED J, V87, P688, DOI 10.1136/pgmj.2011.118885; Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313; Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153; Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lujan J, 2007, DIABETES EDUCATOR, V33, P660, DOI 10.1177/0145721707304080; Lynch EB, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130349; Mandel SE, 2013, DIABETES EDUCATOR, V39, P568, DOI 10.1177/0145721713492216; Mayer-Davis EJ, 2004, AM J PUBLIC HEALTH, V94, P1736, DOI 10.2105/AJPH.94.10.1736; McGowan P, 2011, CAN J DIABETES, V35, P46, DOI 10.1016/S1499-2671(11)51008-1; Melkus GD, 2010, BIOL RES NURS, V12, P7, DOI 10.1177/1099800410369825; Miller CK, 2014, HEALTH EDUC BEHAV, V41, P145, DOI 10.1177/1090198113493092; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Moncrieft AE, 2014, DISS ABSTR INT B, V75, P1; Moriyama M, 2009, JPN J NURS SCI, V6, P51, DOI 10.1111/j.1742-7924.2009.00120.x; MUCHMORE DB, 1994, ACTA DIABETOL, V31, P215, DOI 10.1007/BF00571954; Murrock CJ, 2009, DIABETES EDUCATOR, V35, P995, DOI 10.1177/0145721709343322; Nam S, 2012, J CARDIOVASC NURS, V27, P505, DOI 10.1097/JCN.0b013e31822375a5; Nishita C, 2013, HEALTH EDUC BEHAV, V40, P581, DOI 10.1177/1090198112465088; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Palmas W, 2014, DIABETES CARE, V37, P963, DOI 10.2337/dc13-2142; Philis-Tsimikas A, 2011, DIABETES CARE, V34, P1926, DOI 10.2337/dc10-2081; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; Plotnikoff RC, 2011, J PHYS ACT HEALTH, V8, P944, DOI 10.1123/jpah.8.7.944; Prezio EA, 2013, DIABETES RES CLIN PR, V100, P19, DOI 10.1016/j.diabres.2013.01.027; Reaney M, 2013, DIABETES SPECTR, V26, P236, DOI DOI 10.2337/DIASPECT.26.4.236; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rickheim PL, 2002, DIABETES CARE, V25, P269, DOI 10.2337/diacare.25.2.269; Ridgeway NA, 1999, SOUTHERN MED J, V92, P667, DOI 10.1097/00007611-199907000-00004; Rock CL, 2014, DIABETES CARE, V37, P1573, DOI 10.2337/dc13-2900; Rosal MC, 2005, ANN BEHAV MED, V29, P225, DOI 10.1207/s15324796abm2903_9; Rosal MC, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3412; Rosal MC, 2011, DIABETES CARE, V34, P838, DOI 10.2337/dc10-1981; Rothschild SK, 2014, AM J PUBLIC HEALTH, V104, P1540, DOI 10.2105/AJPH.2013.301439; Ruggiero L, 2014, WESTERN J NURS RES, V36, P1052, DOI 10.1177/0193945914522862; Ruggiero L, 2010, DIABETES EDUCATOR, V36, P127, DOI 10.1177/0145721709355487; Sacco WP, 2009, J BEHAV MED, V32, P349, DOI 10.1007/s10865-009-9209-4; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salinero-Fort MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-267; Samuel-Hodge CD, 2009, DIABETES EDUCATOR, V35, P439, DOI 10.1177/0145721709333270; Sarkadi A, 2004, PATIENT EDUC COUNS, V53, P291, DOI 10.1016/j.pec.2003.10.009; Sevick MA, 2012, J ACAD NUTR DIET, V112, P1147, DOI 10.1016/j.jand.2012.05.008; Shibayama T, 2007, DIABETES RES CLIN PR, V76, P265, DOI 10.1016/j.diabres.2006.09.017; Sidik K, 2002, STAT MED, V21, P3153, DOI 10.1002/sim.1262; Sigurdardottir AK, 2009, J ADV NURS, V65, P2118, DOI 10.1111/j.1365-2648.2009.05040.x; Siminerio L, 2013, DIABETES EDUCATOR, V39, P705, DOI 10.1177/0145721713492570; Sinclair KA, 2013, ANN BEHAV MED, V45, P24, DOI 10.1007/s12160-012-9422-1; Sixta CS, 2008, DIABETES EDUCATOR, V34, P299, DOI 10.1177/0145721708314490; Skelly AH, 2005, APPL NURS RES, V18, P213, DOI 10.1016/j.apnr.2004.08.008; Skelly AH, 2009, NURS RES, V58, P410, DOI 10.1097/NNR.0b013e3181bee597; Smith DE, 1997, DIABETES CARE, V20, P52, DOI 10.2337/diacare.20.1.52; Sorkin DH, 2014, HEALTH PSYCHOL, V33, P566, DOI 10.1037/hea0000063; Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106; Sperl-Hillen J, 2013, AM J MANAG CARE, V19, P104; Steed L, 2005, J HEALTH PSYCHOL, V10, P261, DOI 10.1177/1359105305049775; Sung K, 2012, NURS HEALTH SCI, V14, P438, DOI 10.1111/j.1442-2018.2012.00690.x; Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161; Thoolen B, 2007, DIABETES CARE, V30, P2832, DOI 10.2337/dc07-0777; Adolfsson ET, 2007, DIABETES RES CLIN PR, V76, P341, DOI 10.1016/j.diabres.2006.09.018; Toobert DJ, 2011, TRANSL BEHAV MED, V1, P416, DOI 10.1007/s13142-010-0011-1; Toobert DJ, 2003, DIABETES CARE, V26, P2288, DOI 10.2337/diacare.26.8.2288; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Trief P, 2011, FAM SYST HEALTH, V29, P253, DOI 10.1037/a0024564; Tucker CM, 2014, J HEALTH CARE POOR U, V25, P292, DOI 10.1353/hpu.2014.0044; U.S. Department of Health and Human Services; U.S. Food and Drug Administration; Center for Drug Evaluation and Research, 2008, GUID IND DIAB MELL D; Utz SW, 2008, DIABETES EDUCATOR, V34, P854, DOI 10.1177/0145721708323642; Vadstrup ES, 2011, PATIENT EDUC COUNS, V84, P185, DOI 10.1016/j.pec.2010.06.031; Varney JE, 2014, INTERN MED J, V44, P890, DOI 10.1111/imj.12515; Vazquez IM, 1998, AM J HEALTH PROMOT, V13, P116, DOI 10.4278/0890-1171-13.2.116; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Vincent D, 2007, BIOL RES NURS, V9, P130, DOI 10.1177/1099800407304980; Walker EA, 2011, DIABETES CARE, V34, P2, DOI 10.2337/dc10-1005; Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502; Welch G, 2011, DIABETES RES CLIN PR, V91, P54, DOI 10.1016/j.diabres.2010.09.036; Welschen LMC, 2013, J BEHAV MED, V36, P556, DOI 10.1007/s10865-012-9451-z; West DS, 2007, DIABETES CARE, V30, P1081, DOI 10.2337/dc06-1966; WIERENGA ME, 1994, PATIENT EDUC COUNS, V23, P33; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wolever RQ, 2010, DIABETES EDUCATOR, V36, P629, DOI 10.1177/0145721710371523; Wolf AM, 2004, DIABETES CARE, V27, P1570, DOI 10.2337/diacare.27.7.1570; Yoo JS, 2007, ASIAN NURS RES, V1, P106, DOI 10.1016/S1976-1317(08)60013-4; Yuan C, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/789761	159	138	139	0	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					848	+		10.7326/M15-1400	http://dx.doi.org/10.7326/M15-1400			45	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX7FB	26414227				2022-12-28	WOS:000365866500008
J	Van Allen, EM; Miao, D; Schilling, B; Shukla, SA; Blank, C; Zimmer, L; Sucker, A; Hillen, U; Foppen, MHG; Goldinger, SM; Utikal, J; Hassel, JC; Weide, B; Kaehler, KC; Loquai, C; Mohr, P; Gutzmer, R; Dummer, R; Gabriel, S; Wu, CJ; Schadendorf, D; Garraway, LA				Van Allen, Eliezer M.; Miao, Diana; Schilling, Bastian; Shukla, Sachet A.; Blank, Christian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Foppen, Marnix H. Geukes; Goldinger, Simone M.; Utikal, Jochen; Hassel, Jessica C.; Weide, Benjamin; Kaehler, Katharina C.; Loquai, Carmen; Mohr, Peter; Gutzmer, Ralf; Dummer, Reinhard; Gabriel, Stacey; Wu, Catherine J.; Schadendorf, Dirk; Garraway, Levi A.			Genomic correlates of response to CTLA-4 blockade in metastatic melanoma	SCIENCE			English	Article							IPILIMUMAB PLUS DACARBAZINE; PD-1 BLOCKADE; NEO-ANTIGENS; MUTATIONS; TUMORS; SURVIVAL; LANDSCAPE; NIVOLUMAB; SAMPLES	Monoclonal antibodies directed against cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), such as ipilimumab, yield considerable clinical benefit for patients with metastatic melanoma by inhibiting immune checkpoint activity, but clinical predictors of response to these therapies remain incompletely characterized. To investigate the roles of tumor-specific neoantigens and alterations in the tumor microenvironment in the response to ipilimumab, we analyzed whole exomes from pretreatment melanoma tumor biopsies and matching germline tissue samples from 110 patients. For 40 of these patients, we also obtained and analyzed transcriptome data from the pretreatment tumor samples. Overall mutational load, neoantigen load, and expression of cytolytic markers in the immune microenvironment were significantly associated with clinical benefit. However, no recurrent neoantigen peptide sequences predicted responder patient populations. Thus, detailed integrated molecular characterization of large patient cohorts may be needed to identify robust determinants of response and resistance to immune checkpoint inhibitors.	[Van Allen, Eliezer M.; Miao, Diana; Shukla, Sachet A.; Wu, Catherine J.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Van Allen, Eliezer M.; Miao, Diana; Shukla, Sachet A.; Gabriel, Stacey; Wu, Catherine J.; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Van Allen, Eliezer M.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA; [Schilling, Bastian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Schadendorf, Dirk] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, D-45147 Essen, Germany; [Schilling, Bastian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Utikal, Jochen; Schadendorf, Dirk] German Canc Consortium DKTK, D-69121 Heidelberg, Germany; [Blank, Christian; Foppen, Marnix H. Geukes] Netherlands Canc Inst, Dept Med Oncol, NL-1066 CX Amsterdam, Netherlands; [Goldinger, Simone M.; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, D-69121 Heidelberg, Germany; [Utikal, Jochen] Heidelberg Univ, Univ Med Ctr, Dept Dermatol Venerol & Allergol, D-68167 Mannheim, Germany; [Hassel, Jessica C.] Heidelberg Univ, Univ Hosp, Dept Dermatol, D-69120 Heidelberg, Germany; [Weide, Benjamin] Univ Hosp Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Kaehler, Katharina C.] Univ Hosp Kiel, Dept Dermatol, D-24105 Kiel, Germany; [Loquai, Carmen] Univ Med Ctr Mainz, Dept Dermatol, D-55131 Mainz, Germany; [Mohr, Peter] Elbe Kliniken, Dept Dermatol, D-21614 Buxtehude, Germany; [Gutzmer, Ralf] Hannover Med Sch, Skin Canc Ctr Hannover, Dept Dermatol & Allergy, D-30625 Hannover, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands Cancer Institute; University of Zurich; University Zurich Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Kiel; Schleswig Holstein University Hospital; Johannes Gutenberg University of Mainz; Hannover Medical School	Garraway, LA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	dirk.schadendorf@uk-essen.de; levi_garraway@dfci.harvard.edu	Schilling, Bastian/AAY-8646-2020; Loquai, Carmen/AAW-9241-2020; Weide, Benjamin/N-3698-2013; Zimmer, Lisa/AAP-8495-2021; wang, edwin/G-5372-2010; Schadendorf, Dirk/AAE-8206-2019	Schilling, Bastian/0000-0001-8859-4103; Zimmer, Lisa/0000-0002-3680-3521; Utikal, Jochen/0000-0001-5316-0241	NIH [U54 HG003067]; Janssen; Novartis; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH U54 HG003067. All sequencing data are available in dbGap, accession number phs000452.v2.p1. We thank the Dermatologic Cooperative Oncology Group (DeCOG; Germany) for clinical accrual and sample coordination, S. Bahl (Broad) for project management effort, and the Broad Genomics Platform for piloting dual extraction and RNA sequencing from formalin samples. S.M.G. is supported by a fellowship from Janssen and is a paid adviser for Merck, Bristol-Myers Squibb, Roche, and Novartis. C.L. is a paid adviser for Merck, Bristol-Myers Squibb, Roche, and Novartis. L.A.G. is a consultant for Novartis, Foundation Medicine, and Boehringer Ingelheim, a paid adviser for Warp Drive, has ownership interest in Foundation Medicine, and holds a Commercial Research Grant from Novartis. E.M.V.A. is a paid adviser for Syapse and a consultant for Roche Ventana. E.M.V.A., D.M., B.S., D. S., and L.A.G. designed the study, performed the analyses, and wrote the manuscript. S. A. S., D. M., E.M.V.A. and C.J.W. performed HLA typing and neoantigen binder analyses. E.M.V.A., S.G., and L.A.G. performed sequencing. B.S., C.B., L.Z., A.S., M.H.G.F., S.M.G., J.U., J.C.H.B.W., K.C.K., C.L., P.M., R.G., R.D., and D.S. developed the clinical samples cohort. U.H. performed pathology review on the samples.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hofbauer GFL, 2004, J IMMUNOTHER, V27, P73, DOI 10.1097/00002371-200401000-00007; Johnson DB, 2015, CANCER IMMUNOL RES, V3, P288, DOI 10.1158/2326-6066.CIR-14-0207; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Maio M, 2015, J CLIN ONCOL, V33, P1191, DOI 10.1200/JCO.2014.56.6018; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schadendorf D, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.3; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Schumacher TN, 2015, CANCER CELL, V27, P12, DOI 10.1016/j.ccell.2014.12.004; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	33	1623	1670	5	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					207	211		10.1126/science.aad0095	http://dx.doi.org/10.1126/science.aad0095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26359337	Green Accepted			2022-12-28	WOS:000362405600039
J	Frank, T; Friedrich, RW				Frank, Thomas; Friedrich, Rainer W.			NEUROBIOLOGY Individuality sniffed out in flies	NATURE			English	Editorial Material							DROSOPHILA MUSHROOM BODY		[Frank, Thomas; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Friedrich, Rainer W.] Univ Basel, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Frank, T (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	rainer.friedrich@fmi.ch		Friedrich, Rainer/0000-0001-9107-0482; Frank, Thomas/0000-0002-5113-176X				Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Gupta N, 2014, CURR BIOL, V24, P2247, DOI 10.1016/j.cub.2014.08.021; Hige T, 2015, NATURE, V526, P258, DOI 10.1038/nature15396; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Proust M., 1913, REMEMBRANCE THINGS, V1; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005	11	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					200	201		10.1038/nature15636	http://dx.doi.org/10.1038/nature15636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26416743				2022-12-28	WOS:000362399000033
J	Fu, YSH; Zhao, HF; Piao, SL; Peaucelle, M; Peng, SS; Zhou, GY; Ciais, P; Huang, MT; Menzel, A; Uelas, JP; Song, Y; Vitasse, Y; Zeng, ZZ; Janssens, IA				Fu, Yongshuo H.; Zhao, Hongfang; Piao, Shilong; Peaucelle, Marc; Peng, Shushi; Zhou, Guiyun; Ciais, Philippe; Huang, Mengtian; Menzel, Annette; Uelas, Josep Pen; Song, Yang; Vitasse, Yann; Zeng, Zhenzhong; Janssens, Ivan A.			Declining global warming effects on the phenology of spring leaf unfolding	NATURE			English	Article							CLIMATE-CHANGE; SENSITIVITY; PHOTOPERIOD; RESPONSES; FEEDBACKS; GROWTH; WINTER	Earlier spring leaf unfolding is a frequently observed response of plants to climate warming(1-4). Many deciduous tree species require chilling for dormancy release, and warming-related reductions in chillingmay counteract the advance of leaf unfolding in response to warming(5,6). Empirical evidence for this, however, is limited to saplings or twigs in climate-controlled chambers(7,8). Using long-termin situ observations of leaf unfolding for seven dominant European tree species at 1,245 sites, here we show that the apparent response of leaf unfolding to climate warming (S-T, expressed in days advance of leaf unfolding per degrees C warming) has significantly decreased from 1980 to 2013 in all monitored tree species. Averaged across all species and sites, S-T decreased by 40% from 4.0 +/- 1.8 days degrees C-1 during 1980-1994 to 2.3 +/- 1.6 days degrees C-1 during 1999-2013. The declining S-T was also simulated by chilling-based phenology models, albeit with a weaker decline (24-30%) than observedin situ. The reduction in S-T is likely to be partly attributable to reduced chilling. Nonetheless, other mechanisms may also have a role, such as 'photo-period limitation' mechanisms that may become ultimately limiting when leaf unfolding dates occur too early in the season. Our results provide empirical evidence for a declining S-T, but also suggest that the predicted strong winter warming in the future may further reduce S-T and therefore result in a slow down in the advance of tree spring phenology.	[Fu, Yongshuo H.; Zhao, Hongfang; Piao, Shilong; Peng, Shushi; Ciais, Philippe; Huang, Mengtian; Zeng, Zhenzhong] Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China; [Fu, Yongshuo H.; Piao, Shilong; Janssens, Ivan A.] Univ Antwerp, Dept Biol, Ctr Excellence PLECO Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Piao, Shilong] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100085, Peoples R China; [Piao, Shilong] Chinese Acad Sci, Ctr Excellence Tibetan Earth Sci, Beijing 100085, Peoples R China; [Peaucelle, Marc; Peng, Shushi; Ciais, Philippe] UVSQ, CEA CNRS, Lab Sci Climat & Environm, F-91190 Gif Sur Yvette, France; [Zhou, Guiyun] Univ Elect Sci & Technol China, Sch Resources & Environm, Chengdu 611731, Peoples R China; [Menzel, Annette] Tech Univ Munich, Ecoclimatol, D-85354 Freising Weihenstephan, Germany; [Menzel, Annette] Tech Univ Munich, Inst Adv Study, D-85748 Garching, Germany; [Uelas, Josep Pen] CREAF, Cerdanyola Valles, Barcelona 08193, Catalonia, Spain; [Uelas, Josep Pen] CSIC, Global Ecol Unit CREAF CSIC UAB, Barcelona 08193, Catalonia, Spain; [Song, Yang] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Vitasse, Yann] Univ Neuchatel, Inst Geog, CH-2000 Neuchatel, Switzerland; [Vitasse, Yann] WSL Swiss Fed Inst Forest Snow & Landscape Res, CH-2000 Neuchatel, Switzerland; [Vitasse, Yann] WSL Inst Snow & Avalanche Res SLF, Grp Mt Ecosyst, CH-7260 Davos, Switzerland	Peking University; University of Antwerp; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Electronic Science & Technology of China; Technical University of Munich; Technical University of Munich; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); University of Illinois System; University of Illinois Urbana-Champaign; University of Neuchatel; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Piao, SL (corresponding author), Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu	Fu, Yongshuo/AAH-7434-2019; Janssens, Ivan A/P-1331-2014; Vitasse, Yann/K-3349-2017; SONG, YANG/I-1986-2019; Fu, Yongshuo/AAF-9446-2021; Ciais, Philippe/A-6840-2011; Zeng, Zhenzhong/A-2212-2019; Menzel, Annette/B-1105-2013; Peng, Shushi/J-4779-2014; Penuelas, Josep/D-9704-2011; Fu, Yongshuo/AAO-4663-2021; PENG, Shushi/AAS-2603-2020	Janssens, Ivan A/0000-0002-5705-1787; Vitasse, Yann/0000-0002-7454-505X; SONG, YANG/0000-0002-3493-3699; Fu, Yongshuo/0000-0002-9761-5292; Ciais, Philippe/0000-0001-8560-4943; Zeng, Zhenzhong/0000-0001-6851-2756; Menzel, Annette/0000-0002-7175-2512; Peng, Shushi/0000-0001-5098-726X; Penuelas, Josep/0000-0002-7215-0150; Fu, Yongshuo/0000-0002-9761-5292; PENG, Shushi/0000-0001-5098-726X; Peaucelle, Marc/0000-0003-0324-4628; Huang, Mengtian/0000-0002-1092-1562	National Natural Science Foundation of China [41125004, 31321061]; 111 Project [B14001]; National Youth Top-notch Talent Support Program in China; FWO Pegasus Marie Curie Fellowship; European Research Council through Synergy grant [ERC-2013-SyG-610028]; ERC [282250]; University of Antwerp Centre of Excellence "GCE"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); National Youth Top-notch Talent Support Program in China; FWO Pegasus Marie Curie Fellowship; European Research Council through Synergy grant; ERC(European Research Council (ERC)European Commission); University of Antwerp Centre of Excellence "GCE"	This study was supported by the National Natural Science Foundation of China (41125004 and 31321061), the 111 Project (B14001), and National Youth Top-notch Talent Support Program in China. Y.H.F. is supported by an FWO Pegasus Marie Curie Fellowship. I.A.J., P.C. and J.P. acknowledge support from the European Research Council through Synergy grant ERC-2013-SyG-610028 "IMBALANCE-P" and A.M. acknowledges support through the (FP7/2007-2013)/ERC grant 282250 "E3-Extreme Event Ecology". I.A.J. acknowledges support from the University of Antwerp Centre of Excellence "GCE". The authors acknowledge all members of the PEP725 project for providing the phenological data.	Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Basler D, 2012, AGR FOREST METEOROL, V165, P73, DOI 10.1016/j.agrformet.2012.06.001; Beer C, 2014, J CLIMATE, V27, P4815, DOI 10.1175/JCLI-D-13-00543.1; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Coville FV, 1920, P NATL ACAD SCI USA, V6, P434, DOI 10.1073/pnas.6.7.434; Field C. B., 2014, IMPACTS ADAPTATION A; Fu YSH, 2014, GLOBAL ECOL BIOGEOGR, V23, P1255, DOI 10.1111/geb.12210; Fu YSH, 2013, AGR FOREST METEOROL, V181, P125, DOI 10.1016/j.agrformet.2013.07.016; Fu YSH, 2014, P NATL ACAD SCI USA, V111, P7355, DOI 10.1073/pnas.1321727111; Harrington CA, 2010, FOREST ECOL MANAG, V259, P798, DOI 10.1016/j.foreco.2009.06.018; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Kimball JS, 2004, REMOTE SENS ENVIRON, V90, P243, DOI 10.1016/j.rse.2004.01.002; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Laube J, 2014, GLOBAL CHANGE BIOL, V20, P170, DOI 10.1111/gcb.12360; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Piao SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7911; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Vitasse Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00541; Vitasse Y, 2013, NEW PHYTOL, V198, P149, DOI 10.1111/nph.12130; Wang T, 2014, GLOBAL CHANGE BIOL, V20, P1473, DOI 10.1111/gcb.12509; Way DA, 2015, PLANT CELL ENVIRON, V38, P1725, DOI 10.1111/pce.12431; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zohner CM, 2014, ECOL LETT, V17, P1016, DOI 10.1111/ele.12308	31	465	505	72	761	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					104	+		10.1038/nature15402	http://dx.doi.org/10.1038/nature15402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416746	Green Submitted, Green Accepted			2022-12-28	WOS:000362095100042
J	Lakdawala, SS; Jayaraman, A; Halpin, RA; Lamirande, EW; Shih, AR; Stockwell, TB; Lin, XD; Simenauer, A; Hanson, CT; Vogel, L; Paskel, M; Minai, M; Moore, I; Orandle, M; Das, SR; Wentworth, DE; Sasisekharan, R; Subbarao, K				Lakdawala, Seema S.; Jayaraman, Akila; Halpin, Rebecca A.; Lamirande, Elaine W.; Shih, Angela R.; Stockwell, Timothy B.; Lin, Xudong; Simenauer, Ari; Hanson, Christopher T.; Vogel, Leatrice; Paskel, Myeisha; Minai, Mahnaz; Moore, Ian; Orandle, Marlene; Das, Suman R.; Wentworth, David E.; Sasisekharan, Ram; Subbarao, Kanta			The soft palate is an important site of adaptation for transmissible influenza viruses	NATURE			English	Article							HUMAN RESPIRATORY-TRACT; AIRBORNE TRANSMISSION; RECEPTOR SPECIFICITY; A/H5N1 VIRUS; IN-VITRO; A VIRUS; FERRETS; H1N1; HEMAGGLUTININ; PATHOGENESIS	Influenza A viruses pose a major public health threat by causing seasonal epidemics and sporadic pandemics. Their epidemiological success relies on airborne transmission from person to person; however, the viral properties governing airborne transmission of influenza A viruses are complex. Influenza A virus infection is mediated via binding of the viral haemagglutinin (HA) to terminally attached alpha 2,3 or alpha 2,6 sialic acids on cell surface glycoproteins. Human influenza A viruses preferentially bind alpha 2,6-linked sialic acids whereas avian influenza A viruses bind alpha 2,3-linked sialic acids on complex glycans on airway epithelial cells(1,2). Historically, influenza A viruses with preferential association with alpha 2,3-linked sialic acids have not been transmitted efficiently by the airborne route in ferrets(3,4). Here we observe efficient airborne transmission of a 2009 pandemic H1N1 (H1N1pdm) virus (A/California/07/2009) engineered to preferentially bind alpha 2,3-linked sialic acids. Airborne transmission was associated with rapid selection of virus with a change at a single HA site that conferred binding to long-chain alpha 2,6-linked sialic acids, without loss of alpha 2,3-linked sialic acid binding. The transmissible virus emerged in experimentally infected ferrets within 24 hours after infection and was remarkably enriched in the soft palate, where long-chain alpha 2,6-linked sialic acids predominate on the nasopharyngeal surface. Notably, presence of long-chain alpha 2,6-linked sialic acids is conserved in ferret, pig and human soft palate. Using a loss-of-function approach with this one virus, we demonstrate that the ferret soft palate, a tissue not normally sampled in animal models of influenza, rapidly selects for transmissible influenza A viruses with human receptor (alpha 2,6-linked sialic acids) preference.	[Lakdawala, Seema S.; Lamirande, Elaine W.; Shih, Angela R.; Hanson, Christopher T.; Vogel, Leatrice; Paskel, Myeisha; Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Jayaraman, Akila; Sasisekharan, Ram] MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, Singapore MIT Alliance Res & Technol, Cambridge, MA 02139 USA; [Halpin, Rebecca A.; Stockwell, Timothy B.; Lin, Xudong; Simenauer, Ari; Das, Suman R.; Wentworth, David E.] J Craig Venter Inst, Rockville, MD 20850 USA; [Minai, Mahnaz; Moore, Ian; Orandle, Marlene] NIAID, Comparat Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sasisekharan, R (corresponding author), MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, Singapore MIT Alliance Res & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu; ksubbarao@niaid.nih.gov	Das, Suman/ABB-7273-2020; Lakdawala, Seema/AAO-2217-2020; Shih, Angela R/AAQ-7578-2020	Das, Suman/0000-0003-2496-9724; Lakdawala, Seema/0000-0002-7679-2150; Shih, Angela R/0000-0002-8945-5997; Subbarao, Kanta/0000-0003-1713-3056; Wentworth, David/0000-0002-5190-980X; Stockwell, Timothy/0000-0002-3595-4539	Intramural Research Program of NIAID, NIH; NIAID, NIH, DHHS [HHSN272200900007C]; NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program [U19-AI-110819]; NIH Merit Award [R37 GM057073-13]; National Research Foundation supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore MIT alliance for Research and Technology); Skolkovo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001047, U19AI110819, ZIAAI001109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program; NIH Merit Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore MIT alliance for Research and Technology); Skolkovo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Intramural Research Program of NIAID, NIH and with federal funds from NIAID, NIH, DHHS under contract number HHSN272200900007C and NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program (U19-AI-110819). This manuscript was reviewed by the NIH's Intramural Research Program's Committee on Dual Use Research of Concern (DURC), who concluded that the methods and results do not meet DURC criteria. We thank the NIAID Comparative Medical Branch for technical assistance, Subbarao laboratory members for critical input, N. B. Fedorova from JCVI for technical help, X. J. Meng (Virginia Tech College of Veterinary Medicine) and P. Pineyro (Iowa State University) for pig soft palate tissues, and the Consortium for Functional Glycomics for providing glycans for the glycan array analysis. The data for this manuscript and its preparation were generated while D.E.W. was employed at JCVI. The opinions expressed in this article are the authors' own and do not reflect the views of the Centers for Disease Control, the Department of Health and Human Services, or the United States government. A. J. and R.S. are supported in part by NIH Merit Award (R37 GM057073-13), National Research Foundation supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore MIT alliance for Research and Technology) and the Skolkovo Foundation supported Infectious Diseases Center at MIT.	Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Chan RWY, 2013, VIRUS RES, V178, P133, DOI 10.1016/j.virusres.2013.03.003; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Lakdawala SS, 2013, VIROLOGY, V446, P349, DOI 10.1016/j.virol.2013.08.011; Lakdawala SS, 2012, NAT MED, V18, P1468, DOI 10.1038/nm.2953; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Pappas C, 2015, VIROLOGY, V477, P61, DOI 10.1016/j.virol.2015.01.002; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Sutton TC, 2014, J VIROL, V88, P6623, DOI 10.1128/JVI.02765-13; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12	30	102	102	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2015	526	7571					122	+		10.1038/nature15379	http://dx.doi.org/10.1038/nature15379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5CY	26416728	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000362095100046
J	Grayson, M				Grayson, Michelle			Cannabis	NATURE			English	Editorial Material																			0	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S1	S1		10.1038/525S1a	http://dx.doi.org/10.1038/525S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26398730	Bronze			2022-12-28	WOS:000361599900001
J	Perez-Belmonte, LM; Gomez-Moyano, E				Perez-Belmonte, Luis M.; Gomez-Moyano, Elisabeth			Osler-Weber-Rendu Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Perez-Belmonte, Luis M.] Hosp Univ Virgen de la Victoria, Malaga, Spain; [Gomez-Moyano, Elisabeth] Hosp Reg Univ Malaga, Malaga, Spain	Hospital Virgen de la Victoria; Universidad de Malaga	Perez-Belmonte, LM (corresponding author), Hosp Univ Virgen de la Victoria, Malaga, Spain.	luismiguelpb@hotmail.com	MOYANO, ELISABETH GOMEZ/T-3752-2019	GOMEZ MOYANO, ELISABETH/0000-0002-2428-4867					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13							e15	10.1056/NEJMicm1414035	http://dx.doi.org/10.1056/NEJMicm1414035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26398095				2022-12-28	WOS:000361635200011
J	Rodriguez, JA; Ivanova, MI; Sawaya, MR; Cascio, D; Reyes, FE; Shi, D; Sangwan, S; Guenther, EL; Johnson, LM; Zhang, M; Jiang, L; Arbing, MA; Nannenga, BL; Hattne, J; Whitelegge, J; Brewster, AS; Messerschmidt, M; Boutet, B; Sauter, NK; Gonen, T; Eisenberg, DS				Rodriguez, Jose A.; Ivanova, Magdalena I.; Sawaya, Michael R.; Cascio, Duilio; Reyes, Francis E.; Shi, Dan; Sangwan, Smriti; Guenther, Elizabeth L.; Johnson, Lisa M.; Zhang, Meng; Jiang, Lin; Arbing, Mark A.; Nannenga, Brent L.; Hattne, Johan; Whitelegge, Julian; Brewster, Aaron S.; Messerschmidt, Marc; Boutet, Bastien; Sauter, Nicholas K.; Gonen, Tamir; Eisenberg, David S.			Structure of the toxic core of alpha-synuclein from invisible crystals	NATURE			English	Article							AMYLOID-LIKE FIBRILS; PARKINSONS-DISEASE; X-RAY; MACROMOLECULAR STRUCTURES; MAXIMUM-LIKELIHOOD; IN-VIVO; PROTEIN; BETA; MUTATION; REFINEMENT	The protein alpha-synuclein is the main component of Lewy bodies, the neuron-associated aggregates seen in Parkinson disease and other neurodegenerative pathologies. An 11-residue segment, which we term NACore, appears to be responsible for amyloid formation and cytotoxicity of human alpha-synuclein. Here we describe crystals of NACore that have dimensions smaller than the wavelength of visible light and thus are invisible by optical microscopy. As the crystals are thousands of times too small for structure determination by synchrotron X-ray diffraction, we use micro-electron diffraction to determine the structure at atomic resolution. The 1.4 angstrom resolution structure demonstrates that this method can determine previously unknown protein structures and here yields, to our knowledge, the highest resolution achieved by any cryo-electron microscopy method to date. The structure exhibits protofibrils built of pairs of face-to-face b-sheets. X-ray fibre diffraction patterns show the similarity of NACore to toxic fibrils of full-length alpha-synuclein. The NACore structure, together with that of a second segment, inspires a model for most of the ordered portion of the toxic, full-length alpha-synuclein fibril, presenting opportunities for the design of inhibitors of alpha-synuclein fibrils.	[Rodriguez, Jose A.; Ivanova, Magdalena I.; Sawaya, Michael R.; Cascio, Duilio; Sangwan, Smriti; Guenther, Elizabeth L.; Johnson, Lisa M.; Zhang, Meng; Jiang, Lin; Arbing, Mark A.; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Dept Chem,Dept Biochem,UCLA DOE Inst, Los Angeles, CA 90095 USA; [Reyes, Francis E.; Shi, Dan; Nannenga, Brent L.; Hattne, Johan; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Whitelegge, Julian] Univ Calif Los Angeles, NPI Semel Inst, Los Angeles, CA 90024 USA; [Brewster, Aaron S.; Sauter, Nicholas K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Messerschmidt, Marc; Boutet, Bastien] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Dept Chem,Dept Biochem,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA.	gonent@janelia.hhmi.org; david@mbi.ucla.edu	Messerschmidt, Marc/F-3796-2010; Sauter, Nicholas K/K-3430-2012; Messerschmidt, Marc/Y-8929-2019	Messerschmidt, Marc/0000-0002-8641-3302; Messerschmidt, Marc/0000-0002-8641-3302; Hattne, Johan/0000-0002-8936-0912; Sawaya, Michael/0000-0003-0874-9043; sangwan, smriti/0000-0003-3772-7142; Nannenga, Brent/0000-0001-6859-3429	National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NIH [GM095887, GM102520]; Office of Science, Department of Energy (DOE) [DE-AC02-05CH11231]; US Department of Energy Office of Science, Office of Biological and Environmental Research program [DE-FC02-02ER63421]; National Science Foundation [MCB-0958111]; National Institutes of Health [1R01-AG029430]; Alzheimer's Disease Research (ADRC) at UCLA [NIH-AG016570]; HHMI; Giannini Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM095887, R01GM102520, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG029430] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Department of Energy (DOE)(United States Department of Energy (DOE)); US Department of Energy Office of Science, Office of Biological and Environmental Research program(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Research (ADRC) at UCLA; HHMI(Howard Hughes Medical Institute); Giannini Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Liu for supplying PC12 cells; APS staff for beam line help solving SubNACore: M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov and F. Murphy at NECAT beam lines 24-ID at APS funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403) and the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank the LCLS injection staff support: S. Botha, R. Shoeman and I. Schlichting. A.S.B. and N.K.S. were supported by NIH grants GM095887 and GM102520 and by the Director, Office of Science, Department of Energy (DOE) under contract DE-AC02-05CH11231 for data-processing methods. This work was supported by the US Department of Energy Office of Science, Office of Biological and Environmental Research program under award number DE-FC02-02ER63421. We also acknowledge the award MCB-0958111 from the National Science Foundation, award 1R01-AG029430 from the National Institutes of Health, award NIH-AG016570 from Alzheimer's Disease Research (ADRC) at UCLA, and HHMI for support. J.A.R. was supported by the Giannini Foundation.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arvai A., 2015, ADXV PROGRAM DISPLAY; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bodles AM, 2001, J NEUROCHEM, V78, P384, DOI 10.1046/j.1471-4159.2001.00408.x; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Danzer KM, 2007, J NEUROCHEM, V103, P2401, DOI 10.1111/j.1471-4159.2007.04933.x; DeLano W.L., PYMOL MOL GRAPHICS S; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; DOYLE PA, 1968, ACTA CRYSTALL A-CRYS, VA 24, P390, DOI 10.1107/S0567739468000756; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hattne J, 2014, NAT METHODS, V11, P545, DOI [10.1038/NMETH.2887, 10.1038/nmeth.2887]; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nannenga BL, 2014, ELIFE, V3, DOI 10.7554/eLife.03600; Nannenga BL, 2014, CURR OPIN STRUC BIOL, V27, P24, DOI 10.1016/j.sbi.2014.03.004; Nannenga BL, 2014, NAT METHODS, V11, P927, DOI [10.1038/nmeth.3043, 10.1038/NMETH.3043]; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sarafian TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063557; Sauter NK, 2013, ACTA CRYSTALLOGR D, V69, P1274, DOI 10.1107/S0907444913000863; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shi D, 2013, ELIFE, V2, DOI 10.7554/eLife.01345; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Yonekura K, 2015, P NATL ACAD SCI USA, V112, P3368, DOI 10.1073/pnas.1500724112; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	60	382	388	2	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					486	+		10.1038/nature15368	http://dx.doi.org/10.1038/nature15368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26352473	Green Submitted, Green Accepted			2022-12-28	WOS:000361599900043
J	Wallace, DC				Wallace, Douglas C.			Mitochondrial DNA Variation in Human Radiation and Disease	CELL			English	Review							HEREDITARY OPTIC NEUROPATHY; BASAL METABOLIC-RATE; ADAPTIVE SELECTION; COMPLEX-I; HUMAN MTDNA; HAPLOGROUPS; GENOME; HETEROPLASMY; POPULATIONS; MUTATIONS	Environmental adaptation, predisposition to common diseases, and, potentially, speciation may all be linked through the adaptive potential of mitochondrial DNA (mtDNA) alterations of bioenergetics. This Perspective synthesizes evidence that human mtDNA variants may be adaptive or deleterious depending on environmental context and proposes that the accrual of mtDNA variation could contribute to animal speciation via adaptation to marginal environments.	[Wallace, Douglas C.] Univ Penn, Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Wallace, DC (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.	wallaced1@email.chop.edu			NATIONAL CANCER INSTITUTE [R33CA182384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NCI NIH HHS [R33CA182384, R33 CA182384] Funding Source: Medline; NINDS NIH HHS [R01NS021328, R01 NS021328] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balloux F, 2009, P ROY SOC B-BIOL SCI, V276, P3447, DOI 10.1098/rspb.2009.0752; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Gershoni M, 2014, GENOME BIOL EVOL, V6, P2665, DOI 10.1093/gbe/evu208; Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029; Gomez-Duran A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kenney MC, 2014, HUM MOL GENET, V23, P3537, DOI 10.1093/hmg/ddu065; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Leonard WR, 2002, AM J HUM BIOL, V14, P609, DOI 10.1002/ajhb.10072; LINDAHL KF, 1991, ANNU REV IMMUNOL, V9, P351, DOI 10.1146/annurev.iy.09.040191.002031; Malik D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099003; Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; MITOMAP, 2015, HUM MIT GEN DAT; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Snodgrass JJ, 2008, AM J PHYS ANTHROPOL, V137, P145, DOI 10.1002/ajpa.20851; Snodgrass JJ, 2005, AM J HUM BIOL, V17, P155, DOI 10.1002/ajhb.20106; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2013, EMERY RIMOINS PRINCI; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Zhu CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004354	49	138	146	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 24	2015	163	1					33	38		10.1016/j.cell.2015.08.067	http://dx.doi.org/10.1016/j.cell.2015.08.067			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CS1RX	26406369	Green Accepted, Bronze			2022-12-28	WOS:000361846500019
J	Karkas, MD; Matsuura, BS; Stephenson, CRJ				Kaerkaes, Markus D.; Matsuura, Bryan S.; Stephenson, Corey R. J.			Enchained by visible light-mediated photoredox catalysis	SCIENCE			English	Editorial Material							CYCLOADDITIONS; PHOTOCATALYSIS; COMPLEXES		[Kaerkaes, Markus D.; Matsuura, Bryan S.; Stephenson, Corey R. J.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Karkas, MD (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	crjsteph@umich.edu	Kärkäs, Markus D./A-5900-2019; Stephenson, Corey/Y-3069-2019; Stephenson, Corey/G-1457-2016	Kärkäs, Markus D./0000-0002-6089-5454; Stephenson, Corey/0000-0002-2443-5514; Stephenson, Corey/0000-0002-2443-5514				BURNETT GM, 1954, CHEM REV, V54, P225, DOI 10.1021/cr60168a002; Chatgilialoglu C., 2012, ENCY RADICALS CHEM B; Cismesia MA, 2015, CHEM SCI, V6, P5426, DOI 10.1039/c5sc02185e; Devery JJ, 2015, CHEM SCI, V6, P537, DOI 10.1039/c4sc03064h; Douglas JJ, 2014, ALDRICHIM ACTA, V47, P15; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Ismaili H, 2013, CATAL SCI TECHNOL, V3, P935, DOI 10.1039/c3cy20759e; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; Lin SS, 2011, J AM CHEM SOC, V133, P19350, DOI 10.1021/ja2093579; Majek M, 2014, BEILSTEIN J ORG CHEM, V10, P981, DOI 10.3762/bjoc.10.97; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Romero NA, 2014, J AM CHEM SOC, V136, P17024, DOI 10.1021/ja506228u; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176	14	77	77	6	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1285	1286		10.1126/science.aad0193	http://dx.doi.org/10.1126/science.aad0193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383937				2022-12-28	WOS:000361357700022
J	Zanet, J; Benrabah, E; Li, T; Pelissier-Monier, A; Chanut-Delalande, H; Ronsin, B; Bellen, HJ; Payre, F; Plaza, S				Zanet, J.; Benrabah, E.; Li, T.; Pelissier-Monier, A.; Chanut-Delalande, H.; Ronsin, B.; Bellen, H. J.; Payre, F.; Plaza, S.			Pri sORF peptides induce selective proteasome-mediated protein processing	SCIENCE			English	Article							OPEN READING FRAMES; POLYCISTRONIC MESSENGER-RNA; UBIQUITIN LIGASE; DROSOPHILA; UBR3; MORPHOGENESIS; TRANSLATION; TRANSCRIPTS; SHAVENBABY; GENES	A wide variety of RNAs encode small open-reading-frame (smORF/sORF) peptides, but their functions are largely unknown. Here, we show that Drosophila polished-rice (pri) sORF peptides trigger proteasome-mediated protein processing, converting the Shavenbaby (Svb) transcription repressor into a shorter activator. A genome-wide RNA interference screen identifies an E2-E3 ubiquitin-conjugating complex, UbcD6-Ubr3, which targets Svb to the proteasome in a pri-dependent manner. Upon interaction with Ubr3, Pri peptides promote the binding of Ubr3 to Svb. Ubr3 can then ubiquitinate the Svb N terminus, which is degraded by the proteasome. The C-terminal domains protect Svb from complete degradation and ensure appropriate processing. Our data show that Pri peptides control selectivity of Ubr3 binding, which suggests that the family of sORF peptides may contain an extended repertoire of protein regulators.	[Zanet, J.; Benrabah, E.; Pelissier-Monier, A.; Chanut-Delalande, H.; Ronsin, B.; Payre, F.; Plaza, S.] Univ Toulouse 3, Ctr Biol Dev, F-31062 Toulouse, France; [Zanet, J.; Benrabah, E.; Pelissier-Monier, A.; Chanut-Delalande, H.; Ronsin, B.; Payre, F.; Plaza, S.] CNRS, UMR5547, Ctr Biol Dev, F-31062 Toulouse, France; [Li, T.; Bellen, H. J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Bellen, H. J.] Baylor Coll Med, Howard Hughes Med Inst, Neurol Res Inst, Dept Mol & Human Genet, Houston, TX 77030 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Payre, F (corresponding author), Univ Toulouse 3, Ctr Biol Dev, Batiment 4R3,118 Route Narbonne, F-31062 Toulouse, France.	francois.payre@univ-tlse3.fr; serge.plaza@univ-tlse3.f	plaza, serge/F-5290-2015	Bellen, Hugo/0000-0001-5992-5989; PAYRE, Francois/0000-0002-8144-6711; CHANUT-DELALANDE, Helene/0000-0002-1720-2069	Agence Nationale de la Recherche (smORFpep); Agence Nationale de la Recherche (ChronoNet); Association pour la Recherche sur le Cancer; Fondation Recherche et Innovation Therapeutique en Cancerologie; Howard Hughes Medical Institute	Agence Nationale de la Recherche (smORFpep)(French National Research Agency (ANR)); Agence Nationale de la Recherche (ChronoNet)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Recherche et Innovation Therapeutique en Cancerologie; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank N. Perrimon, S. Mohr, O. Coux, P. Meier, N. Tapon, P. Demange, L. Twyffels, the Drosophila Screening Center, C. Polesello, M. Soulard, Y. Latapie, and P. Valenti for invaluable support. This work was supported by Agence Nationale de la Recherche (smORFpep and ChronoNet), Association pour la Recherche sur le Cancer, Fondation Recherche et Innovation Therapeutique en Cancerologie, and Howard Hughes Medical Institute. The authors declare no conflict of interest.	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Chanut-Delalande H, 2014, NAT CELL BIOL, V16, P1035, DOI 10.1038/ncb3052; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Hanada K, 2013, P NATL ACAD SCI USA, V110, P2395, DOI 10.1073/pnas.1213958110; Huang Q, 2014, CELL DEATH DIFFER, V21, P1961, DOI 10.1038/cdd.2014.115; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lauressergues D, 2015, NATURE, V520, P90, DOI 10.1038/nature14346; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Meisenberg C, 2012, NUCLEIC ACIDS RES, V40, P701, DOI 10.1093/nar/gkr744; Menoret D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r86; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Slavoff SA, 2014, J BIOL CHEM, V289, P10950, DOI 10.1074/jbc.C113.533968; Smith JE, 2014, CELL REP, V7, P1858, DOI 10.1016/j.celrep.2014.05.023; Stern DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0028; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Vinayagam A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003629; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002	30	56	65	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1356	1358		10.1126/science.aac5677	http://dx.doi.org/10.1126/science.aac5677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26383956				2022-12-28	WOS:000361357700053
J	Slusher, TM; Olusanya, BO; Vreman, HJ; Brearley, AM; Vaucher, YE; Lund, TC; Wong, RJ; Emokpae, AA; Stevenson, DK				Slusher, Tina M.; Olusanya, Bolajoko O.; Vreman, Hendrik J.; Brearley, Ann M.; Vaucher, Yvonne E.; Lund, Troy C.; Wong, Ronald J.; Emokpae, Abieyuwa A.; Stevenson, David K.			A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; HYPERBILIRUBINEMIA; JAUNDICE; KERNICTERUS; IMPAIRMENT; MANAGEMENT; ETIOLOGY; OUTCOMES	BACKGROUND Sequelae of severe neonatal hyperbilirubinemia constitute a substantial disease burden in areas where effective conventional phototherapy is unavailable. We previously found that the use of filtered sunlight for the purpose of phototherapy is a safe and efficacious method for reducing total bilirubin. However, its relative safety and efficacy as compared with conventional phototherapy are unknown. METHODS We conducted a randomized, controlled noninferiority trial in which filtered sunlight was compared with conventional phototherapy for the treatment of hyperbilirubinemia in term and late-preterm neonates in a large, urban Nigerian maternity hospital. The primary end point was efficacy, which was defined as a rate of increase in total serum bilirubin of less than 0.2 mg per deciliter per hour for infants up to 72 hours of age or a decrease in total serum bilirubin for infants older than 72 hours of age who received at least 5 hours of phototherapy; we pre-specified a noninferiority margin of 10% for the difference in efficacy rates between groups. The need for an exchange transfusion was a secondary end point. We also assessed safety, which was defined as the absence of the need to withdraw therapy because of hyperthermia, hypothermia, dehydration, or sunburn. RESULTS We enrolled 447 infants and randomly assigned 224 to filtered sunlight and 223 to conventional phototherapy. Filtered sunlight was efficacious on 93% of treatment days that could be evaluated, as compared with 90% for conventional phototherapy, and had a higher mean level of irradiance (40 vs. 17 mu W per square centimeter per nanometer, P<0.001). Temperatures higher than 38.0 degrees C occurred in 5% of the infants receiving filtered sunlight and in 1% of those receiving conventional phototherapy (P<0.001), but no infant met the criteria for withdrawal from the study for reasons of safety or required an exchange transfusion. CONCLUSIONS Filtered sunlight was noninferior to conventional phototherapy for the treatment of neonatal hyperbilirubinemia and did not result in any study withdrawals for reasons of safety.	[Slusher, Tina M.; Lund, Troy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55414 USA; [Brearley, Ann M.] Univ Minnesota, Clin & Translat Sci Inst, Biostat Design & Anal Ctr, Minneapolis, MN 55414 USA; [Slusher, Tina M.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Emokpae, Abieyuwa A.] Massey St Childrens Hosp, Lagos, Nigeria; [Vreman, Hendrik J.; Wong, Ronald J.; Stevenson, David K.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Vaucher, Yvonne E.] Univ Calif San Diego, San Diego, CA 92103 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; Stanford University; University of California System; University of California San Diego	Slusher, TM (corresponding author), Univ Minnesota, Dept Pediat, Ctr Global Pediat, 717 Delaware St SE,3rd Fl, Minneapolis, MN 55414 USA.	tslusher@umn.edu	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583	Thrasher Research Fund, Salt Lake City; National Center for Advancing Translational Sciences of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	Thrasher Research Fund, Salt Lake City; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the Thrasher Research Fund, Salt Lake City, and the National Center for Advancing Translational Sciences of the National Institutes of Health; Clinical Trials.gov number, NCT01434810.	BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; Bhutani VK, 2011, PEDIATRICS, V128, pE1046, DOI 10.1542/peds.2011-1494; Burke BL, 2009, PEDIATRICS, V123, P524, DOI 10.1542/peds.2007-2915; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Cline BK, 2013, J TROP PEDIATRICS, V59, P321, DOI 10.1093/tropej/fmt027; CREMER RJ, 1958, LANCET, V1, P1094; Gladstone M, 2010, ANN TROP PAEDIATR, V30, P181, DOI 10.1179/146532810X12786388978481; Hansen TWR, 1997, ACTA PAEDIATR, V86, P843; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison S, 2013, J TROP PEDIATRICS, V59, P403, DOI 10.1093/tropej/fmt042; JAHRIG K, 1982, ACTA PAEDIATR SCAND, V71, P293, DOI 10.1111/j.1651-2227.1982.tb09417.x; Johnson L, 2009, J PERINATOL, V29, pS25, DOI 10.1038/jp.2008.211; Kuzniewicz MW, 2014, PEDIATRICS, V134, P504, DOI 10.1542/peds.2014-0987; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Maisels MJ, 2008, NEW ENGL J MED, V358, P920, DOI 10.1056/NEJMct0708376; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; McDonagh A F, 2001, J Perinatol, V21 Suppl 1, pS7, DOI 10.1038/sj.jp.7210625; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Okperi BO, 2013, INT J MED BIOMED RES, V2, P226; Olusanya BO, 2015, SEMIN FETAL NEONAT M, V20, P58, DOI 10.1016/j.siny.2014.12.009; Olusanya BO, 2014, ACTA PAEDIATR, V103, P1102, DOI 10.1111/apa.12735; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Olusanya BO, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-180; Owa JA, 2011, INDIAN J PEDIATR, V78, P996, DOI 10.1007/s12098-011-0382-4; Pejaver Ranjan Kumar, 2000, Indian Journal of Pediatrics, V67, P883, DOI 10.1007/BF02723951; Petrova Anna, 2006, BMC Pediatr, V6, P6, DOI 10.1186/1471-2431-6-6; Salih FM, 2001, PHOTODERMATOL PHOTO, V17, P272, DOI 10.1034/j.1600-0781.2001.170605.x; Satrom K, 2014, J TROP PEDIATRICS, V60, P264, DOI [10.1093/tropej/fmt110, 10.1093/t]; Scrafford CG, 2013, TROP MED INT HEALTH, V18, P1317, DOI 10.1111/tmi.12189; Slusher T, 2012, TXB GOBAL CHILD HLTH; Slusher TM, 2014, PEDIATRICS, V133, pE1568, DOI 10.1542/peds.2013-3500; Slusher TM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-446; Strauss KA, 2006, EUR J PEDIATR, V165, P306, DOI 10.1007/s00431-005-0055-2; Tomashek KM, 2006, PAEDIATR PERINAT EP, V20, P24, DOI 10.1111/j.1365-3016.2006.00690.x; Vreman HJ, 2013, J TROP PEDIATRICS, V59, P496, DOI 10.1093/tropej/fmt062	38	45	45	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1115	1124		10.1056/NEJMoa1501074	http://dx.doi.org/10.1056/NEJMoa1501074			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR7UG	26376136				2022-12-28	WOS:000361556400007
J	Schweitzer, J				Schweitzer, Julian		Expert Consultative Grp Every	Accountability in the 2015 Global Strategy for Women's, Children's and Adolescents' Health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schweitzer, Julian; Expert Consultative Grp Every] Results Dev Inst, Washington, DC 20005 USA		Schweitzer, J (corresponding author), Results Dev Inst, 1100 15th St, Washington, DC 20005 USA.	jschweitzer@resultsfordevelopment.org						[Anonymous], 2014, MUT ACC; [Anonymous], 2014, GLOB FIN FAC SUPP EV; [Anonymous], 2015, COUNTR ACC FRAM CAF; [Anonymous], 2011, KEEP PROM MEAS RES; [Anonymous], 2015, UPDATING GLOBAL STRA; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Center for Reproductive Rights, 2011, ROL HUM RIGHTS BAS A; CoIA, 2014, ACC WOM CHILDR HLTH; Global Strategy for Women's Children's and Adolescents' Health, 2015, GLOBAL STRATEGY WOME; Godwin P, EVERY WOMEN EVERY CH; iERG, 2014, EV WOM EV CHILD POST; Kuruvilla Shyama, 2014, Bull World Health Organ, V92, P533, DOI 10.2471/BLT.14.138131; Kuruvilla S, 2012, HUM RIGHTS QUART, V34, P141, DOI 10.1353/hrq.2012.0010; Malena M, 2004, WORLD BANK SOCIAL DE; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; UN Secretary General, 2010, FULL DOC GLOB STRAT; UN (United Nations) & WHO (World Health Organization), 2008, RIGHT HLTH; UNAIDS, 32 M REP; WHO, 2012, EV WOM EV CHILD COMM; World Bank, GLOB FIN FAC SUPP EV	20	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4248	10.1136/bmj.h4248	http://dx.doi.org/10.1136/bmj.h4248			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371221	hybrid			2022-12-28	WOS:000361678200009
J	Amigorena, S				Amigorena, Sebastian			Helping the Help for CD8+T Cell Responses	CELL			English	Editorial Material							DENDRITIC CELL; T-LYMPHOCYTES; MEMORY	Eickhoff et al. and Hor et al. use time-lapse intravital microscopy to show an unexpected choreography of CD4+ and CD8+ T cells "`dancing'' between different dendritic cell sub-populations during priming of cytotoxic immune responses to viruses.	Inst Curie, INSERM, U932, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Amigorena, S (corresponding author), Inst Curie, INSERM, U932, 26 Rue Ulm, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr		Amigorena, Sebastian/0000-0001-8583-8416				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305	7	4	4	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1210	1212		10.1016/j.cell.2015.08.051	http://dx.doi.org/10.1016/j.cell.2015.08.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359981	Bronze			2022-12-28	WOS:000361247900010
J	Goldstein, JL				Goldstein, Joseph L.			A Well-Hung Horse: Sired by Knowledge and Imagination	CELL			English	Editorial Material								For more than a century, historians of science have been spinning a philosophical roulette wheel, pondering which is more important in the creative process: imagination or knowledge. The most original scientists (and artists) in our day discover newness by blending existing knowledge with imaginative thinking.	Lasker Awards, Boston, MA USA		Goldstein, JL (corresponding author), Lasker Awards, Boston, MA USA.	joe.goldstein@utsouthwestern.edu						Hood J, 2005, TRAFALGAR SQUARE; Hughes R, 1984, TIME; London Gov UK, 2015, GIFT HORS 4 PLINTH; Longmuir E, 1997, NATL GALLERY COMPANI; McCunn J.C., 1976, ANATOMY HORSE G STUB; Rott H.W., 2012, G STUBBS SCI ART; Springer G.F., 1967, JH VANTHOFFS 1878 IM, VSpringer-Verlag; Viereck G.S., 1929, SATURDAY EVENIN 1026; Warner M., 2004, STUBBS THE HORSE	9	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1179	1182		10.1016/j.cell.2015.08.039	http://dx.doi.org/10.1016/j.cell.2015.08.039			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359973	Bronze			2022-12-28	WOS:000361247900002
J	Tay, S				Tay, Savas			Single-Cell Analysis: The Differences That Kill	CELL			English	Editorial Material							TRANSMISSION; VARIABILITY; DYNAMICS	Using single-cell RNA sequencing, Avraham et al. investigate how variability in macrophage response to infection is controlled by variability within the pathogen population. They find that heterogeneous expression of the Salmonella virulence factor PhoP and subsequent cell- wall modifications lead to the bimodal induction of the interferon-response in infected macrophages.	[Tay, Savas] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Tay, Savas] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Chicago	Tay, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	tays@uchicago.edu						Avraham R, 2015, CELL, V162, P1309, DOI 10.1016/j.cell.2015.08.027; Frank T, 2015, LAB CHIP, V15, P2192, DOI 10.1039/c5lc00182j; Kellogg RA, 2015, CELL, V160, P381, DOI 10.1016/j.cell.2015.01.013; Kellogg RA, 2014, NAT PROTOC, V9, P1713, DOI 10.1038/nprot.2014.120; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002	10	3	4	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1208	1210		10.1016/j.cell.2015.08.053	http://dx.doi.org/10.1016/j.cell.2015.08.053			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26359980	Bronze			2022-12-28	WOS:000361247900009
J	Marmot, M				Marmot, Michael			The health gap: the challenge of an unequal world	LANCET			English	Editorial Material									[Marmot, Michael] UCL Inst Hlth Equ, UCL Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London	Marmot, M (corresponding author), UCL Inst Hlth Equ, UCL Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0701830, G0902037, G0601647, G1000616] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G1000616, G0601647, G0902037, G0701830, G0100222, G19/35] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Dickens WT, 2001, PSYCHOL REV, V108, P346, DOI 10.1037/0033-295X.108.2.346; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Kelly Y, 2011, ARCH DIS CHILD, V96, P832, DOI 10.1136/adc.2010.195917; Marmot M, 2015, HLTH GAP CHALLENGE U; Marmot M, 2004, STATUS SYNDROME; Marmot M, 2010, FAIR SOC HLTH LIV ST; Pinker S., 2002, BLANK SLATE; Sen A, 1992, INEQUALITY RE EXAMIN; SINGLETON N, 1999, PSYCHIAT MORBIDITY P; UCL Institute of Health Equity, 2013, HLTH IN EU FIN REP C; Walsh D, 2010, PUBLIC HEALTH, V124, P487, DOI 10.1016/j.puhe.2010.02.006	12	269	272	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2442	2444		10.1016/S0140-6736(15)00150-6	http://dx.doi.org/10.1016/S0140-6736(15)00150-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26364261				2022-12-28	WOS:000366290400038
J	Shieh, YW; Minguez, P; Bork, P; Auburger, JJ; Guilbride, DL; Kramer, G; Bukau, B				Shieh, Yu-Wei; Minguez, Pablo; Bork, Peer; Auburger, Josef J.; Guilbride, D. Lys; Kramer, Guener; Bukau, Bernd			Operon structure and cotranslational subunit association direct protein assembly in bacteria	SCIENCE			English	Article							IN-VIVO	Assembly of protein complexes is considered a posttranslational process involving random collision of subunits. We show that within the Escherichia coli cytosol, bacterial luciferase subunits LuxA and LuxB assemble into complexes close to the site of subunit synthesis. Assembly efficiency decreases markedly if subunits are synthesized on separate messenger RNAs from genes integrated at distant chromosomal sites. Subunit assembly initiates cotranslationally on nascent LuxB in vivo. The ribosome-associated chaperone trigger factor delays the onset of cotranslational interactions until the LuxB dimer interface is fully exposed. Protein assembly is thus directly coupled to the translation process and involves spatially confined, actively chaperoned cotranslational subunit interactions. Bacterial gene organization into operons therefore reflects a fundamental cotranslational mechanism for spatial and temporal regulation that is vital to effective assembly of protein complexes.	[Shieh, Yu-Wei; Auburger, Josef J.; Guilbride, D. Lys; Kramer, Guener; Bukau, Bernd] Univ Heidelberg ZMBH, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Shieh, Yu-Wei; Auburger, Josef J.; Guilbride, D. Lys; Kramer, Guener; Bukau, Bernd] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Minguez, Pablo; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Guilbride, D. Lys] Malaria Res Fdn, Aspen, CO 81612 USA	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kramer, G (corresponding author), Univ Heidelberg ZMBH, Ctr Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	g.kramer@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	Bork, Peer/F-1813-2013; Miguez, Pablo/D-4822-2013	Bork, Peer/0000-0002-2627-833X; Miguez, Pablo/0000-0003-4099-9421; Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393	German Science Foundation [DFG SFB638, FOR1805]	German Science Foundation(German Research Foundation (DFG))	We thank A. Becker, V. van Noort, and C. Andreasson for valuable contributions; V. Sourjik and co-workers for help with in vivo FRET analysis; M. Langlotz and the fluorescence-activated cell sorting facility of the ZMBH for support; D. Ibberson for optimizing DNA sample preparation protocols; Y. Vainshtein for support with data analysis; and B. Zachmann-Brand for technical support. Sequencing was carried out at Genomics and Proteomics Core (DKFZ) and Genomics Core (EMBL) facilities. This work was supported by research grants from the German Science Foundation (DFG SFB638 and FOR1805) to G.K. and B.B.	Baldwin TO, 1995, CURR OPIN STRUC BIOL, V5, P798, DOI 10.1016/0959-440X(95)80014-X; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; MIYAMOTO CM, 1985, J BACTERIOL, V161, P995, DOI 10.1128/JB.161.3.995-1001.1985; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Pradhan P, 2009, J MOL BIOL, V385, P831, DOI 10.1016/j.jmb.2008.11.027	7	109	110	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					678	680		10.1126/science.aac8171	http://dx.doi.org/10.1126/science.aac8171			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26405228				2022-12-28	WOS:000364162800050
J	Teo, AED; Garg, S; Shaikh, LH; Zhou, J; Frankl, FEK; Gurnell, M; Happerfield, L; Marker, A; Bienz, M; Azizan, EAB; Brown, MJ				Teo, Ada E. D.; Garg, Sumedha; Shaikh, Lalarukh Haris; Zhou, Junhua; Frankl, Fiona E. Karet; Gurnell, Mark; Happerfield, Lisa; Marker, Alison; Bienz, Mariann; Azizan, Elena A. B.; Brown, Morris J.			Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CATENIN; ZONA GLOMERULOSA; HORMONE RECEPTOR; EXPRESSION; CELLS; ACTIVATION; PROFILES; ADENOMA	Recent discoveries of somatic mutations permit the recognition of subtypes of aldosterone-producing adenomas with distinct clinical presentations and pathological features. Here we describe three women with hyperaldosteronism, two who presented in pregnancy and one who presented after menopause. Their aldosterone-producing adenomas harbored activating mutations of CTNNB1, encoding beta-catenin in the Wnt cell-differentiation pathway, and expressed LHCGR and GNRHR, encoding gonadal receptors, at levels that were more than 100 times as high as the levels in other aldosterone-producing adenomas. The mutations stimulate Wnt activation and cause adrenocortical cells to de-differentiate toward their common adrenal-gonadal precursor cell type.	[Teo, Ada E. D.; Garg, Sumedha; Shaikh, Lalarukh Haris; Zhou, Junhua; Azizan, Elena A. B.; Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Ctr Clin Invest, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Frankl, Fiona E. Karet] Univ Cambridge, Dept Med Genet, Div Renal Med, Cambridge CB2 2QQ, England; [Gurnell, Mark] Univ Cambridge, Metab Res Labs, Wellcome Trust Med Res Council MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Happerfield, Lisa; Marker, Alison] Addenbrookes Hosp, Dept Pathol, Cambridge, England; [Bienz, Mariann] MRC Lab Mol Biol, Cambridge, England; [Azizan, Elena A. B.] Natl Univ Malaysia, Med Ctr, Dept Med, Kuala Lumpur, Malaysia	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Laboratory Molecular Biology; Universiti Kebangsaan Malaysia	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Ctr Clin Invest, Clin Pharmacol Unit, Box 110, Cambridge CB2 2QQ, England.	m.j.brown@cai.cam.ac.uk	Azizan, Elena AB/J-6245-2018; Zhou, Junhua/E-3528-2016	Azizan, Elena AB/0000-0002-5549-4242; Zhou, Junhua/0000-0002-8593-8393; Karet, Fiona/0000-0002-2457-2869; Teo, Ada/0000-0002-8832-0409	National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (Cardiovascular) [NF-SI-0512-10052]; Agency for Science, Technology and Research (AstarSTAR) Singapore; Wellcome Trust [085686/Z/08/A]; British Heart Foundation [FS/14/75/31134, FS/11/35/28871]; Cambridge Overseas Trust; NIHR Cambridge Biomedical Research Centre (Metabolic); Medical Research Council [U105192713]; Tunku Abdul Rahman Centenary Fund, Cambridge; Austin Doyle Award (Servier Australia); MRC [MC_U105184273, MC_U105192713] Funding Source: UKRI; British Heart Foundation [PG/07/085/23349, FS/14/12/30540, SP/08/002/24118] Funding Source: researchfish; Medical Research Council [MR/K501050/1, MC_U105184273, MC_U105192713] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10052] Funding Source: researchfish	National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (Cardiovascular)(National Institute for Health Research (NIHR)); Agency for Science, Technology and Research (AstarSTAR) Singapore(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Cambridge Overseas Trust; NIHR Cambridge Biomedical Research Centre (Metabolic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tunku Abdul Rahman Centenary Fund, Cambridge; Austin Doyle Award (Servier Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by grants from the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (Cardiovascular) (NF-SI-0512-10052, to Prof. Brown), the Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Singapore (to Ms. Teo), Wellcome Trust (085686/Z/08/A, to Ms. Teo), the British Heart Foundation (FS/14/75/31134, to Ms. Garg; and FS/11/35/28871, to Ms. Haris Shaikh), Cambridge Overseas Trust (to Dr. Zhou), NIHR Cambridge Biomedical Research Centre (Metabolic) (to Dr. Gurnell), and Medical Research Council (U105192713, to Dr. Bienz); the Tunku Abdul Rahman Centenary Fund, Cambridge (to Dr. Azizan); and the Austin Doyle Award (Servier Australia) (to Dr. Azizan).	Al-Ali NA, 2007, J OBSTET GYNAECOL, V27, P730, DOI 10.1080/01443610701667098; Albiger NM, 2011, EUR J ENDOCRINOL, V164, P405, DOI 10.1530/EJE-10-0879; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; Barlaskar FM, 2009, J CLIN ENDOCR METAB, V94, P204, DOI 10.1210/jc.2008-1456; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; CHAKRAVARTI S, 1976, BRIT MED J, V2, P784, DOI 10.1136/bmj.2.6039.784; Eguchi K, 2014, INTERNAL MED, V53, P2499, DOI 10.2169/internalmedicine.53.2762; El Ghorayeb N, 2015, EUR J ENDOCRINOL; Gummow BM, 2003, J BIOL CHEM, V278, P26572, DOI 10.1074/jbc.M212677200; Hatano O, 1996, GENES CELLS, V1, P663, DOI 10.1046/j.1365-2443.1996.00254.x; Kim AC, 2008, DEVELOPMENT, V135, P2593, DOI 10.1242/dev.021493; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Nakamura Y, 2014, MOL CELL ENDOCRINOL, V384, P102, DOI 10.1016/j.mce.2014.01.016; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Saner-Amigh K, 2006, J CLIN ENDOCR METAB, V91, P1136, DOI 10.1210/jc.2005-1298; Savard S, 2013, HYPERTENSION, V62, P331, DOI 10.1161/HYPERTENSIONAHA.113.01060; Shigematsu K, 2009, ENDOCR PATHOL, V20, P66, DOI 10.1007/s12022-009-9060-8; SILERKHODR TM, 1984, AM J OBSTET GYNECOL, V150, P376, DOI 10.1016/S0002-9378(84)80142-8; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Zhou JH, 2015, HYPERTENSION, V65, P1103, DOI 10.1161/HYP.0000000000000025	25	86	88	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1429	1436		10.1056/NEJMoa1504869	http://dx.doi.org/10.1056/NEJMoa1504869			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8XI	26397949	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000362372800009
J	Dou, LT; Wong, AB; Yu, Y; Lai, ML; Kornienko, N; Eaton, SW; Fu, A; Bischak, CG; Ma, J; Ding, TN; Ginsberg, NS; Wang, LW; Alivisatos, AP; Yang, PD				Dou, Letian; Wong, Andrew B.; Yu, Yi; Lai, Minliang; Kornienko, Nikolay; Eaton, Samuel W.; Fu, Anthony; Bischak, Connor G.; Ma, Jie; Ding, Tina; Ginsberg, Naomi S.; Wang, Lin-Wang; Alivisatos, A. Paul; Yang, Peidong			Atomically thin two-dimensional organic-inorganic hybrid perovskites	SCIENCE			English	Article							REDUCED BAND-GAP; TRANSITION; EMISSION; HYDROGEN; PHASE	Organic-inorganic hybrid perovskites, which have proved to be promising semiconductor materials for photovoltaic applications, have been made into atomically thin two-dimensional (2D) sheets. We report the solution-phase growth of single-and few-unit-cell-thick single-crystalline 2D hybrid perovskites of (C4H9NH3)(2)PbBr4 with well-defined square shape and large size. In contrast to other 2D materials, the hybrid perovskite sheets exhibit an unusual structural relaxation, and this structural change leads to a band gap shift as compared to the bulk crystal. The high-quality 2D crystals exhibit efficient photoluminescence, and color tuning could be achieved by changing sheet thickness as well as composition via the synthesis of related materials.	[Dou, Letian; Wong, Andrew B.; Yu, Yi; Lai, Minliang; Kornienko, Nikolay; Eaton, Samuel W.; Fu, Anthony; Bischak, Connor G.; Ma, Jie; Ding, Tina; Ginsberg, Naomi S.; Alivisatos, A. Paul; Yang, Peidong] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Dou, Letian; Wong, Andrew B.; Yu, Yi; Kornienko, Nikolay; Fu, Anthony; Ma, Jie; Ding, Tina; Ginsberg, Naomi S.; Wang, Lin-Wang; Alivisatos, A. Paul; Yang, Peidong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Yu, Yi] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China; [Ginsberg, Naomi S.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Ginsberg, Naomi S.; Alivisatos, A. Paul; Yang, Peidong] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Ginsberg, Naomi S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Alivisatos, A. Paul; Yang, Peidong] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; ShanghaiTech University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yang, PD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	p_yang@berkeley.edu	wang, lili/HDL-7210-2022; Dou, Letian/L-6031-2019; Zhang, Xun/HHM-9059-2022; wang, lin/GSE-3040-2022; Lai, Minliang/AGX-7294-2022; Wong, Andrew/AAW-3799-2020; Bischak, Connor/ABG-8968-2021; Alivisatos, Paul/N-8863-2015; wang, lin/HHM-2225-2022	Zhang, Xun/0000-0001-5411-2727; Bischak, Connor/0000-0002-3071-4069; Alivisatos, Paul/0000-0001-6895-9048; Kornienko, Nikolay/0000-0001-7193-2428; Yu, Yi/0000-0003-4326-5992; Wong, Andrew/0000-0002-0731-1931; Dou, Letian/0000-0001-6411-8591; Lai, Minliang/0000-0001-6918-378X; Eaton, Samuel Wilson/0000-0002-8671-9707	U.S. Department of Energy [DE-AC02-05CH11231 (PChem KC3103)]; NIH Shared Instrumentation Grant [S10-RR027172]; BES/SC, U.S. Department of Energy under Material Theory program [DE-AC02-05CH11231]; NSF Graduate Research Fellowship [DGE 1106400]; Camille and Henry Dreyfus Foundation [EP-14-151]; Suzhou Industrial Park; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BES/SC, U.S. Department of Energy under Material Theory program(United States Department of Energy (DOE)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Camille and Henry Dreyfus Foundation; Suzhou Industrial Park; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the U.S. Department of Energy under contract no. DE-AC02-05CH11231 (PChem KC3103). TEM and CL characterization were carried out at the National Center for Electron Microscopy and Molecular Foundry, supported by the U.S. Department of Energy. GIWAXS measurements were carried out at beamline 7.3.3 at the Advanced Light Source, supported by the U.S. Department of Energy. X-ray crystallography was supported by NIH Shared Instrumentation Grant S10-RR027172; data collected and analyzed by A. DiPasquale. Theoretical calculation was supported by the BES/SC, U.S. Department of Energy, under contract no. DE-AC02-05CH11231 through the Material Theory program. CL characterization was supported by a David and Lucile Packard Fellowship for Science and Engineering to N.S.G. C.G.B. acknowledges an NSF Graduate Research Fellowship (DGE 1106400), and N.S.G. acknowledges an Alfred P. Sloan Research Fellowship. S.W.E. thanks the Camille and Henry Dreyfus Foundation for funding, award no. EP-14-151. M. L. thanks the fellowship support from Suzhou Industrial Park. We thank C. Zhu, C. Liu, and D. Zhang for the help with GIWAXS, AFM, and XRD measurements and H. Peng and F. Cui for fruitful discussions.	ABID Y, 1994, J PHYS-CONDENS MAT, V6, P6447, DOI 10.1088/0953-8984/6/32/007; Borriello I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235214; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; CALABRESE J, 1991, J AM CHEM SOC, V113, P2328, DOI 10.1021/ja00006a076; Cunningham G, 2012, ACS NANO, V6, P3468, DOI 10.1021/nn300503e; Dohner ER, 2014, J AM CHEM SOC, V136, P13154, DOI 10.1021/ja507086b; Dou LT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6404; Filip MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6757; Gargas DJ, 2011, NANO LETT, V11, P3792, DOI 10.1021/nl201850k; Gauthron K, 2010, OPT EXPRESS, V18, P5912, DOI 10.1364/OE.18.005912; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Ha ST, 2014, ADV OPT MATER, V2, P838, DOI 10.1002/adom.201400106; Hobbs L. W., 1979, INTRO ANAL ELECT MIC; ISHIHARA T, 1989, SOLID STATE COMMUN, V69, P933, DOI 10.1016/0038-1098(89)90935-6; Kawano N, 2014, J PHYS CHEM C, V118, P9101, DOI 10.1021/jp4114305; Lanty G, 2014, J PHYS CHEM LETT, V5, P3958, DOI 10.1021/jz502086e; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mercier N, 2004, INORG CHEM, V43, P8361, DOI 10.1021/ic048814u; MERESSE A, 1989, ACTA CRYSTALLOGR C, V45, P194, DOI 10.1107/S0108270188003634; Mitzi D. B., 2007, PROG INORG CHEM, V48, P10; MITZI DB, 1995, SCIENCE, V267, P1473, DOI 10.1126/science.267.5203.1473; Mitzi DB, 2001, J CHEM SOC DALTON, P1, DOI 10.1039/b007070j; Niu W, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4874846; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Papavassiliou GC, 1997, PROG SOLID STATE CH, V25, P125, DOI 10.1016/S0079-6786(97)80886-2; Sourisseau S, 2007, CHEM MATER, V19, P600, DOI 10.1021/cm062380e; Takeoka Y, 2006, B CHEM SOC JPN, V79, P1607, DOI 10.1246/bcsj.79.1607; Tanaka K, 2005, JPN J APPL PHYS 1, V44, P5923, DOI 10.1143/JJAP.44.5923; WILLETT R, 1988, J AM CHEM SOC, V110, P8639, DOI 10.1021/ja00234a010; Wu XX, 2015, J AM CHEM SOC, V137, P2089, DOI 10.1021/ja512833n; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050	32	964	986	76	1604	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1518	1521		10.1126/science.aac7660	http://dx.doi.org/10.1126/science.aac7660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404831	Green Published			2022-12-28	WOS:000361707000042
J	Dunham-Snary, KJ; Ballinger, SW				Dunham-Snary, Kimberly J.; Ballinger, Scott W.			Mitochondrial-nuclear DNA mismatch matters	SCIENCE			English	Editorial Material							GENE REPLACEMENT; DISEASE; TRANSMISSION; THERAPY; ETHICS		[Dunham-Snary, Kimberly J.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Ballinger, Scott W.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Ballinger, Scott W.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA	Queens University - Canada; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dunham-Snary, KJ (corresponding author), Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada.	sballing@uab.edu	Dunham-Snary, Kimberly J/O-4702-2018	Dunham-Snary, Kimberly J/0000-0001-9760-342X	NHLBI NIH HHS [R01 HL103859, R01 HL094518] Funding Source: Medline; NIDDK NIH HHS [P30 DK079626] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amato P, 2014, FERTIL STERIL, V101, P31, DOI 10.1016/j.fertnstert.2013.11.030; Baylis F, 2013, REPROD BIOMED ONLINE, V26, P531, DOI 10.1016/j.rbmo.2013.03.006; Betancourt AM, 2014, BIOCHEM J, V461, P223, DOI 10.1042/BJ20131433; Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P669, DOI 10.1093/humupd/dmn035; Chiaratti MR, 2011, MITOCHONDRION, V11, P820, DOI 10.1016/j.mito.2010.11.004; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Deuse T, 2015, CELL STEM CELL, V16, P33, DOI 10.1016/j.stem.2014.11.003; Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029; Poulton J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6651; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; RUBENSTEIN DS, 1995, CAMB Q HEALTHC ETHIC, V4, P316, DOI 10.1017/S0963180100006071; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tavare A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e540; Torroni A, 1997, AM J HUM GENET, V60, P1107	15	24	25	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1449	1450		10.1126/science.aac5271	http://dx.doi.org/10.1126/science.aac5271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26404813	Green Accepted			2022-12-28	WOS:000361707000023
J	Williams, SD				Williams, S. D.			WHAT YOUR PATIENT IS THINKING If you only have a few minutes with a drug addict	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2015	351								h4211	10.1136/bmj.h4211	http://dx.doi.org/10.1136/bmj.h4211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3FL	26399262	Bronze			2022-12-28	WOS:000361957200001
J	Muzerengi, S; Clarke, CE				Muzerengi, Sharon; Clarke, Carl E.			Initial drug treatment in Parkinson's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPULSE CONTROL DISORDERS; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE		[Muzerengi, Sharon; Clarke, Carl E.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Muzerengi, Sharon] Univ Hosp Birmingham Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Clarke, Carl E.] Sandwell & West Birmingham Hosp NHS Trust, Dept Neurol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Muzerengi, S (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	shammuzerengi@yahoo.com		Clarke, Carl/0000-0003-2478-3436				Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; [Anonymous], 2006, PARK DIS DIAGN MAN P; Barone P, 2004, NEUROLOGY, V63, pS35, DOI 10.1212/WNL.63.8_suppl_3.S35; Caslake R, 2009, COCHRANE DB SYST REV, V4; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Dodel R, 2014, MOVEMENT DISORD, V29, P169, DOI 10.1002/mds.25571; Dostal M, 2013, EUR J NEUROL, V20, P1241, DOI 10.1111/ene.12001; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Ferreira JJ, 2013, EUR J NEUROL, V20, P5, DOI 10.1111/j.1468-1331.2012.03866.x; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Haycox A, 2009, DRUG AGING, V26, P791, DOI 10.2165/11316770-000000000-00000; Iskedjian M, 2003, PHARMACOECONOMICS, V21, P115, DOI 10.2165/00019053-200321020-00004; Liu R, 2011, NEUROLOGY, V76, P2002, DOI 10.1212/WNL.0b013e31821e554e; Macleod A, 2005, COCHRANE DB SYST REV, V3; Miyasaki JM, 2002, NEUROLOGY, V58, P11, DOI 10.1212/WNL.58.1.11; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; Noyes K, 2005, PHARMACOECONOMICS, V23, P1257, DOI 10.2165/00019053-200523120-00009; Noyes K, 2004, MED DECIS MAKING, V24, P472, DOI 10.1177/0272989X04268960; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Poewe W, 2011, NEUROLOGY, V77, P759, DOI 10.1212/WNL.0b013e31822affb0; Robottom BJ, 2011, ARCH NEUROL-CHICAGO, V68, P567, DOI 10.1001/archneurol.2011.84; Sethi KD, 1998, ARCH NEUROL-CHICAGO, V55, P1211, DOI 10.1001/archneur.55.9.1211; Stowe R, 2009, COCHRANE DB SYST REV, V2; Watts RL, 2007, NEUROLOGY, V68, P272, DOI 10.1212/01.wnl.0000252355.79284.22; Weintraub D, 2015, MOVEMENT DISORD, V30, P121, DOI 10.1002/mds.26016; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65	27	8	10	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2015	351								h4669	10.1136/bmj.h4669	http://dx.doi.org/10.1136/bmj.h4669			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9ME	26385603				2022-12-28	WOS:000361679100001
J	Brown, RR; Deletic, A; Wong, THF				Brown, Rebekah R.; Deletic, Ana; Wong, Tony H. F.			Interdisciplinarity: How to catalyse collaboration	NATURE			English	Editorial Material							MANAGEMENT		[Brown, Rebekah R.; Deletic, Ana; Wong, Tony H. F.] Monash Univ, Melbourne, Vic 3004, Australia; [Brown, Rebekah R.; Deletic, Ana; Wong, Tony H. F.] Cooperat Res Ctr Water Sensit Cities, Tokyo, Japan; [Brown, Rebekah R.] Monash Sustainabil Inst, Melbourne, Vic, Australia	Monash University	Brown, RR (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	rebekah.brown@monash.edu	Deletic, Ana/CAG-2385-2022	Deletic, Ana/0000-0002-3535-7451; Brown, Rebekah/0000-0002-8689-7562				Australian Public Service Commission (APSC), 2007, TACKL WICK PROBL PUB; Brown RR, 2009, WATER SCI TECHNOL, V59, P847, DOI 10.2166/wst.2009.029; Brown RR, 2013, GLOBAL ENVIRON CHANG, V23, P701, DOI 10.1016/j.gloenvcha.2013.02.013; Deletic A., 2008, WATER, V35, P64; Hansen MT, 2001, HARVARD BUS REV, V79, P106; ICSU [International Council for Science], 2010, EARTH SYST SCI GLOB; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; UN, 2015, 2030 AG SUST DEV; Wong T.F.H., 2013, BLUEPRINT 2013 STORM; Wong THF, 2009, WATER SCI TECHNOL, V60, P673, DOI 10.2166/wst.2009.436	10	136	136	8	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					315	317		10.1038/525315a	http://dx.doi.org/10.1038/525315a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR4JL	26381970	Bronze			2022-12-28	WOS:000361297900019
J	Tanner, M				Tanner, Michael			Review: Type 2 diabetes screening does not reduce mortality, but treating dysglycemia delays onset of diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10016 USA	New York University	Tanner, M (corresponding author), NYU, Sch Med, New York, NY 10016 USA.			Tanner, Michael/0000-0002-3012-8641				[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Centers for Disease Control, 2020, NATL DIABETES STAT R; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427	3	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6							JC2	10.7326/ACPJC-2015-163-6-002	http://dx.doi.org/10.7326/ACPJC-2015-163-6-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26370029				2022-12-28	WOS:000361365900002
J	Zeid, S; Gilmore, K; Khosla, R; Papowitz, H; Engel, D; Dakkak, H; Rahab, N; Sharma, A; Fair, M				Zeid, Sarah; Gilmore, Kate; Khosla, Rajat; Papowitz, Heather; Engel, Danielle; Dakkak, Henia; Rahab, Njoki; Sharma, Anita; Fair, Mollie			Women's, children's, and adolescents' health in humanitarian and other crises	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zeid, Sarah] WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva, Switzerland; [Gilmore, Kate; Engel, Danielle; Dakkak, Henia; Fair, Mollie] United Nations Populat Fund, New York, NY 10158 USA; [Khosla, Rajat] WHO, Dept Reprod Hlth & Res, CH-2211 Geneva, Switzerland; [Papowitz, Heather] Unicef, New York, NY USA; [Rahab, Njoki] United Nations Off Coordinat Humanitarian Affairs, New York, NY USA; [Sharma, Anita] United Nations Fdn, Washington, DC USA	World Health Organization; United Nations Population Fund; World Health Organization; UNICEF	Gilmore, K (corresponding author), United Nations Populat Fund, New York, NY 10158 USA.	gilmore@unfpa.org						Enarsson E., 2005, URBAN DEV DEBATES NE, P25; Hutton D, 2008, OLDER PEOPLE EMERGEN; Inter-Agency Working Group on Reproductive Health in Crises, 2011, INT REPR HLTH KITS C; International Center for Research on Women, CHILD MARR FACTS FIG; Lewis J., 2001, CONTINUUM CONTIGUUM; Meier P, 2011, INT REV RED CROSS, V93, P1239, DOI 10.1017/S1816383112000318; Morof Diane F, 2014, Confl Health, V8, P8, DOI 10.1186/1752-1505-8-8; OCHA, 2013, OV GLOB HUM RESP 201; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Organisation for Economic Cooperation and Development, 2015, STAT FRAG 2015; Peterson K., 1997, NATURAL HAZARDS OBSE, V21, P3; Save the Children, 2014, STAT WORLDS MOTH 201; The Atlas Alliance CBM, DIS CONFL EM; The Partnership for Maternal Newborn and Child Health, PMNCH KNOWL SUMM 32; Unicef, 2014, HUM ACT CHILDR 2014; UNIDSR, 2015, SEND FRAM DIS RISK R; United Nations Development Programme, 2014, UNDP FAST FACTS DIS; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Bank Group, 2014, VIOL WOM GIRLS LESS; World Health Organization, LEV TRENDS CHILD MOR; WRC Save the Children UNHCR UNFPA, 2012, AD SEX REPR HLTH PRO	21	16	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2015	351								h4346					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9LW	26371227	hybrid			2022-12-28	WOS:000361678200015
J	Landschutzer, P; Gruber, N; Haumann, A; Rodenbeck, C; Bakker, DCE; van Heuven, S; Hoppema, M; Metzl, N; Sweeney, C; Takahashi, T; Tilbrook, B; Wanninkhof, R				Landschutzer, Peter; Gruber, Nicolas; Haumann, Alexander; Rodenbeck, Christian; Bakker, Dorothee C. E.; van Heuven, Steven; Hoppema, Mario; Metzl, Nicolas; Sweeney, Colm; Takahashi, Taro; Tilbrook, Bronte; Wanninkhof, Rik			The reinvigoration of the Southern Ocean carbon sink	SCIENCE			English	Article							CO2 FLUX VARIABILITY; ATLANTIC-OCEAN; INVERSION; PCO(2); TRENDS	Several studies have suggested that the carbon sink in the Southern Ocean-the ocean's strongest region for the uptake of anthropogenic CO2-has weakened in recent decades. We demonstrated, on the basis of multidecadal analyses of surface ocean CO2 observations, that this weakening trend stopped around 2002, and by 2012 the Southern Ocean had regained its expected strength based on the growth of atmospheric CO2. All three Southern Ocean sectors have contributed to this reinvigoration of the carbon sink, yet differences in the processes between sectors exist, related to a tendency toward a zonally more asymmetric atmospheric circulation. The large decadal variations in the Southern Ocean carbon sink suggest a rather dynamic ocean carbon cycle that varies more in time than previously recognized.	[Landschutzer, Peter; Gruber, Nicolas; Haumann, Alexander] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys, Zurich, Switzerland; [Gruber, Nicolas; Haumann, Alexander] ETH, C2SM, Zurich, Switzerland; [Rodenbeck, Christian] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Bakker, Dorothee C. E.] Univ E Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England; [van Heuven, Steven; Hoppema, Mario] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Metzl, Nicolas] Univ Paris 06, Sorbonne Univ, CNRS, IRD,MNHN,LOCEAN,IPSL Lab, F-75005 Paris, France; [Sweeney, Colm] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Sweeney, Colm] NOAA, Earth Syst Res Lab, Boulder, CO USA; [Takahashi, Taro] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Tilbrook, Bronte] CSIRO, Hobart, Tas, Australia; [Tilbrook, Bronte] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Wanninkhof, Rik] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; University of East Anglia; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; Columbia University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Landschutzer, P (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys, Zurich, Switzerland.	peter.landschuetzer@usys.ethz.ch	Sweeney, Colm/AAE-9291-2019; Hoppema, Mario/I-6286-2013; Tilbrook, Bronte/W-4007-2019; Haumann, Alexander/J-6679-2014; Bakker, Dorothee C E/E-4951-2015; Gruber, Nicolas/B-7013-2009; Tilbrook, Bronte/A-1522-2012	Hoppema, Mario/0000-0002-2326-619X; Tilbrook, Bronte/0000-0001-9385-3827; Haumann, Alexander/0000-0002-8218-977X; Bakker, Dorothee C E/0000-0001-9234-5337; Gruber, Nicolas/0000-0002-2085-2310; Tilbrook, Bronte/0000-0001-9385-3827; Sweeney, Colm/0000-0002-4517-0797; Landschutzer, Peter/0000-0002-7398-3293; metzl, nicolas/0000-0002-1165-1074	European Union (EU) from the European Commission's Seventh Framework Programme [264879, 283080]; ETH [CH2-01 11-1]; Climate Observation Division of NOAA; NOAA [NA10OAR4320143]; U.S. National Science Foundation's Office of Polar Programs [AOAS 0944761, AOAS 0636975]; Antarctic Climate and Ecosystems CRC; Australian Climate Change Science Program; Integrated Marine Observing System; Institut National des Sciences de l'Univers/Centre National de la Recherche Scientifique; Institut Polaire Francaise for the Ocean Indien Service d'Observation cruises; Office of Polar Programs (OPP) [1341647] Funding Source: National Science Foundation	European Union (EU) from the European Commission's Seventh Framework Programme; ETH(ETH Zurich); Climate Observation Division of NOAA; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. National Science Foundation's Office of Polar Programs(National Science Foundation (NSF)); Antarctic Climate and Ecosystems CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Climate Change Science Program; Integrated Marine Observing System; Institut National des Sciences de l'Univers/Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Polaire Francaise for the Ocean Indien Service d'Observation cruises; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by European Union (EU) grant 264879 (CARBOCHANGE) (P.L., N.G., D.C.E.B., M.H., S.v.H., and N.M.) and EU grant 283080 (GEO-CARBON) (P.L. and N.G.), both of which received funding from the European Commission's Seventh Framework Programme. F.A.H. was supportetd by ETH research grant CH2-01 11-1. T.T., R.W., and C.S. acknowledge funding for the pCO<INF>2</INF> from ship projects from the Climate Observation Division of NOAA. T.T. and the Ship of Opportunity Observation Program were supported by a grant (NA10OAR4320143) from NOAA. C.S.'s contribution to this research was made possible by support from the U.S. National Science Foundation's Office of Polar Programs (grants AOAS 0944761 and AOAS 0636975). B.T. was funded through the Antarctic Climate and Ecosystems CRC, the Australian Climate Change Science Program, and the Integrated Marine Observing System. N.M. is grateful for support from the Institut National des Sciences de l'Univers/Centre National de la Recherche Scientifique and the Institut Polaire Francaise for the Ocean Indien Service d'Observation cruises. C.R. thanks the providers of atmospheric CO<INF>2</INF> measurements and the Deutsches Klimarechenzentrum computing center for their support. SOCAT is an international effort, supported by the International Ocean Carbon Coordination Project, the Surface Ocean Lower Atmosphere Study, and the Integrated Marine Biogeochemistry and Ecosystem Research program, to deliver a uniformly quality-controlled surface ocean CO<INF>2</INF> database. The many researchers and funding agencies responsible for the collection of data and quality control are thanked for their contributions to SOCAT. We also thank A. Hogg for fruitful discussions. The surface ocean CO<INF>2</INF> observations are available from the SOCAT website (www.socat.info). The sea surface pCO<INF>2</INF> and air-sea CO<INF>2</INF> flux data leading conclusions of this manuscript are available to the public via the Carbon Dioxide Information Analysis Center (http://cdiac.ornl.gov/oceans/SPCO2_1982_2011_ETH_SOM_FFN.html). The mixed-layer scheme and inversion data supporting the main findings can be obtained from www.bgc-jena.mpg.de/similar to christian.roedenbeck/download-CO<INF>2</INF>-ocean/ and www.bgc-jena.mpg.de/similar to christian.roedenbeck/download-CO2/. P.L. and N.G. designed the study and wrote the paper together with F.A.H. P.L. developed the neural network estimation and performed the majority of the analyses, assisted by F.A.H. C.R. developed the mixed-layer scheme and the atmospheric inversion. S.v.H., M.H., N.M., C.S., T.T., B.T., and R.W. were responsible for the collection of the majority of the surface ocean CO<INF>2</INF> data in the Southern Ocean. D.C.E.B. led the SOCAT synthesis effort that underlies this work. All authors discussed the results and implications and commented on the manuscript at all stages.	Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Carril AF, 2001, GEOPHYS RES LETT, V28, P4623, DOI 10.1029/2001GL013804; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Fay AR, 2014, GEOPHYS RES LETT, V41, P6833, DOI 10.1002/2014GL061324; Fletcher SEM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002530; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Graven HD, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008074; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Haumann FA, 2014, GEOPHYS RES LETT, V41, P8429, DOI 10.1002/2014GL061659; Jacobs SS, 2010, J CLIMATE, V23, P4508, DOI 10.1175/2010JCLI3284.1; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Landschutzer P, 2013, BIOGEOSCIENCES, V10, P7793, DOI 10.5194/bg-10-7793-2013; Landschutzer P., 2015, 30 YEARS OBSERVATION; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lenton A, 2013, BIOGEOSCIENCES, V10, P4037, DOI 10.5194/bg-10-4037-2013; Li XC, 2014, NATURE, V505, P538, DOI 10.1038/nature12945; Lovenduski NS, 2015, GLOBAL BIOGEOCHEM CY, V29, P416, DOI 10.1002/2014GB004933; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; Majkut JD, 2014, GLOBAL BIOGEOCHEM CY, V28, P335, DOI 10.1002/2013GB004585; Metzl N, 2009, DEEP-SEA RES PT II, V56, P607, DOI 10.1016/j.dsr2.2008.12.007; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Rodenbeck C, 2014, BIOGEOSCIENCES, V11, P4599, DOI 10.5194/bg-11-4599-2014; Rodenbeck C, 2013, OCEAN SCI, V9, P193, DOI 10.5194/os-9-193-2013; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Takahashi T, 2012, OCEANOGRAPHY, V25, P26, DOI 10.5670/oceanog.2012.71; Xue L, 2015, GEOPHYS RES LETT, V42, P3973, DOI 10.1002/2015GL063926	29	254	257	21	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2015	349	6253					1221	1224		10.1126/science.aab2620	http://dx.doi.org/10.1126/science.aab2620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9XH	26359401	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000360968400042
J	Garfall, AL; Maus, MV; Hwang, WT; Lacey, SF; Mahnke, YD; Melenhorst, JJ; Zheng, ZH; Vogl, DT; Cohen, AD; Weiss, BM; Dengel, K; Kerr, NDS; Bagg, A; Levine, BL; June, CH; Stadtmauer, EA				Garfall, Alfred L.; Maus, Marcela V.; Hwang, Wei-Ting; Lacey, Simon F.; Mahnke, Yolanda D.; Melenhorst, J. Joseph; Zheng, Zhaohui; Vogl, Dan T.; Cohen, Adam D.; Weiss, Brendan M.; Dengel, Karen; Kerr, Naseem D. S.; Bagg, Adam; Levine, Bruce L.; June, Carl H.; Stadtmauer, Edward A.			Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMA-CELLS; B-CELLS; BONE-MARROW; CHEMOTHERAPY; PLASTICITY; PHENOTYPE; LEUKEMIA	A patient with refractory multiple myeloma received an infusion of CTL019 cells, a cellular therapy consisting of autologous T cells transduced with an anti-CD19 chimeric antigen receptor, after myeloablative chemotherapy (melphalan, 140 mg per square meter of body-surface area) and autologous stem-cell transplantation. Four years earlier, autologous transplantation with a higher melphalan dose (200 mg per square meter) had induced only a partial, transient response. Autologous transplantation followed by treatment with CTL019 cells led to a complete response with no evidence of progression and no measurable serum or urine monoclonal protein at the most recent evaluation, 12 months after treatment. This response was achieved despite the absence of CD19 expression in 99.95% of the patient's neoplastic plasma cells. (Funded by Novartis and others; ClinicalTrials.gov number, NCT02135406.)	[Garfall, Alfred L.; Maus, Marcela V.; Vogl, Dan T.; Cohen, Adam D.; Weiss, Brendan M.; Stadtmauer, Edward A.] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Hwang, Wei-Ting] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Lacey, Simon F.; Mahnke, Yolanda D.; Melenhorst, J. Joseph; Zheng, Zhaohui; Bagg, Adam; Levine, Bruce L.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Garfall, Alfred L.; Maus, Marcela V.; Hwang, Wei-Ting; Lacey, Simon F.; Mahnke, Yolanda D.; Melenhorst, J. Joseph; Zheng, Zhaohui; Vogl, Dan T.; Cohen, Adam D.; Weiss, Brendan M.; Dengel, Karen; Kerr, Naseem D. S.; Bagg, Adam; Levine, Bruce L.; June, Carl H.; Stadtmauer, Edward A.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	June, CH (corresponding author), Univ Penn, 3400 Civic Ctr Blvd,Bldg 421,8th Fl,Rm 123, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu	Bagg, Adam/R-8450-2019; Melenhorst, Jan/AAW-2546-2020	Melenhorst, Jan/0000-0001-7677-537X; Maus, Marcela/0000-0002-7578-0393; Cohen, Adam/0000-0003-0939-3843; Mahnke, Yolanda/0000-0002-2727-9887; Garfall, Alfred/0000-0003-2791-5748	Novartis; NATIONAL CANCER INSTITUTE [R01CA165206, K12CA076931, R01CA120409, T32CA009615, P30CA016520, K08CA166039] Funding Source: NIH RePORTER	Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Novartis and others; ClinicalTrials.gov number, NCT02135406.	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gunderson AJ, 2013, EXP CELL RES, V319, P1644, DOI 10.1016/j.yexcr.2013.03.005; Hajek R, 2013, BRIT J HAEMATOL, V163, P551, DOI 10.1111/bjh.12563; Hideshima T, 2010, BLOOD, V115, P3772, DOI 10.1182/blood-2010-02-270082; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rapoport AP, 2009, CLIN CANCER RES, V15, P4499, DOI 10.1158/1078-0432.CCR-09-0418; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Stadtmauer EA, 2011, BLOOD, V117, P63, DOI 10.1182/blood-2010-07-296822; Tembhare PR, 2014, LEUKEMIA RES, V38, P371, DOI 10.1016/j.leukres.2013.12.007; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523	19	401	432	4	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1040	1047		10.1056/NEJMoa1504542	http://dx.doi.org/10.1056/NEJMoa1504542			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26352815	Green Accepted, Bronze			2022-12-28	WOS:000360959000009
J	Horton, R				Horton, Richard			Offline: Medicine's precarious place in the history of humanity	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					840	840		10.1016/S0140-6736(15)00003-3	http://dx.doi.org/10.1016/S0140-6736(15)00003-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26369316				2022-12-28	WOS:000360290000009
J	Eisenstein, M				Eisenstein, Michael			Showdown at the cannabis corral	NATURE			English	Editorial Material							CONTROLLED-TRIAL; MARIJUANA USE											Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Bechtold J., 2015, PSYCHOL ADDICT BEHAV; Hasin DS, 2015, LANCET PSYCHIAT, V2, P601, DOI 10.1016/S2215-0366(15)00217-5; Hazekamp A, 2013, EUR J CLIN PHARMACOL, V69, P1575, DOI 10.1007/s00228-013-1503-y; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Naftali T, 2013, CLIN GASTROENTEROL H, V11, P1276, DOI 10.1016/j.cgh.2013.04.034; Press CA, 2015, EPILEPSY BEHAV, V45, P49, DOI 10.1016/j.yebeh.2015.02.043; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Ware MA, 2010, CAN MED ASSOC J, V182, DOI [DOI 10.1503/cmaj.091414, 10.1503/cmaj.091414]; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358	10	12	12	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					S15	S17		10.1038/525S15a	http://dx.doi.org/10.1038/525S15a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26443869	Bronze			2022-12-28	WOS:000361599900007
J	Shen, H				Shen, Helen			Japan to upgrade biolab security	NATURE			English	News Item																			0	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					274	275		10.1038/nature.2015.18179	http://dx.doi.org/10.1038/nature.2015.18179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26289185	Bronze			2022-12-28	WOS:000359714000005
